PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lindvall, O				Lindvall, Olle			Why Is It Taking So Long to Develop Clinically Competitive Stem Cell Therapies for CNS Disorders?	CELL STEM CELL			English	Editorial Material							PARKINSONS-DISEASE; DOPAMINE NEURONS; TRANSPLANTATION	The remarkable advancements in basic stem cell research with implications for several central nervous system disorders have so far not been translated into clinically effective therapies. Here I discuss some of the underlying problems and how they could be overcome.	Univ Lund Hosp, Lund Stem Cell Ctr, SE-22184 Lund, Sweden	Lund University; Skane University Hospital	Lindvall, O (corresponding author), Univ Lund Hosp, Lund Stem Cell Ctr, SE-22184 Lund, Sweden.	olle.lindvall@med.lu.se		Barker, Roger Alistair/0000-0001-8843-7730; Isacson, Ole/0000-0001-8091-8302	Medical Research Council [G0800784B] Funding Source: researchfish; MRC [G0800784] Funding Source: UKRI; Medical Research Council [G0800784] Funding Source: Medline; NINDS NIH HHS [P01 NS057778, P50 NS039793] Funding Source: Medline; Wellcome Trust [079249] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome Trust)		BACKLUND EO, 1985, J NEUROSURG, V62, P169, DOI 10.3171/jns.1985.62.2.0169; Cicchetti F, 2009, P NATL ACAD SCI USA, V106, P12483, DOI 10.1073/pnas.0904239106; Erdo F, 2003, J CEREBR BLOOD F MET, V23, P780, DOI 10.1097/01.WCB.0000071886.63724.FB; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lindvall O, 2012, CELL STEM CELL, V10, P660, DOI [10.1016/j.stem.2012.04.004, 10.1016/j.stem.2012.01.009]; Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543; Piccini P, 2005, BRAIN, V128, P2977, DOI 10.1093/brain/awh649	9	83	86	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 14	2012	10	6					660	662		10.1016/j.stem.2012.04.004	http://dx.doi.org/10.1016/j.stem.2012.04.004			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	965LD	22704504	Bronze			2022-12-28	WOS:000305768400010
J	Braun, CJ; Hemann, MT				Braun, Christian J.; Hemann, Michael T.			Unraveling Tumor Suppressor Networks with In Vivo RNAi	CELL STEM CELL			English	Editorial Material							IDENTIFICATION; REGULATORS; GLIOMA; SCREEN; MODEL	BMI1 is a known oncogenic transcriptional repressor in glioblastoma stem-like cells, but its downstream mediators are poorly understood. Recently, in Cancer Cell, Gargiulo et al. (2013) designed a rational in vivo RNAi screen based on BMI1 ChIP-seq from neural progenitors and identified functional tumor suppressor targets, including Atf3 and Cbx7.	[Braun, Christian J.; Hemann, Michael T.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Hemann, MT (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	hemann@mit.edu	Braun, Christian J/N-3755-2018	Braun, Christian J/0000-0003-1704-6219				Abdouh M, 2009, J NEUROSCI, V29, P8884, DOI 10.1523/JNEUROSCI.0968-09.2009; Bric A, 2009, CANCER CELL, V16, P324, DOI 10.1016/j.ccr.2009.08.015; Bruggeman SWM, 2007, CANCER CELL, V12, P328, DOI 10.1016/j.ccr.2007.08.032; Gargiulo G, 2013, CANCER CELL, V23, P660, DOI 10.1016/j.ccr.2013.03.030; Mattison J, 2009, BBA-REV CANCER, V1796, P140, DOI 10.1016/j.bbcan.2009.03.001; Meacham CE, 2009, NAT GENET, V41, P1133, DOI 10.1038/ng.451; Pietersen AM, 2008, CURR OPIN CELL BIOL, V20, P201, DOI 10.1016/j.ceb.2008.01.004; Uren AG, 2005, ONCOGENE, V24, P7656, DOI 10.1038/sj.onc.1209043; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9	9	3	3	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 6	2013	12	6					639	641		10.1016/j.stem.2013.05.020	http://dx.doi.org/10.1016/j.stem.2013.05.020			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VH	23746971	Bronze, Green Published			2022-12-28	WOS:000329569900005
J	Myant, KB; Cammareri, P; McGhee, EJ; Ridgway, RA; Huels, DJ; Cordero, JB; Schwitalla, S; Kalna, G; Ogg, EL; Athineos, D; Timpson, P; Vidal, M; Murray, GI; Greten, FR; Anderson, KI; Sansom, OJ				Myant, Kevin B.; Cammareri, Patrizia; McGhee, Ewan J.; Ridgway, Rachel A.; Huels, David J.; Cordero, Julia B.; Schwitalla, Sarah; Kalna, Gabriela; Ogg, Erinn-Lee; Athineos, Dimitris; Timpson, Paul; Vidal, Marcos; Murray, Graeme I.; Greten, Florian R.; Anderson, Kurt I.; Sansom, Owen J.			ROS Production and NF-kappa B Activation Triggered by RAC1 Facilitate WNT-Driven Intestinal Stem Cell Proliferation and Colorectal Cancer Initiation	CELL STEM CELL			English	Article							BETA-CATENIN; MOUSE MODEL; TUMOR PROGRESSION; GENE-EXPRESSION; APC DEFICIENCY; IN-VIVO; COLON; TUMORIGENESIS; MUTATIONS; PROTEIN	The Adenomatous Polyposis Coli (APC) gene is mutated in the majority of colorectal cancers (CRCs). Loss of APC leads to constitutively active WNT signaling, hyperproliferation, and tumorigenesis. Identification of pathways that facilitate tumorigenesis after APC loss is important for therapeutic development. Here, we show that RAC1 is a critical mediator of tumorigenesis after APC loss. We find that RAC1 is required for expansion of the LGR5 intestinal stem cell (ISC) signature, progenitor hyperproliferation, and transformation. Mechanistically, RAC1-driven ROS and NF-kappa B signaling mediate these processes. Together, these data highlight that ROS production and NF-kappa B activation triggered by RAC1 are critical events in CRC initiation.	[Myant, Kevin B.; Cammareri, Patrizia; McGhee, Ewan J.; Ridgway, Rachel A.; Huels, David J.; Cordero, Julia B.; Kalna, Gabriela; Ogg, Erinn-Lee; Athineos, Dimitris; Timpson, Paul; Vidal, Marcos; Anderson, Kurt I.; Sansom, Owen J.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Schwitalla, Sarah; Greten, Florian R.] Tech Univ Munich, Klinikum Rechts Isar, Inst Mol Immunol, D-81675 Munich, Germany; [Murray, Graeme I.] Univ Aberdeen, Sch Med & Dent, Div Appl Med, Dept Pathol, Aberdeen AB25 2ZD, Scotland	Beatson Institute; Technical University of Munich; University of Aberdeen	Sansom, OJ (corresponding author), Beatson Inst Canc Res, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	o.sansom@beatson.gla.ac.uk	Timpson, Paul/A-9429-2016; Greten, Florian R/AAF-5196-2020; Sch/AAA-9548-2021	Greten, Florian R/0000-0002-3928-6080; Cammareri, Patrizia/0000-0002-5888-6903; Cordero, Julia/0000-0003-1701-9480; Athineos, Dimitris/0000-0001-5298-7941; Sansom, Owen J./0000-0001-9540-3010; Huels, David/0000-0001-6154-1183; Anderson, Kurt/0000-0002-9324-9598; Timpson, Paul/0000-0002-5514-7080; myant, kevin/0000-0001-8017-1093	Cancer Research UK; AICR grant; European Union [278568]; Cancer Research UK [12481, 15565] Funding Source: researchfish; National Centre for the Replacement [G1000078/1] Funding Source: researchfish; Worldwide Cancer Research [10-0643] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); AICR grant; European Union(European Commission); Cancer Research UK(Cancer Research UK); National Centre for the Replacement; Worldwide Cancer Research	All authors are supported by Cancer Research UK. K.B.M. is funded by an AICR grant. The research leading to these results has received funding from the European Union Seventh Framework Programme FP7/2007-2013 under grant agreement number 278568. Thanks to histology, microscopy, and the BSU for enabling this work to be performed and Florian Greten for discussions. We thank Victor Tybulewicz for Rac1 flox and Ian Tomlinson for Apc<SUP>1322T/+</SUP> mice. The ROSA-tdRFP mice were imported from the EMMA repository (strain 02112) and were a kind gift from Hans Jorg Fehling. We thank David Tuveson and Tim Humpton for help with ROS staining. We thank Bryan Miller for help preparing the manuscript. O.J.S., K.B.M., and F.R.G. conceived and designed the project. K.B.M., P.C., E.J.M., R.A.R., D.J.H., S.S., G.K., E.-L.O., D.A., and P.T. performed the experiments and analyzed the data. K.B.M., O.J.S., P.C., D.J.H., E.J.M., and K.I.A.interpreted the data. O.J.S, K.B.M., P.C., and R.A.R. wrote the manuscript.	Athineos D, 2010, ONCOGENE, V29, P2585, DOI 10.1038/onc.2010.5; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; BROMBERG Y, 1994, J BIOL CHEM, V269, P7055; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Cole AM, 2010, CANCER RES, V70, P8149, DOI 10.1158/0008-5472.CAN-10-0315; de Sousa e Melo F, 2011, CELL STEM CELL, V9, P476, DOI 10.1016/j.stem.2011.10.008; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Duncan R, 2008, BRIT J CANCER, V98, P426, DOI 10.1038/sj.bjc.6604128; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Ellenbroek SIJ, 2007, CLIN EXP METASTAS, V24, P657, DOI 10.1007/s10585-007-9119-1; Espina C, 2008, AM J PATHOL, V172, P156, DOI 10.2353/ajpath.2008.070561; Fujishita T, 2008, P NATL ACAD SCI USA, V105, P13544, DOI 10.1073/pnas.0800041105; Gold DL, 2007, BRIEF BIOINFORM, V8, P71, DOI 10.1093/bib/bbl019; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Heid I, 2011, GASTROENTEROLOGY, V141, P719, DOI 10.1053/j.gastro.2011.04.043; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hung KE, 2010, P NATL ACAD SCI USA, V107, P1565, DOI 10.1073/pnas.0908682107; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kissil JL, 2007, CANCER RES, V67, P8089, DOI 10.1158/0008-5472.CAN-07-2300; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Li A, 2012, J INVEST DERMATOL, V132, P2610, DOI 10.1038/jid.2012.186; Lindsay CR, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1560; Liu KC, 2013, CELL STEM CELL, V12, P304, DOI 10.1016/j.stem.2013.01.007; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Mitsushita J, 2004, CANCER RES, V64, P3580, DOI 10.1158/0008-5472.CAN-03-3909; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Musteanu M, 2010, GASTROENTEROLOGY, V138, P1003, DOI 10.1053/j.gastro.2009.11.049; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; O'Dwyer D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027718; Obrador-Hevia A, 2010, J PATHOL, V221, P57, DOI 10.1002/path.2685; Phelps RA, 2009, CELL, V137, P623, DOI 10.1016/j.cell.2009.02.037; Phesse TJ, 2008, MOL CELL BIOL, V28, P6094, DOI 10.1128/MCB.00539-08; Pollard P, 2009, GASTROENTEROLOGY, V136, P2204, DOI 10.1053/j.gastro.2009.02.058; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Saci A, 2011, MOL CELL, V42, P50, DOI 10.1016/j.molcel.2011.03.017; Samuel MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017143; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Segditsas S, 2008, HUM MOL GENET, V17, P3864, DOI 10.1093/hmg/ddn286; Simon AR, 2000, SCIENCE, V290, P144, DOI 10.1126/science.290.5489.144; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; Walmsley MJ, 2003, SCIENCE, V302, P459, DOI 10.1126/science.1089709; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Zeilstra J, 2008, CANCER RES, V68, P3655, DOI 10.1158/0008-5472.CAN-07-2940; Zhou C, 2013, ONCOGENE, V32, P903, DOI 10.1038/onc.2012.99	62	274	285	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 6	2013	12	6					761	773		10.1016/j.stem.2013.04.006	http://dx.doi.org/10.1016/j.stem.2013.04.006			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VH	23665120	Green Published, hybrid			2022-12-28	WOS:000329569900018
J	Hanoun, M; Frenette, PS				Hanoun, Maher; Frenette, Paul S.			This Niche Is a Maze; An Amazing Niche	CELL STEM CELL			English	Editorial Material							HEMATOPOIETIC STEM-CELLS	The cellular identity of niche cells that regulate hematopoietic stem cell (HSC) self-renewal and differentiation has been debated for several years. Two recent studies in Nature (Ding and Morrison, 2013; Greenbaum et al., 2013) have shed light into the bone marrow stromal subsets making CXCL12, a chemokine critical for HSC maintenance.	[Hanoun, Maher; Frenette, Paul S.] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10461 USA; [Hanoun, Maher; Frenette, Paul S.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Frenette, Paul S.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Frenette, PS (corresponding author), Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10461 USA.	paul.frenette@einstein.yu.edu	Frenette, Paul S/J-8272-2012	Frenette, Paul S/0000-0003-0862-9922	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097819, R01HL116340, R01HL069438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056638] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL069438, R01 HL116340, R01 HL097819] Funding Source: Medline; NIDDK NIH HHS [R01 DK056638] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mercier FE, 2012, NAT REV IMMUNOL, V12, P49, DOI 10.1038/nri3132; Morikawa S, 2009, BIOCHEM BIOPH RES CO, V379, P1114, DOI 10.1016/j.bbrc.2009.01.031; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Sugiyama Tatsuki, 2012, Inflammation & Allergy Drug Targets, V11, P201; Tzeng YS, 2011, BLOOD, V117, P429, DOI 10.1182/blood-2010-01-266833	9	36	37	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 4	2013	12	4					391	392		10.1016/j.stem.2013.03.012	http://dx.doi.org/10.1016/j.stem.2013.03.012			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VD	23561440	Green Accepted, Bronze			2022-12-28	WOS:000329569500005
J	Liu, KC; Jiang, M; Lu, Y; Chen, H; Sun, J; Wu, SP; Ku, WY; Nakagawa, H; Kita, Y; Natsugoe, S; Peters, JH; Rustgi, AK; Onaitis, MW; Kiernan, A; Chen, XX; Que, JW				Liu, Kuancan; Jiang, Ming; Lu, Yun; Chen, Hao; Sun, Jun; Wu, Shaoping; Ku, Wei-Yao; Nakagawa, Hiroshi; Kita, Yoshiaki; Natsugoe, Shoji; Peters, Jeffrey H.; Rustgi, Anil K.; Onaitis, Mark W.; Kiernan, Amy; Chen, Xiaoxin; Que, Jianwen			Sox2 Cooperates with Inflammation-Mediated Stat3 Activation in the Malignant Transformation of Foregut Basal Progenitor Cells	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; IN-VITRO; ESOPHAGEAL EPITHELIUM; ANTERIOR FOREGUT; MOUSE TRACHEA; CANCER; REFLUX; TUMOR; DIFFERENTIATION; PROLIFERATION	Sox2 regulates the self-renewal of multiple types of stem cells. Recent studies suggest it also plays oncogenic roles in the formation of squamous carcinoma in several organs, including the esophagus where Sox2 is predominantly expressed in the basal progenitor cells of the stratified epithelium. Here, we use mouse genetic models to reveal a mechanism by which Sox2 cooperates with microenvironmental signals to malignantly transform epithelial progenitor cells. Conditional overexpression of Sox2 in basal cells expands the progenitor population in both the esophagus and forestomach. Significantly, carcinoma only develops in the forestomach, where pathological progression correlates with inflammation and nuclear localization of Stat3 in progenitor cells. Importantly, co-overexpression of Sox2 and activated Stat3 (Stat3C) also transforms esophageal basal cells but not the differentiated suprabasal cells. These findings indicate that basal stem/progenitor cells are the cells of origin of squamous carcinoma and that cooperation between Sox2 and microenvironment-activated Stat3 is required for Sox2-driven tumorigenesis.	[Liu, Kuancan; Jiang, Ming; Ku, Wei-Yao; Que, Jianwen] Univ Rochester, Dept Biomed Genet, Rochester, NY 14642 USA; [Que, Jianwen] Univ Rochester, Stem Cell & Regenerat Med Inst, Rochester, NY 14642 USA; [Peters, Jeffrey H.] Univ Rochester, Dept Surg, Rochester, NY 14642 USA; [Kiernan, Amy] Univ Rochester, Dept Ophthalmol, Rochester, NY 14642 USA; [Chen, Hao; Chen, Xiaoxin] N Carolina Cent Univ, Julius L Chambers Biomed Biotechnol Res Inst, Durham, NC 27707 USA; [Onaitis, Mark W.] Duke Univ, Dept Surg, Durham, NC 27710 USA; [Sun, Jun; Wu, Shaoping] Rush Univ, Med Ctr, Dept Biochem, Chicago, IL 60612 USA; [Rustgi, Anil K.] Univ Penn, Sch Med, Abramson Canc Ctr, Div Dept Med, Philadelphia, PA 19104 USA; [Rustgi, Anil K.] Univ Penn, Sch Med, Abramson Canc Ctr, Div Dept Genet, Philadelphia, PA 19104 USA; [Lu, Yun] Tsinghua Univ, Dept Environm Sci & Engn, Beijing 100084, Peoples R China; [Kita, Yoshiaki; Natsugoe, Shoji] Kagoshima Univ, Dept Digest Surg, Kagoshima 8908520, Japan	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of North Carolina; North Carolina Central University; Duke University; Rush University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Tsinghua University; Kagoshima University	Que, JW (corresponding author), Univ Rochester, Dept Biomed Genet, 601 Elmwood Ave, Rochester, NY 14642 USA.	jianwen_que@urmc.rochester.edu	Sun, Jun/S-7440-2019; liu, kuancan/AAE-4400-2020	Sun, Jun/0000-0001-7465-3133; liu, kuancan/0000-0002-2470-7479	NIDDK [K99/R00 DK082650]; NCI [U54 CA156735, P01-CA098101, U01-CA143056]; American Cancer Society; NATIONAL CANCER INSTITUTE [U01CA143056, U54CA156735, P01CA098101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK082650, R00DK082650] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was initiated in Dr. Brigid Hogan's laboratory at the Department of Cell Biology, Duke University. We are grateful to Dr. Brigid Hogan and Dr. Mark Noble, Dr. Hartmut Land, Dr. Craig Jordan, and Dr. Dirk Bohmann at the Department of Biomedical Genetics in the University of Rochester for helpful discussion and critical reading of the manuscript. We also wish to thank Ian Jacobs and other members of the Que laboratory for discussion and technical assistance. This work was supported by the following grants: NIDDK K99/R00 DK082650 (J.Q.), NCI U54 CA156735 (X. C.), NCI P01-CA098101 (and its Molecular Pathology/Imaging and Molecular Biology Core Facilities, A. R.), NCI U01-CA143056 (A. R.), and American Cancer Society (A.R.).	Andl CD, 2003, J BIOL CHEM, V278, P1824, DOI 10.1074/jbc.M209148200; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bazzoli E, 2012, CELL STEM CELL, V11, P836, DOI 10.1016/j.stem.2012.09.012; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Chan KS, 2008, ONCOGENE, V27, P1087, DOI 10.1038/sj.onc.1210726; Chen KH, 2007, ANTICANCER RES, V27, P175; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Corcoran RB, 2011, CANCER RES, V71, P5020, DOI 10.1158/0008-5472.CAN-11-0908; Doupe DP, 2012, SCIENCE, V337, P1091, DOI 10.1126/science.1218835; Freier K, 2010, GENE CHROMOSOME CANC, V49, P9, DOI 10.1002/gcc.20714; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Gen Y., 2010, CANCER GENET CYTOGEN, V202, P82; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hao J, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-59; Iwamaru A, 2007, ONCOGENE, V26, P2435, DOI 10.1038/sj.onc.1210031; Jacobs IJ, 2012, DEV BIOL, V369, P54, DOI 10.1016/j.ydbio.2012.06.016; Jovov B, 2011, AM J GASTROENTEROL, V106, P1039, DOI 10.1038/ajg.2011.102; Kalabis J, 2008, J CLIN INVEST, V118, P3860, DOI 10.1172/JCI35012; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Lu Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011022; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; McMurray HR, 2008, NATURE, V453, P1112, DOI 10.1038/nature06973; Okawa T, 2007, GENE DEV, V21, P2788, DOI 10.1101/gad.1544507; Okumura T, 2003, ONCOGENE, V22, P4017, DOI 10.1038/sj.onc.1206525; Pandeya N, 2010, GUT, V59, P31, DOI 10.1136/gut.2009.190827; Quante M, 2012, CANCER CELL, V21, P36, DOI 10.1016/j.ccr.2011.12.004; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; Que JW, 2009, DEVELOPMENT, V136, P1899, DOI 10.1242/dev.034629; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Seery JP, 2000, CURR BIOL, V10, P1447, DOI 10.1016/S0960-9822(00)00803-4; Souza RF, 2010, BIOCHEM SOC T, V38, P348, DOI 10.1042/BST0380348; Stairs DB, 2011, CANCER CELL, V19, P470, DOI 10.1016/j.ccr.2011.02.007; Taccioli C, 2012, ONCOGENE, V31, P4550, DOI 10.1038/onc.2011.592; Tompkins DH, 2011, AM J RESP CELL MOL, V45, P101, DOI 10.1165/rcmb.2010-0149OC; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011; Uno K, 2011, AM J GASTROENTEROL, V106, P1923, DOI 10.1038/ajg.2011.282; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Wang X, 2011, CELL, V145, P1023, DOI 10.1016/j.cell.2011.05.026	45	136	139	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 7	2013	12	3					304	315		10.1016/j.stem.2013.01.007	http://dx.doi.org/10.1016/j.stem.2013.01.007			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VC	23472872	Green Accepted, Bronze			2022-12-28	WOS:000329569400009
J	Takubo, K; Nagamatsu, G; Kobayashi, CI; Nakamura-Ishizu, A; Kobayashi, H; Ikeda, E; Goda, N; Rahimi, Y; Johnson, RS; Soga, T; Hirao, A; Suematsu, M; Suda, T				Takubo, Keiyo; Nagamatsu, Go; Kobayashi, Chiharu I.; Nakamura-Ishizu, Ayako; Kobayashi, Hiroshi; Ikeda, Eiji; Goda, Nobuhito; Rahimi, Yasmeen; Johnson, Randall S.; Soga, Tomoyoshi; Hirao, Atsushi; Suematsu, Makoto; Suda, Toshio			Regulation of Glycolysis by Pdk Functions as a Metabolic Checkpoint for Cell Cycle Quiescence in Hematopoietic Stem Cells	CELL STEM CELL			English	Article							BONE-MARROW; INHIBITOR; KINASE; CANCER; ACETYLPHOSPHINATE; RESPIRATION; HOMEOSTASIS; ACTIVATION; ADAPTATION; DISTINCT	Defining the metabolic programs that underlie stem cell maintenance will be essential for developing strategies to manipulate stem cell capacity. Mammalian hematopoietic stem cells (HSCs) maintain cell cycle quiescence in a hypoxic microenvironrnent. It has been proposed that HSCs exhibit a distinct metabolic phenotype under these conditions. Here we directly investigated this idea using metabolomic analysis and found that HSCs generate adenosine-5'-triphosphate by anaerobic glycolysis through a pyruvate dehydrogenase kinase (Pdk)-dependent mechanism. Elevated Pdk expression leads to active suppression of the influx of glycolytic metabolites into mitochondria. Pdk overexpression in glycolysis-defective HSCs restored glycolysis, cell cycle quiescence, and stem cell capacity, while loss of both Pdk2 and Pdk4 attenuated HSC quiescence, glycolysis, and transplantation capacity. Moreover, treatment of HSCs with a Pdk mimetic promoted their survival and transplantation capacity. Thus, glycolytic metabolic status governed by Pdk acts as a cell cycle checkpoint that modulates HSC quiescence and function.	[Takubo, Keiyo; Nagamatsu, Go; Kobayashi, Chiharu I.; Nakamura-Ishizu, Ayako; Kobayashi, Hiroshi; Suda, Toshio] Keio Univ, Dept Cell Differentiat, Sakaguchi Lab Dev Biol, Sch Med,Shinjuku Ku, Tokyo 1608582, Japan; [Suematsu, Makoto] Keio Univ, Dept Biochem, Sch Med, Tokyo 1608582, Japan; [Suematsu, Makoto] Japan Sci Technol Agcy JST, Exploratory Res Adv Technol ERATO, Suematsu Gas Biol Project, Shinjuku Ku, Tokyo 1608582, Japan; [Ikeda, Eiji] Yamaguchi Univ, Dept Pathol, Grad Sch Med, Ube, Yamaguchi 7558505, Japan; [Goda, Nobuhito] Waseda Univ, Dept Life Sci & Med Biosci, Sch Adv Sci & Engn, Shinjuku Ku, Tokyo 1628480, Japan; [Goda, Nobuhito; Soga, Tomoyoshi; Hirao, Atsushi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo 1020075, Japan; [Johnson, Randall S.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Soga, Tomoyoshi] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970052, Japan; [Rahimi, Yasmeen] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Richard L Roudebush VA Med Ctr, Indianapolis, IN 46202 USA	Keio University; Keio University; Japan Science & Technology Agency (JST); Yamaguchi University; Waseda University; Japan Science & Technology Agency (JST); University of Cambridge; Keio University; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Takubo, K (corresponding author), Keio Univ, Dept Cell Differentiat, Sakaguchi Lab Dev Biol, Sch Med,Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	keiyot@gmail.com; sudato@z3.keio.jp	Johnson, Randall/AAM-1189-2021; Goda, Nobuhito/W-2468-2019; Soga, Tomoyoshi/B-8105-2014; Suematsu, Makoto/I-8135-2013; Suematsu, Makoto/O-5762-2018; Takubo, Keiyo/AAX-5546-2020; Suda, Toshio/H-6761-2013	Johnson, Randall/0000-0002-4084-6639; Soga, Tomoyoshi/0000-0001-9502-2509; Suematsu, Makoto/0000-0002-7165-6336; Suematsu, Makoto/0000-0002-7165-6336; Takubo, Keiyo/0000-0002-1736-7592; Suda, Toshio/0000-0001-7540-1771; Goda, Nobuhito/0000-0003-0295-4257	Global COE Program for Human Metabolomic Systems Biology; Global COE Program for Stem Cell Medicine; MEXT [17GS0419]	Global COE Program for Human Metabolomic Systems Biology; Global COE Program for Stem Cell Medicine; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank T. Kitamura for providing the Plat-E packaging cell line and pMY-IRES-EGFP vector, K. Rajewsky for providing Mx1-Cre mice, Primetech for OCR analysis by XF96, V. Haase for providing VHL<SUP>flox/flox</SUP> mice, R.A. Harris for providing Pdk2<SUP>-/-</SUP>:Pdk4<SUP>-/-</SUP> mice, and T. Muraki, K. Igarashi, K. Saito, and T. Hirose for technical support and laboratory management. K.T. is supported by the Global COE Programs for Human Metabolomic Systems Biology (for M.S.) and for Stem Cell Medicine and in part by a MEXT Grant-in-Aid for Young Scientists (A). A.H. and M.S. were supported in part by a MEXT Grant-in-Aid for Creative Scientific Research (17GS0419). FACS analysis was supported by M.S., the Leader of the JST, ERATO, and Suematsu Gas Biology Project. T.S. and K.T. were supported in part by a MEXT Grant-in-Aid for Scientific Research (A), a MEXT Grant-in-Aid for Scientific Research on Innovative Areas, and the Project for Realization of Regenerative Medicine from MEXT.	Allen C, 2006, J CELL BIOL, V174, P89, DOI 10.1083/jcb.200604072; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Dunford EC, 2011, AM J PHYSIOL-REG I, V300, pR1487, DOI 10.1152/ajpregu.00498.2010; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Jeoung NH, 2006, BIOCHEM J, V397, P417, DOI 10.1042/BJ20060125; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kim MJ, 1998, BLOOD, V91, P4106, DOI 10.1182/blood.V91.11.4106.411k40_4106_4117; Klosinska MM, 2011, GENE DEV, V25, P336, DOI 10.1101/gad.2011311; Kobayashi CI, 2012, J CELL PHYSIOL, V227, P421, DOI 10.1002/jcp.22764; LABER B, 1987, BIOCHEM J, V248, P351, DOI 10.1042/bj2480351; Laporte D, 2011, J CELL BIOL, V192, P949, DOI 10.1083/jcb.201009028; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Lum JJ, 2007, GENE DEV, V21, P1037, DOI 10.1101/gad.1529107; Miharada K, 2011, CELL STEM CELL, V9, P330, DOI 10.1016/j.stem.2011.07.016; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Nemeria NS, 2006, BIOORG CHEM, V34, P362, DOI 10.1016/j.bioorg.2006.09.001; Noda S, 2008, STEM CELLS, V26, P646, DOI 10.1634/stemcells.2007-0623; Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Seita J, 2010, WIRES SYST BIOL MED, V2, P640, DOI 10.1002/wsbm.86; Semenza GL, 2010, WIRES SYST BIOL MED, V2, P336, DOI 10.1002/wsbm.69; Shintani T, 2009, HEPATOLOGY, V49, P141, DOI 10.1002/hep.22604; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; SUEMATSU M, 1992, GASTROENTEROLOGY, V103, P994, DOI 10.1016/0016-5085(92)90034-V; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; Takubo K, 2008, CELL STEM CELL, V2, P170, DOI 10.1016/j.stem.2007.10.023; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Voet D., 2010, BIOCHEMISTRY; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038; Zwerschke W, 2003, BIOCHEM J, V376, P403, DOI 10.1042/BJ20030816	48	491	507	4	73	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 3	2013	12	1					49	61		10.1016/j.stem.2012.10.011	http://dx.doi.org/10.1016/j.stem.2012.10.011			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	074UM	23290136	Bronze, Green Accepted			2022-12-28	WOS:000313839500010
J	Warr, MR; Passegue, E				Warr, Matthew R.; Passegue, Emmanuelle			Metabolic Makeover for HSCs	CELL STEM CELL			English	Editorial Material							HEMATOPOIETIC STEM-CELLS; HYPOXIC NICHE	Hematopoietic stem cells (HSCs) must at times exit quiescence to divide and produce differentiated blood cells. In this issue of Cell Stem Cell, Takubo et al. (2013) and Yu et al. (2013) show that these opposing actions require distinct metabolic programs to meet the changing energy demands of self-renewing HSCs.	[Warr, Matthew R.; Passegue, Emmanuelle] Univ Calif San Francisco, Dept Med, Div Hematol Oncol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Passegue, E (corresponding author), Univ Calif San Francisco, Dept Med, Div Hematol Oncol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.	passeguee@stemcell.ucsf.edu		Passegue, Emmanuelle/0000-0002-3516-297X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111266] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL111266] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Csaszar E, 2012, CELL STEM CELL, V10, P218, DOI 10.1016/j.stem.2012.01.003; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; Ito K, 2012, NAT MED, V18, P1350, DOI 10.1038/nm.2882; Pietras EM, 2011, J CELL BIOL, V195, P709, DOI 10.1083/jcb.201102131; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Warr MR, 2011, WIRES SYST BIOL MED, V3, P681, DOI 10.1002/wsbm.145; Yu WM, 2013, CELL STEM CELL, V12, P62, DOI 10.1016/j.stem.2012.11.022	10	24	24	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JAN 3	2013	12	1					1	3		10.1016/j.stem.2012.12.005	http://dx.doi.org/10.1016/j.stem.2012.12.005			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	074UM	23290130	Bronze			2022-12-28	WOS:000313839500001
J	Nazor, KL; Altun, G; Lynch, C; Tran, H; Harness, JV; Slavin, I; Garitaonandia, I; Muller, FJ; Wang, YC; Boscolo, FS; Fakunle, E; Dumevska, B; Lee, S; Park, HS; Olee, T; D'Lima, DD; Semechkin, R; Parast, MM; Galat, V; Laslett, AL; Schmidt, U; Keirstead, HS; Loring, JF; Laurent, LC				Nazor, Kristopher L.; Altun, Gulsah; Lynch, Candace; Tran, Ha; Harness, Julie V.; Slavin, Ileana; Garitaonandia, Ibon; Mueller, Franz-Josef; Wang, Yu-Chieh; Boscolo, Francesca S.; Fakunle, Eyitayo; Dumevska, Biljana; Lee, Sunray; Park, Hyun Sook; Olee, Tsaiwei; D'Lima, Darryl D.; Semechkin, Ruslan; Parast, Mana M.; Galat, Vasiliy; Laslett, Andrew L.; Schmidt, Uli; Keirstead, Hans S.; Loring, Jeanne F.; Laurent, Louise C.			Recurrent Variations in DNA Methylation in Human Pluripotent Stem Cells and Their Differentiated Derivatives	CELL STEM CELL			English	Article							X-CHROMOSOME INACTIVATION; TRANSCRIPTION FACTORS; DYNAMIC CHANGES; SOMATIC-CELLS; LINES; CULTURE; EXPRESSION; GENES; INDUCTION; SIGNATURE	Human pluripotent stem cells (hPSCs) are potential sources of cells for modeling disease and development, drug discovery, and regenerative medicine. However, it is important to identify factors that may impact the utility of hPSCs for these applications. In an unbiased analysis of 205 hPSC and 130 somatic samples, we identified hPSC-specific epigenetic and transcriptional aberrations in genes subject to X chromosome inactivation (XCI) and genomic imprinting, which were not corrected during directed differentiation. We also found that specific tissue types were distinguished by unique patterns of DNA hypomethylation, which were recapitulated by DNA demethylation during in vitro directed differentiation. Our results suggest that verification of baseline epigenetic status is critical for hPSC-based disease models in which the observed phenotype depends on proper XCI or imprinting and that tissue-specific DNA methylation patterns can be accurately modeled during directed differentiation of hPSCs, even in the presence of variations in XCI or imprinting.	[Nazor, Kristopher L.; Altun, Gulsah; Lynch, Candace; Tran, Ha; Slavin, Ileana; Garitaonandia, Ibon; Mueller, Franz-Josef; Wang, Yu-Chieh; Boscolo, Francesca S.; Fakunle, Eyitayo; Loring, Jeanne F.; Laurent, Louise C.] Scripps Res Inst, Dept Chem Physiol, Ctr Regenerat Med, La Jolla, CA 92037 USA; [Harness, Julie V.; Keirstead, Hans S.] Univ Calif Irvine, Sue & Bill Gross Stem Cell Res Ctr, Dept Neurol Surg, Dept Anat & Neurobiol,Sch Med,Reeve Irvine Res Ct, Irvine, CA 92697 USA; [Mueller, Franz-Josef] Univ Hosp Schleswig Holstein, ZIP Kiel, Ctr Psychiat, D-4105 Kiel, Germany; [Dumevska, Biljana; Schmidt, Uli] Genea, Stem Cell Lab, Sydney, NSW 2000, Australia; [Lee, Sunray] CEFO Co Inc, Lab Stem Cell Niche, Seoul 110140, South Korea; [Park, Hyun Sook] MCTT, Seoul 139743, South Korea; [Olee, Tsaiwei; D'Lima, Darryl D.] Scripps Clin, Shiley Ctr Orthopaed Res & Educ, La Jolla, CA 92037 USA; [Semechkin, Ruslan] Int Stem Cell Corp, Carlsbad, CA 92008 USA; [Parast, Mana M.] Univ Calif San Diego, Dept Pathol, San Diego, CA 92035 USA; [Loring, Jeanne F.; Laurent, Louise C.] Univ Calif San Diego, Dept Reprod Med, San Diego, CA 92035 USA; [Galat, Vasiliy] Northwestern Univ, Feinberg Sch Med, Childrens Mem Res Ctr, Dev Biol Program,iPS, Chicago, IL 60614 USA; [Galat, Vasiliy] Northwestern Univ, Feinberg Sch Med, Childrens Mem Res Ctr, Human Stem Cell Core Facil, Chicago, IL 60614 USA; [Laslett, Andrew L.] CSIRO, Div Mat Sci & Engn, Clayton, Vic 3168, Australia; [Laslett, Andrew L.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3168, Australia	Scripps Research Institute; University of California System; University of California Irvine; University of Kiel; Schleswig Holstein University Hospital; Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Monash University	Laurent, LC (corresponding author), Scripps Res Inst, Dept Chem Physiol, Ctr Regenerat Med, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	llaurent@ucsd.edu	Loring, Jeanne F/A-1620-2011; Laslett, Andrew L/A-9760-2011; Müller, Franz-Josef/E-3336-2010	Loring, Jeanne F/0000-0001-6226-9767; Laslett, Andrew L/0000-0003-4729-8193; Müller, Franz-Josef/0000-0001-9478-8430; D'Lima, Darryl/0000-0002-8707-1455; Laurent, Louise/0000-0002-2095-7534; Fakunle, Eyitayo/0000-0001-7123-008X; Galat, Vasiliy/0000-0003-3612-098X	NIH/NICHD; Hartwell Foundation; CIRM [CL100502, RT1-01108, TR1-01250, RN2-00931-1]; NIH [R33MH87925]; Millipore Foundation; Esther O'Keefe Foundation; Autism Speaks Dennis Weatherstone fellowship; Marie Mayer Foundation; Bill and Melinda Gates Grand Challenges Explorations Award; Australian Stem Cell Centre; Stem Cells Australia; Victoria-California Stem Cell Alliance (CIRM) [TR101250]; Stem Cell Research Center [SC2250]; Ministry of Educational Science and Technology; Else-Kroner Fresenius Stiftung fellowship; Pew Charitable Trust; UNCF/Merck; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R33MH087925] Funding Source: NIH RePORTER	NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Hartwell Foundation; CIRM(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Millipore Foundation; Esther O'Keefe Foundation; Autism Speaks Dennis Weatherstone fellowship; Marie Mayer Foundation; Bill and Melinda Gates Grand Challenges Explorations Award; Australian Stem Cell Centre; Stem Cells Australia; Victoria-California Stem Cell Alliance (CIRM)(California Institute for Regenerative Medicine); Stem Cell Research Center; Ministry of Educational Science and Technology; Else-Kroner Fresenius Stiftung fellowship; Pew Charitable Trust; UNCF/Merck(Merck & Company); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to gratefully acknowledge the following for contributing samples for this study: Juan-Carlos Belmonte, Eirini Papapetrou (Sadelain lab), Dongbao Chen, Jerold Chun, Martin Pera, James Shen, Scott McKercher, Timo Otonkoski, Allan Robins, Thomas Schulz, Philip Schwartz, Scott McKercher, Ralph Graichen, Jeong Beom Kim, Nils O. Schmidt, Christopher Barry, Robin Wesselschmidt, James Shen, Joel Gottesfeld, Christina Lu, the NICHD Brain and Tissue Bank for Developmental Disorders, and Planned Parenthood of the Pacific Southwest. We would also like to acknowledge Yinchun Li for generously contributing his expertise in histological evaluation of iPSC-derived teratomas. We would like to thank Trevor Leonardo, Robert Morey, Sara Abdelrahman, Inbar Friedrich Ben-Nun, Victoria Glenn, Dumitru Brinza, Dmitry Pushkarev, Tenneille Ludwig, and Kristen Brennand for their valuable help in the laboratory and for useful discussions. Many thanks to Marina Bibikova and Jian-Bing Fan at Illumina for their assistance and expertise with the 450K DNA Methylation array. L.C.L. is supported by an NIH/NICHD K12 Career Development Award and the Hartwell Foundation. G.A., K.L.N., CL., IS., F.-J.M., E.F., and J.F.L. are supported by CIRM (CL100502, RT1-01108, TR1-01250, RN2-00931-1), NIH (R33MH87925), the Millipore Foundation, and the Esther O'Keefe Foundation. K.L.N. is supported by an Autism Speaks Dennis Weatherstone fellowship. Y.-C.W. is supported by the Marie Mayer Foundation. E.F. was supported by a Bill and Melinda Gates Grand Challenges Explorations Award and a UNCF/Merck Postdoctoral Fellowship. A.L.L. is supported by the Australian Stem Cell Centre, Stem Cells Australia, and the Victoria-California Stem Cell Alliance (CIRM grant TR101250). H.S.P. and S.L. were supported by a grant (SC2250) from the Stem Cell Research Center of the 21st Century Frontier Research Program funded by Ministry of Educational Science and Technology. F.-J.M. is supported by an Else-Kroner Fresenius Stiftung fellowship. I.S. is supported by the Pew Charitable Trusts. R.S. is Vice President of International Stem Cell Corporation, from which this study included several parthenogenic human embryonic stem cell lines.	Aberg K, 2006, P NATL ACAD SCI USA, V103, P7482, DOI 10.1073/pnas.0601213103; Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Allegrucci C, 2007, HUM MOL GENET, V16, P1253, DOI 10.1093/hmg/ddm074; Atanasoski S, 2004, NEURON, V43, P499, DOI 10.1016/j.neuron.2004.08.001; Bhusari S, 2011, PROSTATE, V71, P1621, DOI 10.1002/pros.21379; Bibikova M, 2006, GENOME RES, V16, P1075, DOI 10.1101/gr.5319906; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Choufani S, 2011, GENOME RES, V21, P465, DOI 10.1101/gr.111922.110; Dolinoy DC, 2007, PEDIATR RES, V61, p30R, DOI 10.1203/pdr.0b013e31804575f7; Dvash T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011330; Feng Q, 2010, STEM CELLS, V28, P704, DOI 10.1002/stem.321; Frost JM, 2011, EPIGENETICS-US, V6, P52, DOI 10.4161/epi.6.1.13361; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hall LL, 2008, J CELL PHYSIOL, V216, P445, DOI 10.1002/jcp.21411; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Harness JV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014499; Hoffman LM, 2005, STEM CELLS, V23, P1468, DOI 10.1634/stemcells.2004-0371; Hough SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007708; Hussein SMI, 2011, CLIN PHARMACOL THER, V89, P741, DOI 10.1038/clpt.2011.37; John RM, 2011, DIFFERENTIATION, V81, P270, DOI 10.1016/j.diff.2011.01.007; Kim DH, 2011, SEMIN CELL DEV BIOL, V22, P336, DOI 10.1016/j.semcdb.2011.02.025; Kim KP, 2007, GENOME RES, V17, P1731, DOI 10.1101/gr.6609207; Kuhn K, 2004, GENOME RES, V14, P2347, DOI 10.1101/gr.2739104; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mekhoubad S, 2012, CELL STEM CELL, V10, P595, DOI 10.1016/j.stem.2012.02.014; Migeon BR, 2002, AM J HUM GENET, V71, P286, DOI 10.1086/341605; Muller FJ, 2011, NAT METHODS, V8, P315, DOI 10.1038/NMETH.1580; Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127; Odom LN, 2010, CURR OPIN ENDOCRINOL, V17, P517, DOI 10.1097/MED.0b013e32834040a3; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Pomp O, 2011, CELL STEM CELL, V9, P156, DOI 10.1016/j.stem.2011.06.004; Rugg-Gunn PJ, 2007, HUM MOL GENET, V16, pR243, DOI 10.1093/hmg/ddm245; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4709, DOI 10.1073/pnas.0712018105; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tchieu J, 2010, CELL STEM CELL, V7, P329, DOI 10.1016/j.stem.2010.06.024; Teichroeb JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023436; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005; Uribe-Lewis S, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399410001717; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	50	272	284	1	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAY 4	2012	10	5					620	634		10.1016/j.stem.2012.02.013	http://dx.doi.org/10.1016/j.stem.2012.02.013			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	944WN	22560082	Bronze, Green Accepted			2022-12-28	WOS:000304234600019
J	de Sousa e Melo, F; Colak, S; Buikhuisen, J; Koster, J; Cameron, K; de Jong, JH; Tuynman, JB; Prasetyanti, PR; Fessler, E; van den Bergh, SP; Rodermond, H; Dekker, E; van der Loos, CM; Pals, ST; van de Vijver, MJ; Versteeg, R; Richel, DJ; Vermeulen, L; Medema, JP				de Sousa e Melo, Felipe; Colak, Selcuk; Buikhuisen, Joyce; Koster, Jan; Cameron, Kate; de Jong, Joan H.; Tuynman, Jurriaan B.; Prasetyanti, Pramudita R.; Fessler, Evelyn; van den Bergh, Saskia P.; Rodermond, Hans; Dekker, Evelien; van der Loos, Chris M.; Pals, Steven T.; van de Vijver, Marc J.; Versteeg, Rogier; Richel, Dick J.; Vermeulen, Louis; Medema, Jan Paul			Methylation of Cancer-Stem-Cell-Associated Wnt Target Genes Predicts Poor Prognosis in Colorectal Cancer Patients	CELL STEM CELL			English	Article							COLON-CANCER; EXPRESSION SIGNATURE; BREAST-CANCER; PHENOTYPE; SPECIMENS; APC	Gene signatures derived from cancer stem cells (CSCs) predict tumor recurrence for many forms of cancer. Here, we derived a gene signature for colorectal CSCs defined by high Wnt signaling activity, which in agreement with previous observations predicts poor prognosis. Surprisingly, however, we found that elevated expression of Wnt targets was actually associated with good prognosis, while patient tumors with low expression of Wnt target genes segregated with immature stem cell signatures. We discovered that several Wnt target genes, including ASCL2 and LGR5, become silenced by CpG island methylation during progression of tumorigenesis, and that their re-expression was associated with reduced tumor growth. Taken together, our data show that promoter methylation of Wnt target genes is a strong predictor for recurrence of colorectal cancer, and suggest that CSC gene signatures, rather than reflecting CSC numbers, may reflect differentiation status of the malignant tissue.	[de Sousa e Melo, Felipe; Colak, Selcuk; Buikhuisen, Joyce; Cameron, Kate; de Jong, Joan H.; Tuynman, Jurriaan B.; Prasetyanti, Pramudita R.; Fessler, Evelyn; van den Bergh, Saskia P.; Rodermond, Hans; Vermeulen, Louis; Medema, Jan Paul] Univ Amsterdam, Acad Med Ctr, Lab Expt Oncol & Radiobiol, Ctr Expt Mol Med, NL-1105 AZ Amsterdam, Netherlands; [Koster, Jan; Versteeg, Rogier] Univ Amsterdam, Acad Med Ctr, Dept Oncogen, NL-1105 AZ Amsterdam, Netherlands; [Dekker, Evelien] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands; [van der Loos, Chris M.; Pals, Steven T.; van de Vijver, Marc J.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Richel, Dick J.] Univ Amsterdam, Acad Med Ctr, Dept Med Oncol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Medema, JP (corresponding author), Univ Amsterdam, Acad Med Ctr, Lab Expt Oncol & Radiobiol, Ctr Expt Mol Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.p.medema@amc.nl	Koster, Jan/C-5934-2008; Versteeg, Rogier/AAQ-1765-2020; Vermeulen, Louis/B-7488-2008; Pillay, Nischalan/F-9536-2012; Tuynman, J/X-2465-2019; Tuynman, JB/AAS-7745-2020	Koster, Jan/0000-0002-0890-7585; Vermeulen, Louis/0000-0002-6066-789X; Tuynman, JB/0000-0001-5952-8000; van de Vijver, Marc/0000-0002-0385-4787; Pals, Steven/0000-0002-1419-0939; Medema, Jan Paul/0000-0003-3045-2924; Dekker, Evelien/0000-0002-4363-0745; Buikhuisen, Joyce/0000-0002-1181-737X; Versteeg, Rogier/0000-0001-7172-0388	Netherlands Organisation for Scientific Research; Dutch Cancer Society [2009-4416]; Academisch Medisch Centrum (AMC)	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society(KWF Kankerbestrijding); Academisch Medisch Centrum (AMC)	The authors would like to specially thank M. Oud for the tumor slides, and prof. T.M. van Gulik, prof. W.A. Bemelman, and Dr. P.J. Tanis for the primary tumor samples. Prof. S. Repping we would like to thank for critically reading the manuscript. This work was supported by a VICI grant from the Netherlands Organisation for Scientific Research and a Dutch Cancer Society grant (2009-4416) (to J.P.M.), and an Academisch Medisch Centrum (AMC) fellowship (to L.V. and F.d.S.E.M.). The TOP-GFP construct was a kind gift of Dr. L. Allies. The pMX-Axin2-ires-CD8 was kindly provided by Prof. H. Mano.	Al-Kofahi Y, 2011, HISTOPATHOLOGY, V59, P40, DOI 10.1111/j.1365-2559.2011.03878.x; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bertucci F, 2007, NEW ENGL J MED, V356, P1887; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Galamb O, 2008, DIS MARKERS, V25, P1, DOI 10.1155/2008/586721; Koinuma K, 2006, ONCOGENE, V25, P139, DOI 10.1038/sj.onc.1209009; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Medema JP, 2011, NATURE, V474, P318, DOI 10.1038/nature10212; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Rai K, 2010, CELL, V142, P930, DOI 10.1016/j.cell.2010.08.030; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Shimomura Y, 2010, NATURE, V464, P1043, DOI 10.1038/nature08875; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Varnat F, 2010, EMBO MOL MED, V2, P440, DOI 10.1002/emmm.201000098; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048	27	229	235	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV 4	2011	9	5					476	485		10.1016/j.stem.2011.10.008	http://dx.doi.org/10.1016/j.stem.2011.10.008			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	850FJ	22056143	Bronze			2022-12-28	WOS:000297180200014
J	Neumuller, RA; Richter, C; Fischer, A; Novatchkova, M; Neumuller, KG; Knoblich, JA				Neumueller, Ralph A.; Richter, Constance; Fischer, Anja; Novatchkova, Maria; Neumueller, Klaus G.; Knoblich, Juergen A.			Genome-Wide Analysis of Self-Renewal in Drosophila Neural Stem Cells by Transgenic RNAi	CELL STEM CELL			English	Article							POLYMERASE-II ELONGATION; RIBOSOMAL-PROTEIN GENES; TRANSCRIPTION FACTORS; BRAIN-TUMOR; NEUROBLAST LINEAGES; PROGENITOR CELLS; SWI/SNF COMPLEX; ALPHA-ADAPTIN; PHOSPHATASE 4; PAF1 COMPLEX	The balance between stem cell self-renewal and differentiation is precisely controlled to ensure tissue homeostasis and prevent tumorigenesis. Here we use genome-wide transgenic RNAi to identify 620 genes potentially involved in controlling this balance in Drosophila neuroblasts. We quantify all phenotypes and derive measurements for proliferation, lineage, cell size, and cell shape. We identify a set of transcriptional regulators essential for self-renewal and use hierarchical clustering and integration with interaction data to create functional networks for the control of neuroblast self-renewal and differentiation. Our data identify key roles for the chromatin remodeling Brm complex, the spliceosome, and the TRiC/CCT-complex and show that the alternatively spliced transcription factor Lola and the transcriptional elongation factors Ssrp and Barc control self-renewal in neuroblast lineages. As our data are strongly enriched for genes highly expressed in murine neural stem cells, they are likely to provide valuable insights into mammalian stem cell biology as well.	[Neumueller, Ralph A.; Richter, Constance; Fischer, Anja; Novatchkova, Maria; Neumueller, Klaus G.; Knoblich, Juergen A.] Austrian Acad Sci IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Novatchkova, Maria] Res Inst Mol Pathol IMP, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Knoblich, JA (corresponding author), Austrian Acad Sci IMBA, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	juergen.knoblich@imba.oeaw.ac.at	Richter, Constance/P-8714-2019; Knoblich, Juergen A/C-2974-2015	Knoblich, Juergen A/0000-0002-6751-3404; Richter, Constance/0000-0003-3312-0941	Austrian Academy of Sciences, Wiener Wissenschafts-, Forschungs- und Technologiefonds (WWTF); EU; FWF; Austrian Science Fund (FWF) [Z 153, I 552] Funding Source: researchfish	Austrian Academy of Sciences, Wiener Wissenschafts-, Forschungs- und Technologiefonds (WWTF); EU(European Commission); FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We wish to thank B. Dickson, K. Keleman, J. Skeath, H. Richardson, G. Dietzl, S. Bhalerao, the Vienna Drosophila RNAi Center (VDRC), the Developmental Studies Hybridoma Bank (DSHB), and the Bloomington Drosophila Stock Center for constructs, antibodies, and flystocks; E. Kleiner and L. Kirschner for technical assistance and C. Juschke for help with data analysis; N. Corsini, E. Eroglu, and M. Lancaster for comments on the manuscript; M. Madalinski for peptide synthesis and affinity purification; and members of the Knoblich lab for discussions. Work in J.A.K.'s lab is supported by the Austrian Academy of Sciences, Wiener Wissenschafts-, Forschungs- und Technologiefonds (WWTF), the EU seventh framework program EuroSyStem, and the FWF.	Adryan B, 2006, BIOINFORMATICS, V22, P1532, DOI 10.1093/bioinformatics/btl143; Bai XY, 2010, CELL, V142, P133, DOI 10.1016/j.cell.2010.05.028; Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429; Bello B, 2007, DEVELOPMENT, V134, P1091, DOI 10.1242/dev.02793; Bello BC, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-5; Belotserkovskaya R, 2004, CURR OPIN GENET DEV, V14, P139, DOI 10.1016/j.gde.2004.02.004; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Bhalerao S, 2005, CURR BIOL, V15, P1583, DOI 10.1016/j.cub.2005.07.061; Boone JQ, 2008, DEV NEUROBIOL, V68, P1185, DOI 10.1002/dneu.20648; Boulay JL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-71; Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Chen YX, 2009, GENE DEV, V23, P2765, DOI 10.1101/gad.1834709; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Copley RR, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-169; Davis RJ, 2003, DEV BIOL, V259, P272, DOI 10.1016/S0012-1606(03)00201-X; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977; Fasano CA, 2009, GENE DEV, V23, P561, DOI 10.1101/gad.1743709; Ferres-Marco D, 2006, NATURE, V439, P430, DOI 10.1038/nature04376; FISHER EMC, 1990, CELL, V63, P1205, DOI 10.1016/0092-8674(90)90416-C; Gingras AC, 2005, MOL CELL PROTEOMICS, V4, P1725, DOI 10.1074/mcp.M500231-MCP200; GINIGER E, 1994, DEVELOPMENT, V120, P1385; Goeke S, 2003, NAT NEUROSCI, V6, P917, DOI 10.1038/nn1105; GonzalezGaitan M, 1997, CELL, V88, P767, DOI 10.1016/S0092-8674(00)81923-6; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Helps NR, 1998, J CELL SCI, V111, P1331; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Kai T, 2005, DEV BIOL, V283, P486, DOI 10.1016/j.ydbio.2005.04.018; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; Lee CY, 2006, DEV CELL, V10, P441, DOI 10.1016/j.devcel.2006.01.017; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Loop T, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-24; MARTINBERMUDO MD, 1991, DEVELOPMENT, V113, P445; Marygold SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r216; Mollereau B, 2001, NATURE, V412, P911, DOI 10.1038/35091076; Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936; Nakao A, 2004, NUCLEIC ACIDS RES, V32, pD168, DOI 10.1093/nar/gkh004; Neumuller RA, 2008, NATURE, V454, P241, DOI 10.1038/nature07014; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; Papoulas O, 1998, DEVELOPMENT, V125, P3955; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Petrova TV, 2008, CANCER CELL, V13, P407, DOI 10.1016/j.ccr.2008.02.020; Pfreundt U, 2010, NUCLEIC ACIDS RES, V38, pD443, DOI 10.1093/nar/gkp910; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Schwabish MA, 2007, MOL CELL BIOL, V27, P6987, DOI 10.1128/MCB.00717-07; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Smith MJ, 2004, MOL CELL BIOL, V24, P9274, DOI 10.1128/MCB.24.21.9274-9285.2004; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; Sousa-Nunes R, 2009, GENE DEV, V23, P359, DOI 10.1101/gad.1723609; Southall TD, 2009, EMBO J, V28, P3799, DOI 10.1038/emboj.2009.309; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sur I, 2009, CURR GENOMICS, V10, P594, DOI 10.2174/138920209789503932; Xi RW, 2005, SCIENCE, V310, P1487, DOI 10.1126/science.1120140; Yoo AS, 2009, CURR OPIN NEUROBIOL, V19, P120, DOI 10.1016/j.conb.2009.04.006; Zheng L, 2008, MECH DEVELOP, V125, P18, DOI 10.1016/j.mod.2007.10.007; Zhou QA, 1996, SCIENCE, V274, P605, DOI 10.1126/science.274.5287.605; Zhu SJ, 2006, CELL, V127, P409, DOI 10.1016/j.cell.2006.08.045	65	187	191	2	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAY 6	2011	8	5					580	593		10.1016/j.stem.2011.02.022	http://dx.doi.org/10.1016/j.stem.2011.02.022			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	768IN	21549331	Green Published, hybrid			2022-12-28	WOS:000290927600017
J	Marteyn, A; Maury, Y; Gauthier, MM; Lecuyer, C; Vernet, R; Denis, JA; Pietu, G; Peschanski, M; Martinat, C				Marteyn, Antoine; Maury, Yves; Gauthier, Morgane M.; Lecuyer, Camille; Vernet, Remi; Denis, Jerome A.; Pietu, Genevieve; Peschanski, Marc; Martinat, Cecile			Mutant Human Embryonic Stem Cells Reveal Neurite and Synapse Formation Defects in Type 1 Myotonic Dystrophy	CELL STEM CELL			English	Article							NEUROMUSCULAR-JUNCTIONS; MUSCULAR-DYSTROPHY; NERVOUS-SYSTEM; MOTOR-NEURONS; RNA; PERSONALITY; DIFFERENTIATION; ABNORMALITIES; TRANSCRIPTION; INVOLVEMENT	Myotonic dystrophy type 1 (DM1) is a multisystem disorder affecting a variety of organs, including the central nervous system. By using neuronal progeny derived from human embryonic stem cells carrying the causal DM1 mutation, we have identified an early developmental defect in genes involved in neurite formation and the establishment of neuromuscular connections. Differential gene expression profiling and quantitative RT-PCR revealed decreased expression of two members of the SLITRK family in DM1 neural cells and in DM1 brain biopsies. In addition, DM1 motoneuron/muscle cell cocultures showed alterations that are consistent with the known role of SLITRK genes in neurite outgrowth, neuritogenesis, and synaptogenesis. Rescue and knockdown experiments suggested that the functional defects can be directly attributed to SLITRK misexpression. These neuropathological mechanisms may be clinically significant for the functional changes in neuromuscular connections associated with DM1.	[Marteyn, Antoine; Gauthier, Morgane M.; Vernet, Remi; Denis, Jerome A.; Pietu, Genevieve; Peschanski, Marc; Martinat, Cecile] I STEM AFM, INSERM UEVE UMR 861, F-91030 Evry, France; [Maury, Yves; Lecuyer, Camille] I STEM AFM, CECS, F-91030 Evry, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Martinat, C (corresponding author), Ectycell SA, F-93230 Romainville, France.	cmartinat@istem.fr	Peschanski, Marc/N-5769-2017; Martinat, Cécile S/F-6777-2010; DENIS, Jérôme Alexandre/AAG-1650-2019	Martinat, Cécile S/0000-0002-5234-1064; DENIS, Jérôme Alexandre/0000-0002-1617-4617; Marteyn, Antoine/0000-0003-2176-3595	MediCen; Genopole; AFM (Association Francaise contre les myopathie); Region Ile de France	MediCen; Genopole; AFM (Association Francaise contre les myopathie)(Association Francaise contre les Myopathies); Region Ile de France(Region Ile-de-France)	We thank Gillian Butler-Brown and Xavier Nissan for helpful discussions, Genevieve Gourdon (INSERM U781, Paris, France) for performing the CTG repeat analysis, and Karen Sermon (AZ-VUB, Brussels, Belgium) for providing DM1 and control hESCs. Part of this work was also supported by grants from MediCen (IngeCell program), Genopole, and the AFM (Association Francaise contre les myopathie). A.M. had a fellowship from the Region Ile de France. None of the authors of this manuscript have a financial interest related to this work.	ABE K, 1994, J NEUROL SCI, V127, P179, DOI 10.1016/0022-510X(94)90071-X; Aruga J, 2003, GENE, V315, P87, DOI 10.1016/S0378-1119(03)00715-7; Aruga J, 2003, MOL CELL NEUROSCI, V24, P117, DOI 10.1016/S1044-7431(03)00129-5; Blochl A, 2007, J NEUROCHEM, V102, P289, DOI 10.1111/j.1471-4159.2007.04496.x; Braun S, 1996, J NEUROL SCI, V136, P17, DOI 10.1016/0022-510X(95)00315-S; Chen SY, 2009, CURR OPIN NEUROBIOL, V19, P471, DOI 10.1016/j.conb.2009.09.005; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; CROS D, 1988, ANN NEUROL, V23, P470, DOI 10.1002/ana.410230508; Damian MS, 2001, NEUROLOGY, V56, P794, DOI 10.1212/WNL.56.6.794; de Leon MB, 2008, J NEUROSCI RES, V86, P18, DOI 10.1002/jnr.21377; Delaporte C, 1998, ARCH NEUROL-CHICAGO, V55, P635, DOI 10.1001/archneur.55.5.635; Denis JA, 2011, STEM CELLS DEV, V20, P1395, DOI 10.1089/scd.2010.0331; DYKEN PR, 1973, NEUROLOGY, V23, P465, DOI 10.1212/WNL.23.5.465; Ebralidze A, 2004, SCIENCE, V303, P383, DOI 10.1126/science.1088679; Eiges R, 2007, CELL STEM CELL, V1, P568, DOI 10.1016/j.stem.2007.09.001; Fenno LE, 2008, CURR OPIN GENET DEV, V18, P324, DOI 10.1016/j.gde.2008.06.004; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; Harper PS, 2001, MYOTONIC DYSTROPHY; Jiang H, 2004, HUM MOL GENET, V13, P3079, DOI 10.1093/hmg/ddh327; Katayama K, 2010, MOL PSYCHIATR, V15, P177, DOI 10.1038/mp.2008.97; Katayama K, 2009, PLOS ONE, V4, pA151, DOI 10.1371/journal.pone.0007786; Krishnan AV, 2006, MUSCLE NERVE, V33, P627, DOI 10.1002/mus.20516; Lefort N, 2008, NAT BIOTECHNOL, V26, P1364, DOI 10.1038/nbt.1509; Llagostera E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001134; Martinat C, 2006, P NATL ACAD SCI USA, V103, P2874, DOI 10.1073/pnas.0511153103; Mateizel I, 2006, HUM REPROD, V21, P503, DOI 10.1093/humrep/dei345; Mateizel I, 2008, REPROD BIOMED ONLINE, V16, P741, DOI 10.1016/S1472-6483(10)60490-7; Meola G, 2003, NEUROMUSCULAR DISORD, V13, P813, DOI 10.1016/S0960-8966(03)00137-8; Modoni A, 2004, ARCH NEUROL-CHICAGO, V61, P1943, DOI 10.1001/archneur.61.12.1943; Nagao M, 2003, ACTA NEUROPATHOL, V106, P557, DOI 10.1007/s00401-003-0759-1; O'Rourke JA, 2009, J PSYCHOSOM RES, V67, P533, DOI 10.1016/j.jpsychores.2009.06.006; Osborne RJ, 2009, HUM MOL GENET, V18, P1471, DOI 10.1093/hmg/ddp058; PACHTER BR, 1986, GRAEF ARCH CLIN EXP, V224, P325, DOI 10.1007/BF02150024; Panaite PA, 2008, J NEUROPATH EXP NEUR, V67, P763, DOI 10.1097/NEN.0b013e318180ec64; PARK YD, 1995, J NEUROL NEUROSUR PS, V58, P512, DOI 10.1136/jnnp.58.4.512; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Ranum LPW, 2006, ANNU REV NEUROSCI, V29, P259, DOI 10.1146/annurev.neuro.29.051605.113014; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Saba S, 1999, J CARDIOVASC ELECTR, V10, P1214, DOI 10.1111/j.1540-8167.1999.tb00298.x; Sergeant N, 2001, HUM MOL GENET, V10, P2143, DOI 10.1093/hmg/10.19.2143; Sistiaga A, 2010, PSYCHOL MED, V40, P487, DOI 10.1017/S0033291709990602; STRANOCK SD, 1978, NEUROPATH APPL NEURO, V4, P407, DOI 10.1111/j.1365-2990.1978.tb01352.x; TURNPENNY P, 1994, J MED GENET, V31, P300, DOI 10.1136/jmg.31.4.300; VANDERVEN PFM, 1993, HUM MOL GENET, V2, P1889; Wheeler TM, 2007, NEUROMUSCULAR DISORD, V17, P242, DOI 10.1016/j.nmd.2006.12.015; Wheeler TM, 2008, NEUROTHERAPEUTICS, V5, P592, DOI 10.1016/j.nurt.2008.08.001; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Yadava RS, 2008, NAT GENET, V40, P61, DOI 10.1038/ng.2007.28; Yoshida Y, 2010, CIRCULATION, V122, P80, DOI 10.1161/CIRCULATIONAHA.109.881433; Ypsilanti AR, 2010, DEVELOPMENT, V137, P1939, DOI 10.1242/dev.044511; Zuchner S, 2006, MOL PSYCHIATR, V11, P888, DOI 10.1038/sj.mp.4001865	51	72	74	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 8	2011	8	4					434	444		10.1016/j.stem.2011.02.004	http://dx.doi.org/10.1016/j.stem.2011.02.004			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	752QI	21458401	Bronze			2022-12-28	WOS:000289707100015
J	Goldman, O; Han, SY; Sourrisseau, M; Dziedzic, N; Hamou, W; Corneo, B; D'Souza, S; Sato, T; Kotton, DN; Bissig, KD; Kalir, T; Jacobs, A; Evans, T; Evans, MJ; Gouon-Evans, V				Goldman, Orit; Han, Songyan; Sourrisseau, Marion; Dziedzic, Noelle; Hamou, Wissam; Corneo, Barbara; D'Souza, Sunita; Sato, Thomas; Kotton, Darrell N.; Bissig, Karl-Dimiter; Kalir, Tamara; Jacobs, Adam; Evans, Todd; Evans, Matthew J.; Gouon-Evans, Valerie			KDR Identifies a Conserved Human and Murine Hepatic Progenitor and Instructs Early Liver Development	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; HEPATOCYTE-LIKE CELLS; C VIRUS-INFECTION; EFFICIENT DIFFERENTIATION; DEFINITIVE ENDODERM; FUNCTIONAL HEPATOCYTES; MOUSE-LIVER; IN-VIVO; FETAL; EXPRESSION	Understanding the fetal hepatic niche is essential for optimizing the generation of functional hepatocyte-like cells (hepatic cells) from human embryonic stem cells (hESCs). Here, we show that KDR (VEGFR2/FLK-1), previously assumed to be mostly restricted to mesodermal lineages, marks a hESCderived hepatic progenitor. hESC-derived endoderm cells do not express KDR but, when cultured in media supporting hepatic differentiation, generate KDR+ hepatic progenitors and KDR-hepatic cells. KDR+ progenitors require active KDR signaling both to instruct their own differentiation into hepatic cells and to non-cell-autonomously support the functional maturation of cocultured KDR-hepatic cells. Analysis of human fetal livers suggests that similar progenitors are present in human livers. Lineage tracing in mice provides in vivo evidence of a KDR+ hepatic progenitor for fetal hepatoblasts, adult hepatocytes, and adult cholangiocytes. Altogether, our findings reveal that KDR is a conserved marker for endoderm- derived hepatic progenitors and a functional receptor instructing early liver development.	[Goldman, Orit; Han, Songyan; Dziedzic, Noelle; Hamou, Wissam; D'Souza, Sunita; Gouon-Evans, Valerie] Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Sourrisseau, Marion; Evans, Matthew J.] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Kalir, Tamara] Icahn Sch Med Mt Sinai, Div Gynecol Pathol, New York, NY 10029 USA; [Jacobs, Adam] Icahn Sch Med Mt Sinai, Dept Obstet Gynecol & Reprod Sci, New York, NY 10029 USA; [Corneo, Barbara] Neural Stem Cell Inst, Rensselaer, NY 12144 USA; [Sato, Thomas] Nara Inst Sci & Technol, Nara 6300101, Japan; [Kotton, Darrell N.] Boston Univ, Ctr Regenerat Med, Boston, MA 02118 USA; [Kotton, Darrell N.] Boston Med Ctr, Boston, MA 02118 USA; [Bissig, Karl-Dimiter] Baylor Coll Med, Dept Mol & Cellular Biol, Stem Cells & Regenerat Med Ctr, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Evans, Todd] Weill Cornell Med Coll, Dept Surg, New York, NY 10065 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Nara Institute of Science & Technology; Boston University; Boston Medical Center; Baylor College of Medicine; Cornell University	Gouon-Evans, V (corresponding author), Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, Dept Dev & Regenerat Biol, New York, NY 10029 USA.	valerie.gouon-evans@mssm.edu	Han, Songyan/D-8351-2012	Gouon-Evans, Valerie/0000-0001-5424-6573; Evans, Matthew/0000-0002-4991-3877; Kotton, Darrell/0000-0002-9604-8476; Corneo, Barbara/0000-0001-5189-6749; hamou, wissam/0000-0002-0731-9386	Black Family Stem Cell Institute; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK087867-01]; American Cancer Society [RSG-12-176-01-MPC]; Pew Charitable Funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087867, R01DK095125] Funding Source: NIH RePORTER	Black Family Stem Cell Institute; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Cancer Society(American Cancer Society); Pew Charitable Funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Black Family Stem Cell Institute, the National Institute of Diabetes and Digestive and Kidney Diseases for the mouse study (R01DK087867-01 to V.G.E.), the Robin Chemers Neustein Postdoctoral Fellowship (M.S.), the American Cancer Society (RSG-12-176-01-MPC to M.J.E.), and the Pew Charitable Funds (M.J.E.).	Agarwal S, 2008, STEM CELLS, V26, P1117, DOI 10.1634/stemcells.2007-1102; Antoniou A, 2009, GASTROENTEROLOGY, V136, P2325, DOI 10.1053/j.gastro.2009.02.051; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Coveney D, 2008, P NATL ACAD SCI USA, V105, P7212, DOI 10.1073/pnas.0707674105; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Dorrell C, 2011, GENE DEV, V25, P1193, DOI 10.1101/gad.2029411; Duan YY, 2010, STEM CELLS, V28, P674, DOI 10.1002/stem.315; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Han S., 2012, J STEM CELL RES TH S, VS10; Han SY, 2011, STEM CELLS, V29, P217, DOI 10.1002/stem.576; Hannan NRF, 2013, NAT PROTOC, V8, P430, DOI 10.1038/nprot.2012.153; Hay DC, 2008, P NATL ACAD SCI USA, V105, P12301, DOI 10.1073/pnas.0806522105; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Kopper O, 2012, STEM CELL RES, V8, P335, DOI 10.1016/j.scr.2011.12.006; LAVERRIERE AC, 1994, J BIOL CHEM, V269, P23177; Lavine KJ, 2006, GENE DEV, V20, P1651, DOI 10.1101/gad.1411406; Lugus JJ, 2009, BLOOD, V113, P563, DOI 10.1182/blood-2008-06-162750; Mahieu-Caputo D, 2004, HUM GENE THER, V15, P1219, DOI 10.1089/hum.2004.15.1219; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; MIGLIACCIO G, 1986, J CLIN INVEST, V78, P51, DOI 10.1172/JCI112572; Motoike T, 2003, GENESIS, V35, P153, DOI 10.1002/gene.10175; Nava S, 2005, DIFFERENTIATION, V73, P249, DOI 10.1111/j.1432-0436.2005.00019.x; Nierhoff D, 2005, HEPATOLOGY, V42, P130, DOI 10.1002/hep.20735; Nierhoff D, 2007, HEPATOLOGY, V46, P535, DOI 10.1002/hep.21721; Nitou M, 2002, EXP CELL RES, V279, P330, DOI 10.1006/excr.2002.5615; Nowak G, 2005, GUT, V54, P972, DOI 10.1136/gut.2005.064477; Nyamath P, 2007, WORLD J GASTROENTERO, V13, P2319, DOI 10.3748/wjg.v13.i16.2319; Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369; Roelandt P, 2012, J HEPATOL, V57, P246, DOI 10.1016/j.jhep.2012.03.030; Sackett SD, 2009, HEPATOLOGY, V49, P920, DOI 10.1002/hep.22705; Schmelzer E, 2007, J EXP MED, V204, P1973, DOI 10.1084/jem.20061603; Schmelzer E, 2006, STEM CELLS, V24, P1852, DOI 10.1634/stemcells.2006-0036; Schwartz RE, 2012, P NATL ACAD SCI USA, V109, P2544, DOI 10.1073/pnas.1121400109; Sherwood RI, 2007, DEV BIOL, V304, P541, DOI 10.1016/j.ydbio.2007.01.011; Shulla A, 2012, CURR OPIN VIROL, V2, P725, DOI 10.1016/j.coviro.2012.09.013; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Sondell M, 2001, NEUROREPORT, V12, P105, DOI 10.1097/00001756-200101220-00028; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sullivan GJ, 2010, HEPATOLOGY, V51, P329, DOI 10.1002/hep.23335; Suzuki A, 2002, J CELL BIOL, V156, P173, DOI 10.1083/jcb.200108066; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tanaka M, 2009, MECH DEVELOP, V126, P665, DOI 10.1016/j.mod.2009.06.939; Tanimizu N, 2003, J CELL SCI, V116, P1775, DOI 10.1242/jcs.00388; Terrace JD, 2007, STEM CELLS DEV, V16, P771, DOI 10.1089/scd.2007.0016; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Touboul T, 2010, HEPATOLOGY, V51, P1754, DOI 10.1002/hep.23506; White AC, 2007, DEVELOPMENT, V134, P3743, DOI 10.1242/dev.004879; Wu XF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002617; Yoshida T, 2011, BIOCHEM BIOPH RES CO, V416, P119, DOI 10.1016/j.bbrc.2011.11.007	55	41	45	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 6	2013	12	6					748	760		10.1016/j.stem.2013.04.026	http://dx.doi.org/10.1016/j.stem.2013.04.026			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VH	23746980	Bronze, Green Accepted			2022-12-28	WOS:000329569900017
J	Winton, DJ				Winton, Douglas J.			miR-34a Sets the "Sweet Spot'' for Notch in Colorectal Cancer Stem Cells	CELL STEM CELL			English	Editorial Material								Mechanisms underlying alternative modes of symmetric versus asymmetric stem cell fates are not well understood. In this issue of Cell Stem Cell, Bu et al. (2013) find that miR-34a acts as a toggle switch for Notch signaling that dictates binary symmetric and asymmetric fates in colon cancer stem cells.	Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England	Cancer Research UK; CRUK Cambridge Institute	Winton, DJ (corresponding author), Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Robinson Way, Cambridge CB2 0RE, England.	doug.winton@cruk.cam.ac.uk			Cancer Research UK [17044] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		Bossuyt W, 2009, PLOS BIOL, V7, P311, DOI 10.1371/journal.pbio.1000039; Bu PC, 2013, CELL STEM CELL, V12, P602, DOI 10.1016/j.stem.2013.03.002; Itzkovitz S, 2012, NAT CELL BIOL, V14, P106, DOI 10.1038/ncb2384; Lal A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002363; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; Pellegrinet L., 2011, GASTROENTEROLOGY, V140, P1230; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Vogt M, 2011, VIRCHOWS ARCH, V458, P313, DOI 10.1007/s00428-010-1030-5	10	13	15	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 2	2013	12	5					499	501		10.1016/j.stem.2013.04.018	http://dx.doi.org/10.1016/j.stem.2013.04.018			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VE	23642356	Bronze			2022-12-28	WOS:000329569600002
J	Julian, LM; Vandenbosch, R; Pakenham, CA; Andrusiak, MG; Nguyen, AP; McClellan, KA; Svoboda, DS; Lagace, DC; Park, DS; Leone, G; Blais, A; Slack, RS				Julian, Lisa M.; Vandenbosch, Renaud; Pakenham, Catherine A.; Andrusiak, Matthew G.; Nguyen, Angela P.; McClellan, Kelly A.; Svoboda, Devon S.; Lagace, Diane C.; Park, David S.; Leone, Gustavo; Blais, Alexandre; Slack, Ruth S.			Opposing Regulation of Sox2 by Cell-Cycle Effectors E2f3a and E2f3b in Neural Stem Cells	CELL STEM CELL			English	Article							MITOTIC SPINDLE ORIENTATION; PROGENITOR CELLS; TRANSCRIPTION FACTORS; PRECURSOR CELLS; MAMMALIAN BRAIN; DIFFERENTIATION; MOUSE; GENE; EXPRESSION; NEURONS	The mechanisms through which cell-cycle control and cell-fate decisions are coordinated in proliferating stem cell populations are largely unknown. Here, we show that E2f3 isoforms, which control cell-cycle progression in cooperation with the retinoblastoma protein (pRb), have critical effects during developmental and adult neurogenesis. Loss of either E2f3 isoform disrupts Sox2 gene regulation and the balance between precursor maintenance and differentiation in the developing cortex. Both isoforms target the Sox2 locus to maintain baseline levels of Sox2 expression but antagonistically regulate Sox2 levels to instruct fate choices. E2f3-mediated regulation of Sox2 and precursor cell fate extends to the adult brain, where E2f3a loss results in defects in hippocampal neurogenesis and memory formation. Our results demonstrate a mechanism by which E2f3a and E2f3b differentially regulate Sox2 dosage in neural precursors, a finding that may have broad implications for the regulation of diverse stem cell populations.	[Julian, Lisa M.; Vandenbosch, Renaud; Pakenham, Catherine A.; Andrusiak, Matthew G.; Nguyen, Angela P.; McClellan, Kelly A.; Svoboda, Devon S.; Lagace, Diane C.; Park, David S.; Slack, Ruth S.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [Blais, Alexandre] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON K1H 8M5, Canada; [Blais, Alexandre] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Leone, Gustavo] Ohio State Univ, Solid Tumor Biol Program, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Leone, Gustavo] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Genet, Columbus, OH 43210 USA	University of Ottawa; University of Ottawa; University of Ottawa; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Blais, A (corresponding author), Univ Ottawa, Ottawa Inst Syst Biol, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	alexandre.blais@uottawa.ca; rslack@uottawa.ca		Blais, Alexandre/0000-0003-2446-1883; Slack, Ruth/0000-0002-1552-2835; Park, David/0000-0002-4490-3784	Canadian Institutes of Health Research (CIHR); CIHR Canada Graduate Scholarships; Ontario Graduate Scholarship (OGS); OGSST studentships; OGS; Heart and Stroke Foundation of Canada (HSFC) scholarships; Alzheimer Society of Canada; HSFC; University of Ottawa; Fonds Leon Fredericq (University of Liege, Belgium)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Canada Graduate Scholarships(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship (OGS)(Ontario Graduate Scholarship); OGSST studentships; OGS(Ontario Graduate Scholarship); Heart and Stroke Foundation of Canada (HSFC) scholarships; Alzheimer Society of Canada; HSFC(Heart & Stroke Foundation of Canada); University of Ottawa; Fonds Leon Fredericq (University of Liege, Belgium)	We thank Drs. Valerie Wallace, Rod Bremner, Marc Germain, and Mireille Khacho for critical review of the manuscript, as well as Jason MacLaurin, Linda Jui, Mirela Hasu, Alysen Clark, and Delphie Dugal-Tessier for excellent technical assistance. We also thank Yubing Liu for help with ChIP-on-chip experiments and Drs. Juliette Godin and Sandrine Humbert for assistance with the spindle-pole analysis. This work was funded by Canadian Institutes of Health Research (CIHR) grants to R. S. S.; and also by CIHR Canada Graduate Scholarships to L.M.J. and K. A. M.; Ontario Graduate Scholarship (OGS) and OGSST studentships to C. A. P. and L.M.J.; OGS and Heart and Stroke Foundation of Canada (HSFC) scholarships to M. G. A.; and fellowships from the Alzheimer Society of Canada, HSFC, University of Ottawa Vision 2010, and a travel award from Fonds Leon Fredericq (University of Liege, Belgium) to R.V.	Adams MR, 2000, MOL CELL BIOL, V20, P3633, DOI 10.1128/MCB.20.10.3633-3639.2000; Andrusiak MG, 2011, MOL CELL BIOL, V31, P238, DOI 10.1128/MCB.00378-10; Marques-Torrejon MA, 2013, CELL STEM CELL, V12, P88, DOI 10.1016/j.stem.2012.12.001; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Asp P, 2009, GENE DEV, V23, P37, DOI 10.1101/gad.1727309; Bani-Yaghoub M, 2006, DEV BIOL, V295, P52, DOI 10.1016/j.ydbio.2006.03.007; Callaghan DA, 1999, DEV BIOL, V207, P257, DOI 10.1006/dbio.1998.9162; Cavallaro M, 2008, DEVELOPMENT, V135, P541, DOI 10.1242/dev.010801; Chen D, 2007, PLOS BIOL, V5, P1504, DOI 10.1371/journal.pbio.0050179; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chong JL, 2009, NATURE, V462, P930, DOI 10.1038/nature08677; Danielian PS, 2008, ONCOGENE, V27, P6561, DOI 10.1038/onc.2008.253; Das RM, 2012, EMBO REP, V13, P448, DOI 10.1038/embor.2012.42; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Farkas LM, 2008, CURR OPIN CELL BIOL, V20, P707, DOI 10.1016/j.ceb.2008.09.008; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Galderisi U, 2006, ONCOGENE, V25, P5250, DOI 10.1038/sj.onc.1209736; Godin JD, 2010, NEURON, V67, P392, DOI 10.1016/j.neuron.2010.06.027; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Hutton SR, 2011, DEV BIOL, V352, P40, DOI 10.1016/j.ydbio.2011.01.015; King JC, 2008, CELL CYCLE, V7, P3775, DOI 10.4161/cc.7.23.7240; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; LeCouter JE, 1998, MOL CELL BIOL, V18, P7455, DOI 10.1128/MCB.18.12.7455; Li H, 2012, CELL STEM CELL, V11, P845, DOI 10.1016/j.stem.2012.09.014; Liu YB, 2010, NUCLEIC ACIDS RES, V38, P6857, DOI 10.1093/nar/gkq585; Marin-Burgin A, 2012, BEHAV BRAIN RES, V227, P391, DOI 10.1016/j.bbr.2011.07.001; McClellan KA, 2007, MOL CELL BIOL, V27, P4825, DOI 10.1128/MCB.02100-06; Miyagi S, 2008, FEBS LETT, V582, P2811, DOI 10.1016/j.febslet.2008.07.011; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; O'Connor MD, 2011, EXP HEMATOL, V39, P866, DOI 10.1016/j.exphem.2011.05.008; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Ruzhynsky VA, 2007, J NEUROSCI, V27, P5926, DOI 10.1523/JNEUROSCI.1538-07.2007; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Tsai SY, 2008, NATURE, V454, P1137, DOI 10.1038/nature07066; Vanderluit JL, 2004, J CELL BIOL, V166, P853, DOI 10.1083/jcb.200403156; Wehner Jeanne M, 2004, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0805cs27; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954	39	55	56	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 4	2013	12	4					440	452		10.1016/j.stem.2013.02.001	http://dx.doi.org/10.1016/j.stem.2013.02.001			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VD	23499385	Bronze			2022-12-28	WOS:000329569500011
J	Goyama, S; Mulloy, JC				Goyama, Susumu; Mulloy, James C.			Making Healthy Stem Cells: The New Role of TPO	CELL STEM CELL			English	Editorial Material							LEUKEMIA-CELLS; THROMBOPOIETIN; ELTROMBOPAG; REPAIR	Thrombopoietin (TPO) attracts much attention as an effective stimulus for blood cell formation in patients with hematopoietic disorders. In this issue of Cell Stem Cell, de Laval et al. (2013) show that TPO can also promote "healthy" hematopoietic stem cells when administered before radiotherapy to minimize HSC injury and mutagenesis in mice.	[Goyama, Susumu; Mulloy, James C.] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center	Mulloy, JC (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA.	james.mulloy@cchmc.org			NIDDK NIH HHS [P30 DK090971] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090971] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Chou FS, 2011, J CELL BIOCHEM, V112, P1491, DOI 10.1002/jcb.23089; de Laval B, 2013, CELL STEM CELL, V12, P37, DOI 10.1016/j.stem.2012.10.012; Kalota A, 2010, BLOOD, V115, P89, DOI 10.1182/blood-2009-06-227751; Kuter DJ, 2007, BLOOD, V109, P4607, DOI 10.1182/blood-2006-10-019315; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Olnes MJ, 2012, NEW ENGL J MED, V367, P11, DOI 10.1056/NEJMoa1200931; Qian H, 2007, CELL STEM CELL, V1, P671, DOI 10.1016/j.stem.2007.10.008; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Roth M, 2012, BLOOD, V120, P386, DOI 10.1182/blood-2011-12-399667; Sugita M., 2012, LEUKEMIA; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020	12	7	8	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 3	2013	12	1					8	9		10.1016/j.stem.2012.12.008	http://dx.doi.org/10.1016/j.stem.2012.12.008			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	074UM	23290133	Bronze			2022-12-28	WOS:000313839500004
J	Li, H; Collado, M; Villasante, A; Matheu, A; Lynch, CJ; Canamero, M; Rizzoti, K; Carneiro, C; Martinez, G; Vidal, A; Lovell-Badge, R; Serrano, M				Li, Han; Collado, Manuel; Villasante, Aranzazu; Matheu, Ander; Lynch, Cian J.; Canamero, Marta; Rizzoti, Karine; Carneiro, Carmen; Martinez, Gloria; Vidal, Anxo; Lovell-Badge, Robin; Serrano, Manuel			p27(Kip1) Directly Represses Sox2 during Embryonic Stem Cell Differentiation	CELL STEM CELL			English	Article							PROGENITOR CELLS; MICE LACKING; MUTATIONS; HYPERPLASIA; INHIBITORS; GROWTH	The mechanisms responsible for the transcriptional silencing of pluripotency genes in differentiated cells are poorly understood. We have observed that cells lacking the tumor suppressor p27 can be reprogrammed into induced pluripotent stem cells (iPSCs) in the absence of ectopic Sox2. Interestingly, cells and tissues from p27 null mice, including brain, lung, and retina, present an elevated basal expression of Sox2, suggesting that p27 contributes to the repression of Sox2. Furthermore, p27 null iPSCs fail to fully repress Sox2 upon differentiation. Mechanistically, we have found that upon differentiation p27 associates to the SRR2 enhancer of the Sox2 gene together with a p130-E2F4-SIN3A repressive complex. Finally, Sox2 haploinsufficiency genetically rescues some of the phenotypes characteristic of p27 null mice, including gigantism, pituitary hyperplasia, pituitary tumors, and retinal defects. Collectively, these results demonstrate an unprecedented connection between p27 and Sox2 relevant for reprogramming and cancer and for understanding human pathologies associated with p27 germline mutations.	[Li, Han; Collado, Manuel; Villasante, Aranzazu; Lynch, Cian J.; Serrano, Manuel] Spanish Natl Canc Res Ctr CNIO, Tumor Suppress Grp, E-28029 Madrid, Spain; [Canamero, Marta] Spanish Natl Canc Res Ctr CNIO, Histopathol Unit, E-28029 Madrid, Spain; [Matheu, Ander; Rizzoti, Karine; Lovell-Badge, Robin] MRC Natl Inst Med Res, Div Stem Cell Biol & Dev Genet, London NW7 1AA, England; [Carneiro, Carmen; Martinez, Gloria; Vidal, Anxo] Univ Santiago Compostela, Inst Invest Sanitarias IDIS, Fac Med, Dept Fisiol, E-15782 Santiago De Compostela, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); MRC National Institute for Medical Research; Universidade de Santiago de Compostela	Collado, M (corresponding author), Spanish Natl Canc Res Ctr CNIO, Tumor Suppress Grp, E-28029 Madrid, Spain.	manuel.collado.rodriguez@sergas.es; mserrano@cnio.es	/AAI-3238-2021; Lynch, Cian J/K-2191-2017; Collado, Manuel/K-8140-2014; matheu, ander/G-9906-2014; Rizzoti, Karine/AAW-1090-2021; Vidal, Anxo/B-5010-2015; Serrano, Manuel/H-2634-2015; Lynch, Cian/AIC-5510-2022; Villasante, Aranzazu/A-9100-2017	Lynch, Cian J/0000-0003-0187-3527; Collado, Manuel/0000-0002-0330-0880; matheu, ander/0000-0002-1848-0781; Rizzoti, Karine/0000-0003-0711-5452; Vidal, Anxo/0000-0002-0866-4202; Serrano, Manuel/0000-0001-7177-9312; Lynch, Cian/0000-0003-0187-3527; Lovell-Badge, Robin/0000-0001-9364-4179; Villasante, Aranzazu/0000-0001-7919-9670	Spanish Association Against Cancer (AECC); Spanish Ministry of Economy (MINECO); CNIO; MINECO (SAF and CONSOLIDER); Regional Government of Madrid; European Research Council (ERC); Botin Foundation; AXA Foundation; Ramon Areces Foundation; Human Frontiers Science Program; UK Medical Research Council [U117512772]; MINECO (SAF); Xunta de Galicia; Medical Research Council [MC_U117562207] Funding Source: researchfish; MRC [MC_U117562207] Funding Source: UKRI	Spanish Association Against Cancer (AECC); Spanish Ministry of Economy (MINECO); CNIO; MINECO (SAF and CONSOLIDER); Regional Government of Madrid; European Research Council (ERC)(European Research Council (ERC)European Commission); Botin Foundation; AXA Foundation; Ramon Areces Foundation; Human Frontiers Science Program(Human Frontier Science Program); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MINECO (SAF); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are indebted to Diego Megias from the CNIO for technical assistance, and to the Biological Services staff at NIMR. H.L. has been funded by the Spanish Association Against Cancer (AECC). H.L. and M. Collado have a "Ramon y Cajal" contract from the Spanish Ministry of Economy (MINECO). Work in the laboratory of M.S. is funded by the CNIO and by grants from the MINECO (SAF and CONSOLIDER), the Regional Government of Madrid, the European Research Council (ERC), the Botin Foundation, the AXA Foundation, and the Ramon Areces Foundation. A.M. is supported by a long-term fellowship of the Human Frontiers Science Program; K.R., R.L.-B., and work in the R.L.-B. laboratory are funded by the UK Medical Research Council (U117512772). Work in the A. Vidal laboratory is funded by grants from the MINECO (SAF) and from the Xunta de Galicia. H.L. and M. Collado performed most of the experiments and contributed to experimental design, data analysis, discussion, and writing the paper; A. Villasante, C.J.L., and C.C. performed the chromatin immunoprecipitations; M. Canamero performed the histological analyses; A.M., K.R., and R.L.-B. provided the Sox2 mouse models, performed mouse manipulations, and contributed to the analysis of the mouse phenotypes; C.C., G.M., and A. Vidal provided MEFs and contributed to the analysis of the pituitary phenotype; M. Collado and M.S. designed and supervised the study, secured funding, analyzed the data, and wrote the manuscript. All authors discussed the results and commented on the manuscript. The authors declare no competing financial interests with this paper.	Aleem E, 2005, NAT CELL BIOL, V7, P831, DOI 10.1038/ncb1284; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bahrami A.R., 2005, MECH DEVELOP, V122, P1034; Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Bryja V, 2005, STEM CELLS, V23, P965, DOI 10.1634/stemcells.2004-0174; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Coats S, 1999, CURR BIOL, V9, P163, DOI 10.1016/S0960-9822(99)80086-4; D'Amour KA, 2003, P NATL ACAD SCI USA, V100, P11866, DOI 10.1073/pnas.1834200100; Dannenberg JH, 2005, GENE DEV, V19, P1581, DOI 10.1101/gad.1286905; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; Engelen E, 2011, NAT GENET, V43, P607, DOI 10.1038/ng.825; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Fauquier T, 2008, P NATL ACAD SCI USA, V105, P2907, DOI 10.1073/pnas.0707886105; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Garcia-Lavandeira M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004815; Gleiberman AS, 2008, P NATL ACAD SCI USA, V105, P6332, DOI 10.1073/pnas.0801644105; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kelberman D, 2006, J CLIN INVEST, V116, P2442, DOI 10.1172/JCI28658; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Marinoni I, 2011, NEUROENDOCRINOLOGY, V93, P19, DOI 10.1159/000320366; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Martin A., 2005, CANCER CELL, V7, P591; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Pippa R, 2012, ONCOGENE, V31, P4207, DOI 10.1038/onc.2011.582; Savatier P, 1996, ONCOGENE, V12, P309; Sikorska M, 2008, J NEUROSCI RES, V86, P1680, DOI 10.1002/jnr.21635; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Vandeva S, 2010, ANN ENDOCRINOL-PARIS, V71, P479, DOI 10.1016/j.ando.2010.08.005; Williamson KA, 2006, HUM MOL GENET, V15, P1413, DOI 10.1093/hmg/ddl064; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002	37	104	105	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 7	2012	11	6					845	852		10.1016/j.stem.2012.09.014	http://dx.doi.org/10.1016/j.stem.2012.09.014			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	055MJ	23217425	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000312420300015
J	Iglesias-Bartolome, R; Patel, V; Cotrim, A; Leelahavanichkul, K; Molinolo, AA; Mitchell, JB; Gutkind, JS				Iglesias-Bartolome, Ramiro; Patel, Vyomesh; Cotrim, Ana; Leelahavanichkul, Kantima; Molinolo, Alfredo A.; Mitchell, James B.; Gutkind, J. Silvio			mTOR Inhibition Prevents Epithelial Stem Cell Senescence and Protects from Radiation-Induced Mucositis	CELL STEM CELL			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; MAMMALIAN TARGET; AGING PHENOTYPES; STRESS-RESPONSE; CANCER PATIENTS; RAPAMYCIN; HEAD; NECK; TUMOR; SKIN	The integrity of the epidermis and mucosal epithelia is highly dependent on resident self-renewing stem cells, which makes them vulnerable to physical and chemical insults compromising the repopulating capacity of the epithelial stem cell compartment. This is frequently the case in cancer patients receiving radiation or chemotherapy, many of whom develop mucositis, a debilitating condition involving painful and deep mucosal ulcerations. Here, we show that inhibiting the mammalian target of rapamycin (mTOR) with rapamycin increases the clonogenic capacity of primary human oral keratinocytes and their resident self-renewing cells by preventing stem cell senescence. This protective effect of rapamycin is mediated by the increase in expression of mitochondrial superoxide dismutase (MnSOD), and the consequent inhibition of ROS formation and oxidative stress. mTOR inhibition also protects from the loss of proliferative basal epithelial stem cells upon ionizing radiation in vivo, thereby preserving the integrity of the oral mucosa and protecting from radiation-induced mucositis.	[Iglesias-Bartolome, Ramiro; Patel, Vyomesh; Leelahavanichkul, Kantima; Molinolo, Alfredo A.; Gutkind, J. Silvio] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20852 USA; [Cotrim, Ana] Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20852 USA; [Mitchell, James B.] NCI, Radiat Biol Branch, Ctr Canc Res, NIH, Bethesda, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gutkind, JS (corresponding author), Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20852 USA.	sg39v@nih.gov	Gutkind, J. Silvio/J-1201-2016; Iglesias-Bartolome, Ramiro/H-4460-2014	Gutkind, J. Silvio/0000-0002-5150-4482; Iglesias-Bartolome, Ramiro/0000-0002-0792-1254	Intramural Research Program of the National Institutes of Health; National Institute of Dental and Craniofacial Research; Human Frontier Science Program [RGP0041-2011]; NATIONAL CANCER INSTITUTE [ZIASC006321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000558] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Human Frontier Science Program(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Bruce J. Baum (NIH, NIDCR) and Thomas Bugge (NIH, NIDCR) for comments and discussions. We thank Mina Konigsberg (Universidad Autonoma, Mexico) for insightful suggestions regarding oxidative stress and senescence. This work was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Dental and Craniofacial Research, and by the Human Frontier Science Program Grant #RGP0041-2011.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Amornphimoltham P, 2005, CANCER RES, V65, P9953, DOI 10.1158/0008-5472.CAN-05-0921; Amornphimoltham P, 2008, CLIN CANCER RES, V14, P8094, DOI 10.1158/1078-0432.CCR-08-0703; Begg AC, 2011, NAT REV CANCER, V11, P239, DOI 10.1038/nrc3007; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Chen HCJ, 2009, INVEST OPHTH VIS SCI, V50, P4660, DOI 10.1167/iovs.09-3377; Citrin D, 2010, ONCOLOGIST, V15, P360, DOI 10.1634/theoncologist.2009-S104; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Cotrim AP, 2007, CLIN CANCER RES, V13, P4928, DOI 10.1158/1078-0432.CCR-07-0662; Cotrim AP, 2005, CLIN CANCER RES, V11, P7564, DOI 10.1158/1078-0432.CCR-05-0958; Cristofalo VJ, 1998, P NATL ACAD SCI USA, V95, P10614, DOI 10.1073/pnas.95.18.10614; Czeminski R, 2009, CANCER PREV RES, V2, P27, DOI 10.1158/1940-6207.CAPR-08-0147; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Delaney G, 2005, CANCER-AM CANCER SOC, V103, P2216, DOI 10.1002/cncr.21084; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Eshleman JS, 2002, CANCER RES, V62, P7291; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; Holley AK, 2011, INT J MOL SCI, V12, P7114, DOI 10.3390/ijms12107114; Hosoki A, 2012, J RADIAT RES, V53, P58, DOI 10.1269/jrr.11034; Iglesias-Bartolome R, 2011, CURR OPIN CELL BIOL, V23, P716, DOI 10.1016/j.ceb.2011.08.002; Jensen KB, 2010, NAT PROTOC, V5, P898, DOI 10.1038/nprot.2010.39; Konstantinidou G, 2009, CANCER RES, V69, P7644, DOI 10.1158/0008-5472.CAN-09-0823; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lee JH, 2010, SCIENCE, V327, P1223, DOI 10.1126/science.1182228; Leelahavanichkul K., 2012, METHOD MOL BIOL EPIT; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Luis NM, 2011, CELL STEM CELL, V9, P233, DOI 10.1016/j.stem.2011.07.013; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Molinolo AA, 2007, CLIN CANCER RES, V13, P4964, DOI 10.1158/1078-0432.CCR-07-1041; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Murphy JD, 2009, CLIN CANCER RES, V15, P589, DOI 10.1158/1078-0432.CCR-08-1019; Nakamura T, 2007, OPHTHALMOLOGY, V114, P1080, DOI 10.1016/j.ophtha.2006.09.034; Nathan CAO, 2007, CANCER RES, V67, P2160, DOI 10.1158/0008-5472.CAN-06-2449; Nonzee NJ, 2008, CANCER-AM CANCER SOC, V113, P1446, DOI 10.1002/cncr.23714; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Rosas SLB, 2001, CANCER RES, V61, P939; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Sonis ST, 2010, ORAL DIS, V16, P597, DOI 10.1111/j.1601-0825.2010.01681.x; Sonis ST, 2009, ORAL ONCOL, V45, P1015, DOI 10.1016/j.oraloncology.2009.08.006; Spitz DR, 2004, CANCER METAST REV, V23, P311, DOI 10.1023/B:CANC.0000031769.14728.bc; Squarize CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010643; Takahashi H, 2011, BIOCHEM BIOPH RES CO, V406, P42, DOI 10.1016/j.bbrc.2011.01.103; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Treiber N, 2011, AGING CELL, V10, P239, DOI 10.1111/j.1474-9726.2010.00658.x; Velarde MC, 2012, AGING-US, V4, P3, DOI 10.18632/aging.100423; Wander SA, 2011, J CLIN INVEST, V121, P1231, DOI 10.1172/JCI44145; Weyemi U, 2012, AGING-US, V4, P116, DOI 10.18632/aging.100433; Zeng XM, 2007, STEM CELL REV, V3, P270, DOI 10.1007/s12015-007-9005-x; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	59	206	214	1	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	SEP 7	2012	11	3					401	414		10.1016/j.stem.2012.06.007	http://dx.doi.org/10.1016/j.stem.2012.06.007			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	018DW	22958932	Bronze, Green Accepted			2022-12-28	WOS:000309641300013
J	Bao, SQ; Leitch, HG; Gillich, A; Nichols, J; Tang, FC; Kim, S; Lee, C; Zwaka, T; Li, XH; Surani, MA				Bao, Siqin; Leitch, Harry G.; Gillich, Astrid; Nichols, Jennifer; Tang, Fuchou; Kim, Shinseog; Lee, Caroline; Zwaka, Thomas; Li, Xihe; Surani, M. Azim			The Germ Cell Determinant Blimp1 Is Not Required for Derivation of Pluripotent Stem Cells	CELL STEM CELL			English	Article							GROUND-STATE; ILLUMINA MICROARRAY; EPIBLAST; MOUSE; MICE; IDENTITY; LINEAGE; ORIGIN	Blimp1 (Prdm1), the key determinant of primordial germ cells (PGCs), plays a combinatorial role with Prdm14 during PGC specification from postimplantation epiblast cells. They together initiate epigenetic reprogramming in early germ cells toward an underlying pluripotent state, which is equivalent to embryonic stem cells (ESCs). Whereas Prdm14 alone can promote reprogramming and is important for the propagation of the pluripotent state, it is not known whether Blimp1 is similarly involved. By using a genetic approach, we demonstrate that Blimp1 is dispensable for the derivation and maintenance of ESCs and postimplantation epiblast stem cells (epiSCs). Notably, Blimp1 is also dispensable for reprogramming epiSCs to ESCs. Thus, although Blimp1 is obligatory for PGC specification, it is not required for the reversion of epiSCs to ESCs and for their maintenance thereafter. This study suggests that reprogramming, including that of somatic cells to ESCs, may not entail an obligatory route through a Blimp1-positive PGC-like state.	[Bao, Siqin; Leitch, Harry G.; Gillich, Astrid; Tang, Fuchou; Kim, Shinseog; Lee, Caroline; Surani, M. Azim] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst Canc & Dev, Cambridge CB2 1QN, England; [Leitch, Harry G.; Gillich, Astrid; Nichols, Jennifer; Surani, M. Azim] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 1QN, England; [Zwaka, Thomas] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Zwaka, Thomas] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Zwaka, Thomas] Baylor Coll Med, Dept Human Genet, Houston, TX 77030 USA; [Li, Xihe] Inner Mongolia Univ, Mengniu RB CO Ltd, Coll Life Sci, Hohhot 010021, Inner Mongolia, Peoples R China	University of Cambridge; University of Cambridge; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Inner Mongolia University	Surani, MA (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst Canc & Dev, Tennis Court Rd, Cambridge CB2 1QN, England.	a.surani@gurdon.cam.ac.uk	Leitch, Harry/D-5516-2011; Leitch, Harry/I-3357-2019	Leitch, Harry/0000-0002-3486-8962; Leitch, Harry/0000-0002-3486-8962; Nichols, Jennifer/0000-0002-8650-1388; Surani, Azim/0000-0002-8640-4318; Kim, Shinseog/0000-0001-9469-7635; Bao, Siqin/0000-0002-9582-3194	Wellcome Trust [RG44593]; Merck, Sharp and Dohme Award from the University of Cambridge School of Clinical Medicine MB/PhD programme; James Baird Fund; Medical Research Council [G0800784B, G0800784] Funding Source: researchfish; MRC [G0800784] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Merck, Sharp and Dohme Award from the University of Cambridge School of Clinical Medicine MB/PhD programme; James Baird Fund; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank William Mansfield and Erna Magnusdottir for assistance and Cambridge Genomic Services for help with the microarray analysis. This work was supported by grants from the Wellcome Trust to M.A.S.; H.G.L. was supported by a Merck, Sharp and Dohme Award from the University of Cambridge School of Clinical Medicine MB/PhD programme and the James Baird Fund; and A.G. is supported by Wellcome Trust PhD studentship (RG44593).	Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Chu LF, 2011, CURR BIOL, V21, P1759, DOI 10.1016/j.cub.2011.09.010; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Durcova-Hills G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003531; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Han DW, 2011, NAT CELL BIOL, V13, P66, DOI 10.1038/ncb2136; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hayashi K, 2009, DEVELOPMENT, V136, P3549, DOI 10.1242/dev.037747; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Leitch HG, 2010, DEVELOPMENT, V137, P2279, DOI 10.1242/dev.050427; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Ma ZY, 2011, NAT STRUCT MOL BIOL, V18, P120, DOI 10.1038/nsmb.2000; Nagamatsu G, 2011, J BIOL CHEM, V286, P10641, DOI 10.1074/jbc.M110.216390; Nagy A., 2003, MANIPULATING MOUSE E; Nichols J, 2011, DEVELOPMENT, V138, P3, DOI 10.1242/dev.050831; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Robertson EJ, 2007, DEVELOPMENT, V134, P4335, DOI 10.1242/dev.012047; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Yang JA, 2010, CELL STEM CELL, V7, P319, DOI 10.1016/j.stem.2010.06.022; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zwaka TP, 2005, DEVELOPMENT, V132, P227, DOI 10.1242/dev.01586	29	19	22	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUL 6	2012	11	1					110	117		10.1016/j.stem.2012.02.023	http://dx.doi.org/10.1016/j.stem.2012.02.023			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	975SS	22770244	hybrid, Green Published			2022-12-28	WOS:000306532400014
J	Kadzik, RS; Morrisey, EE				Kadzik, Rachel S.; Morrisey, Edward E.			Directing Lung Endoderm Differentiation in Pluripotent Stem Cells	CELL STEM CELL			English	Review							FOREGUT; BETA; SOX2; MORPHOGENESIS; EPITHELIUM; IDENTITY; ROLES	The lung is composed of numerous epithelial lineages that arise from the anterior foregut endoderm. This review discusses how insights into the signaling mechanisms that regulate lung endoderm specification and subsequent differentiation have recently been exploited to direct differentiation of hESCs/iPSCs into expandable lung progenitors.	[Morrisey, Edward E.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Kadzik, Rachel S.; Morrisey, Edward E.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Morrisey, Edward E.] Univ Penn, Inst Regenerat Med, Philadelphia, PA 19104 USA; [Morrisey, Edward E.] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Morrisey, EE (corresponding author), Univ Penn, Dept Med, Philadelphia, PA 19104 USA.	emorrise@mail.med.upenn.edu			National Institutes of Health [HL087825, HL071589, HL110942]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087825, R01HL064632, U01HL110942, R01HL071589] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We apologize in advance to investigators whose outstanding research, which led to these important findings, was not cited due to space limitations. These studies are supported by funding from the National Institutes of Health (HL087825, HL071589, and HL110942).	Basma H, 2009, GASTROENTEROLOGY, V136, P990, DOI 10.1053/j.gastro.2008.10.047; Chapman HA, 2011, J CLIN INVEST, V121, P2855, DOI 10.1172/JCI57673; Chen F, 2010, J CLIN INVEST, V120, P2040, DOI 10.1172/JCI40253; Cheng X, 2012, CELL STEM CELL, V10, P371, DOI 10.1016/j.stem.2012.02.024; Desai TJ, 2006, DEV BIOL, V291, P12, DOI 10.1016/j.ydbio.2005.10.045; Domyan ET, 2011, DEVELOPMENT, V138, P971, DOI 10.1242/dev.053694; Gadue P, 2005, EXP HEMATOL, V33, P955, DOI 10.1016/j.exphem.2005.06.009; Goss AM, 2009, DEV CELL, V17, P290, DOI 10.1016/j.devcel.2009.06.005; Green MD, 2011, NAT BIOTECHNOL, V29, P267, DOI 10.1038/nbt.1788; Guseh JS, 2009, DEVELOPMENT, V136, P1751, DOI 10.1242/dev.029249; Harris-Johnson KS, 2009, P NATL ACAD SCI USA, V106, P16287, DOI 10.1073/pnas.0902274106; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Longmire TA, 2012, CELL STEM CELL, V10, P398, DOI 10.1016/j.stem.2012.01.019; Minoo P, 1999, DEV BIOL, V209, P60, DOI 10.1006/dbio.1999.9234; Morimoto M, 2010, J CELL SCI, V123, P213, DOI 10.1242/jcs.058669; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Mou HM, 2012, CELL STEM CELL, V10, P385, DOI 10.1016/j.stem.2012.01.018; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Que JW, 2009, DEVELOPMENT, V136, P1899, DOI 10.1242/dev.034629; Rawlins EL, 2009, DEVELOPMENT, V136, P3741, DOI 10.1242/dev.037317; Shannon JM, 2004, ANNU REV PHYSIOL, V66, P625, DOI 10.1146/annurev.physiol.66.032102.135749; Sherwood RI, 2011, MECH DEVELOP, V128, P387, DOI 10.1016/j.mod.2011.07.005; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Tompkins DH, 2011, AM J RESP CELL MOL, V45, P101, DOI 10.1165/rcmb.2010-0149OC; Tsao PN, 2009, DEVELOPMENT, V136, P2297, DOI 10.1242/dev.034884; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	26	39	43	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	APR 6	2012	10	4					355	361		10.1016/j.stem.2012.03.013	http://dx.doi.org/10.1016/j.stem.2012.03.013			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	929QA	22482501	Bronze, Green Accepted			2022-12-28	WOS:000303079400005
J	Parson, A				Parson, Ann			Regenerating Battle Wounds, Together	CELL STEM CELL			English	News Item												parson-a@verizon.net							0	1	1	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAR 2	2012	10	3					241	243		10.1016/j.stem.2012.02.006	http://dx.doi.org/10.1016/j.stem.2012.02.006			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	908BX	22486005	Bronze			2022-12-28	WOS:000301466500006
J	Chen, MJ; Li, Y; De Obaldia, ME; Yang, Q; Yzaguirre, AD; Yamada-Inagawa, T; Vink, CS; Bhandoola, A; Dzierzak, E; Speck, NA				Chen, Michael J.; Li, Yan; De Obaldia, Maria Elena; Yang, Qi; Yzaguirre, Amanda D.; Yamada-Inagawa, Tomoko; Vink, Chris S.; Bhandoola, Avinash; Dzierzak, Elaine; Speck, Nancy A.			Erythroid/Myeloid Progenitors and Hematopoietic Stem Cells Originate from Distinct Populations of Endothelial Cells	CELL STEM CELL			English	Article							CORE-BINDING-FACTOR; CBF-BETA; DEFINITIVE HEMATOPOIESIS; AORTIC ENDOTHELIUM; RUNX1 EXPRESSION; YOLK-SAC; AML1; IDENTIFICATION; GENERATION; TRANSGENE	Hematopoietic stem cells (HSCs) and an earlier wave of definitive erythroid/myeloid progenitors (EMPs) differentiate from hemogenic endothelial cells in the conceptus. EMPs can be generated in vitro from embryonic or induced pluripotent stem cells, but efforts to produce HSCs have largely failed. The formation of both EMPs and HSCs requires the transcription factor Runx1 and its non-DNA binding partner core binding factor beta (CBF beta). Here we show that the requirements for CBF beta in EMP and HSC formation in the conceptus are temporally and spatially distinct. Panendothelial expression of CBF beta in Tek-expressing cells was sufficient for EMP formation, but was not adequate for HSC formation. Expression of CBF beta in Ly6a-expressing cells, on the other hand, was sufficient for HSC, but not EMP, formation. The data indicate that EMPs and HSCs differentiate from distinct populations of hemogenic endothelial cells, with Ly6a expression specifically marking the HSC-generating hemogenic endothelium.	[Chen, Michael J.; Li, Yan; Yzaguirre, Amanda D.; Speck, Nancy A.] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Chen, Michael J.; Li, Yan; Yzaguirre, Amanda D.; Speck, Nancy A.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [De Obaldia, Maria Elena; Yang, Qi; Bhandoola, Avinash] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Yamada-Inagawa, Tomoko; Vink, Chris S.; Dzierzak, Elaine] Erasmus MC, Erasmus Stem Cell Inst, Dept Cell Biol, NL-3000 DR Rotterdam, Netherlands	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Erasmus University Rotterdam; Erasmus MC	Speck, NA (corresponding author), Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	nancyas@exchange.upenn.edu		Vink, Chris S./0000-0002-3202-8361; De Obaldia, Maria/0000-0003-2488-3672	Netherlands Institute of Regenerative Medicine;  [R01HL091724]; NATIONAL CANCER INSTITUTE [R01CA058343, P30CA016520] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK054077] Funding Source: NIH RePORTER	Netherlands Institute of Regenerative Medicine; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Tomomasa Yokomizo for teaching us how to perform the whole-mount immunohistochemistry. We are especially grateful to Andrea Stout for her help with confocal microscopy. This work was supported by R01HL091724 (N.A.S.) and Netherlands Institute of Regenerative Medicine (E.D.). Core services were supported by the Abramson Family Cancer Research Institute and the Abramson Cancer Center.	ADJA N, 1998, MOL CELL BIOL, V18, P7432; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Bollerot K, 2005, GENE EXPR PATTERNS, V6, P29, DOI 10.1016/j.modgep.2005.05.003; CAI X, 2011, PLOS ONE IN PRESS; Cai ZL, 2000, IMMUNITY, V13, P423, DOI 10.1016/S1074-7613(00)00042-X; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Cho SK, 1999, P NATL ACAD SCI USA, V96, P9797, DOI 10.1073/pnas.96.17.9797; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; de Bruijn MFTR, 2002, IMMUNITY, V16, P673, DOI 10.1016/S1074-7613(02)00313-8; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; Gekas C, 2005, DEV CELL, V8, P365, DOI 10.1016/j.devcel.2004.12.016; Holmes C, 2007, STEM CELLS, V25, P1339, DOI 10.1634/stemcells.2006-0644; Hsu HC, 2000, BLOOD, V96, P3757, DOI 10.1182/blood.V96.12.3757.h8003757_3757_3762; HUANG H, 1993, P NATL ACAD SCI USA, V90, P10110, DOI 10.1073/pnas.90.21.10110; Irion S, 2010, DEVELOPMENT, V137, P2829, DOI 10.1242/dev.042119; Jaffredo T, 2005, EXP HEMATOL, V33, P1029, DOI 10.1016/j.exphem.2005.06.005; Kissa K, 2008, BLOOD, V111, P1147, DOI 10.1182/blood-2007-07-099499; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Lengerke C, 2010, BLOOD REV, V24, P27, DOI 10.1016/j.blre.2009.10.001; Li Z, 2006, BLOOD, V107, P106, DOI 10.1182/blood-2005-05-1955; Liakhovitskaia A, 2009, STEM CELLS, V27, P1616, DOI 10.1002/stem.71; Ling KW, 2004, J EXP MED, V200, P871, DOI 10.1084/jem.20031556; Ma XQ, 2002, STEM CELLS, V20, P514, DOI 10.1634/stemcells.20-6-514; Ma XQ, 2002, BRIT J HAEMATOL, V116, P401, DOI 10.1046/j.1365-2141.2002.03250.x; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Medvinsky AL, 1996, BLOOD, V87, P557, DOI 10.1182/blood.V87.2.557.bloodjournal872557; Miller J, 2002, NAT GENET, V32, P645, DOI 10.1038/ng1049; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; North T, 1999, DEVELOPMENT, V126, P2563; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Ottersbach K, 2005, DEV CELL, V8, P377, DOI 10.1016/j.devcel.2005.02.001; Palis J, 1999, DEVELOPMENT, V126, P5073; Robert-Moreno A, 2008, EMBO J, V27, P1886, DOI 10.1038/emboj.2008.113; Robin C, 2006, DEV CELL, V11, P171, DOI 10.1016/j.devcel.2006.07.002; Sasaki K, 1996, P NATL ACAD SCI USA, V93, P12359, DOI 10.1073/pnas.93.22.12359; Schmitt TM, 2004, NAT IMMUNOL, V5, P410, DOI 10.1038/ni1055; Schmitt TM, 2006, IMMUNOL REV, V209, P95, DOI 10.1111/j.0105-2896.2006.00353.x; SINCLAIR AM, 1993, BLOOD, V82, P3052; SPANGRUDE GJ, 1993, BLOOD, V82, P3327; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Talebian L, 2007, BLOOD, V109, P11, DOI 10.1182/blood-2006-05-021188; Wang Q, 1996, CELL, V87, P697, DOI 10.1016/S0092-8674(00)81389-6; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Yan JL, 2004, NAT STRUCT MOL BIOL, V11, P901, DOI 10.1038/nsmb819; Yoder MC, 1997, P NATL ACAD SCI USA, V94, P6776, DOI 10.1073/pnas.94.13.6776; YOKOMIZO T, 2011, NAT PROTOC IN PRESS; Yokomizo T, 2010, DEVELOPMENT, V137, P3651, DOI 10.1242/dev.051094; Yokota T, 2009, BLOOD, V113, P2914, DOI 10.1182/blood-2008-07-167106; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	55	172	176	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 2	2011	9	6					541	552		10.1016/j.stem.2011.10.003	http://dx.doi.org/10.1016/j.stem.2011.10.003			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	859SB	22136929	Green Accepted, Bronze			2022-12-28	WOS:000297895000014
J	Yang, N; Ng, YH; Pang, ZPP; Sudhof, TC; Wernig, M				Yang, Nan; Ng, Yi Han; Pang, Zhiping P.; Suedhof, Thomas C.; Wernig, Marius			Induced Neuronal Cells: How to Make and Define a Neuron	CELL STEM CELL			English	Review							PLURIPOTENT STEM-CELLS; HUMAN FIBROBLASTS; DOPAMINERGIC-NEURONS; FUNCTIONAL-NEURONS; MOUSE FIBROBLASTS; DIRECT CONVERSION; MOTOR-NEURON; HIPPOCAMPAL-NEURONS; FACTOR OLIG2; DIFFERENTIATION	Cellular plasticity is a major focus of investigation in developmental biology. The recent discovery that induced neuronal (iN) cells can be generated from mouse and human fibroblasts by expression of defined transcription factors suggested that cell fate plasticity is much wider than previously anticipated. In this review, we summarize the most recent developments in this nascent field and suggest criteria to help define and categorize iN cells that take into account the complexity of neuronal identity.	[Yang, Nan; Ng, Yi Han; Wernig, Marius] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Dept Pathol, Stanford, CA 94305 USA; [Pang, Zhiping P.; Suedhof, Thomas C.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Suedhof, Thomas C.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Wernig, M (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Dept Pathol, 265 Campus Dr, Stanford, CA 94305 USA.	wernig@stanford.edu	Pang, Zhiping/AAF-5757-2020; Yang, Nan/H-3174-2012	Pang, Zhiping/0000-0002-6183-1233; Yang, Nan/0000-0003-3663-1288	NIMH NIH HHS [R01 MH092931] Funding Source: Medline; NINDS NIH HHS [RC4 NS073015] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC4NS073015] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ambasudhan R, 2011, CELL STEM CELL, V9, P113, DOI 10.1016/j.stem.2011.07.002; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; BANKER GA, 1980, SCIENCE, V209, P809, DOI 10.1126/science.7403847; BONFANTI L, 1992, NEUROSCIENCE, V49, P419, DOI 10.1016/0306-4522(92)90107-D; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Graf T, 2011, CELL STEM CELL, V9, P504, DOI 10.1016/j.stem.2011.11.012; Gurdon JB, 2006, ANNU REV CELL DEV BI, V22, P1, DOI 10.1146/annurev.cellbio.22.090805.140144; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Hobert O, 2011, ANNU REV CELL DEV BI, V27, P681, DOI 10.1146/annurev-cellbio-092910-154226; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Kim J, 2011, CELL STEM CELL, V9, P413, DOI 10.1016/j.stem.2011.09.011; KOESTER J., 2000, PRINCIPLES NEURAL SC, P150; KRIKS S, 2011, NATURE, P6; LEE SK, 2002, GENE DEV, V19, P282; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Lockery SR, 2009, NAT NEUROSCI, V12, P365, DOI 10.1038/nn0409-365; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Marro S, 2011, CELL STEM CELL, V9, P374, DOI 10.1016/j.stem.2011.09.002; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Park HC, 2002, DEV BIOL, V248, P356, DOI 10.1006/dbio.2002.0738; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Qiang L, 2011, CELL, V146, P359, DOI 10.1016/j.cell.2011.07.007; REGEHR WG, 2001, PHYSL SYNAPTIC TRANS, P135; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Silverman MA, 2001, P NATL ACAD SCI USA, V98, P7051, DOI 10.1073/pnas.111146198; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Vicario-Abejon C, 2000, EUR J NEUROSCI, V12, P677, DOI 10.1046/j.1460-9568.2000.00953.x; Vierbuchen T, 2011, NAT BIOTECHNOL, V29, P892, DOI 10.1038/nbt.1946; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Wernig M, 2004, J NEUROSCI, V24, P5258, DOI 10.1523/JNEUROSCI.0428-04.200; Wu H, 2007, P NATL ACAD SCI USA, V104, P13821, DOI 10.1073/pnas.0706199104; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Yang DL, 2008, STEM CELLS, V26, P55, DOI 10.1634/stemcells.2007-0494; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7	61	138	149	2	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 2	2011	9	6					517	525		10.1016/j.stem.2011.11.015	http://dx.doi.org/10.1016/j.stem.2011.11.015			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	859SB	22136927	Bronze, Green Accepted			2022-12-28	WOS:000297895000012
J	Miharada, K; Karlsson, G; Rehn, M; Rorby, E; Siva, K; Cammenga, J; Karlsson, S				Miharada, Kenichi; Karlsson, Goran; Rehn, Matilda; Rorby, Emma; Siva, Kavitha; Cammenga, Jorg; Karlsson, Stefan			Cripto Regulates Hematopoietic Stem Cells as a Hypoxic-Niche-Related Factor through Cell Surface Receptor GRP78	CELL STEM CELL			English	Article							BONE-MARROW NICHE; SELF-RENEWAL; MOLECULAR CHARACTERIZATION; PROGENITOR CELLS; TGF-BETA; IN-VIVO; MAINTENANCE; PROTEINS; FAMILY; GROWTH	Hematopoietic stem cells (HSCs) are maintained in hypoxic niches in endosteal regions of bones. Here we demonstrate that Cripto and its receptor GRP78 are important regulators of HSCs in the niche. Flow cytometry analyses revealed two distinct subpopulations of CD34(-)KSL cells based on the expression of GRP78, and these populations showed different reconstitution potential in transplantation assays. GRP78(+)HSCs mainly reside in the endosteal area, are more hypoxic, and exhibit a lower mitochondrial potential, and their HSC capacity was maintained in vitro by Cripto through induction of higher glycolytic activity. Additionally, HIF-1 alpha KO mice have decreased numbers of GRP78(+)HSCs and reduced expression of Cripto in the endosteal niche. Furthermore, blocking GRP78 induced a movement of HSCs from the endosteal to the central marrow area. These data suggest that Cripto/GRP78 signaling is an important pathway that regulates HSC quiescence and maintains HSCs in hypoxia as an intermediary of HIF-1 alpha.	[Miharada, Kenichi; Karlsson, Goran; Rehn, Matilda; Rorby, Emma; Siva, Kavitha; Cammenga, Jorg; Karlsson, Stefan] Lund Univ, Lund Strateg Ctr Stem Cell Biol, Dept Mol Med & Gene Therapy, S-22184 Lund, Sweden	Lund University	Miharada, K (corresponding author), Lund Univ, Lund Strateg Ctr Stem Cell Biol, Dept Mol Med & Gene Therapy, S-22184 Lund, Sweden.	kenichi.miharada@med.lu.se; stefan.karlsson@med.lu.se	Miharada, Kenichi/C-1397-2014	Miharada, Kenichi/0000-0001-8073-4001; Karlsson, Goran/0000-0001-8197-754X; Siva, Kavitha/0000-0001-9480-4496; Rehn, Matilda/0000-0002-9436-9655	Swedish Research Council Linnaeus; Swedish Cancer Foundation (Cancerfonden); The Swedish Cancer Society; Swedish Children's Cancer Society; Swedish Medical Research Council; The Tobias Foundation; EU; PERSIST; Marie Curie actions; Center of Excellence; Swedish Foundation for Strategic Research	Swedish Research Council Linnaeus(Swedish Research Council); Swedish Cancer Foundation (Cancerfonden)(Swedish Cancer Society); The Swedish Cancer Society(Swedish Cancer Society); Swedish Children's Cancer Society; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); The Tobias Foundation; EU(European Commission); PERSIST; Marie Curie actions(European Commission); Center of Excellence; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	We thank Leif Carlsson for providing Lhx2 cells; Susie Nilsson for sending a detailed protocol for analyzing eHSCs/cHSCs; Tariq Enver and Jonas Larsson for critical discussions; and Zhi Ma for excellent advice on flow cytometry analyses. This work was supported by the Hemato-Linne grant (Swedish Research Council Linnaeus), the Swedish Cancer Foundation (Cancerfonden), The Swedish Cancer Society (S.K.), the Swedish Children's Cancer Society (S.K.), the Swedish Medical Research Council (S.K.), The Tobias Prize awarded by The Royal Swedish Academy of Sciences financed by The Tobias Foundation (S.K.), and the EU project grants CONSERT, STEMEXPAND, and PERSIST. K.M. was funded by the EU-funded NOVEXPAND project in Marie Curie actions. The Lund Stem Cell Center was supported by a Center of Excellence grant in life sciences from the Swedish Foundation for Strategic Research.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Arai F, 2007, ANN NY ACAD SCI, V1106, P41, DOI 10.1196/annals.1392.005; Bianco C, 2010, AM J PATHOL, V177, P532, DOI 10.2353/ajpath.2010.100102; Bianco C, 2009, AM J PATHOL, V175, P2146, DOI 10.2353/ajpath.2009.090218; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; CICCODICOLA A, 1989, EMBO J, V8, P1987, DOI 10.1002/j.1460-2075.1989.tb03605.x; Danet GH, 2003, J CLIN INVEST, V112, P126, DOI 10.1172/JCI200317669; Davidson DJ, 2005, CANCER RES, V65, P4663, DOI 10.1158/0008-5472.CAN-04-3426; Ding JX, 1998, NATURE, V395, P702, DOI 10.1038/27215; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Grassinger J, 2010, BLOOD, V116, P3185, DOI 10.1182/blood-2009-12-260703; Gray PC, 2006, MOL CELL BIOL, V26, P9268, DOI 10.1128/MCB.01168-06; Hardy B, 2010, J MOL MED, V88, P1157, DOI 10.1007/s00109-010-0657-7; Haug JS, 2008, CELL STEM CELL, V2, P367, DOI 10.1016/j.stem.2008.01.017; Hough SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007708; Huang YP, 2007, J CELL SCI, V120, P723, DOI 10.1242/jcs.000786; Kahn J, 2004, BLOOD, V103, P2942, DOI 10.1182/blood-2003-07-2607; Karlsson G, 2007, J EXP MED, V204, P467, DOI 10.1084/jem.20060465; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kelber JA, 2009, ONCOGENE, V28, P2324, DOI 10.1038/onc.2009.97; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kubota Y, 2008, BIOCHEM BIOPH RES CO, V366, P335, DOI 10.1016/j.bbrc.2007.11.086; LI CL, 1995, BLOOD, V85, P1472, DOI 10.1182/blood.V85.6.1472.bloodjournal8561472; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Malhotra S, 2009, CELL STEM CELL, V4, P27, DOI 10.1016/j.stem.2008.12.004; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nakamura Y, 2010, BLOOD, V116, P1422, DOI 10.1182/blood-2009-08-239194; Ogaeri T, 2009, STEM CELLS, V27, P1120, DOI 10.1002/stem.42; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Ostergaard L, 2009, PROTEOMICS, V9, P4457, DOI 10.1002/pmic.200800130; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Richter K., 2002, BLOOD, V99, P3939; Salomon DS, 2000, ENDOCR-RELAT CANCER, V7, P199, DOI 10.1677/erc.0.0070199; Sato N, 2003, DEV BIOL, V260, P404, DOI 10.1016/S0012-1606(03)00256-2; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Schroeder T, 2010, CELL STEM CELL, V6, P203, DOI 10.1016/j.stem.2010.02.006; Shani G, 2008, MOL CELL BIOL, V28, P666, DOI 10.1128/MCB.01716-07; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Strizzi L, 2005, ONCOGENE, V24, P5731, DOI 10.1038/sj.onc.1208918; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Xu CH, 1998, DEV BIOL, V196, P237, DOI 10.1006/dbio.1998.8862; Yamazaki S, 2009, BLOOD, V113, P1250, DOI 10.1182/blood-2008-04-146480; Zhou J, 2004, J BIOL CHEM, V279, P13506, DOI 10.1074/jbc.M310164200	49	129	134	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	OCT 7	2011	9	4					330	344		10.1016/j.stem.2011.07.016	http://dx.doi.org/10.1016/j.stem.2011.07.016			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	835MT	21982233	Bronze			2022-12-28	WOS:000296041200011
J	Hong, SH; Pampalli, S; Lee, JB; McNicol, J; Collins, T; Draper, JS; Bhatia, M				Hong, Seok-Ho; Pampalli, Shravanti; Lee, Jung Bok; McNicol, Jamie; Collins, Tony; Draper, Jonathan S.; Bhatia, Mickie			Cell Fate Potential of Human Pluripotent Stem Cells Is Encoded by Histone Modifications	CELL STEM CELL			English	Article							DIFFERENTIATION; SUBPOPULATIONS; HETEROGENEITY; NICHE; STATE	Human embryonic stem cells (hESCs) expressing pluripotency markers are assumed to possess equipotent developmental potential. However, disparate responses to differentiation stimuli functionally illustrate that hESCs generate a spectrum of differentiated cell types, suggestive of lineage bias. Here, we reveal specific cell surface markers that allow sub-fractionation of hESCs expressing hallmark markers of pluripotency. By direct de novo isolation of these subsets, we demonstrate that propensities for lineage differentiation are balanced with reduced clonogenic self-renewal. Histone modification marks of gene loci associated with pluripotency versus lineage specificity predicted cell fate potential of these subfractions, thereby supporting the absence of uniform bivalency as a molecular paradigm to describe cell fate determination of pluripotent cells. Our study reveals that cell fate potential is encoded within cells comprising hESC cultures, highlighting them as a means to understand the mechanisms of lineage specification of pluripotent cells.	[Hong, Seok-Ho; Pampalli, Shravanti; Lee, Jung Bok; McNicol, Jamie; Collins, Tony; Draper, Jonathan S.; Bhatia, Mickie] McMaster Univ, McMaster Stem Cell & Canc Res Inst, Michael G DeGroote Sch Med, Hamilton, ON L8N 3Z5, Canada; [Draper, Jonathan S.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8N 3Z5, Canada; [Draper, Jonathan S.; Bhatia, Mickie] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada	McMaster University; McMaster University; McMaster University	Bhatia, M (corresponding author), McMaster Univ, McMaster Stem Cell & Canc Res Inst, Michael G DeGroote Sch Med, Hamilton, ON L8N 3Z5, Canada.	mbhatia@mcmaster.ca		Rampalli, Shravanti/0000-0002-6391-6409; Draper, Jonathan/0000-0002-3241-7009	Canadian Institute of Health Research; Ontario Ministry of Research Innovation-(OCRiT GL2); Canadian Chair Program	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Research Innovation-(OCRiT GL2)(Ministry of Research and Innovation, Ontario); Canadian Chair Program	This research was supported by the Canadian Institute of Health Research to M.B., Ontario Ministry of Research Innovation-(OCRiT GL2), and the Canadian Chair Program (CRC) to J.D. and M.B. We are grateful to Marilyne Levadoux-Martin for FACS expertise and Monica Graham for hESC culture. S.H and S.R designed the study, assisted in writing the manuscript, and performed most of the experiments. J.B. performed experiments. J.M. and T.C. performed Montage imaging and time lapse. J.D. provided intellectual input to the analysis of results and assisted in the initial drafts of the manuscript. M.B. supervised the experiments, provided intellectual support toward design and interpretation of the results, and wrote the final version of the manuscript.	Akkers RC, 2009, DEV CELL, V17, P425, DOI 10.1016/j.devcel.2009.08.005; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bendall SC, 2008, REGEN MED, V3, P365, DOI 10.2217/17460751.3.3.365; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009; Carpenter MK, 2001, EXP NEUROL, V172, P383, DOI 10.1006/exnr.2001.7832; CERDAN C, 2007, CURR PROTOC STEM CEL, V1, pCH1; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Cherry A, 2010, CELL STEM CELL, V7, P641, DOI 10.1016/j.stem.2010.11.020; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Han DW, 2010, CELL, V143, P617, DOI 10.1016/j.cell.2010.10.015; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hough SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007708; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Jang S, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-25; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Ng ES, 2005, DEVELOPMENT, V132, P873, DOI 10.1242/dev.01657; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pietersen AM, 2008, CURR OPIN CELL BIOL, V20, P201, DOI 10.1016/j.ceb.2008.01.004; Shin SJ, 2006, STEM CELLS, V24, P125, DOI 10.1634/stemcells.2004-0150; Stewart MH, 2008, J MOL MED, V86, P875, DOI 10.1007/s00109-008-0356-9; Stewart MH, 2006, NAT METHODS, V3, P807, DOI 10.1038/nmeth939; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Vijayaragavan K, 2009, CELL STEM CELL, V4, P248, DOI 10.1016/j.stem.2008.12.011; Wang LS, 2004, IMMUNITY, V21, P31, DOI 10.1016/j.immuni.2004.06.006; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wu H, 2007, P NATL ACAD SCI USA, V104, P13821, DOI 10.1073/pnas.0706199104; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	38	69	72	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 8	2011	9	1					24	36		10.1016/j.stem.2011.06.002	http://dx.doi.org/10.1016/j.stem.2011.06.002			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	797VA	21726831	Bronze			2022-12-28	WOS:000293157000007
J	Faddah, DA; Wang, HY; Cheng, AW; Katz, Y; Buganim, Y; Jaenisch, R				Faddah, Dina A.; Wang, Haoyi; Cheng, Albert Wu; Katz, Yarden; Buganim, Yosef; Jaenisch, Rudolf			Single-Cell Analysis Reveals that Expression of Nanog Is Biallelic and Equally Variable as that of Other Pluripotency Factors in Mouse ESCs	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; GROUND-STATE; AUTOREPRESSION; HETEROGENEITY	The homeodomain transcription factor Nanog is a central part of the core pluripotency transcriptional network and plays a critical role in embryonic stem cell (ESC) self-renewal. Several reports have suggested that Nanog expression is allelically regulated and that transient downregulation of Nanog in a subset of pluripotent cells predisposes them toward differentiation. Using single-cell gene expression analyses combined with different reporters for the two alleles of Nanog, we show that Nanog is biallelically expressed in ESCs independently of culture condition. We also show that the overall variation in endogenous Nanog expression in ESCs is very similar to that of several other pluripotency markers. Our analysis suggests that reporter-based studies of gene expression in pluripotent cells can be significantly influenced by the gene-targeting strategy and genetic background employed.	[Faddah, Dina A.; Wang, Haoyi; Cheng, Albert Wu; Katz, Yarden; Buganim, Yosef; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Faddah, Dina A.; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02139 USA; [Cheng, Albert Wu] MIT, Dept Computat & Syst Biol, Cambridge, MA 02139 USA; [Katz, Yarden] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu		Cheng, Albert/0000-0003-2653-5743	National Science Foundation Graduate Research Fellowship; Jerome and Florence Brill Graduate Student Fellowship; Croucher and Ludwig Research Fellowship; National Institutes of Health (NIH) Kirschstein National Research Service Award [1 F32 GM099153-01A1]; NIH [HD 045022, R37CA084198]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA084198, R01CA084198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM099153] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Jerome and Florence Brill Graduate Student Fellowship; Croucher and Ludwig Research Fellowship; National Institutes of Health (NIH) Kirschstein National Research Service Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Smith for sharing TNGA cells; B. Carey, M. Dawlaty, F. Soldner, and A. Salama for helpful discussions; T. Theunissen for help with sorting; and A. van Oudenaarden and S. Klemm for insightful discussions and Stella probe. D. A. F. is a Vertex scholar and was supported by a National Science Foundation Graduate Research Fellowship and a Jerome and Florence Brill Graduate Student Fellowship. A. W. C. was supported by a Croucher and Ludwig Research Fellowship. Y.B. was supported by a National Institutes of Health (NIH) Kirschstein National Research Service Award (1 F32 GM099153-01A1). This work was supported by NIH grants HD 045022 and R37CA084198 to R.J. R.J. is a cofounder of Fate Therapeutics and an advisor to Stemgent.	Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Fidalgo M, 2012, P NATL ACAD SCI USA, V109, P16202, DOI 10.1073/pnas.1208533109; Filipczyk A, 2013, CELL STEM CELL, V13, P12, DOI 10.1016/j.stem.2013.04.025; Fischer Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012533; Hatano S, 2005, MECH DEVELOP, V122, P67, DOI 10.1016/j.mod.2004.08.008; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Karwacki-Neisius V, 2013, CELL STEM CELL, V12, P531, DOI 10.1016/j.stem.2013.04.023; MacArthur BD, 2012, NAT CELL BIOL, V14, P1139, DOI 10.1038/ncb2603; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Miyanari Y, 2012, NATURE, V483, P470, DOI 10.1038/nature10807; Navarro P, 2012, EMBO J, V31, P4547, DOI 10.1038/emboj.2012.321; Orkin SH, 2008, COLD SH Q B, V73, P195, DOI 10.1101/sqb.2008.72.001; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	22	90	91	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2013	13	1					23	29		10.1016/j.stem.2013.04.019	http://dx.doi.org/10.1016/j.stem.2013.04.019			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VJ	23827708	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000329570100009
J	Borgelt, EL; Dharamsi, S; Scott, CT				Borgelt, Emily L.; Dharamsi, Shafik; Scott, Christopher Thomas			Dear Student: Stem Cell Scientists' Advice to the Next Generation	CELL STEM CELL			English	Editorial Material							POLICY	For the field of pluripotent stem cell biology to realize its promising future, current researchers will need to pass the torch to new generations. We asked a group of successful scientists in this area, "What advice would you give a young person considering a career in stem cell research?''	[Borgelt, Emily L.; Scott, Christopher Thomas] Program Stem Cells Soc, Ctr Biomed Eth, Stanford, CA 94305 USA; [Dharamsi, Shafik] Univ British Columbia, Dept Family Practice, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Borgelt, EL (corresponding author), Program Stem Cells Soc, Ctr Biomed Eth, Stanford, CA 94305 USA.	eborgelt@stanford.edu; cscott@stanford.edu	Dharamsi, Shafik/AAC-7427-2020	Dharamsi, Shafik/0000-0003-3971-4169				Adams V, 2009, SUBJECTIVITY, V28, P246, DOI 10.1057/sub.2009.18; Levine AD, 2006, NAT BIOTECHNOL, V24, P865, DOI 10.1038/nbt0706-865; Levine AD, 2011, CELL STEM CELL, V8, P132, DOI 10.1016/j.stem.2011.01.002; Longstaff H, 2013, CELL STEM CELL, V12, P517, DOI 10.1016/j.stem.2013.04.016; Owen-Smith J, 2012, J POLICY ANAL MANAG, V31, P714, DOI 10.1002/pam.21607; Ramon y Cajal S., 1897, ADVICE FOR A YOUNG I, P129; Scott CT, 2011, CELL, V145, P820, DOI 10.1016/j.cell.2011.05.032	7	4	4	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 6	2013	12	6					652	655		10.1016/j.stem.2013.05.007	http://dx.doi.org/10.1016/j.stem.2013.05.007			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VH	23746974	Bronze			2022-12-28	WOS:000329569900008
J	Seib, DRM; Corsini, NS; Ellwanger, K; Plaas, C; Mateos, A; Pitzer, C; Niehrs, C; Celikel, T; Martin-Villalba, A				Seib, Desiree R. M.; Corsini, Nina S.; Ellwanger, Kristina; Plaas, Christian; Mateos, Alvaro; Pitzer, Claudia; Niehrs, Christof; Celikel, Tansu; Martin-Villalba, Ana			Loss of Dickkopf-1 Restores Neurogenesis in Old Age and Counteracts Cognitive Decline	CELL STEM CELL			English	Article							NEURAL STEM-CELLS; ADULT HIPPOCAMPAL NEUROGENESIS; DENTATE GYRUS; SYNAPTIC PLASTICITY; PATTERN SEPARATION; GRANULE CELLS; NEURONS; BRAIN; MODEL; DIFFERENTIATION	Memory impairment has been associated with age-related decline in adult hippocampal neurogenesis. Although Notch, bone morphogenetic protein, and Wnt signaling pathways are known to regulate multiple aspects of adult neural stem cell function, the molecular basis of declining neurogenesis in the aging hippocampus remains unknown. Here, we show that expression of the Wnt antagonist Dickkopf-1 (Dkk1) increases with age and that its loss enhances neurogenesis in the hippocampus. Neural progenitors with inducible loss of Dkk1 increase their Wnt activity, which leads to enhanced self-renewal and increased generation of immature neurons. This Wnt-expanded progeny subsequently matures into glutamatergic granule neurons with increased dendritic complexity. As a result, mice deficient in Dkk1 exhibit enhanced spatial working memory and memory consolidation and also show improvements in affective behavior. Taken together, our findings show that upregulating Wnt signaling by reducing Dkk1 expression can counteract age-related decrease in neurogenesis and its associated cognitive decline.	[Seib, Desiree R. M.; Corsini, Nina S.; Mateos, Alvaro; Martin-Villalba, Ana] German Canc Res Ctr, DKFZ ZMBH Alliance, Div Mol Neurobiol, D-69120 Heidelberg, Germany; [Ellwanger, Kristina; Niehrs, Christof] German Canc Res Ctr, DKFZ ZMBH Alliance, Div Mol Embryol, D-69120 Heidelberg, Germany; [Plaas, Christian; Pitzer, Claudia] SYGNIS Biosci, D-69120 Heidelberg, Germany; [Celikel, Tansu] Univ So Calif, Lab Neural Circuits & Plast, Los Angeles, CA 90089 USA	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Southern California	Martin-Villalba, A (corresponding author), German Canc Res Ctr, DKFZ ZMBH Alliance, Div Mol Neurobiol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	a.martin-villalba@dkfz.de	Seib, Desiree/AAF-2801-2021; Celikel, Tansu/P-4235-2018	Seib, Desiree/0000-0001-9953-8270; Martin-Villalba, Ana/0000-0002-9405-8910; Corsini, Nina/0000-0001-6731-3544	DKFZ Light Microscopy Facility; Nikon Imaging Center at the University of Heidelberg; German Research Foundation (DFG) [SFB873]; Federal Ministry of Education and Research (BMBF independent research group); German Cancer Research Center (DKFZ)	DKFZ Light Microscopy Facility; Nikon Imaging Center at the University of Heidelberg; German Research Foundation (DFG)(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF independent research group); German Cancer Research Center (DKFZ)(Helmholtz Association)	We thank Gunther Schutz for the Nestin-Cre and Nestin-CreER<SUP>T2</SUP> mouse lines and Roel Nusse for the 7TGC plasmid. Automatized analysis of behavioral experiments was performed with SYGNIS TRACKER V4.1.14, SYGNIS Bioscience, Heidelberg. Support by the DKFZ Light Microscopy Facility and the Nikon Imaging Center at the University of Heidelberg is gratefully acknowledged. We thank Carmen Ruiz de Almodovar for help with in situ hybridization and discussion of the data. We thank Lola Buades for help with the design of the GA. We also thank Lothar Pilz and Simone Braun for help with statistical analysis. In addition, we thank Jennifer Hermes, Carina Konrad, Stefanie Limpert, Katrin Volk, Michaela Muller, and Christin Hannusch for experimental support. This work was funded by the German Research Foundation (DFG) (SFB873), the Federal Ministry of Education and Research (BMBF independent research group), and the German Cancer Research Center (DKFZ).	Aimone JB, 2011, NEURON, V70, P589, DOI 10.1016/j.neuron.2011.05.010; Aimone JB, 2010, TRENDS COGN SCI, V14, P325, DOI 10.1016/j.tics.2010.04.003; Ben Abdallah NMB, 2010, NEUROBIOL AGING, V31, P151, DOI 10.1016/j.neurobiolaging.2008.03.002; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Cameron HA, 1999, NAT NEUROSCI, V2, P894, DOI 10.1038/13197; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Cimadevilla JM, 2001, BRAIN RES BULL, V54, P559, DOI 10.1016/S0361-9230(01)00448-8; Corsini NS, 2009, CELL STEM CELL, V5, P178, DOI 10.1016/j.stem.2009.05.004; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Denny CA, 2012, HIPPOCAMPUS, V22, P1188, DOI 10.1002/hipo.20964; Duman CH, 2010, VITAM HORM, V82, P1, DOI 10.1016/S0083-6729(10)82001-1; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Gao X, 2007, J NEUROSCI, V27, P14317, DOI 10.1523/JNEUROSCI.3206-07.2007; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Hanson ND, 2011, NEUROPSYCHOPHARMACOL, V36, P2589, DOI 10.1038/npp.2011.220; Jang MH, 2013, CELL STEM CELL, V12, P215, DOI 10.1016/j.stem.2012.11.021; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; Jayatissa MN, 2009, BRAIN RES, V1290, P133, DOI 10.1016/j.brainres.2009.07.001; Jinno S, 2011, J COMP NEUROL, V519, P451, DOI 10.1002/cne.22527; Kim CS, 2012, NEURON, V75, P503, DOI 10.1016/j.neuron.2012.05.027; Korb E, 2011, TRENDS NEUROSCI, V34, P591, DOI 10.1016/j.tins.2011.08.007; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Lee SW, 2012, BEHAV BRAIN RES, V227, P497, DOI 10.1016/j.bbr.2011.10.009; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017; Matrisciano F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016447; Michaelidis TM, 2008, CELL TISSUE RES, V331, P193, DOI 10.1007/s00441-007-0476-5; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Munji RN, 2011, J NEUROSCI, V31, P1676, DOI 10.1523/JNEUROSCI.5404-10.2011; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Pietila I, 2011, DEV BIOL, V353, P50, DOI 10.1016/j.ydbio.2011.02.019; Qu QH, 2010, NAT CELL BIOL, V12, P31, DOI 10.1038/ncb2001; Rey JP, 2010, DEV DYNAM, V239, P102, DOI 10.1002/dvdy.22181; Sahay A, 2011, NEURON, V70, P582, DOI 10.1016/j.neuron.2011.05.012; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; SLOVITER RS, 1989, SCIENCE, V243, P535, DOI 10.1126/science.2911756; Small SA, 2011, NAT REV NEUROSCI, V12, P585, DOI 10.1038/nrn3085; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Solberg N, 2008, DEV DYNAM, V237, P1799, DOI 10.1002/dvdy.21586; Song J, 2012, NATURE, V489, P150, DOI 10.1038/nature11306; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Surget A, 2008, BIOL PSYCHIAT, V64, P293, DOI 10.1016/j.biopsych.2008.02.022; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Yassa MA, 2011, P NATL ACAD SCI USA, V108, P8873, DOI 10.1073/pnas.1101567108	51	212	220	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 7	2013	12	2					204	214		10.1016/j.stem.2012.11.010	http://dx.doi.org/10.1016/j.stem.2012.11.010			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VB	23395445	Bronze			2022-12-28	WOS:000329569300011
J	Lechman, ER; Gentner, B; van Galen, P; Giustacchini, A; Saini, M; Boccalatte, FE; Hiramatsu, H; Restuccia, U; Bachi, A; Voisin, V; Bader, GD; Dick, JE; Naldini, L				Lechman, Eric R.; Gentner, Bernhard; van Galen, Peter; Giustacchini, Alice; Saini, Massimo; Boccalatte, Francesco E.; Hiramatsu, Hidefumi; Restuccia, Umberto; Bachi, Angela; Voisin, Veronique; Bader, Gary D.; Dick, John E.; Naldini, Luigi			Attenuation of miR-126 Activity Expands HSC In Vivo without Exhaustion	CELL STEM CELL			English	Article							HEMATOPOIETIC STEM-CELLS; SELF-RENEWAL; MICRORNAS; PROGENITORS; GROWTH; PTEN; GENE; RNA	Lifelong blood cell production is governed through the poorly understood integration of cell-intrinsic and -extrinsic control of hematopoietic stem cell (HSC) quiescence and activation. MicroRNAs (miRNAs) coordinately regulate multiple targets within signaling networks, making them attractive candidate HSC regulators. We report that miR-126, a miRNA expressed in HSC and early progenitors, plays a pivotal role in restraining cell-cycle progression of HSC in vitro and in vivo. miR-126 knockdown by using lentiviral sponges increased HSC proliferation without inducing exhaustion, resulting in expansion of mouse and human long-term repopulating HSC. Conversely, enforced miR-126 expression impaired cell-cycle entry, leading to progressively reduced hematopoietic contribution. In HSC/early progenitors, miR-126 regulates multiple targets within the PI3K/AKT/GSK3 beta pathway, attenuating signal transduction in response to extrinsic signals. These data establish that miR-126 sets a threshold for HSC activation and thus governs HSC pool size, demonstrating the importance of miRNA in the control of HSC function.	[Lechman, Eric R.; van Galen, Peter; Dick, John E.] Univ Hlth Network, Princess Margaret Canc Ctr, Ontario Canc Inst, Campbell Family Inst, Toronto, ON M5G 1L7, Canada; [Lechman, Eric R.; van Galen, Peter; Voisin, Veronique; Bader, Gary D.; Dick, John E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1L7, Canada; [Voisin, Veronique; Bader, Gary D.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Gentner, Bernhard; Giustacchini, Alice; Saini, Massimo; Boccalatte, Francesco E.; Naldini, Luigi] San Raffaele Telethon Inst Gene Therapy, Div Regenerat Med, I-20132 Milan, Italy; [Gentner, Bernhard; Giustacchini, Alice; Saini, Massimo; Boccalatte, Francesco E.; Naldini, Luigi] Univ Vita Salute San Raffaele, I-20132 Milan, Italy; [Restuccia, Umberto; Bachi, Angela] Ist Sci San Raffaele, Bimol Mass Spectrometry Unit, Div Genet & Cell Biol, I-20132 Milan, Italy; [Hiramatsu, Hidefumi] Kyoto Univ, Grad Sch Med, Dept Pediat, Kyoto 6068507, Japan	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Kyoto University	Dick, JE (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Ontario Canc Inst, Campbell Family Inst, Toronto, ON M5G 1L7, Canada.	jdick@uhnresearch.ca; naldini.luigi@hsr.it	Boccalatte, Francesco/AAM-6186-2020; Giustacchini, Alice/D-4074-2018; Naldini, Luigi/E-9083-2012; Bader, Gary/C-1176-2009; bachi, angela/B-3527-2015; Boccalatte, Francesco/M-3511-2017	Boccalatte, Francesco/0000-0003-1732-2033; Giustacchini, Alice/0000-0002-8733-8594; Bader, Gary/0000-0003-0185-8861; bachi, angela/0000-0003-4842-6556; NALDINI, Luigi/0000-0002-7835-527X; Gentner, Bernhard/0000-0001-6024-4718; Lechman, Eric/0000-0001-8874-2874; Dick, John/0000-0002-9527-8317; Saini, Massimo/0000-0002-5916-8516; van Galen, Peter/0000-0002-0735-1570	Telethon; EU [249845]; Italian Ministry of Health; Canadian Institutes for Health Research; Canadian Cancer Society Research Institute; Terry Fox Foundation; Genome Canada through the Ontario Genomics Institute; Ontario Institute for Cancer Research; province of Ontario; Canada Research Chair; Ontario Ministry of Health and Long Term Care (OMOHLTC); NATIONAL CANCER INSTITUTE [R01CA121941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103504] Funding Source: NIH RePORTER	Telethon(Fondazione Telethon); EU(European Commission); Italian Ministry of Health(Ministry of Health, Italy); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Terry Fox Foundation; Genome Canada through the Ontario Genomics Institute(Genome Canada); Ontario Institute for Cancer Research; province of Ontario; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Ontario Ministry of Health and Long Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Schira, F. Benedicenti, and L. Sergi Sergi for technical help; Arian Khandani and P.A. Penttila and the UHN/Sickkids flow cytometry facility, A. Palini and E. Canonico from the San Raffaele flow cytometry facility, K. Moore and the obstetrics unit of Trillium Hospital (Mississauga, Ontario), and the Obstetrics and Gynecology Unit of the San Raffaele Hospital for providing CB; R. Tsien for providing the mOrange2 FP construct; E. Zonari, M. Amendola and Marie F. Andre for help with experiments; and A. Kreso and the entire Dick and Naldini labs for editorial and critical review of the manuscript. This work was supported by grants to L.N. from Telethon (TIGET grant), EU (FP7 GA 222878 PERSIST, ERC Advanced Grant 249845 TARGETINGGENETHERAPY), and the Italian Ministry of Health and to J.E.D. from the Canadian Institutes for Health Research, Canadian Cancer Society Research Institute, Terry Fox Foundation, Genome Canada through the Ontario Genomics Institute, Ontario Institute for Cancer Research with funds from the province of Ontario, and a Canada Research Chair. This research was funded in part by the Ontario Ministry of Health and Long Term Care (OMOHLTC). The views expressed do not necessarily reflect those of the OMOHLTC. A.G. and F.E.B. conducted this study as partial fulfilment of their PhD program in Molecular Medicine, program in Cellular and Molecular Biology and Biology and Biotherapy of Cancer, respectively (San Raffaele University, Milan, Italy).	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Buitenhuis M, 2011, CURR OPIN HEMATOL, V18, P226, DOI 10.1097/MOH.0b013e32834760e5; Buitenhuis M, 2009, CELL CYCLE, V8, P560, DOI 10.4161/cc.8.4.7654; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Feng RH, 2010, CANCER LETT, V298, P50, DOI 10.1016/j.canlet.2010.06.004; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Gentner B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001522; Gruber JJ, 2009, CELL, V138, P328, DOI 10.1016/j.cell.2009.04.046; Guo CG, 2008, GENE CHROMOSOME CANC, V47, P939, DOI 10.1002/gcc.20596; Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107; Han YC, 2010, J EXP MED, V207, P475, DOI 10.1084/jem.20090831; Harman BC, 2008, J IMMUNOL, V181, P7514, DOI 10.4049/jimmunol.181.11.7514; Havelange V, 2010, AM J HEMATOL, V85, P935, DOI 10.1002/ajh.21863; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Huang J, 2009, J CLIN INVEST, V119, P3519, DOI 10.1172/JCI40572; Huang XQ, 2011, BLOOD, V117, P2157, DOI 10.1182/blood-2010-08-302711; Juntilla MM, 2010, BLOOD, V115, P4030, DOI 10.1182/blood-2009-09-241000; Kuhnert F, 2008, DEVELOPMENT, V135, P3989, DOI 10.1242/dev.029736; Li J, 2011, EXP HEMATOL, V39, P511, DOI 10.1016/j.exphem.2011.01.008; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; McDermott SP, 2010, BLOOD, V116, P193, DOI 10.1182/blood-2010-02-271841; Miko E, 2009, EXP LUNG RES, V35, P646, DOI 10.3109/01902140902822312; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; O'Connell RM, 2010, P NATL ACAD SCI USA, V107, P14235, DOI 10.1073/pnas.1009798107; Ooi AGL, 2010, P NATL ACAD SCI USA, V107, P21505, DOI 10.1073/pnas.1016218107; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Thoren LA, 2008, J IMMUNOL, V180, P2045, DOI 10.4049/jimmunol.180.4.2045; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang J, 2008, BIOCHEM BIOPH RES CO, V377, P136, DOI 10.1016/j.bbrc.2008.09.089	34	151	156	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 7	2012	11	6					799	811		10.1016/j.stem.2012.09.001	http://dx.doi.org/10.1016/j.stem.2012.09.001			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	055MJ	23142521	Green Published, hybrid			2022-12-28	WOS:000312420300011
J	Lallemand-Breitenbach, V; de The, H				Lallemand-Breitenbach, Valerie; de The, Hugues			Hematopoietic Stem Cells Burn Fat to Prevent Exhaustion	CELL STEM CELL			English	Editorial Material							PML	Ito et al. (2012) recently report in Nature Medicine that fatty acid oxidation (FAO) regulated by PPAR delta controls asymmetric division in hematopoietic stem cells (HSCs). This metabolic mechanism prevents HSC exhaustion and is downstream of the promyelocytic leukemia protein PML, suggesting therapeutic implications for HSC function and disease.	[Lallemand-Breitenbach, Valerie; de The, Hugues] Univ Paris Diderot, F-75475 Paris 10, France; [Lallemand-Breitenbach, Valerie; de The, Hugues] Inst Univ Hematol, INSERM UMR 944, Equipe Labellisee Ligue Natl Canc, F-75475 Paris 10, France; [Lallemand-Breitenbach, Valerie; de The, Hugues] CNRS UMR 7212, F-75475 Paris 10, France; [de The, Hugues] Assistance Publ Hop Paris, Serv Biochim, F-75475 Paris 10, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	de The, H (corresponding author), Univ Paris Diderot, Hop St Louis 1,Ave Claude Vellefaux, F-75475 Paris 10, France.	hugues.dethe@inserm.fr		Lallemand, Valerie/0000-0001-9852-204X				Bug G, 2005, CANCER RES, V65, P2537, DOI 10.1158/0008-5472.CAN-04-3011; Carracedo A, 2012, J CLIN INVEST, V122, P3088, DOI 10.1172/JCI62129; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Ito K, 2012, NAT MED IN PRESS; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Jeanne M, 2010, CANCER CELL, V18, P88, DOI 10.1016/j.ccr.2010.06.003; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Regad T, 2009, NAT NEUROSCI, V12, P132, DOI 10.1038/nn.2251; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; Vernier M, 2011, GENE DEV, V25, P41, DOI 10.1101/gad.1975111	10	8	8	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 5	2012	11	4					447	449		10.1016/j.stem.2012.09.008	http://dx.doi.org/10.1016/j.stem.2012.09.008			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	021OZ	23040473	Bronze			2022-12-28	WOS:000309896500004
J	Pan, GJ; Pei, DQ				Pan, Guangjin; Pei, Duanqing			Order from Chaos: Single Cell Reprogramming in Two Phases	CELL STEM CELL			English	Editorial Material							GENERATION	The generation of induced pluripotent stem cells (iPSCs) is considered to be stochastic with a minute fraction of cells becoming pluripotent. Recently in Cell, Buganim et al. (2012) changed this view using single cell analyses to reveal a stochastic early and hierarchical late phase, with implications for productive alternative reprogramming strategies.	[Pan, Guangjin; Pei, Duanqing] Chinese Acad Sci, S China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth, CAS Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Pan, Guangjin; Pei, Duanqing] Chinese Acad Sci, S China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Pei, DQ (corresponding author), Chinese Acad Sci, S China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth, CAS Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China.	pei_duanqing@gibh.ac.cn		Pan, Guangjin/0000-0002-2378-7198				Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Chen JK, 2011, CELL RES, V21, P884, DOI 10.1038/cr.2011.51; GURDON JB, 1958, NATURE, V182, P64, DOI 10.1038/182064a0; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Pei DQ, 2009, J BIOL CHEM, V284, P3365, DOI 10.1074/jbc.R800063200; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180	10	3	4	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	OCT 5	2012	11	4					445	447		10.1016/j.stem.2012.09.004	http://dx.doi.org/10.1016/j.stem.2012.09.004			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	021OZ	23040472	Bronze			2022-12-28	WOS:000309896500003
J	Chell, JM; Frisen, J				Chell, James M.; Frisen, Jonas			Noisy Neurons Keep Neural Stem Cells Quiet	CELL STEM CELL			English	Editorial Material							ADULT HIPPOCAMPUS; PROLIFERATION	Recently in Nature, Song et al. (2012) show that the neurotransmitter GABA acts directly on radial glia-like neural stem cells to maintain quiescence and provide a mechanism for how neuronal activity controls the production of new neurons in the hippocampus.	[Chell, James M.; Frisen, Jonas] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden	Karolinska Institutet	Frisen, J (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden.	jonas.frisen@ki.se						Andang M, 2008, NATURE, V451, P460, DOI 10.1038/nature06488; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Dranovsky A, 2011, NEURON, V70, P908, DOI 10.1016/j.neuron.2011.05.022; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Fernando RN, 2011, P NATL ACAD SCI USA, V108, P5837, DOI 10.1073/pnas.1014993108; Liu XX, 2005, NAT NEUROSCI, V8, P1179, DOI 10.1038/nn1522; Masiulis I, 2011, MOL NEUROBIOL, V44, P287, DOI 10.1007/s12035-011-8207-z; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mira H, 2010, CELL STEM CELL, V7, P78, DOI 10.1016/j.stem.2010.04.016; Song J., 2012, NATURE	10	6	6	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	SEP 7	2012	11	3					282	284		10.1016/j.stem.2012.08.009	http://dx.doi.org/10.1016/j.stem.2012.08.009			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	018DW	22958925	Bronze			2022-12-28	WOS:000309641300002
J	Qin, JZ; Whyte, WA; Anderssen, E; Apostolou, E; Chen, HH; Akbarian, S; Bronson, RT; Hochedlinger, K; Ramaswamy, S; Young, RA; Hock, H				Qin, Jinzhong; Whyte, Warren A.; Anderssen, Endre; Apostolou, Effie; Chen, Hsu-Hsin; Akbarian, Schahram; Bronson, Roderick T.; Hochedlinger, Konrad; Ramaswamy, Sridhar; Young, Richard A.; Hock, Hanno			The Polycomb Group Protein L3mbtl2 Assembles an Atypical PRC1-Family Complex that Is Essential in Pluripotent Stem Cells and Early Development	CELL STEM CELL			English	Article							GENE-EXPRESSION; HOX GENE; DIFFERENTIATION; METHYLATION; DEMETHYLASE; BINDING; STATE; E2F6; MICE; H2A	L3mbtl2 has been implicated in transcriptional repression and chromatin compaction but its biological function has not been defined. Here we show that disruption of L3mbtl2 results in embryonic lethality with failure of gastrulation. This correlates with compromised proliferation and abnormal differentiation of L3mbtl2(-/-) embryonic stem (ES) cells. L3mbtl2 regulates genes by recruiting a Polycomb Repressive Complex1 (PRC1)-related complex, resembling the previously described E2F6-complex, and including G9A, Hdac1, and Ring1b. The presence of L3mbtl2 at target genes is associated with H3K9 dimethylation, low histone acetylation, and H2AK119 ubiquitination, but the latter is neither dependent on L3mbtl2 nor sufficient for repression. Genomewide studies revealed that the L3mbtl2-dependent complex predominantly regulates genes not bound by canonical PRC1 and PRC2. However, some developmental regulators are repressed by the combined activity of all three complexes. Together, we have uncovered a highly selective, essential role for an atypical PRC1-family complex in ES cells and early development.	[Qin, Jinzhong; Anderssen, Endre; Apostolou, Effie; Hochedlinger, Konrad; Ramaswamy, Sridhar; Hock, Hanno] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Qin, Jinzhong; Apostolou, Effie; Chen, Hsu-Hsin; Hochedlinger, Konrad; Ramaswamy, Sridhar; Hock, Hanno] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Qin, Jinzhong; Apostolou, Effie; Bronson, Roderick T.; Hochedlinger, Konrad; Ramaswamy, Sridhar; Hock, Hanno] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Apostolou, Effie; Hochedlinger, Konrad; Ramaswamy, Sridhar; Hock, Hanno] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Akbarian, Schahram] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Akbarian, Schahram] Mt Sinai Sch Med, Dept Neurobiol, New York, NY 10029 USA; [Whyte, Warren A.; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Whyte, Warren A.; Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Hock, H (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA.	hock.hanno@mgh.harvard.edu	Young, Richard A/F-6495-2012; Apostolou, Effie/AAG-1559-2020	Young, Richard A/0000-0001-8855-8647; 	Ellison Foundation; Federal Share of the Program Income [C06 CA059267]; Proton Therapy Research and Treatment Center; Silvio O Conte Center "Epigenetic Mechanisms of Depression" [P50MH096890 01]; MGH ECOR Fund for Medical Discovery Award; NATIONAL CANCER INSTITUTE [C06CA059267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH096890] Funding Source: NIH RePORTER	Ellison Foundation(Lawrence Ellison Foundation); Federal Share of the Program Income; Proton Therapy Research and Treatment Center; Silvio O Conte Center "Epigenetic Mechanisms of Depression"; MGH ECOR Fund for Medical Discovery Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to Laura Prickett and Kat Folz-Donahue from the HSCI Flow-core at MGH. We thank Denille Van Buren for help with editing the manuscript, Kelly L. Shea for help with dissecting embryos, and Jose M. Polo for advice on ChIP. We thank G. Mostoslavsky for the PHAGE vector, Peter Rahl for the Ring1b ChIP-seq data set, and Daniel Grau and Robert Kingston for help with planning the mass spectometry experiments and antibody for Bmi1. This work was supported by a contribution from the Ellison Foundation to MGH start-up funds for H.H., by the Federal Share of the Program Income earned by Massachusetts General Hospital on C06 CA059267, Proton Therapy Research and Treatment Center, and by the Silvio O Conte Center "Epigenetic Mechanisms of Depression" (P50MH096890 01). J.Q. was a recipient of an MGH ECOR Fund for Medical Discovery Award.	Akasaka T, 2001, DEVELOPMENT, V128, P1587; Arai S., 2005, NATURE, V24, P1863; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Guo YH, 2009, NUCLEIC ACIDS RES, V37, P2204, DOI 10.1093/nar/gkp086; Hock H, 2012, GENE DEV, V26, P751, DOI 10.1101/gad.191163.112; Honda H, 2011, P NATL ACAD SCI USA, V108, P2468, DOI 10.1073/pnas.1003403108; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lee J, 2010, BIOCHEM J, V426, P171, DOI 10.1042/BJ20091439; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Pohlers M, 2005, CURR BIOL, V15, P1051, DOI 10.1016/j.cub.2005.04.060; Qin JZ, 2010, J BIOL CHEM, V285, P27767, DOI 10.1074/jbc.M110.115410; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Storre J, 2005, J BIOL CHEM, V280, P41380, DOI 10.1074/jbc.M506797200; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; Takada Y, 2007, DEVELOPMENT, V134, P579, DOI 10.1242/dev.02747; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Trojer P, 2011, MOL CELL, V42, P438, DOI 10.1016/j.molcel.2011.04.004; van der Stoop P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002235; Wang LJ, 2010, MOL CELL BIOL, V30, P2584, DOI 10.1128/MCB.01451-09; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032	32	92	95	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	SEP 7	2012	11	3					319	332		10.1016/j.stem.2012.06.002	http://dx.doi.org/10.1016/j.stem.2012.06.002			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	018DW	22770845	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000309641300007
J	Fordham, RP; Jensen, KB				Fordham, Robert P.; Jensen, Kim B.			Reporting Live from the Epidermal Stem Cell Compartment!	CELL STEM CELL			English	Editorial Material							SKIN; NICHE	Hair follicle regeneration is controlled by an intricate relationship between epidermal stem cells and their microenvironment. A recent report in Nature by Rompolas et al. (2012) uses two-photon live imaging to interrogate the spatial organization and cellular requirements for hair follicle regeneration by epidermal stem cells and their immediate progeny.	[Fordham, Robert P.; Jensen, Kim B.] Univ Cambridge, Wellcome Trust & Med Res Council Stem Cell Inst, Ctr Stem Cell Res, Cambridge CB2 1QR, England	University of Cambridge	Jensen, KB (corresponding author), Univ Cambridge, Wellcome Trust & Med Res Council Stem Cell Inst, Ctr Stem Cell Res, Tennis Court Rd, Cambridge CB2 1QR, England.	kbj22@cam.ac.uk	Jensen, Kim/F-5333-2014	Jensen, Kim/0000-0001-6569-1664	Medical Research Council [G0800784B] Funding Source: researchfish; MRC [G0800784] Funding Source: UKRI; Medical Research Council [G0800784] Funding Source: Medline; Wellcome Trust [079249] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; JAHODA CAB, 1984, NATURE, V311, P560, DOI 10.1038/311560a0; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Rompolas P, 2012, NATURE, V487, P496, DOI 10.1038/nature11218; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Watt FM, 2009, EMBO MOL MED, V1, P260, DOI 10.1002/emmm.200900033	10	2	2	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	AUG 3	2012	11	2					141	142		10.1016/j.stem.2012.07.008	http://dx.doi.org/10.1016/j.stem.2012.07.008			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	987QQ	22862938	Bronze			2022-12-28	WOS:000307432600003
J	Hansson, EM; Chien, KR				Hansson, Emil M.; Chien, Kenneth R.			Reprogramming a Broken Heart	CELL STEM CELL			English	Editorial Material							FIBROBLASTS; CARDIOMYOCYTES; MYOCYTES	Fibrosis resulting from cardiac injury presents a major challenge to restoring heart function after myocardial infarction. Two recent papers in Nature report successful in vivo reprogramming of fibroblasts to cardiomyocytes in injured mouse hearts (Qian et al., 2012; Song et al., 2012), resulting in improved cardiac function and reduced scar formation.	[Hansson, Emil M.; Chien, Kenneth R.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 01238 USA; [Hansson, Emil M.; Chien, Kenneth R.] MGH Cardiovasc Res Ctr, Boston, MA 02114 USA	Harvard University	Chien, KR (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 01238 USA.	kchien@harvard.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100408] Funding Source: NIH RePORTER; NHLBI NIH HHS [U01 HL100408] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Chen JX, 2012, CIRC RES, V111, P50, DOI 10.1161/CIRCRESAHA.112.270264; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; EVANS SM, 1994, MOL CELL BIOL, V14, P4269, DOI 10.1128/MCB.14.6.4269; Graf T, 2011, CELL STEM CELL, V9, P504, DOI 10.1016/j.stem.2011.11.012; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Protze S, 2012, J MOL CELL CARDIOL, V53, P323, DOI 10.1016/j.yjmcc.2012.04.010; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529	10	7	8	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUL 6	2012	11	1					3	4		10.1016/j.stem.2012.06.014	http://dx.doi.org/10.1016/j.stem.2012.06.014			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	975SS	22770235	Bronze			2022-12-28	WOS:000306532400002
J	Wagers, AJ				Wagers, Amy J.			The Stem Cell Niche in Regenerative Medicine	CELL STEM CELL			English	Review							HUMAN HEMATOPOIETIC STEM; PROGENITOR CELLS; MOTOR-NEURONS; SELF-RENEWAL; PLURIPOTENT; PROMOTE; DISEASE; MURINE; ALS; REJUVENATION	Stem cells are fundamental units for achieving regenerative therapies, which leads naturally to a theoretical and experimental focus on these cells for therapeutic screening and intervention. A growing body of data in many tissue systems indicates that stem cell function is critically influenced by extrinsic signals derived from the microenvironment, or "niche." In this vein, the stem cell niche represents a significant, and largely untapped, entry point for therapeutic modulation of stem cell behavior. This Perspective will discuss how the niche influences stem cells in homeostasis, in the progression of degenerative and malignant diseases, and in therapeutic strategies for tissue repair.	[Wagers, Amy J.] Howard Hughes Med Inst, Boston, MA 02215 USA; [Wagers, Amy J.] Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Boston, MA 02215 USA; [Wagers, Amy J.] Joslin Diabet Ctr, Cambridge, MA 02215 USA	Howard Hughes Medical Institute; Harvard University; Harvard University; Joslin Diabetes Center, Inc.	Wagers, AJ (corresponding author), Howard Hughes Med Inst, 7 Divin Ave, Boston, MA 02215 USA.	amy.wagers@joslin.harvard.edu						Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Bautch VL, 2011, NAT MED, V17, P1437, DOI 10.1038/nm.2539; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Brack AS, 2005, J CELL SCI, V118, P4813, DOI 10.1242/jcs.02602; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Christopher MJ, 2011, J EXP MED, V208, P251, DOI 10.1084/jem.20101700; Collins CA, 2007, STEM CELLS, V25, P885, DOI 10.1634/stemcells.2006-0372; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Dahlberg A, 2011, BLOOD, V117, P6083, DOI 10.1182/blood-2011-01-283606; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Dykstra B, 2011, J EXP MED, V208, P2691, DOI 10.1084/jem.20111490; Ehninger A, 2011, J EXP MED, V208, P421, DOI 10.1084/jem.20110132; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Essers MAG, 2010, MOL ONCOL, V4, P443, DOI 10.1016/j.molonc.2010.06.001; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Ferraro F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002191; Gale EAM, 2002, NEW ENGL J MED, V346, P1740, DOI 10.1056/NEJM200205303462211; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Hu ZY, 2010, DIABETES, V59, P1312, DOI 10.2337/db09-1155; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; Jones DL, 2011, NAT CELL BIOL, V13, P506, DOI 10.1038/ncb0511-506; Kaplan RN, 2006, CANCER RES, V66, P11089, DOI 10.1158/0008-5472.CAN-06-2407; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kiskinis E, 2010, J CLIN INVEST, V120, P51, DOI 10.1172/JCI40553; Klinke DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001374; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Lane SW, 2009, BLOOD, V114, P1150, DOI 10.1182/blood-2009-01-202606; Liu GH, 2011, NATURE, V472, P221, DOI 10.1038/nature09879; Liu JN, 2010, CURR TOP DEV BIOL, V92, P367, DOI [10.1016/S0070-2153(10)92012-7, 10.1016/S0070-2153(10)91012-7]; Liu L, 2011, J CELL BIOL, V193, P257, DOI 10.1083/jcb.201010131; MARSDEN CD, 1990, LANCET, V335, P948, DOI 10.1016/0140-6736(90)91006-V; Mason C, 2008, REGEN MED, V3, P1, DOI 10.2217/17460751.3.1.1; Mathis D, 2011, NAT REV IMMUNOL, V11, P81, DOI 10.1038/nri2922; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mendez-Ferrer S, 2009, CURR OPIN HEMATOL, V16, P235, DOI 10.1097/MOH.0b013e32832bd0f5; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Peerani R, 2010, J CLIN INVEST, V120, P60, DOI 10.1172/JCI41158; Pietramaggiori G, 2009, J INVEST DERMATOL, V129, P2265, DOI 10.1038/jid.2009.60; Raaijmakers MHGP, 2011, HAEMATOL-HEMATOL J, V96, P1041, DOI 10.3324/haematol.2010.028035; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Rafehi H, 2011, INT WOUND J, V8, P12, DOI 10.1111/j.1742-481X.2010.00745.x; Ross GW, 2004, ANN NEUROL, V56, P532, DOI 10.1002/ana.20226; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; Sim FJ, 2002, J NEUROSCI, V22, P2451, DOI 10.1523/JNEUROSCI.22-07-02451.2002; Sneddon JB, 2007, CELL STEM CELL, V1, P607, DOI 10.1016/j.stem.2007.11.009; Sneddon JB, 2006, P NATL ACAD SCI USA, V103, P14842, DOI 10.1073/pnas.0606857103; Soen Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100076; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomas DE, 2000, WORLD J SURG, V24, P815; Varnum-Finney B, 2000, NAT MED, V6, P1278, DOI 10.1038/81390; Varnum-Finney B, 2003, BLOOD, V101, P1784, DOI 10.1182/blood-2002-06-1862; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Voog J, 2010, CELL STEM CELL, V6, P103, DOI 10.1016/j.stem.2010.01.011; Wang LD, 2011, NAT REV MOL CELL BIO, V12, P643, DOI 10.1038/nrm3184; Wels J, 2008, GENE DEV, V22, P559, DOI 10.1101/gad.1636908; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Yang FC, 2006, HUM MOL GENET, V15, P2421, DOI 10.1093/hmg/ddl165; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang JQ, 2011, CELL STEM CELL, V8, P31, DOI 10.1016/j.stem.2010.12.002; Zhu Y, 2002, SCIENCE, V296, P920, DOI 10.1126/science.1068452	84	168	175	3	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 6	2012	10	4					362	369		10.1016/j.stem.2012.02.018	http://dx.doi.org/10.1016/j.stem.2012.02.018			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	929QA	22482502	Bronze			2022-12-28	WOS:000303079400006
J	Hall, CJ; Flores, MV; Oehlers, SH; Sanderson, LE; Lam, EY; Crosier, KE; Crosier, PS				Hall, Christopher J.; Flores, Maria Vega; Oehlers, Stefan H.; Sanderson, Leslie E.; Lam, Enid Y.; Crosier, Kathryn E.; Crosier, Philip S.			Infection-Responsive Expansion of the Hematopoietic Stem and Progenitor Cell Compartment in Zebrafish Is Dependent upon Inducible Nitric Oxide	CELL STEM CELL			English	Article							C/EBP-BETA; EMERGENCY GRANULOPOIESIS; AORTIC ENDOTHELIUM; BLOOD PROGENITORS; BONE-MARROW; EXPRESSION; INFLAMMATION; MECHANISMS; LEUKOCYTES; BINDING	Hematopoietic stem cells (HSCs) are rare multipotent cells that contribute to all blood lineages. During inflammatory stress, hematopoietic stem and progenitor cells (HSPCs) can be stimulated to proliferate and differentiate into the required immune cell lineages. Manipulating signaling pathways that alter HSPC capacity holds great promise in the treatment of hematological malignancies. To date, signaling pathways that influence HSPC capacity, in response to hematopoietic stress, remain largely unknown. Using a zebrafish model of demand-driven granulopoiesis to explore the HSPC response to infection, we present data supporting a model where the zebrafish ortholog of the cytokine-inducible form of nitric oxide synthase (iNOS/NOS2) Nos2a acts downstream of the transcription factor C/ebp beta to control expansion of HSPCs following infection. These results provide new insights into the reactive capacity of HSPCs and how the blood system is "fine-tuned" in response to inflammatory stress.	[Hall, Christopher J.; Flores, Maria Vega; Oehlers, Stefan H.; Sanderson, Leslie E.; Lam, Enid Y.; Crosier, Kathryn E.; Crosier, Philip S.] Univ Auckland, Dept Mol Med & Pathol, Sch Med Sci, Auckland 1, New Zealand	University of Auckland	Crosier, PS (corresponding author), Univ Auckland, Dept Mol Med & Pathol, Sch Med Sci, Private Bag 92019, Auckland 1, New Zealand.	ps.crosier@auckland.ac.nz	Oehlers, Stefan/L-5341-2019; Sanderson, Leslie/GZG-9357-2022	Oehlers, Stefan/0000-0003-0260-672X; Sanderson, Leslie/0000-0002-8026-406X; Hall, Chris/0000-0001-6473-7720; Lam, Enid Yi Ni/0000-0001-5843-7836	Ministry of Science & Innovation, New Zealand	Ministry of Science & Innovation, New Zealand	We thank Annie Chien, Sophie Wicker, Pauline Misa, Alisha Malik, and Alhad Mahagaonkar for excellent technical assistance. We also thank Nick Trede and Len Zon for supplying reporter lines and Graham Lieschke for supplying probe templates. Funding for this work was provided by a grant awarded to P.C. from the Ministry of Science & Innovation, New Zealand.	Adamo L, 2009, NATURE, V459, P1131, DOI 10.1038/nature08073; Akagi T, 2008, BLOOD, V111, P2999, DOI 10.1182/blood-2007-04-087213; Baldridge MT, 2011, TRENDS IMMUNOL, V32, P57, DOI 10.1016/j.it.2010.12.003; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Clay H, 2005, ZEBRAFISH, V2, P105, DOI 10.1089/zeb.2005.2.105; Dahlberg A, 2011, BLOOD, V117, P6083, DOI 10.1182/blood-2011-01-283606; Ellett F, 2011, BLOOD, V117, pE49, DOI 10.1182/blood-2010-10-314120; Guo Z, 2003, FASEB J, V17, P1718, DOI 10.1096/fj.02-1172fje; Guthrie SM, 2005, BLOOD, V105, P1916, DOI 10.1182/blood-2004-09-3415; Hall C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-42; Hall Chris, 2009, V546, P255, DOI 10.1007/978-1-60327-977-2_16; Hall C, 2009, J LEUKOCYTE BIOL, V85, P751, DOI 10.1189/jlb.0708405; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; JOWETT T, 1994, TRENDS GENET, V10, P73, DOI 10.1016/0168-9525(94)90220-8; KASTAN MB, 1989, BLOOD, V73, P1444; Kaushansky K, 2006, NEW ENGL J MED, V354, P2034, DOI 10.1056/NEJMra052706; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; King KY, 2011, NAT REV IMMUNOL, V11, P685, DOI 10.1038/nri3062; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Korhonen Riku, 2005, Current Drug Targets - Inflammation and Allergy, V4, P471, DOI 10.2174/1568010054526359; Krasnov P, 2008, MOL MED, V14, P141, DOI 10.2119/2007-00011.Krasnov; Krstic A, 2009, GROWTH FACTORS, V27, P79, DOI 10.1080/08977190902757153; Lam EYN, 2010, BLOOD, V116, P909, DOI 10.1182/blood-2010-01-264382; Lam EYN, 2009, BLOOD, V113, P1241, DOI 10.1182/blood-2008-04-149898; Le Guyader D, 2008, BLOOD, V111, P132, DOI 10.1182/blood-2007-06-095398; Lepiller S, 2007, FREE RADICAL BIO MED, V43, P619, DOI 10.1016/j.freeradbiomed.2007.05.025; Lepiller S, 2009, GENE, V445, P58, DOI 10.1016/j.gene.2009.05.016; Lieschke GJ, 2002, DEV BIOL, V246, P274, DOI 10.1006/dbio.2002.0657; Lyons SE, 2001, BLOOD, V97, P2611, DOI 10.1182/blood.V97.9.2611; Meijer AH, 2008, DEV COMP IMMUNOL, V32, P36, DOI 10.1016/j.dci.2007.04.003; Michurina T, 2004, MOL THER, V10, P241, DOI 10.1016/j.ymthe.2004.05.030; Motoyoshi K, 1998, INT J HEMATOL, V67, P109; Murayama E, 2006, IMMUNITY, V25, P963, DOI 10.1016/j.immuni.2006.10.015; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; Oehlers SHB, 2010, DEV COMP IMMUNOL, V34, P352, DOI 10.1016/j.dci.2009.11.007; Panopoulos AD, 2008, CYTOKINE, V42, P277, DOI 10.1016/j.cyto.2008.03.002; Rezzoug F, 2008, J IMMUNOL, V180, P49, DOI 10.4049/jimmunol.180.1.49; Scumpia PO, 2010, J IMMUNOL, V184, P2247, DOI 10.4049/jimmunol.0903652; Takizawa H, 2011, J EXP MED, V208, P273, DOI 10.1084/jem.20101643; Teng XW, 2002, CIRC RES, V90, P125, DOI 10.1161/hh0202.103647; Trumpp A, 2010, NAT REV IMMUNOL, V10, P201, DOI 10.1038/nri2726; Ueda Y, 2005, J EXP MED, V201, P1771, DOI 10.1084/jem.20041419; Villalobo A, 2006, FEBS J, V273, P2329, DOI 10.1111/j.1742-4658.2006.05250.x; Willett CE, 2001, DEV DYNAM, V222, P694, DOI 10.1002/dvdy.1223; Zhang HY, 2010, BLOOD, V116, P2462, DOI 10.1182/blood-2009-12-259630	48	90	91	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 3	2012	10	2					198	209		10.1016/j.stem.2012.01.007	http://dx.doi.org/10.1016/j.stem.2012.01.007			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	892FM	22305569	Bronze			2022-12-28	WOS:000300272100012
J	Zeuner, A; De Maria, R				Zeuner, Ann; De Maria, Ruggero			Not So Lonely at the Top for Cancer Stem Cells	CELL STEM CELL			English	Editorial Material							GLIOBLASTOMA; HIERARCHY		[Zeuner, Ann; De Maria, Ruggero] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [De Maria, Ruggero] Mediterranean Inst Oncol, Catania, Italy	Istituto Superiore di Sanita (ISS); Mediterranean Institute of Oncology	De Maria, R (corresponding author), Ist Super Sanita, Dept Hematol Oncol & Mol Med, Viale Regina Elena 299, I-00161 Rome, Italy.	demaria@iss.it	Zeuner, Ann/K-8607-2016; De Maria, Ruggero/S-6385-2019; Zeuner, Ann/A-8529-2010	De Maria, Ruggero/0000-0003-2255-0583; Zeuner, Ann/0000-0002-8295-3715	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chen RH, 2010, CANCER CELL, V17, P362, DOI 10.1016/j.ccr.2009.12.049; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Dieter SM, 2011, CELL STEM CELL, V9, P357, DOI 10.1016/j.stem.2011.08.010; Ricci-Vitiani L, 2008, CELL DEATH DIFFER, V15, P1491, DOI 10.1038/cdd.2008.72; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020	7	11	11	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	OCT 7	2011	9	4					289	290		10.1016/j.stem.2011.09.006	http://dx.doi.org/10.1016/j.stem.2011.09.006			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	835MT	21982226	Bronze			2022-12-28	WOS:000296041200004
J	Gonzales, KAU; Ng, HH				Gonzales, Kevin Andrew Uy; Ng, Huck-Hui			FoxO: A New Addition to the ESC Cartel	CELL STEM CELL			English	Editorial Material							PLURIPOTENCY FACTORS; CELL; LINEAGE		[Gonzales, Kevin Andrew Uy; Ng, Huck-Hui] Genome Inst Singapore, Gene Regulat Lab, Singapore 138672, Singapore; [Gonzales, Kevin Andrew Uy; Ng, Huck-Hui] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117456, Singapore; [Ng, Huck-Hui] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore; [Ng, Huck-Hui] Natl Univ Singapore, Dept Biol Sci, Singapore 117597, Singapore; [Ng, Huck-Hui] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Ng, HH (corresponding author), Genome Inst Singapore, Gene Regulat Lab, Singapore 138672, Singapore.	nghh@gis.a-star.edu.sg	Ng, Huck Hui/A-1135-2009	Gonzales, Kevin Andrew/0000-0001-7418-965X				Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Gonzales KAU, 2011, BBA-GENE REGUL MECH, V1809, P337, DOI 10.1016/j.bbagrm.2011.06.009; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; van den Berg MCW, 2011, ANTIOXID REDOX SIGN, V14, P607, DOI 10.1089/ars.2010.3415; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhang X, 2011, NAT CELL BIOL, V13, P1092, DOI 10.1038/ncb2293	8	5	5	1	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	SEP 2	2011	9	3					181	183		10.1016/j.stem.2011.08.003	http://dx.doi.org/10.1016/j.stem.2011.08.003			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	822DN	21885013	Bronze			2022-12-28	WOS:000295024200003
J	Gimble, JM; Bunnell, BA; Floyd, ZE				Gimble, Jeffrey M.; Bunnell, Bruce A.; Floyd, Z. Elizabeth			Prospecting for Adipose Progenitor Cell Biomarkers: Biopanning for Gold with In Vivo Phage Display	CELL STEM CELL			English	Editorial Material							STEM-CELLS; OBESITY	In this issue of Cell Stem Cell, Daquinag et al. (2011) take a lesson from the oncology field to search for stromal progenitor cells within adipose tissue. Their use of phage display biopanning in vivo identified an isoform of the extracellular matrix protein decorin as a receptor for the adipokine resistin.	[Gimble, Jeffrey M.; Floyd, Z. Elizabeth] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Bunnell, Bruce A.] Tulane Univ, Sch Med, Ctr Stem Cell Res & Regenerat Med, Dept Pharmacol, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Tulane University	Gimble, JM (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA.	gimblejm@pbrc.edu	Floyd, Elizabeth/W-2758-2019; Floyd, Elizabeth/N-1962-2017	Floyd, Elizabeth/0000-0002-3002-6186; Floyd, Elizabeth/0000-0002-3002-6186; Bunnell, Bruce/0000-0001-6196-3722				Bolton K, 2008, INT J OBESITY, V32, P1113, DOI 10.1038/ijo.2008.41; Brown KC, 2010, CURR PHARM DESIGN, V16, P1040, DOI 10.2174/138161210790963788; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Daquinag AC, 2011, CELL STEM CELL, V9, P74, DOI 10.1016/j.stem.2011.05.017; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; Schwartz DR, 2011, TRENDS ENDOCRIN MET, V22, P259, DOI 10.1016/j.tem.2011.03.005; SIMMONS PJ, 1991, BLOOD, V78, P55; Staszkiewicz J, 2009, BIOCHEM BIOPH RES CO, V378, P539, DOI 10.1016/j.bbrc.2008.11.092; Zannettino ACW, 2008, J CELL PHYSIOL, V214, P413, DOI 10.1002/jcp.21210	10	3	4	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUL 8	2011	9	1					1	2		10.1016/j.stem.2011.06.001	http://dx.doi.org/10.1016/j.stem.2011.06.001			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	797VA	21683669	Bronze			2022-12-28	WOS:000293157000001
J	Levens, D; Aplan, PD				Levens, David; Aplan, Peter D.			Notching Up MYC Gives a LIC	CELL STEM CELL			English	Editorial Material							C-MYC; INHIBITION; CELLS	In a recent issue of Cell, King et al. (2013) show that mutations in the ubiquitin ligase subcomponent FBXW7 increase MYC protein levels and expand the number of leukemia-initiating cells (LICs) in Notch1-induced T-ALL. Genetic and pharmacological inhibition of MYC abolishes LIC activity with broader therapeutic implications.	[Levens, David] NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA; [Aplan, Peter D.] NCI, Genet Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Levens, D (corresponding author), NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA.	levensd@mail.nih.gov; peter.aplan@nih.gov	Levens, David/C-9216-2009; Aplan, Peter D/K-9064-2016	Levens, David/0000-0002-7616-922X; 	Intramural NIH HHS [Z99 CA999999] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIASC010378, ZIABC010982, ZIABC011465] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aster JC, 2011, J PATHOL, V223, P262, DOI 10.1002/path.2789; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Inoue S, 2013, GENE DEV, V27, P1101, DOI 10.1101/gad.214577.113; King B, 2013, CELL, V153, P1552, DOI 10.1016/j.cell.2013.05.041; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Shachaf CM, 2008, CANCER RES, V68, P5132, DOI 10.1158/0008-5472.CAN-07-6192; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045	10	3	3	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2013	13	1					8	9		10.1016/j.stem.2013.06.008	http://dx.doi.org/10.1016/j.stem.2013.06.008			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VJ	23827704	Bronze, Green Accepted			2022-12-28	WOS:000329570100005
J	Kreiner, T; Irion, S				Kreiner, Thane; Irion, Stefan			Whole-Genome Analysis, Stem Cell Research, and the Future of Biobanks	CELL STEM CELL			English	Editorial Material							ISSUES	The convergence of the genomic revolution and biobanking with rapid progress in stem cell research holds vast potential for personalized medicine and novel therapies. In this Forum, we explore social and ethical considerations emerging from strategies to realize the promise of these remarkable technologies.	[Kreiner, Thane; Irion, Stefan] Santa Clara Univ, Ctr Sci Technol & Soc, Santa Clara, CA 95053 USA	Santa Clara University	Kreiner, T (corresponding author), Santa Clara Univ, Ctr Sci Technol & Soc, Santa Clara, CA 95053 USA.	tkreiner@scu.edu						Bellin M, 2012, NAT REV MOL CELL BIO, V13, P713, DOI 10.1038/nrm3448; Bush WS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002822; Cambon-Thomsen A, 2004, NAT REV GENET, V5, P866, DOI 10.1038/nrg1473; Gymrek M, 2013, SCIENCE, V339, P321, DOI 10.1126/science.1229566; Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Knoppers BM, 2012, ANNU REV GENOM HUM G, V13, P395, DOI 10.1146/annurev-genom-090711-163834; Mathews DJH, 2013, CELL STEM CELL, V12, P508, DOI 10.1016/j.stem.2013.04.015; Sullivan GJ, 2010, MOL HUM REPROD, V16, P880, DOI 10.1093/molehr/gaq091; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019	10	10	10	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 2	2013	12	5					513	516		10.1016/j.stem.2013.04.024	http://dx.doi.org/10.1016/j.stem.2013.04.024			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VE	23642361	Bronze			2022-12-28	WOS:000329569600007
J	Marin, O				Marin, Oscar			Human Cortical Interneurons Take Their Time	CELL STEM CELL			English	Editorial Material							STEM-CELLS; MIGRATION	In this issue, Maroof et al. (2013) and Nicholas et al. (2013) describe strategies for deriving cortical interneurons from human pluripotent stem cells. Functional maturation of these neurons occurs over a protracted period, which resembles normal human development, and suggests these cells may be useful for modeling brain development and disease.	[Marin, Oscar] CSIC, Inst Neurociencias, Sant Joan dAlacant 03550, Spain; [Marin, Oscar] Univ Miguel Hernandez, Sant Joan dAlacant 03550, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Universidad Miguel Hernandez de Elche	Marin, O (corresponding author), CSIC, Inst Neurociencias, Sant Joan dAlacant 03550, Spain.	o.marin@umh.es	Marin, Oscar/F-3856-2012	Marin, Oscar/0000-0001-6264-7027				Anderson SA., 2012, JASPERS BASIC MECH E, V4th ed.; Espuny-Camacho I, 2013, NEURON, V77, P440, DOI 10.1016/j.neuron.2012.12.011; Fasano CA, 2010, CELL STEM CELL, V6, P336, DOI 10.1016/j.stem.2010.03.001; Goulburn AL, 2011, STEM CELLS, V29, P462, DOI 10.1002/stem.587; Liodis P, 2007, J NEUROSCI, V27, P3078, DOI 10.1523/JNEUROSCI.3055-06.2007; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Maroof AM, 2013, CELL STEM CELL, V12, P559, DOI 10.1016/j.stem.2013.04.008; Nicholas CR, 2013, CELL STEM CELL, V12, P573, DOI 10.1016/j.stem.2013.04.005; Nobrega-Pereira S, 2008, NEURON, V59, P733, DOI 10.1016/j.neuron.2008.07.024; Sussel L, 1999, DEVELOPMENT, V126, P3359	10	13	13	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 2	2013	12	5					497	499		10.1016/j.stem.2013.04.017	http://dx.doi.org/10.1016/j.stem.2013.04.017			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VE	23642355	Bronze			2022-12-28	WOS:000329569600001
J	Ramos, AD; Diaz, A; Nellore, A; Delgado, RN; Park, KY; Gonzales-Roybal, G; Oldham, MC; Song, JS; Lim, DA				Ramos, Alexander D.; Diaz, Aaron; Nellore, Abhinav; Delgado, Ryan N.; Park, Ki-Youb; Gonzales-Roybal, Gabriel; Oldham, Michael C.; Song, Jun S.; Lim, Daniel A.			Integration of Genome-wide Approaches Identifies lncRNAs of Adult Neural Stem Cells and Their Progeny In Vivo	CELL STEM CELL			English	Article							LONG NONCODING RNAS; RETINAL DEVELOPMENT; GENE-EXPRESSION; MOUSE-BRAIN; CHROMATIN; DIFFERENTIATION; REVEALS; NEUROGENESIS; LINCRNAS; LINEAGE	Long noncoding RNAs (lncRNAs) have been described in cell lines and various whole tissues, but lncRNA analysis of development in vivo is limited. Here, we comprehensively analyze lncRNA expression for the adult mouse subventricular zone neural stem cell lineage. We utilize complementary genome-wide techniques including RNA-seq, RNA CaptureSeq, and ChIP-seq to associate specific lncRNAs with neural cell types, developmental processes, and human disease states. By integrating data from chromatin state maps, custom microarrays, and FACS purification of the subventricular zone lineage, we stringently identify lncRNAs with potential roles in adult neurogenesis. shRNA-mediated knockdown of two such lncRNAs, Six3os and Dlx1as, indicate roles for lncRNAs in the glial-neuronal lineage specification of multipotent adult stem cells. Our data and workflow thus provide a uniquely coherent in vivo lncRNA analysis and form the foundation of a user-friendly online resource for the study of lncRNAs in development and disease.	[Ramos, Alexander D.; Delgado, Ryan N.; Park, Ki-Youb; Gonzales-Roybal, Gabriel; Lim, Daniel A.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Ramos, Alexander D.; Delgado, Ryan N.; Park, Ki-Youb; Gonzales-Roybal, Gabriel; Oldham, Michael C.; Song, Jun S.; Lim, Daniel A.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Ramos, Alexander D.; Delgado, Ryan N.] Univ Calif San Francisco, Med Scientist Training Program, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Diaz, Aaron; Nellore, Abhinav; Song, Jun S.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Oldham, Michael C.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Song, Jun S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Lim, Daniel A.] San Francisco VA Med Ctr, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Lim, DA (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	limd@neurosurg.ucsf.edu	Song, Jun S/E-2526-2016	Song, Jun S/0000-0002-0422-2175; Lim, Daniel/0000-0001-7221-3425; Nellore, Abhinav/0000-0001-8145-1484	NIH [DP2-OD006505-01, R01CA163336]; VA [1I01 BX000252-01]; Sontag Foundation; Sandler Foundation; NIH GMS [K12-GM081266]; California Institute for Regenerative Medicine (CIRM); UCSF Program for Breakthrough Biomedical Research; MSTP [2T32GM007618-34]; NATIONAL CANCER INSTITUTE [R01CA163336, R25CA112355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618, K12GM081266] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006505] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000252] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA(US Department of Veterans Affairs); Sontag Foundation; Sandler Foundation; NIH GMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); UCSF Program for Breakthrough Biomedical Research; MSTP; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	This project was supported by NIH DP2-OD006505-01, VA 1I01 BX000252-01, and the Sontag Foundation to D.A.L., NIH R01CA163336 and the Sontag Foundation to J.S.S., the UCSF Program for Breakthrough Biomedical Research, which is funded in part by the Sandler Foundation, to M.C.O., NIH GMS K12-GM081266 to G.G.-R., a training grant from the California Institute for Regenerative Medicine (CIRM) to A.D.R., MSTP training grant 2T32GM007618-34 to A.D.R. and R.N.D, and facilities and resources provided by the San Francisco Veterans Affairs Medical Center.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Ayoub AE, 2011, P NATL ACAD SCI USA, V108, P14950, DOI 10.1073/pnas.1112213108; Belgard TG, 2011, NEURON, V71, P605, DOI 10.1016/j.neuron.2011.06.039; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bertani S, 2011, MOL CELL, V43, P1040, DOI 10.1016/j.molcel.2011.08.019; Bond AM, 2009, NAT NEUROSCI, V12, P1020, DOI 10.1038/nn.2371; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Hsieh J, 2012, GENE DEV, V26, P1010, DOI 10.1101/gad.187336.112; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Ihrie RA, 2011, NEURON, V70, P674, DOI 10.1016/j.neuron.2011.05.004; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim EJ, 2007, J NEUROSCI, V27, P12764, DOI 10.1523/JNEUROSCI.3178-07.2007; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lien WH, 2011, CELL STEM CELL, V9, P219, DOI 10.1016/j.stem.2011.07.015; Lim DA, 2006, MOL CELL NEUROSCI, V31, P131, DOI 10.1016/j.mcn.2005.10.005; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Liu JK, 1997, DEV DYNAM, V210, P498, DOI 10.1002/(SICI)1097-0177(199712)210:4<498::AID-AJA12>3.0.CO;2-3; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Mercer TR, 2012, NAT BIOTECHNOL, V30, P99, DOI 10.1038/nbt.2024; Mercer TR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-14; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Rapicavoli NA, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-32; Rapicavoli NA, 2009, DEV DYNAM, V238, P2103, DOI 10.1002/dvdy.21844; Scheffler B, 2005, P NATL ACAD SCI USA, V102, P9353, DOI 10.1073/pnas.0503965102; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thomas EA, 2011, HUM MOL GENET, V20, P1049, DOI 10.1093/hmg/ddq548; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang YQ, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-1; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	55	185	192	2	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 2	2013	12	5					616	628		10.1016/j.stem.2013.03.003	http://dx.doi.org/10.1016/j.stem.2013.03.003			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VE	23583100	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000329569600016
J	Reinhardt, P; Schmid, B; Burbulla, LF; Schondorf, DC; Wagner, L; Glatza, M; Hoing, S; Hargus, G; Heck, SA; Dhingra, A; Wu, GM; Muller, S; Brockmann, K; Kluba, T; Maisel, M; Kruger, R; Berg, D; Tsytsyura, Y; Thiel, CS; Psathaki, OE; Klingauf, J; Kuhlmann, T; Klewin, M; Muller, H; Gasser, T; Scholer, HR; Sterneckert, J				Reinhardt, Peter; Schmid, Benjamin; Burbulla, Lena F.; Schoendorf, David C.; Wagner, Lydia; Glatza, Michael; Hoeing, Susanne; Hargus, Gunnar; Heck, Susanna A.; Dhingra, Ashutosh; Wu, Guangming; Mueller, Stephan; Brockmann, Kathrin; Kluba, Torsten; Maisel, Martina; Krueger, Rejko; Berg, Daniela; Tsytsyura, Yaroslav; Thiel, Cora S.; Psathaki, Olympia-Ekaterini; Klingauf, Juergen; Kuhlmann, Tanja; Klewin, Marlene; Mueller, Heiko; Gasser, Thomas; Schoeler, Hans R.; Sterneckert, Jared			Genetic Correction of a LRRK2 Mutation in Human iPSCs Links Parkinsonian Neurodegeneration to ERK-Dependent Changes in Gene Expression	CELL STEM CELL			English	Article							NEURAL STEM-CELLS; ALPHA-SYNUCLEIN; KINASE-ACTIVITY; SH-SY5Y CELLS; LEWY BODIES; DISEASE; NEUROPATHOLOGY; INDUCTION; DEGENERATION; INHIBITION	The LRRK2 mutation G2019S is the most common genetic cause of Parkinson's disease (PD). To better understand the link between mutant LRRK2 and PD pathology, we derived induced pluripotent stem cells from PD patients harboring LRRK2 G2019S and then specifically corrected the mutant LRRK2 allele. We demonstrate that gene correction resulted in phenotypic rescue in differentiated neurons and uncovered expression changes associated with LRRK2 G2019S. We found that LRRK2 G2019S induced dysregulation of CPNE8, MAP7, UHRF2, ANXA1, and CADPS2. Knockdown experiments demonstrated that four of these genes contribute to dopaminergic neurodegeneration. LRRK2 G2019S induced increased extracellular-signal-regulated kinase 1/2 (ERK) phosphorylation. Transcriptional dysregulation of CADPS2, CPNE8, and UHRF2 was dependent on ERK activity. We show that multiple PD-associated phenotypes were ameliorated by inhibition of ERK. Therefore, our results provide mechanistic insight into the pathogenesis induced by mutant LRRK2 and pointers for the development of potential new therapeutics.	[Reinhardt, Peter; Glatza, Michael; Hoeing, Susanne; Hargus, Gunnar; Wu, Guangming; Psathaki, Olympia-Ekaterini; Schoeler, Hans R.; Sterneckert, Jared] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Schmid, Benjamin; Burbulla, Lena F.; Schoendorf, David C.; Heck, Susanna A.; Dhingra, Ashutosh; Brockmann, Kathrin; Maisel, Martina; Krueger, Rejko; Berg, Daniela; Gasser, Thomas] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat Dis, D-72076 Tubingen, Germany; [Mueller, Stephan] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Epileptol, D-72076 Tubingen, Germany; German Ctr Neurodegenerat Dis, D-72076 Tubingen, Germany; [Schoendorf, David C.; Hargus, Gunnar] Univ Hosp Munster, Inst Neuropathol, D-48149 Munster, Germany; [Dhingra, Ashutosh] Univ Tubingen, Grad Sch Cellular & Mol Neurosci, D-72076 Tubingen, Germany; [Kluba, Torsten] Univ Tubingen, Dept Orthopaed Surg, D-72076 Tubingen, Germany; [Tsytsyura, Yaroslav; Thiel, Cora S.] Univ Munster, Inst Med Phys & Biophys, Cellular Biophys Grp, D-41849 Munster, Germany; [Klewin, Marlene; Mueller, Heiko] Lead Discovery Ctr GmbH, Dept Pharmacol, D-44227 Dortmund, Germany; [Schoeler, Hans R.] Univ Munster, Fac Med, D-48149 Munster, Germany	Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munster; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; University of Munster; Lead Discovery Center GmbH (LDC); University of Munster	Gasser, T (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat Dis, D-72076 Tubingen, Germany.	thomas.gasser@uni-tuebingen.de; office@mpi-muenster.mpg.de	Gasser, Thomas/GNH-5293-2022; Berg, Daniela/A-8728-2019; Sterneckert, Jared/E-6802-2015; , HS/AAB-4434-2019	Gasser, Thomas/0000-0002-1069-1146; Berg, Daniela/0000-0001-5796-5442; , HS/0000-0003-2643-5136; Wu, Guangming/0000-0003-1923-7609; Sterneckert, Jared/0000-0002-7688-3124; Krueger, Rejko/0000-0003-4258-6241	German Research [WO 1610/2-1, KR2119/8-1]; Fortuene [1831-0-0-0-0]; German Research Council (DFG) [KR2119/8-1]; Fritz Thyssen Foundation [10.11.2.153]; Michael J. Fox Foundation (LRRK2 Biology LEAPS); charitable Hertie Foundation	German Research; Fortuene; German Research Council (DFG)(German Research Foundation (DFG)); Fritz Thyssen Foundation; Michael J. Fox Foundation (LRRK2 Biology LEAPS); charitable Hertie Foundation	This work was supported by grants from the German Research (WO 1610/2-1 to M. M. and T. G.; KR2119/8-1 to R. K. and T. G.); Fortuene (Nr. 1831-0-0-0-0 to M. M.); the German Research Council (DFG, KR2119/8-1 to R. K. and T. G.); Fritz Thyssen Foundation (10.11.2.153 to R. K.); the Michael J. Fox Foundation (LRRK2 Biology LEAPS Award, 2012); and by a doctoral scholarship from the charitable Hertie Foundation (to L. F. B.). Plasmids for reprogramming were obtained from Addgene: Addgene plasmids 8449, 8454, 17217, 17218, 17219, and 17220. We would like to acknowledge Ann-Kathrin Hauser for the sequencing analysis. We would like to thank Kerstin Hergarten and Rhea Brintrup for excellent technical support.	Badiola N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026609; Berg D, 2005, BRAIN, V128, P3000, DOI 10.1093/brain/awh666; Botta-Orfila T, 2012, J MOL NEUROSCI, V48, P245, DOI 10.1007/s12031-012-9820-7; Bravo-San Pedro JM, 2013, CELL MOL LIFE SCI, V70, P121, DOI 10.1007/s00018-012-1061-y; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brunk I, 2009, J BIOL CHEM, V284, P1050, DOI 10.1074/jbc.M805328200; Carballo-Carbajal I, 2010, CELL SIGNAL, V22, P821, DOI 10.1016/j.cellsig.2010.01.006; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Cookson MR, 2008, INT J CLIN EXP PATHO, V1, P217; European Brain Council, 2011, PARK DIS FACT SHEET; Fu XP, 2011, MOL BIOL CELL, V22, P3684, DOI 10.1091/mbc.E11-04-0308; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Golub Y, 2009, PARKINSONISM RELAT D, V15, P539, DOI 10.1016/j.parkreldis.2008.10.008; Greber B, 2011, EMBO J, V30, P4874, DOI 10.1038/emboj.2011.407; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Hitoshi S, 2004, GENE DEV, V18, P1806, DOI 10.1101/gad.1208404; Hotta A, 2008, J CELL BIOCHEM, V105, P940, DOI 10.1002/jcb.21912; Inden M, 2011, BIOL PHARM BULL, V34, P92, DOI 10.1248/bpb.34.92; Ishizawa T, 2003, J NEUROPATH EXP NEUR, V62, P389, DOI 10.1093/jnen/62.4.389; Iwata A, 2009, J BIOL CHEM, V284, P9796, DOI 10.1074/jbc.M809739200; Li XT, 2010, J NEUROSCI, V30, P1788, DOI 10.1523/JNEUROSCI.5604-09.2010; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; Liu GH, 2012, NATURE, V491, P603, DOI 10.1038/nature11557; Lloyd SE, 2010, NEUROGENETICS, V11, P185, DOI 10.1007/s10048-009-0219-8; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Maldonado H, 2011, J NEUROSCI RES, V89, P1489, DOI 10.1002/jnr.22678; Maldonado H, 2008, BIOL RES, V41, P239, DOI [/S0716-97602008000300001, 10.4067/S0716-97602008000300001]; Matta S, 2012, NEURON, V75, P1008, DOI 10.1016/j.neuron.2012.08.022; Napolitano A, 2011, CURR MED CHEM, V18, P1832, DOI 10.2174/092986711795496863; Ozelius LJ, 2006, NEW ENGL J MED, V354, P424, DOI 10.1056/NEJMc055509; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Polymenidou M, 2012, J EXP MED, V209, P889, DOI 10.1084/jem.20120741; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rajput A, 2006, NEUROLOGY, V67, P1506, DOI 10.1212/01.wnl.0000240220.33950.0c; Ross OA, 2006, ANN NEUROL, V59, P388, DOI 10.1002/ana.20731; Sanchez-Danes A, 2012, EMBO MOL MED, V4, P380, DOI 10.1002/emmm.201200215; Schiesling C, 2008, NEUROPATH APPL NEURO, V34, P255, DOI 10.1111/j.1365-2990.2008.00952.x; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Zach S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013191; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	46	361	381	2	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 7	2013	12	3					354	367		10.1016/j.stem.2013.01.008	http://dx.doi.org/10.1016/j.stem.2013.01.008			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VC	23472874	Bronze			2022-12-28	WOS:000329569400013
J	Wu, MV; Hen, R				Wu, Melody V.; Hen, Rene			The Young and the Restless: Regulation of Adult Neurogenesis by Wnt Signaling	CELL STEM CELL			English	Editorial Material								Wnt signaling plays a critical role in developmental and adult neurogenesis. In this issue of Cell Stem Cell, Jang et al. (2013) and Seib et al. (2013) show how age and neuronal activity regulate adult hippocampal neurogenesis by inhibiting or activating, respectively, distinct components of the Wnt signaling machinery.	[Wu, Melody V.; Hen, Rene] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Hen, Rene] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Hen, Rene] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Wu, Melody V.; Hen, Rene] New York State Psychiat Inst & Hosp, Div Integrat Neurosci, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute	Hen, R (corresponding author), Columbia Univ, Dept Psychiat, New York, NY 10032 USA.	rh95@columbia.edu		Wu, Melody/0000-0002-5246-2659	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH068542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG043688] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG043688] Funding Source: Medline; NIMH NIH HHS [R37 MH068542] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Fuentealba LC, 2012, CELL STEM CELL, V10, P698, DOI 10.1016/j.stem.2012.05.012; Jang M.H., 2012, MOL PSYCH; Jang MH, 2013, CELL STEM CELL, V12, P215, DOI 10.1016/j.stem.2012.11.021; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kheirbek MA, 2012, NAT NEUROSCI, V15, P1613, DOI 10.1038/nn.3262; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Okamoto M, 2011, FASEB J, V25, P3570, DOI 10.1096/fj.11-184697; Seib DRM, 2013, CELL STEM CELL, V12, P204, DOI 10.1016/j.stem.2012.11.010; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	10	11	13	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 7	2013	12	2					139	140		10.1016/j.stem.2013.01.013	http://dx.doi.org/10.1016/j.stem.2013.01.013			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VB	23395437	Green Accepted, Bronze			2022-12-28	WOS:000329569300001
J	Lee, RH; Yoon, N; Reneau, JC; Prockop, DJ				Lee, Ryang Hwa; Yoon, Nara; Reneau, John C.; Prockop, Darwin J.			Preactivation of Human MSCs with TNF-alpha Enhances Tumor-Suppressive Activity	CELL STEM CELL			English	Article							MESENCHYMAL STEM-CELLS; APOPTOSIS-INDUCING LIGAND; MULTIPOTENT STROMAL CELLS; NF-KAPPA-B; GROWTH-INHIBITION; TARGETED-DELIVERY; INTERFERON-BETA; WNT PATHWAY; IN-VITRO; CANCER	Mesenchymal stem/stromal cells (MSCs) can either suppress or promote tumors. We found previously that incubation of human bone marrow MSCs (hMSCs) with TNF-alpha upregulated multiple genes including TRAIL, which has cancer apoptotic activity. Here, we show that weekly infusions into mice of hMSCs preactivated with TNF-alpha inhibited the progression of lung tumors formed from MDA-MB-231 breast cancer cells (MDA). In coculture, preactivated hMSCs induced apoptosis in MDA and several other TRAIL-sensitive cancer cell lines. TRAIL was further upregulated by apoptotic MDA cells in a TLR3-dependent manner; this feedforward cycle increased MDA cell apoptosis, and the chemotherapeutic drug doxorubicin had a synergistic effect. Also, activated hMSCs secreted DKK3 to suppress MDA cell cycling, leading to a decrease in beta-catenin and cyclin D1/D3 and an increase in p21. Thus, culturing hMSCs with TNF-alpha enhances their tumor-suppressive properties and may represent a useful strategy to develop hMSC-based approaches for the treatment of cancer.	[Lee, Ryang Hwa; Yoon, Nara; Reneau, John C.; Prockop, Darwin J.] Texas A&M Hlth Sci Ctr, Coll Med, Inst Regenerat Med Scott & White, Temple, TX 76502 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Lee, RH (corresponding author), Texas A&M Hlth Sci Ctr, Coll Med, Inst Regenerat Med Scott & White, Temple, TX 76502 USA.	rlee@medicine.tamhsc.edu; prockop@medicine.tamhsc.edu			Cancer Prevention & Research Institute of Texas [RP100781]; Temple Therapeutics, LLC	Cancer Prevention & Research Institute of Texas; Temple Therapeutics, LLC	This work was supported by grants from Cancer Prevention & Research Institute of Texas (RP100781) and from Temple Therapeutics, LLC. We thank Texas A&M Health Science Center Integrated Microscopy and Imaging Laboratory for the use of a microscope. We thank Dr. Carl Gregory for much helpful discussion on the osteoprotegerin inhibitor and Dr. Ulf Krause for cell sorting.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Arbour N, 2005, MULT SCLER J, V11, P652, DOI 10.1191/1352458505ms1222oa; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Borden EC, 2011, J INTERF CYTOK RES, V31, P433, DOI 10.1089/jir.2010.0054; Buchsbaum DJ, 2003, CLIN CANCER RES, V9, P3731; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Devitt A, 2003, CELL DEATH DIFFER, V10, P371, DOI 10.1038/sj.cdd.4401168; DiGirolamo CM, 1999, BRIT J HAEMATOL, V107, P275, DOI 10.1046/j.1365-2141.1999.01715.x; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Djouad F, 2006, TRANSPLANTATION, V82, P1060, DOI 10.1097/01.tp.0000236098.13804.0b; Gazitt Y, 1999, LEUKEMIA, V13, P1817, DOI 10.1038/sj.leu.2401501; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Grisendi G, 2010, CANCER RES, V70, P3718, DOI 10.1158/0008-5472.CAN-09-1865; IDA N, 1982, GANN, V73, P952; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kanehira M, 2007, CANCER GENE THER, V14, P894, DOI 10.1038/sj.cgt.7701079; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Keane MM, 1999, CANCER RES, V59, P734; Kelley SK, 2001, J PHARMACOL EXP THER, V299, P31; Kidd S, 2010, CYTOTHERAPY, V12, P615, DOI 10.3109/14653241003631815; Klopp AH, 2007, CANCER RES, V67, P11687, DOI 10.1158/0008-5472.CAN-07-1406; Krause U, 2010, P NATL ACAD SCI USA, V107, P4147, DOI 10.1073/pnas.0914360107; Kucerova L, 2007, CANCER RES, V67, P6304, DOI 10.1158/0008-5472.CAN-06-4024; Kuphal S, 2006, ONCOGENE, V25, P5027, DOI 10.1038/sj.onc.1209508; Kurtova AV, 2009, BLOOD, V114, P4441, DOI 10.1182/blood-2009-07-233718; Larson BL, 2010, TISSUE ENG PT A, V16, P3385, DOI 10.1089/ten.tea.2010.0085; Lee EJ, 2009, INT J CANCER, V124, P287, DOI 10.1002/ijc.23913; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Ling XY, 2010, CANCER MICROENVIRON, V3, P83, DOI 10.1007/s12307-010-0041-8; Loebinger MR, 2009, CANCER RES, V69, P4134, DOI 10.1158/0008-5472.CAN-08-4698; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Mallory JC, 2005, MOL PHARMACOL, V68, P1747, DOI 10.1124/mol.105.016519; Menon LG, 2009, STEM CELLS, V27, P2320, DOI 10.1002/stem.136; Mohr A, 2008, J CELL MOL MED, V12, P2628, DOI 10.1111/j.1582-4934.2008.00317.x; Mueller LP, 2011, CANCER GENE THER, V18, P229, DOI 10.1038/cgt.2010.68; Patel SA, 2010, J IMMUNOL, V184, P5885, DOI 10.4049/jimmunol.0903143; Phinney DG, 1999, J CELL BIOCHEM, V75, P424, DOI 10.1002/(SICI)1097-4644(19991201)75:3<424::AID-JCB8>3.0.CO;2-8; Prockop DJ, 2010, J CELL MOL MED, V14, P2190, DOI 10.1111/j.1582-4934.2010.01151.x; Rahman M, 2009, BREAST CANCER RES TR, V113, P217, DOI 10.1007/s10549-008-9924-5; Reich CF, 2009, EXP CELL RES, V315, P760, DOI 10.1016/j.yexcr.2008.12.014; Rivera-Walsh I, 2001, J BIOL CHEM, V276, P40385, DOI 10.1074/jbc.C100501200; Rus V, 2005, CLIN IMMUNOL, V117, P48, DOI 10.1016/j.clim.2005.05.001; Sekiya I, 2002, STEM CELLS, V20, P530, DOI 10.1634/stemcells.20-6-530; Shao JY, 2005, J BIOL CHEM, V280, P26565, DOI 10.1074/jbc.M413056200; Singh TR, 2003, CANCER RES, V63, P5390; Studeny M, 2004, JNCI-J NATL CANCER I, V96, P1593, DOI 10.1093/jnci/djh299; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Tecchio C, 2004, BLOOD, V103, P3837, DOI 10.1182/blood-2003-08-2806; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tian K, 2010, CELL PHYSIOL BIOCHEM, V26, P799, DOI 10.1159/000323973; Veeck J, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2151; Veeck J, 2012, BBA-REV CANCER, V1825, P18, DOI 10.1016/j.bbcan.2011.09.003; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wolfe Margaret, 2008, V449, P3, DOI 10.1007/978-1-60327-169-1_1; Xin H, 2007, STEM CELLS, V25, P1618, DOI 10.1634/stemcells.2006-0461; Yue W, 2008, CARCINOGENESIS, V29, P84, DOI 10.1093/carcin/bgm267; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhu Y, 2009, LEUKEMIA, V23, P925, DOI 10.1038/leu.2008.384	62	99	103	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 7	2012	11	6					825	835		10.1016/j.stem.2012.10.001	http://dx.doi.org/10.1016/j.stem.2012.10.001			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	055MJ	23142520	Bronze			2022-12-28	WOS:000312420300013
J	Akiyama, K; Chen, C; Wang, DD; Xu, XT; Qu, CY; Yamaza, T; Cai, T; Chen, WJ; Sun, LY; Shi, ST				Akiyama, Kentaro; Chen, Chider; Wang, DanDan; Xu, Xingtian; Qu, Cunye; Yamaza, Takayoshi; Cai, Tao; Chen, WanJun; Sun, Lingyun; Shi, Songtao			Mesenchymal-Stem-Cell-Induced Immunoregulation Involves FAS-Ligand-/FAS-Mediated T Cell Apoptosis	CELL STEM CELL			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GROWTH-FACTOR-BETA; TISSUE; TRANSPLANTATION; ACTIVATION; CHEMOKINES; TOLERANCE; RESPONSES; PATHWAY; PROTEIN	Systemic infusion of bone marrow mesenchymal stem cells (BMMSCs) yields therapeutic benefit for a variety of autoimmune diseases, but the underlying mechanisms are poorly understood. Here we show that in mice systemic infusion of BMMSCs induced transient T cell apoptosis via the FAS ligand (FASL)dependent FAS pathway and could ameliorate disease phenotypes in fibrillin-1 mutated systemic sclerosis (SS) and dextran-sulfate-sodium-induced experimental colitis. FASL(-/-) BMMSCs did not induce T cell apoptosis in recipients, and could not ameliorate SS and colitis. Mechanistic analysis revealed that FAS-regulated monocyte chemotactic protein 1 (MCP-1) secretion by BMMSCs recruited T cells for FASL-mediated apoptosis. The apoptotic T cells subsequently triggered macrophages to produce high levels of TGF beta, which in turn led to the upregulation of Ca4(+)CD25(+)Foxp3(+) regulatory T cells and, ultimately, immune tolerance. These data therefore demonstrate a previously unrecognized mechanism underlying BMMSC-based immunotherapy involving coupling via FAS/FASL to induce T cell apoptosis.	[Wang, DanDan; Sun, Lingyun] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Rheumatol & Immunol, Nanjing 210008, Jiangsu, Peoples R China; [Akiyama, Kentaro; Chen, Chider; Xu, Xingtian; Qu, Cunye; Yamaza, Takayoshi; Shi, Songtao] Univ So Calif, Ostrow Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA; [Akiyama, Kentaro] Okayama Univ, Grad Sch, Dept Oral Rehabil & Regenerat Med, Kita Ku, Okayama 7008525, Japan; [Cai, Tao; Chen, WanJun] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA	Nanjing University; University of Southern California; Okayama University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Sun, LY (corresponding author), Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Rheumatol & Immunol, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China.	lingyunsun2011@yahoo.com.cn; songtaos@usc.edu	XU, XINGTIAN/E-4518-2014; Chen, Chider/L-9880-2016	Chen, Chider/0000-0003-2899-1208; Cai, Tao/0000-0002-2877-8637; Yamaza, Takayoshi/0000-0001-7055-3370	National Institute of Dental and Craniofacial Research, National Institutes of Health, Department of Health and Human Services [RO1DE017449, RO1 DE019932, RO1 DE019413]; California Institute for Regenerative Medicine [RN1-00572]; NIDCR; NIH; China Major International [81120108021]; ClinicalTrials.gov [NCT00962923]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019932, R01DE017449, ZIADE000101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE019413] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Major International; ClinicalTrials.gov; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Basic research parts of this work were supported by grants from the National Institute of Dental and Craniofacial Research, National Institutes of Health, Department of Health and Human Services (RO1DE017449, RO1 DE019932, and RO1 DE019413 to S.S.), a grant from the California Institute for Regenerative Medicine (RN1-00572 for S.S.), and the Intramural Research Program of NIDCR, NIH (for W.J.C. and T.C.). Clinical studies were supported by a grant from the China Major International (Regional) Joint Research Project (81120108021). ClinicalTrials.gov Identifier: NCT00962923.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Augello A, 2007, ARTHRITIS RHEUM-US, V56, P1175, DOI 10.1002/art.22511; Batten P, 2006, TISSUE ENG, V12, P2263, DOI 10.1089/ten.2006.12.2263; Bernardo ME, 2009, ANN NY ACAD SCI, V1176, P101, DOI 10.1111/j.1749-6632.2009.04607.x; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; Chatenoud L, 1997, J IMMUNOL, V158, P2947; CHATENOUD L, 1994, P NATL ACAD SCI USA, V91, P123, DOI 10.1073/pnas.91.1.123; Chen X, 2006, IMMUNOL CELL BIOL, V84, P413, DOI 10.1111/j.1440-1711.2006.01458.x; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Gonzalez MA, 2009, GASTROENTEROLOGY, V136, P978, DOI 10.1053/j.gastro.2008.11.041; GREEN MC, 1976, AM J PATHOL, V82, P493; Hohlbaum AM, 2000, J EXP MED, V191, P1209, DOI 10.1084/jem.191.7.1209; Kleinclauss F, 2006, CELL DEATH DIFFER, V13, P41, DOI 10.1038/sj.cdd.4401699; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Liang J, 2009, MULT SCLER J, V15, P644, DOI 10.1177/1352458509104590; Mazar J, 2009, J BIOL CHEM, V284, P22022, DOI 10.1074/jbc.M109.032235; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Parekkadan B, 2008, STEM CELLS, V26, P1913, DOI 10.1634/stemcells.2007-0790; Park MJ, 2011, ARTHRITIS RHEUM-US, V63, P1668, DOI 10.1002/art.30326; Perruche S, 2008, NAT MED, V14, P528, DOI 10.1038/nm1749; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Polchert D, 2008, EUR J IMMUNOL, V38, P1745, DOI 10.1002/eji.200738129; Rafei M, 2009, J IMMUNOL, V182, P5994, DOI 10.4049/jimmunol.0803962; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Roddy GW, 2011, STEM CELLS, V29, P1572, DOI 10.1002/stem.708; Sato K, 2007, BLOOD, V109, P228, DOI 10.1182/blood-2006-02-002246; Sun LY, 2009, STEM CELLS, V27, P1421, DOI 10.1002/stem.68; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Uccelli A, 2007, TRENDS IMMUNOL, V28, P219, DOI 10.1016/j.it.2007.03.001; Xu LL, 1996, J LEUKOCYTE BIOL, V60, P365, DOI 10.1002/jlb.60.3.365; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496; Zhang Q., 2010, J IMMUNOL, V183, P7787; Zhang YY, 2008, J IMMUNOL, V181, P190, DOI 10.4049/jimmunol.181.1.190	35	495	542	1	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 4	2012	10	5					544	555		10.1016/j.stem.2012.03.007	http://dx.doi.org/10.1016/j.stem.2012.03.007			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	944WN	22542159	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000304234600013
J	Park, D; Spencer, JA; Koh, BI; Kobayashi, T; Fujisaki, J; Clemens, TL; Lin, CP; Kronenberg, HM; Scadden, DT				Park, Dongsu; Spencer, Joel A.; Koh, Bong Ihn; Kobayashi, Tatsuya; Fujisaki, Joji; Clemens, Thomas L.; Lin, Charles P.; Kronenberg, Henry M.; Scadden, David T.			Endogenous Bone Marrow MSCs Are Dynamic, Fate-Restricted Participants in Bone Maintenance and Regeneration	CELL STEM CELL			English	Article							MESENCHYMAL STEM-CELLS; HEMATOPOIETIC STEM; PROGENITOR CELLS; OSTEOBLAST; MICROENVIRONMENT; NICHE; DIFFERENTIATION; SPECIFICATION; POPULATION	Mesenchymal stem cells (MSCs) commonly defined by in vitro functions have entered clinical application despite little definition of their function in residence. Here, we report genetic pulse-chase experiments that define osteoblastic cells as short-lived and nonreplicative, requiring replenishment from bone-marrow-derived, Mx1(+) stromal cells with "MSC" features. These cells respond to tissue stress and migrate to sites of injury, supplying new osteoblasts during fracture healing. Single cell transplantation yielded progeny that both preserve progenitor function and differentiate into osteoblasts, producing new bone. They are capable of local and systemic translocation and serial transplantation. While these cells meet current definitions of MSCs in vitro, they are osteolineage restricted in vivo in growing and adult animals. Therefore, bone-marrow-derived MSCs may be a heterogeneous population with the Mx1(+) population, representing a highly dynamic and stress responsive stem/progenitor cell population of fate-restricted potential that feeds the high cell replacement demands of the adult skeleton.	[Park, Dongsu; Koh, Bong Ihn; Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Spencer, Joel A.; Fujisaki, Joji; Lin, Charles P.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Adv Microscopy Program, Boston, MA 02114 USA; [Spencer, Joel A.; Fujisaki, Joji; Lin, Charles P.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Kobayashi, Tatsuya; Kronenberg, Henry M.] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Park, Dongsu; Spencer, Joel A.; Koh, Bong Ihn; Fujisaki, Joji; Lin, Charles P.; Scadden, David T.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Clemens, Thomas L.] Johns Hopkins Med, Ctr Musculoskeletal Res, Baltimore, MD 21287 USA; [Park, Dongsu; Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Johns Hopkins University; Johns Hopkins Medicine; Harvard University	Scadden, DT (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, 185 Cambridge St, Boston, MA 02114 USA.	david_scadden@harvard.edu	Spencer, Joel/GLT-9687-2022; Spencer, Joel/A-4590-2013	Spencer, Joel/0000-0002-4013-8763; Kobayashi, Tatsuya/0000-0003-4264-5117; Park, Dongsu/0000-0002-2570-3250	Leukemia & Lymphoma Society; National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044851, U01HL100402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR061434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER	Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. Lo Celso, S. Mukherjee, J. Schoonmaker, S. Guo, R. Schlanger, and M. Kim for advice and technical assistance; N. Jeanson, A. Catic, J. Dietrich, and D. Sykes for reading the manuscript; the HSCl/MGH CRM Flow Core (L. Prickett, K. Folz-Donahue, and D. Dombkowski); and the Leukemia & Lymphoma Society (Fellowship Award to D.P.) and the National Institutes of Health (grants to T.L.C., C.P.L., H.M.K., and D.T.S.).	Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dallas SL, 2010, ANN NY ACAD SCI, V1192, P437, DOI 10.1111/j.1749-6632.2009.05246.x; Dominici M, 2009, BLOOD, V114, P2333, DOI 10.1182/blood-2008-10-183459; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Eghbali-Fatourechi GZ, 2005, NEW ENGL J MED, V352, P1959, DOI 10.1056/NEJMoa044264; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; Jilka RL, 1998, J BONE MINER RES, V13, P793, DOI 10.1359/jbmr.1998.13.5.793; Kalajzic Z, 2008, BONE, V43, P501, DOI 10.1016/j.bone.2008.04.023; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Lana-Elola E, 2007, DEV BIOL, V311, P335, DOI 10.1016/j.ydbio.2007.08.028; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Leucht P, 2007, BONE, V40, P919, DOI 10.1016/j.bone.2006.10.027; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; MCCULLOCH CAG, 1988, ANAT REC, V222, P128, DOI 10.1002/ar.1092220204; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Otsuru S, 2008, STEM CELLS, V26, P223, DOI 10.1634/stemcells.2007-0515; OWEN M, 1963, J CELL BIOL, V19, P19, DOI 10.1083/jcb.19.1.19; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014	33	446	472	1	57	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAR 2	2012	10	3					259	272		10.1016/j.stem.2012.02.003	http://dx.doi.org/10.1016/j.stem.2012.02.003			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	908BX	22385654	Green Accepted, Bronze			2022-12-28	WOS:000301466500008
J	Carey, BW; Markoulaki, S; Hanna, JH; Faddah, DA; Buganim, Y; Kim, J; Ganz, K; Steine, EJ; Cassady, JP; Creyghton, MP; Welstead, GG; Gao, Q; Jaenisch, R				Carey, Bryce W.; Markoulaki, Styliani; Hanna, Jacob H.; Faddah, Dina A.; Buganim, Yosef; Kim, Jongpil; Ganz, Kibibi; Steine, Eveline J.; Cassady, John P.; Creyghton, Menno P.; Welstead, G. Grant; Gao, Qing; Jaenisch, Rudolf			Reprogramming Factor Stoichiometry Influences the Epigenetic State and Biological Properties of Induced Pluripotent Stem Cells	CELL STEM CELL			English	Article							SOMATIC-CELLS; MEMORY; MICE; DIFFERENTIATION; ACTIVATION; GENES; ES	We compared two genetically highly defined transgenic systems to identify parameters affecting reprogramming of somatic cells to a pluripotent state. Our results demonstrate that the level and stoichiometry of reprogramming factors during the reprogramming process strongly influence the resulting pluripotency of iPS cells. High expression of Oct4 and Klf4 combined with lower expression of c-Myc and Sox2 produced iPS cells that efficiently generated "all-iPSC mice" by tetraploid (4n) complementation, maintained normal imprinting at the Dlk1-Dio3 locus, and did not create mice with tumors. Loss of imprinting (LOI) at the Dlk1-Dio3 locus did not strictly correlate with reduced pluripotency though the efficiency of generating "all-iPSC mice" was diminished. Our data indicate that stoichiometry of reprogramming factors can influence epigenetic and biological properties of iPS cells. This concept complicates efforts to define a "generic" epigenetic state of iPSCs and ESCs and should be considered when comparing different iPS and ES cell lines.	[Carey, Bryce W.; Markoulaki, Styliani; Faddah, Dina A.; Buganim, Yosef; Kim, Jongpil; Ganz, Kibibi; Steine, Eveline J.; Cassady, John P.; Welstead, G. Grant; Gao, Qing; Jaenisch, Rudolf] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Carey, Bryce W.; Faddah, Dina A.; Cassady, John P.; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02142 USA; [Hanna, Jacob H.] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Creyghton, Menno P.] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Weizmann Institute of Science; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Jaenisch, R (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu	Hanna, Jacob/K-1339-2012	Hanna, Jacob/0000-0003-2042-9974	NSF; NIH [5-RO1-HDO45022, 5-R37-CA084198, 5-RO1-CA087869]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA084198, R01CA084198, R01CA087869] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. Flannery for help with mouse husbandry and D. Fu, K. Saha, A.W. Cheng, F. Soldner, and M. Dawlaty for excellent assistance and helpful comments. We also thank K. Hochedlinger and M. Stadtfeld for the Col1a1-OKSM mice and for iPSC DNA and for comments on the manuscript. D.A.F. was supported by a NSF graduate research fellowship (NSF GFRP). R.J. is supported by grants from the NIH: 5-RO1-HDO45022, 5-R37-CA084198, and 5-RO1-CA087869. R.J. is an adviser to Stemgent and cofounder of Fate Therapeutics.	Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Carey BW, 2010, NAT METHODS, V7, P56, DOI [10.1038/NMETH.1410, 10.1038/nmeth.1410]; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Eakin GS, 2005, DEV BIOL, V288, P150, DOI 10.1016/j.ydbio.2005.09.028; Eggan K, 2003, METHOD ENZYMOL, V365, P25; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Quinlan AR, 2011, CELL STEM CELL, V9, P366, DOI 10.1016/j.stem.2011.07.018; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Stadtfeld M, 2010, NAT METHODS, V7, P53, DOI [10.1038/NMETH.1409, 10.1038/nmeth.1409]; Takada S, 2002, HUM MOL GENET, V11, P77, DOI 10.1093/hmg/11.1.77; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zhou YL, 2010, DEVELOPMENT, V137, P2643, DOI 10.1242/dev.045724	28	245	249	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 2	2011	9	6					588	598		10.1016/j.stem.2011.11.003	http://dx.doi.org/10.1016/j.stem.2011.11.003			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	859SB	22136932	Bronze, Green Published			2022-12-28	WOS:000297895000018
J	Millar, SE				Millar, Sarah E.			Committing to a Hairy Fate: Epigenetic Regulation of Hair Follicle Stem Cells	CELL STEM CELL			English	Editorial Material							HISTONE MODIFICATIONS		[Millar, Sarah E.] Univ Penn Perelman Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA; [Millar, Sarah E.] Univ Penn Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Millar, SE (corresponding author), Univ Penn Perelman Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA.	millars@mail.med.upenn.edu		Millar, Sarah/0000-0001-8792-6890				Biernaskie J, 2009, CELL STEM CELL, V5, P610, DOI 10.1016/j.stem.2009.10.019; De Gobbi M, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-9; Ezhkova E, 2011, GENE DEV, V25, P485, DOI 10.1101/gad.2019811; Fisher CL, 2011, CURR OPIN GENET DEV, V21, P140, DOI 10.1016/j.gde.2011.01.015; Hong SH, 2011, CELL STEM CELL, V9, P24, DOI 10.1016/j.stem.2011.06.002; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Lien WH, 2011, CELL STEM CELL, V9, P219, DOI 10.1016/j.stem.2011.07.015; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347	10	4	5	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	SEP 2	2011	9	3					183	184		10.1016/j.stem.2011.08.009	http://dx.doi.org/10.1016/j.stem.2011.08.009			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	822DN	21885014	Bronze			2022-12-28	WOS:000295024200004
J	Caplan, AI; Correa, D				Caplan, Arnold I.; Correa, Diego			The MSC: An Injury Drugstore	CELL STEM CELL			English	Article							MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; PROGENITOR CELLS; ADIPOSE-TISSUE; ADULT; CULTURES; THERAPY; DIFFERENTIATION; TRANSPLANTATION; MECHANISMS	Now that mesenchymal stem cells (MSCs) have been shown to be perivascular in vivo, the existing traditional view that focuses on the multipotent differentiation capacity of these cells should be expanded to include their equally interesting role as cellular modulators that brings them into a broader therapeutic scenario. We discuss existing evidence that leads us to propose that during local injury, MSCs are released from their perivascular location, become activated, and establish a regenerative microenvironment by secreting bioactive molecules and regulating the local immune response. These trophic and immunomodulatory activities suggest that MSCs may serve as site-regulated "drugstores" in vivo.	[Caplan, Arnold I.; Correa, Diego] Case Western Reserve Univ, Skeletal Res Ctr, Dept Biol, Cleveland, OH 44106 USA	Case Western Reserve University	Caplan, AI (corresponding author), Case Western Reserve Univ, Skeletal Res Ctr, Dept Biol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	arnold.caplan@case.edu		Caplan, Arnold/0000-0002-8677-6621	E. Virginia and L. David Baldwin Research Fund; NIH [PO1-AR053622]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR053622] Funding Source: NIH RePORTER	E. Virginia and L. David Baldwin Research Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Support for this article was provided by the E. Virginia and L. David Baldwin Research Fund and the NIH (PO1-AR053622).	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Bai LH, 2009, GLIA, V57, P1192, DOI 10.1002/glia.20841; Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bonfield TL, 2010, AM J PHYSIOL-LUNG C, V299, pL760, DOI 10.1152/ajplung.00182.2009; Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Caplan AI, 2008, CELL STEM CELL, V3, P229, DOI 10.1016/j.stem.2008.08.008; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Caplan AI, 2010, TISSUE ENG PT A, V16, P2415, DOI 10.1089/ten.TEA.2010.0216; Colter DC, 2000, P NATL ACAD SCI USA, V97, P3213, DOI 10.1073/pnas.070034097; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Daquinag AC, 2011, CELL STEM CELL, V9, P74, DOI 10.1016/j.stem.2011.05.017; Dennis JE, 1999, J BONE MINER RES, V14, P700, DOI 10.1359/jbmr.1999.14.5.700; Diaz-Flores L, 2009, HISTOL HISTOPATHOL, V24, P909, DOI 10.14670/HH-24.909; FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381; FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x; Giordano A, 2007, J CELL PHYSIOL, V211, P27, DOI 10.1002/jcp.20959; Gonzalez-Rey E, 2009, GUT, V58, P929, DOI 10.1136/gut.2008.168534; Guilak F, 2010, CLIN ORTHOP RELAT R, V468, P2530, DOI 10.1007/s11999-010-1410-9; Hall BK, 2008, J BIOSCIENCES, V33, P781, DOI 10.1007/s12038-008-0098-4; Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12; Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Itescu S, 2003, J MOL MED, V81, P288, DOI 10.1007/s00109-003-0432-0; Iyer SS, 2008, EXPERT OPIN BIOL TH, V8, P569, DOI 10.1517/14712598.8.5.569 ; Jones BJ, 2008, EXP HEMATOL, V36, P733, DOI 10.1016/j.exphem.2008.03.006; Koc ON, 2002, BONE MARROW TRANSPL, V30, P215, DOI 10.1038/sj.bmt.1703650; Krasnodembskaya A, 2010, STEM CELLS, V28, P2229, DOI 10.1002/stem.544; LAZARUS HM, 1995, BONE MARROW TRANSPL, V16, P557; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415; Majumdar MK, 1998, J CELL PHYSIOL, V176, P57, DOI 10.1002/(SICI)1097-4652(199807)176:1<57::AID-JCP7>3.0.CO;2-7; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Miller RH, 2010, DISCOV MED, V9, P236; Minguell JJ, 2006, EXP BIOL MED, V231, P39; Moretti P, 2010, ADV BIOCHEM ENG BIOT, V123, P29, DOI 10.1007/10_2009_15; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; OWEN M, 1988, CIBA F SYMP, V136, P42; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Ringden O, 2006, TRANSPLANTATION, V81, P1390, DOI 10.1097/01.tp.0000214462.63943.14; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Schuster MD, 2004, AM J PHYSIOL-HEART C, V287, pH525, DOI 10.1152/ajpheart.00058.2004; Singer NG, 2011, ANNU REV PATHOL-MECH, V6, P457, DOI 10.1146/annurev-pathol-011110-130230; Sorrell JM, 2009, TISSUE ENG PT A, V15, P1751, DOI 10.1089/ten.tea.2008.0254; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; TAVASSOLI M, 1968, SCIENCE, V161, P54, DOI 10.1126/science.161.3836.54; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Wagner J, 2009, CURR OPIN BIOTECH, V20, P531, DOI 10.1016/j.copbio.2009.08.009	53	1070	1110	2	115	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 8	2011	9	1					11	15		10.1016/j.stem.2011.06.008	http://dx.doi.org/10.1016/j.stem.2011.06.008			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	797VA	21726829	Green Accepted, Bronze			2022-12-28	WOS:000293157000005
J	Haimes, E; Taylor, K				Haimes, Erica; Taylor, Ken			Researching the Relationships between Tissue Providers, Clinicians, and Stem Cell Scientists	CELL STEM CELL			English	Editorial Material							EMBRYOS; DONATION	Access to human reproductive tissue is essential for many forms of stem cell research. We identify questions for future studies of tissue providers, procurers, and end-user scientists, and suggest that international comparative studies of all three parties, and of the relationships between them, will improve the ethical supply of tissue.	[Haimes, Erica; Taylor, Ken] Newcastle Univ, Policy Eth & Life Sci PEALS Res Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Haimes, E (corresponding author), Newcastle Univ, Policy Eth & Life Sci PEALS Res Ctr, 4th Floor, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	erica.haimes@newcastle.ac.uk			MRC [G0701109] Funding Source: UKRI; Medical Research Council [G0701109] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2007, AUTONOMY TRUST BIOET; Cohen CB, 2008, CELL STEM CELL, V2, P416, DOI 10.1016/j.stem.2008.04.002; Gottweis H, 2010, CELL STEM CELL, V7, P555, DOI 10.1016/j.stem.2010.10.008; Haimes E, 2009, HUM REPROD, V24, P2142, DOI 10.1093/humrep/dep124; Haimes E, 2011, BIOETHICS, V25, P334, DOI 10.1111/j.1467-8519.2009.01792.x; Kalista T, 2011, CELL STEM CELL, V8, P360, DOI 10.1016/j.stem.2011.02.018; Lyerly AD, 2011, HUM REPROD, V26, P646, DOI 10.1093/humrep/deq368; Moreno JD, 2010, NATURE, V467, P1031, DOI 10.1038/4671031a; Pfeffer N, 2008, SOC SCI MED, V66, P2544, DOI 10.1016/j.socscimed.2008.01.050; Woods S., 2008, CLIN ETHICS, V3, P14	10	6	6	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 3	2011	8	6					613	615		10.1016/j.stem.2011.05.005	http://dx.doi.org/10.1016/j.stem.2011.05.005			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Cell Biology	780HC	21624805	Bronze			2022-12-28	WOS:000291844100009
J	Sridharan, R; Plath, K				Sridharan, Rupa; Plath, Kathrin			Small RNAs Loom Large During Reprogramming	CELL STEM CELL			English	Editorial Material							CELLS; PLURIPOTENCY; MIR-302; MICRORNAS	In two independent Cell Stem Cell reports, the Morrisey and Mori groups show that human and mouse somatic cells can be reprogrammed to produce induced pluripotent stem cells by expressing microRNAs, completely eliminating the need for ectopic protein expression (Anokye-Danso et al., 2011; Miyoshi et al., 2011).	[Sridharan, Rupa; Plath, Kathrin] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Sridharan, Rupa; Plath, Kathrin] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Sridharan, Rupa; Plath, Kathrin] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Sridharan, Rupa; Plath, Kathrin] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Sridharan, Rupa; Plath, Kathrin] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Plath, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.	kplath@mednet.ucla.edu		Plath, Kathrin/0000-0001-7796-3372	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001686] Funding Source: NIH RePORTER; NIH HHS [DP2 OD001686-01, DP2 OD001686] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Li ZH, 2011, EMBO J, V30, P823, DOI 10.1038/emboj.2011.2; Liao BJ, 2011, J BIOL CHEM, V286, P17359, DOI 10.1074/jbc.C111.235960; Lin SL, 2008, RNA, V14, P2115, DOI 10.1261/rna.1162708; Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012	11	9	10	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 3	2011	8	6					599	601		10.1016/j.stem.2011.05.009	http://dx.doi.org/10.1016/j.stem.2011.05.009			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	780HC	21624799	Bronze, Green Accepted			2022-12-28	WOS:000291844100003
J	Whitsett, JA; Kalinichenko, VV				Whitsett, Jeffrey A.; Kalinichenko, Vladimir V.			Notch and Basal Cells Take Center Stage during Airway Epithelial Regeneration	CELL STEM CELL			English	Editorial Material							STEM-CELLS; ALVEOLAR; CLARA; LUNG	Airway epithelium is maintained by basal cells, but the mechanisms responsible for repair are poorly characterized. In this issue of Cell Stem Cell, Rock et al. (2011) show that Notch signals regulate differentiation, but not self-renewal of basal cells after injury, and that this role appears conserved in mouse and human lung.	[Whitsett, Jeffrey A.; Kalinichenko, Vladimir V.] Univ Cincinnati, Perinatal Inst, Sect Neonatol Perinatal & Pulm Biol, Cincinnati Childrens Hosp Med Ctr,Coll Med, Cincinnati, OH 45229 USA; [Whitsett, Jeffrey A.; Kalinichenko, Vladimir V.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Coll Med, Dept Pediat, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Whitsett, JA (corresponding author), Univ Cincinnati, Perinatal Inst, Sect Neonatol Perinatal & Pulm Biol, Cincinnati Childrens Hosp Med Ctr,Coll Med, Cincinnati, OH 45229 USA.	jeff.whitsett@cchmc.org						Chiba S, 2006, STEM CELLS, V24, P2437, DOI 10.1634/stemcells.2005-0661; Guseh JS, 2009, DEVELOPMENT, V136, P1751, DOI 10.1242/dev.029249; Kang JH, 2009, AM J RESP CRIT CARE, V179, P875, DOI 10.1164/rccm.200806-893OC; Morimoto M, 2010, J CELL SCI, V123, P213, DOI 10.1242/jcs.058669; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Rock JR, 2011, CELL STEM CELL, V8, P639, DOI 10.1016/j.stem.2011.04.003; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Tilley AE, 2009, AM J RESP CRIT CARE, V179, P457, DOI 10.1164/rccm.200705-795OC; Tsao PN, 2009, DEVELOPMENT, V136, P2297, DOI 10.1242/dev.034884; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145	10	15	16	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 3	2011	8	6					597	598		10.1016/j.stem.2011.05.008	http://dx.doi.org/10.1016/j.stem.2011.05.008			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	780HC	21624798	Bronze			2022-12-28	WOS:000291844100002
J	Pastrana, E; Silva-Vargas, V; Doetsch, F				Pastrana, Erika; Silva-Vargas, Violeta; Doetsch, Fiona			Eyes Wide Open: A Critical Review of Sphere-Formation as an Assay for Stem Cells	CELL STEM CELL			English	Review							ADULT MAMMALIAN BRAIN; CENTRAL-NERVOUS-SYSTEM; NEURAL STEM/PROGENITOR CELLS; SUBVENTRICULAR ZONE; PROGENITOR CELLS; SELF-RENEWAL; OLFACTORY-BULB; IN-VITRO; SUBEPENDYMAL ZONE; EPENDYMAL CELLS	Sphere-forming assays have been widely used to retrospectively identify stem cells based on their reported capacity to evaluate self-renewal and differentiation at the single-cell level in vitro. The discovery of markers that allow the prospective isolation of stem cells and their progeny from their in vivo niche allows the functional properties of purified populations to be defined. We provide a historical perspective of the evolution of the neurosphere assay and highlight limitations in the use of sphere-forming assays in the context of neurospheres. We discuss theoretical and technical considerations of experimental design and interpretation that surround the use of this assay with any tissue.	[Pastrana, Erika; Silva-Vargas, Violeta; Doetsch, Fiona] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Pastrana, Erika; Silva-Vargas, Violeta; Doetsch, Fiona] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA; [Pastrana, Erika; Silva-Vargas, Violeta; Doetsch, Fiona] Columbia Univ, Med Ctr, Ctr Motor Neuron Biol & Dis, Columbia Stem Cell Initiat,Dept Neurosci, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Doetsch, F (corresponding author), Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA.	fkd2101@columbia.edu		Pastrana, Erika/0000-0003-1745-8635	Human Frontiers Scientific Program Long-Term Fellowship [T32 MH15174-29]; Spanish Ministerio de Educacion y Ciencia; NIH NINDS, NYSTEM; Jerry and Emily Spiegel Laboratory for Cell Replacement Therapies; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH015174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053884] Funding Source: NIH RePORTER	Human Frontiers Scientific Program Long-Term Fellowship; Spanish Ministerio de Educacion y Ciencia(Spanish Government); NIH NINDS, NYSTEM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Jerry and Emily Spiegel Laboratory for Cell Replacement Therapies; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Maldonado-Soto for the image of the pinwheel. We apologize to the many studies we could not cite due to space limitations. V.S.V. is supported by a Human Frontiers Scientific Program Long-Term Fellowship, E.P. was supported by Grant T32 MH15174-29 and by a fellowship from the Spanish Ministerio de Educacion y Ciencia, and F.D. is a Packard Foundation Fellow and Irma T. Hirschl Fellow. We receive support from NIH NINDS, NYSTEM, and the Jerry and Emily Spiegel Laboratory for Cell Replacement Therapies.	Alexander CM, 2009, CELL STEM CELL, V5, P579, DOI 10.1016/j.stem.2009.11.008; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; Andreu-Agullo C, 2009, NAT NEUROSCI, V12, P1514, DOI 10.1038/nn.2437; Barraud P, 2005, EUR J NEUROSCI, V22, P1555, DOI 10.1111/j.1460-9568.2005.04352.x; Bauer S, 2009, ANN NY ACAD SCI, V1153, P48, DOI 10.1111/j.1749-6632.2009.03986.x; Beckervordersandforth R, 2010, CELL STEM CELL, V7, P744, DOI 10.1016/j.stem.2010.11.017; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Chaichana K, 2006, STEM CELLS, V24, P2851, DOI 10.1634/stemcells.2006-0399; Chen JH, 2005, ENDOCRINOLOGY, V146, P3985, DOI 10.1210/en.2005-0185; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Chojnacki A, 2008, NAT PROTOC, V3, P935, DOI 10.1038/nprot.2008.55; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Cohen AR, 2010, NAT METHODS, V7, P213, DOI [10.1038/NMETH.1424, 10.1038/nmeth.1424]; Coles-Takabe BLK, 2008, STEM CELLS, V26, P2938, DOI 10.1634/stemcells.2008-0558; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Cordey M, 2008, STEM CELLS, V26, P2586, DOI 10.1634/stemcells.2008-0498; Corti S, 2007, EXP NEUROL, V205, P547, DOI 10.1016/j.expneurol.2007.03.021; Corti S, 2006, STEM CELLS, V24, P975, DOI 10.1634/stemcells.2005-0217; Coskun V, 2008, P NATL ACAD SCI USA, V105, P1026, DOI 10.1073/pnas.0710000105; Costa MR, 2011, DEVELOPMENT, V138, P1057, DOI 10.1242/dev.061663; Davies EL, 2008, COLD SH Q B, V73, P137, DOI 10.1101/sqb.2008.73.063; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Doetsch F, 1997, J NEUROSCI, V17, P5046; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Ferron SR, 2007, NAT PROTOC, V2, P849, DOI 10.1038/nprot.2007.104; Golebiewska A, 2011, CELL STEM CELL, V8, P136, DOI 10.1016/j.stem.2011.01.007; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Hamanoue M, 2009, J NEUROCHEM, V110, P1575, DOI 10.1111/j.1471-4159.2009.06256.x; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; HSU YC, 2001, DEV DYNAM, V238, P302; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; Imura T, 2003, J NEUROSCI, V23, P2824; Jacquet BV, 2009, DEVELOPMENT, V136, P4021, DOI 10.1242/dev.041129; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kageyama R, 2010, CURR TOP DEV BIOL, V92, P311, DOI 10.1016/S0070-2153(10)92010-3; Kawaguchi A, 2001, MOL CELL NEUROSCI, V17, P259, DOI 10.1006/mcne.2000.0925; Kazanis I, 2010, J NEUROSCI, V30, P9771, DOI 10.1523/JNEUROSCI.0700-10.2010; Kelsch W, 2007, PLOS BIOL, V5, P2501, DOI 10.1371/journal.pbio.0050300; Kim M, 2003, J NEUROSCI, V23, P10703; KIRSCHENBAUM B, 1995, P NATL ACAD SCI USA, V92, P210, DOI 10.1073/pnas.92.1.210; Kokovay E, 2008, NEURON, V60, P420, DOI 10.1016/j.neuron.2008.10.025; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lim DA, 1999, P NATL ACAD SCI USA, V96, P7526, DOI 10.1073/pnas.96.13.7526; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Louis SA, 2008, STEM CELLS, V26, P988, DOI 10.1634/stemcells.2007-0867; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Maslov AY, 2007, STEM CELLS, V25, P132, DOI 10.1634/stemcells.2006-0032; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Mori H, 2006, J NEUROSCI RES, V84, P1682, DOI 10.1002/jnr.21082; Morshead CM, 2003, EUR J NEUROSCI, V18, P76, DOI 10.1046/j.1460-9568.2003.02727.x; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; Nam HS, 2009, CELL STEM CELL, V5, P515, DOI 10.1016/j.stem.2009.08.017; Neumeister B, 2009, STEM CELLS, V27, P714, DOI 10.1634/stemcells.2008-0985; Nottebohm F, 2004, ANN NY ACAD SCI, V1016, P628, DOI 10.1196/annals.1298.027; Obermair FJ, 2010, STEM CELL RES, V5, P131, DOI 10.1016/j.scr.2010.05.001; Panchision DM, 2007, STEM CELLS, V25, P1560, DOI 10.1634/stemcells.2006-0260; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Pfenninger CV, 2011, GLIA, V59, P68, DOI 10.1002/glia.21077; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Purton LE, 2007, CELL STEM CELL, V1, P263, DOI 10.1016/j.stem.2007.08.016; Qian XM, 1998, DEVELOPMENT, V125, P3143; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Rovira M, 2010, P NATL ACAD SCI USA, V107, P75, DOI 10.1073/pnas.0912589107; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Scheffler B, 2005, P NATL ACAD SCI USA, V102, P9353, DOI 10.1073/pnas.0503965102; Seaberg RM, 2004, NAT BIOTECHNOL, V22, P1115, DOI 10.1038/nbt1004; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Stingl J, 2009, J PATHOL, V217, P229, DOI 10.1002/path.2457; Sun YR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005498; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Tomita Y, 2005, J CELL BIOL, V170, P1135, DOI 10.1083/jcb.200504061; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; Ventura RE, 2007, J NEUROSCI, V27, P4297, DOI 10.1523/JNEUROSCI.0399-07.2007; VESCOVI AL, 1993, NEURON, V11, P951, DOI 10.1016/0896-6273(93)90124-A; Vunjak-Novakovic G, 2011, CELL STEM CELL, V8, P252, DOI 10.1016/j.stem.2011.02.014; Walker TL, 2007, J NEUROSCI, V27, P3734, DOI 10.1523/JNEUROSCI.5060-06.2007; Weiss S, 1996, J NEUROSCI, V16, P7599; Yokoo S, 2005, INVEST OPHTH VIS SCI, V46, P1626, DOI 10.1167/iovs.04-1263; Young KM, 2007, J NEUROSCI, V27, P8286, DOI 10.1523/JNEUROSCI.0476-07.2007	103	592	603	4	101	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 6	2011	8	5					486	498		10.1016/j.stem.2011.04.007	http://dx.doi.org/10.1016/j.stem.2011.04.007			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	768IN	21549325	Bronze, Green Accepted			2022-12-28	WOS:000290927600010
J	Solbakk, JH; Zoloth, L				Solbakk, Jan Helge; Zoloth, Laurie			The Tragedy of Translation: The Case of "First Use" in Human Embryonic Stem Cell Research	CELL STEM CELL			English	Editorial Material							TRIALS	Who should go first in phase-I human trials when neither risks nor benefits can be estimated? By assessing concerns raised by Bretzner et al. (2011), we highlight a tragic dimension underlying all such trials. We discuss strategies to avoid the pitfalls of ethical hubris by promoting fidelity and trust.	[Solbakk, Jan Helge] Univ Oslo, Inst Hlth & Soc, Fac Med, Ctr Med Eth, N-0318 Oslo, Norway; [Zoloth, Laurie] Northwestern Univ, Ctr Bioeth Sci & Soc, Chicago, IL 60611 USA	University of Oslo; Northwestern University	Solbakk, JH (corresponding author), Univ Oslo, Inst Hlth & Soc, Fac Med, Ctr Med Eth, Box 1130 Blindern, N-0318 Oslo, Norway.	j.h.solbakk@medisin.uio.no; lzoloth@northwestern.edu						Anderson JA, 2010, KENNEDY INST ETHIC J, V20, P75, DOI 10.1353/ken.0.0307; Bretzner F, 2011, CELL STEM CELL, V8, P468, DOI 10.1016/j.stem.2011.04.012; Hurlbut WB, 2007, BIODRUGS, V21, P79, DOI 10.2165/00063030-200721020-00002; Kimmelman J, 2006, HASTINGS CENT REP, V36, P23, DOI 10.1353/hcr.2006.0012; Kimmelman J, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001010; Mathews DJH, 2008, NEUROLOGY, V71, P288, DOI 10.1212/01.wnl.0000316436.13659.80; PERKEL JM, 2011, STEMBOOK; Rortveit G, 2001, Tidsskr Nor Laegeforen, V121, P1382; ROTHMAN D, 1999, STRANGERS BEDSIDE; SOLBAKK J, 2010, REV REDBIOETICS, V1, P51; Wirth E, 2011, CELL STEM CELL, V8, P476, DOI 10.1016/j.stem.2011.04.008; ZOLOTH L, 2010, CROSSING BORDAR NIGH, pCH7	12	22	23	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAY 6	2011	8	5					479	481		10.1016/j.stem.2011.04.009	http://dx.doi.org/10.1016/j.stem.2011.04.009			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	768IN	21549323	Bronze			2022-12-28	WOS:000290927600008
J	Mignone, JL; Murry, CE				Mignone, John L.; Murry, Charles E.			A Repair "Kit" for the Infarcted Heart	CELL STEM CELL			English	Editorial Material							HEMATOPOIETIC STEM-CELLS; CARDIOMYOCYTES; MYOCARDIUM	Transplanted, c-kit expressing marrow-derived progenitors can enhance the function of an infarcted heart, but the mechanism remains unclear. In this issue of Cell Stem Cell, Loffredo et al. (2011) provide evidence that hematopoietic precursors do not differentiate into new cardiomyocytes but, rather, stimulate production of new cardiomyocytes from endogenous progenitors.	[Mignone, John L.; Murry, Charles E.] Univ Washington, Inst Stem Cell & Regenerat Med, Dept Med Cardiol, Seattle, WA 98109 USA; [Murry, Charles E.] Univ Washington, Inst Stem Cell & Regenerat Med, Dept Pathol, Seattle, WA 98109 USA; [Murry, Charles E.] Univ Washington, Inst Stem Cell & Regenerat Med, Dept Bioengn, Seattle, WA 98109 USA; [Murry, Charles E.] Univ Washington, Inst Stem Cell & Regenerat Med, Ctr Cardiovasc Biol, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Murry, CE (corresponding author), Univ Washington, Inst Stem Cell & Regenerat Med, Dept Med Cardiol, Seattle, WA 98109 USA.	murry@u.washington.edu			NHLBI NIH HHS [R01 HL084642-06, P01 HL094374-02, R01 HL084642, P01 HL094374] Funding Source: Medline; NIGMS NIH HHS [P01 GM081619, P01 GM081619-05] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL094374, R01HL084642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081619] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Loffredo FS, 2011, CELL STEM CELL, V8, P389, DOI 10.1016/j.stem.2011.02.002; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718	9	4	4	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 8	2011	8	4					350	352		10.1016/j.stem.2011.03.005	http://dx.doi.org/10.1016/j.stem.2011.03.005			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	752QI	21474095	Bronze, Green Accepted			2022-12-28	WOS:000289707100003
J	Song, SJ; Ito, K; Ala, U; Kats, L; Webster, K; Sun, SM; Jongen-Lavrencic, M; Manova-Todorova, K; Teruya-Feldstein, J; Avigan, DE; Delwel, R; Pandolfi, PP				Song, Su Jung; Ito, Keisuke; Ala, Ugo; Kats, Lev; Webster, Kaitlyn; Sun, Su Ming; Jongen-Lavrencic, Mojca; Manova-Todorova, Katia; Teruya-Feldstein, Julie; Avigan, David E.; Delwel, Ruud; Pandolfi, Pier Paolo			The Oncogenic MicroRNA miR-22 Targets the TET2 Tumor Suppressor to Promote Hematopoietic Stem Cell Self-Renewal and Transformation	CELL STEM CELL			English	Article							ACUTE MYELOID-LEUKEMIA; MYELOPROLIFERATIVE NEOPLASMS; DNA METHYLATION; MUTANT TET2; MALIGNANCIES; MUTATIONS; LNA; DIFFERENTIATION; EXPRESSION; CANCERS	MicroRNAs are frequently deregulated in cancer. Here we show that miR-22 is upregulated in myelodysplastic syndrome (MDS) and leukemia and its aberrant expression correlates with poor survival. To explore its role in hematopoietic stem cell function and malignancy, we generated transgenic mice conditionally expressing miR-22 in the hematopoietic compartment. These mice displayed reduced levels of global 5-hydroxymethylcytosine (5-hmC) and increased hematopoietic stem cell self-renewal-accompanied by defective differentiation. Conversely, miR-22 inhibition blocked proliferation in both mouse and human leukemic cells. Over time, miR-22 transgenic mice developed MDS and hematological malignancies. We also identify TET2 as a key target of miR-22 in this context. Ectopic expression of TET2 suppressed the miR-22-induced phenotypes. Downregulation of TET2 protein also correlated with poor clinical outcomes and miR-22 overexpression in MDS patients. Our results therefore identify miR-22 as a potent proto-oncogene and suggest that aberrations in the miR-22/TET2 regulatory network are common in hematopoietic malignancies.	[Song, Su Jung; Ito, Keisuke; Ala, Ugo; Kats, Lev; Webster, Kaitlyn; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Canc Genet Program, Boston, MA 02215 USA; [Song, Su Jung; Ito, Keisuke; Ala, Ugo; Kats, Lev; Webster, Kaitlyn; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Genet,Dept Med, Boston, MA 02215 USA; [Song, Su Jung; Ito, Keisuke; Ala, Ugo; Kats, Lev; Webster, Kaitlyn; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Song, Su Jung; Ito, Keisuke; Ala, Ugo; Kats, Lev; Webster, Kaitlyn; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Genet, Boston, MA 02215 USA; [Avigan, David E.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Hematol & Oncol, Boston, MA 02215 USA; [Sun, Su Ming; Jongen-Lavrencic, Mojca; Delwel, Ruud] Erasmus MC, Inst Hematol, NL-5201 Rotterdam, Netherlands; [Manova-Todorova, Katia] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Teruya-Feldstein, Julie] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, New York, NY 10065 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Erasmus University Rotterdam; Erasmus MC; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Pandolfi, PP (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Canc Genet Program, Boston, MA 02215 USA.	ppandolf@bidmc.harvard.edu	Ala, Ugo/K-2029-2016; Kats, Lev/AAW-3252-2021	Ala, Ugo/0000-0001-5408-6397; Kats, Lev/0000-0001-8742-8138; Webster, Kaitlyn/0000-0001-9902-0500; Pandolfi, Pier Paolo/0000-0002-5352-5295	NIH [R00CA139009, R01DK10068901]; NHMRC Overseas Biomedical Fellowship;  [CA141457-03 NIH]; NATIONAL CANCER INSTITUTE [R00CA139009, P30CA008748, U01CA141457, R01CA082328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098263, R01DK100689] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC Overseas Biomedical Fellowship(National Health and Medical Research Council (NHMRC) of Australia); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank all the members of the Pandolfi laboratory for their comments and discussion. We are grateful to Thomas Garvey and Min Sup Song for critical editing of the manuscript. We are also especially thankful to Akinobu Matsumoto, Dina Stroopinsky, and Mesruh Turkekul for technical support and help on in situ hybridization; to Lourdes Mendez for comments and help on hematological analysis; to Aviv Bergman for comments and support on statistical analysis of human patients' data; and to Miriam Fayad for support on cohort study of patients with hematological malignancies. K. I. was supported by NIH grants R00CA139009 and R01DK10068901. L. K. was supported by an NHMRC Overseas Biomedical Fellowship. This work was supported by CA141457-03 NIH grants to P.P.P.	Abdel-Wahab O, 2010, CANCER RES, V70, P447, DOI 10.1158/0008-5472.CAN-09-3783; Abdel-Wahab O, 2009, BLOOD, V114, P144, DOI 10.1182/blood-2009-03-210039; Arnold CP, 2011, GENOME RES, V21, P798, DOI 10.1101/gr.111385.110; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berger AH, 2011, NATURE, V476, P163, DOI 10.1038/nature10275; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jankowska AM, 2009, BLOOD, V113, P6403, DOI 10.1182/blood-2009-02-205690; Jongen-Lavrencic M, 2008, BLOOD, V111, P5078, DOI 10.1182/blood-2008-01-133355; Kallin EM, 2012, MOL CELL, V48, P266, DOI 10.1016/j.molcel.2012.08.007; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Kosmider O, 2009, BLOOD, V114, P3285, DOI 10.1182/blood-2009-04-215814; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Z, 2011, BLOOD, V118, P4509, DOI 10.1182/blood-2010-12-325241; Liu TC, 2000, AM J HEMATOL, V63, P170, DOI 10.1002/(SICI)1096-8652(200004)63:4<170::AID-AJH2>3.0.CO;2-0; Merkerova MD, 2011, EUR J HUM GENET, V19, P313, DOI 10.1038/ejhg.2010.209; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Patsos G, 2010, INT J CANCER, V126, P1838, DOI 10.1002/ijc.24905; Petersen M, 2003, TRENDS BIOTECHNOL, V21, P74, DOI 10.1016/S0167-7799(02)00038-0; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Sasaki M, 2012, NATURE, V488, P656, DOI 10.1038/nature11323; Shen LL, 2010, J CLIN ONCOL, V28, P605, DOI 10.1200/JCO.2009.23.4781; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Smith AE, 2010, BLOOD, V116, P3923, DOI 10.1182/blood-2010-03-274704; Song S.J., 2013, CELL IN PRESS, V154, DOI DOI 10.1016/J.CELL.2013.06.026; Stenvang J, 2008, SEMIN CANCER BIOL, V18, P89, DOI 10.1016/j.semcancer.2008.01.004; Tefferi A, 2009, LEUKEMIA, V23, P1343, DOI 10.1038/leu.2009.59; Wang J, 2012, BIOTECHNOL LETT, V34, P2007, DOI 10.1007/s10529-012-1018-0; Yamazaki J, 2012, EPIGENETICS-US, V7, P201, DOI 10.4161/epi.7.2.19015; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhang Y, 2012, BLOOD, V120, P1678, DOI 10.1182/blood-2012-02-410647	47	237	244	1	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2013	13	1					87	101		10.1016/j.stem.2013.06.003	http://dx.doi.org/10.1016/j.stem.2013.06.003			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VJ	23827711	Green Accepted, Bronze			2022-12-28	WOS:000329570100015
J	Zhang, H; Jiao, WW; Sun, L; Fan, JY; Chen, MF; Wang, H; Xu, XY; Shen, AD; Li, T; Niu, BB; Ge, SF; Li, W; Cui, JW; Wang, GJ; Sun, JN; Fan, XQ; Hu, X; Mrsny, RJ; Hoffman, AR; Hu, JF				Zhang, He; Jiao, Weiwei; Sun, Lin; Fan, Jiayan; Chen, Mengfei; Wang, Hong; Xu, Xiaoyi; Shen, Adong; Li, Tao; Niu, Beibei; Ge, Shengfang; Li, Wei; Cui, Jiuwei; Wang, Guanjun; Sun, Jingnan; Fan, Xianqun; Hu, Xiang; Mrsny, Randall J.; Hoffman, Andrew R.; Hu, Ji-Fan			Intrachromosomal Looping Is Required for Activation of Endogenous Pluripotency Genes during Reprogramming	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTOR; DEFINED FACTORS; EXPRESSION; CHROMATIN; BINDING; NETWORK; OCT4	Generation of induced pluripotent stem cells (iPSCs) by defined factors is an extremely inefficient process, because there is a strong epigenetic block preventing cells from achieving pluripotency. Here we report that virally expressed factors bound to the promoters of their target genes to the same extent in both iPSCs and unreprogrammed cells (URCs). However, expression of endogenous pluripotentcy genes was observed only in iPSCs. Comparison of local chromatin structure of the OCT4 locus revealed that there was a cohesin-complex-mediated intrachromosomal loop that juxtaposes a downstream enhancer to the gene's promoter, enabling activation of endogenous stemness genes. None of these long-range interactions were observed in URCs. Knockdown of the cohesin-complex gene SMC1 by RNAi abolished the intrachromosomal interaction and affected pluripotency. These findings highlight the importance of the SMC1-orchestrated intrachromosomal loop as a critical epigenetic barrier to the induction of pluripotency.	[Wang, Hong; Xu, Xiaoyi; Li, Wei; Cui, Jiuwei; Wang, Guanjun; Sun, Jingnan; Hu, Ji-Fan] Jilin Univ, Affiliated Hosp 1, Stem Cell & Canc Ctr, Changchun 130021, Peoples R China; [Zhang, He; Fan, Jiayan; Ge, Shengfang; Fan, Xianqun] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Ophthalmol, Shanghai 200025, Peoples R China; [Jiao, Weiwei; Sun, Lin; Shen, Adong] Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Inst, Beijing 100045, Peoples R China; [Chen, Mengfei; Li, Tao; Hu, Xiang] Shenzhen Beike Cell Engn Res Inst, Shenzhen 518057, Peoples R China; [Zhang, He; Jiao, Weiwei; Sun, Lin; Fan, Jiayan; Niu, Beibei; Hoffman, Andrew R.; Hu, Ji-Fan] Stanford Univ, Sch Med, VA Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Mrsny, Randall J.; Hu, Ji-Fan] GMR Epigenet, Palo Alto, CA 94303 USA; [Mrsny, Randall J.] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England	Jilin University; Shanghai Jiao Tong University; Capital Medical University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of Bath	Hu, JF (corresponding author), Jilin Univ, Affiliated Hosp 1, Stem Cell & Canc Ctr, Changchun 130021, Peoples R China.	fanxq@sh163.net; arhoffman@stanford.edu; jifan@stanford.edu	Chen, Mengfei/N-2474-2019; Hu, Jifan/Q-3003-2019; Chen, Mengfei/T-7020-2018	Chen, Mengfei/0000-0001-6922-1221; HU, Jifan/0000-0002-2174-0361; ZHANG, HE/0000-0001-9954-4451; Hoffman, Andrew/0000-0002-0145-1917	California Institute of Regenerative Medicine (CIRM) [RT2-01942]; Jilin International Collaboration Grant [20120720]; NSFC [81272294, 81172323]; Jilin Science and Technique Program grant [11GG003]; Merit Review grant from the Medical Research Service of the Department of Veterans Affairs; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01040411]; Shanghai Leading Academic Discipline Project [S30205]	California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Jilin International Collaboration Grant; NSFC(National Natural Science Foundation of China (NSFC)); Jilin Science and Technique Program grant; Merit Review grant from the Medical Research Service of the Department of Veterans Affairs(US Department of Veterans Affairs); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by the California Institute of Regenerative Medicine (CIRM) (grant RT2-01942), a Jilin International Collaboration Grant (20120720), and an NSFC grant (81272294) to J.F.H; a Jilin Science and Technique Program grant (11GG003) to W. L.; a Merit Review grant from the Medical Research Service of the Department of Veterans Affairs to A. R. H.; an NSFC grant (81172323) and the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA01040411) to S. F. G; and a Shanghai Leading Academic Discipline Project grant (S30205) to X. Q. F. H.Z. is an Early Career Scientist of Shanghai JiaoTong University School of Medicine.	Apostolou E, 2013, CELL STEM CELL, V13, P1; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Burns KH, 2003, SCIENCE, V300, P633, DOI 10.1126/science.1081813; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; IMAGAWA M, 1991, NUCLEIC ACIDS RES, V19, P4503, DOI 10.1093/nar/19.16.4503; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Simonsson S, 2005, CELL CYCLE, V4, P513, DOI 10.4161/cc.4.4.1581; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024	17	103	110	0	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2013	13	1					30	35		10.1016/j.stem.2013.05.012	http://dx.doi.org/10.1016/j.stem.2013.05.012			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VJ	23747202	Bronze			2022-12-28	WOS:000329570100010
J	Benraiss, A; Toner, MJ; Xu, QW; Bruel-Jungerman, E; Rogers, EH; Wang, FS; Economides, AN; Davidson, BL; Kageyama, R; Nedergaard, M; Goldman, SA				Benraiss, Abdellatif; Toner, Michael J.; Xu, Qiwu; Bruel-Jungerman, Elodie; Rogers, Eloise H.; Wang, Fushun; Economides, Aris N.; Davidson, Beverly L.; Kageyama, Ryoichiro; Nedergaard, Maiken; Goldman, Steven A.			Sustained Mobilization of Endogenous Neural Progenitors Delays Disease Progression in a Transgenic Model of Huntington's Disease	CELL STEM CELL			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; STEM-CELLS; ADULT FOREBRAIN; SPINY NEURONS; GENE-THERAPY; MOUSE MODEL; BRAIN; MICE; NEUROGENESIS; EXPRESSION	Huntington's disease (HD) is a neurodegenerative disease characterized in part by the loss of striatopallidal medium spiny projection neurons (MSNs). Expression of BDNF and noggin via intracerebroventricular (ICV) delivery in an adenoviral vector triggers the addition of new neurons to the neostriatum. In this study, we found that a single ICV injection of the adeno-associated viruses AAV4-BDNF and AAV4-noggin triggered the sustained recruitment of new MSNs in both wild-type and R6/2 mice, a model of HD. Mice treated with AAV4-BDNF/noggin or with BDNF and noggin proteins actively recruited subependymal progenitor cells to form new MSNs that matured and achieved circuit integration. Importantly, the AAV4-BDNF/noggin-treated R6/2 mice showed delayed deterioration of motor function and substantially increased survival. In addition, squirrel monkeys given ICV injections of adenoviral BDNF/ noggin showed similar addition of striatal neurons. Induced neuronal addition may therefore represent a promising avenue for disease amelioration in HD.	[Benraiss, Abdellatif; Toner, Michael J.; Bruel-Jungerman, Elodie; Rogers, Eloise H.; Goldman, Steven A.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Benraiss, Abdellatif; Toner, Michael J.; Xu, Qiwu; Wang, Fushun; Nedergaard, Maiken; Goldman, Steven A.] Univ Rochester, Med Ctr, Dept Neurosurg, Rochester, NY 14642 USA; [Xu, Qiwu; Bruel-Jungerman, Elodie; Wang, Fushun; Nedergaard, Maiken; Goldman, Steven A.] Univ Rochester, Med Ctr, Ctr Translat Neuromed, Rochester, NY 14642 USA; [Economides, Aris N.] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; [Davidson, Beverly L.] Univ Iowa, Dept Med, Iowa City, IA 52242 USA; [Kageyama, Ryoichiro] Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan	University of Rochester; University of Rochester; University of Rochester; Regeneron; University of Iowa; Kyoto University	Benraiss, A (corresponding author), Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA.	abdellatif_benraiss@urmc.rochester.edu; steven_goldman@urmc.rochester.edu	Benraiss, Abdellatif/AAI-8584-2021	Benraiss, Abdellatif/0000-0002-0325-6234; Economides, Aris/0000-0002-6508-8942; Goldman, Steven/0000-0002-5498-4303; Davidson, Beverly/0000-0002-3715-6290	NINDS [R01NS52534, R37NS29813]; Hereditary Disease Foundation; CHDI; New York State Stem Cell Research Program (NYSTEM); Davidson laboratory [DK54759, NS34568, HD3353]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS029813, R01NS078304, R01NS034568, R01NS078167, R01NS075177, R01NS075345, R01NS052534] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Hereditary Disease Foundation; CHDI; New York State Stem Cell Research Program (NYSTEM); Davidson laboratory; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NINDS R01NS52534 and R37NS29813, the Hereditary Disease Foundation, CHDI, and the New York State Stem Cell Research Program (NYSTEM). Work in the Davidson laboratory was supported by DK54759, NS34568, and HD3353. We thank Dr. Louis DiVincenti, Jr. for his veterinary expertise and assistance with the squirrel monkey arm of this project. We also thank the referees for their consistently helpful critiques and suggestions during the progression of this study. Dr. Goldman and colleagues have received the following patents relevant to this study: "Gene-therapymediated induction of neurogenesis in the adult brain,'' U.S. Patent 7,037,493, and "Enhancing neurotrophin-induced neurogenesis by endogenous neural progenitor cells by concurrent overexpression of BDNF and an inhibitor of a progliogenic bone morphogenetic protein,'' U. S. Patent 7,576,065. These patents are owned by the Cornell University Center for Technology Enterprise; neither Dr. Goldman nor any coauthors have received income from these patents.	Andre VM, 2011, J NEUROSCI, V31, P1170, DOI 10.1523/JNEUROSCI.3539-10.2011; Bates G, 2003, LANCET, V361, P1642, DOI 10.1016/S0140-6736(03)13304-1; Becher MW, 1998, NEUROBIOL DIS, V4, P387, DOI 10.1006/nbdi.1998.0168; Bedard A, 2006, EXP BRAIN RES, V170, P501, DOI 10.1007/s00221-005-0233-5; Bekar L, 2008, NAT MED, V14, P75, DOI 10.1038/nm1693; Benraiss A, 2012, GENE THER, V19, P483, DOI 10.1038/gt.2011.114; Benraiss A, 2001, J NEUROSCI, V21, P6718, DOI 10.1523/JNEUROSCI.21-17-06718.2001; Benraiss A, 2011, NEUROTHERAPEUTICS, V8, P577, DOI 10.1007/s13311-011-0075-8; Chmielnicki E, 2004, J NEUROSCI, V24, P2133, DOI 10.1523/JNEUROSCI.1554-03.2004; Cho SR, 2007, J CLIN INVEST, V117, P2889, DOI 10.1172/JCI31778; Christine CW, 2009, NEUROLOGY, V73, P1662, DOI 10.1212/WNL.0b013e3181c29356; Curtis MA, 2003, P NATL ACAD SCI USA, V100, P9023, DOI 10.1073/pnas.1532244100; DAI YF, 1995, P NATL ACAD SCI USA, V92, P1401, DOI 10.1073/pnas.92.5.1401; Davidson BL, 2000, P NATL ACAD SCI USA, V97, P3428, DOI 10.1073/pnas.050581197; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Dodge JC, 2010, MOL THER, V18, P2075, DOI 10.1038/mt.2010.206; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Gutekunst CA, 2002, HUNTINGTONS DIS, P251; Henry RA, 2007, EUR J NEUROSCI, V25, P3513, DOI 10.1111/j.1460-9568.2007.05625.x; Hickey MA, 2003, PROG NEURO-PSYCHOPH, V27, P255, DOI 10.1016/S0278-5846(03)00021-6; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Imayoshi I, 2006, GENESIS, V44, P233, DOI 10.1002/dvg.20212; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Keyoung HM, 2001, NAT BIOTECHNOL, V19, P843, DOI 10.1038/nbt0901-843; KIRSCHENBAUM B, 1994, CEREB CORTEX, V4, P576, DOI 10.1093/cercor/4.6.576; Klapstein GJ, 2001, J NEUROPHYSIOL, V86, P2667, DOI 10.1152/jn.2001.86.6.2667; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LeWitt PA, 2011, LANCET NEUROL, V10, P309, DOI 10.1016/S1474-4422(11)70039-4; Liu G, 2005, GENE THER, V12, P1503, DOI 10.1038/sj.gt.3302554; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Meade CA, 2002, J COMP NEUROL, V449, P241, DOI 10.1002/cne.10295; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Mueller C, 2008, GENE THER, V15, P858, DOI 10.1038/gt.2008.68; Paine-Saunders S, 2002, J BIOL CHEM, V277, P2089, DOI 10.1074/jbc.M109151200; Pincus DW, 1998, ANN NEUROL, V43, P576, DOI 10.1002/ana.410430505; Reumers V, 2008, STEM CELLS, V26, P2382, DOI 10.1634/stemcells.2007-1062; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Sirn FJ, 2006, ANN NEUROL, V59, P763, DOI 10.1002/ana.20812; Southwell AL, 2013, HUM MOL GENET, V22, P18, DOI 10.1093/hmg/dds397; Tamura Y, 2007, EUR J NEUROSCI, V25, P3489, DOI 10.1111/j.1460-9568.2007.05617.x; Turmaine M, 2000, P NATL ACAD SCI USA, V97, P8093, DOI 10.1073/pnas.110078997; Yu-Taeger L, 2012, J NEUROSCI, V32, P15426, DOI 10.1523/JNEUROSCI.1148-12.2012; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	44	41	45	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 6	2013	12	6					787	799		10.1016/j.stem.2013.04.014	http://dx.doi.org/10.1016/j.stem.2013.04.014			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VH	23746982	Bronze, Green Accepted			2022-12-28	WOS:000329569900020
J	Jackson, SA; Sridharan, R				Jackson, Steven A.; Sridharan, Rupa			The Nexus of Tet1 and the Pluripotency Network	CELL STEM CELL			English	Editorial Material							SOMATIC-CELLS	Resetting DNA methylation and reactivation of pluripotency genes are late events in the formation of iPSCs. Recent work by Costa et al. (2013) and Gao et al. (2013) has examined the role of Tet proteins in the hydroxymethylation of pluripotency genes, with the latter replacing Oct4 with Tet1 for reprogramming.	[Jackson, Steven A.; Sridharan, Rupa] Univ Wisconsin, Dept Cell & Regenerat Biol, Wisconsin Inst Discovery, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Sridharan, R (corresponding author), Univ Wisconsin, Dept Cell & Regenerat Biol, Wisconsin Inst Discovery, Madison, WI 53706 USA.	rsridharan@discovery.wisc.edu						Balasubramani A, 2013, MOL CELL, V49, P618, DOI 10.1016/j.molcel.2013.02.006; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Costa Y, 2013, NATURE, V495, P370, DOI 10.1038/nature11925; Dawlaty MM, 2013, DEV CELL, V24, P310, DOI 10.1016/j.devcel.2012.12.015; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Gao YW, 2013, CELL STEM CELL, V12, P453, DOI 10.1016/j.stem.2013.02.005; Golipour A, 2012, CELL STEM CELL, V11, P769, DOI 10.1016/j.stem.2012.11.008; Pawlak M, 2011, GENE DEV, V25, P1035, DOI 10.1101/gad.2039011; Piccolo F. M., 2013, MOL CELL IN PRESS; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039	10	5	8	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 4	2013	12	4					387	388		10.1016/j.stem.2013.03.007	http://dx.doi.org/10.1016/j.stem.2013.03.007			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VD	23561438	Bronze			2022-12-28	WOS:000329569500003
J	Franklin, RJM; Bussey, TJ				Franklin, Robin J. M.; Bussey, Timothy J.			Do Your Glial Cells Make You Clever?	CELL STEM CELL			English	Editorial Material							PROGENITOR CELLS	The cellular basis for cognition is generally believed to derive from neurons. In this issue of Cell Stem Cell, Han et al. (2013) transplant human glial progenitors into mouse brains and thereby improve their learning and memory and implicate a previously unknown role for glial cells in contributing to cognition.	[Franklin, Robin J. M.] Univ Cambridge, Wellcome Trust, Cambridge CB3 0ES, England; [Franklin, Robin J. M.] Univ Cambridge, MRC Cambridge Stem Cell Inst, Cambridge CB3 0ES, England; [Franklin, Robin J. M.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England; [Bussey, Timothy J.] Univ Cambridge, Dept Psychol, Cambridge CB2 3EB, England; [Bussey, Timothy J.] Univ Cambridge, Wellcome Trust, Cambridge CB2 3EB, England; [Bussey, Timothy J.] Univ Cambridge, MRC Behav & Clin Neurosci Inst, Cambridge CB2 3EB, England	University of Cambridge; Wellcome Trust Sanger Institute; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; University of Cambridge	Franklin, RJM (corresponding author), Univ Cambridge, Wellcome Trust, Madingley Rd, Cambridge CB3 0ES, England.	rjf1000@cam.ac.uk	Bussey, Timothy J/M-2758-2016	Bussey, Timothy J/0000-0001-7518-4041; Franklin, Robin/0000-0001-6522-2104	Wellcome Trust [079249] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BLAKEMORE WF, 1991, TRENDS NEUROSCI, V14, P323, DOI 10.1016/0166-2236(91)90155-N; Fields RD, 2004, SCI AM, V290, P54, DOI 10.1038/scientificamerican0404-54; Gupta N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004373; Han XN, 2013, CELL STEM CELL, V12, P342, DOI 10.1016/j.stem.2012.12.015; Karadottir R, 2008, NAT NEUROSCI, V11, P450, DOI 10.1038/nn2060; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Windrem MS, 2008, CELL STEM CELL, V2, P553, DOI 10.1016/j.stem.2008.03.020; Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002	9	5	6	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 7	2013	12	3					265	266		10.1016/j.stem.2013.02.003	http://dx.doi.org/10.1016/j.stem.2013.02.003			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VC	23472865	Bronze			2022-12-28	WOS:000329569400001
J	Wakayama, S; Kohda, T; Obokata, H; Tokoro, M; Li, C; Terashita, Y; Mizutani, E; Nguyen, VT; Kishigami, S; Ishino, F; Wakayama, T				Wakayama, Sayaka; Kohda, Takashi; Obokata, Haruko; Tokoro, Mikiko; Li, Chong; Terashita, Yukari; Mizutani, Eiji; Van Thuan Nguyen; Kishigami, Satoshi; Ishino, Fumitoshi; Wakayama, Teruhiko			Successful Serial Recloning in the Mouse over Multiple Generations	CELL STEM CELL			English	Article							CLONED MICE; TELOMERE LENGTHS; GENE-EXPRESSION; TRICHOSTATIN-A; CLONING; EMBRYOS; DEATH; PIGS; COWS	Previous studies of serial cloning in animals showed a decrease in efficiency over repeated iterations and a failure in all species after a few generations. This limitation led to the suggestion that repeated recloning might be inherently impossible because of the accumulation of lethal genetic or epigenetic abnormalities. However, we have now succeeded in carrying out repeated recloning in the mouse through a somatic cell nuclear transfer method that includes a histone deacetylase inhibitor. The cloning efficiency did not decrease over 25 generations, and, to date, we have obtained more than 500 viable offspring from a single original donor mouse. The reprogramming efficiency also did not increase over repeated rounds of nuclear transfer, and we did not see the accumulation of reprogramming errors or clone-specific abnormalities. Therefore, our results show that repeated iterative recloning is possible and suggest that, with adequately efficient techniques, it may be possible to reclone animals indefinitely.	[Wakayama, Sayaka; Obokata, Haruko; Tokoro, Mikiko; Li, Chong; Terashita, Yukari; Mizutani, Eiji; Van Thuan Nguyen; Kishigami, Satoshi; Wakayama, Teruhiko] RIKEN Ctr Dev Biol, Kobe, Hyogo 6500047, Japan; [Kohda, Takashi; Ishino, Fumitoshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Epigenet, Tokyo 1130034, Japan; [Obokata, Haruko] Harvard Univ, Brigham & Womens Hosp, Sch Med, Lab Tissue Engn & Regenerat Med, Boston, MA 02115 USA; [Tokoro, Mikiko] Asada Ladies Clin, Nagoya, Aichi 4860931, Japan; [Li, Chong] Tongji Univ, Sch Med, Dept Regenerat Med, Shanghai 200092, Peoples R China; [Terashita, Yukari] Tohoku Univ, Grad Sch Agr Sci, Lab Anim Reprod, Sendai, Miyagi 9818555, Japan; [Mizutani, Eiji] Univ Yamanashi, Fac Life & Environm Sci, Tamaho, Yamanashi 4008510, Japan; [Van Thuan Nguyen] Vietnam Natl Univ, Int Univ, Sch Biotechnol, Dept Biotechnol, Ho Chi Minh City 70000, Vietnam; [Kishigami, Satoshi] Kinki Univ, Dept Genet Engn, Wakayama 6496493, Japan	RIKEN; Tokyo Medical & Dental University (TMDU); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Tongji University; Tohoku University; University of Yamanashi; Vietnam National University Hochiminh City; Kindai University (Kinki University)	Wakayama, T (corresponding author), RIKEN Ctr Dev Biol, Kobe, Hyogo 6500047, Japan.	teru@cdb.riken.jp	Kohda, Takashi/C-2879-2014	Kohda, Takashi/0000-0002-6856-5601; Kishigami, Satoshi/0000-0001-9447-5100; Tokoro, Mikiko/0000-0003-1589-0889	 [20062015];  [23248048]	; 	We thank J. Cummins for critical and useful comments on the manuscript. We also thank T. Oyanagi, Y. Sakaide, S. Hirauchi, K. Yamagata, and T. Ono for preparing this manuscript. We are grateful to the laboratory for animal resources and genetic engineering for housing the mice. Financial support for this research was provided by the Grant-in-Aid for Scientific Research on Priority Areas (20062015) and Scientific Research (A) (23248048) to T. W. All animal experiments were approved by the Animal Experiment Committee of the RIKEN Center for Developmental Biology (approval no. AH14-13-19).	Cho SK, 2007, DEV DYNAM, V236, P3369, DOI 10.1002/dvdy.21308; Graf T, 2011, CELL STEM CELL, V9, P504, DOI 10.1016/j.stem.2011.11.012; Inoue K, 2002, SCIENCE, V295, P297, DOI 10.1126/science.295.5553.297; Inoue K, 2010, SCIENCE, V330, P496, DOI 10.1126/science.1194174; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; Kishigami S, 2007, J REPROD DEVELOP, V53, P165, DOI 10.1262/jrd.18098; Kohda T, 2005, BIOL REPROD, V73, P1302, DOI 10.1095/biolreprod.105.044958; Kohda T, 2012, CELL REPROGRAM, V14, P45, DOI 10.1089/cell.2011.0062; Konishi K, 2011, J REPROD DEVELOP, V57, P572, DOI 10.1262/jrd.10-174A; Kubota C, 2004, NAT BIOTECHNOL, V22, P693, DOI 10.1038/nbt975; Kurome M, 2008, J REPROD DEVELOP, V54, P254, DOI 10.1262/jrd.20038; Lanza RP, 2000, SCIENCE, V288, P665, DOI 10.1126/science.288.5466.665; Lin JW, 2011, CELL STEM CELL, V8, P371, DOI 10.1016/j.stem.2011.02.007; Miyashita N, 2011, J REPROD DEVELOP, V57, P636, DOI 10.1262/jrd.11-017A; Ogonuki N, 2002, NAT GENET, V30, P253, DOI 10.1038/ng841; Shiels PG, 1999, NATURE, V399, P316, DOI 10.1038/20580; Tamashiro KLK, 2002, NAT MED, V8, P262, DOI 10.1038/nm0302-262; Tanaka S, 2001, BIOL REPROD, V65, P1813, DOI 10.1095/biolreprod65.6.1813; Van Thuan N, 2010, J REPROD DEVELOP, V56, P20, DOI 10.1262/jrd.09-221A; Wakayama S, 2008, P NATL ACAD SCI USA, V105, P17318, DOI 10.1073/pnas.0806166105; Wakayama T, 2000, NATURE, V407, P318, DOI 10.1038/35030301; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 1999, NAT GENET, V22, P127, DOI 10.1038/9632; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; Yin XJ, 2008, THERIOGENOLOGY, V69, P1001, DOI 10.1016/j.theriogenology.2008.01.017	26	55	61	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 7	2013	12	3					293	297		10.1016/j.stem.2013.01.005	http://dx.doi.org/10.1016/j.stem.2013.01.005			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VC	23472871	Bronze			2022-12-28	WOS:000329569400007
J	Signer, RAJ; Morrison, SJ				Signer, Robert A. J.; Morrison, Sean J.			Mechanisms that Regulate Stem Cell Aging and Life Span	CELL STEM CELL			English	Review							DNA-DAMAGE RESPONSE; INSULIN-LIKE SIGNALS; SELF-RENEWAL; CAENORHABDITIS-ELEGANS; OXIDATIVE STRESS; TELOMERE DYSFUNCTION; TUMOR SUPPRESSION; DIETARY RESTRICTION; MTOR COMPLEX; INK4A LOCUS	Mammalian aging is associated with reduced tissue regeneration, increased degenerative disease, and cancer. Because stem cells regenerate many adult tissues and contribute to the development of cancer by accumulating mutations, age-related changes in stem cells likely contribute to age-related morbidity. Consistent with this, stem cell function declines with age in numerous tissues as a result of gate-keeping tumor suppressor expression, DNA damage, changes in cellular physiology, and environmental changes in tissues. It remains unknown whether declines in stem cell function during aging influence organismal longevity. However, mechanisms that influence longevity also modulate age-related morbidity, partly through effects on stem cells.	[Signer, Robert A. J.; Morrison, Sean J.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Childrens Res Inst, Dallas, TX 75390 USA; [Morrison, Sean J.] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute	Morrison, SJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, Childrens Res Inst, Dallas, TX 75390 USA.	sean.morrison@utsouthwestern.edu	Morrison, Sean/ABD-5326-2021	Signer, Robert/0000-0003-3286-1334; Morrison, Sean/0000-0003-1587-8329	Howard Hughes Medical Institute; Cancer Prevention and Research Institute of Texas; National Institute on Aging [R37 AG024945]; Leukemia & Lymphoma Society [5541-11]; Canadian Institutes of Health Research [MFE-106993]; NATIONAL INSTITUTE ON AGING [R37AG024945, R01AG024945] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Cancer Prevention and Research Institute of Texas; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Howard Hughes Medical Institute, the Cancer Prevention and Research Institute of Texas, and the National Institute on Aging (R37 AG024945). R.A.J.S. is supported by fellowships from the Leukemia & Lymphoma Society (5541-11) and the Canadian Institutes of Health Research (MFE-106993). We apologize to authors whose papers we could not cite due to space limitations.	Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012; Allsopp RC, 2003, BLOOD, V102, P517, DOI 10.1182/blood-2002-07-2334; AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Begus-Nahrmann Y, 2009, NAT GENET, V41, P1138, DOI 10.1038/ng.426; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Biteau B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001159; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Boyle M, 2007, CELL STEM CELL, V1, P470, DOI 10.1016/j.stem.2007.08.002; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Buckley SM, 2012, CELL STEM CELL, V11, P783, DOI 10.1016/j.stem.2012.09.011; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Cerletti M, 2012, CELL STEM CELL, V10, P515, DOI 10.1016/j.stem.2012.04.002; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Chang S, 2004, NAT GENET, V36, P877, DOI 10.1038/ng1389; Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559; Chen HA, 2009, GENE DEV, V23, P975, DOI 10.1101/gad.1742509; Chen JC, 2000, EXP HEMATOL, V28, P442, DOI 10.1016/S0301-472X(99)00157-5; Chen JC, 2003, EXP HEMATOL, V31, P1097, DOI 10.1016/S0301-472X(03)00238-8; Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Chiocchetti A, 2007, EXP GERONTOL, V42, P275, DOI 10.1016/j.exger.2006.11.002; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; Chuikov S, 2010, NAT CELL BIOL, V12, P999, DOI 10.1038/ncb2101; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Cohen E, 2009, CELL, V139, P1157, DOI 10.1016/j.cell.2009.11.014; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; deHaan G, 1997, BLOOD, V89, P1543, DOI 10.1182/blood.V89.5.1543.1543_1543_1550; Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Dorshkind K, 2009, NAT REV IMMUNOL, V9, P57, DOI 10.1038/nri2471; Dumble M, 2007, BLOOD, V109, P1736, DOI 10.1182/blood-2006-03-010413; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Ferron SR, 2009, J NEUROSCI, V29, P14394, DOI 10.1523/JNEUROSCI.3836-09.2009; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533; Gan B, 2008, P NATL ACAD SCI USA, V105, P19384, DOI 10.1073/pnas.0810584105; Gannon HS, 2011, DEV BIOL, V353, P1, DOI 10.1016/j.ydbio.2011.02.007; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Giannakou ME, 2007, AGING CELL, V6, P429, DOI 10.1111/j.1474-9726.2007.00290.x; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hansen M, 2007, WESTERN HUM REV, V61, P6; Hao LY, 2005, CELL, V123, P1121, DOI 10.1016/j.cell.2005.11.020; HARLEY CB, 1992, EXP GERONTOL, V27, P375, DOI 10.1016/0531-5565(92)90068-B; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; HARRISON DE, 1987, J NUTR, V117, P376, DOI 10.1093/jn/117.2.376; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Heidinger BJ, 2012, P NATL ACAD SCI USA, V109, P1743, DOI 10.1073/pnas.1113306109; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Inomata K, 2009, CELL, V137, P1088, DOI 10.1016/j.cell.2009.03.037; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; Jeck WR, 2012, AGING CELL, V11, P727, DOI 10.1111/j.1474-9726.2012.00871.x; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Ju ZY, 2007, NAT MED, V13, P742, DOI 10.1038/nm1578; Kalaitzidis D, 2012, CELL STEM CELL, V11, P429, DOI 10.1016/j.stem.2012.06.009; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Kuhn HG, 1996, J NEUROSCI, V16, P2027; LaFever L, 2005, SCIENCE, V309, P1071, DOI 10.1126/science.1111410; Lansdorp PM, 2009, EMBO J, V28, P2532, DOI 10.1038/emboj.2009.172; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lee JY, 2010, CELL STEM CELL, V7, P593, DOI 10.1016/j.stem.2010.09.015; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Liu F, 2010, BLOOD, V116, P4806, DOI 10.1182/blood-2010-06-288589; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Liu Y, 2011, BLOOD, V117, P3257, DOI 10.1182/blood-2010-09-304402; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Magee JA, 2012, CELL STEM CELL, V11, P415, DOI 10.1016/j.stem.2012.05.026; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Mair W, 2010, AGING CELL, V9, P916, DOI 10.1111/j.1474-9726.2010.00602.x; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Martin GM, 2005, CELL, V120, P523, DOI 10.1016/j.cell.2005.01.031; Maryanovich M, 2012, NAT CELL BIOL, V14, P535, DOI 10.1038/ncb2468; Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004; Matheu A, 2004, GENE DEV, V18, P2736, DOI 10.1101/gad.310304; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; MERRITT AJ, 1994, CANCER RES, V54, P614; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Morrison SJ, 1996, IMMUNITY, V5, P207, DOI 10.1016/S1074-7613(00)80316-7; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Navarro S, 2006, MOL THER, V14, P525, DOI 10.1016/j.ymthe.2006.05.018; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Pan L, 2007, CELL STEM CELL, V1, P458, DOI 10.1016/j.stem.2007.09.010; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Reese JS, 2003, BLOOD, V102, P1626, DOI 10.1182/blood-2002-10-3035; Renault VM, 2009, CELL STEM CELL, V5, P527, DOI 10.1016/j.stem.2009.09.014; Rera M, 2011, CELL METAB, V14, P623, DOI 10.1016/j.cmet.2011.09.013; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Ruzankina Y, 2009, NAT GENET, V41, P1144, DOI 10.1038/ng.441; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schoppy DW, 2010, CELL CYCLE, V9, P1313, DOI 10.4161/cc.9.7.11194; Seib DRM, 2013, CELL STEM CELL, V12, P204, DOI 10.1016/j.stem.2012.11.010; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Signer RAJ, 2008, GENE DEV, V22, P3115, DOI 10.1101/gad.1715808; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Sotiropoulou PA, 2010, NAT CELL BIOL, V12, P572, DOI 10.1038/ncb2059; Sperka T, 2012, NAT CELL BIOL, V14, P73, DOI 10.1038/ncb2388; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Takubo K, 2008, CELL STEM CELL, V2, P170, DOI 10.1016/j.stem.2007.10.023; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Tatar M, 1997, NATURE, V390, P30, DOI 10.1038/36237; Taylor RC, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004440; TeKippe M, 2003, EXP HEMATOL, V31, P521, DOI 10.1016/S0301-472X(03)00072-9; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Toledano H, 2012, NATURE, V485, P605, DOI 10.1038/nature11061; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; van Heemst D, 2005, EXP GERONTOL, V40, P11, DOI 10.1016/j.exger.2004.10.001; VAZIRI H, 1993, AM J HUM GENET, V52, P661; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988; Vilchez D, 2012, NATURE, V489, P263, DOI 10.1038/nature11315; Vilchez D, 2012, NATURE, V489, P304, DOI 10.1038/nature11468; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Walker GA, 2003, AGING CELL, V2, P131, DOI 10.1046/j.1474-9728.2003.00045.x; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallenfang MR, 2006, AGING CELL, V5, P297, DOI 10.1111/j.1474-9726.2006.00221.x; Walne AJ, 2009, BRIT J HAEMATOL, V145, P164, DOI 10.1111/j.1365-2141.2009.07598.x; Wang JW, 2012, CELL, V148, P1001, DOI 10.1016/j.cell.2012.01.040; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; Yalcin S, 2008, J BIOL CHEM, V283, P25692, DOI 10.1074/jbc.M800517200; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	195	231	243	2	66	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 7	2013	12	2					152	165		10.1016/j.stem.2013.01.001	http://dx.doi.org/10.1016/j.stem.2013.01.001			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VB	23395443	Green Accepted, Bronze			2022-12-28	WOS:000329569300007
J	Bentzinger, CF; Wang, YX; von Maltzahn, J; Soleimani, VD; Yin, H; Rudnicki, MA; Rudnicki, A				Bentzinger, C. Florian; Wang, Yu Xin; von Maltzahn, Julia; Soleimani, Vahab D.; Yin, Hang; Rudnicki, Michael A.; Rudnicki, A.			Fibronectin Regulates Wnt7a Signaling and Satellite Cell Expansion	CELL STEM CELL			English	Article							GROWTH-FACTOR-BETA; MUSCLE STEM-CELLS; SKELETAL-MUSCLE; SELF-RENEWAL; EXTRACELLULAR-MATRIX; SYNDECAN-4 BINDING; PROGENITOR CELLS; FACTOR-I; IGF-I; DIFFERENTIATION	The influence of the extracellular matrix (ECM) within the stem cell niche remains poorly understood. We found that Syndecan-4 (Sdc4) and Frizzled-7 (Fzd7) form a coreceptor complex in satellite cells and that binding of the ECM glycoprotein Fibronectin (FN) to Sdc4 stimulates the ability of Wnt7a to induce the symmetric expansion of satellite stem cells. Newly activated satellite cells dynamically remodel their niche via transient high-level expression of FN. Knockdown of FN in prospectively isolated satellite cells severely impaired their ability to repopulate the satellite cell niche. Conversely, in vivo overexpression of FN with Wnt7a dramatically stimulated the expansion of satellite stem cells in regenerating muscle. Therefore, activating satellite cells remodel their niche through autologous expression of FN that provides feedback to stimulate Wnt7a signaling through the Fzd7/Sdc4 coreceptor complex. Thus, FN and Wnt7a together regulate the homeostatic levels of satellite stem cells and satellite myogenic cells during regenerative myogenesis.	[Bentzinger, C. Florian; Wang, Yu Xin; von Maltzahn, Julia; Soleimani, Vahab D.; Yin, Hang; Rudnicki, Michael A.; Rudnicki, A.] Ottawa Hosp Res Inst, Regenerat Med Program, Ottawa, ON K1H 8L6, Canada; [Bentzinger, C. Florian; Wang, Yu Xin; von Maltzahn, Julia; Soleimani, Vahab D.; Yin, Hang; Rudnicki, Michael A.; Rudnicki, A.] Univ Ottawa, Dept Cellular & Mol Med, Fac, Ottawa, ON K1H 8M5, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Rudnicki, MA (corresponding author), Ottawa Hosp Res Inst, Regenerat Med Program, Ottawa, ON K1H 8L6, Canada.	mrudnicki@ohri.ca	Yin, Hang/J-3613-2019; von Maltzahn, Julia/A-6689-2017; von Maltzahn, Julia/AFP-2284-2022; Bentzinger, C. Florian/A-1151-2015	Yin, Hang/0000-0002-9621-0138; von Maltzahn, Julia/0000-0001-7674-1487; von Maltzahn, Julia/0000-0001-7674-1487; Bentzinger, C. Florian/0000-0003-0422-9622; Wang, Yu Xin/0000-0001-8440-9388; Rudnicki, Michael/0000-0002-3866-5249	Swiss National Science Foundation; QEII-GSST; Training Program in Regenerative Medicine of the Canadian Institutes of Health Research (CIHR); CIHR; National Institutes of Health; Howard Hughes Medical Institute; Canadian Stem Cell Network; Canada Research Chair Program; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044031] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); QEII-GSST; Training Program in Regenerative Medicine of the Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Canadian Stem Cell Network; Canada Research Chair Program(Canada Research Chairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Bradley Olwin for the chicken Sdc4 antibody and Addolorata Pisconti and Adam B. Cadwallader for technical support with the PLA. C.F.B. is supported by a grant from the Swiss National Science Foundation. Y.X.W. is supported by fellowships from QEII-GSST and the Training Program in Regenerative Medicine of the Canadian Institutes of Health Research (CIHR). This work was supported by grants to M.A.R. from CIHR, the National Institutes of Health, the Howard Hughes Medical Institute, the Canadian Stem Cell Network, and the Canada Research Chair Program. M.A.R. is a founder of Fate Therapeutics and a member of its scientific advisory board.	Adi S, 2002, ENDOCRINOLOGY, V143, P511, DOI 10.1210/en.143.2.511; ALLEN RE, 1989, J CELL PHYSIOL, V138, P311, DOI 10.1002/jcp.1041380213; Ates K, 2007, FEBS LETT, V581, P2727, DOI 10.1016/j.febslet.2007.05.030; Bass MD, 2007, J CELL BIOL, V177, P527, DOI 10.1083/jcb.200610076; Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bentzinger CF, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt27; Bentzinger CF, 2005, FASEB J, V19, P934, DOI 10.1096/fj.04-3376com; Bosnakovski D, 2008, STEM CELLS, V26, P3194, DOI 10.1634/stemcells.2007-1017; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Burkin DJ, 1999, CELL TISSUE RES, V296, P183, DOI 10.1007/s004410051279; Carlson ME, 2009, AGING CELL, V8, P676, DOI 10.1111/j.1474-9726.2009.00517.x; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chazaud B, 2003, J CELL BIOL, V163, P1133, DOI 10.1083/jcb.200212046; Cohn RD, 2002, CELL, V110, P639, DOI 10.1016/S0092-8674(02)00907-8; Cornelison DDW, 2004, GENE DEV, V18, P2231, DOI 10.1101/gad.1214204; Cornelison DDW, 2001, DEV BIOL, V239, P79, DOI 10.1006/dbio.2001.0416; Cosgrove BD, 2009, DIFFERENTIATION, V78, P185, DOI 10.1016/j.diff.2009.08.004; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Daley WP, 2011, DEV DYNAM, V240, P2069, DOI 10.1002/dvdy.22714; Daley WP, 2009, DEV BIOL, V336, P169, DOI 10.1016/j.ydbio.2009.09.037; Davidson LA, 2006, CURR BIOL, V16, P833, DOI 10.1016/j.cub.2006.03.038; DIMARIO J, 1989, SCIENCE, V244, P688, DOI 10.1126/science.2717945; Doumit ME, 1996, ENDOCRINOLOGY, V137, P1385, DOI 10.1210/en.137.4.1385; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Goetsch SC, 2003, PHYSIOL GENOMICS, V14, P261, DOI 10.1152/physiolgenomics.00056.2003; Grande JP, 1997, J LAB CLIN MED, V130, P476, DOI 10.1016/S0022-2143(97)90124-4; Hamon M, 2004, GLYCOBIOLOGY, V14, P311, DOI 10.1093/glycob/cwh038; HAYMAN EG, 1979, J CELL BIOL, V83, P255, DOI 10.1083/jcb.83.1.255; Huang WT, 2001, CANCER RES, V61, P8586; HYNES RO, 1982, J CELL BIOL, V95, P369, DOI 10.1083/jcb.95.2.369; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Kuang S, 2006, J CELL BIOL, V172, P103, DOI 10.1083/jcb.200508001; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; LeRoy E C, 1990, Eur Cytokine Netw, V1, P215; Li Y, 2004, AM J PATHOL, V164, P1007, DOI 10.1016/S0002-9440(10)63188-4; Lyon M, 2000, J BIOL CHEM, V275, P4599, DOI 10.1074/jbc.275.7.4599; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; Miller KJ, 2000, AM J PHYSIOL-CELL PH, V278, pC174, DOI 10.1152/ajpcell.2000.278.1.C174; Mitchell KJ, 2010, NAT CELL BIOL, V12, P257, DOI 10.1038/ncb2025; Mousavi K, 2006, J NEUROSCI, V26, P5739, DOI 10.1523/JNEUROSCI.5398-05.2006; Munoz R, 2006, NAT CELL BIOL, V8, P492, DOI 10.1038/ncb1399; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Ohtake Y, 2006, J CELL SCI, V119, P3822, DOI 10.1242/jcs.03158; Peters JH, 1996, CELL ADHES COMMUN, V4, P127, DOI 10.3109/15419069609010767; Pisconti A, 2010, J CELL BIOL, V190, P427, DOI 10.1083/jcb.201003081; PODLESKI TR, 1979, EXP CELL RES, V122, P317, DOI 10.1016/0014-4827(79)90308-2; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Sanes JR, 2003, J BIOL CHEM, V278, P12601, DOI 10.1074/jbc.R200027200; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Serrano AL, 2010, EXP CELL RES, V316, P3050, DOI 10.1016/j.yexcr.2010.05.035; Shea KL, 2010, CELL STEM CELL, V6, P117, DOI 10.1016/j.stem.2009.12.015; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; SOCHOROVA L, 1983, PHYSIOL BOHEMOSLOV, V32, P481; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tajbakhsh S, 1996, NATURE, V384, P266, DOI 10.1038/384266a0; Tallquist MD, 2000, DEVELOPMENT, V127, P5059; To WS, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-21; von Maltzahn J, 2012, NAT CELL BIOL, V14, P186, DOI 10.1038/ncb2404; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Woods A, 2000, ARCH BIOCHEM BIOPHYS, V374, P66, DOI 10.1006/abbi.1999.1607; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Zhang LP, 2012, J BIOL CHEM, V287, P6177, DOI 10.1074/jbc.M111.292649	69	221	227	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 3	2013	12	1					75	87		10.1016/j.stem.2012.09.015	http://dx.doi.org/10.1016/j.stem.2012.09.015			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	074UM	23290138	Bronze, Green Accepted			2022-12-28	WOS:000313839500012
J	Golipour, A; David, L; Liu, Y; Jayakumaran, G; Hirsch, CL; Trcka, D; Wrana, JL				Golipour, Azadeh; David, Laurent; Liu, Yu; Jayakumaran, Gowtham; Hirsch, Calley L.; Trcka, Dan; Wrana, Jeffrey L.			A Late Transition in Somatic Cell Reprogramming Requires Regulators Distinct from the Pluripotency Network	CELL STEM CELL			English	Article							FIBROBLASTS; GENERATION; EXPRESSION	Reprogramming of somatic cells to a pluripotent state via expression of Oct4, Klf4, Myc, and Sox2 is a multistep process involving phased changes in gene expression. Here, we focus on the later stages of reprogramming, termed maturation and stabilization. We show that the stabilization phase and the acquisition of pluripotency are dependent on the removal of transgene expression late in the maturation phase. Clonal analysis of cells undergoing reprogramming revealed subsets of stabilization-competent (SC) and stabilization-incompetent (SI) cells. SC clones acquire a competency gene-expression signature late in the maturation phase. Functional analysis of SC signature genes identified enhancers of the transition to the stabilization phase and a distinct subset of genes required for the maintenance of pluripotency. Thus, the acquisition and maintenance of pluripotency are regulated by distinct molecular networks, and a specific regulatory program not previously implicated in reprogramming is required for the transition to transgene independence.	[Golipour, Azadeh; Liu, Yu; Jayakumaran, Gowtham; Wrana, Jeffrey L.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Golipour, Azadeh; David, Laurent; Liu, Yu; Jayakumaran, Gowtham; Hirsch, Calley L.; Trcka, Dan; Wrana, Jeffrey L.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Wrana, JL (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada.	wrana@lunenfeld.ca	Wrana, Jeffrey/F-8857-2013	LIU, YU/0000-0001-8359-6732; David, Laurent/0000-0003-3594-0353	Canadian Institutes of Health Research (CIHR) [MOP12860]; Canadian Stem Cell Network; Ontario Research Fund GL2 grant; CIHR Fellowship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Stem Cell Network; Ontario Research Fund GL2 grant; CIHR Fellowship(Canadian Institutes of Health Research (CIHR))	The authors wish to thank Fred Vizeacoumar and Dr. Alessandro Datti for assistance with robotics, Kin Chan and Sergey Mokin for assistance with the RNA-seq sample preparation and RNA-seq analysis, Drs. Tobias Beyer, Alex Weiss, and Liliana Attisano for critical comments on the manuscript, and Dr. Masahiro Narimatsu for assistance with embryo processing. This work was supported by funds from the Canadian Institutes of Health Research (CIHR #MOP12860), the Canadian Stem Cell Network, and an Ontario Research Fund GL2 grant. L.D. is the recipient of a CIHR Fellowship. J.L.W. is the Mary Janigan Chair in Experimental Therapeutics.	Airaksinen MS, 2006, BRAIN BEHAV EVOLUT, V68, P181, DOI 10.1159/000094087; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Chen JK, 2011, CELL RES, V21, P205, DOI 10.1038/cr.2010.172; David L, 2011, GENES-BASEL, V2, P81, DOI 10.3390/genes2010081; Du J, 2010, J BIOCHEM, V147, P265, DOI 10.1093/jb/mvp161; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Inoue N, 1999, HUM MOL GENET, V8, P1201, DOI 10.1093/hmg/8.7.1201; Kobayashi K, 2012, ONCOGENE; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Lorenzon E, 2012, ONCOGENE, V31, P3136, DOI 10.1038/onc.2011.487; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Smith KN, 2010, CELL STEM CELL, V7, P343, DOI 10.1016/j.stem.2010.06.023; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhou RY, 2009, CELL, V139, P802, DOI 10.1016/j.cell.2009.10.023	32	119	119	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 7	2012	11	6					769	782		10.1016/j.stem.2012.11.008	http://dx.doi.org/10.1016/j.stem.2012.11.008			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	055MJ	23217423	Bronze			2022-12-28	WOS:000312420300009
J	Hoing, S; Rudhard, Y; Reinhardt, P; Glatza, M; Stehling, M; Wu, GM; Peiker, C; Bocker, A; Parga, JA; Bunk, E; Schwamborn, JC; Slack, M; Sterneckert, J; Scholer, HR				Hoeing, Susanne; Rudhard, York; Reinhardt, Peter; Glatza, Michael; Stehling, Martin; Wu, Guangming; Peiker, Christiane; Boecker, Alexander; Parga, Juan A.; Bunk, Eva; Schwamborn, Jens C.; Slack, Mark; Sterneckert, Jared; Schoeler, Hans R.			Discovery of Inhibitors of Microglial Neurotoxicity Acting Through Multiple Mechanisms Using a Stem-Cell-Based Phenotypic Assay	CELL STEM CELL			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SPINAL-CORD TISSUE; MOTOR-NEURONS; MOUSE MODEL; IN-VITRO; HUMAN ES; ACTIVATION; DISEASE; PROGRESSION; ALS	Stem cells, through their ability to both self-renew and differentiate, can produce a virtually limitless supply of specialized cells that behave comparably to primary cells. We took advantage of this property to develop an assay for small-molecule-based neuroprotection using stem-cell-derived motor neurons and astrocytes, together with activated microglia as a stress paradigm. Here, we report on the discovery of hit compounds from a screen of more than 10,000 small molecules. These compounds act through diverse pathways, including the inhibition of nitric oxide production by microglia, activation of the Nrf2 pathway in microglia and astrocytes, and direct protection of neurons from nitric-oxide-induced degeneration. We confirm the activity of these compounds using human neurons. Because microglial cells are activated in many neurological disorders, our hit compounds could be ideal starting points for the development of new drugs to treat various neurodegenerative and neurological diseases.	[Hoeing, Susanne; Reinhardt, Peter; Glatza, Michael; Stehling, Martin; Wu, Guangming; Sterneckert, Jared; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Rudhard, York; Peiker, Christiane; Boecker, Alexander; Slack, Mark] Evotec AG, D-22419 Hamburg, Germany; [Parga, Juan A.] Univ Santiago de Compostela, Ctr Res Mol Med & Chron Dis, E-15782 Santiago De Compostela, Spain; [Bunk, Eva; Schwamborn, Jens C.] Univ Munster, ZMBE, Inst Cell Biol, Stem Cell Biol & Regenerat Grp, D-48149 Munster, Germany; [Schoeler, Hans R.] Univ Munster, Fac Med, D-48149 Munster, Germany	Max Planck Society; Evotec; Universidade de Santiago de Compostela; University of Munster; University of Munster	Sterneckert, J (corresponding author), Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Rontgenstr 20, D-48149 Munster, Germany.	jsternec@mpi-muenster.mpg.de; office@mpi-muenster.mpg.de	Parga, Juan A/H-4503-2015; Schwamborn, Jens C/F-9395-2011; Sterneckert, Jared/E-6802-2015; , HS/AAB-4434-2019	Parga, Juan A/0000-0003-2072-5642; Schwamborn, Jens C/0000-0003-4496-0559; , HS/0000-0003-2643-5136; Wu, Guangming/0000-0003-1923-7609; Sterneckert, Jared/0000-0002-7688-3124	Angeles Alvarino's fellowship; European Social Fund	Angeles Alvarino's fellowship; European Social Fund(European Social Fund (ESF))	We are especially grateful to Rosario Donato for kindly providing the BV2 microglial cell line and to the GENSAT consortium for providing the HB9-GFP mice. Special thanks go to Rhea Brintrup, Kerstin Hergarten, Gisela Abt, and Katharina Moellmann for technical assistance; to Pierre Illouga for statistical analysis of screening data; to Annett Muller and colleagues for compound logistics; and to Arne Dusedau (HPI, Hamburg) for FAGS. We would like to thank Fred Brookfield for assistance with SciFinder database searches and assessment of chemical structures. J.A.P. was funded by an Angeles Alvarino's fellowship (cofunded by the European Social Fund). We would also like to thank Areti Malapetsas for editing the manuscript. YR., C.P., A.B., and M.S. are employees of Evotech AG.	Aarum J, 2003, P NATL ACAD SCI USA, V100, P15983, DOI 10.1073/pnas.2237050100; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Czvitkovich S, 2011, J MOL NEUROSCI, V43, P257, DOI 10.1007/s12031-010-9416-z; Deshpande DM, 2006, ANN NEUROL, V60, P32, DOI 10.1002/ana.20901; Do JT, 2007, STEM CELLS, V25, P1013, DOI 10.1634/stemcells.2006-0691; Gharavi N, 2005, DRUG METAB DISPOS, V33, P365, DOI 10.1124/dmd.104.002253; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Henkel JS, 2004, ANN NEUROL, V55, P221, DOI 10.1002/ana.10805; Jazwa A, 2011, ANTIOXID REDOX SIGN, V14, P2347, DOI 10.1089/ars.2010.3731; Julien JP, 2007, NAT NEUROSCI, V10, P535, DOI 10.1038/nn0507-535; KAWAMATA T, 1992, AM J PATHOL, V140, P691; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Koh K, 2009, BIOCHEM BIOPH RES CO, V380, P449, DOI 10.1016/j.bbrc.2009.01.082; Kriz J, 2002, NEUROBIOL DIS, V10, P268, DOI 10.1006/nbdi.2002.0487; Li XH, 2012, NEUROSCI LETT, V514, P46, DOI 10.1016/j.neulet.2012.02.054; McNeish J, 2010, J BIOL CHEM, V285, P17209, DOI 10.1074/jbc.M109.098814; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Neymotin A, 2011, FREE RADICAL BIO MED, V51, P88, DOI 10.1016/j.freeradbiomed.2011.03.027; Nguyen MD, 2004, J NEUROSCI, V24, P1340, DOI 10.1523/JNEUROSCI.4786-03.2004; OSIECKI JH, 1968, J AM CHEM SOC, V90, P1078, DOI 10.1021/ja01006a053; REES DD, 1990, BRIT J PHARMACOL, V101, P746, DOI 10.1111/j.1476-5381.1990.tb14151.x; Rojo AI, 2010, GLIA, V58, P588, DOI 10.1002/glia.20947; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Turner MR, 2004, NEUROBIOL DIS, V15, P601, DOI 10.1016/j.nbd.2003.12.012; Vargas MR, 2008, J NEUROSCI, V28, P13574, DOI 10.1523/JNEUROSCI.4099-08.2008; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8	33	63	64	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV 2	2012	11	5					620	632		10.1016/j.stem.2012.07.005	http://dx.doi.org/10.1016/j.stem.2012.07.005			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	042LE	23064101	Bronze			2022-12-28	WOS:000311471900009
J	Goulas, S; Conder, R; Knoblich, JA				Goulas, Spyros; Conder, Ryan; Knoblich, Juergen A.			The Par Complex and Integrins Direct Asymmetric Cell Division in Adult Intestinal Stem Cells	CELL STEM CELL			English	Article							NEUROBLAST SELF-RENEWAL; APICAL-BASAL POLARITY; DROSOPHILA-MELANOGASTER; SPINDLE ORIENTATION; FOLLICULAR-EPITHELIUM; POSTERIOR MIDGUT; TUMOR-SUPPRESSOR; PKC-IOTA; KINASE; DIFFERENTIATION	The adult Drosophila midgut is maintained by intestinal stem cells (ISCs) that generate both self-renewing and differentiating daughter cells. How this asymmetry is generated is currently unclear. Here, we demonstrate that asymmetric ISC division is established by a unique combination of extracellular and intracellular polarity mechanisms. We show that Integrin-dependent adhesion to the basement membrane induces cell-intrinsic polarity and results in the asymmetric segregation of the Par proteins Par-3, Par-6, and aPKC into the apical daughter cell. Cell-specific knockdown and overexpression experiments suggest that increased activity of aPKC enhances Delta/Notch signaling in one of the two daughter cells to induce terminal differentiation. Perturbing this mechanism or altering the orientation of ISC division results in the formation of intestinal tumors. Our data indicate that mechanisms for intrinsically asymmetric cell division can be adapted to allow for the flexibility in lineage decisions that is required in adult stem cells.	[Goulas, Spyros; Conder, Ryan; Knoblich, Juergen A.] Austrian Acad Sci IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Knoblich, JA (corresponding author), Austrian Acad Sci IMBA, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	juergen.knoblich@imba.oeaw.ac.at	Knoblich, Juergen A/C-2974-2015	Knoblich, Juergen A/0000-0002-6751-3404; Goulas, Spyros/0000-0002-7445-8917	EMBO Long Term Fellowship; Austrian Academy of Sciences; Austrian Science Fund (FWF); EU FP7 network Euro Systems; European Research Council (ERC); Austrian Science Fund (FWF) [I 552, Z 153] Funding Source: researchfish	EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO)); Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); EU FP7 network Euro Systems; European Research Council (ERC)(European Research Council (ERC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank Heike Harzer and Christian Berger for generating rabbit and guinea pig anti-Pros; Christoph Jueschke for comments on the manuscript and data analysis; all Knoblich lab members for discussion; Norbert Perrimon, Bruce Edgar, Andreas Wodarz, Ruth Palmer, Nick Brown, Alana O'Reilly, Michael Simon, Guy Tanentzapf, Thom Kaufman, Xiankun Zeng, Steven Hou, the Bloomington Drosophila stock center, the Vienna Drosophila RNAi center (VDRC), and the Developmental Studies Hybridoma Bank (DSHB) for fly stocks and reagents; and Karin Aumayr and Pawel Pasierbek for imaging support. R.C. is supported by an EMBO Long Term Fellowship. Work in J.A.K.'s laboratory is supported by the Austrian Academy of Sciences, the Austrian Science Fund (FWF), the EU FP7 network Euro Systems, and an advanced grant from the European Research Council (ERC). Experiments were conceived and designed by S.G., R.C., and J.A.K and performed and analyzed by S.G and R.C. The manuscript was written by S.G., R.C., and J.A.K.	Atwood SX, 2009, CURR BIOL, V19, P723, DOI 10.1016/j.cub.2009.03.056; Bardin AJ, 2010, DEVELOPMENT, V137, P705, DOI 10.1242/dev.039404; Baumann O, 2001, EXP CELL RES, V270, P176, DOI 10.1006/excr.2001.5343; BROWER DL, 1989, NATURE, V342, P285, DOI 10.1038/342285a0; Brown NH, 2000, MATRIX BIOL, V19, P191, DOI 10.1016/S0945-053X(00)00064-0; Cabernard C, 2009, DEV CELL, V17, P134, DOI 10.1016/j.devcel.2009.06.009; Conder R, 2007, DEV BIOL, V305, P470, DOI 10.1016/j.ydbio.2007.02.034; Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977; Durgan J, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.174235; Eder AM, 2005, P NATL ACAD SCI USA, V102, P12519, DOI 10.1073/pnas.0505641102; EKBLOM P, 1989, FASEB J, V3, P2141, DOI 10.1096/fasebj.3.10.2666230; Ellis SJ, 2010, CELL TISSUE RES, V339, P121, DOI 10.1007/s00441-009-0828-4; Fernandez-Minan A, 2007, CURR BIOL, V17, P683, DOI 10.1016/j.cub.2007.02.052; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Furriols M, 2001, CURR BIOL, V11, P60, DOI 10.1016/S0960-9822(00)00044-0; Galvez AS, 2009, MOL CELL BIOL, V29, P104, DOI 10.1128/MCB.01294-08; Grifoni D, 2007, ONCOGENE, V26, P5960, DOI 10.1038/sj.onc.1210389; Hao Y, 2010, CURR BIOL, V20, P1809, DOI 10.1016/j.cub.2010.09.032; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Jones RG, 2006, J CELL BIOL, V175, P505, DOI 10.1083/jcb.200602160; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Kirilly D, 2007, CELL RES, V17, P15, DOI 10.1038/sj.cr.7310123; Klein AM, 2011, DEVELOPMENT, V138, P3103, DOI 10.1242/dev.060103; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010; Kojima Y, 2008, HUM PATHOL, V39, P824, DOI 10.1016/j.humpath.2007.11.001; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lee CY, 2006, GENE DEV, V20, P3464, DOI 10.1101/gad.1489406; Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Lin GN, 2008, NATURE, V455, P1119, DOI 10.1038/nature07329; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Martin-Bermudo MD, 1999, GENE DEV, V13, P729, DOI 10.1101/gad.13.6.729; McCaffrey LM, 2009, GENE DEV, V23, P1450, DOI 10.1101/gad.1795909; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; O'Brien LE, 2011, CELL, V147, P603, DOI 10.1016/j.cell.2011.08.048; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Palmer RH, 1999, J BIOL CHEM, V274, P35621, DOI 10.1074/jbc.274.50.35621; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Regala RP, 2005, CANCER RES, V65, P8905, DOI 10.1158/0008-5472.CAN-05-2372; Roegiers F, 2001, NAT CELL BIOL, V3, P58, DOI 10.1038/35050568; Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Sheng XR, 2011, DEVELOPMENT, V138, P3367, DOI 10.1242/dev.065797; Siegrist SE, 2006, DEVELOPMENT, V133, P529, DOI 10.1242/dev.02211; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Smith CA, 2007, EMBO J, V26, P468, DOI 10.1038/sj.emboj.7601495; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Wang H, 2006, GENE DEV, V20, P3453, DOI 10.1101/gad.1487506; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Wirtz-Peitz F, 2008, CELL, V135, P161, DOI 10.1016/j.cell.2008.07.049; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Wu PS, 2008, SEMIN CELL DEV BIOL, V19, P283, DOI 10.1016/j.semcdb.2008.01.007; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; YEE GH, 1993, DEVELOPMENT, V118, P845; Zeng XK, 2010, GENESIS, V48, P607, DOI 10.1002/dvg.20661; Zhang L, 2006, CANCER RES, V66, P4627, DOI 10.1158/0008-5472.CAN-05-4527	66	132	132	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 5	2012	11	4					529	540		10.1016/j.stem.2012.06.017	http://dx.doi.org/10.1016/j.stem.2012.06.017			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	021OZ	23040479	hybrid, Green Published			2022-12-28	WOS:000309896500013
J	Lepper, C; Low, S; Partridge, TA				Lepper, Christoph; Low, SiewHui; Partridge, Terence A.			The Satellite Cell Builds Its Nest under Notch's Guidance	CELL STEM CELL			English	Editorial Material							MUSCLE PROGENITOR CELLS; REGENERATION; REQUIREMENT	Recently in Developmental Cell, Brohl et al. (2012) reported that Notch regulates muscle stem cell homing to its niche. Notch is required when myogenic cells cease producing new fibers and become sequestered between a newly forming basement membrane and the muscle fiber surface: the position that defines them as satellite cells.	[Partridge, Terence A.] Childrens Natl Med Ctr, Res Ctr Genet Med, Washington, DC 20010 USA; [Lepper, Christoph; Low, SiewHui] Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA	Children's National Health System; Carnegie Institution for Science	Partridge, TA (corresponding author), Childrens Natl Med Ctr, Res Ctr Genet Med, 111 Michigan Ave NW, Washington, DC 20010 USA.	tpartridge@cnmcresearch.org	Low, SiewHui/E-1117-2016		OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD009208] Funding Source: NIH RePORTER; NIH HHS [DP5 OD009208] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bjornson CRR, 2012, STEM CELLS, V30, P232, DOI 10.1002/stem.773; Brohl D, 2012, DEV CELL, V23, P469, DOI 10.1016/j.devcel.2012.07.014; HUGHES SM, 1990, NATURE, V345, P350, DOI 10.1038/345350a0; Kitamoto T, 2010, STEM CELLS, V28, P2205, DOI 10.1002/stem.547; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Mourikis P, 2012, STEM CELLS, V30, P243, DOI 10.1002/stem.775; PARTRIDGE T, 2008, RECENT ADV SKELETAL, P93; Relaix F, 2009, CURR OPIN CELL BIOL, V21, P748, DOI 10.1016/j.ceb.2009.10.002; Vasyutina E, 2007, P NATL ACAD SCI USA, V104, P4443, DOI 10.1073/pnas.0610647104	10	3	3	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	OCT 5	2012	11	4					443	444		10.1016/j.stem.2012.09.010	http://dx.doi.org/10.1016/j.stem.2012.09.010			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	021OZ	23040471	Bronze			2022-12-28	WOS:000309896500002
J	Kokovay, E; Wang, Y; Kusek, G; Wurster, R; Lederman, P; Lowry, N; Shen, Q; Temple, S				Kokovay, Erzsebet; Wang, Yue; Kusek, Gretchen; Wurster, Rachel; Lederman, Patty; Lowry, Natalia; Shen, Qin; Temple, Sally			VCAM1 Is Essential to Maintain the Structure of the SVZ Niche and Acts as an Environmental Sensor to Regulate SVZ Lineage Progression	CELL STEM CELL			English	Article							NEURAL STEM-CELLS; ADULT MAMMALIAN FOREBRAIN; CEREBROSPINAL-FLUID; VASCULAR NICHE; SELF-RENEWAL; ADHESION MOLECULE-1; CHOROID-PLEXUS; HEMATOPOIETIC PROGENITORS; LYMPHOCYTE MIGRATION; BONE-MARROW	Neurons arise in the adult forebrain subventricular zone (SVZ) from Type B neural stem cells (NSCs), raising considerable interest in the molecules that maintain this life-long neurogenic niche. Type B cells are anchored by specialized apical endfeet in the center of a pinwheel of ependymal cells. Here we show that the apical endfeet express high levels of the adhesion and signaling molecule vascular cell adhesion molecule-1 (VCAM1). Disruption of VCAM1 in vivo causes loss of the pinwheels, disrupted SVZ cytoarchitecture, proliferation and depletion of the normally quiescent apical Type B cells, and increased neurogenesis in the olfactory bulb, demonstrating a key role in niche structure and function. We show that VCAM1 signals via NOX2 production of reactive oxygen species (ROS) to maintain NSCs. VCAM1 on Type B cells is increased by IL-1 beta, demonstrating that it can act as an environmental sensor, responding to chemokines involved in tissue repair.	[Shen, Qin] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Sch Med, Ctr Stem Cell Biol & Regenerat Med, Beijing 100084, Peoples R China; [Kokovay, Erzsebet] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Wang, Yue; Kusek, Gretchen; Wurster, Rachel; Lederman, Patty; Lowry, Natalia; Temple, Sally] Regenerat Res Fdn, Neural Stem Cell Inst, Rensselaer, NY 12144 USA	Tsinghua University; University of Texas System; University of Texas Health San Antonio	Shen, Q (corresponding author), Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Sch Med, Ctr Stem Cell Biol & Regenerat Med, Beijing 100084, Peoples R China.	shenqin@mail.tsinghua.edu.cn; sallytemple@nynsci.org			NIH from the National Institutes of Neurological Disorders and Stroke [NS051531]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051531] Funding Source: NIH RePORTER	NIH from the National Institutes of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was funded by NIH grant NS051531 from the National Institutes of Neurological Disorders and Stroke. The authors would like to thank Christopher Fasano and John Dimas for help with Vcam1 shRNA design and production.	Aguirre A, 2010, NATURE, V467, P323, DOI 10.1038/nature09347; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Barkho BZ, 2006, STEM CELLS DEV, V15, P407, DOI 10.1089/scd.2006.15.407; BARON JL, 1994, J CLIN INVEST, V93, P1700, DOI 10.1172/JCI117153; Beckervordersandforth R, 2010, CELL STEM CELL, V7, P744, DOI 10.1016/j.stem.2010.11.017; Bettcher BM, 2012, BRAIN BEHAV IMMUN, V26, P103, DOI 10.1016/j.bbi.2011.07.240; Bonneh-Barkay D, 2010, J NEUROTRAUM, V27, P1215, DOI 10.1089/neu.2010.1310; CACABELOS R, 1991, METHOD FIND EXP CLIN, V13, P455; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Cook-Mills JM, 2002, MOL IMMUNOL, V39, P499, DOI 10.1016/S0161-5890(02)00206-7; Cook-Mills JM, 2006, CELL MOL BIOL, V52, P8, DOI 10.1170/T721; Cook-Mills JM, 2011, ANTIOXID REDOX SIGN, V15, P1607, DOI 10.1089/ars.2010.3522; Deem TL, 2007, J IMMUNOL, V178, P3865, DOI 10.4049/jimmunol.178.6.3865; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1997, J NEUROSCI, V17, P5046; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Emerich DF, 2005, BIOESSAYS, V27, P262, DOI 10.1002/bies.20193; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Fasano CA, 2009, GENE DEV, V23, P561, DOI 10.1101/gad.1743709; Ferreira T., 2011, IMAGE J USER GUIDE I; Garton KJ, 2006, J LEUKOCYTE BIOL, V79, P1105, DOI 10.1189/jlb.0106038; Gemma C, 2007, EUR J NEUROSCI, V26, P2795, DOI 10.1111/j.1460-9568.2007.05875.x; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Gourin CG, 1997, J TRAUMA, V42, P1101, DOI 10.1097/00005373-199706000-00020; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Jiang F, 2011, PHARMACOL REV, V63, P218, DOI 10.1124/pr.110.002980; Johanson C, 2011, J NEURAL TRANSM, V118, P115, DOI 10.1007/s00702-010-0498-0; Johanson CE, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-10; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kawaguchi A, 2008, DEVELOPMENT, V135, P3113, DOI 10.1242/dev.022616; Kazanis I, 2010, J NEUROSCI, V30, P9771, DOI 10.1523/JNEUROSCI.0700-10.2010; Kim EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018472; Kokovay E, 2010, CELL STEM CELL, V7, P163, DOI 10.1016/j.stem.2010.05.019; Koo JW, 2008, P NATL ACAD SCI USA, V105, P751, DOI 10.1073/pnas.0708092105; Koo JW, 2010, P NATL ACAD SCI USA, V107, P2669, DOI 10.1073/pnas.0910658107; Kuzumaki N, 2010, SYNAPSE, V64, P721, DOI 10.1002/syn.20800; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Luo J, 2008, J NEUROSCI, V28, P3804, DOI 10.1523/JNEUROSCI.0224-08.2008; Marques F, 2007, NEUROSCIENCE, V144, P424, DOI 10.1016/j.neuroscience.2006.09.029; Matheny HE, 2000, J IMMUNOL, V164, P6550, DOI 10.4049/jimmunol.164.12.6550; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Nam HS, 2009, CELL STEM CELL, V5, P515, DOI 10.1016/j.stem.2009.08.017; Nystul T, 2007, CELL STEM CELL, V1, P277, DOI 10.1016/j.stem.2007.07.009; Oostendorp RAJ, 1997, LEUKEMIA LYMPHOMA, V24, P423, DOI 10.3109/10428199709055581; OSBORN L, 1989, CELL, V59, P1203, DOI 10.1016/0092-8674(89)90775-7; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; PAPAYANNOPOULOU T, 1995, P NATL ACAD SCI USA, V92, P9647, DOI 10.1073/pnas.92.21.9647; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Petry A, 2010, ANTIOXID REDOX SIGN, V13, P467, DOI 10.1089/ars.2009.3026; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; SHEPPARD AM, 1995, J BIOL CHEM, V270, P3710, DOI 10.1074/jbc.270.8.3710; SIMMONS PJ, 1992, BLOOD, V80, P388; Spulber S, 2008, EUR J NEUROSCI, V27, P549, DOI 10.1111/j.1460-9568.2008.06050.x; Sun Y, 2009, EUR J NEUROL, V16, P858, DOI 10.1111/j.1468-1331.2009.02609.x; Szmydynger-Chodobska J, 2009, J CEREBR BLOOD F MET, V29, P1503, DOI 10.1038/jcbfm.2009.71; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Veening JG, 2010, FLUIDS BARRIERS CNS, V7, DOI 10.1186/1743-8454-7-1; Vieira HLA, 2011, PROG NEUROBIOL, V93, P444, DOI 10.1016/j.pneurobio.2011.01.007; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601	69	136	140	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 3	2012	11	2					220	230		10.1016/j.stem.2012.06.016	http://dx.doi.org/10.1016/j.stem.2012.06.016			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	987QQ	22862947	Bronze			2022-12-28	WOS:000307432600012
J	Mistry, DS; Chen, YF; Sen, GL				Mistry, Devendra S.; Chen, Yifang; Sen, George L.			Progenitor Function in Self-Renewing Human Epidermis Is Maintained by the Exosome	CELL STEM CELL			English	Article							MESSENGER-RNA DECAY; 5.8S RIBOSOMAL-RNA; STEM-CELLS; NONCODING RNA; POLYMERASE-II; DIFFERENTIATION; TISSUE; SKIN; DEGRADATION; TRANSCRIPTS	Stem and progenitor cells maintain the tissue they reside in for life by regulating the balance between proliferation and differentiation. How this is done is not well understood. Here, we report that the human exosome maintains progenitor cell function. The expression of several subunits of the exosome were found to be enriched in epidermal progenitor cells, which were required to retain proliferative capacity and to prevent premature differentiation. Loss of PM/Scl-75 also known as EXOSC9, a key subunit of the exosome complex, resulted in loss of cells from the progenitor cell compartment, premature differentiation, and loss of epidermal tissue. EXOSC9 promotes self-renewal and prevents premature differentiation by maintaining transcript levels of a transcription factor necessary for epidermal differentiation, GRHL3, at low levels through mRNA degradation. These data demonstrate that control of differentiation specific transcription factors through mRNA degradation is required for progenitor cell maintenance in mammalian tissue.	[Mistry, Devendra S.; Chen, Yifang; Sen, George L.] Univ Calif San Diego, Dept Med, Dept Cellular & Mol Med, Div Dermatol,UCSD Stem Cell Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Sen, GL (corresponding author), Univ Calif San Diego, Dept Med, Dept Cellular & Mol Med, Div Dermatol,UCSD Stem Cell Program, La Jolla, CA 92093 USA.	gsen@ucsd.edu			Ray Thomas Edwards Award;  [K01AR057828-04]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR062496, K01AR057828] Funding Source: NIH RePORTER	Ray Thomas Edwards Award; ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Y. Wang for presubmission review and helpful discussions. We thank D. Webster and P. Khavari for the LZRS GFP and LZRS dsRED phoenix cells. This work is supported by a K01AR057828-04 and Ray Thomas Edwards Award to G.L.S.	Andrulis ED, 2002, NATURE, V420, P837, DOI 10.1038/nature01181; Belostotsky D, 2009, CURR OPIN CELL BIOL, V21, P352, DOI 10.1016/j.ceb.2009.04.011; Belostotsky DA, 2009, CURR OPIN PLANT BIOL, V12, P96, DOI 10.1016/j.pbi.2008.09.003; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Callahan KP, 2008, NUCLEIC ACIDS RES, V36, P6645, DOI 10.1093/nar/gkn743; Chekanova JA, 2007, CELL, V131, P1340, DOI 10.1016/j.cell.2007.10.056; Ciaudo C, 2006, PLOS GENET, V2, P874, DOI 10.1371/journal.pgen.0020094; de la Cruz J, 1998, EMBO J, V17, P1128, DOI 10.1093/emboj/17.4.1128; Ezhkova E, 2011, GENE DEV, V25, P485, DOI 10.1101/gad.2019811; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Khavari PA, 2006, NAT REV CANCER, V6, P270, DOI 10.1038/nrc1838; Kiss DL, 2010, RNA, V16, P781, DOI 10.1261/rna.1906710; Leclerc Guy J, 2002, Cancer Cell Int, V2, P1, DOI 10.1186/1475-2867-2-1; Lopez RG, 2009, NAT CELL BIOL, V11, P1181, DOI 10.1038/ncb1960; Lubas M, 2011, MOL CELL, V43, P624, DOI 10.1016/j.molcel.2011.06.028; Milligan L, 2008, MOL CELL BIOL, V28, P5446, DOI 10.1128/MCB.00463-08; Mitchell P, 2003, MOL CELL BIOL, V23, P6982, DOI 10.1128/MCB.23.19.6982-6992.2003; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Schilders G, 2005, NUCLEIC ACIDS RES, V33, P6795, DOI 10.1093/nar/gki982; Schilders G, 2007, NUCLEIC ACIDS RES, V35, P2564, DOI 10.1093/nar/gkm082; Segre JA, 2006, J CLIN INVEST, V116, P1150, DOI 10.1172/JCI28521; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Sen GL, 2012, DEV CELL, V22, P669, DOI 10.1016/j.devcel.2011.12.001; Sen GL, 2011, FASEB J, V25, P2123, DOI 10.1096/fj.11-182774; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Ting SB, 2005, SCIENCE, V308, P411, DOI 10.1126/science.1107511; Tomecki R, 2010, EMBO J, V29, P2342, DOI 10.1038/emboj.2010.121; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; van Dijk EL, 2011, NATURE, V475, P114, DOI 10.1038/nature10118; Vasiljeva L, 2006, MOL CELL, V21, P239, DOI 10.1016/j.molcel.2005.11.028	36	56	58	2	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUL 6	2012	11	1					127	135		10.1016/j.stem.2012.04.022	http://dx.doi.org/10.1016/j.stem.2012.04.022			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	975SS	22770246	Bronze, Green Accepted			2022-12-28	WOS:000306532400016
J	Brack, AS; Rando, TA				Brack, Andrew S.; Rando, Thomas A.			Tissue-Specific Stem Cells: Lessons from the Skeletal Muscle Satellite Cell	CELL STEM CELL			English	Review							TEMPLATE DNA STRANDS; SELF-RENEWAL; PROGENITOR CELLS; UP-REGULATION; MOUSE; PAX7; MAINTENANCE; MYOGENESIS; GROWTH; MYOD	In 1961, the satellite cell was first identified when electron microscopic examination of skeletal muscle demonstrated a cell wedged between the plasma membrane of the muscle fiber and the basement membrane. In recent years it has been conclusively demonstrated that the satellite cell is the primary cellular source for muscle regeneration and is equipped with the potential to self renew, thus functioning as a bona fide skeletal muscle stem cell (MuSC). As we move past the 50th anniversary of the satellite cell, we take this opportunity to discuss the current state of the art and dissect the unknowns in the MuSC field.	[Brack, Andrew S.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Brack, Andrew S.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Brack, Andrew S.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Rando, Thomas A.] Stanford Univ, Sch Med, Paul F Glenn Labs Biol Aging, Stanford, CA 94305 USA; [Rando, Thomas A.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Rando, Thomas A.] Vet Affairs Palo Alto Hlth Care Syst, Neurol Serv, Palo Alto, CA 94304 USA; [Rando, Thomas A.] Vet Affairs Palo Alto Hlth Care Syst, Rehabil Res & Dev Ctr Excellence, Palo Alto, CA 94304 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Brack, AS (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.	abrack@partners.org		Rando, Thomas/0000-0001-5843-8564	NIH [R01 AIR060868, P01 AG036695, R37 AG23806, RO1 AR056849]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056849, R01AR061002, R01AR060868, R01AR062185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG023806, P01AG036695] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the NIH (R01 AIR060868 to A.S.B. and P01 AG036695, R37 AG23806, [MERIT Award], and RO1 AR056849 to T.A.R.). We thank Jenna Norton for artwork and Josef Christensen for critical reading of the manuscript.	Abou-Khalil R, 2010, CELL CYCLE, V9, P2575, DOI 10.4161/cc.9.13.12149; Abou-Khalil R, 2009, CELL STEM CELL, V5, P298, DOI 10.1016/j.stem.2009.06.001; ALLBROOK D, 1962, J ANAT, V96, P137; Amini-Nik S, 2011, STEM CELLS, V29, P1371, DOI 10.1002/stem.688; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; BISCHOFF R, 1986, DEV BIOL, V115, P129, DOI 10.1016/0012-1606(86)90234-4; BISCHOFF R, 1986, DEV BIOL, V115, P140, DOI 10.1016/0012-1606(86)90235-6; Bjornson CRR, 2012, STEM CELLS, V30, P232, DOI 10.1002/stem.773; Boutet SC, 2012, CELL STEM CELL, V10, P327, DOI 10.1016/j.stem.2012.01.017; Brack AS, 2007, STEM CELL REV, V3, P226, DOI 10.1007/s12015-007-9000-2; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Brack AS, 2005, J CELL SCI, V118, P4813, DOI 10.1242/jcs.02602; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Charge SB, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-5; Charville GW, 2011, PHILOS T R SOC B, V366, P85, DOI 10.1098/rstb.2010.0279; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Christov C, 2007, MOL BIOL CELL, V18, P1397, DOI 10.1091/mbc.E06-08-0693; CHURCH JCT, 1969, J ANAT, V105, P419; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy MJ, 2007, PLOS BIOL, V5, P1120, DOI 10.1371/journal.pbio.0050102; Day K, 2009, DEV DYNAM, V238, P1001, DOI 10.1002/dvdy.21903; Dellavalle A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1508; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Gensch N, 2008, DEVELOPMENT, V135, P1597, DOI 10.1242/dev.019331; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Haldar M, 2008, DEV CELL, V14, P437, DOI 10.1016/j.devcel.2008.01.002; Halevy O, 2004, DEV DYNAM, V231, P489, DOI 10.1002/dvdy.20151; Hughes SM, 1999, ACTA PHYSIOL SCAND, V167, P307; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Jones NC, 2005, J CELL BIOL, V169, P105, DOI 10.1083/jcb.200408066; Jory A, 2009, STEM CELLS, V27, P2769, DOI 10.1002/stem.220; Juan AH, 2011, GENE DEV, V25, P789, DOI 10.1101/gad.2027911; Kanisicak O, 2009, DEV BIOL, V332, P131, DOI 10.1016/j.ydbio.2009.05.554; Kitamoto T, 2010, STEM CELLS, V28, P2205, DOI 10.1002/stem.547; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Lepper C, 2010, GENESIS, V48, P424, DOI 10.1002/dvg.20630; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; LIPTON BH, 1979, SCIENCE, V205, P1292, DOI 10.1126/science.472747; Lu R, 2011, NAT BIOTECHNOL, V29, P928, DOI 10.1038/nbt.1977; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; McFarlane C, 2008, EXP CELL RES, V314, P317, DOI 10.1016/j.yexcr.2007.09.012; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Mitchell KJ, 2010, NAT CELL BIOL, V12, P257, DOI 10.1038/ncb2025; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; MOSS FP, 1970, J CELL BIOL, V44, P459, DOI 10.1083/jcb.44.2.459; MOSS FP, 1971, ANAT REC, V170, P421, DOI 10.1002/ar.1091700405; Mourikis P, 2012, STEM CELLS, V30, P243, DOI 10.1002/stem.775; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; PARTRIDGE TA, 1978, NATURE, V273, P306, DOI 10.1038/273306a0; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Petersen PH, 2004, NAT NEUROSCI, V7, P803, DOI 10.1038/nn1289; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 2004, GENE DEV, V18, P1088, DOI 10.1101/gad.301004; REZNIK M, 1969, J CELL BIOL, V40, P568, DOI 10.1083/jcb.40.2.568; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sacco A, 2010, CELL, V143, P1059, DOI 10.1016/j.cell.2010.11.039; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Scharner J, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-28; Schienda J, 2006, P NATL ACAD SCI USA, V103, P945, DOI 10.1073/pnas.0510164103; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; SCHULTZ E, 1989, MED SCI SPORT EXER, V21, pS181; SCHULTZ E, 1978, J EXP ZOOL, V206, P451, DOI 10.1002/jez.1402060314; Schultz E, 1996, DEV BIOL, V175, P84, DOI 10.1006/dbio.1996.0097; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; SHAFIQ SA, 1965, J PATHOL BACTERIOL, V90, P123, DOI 10.1002/path.1700900113; Shea KL, 2010, CELL STEM CELL, V6, P117, DOI 10.1016/j.stem.2009.12.015; Sheehan SM, 1999, J CELL PHYSIOL, V181, P499, DOI 10.1002/(SICI)1097-4652(199912)181:3<499::AID-JCP14>3.0.CO;2-1; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Shinin Vasily, 2009, V482, P295, DOI 10.1007/978-1-59745-060-7_19; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; SNOW MH, 1977, ANAT REC, V188, P201, DOI 10.1002/ar.1091880206; Starkey JD, 2011, J HISTOCHEM CYTOCHEM, V59, P33, DOI 10.1369/jhc.2010.956995; Tajbakbsh S, 2009, ANNU REV CELL DEV BI, V25, P671, DOI 10.1146/annurev.cellbio.24.110707.175415; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; WATT DJ, 1982, J NEUROL SCI, V57, P319, DOI 10.1016/0022-510X(82)90038-7; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yablonka-Reuveni Z, 2011, J HISTOCHEM CYTOCHEM, V59, P1041, DOI 10.1369/0022155411426780; Yoshida N, 1998, J CELL SCI, V111, P769; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	106	288	300	1	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 4	2012	10	5					504	514		10.1016/j.stem.2012.04.001	http://dx.doi.org/10.1016/j.stem.2012.04.001			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	944WN	22560074	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000304234600009
J	Reynolds, N; Latos, P; Hynes-Allen, A; Loos, R; Leaford, D; O'Shaughnessy, A; Mosaku, O; Signolet, J; Brennecke, P; Kalkan, T; Costello, I; Humphreys, P; Mansfield, W; Nakagawa, K; Strouboulis, J; Behrens, A; Bertone, P; Hendrich, B				Reynolds, Nicola; Latos, Paulina; Hynes-Allen, Antony; Loos, Remco; Leaford, Donna; O'Shaughnessy, Aoife; Mosaku, Olukunbi; Signolet, Jason; Brennecke, Philip; Kalkan, Tuezer; Costello, Ita; Humphreys, Peter; Mansfield, William; Nakagawa, Kentaro; Strouboulis, John; Behrens, Axel; Bertone, Paul; Hendrich, Brian			NuRD Suppresses Pluripotency Gene Expression to Promote Transcriptional Heterogeneity and Lineage Commitment	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; CHROMATIN REMODELER MI-2-BETA; PRIMORDIAL GERM-CELLS; SELF-RENEWAL; SIGNALING PATHWAYS; GROUND-STATE; DIFFERENTIATION; COMPLEX; COMPONENT; CULTURE	Transcriptional heterogeneity within embryonic stem cell (ESC) populations has been suggested as a mechanism by which a seemingly homogeneous cell population can initiate differentiation into an array of different cell types. Chromatin remodeling proteins have been shown to control transcriptional variability in yeast and to be important for mammalian ESC lineage commitment. Here we show that the Nucleosome Remodeling and Deacetylation (NuRD) complex, which is required for ESC lineage commitment, modulates both transcriptional heterogeneity and the dynamic range of a set of pluripotency genes in ESCs. In self-renewing conditions, the influence of NuRD at these genes is balanced by the opposing action of self-renewal factors. Upon loss of self-renewal factors, the action of NuRD is sufficient to silence transcription of these pluripotency genes, allowing cells to exit self-renewal. We propose that modulation of transcription levels by NuRD is key to maintaining the differentiation responsiveness of pluripotent cells.	[Reynolds, Nicola; Latos, Paulina; Hynes-Allen, Antony; Leaford, Donna; O'Shaughnessy, Aoife; Mosaku, Olukunbi; Signolet, Jason; Brennecke, Philip; Kalkan, Tuezer; Humphreys, Peter; Mansfield, William; Hendrich, Brian] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QR, England; [Reynolds, Nicola; Hynes-Allen, Antony; Leaford, Donna; O'Shaughnessy, Aoife; Mosaku, Olukunbi; Signolet, Jason; Kalkan, Tuezer; Humphreys, Peter; Mansfield, William; Bertone, Paul; Hendrich, Brian] Univ Cambridge, Stem Cell Inst, Cambridge CB2 1QR, England; [O'Shaughnessy, Aoife; Signolet, Jason; Hendrich, Brian] Univ Cambridge, Dept Biochem, Cambridge CB2 1QR, England; [Loos, Remco; Bertone, Paul] EMBL European Bioinformat Inst, Cambridge CB10 1SD, England; [Costello, Ita] Univ Edinburgh, Inst Stem Cell Res, Edinburgh EH9 3JQ, Midlothian, Scotland; [Costello, Ita] Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh EH9 3JQ, Midlothian, Scotland; [Nakagawa, Kentaro; Behrens, Axel] Lincolns Inn Fields Labs, London Res Inst, London WC2A 3PX, England; [Strouboulis, John] BSRC Alexander Fleming, Inst Mol Oncol, Varkiza, Greece; [Bertone, Paul] European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany; [Bertone, Paul] European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany	University of Cambridge; University of Cambridge; University of Cambridge; European Molecular Biology Laboratory (EMBL); University of Edinburgh; University of Edinburgh; Alexander Fleming Biomedical Sciences Research Center; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	Hendrich, B (corresponding author), Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Tennis Court Rd, Cambridge CB2 1QR, England.	brian.hendrich@cscr.cam.ac.uk	Bertone, Paul/Z-3734-2019; Bertone, Paul/A-6600-2013; Strouboulis, John/U-4459-2019; Hendrich, Brian/AAG-5898-2020	Bertone, Paul/0000-0001-5059-4829; Bertone, Paul/0000-0001-5059-4829; Hendrich, Brian/0000-0002-0231-3073; Loos, Remco/0000-0002-9850-6821; Strouboulis, John/0000-0002-6133-2872; Behrens, Axel/0000-0002-1557-1143	Wellcome Trust; EMBO; BBSRC; Pfizer Neusentis; Cancer Research UK; MAC; Cancer Research UK [15679] Funding Source: researchfish; Medical Research Council [G0800784, G1000847, G0800784B, G0600275] Funding Source: researchfish; MRC [G0800784, G0600275, G1000847] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); EMBO(European Molecular Biology Organization (EMBO)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Pfizer Neusentis; Cancer Research UK(Cancer Research UK); MAC; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Austin Smith, Jeffrey Whitsett, Anne Ferguson-Smith, Dies Meijer, and Katia Georgopoulos for providing reagents; Graziano Martell for help with Stat3 ChIP; Sarah Gharbi for technical assistance; and Austin Smith, Alfonso Martinez Arias, and members of the B.H. lab for helpful discussions and critical reading of the manuscript. Libraries for mRNA sequencing were prepared by Maike Paramor of the Gene Service Facility, CSCR, University of Cambridge, and sequencing was carried out at EMBL Genomics Core Facility, Heidelberg, Germany. This work was supported by a Wellcome Trust Senior Fellowship in the Basic Biomedical Sciences held by B.H., an EMBO Long Term Postdoctoral Fellowship awarded to P.L., an MAC Four Year Ph.D. studentship (J.S.), a BBSRC Case Ph.D. studentship in conjunction with Pfizer Neusentis (A.O'S.), a Wellcome Trust Four-Year Ph.D. Studentship (IC.), and Cancer Research UK (K.N. and A.B.).	Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; Chambers I, 2004, CLONING STEM CELLS, V6, P386, DOI 10.1089/clo.2004.6.386; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen CS, 2005, ONCOGENE, V24, P3319, DOI 10.1038/sj.onc.1208497; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chen ZY, 2005, CANCER RES, V65, P10394, DOI 10.1158/0008-5472.CAN-05-2059; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Huang S, 2009, DEVELOPMENT, V136, P3853, DOI 10.1242/dev.035139; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kaji K, 2007, DEVELOPMENT, V134, P1123, DOI 10.1242/dev.02802; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kashiwagi M, 2007, DEVELOPMENT, V134, P1571, DOI 10.1242/dev.001750; Kolodziej KE, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-6; Latos PA, 2012, BIOL OPEN, V1, P341, DOI 10.1242/bio.2012513; Leitch HG, 2010, DEVELOPMENT, V137, P2279, DOI 10.1242/dev.050427; Li XJ, 2008, DEV CELL, V15, P547, DOI 10.1016/j.devcel.2008.08.014; Li Y, 2005, BLOOD, V105, P635, DOI 10.1182/blood-2004-07-2681; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; McDonel P, 2009, INT J BIOCHEM CELL B, V41, P108, DOI 10.1016/j.biocel.2008.07.022; Miccio A, 2010, EMBO J, V29, P442, DOI 10.1038/emboj.2009.336; Murawska M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002206; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Nobrega MA, 2004, NATURE, V431, P988, DOI 10.1038/nature03022; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Reynolds N, 2012, EMBO J, V31, P593, DOI 10.1038/emboj.2011.431; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yoshida T, 2008, GENE DEV, V22, P1174, DOI 10.1101/gad.1642808; Zhang JW, 2012, NAT IMMUNOL, V13, P86, DOI 10.1038/ni.2150; Zhang XF, 2008, J BIOL CHEM, V283, P35825, DOI 10.1074/jbc.M803481200; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhu DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007684	48	162	166	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAY 4	2012	10	5					583	594		10.1016/j.stem.2012.02.020	http://dx.doi.org/10.1016/j.stem.2012.02.020			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	944WN	22560079	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000304234600016
J	Longmire, TA; Ikonomou, L; Hawkins, F; Christodoulou, C; Cao, YX; Jean, JC; Kwok, LW; Mou, HM; Rajagopal, J; Shen, SS; Dowton, AA; Serra, M; Weiss, DJ; Green, MD; Snoeck, HW; Ramirez, MI; Kotton, DN				Longmire, Tyler A.; Ikonomou, Laertis; Hawkins, Finn; Christodoulou, Constantina; Cao, Yuxia; Jean, J. C.; Kwok, Letty W.; Mou, Hongmei; Rajagopal, Jayaraj; Shen, Steven S.; Dowton, Anne A.; Serra, Maria; Weiss, Daniel J.; Green, Michael D.; Snoeck, Hans-Willem; Ramirez, Maria I.; Kotton, Darrell N.			Efficient Derivation of Purified Lung and Thyroid Progenitors from Embryonic Stem Cells	CELL STEM CELL			English	Article							DEFINITIVE ENDODERM; II CELLS; IPS CELLS; MOUSE; DIFFERENTIATION; EPITHELIUM; FOREGUT; PROTEIN; LIVER; MORPHOGENESIS	Two populations of Nicx2-1+ progenitors in the developing foregut endoderm give rise to the entire postnatal lung and thyroid epithelium, but little is known about these cells because they are difficult to isolate in a pure form. We demonstrate here the purification and directed differentiation of primordial lung and thyroid progenitors derived from mouse embryonic stem cells (ESCs). Inhibition of TGF beta and BMP signaling, followed by combinatorial stimulation of BMP and FGF signaling, can specify these cells efficiently from definitive endodermal precursors. When derived using Nkx2-1(GFP) knockin reporter ESCs, these progenitors can be purified for expansion in culture and have a transcriptome that overlaps with developing lung epithelium. Upon induction, they can express a broad repertoire of markers indicative of lung and thyroid lineages and can recellularize a 3D lung tissue scaffold. Thus, we have derived a pure population of progenitors able to recapitulate the developmental milestones of lung/thyroid development.	[Longmire, Tyler A.; Ikonomou, Laertis; Hawkins, Finn; Christodoulou, Constantina; Cao, Yuxia; Jean, J. C.; Kwok, Letty W.; Dowton, Anne A.; Serra, Maria; Ramirez, Maria I.; Kotton, Darrell N.] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [Shen, Steven S.] Boston Univ, Sch Med, Sect Computat Biomed, Boston, MA 02118 USA; [Shen, Steven S.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Longmire, Tyler A.; Ikonomou, Laertis; Hawkins, Finn; Christodoulou, Constantina; Cao, Yuxia; Jean, J. C.; Kwok, Letty W.; Dowton, Anne A.; Serra, Maria; Ramirez, Maria I.; Kotton, Darrell N.] Boston Univ, Ctr Regenerat Med CReM, Boston, MA 02118 USA; [Mou, Hongmei; Rajagopal, Jayaraj] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Shen, Steven S.] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA; [Shen, Steven S.] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; [Shen, Steven S.] NYU, Sch Med, Dept Med, New York, NY 10016 USA; [Weiss, Daniel J.] Univ Vermont, Coll Med, Vermont Lung Ctr, Burlington, VT 05405 USA; [Green, Michael D.; Snoeck, Hans-Willem] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Longmire, Tyler A.; Ikonomou, Laertis; Hawkins, Finn; Christodoulou, Constantina; Cao, Yuxia; Jean, J. C.; Kwok, Letty W.; Dowton, Anne A.; Serra, Maria; Ramirez, Maria I.; Kotton, Darrell N.] Boston Med Ctr, Boston, MA 02118 USA	Boston University; Boston University; Boston University; Boston University; Harvard University; Massachusetts General Hospital; New York University; New York University; New York University; University of Vermont; Icahn School of Medicine at Mount Sinai; Boston Medical Center	Kotton, DN (corresponding author), Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA.	dkotton@bu.edu	Serra, Maria/AAA-9222-2020; Ikonomou, Laertis/D-4579-2009	Ikonomou, Laertis/0000-0003-0993-6713; Longmire, Tyler/0000-0002-1621-1895; Kotton, Darrell/0000-0002-9604-8476; Shen, Steven/0000-0001-7725-1260; Serra, Maria/0000-0002-1559-250X; Hawkins, Finn/0000-0002-2246-6448; Cao, Yu-Xia/0000-0001-7396-9988; Ramirez, Maria Isabel/0000-0001-6294-4419; Green, Michael/0000-0003-4951-7118; Jean, Jyh-Chang/0000-0002-6569-5910; Christodoulou, Constantina/0000-0001-5371-2210	NIH [PO1 HL047049-16A1, 1RC2HL101535-01, 1R01 HL095993-01, 1R01 HL108678, T32 HL007035, R01 HL111574]; USAMRRA; Alpha-1 Foundation; ARC from Evans Center for Interdisciplinary Research at Boston University; ATS/ChILD Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095993, R01HL108678, R21HL109786, T32HL007035, R21HL108055, R01HL111574, RC2HL101535, P01HL047049] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USAMRRA; Alpha-1 Foundation; ARC from Evans Center for Interdisciplinary Research at Boston University; ATS/ChILD Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Paul Gadue for supplying the TV8-Puro gene targeting vector; Raul Mostoslavsky for assistance with Southern blotting techniques; Susan Guttentag for DCI+K media protocols; and Mary C. Williams, Wellington V. Cardoso, Bess P. Rosen, George Murphy, Gustavo Mostoslavsky, and Jerome Brody for insightful manuscript editing. For technical support, we thank Dr. Yuriy Alekseyev, Sherry Zang, and Dr. Gang Liu for microarray processing; Dr. Jining Lu and Avrum Spira for bioinformatics analysis assistance; and John M. Wallis for lung slice culture technical support. D.N.K. is supported by NIH PO1 HL047049-16A1, 1RC2HL101535-01, 1R01 HL095993-01, 1R01 HL108678, a USAMRRA Award, an Alpha-1 Foundation Award, and an ARC award from the Evans Center for Interdisciplinary Research at Boston University. T.A.L. is supported by NIH training grant T32 HL007035. L.I. is supported by R01 HL111574 and an ATS/ChILD Foundation Award. The authors have no conflicts of interest to declare.	Ali NN, 2002, TISSUE ENG, V8, P541, DOI 10.1089/107632702760240463; Ameri J, 2010, STEM CELLS, V28, P45, DOI 10.1002/stem.249; Arufe MC, 2006, ENDOCRINOLOGY, V147, P3007, DOI 10.1210/en.2005-1239; Arufe MC, 2009, BIOCHEM BIOPH RES CO, V381, P264, DOI 10.1016/j.bbrc.2009.02.035; Barbera JPM, 2000, DEVELOPMENT, V127, P2433; Cao YX, 2010, J BIOL CHEM, V285, P2152, DOI 10.1074/jbc.M109.039172; Cardoso W.V., 2008, STEMBOOK, DOI DOI 10.3824/STEM-BOOK.1.10.1; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Christodoulou C, 2011, J CLIN INVEST, V121, P2313, DOI 10.1172/JCI43853; Coraux C, 2005, AM J RESP CELL MOL, V32, P87, DOI 10.1165/rcmb.2004-0079RC; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Daly AB, 2012, TISSUE ENG PT A, V18, P1, DOI [10.1089/ten.tea.2011.0301, 10.1089/ten.TEA.2011.0301]; Domyan ET, 2011, DEVELOPMENT, V138, P971, DOI 10.1242/dev.053694; Gadue P, 2005, EXP HEMATOL, V33, P955, DOI 10.1016/j.exphem.2005.06.009; Gadue P, 2009, STEM CELLS, V27, P2103, DOI 10.1002/stem.147; GLASSER SW, 1991, AM J PHYSIOL, V261, pL349, DOI 10.1152/ajplung.1991.261.4.L349; Gonzales LW, 2002, AM J PHYSIOL-LUNG C, V283, pL940, DOI 10.1152/ajplung.00127.2002; Goss AM, 2009, DEV CELL, V17, P290, DOI 10.1016/j.devcel.2009.06.005; Goulburn AL, 2011, STEM CELLS, V29, P462, DOI 10.1002/stem.587; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Green MD, 2011, NAT BIOTECHNOL, V29, P267, DOI 10.1038/nbt.1788; Harris-Johnson KS, 2009, P NATL ACAD SCI USA, V106, P16287, DOI 10.1073/pnas.0902274106; Jiang NY, 2010, THYROID, V20, P77, DOI 10.1089/thy.2008.0291; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; Krude H, 2002, J CLIN INVEST, V109, P475, DOI 10.1172/JC1200214341; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Lu JN, 2005, J BIOL CHEM, V280, P4834, DOI 10.1074/jbc.M410714200; Ma RS, 2009, ENDOCRINOLOGY, V150, P1970, DOI 10.1210/en.2008-1374; Micallef SJ, 2005, DIABETES, V54, P301, DOI 10.2337/diabetes.54.2.301; Minoo P, 1999, DEV BIOL, V209, P60, DOI 10.1006/dbio.1999.9234; MONAGHAN AP, 1993, DEVELOPMENT, V119, P567; Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193; Perl AKT, 2005, GENESIS, V41, P23, DOI 10.1002/gene.20093; Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345; Qin M, 2005, STEM CELLS, V23, P712, DOI 10.1634/stemcells.2004-0195; Que JW, 2009, DEVELOPMENT, V136, P1899, DOI 10.1242/dev.034629; Ramasamy SK, 2007, DEV BIOL, V307, P237, DOI 10.1016/j.ydbio.2007.04.033; Rawlins EL, 2009, DEVELOPMENT, V136, P3741, DOI 10.1242/dev.037317; Rippon HJ, 2006, STEM CELLS, V24, P1389, DOI 10.1634/stemcells.2005-0465; Rippon HJ, 2004, CLONING STEM CELLS, V6, P49, DOI 10.1089/1536230041372328; Roszell B, 2009, TISSUE ENG PT A, V15, P3351, DOI 10.1089/ten.TEA.2008.0664; Samadikuchaksaraei A, 2006, TISSUE ENG, V12, P867, DOI 10.1089/ten.2006.12.867; Serls AE, 2005, DEVELOPMENT, V132, P35, DOI 10.1242/dev.01570; Sherwood RI, 2009, DEV DYNAM, V238, P29, DOI 10.1002/dvdy.21810; Smith JR, 2008, DEV BIOL, V313, P107, DOI 10.1016/j.ydbio.2007.10.003; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Tagne JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029907; Tiso N, 2002, MECH DEVELOP, V118, P29, DOI 10.1016/S0925-4773(02)00252-6; van Vranken BE, 2005, TISSUE ENG, V11, P1177; Wallis JM, 2012, TISSUE ENG PART C-ME, V18, P420, DOI [10.1089/ten.tec.2011.0567, 10.1089/ten.TEC.2011.0567]; Wang D, 2007, P NATL ACAD SCI USA, V104, P4449, DOI 10.1073/pnas.0700052104; Williams MC, 2003, ANNU REV PHYSIOL, V65, P669, DOI 10.1146/annurev.physiol.65.092101.142446; Winkler ME, 2008, CLONING STEM CELLS, V10, P49, DOI 10.1089/clo.2007.0075; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zaret KS, 2008, COLD SH Q B, V73, P119, DOI 10.1101/sqb.2008.73.040	57	255	277	2	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 6	2012	10	4					398	411		10.1016/j.stem.2012.01.019	http://dx.doi.org/10.1016/j.stem.2012.01.019			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	929QA	22482505	Green Accepted, Bronze			2022-12-28	WOS:000303079400009
J	Miharada, K; Karlsson, S				Miharada, Kenichi; Karlsson, Stefan			Common Signaling Networks Characterize Leukemia-Initiating Cells in Acute Myeloid Leukemia	CELL STEM CELL			English	Editorial Material							STEM-CELLS		[Miharada, Kenichi; Karlsson, Stefan] Univ Lund Hosp, Lund Stem Cell Ctr, S-22184 Lund, Sweden	Lund University; Skane University Hospital	Karlsson, S (corresponding author), Univ Lund Hosp, Lund Stem Cell Ctr, BMC A12, S-22184 Lund, Sweden.	stefan.karlsson@med.lu.se	Miharada, Kenichi/C-1397-2014	Miharada, Kenichi/0000-0001-8073-4001				Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Dick JE, 2009, NAT BIOTECHNOL, V27, P44, DOI 10.1038/nbt0109-44; Gibbs KD, 2012, CELL STEM CELL, V10, P210, DOI 10.1016/j.stem.2012.01.004; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Quere R, 2011, LEUKEMIA, V25, P515, DOI 10.1038/leu.2010.281; Sarry JE, 2011, J CLIN INVEST, V121, P384, DOI 10.1172/JCI41495	8	1	1	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	FEB 3	2012	10	2					109	110		10.1016/j.stem.2012.01.008	http://dx.doi.org/10.1016/j.stem.2012.01.008			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	892FM	22305558	Bronze			2022-12-28	WOS:000300272100003
J	Hyun, I				Hyun, Insoo			Moving Human SCNT Research Forward Ethically	CELL STEM CELL			English	Editorial Material							PAYMENT		Case Western Reserve Univ, Sch Med, Dept Bioeth, Cleveland, OH 44106 USA	Case Western Reserve University	Hyun, I (corresponding author), Case Western Reserve Univ, Sch Med, Dept Bioeth, Cleveland, OH 44106 USA.	insoo.hyun@case.edu						Barrilleaux B, 2011, CELL STEM CELL, V9, P103, DOI 10.1016/j.stem.2011.07.006; Crockin SL, 2010, CELL STEM CELL, V6, P99, DOI 10.1016/j.stem.2010.01.010; Daley GQ, 2007, SCIENCE, V315, P603, DOI 10.1126/science.1139337; Egli D, 2007, NATURE, V447, P679, DOI 10.1038/nature05879; Egli D, 2011, CELL STEM CELL, V9, P293, DOI 10.1016/j.stem.2011.08.002; Hyun I, 2006, NATURE, V442, P629, DOI 10.1038/442629a; *ISSCR, 2006, GUID COND HUM EMBR S; Jullien J, 2011, NAT REV MOL CELL BIO, V12, P453, DOI 10.1038/nrm3140; Klitzman R, 2009, REPROD BIOMED ONLINE, V18, P603, DOI 10.1016/S1472-6483(10)60002-8; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Marshall LA, 1999, TOWARDS REPRODUCTIVE CERTAINTY, P141; Noggle S., 2011, NATURE IN PRESS, DOI DOI 10.1038/NATURE10397	12	18	18	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 7	2011	9	4					295	297		10.1016/j.stem.2011.08.001	http://dx.doi.org/10.1016/j.stem.2011.08.001			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	835MT	21982229	Bronze			2022-12-28	WOS:000296041200007
J	Marro, S; Pang, ZPP; Yang, N; Tsai, MC; Qu, K; Chang, HY; Sudhof, TC; Wernig, M				Marro, Samuele; Pang, Zhiping P.; Yang, Nan; Tsai, Miao-Chih; Qu, Kun; Chang, Howard Y.; Suedhof, Thomas C.; Wernig, Marius			Direct Lineage Conversion of Terminally Differentiated Hepatocytes to Functional Neurons	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; HUMAN FIBROBLASTS; TRANSCRIPTION FACTORS; DOPAMINERGIC-NEURONS; EPIGENETIC MEMORY; MOUSE HEPATOCYTES; GENE-EXPRESSION; CRE RECOMBINASE; BETA-CELLS; LIVER	Several recent studies have showed that mouse and human fibroblasts can be directly reprogrammed into induced neuronal (iN) cells, bypassing a pluripotent intermediate state. However, fibroblasts represent heterogeneous mesenchymal progenitor cells that potentially contain neural crest lineages, and the cell of origin remained undefined. This raises the fundamental question of whether lineage reprogramming is possible between cell types derived from different germ layers. Here, we demonstrate that terminally differentiated hepatocytes can be directly converted into functional iN cells. Importantly, single-cell and genome-wide expression analyses showed that fibroblast- and hepatocyte-derived iN cells not only induced a neuronal transcriptional program, but also silenced their donor transcriptome. The remaining donor signature decreased over time and could not support functional hepatocyte properties. Thus, the reprogramming factors lead to a binary lineage switch decision rather than an induction of hybrid phenotypes, but iN cells retain a small but detectable epigenetic memory of their donor cells.	[Marro, Samuele; Yang, Nan; Wernig, Marius] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Marro, Samuele; Yang, Nan; Wernig, Marius] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Pang, Zhiping P.; Suedhof, Thomas C.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Chang, Howard Y.; Suedhof, Thomas C.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Tsai, Miao-Chih; Qu, Kun; Chang, Howard Y.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Wernig, M (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, 265 Campus Dr, Stanford, CA 94305 USA.	wernig@stanford.edu	Qu, Kun/G-3359-2012; Yang, Nan/H-3174-2012; Marro, Samuele G./I-4493-2014; Pang, Zhiping/AAF-5757-2020	Marro, Samuele G./0000-0002-9326-6945; Pang, Zhiping/0000-0002-6183-1233; Tsai, Miao-Chih/0000-0003-4471-4825; Yang, Nan/0000-0003-3663-1288	Stanford School of Medicine; NARSAD; Stinehart-Reed Foundation; Ellison Medical Foundation; Howard Hughes Medical Institute; NIH [RC4NS073015-01, R01MH092931-01]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC4NS073015] Funding Source: NIH RePORTER	Stanford School of Medicine; NARSAD(NARSAD); Stinehart-Reed Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank T. Vierbuchen for providing MEF cultures, TTF cultures, NPC cultures, and critical comments on the manuscript; A. Lanctot for help with mouse genotyping; P. Lovelace for support with FACS; and C. Kuo and I. Graef for mice. M.W. is a New York Stem Cell Foundation-Robertson Investigator. In addition, this work was supported by the Dean's Postdoctoral Fellowship at the Stanford School of Medicine (S.M.), a NARSAD Young Investigator Award (Z.P.P.), the Stinehart-Reed Foundation, (MW.) the Ellison Medical Foundation (MW.), the Howard Hughes Medical Institute (H.Y.C. and T.C.S.), and the NIH grants RC4NS073015-01 (MW. and H.Y.C.) and R01MH092931-01 (MW. and T.C.S.).	Ambasudhan R, 2011, CELL STEM CELL, V9, P113, DOI 10.1016/j.stem.2011.07.002; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Braeuning A, 2006, FEBS J, V273, P5051, DOI 10.1111/j.1742-4658.2006.05503.x; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Horb ME, 2003, CURR BIOL, V13, P105, DOI 10.1016/S0960-9822(02)01434-3; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Li WC, 2007, INT J BIOCHEM CELL B, V39, P541, DOI 10.1016/j.biocel.2006.10.017; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Maximov A, 2007, J NEUROSCI METH, V161, P75, DOI 10.1016/j.jneumeth.2006.10.009; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Qiang L, 2011, CELL, V146, P359, DOI 10.1016/j.cell.2011.07.007; Sapir T, 2005, P NATL ACAD SCI USA, V102, P7964, DOI 10.1073/pnas.0405277102; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Weisend CM, 2009, GENESIS, V47, P789, DOI 10.1002/dvg.20568; Wernig M, 2002, J NEUROSCI RES, V69, P918, DOI 10.1002/jnr.10395; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Zhao R, 2005, HEPATOLOGY, V41, P956, DOI 10.1002/hep.20691; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	25	247	264	0	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	OCT 7	2011	9	4					374	382		10.1016/j.stem.2011.09.002	http://dx.doi.org/10.1016/j.stem.2011.09.002			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	835MT	21962918	Green Accepted, Bronze			2022-12-28	WOS:000296041200015
J	Suda, T; Takubo, K; Semenza, GL				Suda, Toshio; Takubo, Keiyo; Semenza, Gregg L.			Metabolic Regulation of Hematopoietic Stem Cells in the Hypoxic Niche	CELL STEM CELL			English	Review							SCID-REPOPULATING CELLS; DNA-DAMAGE RESPONSE; BONE-MARROW; OXIDATIVE STRESS; PYRUVATE-KINASE; SELF-RENEWAL; GLUTATHIONE-PEROXIDASE; CELLULAR SENESCENCE; HEME OXYGENASE-1; LIFE-SPAN	Tissue homeostasis over the life of an organism relies on both self-renewal and multipotent differentiation of stem cells. Hematopoietic stem cells(HSCs) reside in a hypoxic bone marrow environment, and their metabolic status is distinct from that of their differentiated progeny. HSCs generate energy mainly via anaerobic metabolism by maintaining a high rate of glycolysis. This metabolic balance promotes HSC maintenance by limiting the production of reactive oxygen species, but leaves HSCs susceptible to changes in redox status. In this review, we discuss the importance of oxygen homeostasis and energy metabolism for maintenance of HSC function and long-term self-renewal.	[Suda, Toshio; Takubo, Keiyo] Keio Univ, Sch Med, Sakaguchi Lab Dev Biol, Dept Cell Differentiat,Shinjuku Ku, Tokyo 1608582, Japan; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Vasc Program, Baltimore, MD 21205 USA	Keio University; Johns Hopkins University	Suda, T (corresponding author), Keio Univ, Sch Med, Sakaguchi Lab Dev Biol, Dept Cell Differentiat,Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	sudato@sc.itc.keio.ac.jp	Takubo, Keiyo/AAX-5546-2020; Suda, Toshio/H-6761-2013	Takubo, Keiyo/0000-0002-1736-7592; Suda, Toshio/0000-0001-7540-1771	Grants-in-Aid for Scientific Research [22130004] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Abbas HA, 2010, CELL STEM CELL, V7, P606, DOI 10.1016/j.stem.2010.09.013; Abo M, 2011, J AM CHEM SOC, V133, P10629, DOI 10.1021/ja203521e; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Bakker WJ, 2007, MOL CELL, V28, P941, DOI 10.1016/j.molcel.2007.10.035; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Blanpain C, 2011, CELL STEM CELL, V8, P16, DOI 10.1016/j.stem.2010.12.012; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Cao YA, 2008, BLOOD, V112, P4494, DOI 10.1182/blood-2007-12-127621; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005-0116; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Chen ZX, 2007, CELL DEATH DIFFER, V14, P1617, DOI 10.1038/sj.cdd.4402165; Chow DC, 2001, BIOPHYS J, V81, P685, DOI 10.1016/S0006-3495(01)75733-5; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Cimmino L, 2011, CELL STEM CELL, V9, P193, DOI 10.1016/j.stem.2011.08.007; CIPOLLESCHI MG, 1993, BLOOD, V82, P2031; COHEN G, 1963, BIOCHEMISTRY-US, V2, P1420, DOI 10.1021/bi00906a038; Danet GH, 2003, J CLIN INVEST, V112, P126, DOI 10.1172/JCI200317669; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; DRAENERT K, 1980, Scanning Electron Microscopy, P113; EAGLE H, 1955, SCIENCE, V122, P501, DOI 10.1126/science.122.3168.501; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Eliasson P, 2010, EXP HEMATOL, V38, P301, DOI 10.1016/j.exphem.2010.01.005; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Fuchs E, 2011, NAT CELL BIOL, V13, P513, DOI 10.1038/ncb0511-513; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595; Gan B, 2008, P NATL ACAD SCI USA, V105, P19384, DOI 10.1073/pnas.0810584105; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572; Hafsi H, 2011, ANTIOXID REDOX SIGN, V15, P1655, DOI 10.1089/ars.2010.3771; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Harrison JS, 2002, BLOOD, V99, P394, DOI 10.1182/blood.V99.1.394; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hermitte F, 2006, STEM CELLS, V24, P65, DOI 10.1634/stemcells.2004-0351; Hochmuth CE, 2011, CELL STEM CELL, V8, P188, DOI 10.1016/j.stem.2010.12.006; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Iriuchishima H, 2011, BLOOD, V117, P2373, DOI 10.1182/blood-2010-07-294801; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Ivanovic Z, 2004, STEM CELLS, V22, P716, DOI 10.1634/stemcells.22-5-716; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Juntilla MM, 2010, BLOOD, V115, P4030, DOI 10.1182/blood-2009-09-241000; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kharas MG, 2010, BLOOD, V115, P1406, DOI 10.1182/blood-2009-06-229443; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kranc KR, 2009, CELL STEM CELL, V5, P659, DOI 10.1016/j.stem.2009.11.001; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398; Laurenti E, 2009, CURR OPIN CELL BIOL, V21, P844, DOI 10.1016/j.ceb.2009.09.006; Lee JY, 2010, CELL STEM CELL, V7, P593, DOI 10.1016/j.stem.2010.09.015; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Lewandowski D, 2010, BLOOD, V115, P443, DOI 10.1182/blood-2009-05-222711; Li TS, 2010, STEM CELLS, V28, P1178, DOI 10.1002/stem.438; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Marinkovic D, 2007, J CLIN INVEST, V117, P2133, DOI 10.1172/JCI31807; Matsuoka S, 2008, GENE DEV, V22, P986, DOI 10.1101/gad.1621808; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; MICHIELS C, 1994, FREE RADICAL BIO MED, V17, P235, DOI 10.1016/0891-5849(94)90079-5; Miharada K, 2011, CELL STEM CELL, V9, P330, DOI 10.1016/j.stem.2011.07.016; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Mogi M, 2003, J BIOL CHEM, V278, P39068, DOI 10.1074/jbc.M306362200; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145; Muller M, 2009, ANTIOXID REDOX SIGN, V11, P59, DOI 10.1089/ars.2008.2104; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Nam EA, 2011, BIOCHEM J, V436, P527, DOI 10.1042/BJ20102162; Nitta E, 2011, BLOOD, V117, P4169, DOI 10.1182/blood-2010-08-297390; NOGUCHI T, 1986, J BIOL CHEM, V261, P3807; Oguro H, 2006, J EXP MED, V203, P2247, DOI 10.1084/jem.20052477; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pervaiz S, 2009, ANTIOXID REDOX SIGN, V11, P2777, DOI 10.1089/ars.2009.2804; Reavie L, 2010, NAT IMMUNOL, V11, P207, DOI 10.1038/ni.1839; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Semenza GL, 2010, WIRES SYST BIOL MED, V2, P336, DOI 10.1002/wsbm.69; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shanware NP, 2011, J MOL MED, V89, P229, DOI 10.1007/s00109-011-0731-9; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shima H, 2010, EXP HEMATOL, V38, P1231, DOI 10.1016/j.exphem.2010.08.004; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Snippert HJ, 2011, EMBO REP, V12, P113, DOI 10.1038/embor.2010.216; Storz P, 2011, ANTIOXID REDOX SIGN, V14, P593, DOI 10.1089/ars.2010.3405; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Takizawa H, 2011, J EXP MED, V208, P273, DOI 10.1084/jem.20101643; Takubo K, 2008, CELL STEM CELL, V2, P170, DOI 10.1016/j.stem.2007.10.023; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tsai WB, 2008, NAT CELL BIOL, V10, P460, DOI 10.1038/ncb1709; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; van der Velden YU, 2011, P NATL ACAD SCI USA, V108, P4358, DOI 10.1073/pnas.1010210108; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Was H, 2010, CURR DRUG TARGETS, V11, P1551, DOI 10.2174/1389450111009011551; Wheaton WW, 2011, AM J PHYSIOL-CELL PH, V300, pC385, DOI 10.1152/ajpcell.00485.2010; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Yamazaki S, 2006, EMBO J, V25, P3515, DOI 10.1038/sj.emboj.7601236; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhang J, 2009, BLOOD, V114, P157, DOI 10.1182/blood-2008-04-151639; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	139	540	559	3	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 7	2011	9	4					298	310		10.1016/j.stem.2011.09.010	http://dx.doi.org/10.1016/j.stem.2011.09.010			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	835MT	21982230	Bronze			2022-12-28	WOS:000296041200008
J	Becker, MW; Jordan, CT				Becker, Michael W.; Jordan, Craig T.			Leukemia Sternness Signatures Step toward the Clinic	CELL STEM CELL			English	Editorial Material							ACUTE MYELOID-LEUKEMIA; CELLS		[Becker, Michael W.; Jordan, Craig T.] Univ Rochester, James P Wilmot Canc Ctr, Rochester, NY 14642 USA	University of Rochester	Jordan, CT (corresponding author), Univ Rochester, James P Wilmot Canc Ctr, 601 Elmwood Ave,Box 704, Rochester, NY 14642 USA.	craig_jordan@urmc.rochester.edu	; jordan, craig/D-7666-2014	Becker, Michael/0000-0001-9890-8815; jordan, craig/0000-0003-0869-3465				Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Gentles AJ, 2010, JAMA-J AM MED ASSOC, V304, P2706, DOI 10.1001/jama.2010.1862; Jordan CT, 2004, ONCOGENE, V23, P7178, DOI 10.1038/sj.onc.1207935; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Majetl R, 2009, P NATL ACAD SCI USA, V106, P3396, DOI 10.1073/pnas.0900089106; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Sarry JE, 2011, J CLIN INVEST, V121, P384, DOI 10.1172/JCI41495; Taussig DC, 2010, BLOOD, V115, P1976, DOI 10.1182/blood-2009-02-206565; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038	10	8	8	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	SEP 2	2011	9	3					185	186		10.1016/j.stem.2011.08.006	http://dx.doi.org/10.1016/j.stem.2011.08.006			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	822DN	21885015	Bronze			2022-12-28	WOS:000295024200005
J	Tesio, M; Trumpp, A				Tesio, Melania; Trumpp, Andreas			Breaking the Cell Cycle of HSCs by p57 and Friends	CELL STEM CELL			English	Review							HEMATOPOIETIC STEM-CELLS; SELF-RENEWAL; CDK INHIBITORS; LIMITED ROLE; IN-VIVO; NICHE; PROLIFERATION; DIFFERENTIATION; P21(CIP1/WAF1); HIBERNATION	The cell cycle regulators involved in maintaining the quiescence, and thereby the self-renewal capacity, of somatic stem cells have long been elusive. Two new Cell Stem Cell articles in this issue (Matsumoto et al., 2011; Zou et al., 2011) now show that the CDK inhibitor p57 is a crucial brake for cycling HSCs, and links self-renewal activity to cell cycle quiescence.	[Tesio, Melania; Trumpp, Andreas] Deutsch Krebsforschungszentrum DKFZ, D-69120 Heidelberg, Germany; [Trumpp, Andreas] Heidelberg Inst Stem Cell Technol & Expt Med HI S, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Trumpp, A (corresponding author), Deutsch Krebsforschungszentrum DKFZ, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	a.trumpp@dkfz.de	Trumpp, Andreas/Z-2141-2019	Trumpp, Andreas/0000-0002-6212-3466; TESIO, Melania/0000-0001-9291-0797	Haematosys Program; German Bundesministerium fur Bildung und Forschung (BMBF); EU; Deutsche Forschungsgemeinschaft (DFG) [SFB 873]; Dietmar Hopp Foundation	Haematosys Program; German Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); EU(European Commission); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Dietmar Hopp Foundation	The authors would like to thank Drs. Irene Baccelli, Nina Cabezas, and Anne Wilson for comments on the manuscript. This work was supported by the Haematosys Program funded by the German Bundesministerium fur Bildung und Forschung (BMBF), the EU-FP7 Program "EuroSyStem," the SFB 873 funded by the Deutsche Forschungsgemeinschaft (DFG), and the Dietmar Hopp Foundation.	Besson A, 2004, NAT REV CANCER, V4, P948, DOI 10.1038/nrc1501; Cheng T, 2000, NAT MED, V6, P1235, DOI 10.1038/81335; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; Ehninger A, 2011, J EXP MED, V208, P421, DOI 10.1084/jem.20110132; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Jose-Eneriz ES, 2008, BRIT J HAEMATOL, V142, P571, DOI 10.1111/j.1365-2141.2008.07221.x; King KY, 2011, BLOOD, V118, P1525, DOI 10.1182/blood-2011-01-328682; Matsumoto A, 2011, CELL STEM CELL, V9, P262, DOI 10.1016/j.stem.2011.06.014; McKenzie JL, 2006, NAT IMMUNOL, V7, P1225, DOI 10.1038/ni1393; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Pateras IS, 2009, MOL CANCER RES, V7, P1902, DOI 10.1158/1541-7786.MCR-09-0317; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Stepanova L, 2005, BLOOD, V106, P827, DOI 10.1182/blood-2004-06-2242; Takizawa H, 2011, J EXP MED, V208, P273, DOI 10.1084/jem.20101643; Van Os R, 2007, STEM CELLS, V25, P836, DOI 10.1634/stemcells.2006-0631; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Walkley CR, 2005, NAT CELL BIOL, V7, P172, DOI 10.1038/ncb1214; Wilson A, 2009, CURR OPIN GENET DEV, V19, P461, DOI 10.1016/j.gde.2009.08.005; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yamazaki S, 2006, EMBO J, V25, P3515, DOI 10.1038/sj.emboj.7601236; Yamazaki S, 2009, BLOOD, V113, P1250, DOI 10.1182/blood-2008-04-146480; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Yu H, 2006, BLOOD, V107, P1200, DOI 10.1182/blood-2005-02-0685; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0; Zou P, 2011, CELL STEM CELL, V9, P247, DOI 10.1016/j.stem.2011.07.003	30	44	46	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	SEP 2	2011	9	3					187	192		10.1016/j.stem.2011.08.005	http://dx.doi.org/10.1016/j.stem.2011.08.005			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	822DN	21885016	Bronze			2022-12-28	WOS:000295024200006
J	Bernardo, AS; Faial, T; Gardner, L; Niakan, KK; Ortmann, D; Senner, CE; Callery, EM; Trotter, MW; Hemberger, M; Smith, JC; Bardwell, L; Moffett, A; Pedersen, RA				Bernardo, Andreia S.; Faial, Tiago; Gardner, Lucy; Niakan, Kathy K.; Ortmann, Daniel; Senner, Claire E.; Callery, Elizabeth M.; Trotter, Matthew W.; Hemberger, Myriam; Smith, James C.; Bardwell, Lee; Moffett, Ashley; Pedersen, Roger A.			BRACHYURY and CDX2 Mediate BMP-Induced Differentiation of Human and Mouse Pluripotent Stem Cells into Embryonic and Extraembryonic Lineages	CELL STEM CELL			English	Article							PRIMITIVE STREAK; MORPHOGENETIC MOVEMENT; TARGETED DISRUPTION; DEFINITIVE ENDODERM; HUMAN-PLACENTA; GERM LAYER; FATE; TROPHOBLAST; MESODERM; EXPRESSION	BMP is thought to induce hESC differentiation toward multiple lineages including mesoderm and trophoblast. The BMP-induced trophoblast phenotype is a long-standing paradox in stem cell biology. Here we readdressed BMP function in hESCs and mouse epiblast-derived cells. We found that BMP4 cooperates with FGF2 (via ERK) to induce mesoderm and to inhibit endoderm differentiation. These conditions induced cells with high levels of BRACHYURY (BRA) that coexpressed CDX2. BRA was necessary for and preceded CDX2 expression; both genes were essential for expression not only of mesodermal genes but also of trophoblast-associated genes. Maximal expression of the latter was seen in the absence of FGF but these cells coexpressed mesodermal genes and moreover they differed in cell surface and epigenetic properties from placental trophoblast. We conclude that BMP induces human and mouse pluripotent stem cells primarily to form mesoderm, rather than trophoblast, acting through BRA and CDX2.	[Bernardo, Andreia S.; Faial, Tiago; Niakan, Kathy K.; Ortmann, Daniel; Callery, Elizabeth M.; Trotter, Matthew W.; Pedersen, Roger A.] Univ Cambridge, Anne McLaren Lab Regenerat Med, Cambridge CB2 0SZ, England; [Gardner, Lucy; Moffett, Ashley] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Senner, Claire E.; Hemberger, Myriam] Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB22 3AT, England; [Faial, Tiago; Callery, Elizabeth M.; Smith, James C.] MRC Natl Inst Med Res, London NW7 1AA, England; [Bardwell, Lee] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Gardner, Lucy; Niakan, Kathy K.; Senner, Claire E.; Hemberger, Myriam; Moffett, Ashley; Pedersen, Roger A.] Univ Cambridge, Ctr Trophoblast Res, Cambridge CB2 3EG, England; [Faial, Tiago] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Niakan, Kathy K.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Bernardo, Andreia S.; Ortmann, Daniel; Trotter, Matthew W.; Pedersen, Roger A.] Univ Cambridge, Dept Surg, Cambridge CB2 0QQ, England	University of Cambridge; University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; MRC National Institute for Medical Research; University of California System; University of California Irvine; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge	Bernardo, AS (corresponding author), Univ Cambridge, Anne McLaren Lab Regenerat Med, Cambridge CB2 0SZ, England.	asb63@cam.ac.uk; ralp2@cam.ac.uk	Bardwell, Lee/I-8284-2019; Moffett, Ashley/J-9754-2013	Bardwell, Lee/0000-0002-2393-8363; Faial, Tiago/0000-0003-0864-1200; Bernardo, Andreia Sofia/0000-0002-5355-6657; Trotter, Matthew/0000-0003-3702-915X; Niakan, Kathy/0000-0003-1646-4734; Senner, Claire/0000-0001-5237-3165; Smith, Jim/0000-0003-2413-9392; Hemberger, Myriam/0000-0003-3332-6958	EU [HEALTH-F4-2009-223485/PluriSys]; MRC; Evelyn Trust; Cambridge Hospitals National Institute for Health Research Biomedical Research Centre; Fundacao para a Ciencia e a Tecnologia, Portugal; British Heart Foundation; Centre for Trophoblast Research; Welcome Trust; British Heart Foundation [FS/10/022/28262] Funding Source: researchfish; Medical Research Council [G0600275, G0800784, G0800784B, MC_U117597140, G1000847] Funding Source: researchfish; MRC [G0600275, G1000847, MC_U117597140, G0800784] Funding Source: UKRI	EU(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Evelyn Trust; Cambridge Hospitals National Institute for Health Research Biomedical Research Centre; Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); British Heart Foundation(British Heart Foundation); Centre for Trophoblast Research; Welcome Trust(Wellcome Trust); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Gabrielle Brons for supporting EpiSC and epiblast culture; Morgan Alexander for assisting with hESC culture; Nigel Miller for performing the flow sorts; Andrew Sharkey for discussions; Jamie Trott for validating KRT7 staining; R&D Systems for the SOX17-APC antibody; Doug Melton for the HuES9 cell line; and members of the Pedersen laboratory for comments. This work was supported by EU FP7 grant HEALTH-F4-2009-223485/PluriSys (mouse work only), MRC Programme grant, The Evelyn Trust, and Cambridge Hospitals National Institute for Health Research Biomedical Research Centre funding (RAP.); Fundacao para a Ciencia e a Tecnologia, Portugal (T.F.); British Heart Foundation (DO.); Centre for Trophoblast Research (K.K.N.); and Welcome Trust (J.C.S.).	Apps R, 2011, PLACENTA, V32, P33, DOI 10.1016/j.placenta.2010.10.010; Apps R, 2009, IMMUNOLOGY, V127, P26, DOI 10.1111/j.1365-2567.2008.03019.x; BECK F, 1995, DEV DYNAM, V204, P219, DOI 10.1002/aja.1002040302; BEDDINGTON RSP, 1992, DEVELOPMENT, P157; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Burtscher I, 2009, DEVELOPMENT, V136, P1029, DOI 10.1242/dev.028415; Chawengsaksophak K, 2004, P NATL ACAD SCI USA, V101, P7641, DOI 10.1073/pnas.0401654101; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Goldman DC, 2009, BLOOD, V114, P4393, DOI 10.1182/blood-2009-02-206433; GURTNER GC, 1995, GENE DEV, V9, P1, DOI 10.1101/gad.9.1.1; Hayashi Y, 2010, IN VITRO CELL DEV-AN, V46, P416, DOI 10.1007/s11626-009-9266-6; He SY, 2008, STEM CELLS, V26, P842, DOI 10.1634/stemcells.2007-0356; Hemberger M, 2010, HUM MOL GENET, V19, P2456, DOI 10.1093/hmg/ddq128; Inman KE, 2006, GENE EXPR PATTERNS, V6, P783, DOI 10.1016/j.modgep.2006.01.010; Kwon GS, 2008, DEV CELL, V15, P509, DOI 10.1016/j.devcel.2008.07.017; LAWSON KA, 1991, DEVELOPMENT, V113, P891; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Naiche LA, 2003, DEVELOPMENT, V130, P2681, DOI 10.1242/dev.00504; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; PARAMESWARAN M, 1995, DEV GENET, V17, P16, DOI 10.1002/dvg.1020170104; Ralston A, 2008, DEV BIOL, V313, P614, DOI 10.1016/j.ydbio.2007.10.054; Rivera-Perez JA, 2005, DEV BIOL, V288, P363, DOI 10.1016/j.ydbio.2005.09.012; Roper S, 2009, CELL CYCLE, V8, P1515, DOI 10.4161/cc.8.10.8381; Rossant J, 2008, CELL, V132, P527, DOI 10.1016/j.cell.2008.01.039; Savory JGA, 2009, DEVELOPMENT, V136, P4099, DOI 10.1242/dev.041582; Schenke-Layland K, 2007, STEM CELLS, V25, P1529, DOI 10.1634/stemcells.2006-0729; Schneider MD, 2003, CYTOKINE GROWTH F R, V14, P1, DOI 10.1016/S1359-6101(02)00053-9; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; SINGER KH, 1989, J INVEST DERMATOL, V92, P166, DOI 10.1111/1523-1747.ep12276685; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; Tarkowski AK, 2010, DEV BIOL, V348, P190, DOI 10.1016/j.ydbio.2010.09.022; TAVARE JM, 1989, CELL SIGNAL, V1, P55, DOI 10.1016/0898-6568(89)90020-X; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; Wiles MV, 1999, EXP CELL RES, V247, P241, DOI 10.1006/excr.1998.4353; Wilson V, 1997, DEV BIOL, V192, P45, DOI 10.1006/dbio.1997.8701; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Wu Z, 2008, J BIOL CHEM, V283, P24991, DOI 10.1074/jbc.M803893200; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; YAMAGUCHI TP, 1993, DEVELOPMENT, V118, P489; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yook JY, 2011, STEM CELLS DEV, V20, P1479, DOI 10.1089/scd.2010.0392; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001; Zhang PB, 2008, BLOOD, V111, P1933, DOI 10.1182/blood-2007-02-074120	49	243	251	1	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	AUG 5	2011	9	2					144	155		10.1016/j.stem.2011.06.015	http://dx.doi.org/10.1016/j.stem.2011.06.015			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	808PM	21816365	Green Published, hybrid			2022-12-28	WOS:000293990900011
J	Kim, H; Lee, G; Ganat, Y; Papapetrou, EP; Lipchina, I; Socci, ND; Sadelain, M; Studer, L				Kim, Hyesoo; Lee, Gabsang; Ganat, Yosif; Papapetrou, Eirini P.; Lipchina, Inna; Socci, Nicholas D.; Sadelain, Michel; Studer, Lorenz			miR-371-3 Expression Predicts Neural Differentiation Propensity in Human Pluripotent Stem Cells	CELL STEM CELL			English	Article							DOPAMINE NEURONS; SELF-RENEWAL; PARKINSONS-DISEASE; DERIVATION; EPIBLAST; LINES; INHIBITION; INDUCTION; CULTURE; SINGLE	The use of pluripotent stem cells in regenerative medicine and disease modeling is complicated by the variation in differentiation properties between lines. In this study, we characterized 13 human embryonic stem cell (hESC) and 26 human induced pluripotent stem cell (hiPSC) lines to identify markers that predict neural differentiation behavior. At a general level, markers previously known to distinguish mouse ESCs from epiblast stem cells (EPI-SCs) correlated with neural differentiation behavior. More specifically, quantitative analysis of miR-371-3 expression prospectively identified hESC and hiPSC lines with differential neurogenic differentiation propensity and in vivo dopamine neuron engraftment potential. Transient KLF4 transduction increased miR-371-3 expression and altered neurogenic behavior and pluripotency marker expression. Conversely, suppression of miR-371-3 expression in KLF4-transduced cells rescued neural differentiation propensity. miR-371-3 expression level therefore appears to have both a predictive and a functional role in determining human pluripotent stem cell neurogenic differentiation behavior.	[Kim, Hyesoo; Lee, Gabsang; Ganat, Yosif; Lipchina, Inna; Studer, Lorenz] Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA; [Papapetrou, Eirini P.; Sadelain, Michel; Studer, Lorenz] Sloan Kettering Inst, Ctr Cell Engn, New York, NY 10065 USA; [Socci, Nicholas D.] Sloan Kettering Inst, Computat Biol Ctr, New York, NY 10065 USA; [Sadelain, Michel] Sloan Kettering Inst, Mol Pharmacol & Chem Program, New York, NY 10065 USA; [Studer, Lorenz] Sloan Kettering Inst, Dept Neurosurg, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Studer, L (corresponding author), Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA.	studerl@mskcc.org	Pillay, Nischalan/F-9536-2012; Studer, Lorenz/ABH-1491-2021	Studer, Lorenz/0000-0003-0741-7987	Kinetics Foundation; Starr Foundation; NYSTEM; European Commission; NYSCF	Kinetics Foundation; Starr Foundation; NYSTEM; European Commission(European CommissionEuropean Commission Joint Research Centre); NYSCF	We would like to thank J. Hendrikx (SKI Flow Cytometry Core lab), A. Viale (SKI Genomics Core lab), and M. Leversha (Molecular Cytogenetics core) for excellent technical support. We also thank M. Tomishima for critical review of the manuscript, P. Tesar for providing mouse EPI-SCs, and C. Rohena for help with teratoma data. The work was supported by grants from the Kinetics Foundation, the Starr Foundation, NYSTEM, and the European Commission project NeuroStemCell. G.L. was supported by a NYSCF, Druckenmiller fellowship.	Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Fasano CA, 2010, CELL STEM CELL, V6, P336, DOI 10.1016/j.stem.2010.03.001; Feng Q, 2010, STEM CELLS, V28, P704, DOI 10.1002/stem.321; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Kittappa R, 2007, PLOS BIOL, V5, P2875, DOI 10.1371/journal.pbio.0050325; Krutzfeldt J, 2007, NUCLEIC ACIDS RES, V35, P2885, DOI 10.1093/nar/gkm024; Lee G, 2010, NAT PROTOC, V5, P688, DOI 10.1038/nprot.2010.35; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Ono Y, 2007, DEVELOPMENT, V134, P3213, DOI 10.1242/dev.02879; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Papapetrou EP, 2011, NAT BIOTECHNOL, V29, P73, DOI 10.1038/nbt.1717; Papapetrou EP, 2010, STEM CELLS, V28, P287, DOI 10.1002/stem.257; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Sanchez-Pernaute R, 2008, BRAIN, V131, P2127, DOI 10.1093/brain/awn144; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stewart MH, 2006, NAT METHODS, V3, P807, DOI 10.1038/nmeth939; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Tavakoli T, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-44; Tchieu J, 2010, CELL STEM CELL, V7, P329, DOI 10.1016/j.stem.2010.06.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Ware CB, 2009, CELL STEM CELL, V4, P359, DOI 10.1016/j.stem.2009.03.001; Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107; Zhang KJ, 2010, DEVELOPMENT, V137, P2095, DOI 10.1242/dev.049494; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	35	103	110	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 3	2011	8	6					695	706		10.1016/j.stem.2011.04.002	http://dx.doi.org/10.1016/j.stem.2011.04.002			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	780HC	21624813	Bronze			2022-12-28	WOS:000291844100017
J	Sweet, DJ				Sweet, Deborah J.			The Value of Connections	CELL STEM CELL			English	Editorial Material																		Iscove N, 2011, CELL STEM CELL, V8, P250, DOI 10.1016/j.stem.2011.02.011; Luong MX, 2011, CELL STEM CELL, V8, P357, DOI 10.1016/j.stem.2011.03.002; Sweet DJ, 2010, CELL STEM CELL, V6, P493, DOI 10.1016/j.stem.2010.05.015; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012	4	0	0	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 3	2011	8	6					595	596		10.1016/j.stem.2011.05.015	http://dx.doi.org/10.1016/j.stem.2011.05.015			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	780HC	21624797	Bronze			2022-12-28	WOS:000291844100001
J	Wirth, E; Lebkowski, JS; Lebacqz, K				Wirth, Edward, III; Lebkowski, Jane S.; Lebacqz, Karen			Response to Frederic Bretzner et al. "Target Populations for First-In-Human Embryonic Stem Cell Research in Spinal Cord Injury"	CELL STEM CELL			English	Editorial Material								We address concerns raised in this issue by Bretzner et al. (2011) by explaining the rationale for including subjects with subacute, neurologically complete spinal cord injuries in the Phase 1 trial of GRNOPC1. We also present elements of the informed consent process that minimize the likelihood of therapeutic misconception.	[Wirth, Edward, III; Lebkowski, Jane S.] Geron Corp, Menlo Pk, CA 94025 USA; [Lebacqz, Karen] Pacific Sch Relig, Berkeley, CA 94709 USA	Geron Corporation	Wirth, E (corresponding author), Geron Corp, Menlo Pk, CA 94025 USA.	ewirth@geron.com						Bretzner F, 2011, CELL STEM CELL, V8, P468, DOI 10.1016/j.stem.2011.04.012; Burns AS, 2003, J NEUROTRAUM, V20, P477, DOI 10.1089/089771503765355540; GILBERT F, 2011, GERONS HESC TRIAL SP; Henderson GE, 2007, PLOS MED, V4, P1735, DOI 10.1371/journal.pmed.0040324; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005	5	26	26	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 6	2011	8	5					476	478		10.1016/j.stem.2011.04.008	http://dx.doi.org/10.1016/j.stem.2011.04.008			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	768IN	21549322	Bronze			2022-12-28	WOS:000290927600007
J	Ables, ET; Drummond-Barbosa, D				Ables, Elizabeth T.; Drummond-Barbosa, Daniela			Food For Thought: Neural Stem Cells on a Diet	CELL STEM CELL			English	Editorial Material							DROSOPHILA; INSULIN; GROWTH	Growing evidence shows that stem cells are modulated by systemic factors that are integrated with local signals in response to physiological status. Two recent Cell (Chell and Brand, 2010) and Nature (Sousa-Nunes et al., 2011) papers reveal that Drosophila neural stem cell proliferation is controlled by a diet-dependent insulin/TOR signaling relay between tissues.	[Ables, Elizabeth T.; Drummond-Barbosa, Daniela] Johns Hopkins Univ, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA; [Drummond-Barbosa, Daniela] Johns Hopkins Univ, Dept Environm Hlth Sci, Baltimore, MD 21205 USA; [Ables, Elizabeth T.; Drummond-Barbosa, Daniela] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Div Reprod Biol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Drummond-Barbosa, D (corresponding author), Johns Hopkins Univ, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA.	dbarbosa@jhsph.edu		Ables, Elizabeth/0000-0002-6934-9302	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM086031, R01GM069875] Funding Source: NIH RePORTER; NIGMS NIH HHS [F32 GM086031, R01 GM069875] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Britton JS, 1998, DEVELOPMENT, V125, P2149; Chell JM, 2010, CELL, V143, P1161, DOI 10.1016/j.cell.2010.12.007; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; D'Ercole AJ, 2008, ENDOCRINOLOGY, V149, P5958, DOI 10.1210/en.2008-0920; Drummond-Barbosa D, 2008, GENETICS, V180, P1787, DOI 10.1534/genetics.108.098244; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Hsu HJ, 2009, P NATL ACAD SCI USA, V106, P1117, DOI 10.1073/pnas.0809144106; Jasper H, 2010, CELL METAB, V12, P561, DOI 10.1016/j.cmet.2010.11.010; LaFever L, 2005, SCIENCE, V309, P1071, DOI 10.1126/science.1111410; Narbonne P, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-29; SOUSANUNES R, 2011, NATURE IN PRESS, DOI DOI 10.1038/NATURE09867	11	8	8	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 8	2011	8	4					352	354		10.1016/j.stem.2011.03.004	http://dx.doi.org/10.1016/j.stem.2011.03.004			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	752QI	21474096	Bronze			2022-12-28	WOS:000289707100004
J	Goessling, W; Allen, RS; Guan, X; Jin, P; Uchida, N; Dovey, M; Harris, JM; Metzger, ME; Bonifacino, AC; Stroncek, D; Stegner, J; Armant, M; Schlaeger, T; Tisdale, JF; Zon, LI; Donahue, RE; North, TE				Goessling, Wolfram; Allen, Robyn S.; Guan, Xiao; Jin, Ping; Uchida, Naoya; Dovey, Michael; Harris, James M.; Metzger, Mark E.; Bonifacino, Aylin C.; Stroncek, David; Stegner, Joseph; Armant, Myriam; Schlaeger, Thorsten; Tisdale, John F.; Zon, Leonard I.; Donahue, Robert E.; North, Trista E.			Prostaglandin E2 Enhances Human Cord Blood Stem Cell Xenotransplants and Shows Long-Term Safety in Preclinical Nonhuman Primate Transplant Models	CELL STEM CELL			English	Article							BONE-MARROW; PROGENITOR CELLS; EXPANSION; MOBILIZATION; REPOPULATION; ENGRAFTMENT; RECEPTOR; DONORS	Hematopoietic stem cells (HSCs) are used in transplantation therapy to reconstitute the hematopoietic system. Human cord blood (hCB) transplantation has emerged as an attractive alternative treatment option when traditional HSC sources are unavailable; however, the absolute number of hCB HSCE.; transplanted is significantly lower than bone marrow or mobilized peripheral blood stem cells (MPBSCs). We previously demonstrated that dimethyl-prostaglandin E2 (dmPGE2), increased HSCs in vertebrate models. Here, we describe preclinical analyses of the therapeutic potential of dmPGE2 treatment by using human and nonhuman primate HSCs. dmPGE2 significantly increased total human hematopoietic colony formation in vitro and enhanced engraftment of unfractionated and CD34(+) hCB after xenotransplantation. In nonhuman primate autologous transplantation, dmPGE2-treated CD34(+) MPBSCs showed stable multilineage engraftment over 1 year postinfusion. Together, our analyses indicated that dmPGE2 mediates conserved responses in HSCs from human and nonhuman primates and provided sufficient preclinical information to support proceeding to an FDA-approved phase 1 clinical trial.	[Goessling, Wolfram; Zon, Leonard I.; North, Trista E.] Harvard Stem Cell Inst, Boston, MA 02115 USA; [Goessling, Wolfram; Zon, Leonard I.; North, Trista E.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Goessling, Wolfram] Brigham & Womens Hosp, Dana Farber Canc Inst, Gastrointestinal Canc Ctr, Div Genet, Boston, MA 02115 USA; [Goessling, Wolfram] Brigham & Womens Hosp, Dana Farber Canc Inst, Gastrointestinal Canc Ctr, Div Gastroenterol, Boston, MA 02115 USA; [Allen, Robyn S.; Metzger, Mark E.; Bonifacino, Aylin C.; Donahue, Robert E.] NHLBI, Hematol Branch, NIH, Rockville, MD 20850 USA; [Guan, Xiao; Schlaeger, Thorsten; Zon, Leonard I.] Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Jin, Ping; Stroncek, David] NIH, Dept Transfus Med, Ctr Clin, Bethesda, MD 20892 USA; [Uchida, Naoya; Tisdale, John F.] NIDDK, Mol & Clin Hematol Branch, NHLBI, NIH, Bethesda, MD 20892 USA; [Dovey, Michael; Harris, James M.; North, Trista E.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA; [Stegner, Joseph; Armant, Myriam] Immune Dis Inst, Ctr Human Cell Therapy, Boston, MA 02115 USA; [Zon, Leonard I.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Boston Children's Hospital; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Howard Hughes Medical Institute	North, TE (corresponding author), Harvard Stem Cell Inst, Boston, MA 02115 USA.	tnorth@bidmc.harvard.edu	Guan, Xiao/D-5656-2013; North, Trista/ABG-4789-2020	North, Trista/0000-0003-1249-563X; Goessling, Wolfram/0000-0001-9972-1569; Harris, James/0000-0002-8995-8324; Schlaeger, Thorsten/0000-0002-1599-9908	Harvard Stern Cell Institute; NIH NIDDK; Howard Hughes Medical Institute; National Institutes of Health, NHLBI; NIDDK; Department of Transfusion Medicine at the NIH Clinical Center; FATE Therapeutics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006008, ZICHL002338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK080226] Funding Source: NIH RePORTER	Harvard Stern Cell Institute; NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Department of Transfusion Medicine at the NIH Clinical Center; FATE Therapeutics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The HMS researchers thank J. Trowbridge, C. Walkley, G.O. Daley J. Ritz, L. Silberstein, G. Kao, J. Antin, R. Soiffer, K. Ballen, C. Cutler, and the members of the Center for Human Cell Therapy at Harvard Medical School, Dana-Farber Cancer Institute for helpful discussions and guidance on the clinical application of dmPGE2 and the FDA application process. We are grateful to the Carolinas Cord Blood Bank for providing us with discarded cord blood units. The NIH researchers thank K. Keyvanfar for cell-sorting assistance, Y. Tian for assisting with the processing of the microarray data, and the veterinary and animal care staff at 5 Research Court and Poolesville for maintaining the nonhuman primates used in this study. This research was supported by the Harvard Stern Cell Institute (VV.G., LIZ., T.E.N.), NIH NIDDK (W.G., LIZ., TEN.), Howard Hughes Medical Institute (LIZ.), the Intramural Research Program of the National Institutes of Health, NHLBI, and/or NIDDK (R.S.A., N.U., M.E.M., A.C.B., J.F.T., RED.), and the Department of Transfusion Medicine at the NIH Clinical Center (P.J., D.S.). T.E.N. and W.G. receive patent royalties and consulting fees from FATE Therapeutics; L.I.Z. is a scientific founder and stockholder of and receives patent royalties from FATE Therapeutics, which is currently testing the use of prostaglandin E2 to enhance the efficacy of hCB transplants in an independently conducted phase I clinical trial.	Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Ballen KK, 2007, BIOL BLOOD MARROW TR, V13, P838, DOI 10.1016/j.bbmt.2007.03.007; Ballen KK, 2007, BIOL BLOOD MARROW TR, V13, P82, DOI 10.1016/j.bbmt.2006.08.041; Ballen KK, 2002, TRANSFUSION, V42, P1279, DOI 10.1046/j.1537-2995.2002.00191.x; Ballinger MN, 2006, J IMMUNOL, V177, P5499, DOI 10.4049/jimmunol.177.8.5499; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Broxmeyer HE, 2009, BONE MARROW TRANSPL, V44, P627, DOI 10.1038/bmt.2009.285; BROXMEYER HE, 1989, P NATL ACAD SCI USA, V86, P3828, DOI 10.1073/pnas.86.10.3828; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Campbell TB, 2007, STEM CELLS DEV, V16, P347, DOI 10.1089/scd.2007.9995; CAYEUX SJ, 1993, BONE MARROW TRANSPL, V12, P603; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Dichtel-Danjoy ML, 2009, DEVELOPMENT, V136, P761, DOI 10.1242/dev.032854; Donahue Robert E, 2005, Curr Protoc Immunol, VChapter 22, DOI 10.1002/0471142735.im22a01s69; Durand C, 2007, P NATL ACAD SCI USA, V104, P20838, DOI 10.1073/pnas.0706923105; Frisch BJ, 2009, BLOOD, V114, P4054, DOI 10.1182/blood-2009-03-205823; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Hoggatt J, 2009, BLOOD, V113, P5444, DOI 10.1182/blood-2009-01-201335; LATERVEER L, 1995, BLOOD, V85, P2269, DOI 10.1182/blood.V85.8.2269.bloodjournal8582269; Laver JH, 2001, BIOL BLOOD MARROW TR, V7, P45, DOI 10.1053/bbmt.2001.v7.pm11215698; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Li PL, 2010, CELL STEM CELL, V6, P199, DOI 10.1016/j.stem.2010.02.007; McDermott SP, 2010, BLOOD, V116, P193, DOI 10.1182/blood-2010-02-271841; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; REGAN JW, 1994, MOL PHARMACOL, V46, P213; Rocha V, 2010, BIOL BLOOD MARROW TR, V16, pS126, DOI 10.1016/j.bbmt.2009.11.001; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Trobridge GD, 2010, GENE THER, V17, P939, DOI 10.1038/gt.2010.47; Trowbridge JJ, 2006, NAT MED, V12, P89, DOI 10.1038/nm1339; Uchida N, 2009, J VIROL, V83, P9854, DOI 10.1128/JVI.00357-09; Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119	32	204	230	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 8	2011	8	4					445	458		10.1016/j.stem.2011.02.003	http://dx.doi.org/10.1016/j.stem.2011.02.003			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	752QI	21474107	Green Accepted, Bronze			2022-12-28	WOS:000289707100016
J	Mason, C; Mason, J; Culme-Seymour, EJ; Bonfiglio, GA; Reeve, BC				Mason, Chris; Mason, Julian; Culme-Seymour, Emily J.; Bonfiglio, Gregory A.; Reeve, Brock C.			Cell Therapy Companies Make Strong Progress from October 2012 to March 2013 Amid Mixed Stock Market Sentiment	CELL STEM CELL			English	News Item							INDUSTRY	During Q4 2012 and Q1 2013, the cell therapy industry made strong progress in translation and commercialization. Continued development of the companies included in a dedicated stock market index suggests emergence of this industry as a distinct healthcare sector.	[Mason, Chris] UCL, Adv Ctr Biochem Engn, London WC1E 6BT, England; [Mason, Julian] Univ Kingston, Fac Sci Engn & Comp, Kingston Upon Thames KT1 2EE, Surrey, England; [Culme-Seymour, Emily J.] London Regenerat Med Network, London EC1R 0DP, England; [Bonfiglio, Gregory A.] Proteus Venture Partners, Portola Valley, CA 94028 USA; [Bonfiglio, Gregory A.] Ctr Commercializat Regenerat Med, Toronto, ON M5G 1L5, Canada; [Reeve, Brock C.] Holyoke Ctr, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	University of London; University College London; Kingston University; Harvard University	Mason, C (corresponding author), UCL, Adv Ctr Biochem Engn, Gower St, London WC1E 6BT, England.	chris.mason@ucl.ac.uk						Baker M, 2013, NATURE, V493, P282, DOI 10.1038/493282a; Brindley DA, 2011, CELL STEM CELL, V9, P397, DOI 10.1016/j.stem.2011.10.010; DeFrancesco L., 2013, NAT BIOTECHNOL, V31, P190; DeFrancesco L, 2013, NAT BIOTECHNOL, V31, P7, DOI 10.1038/nbt0113-7; Mason C, 2011, REGEN MED, V6, P265, DOI [10.2217/RME.11.28, 10.2217/rme.11.28]; Mason C, 2012, CELL STEM CELL, V11, P735, DOI 10.1016/j.stem.2012.11.013; Osborne R, 2013, NAT BIOTECHNOL, V31, P100, DOI 10.1038/nbt.2498; Thomas D., 2012, INSIDE NBI GUIDE PER, P1; Yang W., 2013, NAT BIOTECHNOL, V31, P99	9	13	13	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 6	2013	12	6					644	647		10.1016/j.stem.2013.05.017	http://dx.doi.org/10.1016/j.stem.2013.05.017			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VH	23746973	Bronze			2022-12-28	WOS:000329569900007
J	Rao, M				Rao, Mahendra			Public Private Partnerships: A Marriage of Necessity	CELL STEM CELL			English	Editorial Material							STEM-CELLS	Harnessing the unprecedented flexibility that iPSC technology and gene editing offer academic and industry-based researchers requires developing an interactive model of collaboration. Such a model will have to leverage the basic research expertise in academia with the pharmaceutical industry's knowledge in manufacturing and high throughput technology to be successful.			Rao, M (corresponding author), 50 South Dr,Suite 1140, Bethesda, MD 20892 USA.	mahendra.rao@nih.gov			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041193] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ben-David U, 2013, CELL STEM CELL, V12, P167, DOI 10.1016/j.stem.2012.11.015; Bubela T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003490; Ginis I, 2004, DEV BIOL, V269, P360, DOI 10.1016/j.ydbio.2003.12.034; Han Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007155; Hazard M, 2011, CTS-CLIN TRANSL SCI, V4, P328, DOI 10.1111/j.1752-8062.2011.00308.x; Lowenthal J, 2012, STEM CELL TRANSL MED, V1, P409, DOI 10.5966/sctm.2012-0029; Peng S, 2010, J PHARMACOL TOX MET, V61, P277, DOI 10.1016/j.vascn.2010.01.014; Pienta KJ, 2010, CTS-CLIN TRANSL SCI, V3, P316, DOI 10.1111/j.1752-8062.2010.00248.x; Rao MS, 2011, CELL STEM CELL, V9, P7, DOI 10.1016/j.stem.2011.06.009	9	16	17	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 7	2013	12	2					149	151		10.1016/j.stem.2013.01.010	http://dx.doi.org/10.1016/j.stem.2013.01.010			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VB	23395442	Bronze			2022-12-28	WOS:000329569300006
J	Wang, S; Bates, J; Li, XJ; Schanz, S; Chandler-Militello, D; Levine, C; Maherali, N; Studer, L; Hochedlinger, K; Windrem, M; Goldman, SA				Wang, Su; Bates, Janna; Li, Xiaojie; Schanz, Steven; Chandler-Militello, Devin; Levine, Corri; Maherali, Nimet; Studer, Lorenz; Hochedlinger, Konrad; Windrem, Martha; Goldman, Steven A.			Human iPSC-Derived Oligodendrocyte Progenitor Cells Can Myelinate and Rescue a Mouse Model of Congenital Hypomyelination	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; TRANSCRIPTION FACTOR; HUMAN ES; DIFFERENTIATION; DISEASE; LINEAGE; BRAIN; FETAL; IDENTIFICATION; REMYELINATE	Neonatal engraftment by oligodendrocyte progenitor cells (OPCs) permits the myelination of the congenitally dysmyelinated brain. To establish a potential autologous source of these cells, we developed a strategy by which to differentiate human induced pluripotent stem cells (hiPSCs) into OPCs. From three hiPSC lines, as well as from human embryonic stem cells (hESCs), we generated highly enriched OLIG2(+)/PDGFR alpha(+)/NKX2.2(+)/SOX10(+) human OPCs, which could be further purified using fluorescence-activated cell sorting. hiPSC OPCs efficiently differentiated into both myelinogenic oligodendrocytes and astrocytes, in vitro and in vivo. Neonatally engrafted hiPSC OPCs robustly myelinated the brains of myelin-deficient shiverer mice and substantially increased their survival. The speed and efficiency of myelination by hiPSC OPCs was higher than that previously observed using fetal-tissue-derived OPCs, and no tumors from these grafts were noted as long as 9 months after transplant. These results suggest the potential utility of hiPSC-derived OPCs in treating disorders of myelin loss.	[Wang, Su; Bates, Janna; Li, Xiaojie; Schanz, Steven; Chandler-Militello, Devin; Levine, Corri; Windrem, Martha; Goldman, Steven A.] Univ Rochester, Med Ctr, Ctr Translat Neuromed, Rochester, NY 14642 USA; [Wang, Su; Bates, Janna; Li, Xiaojie; Schanz, Steven; Chandler-Militello, Devin; Levine, Corri; Windrem, Martha; Goldman, Steven A.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Maherali, Nimet; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Regenerat Med, Cambridge, MA 02138 USA; [Maherali, Nimet; Hochedlinger, Konrad] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Studer, Lorenz] Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA	University of Rochester; University of Rochester; Harvard University; Massachusetts General Hospital; Harvard University; Memorial Sloan Kettering Cancer Center	Goldman, SA (corresponding author), Univ Rochester, Med Ctr, Ctr Translat Neuromed, Rochester, NY 14642 USA.	steven_goldman@urmc.rochester.edu	Studer, Lorenz/ABH-1491-2021; Levine, Corri/AAI-6980-2020	Studer, Lorenz/0000-0003-0741-7987; Goldman, Steven/0000-0002-5498-4303; Levine, Corri/0000-0003-0405-5191	New York State Stem Cell Science (NYSTEM); National Multiple Sclerosis Society; NIH [R01NS75345, R01NS39559]; G. Harold and Leila Y. Mathers Charitable Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075345, R01NS039559] Funding Source: NIH RePORTER	New York State Stem Cell Science (NYSTEM); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Charitable Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by New York State Stem Cell Science (NYSTEM); the National Multiple Sclerosis Society; NIH grants R01NS75345 and R01NS39559; the G. Harold and Leila Y. Mathers Charitable Foundation; and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation. We thank Karen Bentley and Gayle Schneider for their assistance in electron microscopy.	Ben-Hur T, 2008, ANN NY ACAD SCI, V1142, P218, DOI 10.1196/annals.1444.014; Berry M, 2002, J NEUROCYTOL, V31, P457, DOI 10.1023/A:1025735513560; Bugiani M, 2011, J NEUROPATH EXP NEUR, V70, P69, DOI 10.1097/NEN.0b013e318203ae74; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Dietrich J, 2002, GLIA, V40, P65, DOI 10.1002/glia.10116; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Goldman SA, 2012, SCIENCE, V338, P491, DOI 10.1126/science.1218071; Hu BY, 2009, NAT PROTOC, V4, P1614, DOI 10.1038/nprot.2009.186; Hu BY, 2009, DEVELOPMENT, V136, P1443, DOI 10.1242/dev.029447; Izrael M, 2007, MOL CELL NEUROSCI, V34, P310, DOI 10.1016/j.mcn.2006.11.008; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Keyoung HM, 2001, NAT BIOTECHNOL, V19, P843, DOI 10.1038/nbt0901-843; Krencik R, 2011, NAT BIOTECHNOL, V29, P528, DOI 10.1038/nbt.1877; Lee JP, 2007, NAT MED, V13, P439, DOI 10.1038/nm1548; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Pruszak J, 2009, STEM CELLS, V27, P2928, DOI 10.1002/stem.211; Qi YC, 2001, DEVELOPMENT, V128, P2723; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Sim FJ, 2011, NAT BIOTECHNOL, V29, P934, DOI 10.1038/nbt.1972; Terada N, 2002, GLIA, V40, P350, DOI 10.1002/glia.10134; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wang S, 2010, J NEUROSCI, V30, P14635, DOI 10.1523/JNEUROSCI.1729-10.2010; Windrem MS, 2008, CELL STEM CELL, V2, P553, DOI 10.1016/j.stem.2008.03.020; Windrem MS, 2004, NAT MED, V10, P93, DOI 10.1038/nm974; Windrem MS, 2002, J NEUROSCI RES, V69, P966, DOI 10.1002/jnr.10397; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3	29	384	406	0	65	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 7	2013	12	2					252	264		10.1016/j.stem.2012.12.002	http://dx.doi.org/10.1016/j.stem.2012.12.002			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VB	23395447	Green Accepted, Bronze			2022-12-28	WOS:000329569300015
J	Ren, GW; Zhao, X; Wang, Y; Zhang, X; Chen, XD; Xu, CL; Yuan, ZR; Roberts, AI; Zhang, LY; Zheng, B; Wen, T; Han, YY; Rabson, AB; Tischfield, JA; Shao, CS; Shi, YF				Ren, Guangwen; Zhao, Xin; Wang, Ying; Zhang, Xin; Chen, Xiaodong; Xu, Chunliang; Yuan, Zeng-rong; Roberts, Arthur I.; Zhang, Liying; Zheng, Betty; Wen, Ting; Han, Yanyan; Rabson, Arnold B.; Tischfield, Jay A.; Shao, Changshun; Shi, Yufang			CCR2-Dependent Recruitment of Macrophages by Tumor-Educated Mesenchymal Stromal Cells Promotes Tumor Development and Is Mimicked by TNF alpha	CELL STEM CELL			English	Article							STEM-CELLS; MICE DEFICIENT; MYELOID CELLS; CANCER; INFLAMMATION; IMMUNOSUPPRESSION; CONTRIBUTES; PROGRESSION; INTERFERON; EXPANSION	Mesenchymal stromal cells (MSCs) tend to infiltrate into tumors and form a major component of the tumor microenvironment. These tumor-resident MSCs are known to affect tumor growth, but the mechanisms are largely unknown. We found that MSCs isolated from spontaneous lymphomas in mouse (L-MSCs) strikingly enhanced tumor growth in comparison to bone marrow MSCs (BM-MSCs). L-MSCs contributed to greater recruitment of CD11b(+)Ly6C(+) monocytes, F4/80(+) macrophages, and CD11b(+)Ly6G(+) neutrophils to the tumor. Depletion of monocytes/macrophages, but not neutrophils, completely abolished tumor promotion of L-MSCs. Furthermore, L-MSCs expressed high levels of CCR2 ligands, and monocyte/macrophage accumulation and L-MSC-mediated tumor promotion were largely abolished in CCR2(-/-) mice. Intriguingly, TNF alpha-pretreated BM-MSCs mimicked L-MSCs in their chemokine production profile and ability to promote tumorigenesis of lymphoma, melanoma, and breast carcinoma. Therefore, our findings demonstrate that, in an inflammatory environment, tumor-resident MSCs promote tumor growth by recruiting monocytes/macrophages.	[Ren, Guangwen; Wang, Ying; Zhang, Xin; Chen, Xiaodong; Xu, Chunliang; Han, Yanyan; Shi, Yufang] Shanghai Jiao Tong Univ, Sch Med, Chinese Acad Sci, Shanghai Inst Biol Sci,Inst Hlth Sci,Key Lab Stem, Shanghai 200025, Peoples R China; [Ren, Guangwen; Yuan, Zeng-rong; Roberts, Arthur I.; Zhang, Liying; Rabson, Arnold B.; Shi, Yufang] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Child Hlth Inst New Jersey, New Brunswick, NJ 08901 USA; [Zhao, Xin; Zheng, Betty; Tischfield, Jay A.; Shao, Changshun] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA; [Zhao, Xin; Zheng, Betty; Tischfield, Jay A.; Shao, Changshun] Rutgers State Univ, Human Genet Inst New Jersey, Piscataway, NJ 08854 USA; [Wen, Ting] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA; [Shao, Changshun] Shandong Univ, Sch Med, Minist Educ, Key Lab Expt Teratol, Jinan 250012, Shandong, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Shandong University	Shi, YF (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Chinese Acad Sci, Shanghai Inst Biol Sci,Inst Hlth Sci,Key Lab Stem, 225 S Chongqing Rd, Shanghai 200025, Peoples R China.	shiyu@umdnj.edu	Shao, Changshun/AAD-8977-2022; Xu, Chunliang/R-7065-2018; Ren, Guangwen/D-8895-2012; Shi, Yufang/AAE-4431-2020	Shao, Changshun/0000-0003-2618-9342; Shi, Yufang/0000-0001-8964-319X; Ren, Guangwen/0000-0003-2436-9593	Ministry of Science and Technology of China [2010CB945600, 2011DFA30630]; Scientific Innovation Project of the Chinese Academy of Science [XDA01040107, KSCX1-YW-22-04]; National Science and Technology Project of China [31010103908]; National Institutes of Health of the United States of America [GM866889, DE014913, DE019932, ES005022]; Robert Wood Johnson Foundation [67038]; Human Genetics Institute of New Jersey; NATIONAL CANCER INSTITUTE [P30CA072720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM866889] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Scientific Innovation Project of the Chinese Academy of Science; National Science and Technology Project of China; National Institutes of Health of the United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Human Genetics Institute of New Jersey; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Yvonne Sun, Dr. Xin Yu, and Dr. Hsinching Lin for collection of spontaneous tumors in mice. This work was supported by grants from the Ministry of Science and Technology of China (2010CB945600 and 2011DFA30630), Scientific Innovation Project of the Chinese Academy of Science (XDA01040107 and KSCX1-YW-22-04), and the National Science and Technology Project of China (31010103908) and grants from the National Institutes of Health of the United States of America (GM866889, DE014913, DE019932, and ES005022). We would also like to thank the Robert Wood Johnson Foundation (Grant 67038) for their support of the Child Health Institute of New Jersey and a grant from the Human Genetics Institute of New Jersey.	Allavena P, 2008, IMMUNOL REV, V222, P155, DOI 10.1111/j.1600-065X.2008.00607.x; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Bergfeld SA, 2010, CANCER METAST REV, V29, P249, DOI 10.1007/s10555-010-9222-7; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Davidson WF, 1998, J EXP MED, V187, P1825, DOI 10.1084/jem.187.11.1825; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; English K, 2010, CELL STEM CELL, V7, P431, DOI 10.1016/j.stem.2010.09.009; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Giordano A, 2007, J CELL PHYSIOL, V211, P27, DOI 10.1002/jcp.20959; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Grivennikov S.I., 2011, ANN RHEUM DIS, V70, pi104; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Lefevre S, 2009, NAT MED, V15, P1414, DOI 10.1038/nm.2050; Li CY, 2009, J HEPATOL, V50, P1174, DOI 10.1016/j.jhep.2009.01.028; Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mishra PJ, 2008, FUTURE ONCOL, V4, P745, DOI 10.2217/14796694.4.6.745; Mishra PJ, 2008, CANCER RES, V68, P4331, DOI 10.1158/0008-5472.CAN-08-0943; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Morse HC, 2002, BLOOD, V100, P246, DOI 10.1182/blood.V100.1.246; Mueller LP, 2011, CANCER GENE THER, V18, P229, DOI 10.1038/cgt.2010.68; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 2010, CYTOTHERAPY, V12, P576, DOI 10.3109/14653249.2010.507330; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Prolla TA, 1998, NAT GENET, V18, P276, DOI 10.1038/ng0398-276; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Rafei M, 2009, J IMMUNOL, V182, P5994, DOI 10.4049/jimmunol.0803962; Rafei M, 2008, BLOOD, V112, P4991, DOI 10.1182/blood-2008-07-166892; Ren CC, 2008, STEM CELLS, V26, P2332, DOI 10.1634/stemcells.2008-0084; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Riss J, 2006, CANCER RES, V66, P7216, DOI 10.1158/0008-5472.CAN-06-0040; Sarkar D, 2010, BIOMATERIALS, V31, P5266, DOI 10.1016/j.biomaterials.2010.03.006; Shao CS, 2004, ONCOGENE, V23, P9017, DOI 10.1038/sj.onc.1208148; Shi C, 2011, IMMUNITY, V34, P590, DOI 10.1016/j.immuni.2011.02.016; Shi YF, 2012, TRENDS IMMUNOL, V33, P136, DOI 10.1016/j.it.2011.11.004; Shi YF, 2010, CELL RES, V20, P510, DOI 10.1038/cr.2010.44; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Studeny M, 2004, JNCI-J NATL CANCER I, V96, P1593, DOI 10.1093/jnci/djh299; Trinchieri G, 2012, ANNU REV IMMUNOL, V30, P677, DOI 10.1146/annurev-immunol-020711-075008; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; von Bahr L, 2012, STEM CELLS, V30, P1575, DOI 10.1002/stem.1118; Wagner J, 2009, CURR OPIN BIOTECH, V20, P531, DOI 10.1016/j.copbio.2009.08.009; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200; Zhang QZ, 2010, STEM CELLS, V28, P1856, DOI 10.1002/stem.503; Zhu W, 2006, EXP MOL PATHOL, V80, P267, DOI 10.1016/j.yexmp.2005.07.004	58	221	237	1	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 7	2012	11	6					812	824		10.1016/j.stem.2012.08.013	http://dx.doi.org/10.1016/j.stem.2012.08.013			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	055MJ	23168163	Green Accepted, Bronze			2022-12-28	WOS:000312420300012
J	Firlej, V; Barraud-Lange, V; Fouchet, P				Firlej, Virginie; Barraud-Lange, Virginie; Fouchet, Pierre			Stem Cell Therapy for Male Infertility Takes a Step Forward	CELL STEM CELL			English	Editorial Material							TRANSPLANTATION	The feasibility of using spermatogonial stem cells (SSCs) for cell-based infertility treatment has suffered from a lack of evidence in a preclinical nonhuman primate model. In this issue, Hermann et al. (2012) demonstrate that autologous and allogeneic transplantation of SSCs in testes of rhesus macaques produced functional sperm.	[Fouchet, Pierre] Commissariat Energie Atom, Direct Sci Vivant, Inst Radiobiol Cellulaire & Mol, Lab Gametogenese, F-92265 Fontenay Aux Roses, France; [Fouchet, Pierre] Inst Natl Sante & Rech Med, U967, Fontenay Aux Roses, France; [Fouchet, Pierre] Univ Paris Diderot, Fontenay Aux Roses, France; [Fouchet, Pierre] Univ Paris 11, Fontenay Aux Roses, France; [Barraud-Lange, Virginie] Hop Cochin, APHP, Serv Biol Reprod, F-75674 Paris, France; [Firlej, Virginie; Barraud-Lange, Virginie] CNRS, UMR 8104, Paris, France; [Firlej, Virginie; Barraud-Lange, Virginie] Univ Paris 05, Paris, France; [Firlej, Virginie; Barraud-Lange, Virginie] Inst Cochin, Inst Natl Sante & Rech Med, U1016, Paris, France	CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Fouchet, P (corresponding author), Commissariat Energie Atom, Direct Sci Vivant, Inst Radiobiol Cellulaire & Mol, Lab Gametogenese, F-92265 Fontenay Aux Roses, France.	pierre.fouchet@cea.fr	Firlej, Virginie/R-2065-2018; Firlej, Virginie/AFQ-6362-2022	Firlej, Virginie/0000-0003-4132-0695; Fouchet, Pierre/0000-0003-0891-079X; Barraud-Lange, Virginie/0000-0001-8507-7303				BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; Buganim Y, 2012, CELL STEM CELL, V11, P373, DOI 10.1016/j.stem.2012.07.019; Clark AT, 2011, NAT MED, V17, P1564, DOI 10.1038/nm.2594; Hermann BP, 2012, CELL STEM CELL, V11, P715, DOI 10.1016/j.stem.2012.07.017; Hermann BP, 2011, HUM REPROD, V26, P3222, DOI 10.1093/humrep/der343; Jahnukainen K, 2011, HUM REPROD, V26, P1945, DOI 10.1093/humrep/der160; Kim Y, 2008, REPRODUCTION, V136, P823, DOI 10.1530/REP-08-0226; Sadri-Ardekani H, 2009, JAMA-J AM MED ASSOC, V302, P2127, DOI 10.1001/jama.2009.1689; Schmidt JA, 2011, BIOL REPROD, V84, P698, DOI 10.1095/biolreprod.110.088229; Templeton A, 2000, BRIT MED BULL, V56, P577, DOI 10.1258/0007142001903283	10	5	5	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 2	2012	11	5					585	586		10.1016/j.stem.2012.10.006	http://dx.doi.org/10.1016/j.stem.2012.10.006			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	042LE	23122284	Bronze			2022-12-28	WOS:000311471900003
J	Barker, N; van Oudenaarden, A; Clevers, H				Barker, Nick; van Oudenaarden, Alexander; Clevers, Hans			Identifying the Stem Cell of the Intestinal Crypt: Strategies and Pitfalls	CELL STEM CELL			English	Review							WNT/BETA-CATENIN; SELF-RENEWAL; WNT RECEPTORS; IN-VITRO; LGR5; EPITHELIUM; IDENTIFICATION; MARKER; COLON; PROGENITORS	Decades ago, two nonoverlapping crypt stem cell populations were proposed: Leblond's Crypt Base Columnar (CBC) cell and Potten's +4 cell. The identification of CBC markers including Lgr5 has confirmed Leblond's predictions that CBC cells are anatomically distinct, long-lived stem cells that permanently cycle. While Potten originally described +4 cells as proliferative and unusually radiation-sensitive, recent efforts to identify +4 stem cells have focused on the identification of cells that are quiescent and radiation-resistant. Here, we describe commonalities and discrepancies between the individual studies and discuss challenges of marker-based lineage tracing.	[van Oudenaarden, Alexander; Clevers, Hans] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [van Oudenaarden, Alexander; Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Barker, Nick] Inst Med Biol, Immunos 138648, Singapore; [van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA; [van Oudenaarden, Alexander] MIT, Dept Biol, Cambridge, MA 02139 USA	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Clevers, H (corresponding author), Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	h.clevers@hubrecht.eu	Barker, Nick/A-5535-2011; Barker, Nick/AAE-9833-2021; Barker, Nick/AAS-2774-2020; van Oudenaarden, Alexander/AAA-1705-2019	Barker, Nick/0000-0003-3566-4475; 				Barker N, 2008, COLD SH Q B, V73, P351, DOI 10.1101/sqb.2008.72.003; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V7, P656, DOI 10.1016/j.stem.2010.11.016; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Bezencon C, 2008, J COMP NEUROL, V509, P514, DOI 10.1002/cne.21768; BJERKNES M, 1981, AM J ANAT, V160, P105, DOI 10.1002/aja.1001600109; BJERKNES M, 1981, AM J ANAT, V160, P51, DOI 10.1002/aja.1001600105; Bjerknes M, 2002, AM J PHYSIOL-GASTR L, V283, pG767, DOI 10.1152/ajpgi.00415.2001; Bjerknes M, 1999, GASTROENTEROLOGY, V116, P7, DOI 10.1016/S0016-5085(99)70222-2; Bjerknes M, 2005, NAT GENET, V37, P1016, DOI 10.1038/ng1005-1016; Breault DT, 2008, P NATL ACAD SCI USA, V105, P10420, DOI 10.1073/pnas.0804800105; CAIRNIE AB, 1965, EXP CELL RES, V39, P528, DOI 10.1016/0014-4827(65)90055-8; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Carmon KS, 2012, MOL CELL BIOL, V32, P2054, DOI 10.1128/MCB.00272-12; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; de Lau W, 2012, MOL CELL BIOL, V32, P3639, DOI 10.1128/MCB.00434-12; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Demidov ON, 2007, CELL STEM CELL, V1, P180, DOI 10.1016/j.stem.2007.05.020; Durand A, 2012, P NATL ACAD SCI USA, V109, P8965, DOI 10.1073/pnas.1201652109; Escobar M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1260; Gerbe F, 2009, GASTROENTEROLOGY, V137, P2179, DOI 10.1053/j.gastro.2009.06.072; Giannakis M, 2006, J BIOL CHEM, V281, P11292, DOI 10.1074/jbc.M512118200; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Heath JP, 1996, CELL BIOL INT, V20, P139, DOI 10.1006/cbir.1996.0018; Itzkovitz S, 2012, NAT CELL BIOL, V14, P106, DOI 10.1038/ncb2384; Koo BK, 2012, NAT METHODS, V9, P81, DOI [10.1038/NMETH.1802, 10.1038/nmeth.1802]; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; May R, 2008, STEM CELLS, V26, P630, DOI 10.1634/stemcells.2007-0621; May R, 2009, STEM CELLS, V27, P2571, DOI 10.1002/stem.193; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Potten CS, 2009, CELL PROLIFERAT, V42, P731, DOI 10.1111/j.1365-2184.2009.00642.x; POTTEN CS, 1977, NATURE, V269, P518, DOI 10.1038/269518a0; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Roth S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038965; Rothenberg ME, 2012, GASTROENTEROLOGY, V142, P1195, DOI 10.1053/j.gastro.2012.02.006; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schepers AG, 2011, EMBO J, V30, P1104, DOI 10.1038/emboj.2011.26; Snippert HJ, 2009, GASTROENTEROLOGY, V136, P2187, DOI 10.1053/j.gastro.2009.03.002; Steinhauser ML, 2012, NATURE, V481, P516, DOI 10.1038/nature10734; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; van Es, 2012, NAT CELL BI IN PRESS; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	61	211	217	0	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 5	2012	11	4					452	460		10.1016/j.stem.2012.09.009	http://dx.doi.org/10.1016/j.stem.2012.09.009			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	021OZ	23040474	Bronze, Green Published			2022-12-28	WOS:000309896500006
J	Lopez-Juarez, A; Remaud, S; Hassani, Z; Jolivet, P; Simons, JP; Sontag, T; Yoshikawa, K; Price, J; Morvan-Dubois, G; Demeneix, BA				Lopez-Juarez, Alejandra; Remaud, Sylvie; Hassani, Zahra; Jolivet, Pascale; Simons, Jacqueline Pierre; Sontag, Thomas; Yoshikawa, Kazuaki; Price, Jack; Morvan-Dubois, Ghislaine; Demeneix, Barbara A.			Thyroid Hormone Signaling Acts as a Neurogenic Switch by Repressing Sox2 in the Adult Neural Stem Cell Niche	CELL STEM CELL			English	Article							GENETIC-ANALYSIS; MOUSE-BRAIN; IN-VIVO; RECEPTOR; EXPRESSION; POLYETHYLENIMINE; DIFFERENTIATION; TRANSCRIPTION; MAINTENANCE; FEEDBACK	The subventricular zone (SVZ) neural stem cell niche contains mixed populations of stem cells, transit-amplifying cells, and migrating neuroblasts. Deciphering how endogenous signals, such as hormones, affect the balance between these cell types is essential for understanding the physiology of niche plasticity and homeostasis. We show that Thyroid Hormone (T-3) and its receptor, TR alpha 1, are directly involved in maintaining this balance. TR alpha 1 is expressed in amplifying and migrating cells. In vivo gain- and loss-of-function experiments demonstrate first, that T3/TR alpha 1 directly repress Sox2 expression, and second, that TR alpha 1 overexpression in the niche favors the appearance of DCX+ migrating neuroblasts. Lack of TR alpha increases numbers of SOX2(+) cells in the SVZ. Hypothyroidism increases proportions of cells in interphase. Thus, in the adult SVZ, T-3/TR alpha 1 together favor neural stem cell commitment and progression toward a migrating neuroblast phenotype; this transition correlates with T-3/TR alpha 1 dependent transcriptional repression of Sox2.	[Lopez-Juarez, Alejandra; Remaud, Sylvie; Jolivet, Pascale; Simons, Jacqueline Pierre; Sontag, Thomas; Morvan-Dubois, Ghislaine; Demeneix, Barbara A.] Museum Natl Hist Nat, Dept Regulat Dev & Divers Mol, UMR CNRS 7221, F-75231 Paris, France; [Hassani, Zahra; Price, Jack] Kings Coll London, Inst Psychiat, James Black Ctr, Ctr Cellular Basis Behav, London SE5 9NU, England; [Yoshikawa, Kazuaki] Osaka Univ, Inst Prot Res, Lab Regulat Neuronal Dev, Suita, Osaka 5650871, Japan; [Lopez-Juarez, Alejandra] Polyplus Transfect, F-67400 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); University of London; King's College London; Osaka University	Demeneix, BA (corresponding author), Museum Natl Hist Nat, Dept Regulat Dev & Divers Mol, UMR CNRS 7221, F-75231 Paris, France.	bdem@mnhn.fr	morvan-dubois, ghislaine/AAI-1765-2019; Price, Jack/G-9510-2011; Lopez Juarez, Silvia Alejandra/D-2617-2017	JOLIVET, Pascale/0000-0002-3896-0598; Price, Jack/0000-0003-2235-9180; Lopez Juarez, Silvia Alejandra/0000-0001-9443-6531; Morvan-Dubois, ghislaine/0000-0003-1285-9130	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Association Francaise contre lea Myopathies (AFM); European Union; French ANR; Association national de la Recherche et technologie (ANRT); CIFRE [251/2007]	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Museum National d'Histoire Naturelle (MNHN); Association Francaise contre lea Myopathies (AFM)(Association Francaise contre les Myopathies); European Union(European Commission); French ANR(French National Research Agency (ANR)); Association national de la Recherche et technologie (ANRT)(French National Research Agency (ANR)); CIFRE	This work was supported by the Centre National de la Recherche Scientifique (CNRS), the Museum National d'Histoire Naturelle (MNHN), the Association Francaise contre lea Myopathies (AFM), European Union contracts "Crescendo" and "Switchbox," and the French ANRs "Signator" and "Thrast." A.L.-J. received a Ph.D. grant from the Association national de la Recherche et technologie (ANRT) and Polyplus-transfection S.A. under CIFRE convention No. 251/2007. We thank P. Bilesimo, L. Sachs, and M.S. Clerget-Froidevaux for advice on experimental techniques; Gladys Alfama for technical assistance; and G. Levi for insightful comments. M. Geze and the Plateforme d'Imagerie du MNHN provided excellent imaging advice. The excellent animal care by Stephane Sosinsky, Philippe Durand, and Fabien Uridat is gratefully acknowledged. J.P. acts as a consultant for ReNeuron. The authors declare that there is no conflict of interest that would prejudice the impartiality of this scientific work.	Andreu-Agullo C, 2012, NATURE, V481, P195, DOI 10.1038/nature10712; Bergsland M, 2011, GENE DEV, V25, P2453, DOI 10.1101/gad.176008.111; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Cimadamore F, 2011, CELL STEM CELL, V8, P538, DOI 10.1016/j.stem.2011.03.011; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Decherf S, 2010, P NATL ACAD SCI USA, V107, P4471, DOI 10.1073/pnas.0905190107; Dentice M, 2009, EXPERT OPIN THER TAR, V13, P1363, DOI 10.1517/14728220903339122; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Forrest D, 1996, RECENT PROG HORM RES, V51, P1; Friesema ECH, 2006, MOL ENDOCRINOL, V20, P2761, DOI 10.1210/me.2005-0256; Gancz D, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001202; Gauthier K, 2001, MOL CELL BIOL, V21, P4748, DOI 10.1128/MCB.21.14.4748-4760.2001; Goula D, 1998, GENE THER, V5, P1291, DOI 10.1038/sj.gt.3300717; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Guissouma H, 2002, MOL ENDOCRINOL, V16, P1652, DOI 10.1210/me.16.7.1652; Hassani Z, 2005, J GENE MED, V7, P198, DOI 10.1002/jgm.659; Hassani Z, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm152; Hu QK, 2010, STEM CELLS, V28, P279, DOI 10.1002/stem.246; Kapoor R, 2010, FASEB J, V24, P4793, DOI 10.1096/fj.10-161802; Kohrle J, 2000, Rev Endocr Metab Disord, V1, P49, DOI 10.1023/A:1010012419869; Kress E, 2010, GASTROENTEROLOGY, V138, P1863, DOI 10.1053/j.gastro.2010.01.041; Kress E, 2009, MOL CELL ENDOCRINOL, V313, P36, DOI 10.1016/j.mce.2009.08.028; Kuwajima T, 2006, J NEUROSCI, V26, P5383, DOI 10.1523/JNEUROSCI.1262-06.2006; Lange C, 2009, CELL STEM CELL, V5, P320, DOI 10.1016/j.stem.2009.05.026; Lemkine GF, 2005, FASEB J, V19, P863, DOI 10.1096/fj.04-2916fje; Lemkine GF, 2002, MOL CELL NEUROSCI, V19, P165, DOI 10.1006/mcne.2001.1084; Lledo PM, 2009, NEURON, V62, P453, DOI 10.1016/j.neuron.2009.05.004; Miyagi S, 2006, J BIOL CHEM, V281, P13374, DOI 10.1074/jbc.M512669200; Moreno-Manzano V, 2010, J BIOL CHEM, V285, P1333, DOI 10.1074/jbc.M109.008326; Oppel F, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-137; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Pilhatsch M, 2010, BEHAV BRAIN RES, V214, P187, DOI 10.1016/j.bbr.2010.05.016; PITTRIVERS R, 1963, NEW YORK STATE J MED, V63, P43; Samuels MH, 2008, CURR OPIN ENDOCRINOL, V15, P429, DOI 10.1097/MED.0b013e32830eb84c; Sikorska M, 2008, J NEUROSCI RES, V86, P1680, DOI 10.1002/jnr.21635; Takanaga H, 2009, STEM CELLS, V27, P165, DOI 10.1634/stemcells.2008-0580; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Van Hooser A, 1998, J CELL SCI, V111, P3497; Venero C, 2005, GENE DEV, V19, P2152, DOI 10.1101/gad.346105; Wiebe MS, 2000, GENE, V246, P383, DOI 10.1016/S0378-1119(00)00086-X; Williams GR, 2011, J ENDOCRINOL, V209, P261, DOI 10.1530/JOE-10-0448; Zhao Z, 2010, NATURE, V465, P1089, DOI 10.1038/nature09126	47	95	98	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 4	2012	10	5					531	543		10.1016/j.stem.2012.04.008	http://dx.doi.org/10.1016/j.stem.2012.04.008			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	944WN	22560077	Bronze			2022-12-28	WOS:000304234600012
J	Qin, JC; Liu, X; Laffin, B; Chen, X; Choy, G; Jeter, CR; Calhoun-Davis, T; Li, HW; Palapattu, GS; Pang, S; Lin, K; Huang, JT; Ivanov, I; Li, W; Suraneni, MV; Tang, DG				Qin, Jichao; Liu, Xin; Laffin, Brian; Chen, Xin; Choy, Grace; Jeter, Collene R.; Calhoun-Davis, Tammy; Li, Hangwen; Palapattu, Ganesh S.; Pang, Shen; Lin, Kevin; Huang, Jiaoti; Ivanov, Ivan; Li, Wei; Suraneni, Mahipal V.; Tang, Dean G.			The PSA(-/Io) Prostate Cancer Cell Population Harbors Self-Renewing Long-Term Tumor-Propagating Cells that Resist Castration	CELL STEM CELL			English	Article							ANDROGEN RECEPTOR; STEM-CELLS; INITIATING CELLS; ANTIGEN-EXPRESSION; PROGENITOR CELLS; GENE-EXPRESSION; CARCINOMA; HETEROGENEITY; PROGRESSION; GROWTH	Prostate cancer (PCa) is heterogeneous and contains both differentiated and undifferentiated tumor cells, but the relative functional contribution of these two cell populations remains unclear. Here we report distinct molecular, cellular, and tumor-propagating properties of PCa cells that express high (PSA(+)) and low (PSA(-/Io)) levels of the differentiation marker PSA. PSA(-/Io) PCa cells are quiescent and refractory to stresses including androgen deprivation, exhibit high clonogenic potential, and possess long-term tumor-propagating capacity. They preferentially express stem cell genes and can undergo asymmetric cell division to generate PSA(+) cells. Importantly, PSA(-/Io) PCa cells can initiate robust tumor development and resist androgen ablation in castrated hosts, and they harbor highly tumorigenic castrationresistant PCa cells that can be prospectively enriched using ALDH(+)CD44(+)alpha 2 beta 1(+) phenotype. In contrast, PSA(+) PCa cells possess more limited tumor-propagating capacity, undergo symmetric division, and are sensitive to castration. Altogether, our study suggests that PSA(-/Io) cells may represent a critical source of castration-resistant PCa cells.	[Qin, Jichao; Liu, Xin; Laffin, Brian; Chen, Xin; Choy, Grace; Jeter, Collene R.; Calhoun-Davis, Tammy; Li, Hangwen; Lin, Kevin; Suraneni, Mahipal V.; Tang, Dean G.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX 78957 USA; [Qin, Jichao] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Surg, Tongji Med Coll, Wuhan 430030, Peoples R China; [Liu, Xin; Li, Hangwen] Univ Texas Austin, Dept Nutr Sci, Austin, TX 78712 USA; [Chen, Xin; Tang, Dean G.] Univ Texas Grad Sch Biomed Sci, Program Mol Carcinogenesis, Houston, TX 77030 USA; [Palapattu, Ganesh S.] Methodist Hosp, Dept Urol, Houston, TX 77030 USA; [Pang, Shen] UCLA Dent Res Inst, Los Angeles, CA 90095 USA; [Pang, Shen] UCLA Sch Dent, Los Angeles, CA 90095 USA; [Huang, Jiaoti] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Ivanov, Ivan] Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA; [Li, Wei] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Tang, Dean G.] Univ Texas MD Anderson Canc Ctr, Ctr Canc Epigenet, Houston, TX 77030 USA; [Tang, Dean G.] Univ Texas MD Anderson Canc Ctr, Ctr Stem Cell & Dev Biol, Houston, TX 77030 USA; [Tang, Dean G.] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNAs, Houston, TX 77030 USA; [Tang, Dean G.] Univ Texas MD Anderson Canc Ctr, Ctr Mol Carcinogenesis, Houston, TX 77030 USA; [Tang, Dean G.] Tongji Univ, East Hosp, Res Ctr Translat Med, Canc Stem Cell Inst, Shanghai 200120, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; Huazhong University of Science & Technology; University of Texas System; University of Texas Austin; The Methodist Hospital System; The Methodist Hospital - Houston; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Texas A&M University System; Texas A&M University College Station; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Tongji University	Tang, DG (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Sci Pk, Smithville, TX 78957 USA.	dtang@mdanderson.org	LIU, XIN/AFR-0503-2022; LIU, XIN/AAD-9918-2022; Tang, Dean/AAI-3457-2020	LIU, XIN/0000-0003-0847-182X; LIU, XIN/0000-0003-0847-182X; Tang, Dean/0000-0001-5029-1174; Qin, Jichao/0000-0002-2961-7624; Li, Wei/0000-0001-9931-5990; Chen, Xin/0000-0002-0566-7678; Jeter, Collene/0000-0002-9627-4529; Huang, Jiaoti/0000-0003-1195-1998	National Institutes of Health [R01-ES015888, 1R21CA 150009]; Department of Defense [W81XWH-11-1-0331]; Cancer Prevention and Research Institute of Texas [RP120380, RP120394]; Elsa Pardee Foundation; M.D. Anderson Cancer Center University; Center for Cancer Epigenetics; Laura & John Arnold Foundation RNA Center;  [CCSG-5 P30 CA166672];  [ES007784]; NATIONAL CANCER INSTITUTE [R01CA166672, P30CA016672, R21CA150009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015888, P30ES007784] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Cancer Prevention and Research Institute of Texas; Elsa Pardee Foundation; M.D. Anderson Cancer Center University; Center for Cancer Epigenetics; Laura & John Arnold Foundation RNA Center; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank K. Claypool and P. Whitney for FAGS, Histology Core for immunohistochemistry, R. Fagin for HPCa samples, J. Shen and J. Repass for qPCR, L. Shen and S. Tsavachidis for initial microarray analysis, and other members of the Tang laboratory for helpful discussions. This work was supported in part by grants from the National Institutes of Health (R01-ES015888 and 1R21CA 150009), Department of Defense (W81XWH-11-1-0331), Cancer Prevention and Research Institute of Texas (RP120380 and RP120394), Elsa Pardee Foundation, and M.D. Anderson Cancer Center University Cancer Fund, Center for Cancer Epigenetics, and Laura & John Arnold Foundation RNA Center pilot grant (all to D.G.T.) and by two Center Grants (CCSG-5 P30 CA166672 and ES007784). We apologize to the colleagues whose work was not cited due to space constraint.	ABRAHAMSSON PA, 1988, PROSTATE, V12, P39, DOI 10.1002/pros.2990120106; Bhatia B, 2008, J BIOL CHEM, V283, P27957, DOI 10.1074/jbc.M803467200; Chan JM, 1998, SCIENCE, V279, P563, DOI 10.1126/science.279.5350.563; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Davis JN, 2006, CANCER RES, V66, P11897, DOI 10.1158/0008-5472.CAN-06-2497; DEWINTER JAR, 1994, AM J PATHOL, V144, P735; FEINER HD, 1986, AM J SURG PATHOL, V10, P765, DOI 10.1097/00000478-198611000-00003; GALLEE MPW, 1990, UROL RES, V18, P181, DOI 10.1007/BF00295844; HOBISCH A, 1995, CANCER RES, V55, P3068; HSIEH JT, 1993, CANCER RES, V53, P2852; Huss WJ, 2005, CANCER RES, V65, P6640, DOI 10.1158/0008-5472.CAN-04-2548; Jeter CR, 2011, ONCOGENE, V30, P3833, DOI 10.1038/onc.2011.114; Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29; Jiang TY, 2009, CANCER RES, V69, P845, DOI 10.1158/0008-5472.CAN-08-2762; Klein KA, 1997, NAT MED, V3, P402, DOI 10.1038/nm0497-402; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Laffin B, 2010, CELL STEM CELL, V7, P639, DOI 10.1016/j.stem.2010.11.019; Li H, 2008, CANCER RES, V68, P1820, DOI 10.1158/0008-5472.CAN-07-5878; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Maitland Norman J., 2011, Hormones & Cancer, V2, P47, DOI 10.1007/s12672-010-0058-y; Memarzadeh S, 2011, P NATL ACAD SCI USA, V108, P7962, DOI 10.1073/pnas.1105243108; Mostaghel EA, 2007, CANCER RES, V67, P5033, DOI 10.1158/0008-5472.CAN-06-3332; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12182, DOI 10.1073/pnas.0804700105; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Patrawala L, 2007, CANCER RES, V67, P6796, DOI 10.1158/0008-5472.CAN-07-0490; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Rajasekhar VK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1159; Roudier MP, 2003, HUM PATHOL, V34, P646, DOI 10.1016/S0046-8177(03)00190-4; Ryan CJ, 2006, UROLOGY, V68, P834, DOI 10.1016/j.urology.2006.04.016; Shah RB, 2004, CANCER RES, V64, P9209, DOI 10.1158/0008-5472.CAN-04-2442; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Tang DG, 2012, CELL RES, V22, P457, DOI 10.1038/cr.2012.13; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; van den Hoogen C, 2010, CANCER RES, V70, P5163, DOI 10.1158/0008-5472.CAN-09-3806; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009; Yoshida T, 2005, CANCER RES, V65, P9611, DOI 10.1158/0008-5472.CAN-05-0817; Yu D, 2001, CANCER GENE THER, V8, P628, DOI 10.1038/sj.cgt.7700344	41	229	232	0	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAY 4	2012	10	5					556	569		10.1016/j.stem.2012.03.009	http://dx.doi.org/10.1016/j.stem.2012.03.009			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	944WN	22560078	Bronze, Green Accepted			2022-12-28	WOS:000304234600014
J	Migliaccio, AR; Whitsett, C; Papayannopoulou, T; Sadelain, M				Migliaccio, Anna Rita; Whitsett, Carolyn; Papayannopoulou, Thalia; Sadelain, Michel			The Potential of Stem Cells as an In Vitro Source of Red Blood Cells for Transfusion	CELL STEM CELL			English	Review							HEMATOPOIETIC STEM; ENUCLEATION		[Migliaccio, Anna Rita] Tisch Canc Ctr, Mt Sinai Sch Med, New York, NY 10029 USA; [Whitsett, Carolyn] Kings Cty Hosp Ctr, Brooklyn, NY 11203 USA; [Papayannopoulou, Thalia] Univ Washington, Seattle, WA 98195 USA; [Sadelain, Michel] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Migliaccio, Anna Rita] Ist Super Sanita, I-00161 Rome, Italy	Icahn School of Medicine at Mount Sinai; University of Washington; University of Washington Seattle; Memorial Sloan Kettering Cancer Center; Istituto Superiore di Sanita (ISS)	Migliaccio, AR (corresponding author), Tisch Canc Ctr, Mt Sinai Sch Med, New York, NY 10029 USA.	annarita.migliaccio@mssm.edu	Migliaccio, Anna Rita/GWZ-9323-2022	FRANCO MIGLIACCIO, ANNA RITA/0000-0003-1800-271X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL053750] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL053750] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Chang AH, 2006, NAT BIOTECHNOL, V24, P1017, DOI 10.1038/nbt1227; Chang CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025761; Chang KH, 2006, BLOOD, V108, P1515, DOI 10.1182/blood-2005-11-011874; Chaurasia P, 2011, BLOOD, V117, P4632, DOI 10.1182/blood-2010-10-314567; Giarratana MC, 2011, BLOOD, V118, P5071, DOI 10.1182/blood-2011-06-362038; Hiroyama T, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/195780; Hiroyama T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001544; Housler GJ, 2012, TISSUE ENG PART C-ME, V18, P133, DOI [10.1089/ten.tec.2011.0305, 10.1089/ten.TEC.2011.0305]; Hu Z, 2011, BLOOD, V118, P5938, DOI 10.1182/blood-2010-11-321414; Keerthivasan G, 2010, BLOOD, V116, P3331, DOI 10.1182/blood-2010-03-277426; Kim HO, 2012, TISSUE ENG PT A, V18, P117, DOI 10.1089/ten.tea.2010.0711; Lu SJ, 2008, BLOOD, V112, P4475, DOI 10.1182/blood-2008-05-157198; Migliaccio AR, 2009, CURR OPIN HEMATOL, V16, P259, DOI 10.1097/MOH.0b013e32832bcaa2; Miharada K, 2006, NAT BIOTECHNOL, V24, P1255, DOI 10.1038/nbt1245; Natanson C, 2008, JAMA-J AM MED ASSOC, V299, P2304, DOI 10.1001/jama.299.19.jrv80007; Papapetrou EP, 2011, NAT BIOTECHNOL, V29, P73, DOI 10.1038/nbt.1717; Peyrard T, 2011, TRANSFUS MED REV, V25, P206, DOI 10.1016/j.tmrv.2011.01.002; Timmins NE, 2011, TISSUE ENG PART C-ME, V17, P1131, DOI [10.1089/ten.tec.2011.0207, 10.1089/ten.TEC.2011.0207]; Wang Y, 2011, BLOOD, V11, p908a; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Zimring JC, 2011, TRANSFUSION, V51, P435, DOI 10.1111/j.1537-2995.2010.03024.x; Zou JZ, 2011, BLOOD, V118, P4599, DOI 10.1182/blood-2011-02-335554	22	50	52	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 3	2012	10	2					115	119		10.1016/j.stem.2012.01.001	http://dx.doi.org/10.1016/j.stem.2012.01.001			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	892FM	22305561	Bronze, Green Accepted			2022-12-28	WOS:000300272100006
J	Centanin, L; Hoeckendorf, B; Wittbrodt, J				Centanin, Lazaro; Hoeckendorf, Burkhard; Wittbrodt, Joachim			Fate Restriction and Multipotency in Retinal Stem Cells	CELL STEM CELL			English	Article							PIGMENT-CHIMERIC EYES; ADULT NEUROGENESIS; VERTEBRATE RETINA; LINEAGE ANALYSIS; NERVOUS-SYSTEM; XENOPUS-LAEVIS; OPTIC TECTUM; FROG RETINA; ZEBRAFISH; GROWTH	Stem cells have the capacity to both self-renew and generate postmitotic cells. Long-term tracking of individual clones in their natural environment constitutes the ultimate way to validate postembryonic stem cells. We identify retinal stem cells (RSCs) using the spatiotemporal organization of the fish retina and follow the complete offspring of a single cell during the postnatal life. RSCs generate two tissues of the adult fish retina, the neural retina (NR) and the retinal-pigmented epithelium (RPE). Despite their common embryonic origin and tight coordination during continuous organ growth, we prove that NR and RPE are maintained by dedicated RSCs that contribute in a fate-restricted manner to either one or the other tissue. We show that in the NR, RSCs are multipotent and generate all neuron types and glia. The clonal origin of these different cell types from a multipotent NSC has far-reaching implications for cell type and tissue homeostasis.	[Centanin, Lazaro; Hoeckendorf, Burkhard; Wittbrodt, Joachim] Univ Heidelberg, Ctr Organismal Studies COS Heidelberg, D-69120 Heidelberg, Germany; [Hoeckendorf, Burkhard] Univ Heidelberg, Hartmut Hoffman Berling Int Grad Sch, D-69120 Heidelberg, Germany; [Hoeckendorf, Burkhard] Karlsruhe Inst Technol, BioInterfaces Programme, BioInterfaces Int Grad Sch, D-76344 Eggenstein Leopoldshafen, Germany; [Wittbrodt, Joachim] Karlsruhe Inst Technol, Inst Toxicol & Genet, D-76344 Eggenstein Leopoldshafen, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology	Centanin, L (corresponding author), Univ Heidelberg, Ctr Organismal Studies COS Heidelberg, Neuenheimer Feld 230, D-69120 Heidelberg, Germany.	lazaro.centanin@cos.uni-heidelberg.de; jochen.wittbrodt@cos.uni-heidelberg.de	Wittbrodt, Joachim/D-4735-2014	Wittbrodt, Joachim/0000-0001-8550-7377; Centanin, Lazaro/0000-0003-3889-4524	Marie Curie IIF fellowship; German Science Funding Agency [SFB 488, SFB 873]	Marie Curie IIF fellowship(European Commission); German Science Funding Agency	We thank T. Auer, D. Inoue, R. Reinhard, P. Haas, A. Schmidt, J.-R. Martinez-Morales, J.L. Mateo, and A. Mateos Gil for critical comments, discussions, and reading of the manuscript, P. Keller for initial recording and reconstruction of DSLM data, and A. Saraceno and E. Leist for fish husbandry. We very much appreciate the feedback during the review process on earlier versions of the manuscript. L.C. was supported by a Marie Curie IIF fellowship. This work was financially supported by the German Science Funding Agency through the SFB 488 and SFB 873 (J.W.).	Adolf B, 2006, DEV BIOL, V295, P278, DOI 10.1016/j.ydbio.2006.03.023; Agathocleous M, 2009, ANNU REV CELL DEV BI, V25, P45, DOI 10.1146/annurev.cellbio.042308.113259; Allison WT, 2010, J COMP NEUROL, V518, P4182, DOI 10.1002/cne.22447; Alunni A, 2010, DEV NEUROBIOL, V70, P693, DOI 10.1002/dneu.20799; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; ALVAREZBUYLLA A, 1992, EXP NEUROL, V115, P110, DOI 10.1016/0014-4886(92)90232-F; Amato MA, 2004, INT J DEV BIOL, V48, P993, DOI 10.1387/ijdb.041879ma; Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Bernardos RL, 2007, J NEUROSCI, V27, P7028, DOI 10.1523/JNEUROSCI.1624-07.2007; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Brown KE, 2010, DEV BIOL, V339, P14, DOI 10.1016/j.ydbio.2009.12.003; Dowling J. E., 1987, RETINA APPROACHABLE; FEKETE DM, 1994, DEV BIOL, V166, P666, DOI 10.1006/dbio.1994.1346; Fimbel SM, 2007, J NEUROSCI, V27, P1712, DOI 10.1523/JNEUROSCI.5317-06.2007; Garrett RW, 2009, CELL STEM CELL, V4, P503, DOI 10.1016/j.stem.2009.05.011; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; HO RK, 1990, NATURE, V348, P728, DOI 10.1038/348728a0; HOLLYFIELD JG, 1968, DEV BIOL, V18, P163, DOI 10.1016/0012-1606(68)90041-9; HOLLYFIELD JG, 1971, DEV BIOL, V24, P264, DOI 10.1016/0012-1606(71)90098-4; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; HUNT RK, 1988, P NATL ACAD SCI USA, V85, P3459, DOI 10.1073/pnas.85.10.3459; HUNT RK, 1987, P NATL ACAD SCI USA, V84, P3302, DOI 10.1073/pnas.84.10.3302; JOHNS PR, 1977, J COMP NEUROL, V176, P343, DOI 10.1002/cne.901760304; JOHNS PR, 1981, NATURE, V293, P141, DOI 10.1038/293141a0; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Koster R, 1997, DEVELOPMENT, V124, P3147; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Martinez-Morales JR, 2004, BIOESSAYS, V26, P766, DOI 10.1002/bies.20064; Moshiri A, 2004, INT J DEV BIOL, V48, P1003, DOI 10.1387/ijdb.041870am; Nakamura S, 2010, SCIENCE, V328, P1561, DOI 10.1126/science.1185473; Nguyen V, 1999, J COMP NEUROL, V413, P385, DOI 10.1002/(SICI)1096-9861(19991025)413:3<385::AID-CNE3>3.0.CO;2-P; Perron M, 2000, BIOESSAYS, V22, P685, DOI 10.1002/1521-1878(200008)22:8<685::AID-BIES1>3.0.CO;2-C; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; Raya A, 2003, P NATL ACAD SCI USA, V100, P11889, DOI 10.1073/pnas.1834204100; Raymond PA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-36; Reh TA, 1998, J NEUROBIOL, V36, P206, DOI 10.1002/(SICI)1097-4695(199808)36:2<206::AID-NEU8>3.3.CO;2-4; Rembold M, 2006, NAT PROTOC, V1, P1133, DOI 10.1038/nprot.2006.165; Rembold M, 2006, SCIENCE, V313, P1130, DOI 10.1126/science.1127144; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; STRAZNICKY K, 1971, J EMBRYOL EXP MORPH, V26, P67; Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Wehman AM, 2005, DEV BIOL, V281, P53, DOI 10.1016/j.ydbio.2005.02.010; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; WETTS R, 1989, DEV BIOL, V136, P254, DOI 10.1016/0012-1606(89)90146-2; White RM, 2008, CELL STEM CELL, V3, P242, DOI 10.1016/j.stem.2008.08.005; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	51	66	67	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	DEC 2	2011	9	6					553	562		10.1016/j.stem.2011.11.004	http://dx.doi.org/10.1016/j.stem.2011.11.004			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	859SB	22136930	Bronze			2022-12-28	WOS:000297895000015
J	Glimm, H; Ball, CR; von Kalle, C				Glimm, Hanno; Ball, Claudia R.; von Kalle, Christof			You Can Count on This: Barcoded Hematopoietic Stem Cells	CELL STEM CELL			English	Editorial Material							GENE-THERAPY; VECTOR INTEGRATION; IN-VIVO; SCID-X1		[Glimm, Hanno; Ball, Claudia R.; von Kalle, Christof] Natl Ctr Tumor Dis NCT, Dept Translat Oncol, D-69120 Heidelberg, Germany; [Glimm, Hanno; Ball, Claudia R.; von Kalle, Christof] German Canc Res Ctr, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Glimm, H (corresponding author), Natl Ctr Tumor Dis NCT, Dept Translat Oncol, D-69120 Heidelberg, Germany.	hanno.glimm@nct-heidelberg.de; christof.kalle@nct-heidelberg.de		Ball, Claudia/0000-0002-1749-3791				Bushman FD, 2003, CELL, V115, P135, DOI 10.1016/S0092-8674(03)00760-8; Deichmann A, 2007, J CLIN INVEST, V117, P2225, DOI 10.1172/JCI31659; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Gabriel R, 2009, NAT MED, V15, P1431, DOI 10.1038/nm.2057; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Kustikova O, 2005, SCIENCE, V308, P1171, DOI 10.1126/science.1105063; Lu R, 2011, NAT BIOTECHNOL, V29, P928, DOI 10.1038/nbt.1977; Manfred S, 2007, NAT METHODS, V4, P1051, DOI 10.1038/nmeth1103; Nolta JA, 2001, LEUKEMIA, V15, P1677, DOI 10.1038/sj.leu.2402254; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Weissman IL, 2008, BLOOD, V112, P3543, DOI 10.1182/blood-2008-08-078220	11	8	10	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 4	2011	9	5					390	392		10.1016/j.stem.2011.10.013	http://dx.doi.org/10.1016/j.stem.2011.10.013			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	850FJ	22056135	Bronze			2022-12-28	WOS:000297180200005
J	Wang, P; Rodriguez, RT; Wang, J; Ghodasara, A; Kim, SK				Wang, Pei; Rodriguez, Ryan T.; Wang, Jing; Ghodasara, Amar; Kim, Seung K.			Targeting SOX17 in Human Embryonic Stem Cells Creates Unique Strategies for Isolating and Analyzing Developing Endoderm	CELL STEM CELL			English	Article							BLOOD-GROUP PROTEIN; TRANSCRIPTION FACTOR; DEFINITIVE ENDODERM; VISCERAL ENDODERM; PROGENITOR CELLS; IN-VIVO; DIFFERENTIATION; EXPRESSION; MOUSE; PANCREAS	Human embryonic stem cells (hESCs) can provide insights into development of inaccessible human tissues such as embryonic endoderm. Progress in this area has been hindered by a lack of methods for isolating endodermal cells and tracing fates of their differentiated progeny. By using homologous recombination in human ESCs, we inserted an enhanced green fluorescent protein (eGFP) transgene into the SOX17 locus, a postulated marker of human endoderm. FACS purification and gene expression profiling confirmed that SOX17(+)-hESC progeny expressed endodermal markers and unveiled specific cell surface protein combinations that permitted FACS-based isolation of primitive gut tube endodermal cells produced from unmodified human ESCs and from induced pluripotent stem cells (iPSC). Differentiating SOX17(+) endodermal cells expressed markers of liver, pancreas, and intestinal epithelium in vitro and gave rise to endodermal progeny in vivo. Thus, prospective isolation, lineage tracing, and developmental studies of SOX17(+) hESC progeny have revealed fundamental aspects of human endodermal biology.	[Wang, Pei; Rodriguez, Ryan T.; Wang, Jing; Ghodasara, Amar; Kim, Seung K.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Kim, Seung K.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Kim, Seung K.] Stanford Univ, Sch Med, Dept Med, Div Oncol, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Kim, SK (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.	seungkim@stanford.edu		Wang, Pei/0000-0003-2373-7315; Kim, Seung/0000-0001-6135-7810	Larry L. Hillblom Foundation (LLHF); Mead Foundation; Harry and Leona Helmsley Trust; California Institute of Regenerative Medicine; Howard Hughes Medical Institute (HHMI)	Larry L. Hillblom Foundation (LLHF); Mead Foundation; Harry and Leona Helmsley Trust; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute)	We thank Drs. R. Ardehali, R. Nusse, T. Blauwkamp, T. Zwaka, J. Thomson, R. Reijo Pera, N. Nguyen, N. Byers, E. Chiao, J. Baker, H. Edlund, H. Vogel, D. Wong, H. Chang, the Birth Defects Research Laboratory at the University of Washington, and members of the S.K.K. group for materials, advice, and assistance. P.W. was supported by a Larry L. Hillblom Foundation (LLHF) fellowship. The S.K.K. group was supported by the Mead Foundation, Harry and Leona Helmsley Trust, LLHF, California Institute of Regenerative Medicine, and the Howard Hughes Medical Institute (HHMI). S.K.K. is an Investigator of the HHMI. P.W. and S.K.K. conceived the project and designed the experiments; P.W., R.T.R., J.W., and A.G. performed the experiments; P.W. and R.T.R. performed the data analysis; and P.W., R.T.R., and S.K.K. wrote the manuscript.	ALBELDA SM, 1991, J CELL BIOL, V114, P1059, DOI 10.1083/jcb.114.5.1059; ARGRAVES WS, 1986, J BIOL CHEM, V261, P2922; Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Carpenter MK, 2009, NAT BIOTECHNOL, V27, P606, DOI 10.1038/nbt0709-606; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chiao E, 2008, METHOD CELL BIOL, V86, P1, DOI 10.1016/S0091-679X(08)00001-0; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Davis RP, 2008, NAT PROTOC, V3, P1550, DOI 10.1038/nprot.2008.146; Duan YY, 2007, STEM CELLS, V25, P3058, DOI 10.1634/stemcells.2007-0291; Engert S, 2009, GENESIS, V47, P603, DOI 10.1002/dvg.20540; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Hoffman BG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r99; Hou J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-92; Isermann B, 2003, NAT MED, V9, P331, DOI 10.1038/nm825; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; LEE S, 1991, P NATL ACAD SCI USA, V88, P6353, DOI 10.1073/pnas.88.14.6353; Lyttle BM, 2008, DIABETOLOGIA, V51, P1169, DOI 10.1007/s00125-008-1006-z; Matveyenko AV, 2010, AM J PHYSIOL-ENDOC M, V299, pE713, DOI 10.1152/ajpendo.00279.2010; McKnight KD, 2010, CELL STEM CELL, V6, P300, DOI 10.1016/j.stem.2010.03.003; Mfopou JK, 2010, GASTROENTEROLOGY, V138, P2233, DOI 10.1053/j.gastro.2010.02.056; Morrison GM, 2008, CELL STEM CELL, V3, P402, DOI 10.1016/j.stem.2008.07.021; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; Russo D, 2000, BLOOD, V96, P340, DOI 10.1182/blood.V96.1.340.013k45_340_346; Sarkar SA, 2008, DIABETOLOGIA, V51, P285, DOI 10.1007/s00125-007-0880-0; Schriebil K, 2010, BIOTECHNOL J, V5, P50, DOI 10.1002/biot.200900115; Sherwood RI, 2007, DEV BIOL, V304, P541, DOI 10.1016/j.ydbio.2007.01.011; Shivdasani RA, 2002, DEV BIOL, V249, P191, DOI 10.1006/dbio.2002.0765; Sohn J, 2006, J NEUROSCI, V26, P9722, DOI 10.1523/JNEUROSCI.1716-06.2006; Spence JR, 2009, DEV CELL, V17, P62, DOI 10.1016/j.devcel.2009.05.012; Tam PPL, 2003, CURR OPIN GENET DEV, V13, P393, DOI 10.1016/S0959-437X(03)00085-6; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; WEN DZ, 1987, BIOCHEMISTRY-US, V26, P4350, DOI 10.1021/bi00388a025; YAMAGUCHI TP, 1993, DEVELOPMENT, V118, P489; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Zeng XM, 2008, CURR OPIN MOL THER, V10, P207; Zhou Q, 2007, DEV CELL, V13, P103, DOI 10.1016/j.devcel.2007.06.001	43	90	94	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 4	2011	8	3					335	346		10.1016/j.stem.2011.01.017	http://dx.doi.org/10.1016/j.stem.2011.01.017			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	735HI	21362573	Green Accepted, Bronze			2022-12-28	WOS:000288404400015
J	Schepers, K; Pietras, EM; Reynaud, D; Flach, J; Binnewies, M; Garg, T; Wagers, AJ; Hsiao, EC; Passegue, E				Schepers, Koen; Pietras, Eric M.; Reynaud, Damien; Flach, Johanna; Binnewies, Mikhail; Garg, Trit; Wagers, Amy J.; Hsiao, Edward C.; Passegue, Emmanuelle			Myeloproliferative Neoplasia Remodels the Endosteal Bone Marrow Niche into a Self-Reinforcing Leukemic Niche	CELL STEM CELL			English	Article							HEMATOPOIETIC STEM-CELLS; CHRONIC MYELOGENOUS LEUKEMIA; CHRONIC MYELOID-LEUKEMIA; OSTEOBLASTIC CELLS; PRIMARY MYELOFIBROSIS; IN-VIVO; MICROENVIRONMENT; DIFFERENTIATION; PROLIFERATION; MAINTENANCE	Multipotent stromal cells (MSCs) and their osteoblastic lineage cell (OBC) derivatives are part of the bone marrow (BM) niche and contribute to hematopoietic stem cell (HSC) maintenance. Here, we show that myeloproliferative neoplasia (MPN) progressively remodels the endosteal BM niche into a self-reinforcing leukemic niche that impairs normal hematopoiesis, favors leukemic stem cell (LSC) function, and contributes to BM fibrosis. We show that leukemic myeloid cells stimulate MSCs to overproduce functionally altered OBCs, which accumulate in the BM cavity as inflammatory myelofibrotic cells. We identify roles for thrombopoietin, CCL3, and direct cell-cell interactions in driving OBC expansion, and for changes in TGF-beta, Notch, and inflammatory signaling in OBC remodeling. MPN-expanded OBCs, in turn, exhibit decreased expression of many HSC retention factors and severely compromised ability to maintain normal HSCs, but effectively support LSCs. Targeting this pathological interplay could represent a novel avenue for treatment of MPN-affected patients and prevention of myelofibrosis.	[Schepers, Koen; Pietras, Eric M.; Reynaud, Damien; Flach, Johanna; Binnewies, Mikhail; Garg, Trit; Passegue, Emmanuelle] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Div Hematol Oncol, San Francisco, CA 94143 USA; [Hsiao, Edward C.] Univ Calif San Francisco, Dept Med, Inst Human Genet, Div Endocrinol & Metab, San Francisco, CA 94143 USA; [Wagers, Amy J.] Harvard Univ, Howard Hughes Med Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Wagers, Amy J.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Howard Hughes Medical Institute; Harvard University	Passegue, E (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Div Hematol Oncol, San Francisco, CA 94143 USA.	passeguee@stemcell.ucsf.edu	Schepers, Koen/H-7108-2013	Schepers, Koen/0000-0003-2442-242X; Reynaud, Damien/0000-0001-8765-8419; Passegue, Emmanuelle/0000-0002-3516-297X	NWO Rubicon fellowship; KWF fellowship; NIH [F32 HL106989, U01 HL100402, K08 AR056299, R01 HL092471]; CIRM New Faculty Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL106989, U01HL100402, R01HL092471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR056299] Funding Source: NIH RePORTER	NWO Rubicon fellowship(Netherlands Organization for Scientific Research (NWO)); KWF fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM New Faculty Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Dr. Paul Frenette (Einstein College of Medicine) for Nes-gfp mice, Dr. Takashi Nagasawa (Kyoto University) for Cxcl12-gfp mice, Dr. Zena Werb (UCSF) for Osx-gfp mice, the UCSF Mouse Pathology and Genomics core facilities, the San Francisco VA Histomorphometry Core, Michael Kissner for management of our Flow Cytometry Core facility, Daniel Carlin for help with the microarray analyses, Zhiqiang Cheng for help with TRAP staining, Stephanie Leong for help with the mouse colonies, and all members of the Passegue laboratory for critical insights and suggestions. This work was supported by NWO Rubicon and KWF fellowships to K.S., NIH F32 HL106989 to E.M.P., NIH U01 HL100402 to A.J.W., NIH K08 AR056299 to E.C.H., and a CIRM New Faculty Award and NIH R01 HL092471 to E.P.	Abdel-Wahab OI, 2009, ANNU REV MED, V60, P233, DOI 10.1146/annurev.med.60.041707.160528; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chitteti BR, 2010, J CELL BIOCHEM, V111, P284, DOI 10.1002/jcb.22694; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Doan PL, 2012, LEUKEMIA, V26, P54, DOI 10.1038/leu.2011.236; Erices A, 2002, EXP CELL RES, V280, P24, DOI 10.1006/excr.2002.5627; Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919; Frisch BJ, 2012, BLOOD, V119, P540, DOI 10.1182/blood-2011-04-348151; GORDON MY, 1987, NATURE, V328, P342, DOI 10.1038/328342a0; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Holyoake T, 1999, BLOOD, V94, P2056, DOI 10.1182/blood.V94.6.2056; Krause DS, 2006, NAT MED, V12, P1175, DOI 10.1038/nm1489; Lane SW, 2009, BLOOD, V114, P1150, DOI 10.1182/blood-2009-01-202606; Lecuyer E, 2004, EXP HEMATOL, V32, P11, DOI 10.1016/j.exphem.2003.10.010; Levine RL, 2008, BLOOD, V112, P2190, DOI 10.1182/blood-2008-03-077966; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Okamoto H, 2008, FEBS J, V275, P4463, DOI 10.1111/j.1742-4658.2008.06582.x; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Reynaud D, 2011, CANCER CELL, V20, P661, DOI 10.1016/j.ccr.2011.10.012; Santaguida M, 2009, CANCER CELL, V15, P341, DOI 10.1016/j.ccr.2009.02.016; Schepers K, 2012, BLOOD, V120, P3425, DOI 10.1182/blood-2011-11-395418; Sonomoto K, 2012, ARTHRITIS RHEUM-US, V64, P3355, DOI 10.1002/art.34555; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; Thiele J, 2006, HISTOL HISTOPATHOL, V21, P1367, DOI 10.14670/HH-21.1367; Vallet S, 2011, LEUKEMIA, V25, P1174, DOI 10.1038/leu.2011.43; Van Etten RA, 2004, CANCER CELL, V6, P547, DOI 10.1016/j.ccr.2004.12.004; Varricchio L, 2009, EXPERT REV HEMATOL, V2, P315, DOI 10.1586/EHM.09.17; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Zhang B, 2012, CANCER CELL, V21, P577, DOI 10.1016/j.ccr.2012.02.018	40	411	420	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 5	2013	13	3					285	299		10.1016/j.stem.2013.06.009	http://dx.doi.org/10.1016/j.stem.2013.06.009			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VQ	23850243	Bronze, Green Accepted			2022-12-28	WOS:000329570800007
J	Yu, B; He, ZY; You, P; Han, QW; Xiang, D; Chen, F; Wang, MJ; Liu, CC; Lin, XW; Borjigin, U; Zi, XY; Li, JX; Zhu, HY; Li, WL; Han, CS; Wangensteen, KJ; Shi, YF; Hui, LJ; Wang, X; Hu, YP				Yu, Bing; He, Zhi-Ying; You, Pu; Han, Qing-Wang; Xiang, Dao; Chen, Fei; Wang, Min-Jun; Liu, Chang-Cheng; Lin, Xi-Wen; Borjigin, Uyunbilig; Zi, Xiao-Yuan; Li, Jian-Xiu; Zhu, Hai-Ying; Li, Wen-Lin; Han, Chun-Sheng; Wangensteen, Kirk J.; Shi, Yufang; Hui, Li-Jian; Wang, Xin; Hu, Yi-Ping			Reprogramming Fibroblasts into Bipotential Hepatic Stem Cells by Defined Factors	CELL STEM CELL			English	Article							LIVER PROGENITOR CELLS; DIRECT CONVERSION; MOUSE FIBROBLASTS; CARDIOMYOCYTES; REGENERATION; REPOPULATION; DYSFUNCTION; GENERATION; NEURONS; ALPHA	Recent studies have demonstrated direct reprogramming of fibroblasts into a range of somatic cell types, but to date stem or progenitor cells have only been reprogrammed for the blood and neuronal lineages. We previously reported generation of induced hepatocyte-like (iHep) cells by transduction of Gata4, Hnf1 alpha, and Foxa3 in p19 Arf null mouse embryonic fibroblasts (MEFs). Here, we show that Hnf1 beta and Foxa3, liver organogenesis transcription factors, are sufficient to reprogram MEFs into induced hepatic stem cells (iHepSCs). iHepSCs can be stably expanded in vitro and possess the potential of bidirectional differentiation into both hepatocytic and cholangiocytic lineages. In the injured liver of fumarylacetoacetate hydrolase (Fah)-deficient mice, repopulating iHepSCs become hepatocyte-like cells. They also engraft as cholangiocytes into bile ducts of mice with DDC-induced bile ductular injury. Lineage conversion into bipotential expandable iHepSCs provides a strategy to enable efficient derivation of both hepatocytes and cholangiocytes for use in disease modeling and tissue engineering.	[Yu, Bing; He, Zhi-Ying; You, Pu; Han, Qing-Wang; Xiang, Dao; Chen, Fei; Wang, Min-Jun; Liu, Chang-Cheng; Zi, Xiao-Yuan; Li, Jian-Xiu; Zhu, Hai-Ying; Li, Wen-Lin; Hu, Yi-Ping] Second Mil Med Univ, Dept Cell Biol, Shanghai 200433, Peoples R China; [Yu, Bing; He, Zhi-Ying; You, Pu; Han, Qing-Wang; Xiang, Dao; Chen, Fei; Wang, Min-Jun; Liu, Chang-Cheng; Zi, Xiao-Yuan; Li, Jian-Xiu; Zhu, Hai-Ying; Li, Wen-Lin; Hu, Yi-Ping] Second Mil Med Univ, Grad Sch, Ctr Stem Cell & Med, Shanghai 200433, Peoples R China; [Lin, Xi-Wen; Han, Chun-Sheng] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Borjigin, Uyunbilig; Wang, Xin] Inner Mongolia Univ, Natl Educ Minist Mammalian Reprod Biol & Biotechn, Key Lab, Hohhot 010070, Peoples R China; [Wangensteen, Kirk J.] Univ Penn, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA; [Shi, Yufang] Shanghai Jiao Tong Univ, Sch Med, Chinese Acad Sci, Key Lab Stem Cell Biol,Inst Hlth Sci,Shanghai Ins, Shanghai 200025, Peoples R China; [Shi, Yufang] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Child Hlth Inst New Jersey, New Brunswick, NJ 08901 USA; [Shi, Yufang] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, New Brunswick, NJ 08901 USA; [Hui, Li-Jian; Wang, Xin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Lab Mol Cell Biol, Shanghai 200031, Peoples R China; [Wang, Xin] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	Naval Medical University; Naval Medical University; Chinese Academy of Sciences; Institute of Zoology, CAS; Inner Mongolia University; University of Pennsylvania; Chinese Academy of Sciences; Shanghai Jiao Tong University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Minnesota System; University of Minnesota Twin Cities	Wang, X (corresponding author), Inner Mongolia Univ, Natl Educ Minist Mammalian Reprod Biol & Biotechn, Key Lab, Hohhot 010070, Peoples R China.	wangxin_cn@imu.edu.cn; yphu@smmu.edu.cn	Yu, Bing/GSD-3362-2022; Shi, Yufang/AAE-4431-2020	Shi, Yufang/0000-0001-8964-319X; Yu, Bing/0000-0002-3421-8601; li, wenlin/0000-0002-0842-222X; Wangensteen, Kirk/0000-0001-6042-6490	National Key Basic Research and Development Program of China [2010CB945600, 2009CB941100, 2011CB966200]; National Natural Science Foundation of China [31171309, 31271474, 31271469, 31271042, 31100996]; Scientific Innovation Project of the Chinese Academy of Science [XDA01040000]; International Science & Technology Cooperation Program of China [2011DFB30010]	National Key Basic Research and Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Innovation Project of the Chinese Academy of Science; International Science & Technology Cooperation Program of China	We thank Dr. Fuming Li (Chinese Academy of Sciences, China) for helpful discussion and critical reading of the manuscript and Dr. Pengyu Huang (Chinese Academy of Sciences, China) for excellent technical support. We thank Professors Yi Sun and Jun Xu (Tongji University, China) for helpful discussion and technical support in laser-capture microdissection, Professors Minghua Zhu and Zhenghua Xiang (Second Military Medical University, China) for histochemical assistance. We thank Professors Joseph T.Y. Lau (Roswell Park Cancer Institute, USA), Gang Wang (Chinese Academy of Sciences, China), and Lixin Feng (Shanghai Jiao Tong University School of Medicine) for helpful discussion. This work was funded by National Key Basic Research and Development Program of China (2010CB945600, 2009CB941100, 2011CB966200), National Natural Science Foundation of China (31171309, 31271474, 31271469, 31271042, 31100996), Scientific Innovation Project of the Chinese Academy of Science (XDA01040000), and International Science & Technology Cooperation Program of China (2011DFB30010).	Ballatori N, 2005, HEPATOLOGY, V42, P1270, DOI 10.1002/hep.20961; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Coffinier C, 2002, DEVELOPMENT, V129, P1829; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Dorrell C, 2011, GENE DEV, V25, P1193, DOI 10.1101/gad.2029411; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; GROMPE M, 1993, GENE DEV, V7, P2298, DOI 10.1101/gad.7.12a.2298; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; He ZY, 2012, INT J BIOCHEM CELL B, V44, P648, DOI 10.1016/j.biocel.2012.01.002; He ZY, 2010, AM J PATHOL, V177, P1311, DOI 10.2353/ajpath.2010.091154; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Ishikawa T, 2012, HEPATOLOGY, V55, P1215, DOI 10.1002/hep.24796; Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Le Lay J, 2010, PHYSIOL REV, V90, P1, DOI 10.1152/physrev.00018.2009; Li FM, 2010, GASTROENTEROLOGY, V139, P2158, DOI 10.1053/j.gastro.2010.08.042; Li WL, 2006, STEM CELLS, V24, P322, DOI 10.1634/stemcells.2005-0108; Liu XJ, 2012, CELL RES, V22, P321, DOI 10.1038/cr.2011.181; Lokmane L, 2008, DEVELOPMENT, V135, P2777, DOI 10.1242/dev.023010; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Moritoki Y, 2006, LIVER INT, V26, P457, DOI 10.1111/j.1478-3231.2006.01250.x; Nejak-Bowen Kari, 2008, Organogenesis, V4, P92; Oertel M, 2008, GASTROENTEROLOGY, V134, P823, DOI 10.1053/j.gastro.2008.01.007; Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369; Overturf K, 1996, NAT GENET, V12, P266, DOI 10.1038/ng0396-266; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Preisegger KH, 1999, LAB INVEST, V79, P103; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Sackett SD, 2009, HEPATOLOGY, V49, P920, DOI 10.1002/hep.22705; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Shafritz D.A., 2002, EINSTEIN Q J BIOL ME, V19, P20; Shin S, 2011, GENE DEV, V25, P1185, DOI 10.1101/gad.2027811; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanimizu N, 2004, J CELL SCI, V117, P6425, DOI 10.1242/jcs.01572; Tanimizu N, 2007, MOL BIOL CELL, V18, P1472, DOI 10.1091/mbc.E06-09-0848; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Thompson MD, 2010, AM J PATHOL, V177, P1812, DOI 10.2353/ajpath.2010.100173; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Wang X, 2003, P NATL ACAD SCI USA, V100, P11881, DOI 10.1073/pnas.1734199100; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zaret KS, 2008, NAT REV GENET, V9, P329, DOI 10.1038/nrg2318	51	120	139	2	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 5	2013	13	3					328	340		10.1016/j.stem.2013.06.017	http://dx.doi.org/10.1016/j.stem.2013.06.017			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VQ	23871605	Bronze			2022-12-28	WOS:000329570800010
J	Morimoto, H; Iwata, K; Ogonuki, N; Inoue, K; Atsuo, O; Kanatsu-Shinohara, M; Morimoto, T; Yabe-Nishimura, C; Shinohara, T				Morimoto, Hiroko; Iwata, Kazumi; Ogonuki, Narumi; Inoue, Kimiko; Atsuo, Ogura; Kanatsu-Shinohara, Mito; Morimoto, Takeshi; Yabe-Nishimura, Chihiro; Shinohara, Takashi			ROS Are Required for Mouse Spermatogonial Stem Cell Self-Renewal	CELL STEM CELL			English	Article							OXIDATIVE STRESS; UNDIFFERENTIATED SPERMATOGONIA; NEUROTROPHIC FACTOR; P38 MAPK; OXYGEN; PROLIFERATION; MICE; ATM; SPERMATOGENESIS; OXIDASE	Reactive oxygen species (ROS) generation is implicated in stem cell self-renewal in several tissues but is thought to be detrimental for spermatogenesis as well as spermatogonial stem cells (SSCs). Using cultured SSCs, we show that ROS are generated via the AKT and MEK signaling pathways under conditions where the growth factors glial cell linederived neurotrophic factor and fibroblast growth factor 2 drive SSC self-renewal and, instead, stimulate self-renewal at physiological levels. SSCs depleted of ROS stopped proliferating, but they showed enhanced self-renewal when ROS levels were increased by the addition of hydrogen peroxide, which induced the phosphorylation of stress kinases p38 mitogen-activated protein kinase (MAPK) and c-jun N-terminal kinase (JNK). Moreover, ROS depletion in vivo decreased SSC number in the testis, and NADPH oxidase 1 (Nox1)-deficient SSCs exhibited reduced self-renewal division upon serial transplantation. These results suggest that ROS generated by Nox1 play critical roles in SSC selfrenewal via the activation of the p38 MAPK and JNK pathways.	[Morimoto, Hiroko; Kanatsu-Shinohara, Mito; Shinohara, Takashi] Kyoto Univ, Grad Sch Med, Dept Mol Genet, Kyoto 6068501, Japan; [Iwata, Kazumi; Yabe-Nishimura, Chihiro] Kyoto Prefectural Univ Med, Dept Pharmacol, Kyoto 6028566, Japan; [Ogonuki, Narumi; Inoue, Kimiko; Atsuo, Ogura] RIKEN BioResource Ctr, Tsukuba, Ibaraki 3050074, Japan; [Morimoto, Takeshi] Kinki Univ, Sch Med, Ctr Gen Int Med & Emergency Care, Osaka 5898511, Japan; [Shinohara, Takashi] Japan Sci & Technol Agcy, CREST, Kyoto 6068501, Japan	Kyoto University; Kyoto Prefectural University of Medicine; RIKEN; Kindai University (Kinki University); Japan Science & Technology Agency (JST)	Shinohara, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Mol Genet, Kyoto 6068501, Japan.	tshinoha@virus.kyoto-u.ac.jp	Ogura, Atsuo/J-3916-2014	Ogura, Atsuo/0000-0003-0447-1988; Iwata, Kazumi/0000-0002-9595-7782	Japan Science and Technology Agency (CREST); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Grants-in-Aid for Scientific Research [25293067] Funding Source: KAKEN	Japan Science and Technology Agency (CREST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Y. Ogata for technical assistance. This research was supported by the Japan Science and Technology Agency (CREST) and the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Arnold RS, 2001, P NATL ACAD SCI USA, V98, P5550, DOI 10.1073/pnas.101505898; Benhar M, 2002, EMBO REP, V3, P420, DOI 10.1093/embo-reports/kvf094; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; Chen C, 2005, NATURE, V436, P1030, DOI 10.1038/nature03894; Chuikov S, 2010, NAT CELL BIOL, V12, P999, DOI 10.1038/ncb2101; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; De Rooij DG, 2000, J ANDROL, V21, P776; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Goertz MJ, 2011, J CLIN INVEST, V121, P3456, DOI 10.1172/JCI57984; Goriely A, 2009, NAT GENET, V41, P1247, DOI 10.1038/ng.470; Ishii K, 2012, DEVELOPMENT, V139, P1734, DOI 10.1242/dev.076539; Ishii T, 2005, FREE RADICAL RES, V39, P697, DOI 10.1080/10715760500130517; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Kamata T, 2009, CANCER SCI, V100, P1382, DOI 10.1111/j.1349-7006.2009.01207.x; Kanatsu-Shinohara M, 2005, DEVELOPMENT, V132, P4155, DOI 10.1242/dev.02004; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2006, BIOL REPROD, V75, P68, DOI 10.1095/biolreprod.106.051193; Kanatsu-Shinohara M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023663; Katsuyama M, 2012, J CLIN BIOCHEM NUTR, V50, P9, DOI 10.3164/jcbn.11-06SR; Kim J, 2009, STEM CELLS, V27, P1987, DOI 10.1002/stem.125; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Lee J, 2007, DEVELOPMENT, V134, P1853, DOI 10.1242/dev.003004; Lee J, 2009, CELL STEM CELL, V5, P76, DOI 10.1016/j.stem.2009.04.020; Li TS, 2010, STEM CELLS, V28, P1178, DOI 10.1002/stem.438; Matsuno K, 2005, CIRCULATION, V112, P2677, DOI 10.1161/CIRCULATIONAHA.105.573709; Meistrich ML, 1993, CELL MOL BIOL TESTIS, P266; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Meng XJ, 2001, CANCER RES, V61, P3267; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Monge M, 2009, CARCINOGENESIS, V30, P1288, DOI 10.1093/carcin/bgp119; MULLANEY BP, 1992, ENDOCRINOLOGY, V131, P2928, DOI 10.1210/en.131.6.2928; Nagano M, 1999, BIOL REPROD, V60, P1429, DOI 10.1095/biolreprod60.6.1429; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Nakamura BN, 2010, FREE RADICAL BIO MED, V49, P1368, DOI 10.1016/j.freeradbiomed.2010.07.019; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Oatley JM, 2007, J BIOL CHEM, V282, P25842, DOI 10.1074/jbc.M703474200; Oatley JM, 2012, PHYSIOL REV, V92, P577, DOI 10.1152/physrev.00025.2011; Ogonuki N, 2006, P NATL ACAD SCI USA, V103, P13098, DOI 10.1073/pnas.0605755103; Piccoli C, 2007, BIOCHEM BIOPH RES CO, V353, P965, DOI 10.1016/j.bbrc.2006.12.148; Sato K, 2008, J NEUROSCI RES, V86, P2179, DOI 10.1002/jnr.21668; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Seth D, 2006, BIOCHEMISTRY-US, V45, P8476, DOI 10.1021/bi060157p; Tadokoro Y, 2002, MECH DEVELOP, V113, P29, DOI 10.1016/S0925-4773(02)00004-7; Takubo K, 2008, CELL STEM CELL, V2, P170, DOI 10.1016/j.stem.2007.10.023; Takubo K, 2006, BIOCHEM BIOPH RES CO, V351, P993, DOI 10.1016/j.bbrc.2006.10.145	46	152	166	4	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 6	2013	12	6					774	786		10.1016/j.stem.2013.04.001	http://dx.doi.org/10.1016/j.stem.2013.04.001			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VH	23746981	Bronze, Green Published			2022-12-28	WOS:000329569900019
J	Mathews, DJH; Cook-Deegan, R; Bubela, T				Mathews, Debra J. H.; Cook-Deegan, Robert; Bubela, Tania			Patents and Misplaced Angst: Lessons for Translational Stem Cell Research from Genomics	CELL STEM CELL			English	Editorial Material							PROPERTY; ACCESS	Realizing the therapeutic potential of both stem cell and genomics research requires harnessing the respective strengths of academic, biotechnology, and pharmaceutical sectors, supported by policies and legal incentives for multisectorial collaboration. Here, we discuss issues facing these fields and lessons from the genomics sector that apply to stem cell research.	[Mathews, Debra J. H.] Johns Hopkins Berman Inst Bioeth, Baltimore, MD 21205 USA; [Cook-Deegan, Robert] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Cook-Deegan, Robert] Duke Univ, Sanford Sch Publ Policy, Durham, NC 27708 USA; [Bubela, Tania] Edmonton Clin Hlth Acad, Sch Publ Hlth, Edmonton, AB T6G 1C9, Canada	Johns Hopkins University; Duke University; Duke University	Bubela, T (corresponding author), Edmonton Clin Hlth Acad, Sch Publ Hlth, 11405 87 Ave, Edmonton, AB T6G 1C9, Canada.	tbubela@ualberta.ca	Bubela, Tania/F-4860-2014	Bubela, Tania/0000-0002-0807-2899; Cook-Deegan, Robert/0000-0002-8251-4237; Mathews, Debra/0000-0002-4897-7617	Biotechnology and Biological Sciences Research Council Funding Source: Medline; Medical Research Council Funding Source: Medline; NHGRI NIH HHS [P50 HG00391, P50 HG003391] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003391] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Wellcome Trust(Wellcome Trust); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Bergman K, 2007, NAT BIOTECHNOL, V25, P419, DOI 10.1038/nbt0407-419; Bubela T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003490; Caulfield T, 2012, GENOME MED, V4, DOI 10.1186/gm316; Cook-Deegan RM, 2001, SCIENCE, V293, P217, DOI 10.1126/science.1058032; Giebel LB, 2005, NAT BIOTECHNOL, V23, P798, DOI 10.1038/nbt0705-798; Gold ER, 2010, GENET MED, V12, pS39, DOI 10.1097/GIM.0b013e3181d72661; Levine AD, 2011, NAT BIOTECHNOL, V29, P1079, DOI 10.1038/nbt.2029; Mathews DJH, 2011, SCIENCE, V331, P725, DOI 10.1126/science.1201382; McCormick JB, 2009, CELL STEM CELL, V4, P107, DOI 10.1016/j.stem.2009.01.002; Williams HL, 2013, J POLIT ECON, V121, P1, DOI 10.1086/669706	10	7	7	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 2	2013	12	5					508	512		10.1016/j.stem.2013.04.015	http://dx.doi.org/10.1016/j.stem.2013.04.015			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VE	23642360	Bronze, Green Accepted			2022-12-28	WOS:000329569600006
J	Allsopp, R				Allsopp, Rich			Short Telomeres Flirt with StemCell Commitment	CELL STEM CELL			English	Editorial Material							CELLS; CANCER	High expression of telomerase in embryonic stem cells (ESCs) is important for their maintenance, but whether telomere length affects lineage commitment is unknown. In this issue of Cell Stem Cell, Pucci et al. (2013) reveal that ESCs with short telomeres exhibit unstable differentiation by inducing altered DNA methylation.	Univ Hawaii, John A Burns Sch Med, Inst Biogenesis Res, Honolulu, HI 96813 USA	University of Hawaii System	Allsopp, R (corresponding author), Univ Hawaii, John A Burns Sch Med, Inst Biogenesis Res, Honolulu, HI 96813 USA.	allsopp@hawaii.edu						Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Liu Y, 2000, CURR BIOL, V10, P1459, DOI 10.1016/S0960-9822(00)00805-8; Niida H, 1998, NAT GENET, V19, P203, DOI 10.1038/580; O'Sullivan RJ, 2010, NAT STRUCT MOL BIOL, V17, P1218, DOI 10.1038/nsmb.1897; Pucci F, 2013, CELL STEM CELL, V12, P479, DOI 10.1016/j.stem.2013.01.018; Shay JW, 2011, SEMIN CANCER BIOL, V21, P349, DOI 10.1016/j.semcancer.2011.10.001; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857	9	0	0	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 4	2013	12	4					383	384		10.1016/j.stem.2013.03.011	http://dx.doi.org/10.1016/j.stem.2013.03.011			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VD	23561436	Bronze			2022-12-28	WOS:000329569500001
J	Vincent, JJ; Huang, Y; Chen, PY; Feng, SH; Calvopina, JH; Nee, K; Lee, SA; Le, T; Yoon, AJ; Faull, K; Fan, GP; Rao, A; Jacobsen, SE; Pellegrini, M; Clark, AT				Vincent, John J.; Huang, Yun; Chen, Pao-Yang; Feng, Suhua; Calvopina, Joseph H.; Nee, Kevin; Lee, Serena A.; Thuc Le; Yoon, Alexander J.; Faull, Kym; Fan, Guoping; Rao, Anjana; Jacobsen, Steven E.; Pellegrini, Matteo; Clark, Amander T.			Stage-Specific Roles for Tet1 and Tet2 in DNA Demethylation in Primordial Germ Cells	CELL STEM CELL			English	Article							IMPRINT ERASURE; MOUSE EMBRYO; METHYLATION; DYNAMICS; GENOME; 5-HYDROXYMETHYLCYTOSINE; LINEAGES	Primordial germ cells (PGCs) undergo dramatic rearrangements to their methylome during embryogenesis, including initial genome-wide DNA demethylation that establishes the germline epigenetic ground state. The role of the 5-methylcytosine (5mC) dioxygenases Tet1 and Tet2 in the initial genome-wide DNA demethylation process has not been examined directly. Using PGCs differentiated from either control or Tet2(-/-); Tet1 knockdown embryonic stem cells (ESCs), we show that in vitro PGC (iPGC) formation and genome-wide DNA demethylation are unaffected by the absence of Tet1 and Tet2, and thus 5-hydroxymethylcytosine (5hmC). However, numerous promoters and gene bodies were hypermethylated in mutant iPGCs, which is consistent with a role for 5hmC as an intermediate in locus-specific demethylation. Altogether, our results support a revised model of PGC DNA demethylation in which the first phase of comprehensive 5mC loss does not involve 5hmC. Instead, Tet1 and Tet2 have a locus-specific role in shaping the PGC epigenome during subsequent development.	[Vincent, John J.; Yoon, Alexander J.; Faull, Kym; Fan, Guoping; Jacobsen, Steven E.; Pellegrini, Matteo; Clark, Amander T.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Vincent, John J.; Chen, Pao-Yang; Feng, Suhua; Calvopina, Joseph H.; Nee, Kevin; Lee, Serena A.; Jacobsen, Steven E.; Pellegrini, Matteo; Clark, Amander T.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Vincent, John J.; Chen, Pao-Yang; Feng, Suhua; Calvopina, Joseph H.; Fan, Guoping; Jacobsen, Steven E.; Pellegrini, Matteo; Clark, Amander T.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Thuc Le; Fan, Guoping] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Thuc Le; Yoon, Alexander J.; Faull, Kym] Univ Calif Los Angeles, Pasarow Mass Spectrometry Lab, Los Angeles, CA 90095 USA; [Jacobsen, Steven E.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Huang, Yun; Rao, Anjana] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA; [Chen, Pao-Yang] Acad Sinica, Inst Plant & Microbial Biol, Taipei 11529, Taiwan	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; La Jolla Institute for Immunology; Academia Sinica - Taiwan	Clark, AT (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA.	clarka@ucla.edu	Chen, Pao-Yang/ABG-9939-2020	Chen, Pao-Yang/0000-0002-7402-3075; Huang, Yun/0000-0001-5950-9168; Fan, Guoping/0000-0001-5235-6410; Pellegrini, Matteo/0000-0001-9355-9564	National Institutes of Health (NIH) [R01HD058047]; Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research; NIH [R01 HD065812, CA151535]; UCLA; Leukemia & Lymphoma Society; California Institute for Regenerative Medicine [TG2-01169]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058047, R01HD065812] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA151535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044432] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA(University of California System); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by grant R01HD058047 from the National Institutes of Health (NIH) and a Research Award from the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research to A. T. C. and NIH grants R01 HD065812 and CA151535 to A. R. The sequencing and FACS experiments were performed at the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research Sequencing Center and FACS facility. J.J.V. is supported by a Dissertation Year Fellowship from UCLA. Y.H. and S. F. are supported by postdoctoral fellowships from the Leukemia & Lymphoma Society and J.H.C. is supported by fellowship TG2-01169 from the California Institute for Regenerative Medicine. Requests for Tet2<SUP>-/-</SUP> ESCs should be directed to A. R. at the La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA.	Ambartsumyan G, 2010, HUM MOL GENET, V19, P3970, DOI 10.1093/hmg/ddq312; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Chen PY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-203; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Feng SH, 2011, METHODS MOL BIOL, V733, P223, DOI 10.1007/978-1-61779-089-8_16; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Gkountela S, 2013, NAT CELL BIOL, V15, P113, DOI 10.1038/ncb2638; Guibert S, 2012, GENOME RES, V22, P633, DOI 10.1101/gr.130997.111; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Laird CD, 2004, P NATL ACAD SCI USA, V101, P204, DOI 10.1073/pnas.2536758100; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; LAWSON KA, 1994, CIBA F SYMP, V182, P68; Lees-Murdock DJ, 2003, GENOMICS, V82, P230, DOI 10.1016/S0888-7543(03)00105-8; Lei H, 1996, DEVELOPMENT, V122, P3195; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; MONK M, 1987, DEVELOPMENT, V99, P371; Ohinata Y, 2006, E SCHERING RES FDN W, V60, P143; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tam PPL, 1996, DEV BIOL, V178, P124, DOI 10.1006/dbio.1996.0203; Tanaka T, 2011, P NATL ACAD SCI USA, V108, P10579, DOI 10.1073/pnas.1015447108; Thuc L, 2011, ANAL BIOCHEM, V412, P203, DOI 10.1016/j.ab.2011.01.026; Vincent JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028960; Yabuta Y, 2011, J CELL BIOL, V192, P781, DOI 10.1083/jcb.201009043; Yamaguchi S, 2012, NATURE, V492, P443, DOI 10.1038/nature11709; Ying Y, 2001, P NATL ACAD SCI USA, V98, P7858, DOI 10.1073/pnas.151242798	40	135	138	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 4	2013	12	4					470	478		10.1016/j.stem.2013.01.016	http://dx.doi.org/10.1016/j.stem.2013.01.016			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VD	23415914	Green Accepted, Bronze			2022-12-28	WOS:000329569500013
J	Goff, DJ; Recart, AC; Sadarangani, A; Chun, HJ; Barrett, CL; Krajewska, M; Leu, H; Low-Marchelli, J; Ma, WX; Shih, AY; Wei, J; Zhai, DY; Geron, I; Pu, MY; Bao, L; Chuang, R; Balaian, L; Gotlib, J; Minden, M; Martinelli, G; Rusert, J; Dao, KH; Shazand, K; Wentworth, P; Smith, KM; Jamieson, CAM; Morris, SR; Messer, K; Goldstein, LSB; Hudson, TJ; Marra, M; Frazer, KA; Pellecchia, M; Reed, JC; Jamieson, CHM				Goff, Daniel J.; Recart, Angela Court; Sadarangani, Anil; Chun, Hye-Jung; Barrett, Christian L.; Krajewska, Maryla; Leu, Heather; Low-Marchelli, Janine; Ma, Wenxue; Shih, Alice Y.; Wei, Jun; Zhai, Dayong; Geron, Ifat; Pu, Minya; Bao, Lei; Chuang, Ryan; Balaian, Larisa; Gotlib, Jason; Minden, Mark; Martinelli, Giovanni; Rusert, Jessica; Dao, Kim-Hien; Shazand, Kamran; Wentworth, Peggy; Smith, Kristen M.; Jamieson, Christina A. M.; Morris, Sheldon R.; Messer, Karen; Goldstein, Lawrence S. B.; Hudson, Thomas J.; Marra, Marco; Frazer, Kelly A.; Pellecchia, Maurizio; Reed, John C.; Jamieson, Catriona H. M.			A Pan-BCL2 Inhibitor Renders Bone-Marrow-Resident Human Leukemia Stem Cells Sensitive to Tyrosine Kinase Inhibition	CELL STEM CELL			English	Article							CHRONIC MYELOID-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; BCL-2 FAMILY PROTEINS; BLAST-CRISIS CML; IN-VIVO; REDUCES PROLIFERATION; HEMATOPOIETIC-CELLS; CANCER-THERAPY; CD34(+) CELLS; CYCLE CONTROL	Leukemia stem cells (LSCs) play a pivotal role in the resistance of chronic myeloid leukemia (CML) to tyrosine kinase inhibitors (TKIs) and its progression to blast crisis (BC), in part, through the alternative splicing of self-renewal and survival genes. To elucidate splice-isoform regulators of human BC LSC maintenance, we performed whole-transcriptome RNA sequencing, splice-isoform-specific quantitative RT-PCR (qRT-PCR), nanoproteomics, stromal coculture, and BC LSC xenotransplantation analyses. Cumulatively, these studies show that the alternative splicing of multiple prosurvival BCL2 family genes promotes malignant transformation of myeloid progenitors into BC LSCS that are quiescent in the marrow niche and that contribute to therapeutic resistance. Notably, sabutoclax, a pan-BCL2 inhibitor, renders marrow-niche-resident BC LSCs sensitive to TKIs at doses that spare normal progenitors. These findings underscore the importance of alternative BCL2 family splice-isoform expression in BC LSC maintenance and suggest that the combinatorial inhibition of prosurvival BCL2 family proteins and BCR-ABL may eliminate dormant LSCs and obviate resistance.	[Goff, Daniel J.; Recart, Angela Court; Sadarangani, Anil; Leu, Heather; Low-Marchelli, Janine; Ma, Wenxue; Shih, Alice Y.; Geron, Ifat; Pu, Minya; Bao, Lei; Chuang, Ryan; Balaian, Larisa; Wentworth, Peggy; Smith, Kristen M.; Jamieson, Christina A. M.; Morris, Sheldon R.; Messer, Karen; Jamieson, Catriona H. M.] Univ Calif San Diego, Moores Canc Ctr, Dept Med, Stem Cell Program, La Jolla, CA 92093 USA; [Barrett, Christian L.; Frazer, Kelly A.] Univ Calif San Diego, Dept Pediat, Div Genome Informat Sci, La Jolla, CA 92093 USA; [Rusert, Jessica; Goldstein, Lawrence S. B.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Rusert, Jessica; Goldstein, Lawrence S. B.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Chun, Hye-Jung; Marra, Marco] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Krajewska, Maryla; Wei, Jun; Zhai, Dayong; Pellecchia, Maurizio; Reed, John C.] Sanford Burnham Med Res Inst, La Jolla, CA 92093 USA; [Gotlib, Jason] Stanford Med Ctr, Div Hematol, Stanford, CA 94305 USA; [Minden, Mark] Princess Margaret Hosp, Toronto, ON M5G 2M9, Canada; [Martinelli, Giovanni] Univ Bologna, Inst Hematol & Med Oncol, I-40126 Bologna, Italy; [Dao, Kim-Hien] Oregon Hlth & Sci Univ, Div Bone Marrow Transplantat, Portland, OR 97239 USA; [Shazand, Kamran; Hudson, Thomas J.] Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; British Columbia Cancer Agency; Sanford Burnham Prebys Medical Discovery Institute; Stanford University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Bologna; Oregon Health & Science University; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Jamieson, CHM (corresponding author), Univ Calif San Diego, Moores Canc Ctr, Dept Med, Stem Cell Program, 3855 Hlth Sci Dr, La Jolla, CA 92093 USA.	cjamieson@ucsd.edu	Ma, Wenxue/A-6344-2012; Ma, Wenxue/D-5383-2019; Pellecchia, Maurizio/Y-7072-2018; Martinelli, Giovanni/AAK-9211-2020; Marra, Marco A/B-5987-2008	Ma, Wenxue/0000-0001-9228-6162; Ma, Wenxue/0000-0001-9228-6162; Martinelli, Giovanni/0000-0002-1025-4210; Marra, Marco A/0000-0001-7146-7175; Goff, Daniel/0000-0003-2109-1696; Hudson, Thomas/0000-0002-1376-4849; Frazer, Kelly/0000-0002-6060-8902; Smith, Kristen/0000-0003-0960-0937	Ratner Family Fund; California Institute for Regenerative Medicine (CIRM) [RN2-00910-1, RS1-00228-1, TR2-01789, DR1-01430]; CIRM UCSD Stem Cell Training Grant II; UCSD Cancer Training Grant; National Cancer Institute (NCI) [CA-55164]; National Institutes of Health (NIH) [CA-149668]; Ontario Institute for Cancer Research through Ontario Ministry of Research and Innovation; Cancer Stem Cell Consortium; Government of Canada through Genome Canada; Government of Canada through Ontario Genomics Institute [OGI-047]; Government of Canada through Canadian Institute of Health Research [CSC-105367]; NATIONAL CANCER INSTITUTE [R01CA149668, P01CA055164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM068524, T32GM007198] Funding Source: NIH RePORTER	Ratner Family Fund; California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); CIRM UCSD Stem Cell Training Grant II; UCSD Cancer Training Grant; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ontario Institute for Cancer Research through Ontario Ministry of Research and Innovation; Cancer Stem Cell Consortium; Government of Canada through Genome Canada(Genome Canada); Government of Canada through Ontario Genomics Institute; Government of Canada through Canadian Institute of Health Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dennis Carson for his continuous advice and mentorship, Dennis Young for his expert assistance on all FACS experiments, Ida Deichaite for her excellent assistance with material transfer and industry relations, Jennifer Black and Rusty Wall for their help with sample preparation and mouse experiments, Isabel Newton for her advice and help with DiR studies, Derrick Duarte for his assistance with immunohistochemistry studies, Jerry Wu for his assistance with FACS cell-cycle experiments, and Kimberly Wilson for her assistance with grant and manuscript preparation and submission. This work was generously supported by the Ratner Family Fund and by the California Institute for Regenerative Medicine (CIRM; grants RN2-00910-1, RS1-00228-1, TR2-01789, and DR1-01430). D.J.G. was supported by the CIRM UCSD Stem Cell Training Grant II and the UCSD Cancer Training Grant. This work was also funded by the National Cancer Institute (NCI; no. CA-55164) and the National Institutes of Health (NIH; no. CA-149668), and supported by the Ontario Institute for Cancer Research, through generous support from the Ontario Ministry of Research and Innovation and the Cancer Stem Cell Consortium with funding from the Government of Canada through Genome Canada and the Ontario Genomics Institute (OGI-047), and through the Canadian Institute of Health Research (CSC-105367). J.C.R., J.W., and M. P. are coinventors of sabutoclax and related compounds, licensed by the SBMRI to Oncothyreon (Seattle). The Oncothyreon license entitles J.C.R. to milestone and royalty payments for studies advancing to clinic. He does not receive consulting fees or lab support, nor does he have stock or stock options.	Abe A, 2008, INT J HEMATOL, V88, P471, DOI 10.1007/s12185-008-0221-1; Abrahamsson AE, 2009, P NATL ACAD SCI USA, V106, P3925, DOI 10.1073/pnas.0900189106; Aichberger KJ, 2005, BLOOD, V105, P3303, DOI 10.1182/blood-2004-02-0749; Akgul C, 2004, CELL MOL LIFE SCI, V61, P2189, DOI 10.1007/s00018-004-4001-7; Amarante-Mendes GP, 1998, ONCOGENE, V16, P1383, DOI 10.1038/sj.onc.1201664; Barnes DJ, 2006, CELL CYCLE, V5, P2862, DOI 10.4161/cc.5.24.3573; Beverly LJ, 2009, ONCOGENE, V28, P1274, DOI 10.1038/onc.2008.466; Bewry NN, 2008, MOL CANCER THER, V7, P3169, DOI 10.1158/1535-7163.MCT-08-0314; Bingle CD, 2000, J BIOL CHEM, V275, P22136, DOI 10.1074/jbc.M909572199; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Chomel JC, 2011, ONCOTARGET, V2, P713; Chomel JC, 2011, BLOOD, V118, P3657, DOI 10.1182/blood-2011-02-335497; Corbin AS, 2011, J CLIN INVEST, V121, P396, DOI 10.1172/JCI35721; Cortes J, 2004, BLOOD, V104, P2204, DOI 10.1182/blood-2004-04-1335; Dai Y, 2004, J BIOL CHEM, V279, P34227, DOI 10.1074/jbc.M402290200; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Deininger Michael, 2008, J Natl Compr Canc Netw, V6 Suppl 2, pS11; Ding QQ, 2007, CANCER RES, V67, P4564, DOI 10.1158/0008-5472.CAN-06-1788; Domen J, 2003, EXP HEMATOL, V31, P631, DOI 10.1016/S0301-472X(03)00084-5; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; ESFAHANI MK, 2006, CURR TREAT OPTION ON, V7, P189; Forsberg EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008785; Gesbert F, 2000, BLOOD, V96, P2269, DOI 10.1182/blood.V96.6.2269.h8002269_2269_2276; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Goldman DA, 2000, STAT MED, V19, P1081, DOI 10.1002/(SICI)1097-0258(20000430)19:8<1081::AID-SIM406>3.0.CO;2-A; Guzman ML, 2002, P NATL ACAD SCI USA, V99, P16220, DOI 10.1073/pnas.252462599; Hermann PC, 2010, SEMIN CANCER BIOL, V20, P77, DOI 10.1016/j.semcancer.2010.03.004; Hogge DE, 1996, BLOOD, V88, P3765, DOI 10.1182/blood.V88.10.3765.bloodjournal88103765; Holyoake T, 1999, BLOOD, V94, P2056, DOI 10.1182/blood.V94.6.2056; Horita M, 2000, J EXP MED, V191, P977, DOI 10.1084/jem.191.6.977; Jaiswal S, 2003, P NATL ACAD SCI USA, V100, P10002, DOI 10.1073/pnas.1633833100; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Konopleva M, 2002, BRIT J HAEMATOL, V118, P521, DOI 10.1046/j.1365-2141.2002.03637.x; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Kuroda J, 2006, P NATL ACAD SCI USA, V103, P14907, DOI 10.1073/pnas.0606176103; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Mak DH, 2012, LEUKEMIA, V26, P788, DOI 10.1038/leu.2011.285; MARTIN PJ, 1980, NATURE, V287, P49, DOI 10.1038/287049a0; McWeeney SK, 2010, BLOOD, V115, P315, DOI 10.1182/blood-2009-03-210732; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Meng Y, 2007, LEUKEMIA LYMPHOMA, V48, P2204, DOI 10.1080/10428190701583991; Milyavsky M, 2010, CELL STEM CELL, V7, P186, DOI 10.1016/j.stem.2010.05.016; Moore MJ, 2010, CELL, V142, P625, DOI 10.1016/j.cell.2010.07.019; Ng KP, 2012, NAT MED, V18, P521, DOI 10.1038/nm.2713; Ninomiya M, 2007, LEUKEMIA, V21, P136, DOI 10.1038/sj.leu.2404432; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; OReilly LA, 1997, J IMMUNOL, V159, P2301; OReilly LA, 1997, INT IMMUNOL, V9, P1291, DOI 10.1093/intimm/9.9.1291; OReilly LA, 1996, EMBO J, V15, P6979, DOI 10.1002/j.1460-2075.1996.tb01090.x; Placzek WJ, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.18; Radich JP, 2006, P NATL ACAD SCI USA, V103, P2794, DOI 10.1073/pnas.0510423103; Reed JC, 2008, BLOOD, V111, P3322, DOI 10.1182/blood-2007-09-078162; Saito Y, 2010, NAT BIOTECHNOL, V28, P275, DOI 10.1038/nbt.1607; SANCHEZGARCIA I, 1995, P NATL ACAD SCI USA, V92, P5287, DOI 10.1073/pnas.92.12.5287; Sawyers CL, 2002, BLOOD, V99, P3530, DOI 10.1182/blood.V99.10.3530; Slape CI, 2012, BLOOD, V120, P2475, DOI 10.1182/blood-2012-05-430736; Stuart SA, 2009, CELL CYCLE, V8, P1338, DOI 10.4161/cc.8.9.8209; Tauchi T, 2003, CLIN CANCER RES, V9, P4267; Vairo G, 1996, ONCOGENE, V13, P1511; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Vogler M, 2009, BLOOD, V113, P4403, DOI 10.1182/blood-2008-08-173310; Wei J, 2010, J MED CHEM, V53, P4166, DOI 10.1021/jm1001265; Wei J, 2009, J MED CHEM, V52, P4511, DOI 10.1021/jm900472s; Yecies D, 2010, BLOOD, V115, P3304, DOI 10.1182/blood-2009-07-233304; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737; Zinkel S, 2006, CELL DEATH DIFFER, V13, P1351, DOI 10.1038/sj.cdd.4401987	71	141	144	1	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 7	2013	12	3					316	328		10.1016/j.stem.2012.12.011	http://dx.doi.org/10.1016/j.stem.2012.12.011			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VC	23333150	Bronze, Green Accepted			2022-12-28	WOS:000329569400010
J	Sarkar, A; Hochedlinger, K				Sarkar, Abby; Hochedlinger, Konrad			The Sox Family of Transcription Factors: Versatile Regulators of Stem and Progenitor Cell Fate	CELL STEM CELL			English	Review							SEX-DETERMINING REGION; SELF-RENEWAL; GENE-EXPRESSION; DNA-BINDING; TGF-BETA; NEURONAL DIFFERENTIATION; REPROGRAMMING FACTORS; IDENTIFIES SOX2; MOUSE; PLURIPOTENCY	Sox family transcription factors are well-established regulators of cell fate decisions during development. Accumulating evidence documents that they play additional roles in adult tissue homeostasis and regeneration. Remarkably, forced expression of Sox factors, in combination with other synergistic factors, reprograms differentiated cells into somatic or pluripotent stem cells. Dysregulation of Sox factors has been further implicated in diseases including cancer. Here, we review molecular and functional evidence linking Sox proteins with stem cell biology, cellular reprogramming, and disease with an emphasis on Sox2.	[Sarkar, Abby; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Canc, Howard Hughes Med Inst, Boston, MA 02114 USA; [Sarkar, Abby; Hochedlinger, Konrad] Ctr Regenerat Med, Boston, MA 02114 USA; [Sarkar, Abby; Hochedlinger, Konrad] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Sarkar, Abby; Hochedlinger, Konrad] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Sarkar, Abby; Hochedlinger, Konrad] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard University; Harvard University	Hochedlinger, K (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Howard Hughes Med Inst, 185 Cambridge St, Boston, MA 02114 USA.	khochedlinger@helix.mgh.harvard.edu			HHMI, NIH [DP2OD003266, R01HD058013, R01DK96034]; Harvard Stem Cell Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096034] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD003266] Funding Source: NIH RePORTER	HHMI, NIH(Howard Hughes Medical InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This Review is dedicated to the memory of Larysa Pevny, who has made seminal contributions to the study of the biology of Sox factors. We apologize to those colleagues whose work we could not cite due to space constraints. We thank Hanno Hock, Michael Rendl, and members of the Hochedlinger laboratory for suggestions and critical reading of the manuscript. K.H. was supported by HHMI, NIH (DP2OD003266, R01HD058013, and R01DK96034), and the Harvard Stem Cell Institute.	Adameyko I, 2012, DEVELOPMENT, V139, P397, DOI 10.1242/dev.065581; Andreu-Agullo C, 2012, NATURE, V481, P195, DOI 10.1038/nature10712; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Marques-Torrejon MA, 2013, CELL STEM CELL, V12, P88, DOI 10.1016/j.stem.2012.12.001; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Baltus GA, 2009, STEM CELLS, V27, P2175, DOI 10.1002/stem.168; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Basu-Roy U, 2010, CELL DEATH DIFFER, V17, P1345, DOI 10.1038/cdd.2010.57; Bazzoli E, 2012, CELL STEM CELL, V11, P836, DOI 10.1016/j.stem.2012.09.012; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Bergsland M, 2011, GENE DEV, V25, P2453, DOI 10.1101/gad.176008.111; Biernaskie J, 2009, CELL STEM CELL, V5, P610, DOI 10.1016/j.stem.2009.10.019; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Cavallaro M, 2008, DEVELOPMENT, V135, P541, DOI 10.1242/dev.010801; Chen JK, 2011, CELL RES, V21, P205, DOI 10.1038/cr.2010.172; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheung M, 2003, DEVELOPMENT, V130, P5681, DOI 10.1242/dev.00808; Cimadamore F, 2011, CELL STEM CELL, V8, P538, DOI 10.1016/j.stem.2011.03.011; Clavel C, 2012, DEV CELL, V23, P981, DOI 10.1016/j.devcel.2012.10.013; Dabdoub A, 2008, P NATL ACAD SCI USA, V105, P18396, DOI 10.1073/pnas.0808175105; Domyan ET, 2011, DEVELOPMENT, V138, P971, DOI 10.1242/dev.053694; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Engelen E, 2011, NAT GENET, V43, P607, DOI 10.1038/ng.825; Fauquier T, 2008, P NATL ACAD SCI USA, V105, P2907, DOI 10.1073/pnas.0707886105; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Fong YW, 2011, CELL, V147, P120, DOI 10.1016/j.cell.2011.08.038; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Gontan C, 2008, DEV BIOL, V317, P296, DOI 10.1016/j.ydbio.2008.02.035; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Guth SIE, 2008, CELL MOL LIFE SCI, V65, P3000, DOI 10.1007/s00018-008-8138-7; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Hanna LA, 2002, GENE DEV, V16, P2650, DOI 10.1101/gad.1020502; He SH, 2011, GENE DEV, V25, P1613, DOI 10.1101/gad.2052911; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Holmes G, 2011, BONE, V49, P653, DOI 10.1016/j.bone.2011.06.008; Hu QK, 2010, STEM CELLS, V28, P279, DOI 10.1002/stem.246; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Ishii Y, 1998, DEV DYNAM, V213, P464, DOI 10.1002/(SICI)1097-0177(199812)213:4<464::AID-AJA11>3.0.CO;2-Z; Jauch R, 2011, STEM CELLS, V29, P940, DOI 10.1002/stem.639; Jeong CH, 2010, STEM CELLS, V28, P2141, DOI 10.1002/stem.540; Jinno H, 2010, STEM CELLS, V28, P2027, DOI 10.1002/stem.525; Juuri E, 2012, DEV CELL, V23, P317, DOI 10.1016/j.devcel.2012.05.012; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kamachi Y, 2001, GENE DEV, V15, P1272, DOI 10.1101/gad.887101; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kelberman D, 2006, J CLIN INVEST, V116, P2442, DOI 10.1172/JCI28658; Keramari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013952; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kim J, 2003, NEURON, V38, P17, DOI 10.1016/S0896-6273(03)00163-6; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Kishi M, 2000, DEVELOPMENT, V127, P791; Kondo T, 2004, GENE DEV, V18, P2963, DOI 10.1101/gad.309404; Kondoh H, 2010, INT J BIOCHEM CELL B, V42, P391, DOI 10.1016/j.biocel.2009.09.003; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Kopp JL, 2011, DEVELOPMENT, V138, P653, DOI 10.1242/dev.056499; Kordes U, 2006, J NEURO-ONCOL, V80, P151, DOI 10.1007/s11060-006-9180-7; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Kuzmichev AN, 2012, CURR BIOL, V22, P1705, DOI 10.1016/j.cub.2012.07.013; Laga AC, 2010, AM J PATHOL, V176, P903, DOI 10.2353/ajpath.2010.090495; Le N, 2005, P NATL ACAD SCI USA, V102, P2596, DOI 10.1073/pnas.0407836102; Li H, 2012, CELL STEM CELL, V11, P845, DOI 10.1016/j.stem.2012.09.014; Li MM, 2012, MOL CELL, V46, P30, DOI 10.1016/j.molcel.2012.01.020; Liber D, 2010, CELL STEM CELL, V7, P114, DOI 10.1016/j.stem.2010.05.020; Lopez-Juarez A, 2012, CELL STEM CELL, V10, P531, DOI 10.1016/j.stem.2012.04.008; Lu Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011022; Mansukhani A, 2005, J CELL BIOL, V168, P1065, DOI 10.1083/jcb.200409182; Maruyama M, 2005, J BIOL CHEM, V280, P24371, DOI 10.1074/jbc.M501423200; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Matsushima D, 2011, DEVELOPMENT, V138, P443, DOI 10.1242/dev.055178; Meeson AP, 2007, EMBO J, V26, P1902, DOI 10.1038/sj.emboj.7601635; Miller SJ, 2006, CANCER RES, V66, P2584, DOI 10.1158/0008-5472.CAN-05-3330; Miyagi S, 2008, FEBS LETT, V582, P2811, DOI 10.1016/j.febslet.2008.07.011; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Ng SY, 2012, EMBO J, V31, P522, DOI 10.1038/emboj.2011.459; Niakan KK, 2010, GENE DEV, V24, P312, DOI 10.1101/gad.1833510; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Okubo T, 2006, GENE DEV, V20, P2654, DOI 10.1101/gad.1457106; Okubo T, 2009, STEM CELLS, V27, P442, DOI 10.1634/stemcells.2008-0611; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Parrinello S, 2010, CELL, V143, P145, DOI 10.1016/j.cell.2010.08.039; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Poche RA, 2008, J COMP NEUROL, V510, P237, DOI 10.1002/cne.21746; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; Que JW, 2009, DEVELOPMENT, V136, P1899, DOI 10.1242/dev.034629; Raverot G, 2005, DEV BIOL, V283, P215, DOI 10.1016/j.ydbio.2005.04.013; Rawlins EL, 2011, DEV DYNAM, V240, P463, DOI 10.1002/dvdy.22482; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Schmidt K, 2003, J BIOL CHEM, V278, P29769, DOI 10.1074/jbc.M301539200; Schober M, 2011, P NATL ACAD SCI USA, V108, P10544, DOI 10.1073/pnas.1107807108; Scott CE, 2010, NAT NEUROSCI, V13, P1181, DOI 10.1038/nn.2646; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Shimozaki K, 2012, J BIOL CHEM, V287, P5969, DOI 10.1074/jbc.M111.290403; Sikorska M, 2008, J NEUROSCI RES, V86, P1680, DOI 10.1002/jnr.21635; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Takemoto T, 2006, DEVELOPMENT, V133, P297, DOI 10.1242/dev.02196; Takemoto T, 2011, NATURE, V470, P394, DOI 10.1038/nature09729; Tanaka S, 2004, MOL CELL BIOL, V24, P8834, DOI 10.1128/MCB.24.20.8834-8846.2004; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Tompkins DH, 2011, AM J RESP CELL MOL, V45, P101, DOI 10.1165/rcmb.2010-0149OC; Tompkins DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008248; Tsuruzoe S, 2006, BIOCHEM BIOPH RES CO, V351, P920, DOI 10.1016/j.bbrc.2006.10.130; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Wegner M, 2010, INT J BIOCHEM CELL B, V42, P381, DOI 10.1016/j.biocel.2009.07.006; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Williamson KA, 2006, HUM MOL GENET, V15, P1413, DOI 10.1093/hmg/ddl064; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; Xu J, 2009, GENE DEV, V23, P2824, DOI 10.1101/gad.1861209; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhao HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027026; Zhao SL, 2004, MOL CELL NEUROSCI, V27, P332, DOI 10.1016/j.mcn.2004.08.002; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	141	594	617	6	159	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 3	2013	12	1					15	30		10.1016/j.stem.2012.12.007	http://dx.doi.org/10.1016/j.stem.2012.12.007			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	074UM	23290134	Green Accepted, Bronze			2022-12-28	WOS:000313839500007
J	Weir, GC				Weir, Gordon C.			Cellular Transplantation into Lymph Nodes May Not Be Such a Crazy Idea	CELL STEM CELL			English	Editorial Material							ISLET TRANSPLANTATION; PANCREATIC-ISLETS; CELLS	A study published in Nature Biotechnology by Komori and colleagues (Komori et al., 2012) has identified the surprising potential of lymph nodes as sites for cellular transplants.	[Weir, Gordon C.] Joslin Diabet Ctr, Sect Islet Cell & Regenerat Biol, Boston, MA 02215 USA; [Weir, Gordon C.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Weir, GC (corresponding author), Joslin Diabet Ctr, Sect Islet Cell & Regenerat Biol, Boston, MA 02215 USA.	gordon.weir@joslin.harvard.edu						GROMPE M, 1995, NAT GENET, V10, P453, DOI 10.1038/ng0895-453; Harlan DM, 2009, DIABETES, V58, P2175, DOI 10.2337/db09-0476; Henriksnas J, 2012, DIABETES, V61, P665, DOI 10.2337/db10-0895; King AJF, 2007, DIABETES, V56, P2312, DOI 10.2337/db07-0191; Komori J, 2012, NAT BIOTECHNOL, V30, P976, DOI 10.1038/nbt.2379; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lau J, 2009, CELL TRANSPLANT, V18, P23, DOI 10.3727/096368909788237131; Rice HE, 2004, J PEDIATR SURG, V39, P1607, DOI 10.1016/j.jpedsurg.2004.07.020	8	3	3	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV 2	2012	11	5					587	588		10.1016/j.stem.2012.10.004	http://dx.doi.org/10.1016/j.stem.2012.10.004			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	042LE	23122285	Bronze			2022-12-28	WOS:000311471900004
J	Vessey, JP; Amadei, G; Burns, SE; Kiebler, MA; Kaplan, DR; Miller, FD				Vessey, John P.; Amadei, Gianluca; Burns, Sarah E.; Kiebler, Michael A.; Kaplan, David R.; Miller, Freda D.			An Asymmetrically Localized Staufen2-Dependent RNA Complex Regulates Maintenance of Mammalian Neural Stem Cells	CELL STEM CELL			English	Article							DENDRITIC SPINE MORPHOGENESIS; MESSENGER-RNA; SOMATODENDRITIC DOMAIN; NEURONS; DIVISION; BRAIN; STAUFEN2; DISTINCT; GRANULE; GENESIS	The cellular mechanisms that regulate self-renewal versus differentiation of mammalian somatic tissue stem cells are still largely unknown. Here, we asked whether an RNA complex regulates this process in mammalian neural stem cells. We show that the RNA-binding protein Staufen2 (Stau2) is apically localized in radial glial precursors of the embryonic cortex, where it forms a complex with other RNA granule proteins including Pumilio2 (Pum2) and DDX1, and the mRNAs for beta-actin and mammalian prospero, prox1. Perturbation of this complex by functional knockdown of Stau2, Pum2, or DDX1 causes premature differentiation of radial glial precursors into neurons and mislocalization and misexpression of prox1 mRNA. Thus, a Stau2- and Pum2-dependent RNA complex directly regulates localization and, potentially, expression of target mRNAs like prox1 in mammalian neural stem cells, and in so doing regulates the balance of stem cell maintenance versus differentiation.	[Vessey, John P.; Amadei, Gianluca; Miller, Freda D.] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1L7, Canada; [Vessey, John P.; Burns, Sarah E.; Kaplan, David R.] Hosp Sick Children, Program Cell Biol, Toronto, ON M5G 1L7, Canada; [Amadei, Gianluca; Kaplan, David R.; Miller, Freda D.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1X5, Canada; [Miller, Freda D.] Univ Toronto, Dept Physiol, Toronto, ON M5G 1X5, Canada; [Kiebler, Michael A.] Med Univ Vienna, Dept Neuronal Cell Biol, Ctr Brain Res, A-1090 Vienna, Austria	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Medical University of Vienna	Miller, FD (corresponding author), Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1L7, Canada.	fredam@sickkids.ca	Amadei, Gianluca/AAB-9343-2021	Amadei, Gianluca/0000-0001-5405-968X; Kiebler, Michael/0000-0002-8850-6297	C.I.H.R. [MOP-13958]; O.G.S.; HSC	C.I.H.R.(Canadian Institutes of Health Research (CIHR)); O.G.S.(Ontario Graduate Scholarship); HSC	This work was supported by C.I.H.R. grant MOP-13958 to F.D.M. and D.R.K., who are Canada Research Chairs. F.D.M. is an HHMI International Research Scholar. J.P.V. was supported by a C.I.H.R. Fellowship and G.A. was supported by studentships from O.G.S. and HSC. We thank Georgia Vedra for advice and Howard Lipshitz, Craig Smibert, and Wayne Sossin for invaluable intellectual input.	Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Chia W, 2008, J CELL BIOL, V180, P267, DOI 10.1083/jcb.200708159; Duchaine TF, 2002, J CELL SCI, V115, P3285; Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144; Elvira G, 2006, MOL CELL PROTEOMICS, V5, P635, DOI 10.1074/mcp.M500255-MCP200; Furic L, 2008, RNA, V14, P324, DOI 10.1261/rna.720308; Gauthier AS, 2007, NEURON, V54, P245, DOI 10.1016/j.neuron.2007.03.027; Gauthier-Fisher A, 2009, NAT NEUROSCI, V12, P735, DOI 10.1038/nn.2339; Goetze B, 2006, J CELL BIOL, V172, P221, DOI 10.1083/jcb.200509035; Kaltezioti V, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000565; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kiebler MA, 1999, J NEUROSCI, V19, P288, DOI 10.1523/JNEUROSCI.19-01-00288.1999; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kugler JM, 2009, FLY, V3, P15, DOI 10.4161/fly.3.1.7751; Kusek G, 2012, CELL STEM CELL; Lavado A, 2007, DEV DYNAM, V236, P518, DOI 10.1002/dvdy.21024; Maher-Laporte M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011350; Maher-Laporte M, 2010, BMB REP, V43, P344, DOI 10.5483/BMBRep.2010.43.5.344; Micklem DR, 2000, EMBO J, V19, P1366, DOI 10.1093/emboj/19.6.1366; Mikl M, 2011, EMBO REP, V12, P1077, DOI 10.1038/embor.2011.149; Moore FL, 2003, P NATL ACAD SCI USA, V100, P538, DOI 10.1073/pnas.0234478100; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Sossin WS, 2006, TRAFFIC, V7, P1581, DOI 10.1111/j.1600-0854.2006.00500.x; Vessey JP, 2008, P NATL ACAD SCI USA, V105, P16374, DOI 10.1073/pnas.0804583105; Zhong WM, 2008, CURR OPIN NEUROBIOL, V18, P4, DOI 10.1016/j.conb.2008.05.002	27	83	83	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	OCT 5	2012	11	4					517	528		10.1016/j.stem.2012.06.010	http://dx.doi.org/10.1016/j.stem.2012.06.010			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	021OZ	22902294	Bronze			2022-12-28	WOS:000309896500012
J	Anguera, MC; Sadreyev, R; Zhang, ZQ; Szanto, A; Payer, B; Sheridan, SD; Kwok, S; Haggarty, SJ; Sur, M; Alvarez, J; Gimelbrant, A; Mitalipova, M; Kirby, JE; Lee, JT				Anguera, Montserrat C.; Sadreyev, Ruslan; Zhang, Zhaoqing; Szanto, Attila; Payer, Bernhard; Sheridan, Steven D.; Kwok, Showming; Haggarty, Stephen J.; Sur, Mriganka; Alvarez, Jason; Gimelbrant, Alexander; Mitalipova, Maisam; Kirby, James E.; Lee, Jeannie T.			Molecular Signatures of Human Induced Pluripotent Stem Cells Highlight Sex Differences and Cancer Genes	CELL STEM CELL			English	Article							HUMAN SOMATIC-CELLS; X-INACTIVATION; CHROMOSOME INACTIVATION; DOSAGE COMPENSATION; IN-VITRO; ES; DIFFERENTIATION; IDENTIFICATION; METHYLATION; FIBROBLASTS	Although human induced pluripotent stem cells (hiPSCs) have enormous potential in regenerative medicine, their epigenetic variability suggests that some lines may not be suitable for human therapy. There are currently few benchmarks for assessing quality. Here we show that X-inactivation markers can be used to separate hiPSC lines into distinct epigenetic classes and that the classes are phenotypically distinct. Loss of XIST expression is strongly correlated with upregulation of X-linked oncogenes, accelerated growth rate in vitro, and poorer differentiation in vivo. Whereas differences in X-inactivation potential result in epigenetic variability of female hiPSC lines, male hiPSC lines generally resemble each other and do not overexpress the oncogenes. Neither physiological oxygen levels nor HDAC inhibitors offer advantages to culturing female hiPSC lines. We conclude that female hiPSCs may be epigenetically less stable in culture and caution that loss of XIST may result in qualitatively less desirable stem cell lines.	[Anguera, Montserrat C.; Sadreyev, Ruslan; Szanto, Attila; Payer, Bernhard; Lee, Jeannie T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Howard Hughes Med Inst, Boston, MA 02114 USA; [Anguera, Montserrat C.; Sadreyev, Ruslan; Szanto, Attila; Payer, Bernhard; Lee, Jeannie T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol, Boston, MA 02114 USA; [Anguera, Montserrat C.; Sadreyev, Ruslan; Szanto, Attila; Payer, Bernhard; Alvarez, Jason; Gimelbrant, Alexander; Lee, Jeannie T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Genet, Boston, MA 02114 USA; [Sheridan, Steven D.; Haggarty, Stephen J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA 02114 USA; [Zhang, Zhaoqing] Qiagen, SAB Biosci, Frederick, MD 21703 USA; [Sheridan, Steven D.; Kwok, Showming; Sur, Mriganka] MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Alvarez, Jason; Gimelbrant, Alexander] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Mitalipova, Maisam] Whitehead Inst Biomed Sci, Cambridge, MA 02142 USA; [Kirby, James E.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Northwell Health; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Beth Israel Deaconess Medical Center	Lee, JT (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Howard Hughes Med Inst, Boston, MA 02114 USA.	lee@molbio.mgh.harvard.edu	Haggarty, Stephen J/M-9495-2016; Payer, Bernhard/F-7353-2010; Szanto, Attila/B-2198-2012; Kirby, James/K-4438-2019	Haggarty, Stephen J/0000-0002-7872-168X; Payer, Bernhard/0000-0002-4694-2082; Gimelbrant, Alexander/0000-0001-6986-0285	NIH [RO1-GM58839, R21MH087896]; ARRA supplement; Stanley Medical Research Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH087896] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARRA supplement; Stanley Medical Research Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank members of the J.T.L. laboratory for critical insight and discussion; G. Daley for pEYK, HD 12D-1, and JDM 6C-1; G. Mostoslovasky for STEMCCA lentiviral cassette; H. Willard and J. Lawrence for PGK1 probe; L. Daheron, T. Ahfeldt, and R. Alagappan for technical assistance; and C. Ware for advice on HDACi. This work was funded by NIH RO1-GM58839 and ARRA supplement to J.T.L. and NIH R21MH087896 and a Stanley Medical Research Institute award to S.J.H. J.T.L. is an Investigator of the Howard Hughes Medical Institute.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; BEARD C, 1995, GENE DEV, V9, P2325, DOI 10.1101/gad.9.19.2325; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Chen BZ, 2011, CELL BIOL INT, V35, P29, DOI 10.1042/CBI20090081; Cheung AYL, 2011, HUM MOL GENET, V20, P2103, DOI 10.1093/hmg/ddr093; Chureau C, 2002, GENOME RES, V12, P894, DOI 10.1101/gr.152902; Clemson CM, 2006, P NATL ACAD SCI USA, V103, P7688, DOI 10.1073/pnas.0601069103; Csankovszki G, 2001, J CELL BIOL, V153, P773, DOI 10.1083/jcb.153.4.773; Dvash T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011330; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Hall LL, 2008, J CELL PHYSIOL, V216, P445, DOI 10.1002/jcp.21411; Hall LL, 2002, P NATL ACAD SCI USA, V99, P8677, DOI 10.1073/pnas.132468999; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Higgins ME, 2007, NUCLEIC ACIDS RES, V35, pD721, DOI 10.1093/nar/gkl811; Hoffman LM, 2005, STEM CELLS, V23, P1468, DOI 10.1634/stemcells.2004-0371; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/NMETH.1426, 10.1038/nmeth.1426]; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Lagarkova MA, 2010, CELL CYCLE, V9, P937, DOI 10.4161/cc.9.5.10869; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Li C, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-8-RESEARCH0032; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Mikkola M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-40; Namekawa SH, 2010, MOL CELL BIOL, V30, P3187, DOI 10.1128/MCB.00227-10; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pageau GJ, 2007, NAT REV CANCER, V7, P628, DOI 10.1038/nrc2172; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Perez SVD, 2012, HUM MOL GENET, V21, P751, DOI 10.1093/hmg/ddr506; Pick M, 2009, STEM CELLS, V27, P2686, DOI 10.1002/stem.205; Pomp O, 2011, CELL STEM CELL, V9, P156, DOI 10.1016/j.stem.2011.06.004; Poplinski A, 2010, EUR J ENDOCRINOL, V162, P169, DOI 10.1530/EJE-09-0768; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; ROGNER UC, 1995, GENOMICS, V29, P725, DOI 10.1006/geno.1995.9945; Rugg-Gunn PJ, 2007, HUM MOL GENET, V16, pR243, DOI 10.1093/hmg/ddm245; Sharov AA, 2005, BIOINFORMATICS, V21, P2548, DOI 10.1093/bioinformatics/bti343; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4709, DOI 10.1073/pnas.0712018105; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Sunwoo H, 2009, GENOME RES, V19, P347, DOI 10.1101/gr.087775.108; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tchieu J, 2010, CELL STEM CELL, V7, P329, DOI 10.1016/j.stem.2010.06.024; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Wang W, 2011, P NATL ACAD SCI USA, V108, P18283, DOI 10.1073/pnas.1100893108; Ware CB, 2009, CELL STEM CELL, V4, P359, DOI 10.1016/j.stem.2009.03.001; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Westfall SD, 2008, STEM CELLS DEV, V17, P869, DOI 10.1089/scd.2007.0240; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang LF, 2007, CELL, V129, P693, DOI 10.1016/j.cell.2007.03.036	63	109	112	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 6	2012	11	1					75	90		10.1016/j.stem.2012.03.008	http://dx.doi.org/10.1016/j.stem.2012.03.008			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	975SS	22770242	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000306532400011
J	Singh, AM; Reynolds, D; Cliff, T; Ohtsuka, S; Mattheyses, AL; Sun, YH; Menendez, L; Kulik, M; Dalton, S				Singh, Amar M.; Reynolds, David; Cliff, Timothy; Ohtsuka, Satoshi; Mattheyses, Alexa L.; Sun, Yuhua; Menendez, Laura; Kulik, Michael; Dalton, Stephen			Signaling Network Crosstalk in Human Pluripotent Cells: A Smad2/3-Regulated Switch that Controls the Balance between Self-Renewal and Differentiation	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; FIBROBLAST-GROWTH-FACTOR; DEFINITIVE ENDODERM; BETA-CATENIN; EFFICIENT DIFFERENTIATION; MAINTAINS PLURIPOTENCY; HEMATOPOIETIC-CELLS; DEFINED CONDITIONS; WNT/BETA-CATENIN; NANOG EXPRESSION	A general mechanism for how intracellular signaling pathways in human pluripotent cells are coordinated and how they maintain self-renewal remain to be elucidated. In this report, we describe a signaling mechanism where PI3K/Akt activity maintains self-renewal by restraining prodifferentiation signaling through suppression of the Raf/Mek/Erk and canonical Wnt signaling pathways. When active, PI3K/Akt establishes conditions where Activin A/Smad2,3 performs a pro-self-renewal function by activating target genes, including Nanog. When PI3K/Akt signaling is low, Wnt effectors are activated and function in conjunction with Smad2,3 to promote differentiation. The switch in Smad2,3 activity after inactivation of PI3K/Akt requires the activation of canonical Wnt signaling by Erk, which targets Gsk313. In sum, we define a signaling framework that converges on Smad2,3 and determines its ability to regulate the balance between alternative cell states. This signaling paradigm has far-reaching implications for cell fate decisions during early embryonic development.	[Singh, Amar M.; Reynolds, David; Cliff, Timothy; Ohtsuka, Satoshi; Sun, Yuhua; Menendez, Laura; Kulik, Michael; Dalton, Stephen] Univ Georgia, Dept Biochem & Mol Biol, Paul D Coverdell Ctr Biomed & Hlth Sci, Athens, GA 30602 USA; [Mattheyses, Alexa L.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA	University System of Georgia; University of Georgia; Emory University	Dalton, S (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Paul D Coverdell Ctr Biomed & Hlth Sci, 500 DW Brooks Dr, Athens, GA 30602 USA.	sdalton@uga.edu	孙, 玉华/AAS-2506-2020; Sun, Yuhua/J-7547-2013	孙, 玉华/0000-0001-7902-9022; Mattheyses, Alexa L/0000-0002-5119-7750; Dalton, Stephen/0000-0002-3450-1263	National Institute of Child Health and Human Development [HD049647]; National Institute for General Medical Sciences [GM75334]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD049647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM085354] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants to S.D. from the National Institute of Child Health and Human Development (HD049647) and the National Institute for General Medical Sciences (GM75334). We would like to thank George Daley for providing hiPSCs and Julie Nelson for assistance with FACS.	Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Bechard M, 2009, MOL CELL BIOL, V29, P2092, DOI 10.1128/MCB.01405-08; Blalock WL, 2000, ONCOGENE, V19, P526, DOI 10.1038/sj.onc.1203337; Bone HK, 2011, J CELL SCI, V124, P1992, DOI 10.1242/jcs.081679; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Conery AR, 2004, NAT CELL BIOL, V6, P366, DOI 10.1038/ncb1117; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Ding VMY, 2010, J CELL PHYSIOL, V225, P417, DOI 10.1002/jcp.22214; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Funaba M, 2000, MOL ENDOCRINOL, V14, P1583, DOI 10.1210/me.14.10.1583; Hagen T, 2002, J BIOL CHEM, V277, P23330, DOI 10.1074/jbc.M201364200; Harvey CD, 2008, P NATL ACAD SCI USA, V105, P19264, DOI 10.1073/pnas.0804598105; Hay DC, 2008, P NATL ACAD SCI USA, V105, P12301, DOI 10.1073/pnas.0806522105; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; LABONNE C, 1994, DEVELOPMENT, V120, P463; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; Li WL, 2012, STEM CELLS, V30, P61, DOI 10.1002/stem.768; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Lyashenko N, 2011, NAT CELL BIOL, V13, P753, DOI 10.1038/ncb2260; McCubrey JA, 1998, LEUKEMIA, V12, P1903, DOI 10.1038/sj.leu.2401215; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Menendez L, 2011, P NATL ACAD SCI USA, V108, P19240, DOI 10.1073/pnas.1113746108; Na J, 2010, STEM CELL RES, V5, P157, DOI 10.1016/j.scr.2010.06.002; Ohtsuka S, 2008, GENE THER, V15, P74, DOI 10.1038/sj.gt.3303065; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; Smith KN, 2010, CELL STEM CELL, V7, P343, DOI 10.1016/j.stem.2010.06.023; Storm MP, 2007, J BIOL CHEM, V282, P6265, DOI 10.1074/jbc.M610906200; Sumi T, 2008, DEVELOPMENT, V135, P2969, DOI 10.1242/dev.021121; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Tsutsui H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1165; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Villa-Diaz LG, 2009, STEM CELLS DEV, V18, P641, DOI 10.1089/scd.2008.0010; Voskas Daniel, 2010, F1000 Biol Rep, V2, P82, DOI 10.3410/B2-82; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Wardle FC, 2006, SEMIN CELL DEV BIOL, V17, P99, DOI 10.1016/j.semcdb.2005.11.008; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; Weisberg E, 1998, MECH DEVELOP, V79, P17, DOI 10.1016/S0925-4773(98)00160-9; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103; Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yu P., 2011, CELL STEM CELL, V8, P326; Zhang SQ, 2002, MOL CELL BIOL, V22, P4062, DOI 10.1128/MCB.22.12.4062-4072.2002	58	248	260	0	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 2	2012	10	3					312	326		10.1016/j.stem.2012.01.014	http://dx.doi.org/10.1016/j.stem.2012.01.014			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	908BX	22385658	Green Accepted, Bronze			2022-12-28	WOS:000301466500012
J	Herbomel, P				Herbomel, Philippe			Infection-Induced Hematopoiesis: A Zebrafish Perspective	CELL STEM CELL			English	Editorial Material							EMERGENCY GRANULOPOIESIS; AORTIC ENDOTHELIUM		Inst Pasteur, Unite Macrophages & Dev Immun, Dept Biol Dev, F-75015 Paris, France; [Herbomel, Philippe] CNRS, URA 2578, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Herbomel, P (corresponding author), Inst Pasteur, Unite Macrophages & Dev Immun, Dept Biol Dev, F-75015 Paris, France.	herbomel@pasteur.fr						Baldridge MT, 2011, TRENDS IMMUNOL, V32, P57, DOI 10.1016/j.it.2010.12.003; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Ciau-Uitz A, 2010, INT J DEV BIOL, V54, P1139, DOI 10.1387/ijdb.093055ac; Hall CJ, 2012, CELL STEM CELL, V10, P198, DOI 10.1016/j.stem.2012.01.007; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Murayama E, 2006, IMMUNITY, V25, P963, DOI 10.1016/j.immuni.2006.10.015; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; Renshaw SA, 2012, DIS MODEL MECH, V5, P38, DOI 10.1242/dmm.007138; Zhang HY, 2010, BLOOD, V116, P2462, DOI 10.1182/blood-2009-12-259630	10	3	3	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	FEB 3	2012	10	2					105	106		10.1016/j.stem.2012.01.015	http://dx.doi.org/10.1016/j.stem.2012.01.015			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	892FM	22305556	Bronze			2022-12-28	WOS:000300272100001
J	Lonardo, E; Hermann, PC; Mueller, MT; Huber, S; Balic, A; Miranda-Lorenzo, I; Zagorac, S; Alcala, S; Roderiguez-Arabaolaza, I; Ramirez, JC; Torres-Ruiz, R; Garcia, E; Hidalgo, M; Cebrian, DA; Heuchel, R; Lohr, M; Berger, F; Bartenstein, P; Aicher, A; Heeschen, C				Lonardo, Enza; Hermann, Patrick C.; Mueller, Maria-Theresa; Huber, Stephan; Balic, Anamaria; Miranda-Lorenzo, Irene; Zagorac, Sladjana; Alcala, Sonia; Roderiguez-Arabaolaza, Iker; Carlos Ramirez, Juan; Torres-Ruiz, Raul; Garcia, Elena; Hidalgo, Manuel; Alvaro Cebrian, David; Heuchel, Rainer; Lohr, Matthias; Berger, Frank; Bartenstein, Peter; Aicher, Alexandra; Heeschen, Christopher			Nodal/Activin Signaling Drives Self-Renewal and Tumorigenicity of Pancreatic Cancer Stem Cells and Provides a Target for Combined Drug Therapy	CELL STEM CELL			English	Article							ACTIVIN-A; STELLATE-CELLS; TGF-BETA; HEDGEHOG PROMOTES; GROWTH-FACTOR; PATHWAYS; AGGRESSIVENESS; INHIBITION; PHENOTYPE; FIBROSIS	Nodal and Activin belong to the TGF-beta superfamily and are important regulators of embryonic stem cell fate. Here we investigated whether Nodal and Activin regulate self-renewal of pancreatic cancer stem cells. Nodal and Activin were hardly detectable in more differentiated pancreatic cancer cells, while cancer stem cells and stroma-derived pancreatic stellate cells markedly overexpressed Nodal and Activin, but not TGF-beta. Knockdown or pharmacological inhibition of the Nodal/Activin receptor Alk4/7 in cancer stem cells virtually abrogated their self-renewal capacity and in vivo tumorigenicity, and reversed the resistance of orthotopically engrafted cancer stem cells to gemcitabine. However, engrafted primary human pancreatic cancer tissue with a substantial stroma showed no response due to limited drug delivery. The addition of a stroma-targeting hedgehog pathway inhibitor enhanced delivery of the Nodal/Activin inhibitor and translated into long-term, progression-free survival. Therefore, inhibition of the Alk4/7 pathway, if combined with hedgehog pathway inhibition and gemcitabine, provides atherapeutic strategy for targeting cancer stem cells.	[Lonardo, Enza; Hermann, Patrick C.; Balic, Anamaria; Miranda-Lorenzo, Irene; Zagorac, Sladjana; Alcala, Sonia; Roderiguez-Arabaolaza, Iker; Aicher, Alexandra; Heeschen, Christopher] Spanish Natl Canc Res Ctr CNIO, Stem Cells & Canc Grp, Clin Res Programme, Madrid 28029, Spain; [Garcia, Elena; Hidalgo, Manuel] Spanish Natl Canc Res Ctr CNIO, Gastrointestinal Canc Clin Res Unit, Madrid 28029, Spain; [Alvaro Cebrian, David] Spanish Natl Canc Res Ctr CNIO, Expt Therapeut Programme, Madrid 28029, Spain; [Mueller, Maria-Theresa] Heidelberg Univ, Dept Surg, D-69120 Heidelberg, Germany; [Huber, Stephan] Univ Munich, Dept Surg, D-81377 Munich, Germany; [Berger, Frank] Univ Munich, Dept Radiol, D-81377 Munich, Germany; [Bartenstein, Peter] Univ Munich, Dept Nucl Med, D-81377 Munich, Germany; [Carlos Ramirez, Juan; Torres-Ruiz, Raul] Spanish Natl Cardiovasc Res Ctr CNIC, Viral Vector Unit, Madrid, Spain; [Heuchel, Rainer; Lohr, Matthias] Karolinska Inst, S-17165 Solna, Sweden	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Ruprecht Karls University Heidelberg; University of Munich; University of Munich; University of Munich; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Karolinska Institutet	Heeschen, C (corresponding author), Spanish Natl Canc Res Ctr CNIO, Stem Cells & Canc Grp, Clin Res Programme, Madrid 28029, Spain.	christopher.heeschen@cnio.es	Arabaolaza, Iker Rodríguez/AAC-3773-2020; Löhr, Matthias/A-3692-2012; Hermann, Patrick/Y-6254-2019; Aicher, Alexandra/GZK-8031-2022; lonardo, enza/AAI-5726-2020; HIDALGO, MANUEL/I-4995-2015; Ruiz, Raul Torres/J-1649-2018; Zagorac, Sladana/R-4897-2019; Ramírez, Juan Carlos/B-7979-2015; Heuchel, Rainer/P-7875-2019; Guba, Markus/M-4309-2019	Löhr, Matthias/0000-0002-7647-198X; Hermann, Patrick/0000-0003-0418-0478; HIDALGO, MANUEL/0000-0002-3765-3318; Ruiz, Raul Torres/0000-0001-9606-0398; Zagorac, Sladana/0000-0001-6389-1830; Heuchel, Rainer/0000-0002-2782-585X; Balic, Anamaria/0000-0001-6796-1197; Heeschen, Christopher/0000-0002-1158-8554; Alcala, Sonia/0000-0002-7644-4973; Aicher, Alexandra/0000-0002-8920-9577; Lonardo, Enza/0000-0001-6654-1043	Dr. Mildred Scheel Foundation [108168]; ERC [Pa-CSC 233460]; Subdireccion General de Evaluacion y Fomento de la Investigacion; Fondo de Investigacion Sanitaria [PS09/02129]; Ministerio de Ciencia e Innovacion, Spain [PLE2009-0105]; Roche	Dr. Mildred Scheel Foundation(Deutsche Krebshilfe); ERC(European Research Council (ERC)European Commission); Subdireccion General de Evaluacion y Fomento de la Investigacion; Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Roche(Roche Holding)	We are indebted to Mercedes Alonso for excellent technical assistance and Francisco X. Real for providing primary tissue samples (both from the Spanish National Cancer Research Centre). This work was supported by the Dr. Mildred Scheel Foundation (108168), the ERC Advanced Investigator Grant (Pa-CSC 233460), the Subdireccion General de Evaluacion y Fomento de la Investigacion, Fondo de Investigacion Sanitaria (PS09/02129), and the Programa Nacional de Internacionalizacion de la I+D, Subprogramma: FCCI 2009 (PLE2009-0105; both Ministerio de Ciencia e Innovacion, Spain). E.L. is supported by the Roche Postdoctoral Fellowship Program. Ludwig-Maximilian-University and the Spanish National Cancer Research Centre have filed a patent application for the use of the described treatment modality for epithelial cancer. The authors (E.L., M.T.M., P.C.H., S.H., and C.H.) are inventors of these patents, and may receive royalties from licensees.	Bailey JM, 2008, CLIN CANCER RES, V14, P5995, DOI 10.1158/1078-0432.CCR-08-0291; Bar EE, 2007, STEM CELLS, V25, P2524, DOI 10.1634/stemcells.2007-0166; Borovski T, 2011, CANCER RES, V71, P634, DOI 10.1158/0008-5472.CAN-10-3220; Engelmann K, 2008, CANCER RES, V68, P2419, DOI 10.1158/0008-5472.CAN-07-2249; FRIESS H, 1994, INT J CANCER, V56, P668, DOI 10.1002/ijc.2910560511; Gallmeier E, 2011, STEM CELLS, V29, P418, DOI 10.1002/stem.595; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Hermann PC, 2008, CELL CYCLE, V7, P188, DOI 10.4161/cc.7.2.5326; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Jesnowski R, 2005, LAB INVEST, V85, P1276, DOI 10.1038/labinvest.3700329; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kleeff J, 1998, INT J CANCER, V77, P860, DOI 10.1002/(SICI)1097-0215(19980911)77:6<860::AID-IJC11>3.0.CO;2-5; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Meyer MJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2449; Mueller MT, 2009, GASTROENTEROLOGY, V137, P1102, DOI 10.1053/j.gastro.2009.05.053; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; Ohnishi N, 2003, GUT, V52, P1487, DOI 10.1136/gut.52.10.1487; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; Piccirillo SGM, 2007, ERNST SCHERING FOUND, V5, P59, DOI 10.1007/2789_2007_044; Postovit LM, 2008, P NATL ACAD SCI USA, V105, P4329, DOI 10.1073/pnas.0800467105; Rubio-Viqueira B, 2006, CLIN CANCER RES, V12, P4652, DOI 10.1158/1078-0432.CCR-06-0113; Scaffidi P, 2011, NAT CELL BIOL, V13, P1051, DOI 10.1038/ncb2308; Schneider Gunter, 2003, Mol Cancer, V2, P15, DOI 10.1186/1476-4598-2-15; Shimizu K, 2008, J GASTROENTEROL, V43, P823, DOI 10.1007/s00535-008-2249-7; Shinozaki S, 2008, J CELL PHYSIOL, V216, P38, DOI 10.1002/jcp.21372; Strizzi L, 2005, ONCOGENE, V24, P5731, DOI 10.1038/sj.onc.1208918; Topczewska JM, 2006, NAT MED, V12, P925, DOI 10.1038/nm1448; Torres R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019794; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Yoshinaga K, 2004, CLIN CANCER RES, V10, P5702, DOI 10.1158/1078-0432.CCR-03-0262; Yoshinaga K, 2008, ANN SURG ONCOL, V15, P96, DOI 10.1245/s10434-007-9631-1; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	37	297	310	0	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 4	2011	9	5					433	446		10.1016/j.stem.2011.10.001	http://dx.doi.org/10.1016/j.stem.2011.10.001			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	850FJ	22056140	Bronze			2022-12-28	WOS:000297180200011
J	Etchegaray, JP; Mostoslavsky, R				Etchegaray, Jean-Pierre; Mostoslavsky, Raul			eNERgizing Pluripotent Gene Transcription	CELL STEM CELL			English	Editorial Material							STEM-CELLS; REPAIR; TFIIH; NANOG		[Etchegaray, Jean-Pierre; Mostoslavsky, Raul] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Mostoslavsky, R (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02114 USA.	rmostoslavsky@mgh.harvard.edu						DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; Fong YW, 2011, CELL, V147, P120, DOI 10.1016/j.cell.2011.08.038; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Le May N, 2010, MOL CELL, V38, P54, DOI 10.1016/j.molcel.2010.03.004; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032	10	3	3	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	OCT 7	2011	9	4					285	286		10.1016/j.stem.2011.09.004	http://dx.doi.org/10.1016/j.stem.2011.09.004			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	835MT	21982224	Bronze			2022-12-28	WOS:000296041200002
J	Greber, B				Greber, Boris			When BMP Meets FGF	CELL STEM CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; PLURIPOTENCY FACTORS; DIFFERENTIATION	Bone morphogenic proteins (BMPs) act as inducers of diverse cellular fates in human embryonic stem cells, but the mechanisms responsible remain poorly understood. In this issue of Cell Stem Cell, Bernardo et al. (2011) demonstrate that different BMP-induced differentiation programs may be orchestrated by similar key target genes.	Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany	Max Planck Society	Greber, B (corresponding author), Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany.	boris.greber@mpi-muenster.mpg.de		Greber, Boris/0000-0002-9404-7293				Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001	10	7	7	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	AUG 5	2011	9	2					91	92		10.1016/j.stem.2011.07.004	http://dx.doi.org/10.1016/j.stem.2011.07.004			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	808PM	21816358	Bronze			2022-12-28	WOS:000293990900003
J	Abell, AN; Jordan, NV; Huang, WC; Prat, A; Midland, AA; Johnson, NL; Granger, DA; Mieczkowski, PA; Perou, CM; Gomez, SM; Li, LP; Johnson, GL				Abell, Amy N.; Jordan, Nicole Vincent; Huang, Weichun; Prat, Aleix; Midland, Alicia A.; Johnson, Nancy L.; Granger, Deborah A.; Mieczkowski, Piotr A.; Perou, Charles M.; Gomez, Shawn M.; Li, Leping; Johnson, Gary L.			MAP3K4/CBP-Regulated H2B Acetylation Controls Epithelial-Mesenchymal Transition in Trophoblast Stem Cells	CELL STEM CELL			English	Article							BREAST-CANCER; MOUSE EMBRYO; SELF-RENEWAL; MECHANISMS; DISEASE; KINASE; LINES	Epithelial stem cells self-renew while maintaining multipotency, but the dependence of stem cell properties on maintenance of the epithelial phenotype is unclear. We previously showed that trophoblast stem (TS) cells lacking the protein kinase MAP3K4 maintain properties of both sternness and epithelial-mesenchymal transition (EMT). Here, we show that MAP3K4 controls the activity of the histone acetyltransferase CBP, and that acetylation of histones H2A and H2B by CBP is required to maintain the epithelial phenotype. Combined loss of MAP3K4/CBP activity represses expression of epithelial genes and causes IS cells to undergo EMT while maintaining their self-renewal and multipotency properties. The expression profile of MAP3K4-deficient TS cells defines an H2B acetylation-regulated gene signature that closely overlaps with that of human breast cancer cells. Taken together, our data define an epigenetic switch that maintains the epithelial phenotype in TS cells and reveals previously unrecognized genes potentially contributing to breast cancer.	[Abell, Amy N.; Jordan, Nicole Vincent; Johnson, Nancy L.; Granger, Deborah A.; Johnson, Gary L.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Abell, Amy N.; Jordan, Nicole Vincent; Prat, Aleix; Johnson, Nancy L.; Granger, Deborah A.; Mieczkowski, Piotr A.; Perou, Charles M.; Johnson, Gary L.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Prat, Aleix; Mieczkowski, Piotr A.; Perou, Charles M.] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC 27599 USA; [Mieczkowski, Piotr A.] Univ N Carolina, Sch Med, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Midland, Alicia A.; Gomez, Shawn M.] Univ N Carolina, Sch Med, Dept Biomed Engn, Chapel Hill, NC 27599 USA; [Midland, Alicia A.; Gomez, Shawn M.] Univ N Carolina, Sch Med, Curriculum Bioinformat & Computat Biol, Chapel Hill, NC 27599 USA; [Huang, Weichun; Li, Leping] Natl Inst Environm Hlth Sci RTP, Biostat Branch, Res Triangle Pk, NC 27709 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Abell, AN (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA.	amy_abell@med.unc.edu; gary_johnson@med.unc.edu	Li, Leping/F-6497-2019; Perou, Charles M/H-9934-2014; Prat, Aleix/P-8561-2014	Li, Leping/0000-0003-4208-0259; Perou, Charles M/0000-0001-9827-2247; Prat, Aleix/0000-0003-2377-540X; Gomez, Shawn/0000-0002-8251-4552; Mieczkowski, Piotr/0000-0003-2418-0096	NIH [GM30324, DK37871, GM007040]; University Cancer Research Fund; NIH, NIEHS [ES-101765]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101765, P30ES010126, Z01ES101765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030324, T32GM007040, R01GM030324] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University Cancer Research Fund; NIH, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	G.L.J. is supported by NIH grants GM30324 and DK37871 and the University Cancer Research Fund for support of the deep Sequencing Genomics Facility. N.V.J. is supported by NIH training grant GM007040. W.H. and L.L. are supported by the Intramural Research Program of NIH, NIEHS (ES-101765). The authors thank N. Sciaky for managing databases, K. Kluckman and the UNC Animal Models Core for production of chimeras, B. Clarke for graphical work, Z. Wang for ChIP-seq discussions, and T.-P. Yao (Duke University) for CBP/p300 constructs and helpful discussions. We thank T. Magnuson, B. Snider, B. Richardson, and J. Zawistowski for careful reading of the manuscript.	Abell AN, 2009, MOL CELL BIOL, V29, P2748, DOI 10.1128/MCB.01391-08; Abell AN, 2005, MOL CELL BIOL, V25, P8948, DOI 10.1128/MCB.25.20.8948-8959.2005; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Maupin KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013002; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Norwitz ER, 2001, NEW ENGL J MED, V345, P1400, DOI 10.1056/NEJMra000763; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Ray ME, 1997, P NATL ACAD SCI USA, V94, P3229, DOI 10.1073/pnas.94.7.3229; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Rugg-Gunn PJ, 2010, P NATL ACAD SCI USA, V107, P10783, DOI 10.1073/pnas.0914507107; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009	19	86	87	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAY 6	2011	8	5					525	537		10.1016/j.stem.2011.03.008	http://dx.doi.org/10.1016/j.stem.2011.03.008			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	768IN	21549327	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000290927600013
J	Charville, GW; Rando, TA				Charville, Gregory W.; Rando, Thomas A.			A Sexy Spin on Nonrandom Chromosome Segregation	CELL STEM CELL			English	Editorial Material							CELL-DIVISION; DNA STRANDS	Nonrandom chromosome segregation is an intriguing phenomenon linked to certain asymmetric stem cell divisions. In a recent report in Nature, Yadlapalli and Yamashita (2013) observe nonrandom segregation of X and Y chromosomes in Drosophila germline stem cells and shed light on the complex mechanisms of this fascinating process.	[Charville, Gregory W.; Rando, Thomas A.] Stanford Univ, Sch Med, Paul F Glenn Labs Biol Aging, Stanford, CA 94305 USA; [Charville, Gregory W.; Rando, Thomas A.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Charville, Gregory W.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Rando, Thomas A.] Vet Affairs Palo Alto Hlth Care Syst, Neurol Serv, Palo Alto, CA 94304 USA; [Rando, Thomas A.] Vet Affairs Palo Alto Hlth Care Syst, Rehabil Res & Dev Ctr Excellence, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Rando, TA (corresponding author), Stanford Univ, Sch Med, Paul F Glenn Labs Biol Aging, Stanford, CA 94305 USA.	rando@stanford.edu		Rando, Thomas/0000-0001-5843-8564	NATIONAL INSTITUTE ON AGING [F30AG035521, R37AG023806, P01AG036695] Funding Source: NIH RePORTER; NIA NIH HHS [F30 AG035521, P01 AG036695, R37 AG023806] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Armakolas A, 2006, SCIENCE, V311, P1146, DOI 10.1126/science.1120519; Charville GW, 2011, PHILOS T R SOC B, V366, P85, DOI 10.1098/rstb.2010.0279; Conboy MJ, 2007, PLOS BIOL, V5, P1120, DOI 10.1371/journal.pbio.0050102; Falconer E, 2010, NATURE, V463, P93, DOI 10.1038/nature08644; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; Rando TA, 2007, CELL, V129, P1239, DOI 10.1016/j.cell.2007.06.019; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Yadlapalli S., 2013, NATURE IN PRESS; Yadlapalli S, 2011, J CELL SCI, V124, P933, DOI 10.1242/jcs.079798; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910	10	0	0	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 6	2013	12	6					641	643		10.1016/j.stem.2013.05.013	http://dx.doi.org/10.1016/j.stem.2013.05.013			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VH	23746972	Green Accepted, Bronze			2022-12-28	WOS:000329569900006
J	Gao, YW; Chen, JY; Li, K; Wu, T; Huang, B; Liu, WQ; Kou, XC; Zhang, Y; Huang, H; Jiang, YH; Yao, C; Liu, XL; Lu, ZW; Xu, ZJ; Kang, L; Chen, J; Wang, HL; Cai, T; Gao, SR				Gao, Yawei; Chen, Jiayu; Li, Ke; Wu, Tong; Huang, Bo; Liu, Wenqiang; Kou, Xiaochen; Zhang, Yu; Huang, Hua; Jiang, Yonghua; Yao, Chao; Liu, Xiaolei; Lu, Zhiwei; Xu, Zijian; Kang, Lan; Chen, Jun; Wang, Hailin; Cai, Tao; Gao, Shaorong			Replacement of Oct4 by Tet1 during iPSC Induction Reveals an Important Role of DNA Methylation and Hydroxymethylation in Reprogramming	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; SOMATIC-CELLS; GENE-EXPRESSION; 5-HYDROXYMETHYLCYTOSINE; MOUSE; GENOME; 5-METHYLCYTOSINE; FIBROBLASTS; MICE; REGULATORS	DNA methylation and demethylation have been proposed to play an important role in somatic cell reprogramming. Here, we demonstrate that the DNA hydroxylase Tet1 facilitates pluripotent stem cell induction by promoting Oct4 demethylation and reactivation. Moreover, Tet1 (T) can replace Oct4 and initiate somatic cell reprogramming in conjunction with Sox2 (S), Klf4 (K), and c-Myc (M). We established an efficient TSKM secondary reprogramming system and used it to characterize the dynamic profiles of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), and gene expression during reprogramming. Our analysis revealed that both 5mC and 5hmC modifications increased at an intermediate stage of the process, correlating with a transition in the transcriptional profile. We also found that 5hmC enrichment is involved in the demethylation and reactivation of genes and regulatory regions that are important for pluripotency. Our data indicate that changes in DNA methylation and hydroxymethylation play important roles in genome-wide epigenetic remodeling during reprogramming.	[Gao, Yawei; Chen, Jiayu; Gao, Shaorong] Peking Union Med Coll, Grad Sch, Beijing 100730, Peoples R China; [Gao, Yawei; Chen, Jiayu; Li, Ke; Wu, Tong; Huang, Bo; Liu, Wenqiang; Kou, Xiaochen; Zhang, Yu; Jiang, Yonghua; Yao, Chao; Liu, Xiaolei; Lu, Zhiwei; Xu, Zijian; Kang, Lan; Chen, Jun; Cai, Tao; Gao, Shaorong] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Huang, Hua; Wang, Hailin] Chinese Acad Sci, State Key Lab Environm Chem & Ecotoxicol, Res Ctr Ecoenvironm Sci, Beijing 100085, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Institute of Biological Sciences, Beijing; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	Cai, T (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	caitao@nibs.ac.cn; gaoshaorong@nibs.ac.cn	huang, bo/A-2690-2017; Li, Ke/I-7327-2019; Chen, Jiayu/ABF-3722-2021	Li, Ke/0000-0002-0737-1045; Chen, Jiayu/0000-0003-4755-8901; CHen, Jun/0000-0002-4493-9082; huang, hua/0000-0002-9881-4197; gao, yawei/0000-0001-8946-9697	Ministry of Science and Technology [2010CB944900, 2011CB812700, 2011CB964800]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	We thank Professor Rudolf Jaenisch from the Whitehead Institute of MIT for generously supplying the lentiviral vectors containing the cDNAs of the original four transcription factors. We thank Dr. Guo-Liang Xu from the Shanghai Institute of Biological Sciences for providing the Tet1 antibody. We thank Dr. Lijun Liu from Lanzhou University for assistance with the karyotype analysis of the TSKM-iPS8 cells. We thank Mr. Ning Yang for assistance with the design of the schematic model. We thank Dr. Bing Zhu and Dr. Dangsheng Li for their comments. We are also grateful to our laboratory colleagues for their assistance with experiments and in the preparation of the manuscript. This work was supported by the Ministry of Science and Technology (grants 2010CB944900, 2011CB812700, and 2011CB964800).	Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Costa Y., 2013, NATURE; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Golipour A, 2012, CELL STEM CELL, V11, P769, DOI 10.1016/j.stem.2012.11.008; Gruntman E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-371; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Hansson J, 2012, CELL REP, V2, P1579, DOI 10.1016/j.celrep.2012.10.014; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Kang L, 2011, CELL RES, V21, P546, DOI 10.1038/cr.2010.164; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kou ZH, 2010, BIOL REPROD, V83, P238, DOI 10.1095/biolreprod.110.084731; Kudo Y, 2012, CANCER SCI, V103, P670, DOI 10.1111/j.1349-7006.2012.02213.x; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Plath K, 2011, NAT REV GENET, V12, P253, DOI 10.1038/nrg2955; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vincent J.J., 2013, CELL STEM CELL; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yang H, 2013, ONCOGENE, V32, P663, DOI 10.1038/onc.2012.67; Yang P, 2011, STEM CELLS, V29, P791, DOI 10.1002/stem.634; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	51	263	287	3	126	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 4	2013	12	4					453	469		10.1016/j.stem.2013.02.005	http://dx.doi.org/10.1016/j.stem.2013.02.005			17	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VD	23499384	Green Published, Bronze			2022-12-28	WOS:000329569500012
J	Vermeulen, L				Vermeulen, Louis			Keeping Stem Cells in Check: A Hippo Balancing Act	CELL STEM CELL			English	Editorial Material							PROLIFERATION; PATHWAY; CATENIN	Knowing when to stop proliferation is crucial for any regenerative process. In a recent issue of Nature, Barry et al. (2012) report that the Hippo pathway component YAP negatively regulates Wnt signaling, thereby preventing stem cell overpopulation after a regenerative response in the intestine.	[Vermeulen, Louis] Cambridge Res Inst, Canc Res UK, Cambridge CB2 0RE, England; [Vermeulen, Louis] Univ Amsterdam, Acad Med Ctr, Ctr Expt Mol Med, Lab Expt Oncol & Radiobiol LEXOR, NL-1105 AZ Amsterdam, Netherlands	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Amsterdam; Academic Medical Center Amsterdam	Vermeulen, L (corresponding author), Cambridge Res Inst, Canc Res UK, Cambridge CB2 0RE, England.	louis.vermeulen@cruk.cam.ac.uk	Vermeulen, Louis/B-7488-2008	Vermeulen, Louis/0000-0002-6066-789X				Barry ER, 2012, NATURE; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Konsavage Jr WM, 2012, ACTA BIOCH BIOPHYS S; Konsavage WM, 2012, J BIOL CHEM, V287, P11730, DOI 10.1074/jbc.M111.327767; Mauviel A, 2012, ONCOGENE, V31, P1743, DOI 10.1038/onc.2011.363; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108	10	6	7	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JAN 3	2013	12	1					3	5		10.1016/j.stem.2012.12.004	http://dx.doi.org/10.1016/j.stem.2012.12.004			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	074UM	23290131	Bronze			2022-12-28	WOS:000313839500002
J	Bulger, M				Bulger, Michael			Maps for Changing Landscapes: Viewing Epigenomic Signatures through Differentiation	CELL STEM CELL			English	Editorial Material								Enormous progress has been made in identifying chromatin "signatures" that define tissue-specific transcriptional networks. Three recent studies by Rada-Iglesias et al. (2012), Wamstad et al. (2012), and Paige et al. (2012) track such signatures during cellular differentiation, revealing a richer understanding of gene regulation and providing hints of new phenomena.	Univ Rochester, Dept Pediat, Rochester, NY 14642 USA	University of Rochester	Bulger, M (corresponding author), Univ Rochester, Dept Pediat, Rochester, NY 14642 USA.	michael_bulger@urmc.rochester.edu						Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Paige SL, 2012, CELL, V151, P221, DOI 10.1016/j.cell.2012.08.027; Rada-Iglesias A., 2012, CELL STEM C IN PRESS; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Stamatoyannopoulos JA, 2012, GENOME RES, V22, P1602, DOI 10.1101/gr.146506.112; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035	6	1	1	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV 2	2012	11	5					581	582		10.1016/j.stem.2012.10.009	http://dx.doi.org/10.1016/j.stem.2012.10.009			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	042LE	23122282	Bronze			2022-12-28	WOS:000311471900001
J	Hidalgo, I; Herrera-Merchan, A; Ligos, JM; Carramolino, L; Nunez, J; Martinez, F; Dominguez, O; Torres, M; Gonzalez, S				Hidalgo, Isabel; Herrera-Merchan, Antonio; Manuel Ligos, Jose; Carramolino, Laura; Nunez, Javier; Martinez, Fernando; Dominguez, Orlando; Torres, Miguel; Gonzalez, Susana			Ezh1 Is Required for Hematopoietic Stem Cell Maintenance and Prevents Senescence-like Cell Cycle Arrest	CELL STEM CELL			English	Article							H3 LYSINE 27; HISTONE METHYLTRANSFERASE; TARGET GENES; POLYCOMB; HETEROCHROMATIN; METHYLATION; ONCOGENE; CANCER; PRC2; DIFFERENTIATION	Polycomb group (PcG) proteins are key epigenetic regulators of hematopietic stem cell (HSC) fate. The PcG members Ezh2 and Ezh2 are important determinants of embryonic stem cell identity, and the transcript levels of these histone methyltransferases are inversely correlated during development. However, the role of Ezh1 in somatic stem cells is largely unknown. Here we show that Ezh1 maintains repopulating HSCs in a slow-cycling, undifferentiated state, protecting them from senescence. Ezh1 ablation induces significant loss of adult HSCs, with concomitant impairment of their self-renewal capacity due to a potent senescence response. Epigenomic and gene expression changes induced by Ezh1 deletion in senesced HSCs demonstrated that Ezh1-mediated PRC2 activity catalyzes monomethylation and dimethylation of H3K27. Deletion of Cdkn2a on the Ezh1 null background rescued HSC proliferation and survival. Our results suggest that Ezh1 is an important histone methyltransferase for HSC maintenance.	[Hidalgo, Isabel; Herrera-Merchan, Antonio; Gonzalez, Susana] CNIC, Stem Cell Aging Grp, E-28029 Madrid, Spain; [Manuel Ligos, Jose] CNIC, Cell Unit, E-28029 Madrid, Spain; [Nunez, Javier; Martinez, Fernando] CNIC, Bioinformat Unit, E-28029 Madrid, Spain; [Dominguez, Orlando] CNIO, Genom Unit, E-28029 Madrid, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Centro Nacional de Investigaciones Cardiovasculares (CNIC); Centro Nacional de Investigaciones Cardiovasculares (CNIC); Centro Nacional de Investigaciones Oncologicas (CNIO)	Gonzalez, S (corresponding author), CNIC, Stem Cell Aging Grp, E-28029 Madrid, Spain.	sgonzalez@cnic.es	HERRERA MERCHAN, ANTONIO/S-4834-2018; Nunez, Javier/B-1981-2016; Martinez, Fernando/E-8026-2016; Torres, Miguel/CAG-0003-2022; Gonzalez, Susana/I-3154-2015; Carramolino, Laura/H-5886-2015; Torres, Miguel/A-7388-2013; Hidalgo-Gavilan, Isabel/G-9859-2016	HERRERA MERCHAN, ANTONIO/0000-0001-8407-1516; Martinez, Fernando/0000-0003-1904-5164; Torres, Miguel/0000-0003-0906-4767; Gonzalez, Susana/0000-0002-7443-6195; Carramolino, Laura/0000-0002-1661-618X; Torres, Miguel/0000-0003-0906-4767; Hidalgo-Gavilan, Isabel/0000-0002-2690-6463; Martinez Estrada, Fernando O/0000-0003-0908-9366	Human Frontiers Science Program Organization; Spanish Ministries of Science and Innovation and Health [SAF2010-15386, FIS PI06/0627]; Ministerio de Economia y Competitividad; Pro-CNIC Foundation	Human Frontiers Science Program Organization(Human Frontier Science Program); Spanish Ministries of Science and Innovation and Health; Ministerio de Economia y Competitividad(Spanish Government); Pro-CNIC Foundation	We thank Dr. Berns for the ckop 16<SUP>INK4a</SUP>/AR<SUP>fl/fl</SUP> mice; A. Hidalgo, A.R. Ramiro, and J.A. Enriquez for helpful discussions; P. Arribas, M. Sonseca, R. Diges, and G. Merfu for excellent technical assistance; G. Giovinazzo, L.-M. Criado, M. Montoya, M. Canamero, and their teams for technical support; and S. Bartlett for English editing. S.G. is funded by the Human Frontiers Science Program Organization and the Spanish Ministries of Science and Innovation (SAF2010-15386) and Health (FIS PI06/0627). The CNIC is supported by the Ministerio de Economia y Competitividad and the Pro-CNIC Foundation.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cao R, 2008, MOL CELL BIOL, V28, P1862, DOI 10.1128/MCB.01589-07; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Chen HA, 2009, GENE DEV, V23, P975, DOI 10.1101/gad.1742509; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Di Micco R, 2011, NAT CELL BIOL, V13, P292, DOI 10.1038/ncb2170; Ezhkova E, 2011, GENE DEV, V25, P485, DOI 10.1101/gad.2019811; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Forsberg EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008785; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Gonzalez S, 2006, NATURE, V440, P702, DOI 10.1038/nature04585; He J, 2008, NAT STRUCT MOL BIOL, V15, P1169, DOI 10.1038/nsmb.1499; Jacob Y, 2010, NATURE, V466, P987, DOI 10.1038/nature09290; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kaneda A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002359; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Laible G, 1997, EMBO J, V16, P3219, DOI 10.1093/emboj/16.11.3219; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Majewski IJ, 2008, PLOS BIOL, V6, P796, DOI 10.1371/journal.pbio.0060093; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Mochizuki-Kashio M, 2011, BLOOD, V118, P6553, DOI 10.1182/blood-2011-03-340554; Nardella C, 2011, NAT REV CANCER, V11, P503, DOI 10.1038/nrc3057; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Ng SYM, 2009, IMMUNITY, V30, P493, DOI 10.1016/j.immuni.2009.01.014; Oguro H, 2010, CELL STEM CELL, V6, P279, DOI 10.1016/j.stem.2010.01.005; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pereira JD, 2010, P NATL ACAD SCI USA, V107, P15957, DOI 10.1073/pnas.1002530107; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Stadtfeld M, 2005, DEVELOPMENT, V132, P203, DOI 10.1242/dev.01558; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Swiers G, 2010, INT J DEV BIOL, V54, P1151, DOI 10.1387/ijdb.103106gs; Wagner W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005846	44	151	157	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 2	2012	11	5					649	662		10.1016/j.stem.2012.08.001	http://dx.doi.org/10.1016/j.stem.2012.08.001			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	042LE	23122289	Bronze			2022-12-28	WOS:000311471900011
J	Rada-Iglesias, A; Bajpai, R; Prescott, S; Brugmann, SA; Swigut, T; Wysocka, J				Rada-Iglesias, Alvaro; Bajpai, Ruchi; Prescott, Sara; Brugmann, Samantha A.; Swigut, Tomek; Wysocka, Joanna			Epigenomic Annotation of Enhancers Predicts Transcriptional Regulators of Human Neural Crest	CELL STEM CELL			English	Article							GENE-EXPRESSION; COUP-TFS; CELLS; DIFFERENTIATION; SPECIFICATION; MORPHOGENESIS; REQUIREMENT; SIGNATURES; MIGRATION; SEQUENCES	Neural crest cells (NCC) are a transient, embryonic cell population characterized by unusual migratory ability and developmental plasticity. To annotate and characterize cis-regulatory elements utilized by the human NCC, we coupled a hESC differentiation model with genome-wide profiling of histone modifications and of coactivator and transcription factor (TF) occupancy. Sequence analysis predicted major TFs binding at epigenomically annotated hNCC enhancers, including a master NC regulator, TFAP2A, and nuclear receptors NR2F1 and NR2F2. Although many TF binding events occur outside enhancers, sites coinciding with enhancer chromatin signatures show significantly higher sequence constraint, nucleosomal depletion, correlation with gene expression, and functional conservation in NCC isolated from chicken embryos. Simultaneous co-occupancy by TFAP2A and NR2F1/F2 is associated with permissive enhancer chromatin states, characterized by high levels of p300 and H3K27ac. Our results provide global insights into human NC chromatin landscapes and a rich resource for studies of craniofacial development and disease.	[Rada-Iglesias, Alvaro; Bajpai, Ruchi; Prescott, Sara; Brugmann, Samantha A.; Swigut, Tomek; Wysocka, Joanna] Stanford Univ, Dept Chem & Syst Biol, Sch Med, Stanford, CA 94305 USA; [Prescott, Sara; Wysocka, Joanna] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Wysocka, J (corresponding author), Stanford Univ, Dept Chem & Syst Biol, Sch Med, Stanford, CA 94305 USA.	wysocka@stanford.edu		Swigut, Tomek/0000-0002-7649-6781; Prescott, Sara/0000-0003-4348-9021; Bajpai, Ruchi/0000-0001-7737-3567; Rada-Iglesias, Alvaro/0000-0001-7137-1341	NIH [RO1 GM095555, P30 DE020750]; CIRM [RN1 00579-1]; Searle Scholar; W.M. Keck Foundation; EMBO; Siebel Scholars Program; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P30DE020750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095555] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); Searle Scholar; W.M. Keck Foundation(W.M. Keck Foundation); EMBO(European Molecular Biology Organization (EMBO)); Siebel Scholars Program; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Crump for insightful comments on this work; R. Srinivasan for assistance; A.K. Roos, E. Calo-Velazquez, and K. Murata for manuscript reading; and Z. Weng and Stanford Sequencing Service Center for Illumina sequencing. This work was supported by NIH RO1 GM095555, CIRM RN1 00579-1, Searle Scholar and W.M. Keck Foundation grants to J.W. A.R-I. was supported by an EMBO long-term fellowship and Siebel Scholars Program and R.B. by the NIH P30 DE020750 grant.	Amiel J, 2010, ANN NY ACAD SCI, V1214, P34, DOI 10.1111/j.1749-6632.2010.05878.x; Aybar MJ, 2003, DEVELOPMENT, V130, P483, DOI 10.1242/dev.00238; Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Bellmeyer A, 2003, DEV CELL, V4, P827, DOI 10.1016/S1534-5807(03)00160-6; Betancur P, 2010, ANNU REV CELL DEV BI, V26, P581, DOI 10.1146/annurev.cellbio.042308.113245; Betters E, 2010, DEV BIOL, V344, P578, DOI 10.1016/j.ydbio.2010.05.012; Biggin MD, 2011, DEV CELL, V21, P611, DOI 10.1016/j.devcel.2011.09.008; Birnbaum S, 2009, NAT GENET, V41, P473, DOI 10.1038/ng.333; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; Brown KK, 2009, AM J MED GENET A, V149A, P931, DOI 10.1002/ajmg.a.32764; Brugmann SA, 2010, HUM MOL GENET, V19, P920, DOI 10.1093/hmg/ddp559; Buecker C, 2012, TRENDS GENET, V28, P276, DOI 10.1016/j.tig.2012.02.008; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Bulger M, 2010, DEV BIOL, V339, P250, DOI 10.1016/j.ydbio.2009.11.035; COONEY AJ, 1992, MOL CELL BIOL, V12, P4153, DOI 10.1128/MCB.12.9.4153; Cotney J, 2012, GENOME RES, V22, P1069, DOI 10.1101/gr.129817.111; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; d'Aquino R, 2011, EUR CELLS MATER, V21, P304, DOI 10.22203/eCM.v021a23; de Croze N, 2011, P NATL ACAD SCI USA, V108, P155, DOI 10.1073/pnas.1010740107; ECHELARD Y, 1994, DEVELOPMENT, V120, P2213; Furlan-Magaril M, 2009, METHODS MOL BIOL, V543, P253, DOI 10.1007/978-1-60327-015-1_17; Gammill LS, 2003, NAT REV NEUROSCI, V4, P795, DOI 10.1038/nrn1219; Garcia-Castro MI, 2002, SCIENCE, V297, P848, DOI 10.1126/science.1070824; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Honore SM, 2003, DEV BIOL, V260, P79, DOI 10.1016/S0012-1606(03)00247-1; Ivey KN, 2008, CIRC RES, V103, P388, DOI 10.1161/CIRCRESAHA.108.180661; Jugessur A, 2009, ORAL DIS, V15, P437, DOI 10.1111/j.1601-0825.2009.01577.x; Kaltschmidt B, 2012, STEM CELL REV REP, V8, P658, DOI 10.1007/s12015-011-9340-9; Kruse SW, 2008, PLOS BIOL, V6, P2002, DOI 10.1371/journal.pbio.0060227; LAMMER EJ, 1985, NEW ENGL J MED, V313, P837, DOI 10.1056/NEJM198510033131401; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; Lin FJ, 2011, ENDOCR REV, V32, P404, DOI 10.1210/er.2010-0021; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Milunsky JM, 2008, AM J HUM GENET, V82, P1171, DOI 10.1016/j.ajhg.2008.03.005; Minoux M, 2010, DEVELOPMENT, V137, P2605, DOI 10.1242/dev.040048; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Naka H, 2008, NAT NEUROSCI, V11, P1014, DOI 10.1038/nn.2168; Passos-Bueno MR, 2009, AM J MED GENET A, V149A, P1853, DOI 10.1002/ajmg.a.32950; Pohl BS, 2001, MECH DEVELOP, V103, P93, DOI 10.1016/S0925-4773(01)00334-3; Poot M, 2007, EUR J MED GENET, V50, P432, DOI 10.1016/j.ejmg.2007.08.003; Qiu YH, 1997, GENE DEV, V11, P1925, DOI 10.1101/gad.11.15.1925; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Sakabe NJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-238; Sato T, 2005, DEVELOPMENT, V132, P2355, DOI 10.1242/dev.01823; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; Soo K, 2002, DEV BIOL, V247, P251, DOI 10.1006/dbio.2002.0699; Taneyhill LA, 2007, DEVELOPMENT, V134, P1481, DOI 10.1242/dev.02834; Tang K, 2010, DEVELOPMENT, V137, P725, DOI 10.1242/dev.040568; Teng L, 2008, DEVELOPMENT, V135, P1615, DOI 10.1242/dev.012179; Theveneau E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001142; Trompouki E, 2011, CELL, V147, P577, DOI 10.1016/j.cell.2011.09.044; Tsai SY, 1997, ENDOCR REV, V18, P229, DOI 10.1210/er.18.2.229; Tucker AS, 1999, DEVELOPMENT, V126, P221; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	58	191	193	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 2	2012	11	5					633	648		10.1016/j.stem.2012.07.006	http://dx.doi.org/10.1016/j.stem.2012.07.006			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	042LE	22981823	Green Accepted, Bronze			2022-12-28	WOS:000311471900010
J	Zwaka, TP				Zwaka, Thomas P.			Pluripotency Network in Embryonic Stem Cells: Maybe Leibniz Was Right All Along	CELL STEM CELL			English	Editorial Material							SELF-RENEWAL; TCF3	The transcription factors Tcf3 and Nanog regulate many genes in embryonic stem cells, but according to two reports in this issue of Cell Stem Cell (Festuccia et al., 2012, Martello et al., 2012), only one, Esrrb, encoding an orphan nuclear hormone receptor, truly matters in the maintenance of self-renewal.	Baylor Coll Med, Houston, TX 77030 USA	Baylor College of Medicine	Zwaka, TP (corresponding author), Baylor Coll Med, 1 Baylor Plaza, Houston, TX 77030 USA.	tpzwaka@bcm.edu						Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Dejosez M., 2012, CELL STEM CELL, V81, P737; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283; Zhang XF, 2008, J BIOL CHEM, V283, P35825, DOI 10.1074/jbc.M803481200	10	7	7	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	OCT 5	2012	11	4					441	442		10.1016/j.stem.2012.09.005	http://dx.doi.org/10.1016/j.stem.2012.09.005			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	021OZ	23040470	Bronze			2022-12-28	WOS:000309896500001
J							HD iPSC Consortium	Induced Pluripotent Stem Cells from Patients with Huntington's Disease Show CAG-Repeat-Expansion-Associated Phenotypes	CELL STEM CELL			English	Article							GENE-EXPRESSION CHANGES; MUTANT HUNTINGTIN; GLUTAMATE TRANSPORT; LENGTH; NEURONS; AGE; HD; TRANSCRIPTION; AGGREGATION; METABOLISM	Huntington's disease (HD) is an inherited neurodegenerative disorder caused by an expanded stretch of CAG trinucleotide repeats that results in neuronal dysfunction and death. Here, The HD Consortium reports the generation and characterization of 14 induced pluripotent stem cell (iPSC) lines from HD patients and controls. Microarray profiling revealed CAG-repeat-expansion-associated gene expression patterns that distinguish patient lines from controls, and early onset versus late onset HD. Differentiated HD neural cells showed disease-associated changes in electrophysiology, metabolism, cell adhesion, and ultimately cell death for lines with both medium and longer CAG repeat expansions. The longer repeat lines were however the most vulnerable to cellular stressors and BDNF withdrawal, as assessed using a range of assays across consortium laboratories. The HD iPSC collection represents a unique and well-characterized resource to elucidate disease mechanisms in HD and provides a human stem cell platform for screening new candidate therapeutics.					Sander-Effron, Samuel/AAX-2231-2020; Chiang, Jason/N-2766-2018; Onorati, Marco/K-3919-2018; Kemp, Paul/A-4634-2010; Resource Center, NINDS Human Genetics/AGF-2474-2022; Onorati, Marco/T-7190-2019	Chiang, Jason/0000-0003-3623-8996; Onorati, Marco/0000-0001-8517-930X; Kemp, Paul/0000-0003-2773-973X; Battersby, Alysia/0000-0002-0715-6935; Allen, Nicholas/0000-0003-4009-186X	CHDI Foundation, Inc.; HD Center Without Walls [P50NS16375, P50NS16367, R01NS32765]; CIRM [TG2-01160, TG2-01152, RL1-00678-1]; Taube-Koret Center; Hellman Family Foundation; Charlotte Geyer Foundation; NIH [PO1 GM081629];  [RC2-NS069422]; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081629, T32GM007618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032765, RC2NS069422, P50NS016375, R01NS039074, P50NS016367, R01NS083390] Funding Source: NIH RePORTER	CHDI Foundation, Inc.; HD Center Without Walls; CIRM(California Institute for Regenerative Medicine); Taube-Koret Center; Hellman Family Foundation; Charlotte Geyer Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank HD patients and their families for their essential contributions to this research and Nissim Benvenisty for critical reading. Primary support for this work was from RC2-NS069422 (L.M.T., C.N.S., J.F.G., C.A.R., and S.F.) and from the CHDI Foundation, Inc. (E.C., N.A., and P.K.). Additional support was provided by P50NS16375, P50NS16367 (HD Center Without Walls), and R01NS32765; CIRM fellowships TG2-01160 (J.A.K.) and TG2-01152 (A.K.); CIRM New Cell Line Grant RL1-00678-1 (L.M.T.); the Taube-Koret Center and the Hellman Family Foundation (S.F.); the Charlotte Geyer Foundation (J.T.); and NIH grant PO1 GM081629 (J.T.). Full membership of the HD iPSC Consortium is provided in Document S2.	Apostol BL, 2008, MOL CELL NEUROSCI, V39, P8, DOI 10.1016/j.mcn.2008.04.007; Arrasate M, 2005, P NATL ACAD SCI USA, V102, P3840, DOI 10.1073/pnas.0409777102; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Aubry L, 2008, P NATL ACAD SCI USA, V105, P16707, DOI 10.1073/pnas.0808488105; Bae BI, 2005, NEURON, V47, P29, DOI 10.1016/j.neuron.2005.06.005; Behrens PF, 2002, BRAIN, V125, P1908, DOI 10.1093/brain/awf180; Blain JF, 2004, NEUROBIOL DIS, V15, P510, DOI 10.1016/j.nbd.2003.12.001; Bradley CK, 2011, STEM CELLS DEV, V20, P495, DOI 10.1089/scd.2010.0120; Camnasio S, 2012, NEUROBIOL DIS, V46, P41, DOI 10.1016/j.nbd.2011.12.042; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Faideau M, 2010, HUM MOL GENET, V19, P3053, DOI 10.1093/hmg/ddq212; Fan MMY, 2007, PROG NEUROBIOL, V81, P272, DOI 10.1016/j.pneurobio.2006.11.003; Gines S, 2010, J BIOL CHEM, V285, P21537, DOI 10.1074/jbc.M109.084202; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Jacobsen JC, 2011, HUM MOL GENET, V20, P2846, DOI 10.1093/hmg/ddr195; Karasinska JM, 2011, NAT REV NEUROL, V7, P561, DOI 10.1038/nrneurol.2011.132; Koch P, 2011, NATURE, V480, P543, DOI 10.1038/nature10671; Langbehn DR, 2010, AM J MED GENET B, V153B, P397, DOI 10.1002/ajmg.b.30992; Lievens JC, 2005, HUM MOL GENET, V14, P713, DOI 10.1093/hmg/ddi067; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mattis VB, 2011, LANCET NEUROL, V10, P383, DOI 10.1016/S1474-4422(11)70022-9; Miller JP, 2010, NEURON, V67, P199, DOI 10.1016/j.neuron.2010.06.021; Molero AE, 2009, P NATL ACAD SCI USA, V106, P21900, DOI 10.1073/pnas.0912171106; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Pruunsild P, 2011, J NEUROSCI, V31, P3295, DOI 10.1523/JNEUROSCI.4540-10.2011; Reis SA, 2011, HUM MOL GENET, V20, P2344, DOI 10.1093/hmg/ddr127; Rosenblatt A, 2012, MOVEMENT DISORD, V27, P272, DOI 10.1002/mds.24024; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Ross CA, 2006, NAT MED, V12, P1239, DOI 10.1038/nm1106-1239; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Royer B, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-72; Seibler P, 2011, J NEUROSCI, V31, P5970, DOI 10.1523/JNEUROSCI.4441-10.2011; Seong IS, 2005, HUM MOL GENET, V14, P2871, DOI 10.1093/hmg/ddi319; Shelbourne PF, 2007, HUM MOL GENET, V16, P1133, DOI 10.1093/hmg/ddm054; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takata K, 2004, J NEUROSCI RES, V78, P880, DOI 10.1002/jnr.20340; Tunez I, 2011, J MED CHEM, V54, P5602, DOI 10.1021/jm200605a; Vonsattel Jean Paul G, 2008, Handb Clin Neurol, V89, P599, DOI 10.1016/S0072-9752(07)01256-0; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Xu EH, 2009, J CLIN NEUROSCI, V16, P1473, DOI 10.1016/j.jocn.2009.03.027; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang N., 2010, PLOS CURR, P1, DOI DOI 10.1371/CURRENTS.RRN1193; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	49	343	352	0	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 3	2012	11	2					264	278		10.1016/j.stem.2012.04.027	http://dx.doi.org/10.1016/j.stem.2012.04.027			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	987QQ	22748968	Green Accepted, Bronze			2022-12-28	WOS:000307432600016
J	Yu, SY; Jing, XF; Colgan, JD; Zhao, DM; Xue, HH				Yu, Shuyang; Jing, Xuefang; Colgan, John D.; Zhao, Dong-Mei; Xue, Hai-Hui			Targeting Tetramer-Forming GABP beta Isoforms Impairs Self-Renewal of Hematopoietic and Leukemic Stem Cells	CELL STEM CELL			English	Article							TRANSCRIPTION FACTOR GABP; CHRONIC MYELOID-LEUKEMIA; BINDING-PROTEIN; LYMPHOCYTE DEVELOPMENT; INITIATING CELLS; B-LYMPHOCYTE; IN-VIVO; C-MYC; DIFFERENTIATION; ACTIVATION	Hematopoietic stem cells (HSCs) and leukemic stem cells (LSCs) are both capable of self-renewal, with HSCs sustaining multiple blood lineage differentiation and LSCs indefinitely propagating leukemia. The GABP complex, consisting of DNA binding GABP alpha subunit and transactivation GABP beta subunit, critically regulates HSC multipotency and self-renewal via controlling an essential gene regulatory module. Two GABP beta isoforms, GABP beta 1L and GABP beta 2, contribute to assembly of GABP alpha(2)beta(2) tetramer. We demonstrate that GABP beta 1L/beta 2 deficiency specifically impairs HSC quiescence and survival, with little impact on cell cycle or apoptosis in differentiated blood cells. The HSC-specific effect is mechanistically ascribed to perturbed integrity of the GABP-controlled gene regulatory module in HSCs. Targeting GABP beta 1L/beta 2 also impairs LSC self-renewal in p210(BCR-ABL)-induced chronic myelogenous leukemia (CML) and exhibits synergistic effects with tyrosine kinase inhibitor imatinib therapy in inhibiting CML propagation. These findings identify the tetramer-forming GABP beta isoforms as specific HSC regulators and potential therapeutic targets in treating LSC-based hematological malignancy.	[Yu, Shuyang; Jing, Xuefang; Zhao, Dong-Mei; Xue, Hai-Hui] Univ Iowa, Carver Coll Med, Dept Microbiol, Iowa City, IA 52242 USA; [Colgan, John D.; Zhao, Dong-Mei] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Colgan, John D.; Xue, Hai-Hui] Univ Iowa, Carver Coll Med, Interdisciplinary Immunol Grad Program, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Xue, HH (corresponding author), Univ Iowa, Carver Coll Med, Dept Microbiol, Iowa City, IA 52242 USA.	hai-hui-xue@uiowa.edu		Xue, Hai-Hui/0000-0002-9163-7669; Colgan, John/0000-0001-9273-2644	Oberley Seed Grant from Holden Comprehensive Cancer Center, the University of Iowa; NIH [AI080966, HL095540]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093737, R21AI080966, R56AI093737] Funding Source: NIH RePORTER	Oberley Seed Grant from Holden Comprehensive Cancer Center, the University of Iowa; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr. Jothi Raja (NIEHS) for analyzing distribution of GABP motifs in genome-wide GABP binding locations, Dr. Justin Fishbaugh at the Flow Cytometry Core for assistance with the use of LSR II flow cytometer, Heath Vignes and George Rasmussen for cell sorting, and Amanda Kalen at the University of Iowa Radiation Core Facility for assistance with mouse irradiation. We thank Dr. Warren S. Pear (University of Pennsylvania) for providing the BCR-ABL plasmid, Jennifer Barr (University of Iowa), and Drs. Shaoguang Li (University of Massachusetts Medical School) and Reya Tannishtha (University of California, San Diego) for advice on establishing the CML model. This study is supported by Oberley Seed Grant from Holden Comprehensive Cancer Center, the University of Iowa, and NIH grants AI080966 and HL095540 (H.H.X.). The authors declare no competing financial interests.	Batchelor AH, 1998, SCIENCE, V279, P1037, DOI 10.1126/science.279.5353.1037; Briguet A, 2000, J NEUROSCI, V20, P5989, DOI 10.1523/JNEUROSCI.20-16-05989.2000; Bush TS, 2003, BLOOD, V101, P311, DOI 10.1182/blood.V101.1.311; Chen YY, 2009, NAT GENET, V41, P783, DOI 10.1038/ng.389; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Chinenov Y, 2000, J BIOL CHEM, V275, P7749, DOI 10.1074/jbc.275.11.7749; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Dakic A, 2005, J EXP MED, V201, P1487, DOI 10.1084/jem.20050075; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; DELABROUSSE FC, 1994, GENE DEV, V8, P1853, DOI 10.1101/gad.8.15.1853; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; Galvagni F, 2001, J MOL BIOL, V306, P985, DOI 10.1006/jmbi.2000.4335; Graves BJ, 1998, SCIENCE, V279, P1000, DOI 10.1126/science.279.5353.1000; GUGNEJA S, 1995, MOL CELL BIOL, V15, P102, DOI 10.1128/MCB.15.1.102; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Holtz M, 2007, CANCER RES, V67, P1113, DOI 10.1158/0008-5472.CAN-06-2014; Huntly BJP, 2005, NAT REV CANCER, V5, P311, DOI 10.1038/nrc1592; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Jing XF, 2008, J BIOL CHEM, V283, P24326, DOI 10.1074/jbc.M804487200; Kang HS, 2008, J MOL BIOL, V377, P636, DOI 10.1016/j.jmb.2008.01.054; LAMARCO K, 1991, SCIENCE, V253, P789, DOI 10.1126/science.1876836; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Opferman JT, 2007, CURR OPIN IMMUNOL, V19, P497, DOI 10.1016/j.coi.2007.06.002; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Ravel-Chapuis A, 2007, EMBO J, V26, P1117, DOI 10.1038/sj.emboj.7601572; Ristevski S, 2004, MOL CELL BIOL, V24, P5844, DOI 10.1128/MCB.24.13.5844-5849.2004; Rosmarin  AG, 2004, BLOOD CELL MOL DIS, V32, P143, DOI 10.1016/j.bcmd.2003.09.005; Sawa C, 2002, J BIOL CHEM, V277, P22484, DOI 10.1074/jbc.M203060200; Sawa C, 1996, NUCLEIC ACIDS RES, V24, P4954, DOI 10.1093/nar/24.24.4954; Schaeffer L, 1998, EMBO J, V17, P3078, DOI 10.1093/emboj/17.11.3078; Spooner CJ, 2009, IMMUNITY, V31, P576, DOI 10.1016/j.immuni.2009.07.011; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Vogel JL, 2000, EMBO J, V19, P683, DOI 10.1093/emboj/19.4.683; Walkley CR, 2005, NAT CELL BIOL, V7, P172, DOI 10.1038/ncb1214; Wallerman O, 2009, NUCLEIC ACIDS RES, V37, P7498, DOI 10.1093/nar/gkp823; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Xue HH, 2008, MOL CELL BIOL, V28, P4300, DOI 10.1128/MCB.01855-07; Xue HH, 2007, IMMUNITY, V26, P421, DOI 10.1016/j.immuni.2007.03.010; Xue HH, 2004, NAT IMMUNOL, V5, P1036, DOI 10.1038/ni1117; Yang ZF, 2011, BLOOD, V118, P2243, DOI 10.1182/blood-2010-07-298802; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yu SY, 2011, BLOOD, V117, P2166, DOI 10.1182/blood-2010-09-306563; Yucel R, 2003, J EXP MED, V197, P831, DOI 10.1084/jem.20021417; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003	55	24	24	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	AUG 3	2012	11	2					207	219		10.1016/j.stem.2012.05.021	http://dx.doi.org/10.1016/j.stem.2012.05.021			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	987QQ	22862946	Green Accepted, Bronze			2022-12-28	WOS:000307432600011
J	Magri, L; Cambiaghi, M; Cominelli, M; Alfaro-Cervello, C; Cursi, M; Pala, M; Bulfone, A; Garcia-Verdugo, JM; Leocani, L; Minicucci, F; Poliani, PL; Galli, R				Magri, Laura; Cambiaghi, Marco; Cominelli, Manuela; Alfaro-Cervello, Clara; Cursi, Marco; Pala, Mauro; Bulfone, Alessandro; Manuel Garcia-Verdugo, Jose; Leocani, Letizia; Minicucci, Fabio; Poliani, Pietro Luigi; Galli, Rossella			Sustained Activation of mTOR Pathway in Embryonic Neural Stem Cells Leads to Development of Tuberous Sclerosis Complex-Associated Lesions	CELL STEM CELL			English	Article							BRAIN PATHOLOGY; SELF-RENEWAL; IN-VIVO; C-MYC; EXPRESSION; TSC2; DIFFERENTIATION; NEURONS; MOUSE; MODEL	Tuberous Sclerosis Complex (TSC) is a multisystem genetic disorder characterized by hamartomatous neurological lesions that exhibit abnormal cell proliferation and differentiation. Hyperactivation of mTOR pathway by mutations in either the Tsc1 or Tsc2 gene underlies TSC pathogenesis, but involvement of specific neural cell populations in the formation of TSC-associated neurological lesions remains unclear. We deleted Tsc1 in Emx1-expressing embryonic telencephalic neural stem cells (NSCs) and found that mutant mice faithfully recapitulated TSC neuropathological lesions, such as cortical lamination defects and subependymal nodules (SENs). These alterations were caused by enhanced generation of SVZ neural progeny, followed by their premature differentiation and impaired maturation during both embryonic and postnatal development. Notably, mTORC1-dependent Akt inhibition and STAT3 activation were involved in the reduced self-renewal and earlier neuronal and astroglial differentiation of mutant NSCs. Thus, finely tuned mTOR activation in embryonic NSCs may be critical to prevent development of TSC-associated brain lesions.	[Magri, Laura; Galli, Rossella] Ist Sci San Raffaele, Neural Stem Cell Biol Unit, Div Regenerat Med Stem Cells & Gene Therapy, I-20132 Milan, Italy; [Cambiaghi, Marco; Leocani, Letizia] Ist Sci San Raffaele, Expt Neurophysiol Unit, Inst Expt Neurol, I-20132 Milan, Italy; [Cursi, Marco; Minicucci, Fabio] Ist Sci San Raffaele, Dept Neurol, Epilepsy Ctr, I-20132 Milan, Italy; [Magri, Laura] Univ Vita Salute San Raffaele, I-20132 Milan, Italy; [Cominelli, Manuela; Poliani, Pietro Luigi] Univ Brescia, Dept Pathol, Spedali Civili Brescia, I-25124 Brescia, Italy; [Alfaro-Cervello, Clara; Manuel Garcia-Verdugo, Jose] Univ Valencia, Inst Cavanilles, Lab Neurobiol Comparada, Valencia 46012, Spain; [Alfaro-Cervello, Clara; Manuel Garcia-Verdugo, Jose] CIBERNED, Ctr Invest Principe Felipe, Lab Morfol Celular, Valencia, Spain; [Pala, Mauro; Bulfone, Alessandro] BioFlag Ltd, I-09010 Cagliari, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; University of Brescia; University of Valencia; CIBERNED; Prince Felipe Research Center	Galli, R (corresponding author), Ist Sci San Raffaele, Neural Stem Cell Biol Unit, Div Regenerat Med Stem Cells & Gene Therapy, Via Olgettina 58, I-20132 Milan, Italy.	galli.rossella@hsr.it	Leocani, Letizia/ABH-4703-2020; Pala, Mauro/AAY-4774-2020; Cambiaghi, Marco/AAJ-3331-2020; Poliani, Pietro Luigi/E-8145-2010; Cambiaghi, Marco/AAB-8739-2019; García-Verdugo, José Manuel/L-8421-2017; Alfaro-Cervello, Clara/D-1900-2015; Galli, Rossella/AAI-8028-2020; Cominelli, Manuela/J-9988-2016; Minicucci, Fabio/AAO-3629-2020	Poliani, Pietro Luigi/0000-0002-5662-8978; Cambiaghi, Marco/0000-0002-0109-012X; García-Verdugo, José Manuel/0000-0001-9872-6499; Galli, Rossella/0000-0001-9023-7033; Cominelli, Manuela/0000-0002-4520-6104; Leocani, Letizia/0000-0001-9326-6753; CURSI, Marco/0000-0002-7928-0417; Alfaro-Cervello, Clara/0000-0002-3737-4028; Pala, Mauro/0000-0002-3165-5291	Associazione Sclerosi Tuberosa (AST)	Associazione Sclerosi Tuberosa (AST)	This work was supported by Associazione Sclerosi Tuberosa (AST) to R.G. We thank Paolo Caferra for help and assistance with molecular analysis and Luca Muzio for critical reading of the manuscript.	Baybis M, 2004, ANN NEUROL, V56, P478, DOI 10.1002/ana.20211; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Chan JA, 2004, J NEUROPATH EXP NEUR, V63, P1236, DOI 10.1093/jnen/63.12.1236; Crino PB, 2010, NEUROLOGY, V74, P1716, DOI 10.1212/WNL.0b013e3181e04325; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Dasgupta B, 2005, J NEUROSCI, V25, P5584, DOI 10.1523/JNEUROSCI.4693-04.2005; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Ess KC, 2004, GLIA, V46, P28, DOI 10.1002/glia.10324; Gan B, 2008, P NATL ACAD SCI USA, V105, P19384, DOI 10.1073/pnas.0810584105; Gorski JA, 2002, J NEUROSCI, V22, P6309; Gregorian C, 2009, J NEUROSCI, V29, P1874, DOI 10.1523/JNEUROSCI.3095-08.2009; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Hobbs RM, 2010, CELL, V142, P468, DOI 10.1016/j.cell.2010.06.041; Holmes GL, 2007, EPILEPSIA, V48, P617, DOI 10.1111/j.1528-1167.2007.01035.x; Jozwiak J, 2008, LANCET ONCOL, V9, P73, DOI 10.1016/S1470-2045(07)70411-4; Kakita A, 1999, NEURON, V23, P461, DOI 10.1016/S0896-6273(00)80800-4; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; Onda H, 2002, MOL CELL NEUROSCI, V21, P561, DOI 10.1006/mcne.2002.1184; Orlova KA, 2010, J NEUROPATH EXP NEUR, V69, P850, DOI 10.1097/NEN.0b013e3181eac1f5; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Ridler K, 2004, J CHILD NEUROL, V19, P658, DOI 10.1177/08830738040190090501; Schmidt EV, 2009, CELL CYCLE, V8, P1344, DOI 10.4161/cc.8.9.8215; Sinor AD, 2004, J NEUROSCI, V24, P8531, DOI 10.1523/JNEUROSCI.1470-04.2004; Sun P, 2010, DEVELOPMENT, V137, P2461, DOI 10.1242/dev.051466; Uhlmann EJ, 2002, ANN NEUROL, V52, P285, DOI 10.1002/ana.10283; Uhlmann EJ, 2002, ONCOGENE, V21, P4050, DOI 10.1038/sj.onc.1205435; Way SW, 2009, HUM MOL GENET, V18, P1252, DOI 10.1093/hmg/ddp025; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; Young KM, 2007, J NEUROSCI, V27, P8286, DOI 10.1523/JNEUROSCI.0476-07.2007	31	179	180	1	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV 4	2011	9	5					447	462		10.1016/j.stem.2011.09.008	http://dx.doi.org/10.1016/j.stem.2011.09.008			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	850FJ	22056141	Bronze			2022-12-28	WOS:000297180200012
J	Meissner, A				Meissner, Alexander			Guiding DNA Methylation	CELL STEM CELL			English	Editorial Material							DIFFERENTIATED CELLS; PLURIPOTENT; GENOME		[Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Meissner, Alexander] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Meissner, Alexander] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Meissner, A (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	alexander_meissner@harvard.edu						Athanasiadou R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009937; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI 10.1038/nbt.1684; Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990	8	7	8	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV 4	2011	9	5					388	390		10.1016/j.stem.2011.10.014	http://dx.doi.org/10.1016/j.stem.2011.10.014			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	850FJ	22056134	Bronze			2022-12-28	WOS:000297180200004
J	Zacharek, SJ; Fillmore, CM; Lau, AN; Gludish, DW; Chou, A; Ho, JWK; Zamponi, R; Gazit, R; Bock, C; Jager, N; Smith, ZD; Kim, TM; Saunders, AH; Wong, J; Lee, JH; Roach, RR; Rossi, DJ; Meissner, A; Gimelbrant, AA; Park, PJ; Kim, CF				Zacharek, Sima J.; Fillmore, Christine M.; Lau, Allison N.; Gludish, David W.; Chou, Alan; Ho, Joshua W. K.; Zamponi, Raffaella; Gazit, Roi; Bock, Christoph; Jaeger, Natalie; Smith, Zachary D.; Kim, Tae-min; Saunders, Arven H.; Wong, Janice; Lee, Joo-Hyeon; Roach, Rebecca R.; Rossi, Derrick J.; Meissner, Alex; Gimelbrant, Alexander A.; Park, Peter J.; Kim, Carla F.			Lung Stem Cell Self-Renewal Relies on BMI1-Dependent Control of Expression at Imprinted Loci	CELL STEM CELL			English	Article							P57(KIP2)	BMI1 is required for the self-renewal of stem cells in many tissues including the lung epithelial stem cells, Bronchioalveolar Stem Cells (BASCs). Imprinted genes, which exhibit expression from only the maternally or paternally inherited allele, are known to regulate developmental processes, but what their role is in adult cells remains a fundamental question. Many imprinted genes were derepressed in Bmi1 knockout mice, and knockdown of Cdkn1c (p57) and other imprinted genes partially rescued the self-renewal defect of Bmi1 mutant lung cells. Expression of p57 and other imprinted genes was required for lung cell self-renewal in culture and correlated with repair of lung epithelial cell injury in vivo. Our data suggest that BM11-dependent regulation of expressed alleles at imprinted loci, distinct from imprinting per se, is required for control of lung stem cells. We anticipate that the regulation and function of imprinted genes is crucial for self-renewal in diverse adult tissue-specific stem cells.	[Zacharek, Sima J.; Fillmore, Christine M.; Lau, Allison N.; Gludish, David W.; Chou, Alan; Zamponi, Raffaella; Saunders, Arven H.; Wong, Janice; Lee, Joo-Hyeon; Roach, Rebecca R.; Kim, Carla F.] Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Gazit, Roi; Rossi, Derrick J.] Childrens Hosp, Immune Dis Inst, Program Cellular & Mol Med, Boston, MA 02115 USA; [Zacharek, Sima J.; Fillmore, Christine M.; Lau, Allison N.; Gludish, David W.; Chou, Alan; Zamponi, Raffaella; Saunders, Arven H.; Wong, Janice; Lee, Joo-Hyeon; Roach, Rebecca R.; Gimelbrant, Alexander A.; Kim, Carla F.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Ho, Joshua W. K.; Kim, Tae-min; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Zacharek, Sima J.; Fillmore, Christine M.; Lau, Allison N.; Gludish, David W.; Chou, Alan; Zamponi, Raffaella; Gazit, Roi; Bock, Christoph; Jaeger, Natalie; Smith, Zachary D.; Saunders, Arven H.; Wong, Janice; Lee, Joo-Hyeon; Roach, Rebecca R.; Rossi, Derrick J.; Meissner, Alex; Kim, Carla F.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Ho, Joshua W. K.; Park, Peter J.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Bock, Christoph; Jaeger, Natalie; Smith, Zachary D.; Meissner, Alex] Broad Inst, Cambridge, MA 02142 USA; [Bock, Christoph; Jaeger, Natalie; Smith, Zachary D.; Rossi, Derrick J.; Meissner, Alex] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Bock, Christoph] Max Planck Inst Informat, D-66123 Saarbrucken, Germany; [Gimelbrant, Alexander A.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Max Planck Society; Harvard University; Dana-Farber Cancer Institute	Kim, CF (corresponding author), Childrens Hosp, Stem Cell Program, 300 Longwood Ave, Boston, MA 02115 USA.	carla.kim@childrens.harvard.edu	Bock, Christoph/AAE-7618-2019; Brainson, Christine/AAG-4688-2020; Ho, Joshua W. K./AAK-7759-2020; Gazit, Roi/J-3352-2017; Zamponi, Raffaella/V-5683-2018; Lee, Joo-Hyeon/AAM-2777-2020	Bock, Christoph/0000-0001-6091-3088; Brainson, Christine/0000-0002-0854-5043; Ho, Joshua W. K./0000-0003-2331-7011; Lee, Joo-Hyeon/0000-0002-7364-6422; Zamponi, Raffaella/0000-0002-3313-1387; Gludish, David/0000-0002-3537-4585; Park, Peter/0000-0001-9378-960X; Gazit, Roi/0000-0002-0548-2147; Gimelbrant, Alexander/0000-0001-6986-0285; Jaeger, Natalie/0000-0002-9589-7580	Ladies Auxiliary to the Veterans of Foreign Wars; National Defense Science Engineering [RO1 HL090136, U01 HL100402]; American Cancer Society [RSG-08-082-01-MGO]; V Foundation for Cancer Research; Basil O'Conner March of Dimes Starter Award; Harvard Stem Cell Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100402, R01HL090136] Funding Source: NIH RePORTER	Ladies Auxiliary to the Veterans of Foreign Wars; National Defense Science Engineering; American Cancer Society(American Cancer Society); V Foundation for Cancer Research; Basil O'Conner March of Dimes Starter Award; Harvard Stem Cell Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Kim Lab members for discussions; S. Temple, C. Dulac, C. Gregg, D. Tenen, C. Hetherington, S. Eliedge, J. Luo, N. Solimini, M. Hemann, C. Meacham, and B. Wilson for reagents and discussions; DFCI and CHB HemOnc FACS facilities; CHB Molecular Genetics Core facility; R. Bronson for histology; L. Zon, S. Orkin, and G. Daley for critical reading; and M. Goodell for sharing unpublished data. This work was supported by the Ladies Auxiliary to the Veterans of Foreign Wars (C.M.F.), the National Defense Science & Engineering Graduate Fellowship (A.N.L.), RO1 HL090136, U01 HL100402, American Cancer Society Research Scholar Grant #RSG-08-082-01-MGO, the V Foundation for Cancer Research, a Basil O'Conner March of Dimes Starter Award, and the Harvard Stem Cell Institute (C.F.K.).	Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bhogal B, 2004, GENOMICS, V84, P961, DOI 10.1016/j.ygeno.2004.08.004; Bilodeau S, 2009, MOL CELL BIOL, V29, P1895, DOI 10.1128/MCB.01885-08; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; Dugas JC, 2007, J NEUROSCI, V27, P6185, DOI 10.1523/JNEUROSCI.0628-07.2007	5	93	96	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	SEP 2	2011	9	3					272	280		10.1016/j.stem.2011.07.007	http://dx.doi.org/10.1016/j.stem.2011.07.007			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	822DN	21885022	Green Accepted, Bronze			2022-12-28	WOS:000295024200013
J	Murtaugh, LC				Murtaugh, L. Charles			Stem Cells and beta Cells: The Same, but Different?	CELL STEM CELL			English	Editorial Material							GROWTH; REGENERATION; GENERATE	Researchers have long debated whether new pancreatic beta cells derive from stem cells or from pre-existing beta cells. A new study in this issue of Cell Stem Cell (Smukler et al., 2011) suggests that both sides may be right.	Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Murtaugh, LC (corresponding author), Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA.	murtaugh@genetics.utah.edu						Blaine SA, 2010, DEVELOPMENT, V137, P2289, DOI 10.1242/dev.048421; Brennand K, 2007, PLOS BIOL, V5, P1520, DOI 10.1371/journal.pbio.0050163; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Liu H, 2010, ENDOCRINOLOGY, V151, P520, DOI 10.1210/en.2009-0992; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Salpeter SJ, 2010, DEVELOPMENT, V137, P3205, DOI 10.1242/dev.054304; Seaberg RM, 2004, NAT BIOTECHNOL, V22, P1115, DOI 10.1038/nbt1004; Smukler SR, 2011, CELL STEM CELL, V8, P281, DOI 10.1016/j.stem.2011.01.015; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011	9	4	4	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 4	2011	8	3					244	245		10.1016/j.stem.2011.02.010	http://dx.doi.org/10.1016/j.stem.2011.02.010			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	735HI	21362562	Bronze			2022-12-28	WOS:000288404400003
J	Boyd, RL; Soh, CL; Boyd, NR; Stanley, EG; Chidgey, AP				Boyd, Richard L.; Soh, Chew-Li; Boyd, Nicholas R.; Stanley, Edouard G.; Chidgey, Ann P.			Rewiring Immunity: Generating a Functional Thymus from hESCs ... Are We There Yet?	CELL STEM CELL			English	Editorial Material							STEM-CELLS; TOLERANCE	Two papers in this issue of Cell Stem Cell have made a significant advance in solving one of the great challenges of modern immunology-resurrecting thymus function through the induction of thymus epithelial cells (TECs) by directed differentiation of human embryonic stem cells (hESCs).	[Boyd, Richard L.; Soh, Chew-Li; Stanley, Edouard G.; Chidgey, Ann P.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia; [Soh, Chew-Li; Stanley, Edouard G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Boyd, Nicholas R.] Monash Univ, Dept Mat Engn, Clayton, Vic 3800, Australia	Monash University; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Monash University	Boyd, RL (corresponding author), Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia.	richard.boyd@monash.edu	Stanley, Ed G/A-2985-2013; Chidgey, Ann P/I-2737-2014	Stanley, Ed G/0000-0002-6389-3665; Chidgey, Ann P/0000-0001-7442-6125				Anderson G, 2007, NAT REV IMMUNOL, V7, P954, DOI 10.1038/nri2187; Chidgey AP, 2008, NATURE, V453, P330, DOI 10.1038/nature07041; Heng TSP, 2010, CURR OPIN PHARMACOL, V10, P425, DOI 10.1016/j.coph.2010.04.006; Lai LJ, 2009, STEM CELLS, V27, P3012, DOI 10.1002/stem.238; Manley NR, 1998, DEV BIOL, V195, P1, DOI 10.1006/dbio.1997.8827; Parent A.V., 2013, CELL STEM CELL; Soh Chew-Li, 2009, P405, DOI 10.1007/978-1-60327-227-8_33; Sun XN, 2013, CELL STEM CELL, V13, P230, DOI 10.1016/j.stem.2013.06.014	8	2	2	1	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 1	2013	13	2					135	136		10.1016/j.stem.2013.07.015	http://dx.doi.org/10.1016/j.stem.2013.07.015			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VO	23910077	Bronze			2022-12-28	WOS:000329570600003
J	Oh, P; Lobry, C; Gao, J; Tikhonova, A; Loizou, E; Manent, J; van Handel, B; Ibrahim, S; Greve, J; Mikkola, H; Artavanis-Tsakonas, S; Aifantis, I				Oh, Philmo; Lobry, Camille; Gao, Jie; Tikhonova, Anastasia; Loizou, Evangelia; Manent, Jan; van Handel, Ben; Ibrahim, Sherif; Greve, Jeffrey; Mikkola, Hanna; Artavanis-Tsakonas, Spyros; Aifantis, Iannis			In Vivo Mapping of Notch Pathway Activity in Normal and Stress Hematopoiesis	CELL STEM CELL			English	Article							ZONE B-CELLS; SELF-RENEWAL; ACTIVATION; LINEAGE; MICE; ERYTHROPOIETIN; MAINTENANCE; EXPRESSION; DISEASE; ANEMIA	Accumulating evidence suggests that Notch signaling is active at multiple points during hematopoiesis. Until recently, the majority of such studies focused on Notch signaling in lymphocyte differentiation and knowledge of individual Notch receptor roles has been limited due to a paucity of genetic tools available. In this manuscript we generate and describe animal models to identify and fate-map stem and progenitor cells expressing each Notch receptor, delineate Notch pathway activation, and perform in vivo gain- and loss-of-function studies dissecting Notch signaling in early hematopoiesis. These models provide comprehensive genetic maps of lineage-specific Notch receptor expression and activation in hematopoietic stem and progenitor cells. Moreover, they establish a previously unknown role for Notch signaling in the commitment of blood progenitors toward the erythrocytic lineage and link Notch signaling to optimal organismal response to stress erythropoiesis.	[Oh, Philmo; Lobry, Camille; Gao, Jie; Tikhonova, Anastasia; Loizou, Evangelia; Aifantis, Iannis] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Oh, Philmo; Lobry, Camille; Gao, Jie; Tikhonova, Anastasia; Loizou, Evangelia; Ibrahim, Sherif; Aifantis, Iannis] NYU, Sch Med, Inst Canc, New York, NY 10016 USA; [Ibrahim, Sherif] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Manent, Jan; Artavanis-Tsakonas, Spyros] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [van Handel, Ben; Mikkola, Hanna] Univ Calif Los Angeles, Eli & Edythe Broad Stem Cell Res Ctr, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Greve, Jeffrey] Exelixis Inc, San Francisco, CA 94080 USA; [Artavanis-Tsakonas, Spyros] Coll France, F-75231 Paris 05, France	Howard Hughes Medical Institute; New York University; New York University; New York University; Harvard University; Harvard Medical School; University of California System; University of California Los Angeles; Exelixis, Inc.; UDICE-French Research Universities; PSL Research University Paris; College de France	Aifantis, I (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA.	iannis.aifantis@nyumc.org	lobry, camille/A-6188-2015; Tikhonova, Anastasia/F-1186-2015	lobry, camille/0000-0003-0550-4921; Manent, Jan/0000-0001-9152-5459	NIH/NCI [P30 CA016087-30, 5 P30CA16087-31]; NYU Cancer Institute Center [5P30CA16087-31]; National Institutes of Health [RO1CA133379, RO1CA105129, RO1CA149655, RO1GM088847]; Leukemia & Lymphoma Society (TRP program grants); V Foundation for Cancer Research; Irma T. Hirschl Trust; St. Baldrick's Foundation for Cancer Research; NYU MSTP Program; Helen and Martin Kimmel Center for Stem Cell Research; NIH [RO1 CA 098402]; NATIONAL CANCER INSTITUTE [R01CA133379, R01CA105129, R01CA149655, R01CA098402, P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088847] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NYU Cancer Institute Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society (TRP program grants); V Foundation for Cancer Research; Irma T. Hirschl Trust; St. Baldrick's Foundation for Cancer Research; NYU MSTP Program; Helen and Martin Kimmel Center for Stem Cell Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to H.-J. Fehling for the ROSA26-RFP mice and Linheng Li, Paul Frenette, and Amy Wagers for sharing experimental tools and advice. We would like to thank the NYU Genome Technology Center (supported in part by NIH/NCI P30 CA016087-30 grant) for expert assistance with microarray experiments; the NYU Flow Cytometry facility (supported in part by NIH/NCI 5 P30CA16087-31) for expert cell sorting; the NYU Histology Core (5P30CA16087-31); the Transgenic Mouse Core (NYU Cancer Institute Center Grant (5P30CA16087-31); and Jacquelyn Freund for technical assistance. I. A. is supported by the National Institutes of Health (RO1CA133379, RO1CA105129, RO1CA149655, and RO1GM088847), the Leukemia & Lymphoma Society (TRP program grants), The V Foundation for Cancer Research, the Irma T. Hirschl Trust, and the St. Baldrick's Foundation for Cancer Research. P.O. was supported by the NYU MSTP Program. C. L. was supported by the Helen and Martin Kimmel Center for Stem Cell Research and is currently a Leukemia and Lymphoma Society Fellow. The research in the S.A.-T. laboratory was supported by the NIH (RO1 CA 098402). I. A. is a Howard Hughes Medical Institute Early Career Scientist. Hes1<SUP>GFP</SUP> and Notch(1-4)<SUP>CreER</SUP> mice are available upon request to Dr. Artavanis-Tsakonas.	ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; Clements WK, 2011, NATURE, V474, P220, DOI 10.1038/nature10107; Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; ESCHBACH JW, 1987, NEW ENGL J MED, V316, P73, DOI 10.1056/NEJM198701083160203; Fiorini E, 2009, J IMMUNOL, V183, P7212, DOI 10.4049/jimmunol.0902432; Fre S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025785; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; JACKSON CW, 1973, BLOOD, V42, P413, DOI 10.1182/blood.V42.3.413.413; Kleinmann E, 2008, MOL CELL BIOL, V28, P7465, DOI 10.1128/MCB.00715-08; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kumano K, 2003, IMMUNITY, V18, P699, DOI 10.1016/S1074-7613(03)00117-1; Lobry C, 2013, J EXP MED, V210, P301, DOI 10.1084/jem.20121484; Lobry C, 2011, J EXP MED, V208, P1931, DOI 10.1084/jem.20111855; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Maillard I, 2008, CELL STEM CELL, V2, P356, DOI 10.1016/j.stem.2008.02.011; Mancini SJC, 2005, BLOOD, V105, P2340, DOI 10.1182/blood-2004-08-3207; Melnikova I, 2006, NAT REV DRUG DISCOV, V5, P627, DOI 10.1038/nrd2113; Mercher T, 2008, CELL STEM CELL, V3, P314, DOI 10.1016/j.stem.2008.07.010; Moriyama Y, 2008, INT IMMUNOL, V20, P763, DOI 10.1093/intimm/dxn034; Ng SYM, 2009, IMMUNITY, V30, P493, DOI 10.1016/j.immuni.2009.01.014; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Peslak SA, 2012, BLOOD, V120, P2501, DOI 10.1182/blood-2011-11-394304; Poirault-Chassac S, 2010, BLOOD, V116, P5670, DOI 10.1182/blood-2010-05-285957; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Sekine C, 2009, INT IMMUNOL, V21, P295, DOI 10.1093/intimm/dxn148; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stadtfeld M, 2005, DEVELOPMENT, V132, P203, DOI 10.1242/dev.01558; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Van der Putten K, 2008, NAT CLIN PRACT NEPHR, V4, P47, DOI 10.1038/ncpneph0655; Varnum-Finney B, 2011, J CLIN INVEST, V121, P1207, DOI 10.1172/JCI43868	40	68	69	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 1	2013	13	2					190	204		10.1016/j.stem.2013.05.015	http://dx.doi.org/10.1016/j.stem.2013.05.015			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VO	23791481	Green Accepted, Bronze			2022-12-28	WOS:000329570600012
J	Pereira, CF; Chang, B; Qiu, JJ; Niu, XH; Papatsenko, D; Hendry, CE; Clark, NR; Nomura-Kitabayashi, A; Kovacic, JC; Ma'ayan, A; Schaniel, C; Lemischka, IR; Moore, K				Pereira, Carlos-Filipe; Chang, Betty; Qiu, Jiajing; Niu, Xiaohong; Papatsenko, Dmitri; Hendry, Caroline E.; Clark, Neil R.; Nomura-Kitabayashi, Aya; Kovacic, Jason C.; Ma'ayan, Avi; Schaniel, Christoph; Lemischka, Ihor R.; Moore, Kateri			Induction of a Hemogenic Program in Mouse Fibroblasts	CELL STEM CELL			English	Article							HEMATOPOIETIC STEM-CELLS; AORTIC ENDOTHELIUM; MICE LACKING; IN-VIVO; C-FOS; HAEMOGENIC ENDOTHELIUM; DIRECT CONVERSION; AGM REGION; BLOOD STEM; GATA-2	Definitive hematopoiesis emerges during embryogenesis via an endothelial-to-hematopoietic transition. We attempted to induce this process in mouse fibroblasts by screening a panel of factors for hemogenic activity. We identified a combination of four transcription factors, Gata2, Gfi1b, cFos, and Etv6, that efficiently induces endothelial-like precursor cells, with the subsequent appearance of hematopoietic cells. The precursor cells express a human CD34 reporter, Sca1, and Prominin1 within a global endothelial transcription program. Emergent hematopoietic cells possess nascent hematopoietic stem cell gene-expression profiles and cell-surface phenotypes. After transgene silencing and reaggregation culture, the specified cells generate hematopoietic colonies in vitro. Thus, we show that a simple combination of transcription factors is sufficient to induce a complex, dynamic, and multistep developmental program in vitro. These findings provide insights into the specification of definitive hemogenesis and a platform for future development of patient-specific stem and progenitor cells, as well as more-differentiated blood products.	[Pereira, Carlos-Filipe; Chang, Betty; Qiu, Jiajing; Niu, Xiaohong; Papatsenko, Dmitri; Hendry, Caroline E.; Lemischka, Ihor R.; Moore, Kateri] Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Clark, Neil R.; Ma'ayan, Avi; Schaniel, Christoph; Lemischka, Ihor R.] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Pereira, Carlos-Filipe; Chang, Betty; Qiu, Jiajing; Niu, Xiaohong; Papatsenko, Dmitri; Hendry, Caroline E.; Clark, Neil R.; Ma'ayan, Avi; Schaniel, Christoph; Lemischka, Ihor R.; Moore, Kateri] Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA; [Nomura-Kitabayashi, Aya; Kovacic, Jason C.] Icahn Sch Med Mt Sinai, Cardiovasc Res Ctr, New York, NY 10029 USA; [Chang, Betty; Qiu, Jiajing] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Pereira, CF (corresponding author), Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, 1 Gustave L Levy Pl,Box 1496, New York, NY 10029 USA.	filipe.pereira@mssm.edu; kateri.moore@mssm.edu	Schaniel, Chrisoph/C-9655-2012; Ma'ayan, Avi/AAG-3131-2019; Papatsenko, Dmitri/G-7375-2016; Schaniel, Christoph/P-3836-2019; Pereira, Carlos-Filipe/B-8438-2013	Ma'ayan, Avi/0000-0002-6904-1017; Papatsenko, Dmitri/0000-0002-4390-5446; Schaniel, Christoph/0000-0002-1343-4858; Pereira, Carlos-Filipe/0000-0002-9724-1382; Kovacic, Jason/0000-0003-4555-769X	NIH [5K08HL111330, 5T32HL007824-15]; EMBO Long-term Postdoctoral Fellowship;  [R01GM098316];  [R01DK088541]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD075735] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL111330, R01HL058739, T32HL007824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098316, P50GM071558] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO Long-term Postdoctoral Fellowship(European Molecular Biology Organization (EMBO)); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Tenen (Harvard Medical School) for the huCD34tTa transgenic mouse. We thank D. F. Lee, Y.S. Ang, S. Mulero-Navarro, A. Freire, and the members of the Lemischka/Moore laboratory for useful discussions and Y. Liu for laboratory management. We would like to thank M. Rendl and V. Gouon-Evans and their laboratories for their assistance. We thank T. Schroeder and K. Kokkaliaris for advice with live imaging and F. Gonzalez for inducible vectors. We thank M. Baron and S. Ghaffari for critical reading of the manuscript. We would also like to thank the Mount Sinai hESC/hiPSC Shared Resource Facility and S. D'Souza for help with materials and protocols and the Mount Sinai Genomics, Flow Cytometry, and Mouse facilities. C. F. P. is a recipient of an EMBO Long-term Postdoctoral Fellowship. J.C.K. and A.N.K are supported by the NIH grants 5K08HL111330 and 5T32HL007824-15; A. M. by R01GM098316 and R01DK088541.	Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Burda P, 2010, LEUKEMIA, V24, P1249, DOI 10.1038/leu.2010.104; Chen MJ, 2011, CELL STEM CELL, V9, P541, DOI 10.1016/j.stem.2011.10.003; Deneault E, 2009, CELL, V137, P369, DOI 10.1016/j.cell.2009.03.026; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107; Hara T, 1999, IMMUNITY, V11, P567, DOI 10.1016/S1074-7613(00)80132-6; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; JOHNSON RS, 1992, CELL, V71, P577, DOI 10.1016/0092-8674(92)90592-Z; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Klug CA, 2000, BLOOD, V96, P894, DOI 10.1182/blood.V96.3.894.015k35_894_901; Kumano K, 2003, IMMUNITY, V18, P699, DOI 10.1016/S1074-7613(03)00117-1; Lancrin C, 2012, BLOOD, V120, P314, DOI 10.1182/blood-2011-10-386094; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Li Z, 2006, BLOOD, V107, P106, DOI 10.1182/blood-2005-05-1955; Ling KW, 2004, J EXP MED, V200, P871, DOI 10.1084/jem.20031556; Linnemann AK, 2011, P NATL ACAD SCI USA, V108, P13641, DOI 10.1073/pnas.1108440108; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Ma GT, 1997, DEVELOPMENT, V124, P907; Marconcini L, 1999, P NATL ACAD SCI USA, V96, P9671, DOI 10.1073/pnas.96.17.9671; Masuda H, 2011, CIRC RES, V109, P20, DOI 10.1161/CIRCRESAHA.110.231837; McKinney-Freeman S, 2012, CELL STEM CELL, V11, P701, DOI 10.1016/j.stem.2012.07.018; Medvinsky A, 2011, DEVELOPMENT, V138, P1017, DOI 10.1242/dev.040998; Minehata K, 2002, BLOOD, V99, P2360, DOI 10.1182/blood.V99.7.2360; Moepps B, 2000, EUR J IMMUNOL, V30, P2924, DOI 10.1002/1521-4141(200010)30:10<2924::AID-IMMU2924>3.0.CO;2-Y; Moignard V, 2013, NAT CELL BIOL, V15, P363, DOI 10.1038/ncb2709; Moore KA, 1997, BLOOD, V89, P4337, DOI 10.1182/blood.V89.12.4337; North T, 1999, DEVELOPMENT, V126, P2563; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Nottingham WT, 2007, BLOOD, V110, P4188, DOI 10.1182/blood-2007-07-100883; Ottersbach K, 2005, DEV CELL, V8, P377, DOI 10.1016/j.devcel.2005.02.001; Pereira CF, 2012, ANN NY ACAD SCI, V1266, P7, DOI 10.1111/j.1749-6632.2012.06508.x; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; Radomska HS, 2002, BLOOD, V100, P4410, DOI 10.1182/blood-2002-02-0355; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Rodrigues NP, 2005, BLOOD, V106, P477, DOI 10.1182/blood-2004-08-2989; Saleque S, 2002, GENE DEV, V16, P301, DOI 10.1101/gad.959102; Schaniel C, 2009, ANN NY ACAD SCI, V1176, P26, DOI 10.1111/j.1749-6632.2009.04608.x; Schreiber M, 2000, DEVELOPMENT, V127, P4937; Sinka L, 2012, BLOOD, V119, P3712, DOI 10.1182/blood-2010-11-314781; Souroullas GP, 2009, CELL STEM CELL, V4, P180, DOI 10.1016/j.stem.2009.01.001; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taoudi S, 2008, CELL STEM CELL, V3, P99, DOI 10.1016/j.stem.2008.06.004; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Wang LC, 1997, EMBO J, V16, P4374, DOI 10.1093/emboj/16.14.4374; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Wu X, 2007, STEM CELLS, V25, P2770, DOI 10.1634/stemcells.2006-0783; Yin KJ, 2012, J BIOL CHEM, V287, P27055, DOI 10.1074/jbc.M112.364414; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	55	157	167	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 1	2013	13	2					205	218		10.1016/j.stem.2013.05.024	http://dx.doi.org/10.1016/j.stem.2013.05.024			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VO	23770078	Green Accepted, Bronze			2022-12-28	WOS:000329570600013
J	Dalerba, P; Clarke, MF				Dalerba, Piero; Clarke, Michael F.			Oncogenic miRNAs and the Perils of Losing Control of a Stem Cell's Epigenetic Identity	CELL STEM CELL			English	Editorial Material							DIFFERENTIATION	Pathways that regulate epigenetic control of stem cell identity are critical to the molecular etiology of cancer. In back-to-back articles in Cell and Cell Stem Cell, Song et al. identify miR-22 as both a repressor of TET proteins and a powerful oncogene in the mammary epithelium and hematopoietic system.	[Dalerba, Piero; Clarke, Michael F.] Stanford Univ, Stanford Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	Stanford University	Dalerba, P (corresponding author), Stanford Univ, Stanford Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	pdalerba@stanford.edu; mfclarke@stanford.edu	Dalerba, Piero/E-2543-2018	Dalerba, Piero/0000-0002-8815-4981				Cimmino L, 2011, CELL STEM CELL, V9, P193, DOI 10.1016/j.stem.2011.08.007; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Pietersen AM, 2008, CURR BIOL, V18, P1094, DOI 10.1016/j.cub.2008.06.070; Sahoo D, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00276; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Song SJ, 2013, CELL, V154, P311, DOI 10.1016/j.cell.2013.06.026; Song SJ, 2013, CELL STEM CELL, V13, P87, DOI 10.1016/j.stem.2013.06.003; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111	10	4	4	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2013	13	1					5	6		10.1016/j.stem.2013.06.012	http://dx.doi.org/10.1016/j.stem.2013.06.012			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VJ	23827702	Bronze			2022-12-28	WOS:000329570100003
J	Pelicci, PG; Dalton, P; Giorgio, M				Pelicci, Pier Giuseppe; Dalton, Paola; Giorgio, Marco			The Other Face of ROS: a Driver of Stem Cell Expansion in Colorectal Cancer	CELL STEM CELL			English	Editorial Material							CATENIN	APC mutations causing Wnt activation are commonly found in colorectal cancer, but downstream pathways that facilitate tumorigenesis are unclear. In this issue of Cell Stem Cell, Myant et al. (2013) show that Rac1 activation is required for Wnt-driven Lgr5+ intestinal stem cell transformation through ROS production and NF-kB activation.	[Pelicci, Pier Giuseppe; Dalton, Paola; Giorgio, Marco] European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy; [Pelicci, Pier Giuseppe] Univ Milan, Dept Med Surg & Dent, I-20142 Milan, Italy	IRCCS European Institute of Oncology (IEO); University of Milan	Pelicci, PG (corresponding author), European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy.	piergiuseppe.pelicci@ieo.eu	Giorgio, Marco/I-9425-2012; Pelicci, Pier Giuseppe/AAL-6572-2020	Giorgio, Marco/0000-0002-5842-6042; 				Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Giorgio M, 2007, NAT REV MOL CELL BIO, V8, p722A; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Myant KB, 2013, CELL STEM CELL, V12, P761, DOI 10.1016/j.stem.2013.04.006; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Zhou C, 2013, ONCOGENE, V32, P903, DOI 10.1038/onc.2012.99	10	17	17	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 6	2013	12	6					635	636		10.1016/j.stem.2013.05.023	http://dx.doi.org/10.1016/j.stem.2013.05.023			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VH	23746969	Bronze			2022-12-28	WOS:000329569900003
J	Guha, P; Morgan, JW; Mostoslavsky, G; Rodrigues, NP; Boyd, AS				Guha, Prajna; Morgan, John W.; Mostoslavsky, Gustavo; Rodrigues, Neil P.; Boyd, Ashleigh S.			Lack of Immune Response to Differentiated Cells Derived from Syngeneic Induced Pluripotent Stem Cells	CELL STEM CELL			English	Article							MOUSE	The prospects for using autologous induced pluripotent stem cells (iPSCs) in cell replacement therapy have been tempered by evidence that undifferentiated, syngeneic mouse iPSCs are immunogenic upon transplantation. However, the immunogenicity of more therapeutically relevant differentiated cells remains unexplored. Here, we differentiated mouse iPSCs into embryoid bodies (EBs) or representative cell types spanning the three embryonic germ layers and assessed their immunogenicity in vitro and after their transplantation into syngeneic recipients. We found no evidence of increased T cell proliferation in vitro, rejection of syngeneic iPSC-derived EBs/tissue-specific cells (TSCs) after transplantation, or an antigen-specific secondary immune response. Thus, differentiated cells derived from syngeneic iPSCs do not appear to be rejected after transplantation. We also found little evidence of an immune response to undifferentiated, syngeneic iPSCs. Our data support the idea that differentiated cells generated from autologous iPSCs could be applied for cell replacement therapy without eliciting immune rejection.	[Guha, Prajna; Morgan, John W.; Rodrigues, Neil P.; Boyd, Ashleigh S.] Boston Univ, Sch Med, Roger Williams Med Ctr, NIH Ctr Biomed Res Excellence COBRE Stem Cell Bio, Providence, RI 02908 USA; [Mostoslavsky, Gustavo; Rodrigues, Neil P.; Boyd, Ashleigh S.] Boston Univ, Sch Med, Ctr Regenerat Med CReM, Boston, MA 02118 USA; [Rodrigues, Neil P.; Boyd, Ashleigh S.] Boston Univ, Sch Med, Dept Dermatol, Boston, MA 02118 USA	Boston University; National Institutes of Health (NIH) - USA; NIH National Institute of General Medical Sciences (NIGMS); Roger Williams Medical Center; Boston University; Boston University	Boyd, AS (corresponding author), Boston Univ, Sch Med, Roger Williams Med Ctr, NIH Ctr Biomed Res Excellence COBRE Stem Cell Bio, Providence, RI 02908 USA.	asboyd@bu.edu		Mostoslavsky, Gustavo/0000-0002-0784-2169; Rodrigues, Neil/0000-0002-1925-7733	NIH [P20RR018757]; Rhode Island Foundation; BD Biosciences; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018757] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rhode Island Foundation; BD Biosciences; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by NIH Grant P20RR018757 (A. S. B. and N.P.R.), the Rhode Island Foundation (A. S. B.), and BD Biosciences (N.P.R.). Additional support to A. S. B. and N.P.R. laboratories was provided by the administrative, imaging, and flow cytometry cores within the NIH COBRE at Roger Williams Medical Center. The authors thank Dr. Yang Xu for generously sharing the episomal iPSC line used in this study, Dr. Darrell Kotton for his advice on derivation of mouse iPSCs, Anthony Berghelli for editorial and technical assistance, and Jasmine Sayegh and Dr. Murugabaskar Balan for technical assistance. The authors declare no conflict of interest. P. G. performed experiments, acquired and analyzed data, and prepared figures; J.W.M. performed cell sorting and assisted with flow cytometry analysis; G. M. contributed vital reagents and advice on derivation of iPSC lines and reviewed the manuscript; N.P.R. conceived the project, designed experiments, analyzed and interpreted data, and wrote the manuscript; and A. S. B. conceived the project, designed experiments, contributed to derivation of iPSC lines, analyzed and interpreted data, and wrote the manuscript.	Abranches E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006286; Boyd AS, 2008, STEM CELLS, V26, P1128, DOI 10.1634/stemcells.2007-0762; Boyd AS, 2012, STEM CELLS, V30, P797, DOI 10.1002/stem.1066; Boyd AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010965; Brook FA, 1997, P NATL ACAD SCI USA, V94, P5709, DOI 10.1073/pnas.94.11.5709; Christodoulou C, 2011, J CLIN INVEST, V121, P2313, DOI 10.1172/JCI43853; Dhodapkar KM, 2010, P NATL ACAD SCI USA, V107, P8718, DOI 10.1073/pnas.0915086107; Huang NF, 2010, ARTERIOSCL THROM VAS, V30, P984, DOI 10.1161/ATVBAHA.110.202796; Kanasaki K, 2008, DEV BIOL, V313, P584, DOI 10.1016/j.ydbio.2007.10.047; Kim K, 2007, SCIENCE, V315, P482, DOI 10.1126/science.1133542; Pruszak J, 2009, STEM CELLS, V27, P2928, DOI 10.1002/stem.211; Qiu Q, 2011, STEM CELLS DEV, V20, P2177, DOI 10.1089/scd.2010.0352; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Tabar V, 2008, NAT MED, V14, P379, DOI 10.1038/nm1732; Vallon V, 2011, J AM SOC NEPHROL, V22, P104, DOI 10.1681/ASN.2010030246; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135	17	251	260	0	60	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 4	2013	12	4					407	412		10.1016/j.stem.2013.01.006	http://dx.doi.org/10.1016/j.stem.2013.01.006			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VD	23352605	Bronze			2022-12-28	WOS:000329569500008
J	Cibelli, J; Emborg, ME; Prockop, DJ; Roberts, M; Schatten, G; Rao, M; Harding, J; Mirochnitchenko, O				Cibelli, Jose; Emborg, Marina E.; Prockop, Darwin J.; Roberts, Michael; Schatten, Gerald; Rao, Mahendra; Harding, John; Mirochnitchenko, Oleg			Strategies for Improving Animal Models for Regenerative Medicine	CELL STEM CELL			English	Editorial Material							MYOCARDIAL-INFARCTION; CELLS	The field of regenerative medicine is moving toward translation to clinical practice. However, there are still knowledge gaps and safety concerns regarding stem cell-based therapies. Improving large animal models and methods for transplantation, engraftment, and imaging should help address these issues, facilitating eventual use of stem cells in the clinic.	[Cibelli, Jose] Michigan State Univ, Cellular Reprogramming Lab, Dept Anim Sci, E Lansing, MI 48824 USA; [Emborg, Marina E.] Univ Wisconsin, Dept Med Phys, Madison, WI 53715 USA; [Emborg, Marina E.] Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA; [Prockop, Darwin J.] Texas A&M Hlth Sci Ctr, Coll Med, Temple, TX 76502 USA; [Prockop, Darwin J.] Inst Regenerat Med Scott & White, Dept Med, Temple, TX 76502 USA; [Roberts, Michael] Univ Missouri, CS Bond Life Sci Ctr 240B, Columbia, MO 65211 USA; [Schatten, Gerald] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA; [Rao, Mahendra] NIH, Ctr Regenerat Med, Bethesda, MD 20892 USA; [Harding, John; Mirochnitchenko, Oleg] NIH, Div Comparat Med ORIP DPCPSI OD, Bethesda, MD 20892 USA	Michigan State University; University of Wisconsin System; University of Wisconsin Madison; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Missouri System; University of Missouri Columbia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA	Mirochnitchenko, O (corresponding author), NIH, Div Comparat Med ORIP DPCPSI OD, 6701 Democracy Blvd,Suite 943-950, Bethesda, MD 20892 USA.	oleg.mirochnitchenko@nih.gov	Schatten, Gerald/B-3253-2009	Schatten, Gerald/0000-0001-5206-7782; Cibelli, Jose/0000-0002-2176-3854	NICHD NIH HHS [P01 HD047675, R01 HD069979] Funding Source: Medline; NIH HHS [P40 OD011050, P51 OD011106] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069979] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD047675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041193] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD011050, P51OD011106] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bell JHA, 2012, TISSUE ENG PART B-RE, V18, P116, DOI [10.1089/ten.teb.2011.0498, 10.1089/ten.TEB.2011.0498]; Frey-Vasconcells J, 2012, STEM CELL TRANSL MED, V1, P353, DOI 10.5966/sctm.2012-0018; Giraud S, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/532127; Gu MX, 2012, CIRC RES, V111, P882, DOI 10.1161/CIRCRESAHA.112.269001; Hatzistergos KE, 2011, CIRC RES, V108, P1300, DOI 10.1161/CIRCRESAHA.111.246611; Kuzmuk KN, 2011, GENETICS OF THE PIG, 2ND EDITION, P426, DOI 10.1079/9781845937560.0426; McCall FC, 2012, NAT PROTOC, V7, P1479, DOI 10.1038/nprot.2012.075; Plews JR, 2012, J CELL MOL MED, V16, P1196, DOI 10.1111/j.1582-4934.2012.01521.x; Suzuki S, 2012, CELL STEM CELL, V10, P753, DOI 10.1016/j.stem.2012.04.021; Templin C, 2012, CIRCULATION, V126, P430, DOI 10.1161/CIRCULATIONAHA.111.087684	10	54	58	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 7	2013	12	3					271	274		10.1016/j.stem.2013.01.004	http://dx.doi.org/10.1016/j.stem.2013.01.004			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VC	23472868	Bronze, Green Accepted			2022-12-28	WOS:000329569400004
J	Nishimura, T; Kaneko, S; Kawana-Tachikawa, A; Tajima, Y; Goto, H; Zhu, DY; Nakayama-Hosoya, K; Iriguchi, S; Uemura, Y; Shimizu, T; Takayama, N; Yamada, D; Nishimura, K; Ohtaka, M; Watanabe, N; Takahashi, S; Iwamoto, A; Koseki, H; Nakanishi, M; Eto, K; Nakauchi, H				Nishimura, Toshinobu; Kaneko, Shin; Kawana-Tachikawa, Ai; Tajima, Yoko; Goto, Haruo; Zhu, Dayong; Nakayama-Hosoya, Kaori; Iriguchi, Shoichi; Uemura, Yasushi; Shimizu, Takafumi; Takayama, Naoya; Yamada, Daisuke; Nishimura, Ken; Ohtaka, Manami; Watanabe, Nobukazu; Takahashi, Satoshi; Iwamoto, Aikichi; Koseki, Haruhiko; Nakanishi, Mahito; Eto, Koji; Nakauchi, Hiromitsu			Generation of Rejuvenated Antigen-Specific T Cells by Reprogramming to Pluripotency and Redifferentiation	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; HUMAN PERIPHERAL-BLOOD; GENE-THERAPY; TELOMERE LENGTH; SUICIDE GENE; IN-VITRO; MATURE B; MEMORY; IMMUNODEFICIENCY; VIRUS	Adoptive immunotherapy with functional T cells is potentially an effective therapeutic strategy for combating many types of cancer and viral infection. However, exhaustion of antigen-specific T cells represents a major challenge to this type of approach. In an effort to overcome this problem, we reprogrammed clonally expanded antigen-specific CD8(+) T cells from an HIV-1-infected patient to pluripotency. The T cell-derived induced pluripotent stem cells were then redifferentiated into CD8(+) T cells that had a high proliferative capacity and elongated telomeres. These "rejuvenated" cells possessed antigen-specific killing activity and exhibited T cell receptor gene-rearrangement patterns identical to those of the original T cell clone from the patient. We also found that this method can be effective for generating specific T cells for other pathology-associated antigens. Thus, this type of approach may have broad applications in the field of adoptive immunotherapy.	[Nishimura, Toshinobu; Kaneko, Shin; Tajima, Yoko; Goto, Haruo; Iriguchi, Shoichi; Shimizu, Takafumi; Nakauchi, Hiromitsu] Univ Tokyo, Div Stem Cell Therapy, Ctr Stem Cell Biol & Regenerat Med, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [Kawana-Tachikawa, Ai; Zhu, Dayong; Nakayama-Hosoya, Kaori; Iwamoto, Aikichi] Univ Tokyo, Div Infect Dis, Adv Clin Res Ctr, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [Takayama, Naoya; Eto, Koji] Univ Tokyo, Stem Cell Bank, Ctr Stem Cell Biol & Regenerat Med, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [Watanabe, Nobukazu] Univ Tokyo, Lab Diagnost Med, Ctr Stem Cell Biol & Regenerat Med, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [Takahashi, Satoshi] Univ Tokyo, Div Mol Therapy, Adv Clin Res Ctr, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [Uemura, Yasushi] Aichi Canc Ctr, Div Immunol, Res Inst, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Yamada, Daisuke; Koseki, Haruhiko] RIKEN Ctr Allergy & Immunol, Lab Lymphocyte Dev, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Nishimura, Ken; Ohtaka, Manami; Nakanishi, Mahito] Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Tsukuba, Ibaraki 3058562, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; Aichi Cancer Center; RIKEN; National Institute of Advanced Industrial Science & Technology (AIST)	Kaneko, S (corresponding author), Kyoto Univ, Dept Fundamental Cell Technol, Ctr iPS Cell Res & Applicat CiRA, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.	kaneko.shin@cira.kyoto-u.ac.jp; nakauchi@ims.u-tokyo.ac.jp	Koseki, Haruhiko/I-3825-2014; Nishimura, Toshinobu/AAZ-7675-2021; Nishimura, KEN/HGC-6147-2022; /AAO-9779-2020; Nakanishi, Mahito/I-9888-2018	Koseki, Haruhiko/0000-0001-8424-5854; Nishimura, Toshinobu/0000-0002-5425-1708; /0000-0002-1076-2338; Nakanishi, Mahito/0000-0002-7068-7587	Project for Realization of Regenerative Medicine; Global Center of Excellence program from MEXT of Japan; Japan Society for the Promotion of Science; Ministry of Health, Labor, and Welfare of Japan; Grants-in-Aid for Scientific Research [23592022] Funding Source: KAKEN	Project for Realization of Regenerative Medicine(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global Center of Excellence program from MEXT of Japan; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Yumiko Ishii and Yuji Yamazaki (The University of Tokyo) for FACS operation; Sou Nakamura, Ryoko Jono-Onishi, and Shuichi Kitayama (The University of Tokyo) for technical help; Hiroshi Kawamoto, Kyoko Masuda, and Raul Vizcardo (RIKEN Center for Allergy and Immunology) for kindly providing OP9-DL1 cells and for helpful discussions; Yasuharu Nishimura and Satoru Senju (Kumamoto University) for kindly providing T cell clones; Makoto Otsu, Akihide Kamiya, Motoo Watanabe, Ayako Kamisato, and Masataka Kasai (The University of Tokyo) and Masaki Yasukawa, Hiroshi Fujiwara, and Toshiki Ochi (Ehime University) for helpful discussions; and Alex Knisely and Huan-Ting Lin for critical reading of the manuscript. The project was supported in part by a grant from the Project for Realization of Regenerative Medicine, by a Grant-in-Aid for Scientific Research (KAKENHI) and by the Global Center of Excellence program from MEXT of Japan, by a Grant-in-Aid for scientific research from the Japan Society for the Promotion of Science, and by grants for AIDS research from the Ministry of Health, Labor, and Welfare of Japan. The experimental protocol was approved by the institutional regulation board for human ethics at the Institute of Medical Science, University of Tokyo (approval number: 20-6-0826). The entire study was conducted in accordance with the Declaration of Helsinki.	ALT FW, 1982, P NATL ACAD SCI-BIOL, V79, P4118, DOI 10.1073/pnas.79.13.4118; Altfeld M, 2006, PLOS MED, V3, P1851, DOI 10.1371/journal.pmed.0030403; Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; Bendle GM, 2010, NAT MED, V16, P565, DOI 10.1038/nm.2128; BORGULYA P, 1992, CELL, V69, P529, DOI 10.1016/0092-8674(92)90453-J; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Brenner Malcolm K, 2009, Hematology Am Soc Hematol Educ Program, P675, DOI 10.1182/asheducation-2009.1.675; Brivanlou AH, 2003, SCIENCE, V300, P913, DOI 10.1126/science.1082940; Brodie SJ, 1999, NAT MED, V5, P34, DOI 10.1038/4716; Brown ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011373; Butler NS, 2011, CELL MICROBIOL, V13, P925, DOI 10.1111/j.1462-5822.2011.01594.x; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Du G, 2006, J IMMUNOL METHODS, V308, P19, DOI 10.1016/j.jim.2005.09.009; Freberg CT, 2007, MOL BIOL CELL, V18, P1543, DOI 10.1091/mbc.E07-01-0029; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; GREENBERG PD, 1991, ADV IMMUNOL, V49, P281; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hara A, 2008, STEM CELLS DEV, V17, P619, DOI 10.1089/scd.2007.0235; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Huang CY, 2001, J IMMUNOL, V166, P2597, DOI 10.4049/jimmunol.166.4.2597; Ikawa T, 2010, SCIENCE, V329, P93, DOI 10.1126/science.1188995; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; June CH, 2007, J CLIN INVEST, V117, P1466, DOI 10.1172/JCI32446; Kaneko S, 2009, BLOOD, V113, P1006, DOI 10.1182/blood-2008-05-156059; Kawana-Tachikawa A, 2002, J VIROL, V76, P11982, DOI 10.1128/JVI.76.23.11982-11988.2002; Khor B, 2002, CURR OPIN IMMUNOL, V14, P230, DOI 10.1016/S0952-7915(02)00326-6; Klebanoff CA, 2006, IMMUNOL REV, V211, P214, DOI 10.1111/j.0105-2896.2006.00391.x; Kohn DB, 2003, NAT REV CANCER, V3, P477, DOI 10.1038/nrc1122; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Krangel MS, 2009, CURR OPIN IMMUNOL, V21, P133, DOI 10.1016/j.coi.2009.03.009; LAFAILLE JJ, 1989, CELL, V59, P859, DOI 10.1016/0092-8674(89)90609-0; Lefranc MP, 2003, LEUKEMIA, V17, P260, DOI 10.1038/sj.leu.2402637; Loh YH, 2010, CELL STEM CELL, V7, P15, DOI 10.1016/j.stem.2010.06.004; LU PH, 1994, J IMMUNOL, V153, P1687; MacLeod MKL, 2010, IMMUNOLOGY, V130, P10, DOI 10.1111/j.1365-2567.2010.03260.x; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; Monteiro J, 1996, J IMMUNOL, V156, P3587; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Neuber K, 2003, IMMUNOLOGY, V109, P24, DOI 10.1046/j.1365-2567.2003.01640.x; Nishimura K, 2011, J BIOL CHEM, V286, P4760, DOI 10.1074/jbc.M110.183780; PADOVAN E, 1993, SCIENCE, V262, P422, DOI 10.1126/science.8211163; PETRIE HT, 1993, J EXP MED, V178, P615, DOI 10.1084/jem.178.2.615; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Prlic M, 2002, J EXP MED, V195, pF49, DOI 10.1084/jem.20020767; Romero P, 2007, J IMMUNOL, V178, P4112, DOI 10.4049/jimmunol.178.7.4112; Rubio V, 2003, NAT MED, V9, P1377, DOI 10.1038/nm942; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Serwold T, 2010, P NATL ACAD SCI USA, V107, P18939, DOI 10.1073/pnas.1013230107; Staerk J, 2010, CELL STEM CELL, V7, P20, DOI 10.1016/j.stem.2010.06.002; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takayama N, 2008, BLOOD, V111, P5298, DOI 10.1182/blood-2007-10-117622; Takayama N, 2010, J EXP MED, V207, P2817, DOI 10.1084/jem.20100844; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Timmermans F, 2009, J IMMUNOL, V182, P6879, DOI 10.4049/jimmunol.0803670; Tsunetsugu-Yokota Y, 2003, J VIROL, V77, P10250, DOI 10.1128/JVI.77.19.10250-10259.2003; TURKA LA, 1991, SCIENCE, V253, P778, DOI 10.1126/science.1831564; Turtle CJ, 2009, IMMUNITY, V31, P834, DOI 10.1016/j.immuni.2009.09.015; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Veldwijk MR, 2004, CANCER GENE THER, V11, P577, DOI 10.1038/sj.cgt.7700718; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Von Boehmer H, 2004, ADV IMMUNOL, V84, P201, DOI 10.1016/S0065-2776(04)84006-9; Watarai H, 2010, BLOOD, V115, P230, DOI 10.1182/blood-2009-04-217729; Weng NP, 1998, IMMUNITY, V9, P151, DOI 10.1016/S1074-7613(00)80597-X; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010	68	238	259	4	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 3	2013	12	1					114	126		10.1016/j.stem.2012.11.002	http://dx.doi.org/10.1016/j.stem.2012.11.002			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	074UM	23290140	Bronze			2022-12-28	WOS:000313839500015
J	Hermann, BP; Sukhwani, M; Winkler, F; Pascarella, JN; Peters, KA; Sheng, Y; Valli, H; Rodriguez, M; Ezzelarab, M; Dargo, G; Peterson, K; Masterson, K; Ramsey, C; Ward, T; Lienesch, M; Volk, A; Cooper, DK; Thomson, AW; Kiss, JE; Penedo, MCT; Schatten, GP; Mitalipov, S; Orwig, KE				Hermann, Brian P.; Sukhwani, Meena; Winkler, Felicity; Pascarella, Julia N.; Peters, Karen A.; Sheng, Yi; Valli, Hanna; Rodriguez, Mario; Ezzelarab, Mohamed; Dargo, Gina; Peterson, Kim; Masterson, Keith; Ramsey, Cathy; Ward, Thea; Lienesch, Maura; Volk, Angie; Cooper, David K.; Thomson, Angus W.; Kiss, Joseph E.; Penedo, Maria Cecilia T.; Schatten, Gerald P.; Mitalipov, Shoukhrat; Orwig, Kyle E.			Spermatogonial Stem Cell Transplantation into Rhesus Testes Regenerates Spermatogenesis Producing Functional Sperm	CELL STEM CELL			English	Article							FERTILITY PRESERVATION; BONE-MARROW; GERMLINE TRANSMISSION; CHILDHOOD-CANCER; MONKEY; FERTILIZATION; RADIATION; PRIMATES; CRYOPRESERVATION; PROPAGATION	Spermatogonial stem cells (SSCs) maintain spermatogenesis throughout a man's life and may have application for treating some cases of male infertility, including those caused by chemotherapy before puberty. We performed autologous and allogeneic SSC transplantations into the testes of 18 adult and 5 prepubertal recipient macaques that were rendered infertile with alkylating chemotherapy. After autologous transplant, the donor genotype from lentivirus-marked SSCs was evident in the ejaculated sperm of 9/12 adult and 3/5 prepubertal recipients after they reached maturity. Allogeneic transplant led to donor-recipient chimerism in sperm from 2/6 adult recipients. Ejaculated sperm from one recipient transplanted with allogeneic donor SSCs were injected into 85 rhesus oocytes via intracytoplasmic sperm injection. Eighty-one oocytes were fertilized, producing embryos ranging from four-cell to blastocyst with donor paternal origin confirmed in 7/81 embryos. This demonstration of functional donor spermatogenesis following SSC transplantation in primates is an important milestone for informed clinical translation.	[Hermann, Brian P.; Sheng, Yi; Schatten, Gerald P.; Orwig, Kyle E.] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA; [Orwig, Kyle E.] Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA 15260 USA; [Kiss, Joseph E.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15260 USA; [Hermann, Brian P.; Orwig, Kyle E.] Univ Pittsburgh, Sch Med, Ctr Res Reprod Physiol, Pittsburgh, PA 15260 USA; [Ezzelarab, Mohamed; Cooper, David K.; Thomson, Angus W.] Univ Pittsburgh, Sch Med, Thomas E Starzl Transplantat Inst, Pittsburgh, PA 15260 USA; [Valli, Hanna] Univ Pittsburgh, Sch Med, Mol Genet & Dev Biol Grad Program, Pittsburgh, PA 15260 USA; [Hermann, Brian P.; Sukhwani, Meena; Winkler, Felicity; Pascarella, Julia N.; Peters, Karen A.; Sheng, Yi; Valli, Hanna; Rodriguez, Mario; Schatten, Gerald P.; Orwig, Kyle E.] Univ Pittsburgh, Sch Med, Magee Womens Res Inst, Pittsburgh, PA 15260 USA; [Masterson, Keith; Ramsey, Cathy; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; [Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Oregon Stem Cell Ctr, Beaverton, OR 97006 USA; [Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Beaverton, OR 97006 USA; [Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Beaverton, OR 97006 USA; [Ward, Thea; Penedo, Maria Cecilia T.] Univ Calif Davis, Vet Genet Lab, Davis, CA 95616 USA; [Dargo, Gina; Peterson, Kim; Kiss, Joseph E.] ITxM Diagnost Pittsburgh, Hemapheresis Dept, Pittsburgh, PA 15213 USA; [Lienesch, Maura; Volk, Angie] CaridianBCT Inc, Lakewood, CO 80401 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of California System; University of California Davis; Institute for Transfusion Medicine	Orwig, KE (corresponding author), Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA.	orwigke@upmc.edu	Ezzelarab, Mohamed/AGJ-9904-2022; Ezzelarab, Mohamed/CAA-4267-2022; Schatten, Gerald/B-3253-2009; Hermann, Brian P/E-7853-2011	Schatten, Gerald/0000-0001-5206-7782; Hermann, Brian P/0000-0002-0503-3616; Orwig, Kyle/0000-0002-7952-8419; Valli-Pulaski, Hanna/0000-0001-8092-0066; Ezzelarab, Mohamed/0000-0002-3919-5250	Magee-Womens Research Institute and Foundation; Richard King Mellon Foundation; NIH [R01 HD055475, R21 HD061289, U54 HD008610, P01 HD047675, K99/R00 HD062687]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055475, R00HD062687] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD047675, R21HD061289, U54HD008610, K99HD062687] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR016001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040101, U24AI126683] Funding Source: NIH RePORTER	Magee-Womens Research Institute and Foundation; Richard King Mellon Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to acknowledge the outstanding work of Tony Battelli, Pam Wintruba, and Joe Hrach, the lab animal staff at Magee-Womens Research institute, who were critical to the conduct of these experiments. Artwork for the graphical abstract was produced by Dr. Bart Phillips. We are grateful to Drs. Robert Donahue and Cynthia Dunbar of the National Heart, Lung and Blood Institute, NIH, who provided critical advice for PBSC transplantation in nonhuman primates. Drs. Tony Plant and Judy Cameron provided advice about central line catheter placement in nonhuman primates. We also thank Drs. Regina Norris, Danielle Sweeney, David Rodeberg, and Francis Schneck from the Departments of Urology and General Surgery at the Children's Hospital of Pittsburgh of UPMC for their assistance with subcapsular testis biopsies. The FUGW lentiviral backbone was provided by Dr. Carlos Lois, University of Massachusetts. The anti-CD154 reagent used in these studies was provided by the NIH Nonhuman Primate Reagent Resource (R24 RR016001, N01 AI040101). The work was supported by Magee-Womens Research Institute and Foundation, The Richard King Mellon Foundation, NIH grants R01 HD055475 and R21 HD061289 to K.E.O., U54 HD008610 to Tony M. Plant and K.E.O., P01 HD047675 to G.P.S., and K99/R00 HD062687 to B.P.H.	Alizadeh M, 2002, BLOOD, V99, P4618, DOI 10.1182/blood.V99.12.4618; AMANN RP, 1976, BIOL REPROD, V15, P586, DOI 10.1095/biolreprod15.5.586; Appelbaum FR, 2007, NEW ENGL J MED, V357, P1472, DOI 10.1056/NEJMp078166; BAVISTER BD, 1984, P NATL ACAD SCI-BIOL, V81, P2218, DOI 10.1073/pnas.81.7.2218; Brinster RL, 2007, SCIENCE, V316, P404, DOI 10.1126/science.1137741; Brinster RL, 2002, SCIENCE, V296, P2174, DOI 10.1126/science.1071607; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; Byrne JA, 2007, NATURE, V450, P497, DOI 10.1038/nature06357; Chan AWS, 2001, SCIENCE, V291, P309, DOI 10.1126/science.291.5502.309; Clark AT, 2011, NAT MED, V17, P1564, DOI 10.1038/nm.2594; CLERMONT Y, 1973, AM J ANAT, V136, P153, DOI 10.1002/aja.1001360204; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; CROUCH BG, 1957, SCIENCE, V125, P1092, DOI 10.1126/science.125.3257.1092; Dobrinski I, 1999, BIOL REPROD, V61, P1331, DOI 10.1095/biolreprod61.5.1331; Dobrinski I, 2000, MOL REPROD DEV, V57, P270, DOI 10.1002/1098-2795(200011)57:3&lt;270::AID-MRD9&gt;3.0.CO;2-Z; Donahue R.E., 2005, CURRENT PROTOCOLS IM; Ezzelarab M, 2008, TRANSPLANTATION, V86, P733, DOI 10.1097/TP.0b013e3181821cad; Fijak M, 2006, IMMUNOL REV, V213, P66, DOI 10.1111/j.1600-065X.2006.00438.x; Geens M, 2008, HUM REPROD UPDATE, V14, P121, DOI 10.1093/humupd/dmm047; Ginsberg JP, 2010, HUM REPROD, V25, P37, DOI 10.1093/humrep/dep371; GOULD KG, 1988, J MED PRIMATOL, V17, P95; Green DM, 2010, J CLIN ONCOL, V28, P332, DOI 10.1200/JCO.2009.24.9037; Hermann BP, 2007, STEM CELLS, V25, P2330, DOI 10.1634/stemcells.2007-0143; Hermann BP, 2011, HUM REPROD, V26, P3222, DOI 10.1093/humrep/der343; Hermann BP, 2011, STEM CELLS BIOL REG, P227, DOI 10.1007/978-1-61737-973-4_11; Hermann BP, 2010, REPRODUCTION, V139, P479, DOI 10.1530/REP-09-0255; Hermann BP, 2009, HUM REPROD, V24, P1704, DOI 10.1093/humrep/dep073; Herrid M, 2009, BIOL REPROD, V81, P898, DOI 10.1095/biolreprod.109.078279; Hewitson L, 1999, NAT MED, V5, P431, DOI 10.1038/7430; Honaramooz A, 2002, BIOL REPROD, V66, P21, DOI 10.1095/biolreprod66.1.21; Honaramooz A, 2003, BIOL REPROD, V69, P1260, DOI 10.1095/biolreprod.103.018788; Izadyar F, 2003, REPRODUCTION, V126, P765, DOI 10.1530/rep.0.1260765; Jahnukainen K, 2011, HUM REPROD, V26, P1945, DOI 10.1093/humrep/der160; Kang EM, 2006, EXP HEMATOL, V34, P132, DOI 10.1016/j.exphem.2005.10.010; Keros V, 2007, HUM REPROD, V22, P1384, DOI 10.1093/humrep/del508; Khouangsathiene S, 2008, BIOINFORMATICS, V24, P2645, DOI 10.1093/bioinformatics/btn493; Kim Y, 2008, REPRODUCTION, V136, P823, DOI 10.1530/REP-08-0226; Kirk AD, 1999, NAT MED, V5, P686, DOI 10.1038/9536; Kubota H, 2006, NAT CLIN PRACT ENDOC, V2, P99, DOI 10.1038/ncpendmet0098; Larsen CP, 2010, AM J TRANSPLANT, V10, P2396, DOI 10.1111/j.1600-6143.2010.03272.x; Lee SJ, 2006, J CLIN ONCOL, V24, P2917, DOI 10.1200/JCO.2006.06.5888; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; MAUCH P, 1995, INT J RADIAT ONCOL, V31, P1319, DOI 10.1016/0360-3016(94)00430-S; MEISTRICH ML, 1993, EUR UROL, V23, P136; Messaoudi I, 2011, ANTIOXID REDOX SIGN, V14, P261, DOI 10.1089/ars.2010.3241; Mikkola M, 2006, REPROD DOMEST ANIM, V41, P124, DOI 10.1111/j.1439-0531.2006.00651.x; Mitalipov S, 2006, STEM CELLS, V24, P2177, DOI 10.1634/stemcells.2006-0125; Mitchell R. T., 2009, V15, P101, DOI 10.1159/000207612; Ogawa T, 1999, TISSUE CELL, V31, P461, DOI 10.1054/tice.1999.0060; Ogawa T, 2000, NAT MED, V6, P29, DOI 10.1038/71496; Ogawa T, 2001, J MOL MED-JMM, V79, P368, DOI 10.1007/s001090100228; Oktay K., 2011, I FERTILITY PRESERVA; Orwig K.E., 2011, FERTILITY PRESERVATI; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Phillips BT, 2010, PHILOS T R SOC B, V365, P1663, DOI 10.1098/rstb.2010.0026; Plant TM, 2001, ENDOCR REV, V22, P764, DOI 10.1210/er.22.6.764; POTTEN CS, 1995, INT J CANCER, V62, P356, DOI 10.1002/ijc.2910620321; POTTEN CS, 1979, BIOCHIM BIOPHYS ACTA, V560, P281, DOI 10.1016/0304-419X(79)90022-2; Potten CS, 1992, OXFORD TXB PATHOLOGY, P43; Powell J.L., 2009, PEDIAT HEMATOPOIETIC; Rodriguez-Sosa JR, 2009, REPRODUCTION, V138, P187, DOI 10.1530/REP-09-0012; Ryu BY, 2003, DEV BIOL, V263, P253, DOI 10.1016/j.ydbio.2003.07.010; Sadri-Ardekani H, 2011, JAMA-J AM MED ASSOC, V305, P2416, DOI 10.1001/jama.2011.791; Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850; Schlatt S, 1999, HUM REPROD, V14, P144, DOI 10.1093/humrep/14.1.144; Schlatt S, 2002, HUM REPROD, V17, P55, DOI 10.1093/humrep/17.1.55; Schlatt S, 2009, PEDIATR BLOOD CANCER, V53, P274, DOI 10.1002/pbc.22002; Sharpe Richard M., 1994, P1363; Shinohara T, 2001, P NATL ACAD SCI USA, V98, P6186, DOI 10.1073/pnas.111158198; THOMAS ED, 1957, NEW ENGL J MED, V257, P491, DOI 10.1056/NEJM195709122571102; Wallace WHB, 2005, LANCET ONCOL, V6, P209, DOI 10.1016/S1470-2045(05)70092-9; Wolf DP, 2004, BIOL REPROD, V71, P486, DOI 10.1095/biolreprod.103.025932; WOLF DP, 1989, BIOL REPROD, V41, P335, DOI 10.1095/biolreprod41.2.335; Wyns C, 2008, HUM REPROD, V23, P2402, DOI 10.1093/humrep/den272; Wyns C, 2010, HUM REPROD UPDATE, V16, P312, DOI 10.1093/humupd/dmp054	76	247	263	1	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 2	2012	11	5					715	726		10.1016/j.stem.2012.07.017	http://dx.doi.org/10.1016/j.stem.2012.07.017			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	042LE	23122294	Bronze, Green Accepted			2022-12-28	WOS:000311471900016
J	Inaba, M; Yamashita, YM				Inaba, Mayu; Yamashita, Yukiko M.			Asymmetric Stem Cell Division: Precision for Robustness	CELL STEM CELL			English	Review							MITOTIC SPINDLE ORIENTATION; DROSOPHILA NEUROBLASTS; NEURAL STEM; PAR-COMPLEX; SELF-RENEWAL; DAUGHTER CENTROSOME; BRAIN-DEVELOPMENT; TUMOR-SUPPRESSOR; PROGENITOR CELLS; SEGREGATION	Asymmetric cell division (ACD) produces two daughter cells with distinct fates or characteristics. Many adult stem cells use ACD as a means of maintaining stem cell number and thus tissue homeostasis. Here, we review recent progress on ACD, discussing conservation between stem and non-stem cell systems, molecular mechanisms, and the biological meaning of ACD.	[Inaba, Mayu; Yamashita, Yukiko M.] Univ Michigan, Life Sci Inst, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA; [Inaba, Mayu; Yamashita, Yukiko M.] Univ Michigan, Dept Cell & Dev Biol, Sch Med, Ann Arbor, MI 48109 USA; [Yamashita, Yukiko M.] Univ Michigan, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Yamashita, YM (corresponding author), Univ Michigan, Life Sci Inst, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA.	yukikomy@umich.edu		Yamashita, Yukiko/0000-0001-5541-0216	NIH [R01GM086481]; John D. and Catherine T. MacArthur Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086481] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John D. and Catherine T. MacArthur Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in the Yamashita laboratory on asymmetric stem cell division is supported by the NIH (R01GM086481 to Y.M.Y.). Y.M.Y. is supported by the John D. and Catherine T. MacArthur Foundation.	Ackermann M, 2003, SCIENCE, V300, P1920, DOI 10.1126/science.1083532; Amon A, 1996, CELL, V84, P651, DOI 10.1016/S0092-8674(00)81041-7; Anderson CT, 2009, CURR BIOL, V19, P1498, DOI 10.1016/j.cub.2009.07.034; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Bello BC, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-5; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Boone JQ, 2008, DEV NEUROBIOL, V68, P1185, DOI 10.1002/dneu.20648; Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Cabernard C, 2009, DEV CELL, V17, P134, DOI 10.1016/j.devcel.2009.06.009; Caydasi AK, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-28; Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386; Conduit PT, 2010, CURR BIOL, V20, P2187, DOI 10.1016/j.cub.2010.11.055; Costa MR, 2008, DEVELOPMENT, V135, P11, DOI 10.1242/dev.009951; Cowan CR, 2004, ANNU REV CELL DEV BI, V20, P427, DOI 10.1146/annurev.cellbio.19.111301.113823; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; Deng W, 1997, DEV BIOL, V189, P79, DOI 10.1006/dbio.1997.8669; Doupe DP, 2012, SCIENCE, V337, P1091, DOI 10.1126/science.1218835; Ettinger AW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1511; Farkas LM, 2008, CURR OPIN CELL BIOL, V20, P707, DOI 10.1016/j.ceb.2008.09.008; Goley ED, 2009, COLD SH Q B, V74, P55, DOI 10.1101/sqb.2009.74.005; GONCZY P, 2005, WORMBOOK, DOI DOI 10.1895/WORMBOOK.1.30.1; Goulas S, 2012, CELL STEM CELL, V11, P529, DOI 10.1016/j.stem.2012.06.017; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Hayashi Y, 2009, J CELL BIOL, V187, P473, DOI 10.1083/jcb.200904118; Henderson KA, 2008, CURR OPIN CELL BIOL, V20, P723, DOI 10.1016/j.ceb.2008.09.004; Inaba M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012473; Januschke J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1245; Januschke J, 2010, J CELL BIOL, V188, P693, DOI 10.1083/jcb.200905024; Klein AM, 2010, CELL STEM CELL, V7, P214, DOI 10.1016/j.stem.2010.05.017; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kuo TC, 2011, NAT CELL BIOL, V13, P1214, DOI 10.1038/ncb2332; Kusek G, 2012, CELL STEM CELL, V11, P505, DOI 10.1016/j.stem.2012.06.006; Lansdorp PM, 2007, CELL, V129, P1244, DOI 10.1016/j.cell.2007.06.017; Laub MT, 2007, ANNU REV GENET, V41, P429, DOI 10.1146/annurev.genet.41.110306.130346; Leatherman JL, 2010, NAT CELL BIOL, V12, P806, DOI 10.1038/ncb2086; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lesage B, 2010, CURR OPIN GENET DEV, V20, P438, DOI 10.1016/j.gde.2010.04.013; Lindner AB, 2008, P NATL ACAD SCI USA, V105, P3076, DOI 10.1073/pnas.0708931105; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; Lu BW, 1998, CELL, V95, P225, DOI 10.1016/S0092-8674(00)81753-5; Lu W, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001357; Michel M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1426; Morin X, 2011, DEV CELL, V21, P102, DOI 10.1016/j.devcel.2011.06.012; Munro E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003400; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; O'Brien LE, 2011, CELL, V147, P603, DOI 10.1016/j.cell.2011.08.048; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Pereira G, 2011, TRENDS CELL BIOL, V21, P526, DOI 10.1016/j.tcb.2011.05.004; Poulson ND, 2010, J CELL BIOL, V191, P915, DOI 10.1083/jcb.201008001; Rando TA, 2007, CELL, V129, P1239, DOI 10.1016/j.cell.2007.06.019; Rujano MA, 2006, PLOS BIOL, V4, P2325, DOI 10.1371/journal.pbio.0040417; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Siegrist SE, 2006, DEVELOPMENT, V133, P529, DOI 10.1242/dev.02211; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Song XQ, 2002, P NATL ACAD SCI USA, V99, P14813, DOI 10.1073/pnas.232389399; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Tajbakhsh S, 2009, NAT REV MOL CELL BIO, V10, P804, DOI 10.1038/nrm2784; Tajbakhsh S, 2008, CURR OPIN CELL BIOL, V20, P716, DOI 10.1016/j.ceb.2008.10.004; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Troy A, 2012, CELL STEM CELL, V11, P541, DOI 10.1016/j.stem.2012.05.025; Unal E, 2011, SCIENCE, V332, P1554, DOI 10.1126/science.1204349; Vessey JP, 2012, CELL STEM CELL, V11, P517, DOI 10.1016/j.stem.2012.06.010; Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910; Yu FW, 2006, NEURON, V51, P13, DOI 10.1016/j.neuron.2006.06.016; Yuan HB, 2012, DEV BIOL, V361, P57, DOI 10.1016/j.ydbio.2011.10.010; Zheng Q, 2011, DEV BIOL, V357, P202, DOI 10.1016/j.ydbio.2011.06.022	74	102	104	0	44	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	OCT 5	2012	11	4					461	469		10.1016/j.stem.2012.09.003	http://dx.doi.org/10.1016/j.stem.2012.09.003			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	021OZ	23040475	Bronze			2022-12-28	WOS:000309896500007
J	Potts, MB; Lim, DA				Potts, Matthew B.; Lim, Daniel A.			An Old Drug for New Ideas: Metformin Promotes Adult Neurogenesis and Spatial Memory Formation	CELL STEM CELL			English	Editorial Material							RUBINSTEIN-TAYBI-SYNDROME; BRAIN; DIFFERENTIATION; PROTEIN; CELLS	Identifying well-tolerated, oral medications that enhance adult neurogenesis is of great clinical interest. In this issue of Cell Stem Cell, Wang et al. (2012) demonstrate that the diabetes medication metformin enhances spatial learning in mice by activating the atypical PKC/CBP pathway in adult neural stem cells.	[Potts, Matthew B.; Lim, Daniel A.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Lim, Daniel A.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Lim, Daniel A.] Univ Calif San Francisco, Vet Affairs Med Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Lim, DA (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	limd@neurosurg.ucsf.edu		Lim, Daniel/0000-0001-7221-3425	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006505] Funding Source: NIH RePORTER; NIH HHS [DP2 OD006505] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Amato S, 2011, CELL CYCLE, V10, P3452, DOI 10.4161/cc.10.20.17953; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Emsley JG, 2005, PROG NEUROBIOL, V75, P321, DOI 10.1016/j.pneurobio.2005.04.002; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Pieper AA, 2010, CELL, V142, P39, DOI 10.1016/j.cell.2010.06.018; Wang J, 2010, DEV CELL, V18, P114, DOI 10.1016/j.devcel.2009.10.023	9	42	42	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUL 6	2012	11	1					5	6		10.1016/j.stem.2012.06.003	http://dx.doi.org/10.1016/j.stem.2012.06.003			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	975SS	22770236	Green Accepted, Bronze			2022-12-28	WOS:000306532400003
J	Shen, H; Laird, PW				Shen, Hui; Laird, Peter W.			In Epigenetic Therapy, Less Is More	CELL STEM CELL			English	Editorial Material							DNA METHYLATION; 5-AZA-2'-DEOXYCYTIDINE; CANCER	How DNA methylation inhibitors exert their anticancer effects in patients is not well understood. In the latest issue of Cancer Cell, Tsai et al. (2012) use low-dose drug treatment to induce persistent attenuation of tumorigenicity by targeting tumor-initiating cells.	[Shen, Hui; Laird, Peter W.] Univ So Calif, Keck Sch Med, USC Epigenome Ctr, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA	University of Southern California	Laird, PW (corresponding author), Univ So Calif, Keck Sch Med, USC Epigenome Ctr, Norris Comprehens Canc Ctr, 1450 Biggy St,Room G511B, Los Angeles, CA 90089 USA.	plaird@usc.edu	Shen, Hui/AAO-4387-2020; Laird, Peter W/G-8683-2012	Laird, Peter W/0000-0001-9117-3641; Shen, Hui/0000-0001-9767-4084				Issa JPJ, 2009, CLIN CANCER RES, V15, P3938, DOI 10.1158/1078-0432.CCR-08-2783; Issa JPJ, 2004, BLOOD, V103, P1635, DOI 10.1182/blood-2003-03-0687; JacksonGrusby L, 1997, P NATL ACAD SCI USA, V94, P4681, DOI 10.1073/pnas.94.9.4681; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Juergens RA, 2011, CANCER DISCOV, V1, P598, DOI 10.1158/2159-8290.CD-11-0214; Kelly TK, 2010, NAT BIOTECHNOL, V28, P1069, DOI 10.1038/nbt.1678; Qin TC, 2009, BLOOD, V113, P659, DOI 10.1182/blood-2008-02-140038; Tsai HC, 2012, CANCER CELL, V21, P430, DOI 10.1016/j.ccr.2011.12.029; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930	9	22	23	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	APR 6	2012	10	4					353	354		10.1016/j.stem.2012.03.012	http://dx.doi.org/10.1016/j.stem.2012.03.012			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	929QA	22482500	Bronze			2022-12-28	WOS:000303079400004
J	Spike, BT; Engle, DD; Lin, JC; Cheung, SK; La, J; Wahl, GM				Spike, Benjamin T.; Engle, Dannielle D.; Lin, Jennifer C.; Cheung, Samantha K.; La, Justin; Wahl, Geoffrey M.			A Mammary Stem Cell Population Identified and Characterized in Late Embryogenesis Reveals Similarities to Human Breast Cancer	CELL STEM CELL			English	Article							GENE-EXPRESSION SIGNATURE; TRANSCRIPTOME ANALYSIS; MESENCHYMAL TRANSITION; DUCTAL MORPHOGENESIS; VIMENTIN EXPRESSION; KINASE INHIBITOR; FAT PADS; GLAND; MOUSE; MODELS	Gene expression signatures relating mammary stem cell populations to breast cancers have focused on adult tissue. Here, we identify, isolate, and characterize the fetal mammary stem cell (fMaSC) state since the invasive and proliferative processes of mammogenesis resemble phases of cancer progression. fMaSC frequency peaks late in embryogenesis, enabling more extensive stem cell purification than achieved with adult tissue. fMaSCs are self-renewing, multipotent, and coexpress multiple mammary lineage markers. Gene expression, transplantation, and in vitro analyses reveal putative autocrine and paracrine regulatory mechanisms, including ErbB and FGF signaling pathways impinging on fMaSC growth. Expression profiles from fMaSCs and associated stroma exhibit significant similarities to basal-like and Her2(+) intrinsic breast cancer subtypes. Our results reveal links between development and cancer and provide resources to identify new candidates for diagnosis, prognosis, and therapy.	[Spike, Benjamin T.; Engle, Dannielle D.; Lin, Jennifer C.; Cheung, Samantha K.; La, Justin; Wahl, Geoffrey M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Spike, Benjamin T.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92037 USA; [Engle, Dannielle D.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92037 USA	Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Wahl, GM (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wahl@salk.edu	La, Justin/AAU-7141-2021	La, Justin/0000-0003-1596-6193; Engle, Dannielle/0000-0003-1876-7675	G. Harold and Leila Y. Mathers Charitable Foundation [CA009523, GM07240, CA009370]; California Breast Cancer Research Program [15GB-0015]; National Cancer Institute [5P30CA014195]; NATIONAL CANCER INSTITUTE [P30CA014195, T32CA009370, T32CA009523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007240] Funding Source: NIH RePORTER	G. Harold and Leila Y. Mathers Charitable Foundation; California Breast Cancer Research Program; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We dedicate this work to Evelyn Lauder, visionary founder and inspirational leader of the Breast Cancer Research Foundation, and Corinne Mentzelopoulos for generously supporting the Salk Institute. We thank J.C. Izpisua Belmonte, T. Bonnefoix, G. Cunha, C. Eaves, P. Eirew, L. Ellies, P. Gray, J. Green, S. Kinkel, A. Legler, D. Medina, C.M. Perou, A. Prat, A. Rodrigues, B. Vonderhaar, and Wahl Lab members for invaluable advice; Pfizer for neratinib; and BCRF, DOD-BCRP, Susan G. Komen for the Cure, the G. Harold and Leila Y. Mathers Charitable Foundation, T32 training grants CA009523 (B.T.S.), GM07240 (D.D.E.), CA009370 (J.C.L.), and California Breast Cancer Research Program 15GB-0015 (D.D.E.) for funding; and National Cancer Institute 5P30CA014195 for core resource support.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Anbazhagan R, 1998, J PATHOL, V184, P197, DOI 10.1002/(SICI)1096-9896(199802)184:2&lt;197::AID-PATH992&gt;3.0.CO;2-J; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bonnefoix T, 1996, J IMMUNOL METHODS, V194, P113, DOI 10.1016/0022-1759(96)00077-4; Brewer BG, 2009, EXP MOL PATHOL, V86, P192, DOI 10.1016/j.yexmp.2008.12.002; Britsch S, 2007, ADV ANAT EMBRYOL CEL, V190, P1; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Cunha GR, 1996, J MAMMARY GLAND BIOL, V1, P21, DOI 10.1007/BF02096300; DEOME KB, 1959, CANCER RES, V19, P515; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Fan C, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-3; Haibe-Kains B, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-394; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HAY ED, 1995, AM J KIDNEY DIS, V26, P678, DOI 10.1016/0272-6386(95)90610-X; Hendrix MJC, 1997, AM J PATHOL, V150, P483; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Howard B, 2006, PLOS GENET, V2, P1121, DOI 10.1371/journal.pgen.0020112; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Jackson-Fisher AJ, 2004, P NATL ACAD SCI USA, V101, P17138, DOI 10.1073/pnas.0407057101; Jackson-Fisher AJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2198; Jacobs TW, 1999, J CLIN ONCOL, V17, P1983, DOI 10.1200/JCO.1999.17.7.1983; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kendrick H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-591; Kikuchi A, 2012, ACTA PHYSIOL, V204, P17, DOI 10.1111/j.1748-1716.2011.02294.x; Korkaya H, 2009, CLIN CANCER RES, V15, P1845, DOI 10.1158/1078-0432.CCR-08-3087; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Livasy CA, 2006, GYNECOL ONCOL, V100, P101, DOI 10.1016/j.ygyno.2005.07.124; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mizuno H, 2010, P NATL ACAD SCI USA, V107, P22745, DOI 10.1073/pnas.1017001108; MORK C, 1990, DIFFERENTIATION, V43, P146; Paik S, 2008, NEW ENGL J MED, V358, P1409, DOI 10.1056/NEJMc0801440; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Pal SK, 2011, BREAST CANCER RES TR, V125, P627, DOI 10.1007/s10549-010-1293-1; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Perou CM, 2010, LANCET ONCOL, V11, P718, DOI 10.1016/S1470-2045(10)70176-5; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Petersen OW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003160; Powers S, 2008, CELL CYCLE, V7, P200, DOI 10.4161/cc.7.2.5284; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Rabindran SK, 2004, CANCER RES, V64, P3958, DOI 10.1158/0008-5472.CAN-03-2868; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; Rody A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3035; Rusnak DW, 2001, MOL CANCER THER, V1, P85; SAKAKURA T, 1979, J NATL CANCER I, V63, P733, DOI 10.1093/jnci/63.3.733; Sell S, 2010, AM J PATHOL, V176, P2584, DOI 10.2353/ajpath.2010.091064; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2007, NAT REV CANCER, V7, P545, DOI 10.1038/nrc2173; Spike Benjamin T, 2011, Genes Cancer, V2, P404, DOI 10.1177/1947601911410224; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Strizzi L, 2009, CANCER RES, V69, P7131, DOI 10.1158/0008-5472.CAN-09-1199; Sun P, 2010, HISTOCHEM CELL BIOL, V133, P213, DOI 10.1007/s00418-009-0662-5; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thomas PA, 1999, CLIN CANCER RES, V5, P2698; Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Veltmaat JM, 2003, DIFFERENTIATION, V71, P1, DOI 10.1046/j.1432-0436.2003.700601.x; Wang SZE, 2006, CANCER CELL, V10, P25, DOI 10.1016/j.ccr.2006.05.023; Wansbury O, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2928; Weigelt B, 2010, BREAST CANCER RES TR, V122, P35, DOI 10.1007/s10549-009-0502-2; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020	74	157	160	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 3	2012	10	2					183	197		10.1016/j.stem.2011.12.018	http://dx.doi.org/10.1016/j.stem.2011.12.018			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	892FM	22305568	Bronze, Green Accepted			2022-12-28	WOS:000300272100011
J	Coffey, P				Coffey, Pete			Untapping the Potential of Human Retinal Pigmented Epithelial Cells	CELL STEM CELL			English	Editorial Material							TRANSPLANTATION	The innate capacity of adult somatic cells has many potential applications in regenerative medicine. In this issue of Cell Stem Cell, Salero et al. (2012) describe an adult retinal stem cell population capable of generating neural and mesenchymal cell lineages.	[Coffey, Pete] UCL Inst Ophthalmol, London EC1V 9EL, England; [Coffey, Pete] Univ Calif Santa Barbara, Inst Neurosci, Santa Barbara, CA 93106 USA	University of London; University College London; University of California System; University of California Santa Barbara	Coffey, P (corresponding author), UCL Inst Ophthalmol, London EC1V 9EL, England.	p.coffey@ucl.ac.uk		Coffey, Peter/0000-0002-5427-2939	Medical Research Council [G1000730, G0300288] Funding Source: Medline; MRC [G0300288, G1000730] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Araki M, 2007, DEV GROWTH DIFFER, V49, P109, DOI 10.1111/j.1440-169x.2007.00911.x; Coffey PJ, 2002, NAT NEUROSCI, V5, P53, DOI 10.1038/nn782; da Cruz L, 2007, PROG RETIN EYE RES, V26, P598, DOI 10.1016/j.preteyeres.2007.07.001; Salero E, 2012, CELL STEM CELL, V10, P88, DOI 10.1016/j.stem.2011.11.018	4	1	1	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JAN 6	2012	10	1					1	2		10.1016/j.stem.2011.12.014	http://dx.doi.org/10.1016/j.stem.2011.12.014			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	880ZQ	22226345	Bronze			2022-12-28	WOS:000299449500001
J	Elling, U; Taubenschmid, J; Wirnsberger, G; O'Malley, R; Demers, SP; Vanhaelen, Q; Shukalyuk, AI; Schmauss, G; Schramek, D; Schnuetgen, F; von Melchner, H; Ecker, JR; Stanford, WL; Zuber, J; Stark, A; Penninger, JM				Elling, Ulrich; Taubenschmid, Jasmin; Wirnsberger, Gerald; O'Malley, Ronan; Demers, Simon-Pierre; Vanhaelen, Quentin; Shukalyuk, Andrey I.; Schmauss, Gerald; Schramek, Daniel; Schnuetgen, Frank; von Melchner, Harald; Ecker, Joseph R.; Stanford, William L.; Zuber, Johannes; Stark, Alexander; Penninger, Josef M.			Forward and Reverse Genetics through Derivation of Haploid Mouse Embryonic Stem Cells	CELL STEM CELL			English	Article							SELF-RENEWAL; TRANSCRIPTIONAL NETWORKS; EXPRESSION; DIFFERENTIATION; PLURIPOTENCY; COMMITMENT; SCREENS; NUMBER; GENES; LINE	All somatic mammalian cells carry two copies of chromosomes (diploidy), whereas organisms with a single copy of their genome, such as yeast, provide a basis for recessive genetics. Here we report the generation of haploid mouse ESC lines from parthenogenetic embryos. These cells carry 20 chromosomes, express stem cell markers, and develop into all germ layers in vitro and in vivo. We also developed a reversible mutagenesis protocol that allows saturated genetic recessive screens and results in homozygous alleles. This system allowed us to generate a knockout cell line for the microRNA processing enzyme Drosha. In a forward genetic screen, we identified Gpr107 as a molecule essential for killing by ricin, a toxin being used as a bioweapon. Our results open the possibility of combining the power of a haploid genome with pluripotency of embryonic stem cells to uncover fundamental biological processes in defined cell types at a genomic scale.	[Elling, Ulrich; Taubenschmid, Jasmin; Wirnsberger, Gerald; Schmauss, Gerald; Schramek, Daniel; Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria; [O'Malley, Ronan; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; [Demers, Simon-Pierre; Vanhaelen, Quentin; Stanford, William L.] Ottawa Hosp Res Inst, Sprott Ctr Stem Cell Res, Ottawa, ON K1H 8L6, Canada; [Shukalyuk, Andrey I.; Stanford, William L.] Univ Toronto, Toronto, ON M5G 1L5, Canada; [Schnuetgen, Frank; von Melchner, Harald] Goethe Univ Frankfurt, Sch Med, Dept Mol Hematol, D-60590 Frankfurt, Germany; [Stanford, William L.] Inst Syst Biol, Seattle, WA USA; [Ecker, Joseph R.] Howard Hughes Med Inst, Seattle, WA USA; [Zuber, Johannes; Stark, Alexander] Inst Mol Pathol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Salk Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; Goethe University Frankfurt; Institute for Systems Biology (ISB); Howard Hughes Medical Institute; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Penninger, JM (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria.	josef.penninger@imba.oeaw.ac.at	Schnütgen, Frank/ABD-8637-2020; Stark, Alexander/D-1473-2012; Penninger, Josef M/I-6860-2013; Zuber, Johannes/E-7517-2011; Schramek, Daniel/J-5792-2014; Schramek, Daniel/AAL-1470-2020; VANHAELEN, QUENTIN/W-3160-2019; Taubenschmid-Stowers, Jasmin/C-3137-2018; Ecker, Joseph R/B-9144-2008	Schnütgen, Frank/0000-0002-2426-6685; Stark, Alexander/0000-0003-2611-0841; Penninger, Josef M/0000-0002-8194-3777; Zuber, Johannes/0000-0001-8810-6835; Schramek, Daniel/0000-0001-9977-2104; VANHAELEN, QUENTIN/0000-0002-4611-2046; Taubenschmid-Stowers, Jasmin/0000-0003-3377-2026; Ecker, Joseph R/0000-0001-5799-5895; Stanford, William/0000-0002-5813-8016; omalley, ronan/0000-0002-4907-0339	Canadian Institutes for Health Research [MOP-89910]; Canada Research Chair in Integrative Stem Cell Biology; FWF [1434-B13]; European Community [FP7/2007-2013, 223151 - INFLA-CARE, 242922]; European Research Council (ERC); IMBA; Austrian Ministry of Sciences; Austrian Academy of Sciences; GEN-AU (Austro-Mouse); EU ERC; Howard Hughes Medical Institute; Gordon and Betty Moore foundation; Austrian Science Fund (FWF) [I 434] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003523] Funding Source: NIH RePORTER	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Integrative Stem Cell Biology; FWF(Austrian Science Fund (FWF)); European Community(European Commission); European Research Council (ERC)(European Research Council (ERC)European Commission); IMBA; Austrian Ministry of Sciences; Austrian Academy of Sciences; GEN-AU (Austro-Mouse); EU ERC(European Research Council (ERC)European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gordon and Betty Moore foundation(Gordon and Betty Moore Foundation); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We would like to thank all members of our laboratories, in particular Dr. Wing Chang, for helpful discussions. Funding was provided by the Canadian Institutes for Health Research (MOP-89910) to W.L.S. W.L.S. is funded by a Canada Research Chair in Integrative Stem Cell Biology. U.E. was supported by a grant from the FWF (Project 1434-B13). G.W. and D.S. were funded from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 223151 - INFLA-CARE. AS. is supported by a European Research Council (ERC) Starting Grant from the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 242922. J.M.P. is supported by grants from IMBA, the Austrian Ministry of Sciences, and the Austrian Academy of Sciences, GEN-AU (Austro-Mouse), and by an EU ERC Advanced Grant. This work was supported, in part, by the Howard Hughes Medical Institute and a grant from the Gordon and Betty Moore foundation to J.R.E. J.R.E. is an HHMI-GBMP Investigator. We thank B. Zuber for helpful discussions and pathologic examination of teratomas. We are grateful to Thijn Brummelkamp for valuable discussions to establish retrovirus-based genome-wide mutagenesis. We thank all IMBA service units, especially Biooptics, the VBC Genomics unit, and the Transgenic Service, for technical support with this project. The ricin hits are currently being evaluated for patent protection.	Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bryja V, 2006, NAT PROTOC, V1, P2082, DOI 10.1038/nprot.2006.355; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Carpenter AE, 2004, NAT REV GENET, V5, P11, DOI 10.1038/nrg1248; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Elling U, 2006, P NATL ACAD SCI USA, V103, P16319, DOI 10.1073/pnas.0607884103; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; HARTWELL LH, 1974, SCIENCE, V183, P46, DOI 10.1126/science.183.4120.46; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; KAUFMAN MH, 1983, J EMBRYOL EXP MORPH, V73, P249; Kotecki M, 1999, EXP CELL RES, V252, P273, DOI 10.1006/excr.1999.4656; Latham KE, 2002, BIOL REPROD, V67, P386, DOI 10.1095/biolreprod67.2.386; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Otto SP, 2001, SCIENCE, V292, P2441, DOI 10.1126/science.1062890; Papaloucas M, 2008, Pak J Biol Sci, V11, P2370, DOI 10.3923/pjbs.2008.2370.2371; Pollard SM, 2006, METHOD ENZYMOL, V418, P151, DOI 10.1016/S0076-6879(06)18010-6; ROBERTSON E, 1986, NATURE, V323, P445, DOI 10.1038/323445a0; Schnuetgen F, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn603; SOUDAIS C, 1995, DEVELOPMENT, V121, P3877; Spooner RA, 2012, CURR TOP MICROBIOL, V357, P19, DOI 10.1007/82_2011_154; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; THOMSON JA, 1988, GENE DEV, V2, P1344, DOI 10.1101/gad.2.10.1344; Walker E, 2007, CELL STEM CELL, V1, P71, DOI 10.1016/j.stem.2007.04.002; Walker E, 2010, CELL STEM CELL, V6, P153, DOI 10.1016/j.stem.2009.12.014; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Yan H, 2000, NATURE, V403, P723, DOI 10.1038/35001659; Yi MS, 2009, SCIENCE, V326, P430, DOI 10.1126/science.1175151; Zhang KJ, 2010, DEVELOPMENT, V137, P2095, DOI 10.1242/dev.049494	34	174	202	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 2	2011	9	6					563	574		10.1016/j.stem.2011.10.012	http://dx.doi.org/10.1016/j.stem.2011.10.012			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	859SB	22136931	Green Accepted, Bronze			2022-12-28	WOS:000297895000016
J	Biteau, B; Hochmuth, CE; Jasper, H				Biteau, Benoit; Hochmuth, Christine E.; Jasper, Heinrich			Maintaining Tissue Homeostasis: Dynamic Control of Somatic Stem Cell Activity	CELL STEM CELL			English	Review							CONTROLS SELF-RENEWAL; INTESTINAL REGENERATION; BACTERIAL-INFECTION; DROSOPHILA MIDGUT; PROGENITOR CELLS; DUAL OXIDASE; NOTCH; PROLIFERATION; PATHWAY; DIFFERENTIATION	Long-term maintenance of tissue homeostasis relies on the accurate regulation of somatic stem cell activity. Somatic stem cells have to respond to tissue damage and proliferate according to tissue requirements while avoiding overproliferation. The regulatory mechanisms involved in these responses are now being unraveled in the intestinal epithelium of Drosophila, providing new insight into strategies and mechanisms of stem cell regulation in barrier epithelia. Here, we review these studies and highlight recent findings in vertebrate epithelia that indicate significant conservation of regenerative strategies between vertebrate and fly epithelia.	[Biteau, Benoit; Hochmuth, Christine E.; Jasper, Heinrich] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	University of Rochester	Jasper, H (corresponding author), Univ Rochester, Dept Biol, River Campus Box 270211, Rochester, NY 14627 USA.	henri_jasper@urmc.rochester.edu			National Institute on Aging (NIH) [RO1 AG028127]; NYSTEM [N08G-048]; Ellison Medical Foundation [AG-SS-2224-08]; AFAR/Ellison Medical Foundation; NATIONAL EYE INSTITUTE [R01EY018177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028127] Funding Source: NIH RePORTER	National Institute on Aging (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NYSTEM; Ellison Medical Foundation(Lawrence Ellison Foundation); AFAR/Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute on Aging (NIH RO1 AG028127), NYSTEM (grant # N08G-048), and the Ellison Medical Foundation (AG-SS-2224-08) to H.J., as well as an AFAR/Ellison Medical Foundation post-doctoral fellowship to B.B.	Abou-Khalil R, 2010, CELL CYCLE, V9, P2575, DOI 10.4161/cc.9.13.12149; Aguirre A, 2010, NATURE, V467, P323, DOI 10.1038/nature09347; Amcheslavsky A, 2011, J CELL BIOL, V193, P695, DOI 10.1083/jcb.201103018; Amcheslavsky A, 2009, CELL STEM CELL, V4, P49, DOI 10.1016/j.stem.2008.10.016; Apidianakis Y, 2009, P NATL ACAD SCI USA, V106, P20883, DOI 10.1073/pnas.0911797106; Ashton GH, 2010, DEV CELL, V19, P259, DOI 10.1016/j.devcel.2010.07.015; Bardin AJ, 2010, DEVELOPMENT, V137, P705, DOI 10.1242/dev.039404; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Beebe K, 2010, DEV BIOL, V338, P28, DOI 10.1016/j.ydbio.2009.10.045; Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024; Biteau B, 2011, DEVELOPMENT, V138, P1045, DOI 10.1242/dev.056671; Biteau B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001159; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Buchon N, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-152; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Casali A, 2009, CELL STEM CELL, V4, P124, DOI 10.1016/j.stem.2009.01.009; Chatterjee M, 2009, J CELL PHYSIOL, V220, P664, DOI 10.1002/jcp.21808; Choi NH, 2008, AGING CELL, V7, P318, DOI 10.1111/j.1474-9726.2008.00380.x; Ciapponi L, 2001, GENE DEV, V15, P1540, DOI 10.1101/gad.886301; Cordero J, 2009, CELL CYCLE, V8, P2926; Cronin SJF, 2009, SCIENCE, V325, P340, DOI 10.1126/science.1173164; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; Deneault E, 2009, CELL, V137, P369, DOI 10.1016/j.cell.2009.03.026; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Fox DT, 2009, CELL STEM CELL, V5, P290, DOI 10.1016/j.stem.2009.06.003; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Gonczy P, 1996, DEVELOPMENT, V122, P2437; Griffin R, 2009, NAT METHODS, V6, P600, DOI 10.1038/nmeth.1349; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Hochmuth CE, 2011, CELL STEM CELL, V8, P188, DOI 10.1016/j.stem.2010.12.006; Hou SX, 2010, J CELL PHYSIOL, V224, P581, DOI 10.1002/jcp.22194; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Jiang HQ, 2011, CELL STEM CELL, V8, P84, DOI 10.1016/j.stem.2010.11.026; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Karpac J, 2011, DEV CELL, V20, P841, DOI 10.1016/j.devcel.2011.05.011; Karpowicz P, 2010, DEVELOPMENT, V137, P4135, DOI 10.1242/dev.060483; Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010; Lapouge G, 2011, P NATL ACAD SCI USA, V108, P7431, DOI 10.1073/pnas.1012720108; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee WC, 2009, DEVELOPMENT, V136, P2255, DOI 10.1242/dev.035196; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lin GN, 2008, NATURE, V455, P1119, DOI 10.1038/nature07329; Lin GN, 2010, J MOL CELL BIOL, V2, P37, DOI 10.1093/jmcb/mjp028; Liu JN, 2010, CURR TOP DEV BIOL, V92, P367, DOI [10.1016/S0070-2153(10)92012-7, 10.1016/S0070-2153(10)91012-7]; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Liu W, 2010, J CELL BIOCHEM, V109, P992, DOI 10.1002/jcb.22482; Liu XY, 2010, FEBS LETT, V584, P911, DOI 10.1016/j.febslet.2010.01.024; Maeda K, 2008, GENES CELLS, V13, P1219, DOI 10.1111/j.1365-2443.2008.01239.x; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; McLeod CJ, 2010, CURR BIOL, V20, P2100, DOI 10.1016/j.cub.2010.10.038; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Miyamoto K, 2008, BLOOD, V112, P4485, DOI 10.1182/blood-2008-05-159848; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Park JS, 2009, AGING-US, V1, P637, DOI 10.18632/aging.100054; Quyn AJ, 2010, CELL STEM CELL, V6, P175, DOI 10.1016/j.stem.2009.12.007; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Ren FF, 2010, P NATL ACAD SCI USA, V107, P21064, DOI 10.1073/pnas.1012759107; Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040; Rock JR, 2011, CELL STEM CELL, V8, P639, DOI 10.1016/j.stem.2011.04.003; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Saleh M, 2011, IMMUNITY, V34, P293, DOI 10.1016/j.immuni.2011.03.008; Sancho R, 2009, EMBO J, V28, P1843, DOI 10.1038/emboj.2009.153; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Seno H, 2009, P NATL ACAD SCI USA, V106, P256, DOI 10.1073/pnas.0803343106; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Shaw RL, 2010, DEVELOPMENT, V137, P4147, DOI 10.1242/dev.052506; Shea KL, 2010, CELL STEM CELL, V6, P117, DOI 10.1016/j.stem.2009.12.015; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Singh SR, 2007, CELL STEM CELL, V1, P191, DOI 10.1016/j.stem.2007.07.003; Slaidina M, 2009, DEV CELL, V17, P874, DOI 10.1016/j.devcel.2009.10.009; Smith J, 2000, P NATL ACAD SCI USA, V97, P10032, DOI 10.1073/pnas.170209797; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Staley BK, 2010, CURR BIOL, V20, P1580, DOI 10.1016/j.cub.2010.07.041; Takashima S, 2008, NATURE, V454, P651, DOI 10.1038/nature07156; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Tothova Z, 2007, CELL STEM CELL, V1, P140, DOI 10.1016/j.stem.2007.07.017; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tsatmali M, 2005, BRAIN RES, V1040, P137, DOI 10.1016/j.brainres.2005.01.087; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; White AC, 2011, P NATL ACAD SCI USA, V108, P7425, DOI 10.1073/pnas.1012670108; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Xu N, 2011, DEV BIOL, V354, P31, DOI 10.1016/j.ydbio.2011.03.018; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; Yu HH, 2009, NAT NEUROSCI, V12, P947, DOI 10.1038/nn.2345	107	202	206	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 4	2011	9	5					402	411		10.1016/j.stem.2011.10.004	http://dx.doi.org/10.1016/j.stem.2011.10.004			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	850FJ	22056138	Bronze, Green Accepted			2022-12-28	WOS:000297180200008
J	Cimmino, L; Abdel-Wahab, O; Levine, RL; Aifantis, I				Cimmino, Luisa; Abdel-Wahab, Omar; Levine, Ross L.; Aifantis, Iannis			TET Family Proteins and Their Role in Stem Cell Differentiation and Transformation	CELL STEM CELL			English	Review							ACTIVE DNA DEMETHYLATION; ACUTE MYELOID-LEUKEMIA; PRIMORDIAL GERM-CELLS; CYTIDINE DEAMINASE AID; BASE EXCISION-REPAIR; SELF-RENEWAL; MYELODYSPLASTIC SYNDROMES; PATERNAL GENOME; GENE-EXPRESSION; IDH2 MUTATIONS	One of the main regulators of gene expression during embryogenesis and stem cell differentiation is DNA methylaton. The recent identification of hydroxymethylcytosine (5hmC) as a novel epigenetic mark sparked an intense effort to characterize its specialized enzymatic machinery and to understand the biological significance of 5hmC. The recent discovery of recurrent deletions and somatic mutations in the TET gene family, which includes proteins that can hydroxylate methylcytosine (5mC), in a large fraction of myeloid malignancies further suggested a key role for dynamic DNA methylation changes in the regulation of stem cell differentiation and transformation.	[Cimmino, Luisa; Aifantis, Iannis] New York Univ Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Cimmino, Luisa; Aifantis, Iannis] New York Univ Sch Med, Dept Pathol, New York, NY 10016 USA; [Abdel-Wahab, Omar; Levine, Ross L.] Mem Sloan Kettering Canc, Human Oncol & Pathogenesis Program, New York, NY 10016 USA; [Abdel-Wahab, Omar; Levine, Ross L.] Mem Sloan Kettering Canc, Dept Med, Leukemia Serv, New York, NY 10016 USA	Howard Hughes Medical Institute; New York University; New York University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Aifantis, I (corresponding author), New York Univ Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA.	iannis.aifantis@nyumc.org	levine, ross/AAE-7658-2019	Abdel-Wahab, Omar/0000-0002-3907-6171	National Institutes of Health [RO1CA133379, RO1CA105129, R21CA141399, RO1CA149655, RO1GM088847, 1R01CA138234-01]; Leukemia & Lymphoma Society; American Cancer Society [RSG0806801]; V Foundation for Cancer Research; Irma T. Hirschl Trust; Chemotherapy Foundation; Dana Foundation; Alex's Lemonade Stand Foundation; NHMRC; National Institutes of Health (Physical Sciences Oncology Center) [U54CA143798-01]; Starr Cancer Consortium; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA105129, R01CA138234, R01CA133379, U54CA143798, R01CA149655, R21CA141399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088847] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); American Cancer Society(American Cancer Society); V Foundation for Cancer Research; Irma T. Hirschl Trust; Chemotherapy Foundation; Dana Foundation; Alex's Lemonade Stand Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health (Physical Sciences Oncology Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Starr Cancer Consortium; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank the members of the Aifantis and Levine labs for critical reading of the manuscript. I.A. is supported by the National Institutes of Health (RO1CA133379, RO1CA105129, R21CA141399, RO1CA149655, and RO1GM088847), the Leukemia & Lymphoma Society (TRP grant), the American Cancer Society (RSG0806801), the V Foundation for Cancer Research, the Irma T. Hirschl Trust, the Chemotherapy Foundation, the Dana Foundation, and the Alex's Lemonade Stand Foundation. L.C. is supported by a NHMRC biomedical research fellowship. O.A.W. is a Basic Research Fellow of the American Society of Hematology. This work was supported in part by grants from the National Institutes of Health (U54CA143798-01, Physical Sciences Oncology Center) and 1R01CA138234-01 to R.L.L., and by grants from the Starr Cancer Consortium and Howard Hughes Medical Institute to R.L.L. R.L.L. is a Geoffrey Beene Junior Faculty Chair at Memorial Sloan Kettering Cancer Center. I.A. is a Howard Hughes Medical Institute Early Career Scientist.	Abdel-Wahab O, 2010, CANCER RES, V70, P447, DOI 10.1158/0008-5472.CAN-09-3783; Abdel-Wahab O, 2009, BLOOD, V114, P144, DOI 10.1182/blood-2009-03-210039; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; Bhattacharya SK, 1999, NATURE, V397, P579, DOI 10.1038/17533; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Gehring M, 2009, TRENDS GENET, V25, P82, DOI 10.1016/j.tig.2008.12.001; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; HE YF, 2011, SCIENCE IN PRESS, DOI DOI 10.1126/SCIENCE.1210944; ITO S, 2011, SCIENCE IN PRESS, DOI DOI 10.1126/SCIENCE.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; Jankowska AM, 2009, BLOOD, V113, P6403, DOI 10.1182/blood-2009-02-205690; Jiang Y, 2009, BLOOD, V113, P1315, DOI 10.1182/blood-2008-06-163246; Jin SG, 2011, NUCLEIC ACIDS RES, V39, P5015, DOI 10.1093/nar/gkr120; Khachatryan V, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.011801; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kosmider O, 2011, HAEMATOL-HEMATOL J, V96, P1059, DOI 10.3324/haematol.2011.040840; Kosmider O, 2009, HAEMATOL-HEMATOL J, V94, P1676, DOI 10.3324/haematol.2009.011205; Kosmider O, 2009, BLOOD, V114, P3285, DOI 10.1182/blood-2009-04-215814; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Lee J, 2002, DEVELOPMENT, V129, P1807; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI Z, 2011, BLOOD IN PRESS, DOI DOI 10.1182/BLOOD-2010-12-325241; Lorsbach RB, 2003, LEUKEMIA, V17, P637, DOI 10.1038/sj.leu.2402834; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Marcucci G, 2010, J CLIN ONCOL, V28, P2348, DOI 10.1200/JCO.2009.27.3730; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Metzeler KH, 2011, J CLIN ONCOL, V29, P1373, DOI 10.1200/JCO.2010.32.7742; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Munzel M, 2010, ANGEW CHEM INT EDIT, V49, P5375, DOI 10.1002/anie.201002033; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nibourel O, 2010, BLOOD, V116, P1132, DOI 10.1182/blood-2009-07-234484; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ono R, 2002, CANCER RES, V62, P4075; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; PENN NW, 1972, BIOCHEM J, V126, P781, DOI 10.1042/bj1260781; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; PRONIER E, 2011, BLOOD IN PRESS, DOI DOI 10.1182/BLOOD-2010-12-324707; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Robertson J, 2011, BIOCHEM BIOPH RES CO, V411, P40, DOI 10.1016/j.bbrc.2011.06.077; Schmitz KM, 2009, MOL CELL, V33, P344, DOI 10.1016/j.molcel.2009.01.015; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Stroud H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r54; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tefferi A, 2009, LEUKEMIA, V23, P905, DOI 10.1038/leu.2009.47; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Valinluck V, 2007, CANCER RES, V67, P946, DOI 10.1158/0008-5472.CAN-06-3123; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Witkowski A, 2009, EUR HEART J, V30, P1736, DOI 10.1093/eurheartj/ehp114; Wu H, 2011, CELL CYCLE, V10, P2428, DOI 10.4161/cc.10.15.16930; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zhang HK, 2010, CELL RES, V20, P1390, DOI 10.1038/cr.2010.156; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205	81	174	184	2	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	SEP 2	2011	9	3					193	204		10.1016/j.stem.2011.08.007	http://dx.doi.org/10.1016/j.stem.2011.08.007			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	822DN	21885017	Green Accepted, Bronze			2022-12-28	WOS:000295024200007
J	Zou, P; Yoshihara, H; Hosokawa, K; Tai, I; Shinmyozu, K; Tsukahara, F; Maru, Y; Nakayama, K; Nakayama, KI; Suda, T				Zou, Peng; Yoshihara, Hiroki; Hosokawa, Kentaro; Tai, Ikue; Shinmyozu, Kaori; Tsukahara, Fujiko; Maru, Yoshiro; Nakayama, Keiko; Nakayama, Keiichi I.; Suda, Toshio			p57(KiP2) and p27(Kip1) Cooperate to Maintain Hematopoietic Stem Cell Quiescence through Interactions with Hsc70	CELL STEM CELL			English	Article							SHOCK COGNATE PROTEIN-70; BONE-MARROW NICHE; CYCLIN D1; NUCLEAR-LOCALIZATION; UP-REGULATION; EXPRESSION; LEUKEMIA; FAMILY; GROWTH; ROLES	Cell cycle regulators play critical roles in the balance between hematopoietic stem cell (HSC) dormancy and proliferation. In this study, we report that cell cycle entry proceeded normally in HSCs null for cyclin-dependent kinase (CDK) inhibitor p57 due to compensatory upregulation of p27. HSCs null for both p57 and p27, however, were more proliferative and had reduced capacity to engraft in transplantation. We found that heat shock cognate protein 70 (Hsc70) interacts with both p57 and p27 and that the subcellular localization of Hsc70 was critical to maintain HSC cell cycle kinetics. Combined deficiency of p57 and p27 in HSCs resulted in nuclear import of an Hsc70/cyclin D1 complex, concomitant with Rb phosphorylation, and elicited severe defects in maintaining HSC quiescence. Taken together, these data suggest that regulation of cytoplasmic localization of Hsc70/cyclin D1 complex by p57 and p27 is a key intracellular mechanism in controlling HSC dormancy.	[Zou, Peng; Yoshihara, Hiroki; Hosokawa, Kentaro; Tai, Ikue; Suda, Toshio] Keio Univ Sch Med, Sakaguchi Lab Dev Biol, Dept Cell Differentiat, Shinjuku Ku, Tokyo 1608582, Japan; [Shinmyozu, Kaori] RIKEN Ctr Dev Biol, Prote Support Unit, Kobe, Hyogo 6500047, Japan; [Tsukahara, Fujiko; Maru, Yoshiro] Tokyo Womens Med Univ Sch Med, Dept Pharmacol, Shinjuku Ku, Tokyo 1628666, Japan; [Nakayama, Keiko] Tohoku Univ, Grad Sch Med, Ctr Translat & Adv Anim Res, Dept Dev Genet, Sendai, Miyagi 9808575, Japan; [Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Fukuoka 8128582, Japan	Keio University; RIKEN; Tohoku University; Kyushu University	Zou, P (corresponding author), Keio Univ Sch Med, Sakaguchi Lab Dev Biol, Dept Cell Differentiat, Shinjuku Ku, Tokyo 1608582, Japan.	zoupeng@sc.itc.heio.ac.jp; sudato@sc.itc.keio.ac.jp	Suda, Toshio/H-6761-2013	Suda, Toshio/0000-0001-7540-1771; Yoshihara, Hiroki/0000-0001-5128-4515	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Keio University; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [22790920, 23590309, 22130004] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Keio University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Cancer Stem Cells" from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, the Global COE program "Education and Research Center for Stem Cell Medicine" of Keio University, and a Grant-in-Aid for Japan Society for the Promotion of Science Fellows.	Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Baharvand H, 2007, STEM CELLS, V25, P1888, DOI 10.1634/stemcells.2007-0107; Bilodeau S, 2009, MOL CELL BIOL, V29, P1895, DOI 10.1128/MCB.01885-08; Cheng T, 2000, NAT MED, V6, P1235, DOI 10.1038/81335; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Diehl JA, 2003, MOL CELL BIOL, V23, P1764, DOI 10.1128/MCB.23.5.1764-1774.2003; Hosokawa K, 2010, CELL STEM CELL, V6, P194, DOI 10.1016/j.stem.2009.04.013; Imamura Y, 2009, J BIOL CHEM, V284, P14316, DOI 10.1074/jbc.M807278200; Iwasaki H, 2010, BLOOD, V116, P544, DOI 10.1182/blood-2009-08-240903; Jose-Eneriz ES, 2008, BRIT J HAEMATOL, V142, P571, DOI 10.1111/j.1365-2141.2008.07221.x; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Matsui H, 2007, MOL CELL, V25, P99, DOI 10.1016/j.molcel.2006.12.007; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; NADLER SG, 1992, SCIENCE, V258, P484, DOI 10.1126/science.1411548; Oguro H, 2006, J EXP MED, V203, P2247, DOI 10.1084/jem.20052477; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Pateras IS, 2009, MOL CANCER RES, V7, P1902, DOI 10.1158/1541-7786.MCR-09-0317; Pocaly M, 2008, PROTEOMICS, V8, P2394, DOI 10.1002/pmic.200701035; Radu A, 2003, MOL CELL BIOL, V23, P6139, DOI 10.1128/MCB.23.17.6139-6149.2003; Ribeil JA, 2007, NATURE, V445, P102, DOI 10.1038/nature05378; Sadaie M, 2008, J BIOL CHEM, V283, P7185, DOI 10.1074/jbc.M709429200; Scandura JM, 2004, P NATL ACAD SCI USA, V101, P15231, DOI 10.1073/pnas.0406771101; Susaki E, 2009, P NATL ACAD SCI USA, V106, P5192, DOI 10.1073/pnas.0811712106; Tamamori-Adachi M, 2003, CIRC RES, V92, pE12, DOI 10.1161/01.RES.0000049105.15329.1C; Tsukahara F, 2004, J BIOL CHEM, V279, P8867, DOI 10.1074/jbc.M308848200; Viatour P, 2008, CELL STEM CELL, V3, P416, DOI 10.1016/j.stem.2008.07.009; Yamamoto M, 2006, MOL CARCINOGEN, V45, P901, DOI 10.1002/mc.20204; Yamazaki S, 2006, EMBO J, V25, P3515, DOI 10.1038/sj.emboj.7601236; Yamazaki S, 2009, BLOOD, V113, P1250, DOI 10.1182/blood-2008-04-146480; Ye ZJ, 2005, P NATL ACAD SCI USA, V102, P18461, DOI 10.1073/pnas.0509314102; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhang PM, 1998, GENE DEV, V12, P3162, DOI 10.1101/gad.12.20.3162	38	198	200	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	SEP 2	2011	9	3					247	261		10.1016/j.stem.2011.07.003	http://dx.doi.org/10.1016/j.stem.2011.07.003			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	822DN	21885020	Bronze			2022-12-28	WOS:000295024200011
J	Brownell, I; Guevara, E; Bai, CB; Loomis, CA; Joyner, AL				Brownell, Isaac; Guevara, Elizabeth; Bai, C. Brian; Loomis, Cynthia A.; Joyner, Alexandra L.			Nerve-Derived Sonic Hedgehog Defines a Niche for Hair Follicle Stem Cells Capable of Becoming Epidermal Stem Cells	CELL STEM CELL			English	Article							MAMMALIAN EPIDERMIS; PROGENITOR CELLS; INDIAN HEDGEHOG; BETA-CATENIN; SKIN; MORPHOGENESIS; INNERVATION; ACTIVATION; RENEWAL; CYCLE	In adult skin, stem cells in the hair follicle bulge cyclically regenerate the follicle, whereas a distinct stem cell population maintains the epidermis. The degree to which all bulge cells have equal regenerative potential is not known. We found that Sonic hedgehog (Shh) from neurons signals to a population of cells in the telogen bulge marked by the Hedgehog response gene Gli1. Gli1-expressing bulge cells function as multipotent stem cells in their native environment and repeatedly regenerate the anagen follicle. Shh-responding perineural bulge cells incorporate into healing skin wounds where, notably, they can change their lineage into epidermal stem cells. The perineural niche (including Shh) is dispensable for follicle contributions to acute wound healing and skin homeostasis, but is necessary to maintain bulge cells capable of becoming epidermal stem cells. Thus, nerves cultivate a microenvironment where Shh creates a molecularly and phenotypically distinct population of hair follicle stem cells.	[Brownell, Isaac; Guevara, Elizabeth; Joyner, Alexandra L.] Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA; [Brownell, Isaac] Mem Sloan Kettering Canc Ctr, Dermatol Serv, New York, NY 10065 USA; [Bai, C. Brian; Joyner, Alexandra L.] NYU, Sch Med, Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA; [Loomis, Cynthia A.] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; New York University; New York University	Joyner, AL (corresponding author), Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA.	joynera@mskcc.org	Brownell, Isaac/Q-1937-2018		NIH [R01CA128158, F32AR55435]; Tr-Institutional Stem Cell Initiative; Dermatology Foundation; Charles A. Dana Foundation; NATIONAL CANCER INSTITUTE [R01CA128158, ZIABC011393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR055435] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tr-Institutional Stem Cell Initiative; Dermatology Foundation; Charles A. Dana Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank A. Patel, R. Turnbull, D. Stephen, and J. Chan for technical assistance. We thank M. Hassimi and Y. "Jeffrey" Zhao of the MSKCC Genomics Core Laboratory for microarray data analysis, support, and training. We thank Dr. R. Boyd for the anti-MTS24 antibody, Dr. M. Wegner for the anti-Sox9 antibody, Dr. L. Reichardt for the anti-TrkA antibody, and Dr. T. Jessell for the anti-Runx1 and anti-Runx3 antibodies. This work was supported by NIH grant R01CA128158 and the Tr-Institutional Stem Cell Initiative (to A.L.J.); and by NIH grant F32AR55435, the Dermatology Foundation, and the Charles A. Dana Foundation (to I.B.).	Adolphe C, 2004, DEVELOPMENT, V131, P5009, DOI 10.1242/dev.01367; Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Bai CB, 2002, DEVELOPMENT, V129, P4753; Bai CYB, 2001, DEVELOPMENT, V128, P5161; Balordi F, 2007, J NEUROSCI, V27, P5936, DOI 10.1523/JNEUROSCI.1040-07.2007; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Bonfanti P, 2010, NATURE, V466, P978, DOI 10.1038/nature09269; Botchkarev VA, 1997, J COMP NEUROL, V386, P379, DOI 10.1002/(SICI)1096-9861(19970929)386:3<379::AID-CNE4>3.0.CO;2-Z; Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; Fan HR, 1999, J CELL BIOL, V147, P71, DOI 10.1083/jcb.147.1.71; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Garcia ADR, 2010, J NEUROSCI, V30, P13597, DOI 10.1523/JNEUROSCI.0830-10.2010; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Greco V, 2010, DEVELOPMENT, V137, P1585, DOI 10.1242/dev.041103; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jensen KB, 2010, NAT PROTOC, V5, P898, DOI 10.1038/nprot.2010.39; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Joyner AL, 2006, DEV DYNAM, V235, P2376, DOI 10.1002/dvdy.20884; Knox SM, 2010, SCIENCE, V329, P1645, DOI 10.1126/science.1192046; Legue E, 2005, DEVELOPMENT, V132, P4143, DOI 10.1242/dev.01975; Levy V, 2007, FASEB J, V21, P1358, DOI 10.1096/fj.06-6926com; Maurer M, 1998, ARCH DERMATOL RES, V290, P574, DOI 10.1007/s004030050354; Mill P, 2003, GENE DEV, V17, P282, DOI 10.1101/gad.1038103; MORRIS RJ, 1994, CELL PROLIFERAT, V27, P279, DOI 10.1111/j.1365-2184.1994.tb01425.x; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Niemann C, 2003, P NATL ACAD SCI USA, V100, P11873, DOI 10.1073/pnas.1834202100; Nijhof JGW, 2006, DEVELOPMENT, V133, P3027, DOI 10.1242/dev.02443; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Oro AE, 2003, DEV BIOL, V255, P238, DOI 10.1016/S0012-1606(02)00042-8; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Peters EMJ, 2002, J COMP NEUROL, V448, P28, DOI 10.1002/cne.10212; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Sharghi-Namini S, 2006, J NEUROSCI, V26, P6364, DOI 10.1523/JNEUROSCI.0157-06.2006; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wallace VA, 1999, DEVELOPMENT, V126, P2901; Wang LC, 2000, J INVEST DERMATOL, V114, P901, DOI 10.1046/j.1523-1747.2000.00951.x; Watt FM, 2009, EMBO MOL MED, V1, P260, DOI 10.1002/emmm.200900033	53	308	313	1	43	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAY 6	2011	8	5					552	565		10.1016/j.stem.2011.02.021	http://dx.doi.org/10.1016/j.stem.2011.02.021			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	768IN	21549329	Bronze, Green Accepted			2022-12-28	WOS:000290927600015
J	Bass, AJ; Wang, TC				Bass, Adam J.; Wang, Timothy C.			An Inflammatory Situation: SOX2 and STAT3 Cooperate in Squamous Cell Carcinoma Initiation	CELL STEM CELL			English	Editorial Material							SURVIVAL; ROLES; MICE; STEM	Although SOX2 has been identified as a squamous cell carcinoma oncogene, mechanisms of SOX2-induce oncogenesis have remained elusive. In this issue of Cell Stem Cell, Li et al. (2013) show that SOX2 synergizes with inflammation-induced STAT3 activation to transform basal progenitors and initiate squamous cell carcinoma.	[Bass, Adam J.] Dana Farber Canc Inst, Div Mol & Cellular Oncol, Boston, MA 02215 USA; [Bass, Adam J.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Bass, Adam J.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Bass, Adam J.] Broad Inst, Cambridge, MA 02142 USA; [Wang, Timothy C.] Columbia Univ Coll Phys & Surg, Div Digest & Liver Dis, New York, NY 10032 USA; [Wang, Timothy C.] Columbia Univ Coll Phys & Surg, Herbert Irving Canc Res Ctr, New York, NY 10032 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Columbia University; Columbia University	Wang, TC (corresponding author), Columbia Univ Coll Phys & Surg, Div Digest & Liver Dis, New York, NY 10032 USA.	tcw21@columbia.edu		Wang, Timothy/0000-0001-5730-3019	NCI NIH HHS [U54 CA163004] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Doupe DP, 2012, SCIENCE, V337, P1091, DOI 10.1126/science.1218835; Liu KC, 2013, CELL STEM CELL, V12, P304, DOI 10.1016/j.stem.2013.01.007; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; Que JW, 2009, DEVELOPMENT, V136, P1899, DOI 10.1242/dev.034629; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011	9	12	14	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 7	2013	12	3					266	268		10.1016/j.stem.2013.02.004	http://dx.doi.org/10.1016/j.stem.2013.02.004			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VC	23472866	Bronze			2022-12-28	WOS:000329569400002
J	Haimes, E; Skene, L; Ballantyne, AJ; Caulfield, T; Goldstein, LS; Hyun, I; Kimmelman, J; Robert, JS; Roxland, BE; Scott, CT; Solbakk, JH; Sugarman, J; Taylor, PL; Testa, G				Haimes, Erica; Skene, Loane; Ballantyne, Angela J.; Caulfield, Timothy; Goldstein, Lawrence S.; Hyun, Insoo; Kimmelman, Jonathan; Robert, Jason S.; Roxland, Beth E.; Scott, Christopher T.; Solbakk, Jan Helge; Sugarman, Jeremy; Taylor, Patrick L.; Testa, Giuseppe			Position Statement on the Provision and Procurement of Human Eggs for Stem Cell Research	CELL STEM CELL			English	Editorial Material							FRESH EMBRYO DONATION; NUCLEAR TRANSFER; OOCYTES; COMPENSATION	The nature of compensation for women who donate eggs (oocytes) for research remains a contentious issue internationally. This position paper lays out the arguments for, and discusses the arrangements in which, a modest payment might be ethically justifiable.	[Haimes, Erica] Newcastle Univ, PEALS Policy Eth & Life Sci Res Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Skene, Loane] Univ Melbourne, Melbourne Law Sch, Melbourne, Vic 3010, Australia; [Ballantyne, Angela J.] Wellington Sch Med & Hlth Sci, Wellington 6242, New Zealand; [Caulfield, Timothy] Univ Alberta, Fac Law, Hlth Law Inst, Edmonton, AB T6G 2H5, Canada; [Caulfield, Timothy] Univ Alberta, Sch Publ Hlth, Edmonton, AB T6G 2H5, Canada; [Goldstein, Lawrence S.] Univ Calif San Diego, Sch Med, Sanford Consortium Regenerat Med, La Jolla, CA 92093 USA; [Hyun, Insoo] Case Western Reserve Univ, Sch Med, Dept Bioeth, Cleveland, OH 44106 USA; [Kimmelman, Jonathan] McGill Univ, Biomed Eth Unit, Montreal, PQ H3A 0G4, Canada; [Robert, Jason S.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA; [Scott, Christopher T.] Ctr Biomed Eth, Stanford Program Stem Cells Soc, Palo Alto, CA 94304 USA; [Solbakk, Jan Helge] Univ Oslo, Inst Hlth & Soc, Fac Med, Ctr Med Eth, NO-0316 Oslo, Norway; [Sugarman, Jeremy] Johns Hopkins Univ, Johns Hopkins Berman Inst Bioeth, Baltimore, MD 21218 USA; [Taylor, Patrick L.] Harvard Univ, Sch Law, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Boston, MA 02138 USA; [Testa, Giuseppe] European Inst Oncol, I-20139 Milan, Italy	Newcastle University - UK; University of Melbourne; University of Otago; University of Alberta; University of Alberta; University of California System; University of California San Diego; Case Western Reserve University; McGill University; Arizona State University; Arizona State University-Tempe; University of Oslo; Johns Hopkins University; Harvard University; IRCCS European Institute of Oncology (IEO)	Haimes, E (corresponding author), Newcastle Univ, PEALS Policy Eth & Life Sci Res Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	erica.haimes@newcastle.ac.uk	Ballantyne, Angela/AAN-1757-2020	Ballantyne, Angela/0000-0003-2666-9557; Testa, Giuseppe/0000-0002-9104-0918; Sugarman, Jeremy/0000-0001-7022-8332; Robert, Jason/0000-0002-5346-0575	MRC [G0701109] Funding Source: UKRI; Medical Research Council [G0701109] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BALLANTYNE A, 2008, INT J FEM APPROACHES, V1, P145; Caulfield T, 2012, EMBO REP, V13, P12, DOI 10.1038/embor.2011.232; Choudhary M, 2012, CELL STEM CELL, V10, P239, DOI 10.1016/j.stem.2012.02.001; Daley GQ, 2007, SCIENCE, V315, P603, DOI 10.1126/science.1139337; Egli D, 2011, CELL STEM CELL, V9, P293, DOI 10.1016/j.stem.2011.08.002; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Haimes E, 2009, HUM REPROD, V24, P2142, DOI 10.1093/humrep/dep124; Haimes E, 2012, SOCIOL HEALTH ILL, V34, P1199, DOI 10.1111/j.1467-9566.2012.01467.x; Haimes E, 2011, BIOETHICS, V25, P334, DOI 10.1111/j.1467-8519.2009.01792.x; Haimes E, 2011, CELL STEM CELL, V8, P613, DOI 10.1016/j.stem.2011.05.005; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Hyun I, 2006, NATURE, V442, P629, DOI 10.1038/442629a; Isasi RM, 2007, STEM CELL RES, V1, P37, DOI 10.1016/j.scr.2007.09.003; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim K, 2007, CELL STEM CELL, V1, P346, DOI 10.1016/j.stem.2007.07.001; London AJ, 2010, SCIENCE, V328, P829, DOI 10.1126/science.1189369; Noggle S, 2011, NATURE, V478, P70, DOI 10.1038/nature10397; Nuffield Council on Bioethics, 2011, HUM BOD DON MED RES; Revazova ES, 2007, CLONING STEM CELLS, V9, P432, DOI 10.1089/clo.2007.0033; Roxland BE, 2012, REGEN MED, V7, P397, DOI [10.2217/rme.12.20, 10.2217/RME.12.20]; Skene L., 2009, MONASH BIOETHICS REV, V28, P281; SKENE L, 2010, IND J GLOBAL LEGAL S, V17, P211; Stojkovic M, 2005, REPROD BIOMED ONLINE, V11, P226; Waldby C, 2008, NEW GENET SOC, V27, P19, DOI 10.1080/14636770701843576; Widdows H., 2009, INT J FEM APPROACHES, V2, P5	25	8	8	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 7	2013	12	3					285	291		10.1016/j.stem.2013.02.002	http://dx.doi.org/10.1016/j.stem.2013.02.002			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VC	23472870	Green Submitted, Bronze			2022-12-28	WOS:000329569400006
J	de Laval, B; Pawlikowska, P; Petit-Cocault, L; Bilhou-Nabera, C; Aubin-Houzelstein, G; Souyri, M; Pouzoulet, F; Gaudry, M; Porteu, F				de Laval, Berengere; Pawlikowska, Patrycja; Petit-Cocault, Laurence; Bilhou-Nabera, Chrystele; Aubin-Houzelstein, Genevieve; Souyri, Michele; Pouzoulet, Frederic; Gaudry, Murielle; Porteu, Francoise			Thrombopoietin-lncreased DNA-PK-Dependent DNA Repair Limits Hematopoietic Stem and Progenitor Cell Mutagenesis in Response to DNA Damage	CELL STEM CELL			English	Article							DOUBLE-STRAND BREAKS; CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA; SELF-RENEWAL; GENOMIC INSTABILITY; MICE LACKING; C-MPL; RADIATION; RECEPTOR; DEFICIENCIES; MOUSE	DNA double-strand breaks (DSBs) represent a serious threat for hematopoietic stem cells (HSCs). How cytokines and environmental signals integrate the DNA damage response and contribute to HSC-intrinsic DNA repair processes remains unknown. Thrombopoietin (TPO) and its receptor, Mpl, are critical factors supporting HSC self-renewal and expansion. Here, we uncover an unknown function for TPO-Mpl in the regulation of DNA damage response. We show that DNA repair following gamma-irradiation (gamma-IR) or the action of topoisomerase-II inhibitors is defective in Mpl(-/-) and in wild-type mouse or human hematopoietic stem and progenitor cells treated in the absence of TPO. TPO stimulates DNA repair in vitro and in vivo by increasing DNA-PK-dependent nonhomologous end-joining efficiency. This ensures HSC chromosomal integrity and limits their long-term injury in response to IR. This shows that niche factors can modulate the HSC DSB repair machinery and opens new avenues for administration of TPO agonists for minimizing radiotherapy-induced HSC injury and mutagenesis.	[de Laval, Berengere; Pawlikowska, Patrycja; Gaudry, Murielle; Porteu, Francoise] Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France; [de Laval, Berengere; Pawlikowska, Patrycja; Gaudry, Murielle; Porteu, Francoise] CNRS, UMR 8104, F-75014 Paris, France; [de Laval, Berengere; Pawlikowska, Patrycja; Gaudry, Murielle; Porteu, Francoise] Univ Paris 05, F-75014 Paris, France; [Petit-Cocault, Laurence; Souyri, Michele] Univ Paris 06, CNRS, UMR 7622, F-75005 Paris, France; [Bilhou-Nabera, Chrystele] Hop St Antoine, Serv Hematol & Immunol Biol, AP HP, F-75012 Paris, France; [Aubin-Houzelstein, Genevieve] Univ Paris Est, INRA, UMR 955, Ecole Natl Vet Alfort, F-94704 Maisons Alfort, France; [Pouzoulet, Frederic] Inst Curie, F-91400 Orsay, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Porteu, F (corresponding author), Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France.	francoise.porteu@inserm.fr	Souyri, Michele/L-5845-2017; Gaudry, Murielle/N-5934-2018; PORTEU, Françoise/I-8445-2016	PORTEU, Françoise/0000-0002-2403-4163; PETIT, Laurence/0000-0002-2475-9367; Pawlikowska, Patrycja/0000-0001-7715-6159; Pouzoulet, Frederic/0000-0003-4819-2876; de Laval, Berengere/0000-0002-5616-2338; Gaudry, Murielle/0000-0002-9281-2334	INSERM; Agence Nationale pour la Recherche [ANR-08-BLAN-0332]; Ligue Contre le Cancer [RS12/75-67]; DIM STEM-Pole; Ministere de l'Enseignement Superieur et de la Recherche; Fondation ARC	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Ligue Contre le Cancer(Ligue nationale contre le cancer); DIM STEM-Pole; Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Fondation ARC	We thank R. Dyunga for technical assistance; the Cochin Animal Facility; B. Durel of the Cochin Imaging Facility for microscopy analysis; D. Clay (Hospital Paul Brousse, Villejuif, France) and the Immunobiology Platform of the Cochin Institute for cell-sorting assistance; Drs. P. Bertrand (UMR CNRS 217, CEA, Fontenay aux Roses, France) and V. Gorbunova (University of Rochester, NY, USA) for the gifts of the pCOH NHEJ substrate, pcDNA-HA-I-Scel, and peGFP-Pem1-Ad2 constructs, respectively; and Dr. P. Sujobert for helpful discussions. This work was supported by INSERM and by grants from Agence Nationale pour la Recherche (ANR-08-BLAN-0332) and Ligue Contre le Cancer (RS12/75-67). P.P. is a recipient of fellowships from DIM STEM-Pole. B.d.L received fellowships from the Ministere de l'Enseignement Superieur et de la Recherche and from the Fondation ARC.	Alexander WS, 1996, BLOOD, V87, P2162, DOI 10.1182/blood.V87.6.2162.bloodjournal8762162; Allix S, 2008, BIOL REPROD, V79, P510, DOI 10.1095/biolreprod.107.066373; Ban N, 2009, BRIT J CANCER, V101, P363, DOI 10.1038/sj.bjc.6605135; Burma S, 2006, DNA REPAIR, V5, P1042, DOI 10.1016/j.dnarep.2006.05.026; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; Fan JS, 2010, BLOOD, V116, P5298, DOI 10.1182/blood-2010-03-272591; Ferguson DO, 2000, P NATL ACAD SCI USA, V97, P6630, DOI 10.1073/pnas.110152897; Fox N, 2002, J CLIN INVEST, V110, P389, DOI 10.1172/JCI200215430; Guirouilh-Barbat J, 2004, MOL CELL, V14, P611, DOI 10.1016/j.molcel.2004.05.008; Hamelin V, 2006, BLOOD, V107, P3106, DOI 10.1182/blood-2005-07-2953; Herodin F, 2003, BLOOD, V101, P2609, DOI 10.1182/blood-2002-06-1634; Ikeda Y, 2009, J THROMB HAEMOST, V7, P239, DOI 10.1111/j.1538-7836.2009.03440.x; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Kimura S, 1998, P NATL ACAD SCI USA, V95, P1195, DOI 10.1073/pnas.95.3.1195; Leon C, 2012, BLOOD, V119, P3333, DOI 10.1182/blood-2011-08-373811; Lliakis G, 2004, CYTOGENET GENOME RES, V104, P14; Lorimore SA, 2005, CANCER RES, V65, P5668, DOI 10.1158/0008-5472.CAN-05-0834; Martin M, 2005, CANCER RES, V65, P10223, DOI 10.1158/0008-5472.CAN-05-0932; Marusyk A, 2009, CANCER RES, V69, P7262, DOI 10.1158/0008-5472.CAN-09-0604; Maserati E, 2008, HAEMATOL-HEMATOL J, V93, P1271, DOI 10.3324/haematol.12748; Michalak EM, 2010, GENE DEV, V24, P1608, DOI 10.1101/gad.1940110; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Neelis KJ, 1998, BLOOD, V92, P1586, DOI 10.1182/blood.V92.5.1586.417a07_1586_1597; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Pardanani AD, 2006, BLOOD, V108, P3472, DOI 10.1182/blood-2006-04-018879; Passegue E, 2005, STEM CELL REV, V1, P181, DOI 10.1385/SCR:1:3:181; Pawlikowska P, 2010, CELL DEATH DIFFER, V17, P1739, DOI 10.1038/cdd.2010.56; Pestina TI, 2001, BLOOD, V98, P2084, DOI 10.1182/blood.V98.7.2084; Petit-Cocault L, 2007, DEVELOPMENT, V134, P3031, DOI 10.1242/dev.001818; Pouzoulet F, 2007, J RADIAT RES, V48, P425, DOI 10.1269/jrr.07013; Qian H, 2007, CELL STEM CELL, V1, P671, DOI 10.1016/j.stem.2007.10.008; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Saulnier N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030788; Seluanov A, 2004, P NATL ACAD SCI USA, V101, P7624, DOI 10.1073/pnas.0400726101; Shao LJ, 2010, BLOOD, V115, P4707, DOI 10.1182/blood-2009-10-248872; Shibuya K, 1998, BLOOD, V91, P37, DOI 10.1182/blood.V91.1.37.37_37_45; Simonnet AJ, 2009, STEM CELLS, V27, P1400, DOI 10.1002/stem.66; Steele M, 2005, PEDIATR BLOOD CANCER, V45, P212, DOI 10.1002/pbc.20332; van Os R, 2000, STEM CELLS, V18, P120, DOI 10.1634/stemcells.18-2-120; Wang JW, 2012, CELL, V148, P1001, DOI 10.1016/j.cell.2012.01.040; Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418; Weinstock David M, 2007, Nat Cell Biol, V9, P978; Wicke DC, 2010, MOL THER, V18, P343, DOI 10.1038/mt.2009.233; Xue XK, 2010, BLOOD, V116, P5419, DOI 10.1182/blood-2010-07-295949; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020	46	66	66	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 3	2013	12	1					37	48		10.1016/j.stem.2012.10.012	http://dx.doi.org/10.1016/j.stem.2012.10.012			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	074UM	23246483	Bronze			2022-12-28	WOS:000313839500009
J	Zhang, J; Nuebel, E; Daley, GQ; Koehler, CM; Teitell, MA				Zhang, Jin; Nuebel, Esther; Daley, George Q.; Koehler, Carla M.; Teitell, Michael A.			Metabolic Regulation in Pluripotent Stem Cells during Reprogramming and Self-Renewal	CELL STEM CELL			English	Review							DIFFERENTIATION; CANCER; STRESS; GROWTH; PROLIFERATION; TRANSITION; EXPRESSION; GLUCOSE; ACETYLATION; CONSUMPTION	Small, rapidly dividing pluripotent stem cells (PSCs) have unique energetic and biosynthetic demands compared with typically larger, quiescent differentiated cells. Shifts between glycolysis and oxidative phosphorylation with PSC differentiation or reprogramming to pluripotency are accompanied by changes in cell cycle, biomass, metabolite levels, and redox state. PSC and cancer cell metabolism are overtly similar, with metabolite levels influencing epigenetic/genetic programs. Here, we discuss the emerging roles for metabolism in PSC self-renewal, differentiation, and reprogramming.	[Zhang, Jin; Teitell, Michael A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Nuebel, Esther; Koehler, Carla M.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Koehler, Carla M.; Teitell, Michael A.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Teitell, Michael A.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Broad Stem Cell Res Ctr, Los Angeles, CA 90095 USA; [Teitell, Michael A.] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Daley, George Q.] Childrens Hosp, Manton Ctr Orphan Dis Res, Stem Cell Transplantat Program, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Daley, George Q.] Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Daley, George Q.] Broad Inst, Cambridge, MA 02142 USA; [Zhang, Jin; Daley, George Q.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Teitell, MA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.	mteitell@ucla.edu	ZHANG, JIN/D-1435-2013		CIRM [RS1-00313, RB1-01397, TB1-01183, TG2-01169]; Broad Stem Cell Research Center at UCLA; NIH [GM061721, GM073981, PNEY018228, P01GM081621, CA156674, CA90571, R24DK092760, RC4-DK090913, UO1-HL100001]; Alex's Lemonade Stand; Doris Duke Medical Foundation; Ellison Medical Foundation; NATIONAL CANCER INSTITUTE [R01CA090571, R01CA156674] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK092760, RC4DK090913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073981, R01GM061721, P01GM081621] Funding Source: NIH RePORTER	CIRM(California Institute for Regenerative Medicine); Broad Stem Cell Research Center at UCLA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alex's Lemonade Stand; Doris Duke Medical Foundation(Doris Duke Charitable Foundation (DDCF)); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from CIRM (RS1-00313, RB1-01397, TB1-01183, and TG2-01169), a training grant from the Broad Stem Cell Research Center at UCLA, and grants from the NIH (GM061721, GM073981, PNEY018228, P01GM081621, CA156674, and CA90571). C.M.K. is an Established Investigator of the American Heart Association and M.A.T. was a Scholar of the Leukemia and Lymphoma Society. G.Q.D. is supported by grants from the NIH (R24DK092760, RC4-DK090913, and UO1-HL100001), Alex's Lemonade Stand, Doris Duke Medical Foundation, and Ellison Medical Foundation. G.Q.D. is an affiliate member of the Broad Institute and an investigator of the Howard Hughes Medical Institute and the Manton Center for Orphan Disease Research. Many original articles were omitted due to space limitations; for this, we apologize.	Ayyasamy V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024792; Birket MJ, 2011, J CELL SCI, V124, P348, DOI 10.1242/jcs.072272; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; Crespo FL, 2010, STEM CELLS, V28, P1132, DOI 10.1002/stem.441; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Divakaruni AS, 2012, SCIENCE, V337, P41, DOI 10.1126/science.1225601; Dunning KR, 2010, BIOL REPROD, V83, P909, DOI 10.1095/biolreprod.110.084145; Fang M, 2010, CELL, V143, P711, DOI 10.1016/j.cell.2010.10.010; Filosa S, 2003, BIOCHEM J, V370, P935, DOI 10.1042/BJ20021614; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Han MK, 2008, CELL STEM CELL, V2, P241, DOI 10.1016/j.stem.2008.01.002; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hom JR, 2011, DEV CELL, V21, P469, DOI 10.1016/j.devcel.2011.08.008; Israelsen WJ, 2010, CELL, V143, P669, DOI 10.1016/j.cell.2010.11.010; Ito K., 2012, NAT MED; Johnson MT, 2003, J BIOL CHEM, V278, P31457, DOI 10.1074/jbc.R300002200; Katada S, 2012, CELL, V148, P24, DOI 10.1016/j.cell.2012.01.001; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Locasale JW, 2011, CELL METAB, V14, P443, DOI 10.1016/j.cmet.2011.07.014; Manganelli G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029321; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Panopoulos AD, 2012, CELL RES, V22, P168, DOI 10.1038/cr.2011.177; Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404; Samudio I, 2009, CANCER RES, V69, P2163, DOI 10.1158/0008-5472.CAN-08-3722; Saretzki G, 2008, STEM CELLS, V26, P455, DOI 10.1634/stemcells.2007-0628; Shyh-Chang N, 2011, EMBO J, V30, P4851, DOI 10.1038/emboj.2011.436; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; Smith J, 2000, P NATL ACAD SCI USA, V97, P10032, DOI 10.1073/pnas.170209797; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Wang J, 2009, SCIENCE, V325, P435, DOI 10.1126/science.1173288; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wion D, 2009, CELL STEM CELL, V5, P242, DOI 10.1016/j.stem.2009.08.009; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yanes O, 2010, NAT CHEM BIOL, V6, P411, DOI 10.1038/nchembio.364; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211; Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401; Zhou WY, 2012, EMBO J, V31, P2103, DOI 10.1038/emboj.2012.71; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	55	319	326	2	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 2	2012	11	5					589	595		10.1016/j.stem.2012.10.005	http://dx.doi.org/10.1016/j.stem.2012.10.005			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	042LE	23122286	Bronze, Green Accepted			2022-12-28	WOS:000311471900005
J	Lee, DF; Su, J; Ang, YS; Carvajal-Vergara, X; Mulero-Navarro, S; Pereira, CF; Gingold, J; Wang, HL; Zhao, RY; Sevilla, A; Darr, H; Williamson, AJK; Chang, B; Niu, XH; Aguilo, F; Flores, ER; Sher, YP; Hung, MC; Whetton, AD; Gelb, BD; Moore, KA; Snoeck, HW; Ma'ayan, A; Schaniel, C; Lemischka, IR				Lee, Dung-Fang; Su, Jie; Ang, Yen-Sin; Carvajal-Vergara, Xonia; Mulero-Navarro, Sonia; Pereira, Carlos F.; Gingold, Julian; Wang, Hung-Liang; Zhao, Ruiying; Sevilla, Ana; Darr, Henia; Williamson, Andrew J. K.; Chang, Betty; Niu, Xiaohong; Aguilo, Francesca; Flores, Elsa R.; Sher, Yuh-Pyng; Hung, Mien-Chie; Whetton, Anthony D.; Gelb, Bruce D.; Moore, Kateri A.; Snoeck, Hans-Willem; Ma'ayan, Avi; Schaniel, Christoph; Lemischka, Ihor R.			Regulation of Embryonic and Induced Pluripotency by Aurora Kinase-p53 Signaling	CELL STEM CELL			English	Article							CELL SELF-RENEWAL; STEM-CELLS; A KINASE; P53; DIFFERENTIATION; PHOSPHORYLATION; EXPRESSION; INDUCTION; GENES; NANOG	Many signals must be integrated to maintain self-renewal and pluripotency in embryonic stem cells (ESCs) and to enable induced pluripotent stem cell (iPSC) reprogramming. However, the exact molecular regulatory mechanisms remain elusive. To unravel the essential internal and external signals required for sustaining the ESC state, we conducted a short hairpin (sh) RNA screen of 104 ESC-associated phosphoregulators. Depletion of one such molecule, aurora kinase A (Aurka), resulted in compromised self-renewal and consequent differentiation. By integrating global gene expression and computational analyses, we discovered that loss of Aurka leads to upregulated p53 activity that triggers ESC differentiation. Specifically, Aurka regulates pluripotency through phosphorylation-mediated inhibition of p53-directed ectodermal and mesodermal gene expression. Phosphorylation of p53 not only impairs p53-induced ESC differentiation but also p53-mediated suppression of iPSC reprogramming. Our studies demonstrate an essential role for Aurka-p53 signaling in the regulation of self-renewal, differentiation, and somatic cell reprogramming.	[Lee, Dung-Fang; Su, Jie; Ang, Yen-Sin; Carvajal-Vergara, Xonia; Pereira, Carlos F.; Gingold, Julian; Sevilla, Ana; Darr, Henia; Chang, Betty; Niu, Xiaohong; Moore, Kateri A.; Schaniel, Christoph; Lemischka, Ihor R.] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Lee, Dung-Fang; Su, Jie; Ang, Yen-Sin; Carvajal-Vergara, Xonia; Pereira, Carlos F.; Gingold, Julian; Sevilla, Ana; Darr, Henia; Chang, Betty; Niu, Xiaohong; Moore, Kateri A.; Schaniel, Christoph; Lemischka, Ihor R.] Mt Sinai Sch Med, Black Family Stem Cell Inst, New York, NY 10029 USA; [Mulero-Navarro, Sonia; Gelb, Bruce D.] Mt Sinai Sch Med, Child Hlth & Dev Inst, New York, NY 10029 USA; [Aguilo, Francesca; Snoeck, Hans-Willem] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Gelb, Bruce D.] Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; [Gelb, Bruce D.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Ma'ayan, Avi; Lemischka, Ihor R.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Wang, Hung-Liang; Sher, Yuh-Pyng; Hung, Mien-Chie] China Med Univ, Grad Inst Canc Biol, Taichung 404, Taiwan; [Wang, Hung-Liang; Sher, Yuh-Pyng; Hung, Mien-Chie] China Med Univ, Ctr Mol Med, Taichung 404, Taiwan; [Zhao, Ruiying; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Flores, Elsa R.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Williamson, Andrew J. K.; Whetton, Anthony D.] Univ Manchester, Wolfson Mol Imaging Ctr, Manchester Acad Hlth Sci Ctr, Sch Canc & Imaging Sci, Manchester M20 3LJ, Lancs, England; [Flores, Elsa R.; Hung, Mien-Chie] Univ Texas Grad Sch Biomed Sci Houston, Houston, TX 77030 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; China Medical University Taiwan; China Medical University Taiwan; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Manchester	Lemischka, IR (corresponding author), Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA.	ihor.lemischka@mssm.edu	Hung, Mien-Chie/ABD-5911-2021; CARVAJAL-VERGARA, XONIA/N-2939-2014; Ma'ayan, Avi/AAG-3131-2019; Carvajal-Vergara, Xonia/ABD-1094-2021; Pereira, Carlos-Filipe/B-8438-2013; Gingold, Julian/AAD-7321-2020; Aguilo, Francesca/ABF-2800-2020; Sevilla, Ana/N-8579-2017; Schaniel, Chrisoph/C-9655-2012; Schaniel, Christoph/P-3836-2019	Hung, Mien-Chie/0000-0003-4317-4740; CARVAJAL-VERGARA, XONIA/0000-0002-6475-3701; Ma'ayan, Avi/0000-0002-6904-1017; Carvajal-Vergara, Xonia/0000-0002-6475-3701; Pereira, Carlos-Filipe/0000-0002-9724-1382; Gingold, Julian/0000-0002-0354-5933; Sevilla, Ana/0000-0002-9251-4759; Schaniel, Christoph/0000-0002-1343-4858; Lee, Dung-Fang/0000-0003-2387-597X; Mulero Navarro, Sonia/0000-0001-5739-8062; Su, Jie/0000-0002-3071-7139; Aguilo, Francesca/0000-0002-2374-2045; WHETTON, ANTHONY D/0000-0002-1098-3878	National Institutes of Health (NIH) [5R01GM078465]; Empire State Stem Cell Fund through New York State Department of Health (NYSTEM) [C024176, C024410]; Sister Institution Fund of China Medical University; MDACC [DOH101-TD-C-005, NSC-3111-B-039-101]; Ministerio de Ciencia e Innovacion/Instituto de Salud Carlos III, Spain; EMBO; Leukaemia Lymphoma Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD075735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071558, R01GM078465, R01GM098316] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Empire State Stem Cell Fund through New York State Department of Health (NYSTEM); Sister Institution Fund of China Medical University; MDACC; Ministerio de Ciencia e Innovacion/Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); EMBO(European Molecular Biology Organization (EMBO)); Leukaemia Lymphoma Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Hochedlinger for the Col-SC, Oct4-GFP, and M2rtTA mice. We also thank J. Huang for p53 ChIP-chip data; S.-Y. Tsai and H.L. Xu for useful discussions; and Y. Liu for laboratory management. We also would like to thank S. Ghaffari, M. Rendl, and their laboratories' assistance. We are grateful to Se fleck Chemicals LLC for kindly providing MLN8237, VX-680, and AT-9283. This research was funded by grants from the National Institutes of Health (NIH) to I.R.L. (5R01GM078465), the Empire State Stem Cell Fund through New York State Department of Health (NYSTEM) to I.R.L. (C024176) and to C.S. and I.R.L. (C024410), and Sister Institution Fund of China Medical University and MDACC to M.-C.H. (DOH101-TD-C-005 and NSC-3111-B-039-101). D.-F.L. is a New York Stem Cell Foundation Stanley and Fiona Druckenmiller Fellow; X.C.-V. was a recipient of a Postdoctoral Fellowship from the Ministerio de Ciencia e Innovacion/Instituto de Salud Carlos III, Spain; and C.F.P. is a recipient of an EMBO Long-Term Postdoctoral Fellowship. A.D.W. and A.J.K.W. were recipients of funding from Leukaemia Lymphoma Research.	Ang YS, 2011, TRENDS PHARMACOL SCI, V32, P394, DOI 10.1016/j.tips.2011.03.002; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Badano JL, 2005, NAT REV GENET, V6, P194, DOI 10.1038/nrg1557; Barr AR, 2007, J CELL SCI, V120, P2987, DOI 10.1242/jcs.013136; Barros TP, 2005, J CELL BIOL, V170, P1039, DOI 10.1083/jcb.200504097; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005; Cowley DO, 2009, MOL CELL BIOL, V29, P1059, DOI 10.1128/MCB.01062-08; Dar AA, 2009, ONCOGENE, V28, P866, DOI 10.1038/onc.2008.434; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Han MK, 2008, CELL STEM CELL, V2, P241, DOI 10.1016/j.stem.2008.01.002; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Katayama H, 2004, NAT GENET, V36, P55, DOI 10.1038/ng1279; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Ku S, 2010, CELL STEM CELL, V7, P631, DOI 10.1016/j.stem.2010.09.014; Kuo HP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000590; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lee DF, 2012, NAT PROTOC, V7, P729, DOI 10.1038/nprot.2012.018; Lee KH, 2010, P NATL ACAD SCI USA, V107, P69, DOI 10.1073/pnas.0909734107; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Li QY, 2004, J BIOL CHEM, V279, P52175, DOI 10.1074/jbc.M406802200; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Lu LY, 2008, J BIOL CHEM, V283, P31785, DOI 10.1074/jbc.M805880200; MacArthur BD, 2010, BIOINFORMATICS, V26, P143, DOI 10.1093/bioinformatics/btp628; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mendez R, 2000, MOL CELL, V6, P1253, DOI 10.1016/S1097-2765(00)00121-0; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mori D, 2007, MOL CELL BIOL, V27, P352, DOI 10.1128/MCB.00878-06; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Pascreau G, 2009, J BIOL CHEM, V284, P5497, DOI 10.1074/jbc.M805959200; Pereira CF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000170; Pritsker M, 2006, P NATL ACAD SCI USA, V103, P6946, DOI 10.1073/pnas.0509861103; Qin H, 2007, J BIOL CHEM, V282, P5842, DOI 10.1074/jbc.M610464200; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Sabapathy K, 1997, EMBO J, V16, P6217, DOI 10.1093/emboj/16.20.6217; Sarig R, 2010, J EXP MED, V207, P2127, DOI 10.1084/jem.20100797; Sasai K, 2008, ONCOGENE, V27, P4122, DOI 10.1038/onc.2008.47; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schaniel C, 2006, NAT METHODS, V3, P397, DOI 10.1038/nmeth0506-397; Schaniel C, 2009, STEM CELLS, V27, P2979, DOI 10.1002/stem.223; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Solozobova V, 2010, EXP CELL RES, V316, P2434, DOI 10.1016/j.yexcr.2010.06.006; Stadtfeld M, 2010, NAT METHODS, V7, P53, DOI [10.1038/NMETH.1409, 10.1038/nmeth.1409]; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang JQ, 2011, CELL STEM CELL, V8, P31, DOI 10.1016/j.stem.2010.12.002; Zhang X, 2011, NAT CELL BIOL, V13, P1092, DOI 10.1038/ncb2293	63	111	114	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 3	2012	11	2					179	194		10.1016/j.stem.2012.05.020	http://dx.doi.org/10.1016/j.stem.2012.05.020			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	987QQ	22862944	Green Accepted, Bronze			2022-12-28	WOS:000307432600009
J	Clark, AT				Clark, Amander T.			Pluripotency Takes Off without Blimp1	CELL STEM CELL			English	Editorial Material							GERM-CELL LINEAGE; STEM-CELLS; EPIBLAST; MICE	In this issue of Cell Stem Cell, Bao et al. demonstrate that Blimp1, which is required for primordial germ cell (PGC) specification, is dispensable for the derivation of embryonic stem cells (ESCs), epiblast stem cells (EpiSCs), and reprogramming. These findings argue that the acquisition of pluripotency does not require a Blimp1-dependent PGC intermediate state.	Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Clark, AT (corresponding author), Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	clarka@ucla.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058047] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD058047] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; REGANUSS U, 1982, J EMBRYOL EXP MORPH, V72, P153, DOI DOI 10.1038/NATURE05934; Sharova LV, 2007, DEV BIOL, V307, P446, DOI 10.1016/j.ydbio.2007.05.004; Wylie C. C., 1993, SEMIN DEV BIOL, V4, P161, DOI DOI 10.1016/J.YDBIO.2007.05.004	9	1	1	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUL 6	2012	11	1					1	2		10.1016/j.stem.2012.06.001	http://dx.doi.org/10.1016/j.stem.2012.06.001			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	975SS	22770234	Green Accepted, Bronze			2022-12-28	WOS:000306532400001
J	Ring, KL; Tong, LM; Balestra, ME; Javier, R; Andrews-Zwilling, Y; Li, G; Walker, D; Zhang, WR; Kreitzer, AC; Huang, YD				Ring, Karen L.; Tong, Leslie M.; Balestra, Maureen E.; Javier, Robyn; Andrews-Zwilling, Yaisa; Li, Gang; Walker, David; Zhang, William R.; Kreitzer, Anatol C.; Huang, Yadong			Direct Reprogramming of Mouse and Human Fibroblasts into Multipotent Neural Stem Cells with a Single Factor	CELL STEM CELL			English	Article							ADULT HUMAN FIBROBLASTS; HUMAN SOMATIC-CELLS; DIRECT CONVERSION; DOPAMINERGIC-NEURONS; FUNCTIONAL-NEURONS; DIFFERENTIATION; PLURIPOTENCY; GENERATION; INDUCTION; EXPRESSION	The generation of induced pluripotent stem cells (iPSCs) and induced neuronal cells (iNCs) from somatic cells provides new avenues for basic research and potential transplantation therapies for neurological diseases. However, clinical applications must consider the risk of tumor formation by iPSCs and the inability of iNCs to self-renew in culture. Here we report the generation of induced neural stem cells (iNSCs) from mouse and human fibroblasts by direct reprogramming with a single factor, Sox2. iNSCs express NSC markers and resemble wild-type NSCs in their morphology, self-renewal, ability to form neurospheres, and gene expression profiles. Cloned iNSCs differentiate into several types of mature neurons, as well as astrocytes and oligodendrocytes, indicating multipotency. Implanted iNSCs can survive and integrate in mouse brains and, unlike iPSC-derived NSCs, do not generate tumors. Thus, self-renewable and multipotent iNSCs without tumorigenic potential can be generated directly from fibroblasts by reprogramming.	[Ring, Karen L.; Tong, Leslie M.; Balestra, Maureen E.; Javier, Robyn; Andrews-Zwilling, Yaisa; Li, Gang; Walker, David; Zhang, William R.; Kreitzer, Anatol C.; Huang, Yadong] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Balestra, Maureen E.; Walker, David; Huang, Yadong] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Ring, Karen L.; Tong, Leslie M.; Javier, Robyn; Kreitzer, Anatol C.; Huang, Yadong] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Andrews-Zwilling, Yaisa; Kreitzer, Anatol C.; Huang, Yadong] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Huang, Yadong] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Huang, YD (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	yhuang@gladstone.ucsf.edu		Li, Gang/0000-0002-1933-484X	J. David Gladstone Institutes; National Institutes of Health [P01 AG022074, P30 NS065780, C06RR18928]; National Science Foundation; California Institute for Regenerative Medicine [RN2-00952]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007470] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS065780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022074] Funding Source: NIH RePORTER	J. David Gladstone Institutes(University of California System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the J. David Gladstone Institutes, grant RN2-00952 from the California Institute for Regenerative Medicine, grants P01 AG022074, P30 NS065780, and C06RR18928 from the National Institutes of Health, a graduate research fellowship from National Science Foundation, and a gift from the S.D. Bechtel, Jr. Foundation, Tau Consortium, and Roddenberry Foundation. We thank Drs. Li Gan, Eric Huang, Deepak Srivastava, and Sheng Ding for critical discussions. We also thank Anna Lisa Lucido and Gary Howard for editorial assistance and Linda Turney for manuscript preparation.	Ambasudhan R, 2011, CELL STEM CELL, V9, P113, DOI 10.1016/j.stem.2011.07.002; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Fong CY, 2010, J CELL BIOCHEM, V111, P769, DOI 10.1002/jcb.22775; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Han DW, 2009, STEM CELLS, V27, P1088, DOI 10.1002/stem.43; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Imamura M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-34; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Jin ZG, 2009, J BIOL CHEM, V284, P8160, DOI 10.1074/jbc.M805632200; Kageyama R, 2008, DEV GROWTH DIFFER, V50, pS97, DOI 10.1111/j.1440-169X.2008.00993.x; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kim J, 2011, CELL STEM CELL, V9, P413, DOI 10.1016/j.stem.2011.09.011; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Marro S, 2011, CELL STEM CELL, V9, P374, DOI 10.1016/j.stem.2011.09.002; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Panman L, 2011, CELL STEM CELL, V8, P663, DOI 10.1016/j.stem.2011.04.001; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Qiang L, 2011, CELL, V146, P359, DOI 10.1016/j.cell.2011.07.007; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Sheng C, 2012, CELL RES, V22, P208, DOI 10.1038/cr.2011.175; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Western PS, 2010, FASEB J, V24, P3026, DOI 10.1096/fj.09-151555; Williams DC, 2004, J BIOL CHEM, V279, P1449, DOI 10.1074/jbc.M309790200; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	56	385	411	2	102	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 6	2012	11	1					100	109		10.1016/j.stem.2012.05.018	http://dx.doi.org/10.1016/j.stem.2012.05.018			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	975SS	22683203	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000306532400013
J	Weissman, I				Weissman, Irving			Stem Cell Therapies Could Change Medicine ... If They Get the Chance	CELL STEM CELL			English	Editorial Material							METASTATIC BREAST-CANCER; HIGH-DOSE CHEMOTHERAPY; TRANSPLANTATION	Stem cell therapies have the potential to revolutionize the way we practice medicine. However, in the current climate several barriers and false assumptions stand in the way of achieving that goal.	Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	Stanford University	Weissman, I (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	irv@stanford.edu						BAUM CM, 1992, P NATL ACAD SCI USA, V89, P2804, DOI 10.1073/pnas.89.7.2804; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Muller AMS, 2012, BIOL BLOOD MARROW TR, V18, P125, DOI 10.1016/j.bbmt.2011.07.009; Prohaska S. S., 2009, BIOL HEMATOPOIETIC S, P36; Stadtmauer EA, 2000, NEW ENGL J MED, V342, P1069, DOI 10.1056/NEJM200004133421501; Taylor PL, 2010, CELL STEM CELL, V7, P43, DOI 10.1016/j.stem.2010.06.001; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Weissman IL, 2002, NEW ENGL J MED, V346, P1576, DOI 10.1056/NEJMsb020693; Weissman IL, 2008, BLOOD, V112, P3543, DOI 10.1182/blood-2008-08-078220	10	25	25	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 14	2012	10	6					663	665		10.1016/j.stem.2012.05.014	http://dx.doi.org/10.1016/j.stem.2012.05.014			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	965LD	22704505	Bronze			2022-12-28	WOS:000305768400011
J	Chong, JJH; Chandrakanthan, V; Xaymardan, M; Asli, NS; Li, J; Ahmed, I; Heffernan, C; Menon, MK; Scarlett, CJ; Rashidianfar, A; Biben, C; Zoellner, H; Colvin, EK; Pimanda, JE; Biankin, AV; Zhou, B; Pu, WT; Prall, OWJ; Harvey, RP				Chong, James J. H.; Chandrakanthan, Vashe; Xaymardan, Munira; Asli, Naisana S.; Li, Joan; Ahmed, Ishtiaq; Heffernan, Corey; Menon, Mary K.; Scarlett, Christopher J.; Rashidianfar, Amirsalar; Biben, Christine; Zoellner, Hans; Colvin, Emily K.; Pimanda, John E.; Biankin, Andrew V.; Zhou, Bin; Pu, William T.; Prall, Owen W. J.; Harvey, Richard P.			Adult Cardiac-Resident MSC-like Stem Cells with a Proepicardial Origin	CELL STEM CELL			English	Article							NEURAL CREST CELLS; BONE-MARROW; PROGENITOR CELLS; C-KIT; PERIPHERAL-BLOOD; IN-VITRO; CFU-F; HEART; EPICARDIUM; MULTIPOTENT	Colony-forming units fibroblast (CFU-Fs), analogous to those giving rise to bone marrow (BM) mesenchymal stem cells (MSCs), are present in many organs, although the relationship between BM and organ-specific CFU-Fs in homeostasis and tissue repair is unknown. Here we describe a population of adult cardiac-resident CFU-Fs (cCFU-Fs) that occupy a perk vascular, adventitial niche and show broad trans-germ layer potency in vitro and in vivo. CRE lineage tracing and embryo analysis demonstrated a proepicardial origin for cCFU-Fs. Furthermore, in BM transplantation chimeras, we found no interchange between BM and cCFU-Fs after aging, myocardial infarction, or BM stem cell mobilization. BM and cardiac and aortic CFU-Fs had distinct CRE lineage signatures, indicating that they arise from different progenitor beds during development. These diverse origins for CFU-Fs suggest an underlying basis for differentiation biases seen in different CFU-F populations, and could also influence their capacity for participating in tissue repair.	[Chong, James J. H.; Chandrakanthan, Vashe; Xaymardan, Munira; Asli, Naisana S.; Li, Joan; Ahmed, Ishtiaq; Heffernan, Corey; Menon, Mary K.; Rashidianfar, Amirsalar; Biben, Christine; Prall, Owen W. J.; Harvey, Richard P.] Victor Chang Cardiac Res Inst, Darlinghurst, NSW 2010, Australia; [Chandrakanthan, Vashe; Pimanda, John E.] Univ New S Wales, Lowy Canc Res Ctr, Prince Wales Clin Sch, Kensington, NSW 2052, Australia; [Li, Joan; Harvey, Richard P.] Univ New S Wales, St Vincents Clin Sch, Fac Med, Kensington, NSW 2052, Australia; [Xaymardan, Munira; Harvey, Richard P.] Univ Sydney, Australian Res Council Special Res Initiat Stem C, Sydney, NSW 2006, Australia; [Xaymardan, Munira; Zoellner, Hans] Univ Sydney, Cellular & Mol Pathol Res Unit, Dept Oral Pathol & Oral Med, Fac Dent, Sydney, NSW 2006, Australia; [Scarlett, Christopher J.; Colvin, Emily K.; Biankin, Andrew V.] St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia; [Scarlett, Christopher J.] Univ Newcastle, Sch Environm & Life Sci, Ourimbah, NSW 2258, Australia; [Biben, Christine; Prall, Owen W. J.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Zhou, Bin; Pu, William T.] Childrens Hosp, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Zhou, Bin; Pu, William T.] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Zhou, Bin] Chinese Acad Sci, Inst Nutr Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China	Victor Chang Cardiac Research Institute; University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney; University of Sydney; Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of Newcastle; Royal Melbourne Hospital; Walter & Eliza Hall Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Harvey, RP (corresponding author), Victor Chang Cardiac Res Inst, Darlinghurst, NSW 2010, Australia.	r.harvey@victorchang.edu.au	Pu, William/AAJ-8301-2020; Chong, James/E-2924-2018; Zoellner, Hans/GWQ-7168-2022; Li, Joan/E-6319-2012	Pu, William/0000-0002-4551-8079; Chong, James/0000-0002-5201-4856; Li, Joan/0000-0003-4037-3592; Xaymardan, Munira/0000-0003-0078-0863; Biankin, Andrew/0000-0002-0362-5597; Scarlett, Christopher/0000-0002-4140-7785; Zhou, Bin/0000-0001-5278-5522; Zoellner, Hans/0000-0003-4804-2464; Colvin, Emily/0000-0002-5435-5902; Harvey, Richard/0000-0002-9950-9792; Seyedasli, Naisana/0000-0001-9012-3984	Victorian State Government; Australian Stem Cell Centre [PO82, S4M1]; National Health and Medical Research Counsel Australia [354400, 573705, 573707, 535903]; Australia-India Strategic Research Fund [BF020084]; Johnson and Johnson; Atlantic Philanthropies [19131]; Cancer Institute New South Wales [09/CDF/2-40, 10/CRF/1-01]; Australian Cancer Research Foundation; Royal Australian College of Surgeons; Avner Nahmani Pancreatic Cancer Foundation; R. T. Hall Trust; National Heart Foundation of Australia (NHF); NHF [CR 08S3958]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094683, U01HL100401] Funding Source: NIH RePORTER	Victorian State Government; Australian Stem Cell Centre; National Health and Medical Research Counsel Australia; Australia-India Strategic Research Fund(Australian GovernmentDepartment of Industry, Innovation and Science); Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA); Atlantic Philanthropies; Cancer Institute New South Wales; Australian Cancer Research Foundation; Royal Australian College of Surgeons; Avner Nahmani Pancreatic Cancer Foundation; R. T. Hall Trust; National Heart Foundation of Australia (NHF)(National Heart Foundation of Australia); NHF(National Heart Foundation of Australia); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank S. Ku, K. Evans, and M. Pinese for technical assistance, and Y. Saga, K. Chien, P. Soriano, P. Ruiz-Lozano, and C. Lobe for mice. Research was supported by the Victorian State Government Operational Infrastructure Support scheme and grants from the Australian Stem Cell Centre (PO82; S4M1), National Health and Medical Research Counsel Australia (IRIISS; 354400; 573705; 573707; and 535903), Australia-India Strategic Research Fund (BF020084), Johnson and Johnson (Focused Giving Program), Atlantic Philanthropies (Flagship Scheme; 19131), Cancer Institute New South Wales (09/CDF/2-40 and 10/CRF/1-01), Australian Cancer Research Foundation, Royal Australian College of Surgeons, The Avner Nahmani Pancreatic Cancer Foundation, and the R. T. Hall Trust. J.C. held a National Heart Foundation of Australia (NHF) scholarship, and O.W.J.P., an NHF Career Development Award (CR 08S3958).	Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bonyadi M, 2003, P NATL ACAD SCI USA, V100, P5840, DOI 10.1073/pnas.1036475100; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Carmona R, 2010, J CELL MOL MED, V14, P2066, DOI 10.1111/j.1582-4934.2010.01088.x; Christoffels VM, 2006, CIRC RES, V98, P1555, DOI 10.1161/01.RES.0000227571.84189.65; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Ebihara Y, 2006, EXP HEMATOL, V34, P219, DOI 10.1016/j.exphem.2005.10.008; Fazel S, 2006, J CLIN INVEST, V116, P1865, DOI 10.1172/JCI27019; Fazel SS, 2008, FASEB J, V22, P930, DOI 10.1096/fj.07-8636com; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Galvez BG, 2008, CELL DEATH DIFFER, V15, P1417, DOI 10.1038/cdd.2008.75; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Iwasaki M, 2011, EUR HEART J, V32, P627, DOI 10.1093/eurheartj/ehq442; Kajstura J, 2011, NEW ENGL J MED, V364, P1795, DOI 10.1056/NEJMoa1101324; Kajstura J, 2010, CIRC RES, V107, P305, DOI 10.1161/CIRCRESAHA.110.223024; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kikuchi K, 2011, DEV CELL, V20, P397, DOI 10.1016/j.devcel.2011.01.010; Lamagna C, 2006, J LEUKOCYTE BIOL, V80, P677, DOI 10.1189/jlb.0506309; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Li M, 2008, CIRC RES, V102, P677, DOI 10.1161/CIRCRESAHA.107.161737; Lie-Venema H, 2008, DIFFERENTIATION, V76, P809, DOI 10.1111/j.1432-0436.2007.00262.x; Linke A, 2005, P NATL ACAD SCI USA, V102, P8966, DOI 10.1073/pnas.0502678102; Louis SA, 2008, STEM CELLS, V26, P988, DOI 10.1634/stemcells.2007-0867; Lund TC, 2008, HAEMATOLOGICA, V93, P908, DOI 10.3324/haematol.12384; Ma Q, 2008, DEV BIOL, V323, P98, DOI 10.1016/j.ydbio.2008.08.013; Martinez-Estrada OM, 2010, NAT GENET, V42, P89, DOI 10.1038/ng.494; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Mellgren AM, 2008, CIRC RES, V103, P1393, DOI 10.1161/CIRCRESAHA.108.176768; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Merki E, 2005, P NATL ACAD SCI USA, V102, P18455, DOI 10.1073/pnas.0504343102; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Mouquet F, 2005, CIRC RES, V97, P1090, DOI 10.1161/01.RES.0000194330.66545.f5; O'Donoghue K, 2004, LANCET, V364, P179, DOI 10.1016/S0140-6736(04)16631-2; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Pelekanos RA, 2012, STEM CELL RES, V8, P58, DOI 10.1016/j.scr.2011.08.003; Rochefort GY, 2006, STEM CELLS, V24, P2202, DOI 10.1634/stemcells.2006-0164; Sarugaser R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006498; Shenje LT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001929; SIMMONS PJ, 1987, NATURE, V328, P429, DOI 10.1038/328429a0; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Stottmann RW, 2004, DEVELOPMENT, V131, P2205, DOI 10.1242/dev.01086; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Tomita Y, 2005, J CELL BIOL, V170, P1135, DOI 10.1083/jcb.200504061; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Xaymardan M, 2009, STEM CELLS, V27, P1911, DOI 10.1002/stem.106; Zamora M, 2007, P NATL ACAD SCI USA, V104, P18109, DOI 10.1073/pnas.0702415104; Zhang N, 2006, STEM CELLS DEV, V15, P17, DOI 10.1089/scd.2006.15.17; Zhang Y, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010498, 10.1371/journal.pone.0015300, 10.1371/journal.pone.0015570, 10.1371/journal.pone.0012559]; Zhou B, 2008, BIOCHEM BIOPH RES CO, V375, P450, DOI 10.1016/j.bbrc.2008.08.044; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zhou B, 2010, DEV BIOL, V338, P251, DOI 10.1016/j.ydbio.2009.12.007	54	288	296	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 2	2011	9	6					527	540		10.1016/j.stem.2011.10.002	http://dx.doi.org/10.1016/j.stem.2011.10.002			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	859SB	22136928	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000297895000013
J	Lien, WH; Guo, XY; Polak, L; Lawton, LN; Young, RA; Zheng, DY; Fuchs, E				Lien, Wen-Hui; Guo, Xingyi; Polak, Lisa; Lawton, Lee N.; Young, Richard A.; Zheng, Deyou; Fuchs, Elaine			Genome-wide Maps of Histone Modifications Unwind In Vivo Chromatin States of the Hair Follicle Lineage	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTIONAL REGULATORY CIRCUITRY; DEVELOPMENTAL REGULATORS; GENE-EXPRESSION; SKIN; METHYLATION; POLYCOMB; BULGE; MARKS; DIFFERENTIATION	Using mouse skin, where bountiful reservoirs of synchronized hair follicle stem cells (HF-SCs) fuel cycles of regeneration, we explore how adult SCs remodel chromatin in response to activating cues. By profiling global mRNA and chromatin changes in quiescent and activated HF-SCs and their committed, transit-amplifying (TA) progeny, we show that polycomb-group (PcG)-mediated H3K27-trimethylation features prominently in HF-lineage progression by mechanisms distinct from embryonic-SCs. In HF-SCs, PcG represses nonskin lineages and HF differentiation. In TA progeny, nonskin regulators remain PcG-repressed, HF-SC regulators acquire H3K27me3-marks, and HF-lineage regulators lose them. Interestingly, genes poised in embryonic stem cells, active in HF-SCs, and PcG-repressed in TA progeny encode not only key transcription factors, but also signaling regulators. We document their importance in balancing HF-SC quiescence, underscoring the power of chromatin mapping in dissecting SC behavior. Our findings explain how HF-SCs cycle through quiescent and activated states without losing stemness and define roles for PcG-mediated repression in governing a fate switch irreversibly.	[Lien, Wen-Hui; Polak, Lisa; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA; [Guo, Xingyi; Zheng, Deyou] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10461 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; [Lawton, Lee N.; Young, Richard A.] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA; [Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Rockefeller University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016; Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Zheng, Deyou/0000-0003-4354-5337; Lien, Wen-Hui/0000-0002-2282-3169	Harvey L. Karp Postdoctoral Fellowship; NIH/NIAMS [R01AR31737]; NIH/NIMH [R21MH087840]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR031737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH087840] Funding Source: NIH RePORTER	Harvey L. Karp Postdoctoral Fellowship; NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank S. Dewell for assistance in high-throughput sequencing and analysis (RU Genomics Resource Center); A. Viale, D. You, and J. Zhao for microarray (MSKCC microarray facility); S. Mazel, L. Li, A. Lloyd, and S. Tadesse for FACS sorting (RU FACS facility); and K.-M. Noh (Allis lab, RU) for providing ESC cDNAs. We also thank Fuchs' lab members N. Stokes and D. Oristian for assistance in mouse research (Fuchs lab); E. Ezhkova for Ezh1/2 dKO cDNA samples; Y.-C. Hsu for unpublished microarray information; and A. Folgueras, E. Ezhkova, L Zhang, S. Beronja, B. Keyes, M. Kadaja, Y.-C. Hsu, and T. Chen for discussions and comments on the manuscript. W.-H.L. was supported by a Harvey L. Karp Postdoctoral Fellowship and is currently a Jane Coffin Child Postdoctoral Fellow. E.F. is an HHMI Investigator. This work was supported by a grant (to E.F.) from the NIH/NIAMS (R01AR31737) and partially by NIH/NIMH (R21MH087840, D.Z.).	Adli M, 2010, NAT METHODS, V7, P615, DOI [10.1038/NMETH.1478, 10.1038/nmeth.1478]; Bardot B, 2004, INT J DEV BIOL, V48, P149, DOI 10.1387/ijdb.15272379; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chen HA, 2009, GENE DEV, V23, P975, DOI 10.1101/gad.1742509; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Ezhkova E, 2011, GENE DEV, V25, P485, DOI 10.1101/gad.2019811; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Ha M, 2011, GENOME RES, V21, P590, DOI 10.1101/gr.116467.110; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; MATZUK MM, 1995, NATURE, V374, P360, DOI 10.1038/374360a0; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nakamura M, 2003, FASEB J, V17, P497, DOI 10.1096/fj.02-0247fje; Nguyen H, 2009, NAT GENET, V41, P1068, DOI 10.1038/ng.431; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Qiu WL, 2011, J INVEST DERMATOL, V131, P1067, DOI 10.1038/jid.2010.400; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	44	158	160	2	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 2	2011	9	3					219	232		10.1016/j.stem.2011.07.015	http://dx.doi.org/10.1016/j.stem.2011.07.015			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	822DN	21885018	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000295024200009
J	Schneider, MD				Schneider, Michael D.			EPO and Super-EPO: Erythropoietins Direct Neoangiogenesis by Cardiac Progenitor Cells	CELL STEM CELL			English	Editorial Material							INFARCTION	Erythropoietin, the red blood cell-making cytokine, is also a potential cytoprotective agent in heart disease. In this issue of Cell Stem Cell, Hoch et al. (2011) use two heart failure models, including chemotherapeutic cardiotoxicity, to reveal a mechanistic connection between reduced cardiomyocyte production of erythropoietin and neoangiogenesis by cardiac progenitors.	Univ London Imperial Coll Sci Technol & Med, British Heart Fdn Ctr Res Excellence, Natl Heart & Lung Inst, London SW7 2AZ, England	Imperial College London	Schneider, MD (corresponding author), Univ London Imperial Coll Sci Technol & Med, British Heart Fdn Ctr Res Excellence, Natl Heart & Lung Inst, London SW7 2AZ, England.	m.d.schneider@imperial.ac.uk		Schneider, Michael/0000-0001-9645-1938				Brade T, 2011, DEVELOPMENT, V138, P139, DOI 10.1242/dev.054239; Brines M, 2008, P NATL ACAD SCI USA, V105, P10925, DOI 10.1073/pnas.0805594105; Force T, 2011, NAT REV DRUG DISCOV, V10, P111, DOI 10.1038/nrd3252; Hoch M, 2011, CELL STEM CELL, V9, P131, DOI 10.1016/j.stem.2011.07.001; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Mercola M, 2011, GENE DEV, V25, P299, DOI 10.1101/gad.2018411; Moon C, 2003, P NATL ACAD SCI USA, V100, P11612, DOI 10.1073/pnas.1930406100; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Ueba H, 2010, P NATL ACAD SCI USA, V107, P14357, DOI 10.1073/pnas.1003019107	10	2	2	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	AUG 5	2011	9	2					95	96		10.1016/j.stem.2011.07.008	http://dx.doi.org/10.1016/j.stem.2011.07.008			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	808PM	21816360	Bronze			2022-12-28	WOS:000293990900005
J	Lam, BS; Adams, GB				Lam, Ben S.; Adams, Gregor B.			Blocking HIF1 alpha Activity Eliminates Hematological Cancer Stem Cells	CELL STEM CELL			English	Editorial Material							MYELOID-LEUKEMIA; THERAPY	Selective targeting of cancer stem cells (CSCs) has the potential to prevent cancer relapse. Wang et al. (2011) report that hypoxia-inducible factor 1 alpha (HIF1 alpha) represses Notch signaling to maintain CSC subsets from lymphoma, and that blocking HIF1 alpha activity eliminates lymphoma and human acute myeloid leukemia (AML) CSCs.	[Lam, Ben S.; Adams, Gregor B.] Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA	University of Southern California	Adams, GB (corresponding author), Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA.	gregorad@usc.edu						Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shih IM, 2007, CANCER RES, V67, P1879, DOI 10.1158/0008-5472.CAN-06-3958; Wang Y, 2011, CELL STEM CELL, V8, P399, DOI 10.1016/j.stem.2011.02.006; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737	9	7	7	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 8	2011	8	4					354	356		10.1016/j.stem.2011.03.006	http://dx.doi.org/10.1016/j.stem.2011.03.006			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	752QI	21474097	Bronze			2022-12-28	WOS:000289707100005
J	Pearl, JI; Lee, AS; Leveson-Gower, DB; Sun, N; Ghosh, Z; Lan, F; Ransohoff, J; Negrin, RS; Davis, MM; Wu, JC				Pearl, Jeremy I.; Lee, Andrew S.; Leveson-Gower, Dennis B.; Sun, Ning; Ghosh, Zhumur; Lan, Feng; Ransohoff, Julia; Negrin, Robert S.; Davis, Mark M.; Wu, Joseph C.			Short-Term Immunosuppression Promotes Engraftment of Embryonic and Induced Pluripotent Stem Cells	CELL STEM CELL			English	Article							REGULATORY T-CELLS; COSTIMULATION BLOCKADE; TRANSPLANTATION; EXPRESSION; GENERATION; TOLERANCE; CTLA-4; SIGNAL; ICAM-1	Embryonic stem cells (ESCs) are an attractive source for tissue regeneration and repair therapies because they can be differentiated into virtually any cell type in the adult body. However, for this approach to succeed, the transplanted ESCs must survive long enough to generate a therapeutic benefit. A major obstacle facing the engraftment of ESCs is transplant rejection by the immune system. Here we show that blocking leukocyte costimulatory molecules permits ESC engraftment. We demonstrate the success of this immunosuppressive therapy for mouse ESCs, human ESCs, mouse induced pluripotent stem cells (iPSCs), human induced pluripotent stem cells, and more differentiated ESC/(iPSCs) derivatives. Additionally, we provide evidence describing the mechanism by which inhibition of costimulatory molecules suppresses T cell activation. This report describes a short-term immunosuppressive approach capable of inducing engraftment of transplanted ESCs and iPSCs, providing a significant improvement in our mechanistic understanding of the critical role costimulatory molecules play in leukocyte activation.	[Davis, Mark M.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Davis, Mark M.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Leveson-Gower, Dennis B.; Negrin, Robert S.] Stanford Univ, Sch Med, Dept Med, Div Blood & Marrow Transplantat, Stanford, CA 94305 USA; [Pearl, Jeremy I.; Lee, Andrew S.; Sun, Ning; Ghosh, Zhumur; Lan, Feng; Ransohoff, Julia; Wu, Joseph C.] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA; [Pearl, Jeremy I.; Wu, Joseph C.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Davis, MM (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.	mmdavis@stanford.edu; joewu@stanford.edu	Lee, Andrew/GVU-2817-2022; Lan, Feng/I-2023-2012; Wu, Joseph/H-1067-2013	Lan, Feng/0000-0002-9038-4014; Ghosh, Zhumur/0000-0002-4877-7551; Davis, Mark/0000-0001-6868-657X; Wu, Joseph/0000-0002-6068-8041; Sun, Ning/0000-0002-7861-3646	National Institutes of Health [AI085575, HL089027, DP2OD004437]; Howard Hughes Medical Institute; Ellison Medical Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL089027, R33HL089027] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC1AG036142] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would like to thank Marcel Daadi for assistance with stereotactic transplantation of murine neural progenitor cells. This work was supported by National Institutes of Health Grants AI085575, HL089027, and DP2OD004437 (J.C.W.), and by a Howard Hughes Medical Institute research training fellowship (J.I.P., A.S.L.). M.M.D. is supported by grants from the Howard Hughes Medical Institute, the Ellison Medical Foundation, and the National Institutes of Health.	Abdullah Z, 2007, J IMMUNOL, V178, P3390, DOI 10.4049/jimmunol.178.6.3390; Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779; Bonde S, 2006, STEM CELLS, V24, P2192, DOI 10.1634/stemcells.2006-0022; Byrne JA, 2008, HUM MOL GENET, V17, pR37, DOI 10.1093/hmg/ddn053; Cao F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003474; Carpenter MK, 2009, NAT BIOTECHNOL, V27, P606, DOI 10.1038/nbt0709-606; Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054; Chidgey AP, 2008, NATURE, V453, P330, DOI 10.1038/nature07041; Diehn M, 2002, P NATL ACAD SCI USA, V99, P11796, DOI 10.1073/pnas.092284399; Dressel R, 2010, FASEB J, V24, P2164, DOI 10.1096/fj.09-134957; Ford ML, 2009, IMMUNOL REV, V229, P294, DOI 10.1111/j.1600-065X.2009.00776.x; Grinnemo KH, 2008, STEM CELLS, V26, P1850, DOI 10.1634/stemcells.2008.0111; JENKINS MK, 1994, IMMUNITY, V1, P443, DOI 10.1016/1074-7613(94)90086-8; Kim JB, 2009, NAT PROTOC, V4, P1464, DOI 10.1038/nprot.2009.173; Kurtz J, 2009, BLOOD, V113, P3475, DOI 10.1182/blood-2008-01-133736; LAFFERTY KJ, 1983, ANNU REV IMMUNOL, V1, P143, DOI 10.1146/annurev.iy.01.040183.001043; Larsen CP, 1996, NATURE, V381, P434, DOI 10.1038/381434a0; LENSCHOW DJ, 1992, SCIENCE, V257, P789, DOI 10.1126/science.1323143; Li L, 2004, STEM CELLS, V22, P448, DOI 10.1634/stemcells.22-4-448; Li ZJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008443; Lomax GP, 2007, PLOS MED, V4, P803, DOI 10.1371/journal.pmed.0040114; Naka H, 2008, NAT NEUROSCI, V11, P1014, DOI 10.1038/nn.2168; Niu G, 2008, DRUGS R&D, V9, P351, DOI 10.2165/0126839-200809060-00002; Pan YS, 2003, TRANSPLANTATION, V76, P216, DOI 10.1097/01.TP.0000069602.30162.A1; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106; Swijnenburg RJ, 2008, P NATL ACAD SCI USA, V105, P12991, DOI 10.1073/pnas.0805802105; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thompson CB, 1997, IMMUNITY, V7, P445, DOI 10.1016/S1074-7613(00)80366-0; Toriumi H, 2009, NEUROL RES, V31, P220, DOI 10.1179/016164108X339378; VANSEVENTER GA, 1990, J IMMUNOL, V144, P4579; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zuckerman LA, 1998, J IMMUNOL, V160, P3259	34	138	140	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 4	2011	8	3					309	317		10.1016/j.stem.2011.01.012	http://dx.doi.org/10.1016/j.stem.2011.01.012			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	735HI	21362570	Green Accepted, Bronze			2022-12-28	WOS:000288404400012
J	Oguro, H; Ding, L; Morrison, SJ				Oguro, Hideyuki; Ding, Lei; Morrison, Sean J.			SLAM Family Markers Resolve Functionally Distinct Subpopulations of Hematopoietic Stem Cells and Multipotent Progenitors	CELL STEM CELL			English	Article							SELF-RENEWAL; DIFFERENTIATION; LINEAGE; IDENTIFICATION; FETAL; MICE; RECONSTITUTION; HETEROGENEITY; PURIFICATION; EXPRESSION	Hematopoietic stem cells (HSCs) and multipotent hematopoietic progenitors (MPPs) are routinely isolated using various markers but remain heterogeneous. Here we show that four SLAM family markers, CD150, CD48, CD229, and CD244, can distinguish HSCs and MPPs from restricted progenitors and subdivide them into a hierarchy of functionally distinct subpopulations with stepwise changes in cell-cycle status, self-renewal, and reconstituting potential. CD229 expression largely distinguished lymphoid-biased HSCs from rarely dividing myeloid-biased HSCs, enabling prospective enrichment of these HSC subsets. Differences in CD229 and CD244 expression resolved CD150(-)CD48(-/low) Lineage(-/low)Sca-1(+)c-Kit(+) cells into a hierarchy of highly purified MPPs that retained erythroid and platelet potential but exhibited progressive changes in mitotic activity and reconstituting potential. Use of these markers, and reconstitution assays, showed that conditional deletion of Scf from endothelial cells and perivascular stromal cells eliminated the vast majority of bone marrow HSCs, including nearly all CD229(-/low) HSCs, demonstrating that quiescent HSCs are maintained by a perivascular niche.	[Oguro, Hideyuki; Ding, Lei; Morrison, Sean J.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Childrens Med Ctr Res Inst, Dallas, TX 75390 USA; [Oguro, Hideyuki; Ding, Lei; Morrison, Sean J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Morrison, SJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, Childrens Med Ctr Res Inst, Dallas, TX 75390 USA.	sean.morrison@utsouthwestern.edu	Morrison, Sean/ABD-5326-2021; Oguro, Hideyuki/Q-5478-2019	Oguro, Hideyuki/0000-0002-9070-4575; Morrison, Sean/0000-0003-1587-8329	National Heart, Lung and Blood Institute [HL097760]; Howard Hughes Medical Institute (HHMI); Cancer Prevention and Research Institute of Texas; Helen Hay Whitney Foundation; HHMI; Japanese Society for the Promotion of Science; Uehara Memorial Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097760] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Cancer Prevention and Research Institute of Texas; Helen Hay Whitney Foundation; HHMI(Howard Hughes Medical Institute); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung and Blood Institute (HL097760), the Howard Hughes Medical Institute (HHMI), and the Cancer Prevention and Research Institute of Texas. L. D. was supported by the Helen Hay Whitney Foundation and by HHMI. H.O. was supported by postdoctoral fellowships from the Japanese Society for the Promotion of Science and from the Uehara Memorial Foundation. H.O. performed most experiments. H.O and L. D. performed experiments in Figures 7C-7E and S7A-S7D. H.O. and S.J.M. designed and interpreted all experiments and wrote the manuscript. The University of Michigan has patented the use of SLAM family markers for the isolation of hematopoietic stem cells.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Balazs AB, 2006, BLOOD, V107, P2317, DOI 10.1182/blood-2005-06-2249; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Boyer SW, 2011, CELL STEM CELL, V9, P64, DOI 10.1016/j.stem.2011.04.021; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Copley MR, 2012, CELL STEM CELL, V10, P690, DOI 10.1016/j.stem.2012.05.006; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Ema H, 2005, DEV CELL, V8, P907, DOI 10.1016/j.devcel.2005.03.019; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; He SH, 2011, GENE DEV, V25, P1613, DOI 10.1101/gad.2052911; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kiel MJ, 2008, BLOOD, V111, P4413, DOI 10.1182/blood-2007-12-129601; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim I, 2006, BLOOD, V108, P737, DOI 10.1182/blood-2005-10-4135; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Luc S, 2008, BLOOD, V111, P3424, DOI 10.1182/blood-2007-08-108324; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1997, DEVELOPMENT, V124, P1929; Muller-Sieburg CE, 2002, BLOOD, V100, P1302, DOI 10.1182/blood.V100.4.1302.h81602001302_1302_1309; Ooi AGL, 2009, STEM CELLS, V27, P653, DOI 10.1634/stemcells.2008-0824; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Papathanasiou P, 2009, STEM CELLS, V27, P2498, DOI 10.1002/stem.170; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; SMITH LG, 1991, P NATL ACAD SCI USA, V88, P2788, DOI 10.1073/pnas.88.7.2788; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; UCHIDA N, 1994, BLOOD, V83, P3758; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159; Yilmaz OH, 2006, BLOOD, V107, P924, DOI 10.1182/blood-2005-05-2140; Yokota T, 2009, BLOOD, V113, P2914, DOI 10.1182/blood-2008-07-167106	47	391	401	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2013	13	1					102	116		10.1016/j.stem.2013.05.014	http://dx.doi.org/10.1016/j.stem.2013.05.014			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VJ	23827712	Green Accepted, Bronze			2022-12-28	WOS:000329570100016
J	Chan, SSK; Shi, XZ; Toyama, A; Arpke, RW; Dandapat, A; Iacovino, M; Kang, J; Le, G; Hagen, HR; Garry, DJ; Kyba, M				Chan, Sunny Sun-Kin; Shi, Xiaozhong; Toyama, Akira; Arpke, Robert W.; Dandapat, Abhijit; Iacovino, Michelina; Kang, Jinjoo; Le, Gengyun; Hagen, Hannah R.; Garry, Daniel J.; Kyba, Michael			Mesp1 Patterns Mesoderm into Cardiac, Hematopoietic, or Skeletal Myogenic Progenitors in a Context-Dependent Manner	CELL STEM CELL			English	Article							STEM-CELL DIFFERENTIATION; EARLY MOUSE EMBRYO; YOLK-SAC; DEFINITIVE HEMATOPOIESIS; GENE-EXPRESSION; IN-VITRO; HUMAN ES; SPECIFICATION; BLOOD; HEAD	Mesp1 is regarded as the master regulator of cardiovascular development, initiating the cardiac transcription factor cascade to direct the generation of cardiac mesoderm. To define the early embryonic cell population that responds to Mesp1, we performed pulse inductions of gene expression over tight temporal windows following embryonic stem cell differentiation. Remarkably, instead of promoting cardiac differentiation in the initial wave of mesoderm, Mesp1 binds to the Tal1 (Scl) +40 kb enhancer and generates Flk-1+ precursors expressing Etv2 (ER71) and Tal1 that undergo hematopoietic differentiation. The second wave of mesoderm responds to Mesp1 by differentiating into PDGFR alpha+ precursors that undergo cardiac differentiation. Furthermore, in the absence of serum-derived factors, Mesp1 promotes skeletal myogenic differentiation. Lineage tracing revealed that the majority of yolk sac and many adult hematopoietic cells derive from Mesp1+ precursors. Thus, Mesp1 is a context-dependent determination factor, integrating the stage of differentiation and the signaling environment to specify different lineage outcomes.	[Chan, Sunny Sun-Kin; Shi, Xiaozhong; Toyama, Akira; Arpke, Robert W.; Dandapat, Abhijit; Iacovino, Michelina; Kang, Jinjoo; Le, Gengyun; Hagen, Hannah R.; Garry, Daniel J.; Kyba, Michael] Univ Minnesota, Lillehei Heart Inst, Minneapolis, MN 55455 USA; [Chan, Sunny Sun-Kin; Dandapat, Abhijit; Kang, Jinjoo; Le, Gengyun; Kyba, Michael] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Shi, Xiaozhong; Toyama, Akira; Arpke, Robert W.; Iacovino, Michelina; Garry, Daniel J.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Kyba, M (corresponding author), Univ Minnesota, Lillehei Heart Inst, Minneapolis, MN 55455 USA.	kyba@umn.edu		Kyba, Michael/0000-0002-5579-7534; iacovino, michelina/0000-0002-1076-3146; Arpke, Robert W/0000-0002-0876-078X	NIH [U01 HL100407, R01 AR055685, T32 AR007612, T32 HL069764]; American Heart Association-Jon Holden DeHaan Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069764, U01HL100407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055685, T32AR007612] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association-Jon Holden DeHaan Foundation(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Nardina Nash and Cara-lin Lonetree for animal husbandry and genotyping and Si Ho Choi for technical assistance in ChIP analysis. This work was supported by NIH grants U01 HL100407 and R01 AR055685 and by the American Heart Association-Jon Holden DeHaan Foundation. R. A. and A. T. were supported by NIH grants T32 AR007612 and T32 HL069764.	Ackerman KG, 2007, AM J MED GENET C, V145C, P109, DOI 10.1002/ajmg.c.30128; Adamo L, 2009, NATURE, V459, P1131, DOI 10.1038/nature08073; Agha-Mohammadi S, 2004, J GENE MED, V6, P817, DOI 10.1002/jgm.566; Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Arpke RW, 2013, STEM CELLS, V31, P1611, DOI 10.1002/stem.1402; Biressi S, 2010, SEMIN CELL DEV BIOL, V21, P845, DOI 10.1016/j.semcdb.2010.09.003; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Bondue A, 2008, CELL STEM CELL, V3, P69, DOI 10.1016/j.stem.2008.06.009; Bondue A, 2011, J CELL BIOL, V192, P751, DOI 10.1083/jcb.201007063; Bosnakovski D, 2008, STEM CELLS, V26, P3194, DOI 10.1634/stemcells.2007-1017; Bothe I, 2011, DEVELOPMENT, V138, P2807, DOI 10.1242/dev.062737; Bryson-Richardson RJ, 2008, NAT REV GENET, V9, P632, DOI 10.1038/nrg2369; Burridge PW, 2012, CELL STEM CELL, V10, P16, DOI 10.1016/j.stem.2011.12.013; Burridge PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018293; Cai M, 2012, BLOOD, V120, P335, DOI 10.1182/blood-2012-01-403139; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; Cumano A, 2001, IMMUNITY, V15, P477, DOI 10.1016/S1074-7613(01)00190-X; Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705; Darabi R, 2012, CELL STEM CELL, V10, P610, DOI 10.1016/j.stem.2012.02.015; Darabi R, 2011, STEM CELLS, V29, P777, DOI 10.1002/stem.625; David R, 2008, NAT CELL BIOL, V10, P338, DOI 10.1038/ncb1696; Duchenne G., 1868, ARCH GEN MED, V11, P305; Duchenne G., 1868, ARCH GEN MED 6 SER, V11, P179; Duchenne G., 1868, ARCH GEN MED, V11, P421; Duchenne G., 1868, ARCH GEN MED, V11, P5; Duchenne G., 1868, ARCH GEN MED, V11, P552; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Ferdous A, 2009, P NATL ACAD SCI USA, V106, P814, DOI 10.1073/pnas.0807583106; Harel I, 2009, DEV CELL, V16, P822, DOI 10.1016/j.devcel.2009.05.007; Hirata H, 2007, J BIOSCI BIOENG, V103, P412, DOI 10.1263/jbb.103.412; HUANG H, 1993, P NATL ACAD SCI USA, V90, P10110, DOI 10.1073/pnas.90.21.10110; Iacovino M, 2011, STEM CELLS, V29, P1580, DOI 10.1002/stem.715; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Irion S, 2010, DEVELOPMENT, V137, P2829, DOI 10.1242/dev.042119; Ismailoglu I, 2008, EXP HEMATOL, V36, P1593, DOI 10.1016/j.exphem.2008.07.005; KALLIANPUR AR, 1994, BLOOD, V83, P1200; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; Kitajima S, 2000, DEVELOPMENT, V127, P3215; Kouskoff V, 2005, P NATL ACAD SCI USA, V102, P13170, DOI 10.1073/pnas.0501672102; Koyano-Nakagawa N, 2012, STEM CELLS, V30, P1611, DOI 10.1002/stem.1131; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Landouzy L, 1885, REV MED, V5, P253; Landouzy L, 1885, REV MED, V5, P81; Lee D, 2008, CELL STEM CELL, V2, P497, DOI 10.1016/j.stem.2008.03.008; Lindsley RC, 2008, CELL STEM CELL, V3, P55, DOI 10.1016/j.stem.2008.04.004; Lux CT, 2008, BLOOD, V111, P3435, DOI 10.1182/blood-2007-08-107086; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; Ogilvy S, 2007, MOL CELL BIOL, V27, P7206, DOI 10.1128/MCB.00931-07; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Ono Y, 2010, DEV BIOL, V337, P29, DOI 10.1016/j.ydbio.2009.10.005; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Palis J, 1999, DEVELOPMENT, V126, P5073; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Ptaszek LM, 2012, LANCET, V379, P933, DOI 10.1016/S0140-6736(12)60075-0; ROBB L, 1995, P NATL ACAD SCI USA, V92, P7075, DOI 10.1073/pnas.92.15.7075; Saga Y, 1999, DEVELOPMENT, V126, P3437; Saga Y, 1996, DEVELOPMENT, V122, P2769; Saga Y, 2000, TRENDS CARDIOVAS MED, V10, P345, DOI 10.1016/S1050-1738(01)00069-X; Sakurai H, 2006, STEM CELLS, V24, P575, DOI 10.1634/stemcells.2005-0256; Sambasivan R, 2009, DEV CELL, V16, P810, DOI 10.1016/j.devcel.2009.05.008; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shi XZ, 2010, BIOCHEM J, V428, P213, DOI 10.1042/BJ20091906; Shih HP, 2008, ACTA HISTOCHEM, V110, P97, DOI 10.1016/j.acthis.2007.08.004; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Tirosh-Finkel L, 2006, DEVELOPMENT, V133, P1943, DOI 10.1242/dev.02365; Van Handel B, 2012, CELL, V150, P590, DOI 10.1016/j.cell.2012.06.026; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894	74	119	122	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 2	2013	12	5					587	601		10.1016/j.stem.2013.03.004	http://dx.doi.org/10.1016/j.stem.2013.03.004			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VE	23642367	Green Accepted, Bronze			2022-12-28	WOS:000329569600014
J	Karwacki-Neisius, V; Goke, J; Osorno, R; Halbritter, F; Ng, JH; Weisse, AY; Wong, FCK; Gagliardi, A; Mullin, NP; Festuccia, N; Colby, D; Tomlinson, SR; Ng, HH; Chambers, I				Karwacki-Neisius, Violetta; Goeke, Jonathan; Osorno, Rodrigo; Halbritter, Florian; Ng, Jia Hui; Weisse, Andrea Y.; Wong, Frederick C. K.; Gagliardi, Alessia; Mullin, Nicholas P.; Festuccia, Nicola; Colby, Douglas; Tomlinson, Simon R.; Ng, Huck-Hui; Chambers, Ian			Reduced Oct4 Expression Directs a Robust Pluripotent State with Distinct Signaling Activity and Increased Enhancer Occupancy by Oct4 and Nanog	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; MOUSE ES CELLS; GENE-EXPRESSION; GROUND-STATE; SELF-RENEWAL; TRANSCRIPTIONAL NETWORK; PREVENT DIFFERENTIATION; PRIMITIVE ENDODERM; RAT BLASTOCYSTS; EPIBLAST	Embryonic stem cell (ESC) pluripotency is governed by a gene regulatory network centered on the transcription factors Oct4 and Nanog. To date, robust self-renewing ESC states have only been obtained through the chemical inhibition of signaling pathways or enforced transgene expression. Here, we show that ESCs with reduced Oct4 expression resulting from heterozygosity also exhibit a stabilized pluripotent state. Despite having reduced Oct4 expression, Oct4(+/-) ESCs show increased genome-wide binding of Oct4, particularly at pluripotency-associated enhancers, homogeneous expression of pluripotency transcription factors, enhanced self-renewal efficiency, and delayed differentiation kinetics. Cells also exhibit increased Wnt expression, enhanced leukemia inhibitory factor (LIF) sensitivity, and reduced responsiveness to fibroblast growth factor. Although they are able to maintain pluripotency in the absence of bone morphogenetic protein, removal of LIF destabilizes pluripotency. Our findings suggest that cells with a reduced Oct4 concentration range are maintained in a robust pluripotent state and that the wild-type Oct4 concentration range enables effective differentiation.	[Karwacki-Neisius, Violetta; Osorno, Rodrigo; Halbritter, Florian; Wong, Frederick C. K.; Gagliardi, Alessia; Mullin, Nicholas P.; Festuccia, Nicola; Colby, Douglas; Tomlinson, Simon R.; Chambers, Ian] Univ Edinburgh, MRC Ctr Regenerat Med, Inst Stem Cell Res, Sch Biol Sci, Edinburgh EH16 4UU, Midlothian, Scotland; [Weisse, Andrea Y.] Univ Edinburgh, SyntheSys Synthet & Syst Biol, Sch Biol Sci, Edinburgh EH9 3JD, Midlothian, Scotland; [Goeke, Jonathan; Ng, Jia Hui; Ng, Huck-Hui] Genome Inst Singapore, Gene Regulat Lab, Singapore 138672, Singapore; [Ng, Huck-Hui] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Dept Biol Sci, Singapore 117597, Singapore; [Ng, Huck-Hui] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore; [Ng, Huck-Hui] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	University of Edinburgh; University of Edinburgh; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Chambers, I (corresponding author), Univ Edinburgh, MRC Ctr Regenerat Med, Inst Stem Cell Res, Sch Biol Sci, 5 Little France Dr, Edinburgh EH16 4UU, Midlothian, Scotland.	ichambers@ed.ac.uk	Ng, Huck Hui/A-1135-2009; Halbritter, Florian/AAI-1000-2019	Halbritter, Florian/0000-0003-2452-4784; Chambers, Ian/0000-0003-2605-1597; Goke, Jonathan/0000-0002-0825-4991; Mullin, Nicholas/0000-0003-4802-440X; NG, HUCK HUI/0000-0001-6352-8417	Medical Research Council of the UK; EU; Wellcome Trust; Human Frontier Sciences Program; Biotechnology and Biological Sciences Research Council (a Council for Advancement and Support of Education); el Consejo Nacional de Ciencia y Tecnologia; Biomedical Research Council; A*STAR; German Academic Exchange Service; MRC [G0901533] Funding Source: UKRI; Medical Research Council [G0700711B, G0901533] Funding Source: researchfish	Medical Research Council of the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU(European Commission); Wellcome Trust(Wellcome Trust); Human Frontier Sciences Program(Human Frontier Science Program); Biotechnology and Biological Sciences Research Council (a Council for Advancement and Support of Education)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); el Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); A*STAR(Agency for Science Technology & Research (A*STAR)); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are particularly indebted to V. Wilson for stimulating discussions and to S. Lowell and P. Navarro for comments on the manuscript. We are grateful to S. Monard and V. Berno for advice on FACS and microscopy, respectively, to M. Tyers and J. Wildenhain for access to and advice on the use of image analysis software, and to L. Robertson, C. Manson and staff for animal husbandry. Research in I.C.'s lab and in S.R.T.'s lab was supported by the Medical Research Council of the UK and the EU Framework 7 project EuroSyStem. I.C.'s lab is also supported by the Wellcome Trust, the Human Frontier Sciences Program, and studentships from Biotechnology and Biological Sciences Research Council (a Council for Advancement and Support of Education award to V.K.-N.) and el Consejo Nacional de Ciencia y Tecnologia (R.O.). Research in H.-H.N.'s lab is supported by the Biomedical Research Council, A*STAR, and by a fellowship from the German Academic Exchange Service (J.G.).	Al-Kofahi Y, 2010, IEEE T BIO-MED ENG, V57, P841, DOI 10.1109/TBME.2009.2035102; Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Canham MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000379; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I., 2005, REND FIS ACC LINCEI, V16, P83, DOI [10.1007/BF02904758, DOI 10.1007/BF02904758]; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Dani C, 1998, DEV BIOL, V203, P149, DOI 10.1006/dbio.1998.9026; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Fidalgo M, 2012, P NATL ACAD SCI USA, V109, P16202, DOI 10.1073/pnas.1208533109; Gilchrist DS, 2003, GENESIS, V36, P168, DOI 10.1002/gene.10209; Glauche I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011238; Hamazaki T, 2006, MOL CELL BIOL, V26, P7539, DOI 10.1128/MCB.00508-06; Han DW, 2010, CELL, V143, P617, DOI 10.1016/j.cell.2010.10.015; Hao J, 2006, DEV BIOL, V290, P81, DOI 10.1016/j.ydbio.2005.11.011; Hatano S, 2005, MECH DEVELOP, V122, P67, DOI 10.1016/j.mod.2004.08.008; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Miyanari Y, 2012, NATURE, V483, P470, DOI 10.1038/nature10807; Mountford P, 1998, REPROD FERT DEVELOP, V10, P527, DOI 10.1071/RD98087; Navarro P, 2012, EMBO J, V31, P4547, DOI 10.1038/emboj.2012.321; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Ogawa K, 2006, BIOCHEM BIOPH RES CO, V343, P159, DOI 10.1016/j.bbrc.2006.02.127; Osorno R, 2012, DEVELOPMENT, V139, P2288, DOI 10.1242/dev.078071; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Savarese F, 2009, GENE DEV, V23, P2625, DOI 10.1101/gad.1815709; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Smith AG., 1991, J TISSUE CULT METHOD, V13, P89, DOI [10.1007/BF01666137, DOI 10.1007/BF01666137, 10.1007/bf01666137]; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; van den Berg DLC, 2008, MOL CELL BIOL, V28, P5986, DOI 10.1128/MCB.00301-08; van Oosten AL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1822; Villasante A, 2011, CELL CYCLE, V10, P1488, DOI 10.4161/cc.10.9.15658; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Yamanaka Y, 2010, DEVELOPMENT, V137, P715, DOI 10.1242/dev.043471; Yeom YI, 1996, DEVELOPMENT, V122, P881; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Yuan H., 1996, GENE DEV, V9, P2635	55	129	134	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 2	2013	12	5					531	545		10.1016/j.stem.2013.04.023	http://dx.doi.org/10.1016/j.stem.2013.04.023			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VE	23642364	hybrid, Green Published			2022-12-28	WOS:000329569600010
J	Noble, M; Mayer-Proschel, M; Proschel, C				Noble, Mark; Mayer-Proeschel, Margot; Proeschel, Christoph			iOPs: A New Tool for Studying Myelin Pathologies?	CELL STEM CELL			English	Editorial Material							OLIGODENDROCYTE; CELLS	Generating patient-specific oligodendrocyte progenitors capable of repairing myelination defects observed in multiple neurological afflictions holds great therapeutic potential. Recently in Nature Biotechnology, Najm et al. (2013) and Yang et al. (2013) generated these progenitors by direct reprogramming, bringing us closer to their use in disease analysis and autologous transplantation strategies.	[Noble, Mark; Mayer-Proeschel, Margot; Proeschel, Christoph] Univ Rochester, Med Ctr, Stem Cell & Regenerat Med Inst, Dept Biomed Genet, Rochester, NY 14642 USA	University of Rochester	Noble, M (corresponding author), Univ Rochester, Med Ctr, Stem Cell & Regenerat Med Inst, Dept Biomed Genet, Rochester, NY 14642 USA.	mark_noble@urmc.rochester.edu						Dietrich J, 2005, NAT MED, V11, P277, DOI 10.1038/nm1195; Dugas JC, 2006, J NEUROSCI, V26, P10967, DOI 10.1523/JNEUROSCI.2572-06.2006; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; GROVES AK, 1993, NATURE, V362, P453, DOI 10.1038/362453a0; Najm FJ, 2013, NAT BIOTECHNOL, V31, P426, DOI 10.1038/nbt.2561; Noble M, 2004, DEV BIOL, V265, P33, DOI 10.1016/j.ydbio.2003.06.002; Power J, 2002, DEV BIOL, V245, P362, DOI 10.1006/dbio.2002.0610; Tanner DC, 2011, J NEUROSCI, V31, P6235, DOI 10.1523/JNEUROSCI.5905-10.2011; Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002; Yang N, 2013, NAT BIOTECHNOL, V31, P434, DOI 10.1038/nbt.2564	10	2	2	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 2	2013	12	5					503	504		10.1016/j.stem.2013.04.021	http://dx.doi.org/10.1016/j.stem.2013.04.021			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VE	23642358	Bronze			2022-12-28	WOS:000329569600004
J	Han, XN; Chen, M; Wang, FS; Windrem, M; Wang, S; Shanz, S; Xu, QW; Oberheim, NA; Bekar, L; Betstadt, S; Silva, AJ; Takano, T; Goldman, SA; Nedergaard, M				Han, Xiaoning; Chen, Michael; Wang, Fushun; Windrem, Martha; Wang, Su; Shanz, Steven; Xu, Qiwu; Oberheim, Nancy Ann; Bekar, Lane; Betstadt, Sarah; Silva, Alcino J.; Takano, Takahiro; Goldman, Steven A.; Nedergaard, Maiken			Forebrain Engraftment by Human Glial Progenitor Cells Enhances Synaptic Plasticity and Learning in Adult Mice	CELL STEM CELL			English	Article							AMPA-RECEPTOR TRAFFICKING; LONG-TERM POTENTIATION; TNF-ALPHA; AREA CA1; D-SERINE; ASTROCYTES; BRAIN; HIPPOCAMPUS; MEMORY; EXCITABILITY	Human astrocytes are larger and more complex than those of infraprimate mammals, suggesting that their role in neural processing has expanded with evolution. To assess the cell-autonomous and species-selective properties of human glia, we engrafted human glial progenitor cells (GPCs) into neonatal immunodeficient mice. Upon maturation, the recipient brains exhibited large numbers and high proportions of both human glial progenitors and astrocytes. The engrafted human glia were gap-junction-coupled to host astroglia, yet retained the size and pleomorphism of hominid astroglia, and propagated Ca2+ signals 3-fold faster than their hosts. Long-term potentiation (LTP) was sharply enhanced in the human glial chimeric mice, as was their learning, as assessed by Barnes maze navigation, object-location memory, and both contextual and tone fear conditioning. Mice allografted with murine GPCs showed no enhancement of either LTP or learning. These findings indicate that human glia differentially enhance both activity-dependent plasticity and learning in mice.	[Han, Xiaoning; Chen, Michael; Wang, Fushun; Windrem, Martha; Wang, Su; Shanz, Steven; Xu, Qiwu; Oberheim, Nancy Ann; Bekar, Lane; Takano, Takahiro; Goldman, Steven A.; Nedergaard, Maiken] Univ Rochester, Med Ctr, Ctr Translat Neuromed, Rochester, NY 14642 USA; [Han, Xiaoning; Chen, Michael; Wang, Fushun; Xu, Qiwu; Oberheim, Nancy Ann; Bekar, Lane; Takano, Takahiro; Goldman, Steven A.; Nedergaard, Maiken] Univ Rochester, Med Ctr, Dept Neurosurg, Rochester, NY 14642 USA; [Windrem, Martha; Wang, Su; Shanz, Steven; Goldman, Steven A.; Nedergaard, Maiken] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Betstadt, Sarah] Univ Rochester, Med Ctr, Dept Obstet & Gynecol, Rochester, NY 14642 USA; [Silva, Alcino J.] Univ Calif Los Angeles, David Geffen Sch Med, Integrat Ctr Learning & Memory, Dept Neurobiol, Los Angeles, CA 90095 USA; [Silva, Alcino J.] Univ Calif Los Angeles, David Geffen Sch Med, Integrat Ctr Learning & Memory, Dept Psychiat, Los Angeles, CA 90095 USA; [Silva, Alcino J.] Univ Calif Los Angeles, David Geffen Sch Med, Integrat Ctr Learning & Memory, Dept Psychol, Los Angeles, CA 90095 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Goldman, SA (corresponding author), Univ Rochester, Med Ctr, Ctr Translat Neuromed, Rochester, NY 14642 USA.	steven_goldman@urmc.rochester.edu; nedergaard@urmc.rochester.edu	Silva, Alcino/ABD-7684-2021; Bekar, Lane K./AAI-2645-2021	Silva, Alcino/0000-0002-1587-4558; Silva, Alcino/0000-0001-5525-0494; Bekar, Lane/0000-0001-5083-0967; Takano, Takahiro/0000-0002-6235-6673; Goldman, Steven/0000-0002-5498-4303	G. Harold and Leila Y. Mathers Charitable Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; National Multiple Sclerosis Society; NIMH; NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078304, R01NS075345, R01NS078167, R01NS052534, R01NS075177] Funding Source: NIH RePORTER	G. Harold and Leila Y. Mathers Charitable Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; National Multiple Sclerosis Society(National Multiple Sclerosis Society); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the G. Harold and Leila Y. Mathers Charitable Foundation, the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, the National Multiple Sclerosis Society, NIMH, and NINDS. We thank R. Malenka for valuable comments on the manuscript. Drs. Goldman and Windrem have a patent on the generation and use of glial chimeric mice, entitled, "Non-human animals with human glial chimeric brains," US patent no. 7,524,491. They receive no income or financial consideration from this patent.	Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; COLINO A, 1993, J NEUROPHYSIOL, V69, P1150, DOI 10.1152/jn.1993.69.4.1150; Colombo J. A., 2001, Neurobiology (Budapest), V9, P1, DOI 10.1556/Neurob.9.2001.1.1; Colombo JA, 1996, ACTA ANAT, V155, P57; COLOMBO JA, 1995, J NEUROSCI RES, V40, P551, DOI 10.1002/jnr.490400414; COTRINA M, 2005, INTRACELLULAR CALCIU; Dawitz J, 2011, J VIS EXP, V56; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; Faurschou A, 2008, EXP DERMATOL, V17, P992, DOI 10.1111/j.1600-0625.2008.00740.x; Fields RD, 2004, SCI AM, V290, P54, DOI 10.1038/scientificamerican0404-54; GROVER LM, 1993, NEUROSCI LETT, V154, P39, DOI 10.1016/0304-3940(93)90166-I; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mangin JM, 2011, ASN NEURO, V3, P37, DOI 10.1042/AN20110001; Manns JR, 2009, LEARN MEMORY, V16, P616, DOI 10.1101/lm.1484509; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Nedergaard M, 2012, GLIA, V60, P1013, DOI 10.1002/glia.22288; Ni YC, 2009, GLIA, V57, P1296, DOI 10.1002/glia.20849; Oberheim NA, 2006, TRENDS NEUROSCI, V29, P547, DOI 10.1016/j.tins.2006.08.004; Oberheim NA, 2012, METHODS MOL BIOL, V814, P23, DOI 10.1007/978-1-61779-452-0_3; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Parpura V, 2012, NEUROCHEM INT, V61, P610, DOI 10.1016/j.neuint.2011.12.001; Parpura V, 2010, BRAIN RES REV, V63, P83, DOI 10.1016/j.brainresrev.2009.11.008; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Rusakov DA, 2011, NEUROSCIENTIST, V17, P513, DOI 10.1177/1073858410387304; Ryu JK, 2008, NEUROBIOL DIS, V29, P254, DOI 10.1016/j.nbd.2007.08.019; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Verkhratsky A, 1998, PHYSIOL REV, V78, P99, DOI 10.1152/physrev.1998.78.1.99; Windrem M.S., 2009, NEONATALLY IMPLANTED; Windrem MS, 2008, CELL STEM CELL, V2, P553, DOI 10.1016/j.stem.2008.03.020; Windrem MS, 2004, NAT MED, V10, P93, DOI 10.1038/nm974; WU LG, 1994, NEURON, V12, P1139, DOI 10.1016/0896-6273(94)90321-2; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7; Zhou Y, 2009, NAT NEUROSCI, V12, P1438, DOI 10.1038/nn.2405	39	388	400	1	78	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 7	2013	12	3					342	353		10.1016/j.stem.2012.12.015	http://dx.doi.org/10.1016/j.stem.2012.12.015			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VC	23472873	Bronze, Green Accepted			2022-12-28	WOS:000329569400012
J	Xie, RY; Everett, LJ; Lim, HW; Patel, NA; Schug, J; Kroon, E; Kelly, OG; Wang, A; D'Amour, KA; Robins, AJ; Won, KJ; Kaestner, KH; Sander, M				Xie, Ruiyu; Everett, Logan J.; Lim, Hee-Woong; Patel, Nisha A.; Schug, Jonathan; Kroon, Evert; Kelly, Olivia G.; Wang, Allen; D'Amour, Kevin A.; Robins, Allan J.; Won, Kyoung-Jae; Kaestner, Klaus H.; Sander, Maike			Dynamic Chromatin Remodeling Mediated by Polycomb Proteins Orchestrates Pancreatic Differentiation of Human Embryonic Stem Cells	CELL STEM CELL			English	Article							GENOME-WIDE MAPS; INSULIN-SECRETION; DEVELOPMENTAL REGULATORS; LYSINE-27 METHYLATION; HISTONE MODIFICATIONS; IN-VIVO; LINEAGE; ISLETS; GENES	Embryonic development is characterized by dynamic changes in gene expression, yet the role of chromatin remodeling in these cellular transitions remains elusive. To address this question, we profiled the transcriptome and select chromatin modifications at defined stages during pancreatic endocrine differentiation of human embryonic stem cells. We identify removal of Polycomb group (PcG)-mediated repression on stage-specific genes as a key mechanism for the induction of developmental regulators. Furthermore, we discover that silencing of transitory genes during lineage progression associates with reinstatement of PcG-dependent repression. Significantly, in vivo-but not in vitro-differentiated endocrine cells exhibit close similarity to primary human islets in regard to transcriptome and chromatin structure. We further demonstrate that endocrine cells produced in vitro do not fully eliminate PcG-mediated repression on endocrine-specific genes, probably contributing to their malfunction. These studies reveal dynamic chromatin remodeling during developmental lineage progression and identify possible strategies for improving cell differentiation in culture.	[Xie, Ruiyu; Patel, Nisha A.; Wang, Allen; Sander, Maike] Univ Calif San Diego, Dept Pediat & Cellular & Mol Med, La Jolla, CA 92093 USA; [Everett, Logan J.; Lim, Hee-Woong; Schug, Jonathan; Won, Kyoung-Jae; Kaestner, Klaus H.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Everett, Logan J.; Lim, Hee-Woong; Schug, Jonathan; Won, Kyoung-Jae; Kaestner, Klaus H.] Univ Penn, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Kroon, Evert; Kelly, Olivia G.; D'Amour, Kevin A.; Robins, Allan J.] ViaCyte Inc, San Diego, CA 92121 USA	University of California System; University of California San Diego; University of Pennsylvania; University of Pennsylvania	Sander, M (corresponding author), Univ Calif San Diego, Dept Pediat & Cellular & Mol Med, La Jolla, CA 92093 USA.	masander@ucsd.edu	Sander, Maike/N-6615-2016; Lim, Hee Woong/AAX-6835-2021; Everett, Logan/AAK-1523-2021; Lim, HW/GRY-3517-2022	Sander, Maike/0000-0001-5308-7785; Lim, Hee Woong/0000-0001-8599-1808; KROON, EVERT/0000-0002-4069-3644; Xie, Ruiyu/0000-0003-0518-2897; Won, Kyoung Jae/0000-0002-2924-9630	National Institutes of Health [U01-DK089567, R01-DK07243, U01-DK089529, R01-DK088383, P30-DK19525]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078803, P30DK019525, R01DK088383, U01DK089529, U01DK089567] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. Wright (Vanderbilt University) and K. Miyabayashi (Kyushu University) for antibodies; T. Harper for lentivirus preparation; N. Shah and E. Lee for technical assistance; and E. Baetge and members of the M. S. laboratory for helpful discussions. We acknowledge use of human fetal pancreas provided by the Birth Defects Research Laboratory of the University of Washington. We are grateful to E. O'Connor for his help with FACS. This work was supported by National Institutes of Health grants U01-DK089567 and R01-DK07243 to M. S., U01-DK089529 and R01-DK088383 to K. H. K., and P30-DK19525 to K.-J.W.	Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bhandare R, 2010, GENOME RES, V20, P428, DOI 10.1101/gr.102038.109; Blum B, 2012, NAT BIOTECHNOL, V30, P261, DOI 10.1038/nbt.2141; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dorrell C, 2011, DIABETOLOGIA, V54, P2832, DOI 10.1007/s00125-011-2283-5; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Henseleit KD, 2005, DEVELOPMENT, V132, P3139, DOI 10.1242/dev.01875; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Kelly OG, 2011, NAT BIOTECHNOL, V29, P750, DOI 10.1038/nbt.1931; Kim SW, 2011, DEV BIOL, V357, P492, DOI 10.1016/j.ydbio.2011.06.009; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li C, 2007, P NATL ACAD SCI USA, V104, P4206, DOI 10.1073/pnas.0611641104; Lien WH, 2011, CELL STEM CELL, V9, P219, DOI 10.1016/j.stem.2011.07.015; Liu HL, 2011, ACTA HISTOCHEM, V113, P340, DOI 10.1016/j.acthis.2010.01.005; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Luco RF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000079; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Preitner F, 2004, J CLIN INVEST, V113, P635, DOI 10.1172/JCI200420518; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Schulz TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037004; Seymour PA, 2011, DIABETES, V60, P364, DOI 10.2337/db10-1068; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Spence JR, 2009, DEV CELL, V17, P62, DOI 10.1016/j.devcel.2009.05.012; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; van Arensbergen J, 2010, GENOME RES, V20, P722, DOI 10.1101/gr.101709.109; Yamada M, 2010, DEV DYNAM, V239, P941, DOI 10.1002/dvdy.22212; Yebra M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022750	38	174	185	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 7	2013	12	2					224	237		10.1016/j.stem.2012.11.023	http://dx.doi.org/10.1016/j.stem.2012.11.023			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VB	23318056	Bronze, Green Accepted			2022-12-28	WOS:000329569300013
J	Kalaitzidis, D; Sykes, SM; Wang, Z; Punt, N; Tang, YF; Ragu, C; Sinha, AU; Lane, SW; Souza, AL; Clish, CB; Anastasiou, D; Gilliland, DG; Scadden, DT; Guertin, DA; Armstrong, SA				Kalaitzidis, Demetrios; Sykes, Stephen M.; Wang, Zhu; Punt, Natalie; Tang, Yuefeng; Ragu, Christine; Sinha, Amit U.; Lane, Steven W.; Souza, Amanda L.; Clish, Clary B.; Anastasiou, Dimitrios; Gilliland, D. Gary; Scadden, David T.; Guertin, David A.; Armstrong, Scott A.			mTOR Complex 1 Plays Critical Roles in Hematopoiesis and Pten-Loss-Evoked Leukemogenesis	CELL STEM CELL			English	Article							STEM-CELLS; LEUKEMIA; REVEALS; DIFFERENTIATION; GROWTH; RENEWAL; RICTOR; GENE; MICE	The mechanistic target of rapamycin (mTOR) pathway serves as a key sensor of cellular-energetic state and functions to maintain tissue homeostasis. Hyperactivation of the mTOR pathway impairs hematopoietic stem cell (HSC) function and is associated with leukemogenesis. However, the roles of the unique mTOR. complexes (mTORCs) in hematopoiesis and leukemogenesis have not been adequately elucidated. We deleted the mTORC1 component, regulatory-associated protein of mTOR (Raptor), in mouse HSCs and its loss causes a nonlethal phenotype characterized by pancytopenia, splenomegaly, and the accumulation of monocytoid cells. Furthermore, Raptor is required for HSC regeneration, and plays largely nonredundant roles with rapamycin-insensitive companion of mTOR (Rictor) in these processes. Ablation of Raptor also significantly extends survival of mice in models of leukemogenesis evoked by Pten deficiency. These data delineate critical roles for mTORC1 in hematopoietic function and leukemogenesis and inform clinical strategies based on chronic mTORC1 inhibition.	[Tang, Yuefeng; Guertin, David A.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Kalaitzidis, Demetrios; Wang, Zhu; Punt, Natalie; Sinha, Amit U.; Armstrong, Scott A.] Harvard Univ, Sch Med, Childrens Hosp Boston, Div Hematol Oncol, Boston, MA 02115 USA; [Kalaitzidis, Demetrios; Wang, Zhu; Punt, Natalie; Sinha, Amit U.; Armstrong, Scott A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Kalaitzidis, Demetrios; Wang, Zhu; Punt, Natalie; Sinha, Amit U.; Armstrong, Scott A.] Harvard Stem Cell Inst, Boston, MA 02115 USA; [Sykes, Stephen M.; Ragu, Christine; Scadden, David T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Stem Cell & Regenerat Biol,Ctr Regenerat Med, Boston, MA 02114 USA; [Sykes, Stephen M.; Ragu, Christine; Scadden, David T.] Harvard Stem Cell Inst, Boston, MA 02114 USA; [Lane, Steven W.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Souza, Amanda L.; Clish, Clary B.] Broad Inst MIT & Harvard, Metabolite Profiling Initiat, Cambridge, MA 02142 USA; [Anastasiou, Dimitrios] Beth Israel Deaconess Med Ctr, Dept Med, Div Signal Transduct, Boston, MA 02215 USA; [Anastasiou, Dimitrios] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Gilliland, D. Gary] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Hematol,Dept Med, Boston, MA 02115 USA	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; QIMR Berghofer Medical Research Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Guertin, DA (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	david.guertin@umassmed.edu; scott.armstrong@childrens.harvard.edu	Clish, Clary/AAB-7124-2019; Clish, Clary B/ABB-9374-2021	Clish, Clary B/0000-0001-8259-9245; Anastasiou, Dimitrios/0000-0002-1269-843X; Ragu, Christine/0000-0002-1150-1105	NIDDK [K01DK092300]; Nestle Research Center; NIH [HL097794, HL097748, HL100402, DK050234, R00 CA129613, CA66996, CA105423, DK049216]; PEW Charitable Trust; Leukemia and Lymphoma Society; American Cancer Society; Charles H. Hood Foundation; NATIONAL CANCER INSTITUTE [R00CA129613, P01CA066996, R00CA158461, K99CA158461, U01CA105423] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044851, U01HL100402, R01HL097794, R01HL097748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050234, K01DK092300, P50DK049216, P30DK049216] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Nestle Research Center(Nestle SA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PEW Charitable Trust; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); American Cancer Society(American Cancer Society); Charles H. Hood Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We wish to thank Rebekka Schneider-Kramann for assistance with pathology, Kristina M. Brumme for assistance with mouse husbandry, and Michael G. Kharas for review of the manuscript. D.K. was supported by NIDDK grant K01DK092300; C.B.C. was partially supported by the Nestle Research Center; D.G.G. is currently a full-time employee of Merck and Co. Inc.; D.T.S. was supported by NIH grants HL097794, HL097748, HL100402, and DK050234; D.A.G. was supported by NIH grant R00 CA129613 and the PEW Charitable Trust; and S.A.A. was supported by grants from the Leukemia and Lymphoma Society, The American Cancer Society, The Charles H. Hood Foundation, and NIH grants CA66996, CA105423, and DK049216.	Calamito M, 2010, BLOOD, V115, P4043, DOI 10.1182/blood-2009-09-241638; Campbell TB, 2009, BLOOD, V114, P3392, DOI 10.1182/blood-2008-12-195214; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Chapuis N, 2010, LEUKEMIA, V24, P1686, DOI 10.1038/leu.2010.170; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Gan B, 2008, P NATL ACAD SCI USA, V105, P19384, DOI 10.1073/pnas.0810584105; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Janes MR, 2010, NAT MED, V16, P205, DOI 10.1038/nm.2091; Kalaitzidis D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003776; Kharas MG, 2010, BLOOD, V115, P1406, DOI 10.1182/blood-2009-06-229443; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee JY, 2010, CELL STEM CELL, V7, P593, DOI 10.1016/j.stem.2010.09.015; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Magee JA, 2012, CELL STEM CELL, V11, P415, DOI 10.1016/j.stem.2012.05.026; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Qian H, 2007, CELL STEM CELL, V1, P671, DOI 10.1016/j.stem.2007.10.008; Ruzankin Y., 1997, CELL STEM CELL, V1, P113; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Sykes SM, 2011, CELL, V146, P697, DOI 10.1016/j.cell.2011.07.032; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Warr MR, 2011, WIRES SYST BIOL MED, V3, P681, DOI 10.1002/wsbm.145; Yang L., 1995, BLOOD, V105, P2717; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zheng JK, 2011, CELL STEM CELL, V9, P119, DOI 10.1016/j.stem.2011.06.003	37	143	150	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 7	2012	11	3					429	439		10.1016/j.stem.2012.06.009	http://dx.doi.org/10.1016/j.stem.2012.06.009			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	018DW	22958934	Green Accepted, Bronze			2022-12-28	WOS:000309641300015
J	Magee, JA; Ikenoue, T; Nakada, D; Lee, JY; Guan, KL; Morrison, SJ				Magee, Jeffrey A.; Ikenoue, Tsuneo; Nakada, Daisuke; Lee, Jae Y.; Guan, Kun-Liang; Morrison, Sean J.			Temporal Changes in PTEN and mTORC2 Regulation of Hematopoietic Stem Cell Self-Renewal and Leukemia Suppression	CELL STEM CELL			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; INTERNAL TANDEM DUPLICATION; DEPENDENCE DISTINGUISHES; PROGNOSTIC-SIGNIFICANCE; FETAL; MICE; LEUKEMOGENESIS; PURIFICATION; ACTIVATION; MECHANISMS	Pten deletion from adult mouse hematopoietic cells activates the PI3-kinase pathway, inducing hematopoietic stem cell (HSC) proliferation, HSC depletion, and leukemogenesis. Pten is also mutated in human leukemias, but rarely in early childhood leukemias. We hypothesized that this reflects developmental changes in P13-kinase pathway regulation. Here we show that Rictor deletion prevents leukemogenesis and HSC depletion after Pten deletion in adult mice, implicating mTORC2 activation in these processes. However, Rictor deletion had little effect on the function of normal HSCs. Moreover, Pten deletion from neonatal HSCs did not activate the P13-kinase pathway or promote HSC proliferation, HSC depletion, or leukemogenesis. Pten is therefore required in adult, but not neonatal, HSCs to negatively regulate mTORC2 signaling. This demonstrates that some critical tumor suppressor mechanisms in adult cells are not required by neonatal cells. Developmental changes in key signaling pathways therefore confer temporal changes upon stem cell self-renewal and tumor suppressor mechanisms.	[Magee, Jeffrey A.; Morrison, Sean J.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Magee, Jeffrey A.; Morrison, Sean J.] Univ Texas SW Med Ctr Dallas, Childrens Res Inst, Dallas, TX 75390 USA; [Morrison, Sean J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Ikenoue, Tsuneo] Univ Tokyo, Inst Med Sci, Div Clin Genome Res, Adv Clin Res Ctr, Tokyo 1088639, Japan; [Nakada, Daisuke; Lee, Jae Y.; Morrison, Sean J.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Tokyo; University of Michigan System; University of Michigan; University of California System; University of California San Diego; University of California System; University of California San Diego	Morrison, SJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA.	sean.morrison@utsouthwestern.edu	Guan, Kun-Liang/ADK-7088-2022; Morrison, Sean/ABD-5326-2021	Nakada, Daisuke/0000-0001-6010-7094; Morrison, Sean/0000-0003-1587-8329; Lee, Jae/0000-0003-2264-9620	National Institute on Aging [R37 AG024945]; Howard Hughes Medical Institute; Cancer Prevention and Research Institute of Texas; Pediatric Scientist Development Program of the Association of Medical School Pediatric Department Chairs; National Institute of Child Health and Human Development; NATIONAL CANCER INSTITUTE [R01CA108941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG024945] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Cancer Prevention and Research Institute of Texas; Pediatric Scientist Development Program of the Association of Medical School Pediatric Department Chairs; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute on Aging (R37 AG024945), the Howard Hughes Medical Institute, and the Cancer Prevention and Research Institute of Texas. J.A.M. was supported by a grant from the Pediatric Scientist Development Program of the Association of Medical School Pediatric Department Chairs and the National Institute of Child Health and Human Development. Torin1 was a gift of Nathaniel Gray (Harvard University). J.A.M. performed all experiments and participated in the design and interpretation of all experiments. T.I. and K.L.G. generated the Rictor<SUP>fl</SUP> allele. D.N. backcrossed the Rictor<SUP>fl</SUP> allele onto a C57BL/6Ka-Thy-1.1 background and assisted with reconstitution experiments. J.Y.L. assisted with the analysis of reconstitution experiments. S.J.M. participated in the design and interpretation of all experiments and wrote the paper with J.A.M.	Aiba Y, 2006, IMMUNITY, V24, P259, DOI 10.1016/j.immuni.2006.01.002; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Clappier E, 2007, BLOOD, V110, P1251, DOI 10.1182/blood-2006-12-064683; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Dahia PLM, 1999, HUM MOL GENET, V8, P185, DOI 10.1093/hmg/8.2.185; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Downing JR, 2002, CANCER CELL, V2, P437, DOI 10.1016/S1535-6108(02)00211-8; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Gan B, 2008, P NATL ACAD SCI USA, V105, P19384, DOI 10.1073/pnas.0810584105; Gedman AL, 2009, LEUKEMIA, V23, P1417, DOI 10.1038/leu.2009.64; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Guo W, 2008, NATURE, V453, P529, DOI 10.1038/nature06933; Gutierrez A, 2009, BLOOD, V114, P647, DOI 10.1182/blood-2009-02-206722; He SH, 2011, GENE DEV, V25, P1613, DOI 10.1101/gad.2052911; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Juntilla MM, 2010, BLOOD, V115, P4030, DOI 10.1182/blood-2009-09-241000; Kalaitzidis D, 2012, CELL STEM CELL, V11, P429, DOI 10.1016/j.stem.2012.06.009; Karrman K, 2009, GENE CHROMOSOME CANC, V48, P795, DOI 10.1002/gcc.20684; Kharas MG, 2008, J CLIN INVEST, V118, P3038, DOI 10.1172/JCI33337; Kharas MG, 2010, BLOOD, V115, P1406, DOI 10.1182/blood-2009-06-229443; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kim I, 2006, BLOOD, V108, P737, DOI 10.1182/blood-2005-10-4135; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lee JY, 2010, CELL STEM CELL, V7, P593, DOI 10.1016/j.stem.2010.09.015; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Martelli AM, 2006, LEUKEMIA, V20, P911, DOI 10.1038/sj.leu.2404245; Meshinchi S, 2001, BLOOD, V97, P89, DOI 10.1182/blood.V97.1.89; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; SMITH M, 1999, SEER PEDIAT MONOGRAP; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wiemels JL, 1999, BLOOD, V94, P1057, DOI 10.1182/blood.V94.3.1057.415k10_1057_1062; Wiemels JL, 1999, LANCET, V354, P1499, DOI 10.1016/S0140-6736(99)09403-9; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yoshimi A, 2011, BLOOD, V117, P3617, DOI 10.1182/blood-2009-12-261602; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zwaan CM, 2003, BLOOD, V102, P2387, DOI 10.1182/blood-2002-12-3627	51	144	151	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 7	2012	11	3					415	428		10.1016/j.stem.2012.05.026	http://dx.doi.org/10.1016/j.stem.2012.05.026			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	018DW	22958933	Green Accepted, Bronze			2022-12-28	WOS:000309641300014
J	O'Loghlen, A; Munoz-Cabello, AM; Gaspar-Maia, A; Wu, HA; Banito, A; Kunowska, N; Racek, T; Pemberton, HN; Beolchi, P; Lavial, F; Masui, O; Vermeulen, M; Carroll, T; Graumann, J; Heard, E; Dillon, N; Azuara, V; Snijders, AP; Peters, G; Bernstein, E; Gil, J				O'Loghlen, Ana; Munoz-Cabello, Ana M.; Gaspar-Maia, Alexandre; Wu, Hsan-Au; Banito, Ana; Kunowska, Natalia; Racek, Tomas; Pemberton, Helen N.; Beolchi, Patrizia; Lavial, Fabrice; Masui, Osamu; Vermeulen, Michiel; Carroll, Thomas; Graumann, Johannes; Heard, Edith; Dillon, Niall; Azuara, Veronique; Snijders, Ambrosius P.; Peters, Gordon; Bernstein, Emily; Gil, Jesus			MicroRNA Regulation of Cbx7 Mediates a Switch of Polycomb Orthologs during ESC Differentiation	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; METHYLATED HISTONE H3; DEVELOPMENTAL REGULATORS; SKELETAL-MUSCLE; GENES; PLURIPOTENT; SENESCENCE; CIRCUITRY; PROTEINS; INK4A	The Polycomb Group (PcG) of chromatin modifiers regulates pluripotency and differentiation. Mammalian genomes encode multiple homologs of the Polycomb repressive complex 1 (PRC1) components, including five orthologs of the Drosophila Polycomb protein (Cbx2, Cbx4, Cbx6, Cbx7, and Cbx8). We have identified Cbx7 as the primary Polycomb ortholog of PRC1 complexes in embryonic stem cells (ESCs). The expression of Cbx7 is downregulated during ESC differentiation, preceding the upregulation of Cbx2, Cbx4, and Cbx8, which are directly repressed by Cbx7. Ectopic expression of Cbx7 inhibits differentiation and X chromosome inactivation and enhances ESC self-renewal. Conversely, Cbx7 knockdown induces differentiation and derepresses lineage-specific markers. In a functional screen, we identified the miR-125 and miR-181 families as regulators of Cbx7 that are induced during ESC differentiation. Ectopic expression of these miRNAs accelerates ESC differentiation via regulation of Cbx7. These observations establish a critical role for Cbx7 and its regulatory miRNAs in determining pluripotency.	[O'Loghlen, Ana; Munoz-Cabello, Ana M.; Banito, Ana; Beolchi, Patrizia; Gil, Jesus] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Cell Proliferat Grp, London W12 0NN, England; [O'Loghlen, Ana; Munoz-Cabello, Ana M.; Banito, Ana; Kunowska, Natalia; Beolchi, Patrizia; Carroll, Thomas; Dillon, Niall; Gil, Jesus] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Epigenet Sect, London W12 0NN, England; [Kunowska, Natalia; Dillon, Niall] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Gene Regulat & Chromatin Grp, London W12 0NN, England; [Snijders, Ambrosius P.] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Biomol Mass Spectrometry & Prote Lab, London W12 0NN, England; [Gaspar-Maia, Alexandre; Wu, Hsan-Au; Bernstein, Emily] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Racek, Tomas; Pemberton, Helen N.; Peters, Gordon] CRUK London Res Inst, Mol Oncol Lab, London WC2A 3PX, England; [Lavial, Fabrice; Azuara, Veronique] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London W12 0NN, England; [Masui, Osamu; Heard, Edith] Inst Curie, F-75248 Paris, France; [Vermeulen, Michiel; Graumann, Johannes] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany; [Vermeulen, Michiel] Univ Med Ctr Utrecht, Dept Mol Canc Res, Utrecht, Netherlands; [Graumann, Johannes] Qatar Fdn, Weill Cornell Med Coll Qatar, Doha, Qatar	Imperial College London; Imperial College London; Imperial College London; Imperial College London; Icahn School of Medicine at Mount Sinai; Cancer Research UK; Imperial College London; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Max Planck Society; Utrecht University; Utrecht University Medical Center; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Gil, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Cell Proliferat Grp, Hammersmith Campus, London W12 0NN, England.	jesus.gil@csc.mrc.ac.uk	Xie, Huangming/B-2260-2012; Heard, Edith/D-7197-2017; O'Loghlen, Ana/K-9965-2014; Masui, Osamu/AAH-4111-2019; Gil, Jesus/C-7739-2012; Graumann, Johannes/C-5241-2008; Gaspar-Maia, Alexandre/AAY-5416-2020; Banito, Ana/P-6168-2017; Cabello, Ana Maria Muñoz/E-5292-2016; Vermeulen, Michiel/C-8883-2013	Heard, Edith/0000-0001-8052-7117; Gil, Jesus/0000-0002-4303-6260; Graumann, Johannes/0000-0002-3015-5850; Gaspar-Maia, Alexandre/0000-0001-8528-5575; Cabello, Ana Maria Muñoz/0000-0002-8047-768X; Vermeulen, Michiel/0000-0003-0836-6894; Lavial, Fabrice/0000-0001-9752-4393; Azuara, Veronique/0000-0003-4608-3713; Banito, Ana/0000-0003-2188-0003; Snijders, Bram/0000-0002-5416-8592; O'Loghlen, Ana/0000-0002-8141-1965	NYSTEM IDEA [C024285]; ANR; ERC; MRC; MRC Technology; CRUK; EMBO; BBSRC [BB/G011117/1] Funding Source: UKRI; MRC [MC_U120036884, MC_U120085810] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G011117/1] Funding Source: researchfish; Medical Research Council [MC_U120085810, MC_U120036884] Funding Source: researchfish	NYSTEM IDEA; ANR(French National Research Agency (ANR)); ERC(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Technology(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CRUK(Cancer Research UK); EMBO(European Molecular Biology Organization (EMBO)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Mathias Mann for his support; Elizabeth Duncan and David Allis for sharing the LF2 Cbx7 ESCs; and Yen-Sin Ang, Kajan Ratnakumar, Haruhiko Koseki, Adrian Bracken, Meng Li, Tristan Rodriguez, Cynthia Fisher, and Sam Wormwald for advice and reagents. This work was supported by an NYSTEM IDEA Award C024285 to E.B. E.H. and O.M. received support from the ANR and ERC Advanced Investigator award. Core support from the MRC and grants from MRC Technology, CRUK, and AICR went to fund J.G.'s research. A.M. was funded by Fundacion Ramon Areces, and A.B., by the Portuguese FCT. J.G. is also supported by the EMBO Young Investigator Programme.	Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Dietrich N, 2007, EMBO J, V26, P1637, DOI 10.1038/sj.emboj.7601632; Gil J, 2004, NAT CELL BIOL, V6, P67, DOI 10.1038/ncb1077; Glud M, 2011, MELANOMA RES, V21, P253, DOI 10.1097/CMR.0b013e328345333b; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Le MTN, 2009, MOL CELL BIOL, V29, P5290, DOI 10.1128/MCB.01694-08; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Maertens GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006380; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Masui O, 2011, CELL, V145, P447, DOI 10.1016/j.cell.2011.03.032; Melton C, 2010, ADV EXP MED BIOL, V695, P105, DOI 10.1007/978-1-4419-7037-4_8; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Whitcomb SJ, 2007, TRENDS GENET, V23, P494, DOI 10.1016/j.tig.2007.08.006; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021	33	159	164	0	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JAN 6	2012	10	1					33	46		10.1016/j.stem.2011.12.004	http://dx.doi.org/10.1016/j.stem.2011.12.004			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	880ZQ	22226354	Green Published, hybrid			2022-12-28	WOS:000299449500009
J	Mahadevan, MS				Mahadevan, Mani S.			Myotonic Muscular Dystrophy, RNA Toxicity, and the Brain: Trouble Making the Connection?	CELL STEM CELL			English	Editorial Material							NEURITE; TYPE-1	The study of rare genetic diseases is complicated by the inaccessibility of relevant cells and tissues, especially for neurologic disorders. In this issue of Cell Stem Cell, Marteyn et al. (2011) use human embryonic stem cells to identify deficits in neuritic outgrowth in myotonic dystrophy type 1.	Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA	University of Virginia	Mahadevan, MS (corresponding author), Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA.	mahadevan@virginia.edu						Aruga J, 2003, MOL CELL NEUROSCI, V24, P117, DOI 10.1016/S1044-7431(03)00129-5; Lee JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011201; Llamusi B, 2008, CURR GENOMICS, V9, P509, DOI 10.2174/138920208786847944; Marteyn A, 2011, CELL STEM CELL, V8, P434, DOI 10.1016/j.stem.2011.02.004; Meola G, 2007, MUSCLE NERVE, V36, P294, DOI 10.1002/mus.20800; Panaite PA, 2008, J NEUROPATH EXP NEUR, V67, P763, DOI 10.1097/NEN.0b013e318180ec64; Proenca CC, 2011, TRENDS NEUROSCI, V34, P143, DOI 10.1016/j.tins.2011.01.001; STRANOCK SD, 1978, NEUROPATH APPL NEURO, V4, P407, DOI 10.1111/j.1365-2990.1978.tb01352.x; Wheeler TM, 2007, NEUROMUSCULAR DISORD, V17, P242, DOI 10.1016/j.nmd.2006.12.015; Yadava RS, 2008, NAT GENET, V40, P61, DOI 10.1038/ng.2007.28	10	1	1	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 8	2011	8	4					349	350		10.1016/j.stem.2011.03.007	http://dx.doi.org/10.1016/j.stem.2011.03.007			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	752QI	21474094	Bronze			2022-12-28	WOS:000289707100002
J	Yu, WM; Liu, X; Shen, JH; Jovanovic, O; Pohl, EE; Gerson, SL; Finkel, T; Broxmeyer, HE; Qu, CK				Yu, Wen-Mei; Liu, Xia; Shen, Jinhua; Jovanovic, Olga; Pohl, Elena E.; Gerson, Stanton L.; Finkel, Toren; Broxmeyer, Hal E.; Qu, Cheng-Kui			Metabolic Regulation by the Mitochondrial Phosphatase PTPMT1 Is Required for Hematopoietic Stem Cell Differentiation	CELL STEM CELL			English	Article							ACTIVATED PROTEIN-KINASE; OF-FUNCTION MUTATION; UNCOUPLING PROTEIN-1; ENERGY-METABOLISM; PROGENITOR CELLS; HYPOXIC NICHE; UCP2; CHECKPOINT; QUIESCENCE; PHOSPHOINOSITIDES	The regulation and coordination of mitochondrial metabolism with hematopoietic stem cell (HSC) self-renewal and differentiation is not fully understood. Here we report that depletion of PTPMT1, a PTEN-like mitochondrial phosphatase, in inducible or hematopoietic-cell-specific knockout mice resulted in hematopoietic failure due to changes in the cell cycle and a block in the differentiation of HSCs. Surprisingly, the HSC pool was increased by similar to 40-fold in PTPMT1 knockout mice. Reintroduction of wild-type PTPMT1, but not catalytically deficient PIPMT1 or truncated PTPMT1 lacking mitochondrial localization, restored differentiation capabilities of PTPMT1 knockout HSCs. Further analyses demonstrated that PTPMT1 deficiency altered mitochondrial metabolism and that phosphatidylinositol phosphate substrates of PTPMT1 directly enhanced fatty-acid-induced activation of mitochondrial uncoupling protein 2. Intriguingly, depletion of PTPMT1 from myeloid, T lymphoid, or B lymphoid progenitors did not cause any defects in lineage-specific knockout mice. This study establishes a crucial role of PTPMT1 in the metabolic regulation of HSC function.	[Yu, Wen-Mei; Liu, Xia; Shen, Jinhua; Gerson, Stanton L.; Qu, Cheng-Kui] Case Western Reserve Univ, Dept Med, Div Hematol & Oncol, Stem Cell & Regenerat Med,Case Comprehens Canc Ct, Cleveland, OH 44106 USA; [Jovanovic, Olga; Pohl, Elena E.] Univ Vet Med, Inst Physiol Pathophysiol & Biophys, A-1210 Vienna, Austria; [Finkel, Toren] NHLBI, Ctr Mol Med, NIH, Bethesda, MD 20892 USA; [Broxmeyer, Hal E.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA	Case Western Reserve University; University of Veterinary Medicine Vienna; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Indiana University System; Indiana University Bloomington	Qu, CK (corresponding author), Case Western Reserve Univ, Dept Med, Div Hematol & Oncol, Stem Cell & Regenerat Med,Case Comprehens Canc Ct, Cleveland, OH 44106 USA.	cxq6@case.edu	Pohl, Elena E./A-4025-2009	Pohl, Elena E./0000-0002-0604-5950	National Institutes of Health [DK092722, HL068212, HL095657]; German Research Foundation [Po 524/5-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006037, R01HL112669, R01HL068212, K18HL095657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092722] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to Dr. Thomas Graf at the Center for Genomic Regulation and ICREA, Spain, for Vav1-Cre transgenic mice; and Dr. Jaburek and Dr. Jezek at Academy of Sciences, Prague, Czech Republic, for providing us with E. coli inclusion bodies containing recombinant hUCP2. This work was supported by National Institutes of Health grants DK092722, HL068212, and HL095657 (to C.K.Q.) and the German Research Foundation grant Po 524/5-1 (to E.E.P).	Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Beck V, 2007, FASEB J, V21, P1137, DOI 10.1096/fj.06-7489com; Beck V, 2006, BBA-BIOENERGETICS, V1757, P474, DOI 10.1016/j.bbabio.2006.03.006; Bouillaud F, 2009, BBA-BIOENERGETICS, V1787, P377, DOI 10.1016/j.bbabio.2009.01.003; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Diano S, 2012, TRENDS MOL MED, V18, P52, DOI 10.1016/j.molmed.2011.08.003; Gamper N, 2007, NAT REV NEUROSCI, V8, P921, DOI 10.1038/nrn2257; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Inoue SI, 2010, FEBS LETT, V584, P3402, DOI 10.1016/j.febslet.2010.06.036; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Lonergan T, 2007, MITOCHONDRION, V7, P289, DOI 10.1016/j.mito.2007.05.002; Mantel C, 2011, CURR OPIN HEMATOL, V18, P208, DOI 10.1097/MOH.0b013e3283475ffe; Matsumoto A, 2011, CELL STEM CELL, V9, P262, DOI 10.1016/j.stem.2011.06.014; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009; Pagliarini DJ, 2005, MOL CELL, V19, P197, DOI 10.1016/j.molcel.2005.06.008; Pagliarini DJ, 2004, J BIOL CHEM, V279, P38590, DOI 10.1074/jbc.M404959200; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; Rupprecht A, 2010, BIOPHYS J, V98, P1503, DOI 10.1016/j.bpj.2009.12.4301; Samudio I, 2009, CANCER RES, V69, P2163, DOI 10.1158/0008-5472.CAN-08-3722; Shen JH, 2011, MOL CELL BIOL, V31, P4902, DOI 10.1128/MCB.05629-11; Simonnet AJ, 2009, STEM CELLS, V27, P1400, DOI 10.1002/stem.66; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; Viollet B, 2009, ACTA PHYSIOL, V196, P81, DOI 10.1111/j.1748-1716.2009.01970.x; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Xu D, 2011, J EXP MED, V208, P1977, DOI 10.1084/jem.20110450; Xu D, 2010, BLOOD, V116, P3611, DOI 10.1182/blood-2010-01-265652; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126; Zhang J, 2011, CELL METAB, V13, P690, DOI 10.1016/j.cmet.2011.04.007; Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401; Zou P, 2011, CELL STEM CELL, V9, P247, DOI 10.1016/j.stem.2011.07.003	42	214	220	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 3	2013	12	1					62	74		10.1016/j.stem.2012.11.022	http://dx.doi.org/10.1016/j.stem.2012.11.022			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	074UM	23290137	Green Accepted, Bronze			2022-12-28	WOS:000313839500011
J	Kanatsu-Shinohara, M; Inoue, K; Takashima, S; Takehashi, M; Ogonuki, N; Morimoto, H; Nagasawa, T; Ogura, A; Shinohara, T				Kanatsu-Shinohara, Mito; Inoue, Kimiko; Takashima, Seiji; Takehashi, Masanori; Ogonuki, Narumi; Morimoto, Hiroko; Nagasawa, Takashi; Ogura, Atsuo; Shinohara, Takashi			Reconstitution of Mouse Spermatogonial Stem Cell Niches in Culture	CELL STEM CELL			English	Article							UNDIFFERENTIATED SPERMATOGONIA; NEUROTROPHIC FACTOR; CHEMOKINE SDF-1; SERTOLI-CELLS; GERM-CELLS; MICE; RET; SPERMATOGENESIS; TRANSPLANTATION; PROLIFERATION	Spermatogonial stem cells (SSCs) reside in specific niches within seminiferous tubules. These niches are thought to secrete chemotactic factors for SSCs, because SSCs migrate to them upon transplantation. However, the identity of these chemotactic molecules remains unknown. Here, we established a testis feeder cell culture system and used it to identify SSC chemotactic factors. When seeded on testis cells from infertile mice, SSCs migrated beneath the Sertoli cells and formed colonies with a cobblestone appearance that were very similar to those produced by hematopoietic stem cells. Cultured cells maintained SSC activity and fertility for at least 5 months. Cobblestone colony formation depended on GDNF and CXCL12, and dominant-negative GDNF receptor transfection or CXCL12 receptor deficiency reduced SSC colonization. Moreover, GDNF upregulated CXCL12 receptor expression, and CXCL12 transfection in Sertoli cells increased homing efficiency. Overall, our findings identify GDNF and CXCL12 as SSC chemotactic factors in vitro and in vivo.	[Kanatsu-Shinohara, Mito; Takashima, Seiji; Takehashi, Masanori; Morimoto, Hiroko; Shinohara, Takashi] Kyoto Univ, Dept Mol Genet, Grad Sch Med, Kyoto 6068501, Japan; [Inoue, Kimiko; Ogonuki, Narumi; Ogura, Atsuo] Inst Phys & Chem Res RIKEN, Bioresource Ctr, Ibaraki 3050074, Japan; [Nagasawa, Takashi] Kyoto Univ, Dept Immunobiol & Hematol, Inst Frontier Med Sci, Kyoto 6068507, Japan; [Nagasawa, Takashi; Shinohara, Takashi] Japan Sci & Technol Agcy, CREST, Kyoto 6068501, Japan	Kyoto University; RIKEN; Kyoto University; Japan Science & Technology Agency (JST)	Kanatsu-Shinohara, M (corresponding author), Kyoto Univ, Dept Mol Genet, Grad Sch Med, Kyoto 6068501, Japan.	mshinoha@virus.kyoto-u.ac.jp	Takashima, Seiji/I-4993-2019; Ogura, Atsuo/J-3916-2014	Takashima, Seiji/0000-0002-9176-3139; Ogura, Atsuo/0000-0003-0447-1988; Nagasawa, Takashi/0000-0002-1085-0960	government of Japan; Japan Science and Technology Agency (CREST); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Senri Life Science Foundation; Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; Grants-in-Aid for Scientific Research [23500507, 22390096] Funding Source: KAKEN	government of Japan; Japan Science and Technology Agency (CREST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Senri Life Science Foundation; Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Ms. Y. Ogata for technical assistance and Dr. J. Milbrandt for the RetDN cDNA. This research was supported by the government of Japan through its "Funding Program for Next Generation World-Leading Researchers," Japan Science and Technology Agency (CREST), The Mochida Memorial Foundation for Medical and Pharmaceutical Research, Senri Life Science Foundation, and the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan. The authors declare that they have no financial conflicts of interest.	Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Ara T, 2003, P NATL ACAD SCI USA, V100, P5319, DOI 10.1073/pnas.0730719100; Arighi E, 2005, CYTOKINE GROWTH F R, V16, P441, DOI 10.1016/j.cytogfr.2005.05.010; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; Castellone MD, 2004, ONCOGENE, V23, P5958, DOI 10.1038/sj.onc.1207790; Chen C, 2005, NATURE, V436, P1030, DOI 10.1038/nature03894; De Rooij DG, 2000, J ANDROL, V21, P776; DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; Donzella GA, 1998, NAT MED, V4, P72, DOI 10.1038/nm0198-072; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; Ikawa M, 2002, P NATL ACAD SCI USA, V99, P7524, DOI 10.1073/pnas.072207299; Jain S, 2004, DEVELOPMENT, V131, P5503, DOI 10.1242/dev.01421; Kanatsu-Shinohara M, 2008, CELL STEM CELL, V3, P533, DOI 10.1016/j.stem.2008.08.002; KODAMA HA, 1982, J CELL PHYSIOL, V112, P83, DOI 10.1002/jcp.1041120113; Lee J, 2007, DEVELOPMENT, V134, P1853, DOI 10.1242/dev.003004; Lu BC, 2009, NAT GENET, V41, P1295, DOI 10.1038/ng.476; Meistrich ML, 1993, CELL MOL BIOL TESTIS, P266; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Morimoto H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007909; Nagano M, 1999, BIOL REPROD, V60, P1429, DOI 10.1095/biolreprod60.6.1429; Nagano MC, 2003, BIOL REPROD, V69, P701, DOI 10.1095/biolreprod.103.016352; Naughton CK, 2006, BIOL REPROD, V74, P314, DOI 10.1095/biolreprod.105.047365; Oatley MJ, 2011, BIOL REPROD, V84, P639, DOI 10.1095/biolreprod.110.087320; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Payne CJ, 2010, STEM CELLS, V28, P1424, DOI 10.1002/stem.464; PLOEMACHER RE, 1989, BLOOD, V74, P2755; RASSOULZADEGAN M, 1993, CELL, V75, P997, DOI 10.1016/0092-8674(93)90543-Y; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Shinohara T, 2001, P NATL ACAD SCI USA, V98, P6186, DOI 10.1073/pnas.111158198; Shinohara T, 2002, BIOL REPROD, V66, P1491, DOI 10.1095/biolreprod66.5.1491; Shinohara T, 1999, P NATL ACAD SCI USA, V96, P5504, DOI 10.1073/pnas.96.10.5504; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Szilvassy SJ, 1996, BLOOD, V87, P4618, DOI 10.1182/blood.V87.11.4618.bloodjournal87114618; Tadokoro Y, 2002, MECH DEVELOP, V113, P29, DOI 10.1016/S0925-4773(02)00004-7; Tang MJ, 1998, J CELL BIOL, V142, P1337, DOI 10.1083/jcb.142.5.1337; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Tzeng YS, 2011, BLOOD, V117, P429, DOI 10.1182/blood-2010-01-266833; Yomogida K, 2003, BIOL REPROD, V69, P1303, DOI 10.1095/biolreprod.103.015958; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885	42	80	85	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	OCT 5	2012	11	4					567	578		10.1016/j.stem.2012.06.011	http://dx.doi.org/10.1016/j.stem.2012.06.011			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	021OZ	23040482	Bronze			2022-12-28	WOS:000309896500016
J	Chu, SHH; Heiser, D; Li, L; Kaplan, I; Collector, M; Huso, D; Sharkis, SJ; Civin, C; Small, D				Chu, S. Haihua; Heiser, Diane; Li, Li; Kaplan, Ian; Collector, Michael; Huso, David; Sharkis, Saul J.; Civin, Curt; Small, Don			FLT3-ITD Knockin Impairs Hematopoietic Stem Cell Quiescence/Homeostasis, Leading to Myeloproliferative Neoplasm	CELL STEM CELL			English	Article							ACUTE MYELOID-LEUKEMIA; INTERNAL TANDEM DUPLICATION; ACUTE MYELOGENOUS LEUKEMIA; CONSTITUTIVE ACTIVATION; SELF-RENEWAL; C-KIT; MYELODYSPLASTIC SYNDROME; PROGNOSTIC-SIGNIFICANCE; PROGENITOR CELLS; GENE-EXPRESSION	Internal tandem duplication (ITD) mutations within the FMS-like tyrosine kinase-3 (FLT3) render the receptor constitutively active driving proliferation and survival in leukemic blasts. Expression of FLT3-ITD from the endogenous promoter in a murine knockin model results in progenitor expansion and a myeloproliferative neoplasm. In this study, we show that this expansion begins with overproliferation within a compartment of normally quiescent long-term hematopoietic stem cells (LT-HSCs), which become rapidly depleted. This depletion is reversible upon treatment with the small molecule inhibitor Sorafenib, which also ablates the disease. Although the normal LT-HSC has been defined as FLT3(-) by flow cytometric detection, we demonstrate that FLT3 is capable of playing a role within this compartment by examining the effects of constitutively activated FLT3-ITD. This indicates an important link between stem cell quiescence/homeostasis and myeloproliferative disease while also giving novel insight into the emergence of FLT3-ITD mutations in the evolution of leukemic transformation.	[Chu, S. Haihua; Heiser, Diane; Li, Li; Kaplan, Ian; Collector, Michael; Huso, David; Sharkis, Saul J.; Small, Don] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD 21231 USA; [Heiser, Diane; Civin, Curt] Univ Maryland, Sch Med, Ctr Stem Cell Biol & Regenerat Med, Baltimore, MD 21201 USA	Johns Hopkins University; Johns Hopkins Medicine; University System of Maryland; University of Maryland Baltimore	Small, D (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD 21231 USA.	donsmall@jhmi.edu		Chu, S. Haihua/0000-0002-8333-5409	National Cancer Institute [CA90668, CA70970]; Leukemia & Lymphoma Society; Giant Food Pediatric Cancer Research Fund; Kyle Haydock Professorship; NATIONAL CANCER INSTITUTE [R01CA090668, P30CA006973, P01CA070970] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Giant Food Pediatric Cancer Research Fund; Kyle Haydock Professorship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank members of the Small Lab and Brown Lab for helpful discussions, and the flow cytometry core in the Department of Oncology at Johns Hopkins University, most notably Lee Blosser and Ada Tam. Moflo studies were completed with the help of Hao Zhang in the Department of MMI. This work was supported by grants from the National Cancer Institute (CA90668, CA70970), Leukemia & Lymphoma Society, and the Giant Food Pediatric Cancer Research Fund. Dr. Small is also supported by the Kyle Haydock Professorship.	Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Akala OO, 2006, CURR OPIN GENET DEV, V16, P496, DOI 10.1016/j.gde.2006.08.011; Auclair D, 2007, LEUKEMIA, V21, P439, DOI 10.1038/sj.leu.2404508; Basham B, 2008, NUCLEIC ACIDS RES, V36, P3802, DOI 10.1093/nar/gkn271; Boyer SW, 2011, CELL STEM CELL, V9, P64, DOI 10.1016/j.stem.2011.04.021; Buza-Vidas N., 2009, BLOOD, V102, P881; Buza-Vidas N, 2011, BLOOD, V118, P1544, DOI 10.1182/blood-2010-10-316232; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Cloos J, 2006, LEUKEMIA, V20, P1217, DOI 10.1038/sj.leu.2404246; Crump M, 2010, LEUKEMIA LYMPHOMA, V51, P252, DOI 10.3109/10428190903585286; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Fenski R, 2000, BRIT J HAEMATOL, V108, P322; Frohling S, 2002, BLOOD, V100, P4372, DOI 10.1182/blood-2002-05-1440; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Goodell Margaret A, 2005, Methods Mol Biol, V290, P343; Greenblatt S, 2012, BLOOD, V119, P2883, DOI 10.1182/blood-2011-10-382283; Grundler R, 2003, BLOOD, V102, P646, DOI 10.1182/blood-2002-11-3441; Hayakawa F, 2000, ONCOGENE, V19, P624, DOI 10.1038/sj.onc.1203354; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; KATAYAMA N, 1993, BLOOD, V82, P2353; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kikushige Y, 2008, J IMMUNOL, V180, P7358, DOI 10.4049/jimmunol.180.11.7358; Kim KT, 2007, BRIT J HAEMATOL, V138, P603, DOI 10.1111/j.1365-2141.2007.06696.x; Kiyoi H, 2002, ONCOGENE, V21, P2555, DOI 10.1038/sj.onc.1205332; Kiyoi H, 1998, LEUKEMIA, V12, P1333, DOI 10.1038/sj.leu.2401130; Knapper S, 2006, BLOOD, V108, P3262, DOI 10.1182/blood-2006-04-015560; Kottaridis PD, 2001, BLOOD, V98, P1752, DOI 10.1182/blood.V98.6.1752; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Levis M, 2005, BLOOD, V106, P673, DOI 10.1182/blood-2004-05-1902; Levis M, 2003, LEUKEMIA, V17, P1738, DOI 10.1038/sj.leu.2403099; Levis M, 2011, BLOOD, V117, P3294, DOI 10.1182/blood-2010-08-301796; Li L, 2008, BLOOD, V111, P3849, DOI 10.1182/blood-2007-08-109942; Li L, 2007, BRIT J HAEMATOL, V137, P64, DOI 10.1111/j.1365-2141.2007.06525.x; Li L, 2011, BLOOD, V117, P3131, DOI 10.1182/blood-2010-05-286070; Lo Celso Cristina, 2007, J Vis Exp, P157, DOI 10.3791/157; Lumkul R, 2002, LEUKEMIA, V16, P1818, DOI 10.1038/sj.leu.2402632; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Meshinchi S, 2001, BLOOD, V97, P89, DOI 10.1182/blood.V97.1.89; Mizuki M, 2000, BLOOD, V96, P3907, DOI 10.1182/blood.V96.12.3907; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Nakao M, 1996, LEUKEMIA, V10, P1911; OKADA S, 1992, BLOOD, V80, P3044; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Pinheiro RF, 2008, CANCER GENET CYTOGEN, V183, P89, DOI 10.1016/j.cancergencyto.2008.02.006; Randall TD, 1996, BLOOD, V87, P4057, DOI 10.1182/blood.V87.10.4057.bloodjournal87104057; Ravandi F, 2010, LEUKEMIA RES, V34, P752, DOI 10.1016/j.leukres.2009.10.001; Ravandi F, 2010, J CLIN ONCOL, V28, P1856, DOI 10.1200/JCO.2009.25.4888; Rombouts WJC, 2000, LEUKEMIA, V14, P675, DOI 10.1038/sj.leu.2401731; Rombouts WJC, 2000, LEUKEMIA, V14, P889, DOI 10.1038/sj.leu.2401777; Safaian NN, 2009, LEUKEMIA RES, V33, P348, DOI 10.1016/j.leukres.2008.04.017; Shih LY, 2002, BLOOD, V100, P2387, DOI 10.1182/blood-2002-01-0195; Sitnicka E, 2002, IMMUNITY, V17, P463, DOI 10.1016/S1074-7613(02)00419-3; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; Stubbs MC, 2008, LEUKEMIA, V22, P66, DOI 10.1038/sj.leu.2404951; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Tong FK, 2006, CYTOM PART B-CLIN CY, V70B, P107, DOI 10.1002/cyto.b.20092; Tse KF, 2001, LEUKEMIA, V15, P1001, DOI 10.1038/sj.leu.2402199; Weisberg E, 2002, CANCER CELL, V1, P433, DOI 10.1016/S1535-6108(02)00069-7; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yoshimoto G, 2009, BLOOD, V114, P5034, DOI 10.1182/blood-2008-12-196055; Zhang WG, 2008, JNCI-J NATL CANCER I, V100, P184, DOI 10.1093/jnci/djm328; Zola H., 2004, CURR PROTOC CYTOM, DOI [10.1002/0471142956.cy0603s30, DOI 10.1002/0471142956.CY0603S30]	68	66	69	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 7	2012	11	3					346	358		10.1016/j.stem.2012.05.027	http://dx.doi.org/10.1016/j.stem.2012.05.027			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	018DW	22958930	Green Accepted, Bronze			2022-12-28	WOS:000309641300009
J	Copley, MR; Beer, PA; Eaves, CJ				Copley, Michael R.; Beer, Philip A.; Eaves, Connie J.			Hematopoietic Stem Cell Heterogeneity Takes Center Stage	CELL STEM CELL			English	Review							IN-VIVO PROLIFERATION; COLONY-FORMING CELLS; SELF-RENEWAL; BONE-MARROW; DEVELOPMENTAL SWITCH; PROGENITOR CELLS; CLONAL ANALYSIS; GENE-THERAPY; CFU-S; FETAL	Over the past 10 years, increasing evidence has accumulated that heterogeneity is a feature of hematopoietic stem cell (HSC) proliferation, self-renewal, and differentiation based on examination of these properties at a clonal level. The heterogeneous behavior of HSCs reflects the operation of a complex interplay of intrinsic and extrinsic variables. In this review, we discuss key findings from the last 5 years that reveal new insights into the mechanisms involved.	[Copley, Michael R.; Beer, Philip A.; Eaves, Connie J.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada	British Columbia Cancer Agency	Eaves, CJ (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	ceaves@bccrc.ca		Eaves, Connie/0000-0002-3452-1926; Beer, Philip/0000-0003-3056-5419	Terry Fox Run; Stem Cell Network; Canadian Institutes of Health Research (CIHR); Michael Smith Foundation for Health Research; Kay Kendall Leukemia Fund Intermediate Fellowship from the UK	Terry Fox Run; Stem Cell Network; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Kay Kendall Leukemia Fund Intermediate Fellowship from the UK	We thank C. Benz and M. Kardel for helpful comments. This review was prepared with support from grants funded by the Terry Fox Run, the Stem Cell Network, and the Canadian Institutes of Health Research (CIHR). M.R.C. holds a Vanier Scholarship from CIHR and a Studentship from the Michael Smith Foundation for Health Research. P.A.B. holds a Kay Kendall Leukemia Fund Intermediate Fellowship from the UK.	Baerlocher GM, 2007, AGING CELL, V6, P121, DOI 10.1111/j.1474-9726.2006.00254.x; BECKER AJ, 1965, BLOOD-J HEMATOL, V26, P296, DOI 10.1182/blood.V26.3.296.296; BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Benz C, 2012, CELL STEM CELL, V10, P273, DOI 10.1016/j.stem.2012.02.007; Berkahn Leanne, 2004, Hematology, V9, P159, DOI 10.1080/10245330410001701468; Bowie MB, 2007, BLOOD, V109, P5043, DOI 10.1182/blood-2006-08-037770; Bowie MB, 2007, P NATL ACAD SCI USA, V104, P5878, DOI 10.1073/pnas.0700460104; Bowie MB, 2006, J CLIN INVEST, V116, P2808, DOI 10.1172/JCI28310; Bradford GB, 1997, EXP HEMATOL, V25, P445; Broske AM, 2009, NAT GENET, V41, P1207, DOI 10.1038/ng.463; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Catlin SN, 2011, BLOOD, V117, P4460, DOI 10.1182/blood-2010-08-303537; Cavazzana-Calvo M, 2007, J CLIN INVEST, V117, P1456, DOI 10.1172/JCI30953; Cavazzana-Calvo M, 2011, BLOOD, V117, P4420, DOI 10.1182/blood-2010-09-255679; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Cho RH, 2008, BLOOD, V111, P5553, DOI 10.1182/blood-2007-11-123547; DICK JE, 1985, CELL, V42, P71, DOI 10.1016/S0092-8674(85)80102-1; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Dorshkind K, 2007, NAT REV IMMUNOL, V7, P213, DOI 10.1038/nri2019; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Dykstra B, 2011, J EXP MED, V208, P2691, DOI 10.1084/jem.20111490; FLEMING WH, 1993, J CELL BIOL, V122, P897, DOI 10.1083/jcb.122.4.897; FORD CE, 1956, NATURE, V177, P452, DOI 10.1038/177452a0; Gerrits A, 2010, BLOOD, V115, P2610, DOI 10.1182/blood-2009-06-229757; Glotzbach JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021211; He SH, 2011, GENE DEV, V25, P1613, DOI 10.1101/gad.2052911; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hodges E, 2011, MOL CELL, V44, P17, DOI 10.1016/j.molcel.2011.08.026; HODGSON GS, 1984, EXP HEMATOL, V12, P683; HUMPHRIES RK, 1979, NATURE, V279, P718, DOI 10.1038/279718a0; HUMPHRIES RK, 1981, P NATL ACAD SCI-BIOL, V78, P3629, DOI 10.1073/pnas.78.6.3629; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; Iscove NN, 1997, CURR BIOL, V7, P805, DOI 10.1016/S0960-9822(06)00341-1; JACOBSON LO, 1951, SCIENCE, V113, P510, DOI 10.1126/science.113.2940.510; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Jones RJ, 1996, BLOOD, V88, P487, DOI 10.1182/blood.V88.2.487.bloodjournal882487; Kent DG, 2008, BLOOD, V112, P560, DOI 10.1182/blood-2007-10-117820; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kikuchi K, 2006, P NATL ACAD SCI USA, V103, P17852, DOI 10.1073/pnas.0603368103; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; Lu R, 2011, NAT BIOTECHNOL, V29, P928, DOI 10.1038/nbt.1977; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; MCCULLOCH EA, 1964, SCIENCE, V144, P844, DOI 10.1126/science.144.3620.844; MICKLEM HS, 1972, J CELL PHYSIOL, V79, P293, DOI 10.1002/jcp.1040790214; Miller JP, 2003, J IMMUNOL, V171, P2326, DOI 10.4049/jimmunol.171.5.2326; Min HY, 2006, J IMMUNOL, V176, P1007, DOI 10.4049/jimmunol.176.2.1007; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Mochizuki-Kashio M, 2011, BLOOD, V118, P6553, DOI 10.1182/blood-2011-03-340554; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Muller-Sieburg CE, 2002, BLOOD, V100, P1302, DOI 10.1182/blood.V100.4.1302.h81602001302_1302_1309; Muller-Sieburg CE, 2012, BLOOD, V119, P3900, DOI 10.1182/blood-2011-12-376749; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; OGAWA M, 1983, BLOOD, V61, P823; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Pawliuk R, 1996, BLOOD, V88, P2852, DOI 10.1182/blood.V88.8.2852.bloodjournal8882852; PLOEMACHER RE, 1989, EXP HEMATOL, V17, P263; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Rufer N, 1999, J EXP MED, V190, P157, DOI 10.1084/jem.190.2.157; Sieburg HB, 2011, P NATL ACAD SCI USA, V108, P4370, DOI 10.1073/pnas.1011414108; Sieburg HB, 2006, BLOOD, V107, P2311, DOI 10.1182/blood-2005-07-2970; SIMINOVITCH L, 1963, J CELL COMPAR PHYSL, V62, P327, DOI 10.1002/jcp.1030620313; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; Trowbridge JJ, 2009, CELL STEM CELL, V5, P442, DOI 10.1016/j.stem.2009.08.016; Wang JW, 2012, CELL, V148, P1001, DOI 10.1016/j.cell.2012.01.040; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yahata T, 2011, BLOOD, V118, P2941, DOI 10.1182/blood-2011-01-330050; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Yamazaki S, 2009, BLOOD, V113, P1250, DOI 10.1182/blood-2008-04-146480; Yuan J, 2012, SCIENCE, V335, P1195, DOI 10.1126/science.1216557; Zou P, 2011, CELL STEM CELL, V9, P247, DOI 10.1016/j.stem.2011.07.003	88	124	136	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 14	2012	10	6					690	697		10.1016/j.stem.2012.05.006	http://dx.doi.org/10.1016/j.stem.2012.05.006			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	965LD	22704509	Bronze			2022-12-28	WOS:000305768400015
J	Lehmann, R				Lehmann, Ruth			Germline Stem Cells: Origin and Destiny	CELL STEM CELL			English	Review							SELF-RENEWAL; DROSOPHILA TESTIS; MESSENGER-RNA; UNDIFFERENTIATED SPERMATOGONIA; TRANSLATIONAL REPRESSION; ECTOPIC EXPRESSION; TET PROTEINS; BRAIN-TUMOR; DIFFERENTIATION; NICHE	Germline stem cells are key to genome transmission to future generations. Over recent years, there have been numerous insights into the regulatory mechanisms that govern both germ cell specification and the maintenance of the germline in adults. Complex regulatory interactions with both the niche and the environment modulate germline stem cell function. This perspective highlights some examples of this regulation to illustrate the diversity and complexity of the mechanisms involved.	[Lehmann, Ruth] NYU, Sch Med, Helen L & Martin S Kimmel Ctr Stem Cell Biol, Howard Hughes Med,Inst Dept Cell Biol, New York, NY 10016 USA; [Lehmann, Ruth] NYU, Sch Med, Helen L & Martin S Kimmel Ctr Stem Cell Biol, Skirball Inst,Dept Cell Biol, New York, NY 10016 USA	New York University; New York University	Lehmann, R (corresponding author), NYU, Sch Med, Helen L & Martin S Kimmel Ctr Stem Cell Biol, Howard Hughes Med,Inst Dept Cell Biol, 540 1st Ave, New York, NY 10016 USA.	lehmann@saturn.med.nyu.edu		Lehmann, Ruth/0000-0002-8454-5651	NIH [R01HD041900]; HHMI; Kimmel Center for Stem Cell Biology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD041900] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); Kimmel Center for Stem Cell Biology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	I would like to thank members of my lab and my colleagues in the Developmental Genetics Program for discussion, and specifically Drs. Daria Siekhaus and Ryan Cinalli for critically reading the manuscript. I apologize to those colleagues whose work I was unable to properly cite due to space restrictions. Research on germ cell development in my lab is supported by the NIH (R01HD041900), the HHMI, and the Kimmel Center for Stem Cell Biology.	Angelo G, 2009, SCIENCE, V326, P954, DOI 10.1126/science.1178343; Biedermann B, 2009, DEV CELL, V17, P355, DOI 10.1016/j.devcel.2009.08.003; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; Chen SY, 2011, CURR OPIN GENET DEV, V21, P684, DOI 10.1016/j.gde.2011.07.008; Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386; Chu LF, 2011, CURR BIOL, V21, P1759, DOI 10.1016/j.cub.2011.09.010; Cinalli RM, 2008, CELL, V132, P559, DOI 10.1016/j.cell.2008.02.003; Cinquin O, 2010, P NATL ACAD SCI USA, V107, P2048, DOI 10.1073/pnas.0912704107; Dalfo D, 2012, CURR BIOL, V22, P712, DOI 10.1016/j.cub.2012.02.064; de Cuevas M, 2011, DEVELOPMENT, V138, P2861, DOI 10.1242/dev.056242; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Filipponi D, 2007, MOL CELL BIOL, V27, P6770, DOI 10.1128/MCB.00479-07; Flaherty MS, 2010, DEV CELL, V18, P556, DOI 10.1016/j.devcel.2010.02.006; Forbes A, 1998, DEVELOPMENT, V125, P679; Gancz D, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001202; Ghosh D, 2008, GENETICS, V178, P235, DOI 10.1534/genetics.107.083212; Gilboa L, 2004, CURR BIOL, V14, P981, DOI 10.1016/j.cub.2004.05.049; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Guo Z, 2009, DEVELOPMENT, V136, P3627, DOI 10.1242/dev.036939; Guven-Ozkan T, 2008, CELL, V135, P149, DOI 10.1016/j.cell.2008.07.040; Hackett JA, 2012, TRENDS GENET, V28, P164, DOI 10.1016/j.tig.2012.01.005; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hanyu-Nakamura K, 2008, NATURE, V451, P730, DOI 10.1038/nature06498; Harris RE, 2011, DEV CELL, V20, P72, DOI 10.1016/j.devcel.2010.11.019; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Hayashi K, 2009, CELL STEM CELL, V4, P493, DOI 10.1016/j.stem.2009.05.007; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hobbs RM, 2012, CELL STEM CELL, V10, P284, DOI 10.1016/j.stem.2012.02.004; Hobbs RM, 2010, CELL, V142, P468, DOI 10.1016/j.cell.2010.06.041; Hsu HJ, 2011, DEV BIOL, V350, P290, DOI 10.1016/j.ydbio.2010.11.032; Inaba M, 2011, DEVELOPMENT, V138, P5079, DOI 10.1242/dev.072579; Inaba M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012473; Insco ML, 2009, P NATL ACAD SCI USA, V106, P22311, DOI 10.1073/pnas.0912454106; Issigonis M, 2009, SCIENCE, V326, P153, DOI 10.1126/science.1176817; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Janic A, 2010, SCIENCE, V330, P1824, DOI 10.1126/science.1195481; Jin ZG, 2008, CELL STEM CELL, V2, P39, DOI 10.1016/j.stem.2007.10.021; Juliano CE, 2010, DEVELOPMENT, V137, P4113, DOI 10.1242/dev.047969; Kadyrova LY, 2007, DEVELOPMENT, V134, P1519, DOI 10.1242/dev.002212; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Kanatsu-Shinohara M, 2008, CELL STEM CELL, V3, P533, DOI 10.1016/j.stem.2008.08.002; Katz DJ, 2009, CELL, V137, P308, DOI 10.1016/j.cell.2009.02.015; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Khurana JS, 2010, J CELL BIOL, V191, P905, DOI 10.1083/jcb.201006034; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Kimble J, 2007, ANNU REV CELL DEV BI, V23, P405, DOI 10.1146/annurev.cellbio.23.090506.123326; Kimble J, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002683; Kobayashi S, 1996, NATURE, V380, P708, DOI 10.1038/380708a0; Korta DZ, 2012, DEVELOPMENT, V139, P859, DOI 10.1242/dev.074047; Kraemer B, 1999, CURR BIOL, V9, P1009, DOI 10.1016/S0960-9822(99)80449-7; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; Lamont LB, 2004, DEV CELL, V7, P697, DOI 10.1016/j.devcel.2004.09.013; LASKO PF, 1990, GENE DEV, V4, P905, DOI 10.1101/gad.4.6.905; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Leatherman JL, 2008, CELL STEM CELL, V3, P44, DOI 10.1016/j.stem.2008.05.001; Leatherman JL, 2010, NAT CELL BIOL, V12, P806, DOI 10.1038/ncb2086; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; Li Y, 2012, DEVELOPMENT, V139, P1547, DOI 10.1242/dev.077412; Liu M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000740; Liu NK, 2009, GENE DEV, V23, P2742, DOI 10.1101/gad.1820709; Lopez-Onieva L, 2008, DEVELOPMENT, V135, P533, DOI 10.1242/dev.016121; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Marin VA, 2003, DEVELOPMENT, V130, P2623, DOI 10.1242/dev.00486; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Merritt C, 2008, CURR BIOL, V18, P1476, DOI 10.1016/j.cub.2008.08.013; Michaelson D, 2010, DEVELOPMENT, V137, P671, DOI 10.1242/dev.042523; Michel M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1426; Monk AC, 2010, CELL STEM CELL, V6, P348, DOI 10.1016/j.stem.2010.02.016; Morris LX, 2011, DEVELOPMENT, V138, P2207, DOI 10.1242/dev.065508; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Nakamura A, 2008, DEVELOPMENT, V135, P3817, DOI 10.1242/dev.022434; Naughton CK, 2006, BIOL REPROD, V74, P314, DOI 10.1095/biolreprod.105.047365; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Oatley JM, 2007, J BIOL CHEM, V282, P25842, DOI 10.1074/jbc.M703474200; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Ohinata Y, 2009, CELL, V137, P571, DOI 10.1016/j.cell.2009.03.014; Ohlstein B, 1997, DEVELOPMENT, V124, P3651; Pan L, 2007, CELL STEM CELL, V1, P458, DOI 10.1016/j.stem.2007.09.010; Park JK, 2007, CURR BIOL, V17, P533, DOI 10.1016/j.cub.2007.01.060; Pek JW, 2011, CURR BIOL, V21, P39, DOI 10.1016/j.cub.2010.11.051; Petrella LN, 2011, DEVELOPMENT, V138, P1069, DOI 10.1242/dev.059501; Richter C, 2011, NAT CELL BIOL, V13, P1029, DOI 10.1038/ncb2306; Richter JD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002758; Sada A, 2012, STEM CELLS, V30, P280, DOI 10.1002/stem.790; Sada A, 2009, SCIENCE, V325, P1394, DOI 10.1126/science.1172645; Saga Y, 2010, CELL MOL LIFE SCI, V67, P3815, DOI 10.1007/s00018-010-0456-x; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Shivdasani AA, 2003, CURR BIOL, V13, P2065, DOI 10.1016/j.cub.2003.10.063; Simon L, 2010, STEM CELLS, V28, P1882, DOI 10.1002/stem.508; Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; Spradling A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002642; Subramaniam K, 1999, DEVELOPMENT, V126, P4861; Suh N, 2006, P NATL ACAD SCI USA, V103, P15108, DOI 10.1073/pnas.0607050103; Sun P, 2010, DEVELOPMENT, V137, P2461, DOI 10.1242/dev.051466; Suzuki A, 2010, P NATL ACAD SCI USA, V107, P3594, DOI 10.1073/pnas.0908664107; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tazuke SI, 2002, DEVELOPMENT, V129, P2529; Tomancak P, 1998, DEVELOPMENT, V125, P1723; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Tursun B, 2011, SCIENCE, V331, P304, DOI 10.1126/science.1199082; Vagin Vasily V, 2004, RNA Biol, V1, P54; Voronina E, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002774; Wallenfang MR, 2006, AGING CELL, V5, P297, DOI 10.1111/j.1474-9726.2006.00221.x; Wang XM, 2008, NATURE, V455, P72, DOI 10.1038/nature07214; Wang Z, 2004, SCIENCE, V303, P2016, DOI 10.1126/science.1093983; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; White YAR, 2012, NAT MED, V18, P413, DOI 10.1038/nm.2669; Wong C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033635; Xia LX, 2010, CELL, V143, P978, DOI 10.1016/j.cell.2010.11.022; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Yadlapalli S, 2011, J CELL SCI, V124, P933, DOI 10.1242/jcs.079798; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910; Yamashita YM, 2010, CURR OPIN CELL BIOL, V22, P605, DOI 10.1016/j.ceb.2010.07.009; Ying Y, 2001, P NATL ACAD SCI USA, V98, P7858, DOI 10.1073/pnas.151242798; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885	122	69	71	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 14	2012	10	6					729	739		10.1016/j.stem.2012.05.016	http://dx.doi.org/10.1016/j.stem.2012.05.016			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	965LD	22704513	Green Accepted, Bronze			2022-12-28	WOS:000305768400019
J	Hu, G; Wade, PA				Hu, Guang; Wade, Paul A.			NuRD and Pluripotency: A Complex Balancing Act	CELL STEM CELL			English	Review							EMBRYONIC STEM-CELLS; LSD1; DIFFERENTIATION; MAINTENANCE; METHYLATION; EXPRESSION; REPRESSION; COMPONENT; PROGRAMS; GENOME	Embryonic stem cells (ESCs) are defined by two essential features-pluripotency and self-renewal whose balance requires the concerted action of signal transduction pathways, transcription factor networks, and epigenetic regulators. Recent findings have implicated the NuRD chromatin remodeling complex in the sophisticated choreography of ESC regulatory pathways.	[Hu, Guang; Wade, Paul A.] NIEHS, Mol Carcinogenesis Lab, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Wade, PA (corresponding author), NIEHS, Mol Carcinogenesis Lab, Res Triangle Pk, NC 27709 USA.	hug4@niehs.nih.gov; wadep2@niehs.nih.gov	Wade, Paul A/D-2374-2019; Hu, Guang/E-7474-2016	Wade, Paul A/0000-0002-6042-357X; Hu, Guang/0000-0003-0437-4723	National Institute of Environmental Health Sciences; NIH [ES102745, ES101965]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102745, Z01ES101965, ZIAES101965] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors express gratitude to Dr. Raja Jothi for many useful discussions during the course of preparation of this manuscript. This manuscript was substantially improved by critical comments derived from the peer review process at Cell Stem Cell. Work in the authors' laboratories is supported by the Intramural Research Program of the National Institute of Environmental Health Sciences, NIH (ES102745 to G.H. and ES101965 to PAW.).	Adamo A, 2011, NAT CELL BIOL, V13, P652, DOI 10.1038/ncb2246; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Forneris F, 2005, J BIOL CHEM, V280, P41360, DOI 10.1074/jbc.M509549200; Freudenberg JM, 2012, NUCLEIC ACIDS RES, V40, P3364, DOI 10.1093/nar/gkr1253; Hashimoto H, 2012, NUCLEIC ACIDS RES, V40, P4841, DOI 10.1093/nar/gks155; Ho L, 2011, NAT CELL BIOL, V13, P903, DOI 10.1038/ncb2285; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kaji K, 2007, DEVELOPMENT, V134, P1123, DOI 10.1242/dev.02802; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI 10.1038/nbt.1684; Miyanari Y, 2012, NATURE, V483, P470, DOI 10.1038/nature10807; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Ram O, 2011, CELL, V147, P1628, DOI 10.1016/j.cell.2011.09.057; Ramirez J, 2009, EPIGENETICS-US, V4, P532, DOI 10.4161/epi.4.8.10108; Reynolds N, 2012, CELL STEM CELL, V10, P583, DOI 10.1016/j.stem.2012.02.020; Reynolds N, 2012, EMBO J, V31, P593, DOI 10.1038/emboj.2011.431; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Zhang JW, 2012, NAT IMMUNOL, V13, P86, DOI 10.1038/ni.2150	32	84	87	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAY 4	2012	10	5					497	503		10.1016/j.stem.2012.04.011	http://dx.doi.org/10.1016/j.stem.2012.04.011			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	944WN	22560073	Green Accepted, Bronze			2022-12-28	WOS:000304234600008
J	Li, ZW; Fei, T; Zhang, JP; Zhu, GY; Wang, L; Lu, DY; Chi, XC; Teng, Y; Hou, N; Yang, X; Zhang, HQ; Han, JDJ; Chen, YG				Li, Zhongwei; Fei, Teng; Zhang, Jianping; Zhu, Gaoyang; Wang, Lu; Lu, Danyu; Chi, Xiaochun; Teng, Yan; Hou, Ning; Yang, Xiao; Zhang, Hongquan; Han, Jing-Dong J.; Chen, Ye-Guang			BMP4 Signaling Acts via Dual-Specificity Phosphatase 9 to Control ERK Activity in Mouse Embryonic Stem Cells	CELL STEM CELL			English	Article							ACTIVATED PROTEIN-KINASE; SELF-RENEWAL; TRANSCRIPTIONAL NETWORK; MAP KINASE; DIFFERENTIATION; PLURIPOTENCY; MAINTENANCE; INVOLVEMENT; SMAD4/DPC4; REGULATORS	Extrinsic BMP and LIF signaling collaboratively maintain mouse embryonic stem cell (ESC) pluripotency, whereas appropriate ERK activity is essential for ESC fate commitment. However, how the extrinsic signals restrain appropriate ERK activity remains elusive. Here, we show that, whereas LIF sustains relatively high ERK activity, BMP4 can steadily attenuate ERK activity by upregulating ERK-specific dual-specificity phosphatase 9 (DUSP9). This upregulation requires Smad1/5 and Smad4 and specifically occurs to DUSP9, but not other DUSPs, and only in ESCs. Through DUSP9-mediated inhibition of ERK activity, BMP signaling reinforces the self-renewal status of mouse ESCs together with LIF. Upon LIF withdrawal, ESCs spontaneously undergo neural differentiation, during which process DUSP9 can partially mediate BMP inhibition on neural commitment. Collectively, our findings identify DUSP9 as a critical mediator of BMP signaling to control appropriate ERK activity critical for ESC fate determination.	[Li, Zhongwei; Fei, Teng; Zhang, Jianping; Zhu, Gaoyang; Wang, Lu; Chen, Ye-Guang] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Lu, Danyu; Chi, Xiaochun; Zhang, Hongquan] Peking Univ, Sch Basic Med Sci, Lab Stem Cells Dev & Reprod Med, Beijing 100191, Peoples R China; [Teng, Yan; Hou, Ning; Yang, Xiao] Inst Biotechnol, Genet Lab Dev & Dis, State Key Lab Prote, Beijing 100071, Peoples R China; [Han, Jing-Dong J.] Chinese Acad Sci, Shanghai Inst Biol Sci, Max Planck Partner Inst Computat Biol, Shanghai 200031, Peoples R China	Tsinghua University; Peking University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Chen, YG (corresponding author), Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	ygchen@tsinghua.edu.cn	Chen, Ye-Guang/L-6998-2019; Fei, Teng/G-5324-2015; XIAO, YANG/GPW-5529-2022	Fei, Teng/0000-0001-5707-0673; Yang, Xiao/0000-0002-0298-9831; FEI, TENG/0000-0001-9620-0450	Ministry of Sciences and Technology of China [2011CBA01104, 2011CB943803, 2010CB833706]; National Natural Science Foundation of China [30921004, 91019003, 30930050]; Tsinghua University [2010THZ0]	Ministry of Sciences and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua University	The authors wish to thank Dr. Stephen M. Keyse for DUSP9 antibodies and plasmids, Dr. Kehkooi Kee for lentiviral expression plasmids, Shanshan Zhu and Wei Zhang for bioinformatics analysis, and Jun Du and Benyu Ma for technical assistance. This work was supported by grants from Ministry of Sciences and Technology of China (2011CBA01104, 2011CB943803, 2010CB833706), National Natural Science Foundation of China (30921004, 91019003, 30930050), and Tsinghua University Initiative Scientific Research Program (2010THZ0) to Y.-G.C.	Abujarour R, 2010, STEM CELLS, V28, P1487, DOI 10.1002/stem.472; Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Bibikova M, 2008, CELL STEM CELL, V2, P123, DOI 10.1016/j.stem.2008.01.005; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Caunt CJ, 2008, J BIOL CHEM, V283, P26612, DOI 10.1074/jbc.M801500200; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Christie GR, 2005, MOL CELL BIOL, V25, P8323, DOI 10.1128/MCB.25.18.8323-8333.2005; Datto M, 2000, CYTOKINE GROWTH F R, V11, P37, DOI 10.1016/S1359-6101(99)00027-1; Fei T, 2010, CELL RES, V20, P1306, DOI 10.1038/cr.2010.158; Fei T, 2010, SCI CHINA LIFE SCI, V53, P497, DOI 10.1007/s11427-010-0096-2; Fei T, 2010, GENOME RES, V20, P36, DOI 10.1101/gr.092114.109; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Hatano N, 2003, GENES CELLS, V8, P847, DOI 10.1046/j.1365-2443.2003.00680.x; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Lanner F, 2010, STEM CELLS, V28, P191, DOI 10.1002/stem.265; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; Liu R, 2009, J BIOL CHEM, V284, P16791, DOI 10.1074/jbc.M808919200; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2000, GENE DEV, V14, P627; Matsuguchi T, 2001, MOL CELL BIOL, V21, P6999, DOI 10.1128/MCB.21.20.6999-7009.2001; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Qi XX, 2004, P NATL ACAD SCI USA, V101, P6027, DOI 10.1073/pnas.0401367101; RUTTER GA, 1995, CURR BIOL, V5, P890, DOI 10.1016/S0960-9822(95)00179-5; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Seuntjens E, 2009, CYTOKINE GROWTH F R, V20, P449, DOI 10.1016/j.cytogfr.2009.10.005; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Sirard C, 1998, GENE DEV, V12, P107, DOI 10.1101/gad.12.1.107; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Theodosiou A, 2002, GENOME BIOL, V3; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yang X, 1998, P NATL ACAD SCI USA, V95, P3667, DOI 10.1073/pnas.95.7.3667; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yoshida-Koide U, 2004, BIOCHEM BIOPH RES CO, V313, P475, DOI 10.1016/j.bbrc.2003.11.138; Yuan P, 2009, GENE DEV, V23, P2507, DOI 10.1101/gad.1831909; Zhang KJ, 2010, DEVELOPMENT, V137, P2095, DOI 10.1242/dev.049494	46	104	110	0	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 3	2012	10	2					171	182		10.1016/j.stem.2011.12.016	http://dx.doi.org/10.1016/j.stem.2011.12.016			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	892FM	22305567	Bronze			2022-12-28	WOS:000300272100010
J	Alfonso, J; Le Magueresse, C; Zuccotti, A; Khodosevich, K; Monyer, H				Alfonso, Julieta; Le Magueresse, Corentin; Zuccotti, Annalisa; Khodosevich, Konstantin; Monyer, Hannah			Diazepam Binding Inhibitor Promotes Progenitor Proliferation in the Postnatal SVZ by Reducing GABA Signaling	CELL STEM CELL			English	Article							SUBVENTRICULAR ZONE; CELL-CYCLE; OLFACTORY-BULB; BENZODIAZEPINE-RECEPTOR; ADULT NEUROGENESIS; RAT-BRAIN; NEURONS; LOCALIZATION; EXPRESSION; MIGRATION	The subventricular zone (SVZ) of the lateral ventricles is the largest neurogenic niche of the postnatal brain. New SVZ-generated neurons migrate via the rostral migratory stream to the olfactory bulb (OB) where they functionally integrate into preexisting neuronal circuits. Nonsynaptic GABA signaling was previously shown to inhibit SVZ-derived neurogenesis. Here we identify the endogenous protein diazepam binding inhibitor (DBI) as a positive modulator of SVZ postnatal neurogenesis by regulating GABA activity in transit-amplifying cells. We performed DBI loss- and gain-of-function experiments in vivo at the peak of postnatal OB neuron generation in mice and demonstrate that DBI enhances proliferation by preventing SVZ progenitors to exit the cell cycle. Furthermore, we provide evidence that DBI exerts its effect on SVZ progenitors via its octadecaneuropeptide proteolytic product (ODN) by inhibiting GABA-induced currents. Together our data reveal a regulatory mechanism by which DBI counteracts the inhibitory effect of nonsynaptic GABA signaling on subventricular neuronal proliferation.	[Alfonso, Julieta; Le Magueresse, Corentin; Zuccotti, Annalisa; Khodosevich, Konstantin; Monyer, Hannah] German Canc Res Ctr, Dept Clin Neurobiol, D-69120 Heidelberg, Germany; [Alfonso, Julieta; Le Magueresse, Corentin] Heidelberg Univ, Fac Med, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Monyer, H (corresponding author), German Canc Res Ctr, Dept Clin Neurobiol, D-69120 Heidelberg, Germany.	h.monyer@dkfz-heidelberg.de		Le Magueresse, Corentin/0000-0001-8418-4991; Monyer, Hannah/0000-0002-9332-5749; Khodosevich, Konstantin/0000-0001-7232-5558	Christiane Nuesslein-Volhard fellowship; Medical Faculty Heidelberg; Schilling Foundation; DFG [SFB 488, SG 643]	Christiane Nuesslein-Volhard fellowship; Medical Faculty Heidelberg; Schilling Foundation; DFG(German Research Foundation (DFG))	We thank R. Hintz-Herkommer, I. Preugschat-Gumprecht, and T. Weber for excellent technical assistance and N. Nilsson for helping with knockdown experiments. We also thank Prof. S. Mandrup and A. Marcher (University of Southern Denmark) for kindly providing brains from knockout mice to test the specificity of the DBI antibody. J.A. was supported in part by a Christiane Nuesslein-Volhard fellowship, C.L.M. was supported by a Postdoctoral Grant from Medical Faculty Heidelberg, and H.M. was supported by the Schilling Foundation and DFG (SFB 488 and SG 643).	Abrahamsen H, 2010, CURR BIOL, V20, pR415, DOI 10.1016/j.cub.2010.03.011; Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; ALHO H, 1995, CELL GROWTH DIFFER, V6, P309; ALHO H, 1988, P NATL ACAD SCI USA, V85, P7018, DOI 10.1073/pnas.85.18.7018; Bandeira F, 2009, P NATL ACAD SCI USA, V106, P14108, DOI 10.1073/pnas.0804650106; BAYER SA, 1983, EXP BRAIN RES, V50, P329; BORMANN J, 1991, NEUROPHARMACOLOGY, V30, P1387, DOI 10.1016/S0028-3908(11)80006-7; BORMANN J, 1988, TRENDS NEUROSCI, V11, P112, DOI 10.1016/0166-2236(88)90156-7; Brill MS, 2009, NAT NEUROSCI, V12, P1524, DOI 10.1038/nn.2416; Caviness VS, 2009, TRENDS NEUROSCI, V32, P443, DOI 10.1016/j.tins.2009.05.003; Cayre M, 2009, PROG NEUROBIOL, V88, P41, DOI 10.1016/j.pneurobio.2009.02.001; Codina C, 2000, NEUROSCI LETT, V287, P53, DOI 10.1016/S0304-3940(00)01134-4; COSTA E, 1991, LIFE SCI, V49, P325, DOI 10.1016/0024-3205(91)90440-M; D'Hulst C, 2009, DRUG DISCOV TODAY, V14, P866, DOI 10.1016/j.drudis.2009.06.009; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Doetsch F, 2002, J NEUROSCI, V22, P2255, DOI 10.1523/JNEUROSCI.22-06-02255.2002; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Fernando RN, 2011, P NATL ACAD SCI USA, V108, P5837, DOI 10.1073/pnas.1014993108; Fukumitsu H, 2006, J NEUROSCI, V26, P13218, DOI 10.1523/JNEUROSCI.4251-06.2006; Gandolfo P, 2000, J NEUROCHEM, V75, P701, DOI 10.1046/j.1471-4159.2000.0750701.x; Gandolfo P, 1999, NEUROPHARMACOLOGY, V38, P725, DOI 10.1016/S0028-3908(98)00231-7; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Haydar TF, 2000, J NEUROSCI, V20, P5764, DOI 10.1523/JNEUROSCI.20-15-05764.2000; HINDS JW, 1968, J COMP NEUROL, V134, P287, DOI 10.1002/cne.901340304; Inta D, 2008, P NATL ACAD SCI USA, V105, P20994, DOI 10.1073/pnas.0807059105; Labrakakis C, 1998, EUR J NEUROSCI, V10, P231, DOI 10.1046/j.1460-9568.1998.00036.x; Lacar B, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00043; Lambert JJ, 2003, PROG NEUROBIOL, V71, P67, DOI 10.1016/j.pneurobio.2003.09.001; Liu XX, 2005, NAT NEUROSCI, V8, P1179, DOI 10.1038/nn1522; Lledo PM, 2008, TRENDS NEUROSCI, V31, P392, DOI 10.1016/j.tins.2008.05.006; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Martynoga B, 2005, DEV BIOL, V283, P113, DOI 10.1016/j.ydbio.2005.04.005; MIETTINEN H, 1995, CANCER RES, V55, P2691; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mitsuhashi T, 2009, BRAIN DEV-JPN, V31, P553, DOI 10.1016/j.braindev.2009.05.002; Morshead CM, 1998, DEVELOPMENT, V125, P2251; MORSHEAD CM, 1992, J NEUROSCI, V12, P249; Neess D, 2011, J BIOL CHEM, V286, P3460, DOI 10.1074/jbc.M110.161109; Nguyen LD, 2003, AEROSPACE ENG, V23, P23; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Platel JC, 2010, BRAIN RES REV, V63, P60, DOI 10.1016/j.brainresrev.2010.02.004; Quinn JC, 2007, DEV BIOL, V302, P50, DOI 10.1016/j.ydbio.2006.08.035; Rogelius N, 2005, J NEUROSCI METH, V142, P285, DOI 10.1016/j.jneumeth.2004.09.008; SLOBODYANSKY E, 1989, J NEUROCHEM, V53, P1276, DOI 10.1111/j.1471-4159.1989.tb07425.x; Smart TG, 2004, NEUROSCIENTIST, V10, P432, DOI 10.1177/1073858404263463; Stefovska VG, 2008, ANN NEUROL, V64, P434, DOI 10.1002/ana.21463; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Takahashi T, 1996, J NEUROSCI, V16, P6183; Teissier A, 2011, CEREB CORTE IN PRESS; TONG Y, 1991, NEUROPEPTIDES, V20, P33, DOI 10.1016/0143-4179(91)90037-J; TONON MC, 1990, NEUROPEPTIDES, V15, P17, DOI 10.1016/0143-4179(90)90155-R; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Wang DD, 2003, J PHYSIOL-LONDON, V550, P785, DOI 10.1113/jphysiol.2003.042572; Yanase H, 2002, ARCH HISTOL CYTOL, V65, P27, DOI 10.1679/aohc.65.27; Zhang RL, 2008, J CEREBR BLOOD F MET, V28, P602, DOI 10.1038/sj.jcbfm.9600556	58	82	83	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 6	2012	10	1					76	87		10.1016/j.stem.2011.11.011	http://dx.doi.org/10.1016/j.stem.2011.11.011			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	880ZQ	22226357	Bronze			2022-12-28	WOS:000299449500012
J	Sweet, DJ				Sweet, Deborah J.			Reprogramming, in Print and in Person	CELL STEM CELL			English	Editorial Material																			0	0	0	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	DEC 2	2011	9	6					487	487		10.1016/j.stem.2011.11.017	http://dx.doi.org/10.1016/j.stem.2011.11.017			1	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	859SB	22136916	Bronze			2022-12-28	WOS:000297895000001
J	Quinlan, AR; Boland, MJ; Leibowitz, ML; Shumilina, S; Pehrson, SM; Baldwin, KK; Hall, IM				Quinlan, Aaron R.; Boland, Michael J.; Leibowitz, Mitchell L.; Shumilina, Svetlana; Pehrson, Sidney M.; Baldwin, Kristin K.; Hall, Ira M.			Genome Sequencing of Mouse Induced Pluripotent Stem Cells Reveals Retroelement Stability and Infrequent DNA Rearrangement during Reprogramming	CELL STEM CELL			English	Article							COPY NUMBER VARIATION; L1 RETROTRANSPOSITION; LINE-1 RETROTRANSPOSITION; IDENTIFICATION; EVOLUTION; INSIGHTS; ELEMENTS; MICE	The biomedical utility of induced pluripotent stem cells (iPSCs) will be diminished if most iPSC lines harbor deleterious genetic mutations. Recent micro-array studies have shown that human iPSCs carry elevated levels of DNA copy number variation compared with those in embryonic stem cells, suggesting that these and other classes of genomic structural variation (SV), including inversions, smaller duplications and deletions, complex rearrangements, and retroelement transpositions, may frequently arise as a consequence of reprogramming. Here we employ whole-genome paired-end DNA sequencing and sensitive mapping algorithms to identify all classes of SV in three fully pluripotent mouse iPSC lines. Despite the improved scope and resolution of this study, we find few spontaneous mutations per line (one or two) and no evidence for endogenous retroelement transposition. These results show that genome stability can persist throughout reprogramming, and argue that it is possible to generate iPSCs lacking gene-disrupting mutations using current reprogramming methods.	[Boland, Michael J.; Pehrson, Sidney M.; Baldwin, Kristin K.] Scripps Res Inst, Dept Cell Biol, Dorris Neurosci Ctr, La Jolla, CA 92037 USA; [Quinlan, Aaron R.; Leibowitz, Mitchell L.; Shumilina, Svetlana; Hall, Ira M.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Quinlan, Aaron R.; Hall, Ira M.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA	Scripps Research Institute; University of Virginia; University of Virginia	Baldwin, KK (corresponding author), Scripps Res Inst, Dept Cell Biol, Dorris Neurosci Ctr, La Jolla, CA 92037 USA.	kbaldwin@scripps.edu; irahall@virginia.edu		Quinlan, Aaron/0000-0003-1756-0859; Baldwin, Kristin/0000-0002-6137-030X; Boland, Michael/0000-0001-5649-9603; Leibowitz, Mitchell/0000-0003-1874-5441	NRSA [1F32HG005197-01]; California Institute for Regenerative Medicine; Pew Scholar Award; Esther B.O'Keeffe Family Foundation; Shapiro Family Foundation; Burroughs Wellcome; NIH [DP2OD006493-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG005197] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006493] Funding Source: NIH RePORTER	NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Pew Scholar Award; Esther B.O'Keeffe Family Foundation; Shapiro Family Foundation; Burroughs Wellcome(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Lindberg for algorithm development and R. Clark for computational support, and A. Prorock and Y. Bao (UVA Sequencing Core) for DNA sequencing. We acknowledge S. Kupriyanov and G. Martin (TSRI Mouse Genetics Facility) for assistance with ESC derivation, and K. Nazor for assistance with cell culture. Support to A.R.Q. was from an NRSA postdoctoral fellowship (1F32HG005197-01); to K.K.B. and M.J.B., from the California Institute for Regenerative Medicine, a Pew Scholar Award, the Esther B.O'Keeffe Family Foundation, and the Shapiro Family Foundation; and to I.M.H., from a Burroughs Wellcome Fund Career Award and the NIH Director's New Innovator Award (DP2OD006493-01). The authors declare no competing financial interests.	Akagi K, 2008, GENOME RES, V18, P869, DOI 10.1101/gr.075770.107; Asiedu M, 2009, MOL BIOL CELL, V20, P1428, DOI 10.1091/mbc.E08-01-0001; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Conrad DF, 2010, NAT GENET, V42, P385, DOI 10.1038/ng.564; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Deng WB, 2009, TRENDS GENET, V25, P425, DOI 10.1016/j.tig.2009.09.004; Fan JS, 2011, MUTAT RES-FUND MOL M, V713, P8, DOI 10.1016/j.mrfmmm.2011.05.018; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hampton OA, 2009, GENOME RES, V19, P167, DOI 10.1101/gr.080259.108; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Hillmer AM, 2011, GENOME RES, V21, P665, DOI 10.1101/gr.113555.110; Howden SE, 2011, P NATL ACAD SCI USA, V108, P6537, DOI 10.1073/pnas.1103388108; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Kidd JM, 2010, CELL, V143, P837, DOI 10.1016/j.cell.2010.10.027; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Maksakova IA, 2008, CELL MOL LIFE SCI, V65, P3329, DOI 10.1007/s00018-008-8494-3; Martins-Taylor K, 2011, NAT BIOTECHNOL, V29, P488, DOI 10.1038/nbt.1890; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Momcilovic O, 2011, RESULTS PROBL CELL D, V53, P415, DOI 10.1007/978-3-642-19065-0_18; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Oyamada Y, 2005, RESP PHYSIOL NEUROBI, V145, P143, DOI 10.1016/j.resp.2004.11.003; Quinlan AR, 2010, GENOME RES, V20, P623, DOI 10.1101/gr.102970.109; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Suto F, 2003, MECH DEVELOP, V120, P385, DOI 10.1016/S0925-4773(02)00421-5; Wang ZD, 2004, DEV BIOL, V275, P192, DOI 10.1016/j.ydbio.2004.06.026; Xing JC, 2009, GENOME RES, V19, P1516, DOI 10.1101/gr.091827.109; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217	35	86	90	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	OCT 7	2011	9	4					366	373		10.1016/j.stem.2011.07.018	http://dx.doi.org/10.1016/j.stem.2011.07.018			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	835MT	21982236	Green Accepted, Bronze			2022-12-28	WOS:000296041200014
J	Willenbring, H				Willenbring, Holger			A Simple Code for Installing Hepatocyte Function	CELL STEM CELL			English	Editorial Material							LIVER DEVELOPMENT; CELLS; EXPRESSION; MICE; FATE	Forced lineage conversion of accessible cell types can supply scarce or inaccessible cells for research and therapy. Two papers in Nature now report the identification of transcription factors sufficient for inducing therapeutically effective hepatocyte function in fibroblasts (Huang et al., 2011; Sekiya and Suzuki, 2011).	[Willenbring, Holger] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Willenbring, Holger] Univ Calif San Francisco, Dept Surg, Div Transplantat, San Francisco, CA 94143 USA; [Willenbring, Holger] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Willenbring, H (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.	willenbringh@stemcell.ucsf.edu						Chambers SM, 2011, CELL, V145, P827, DOI 10.1016/j.cell.2011.05.036; Dorrell C, 2011, GENE DEV, V25, P1193, DOI 10.1101/gad.2029411; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Kyrmizi I, 2006, GENE DEV, V20, P2293, DOI 10.1101/gad.390906; Lazarevich N, 2004, HEPATOLOGY, V39, P1038, DOI 10.1002/hep.20155; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Shin S, 2011, GENE DEV, V25, P1185, DOI 10.1101/gad.2027811; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Suzuki A, 2008, DEVELOPMENT, V135, P1589, DOI 10.1242/dev.016634; Yamanouchi K, 2009, HEPATOLOGY, V49, P258, DOI 10.1002/hep.22573; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431	11	11	12	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	AUG 5	2011	9	2					89	91		10.1016/j.stem.2011.07.009	http://dx.doi.org/10.1016/j.stem.2011.07.009			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	808PM	21816357	Bronze			2022-12-28	WOS:000293990900002
J	Lee, TKW; Castilho, A; Cheung, VCH; Tang, KH; Ma, S; Irene, OLN				Lee, Terence Kin Wah; Castilho, Antonia; Cheung, Vincent Chi Ho; Tang, Kwan Ho; Ma, Stephanie; Irene Oi Lin Ng			CD24(+) Liver Tumor-Initiating Cells Drive Self-Renewal and Tumor Initiation through STAT3-Mediated NANOG Regulation	CELL STEM CELL			English	Article							CANCER STEM-CELLS; HEPATOCELLULAR-CARCINOMA; PROSPECTIVE IDENTIFICATION; TGF-BETA; EXPRESSION; GENE; RECURRENCE; MODELS	Tumor-initiating cells (T-ICs) are a subpopulation of chemoresistant tumor cells that have been shown to cause tumor recurrence upon chemotherapy. Identification of T-ICs and their related pathways are therefore priorities for the development of new therapeutic paradigms. We established chemoresistant hepatocellular carcinoma (HCC) xenograft tumors in immunocompromised mice in which an enriched T-IC population was capable of tumor initiation and self-renewal. With this model, we found CD24 to be upregulated in residual chemoresistant tumors when compared with bulk tumor upon cisplatin treatment. CD24(+) HCC cells were found to be critical for the maintenance, self-renewal, differentiation, and metastasis of tumors and to significantly impact patients' clinical outcome. With a lentiviral-based knockdown approach, CD24 was found to be a functional liver T-IC marker that drives T-IC genesis through STAT3-mediated NANOG regulation. Our findings point to a CD24 cascade in liver T-ICs that may provide an attractive therapeutic target for HCC patients.	[Lee, Terence Kin Wah; Castilho, Antonia; Cheung, Vincent Chi Ho; Ma, Stephanie; Irene Oi Lin Ng] Univ Hong Kong, State Key Lab Liver Res, Pokfulam, Hong Kong, Peoples R China; [Lee, Terence Kin Wah; Castilho, Antonia; Cheung, Vincent Chi Ho; Tang, Kwan Ho; Ma, Stephanie; Irene Oi Lin Ng] Univ Hong Kong, Liver Canc & Hepatitis Res Lab, Dept Pathol, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Irene, OLN (corresponding author), Univ Hong Kong, State Key Lab Liver Res, Pokfulam, Hong Kong, Peoples R China.	iolng@hku.hk	Ma, Stephanie Kwai Yee/C-4766-2009	Ma, Stephanie Kwai Yee/0000-0002-2029-7943; Tang, Kwan Ho/0000-0001-7729-5159; Ng, Irene Oi-lin/0000-0001-7532-2029; Lee, Kin Wah/0000-0003-0682-322X	Hong Kong Research Grants Council [HKU 1/06C, HKU 7/CRF/09]	Hong Kong Research Grants Council(Hong Kong Research Grants Council)	The authors would like to thank LKS Faculty of Medicine at The University of Hong Kong for the Faculty Core Facility. The study was supported by Hong Kong Research Grants Council Collaborative Research Fund (HKU 1/06C and HKU 7/CRF/09). I.O.L.N. is Loke Yew Professor in Pathology.	Aguayo A, 2001, SEMIN ONCOL, V28, P503, DOI 10.1053/sonc.2001.26953; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2007, CURR OPIN ONCOL, V19, P61; ARII S, 1992, CANCER, V69, P913, DOI 10.1002/1097-0142(19920215)69:4<913::AID-CNCR2820690413>3.0.CO;2-T; Averbook BJ, 2002, SURGERY, V132, P611; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Byers LA, 2009, CLIN CANCER RES, V15, P6852, DOI 10.1158/1078-0432.CCR-09-0767; Carr BI, 2004, GASTROENTEROLOGY, V127, pS218, DOI 10.1053/j.gastro.2004.09.036; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Cram DS, 1999, DIFFERENTIATION, V64, P237, DOI 10.1046/j.1432-0436.1999.6440237.x; Dalerba P, 2007, CELL STEM CELL, V1, P241, DOI 10.1016/j.stem.2007.08.012; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Friel AM, 2008, CELL CYCLE, V7, P242, DOI 10.4161/cc.7.2.5207; FU XY, 1991, P NATL ACAD SCI USA, V88, P9345, DOI 10.1073/pnas.88.20.9345; HEDVAT M, 2003, CANCER CELL, V16, P487; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; HUANG LR, 1995, CANCER RES, V55, P4717; Humphrey RK, 2004, STEM CELLS, V22, P522, DOI 10.1634/stemcells.22-4-522; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29; Kassahun Woubet T, 2006, Exp Clin Transplant, V4, P549; Kristiansen G, 2003, CLIN CANCER RES, V9, P4906; Kristiansen G, 2002, AM J PATHOL, V161, P1215, DOI 10.1016/S0002-9440(10)64398-2; Kuvshinoff BW, 2002, SURGERY, V132, P605, DOI 10.1067/msy.2002.127545; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Lin L, 2009, ONCOGENE, V28, P961, DOI 10.1038/onc.2008.448; Liu SL, 2005, BREAST CANCER RES, V7, P86, DOI 10.1186/bcr1021; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Ma S, 2010, CELL STEM CELL, V7, P694, DOI 10.1016/j.stem.2010.11.010; Marquardt JU, 2010, SEMIN LIVER DIS, V30, P26, DOI 10.1055/s-0030-1247130; Mattison J, 2010, CANCER RES, V70, P883, DOI 10.1158/0008-5472.CAN-09-1737; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; PIRRUCCELLO SJ, 1986, J IMMUNOL, V136, P3779; Sammar M, 1997, BIOCHEM BIOPH RES CO, V234, P330, DOI 10.1006/bbrc.1997.6639; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Singh SK, 2003, CANCER RES, V63, P5821; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Tang Y, 2008, P NATL ACAD SCI USA, V105, P2445, DOI 10.1073/pnas.0705395105; Wang M, 2011, INT J CANCER, V128, P72, DOI 10.1002/ijc.25317; Woo HG, 2008, CLIN CANCER RES, V14, P2056, DOI 10.1158/1078-0432.CCR-07-1473; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yang XR, 2009, CLIN CANCER RES, V15, P5518, DOI 10.1158/1078-0432.CCR-09-0151; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Yeung TM, 2010, P NATL ACAD SCI USA, V107, P3722, DOI 10.1073/pnas.0915135107; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	51	464	492	3	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 8	2011	9	1					50	63		10.1016/j.stem.2011.06.005	http://dx.doi.org/10.1016/j.stem.2011.06.005			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	797VA	21726833	Bronze, Green Submitted			2022-12-28	WOS:000293157000009
J	Vunjak-Novakovic, G; Scadden, DT				Vunjak-Novakovic, Gordana; Scadden, David T.			Biomimetic Platforms for Human Stem Cell Research	CELL STEM CELL			English	Article							HEMATOPOIETIC PROGENITOR CELLS; BONE-MARROW; EXTRACELLULAR-MATRIX; ADULT-MOUSE; ELECTRICAL-STIMULATION; SKELETAL-MUSCLE; PRECURSOR CELLS; HAIR FOLLICLE; SELF-RENEWAL; IN-VITRO	Stem cells are central to developing new treatment options for tissue regeneration and constructing controllable models for biological research. Bioengineered cell culture environments that combine microenvironmental control with tissue-specific transport and signaling are critical tools in our efforts to study tissue development, regeneration, and disease under conditions that predict the human in vivo context. We propose that experimentation at the interfaces of biology, engineering, and medical sciences is critical for unlocking the full potential of stem cells. Here, we focus on the design and utilization of in vitro platforms that recapitulate the environments associated with tissue development, disease, and regeneration.	[Vunjak-Novakovic, Gordana] Columbia Univ, Dept Biomed Engn, New York, NY 10032 USA; [Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Harvard Stem Cell Inst, Boston, MA 02114 USA	Columbia University; Harvard University; Massachusetts General Hospital	Vunjak-Novakovic, G (corresponding author), Columbia Univ, Dept Biomed Engn, New York, NY 10032 USA.	gv2131@columbia.edu	vunjak-novakovic, gordana/J-9279-2012	Vunjak-Novakovic, Gordana/0000-0002-9382-1574	NIH [HL076485, DE16525, HL089913, EB002520, HL044851, HL097794, HL100402, DK050234]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR026244] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076485, U01HL100402, R01HL097794, R01HL044851, R21HL089913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002520, R21EB011869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050234] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The fusion of the fields of cell biology and bioengineering has been driven by the pioneering efforts of many contributors working at the interface of the two disciplines. We acknowledge their collective contributions and regret that space constraints prevented us from citing many meritorious studies that will continue to inspire future efforts. We also acknowledge research funding by NIH (HL076485, DE16525, HL089913, and EB002520 to G.V.-N. and HL044851, HL097794, HL100402, and DK050234 to D.T.S.) and thank Dr. N. Mirkovic for his expert help with illustrations.	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Altman GH, 2001, FASEB J, V15, P270, DOI 10.1096/fj.01-0656fje; Au HTH, 2007, BIOMATERIALS, V28, P4277, DOI 10.1016/j.biomaterials.2007.06.001; Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Borowiak M, 2009, CURR OPIN CELL BIOL, V21, P727, DOI 10.1016/j.ceb.2009.08.006; Burdick JA, 2009, TISSUE ENG PT A, V15, P205, DOI 10.1089/ten.tea.2008.0131; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cimetta E, 2009, METHODS, V47, P81, DOI 10.1016/j.ymeth.2008.10.015; Connelly JT, 2010, NAT CELL BIOL, V12, P711, DOI 10.1038/ncb2074; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Dawson E, 2008, ADV DRUG DELIVER REV, V60, P215, DOI 10.1016/j.addr.2007.08.037; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Elkins RC, 2001, ANN THORAC SURG, V71, pS428, DOI 10.1016/S0003-4975(01)02503-6; Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316; Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Ferreira LS, 2007, BIOMATERIALS, V28, P2706, DOI 10.1016/j.biomaterials.2007.01.021; Figallo E, 2007, LAB CHIP, V7, P710, DOI 10.1039/b700063d; Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736; FREDERIKSEN K, 1988, NEURON, V1, P439, DOI 10.1016/0896-6273(88)90175-4; Freytes DO, 2009, J CELL BIOCHEM, V108, P1047, DOI 10.1002/jcb.22355; Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104; Gerecht-Nir S, 2004, BIOTECHNOL BIOENG, V88, P313, DOI 10.1002/bit.20248; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Gong ZD, 2008, FASEB J, V22, P1635, DOI 10.1096/fj.07-087924; Grayson WL, 2010, P NATL ACAD SCI USA, V107, P3299, DOI 10.1073/pnas.0905439106; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; HAYFLICK L, 1979, J INVEST DERMATOL, V73, P8, DOI 10.1111/1523-1747.ep12532752; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Hui EE, 2007, P NATL ACAD SCI USA, V104, P5722, DOI 10.1073/pnas.0608660104; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Kamei KI, 2009, LAB CHIP, V9, P555, DOI 10.1039/b809105f; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X; Lucchetta EM, 2005, NATURE, V434, P1134, DOI 10.1038/nature03509; Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602; Lutolf MP, 2009, INTEGR BIOL, V1, P235, DOI 10.1039/b902243k; Lysaght MJ, 2001, TISSUE ENG, V7, P485, DOI 10.1089/107632701753213110; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822; Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000; Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102; Nelson CM, 2005, SEMIN CANCER BIOL, V15, P342, DOI 10.1016/j.semcancer.2005.05.001; Niebruegge S, 2009, BIOTECHNOL BIOENG, V102, P493, DOI 10.1002/bit.22065; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193; Park JY, 2009, STEM CELLS, V27, P2646, DOI 10.1002/stem.202; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; PEREIRA RF, 1995, P NATL ACAD SCI USA, V92, P4857, DOI 10.1073/pnas.92.11.4857; Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Ruiz SA, 2008, STEM CELLS, V26, P2921, DOI 10.1634/stemcells.2008-0432; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Saha K, 2009, CELL STEM CELL, V5, P584, DOI 10.1016/j.stem.2009.11.009; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Serena E, 2009, EXP CELL RES, V315, P3611, DOI 10.1016/j.yexcr.2009.08.015; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Skelley AM, 2009, NAT METHODS, V6, P147, DOI [10.1038/NMETH.1290, 10.1038/nmeth.1290]; Smukler SR, 2011, CELL STEM CELL, V8, P281, DOI 10.1016/j.stem.2011.01.015; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tandon N, 2010, LAB CHIP, V10, P692, DOI 10.1039/b917743d; Tandon N, 2009, NAT PROTOC, V4, P155, DOI 10.1038/nprot.2008.183; Terraciano V, 2007, STEM CELLS, V25, P2730, DOI 10.1634/stemcells.2007-0228; Underhill GH, 2007, CURR OPIN CHEM BIOL, V11, P357, DOI 10.1016/j.cbpa.2007.05.036; Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170; Voog J, 2010, CELL STEM CELL, V6, P103, DOI 10.1016/j.stem.2010.01.011; Wan LQ, 2010, INTEGR BIOL-UK, V2, P346, DOI 10.1039/c0ib00016g; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534; Yuan X, 2011, PROG DRUG RES, V67, P253, DOI 10.1007/978-3-7643-8989-5_13; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhao XH, 2011, P NATL ACAD SCI USA, V108, P67, DOI 10.1073/pnas.1007862108; Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394	90	100	107	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 4	2011	8	3					252	261		10.1016/j.stem.2011.02.014	http://dx.doi.org/10.1016/j.stem.2011.02.014			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	735HI	21362565	Green Accepted, Bronze			2022-12-28	WOS:000288404400007
J	Kondo, T; Asai, M; Tsukita, K; Kutoku, Y; Ohsawa, Y; Sunada, Y; Imamura, K; Egawa, N; Yahata, N; Okita, K; Takahashi, K; Asaka, I; Aoi, T; Watanabe, A; Watanabe, K; Kadoya, C; Nakano, R; Watanabe, D; Maruyama, K; Hori, O; Hibino, S; Choshi, T; Nakahata, T; Hioki, H; Kaneko, T; Naitoh, M; Yoshikawa, K; Yamawaki, S; Suzuki, S; Hata, R; Ueno, S; Seki, T; Kobayashi, K; Toda, T; Murakami, K; Irie, K; Klein, WL; Mori, H; Asada, T; Takahashi, R; Iwata, N; Yamanaka, S; Inoue, H				Kondo, Takayuki; Asai, Masashi; Tsukita, Kayoko; Kutoku, Yumiko; Ohsawa, Yutaka; Sunada, Yoshihide; Imamura, Keiko; Egawa, Naohiro; Yahata, Naoki; Okita, Keisuke; Takahashi, Kazutoshi; Asaka, Isao; Aoi, Takashi; Watanabe, Akira; Watanabe, Kaori; Kadoya, Chie; Nakano, Rie; Watanabe, Dai; Maruyama, Kei; Hori, Osamu; Hibino, Satoshi; Choshi, Tominari; Nakahata, Tatsutoshi; Hioki, Hiroyuki; Kaneko, Takeshi; Naitoh, Motoko; Yoshikawa, Katsuhiro; Yamawaki, Satoko; Suzuki, Shigehiko; Hata, Ryuji; Ueno, Shu-ichi; Seki, Tsuneyoshi; Kobayashi, Kazuhiro; Toda, Tatsushi; Murakami, Kazuma; Irie, Kazuhiro; Klein, William L.; Mori, Hiroshi; Asada, Takashi; Takahashi, Ryosuke; Iwata, Nobuhisa; Yamanaka, Shinya; Inoue, Haruhisa			Modeling Alzheimer's Disease with iPSCs Reveals Stress Phenotypes Associated with Intracellular A beta and Differential Drug Responsiveness	CELL STEM CELL			English	Article							OXIDATIVE STRESS; PROTEIN; OLIGOMERS; NEURODEGENERATION; GENERATION; BRAIN	Oligomeric forms of amyloid-beta peptide (A beta) are thought to play a pivotal role in the pathogenesis of Alzheimer's disease (AD), but the mechanism involved is still unclear. Here, we generated induced pluripotent stem cells (iPSCs) from familial and sporadic AD patients and differentiated them into neural cells. A beta oligomers accumulated in iPSC-derived neurons and astrocytes in cells from patients with a familial amyloid precursor protein (APP)-E693 Delta mutation and sporadic AD, leading to endoplasmic reticulum (ER) and oxidative stress. The accumulated A beta oligomers were not proteolytically resistant, and docosahexaenoic acid (DHA) treatment alleviated the stress responses in the AD neural cells. Differential manifestation of ER stress and DHA responsiveness may help explain variable clinical results obtained with the use of DHA treatment and suggests that DHA may in fact be effective for a subset of patients. It also illustrates how patient-specific iPSCs can be useful for analyzing AD pathogenesis and evaluating drugs.	[Kondo, Takayuki; Tsukita, Kayoko; Imamura, Keiko; Egawa, Naohiro; Yahata, Naoki; Okita, Keisuke; Takahashi, Kazutoshi; Asaka, Isao; Aoi, Takashi; Watanabe, Akira; Nakahata, Tatsutoshi; Yamanaka, Shinya; Inoue, Haruhisa] Kyoto Univ, Ctr IPS Cell Res & Applicat CiRA, Kyoto 6068507, Japan; [Kondo, Takayuki; Takahashi, Ryosuke] Kyoto Univ, Grad Sch Med, Dept Neurol, Kyoto 6068507, Japan; [Watanabe, Dai] Kyoto Univ, Grad Sch Med, Dept Biol Sci, Kyoto 6068507, Japan; [Watanabe, Dai] Kyoto Univ, Grad Sch Biostudies, Dept Mol & Syst Biol, Kyoto 6068507, Japan; [Hioki, Hiroyuki; Kaneko, Takeshi] Kyoto Univ, Grad Sch Med, Dept Morphol Brain Sci, Kyoto 6068507, Japan; [Naitoh, Motoko; Yoshikawa, Katsuhiro; Yamawaki, Satoko; Suzuki, Shigehiko] Kyoto Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Kyoto 6068507, Japan; [Murakami, Kazuma; Irie, Kazuhiro] Kyoto Univ, Div Food Sci & Biotechnol, Grad Sch Agr, Kyoto 6068507, Japan; [Kondo, Takayuki; Asai, Masashi; Tsukita, Kayoko; Yahata, Naoki; Watanabe, Kaori; Kadoya, Chie; Nakano, Rie; Iwata, Nobuhisa; Inoue, Haruhisa] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol CREST, Saitama 3320012, Japan; [Inoue, Haruhisa] Japan Sci & Technol Agcy JST, Yamanaka IPS Cell Special Project, Saitama 3320012, Japan; [Asai, Masashi; Maruyama, Kei] Saitama Med Univ, Fac Med, Dept Pharmacol, Saitama 3500495, Japan; [Asai, Masashi; Watanabe, Kaori; Kadoya, Chie; Nakano, Rie; Iwata, Nobuhisa] Nagasaki Univ, Lab Mol Biol & Biotechnol, Dept Mol Med Sci, Grad Sch Biomed Sci, Nagasaki 8528521, Japan; [Kutoku, Yumiko; Ohsawa, Yutaka; Sunada, Yoshihide] Kawasaki Med Sch, Dept Neurol, Okayama 7010192, Japan; [Hori, Osamu] Kanazawa Univ, Grad Sch Med Sci, Dept Neuroanat Biotargeting, Kanazawa, Ishikawa 9208640, Japan; [Hibino, Satoshi; Choshi, Tominari] Fukuyama Univ, Fac Pharm & Pharmaceut Sci, Hiroshima 7290292, Japan; [Hata, Ryuji] Ehime Univ, Grad Sch Med, Dept Funct Histol, Matsuyama, Ehime 7910295, Japan; [Ueno, Shu-ichi] Ehime Univ, Grad Sch Med, Dept Psychiat, Matsuyama, Ehime 7910295, Japan; [Seki, Tsuneyoshi; Kobayashi, Kazuhiro; Toda, Tatsushi] Kobe Univ, Grad Sch Med, Div Neurol Mol Brain Sci, Kobe, Hyogo 6500017, Japan; [Klein, William L.] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA; [Mori, Hiroshi] Osaka City Univ, Grad Sch Med, Dept Neurosci, Osaka 5458585, Japan; [Asada, Takashi] Univ Tsukuba, Inst Clin Med, Dept Neuropsychiat, Ibaraki 3058577, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Saitama Medical University; Nagasaki University; Kawasaki Medical School; Kanazawa University; Fukuyama University; Ehime University; Ehime University; Kobe University; Northwestern University; Osaka Metropolitan University; University of Tsukuba	Iwata, N (corresponding author), Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol CREST, Saitama 3320012, Japan.	iwata-n@nagasaki-u.ac.jp; haruhisa@cira.kyoto-u.ac.jp	Hioki, Hiroyuki/J-9412-2017; Asai, Masashi/AAB-7672-2022; Takahashi, Kazutoshi/ABE-5504-2020; Murakami, Kazuma/GQA-7062-2022; Yoshikawa, Katsuhiro/X-1186-2019; Irie, Kazuhiro/A-6121-2014; Kobayashi, Kazuhiro/AAH-8638-2021	Hioki, Hiroyuki/0000-0002-0152-7854; Asai, Masashi/0000-0001-6392-0910; Takahashi, Kazutoshi/0000-0002-5329-8395; Murakami, Kazuma/0000-0003-3152-1784; Irie, Kazuhiro/0000-0001-7109-8568; Kobayashi, Kazuhiro/0000-0001-7801-147X; Okita, Keisuke/0000-0001-5806-1090; Inoue, Haruhisa/0000-0003-4736-9537	Japan Society for the Promotion of Science (JSPS); Alzheimer's Association [IIRG-09-132098]; JST Yamanaka iPS Cell Special Project; CREST; Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [22110007]; Japan Research Foundation for Clinical Pharmacology; Grants-in-Aid for Scientific Research [24700367, 24590040, 21248015, 23592093] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Alzheimer's Association(Alzheimer's Association); JST Yamanaka iPS Cell Special Project(Japan Science & Technology Agency (JST)); CREST(Core Research for Evolutional Science and Technology (CREST)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Research Foundation for Clinical Pharmacology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We would like to express our sincere gratitude to all our coworkers and collaborators, Mari Ohnuki, Megumi Kumazaki, Mitsuyo Kawada, Fumihiko Adachi, Takako Enami, and Misato Funayama for technical assistance; Nobuya Inagaki and Norio Harada for technical advice; and Kazumi Murai for editing the manuscript. This research was funded in part by a grant from the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) of the Japan Society for the Promotion of Science (JSPS) to S.Y., from the Alzheimer's Association (IIRG-09-132098) to H. M., from the JST Yamanaka iPS Cell Special Project to S.Y. and H. I., from CREST to H. I., H. M., N.I., and T. T., from a Grant-in-Aid from the Ministry of Health, Labour and Welfare of Japan to H. I., from a Grant-in-Aid for Scientific Research on Innovative Area "Foundation of Synapse and Neurocircuit Pathology" (22110007) from the Ministry of Education, Culture, Sports, Science and Technology of Japan to H. I. and N.I., and from the Japan Research Foundation for Clinical Pharmacology to H. I. H. I. conceived the project; T. K., N.I., M. A., and H. I. designed the experiments; T. K., N.I., M. A., K. W., C. K., R.N., N.E., N.Y. and K. Tsukita performed the experiments; T. K., N.I., M. A., and H. I. analyzed the data; K.O., I. A., K. M., T.N., K. I., W. L. K., O.H., S. H., and T. C. contributed reagents, materials and analysis tools; Y.K., Y.O., Y.S., M.N., K.Y., S.Y., S. S., T. A., R. H., and S. U. recruited the patients; R. T., H. M., and S.Y. provided critical reading and scientific discussions; T. S., K. K., T. T., and K. Takahashi performed microarray analysis; T. A. performed karyotyping; A. W. performed bisulfite genomic sequencing; K. I. and D. W. performed electrophysiology; K. Tsukita, T. K., and H. H. produced the lentivirus; H. I., N.I., M. A., and T. K. wrote the paper. The experimental protocols dealing with human or animal subjects were approved by the institutional review board at each institute. S.Y. is a member without salary of the scientific advisory boards of iPierian, iPS Academia Japan, Megakaryon Corporation, and Retina Institute Japan.	Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Begum G, 2012, J NEUROCHEM, V120, P622, DOI 10.1111/j.1471-4159.2011.07606.x; Butterfield DA, 2003, CURR MED CHEM, V10, P2651, DOI 10.2174/0929867033456422; Cole Greg M., 2006, Nutrition and Health (Bicester), V18, P249; Freund-Levi Y, 2006, ARCH NEUROL-CHICAGO, V63, P1402, DOI 10.1001/archneur.63.10.1402; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HENSLEY K, 1994, P NATL ACAD SCI USA, V91, P3270, DOI 10.1073/pnas.91.8.3270; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Kassler K, 2010, J MOL MODEL, V16, P1011, DOI 10.1007/s00894-009-0611-1; Krafft GA, 2010, NEUROPHARMACOLOGY, V59, P230, DOI 10.1016/j.neuropharm.2010.07.012; Krencik R, 2011, NAT BIOTECHNOL, V29, P528, DOI 10.1038/nbt.1877; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lee M, 2002, BIOCHEM J, V366, P937, DOI 10.1042/BJ20020453; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Morizane A, 2011, J NEUROSCI RES, V89, P117, DOI 10.1002/jnr.22547; Murakami K, 2010, ACS CHEM NEUROSCI, V1, P747, DOI 10.1021/cn100072e; Nishitsuji K, 2009, AM J PATHOL, V174, P957, DOI 10.2353/ajpath.2009.080480; Noguchi A, 2009, J BIOL CHEM, V284, P32895, DOI 10.1074/jbc.M109.000208; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Quinn JF, 2010, JAMA-J AM MED ASSOC, V304, P1903, DOI 10.1001/jama.2010.1510; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shimada H, 2011, DEMENT GERIATR COGN, V32, P45, DOI 10.1159/000330017; Takano K, 2007, AM J PHYSIOL-CELL PH, V293, pC1884, DOI 10.1152/ajpcell.00305.2007; Tomiyama T, 2008, ANN NEUROL, V63, P377, DOI 10.1002/ana.21321; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Yagi T, 2011, HUM MOL GENET, V20, P4530, DOI 10.1093/hmg/ddr394	30	505	534	10	189	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 4	2013	12	4					487	496		10.1016/j.stem.2013.01.009	http://dx.doi.org/10.1016/j.stem.2013.01.009			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VD	23434393	Bronze, Green Submitted			2022-12-28	WOS:000329569500015
J	Ashton, JM; Balys, M; Neering, SJ; Hassane, DC; Cowley, G; Root, DE; Miller, PG; Ebert, BL; McMurray, HR; Land, H; Jordan, CT				Ashton, John M.; Balys, Marlene; Neering, Sarah J.; Hassane, Duane C.; Cowley, Glenn; Root, David E.; Miller, Peter G.; Ebert, Benjamin L.; McMurray, Helene R.; Land, Hartmut; Jordan, Craig T.			Gene Sets Identified with Oncogene Cooperativity Analysis Regulate In Vivo Growth and Survival of Leukemia Stem Cells	CELL STEM CELL			English	Article							ACUTE MYELOID-LEUKEMIA; INDUCED APOPTOSIS; CONNECTIVITY MAP; MURINE MODEL; KAPPA-B; EXPRESSION; DISCOVERY; HIERARCHY; PAI-2	Leukemia stem cells (LSCs) represent a biologically distinct subpopulation of myeloid leukemias, with reduced cell cycle activity and increased resistance to therapeutic challenge. To better characterize key properties of LSCs, we employed a strategy based on identification of genes synergistically dysregulated by cooperating oncogenes. We hypothesized that such genes, termed "cooperation response genes" (CRGs), would represent regulators of LSC growth and survival. Using both a primary mouse model and human leukemia specimens, we show that CRGs comprise genes previously undescribed in leukemia pathogenesis in which multiple pathways modulate the biology of LSCs. In addition, our findings demonstrate that the CRG expression profile can be used as a drug discovery tool for identification of compounds that selectively target the LSC population. We conclude that CRG-based analyses provide a powerful means to characterize the basic biology of LSCs as well as to identify improved methods for therapeutic targeting.	[Ashton, John M.; Balys, Marlene; Neering, Sarah J.; Jordan, Craig T.] Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Rochester, NY 14642 USA; [Hassane, Duane C.] Weill Cornell Med Coll, Dept Med, Div Hematol & Med Oncol, New York, NY 10021 USA; [Cowley, Glenn; Root, David E.] Seven Cambridge Ctr, Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Miller, Peter G.; Ebert, Benjamin L.] Brigham & Womens Hosp, Boston, MA 02115 USA; [McMurray, Helene R.; Land, Hartmut] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA	University of Rochester; Cornell University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; University of Rochester	Jordan, CT (corresponding author), Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, 601 Elmwood Ave, Rochester, NY 14642 USA.	craig_jordan@urmc.rochester.edu	Hassane, Duane/AAA-3456-2021; jordan, craig/D-7666-2014	Miller, Peter/0000-0002-6797-9335; Hassane, Duane/0000-0002-0719-9572; jordan, craig/0000-0003-0869-3465; McMurray, Helene/0000-0003-1738-8622; Ashton, John/0000-0001-9875-5994	New York State Stem Cell Foundation [C024964]; Department of Defense [W81XWH-07-1-0601]; University of Rochester Hematology/Oncology Training Grant [T32-HL007152];  [NIHRO1-CA122206];  [NIHRO1-CA138249]; NATIONAL CANCER INSTITUTE [R01CA138249, R01CA122206, P50CA130805] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	New York State Stem Cell Foundation; Department of Defense(United States Department of Defense); University of Rochester Hematology/Oncology Training Grant; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors gratefully acknowledge Randall Rossi, Monica Guzman, and Mark Noble for many helpful discussions and critical evaluation of the work and manuscript. We also thank Timothy Bushnell and the URMC Flow Cytometry Core for help with cell sorting experiments and Chris Proschel for supplying the SerpinB2<SUP>-/-</SUP> animals. The research was supported by NIHRO1-CA122206, NIHRO1-CA138249, New York State Stem Cell Foundation grant C024964, Department of Defense grant W81XWH-07-1-0601, and University of Rochester Hematology/Oncology Training Grant T32-HL007152.	Antalis TM, 1998, J EXP MED, V187, P1799, DOI 10.1084/jem.187.11.1799; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Brookes MJ, 2006, GUT, V55, P1449, DOI 10.1136/gut.2006.094060; Burnett A, 2011, J CLIN ONCOL, V29, P487, DOI 10.1200/JCO.2010.30.1820; Cancelas JA, 2000, BLOOD, V96, P498; Costello RT, 2000, CANCER RES, V60, P4403; Dash AB, 2002, P NATL ACAD SCI USA, V99, P7622, DOI 10.1073/pnas.102583199; DICKINSON JL, 1995, J BIOL CHEM, V270, P27894, DOI 10.1074/jbc.270.46.27894; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GLEESON N, 1992, GYNECOL ONCOL, V47, P58, DOI 10.1016/0090-8258(92)90076-U; Guzman ML, 2001, BLOOD, V98, P2301, DOI 10.1182/blood.V98.8.2301; Hassane DC, 2008, BLOOD, V111, P5654, DOI 10.1182/blood-2007-11-126003; Hassane DC, 2010, BLOOD, V116, P5983, DOI 10.1182/blood-2010-04-278044; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lloyd AC, 1997, GENE DEV, V11, P663, DOI 10.1101/gad.11.5.663; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; McMurray HR, 2008, NATURE, V453, P1112, DOI 10.1038/nature06973; Nasr R, 2008, NAT MED, V14, P1333, DOI 10.1038/nm.1891; Neering SJ, 2007, BLOOD, V110, P2578, DOI 10.1182/blood-2007-02-073031; Nordengren J, 2002, INT J CANCER, V97, P379, DOI 10.1002/ijc.1611; OSHEROV N, 1993, J BIOL CHEM, V268, P11134; Park JM, 2005, IMMUNITY, V23, P319, DOI 10.1016/j.immuni.2005.08.010; Sewing A, 1997, MOL CELL BIOL, V17, P5588, DOI 10.1128/MCB.17.9.5588; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Tonnetti L, 2008, CANCER RES, V68, P5648, DOI 10.1158/0008-5472.CAN-07-5850; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624; Worsdorfer P, 2008, STEM CELLS, V26, P431, DOI 10.1634/stemcells.2007-0482; Wong P, 2007, GENE DEV, V21, P2762, DOI 10.1101/gad.1602107; Xia MX, 2007, NAT STRUCT MOL BIOL, V14, P215, DOI 10.1038/nsmb1208	35	43	45	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 7	2012	11	3					359	372		10.1016/j.stem.2012.05.024	http://dx.doi.org/10.1016/j.stem.2012.05.024			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	018DW	22863534	Bronze, Green Accepted			2022-12-28	WOS:000309641300010
J	Mao, JJ; Robey, PG; Prockop, DJ				Mao, Jeremy J.; Robey, Pamela G.; Prockop, Darwin J.			Stem Cells in the Face: Tooth Regeneration and Beyond	CELL STEM CELL			English	Review							MARROW STROMAL CELLS; EPITHELIAL PROGENITOR CELLS; DENTAL MESENCHYMAL CELLS; BONE-MARROW; CERVICAL-LOOP; IN-VITRO; TISSUE; MOUSE; DIFFERENTIATION; ORGAN	The face distinguishes one person from another. Postnatal orofacial tissues harbor rare cells that exhibit stem cell properties. Despite unmet clinical needs for reconstruction of tissues lost in congenital anomalies, infections, trauma, or tumor resection, how orofacial stem/progenitor cells contribute to tissue development, pathogenesis, and regeneration is largely obscure. This perspective article critically analyzes the current status of our understanding of orofacial stem/progenitor cells, identifies gaps in our knowledge, and highlights pathways for the development of regenerative therapies.	[Mao, Jeremy J.] Columbia Univ, Med Ctr, Ctr Craniofacial Regenerat, New York, NY 10032 USA; [Robey, Pamela G.] Natl Inst Dent & Craniofacial Res, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD 20892 USA; [Prockop, Darwin J.] Texas A&M Univ, Hlth Sci Ctr, Inst Regenerat Med Scott & White, Temple, TX 76502 USA	Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Mao, JJ (corresponding author), Columbia Univ, Med Ctr, Ctr Craniofacial Regenerat, 630 W 168 St,PH7E, New York, NY 10032 USA.	jmao@columbia.edu	Robey, Pamela Gehron/H-1429-2011	Robey, Pamela Gehron/0000-0002-5316-5576	NIH [R01DE018248, R01EB009663, RC2DE020767, R01HL073755, P01RR17447, R21EY020962]; New York Stem Cell Foundation Grant; NATIONAL EYE INSTITUTE [R21EY020962] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018248, R01DE023112] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020767] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Stem Cell Foundation Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Dr. N. Lumelsky from NIH/NIDCR for her critical comments and Dr. M. Embree for interactions with medical graphics for illustration. The work for composition of this manuscript is supported by NIH grants R01DE018248, R01EB009663, and RC2DE020767 (to J.J.M.); New York Stem Cell Foundation Grant (to J.J.M.); and NIH grants R01HL073755, P01RR17447, and R21EY020962 (to D.J.P.). All three authors conceived the general framework of the manuscript. J.J.M. composed the first draft and revised the manuscript. P.G.R. and D.J.P. provided insightful and critical suggestions and participated in the revision of the manuscript.	Aida T, 2012, SCIENCE, V335, P813, DOI 10.1126/science.1205962; Akintoye SO, 2006, BONE, V38, P758, DOI 10.1016/j.bone.2005.10.027; Arthur A, 2009, STEM CELLS, V27, P2229, DOI 10.1002/stem.138; Batouli S, 2003, J DENT RES, V82, P976, DOI 10.1177/154405910308201208; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bianco P, 2011, BLOOD, V117, P5281, DOI 10.1182/blood-2011-01-315069; BOYNE PJ, 1970, J DENT RES, V49, P556, DOI 10.1177/00220345700490031501; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Chai Y, 2000, DEVELOPMENT, V127, P1671; Cordeiro MM, 2008, J ENDODONT, V34, P962, DOI 10.1016/j.joen.2008.04.009; Cordero DR, 2011, AM J MED GENET A, V155A, P270, DOI 10.1002/ajmg.a.33702; Du C, 2005, SCIENCE, V307, P1450, DOI 10.1126/science.1105675; Duailibi MT, 2004, J DENT RES, V83, P523, DOI 10.1177/154405910408300703; Felszeghy S, 2010, DIFFERENTIATION, V80, P241, DOI 10.1016/j.diff.2010.06.004; Feng JF, 2011, P NATL ACAD SCI USA, V108, P6503, DOI 10.1073/pnas.1015449108; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; Fujimori S, 2010, DEV BIOL, V348, P97, DOI 10.1016/j.ydbio.2010.09.009; Galler KM, 2012, TISSUE ENG PT A, V18, P176, DOI [10.1089/ten.tea.2011.0222, 10.1089/ten.TEA.2011.0222]; Gandia C, 2008, STEM CELLS, V26, P638, DOI 10.1634/stemcells.2007-0484; Govindasamy V, 2011, CYTOTHERAPY, V13, P1221, DOI 10.3109/14653249.2011.602337; Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463; Handrigan GR, 2010, DEVELOPMENT, V137, P3545, DOI 10.1242/dev.052415; Harada H, 1999, J CELL BIOL, V147, P105, DOI 10.1083/jcb.147.1.105; Harada H, 2002, DEVELOPMENT, V129, P1533; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Huang GTJ, 2009, J DENT RES, V88, P792, DOI 10.1177/0022034509340867; Huang Z, 2010, BIOMATERIALS, V31, P9202, DOI 10.1016/j.biomaterials.2010.08.013; Ikeda E, 2009, P NATL ACAD SCI USA, V106, P13475, DOI 10.1073/pnas.0902944106; Iohara K, 2006, STEM CELLS, V24, P2493, DOI 10.1634/stemcells.2006-0161; Iohara K, 2011, TISSUE ENG PT A, V17, P1911, DOI [10.1089/ten.tea.2010.0615, 10.1089/ten.TEA.2010.0615]; Ishkitiev N, 2010, J ENDODONT, V36, P469, DOI 10.1016/j.joen.2009.12.022; Izumi K, 2007, J DENT RES, V86, P341, DOI 10.1177/154405910708600408; Jarvinen E, 2006, P NATL ACAD SCI USA, V103, P18627, DOI 10.1073/pnas.0607289103; Jiang XB, 2002, DEV BIOL, V241, P106, DOI 10.1006/dbio.2001.0487; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Kawano S, 2004, J DENT RES, V83, P129, DOI 10.1177/154405910408300209; Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015; Keller L, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00007; Kim JY, 2010, TISSUE ENG PT A, V16, P3023, DOI [10.1089/ten.tea.2010.0181, 10.1089/ten.TEA.2010.0181]; Kim K, 2010, J DENT RES, V89, P842, DOI 10.1177/0022034510370803; Klein OD, 2008, DEVELOPMENT, V135, P377, DOI 10.1242/dev.015081; Knox SM, 2010, SCIENCE, V329, P1645, DOI 10.1126/science.1192046; KOLLAR EJ, 1980, SCIENCE, V207, P993, DOI 10.1126/science.7352302; Kuo TF, 2008, J BIOMED MATER RES A, V86A, P1062, DOI 10.1002/jbm.a.31746; Lee CH, 2010, J CLIN INVEST, V120, P3340, DOI 10.1172/JCI43230; Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Lee RH, 2009, BLOOD, V113, P816, DOI 10.1182/blood-2007-12-128702; Lin YS, 2009, DEV DYNAM, V238, P324, DOI 10.1002/dvdy.21778; Lindroos B, 2008, BIOCHEM BIOPH RES CO, V368, P329, DOI 10.1016/j.bbrc.2008.01.081; Mankani MH, 2006, STEM CELLS, V24, P2140, DOI 10.1634/stemcells.2005-0567; Mao JJ, 2006, J DENT RES, V85, P966, DOI 10.1177/154405910608501101; Marion NW, 2006, METHOD ENZYMOL, V420, P339, DOI 10.1016/S0079-6879(06)20016-8; Marynka-Kalmani K, 2010, STEM CELLS, V28, P984, DOI 10.1002/stem.425; Matsubara T, 2005, J BONE MINER RES, V20, P399, DOI 10.1359/JBMR.041117; McLain RF, 2005, J BONE JOINT SURG AM, V87A, P2655, DOI 10.2106/JBJS.E.00230; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mitsiadis TA, 2010, DEVELOPMENT, V137, P3025, DOI 10.1242/dev.049528; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Modino SAC, 2005, ARCH ORAL BIOL, V50, P255, DOI 10.1016/j.archoralbio.2005.01.002; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Nakao K, 2007, NAT METHODS, V4, P227, DOI 10.1038/nmeth1012; Nakashima M, 2003, NAT BIOTECHNOL, V21, P1025, DOI 10.1038/nbt864; O'Connell DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002414; Ohazama A, 2004, J DENT RES, V83, P518, DOI 10.1177/154405910408300702; Oshima M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021531; OWEN M, 1988, CIBA F SYMP, V136, P42, DOI 10.1002/9780470513637.ch4; Prockop DJ, 2009, MOL THER, V17, P939, DOI 10.1038/mt.2009.62; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Reynolds AJ, 2004, DIFFERENTIATION, V72, P566, DOI 10.1111/j.1432-0436.2004.07209010.x; Robey PG, 2011, TISSUE ENG PART B-RE, V17, P423, DOI 10.1089/ten.teb.2011.0199; Robey PG, 2000, J CLIN INVEST, V105, P1489, DOI 10.1172/JCI10256; Rothova M, 2012, DEV DYNAM, V241, P1183, DOI 10.1002/dvdy.23804; Rothova M, 2011, INT J DEV BIOL, V55, P59, DOI 10.1387/ijdb.103083mr; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; SAMUEL N, 1983, J CRAN GENET DEV BIO, V3, P29; Seidel K, 2010, DEVELOPMENT, V137, P3753, DOI 10.1242/dev.056358; Sekiya I, 2002, STEM CELLS, V20, P530, DOI 10.1634/stemcells.20-6-530; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; SMITH AJ, 1995, INT J DEV BIOL, V39, P273; SMITH CE, 1980, AM J ANAT, V158, P321, DOI 10.1002/aja.1001580307; Smith JR, 2004, STEM CELLS, V22, P823, DOI 10.1634/stemcells.22-5-823; Song JH, 2010, BLOOD, V115, P2592, DOI 10.1182/blood-2009-01-200071; Sonoyama W, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000079; Sugiyama M, 2011, TISSUE ENG PT A, V17, P1303, DOI [10.1089/ten.tea.2010.0306, 10.1089/ten.TEA.2010.0306]; Thesleff I, 2003, QUINTESSENCE INT, V34, P613; Thesleff I., 2008, TOOTH ORGANOGENESIS; Thesleff I, 2007, CR BIOL, V330, P561, DOI 10.1016/j.crvi.2007.03.005; Thesleff I, 2006, AM J MED GENET A, V140A, P2530, DOI 10.1002/ajmg.a.31360; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; Tucker AS, 2007, SEMIN CELL DEV BIOL, V18, P237, DOI 10.1016/j.semcdb.2007.01.006; Volponi AA, 2010, TRENDS CELL BIOL, V20, P715, DOI 10.1016/j.tcb.2010.09.012; Wada N, 2009, J CELL PHYSIOL, V219, P667, DOI 10.1002/jcp.21710; Wagner W, 2007, STEM CELL REV, V3, P239, DOI 10.1007/s12015-007-9001-1; Wang XP, 2007, PLOS BIOL, V5, P1324, DOI 10.1371/journal.pbio.0050159; Wang XP, 2009, DEVELOPMENT, V136, P1939, DOI 10.1242/dev.033803; Wang XP, 2004, DEV DYNAM, V231, P98, DOI 10.1002/dvdy.20118; Yamaza T, 2011, J DENT RES, V90, P317, DOI 10.1177/0022034510387796; Yamazaki H, 2007, STEM CELLS, V25, P78, DOI 10.1634/stemcells.2006-0360; Yang B, 2012, BIOMATERIALS, V33, P2449, DOI 10.1016/j.biomaterials.2011.11.074; Yang RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013547; Yao S, 2008, J DENT RES, V87, P767, DOI 10.1177/154405910808700801; Yelick P.C., 2006, DENT CLIN N AM, V50, pviii; Yelick Pamela C, 2006, Dent Clin North Am, V50, P191, DOI 10.1016/j.cden.2005.11.005; Yildirim S, 2011, INT J ORAL SCI, V3, P107, DOI 10.4248/IJOS11042; Yokohama-Tamaki T, 2006, DEVELOPMENT, V133, P1359, DOI 10.1242/dev.02307; Yoshida T, 2008, MECH DEVELOP, V125, P797, DOI 10.1016/j.mod.2008.06.007; Young CS, 2002, J DENT RES, V81, P695, DOI 10.1177/154405910208101008; Yu JH, 2007, BIOL CELL, V99, P465, DOI 10.1042/BC20070013; Yuan ZL, 2011, TISSUE ENG PART B-RE, V17, P373, DOI [10.1089/ten.TEB.2011.0041, 10.1089/ten.teb.2011.0041]; Zhang C, 2008, J DENT RES, V87, P250, DOI 10.1177/154405910808700312; Zhang QZ, 2010, STEM CELLS, V28, P1856, DOI 10.1002/stem.503	117	87	90	0	81	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 7	2012	11	3					291	301		10.1016/j.stem.2012.08.010	http://dx.doi.org/10.1016/j.stem.2012.08.010			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	018DW	22958928	Green Accepted, Bronze			2022-12-28	WOS:000309641300005
J	Lehtinen, MK				Lehtinen, Maria K.			Adult Neurogenesis: VCAM Stems the Tide	CELL STEM CELL			English	Editorial Material							CELLS; NICHE; BRAIN	In this issue of Cell Stem Cell, Kokovay et al. uncover that VCAM1 expression in neural stem cells regulates adult neurogenesis. Cerebrospinal fluid-borne IL-1 beta upregulates VCAM1 expression, which in turn regulates the architecture of the stem cell niche, redox homeostasis, and neurogenesis.	Harvard Univ, Boston Childrens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Lehtinen, MK (corresponding author), Harvard Univ, Boston Childrens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA.	maria.lehtinen@childrens.harvard.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS072192] Funding Source: NIH RePORTER; NINDS NIH HHS [R00 NS072192] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Fuentealba LC, 2012, CELL STEM CELL, V10, P698, DOI 10.1016/j.stem.2012.05.012; Kokovay E, 2010, CELL STEM CELL, V7, P163, DOI 10.1016/j.stem.2010.05.019; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Lehtinen MK, 2011, ANNU REV CELL DEV BI, V27, P653, DOI 10.1146/annurev-cellbio-092910-154026; Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Renault VM, 2009, CELL STEM CELL, V5, P527, DOI 10.1016/j.stem.2009.09.014; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357	9	2	2	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	AUG 3	2012	11	2					137	138		10.1016/j.stem.2012.07.012	http://dx.doi.org/10.1016/j.stem.2012.07.012			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	987QQ	22862936	Bronze, Green Accepted			2022-12-28	WOS:000307432600001
J	Westerterp, M; Gourion-Arsiquaud, S; Murphy, AJ; Shih, A; Cremers, S; Levine, RL; Tall, AR; Yvan-Charvet, L				Westerterp, Marit; Gourion-Arsiquaud, Samuel; Murphy, Andrew J.; Shih, Alan; Cremers, Serge; Levine, Ross L.; Tall, Alan R.; Yvan-Charvet, Laurent			Regulation of Hematopoietic Stem and Progenitor Cell Mobilization by Cholesterol Efflux Pathways	CELL STEM CELL			English	Article							BONE-MARROW; ATHEROSCLEROTIC LESIONS; G-CSF; MYELOPROLIFERATIVE DISEASE; STROMAL CELLS; MACROPHAGES; NICHE; EXPRESSION; CYTOKINES; MICE	Intact cholesterol homeostasis helps to maintain hematopoietic stem and multipotential progenitor cell (HSPC) quiescence. Mice with defects in cholesterol efflux pathways due to deficiencies of the ATP binding cassette transporters ABCA1 and ABCG1 displayed a dramatic increase in HSPC mobilization and extramedullary hematopoiesis. Increased extramedullary hematopoiesis was associated with elevated serum levels of G-CSF due to generation of IL-23 by splenic macrophages and dendritic cells. This favored hematopoietic lineage decisions toward granulocytes rather than macrophages in the bone marrow leading to impaired support for osteoblasts and decreased Cxcl12/SDF-1 production by mesenchymal progenitors. Greater HSPC mobilization and extramedullary hematopoiesis were reversed by raising HDL levels in Abca1(-/-) Abcg1(-/-) and Apoe(-/-) mice or in a mouse model of myeloproliferative neoplasm mediated by Flt3-ITD mutation. Our data identify a role of cholesterol efflux pathways in the control of HSPC mobilization. This may translate into therapeutic strategies for atherosclerosis and hematologic malignancies.	[Westerterp, Marit; Murphy, Andrew J.; Cremers, Serge; Tall, Alan R.; Yvan-Charvet, Laurent] Columbia Univ, Div Mol Med, Dept Med, New York, NY 10032 USA; [Westerterp, Marit] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [Gourion-Arsiquaud, Samuel] Hosp Special Surg, New York, NY 10021 USA; [Gourion-Arsiquaud, Samuel] TRI Princeton, Princeton, NJ 08542 USA; [Shih, Alan; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Dept Med, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Shih, Alan; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10065 USA	Columbia University; University of Amsterdam; Academic Medical Center Amsterdam; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Yvan-Charvet, L (corresponding author), Columbia Univ, Div Mol Med, Dept Med, New York, NY 10032 USA.	ly2159@columbia.edu	levine, ross/AAE-7658-2019; Tall, Alan/AAT-8528-2021	Westerterp, Marit/0000-0003-2230-1659; Yvan-Charvet, Laurent/0000-0002-7748-4942; Gourion-Arsiquaud, Samuel/0000-0003-1619-1342; Murphy, Andrew/0000-0001-7039-7777	American Heart Association [SDG2160053]; Netherlands Organization of Scientific Research [NWO VENI 916.11.072]; NIH [HL54591]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL054591, R01HL107653] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Netherlands Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Dr. Kristie Gordon for assistance with flow cytometry, CSL Australia for providing the rHDL used in this study, and Dr. David W. Dempster for help on bone histomorphometry analysis. This work was supported by grants to L.Y.C. from the American Heart Association (SDG2160053), to M.W. from the Netherlands Organization of Scientific Research (NWO VENI 916.11.072), and to A.R.T. from the NIH (HL54591).	Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Christopher MJ, 2008, J BONE MINER RES, V23, P1765, DOI 10.1359/JBMR.080612; Christopher MJ, 2011, J EXP MED, V208, P251, DOI 10.1084/jem.20101700; Dar A, 2005, NAT IMMUNOL, V6, P1038, DOI 10.1038/ni1251; DESSI S, 1995, CLIN SCI, V89, P505, DOI 10.1042/cs0890505; Ehninger A, 2011, J EXP MED, V208, P421, DOI 10.1084/jem.20110132; Fibbe WE, 1999, ANN NY ACAD SCI, V872, P71, DOI 10.1111/j.1749-6632.1999.tb08454.x; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; GILBERT HS, 1981, AM J MED, V71, P595, DOI 10.1016/0002-9343(81)90212-6; Gordy C, 2011, BLOOD, V117, P618, DOI 10.1182/blood-2010-01-265959; Gourion-Arsiquaud S, 2010, BONE, V46, P666, DOI 10.1016/j.bone.2009.11.011; Greenbaum AM, 2011, LEUKEMIA, V25, P211, DOI 10.1038/leu.2010.248; GUILLAUME T, 1993, STEM CELLS, V11, P173, DOI 10.1002/stem.5530110303; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Kelly LM, 2002, BLOOD, V99, P310, DOI 10.1182/blood.V99.1.310; Kiel MJ, 2007, CELL STEM CELL, V1, P204, DOI 10.1016/j.stem.2007.06.001; Kraus MD, 1998, AM J SURG PATHOL, V22, P1255, DOI 10.1097/00000478-199810000-00011; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Levesque JP, 2004, BLOOD, V104, P65, DOI 10.1182/blood-2003-05-1589; Levesque JP, 2002, EXP HEMATOL, V30, P440, DOI 10.1016/S0301-472X(02)00788-9; Levesque JP, 2003, J CLIN INVEST, V111, P187, DOI 10.1172/JCI200315994; Liu FL, 2000, BLOOD, V95, P3025, DOI 10.1182/blood.V95.10.3025.010k32_3025_3031; Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x; Lymperi S, 2008, BLOOD, V111, P1173, DOI 10.1182/blood-2007-03-082800; Lymperi S, 2010, ANN NY ACAD SCI, V1192, P12, DOI 10.1111/j.1749-6632.2009.05223.x; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Metcalf D, 2008, BLOOD, V111, P485, DOI 10.1182/blood-2007-03-079681; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; Murphy AJ, 2011, J CLIN INVEST, V121, P4138, DOI 10.1172/JCI57559; O'Malley DP, 2005, MODERN PATHOL, V18, P1550, DOI 10.1038/modpathol.3800480; Perry JM, 2007, CELL, V129, P1045, DOI 10.1016/j.cell.2007.05.053; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Rieger MA, 2009, SCIENCE, V325, P217, DOI 10.1126/science.1171461; Robbins CS, 2012, CIRCULATION, V125, P364, DOI 10.1161/CIRCULATIONAHA.111.061986; Semerad CL, 2005, BLOOD, V106, P3020, DOI 10.1182/blood-2004-01-0272; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Wang X, 2007, J CLIN INVEST, V117, P2216, DOI 10.1172/JCI32057; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534; Yvan-Charvet L, 2008, CIRCULATION, V118, P1837, DOI 10.1161/CIRCULATIONAHA.108.793869; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhu J, 2002, ONCOGENE, V21, P3295, DOI 10.1038/sj.onc.1205318	47	184	191	2	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	AUG 3	2012	11	2					195	206		10.1016/j.stem.2012.04.024	http://dx.doi.org/10.1016/j.stem.2012.04.024			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	987QQ	22862945	Green Accepted, Bronze			2022-12-28	WOS:000307432600010
J	Grompe, M				Grompe, Markus			Tissue Stem Cells: New Tools and Functional Diversity	CELL STEM CELL			English	Review							LABEL-RETAINING CELLS; PROGENITOR-CELL; SMALL-INTESTINE; HAIR FOLLICLE; MAMMARY-GLAND; SELF-RENEWAL; BETA-CELLS; IN-VITRO; ADULT; LGR5	The detailed understanding of adult tissue stem cells has significance for both regenerative medicine and oncology. This perspective will discuss how major advances in our ability to identify and monitor these cells, which include genetic lineage tracing, FACS purification, and robust in vitro clonogenic assays, have changed our view of their roles in many organs. Label retention and quiescence are no longer considered obligatory stem cell features. Furthermore, some tissues have more than one type of stem cell, each used in only particular situations of regenerative stress. Thus, there is no "one size fits all" adult tissue stem cell paradigm.	Oregon Hlth & Sci Univ, Pape Family Pediat Res Inst, Portland, OR 97239 USA	Oregon Health & Science University	Grompe, M (corresponding author), Oregon Hlth & Sci Univ, Pape Family Pediat Res Inst, 3181 SW Sam Jackson Pk Rd,Mail Code L321, Portland, OR 97239 USA.	grompem@ohsu.edu		Grompe, Markus/0000-0002-6616-4345	NIH [DK51592]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051592, R55DK051592] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grant DK51592 (M.G.)	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Burness ML, 2010, SEMIN CANCER BIOL, V20, P107, DOI 10.1016/j.semcancer.2010.05.006; Cabarcas SM, 2011, INT J CANCER, V129, P2315, DOI 10.1002/ijc.26312; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Clarke RB, 2003, CELL PROLIFERAT, V36, P45, DOI 10.1046/j.1365-2184.36.s.1.5.x; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Criscimanna A, 2011, GASTROENTEROLOGY, V141, P1451, DOI 10.1053/j.gastro.2011.07.003; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Dorrell C, 2011, GENE DEV, V25, P1193, DOI 10.1101/gad.2029411; Duncan AW, 2009, GASTROENTEROLOGY, V137, P466, DOI 10.1053/j.gastro.2009.05.044; Duvillie B, 2003, DIABETES, V52, P2035, DOI 10.2337/diabetes.52.8.2035; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Garraway IP, 2010, PROSTATE, V70, P491, DOI 10.1002/pros.21083; Greene SB, 2010, RNA BIOL, V7, P300, DOI 10.4161/rna.7.3.11837; Haegebarth A, 2009, AM J PATHOL, V174, P715, DOI 10.2353/ajpath.2009.080758; Ibarra I, 2007, GENE DEV, V21, P3238, DOI 10.1101/gad.1616307; Iverson SV, 2011, HEPATOLOGY, V54, P655, DOI 10.1002/hep.24398; Jaks V, 2010, EXP CELL RES, V316, P1422, DOI 10.1016/j.yexcr.2010.03.014; Kopp JL, 2011, CELL CYCLE, V10, P1921, DOI 10.4161/cc.10.12.16010; Kopp JL, 2011, DEVELOPMENT, V138, P653, DOI 10.1242/dev.056499; Kretzschmar K, 2012, CELL, V148, P33, DOI 10.1016/j.cell.2012.01.002; Lander AD, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-19; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; MACKENZIE IC, 1985, CELL TISSUE RES, V242, P551; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; MORRIS RJ, 1994, CELL PROLIFERAT, V27, P279, DOI 10.1111/j.1365-2184.1994.tb01425.x; Ng R, 2012, J CLIN INVEST, V122, P1097, DOI 10.1172/JCI46039; POTTEN C S, 1975, International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine, V27, P413, DOI 10.1080/09553007514550411; Potten CS, 2009, CELL PROLIFERAT, V42, P731, DOI 10.1111/j.1365-2184.2009.00642.x; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shin S, 2011, GENE DEV, V25, P1185, DOI 10.1101/gad.2027811; Smith SM, 2012, METHODS MOL BIOL, V823, P119, DOI 10.1007/978-1-60327-216-2_9; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tanos Tamara, 2008, Breast Dis, V29, P69; Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373; Terskikh VV, 2012, STEM CELL REV REP, V8, P414, DOI 10.1007/s12015-011-9299-6; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; van der Kooy D, 2000, SCIENCE, V287, P1439, DOI 10.1126/science.287.5457.1439; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Xiang Shuanglin, 2009, V487, P147, DOI 10.1007/978-1-60327-547-7_7; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Yi R, 2011, J CELL SCI, V124, P1775, DOI 10.1242/jcs.069104; Zhang LA, 2011, CELL STEM CELL, V8, P294, DOI 10.1016/j.stem.2011.01.014	56	42	47	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 14	2012	10	6					685	689		10.1016/j.stem.2012.04.006	http://dx.doi.org/10.1016/j.stem.2012.04.006			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	965LD	22704508	Bronze, Green Accepted			2022-12-28	WOS:000305768400014
J	Heidel, FH; Bullinger, L; Feng, ZH; Wang, Z; Neff, TA; Stein, L; Kalaitzidis, D; Lane, SW; Armstrong, SA				Heidel, Florian H.; Bullinger, Lars; Feng, Zhaohui; Wang, Zhu; Neff, Tobias A.; Stein, Lauren; Kalaitzidis, Demetrios; Lane, Steve W.; Armstrong, Scott A.			Genetic and Pharmacologic Inhibition of beta-Catenin Targets Imatinib-Resistant Leukemia Stem Cells in CML	CELL STEM CELL			English	Article							CHRONIC MYELOID-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; COMPLETE MOLECULAR REMISSION; ABL TYROSINE KINASE; HEMATOPOIETIC STEM; COLORECTAL-CANCER; PHILADELPHIA-CHROMOSOME; SIGNALING PATHWAY; CD34(+) CELLS; COLON-CANCER	A key characteristic of hematopoietic stem cells (HSCs) is the ability to self-renew. Genetic deletion of beta-catenin during fetal HSC development leads to impairment of self-renewal while beta-catenin is dispensable in fully developed adult HSCs. Whether beta-catenin is required for maintenance of fully developed CML leukemia stem cells (LSCs) is unknown. Here, we use a conditional mouse model to show that deletion of beta-catenin after CML initiation does not lead to a significant increase in survival. However, deletion of beta-catenin synergizes with imatinib (IM) to delay disease recurrence after imatinib discontinuation and to abrogate CML stem cells. These effects can be mimicked by pharmacologic inhibition of beta-catenin via modulation of prostaglandin signaling. Treatment with the cyclooxygenase inhibitor indomethacin reduces beta-catenin levels and leads to a reduction in LSCs. In conclusion, inhibiting beta-catenin by genetic inactivation or pharmacologic modulation is an effective combination therapy with imatinib and targets CML stem cells.	[Heidel, Florian H.; Bullinger, Lars; Feng, Zhaohui; Wang, Zhu; Neff, Tobias A.; Stein, Lauren; Kalaitzidis, Demetrios; Lane, Steve W.; Armstrong, Scott A.] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Heidel, Florian H.; Bullinger, Lars; Feng, Zhaohui; Wang, Zhu; Neff, Tobias A.; Stein, Lauren; Kalaitzidis, Demetrios; Armstrong, Scott A.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Heidel, Florian H.; Bullinger, Lars; Feng, Zhaohui; Wang, Zhu; Neff, Tobias A.; Stein, Lauren; Kalaitzidis, Demetrios; Armstrong, Scott A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Heidel, Florian H.] Univ Magdeburg, Univ Hosp, Dept Hematol Oncol, F-39120 Magdeburg, Germany; [Bullinger, Lars] Univ Hosp Ulm, Dept Hematol Oncol, D-89081 Ulm, Germany; [Lane, Steve W.] Queensland Inst Med Res, Herston, Qld 4006, Australia; [Armstrong, Scott A.] Harvard Stem Cell Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Otto von Guericke University; University Hospital Magdeburg; Ulm University; QIMR Berghofer Medical Research Institute; Harvard University	Armstrong, SA (corresponding author), Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA.	scott.armstrong@childrens.harvard.edu	Bullinger, Lars/AAL-7965-2020; Lane, Steven/C-3215-2012	Lane, Steven/0000-0002-8050-6209; Bullinger, Lars/0000-0002-5890-5510; Neff, Tobias/0000-0002-0188-8393; Heidel, Florian/0000-0003-2438-1955	Deutsche Krebshilfe [DKH D/08/00661]; NCI [CA66996]; German Research Foundation [BU 1339/3-1]; NATIONAL CANCER INSTITUTE [P01CA066996] Funding Source: NIH RePORTER	Deutsche Krebshilfe(Deutsche Krebshilfe); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); German Research Foundation(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Mildred-Scheel grant (DKH D/08/00661, Deutsche Krebshilfe to F.H.H.) and an NCI grant (#CA66996 to S.A.A.). S.A.A. is a Leukemia and Lymphoma Society Scholar, and L.B. was supported in part by the German Research Foundation (Heisenberg-Stipendium BU 1339/3-1).	Alvarez RH, 2010, J CLIN ONCOL, V28, P3366, DOI 10.1200/JCO.2009.25.4011; Behrens J, 2000, ANN NY ACAD SCI, V910, P21; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 2000, ANN NY ACAD SCI, V910, P33; BEN-NERIAH Y, 1986, SCIENCE, V233, P212, DOI 10.1126/science.3460176; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chen Y, 2009, LEUKEMIA, V23, P1446, DOI 10.1038/leu.2009.52; Corbin AS, 2011, J CLIN INVEST, V121, P396, DOI 10.1172/JCI35721; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; De Roock W, 2011, LANCET ONCOL, V12, P594, DOI 10.1016/S1470-2045(10)70209-6; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Fischer T, 2010, J CLIN ONCOL, V28, P4339, DOI 10.1200/JCO.2010.28.9678; Frisch BJ, 2009, BLOOD, V114, P4054, DOI 10.1182/blood-2009-03-205823; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Gothot A, 1998, BLOOD, V92, P2641, DOI 10.1182/blood.V92.8.2641.420k36_2641_2649; Guilhot F, 1997, NEW ENGL J MED, V337, P223, DOI 10.1056/NEJM199707243370402; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Heidel F, 2006, BLOOD, V107, P293, DOI 10.1182/blood-2005-06-2469; Higashi AY, 2009, J IMMUNOL, V182, P5633, DOI 10.4049/jimmunol.0802413; Hoggatt J, 2009, BLOOD, V113, P5444, DOI 10.1182/blood-2009-01-201335; Holmes T, 2008, STEM CELLS, V26, P1288, DOI 10.1634/stemcells.2007-0600; Hu Y, 2009, LEUKEMIA, V23, P109, DOI 10.1038/leu.2008.262; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Kalaitzidis D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003776; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Koch U, 2008, BLOOD, V111, P160, DOI 10.1182/blood-2007-07-099754; Krivtsov Andrei V., 2009, V538, P231, DOI 10.1007/978-1-59745-418-6_11; Lane SW, 2010, BLOOD, V115, P3489, DOI 10.1182/blood-2009-11-251728; Luck SC, 2011, LEUKEMIA, V25, P1728, DOI 10.1038/leu.2011.154; Luis TC, 2011, CELL STEM CELL, V9, P345, DOI 10.1016/j.stem.2011.07.017; Mahon FX, 2010, LANCET ONCOL, V11, P1029, DOI 10.1016/S1470-2045(10)70233-3; Majetl R, 2009, P NATL ACAD SCI USA, V106, P3396, DOI 10.1073/pnas.0900089106; Malhotra S, 2009, CELL STEM CELL, V4, P27, DOI 10.1016/j.stem.2008.12.004; Mason KD, 2009, LEUKEMIA, V23, P2034, DOI 10.1038/leu.2009.151; McWeeney SK, 2010, BLOOD, V115, P315, DOI 10.1182/blood-2009-03-210732; Muller-Tidow C, 2004, MOL CELL BIOL, V24, P2890, DOI 10.1128/MCB.24.7.2890-2904.2004; Oving IM, 2002, EUR J CLIN INVEST, V32, P448, DOI 10.1046/j.1365-2362.2002.01004.x; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; PETERSON LF, 2009, BLOOD, V114, P2168; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Ross DM, 2010, LEUKEMIA, V24, P1719, DOI 10.1038/leu.2010.185; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Rousselot P, 2007, BLOOD, V109, P58, DOI 10.1182/blood-2006-03-011239; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Saglio G, 2010, NEW ENGL J MED, V362, P2251, DOI 10.1056/NEJMoa0912614; Savona M, 2008, NAT REV CANCER, V8, P341, DOI 10.1038/nrc2368; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Trowbridge JJ, 2006, NAT MED, V12, P89, DOI 10.1038/nm1339; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624; Wang Z, 2008, NATURE, V455, P1205, DOI 10.1038/nature07284; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003	56	187	200	1	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	APR 6	2012	10	4					412	424		10.1016/j.stem.2012.02.017	http://dx.doi.org/10.1016/j.stem.2012.02.017			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	929QA	22482506	Bronze, Green Accepted			2022-12-28	WOS:000303079400010
J	Parmar, M; Bjorklund, A				Parmar, Malin; Bjorklund, Anders			Generation of Transplantable Striatal Projection Neurons from Human ESCs	CELL STEM CELL			English	Editorial Material							STEM-CELLS	In this issue of Cell Stem Cell, Ma et al. (2012) report a differentiation protocol for generating striatal projection neurons from human embryonic stem cells with high efficiency. The cells survive transplantation, reconnect striatal circuitry, and restore motor function in a mouse model of striatal neurodegeneration that mimics the central pathohology of Huntington's disease.	[Parmar, Malin; Bjorklund, Anders] Lund Univ, Dept Expt Med Sci, Wallenberg Neurosci Ctr, S-22184 Lund, Sweden	Lund University	Bjorklund, A (corresponding author), Lund Univ, Dept Expt Med Sci, Wallenberg Neurosci Ctr, S-22184 Lund, Sweden.	anders.bjorklund@med.lu.se	Björklund, Anders/ABA-1326-2020	Parmar, Malin/0000-0001-5002-4199; Bjorklund, Anders/0000-0002-5676-6203				Aubry L, 2008, P NATL ACAD SCI USA, V105, P16707, DOI 10.1073/pnas.0808488105; Chambers SM, 2011, CELL, V145, P827, DOI 10.1016/j.cell.2011.05.036; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Gogel S, 2011, GENE THER, V18, P1, DOI 10.1038/gt.2010.130; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lindvall O, 2012, CELL STEM CELL, V10, P660, DOI [10.1016/j.stem.2012.04.004, 10.1016/j.stem.2012.01.009]; Ma LX, 2012, CELL STEM CELL, V10, P455, DOI 10.1016/j.stem.2012.01.021; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Thomson J.A., 1998, SCIENCE, V282, P6467	10	8	9	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 6	2012	10	4					349	350		10.1016/j.stem.2012.03.004	http://dx.doi.org/10.1016/j.stem.2012.03.004			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	929QA	22482498	Bronze			2022-12-28	WOS:000303079400002
J	Wagner, DE; Ho, JJ; Reddien, PW				Wagner, Daniel E.; Ho, Jaclyn J.; Reddien, Peter W.			Genetic Regulators of a Pluripotent Adult Stem Cell System in Planarians Identified by RNAi and Clonal Analysis	CELL STEM CELL			English	Article							SCHMIDTEA-MEDITERRANEA; SELF-RENEWAL; DEVELOPMENTAL REGULATORS; MOUSE DEVELOPMENT; REGENERATION; EXPRESSION; GERMLINE; POLYCOMB; DROSOPHILA; MAINTENANCE	Pluripotency is a central, well-studied feature of embryonic development, but the role of pluripotent cell regulation in somatic tissue regeneration remains poorly understood. In planarians, regeneration of entire animals from tissue fragments is promoted by the activity of adult pluripotent stem cells (cNeoblasts). We utilized transcriptional profiling to identify planarian genes expressed in adult proliferating, regenerative cells (neoblasts). We also developed quantitative clonal analysis methods for expansion and differentiation of cNeoblast descendants that, together with RNAi, revealed gene roles in stem cell biology. Genes encoding two zinc finger proteins, Vasa, a LIM domain protein, Sox and Jun-like transcription factors, two candidate RNA-binding proteins, a Setd8-like protein, and PRC2 (Polycomb) were required for proliferative expansion and/or differentiation of cNeoblast-derived clones. These findings suggest that planarian stem cells utilize molecular mechanisms found in germ cells and other pluripotent cell types and identify genetic regulators of the planarian stem cell system.	[Wagner, Daniel E.; Ho, Jaclyn J.; Reddien, Peter W.] MIT Biol, Howard Hughes Med Inst, Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute	Reddien, PW (corresponding author), MIT Biol, Howard Hughes Med Inst, Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA.	reddien@wi.mit.edu		Wagner, Daniel/0000-0002-2983-635X; Ho, Jaclyn/0000-0001-9166-5953; /0000-0002-5569-333X	NIH [R01GM080639]; Keck Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080639] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Bell for microarray assistance; J. van Wolfswinkel for cDNA sequence assembly; D. Wenemoser and K. Li for fgfr cloning; and P. Hsu, R. Young, D. Kim, S. Lapan, and all P.W.R. lab members for comments and discussion. P.W.R. is an early career scientist of the Howard Hughes Medical Institute and an associate member of the Broad Institute of Harvard and MIT. We acknowledge support from the NIH (R01GM080639) and the Keck Foundation.	Alvarado AS, 2002, DEVELOPMENT, V129, P5659, DOI 10.1242/dev.00167; Alvarado AS, 1999, P NATL ACAD SCI USA, V96, P5049, DOI 10.1073/pnas.96.9.5049; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bardeen CR, 1904, J EXP ZOOL, V1, P191, DOI 10.1002/jez.1400010107; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; DENELL RE, 1978, GENETICS, V90, P277; Dubois F, 1949, B BIOL FR BELG, V83, P213; Eisenhoffer GT, 2008, CELL STEM CELL, V3, P327, DOI 10.1016/j.stem.2008.07.002; Ezhkova E, 2011, GENE DEV, V25, P485, DOI 10.1101/gad.2019811; Fong YY, 2002, SCIENCE, V296, P2235, DOI 10.1126/science.1070790; Garvin C, 1998, GENETICS, V148, P167; Guo TX, 2006, DEV CELL, V11, P159, DOI 10.1016/j.devcel.2006.06.004; Hayashi T, 2006, DEV GROWTH DIFFER, V48, P371, DOI 10.1111/j.1440-169x.2006.00876.x; Hayashi T, 2010, DEV GROWTH DIFFER, V52, P131, DOI 10.1111/j.1440-169X.2009.01157.x; Higuchi S, 2007, DEV GROWTH DIFFER, V49, P571, DOI 10.1111/j.1440-169X.2007.00947.x; Janic A, 2010, SCIENCE, V330, P1824, DOI 10.1126/science.1195481; Juan AH, 2011, GENE DEV, V25, P789, DOI 10.1101/gad.2027911; Juliano CE, 2010, DEVELOPMENT, V137, P4113, DOI 10.1242/dev.047969; Lapan SW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002226; LASKO PF, 1988, NATURE, V335, P611, DOI 10.1038/335611a0; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Mochizuki K, 2001, DEV GENES EVOL, V211, P299, DOI 10.1007/s004270100156; Newmark PA, 2000, DEV BIOL, V220, P142, DOI 10.1006/dbio.2000.9645; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Oda H, 2009, MOL CELL BIOL, V29, P2278, DOI 10.1128/MCB.01768-08; Ogawa K, 2002, DEV GROWTH DIFFER, V44, P191; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Palakodeti D, 2008, RNA, V14, P1174, DOI 10.1261/rna.1085008; Pearson BJ, 2010, DEVELOPMENT, V137, P213, DOI 10.1242/dev.044297; Pearson BJ, 2009, DEV DYNAM, V238, P443, DOI 10.1002/dvdy.21849; Reddien PW, 2005, SCIENCE, V310, P1327, DOI 10.1126/science.1116110; Reddien PW, 2005, DEV CELL, V8, P635, DOI 10.1016/j.devcel.2005.02.014; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Robb SMC, 2008, NUCLEIC ACIDS RES, V36, pD599, DOI 10.1093/nar/Gkm684; Rongo C, 1996, TRENDS GENET, V12, P102, DOI 10.1016/0168-9525(96)81421-1; Rossi L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r62; Rouhana L, 2010, DEV BIOL, V341, P429, DOI 10.1016/j.ydbio.2010.02.037; Salvetti A, 2005, DEVELOPMENT, V132, P1863, DOI 10.1242/dev.01785; Salvetti A, 2009, DEV BIOL, V328, P305, DOI 10.1016/j.ydbio.2009.01.029; Scimone ML, 2011, DEVELOPMENT, V138, P4387, DOI 10.1242/dev.068098; Scimone ML, 2010, DEVELOPMENT, V137, P1231, DOI 10.1242/dev.042051; Seydoux G, 2006, CELL, V127, P891, DOI 10.1016/j.cell.2006.11.016; Shibata N, 1999, DEV BIOL, V206, P73, DOI 10.1006/dbio.1998.9130; Shibata N, 2010, DEV GROWTH DIFFER, V52, P27, DOI 10.1111/j.1440-169X.2009.01155.x; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Solana J, 2009, DEV BIOL, V328, P410, DOI 10.1016/j.ydbio.2009.01.043; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Styhler S, 1998, DEVELOPMENT, V125, P1569; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugiura T, 2007, EXP CELL RES, V313, P782, DOI 10.1016/j.yexcr.2006.11.014; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; Tomancak P, 1998, DEVELOPMENT, V125, P1723; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Wagner DE, 2011, SCIENCE, V332, P811, DOI 10.1126/science.1203983; Wang L, 2002, MOL BIOL REP, V29, P369, DOI 10.1023/A:1021246109101; Yamazaki T., 2010, MOL BIOL CELL, V21, P2953; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zayas RM, 2005, P NATL ACAD SCI USA, V102, P18491, DOI 10.1073/pnas.0509507102	62	130	133	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAR 2	2012	10	3					299	311		10.1016/j.stem.2012.01.016	http://dx.doi.org/10.1016/j.stem.2012.01.016			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	908BX	22385657	Bronze, Green Accepted			2022-12-28	WOS:000301466500011
J	Kim, J; Su, SC; Wang, HY; Cheng, AW; Cassady, JP; Lodato, MA; Lengner, CJ; Chung, CY; Dawlaty, MM; Tsai, LH; Jaenisch, R				Kim, Jongpil; Su, Susan C.; Wang, Haoyi; Cheng, Albert W.; Cassady, John P.; Lodato, Michael A.; Lengner, Christopher J.; Chung, Chee-Yeun; Dawlaty, Meelad M.; Tsai, Li-Huei; Jaenisch, Rudolf			Functional Integration of Dopaminergic Neurons Directly Converted from Mouse Fibroblasts	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; PARKINSONS-DISEASE; DIRECT CONVERSION; DEFINED FACTORS; ANIMAL-MODEL; MIDBRAIN; GENERATION; PROTEIN; FETAL	Recent advances in somatic cell reprogramming have highlighted the plasticity of the somatic epigenome, particularly through demonstrations of direct lineage reprogramming of one somatic cell type to another by defined factors. However, it is not clear to what extent this type of reprogramming is able to generate fully functional differentiated cells. In addition, the activity of the reprogrammed cells in cell transplantation assays, such as those envisaged for cell-based therapy of Parkinson's disease (PD), remains to be determined. Here we show that ectopic expression of defined transcription factors in mouse tail tip fibroblasts is sufficient to induce Pitx3+ neurons that closely resemble midbrain dopaminergic (DA) neurons. In addition, transplantation of these induced DA (iDA) neurons alleviates symptoms in a mouse model of PD. Thus, iDA neurons generated from abundant somatic fibroblasts by direct lineage reprogramming hold promise for modeling neurodegenerative disease and for cell-based therapies of PD.	[Kim, Jongpil; Wang, Haoyi; Cheng, Albert W.; Cassady, John P.; Lodato, Michael A.; Lengner, Christopher J.; Chung, Chee-Yeun; Dawlaty, Meelad M.; Jaenisch, Rudolf] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Cheng, Albert W.; Cassady, John P.; Lodato, Michael A.; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02142 USA; [Su, Susan C.; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Su, Susan C.; Tsai, Li-Huei] Howard Hughes Med Inst, Chevy Chase, MD USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Northwell Health; Howard Hughes Medical Institute	Jaenisch, R (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu	Lodato, Michael/AAX-9211-2021	Cheng, Albert/0000-0003-2653-5743; Lengner, Christopher/0000-0002-0574-5189; Lodato, Michael/0000-0003-4175-1073	National Institutes of Health (NIH) [R37 HD045022 (6-9)]; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We are grateful to Dr. M. Li for the Pitx3-eGFP targeting construct. We thank Dr. M. Wernig, for kindly providing Ascl1, Brn2, and Myth1 lentiviral constructs, and Dr. T. Petryshen for technical supports. We also thank R. Flannery for veterinary assistance, D. Fu for technical assistance, and B. Carey, D. Hockemeyer, Y. Li, G. Welstead, and C. Garrett-Engele for comments. This work was supported by grants from the National Institutes of Health (NIH R37 HD045022 (6-9)/RJ) and the Howard Hughes Medical Institute. R.J. is an adviser to Stemgent and a cofounder of Fate Therapeutics.	Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; BRUNDIN P, 1986, EXP BRAIN RES, V65, P235; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hedlund E, 2008, STEM CELLS, V26, P1526, DOI 10.1634/stemcells.2007-0996; Hedlund E, 2007, STEM CELLS, V25, P1126, DOI 10.1634/stemcells.2006-0540; Huse DM, 2005, MOVEMENT DISORD, V20, P1449, DOI 10.1002/mds.20609; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Martinat C, 2006, P NATL ACAD SCI USA, V103, P2874, DOI 10.1073/pnas.0511153103; Olanow C.W., 1996, P NATL ACAD SCI USA, V19, p[102, 10343]; RAYPORT S, 1992, J NEUROSCI, V12, P4264; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Zhao SL, 2004, EUR J NEUROSCI, V19, P1133, DOI 10.1111/j.1460-9568.2004.03206.x; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	20	198	207	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 4	2011	9	5					413	419		10.1016/j.stem.2011.09.011	http://dx.doi.org/10.1016/j.stem.2011.09.011			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	850FJ	22019014	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000297180200009
J	Matsumoto, A; Takeishi, S; Kanie, T; Susaki, E; Onoyama, I; Tateishi, Y; Nakayama, K; Nakayama, KI				Matsumoto, Akinobu; Takeishi, Shoichiro; Kanie, Tomoharu; Susaki, Etsuo; Onoyama, Ichiro; Tateishi, Yuki; Nakayama, Keiko; Nakayama, Keiichi I.			p57 Is Required for Quiescence and Maintenance of Adult Hematopoietic Stem Cells	CELL STEM CELL			English	Article							TUMOR-SUPPRESSOR; CDK INHIBITOR; MICE LACKING; IN-VIVO; MOUSE DEVELOPMENT; P57(KIP2); P27(KIP1); DIFFERENTIATION; P21(CIP1/WAF1); APOPTOSIS	Quiescence is required for the maintenance of hematopoietic stem cells (HSCs). Members of the Cip/Kip family of cyclin-dependent kinase (CDK) inhibitors (p21, p27, p57) have been implicated in HSC quiescence, but loss of p21 or p27 in mice affects HSC quiescence or functionality only under conditions of stress. Although p57 is the most abundant family member in quiescent HSCs, its role has remained un-characterized. Here we show a severe defect in the self-renewal capacity of p57-deficient HSCs and a reduction of the proportion of the cells in G(0) phase. Additional ablation of p21 in a p57-null background resulted in a further decrease in the colony-forming activity of HSCs. Moreover, the HSC abnormalities of p57-deficient mice were corrected by knocking in the p27 gene at the p57 locus. Our results therefore suggest that, among Cip/Kip family CDK inhibitors, p57 plays a predominant role in the quiescence and maintenance of adult HSCs.	[Matsumoto, Akinobu; Takeishi, Shoichiro; Kanie, Tomoharu; Susaki, Etsuo; Onoyama, Ichiro; Tateishi, Yuki; Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan; [Matsumoto, Akinobu; Takeishi, Shoichiro; Kanie, Tomoharu; Susaki, Etsuo; Onoyama, Ichiro; Tateishi, Yuki; Nakayama, Keiko; Nakayama, Keiichi I.] Japan Sci & Technol Agcy JST, CREST, Kawaguchi, Saitama 3320012, Japan; [Nakayama, Keiko] Tohoku Univ, Grad Sch Med, Ctr Translat & Adv Anim Res, Dept Dev Genet,Aoba Ku, Sendai, Miyagi 9808575, Japan	Kyushu University; Japan Science & Technology Agency (JST); Tohoku University	Nakayama, KI (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	nakayak1@bioreg.kyushu-u.ac.jp	Kanie, Tomoharu/AAI-5682-2020; Matsumoto, Akinobu/GPF-4945-2022	Kanie, Tomoharu/0000-0002-2084-1451; Takeishi, Shoichiro/0000-0003-1640-909X; Susaki, Etsuo/0000-0001-5621-7311; Matsumoto, Akinobu/0000-0002-4077-3935	Grants-in-Aid for Scientific Research [19057011] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Aleem E, 2005, NAT CELL BIOL, V7, P831, DOI 10.1038/ncb1284; Arai F, 2007, ANN NY ACAD SCI, V1106, P41, DOI 10.1196/annals.1392.005; Berthet C, 2007, MOL CELL BIOL, V27, P5079, DOI 10.1128/MCB.00029-07; Cheng T, 2000, NAT MED, V6, P1235, DOI 10.1038/81335; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Daria D, 2008, BLOOD, V111, P1894, DOI 10.1182/blood-2007-02-071746; Halaban R, 2005, CANCER METAST REV, V24, P339, DOI 10.1007/s10555-005-1582-z; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kalaszczynska I, 2009, CELL, V138, P352, DOI 10.1016/j.cell.2009.04.062; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; MATSUOKA S, 1995, GENE DEV, V9, P650, DOI 10.1101/gad.9.6.650; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Moshinsky DJ, 2003, BIOCHEM BIOPH RES CO, V310, P1026, DOI 10.1016/j.bbrc.2003.09.114; Nagahama H, 2001, ANAT EMBRYOL, V203, P77, DOI 10.1007/s004290000146; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Pawliuk R, 1996, BLOOD, V88, P2852, DOI 10.1182/blood.V88.8.2852.bloodjournal8882852; Qian H, 2007, CELL STEM CELL, V1, P671, DOI 10.1016/j.stem.2007.10.008; Rosu-Myles M, 2007, EXP HEMATOL, V35, P394, DOI 10.1016/j.exphem.2006.11.005; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Susaki E, 2009, P NATL ACAD SCI USA, V106, P5192, DOI 10.1073/pnas.0811712106; Takahashi K, 2000, J BIOCHEM-TOKYO, V127, P73, DOI 10.1093/oxfordjournals.jbchem.a022586; Van Os R, 2007, STEM CELLS, V25, P836, DOI 10.1634/stemcells.2006-0631; Viatour P, 2008, CELL STEM CELL, V3, P416, DOI 10.1016/j.stem.2008.07.009; Yamazaki S, 2006, EMBO J, V25, P3515, DOI 10.1038/sj.emboj.7601236; Yan Y, 1997, GENE DEV, V11, P973, DOI 10.1101/gad.11.8.973; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0; Zou P, 2011, CELL STEM CELL, V9, P247, DOI 10.1016/j.stem.2011.07.003	30	220	224	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	SEP 2	2011	9	3					262	271		10.1016/j.stem.2011.06.014	http://dx.doi.org/10.1016/j.stem.2011.06.014			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	822DN	21885021	Bronze			2022-12-28	WOS:000295024200012
J	Son, EY; Ichida, JK; Wainger, BJ; Toma, JS; Rafuse, VF; Woolf, CJ; Eggan, K				Son, Esther Y.; Ichida, Justin K.; Wainger, Brian J.; Toma, Jeremy S.; Rafuse, Victor F.; Woolf, Clifford J.; Eggan, Kevin			Conversion of Mouse and Human Fibroblasts into Functional Spinal Motor Neurons	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; GENE-EXPRESSION; MOTONEURONS; DIFFERENTIATION; NESTIN	The mammalian nervous system comprises many distinct neuronal subtypes, each with its own phenotype and differential sensitivity to degenerative disease. Although specific neuronal types can be isolated from rodent embryos or engineered from stem cells for translational studies, transcription factor-mediated reprogramming might provide a more direct route to their generation. Here we report that the forced expression of select transcription factors is sufficient to convert mouse and human fibroblasts into induced motor neurons (iMNs). iMNs displayed a morphology, gene expression signature, electrophysiology, synaptic functionality, in vivo engraftment capacity, and sensitivity to degenerative stimuli similar to those of embryo-derived motor neurons. We show that the converting fibroblasts do not transit through a proliferative neural progenitor state, and thus form bona fide motor neurons via a route distinct from embryonic development. Our findings demonstrate that fibroblasts can be converted directly into a specific differentiated and functional neural subtype, the spinal motor neuron.	[Son, Esther Y.; Ichida, Justin K.; Eggan, Kevin] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Son, Esther Y.; Ichida, Justin K.; Eggan, Kevin] Harvard Univ, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Son, Esther Y.; Eggan, Kevin] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Wainger, Brian J.; Woolf, Clifford J.] Childrens Hosp, Program Neurobiol, Boston, MA 02115 USA; [Wainger, Brian J.; Woolf, Clifford J.] Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Wainger, Brian J.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Woolf, Clifford J.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Toma, Jeremy S.; Rafuse, Victor F.] Dalhousie Univ, Dept Anat & Neurobiol, Halifax, NS B3H 1X5, Canada	Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Dalhousie University	Eggan, K (corresponding author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.	keggan@scrb.harvard.edu	Woolf, Clifford/A-9784-2010; Eggan, Kevin/P-7119-2018; Wainger, Brian/L-7553-2017		Howard Hughes Medical Institute; Harvard Stem Cell Institute; P<SUP>2</SUP>ALS; New York Stem Cell Foundation; NIH [1RC2 NS069395-01, R01 HD045732-03, 5T32GM007592]; Novartis Institutes for BioMedical Research; Stan and Fiona Druckenmiller/New York Stem Cell Foundation; Natural Sciences and Engineering Research Council of Canada; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038253, K99NS077435, RC2NS069395, R00NS077435] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Harvard Stem Cell Institute; P<SUP>2</SUP>ALS; New York Stem Cell Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Institutes for BioMedical Research; Stan and Fiona Druckenmiller/New York Stem Cell Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to A.C. Carter for help with lineage tracing experiments and E. Kiskinis, S. de Boer, G. Boulting, and J. Rivera-Feliciano for providing reagents and helpful discussions. We would also like to thank B. Tilton for assistance with FAGS, K. Harrison for providing the mouse Hb9 cDNA, N. Atwater for assistance with glia preparation, J. Sandoe and K. Sandor for help with molecular cloning, K. Koszka for help with mouse husbandry, and M.Y. Son for help with the diagram in Figure 1. This work was made possible by support provided by the Howard Hughes Medical Institute, the Harvard Stem Cell Institute, P<SUP>2</SUP>ALS, the New York Stem Cell Foundation, NIH GO grant 1RC2 NS069395-01, and NIH grant R01 HD045732-03 to K.E. J.K.I. is supported by the Novartis Institutes for BioMedical Research and a Stan and Fiona Druckenmiller/New York Stem Cell Foundation postdoctoral fellowship. B.J.W. is supported by NIH Training Grant 5T32GM007592. C.J.W. used facilities provided by the Children's Hospital Boston Intellectual and Developmental Disabilities Research Center and the NIH. J.S.T. was funded by a Natural Sciences and Engineering Research Council of Canada graduate student scholarship award. V.F.R is supported by the Natural Sciences and Engineering Research Council of Canada. The authors are filing a patent based on the results reported in this paper. K.E. is a member of the iPierian scientific advisory board.	Abe T, 2011, GENESIS, V49, P579, DOI 10.1002/dvg.20753; Alessandri-Haber N, 1999, J PHYSIOL-LONDON, V518, P203, DOI 10.1111/j.1469-7793.1999.0203r.x; Burns KA, 2007, CEREB CORTEX, V17, P2585, DOI 10.1093/cercor/bhl164; CAIAZZO M, 2011, NATURE IN PRESS, DOI DOI 10.1038/NATURE10284; Cui DP, 2006, PHYSIOL GENOMICS, V24, P276, DOI 10.1152/physiolgenomics.00109.2005; DAHM LM, 1988, DEV BIOL, V130, P621, DOI 10.1016/0012-1606(88)90357-0; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Lee SK, 2005, GENE DEV, V19, P282, DOI 10.1101/gad.1257105; LUPA MT, 1989, J NEUROSCI, V9, P3937; Messam CA, 2002, DEV BRAIN RES, V134, P87, DOI 10.1016/S0165-3806(01)00325-X; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; PANG ZP, 2011, NATURE IN PRESS, DOI DOI 10.1038/NATURE10202; Peljto M, 2011, CURR OPIN NEUROBIOL, V21, P43, DOI 10.1016/j.conb.2010.09.012; Peljto M, 2010, CELL STEM CELL, V7, P355, DOI 10.1016/j.stem.2010.07.013; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; PUIA G, 1990, NEURON, V4, P759, DOI 10.1016/0896-6273(90)90202-Q; Soundararajan P, 2006, J NEUROSCI, V26, P3256, DOI 10.1523/JNEUROSCI.5537-05.2006; Soundararajan P, 2007, STEM CELLS, V25, P1697, DOI 10.1634/stemcells.2006-0654; Soundararajan P, 2010, J NEUROSCI, V30, P6595, DOI 10.1523/JNEUROSCI.4932-09.2010; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8	29	480	514	3	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 2	2011	9	3					205	218		10.1016/j.stem.2011.07.014	http://dx.doi.org/10.1016/j.stem.2011.07.014			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	822DN	21852222	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000295024200008
J	Hoch, M; Fischer, P; Stapel, B; Missol-Kolka, E; Sekkali, B; Scherr, M; Favret, F; Braun, T; Eder, M; Schuster-Gossler, K; Gossler, A; Hilfiker, A; Balligand, JL; Drexler, H; Hilfiker-Kleiner, D				Hoch, Melanie; Fischer, Philipp; Stapel, Britta; Missol-Kolka, Ewa; Sekkali, Belaid; Scherr, Michaela; Favret, Fabrice; Braun, Thomas; Eder, Matthias; Schuster-Gossler, Karin; Gossler, Achim; Hilfiker, Andres; Balligand, Jean-Luc; Drexler, Helmut; Hilfiker-Kleiner, Denise			Erythropoietin Preserves the Endothelial Differentiation Capacity of Cardiac Progenitor Cells and Reduces Heart Failure during Anticancer Therapies	CELL STEM CELL			English	Article							STEM-CELLS; SIGNAL TRANSDUCER; PROTECTIVE ROLE; INFLAMMATION; ACTIVATOR; SYSTEM; GROWTH; PLAYS; MODEL	Anticancer therapies, such as targeting of STAT3 or the use of anthracyclins (doxorubicin), can induce cardiomyopathy. In mice prone to developing heart failure as a result of reduced cardiac STAT3 expression (cardiomyocyte-restricted deficiency of STAT3) or treatment with doxorubicin, we observed impaired endothelial differentiation capacity of Sca-1(+) cardiac progenitor cells (CPCs) in conjunction with attenuated CCL2/CCR2 activation. Mice in both models also displayed reduced erythropoietin (EPO) levels in the cardiac microenvironment. EPO binds to CPCs and seems to be responsible for maintaining an active CCL2/CCR2 system. Supplementation with the EPO derivative CERA in a hematocrit-inactive low dose was sufficient to upregulate CCL2, restore endothelial differentiation of CPCs, and preserve the cardiac microvasculature and cardiac function in both mouse models. Thus, low-dose EPO treatment could potentially be exploited as a therapeutic strategy to reduce the risk of heart failure in certain treatment regimens.	[Hoch, Melanie; Fischer, Philipp; Stapel, Britta; Missol-Kolka, Ewa; Drexler, Helmut; Hilfiker-Kleiner, Denise] Hannover Med Sch, Dept Cardiol & Angiol, D-30625 Hannover, Germany; [Scherr, Michaela; Eder, Matthias] Hannover Med Sch, Dept Haematol Haemostasis Oncol & Stem Cell Trans, D-30625 Hannover, Germany; [Schuster-Gossler, Karin; Gossler, Achim] Hannover Med Sch, Dept Mol Biol, D-30625 Hannover, Germany; [Hilfiker, Andres] Hannover Med Sch, Dept HTTG, D-30625 Hannover, Germany; [Sekkali, Belaid; Balligand, Jean-Luc] Univ Louvain, Sch Med, Expt & Clin Res Inst, B-1200 Brussels, Belgium; [Favret, Fabrice] Univ Paris 13, EA Reponses Cellulaires & Fonct Hypoxie 2363, F-93017 Paris, France; [Braun, Thomas] Max Planck Inst Heart & Lung Res, D-61231 Bad Nauheim, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School; Universite Catholique Louvain; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Paris 13; Max Planck Society	Hilfiker-Kleiner, D (corresponding author), Hannover Med Sch, Dept Cardiol & Angiol, D-30625 Hannover, Germany.	hilfiker.denise@mh-hannover.de	Balligand, Jean-Luc J/D-7543-2012; Braun, Thomas/B-2310-2008	Favret, Fabrice/0000-0002-2827-9758; Braun, Thomas/0000-0002-6165-4804; BALLIGAND, Jean-Luc/0000-0002-0522-4156	DFG [HI 842/3-2]; Foundation Leducq	DFG(German Research Foundation (DFG)); Foundation Leducq(Leducq Foundation)	We thank the cell sorting core facility and the core facility for laser microscopy of the Hannover Medical School (Braukmann-Wittenberg-Herz-Stiftung and DFG), Martina Kasten, Tibor Horvath, Silvia Gutzke, Sergej Erschow, Inga Sorensen, and Birgit Brandt for excellent technical assistance. This work was supported by the DFG (HI 842/3-2 and REBIRTH) and the Foundation Leducq.	Asaumi Y, 2007, CIRCULATION, V115, P2022, DOI 10.1161/CIRCULATIONAHA.106.659037; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Bergmann MW, 2011, EUR J HEART FAIL, V13, P560, DOI 10.1093/eurjhf/hfr002; Chen X, 2007, CARDIOVASC DRUG THER, V21, P367, DOI 10.1007/s10557-007-6052-0; Contreras-Shannon V, 2007, AM J PHYSIOL-CELL PH, V292, pC953, DOI 10.1152/ajpcell.00154.2006; Dean RA, 2008, BLOOD, V112, P3455, DOI 10.1182/blood-2007-12-129080; Deng JX, 2007, CURR CANCER DRUG TAR, V7, P91, DOI 10.2174/156800907780006922; El Hasnaoui-Saadani R, 2009, AM J PHYSIOL-REG I, V296, pR801, DOI 10.1152/ajpregu.00119.2008; Ferreira A. L. A., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P278, DOI 10.2174/187152508785909474; Gewirtz DA, 2006, CLIN CANCER RES, V12, P2232, DOI 10.1158/1078-0432.CCR-05-2287; Haghikia A, 2011, EUR HEART J, V32, P1287, DOI 10.1093/eurheartj/ehq369; Hilfiker-Kleiner D, 2004, CIRC RES, V95, P187, DOI 10.1161/01.RES.0000134921.50377.61; Hilfiker-Kleiner D, 2007, CELL, V128, P589, DOI 10.1016/j.cell.2006.12.036; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Iwakura T, 2011, J MOL CELL CARDIOL, V51, P207, DOI 10.1016/j.yjmcc.2011.04.013; Jacoby JJ, 2003, P NATL ACAD SCI USA, V100, P12929, DOI 10.1073/pnas.2134694100; Kittleson MM, 2005, PHYSIOL GENOMICS, V21, P299, DOI 10.1152/physiolgenomics.00255.2004; Kunisada K, 2000, P NATL ACAD SCI USA, V97, P315, DOI 10.1073/pnas.97.1.315; Lin JS, 2008, J PHYSIOL-LONDON, V586, P5757, DOI 10.1113/jphysiol.2008.160887; Madonna R, 2009, EXP CELL RES, V315, P2921, DOI 10.1016/j.yexcr.2009.07.016; Miller Cindy L, 2005, Methods Mol Biol, V290, P71; Mohri T, 2009, ARTERIOSCL THROM VAS, V29, P754, DOI 10.1161/ATVBAHA.108.174870; Najjar SS, 2011, JAMA-J AM MED ASSOC, V305, P1863, DOI 10.1001/jama.2011.592; Nakagami H, 2006, HYPERTENSION, V48, P112, DOI 10.1161/01.HYP.0000225426.12101.15; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Podewski EK, 2003, CIRCULATION, V107, P798, DOI 10.1161/01.CIR.0000057545.82749.FF; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Tada H, 2006, CARDIOVASC RES, V71, P466, DOI 10.1016/j.cardiores.2006.05.010; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Tamura Y, 2011, ARTERIOSCL THROM VAS, V31, P582, DOI 10.1161/ATVBAHA.110.214726; Tarzami ST, 2005, BIOCHEM BIOPH RES CO, V335, P1008, DOI 10.1016/j.bbrc.2005.07.168; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Torella D, 2004, CIRC RES, V94, P514, DOI 10.1161/01.RES.0000117306.10142.50; Ueba H, 2010, P NATL ACAD SCI USA, V107, P14357, DOI 10.1073/pnas.1003019107; Vogiatzi G, 2010, EXPERT OPIN BIOL TH, V10, P251, DOI 10.1517/14712590903547819; Zelarayan LC, 2008, P NATL ACAD SCI USA, V105, P19762, DOI 10.1073/pnas.0808393105	37	57	58	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 5	2011	9	2					131	143		10.1016/j.stem.2011.07.001	http://dx.doi.org/10.1016/j.stem.2011.07.001			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	808PM	21816364	Bronze			2022-12-28	WOS:000293990900010
J	Loh, KM; Lim, B				Loh, Kyle M.; Lim, Bing			A Precarious Balance: Pluripotency Factors as Lineage Specifiers	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; GENE REGULATORY NETWORKS; SELF-RENEWAL; TRANSCRIPTION FACTORS; ES CELLS; DIFFERENTIATION; MAINTENANCE; ACTIVATION; INDUCTION; STATE	Understanding the basis of the unrestricted multilineage differentiation potential of pluripotent cells will be of developmental and translational consequence. We propose that pluripotency transcription factors are lineage specifiers that direct commitment to specific fetal lineages. Individual factors bestow the ability to differentiate into particular cell types, and concomitant expression of multiple lineage specifiers within pluripotent cells enables differentiation into every fetal lineage. Moreover, we speculate that, rather than being an intrinsically stable "ground state," pluripotency is an inherently precarious condition in which rival lineage specifiers continually compete to specify differentiation along mutually exclusive lineages.	[Loh, Kyle M.; Lim, Bing] Genome Inst Singapore, Stem Cell & Dev Biol Grp, Singapore 138672, Singapore; [Lim, Bing] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Lim, Bing] Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02115 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Loh, KM (corresponding author), Genome Inst Singapore, Stem Cell & Dev Biol Grp, Singapore 138672, Singapore.	kyle.m.loh@gmail.com; limb1@gis.a-star.edu.sg		Loh, Kyle/0000-0002-8042-0149	Davidson Institute of Talent Development; Singapore Agency for Science, Technology, and Research (A*STAR)	Davidson Institute of Talent Development; Singapore Agency for Science, Technology, and Research (A*STAR)(Agency for Science Technology & Research (A*STAR))	We thank L.T. Ang, P.P.L. Tam, K.L. Lee, D.J.C. Heng, M.T. Fuller, S.W.S. Lim, G. Guo, and three anonymous reviewers for critical review of the manuscript and evaluation of the model disclosed therein. Moreover, we are indebted to all members of the embryonic stem cell field whose work over the past 30 years has provided the inspiration for our present proposal. K.M.L. is supported by the Davidson Institute of Talent Development and B.L. is supported by the Singapore Agency for Science, Technology, and Research (A*STAR). This manuscript is dedicated to Dale L. Woodbury for his provision of uncommon mentorship.	Canham MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000379; Chng ZZ, 2010, CELL STEM CELL, V6, P59, DOI 10.1016/j.stem.2009.11.015; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; Enver T, 1998, CELL, V94, P9, DOI 10.1016/S0092-8674(00)81215-5; FIERING S, 1990, GENE DEV, V4, P1823, DOI 10.1101/gad.4.10.1823; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kobayashi T, 2009, GENE DEV, V23, P1870, DOI 10.1101/gad.1823109; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Lessard JA, 2010, ANNU REV CELL DEV BI, V26, P503, DOI 10.1146/annurev-cellbio-051809-102012; Liber D, 2010, CELL STEM CELL, V7, P114, DOI 10.1016/j.stem.2010.05.020; Lu R, 2011, J BIOL CHEM, V286, P8425, DOI 10.1074/jbc.M110.202150; Nichols J, 2001, DEVELOPMENT, V128, P2333; Nishiyama A, 2009, CELL STEM CELL, V5, P420, DOI 10.1016/j.stem.2009.07.012; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Ogawa K, 2007, J CELL SCI, V120, P55, DOI 10.1242/jcs.03296; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Smith A, 2005, CELL, V123, P757, DOI 10.1016/j.cell.2005.11.012; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; SMITH AG, 1992, DEV BIOL, V151, P339, DOI 10.1016/0012-1606(92)90174-F; Sun CH, 2009, MOL CELL BIOL, V29, P4574, DOI 10.1128/MCB.01863-08; Suzuki Atsushi, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS114, DOI 10.1038/ncpcardio0442; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Xu J, 2009, GENE DEV, V23, P2824, DOI 10.1101/gad.1861209; Yamada Y, 2010, CELL STEM CELL, V6, P10, DOI 10.1016/j.stem.2009.12.003; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001; Zeineddine D, 2006, DEV CELL, V11, P535, DOI 10.1016/j.devcel.2006.07.013; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481	39	175	181	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 8	2011	8	4					363	369		10.1016/j.stem.2011.03.013	http://dx.doi.org/10.1016/j.stem.2011.03.013			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	752QI	21474100	Bronze			2022-12-28	WOS:000289707100008
J	Parent, AV; Russ, HA; Khan, IS; LaFlam, TN; Metzger, TC; Anderson, MS; Hebrok, M				Parent, Audrey V.; Russ, Holger A.; Khan, Imran S.; LaFlam, Taylor N.; Metzger, Todd C.; Anderson, Mark S.; Hebrok, Matthias			Generation of Functional Thymic Epithelium from Human Embryonic Stem Cells that Supports Host T Cell Development	CELL STEM CELL			English	Article							FETAL THYMUS; NUDE-MICE; ENDODERM; MOUSE; EXPRESSION; MATURATION; TOLERANCE; BMP4; MICROENVIRONMENTS; DIFFERENTIATION	Inducing immune tolerance to prevent rejection is a key step toward successful engraftment of stem-cell-derived tissue in a clinical setting. Using human pluripotent stem cells to generate thymic epithelial cells (TECs) capable of supporting T cell development represents a promising approach to reach this goal; however, progress toward generating functional TECs has been limited. Here, we describe a robust in vitro method to direct differentiation of human embryonic stem cells (hESCs) into thymic epithelial progenitors (TEPs) by precise regulation of TGF beta, BMP4, RA, Wnt, Shh, and FGF signaling. The hESC-derived TEPs further mature into functional TECs that support T cell development upon transplantation into thymus-deficient mice. Importantly, the engrafted TEPs produce T cells capable of in vitro proliferation as well as in vivo immune responses. Thus, hESC-derived TEP grafts may have broad applications for enhancing engraftment in cell-based therapies as well as restoring age- and stress-related thymic decline.	[Parent, Audrey V.; Russ, Holger A.; Khan, Imran S.; LaFlam, Taylor N.; Metzger, Todd C.; Anderson, Mark S.; Hebrok, Matthias] Univ Calif San Francisco, Dept Med, Ctr Diabet, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Anderson, MS (corresponding author), Univ Calif San Francisco, Dept Med, Ctr Diabet, San Francisco, CA 94143 USA.	manderson@diabetes.ucsf.edu; mhebrok@diabetes.ucsf.edu		Khan, Imran/0000-0003-4570-4143	Canadian Institutes of Health Research fellowship; Richard G. Klein fellowship; JDRF fellowship [3-2012-266]; CIRM grant [CIRM RM1-01702]; UCSF Diabetes and Endocrinology Research Center (DERC); UCSF Flow Cytometry Core; NATIONAL CANCER INSTITUTE [F30CA174154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER	Canadian Institutes of Health Research fellowship(Canadian Institutes of Health Research (CIHR)); Richard G. Klein fellowship; JDRF fellowship; CIRM grant; UCSF Diabetes and Endocrinology Research Center (DERC); UCSF Flow Cytometry Core; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Anderson and Hebrok laboratories for helpful discussion. We thank Na Li, Kellsey Johannes, Debbie Ngow, and Jennifer Ringler for technical help; C. Stoddart and J. Rivera for help with kidney capsule transplantations; J. Puck and Y. Wang for help with analysis of the spectratyping data; Q. Tang and K. Lee for help with skin transplantations; and Viacyte for providing the CyT49 cell line. A. V. P. was supported by a Canadian Institutes of Health Research fellowship, H. A. R by a Richard G. Klein fellowship and JDRF fellowship (3-2012-266), and I. S. K. and T.N.L. by the UCSF Medical Scientist Training Program. Research in M.S.A.'s and M.H.'s laboratories was supported by a CIRM grant (CIRM RM1-01702). Imaging and flow cytometry experiments were supported by resources from the UCSF Diabetes and Endocrinology Research Center (DERC) and UCSF Flow Cytometry Core.	Anderson G, 2007, NAT REV IMMUNOL, V7, P954, DOI 10.1038/nri2187; Balciunaite G, 2002, NAT IMMUNOL, V3, P1102, DOI 10.1038/ni850; Bleul CC, 2005, J IMMUNOL, V175, P5213, DOI 10.4049/jimmunol.175.8.5213; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Calderon L, 2012, CELL, V149, P159, DOI 10.1016/j.cell.2012.01.049; Currier Jeffrey R, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1028s38; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Frank DU, 2002, DEVELOPMENT, V129, P4591; Fudaba Y, 2008, J IMMUNOL, V181, P7649, DOI 10.4049/jimmunol.181.11.7649; Gordon J, 2004, NAT IMMUNOL, V5, P546, DOI 10.1038/ni1064; Gordon J, 2010, DEV BIOL, V339, P141, DOI 10.1016/j.ydbio.2009.12.026; Green MD, 2011, NAT BIOTECHNOL, V29, P267, DOI 10.1038/nbt.1788; HOLLANDER GA, 1995, NATURE, V373, P350, DOI 10.1038/373350a0; KENNEDY JD, 1992, J IMMUNOL, V148, P1620; Klug DB, 2002, J IMMUNOL, V169, P2842, DOI 10.4049/jimmunol.169.6.2842; KOLLMANN TR, 1993, J EXP MED, V177, P821, DOI 10.1084/jem.177.3.821; LEDOUARIN NM, 1975, J EXP MED, V142, P17, DOI 10.1084/jem.142.1.17; Longmire TA, 2012, CELL STEM CELL, V10, P398, DOI 10.1016/j.stem.2012.01.019; MANLEY NR, 1995, DEVELOPMENT, V121, P1989; Moore-Scott BA, 2005, DEV BIOL, V278, P323, DOI 10.1016/j.ydbio.2004.10.027; Mou HM, 2012, CELL STEM CELL, V10, P385, DOI 10.1016/j.stem.2012.01.018; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; Neves H, 2012, DEV BIOL, V361, P208, DOI 10.1016/j.ydbio.2011.10.022; Nobori S, 2006, P NATL ACAD SCI USA, V103, P19081, DOI 10.1073/pnas.0605159103; Patel SR, 2006, GENE EXPR PATTERNS, V6, P794, DOI 10.1016/j.modgep.2006.01.011; Rodewald HR, 2008, ANNU REV IMMUNOL, V26, P355, DOI 10.1146/annurev.immunol.26.021607.090408; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; Russ H.A., 2011, CELL TRANSPLANTATION; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; SHORES EW, 1994, INT IMMUNOL, V6, P1393, DOI 10.1093/intimm/6.9.1393; TAGUCHI O, 1986, J EXP MED, V164, P60, DOI 10.1084/jem.164.1.60; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	33	100	104	1	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 1	2013	13	2					219	229		10.1016/j.stem.2013.04.004	http://dx.doi.org/10.1016/j.stem.2013.04.004			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VO	23684540	Green Accepted, Bronze			2022-12-28	WOS:000329570600014
J	Asada, N; Katayama, Y; Sato, M; Minagawa, K; Wakahashi, K; Kawano, H; Kawano, Y; Sada, A; Ikeda, K; Matsui, T; Tanimoto, M				Asada, Noboru; Katayama, Yoshio; Sato, Mari; Minagawa, Kentaro; Wakahashi, Kanako; Kawano, Hiroki; Kawano, Yuko; Sada, Akiko; Ikeda, Kyoji; Matsui, Toshimitsu; Tanimoto, Mitsune			Matrix-Embedded Osteocytes Regulate Mobilization of Hematopoietic Stem/Progenitor Cells	CELL STEM CELL			English	Article							STEM-CELLS; RECEPTOR; RELEASE; NICHE	The bone marrow (BM) niche comprises multiple cell types that regulate hematopoietic stem/progenitor cell (HSPC) migration out of the niche and into the circulation. Here, we demonstrate that osteocytes, the major cellular component of mature bone, are regulators of HSPC egress. Granulocyte colony-stimulating factor (G-CSF), used clinically to mobilize HSPCs, induces changes in the morphology and gene expression of the osteocytic network that precedes changes in osteoblasts. This rapid response is likely under control of the sympathetic nervous system, since osteocytes express the b2-adrenergic receptor and surgical sympathectomy prevents it. Mice with targeted ablation of osteocytes or a disrupted osteocyte network have comparable numbers of HSPCs in the BM but fail to mobilize HSPCs in response to G-CSF. Taken together, these results indicate that the BM/bone niche interface is critically controlled from inside of the bone matrix and establish an important physiological role for skeletal tissues in hematopoietic function.	[Asada, Noboru; Tanimoto, Mitsune] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama 7008558, Japan; [Asada, Noboru; Katayama, Yoshio; Sato, Mari; Minagawa, Kentaro; Wakahashi, Kanako; Kawano, Hiroki; Kawano, Yuko; Sada, Akiko; Matsui, Toshimitsu] Kobe Univ, Grad Sch Med, Dept Med, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Katayama, Yoshio] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Ikeda, Kyoji] NCGG, Dept Bone & Joint Dis, Obu, Aichi 4748511, Japan	Okayama University; Kobe University; Japan Science & Technology Agency (JST)	Katayama, Y (corresponding author), Kobe Univ, Grad Sch Med, Dept Med, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	katayama@med.kobe-u.ac.jp		Minagawa, Kentaro/0000-0003-1740-7109; Matsui, Toshimitsu/0000-0002-2536-7584	Japan Society for the Promotion of Science [23390251]; Ministry of Education, Culture, Sports, Science and Technology in Japan [23118517]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We would like to thank the following: Drs. Hidetsugu Tsujigiwa and Hitoshi Nagatsuka (Okayama University) for the technical help and valuable suggestions on immunohistological analysis of bone; Dr. Hiroshi Kamioka (Okayama University) for the superb advice about osteocyte staining and for stimulating discussions; and Dr. Toshitaka Oohashi (Okayama University) for the technical help on making frozen sections. This work was supported by the Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (# 23390251 to Y. Katayama) and for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology in Japan (# 23118517 to Y. Katayama). N.A. performed all experiments and wrote the manuscript; M.S., K.M., K.W., H.K., Y. Kawano, and A. S. helped with animal maintenance, tissue sample preparation, and qRT-PCR; K.I. and T.M. supervised the studies for DMP-1 DTR Tg mice; M.T. supervised the studies for surgical denervation and kl/kl mice; and Y. Katayama supervised all experiments and wrote the manuscript. The authors declare no competing financial interests.	Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Calvi LM, 2012, BLOOD, V119, P2489, DOI 10.1182/blood-2011-06-360933; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Christopher MJ, 2008, J BONE MINER RES, V23, P1765, DOI 10.1359/JBMR.080612; Christopher MJ, 2011, J EXP MED, V208, P251, DOI 10.1084/jem.20101700; Crucian B, 2009, J LEUKOCYTE BIOL, V86, P1017, DOI 10.1189/jlb.0709500; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Ferraro F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002191; Fulzele K, 2013, BLOOD, V121, P930, DOI 10.1182/blood-2012-06-437160; Genetos DC, 2007, J CELL PHYSIOL, V212, P207, DOI 10.1002/jcp.21021; Gonzalez-Nieto D, 2012, BLOOD, V119, P5144, DOI 10.1182/blood-2011-07-368506; Kamioka H, 2001, BONE, V28, P145, DOI 10.1016/S8756-3282(00)00421-X; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kawamori Y, 2010, BLOOD, V116, P5528, DOI 10.1182/blood-2010-04-279216; KLEINNULEND J, 1995, FASEB J, V9, P441, DOI 10.1096/fasebj.9.5.7896017; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Levesque JP, 2003, J CLIN INVEST, V111, P187, DOI 10.1172/JCI200315994; Marotti G., 2000, Journal of Musculoskeletal & Neuronal Interactions, V1, P133; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Spiegel A, 2008, CELL STEM CELL, V3, P484, DOI 10.1016/j.stem.2008.10.006; Stern AR, 2012, BIOTECHNIQUES, V52, P361, DOI 10.2144/0000113876; Sugimura R, 2012, CELL, V150, P351, DOI 10.1016/j.cell.2012.05.041; Suzuki H, 2005, ARCH HISTOL CYTOL, V68, P371, DOI 10.1679/aohc.68.371; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Taylor AF, 2007, AM J PHYSIOL-CELL PH, V292, pC545, DOI 10.1152/ajpcell.00611.2005; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Wang LD, 2011, NAT REV MOL CELL BIO, V12, P643, DOI 10.1038/nrm3184; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	38	110	115	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 6	2013	12	6					737	747		10.1016/j.stem.2013.05.001	http://dx.doi.org/10.1016/j.stem.2013.05.001			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VH	23746979	Green Submitted, Bronze			2022-12-28	WOS:000329569900016
J	Garbern, JC; Lee, RT				Garbern, Jessica C.; Lee, Richard T.			Cardiac Stem Cell Therapy and the Promise of Heart Regeneration	CELL STEM CELL			English	Review							ACUTE MYOCARDIAL-INFARCTION; CARDIOSPHERE-DERIVED CELLS; PROGENITOR CELLS; SMOOTH-MUSCLE; CARDIOMYOCYTE PROLIFERATION; FUNCTIONAL CARDIOMYOCYTES; ISCHEMIC CARDIOMYOPATHY; MITOTIC DIVISION; DNA-SYNTHESIS; FIBROBLASTS	Stem cell therapy for cardiac disease is an exciting but highly controversial research area. Strategies such as cell transplantation and reprogramming have demonstrated both intriguing and sobering results. Yet as clinical trials proceed, our incomplete understanding of stem cell behavior is made evident by numerous unresolved matters, such as the mechanisms of cardiomyocyte turnover or the optimal therapeutic strategies to achieve clinical efficacy. In this Perspective, we consider how cardiac stem cell biology has led us into clinical trials, and we suggest that achieving true cardiac regeneration in patients may ultimately require resolution of critical controversies in experimental cardiac regeneration.	[Garbern, Jessica C.] Boston Childrens Hosp, Dept Med, Boston, MA 02115 USA; [Lee, Richard T.] Brigham & Womens Hosp, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Lee, Richard T.] Brigham & Womens Hosp, Brigham Regenerat Med Ctr, Boston, MA 02115 USA; [Lee, Richard T.] Brigham & Womens Hosp, Dept Med, Cardiovasc Div, Boston, MA 02115 USA; [Lee, Richard T.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Lee, RT (corresponding author), Brigham & Womens Hosp, Harvard Stem Cell Inst, 75 Francis St, Boston, MA 02115 USA.	rlee@partners.org		Lee, Richard/0000-0003-4687-1381	NIH [R01 AG032977, 1R01 AG040019]; NATIONAL INSTITUTE ON AGING [R01AG032977, R01AG040019] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded in part by grants from NIH (R01 AG032977 1R01 AG040019) to R.T.L. The authors thank Sean M. Wu of Stanford University for his helpful comments. R. L. is cofounder and coowner of Provasculon, Inc. R. L. is a paid consultant to the company and serves on the company's Board of Directors. Provasculon has interests in regenerative cell therapy, an area related to this work. R. L.'s interests were reviewed by the Brigham and Women's Hospital and Partners HealthCare in accordance with their institutional policies.	Aasen T, 2010, NAT PROTOC, V5, P371, DOI 10.1038/nprot.2009.241; Aguirre A, 2013, CELL STEM CELL, V12, P275, DOI 10.1016/j.stem.2013.02.008; Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102; Assmus B, 2010, CIRC-HEART FAIL, V3, P89, DOI 10.1161/CIRCHEARTFAILURE.108.843243; Baffour R, 2006, CARDIOVASC REVASCULA, V7, P222, DOI 10.1016/j.carrev.2006.06.005; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Blin G, 2010, J CLIN INVEST, V120, P1125, DOI 10.1172/JCI40120; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Bollini S, 2011, J MOL CELL CARDIOL, V50, P296, DOI 10.1016/j.yjmcc.2010.07.006; Chen JX, 2012, CIRC RES, V111, P50, DOI 10.1161/CIRCRESAHA.112.270264; Clifford DM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006536.pub3; Davis RP, 2012, CIRCULATION, V125, P3079, DOI 10.1161/CIRCULATIONAHA.111.066092; Dib N, 2011, J CARDIOVASC TRANSL, V4, P177, DOI 10.1007/s12265-010-9253-z; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Drenckhahn JD, 2008, DEV CELL, V15, P521, DOI 10.1016/j.devcel.2008.09.005; Fransioli J, 2008, STEM CELLS, V26, P1315, DOI 10.1634/stemcells.2007-0751; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Govaert JA, 2009, J HEART LUNG TRANSPL, V28, P1158, DOI 10.1016/j.healun.2009.06.018; Hare JM, 2012, JAMA-J AM MED ASSOC, V308, P2369, DOI 10.1001/jama.2012.25321; Huang GN, 2012, SCIENCE, V338, P1599, DOI 10.1126/science.1229765; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Islas JF, 2012, P NATL ACAD SCI USA, V109, P13016, DOI 10.1073/pnas.1120299109; Iso Y, 2007, BIOCHEM BIOPH RES CO, V354, P700, DOI 10.1016/j.bbrc.2007.01.045; Jayawardena TM, 2012, CIRC RES, V110, P1465, DOI 10.1161/CIRCRESAHA.112.269035; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kajstura J, 1998, P NATL ACAD SCI USA, V95, P8801, DOI 10.1073/pnas.95.15.8801; Kajstura J, 2012, CIRCULATION, V126, P1869, DOI 10.1161/CIRCULATIONAHA.112.118380; Kajstura J, 2010, CIRC RES, V107, P1374, DOI 10.1161/CIRCRESAHA.110.231498; Kantrowitz A, 1998, ASAIO J, V44, P244, DOI 10.1097/00002480-199807000-00003; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Kouskoff V, 2005, P NATL ACAD SCI USA, V102, P13170, DOI 10.1073/pnas.0501672102; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Laube F, 2006, J CELL SCI, V119, P4719, DOI 10.1242/jcs.03252; Leobon B, 2003, P NATL ACAD SCI USA, V100, P7808, DOI 10.1073/pnas.1232447100; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Li TS, 2012, J AM COLL CARDIOL, V59, P942, DOI 10.1016/j.jacc.2011.11.029; Limbourg FP, 2005, CIRC RES, V96, P6, DOI 10.1161/01.RES.0000153667.26414.10; Loffredo FS, 2011, CELL STEM CELL, V8, P389, DOI 10.1016/j.stem.2011.02.002; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Malliaras K, 2013, EMBO MOL MED, V5, P191, DOI 10.1002/emmm.201201737; Marban E, 2012, JAMA-J AM MED ASSOC, V308, P2405, DOI 10.1001/jama.2012.64751; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Mollova M, 2013, P NATL ACAD SCI USA, V110, P1446, DOI 10.1073/pnas.1214608110; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Motoike T, 2003, GENESIS, V35, P153, DOI 10.1002/gene.10175; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Nelson TJ, 2009, CIRCULATION, V120, P408, DOI 10.1161/CIRCULATIONAHA.109.865154; OBERPRILLER JO, 1974, J EXP ZOOL, V187, P249, DOI 10.1002/jez.1401870208; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Ohnishi S, 2007, INT J HEMATOL, V86, P17, DOI 10.1532/IJH97.07041; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; QUAINI F, 1994, CIRC RES, V75, P1050, DOI 10.1161/01.RES.75.6.1050; RUMYANTSEV PP, 1974, VIRCHOWS ARCH B, V15, P357; Schmidt D, 2007, CIRCULATION, V116, pI64, DOI 10.1161/CIRCULATIONAHA.106.6806637; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Shiba Y, 2012, NATURE, V489, P322, DOI 10.1038/nature11317; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Soonpaa MH, 2013, BBA-MOL CELL RES, V1833, P799, DOI 10.1016/j.bbamcr.2012.10.029; Soonpaa MH, 1997, AM J PHYSIOL-HEART C, V272, pH220, DOI 10.1152/ajpheart.1997.272.1.H220; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAUSSIG HB, 1969, J AMER MED ASSOC, V207, P951, DOI 10.1001/jama.1969.03150180081020; Terrovitis JV, 2010, CIRC RES, V106, P479, DOI 10.1161/CIRCRESAHA.109.208991; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tohyama S, 2013, CELL STEM CELL, V12, P127, DOI 10.1016/j.stem.2012.09.013; Traverse JH, 2012, JAMA-J AM MED ASSOC, V308, P2380, DOI 10.1001/jama.2012.28726; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wei HJ, 2008, BIOMATERIALS, V29, P3547, DOI 10.1016/j.biomaterials.2008.05.009; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Ye ZY, 2011, ADV DRUG DELIVER REV, V63, P688, DOI 10.1016/j.addr.2011.02.007; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zhou B, 2012, J MOL CELL CARDIOL, V52, P43, DOI 10.1016/j.yjmcc.2011.08.020; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	86	280	290	0	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 6	2013	12	6					689	698		10.1016/j.stem.2013.05.008	http://dx.doi.org/10.1016/j.stem.2013.05.008			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VH	23746978	Green Accepted, Bronze			2022-12-28	WOS:000329569900012
J	Ding, QR; Lee, YK; Schaefer, EAK; Peters, DT; Veres, A; Kim, K; Kuperwasser, N; Motola, DL; Meissner, TB; Hendriks, WT; Trevisan, M; Gupta, RM; Moisan, A; Banks, E; Friesen, M; Schinzel, RT; Xia, F; Tang, A; Xia, YL; Figueroa, E; Wann, A; Ahfeldt, T; Daheron, L; Zhang, F; Rubin, LL; Peng, LF; Chung, RT; Musunuru, K; Cowan, CA				Ding, Qiurong; Lee, Youn-Kyoung; Schaefer, Esperance A. K.; Peters, Derek T.; Veres, Adrian; Kim, Kevin; Kuperwasser, Nicolas; Motola, Daniel L.; Meissner, Torsten B.; Hendriks, William T.; Trevisan, Marta; Gupta, Rajat M.; Moisan, Annie; Banks, Eric; Friesen, Max; Schinzel, Robert T.; Xia, Fang; Tang, Alexander; Xia, Yulei; Figueroa, Emmanuel; Wann, Amy; Ahfeldt, Tim; Daheron, Laurence; Zhang, Feng; Rubin, Lee L.; Peng, Lee F.; Chung, Raymond T.; Musunuru, Kiran; Cowan, Chad A.			A TALEN Genome-Editing System for Generating Human Stem Cell-Based Disease Models	CELL STEM CELL			English	Article							INSULIN-RESISTANCE; ADIPOSE-TISSUE; MICE LACKING; DNA; EFFECTORS; PERILIPIN; NUCLEASES; SORTILIN; MUTATION; AKT2	Transcription activator-like effector nucleases (TALENs) are a new class of engineered nucleases that are easier to design to cleave at desired sites in a genome than previous types of nucleases. We report here the use of TALENs to rapidly and efficiently generate mutant alleles of 15 genes in cultured somatic cells or human pluripotent stem cells, the latter for which we differentiated both the targeted lines and isogenic control lines into various metabolic cell types. We demonstrate cell-autonomous phenotypes directly linked to disease-dyslipidemia, insulin resistance, hypoglycemia, lipodystrophy, motor-neuron death, and hepatitis C infection. We found little evidence of TALEN off-target effects, but each clonal line nevertheless harbors a significant number of unique mutations. Given the speed and ease with which we were able to derive and characterize these cell lines, we anticipate TALEN-mediated genome editing of human cells becoming a mainstay for the investigation of human biology and disease.	[Ding, Qiurong; Lee, Youn-Kyoung; Peters, Derek T.; Veres, Adrian; Kim, Kevin; Kuperwasser, Nicolas; Meissner, Torsten B.; Hendriks, William T.; Trevisan, Marta; Gupta, Rajat M.; Friesen, Max; Schinzel, Robert T.; Xia, Fang; Tang, Alexander; Xia, Yulei; Figueroa, Emmanuel; Wann, Amy; Ahfeldt, Tim; Daheron, Laurence; Rubin, Lee L.; Musunuru, Kiran; Cowan, Chad A.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Hendriks, William T.; Trevisan, Marta; Daheron, Laurence; Rubin, Lee L.; Musunuru, Kiran; Cowan, Chad A.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Schaefer, Esperance A. K.; Motola, Daniel L.; Rubin, Lee L.; Peng, Lee F.] Massachusetts Gen Hosp, Dept Med, Gastrointestinal Unit, Boston, MA 02114 USA; [Cowan, Chad A.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Schaefer, Esperance A. K.; Peters, Derek T.; Veres, Adrian; Motola, Daniel L.; Gupta, Rajat M.; Peng, Lee F.; Chung, Raymond T.; Musunuru, Kiran; Cowan, Chad A.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Kuperwasser, Nicolas; Gupta, Rajat M.; Musunuru, Kiran] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Moisan, Annie] Roche Pharmaceut, Metab Discovery & Translat Area, CH-4070 Basel, Switzerland; [Banks, Eric; Zhang, Feng; Musunuru, Kiran; Cowan, Chad A.] Broad Inst, Cambridge, MA 02142 USA; [Zhang, Feng] MIT, McGovern Inst Brain Res, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Harvard University; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Roche Holding; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Musunuru, K (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	kiranmusunuru@gmail.com; ccowan@fas.harvard.edu	Macrae, Rhiannon/AAX-1536-2020; Ahfeldt, Tim/E-2935-2017; TREVISAN, MARTA/K-6591-2016	Ahfeldt, Tim/0000-0001-6377-7376; Moisan, Annie/0000-0002-4944-4548; TREVISAN, MARTA/0000-0002-3148-7240; Veres, Adrian/0000-0002-3849-3475; Kim, Kevin/0000-0002-7015-5871; Schaefer, Esperance/0000-0002-7198-3863; Rubin, Lee/0000-0002-8658-841X; ding, qiu rong/0000-0001-9906-6787	Roche Postdoctoral Fellowship; Harvard Stem Cell Institute; Harvard Presidential Scholars Fund of the Harvard Medical School MD/PhD Program; United States National Institutes of Health [T32-DK007191, T32-HL007604, K08-DK088951, K24-DK078772, P01-NS066888, R00-HL098364, U01-HL107440, R01-DK097768]; New York Stem Cell Foundation; Broad Institute's Lawrence H. Summers Fellowship; Carlos Slim Foundation; Harvard University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL098364, R01HL118744, U01HL107440, T32HL007604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK078772, T32DK007191, P30DK043351, F32DK097855, R01DK095384, K08DK088951, R01DK097768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS066888] Funding Source: NIH RePORTER	Roche Postdoctoral Fellowship; Harvard Stem Cell Institute; Harvard Presidential Scholars Fund of the Harvard Medical School MD/PhD Program; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Stem Cell Foundation; Broad Institute's Lawrence H. Summers Fellowship; Carlos Slim Foundation; Harvard University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by a Roche Postdoctoral Fellowship (Q. D.); the Sternlicht Director's Fund Award for Graduate Students from the Harvard Stem Cell Institute (D. T. P.); the Harvard Presidential Scholars Fund of the Harvard Medical School MD/PhD Program (A. V.); grants T32-DK007191 (E. A. K. S. and D. L. M.), T32-HL007604 (R. M. G.), K08-DK088951 (L. F. P.), K24-DK078772 (R. T. C.), P01-NS066888 (L. L. R.), R00-HL098364 (K. M.), U01-HL107440 (C. A. C.), and R01-DK097768 (F.Z., K. M., and C. A. C.) from the United States National Institutes of Health; the New York Stem Cell Foundation (L. L. R.); the Broad Institute's Lawrence H. Summers Fellowship and the Carlos Slim Foundation (K. M.); the Harvard Stem Cell Institute (T. B. M., L. L. R., K. M., and C. A. C.); and Harvard University (L. L. R., K. M., and C. A. C.). A. M. is a full-time employee of Roche Pharmaceuticals. We thank David Altshuler, Noel Burtt, Guillermo del Angel, Mark DePristo, Stacey Gabriel, Namrata Gupta, J. Keith Joung, Adam Kaplan, Ami Levy-Moonshine, Heng Li, Elyse Macksoud, Khalid Shakir, Alanna Strong, Kristin Thompson, Jayaraj Rajagopal, Stephanie Regan, Jennifer Shay, and the staffs of the HSCRB-HSCI Flow Cytometry Core and the Broad Institute's Genomics Platform for assistance and suggestions.	Agarwal AK, 2006, ANNU REV GENOM HUM G, V7, P175, DOI 10.1146/annurev.genom.7.080505.115715; Ahfeldt T, 2012, NAT CELL BIOL, V14, P209, DOI 10.1038/ncb2411; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Brasaemle DL, 2009, MOL CELL BIOCHEM, V326, P15, DOI 10.1007/s11010-008-9998-8; Briggs AW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks624; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1962; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; Gandotra S, 2011, NEW ENGL J MED, V364, P740, DOI 10.1056/NEJMoa1007487; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; George S, 2004, SCIENCE, V304, P1325, DOI 10.1126/science.1096706; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Guo J, 2010, J MOL BIOL, V400, P96, DOI 10.1016/j.jmb.2010.04.060; Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Hussain K, 2011, SCIENCE, V334, P474, DOI 10.1126/science.1210878; Jiang JY, 2009, J VIROL, V83, P12680, DOI 10.1128/JVI.01476-09; Kjolby M, 2010, CELL METAB, V12, P213, DOI 10.1016/j.cmet.2010.08.006; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nahmias Y, 2008, HEPATOLOGY, V47, P1437, DOI 10.1002/hep.22197; Nykjaer A, 2012, TRENDS NEUROSCI, V35, P261, DOI 10.1016/j.tins.2012.01.003; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Schinzel RT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027495; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Streubel J, 2012, NAT BIOTECHNOL, V30, P593, DOI 10.1038/nbt.2304; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Taylor AR, 2012, DEV NEUROBIOL, V72, P699, DOI 10.1002/dneu.20964; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Zhai W, 2010, HORM METAB RES, V42, P247, DOI 10.1055/s-0029-1243599; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	46	362	443	3	112	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 7	2013	12	2					238	251		10.1016/j.stem.2012.11.011	http://dx.doi.org/10.1016/j.stem.2012.11.011			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VB	23246482	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000329569300014
J	Ceccaldi, R; Parmar, K; Mouly, E; Delord, M; Kim, JM; Regairaz, M; Pla, M; Vasquez, N; Zhang, QS; Pondarre, C; de Latour, RP; Gluckman, E; Cavazzana-Calvo, M; Leblanc, T; Larghero, J; Grompe, M; Socie, G; D'Andrea, AD; Soulier, J				Ceccaldi, Raphael; Parmar, Kalindi; Mouly, Enguerran; Delord, Marc; Kim, Jung Min; Regairaz, Marie; Pla, Marika; Vasquez, Nadia; Zhang, Qing-Shuo; Pondarre, Corinne; de Latour, Regis Peffault; Gluckman, Eliane; Cavazzana-Calvo, Marina; Leblanc, Thierry; Larghero, Jerome; Grompe, Markus; Socie, Gerard; D'Andrea, Alan D.; Soulier, Jean			Bone Marrow Failure in Fanconi Anemia Is Triggered by an Exacerbated p53/p21 DNA Damage Response that Impairs Hematopoietic Stem and Progenitor Cells	CELL STEM CELL			English	Article							TNF-ALPHA; P53; CANCER; REPAIR; PATHWAY; SENESCENCE; FANCD2; DEFICIENCY; CHECKPOINT; COOPERATE	Fanconi anemia (FA) is an inherited DNA repair deficiency syndrome. FA patients undergo progressive bone marrow failure (BMF) during childhood, which frequently requires allogeneic hematopoietic stem cell transplantation. The pathogenesis of this BMF has been elusive to date. Here we found that FA patients exhibit a profound defect in hematopoietic stem and progenitor cells (HSPCs) that is present before the onset of clinical BMF. In response to replicative stress and unresolved DNA damage, p53 is hyperactivated in FA cells and triggers a late p21(Cdkn1a)-dependent G0/G1 cell-cycle arrest. Knockdown of p53 rescued the HSPC defects observed in several in vitro and in vivo models, including human FA or FA-like cells. Taken together, our results identify an exacerbated p53/p21 "physiological" response to cellular stress and DNA damage accumulation as a central mechanism for progressive HSPC elimination in FA patients, and have implications for clinical care.	[Ceccaldi, Raphael; Mouly, Enguerran; Delord, Marc; Regairaz, Marie; Pla, Marika; Larghero, Jerome; Socie, Gerard; Soulier, Jean] Univ Paris Diderot, Sorbonne Paris Cite, Inst Hematol IUH, Paris 75010, France; [Ceccaldi, Raphael; Regairaz, Marie; Soulier, Jean] St Louis Hosp, INSERM, U944, F-75010 Paris, France; [Ceccaldi, Raphael; Regairaz, Marie; Soulier, Jean] St Louis Hosp, CNRS, UMR7212, F-75010 Paris, France; [Ceccaldi, Raphael; Vasquez, Nadia; Soulier, Jean] St Louis Hosp, APHP, Hematol Lab, F-75010 Paris, France; [Pla, Marika; Larghero, Jerome] St Louis Hosp, INSERM, UMRS 940, F-75010 Paris, France; [de Latour, Regis Peffault; Gluckman, Eliane; Socie, Gerard] St Louis Hosp, APHP, Hematol Transplantat Dept, F-75010 Paris, France; [Socie, Gerard] St Louis Hosp, INSERM, U728, F-75010 Paris, France; [Larghero, Jerome] St Louis Hosp, APHP, Cell Therapy Unit, F-75010 Paris, France; [Larghero, Jerome] St Louis Hosp, APHP, CIC BT501, F-75010 Paris, France; [Parmar, Kalindi; Kim, Jung Min; D'Andrea, Alan D.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; [Zhang, Qing-Shuo; Grompe, Markus] Oregon Hlth & Sci Univ, Oregon Stem Cell Ctr, Portland, OR 97239 USA; [Pondarre, Corinne] Hosp Civils Lyon, Inst Pediat Hematol & Oncol, F-69008 Lyon, France; [Cavazzana-Calvo, Marina] Hop Necker Enfants Malad, INSERM, U768, F-75015 Paris, France; [Leblanc, Thierry] Robert Debre Hosp, Dept Pediat Hematol, F-75019 Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Oregon Health & Science University; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Soulier, J (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Inst Hematol IUH, Paris 75010, France.	jean.soulier@sls.aphp.fr	eliane, Gluckman/AAA-5024-2021	GLUCKMAN, ELIANE/0000-0001-7893-2199; Delord, Marc/0000-0002-0455-6749; Cavazzana, Marina/0000-0002-0264-0891; Grompe, Markus/0000-0002-6616-4345; Zhang, Qing-shuo/0000-0002-4407-6053	AFMF (Association Francaise de la Maladie de Fanconi); FARF (Fanconi Anemia Research Fund); Agence Nationale de la Recherche (ANR) "Genopath"; National Institutes of Health (NIH) [P01HL048546, RC4DK090913, R01DK43889]; NIH/NHLB [P01HL048546-16]; Association pour la Recherche contre le Cancer (ARC); Association Laurette Fugain; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048546, R37HL052725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC4DK090913, R01DK043889] Funding Source: NIH RePORTER	AFMF (Association Francaise de la Maladie de Fanconi); FARF (Fanconi Anemia Research Fund); Agence Nationale de la Recherche (ANR) "Genopath"(French National Research Agency (ANR)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NHLB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Association Laurette Fugain; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to William Vainchenker, Jean-Claude Gluckman, and Hugues de The for helpful discussion. We thank Lucie Hernandez (Genomic facility, IUH), Niclas Setterblad (Plateau technique, IUH), Abigail Hamilton (DFCI), and Aurelie Coquin (APHP, Saint-Louis Hospital) for their technical assistance; Eric Benedetti (OHSU) for maintaining the Fancd2/p53 mouse colony; Daniela Geromin at the Cellulotheque of Saint-Louis Hospital; and Patrizia Vinciguerra (DFCI) for her initial observations on the role of p53 in the cytokinesis failure of HSCs. We thank the patients and their families, and the AFMF (Association Francaise de la Maladie de Fanconi) and FARF (Fanconi Anemia Research Fund) for their support to J.S. and A.D.D., respectively, and the physicians and nurses from French pediatric, genetic, and/or hematological centers who have taken care of the patients. We also thank Joelle Roume, Laurence Loeuillet, Christine Francannet, and Anne-Marie Beaufrere, who referred FA fetus samples to our laboratory. Our center is supported by the French Government (Direction de l'Hospitalisation et de l'Organisation des Solos) as Centre de Reference Maladies Rares "Aplasies Medullaires Constitutionnelles" (coordination: G. Socie), and by the "Reseau INCa des Maladies Cassantes de l'AND" (coordination: D. Stoppa-Lyonnet and A. Sarasin). This work was supported by a grant from the Agence Nationale de la Recherche (ANR) "Genopath" to J.S., and by grants of the National Institutes of Health (NIH) (P01HL048546, RC4DK090913, and R01DK43889 to A.D.D.) and NIH/NHLB (P01HL048546-16 to M.G.). R.C. was supported by a fellowship of the Association pour la Recherche contre le Cancer (ARC) and by the Association Laurette Fugain.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; [Anonymous], 2006, [No title captured]; Bagby Grover C, 2007, Hematology Am Soc Hematol Educ Program, P40; Barroca V, 2012, HUM MOL GENET, V21, P121, DOI 10.1093/hmg/ddr447; Bellodi C, 2010, EMBO J, V29, P1865, DOI 10.1038/emboj.2010.83; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Blanpain C, 2011, CELL STEM CELL, V8, P16, DOI 10.1016/j.stem.2010.12.012; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Ceccaldi R, 2011, J CLIN INVEST, V121, P184, DOI 10.1172/JCI43836; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; Chen CC, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-24; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; de Winter JP, 2009, MUTAT RES-FUND MOL M, V668, P11, DOI 10.1016/j.mrfmmm.2008.11.004; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Dirac AMG, 2003, J BIOL CHEM, V278, P11731, DOI 10.1074/jbc.C300023200; Dokal I, 2008, BLOOD REV, V22, P141, DOI 10.1016/j.blre.2007.11.003; Dufour C, 2008, BONE MARROW TRANSPL, V41, pS90, DOI 10.1038/bmt.2008.63; Dufour C, 2003, BLOOD, V102, P2053, DOI 10.1182/blood-2003-01-0114; Freie B, 2003, BLOOD, V102, P4146, DOI 10.1182/blood-2003-03-0971; Gabert J, 2003, LEUKEMIA, V17, P2318, DOI 10.1038/sj.leu.2403135; Gluckman E, 2008, BONE MARROW TRANSPL, V41, P127, DOI 10.1038/sj.bmt.1705960; Gothot A, 1997, BLOOD, V90, P4384, DOI 10.1182/blood.V90.11.4384.4384_4384_4393; Gudkov AV, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001180; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Houghtaling S, 2005, CANCER RES, V65, P85; Houghtaling S, 2003, GENE DEV, V17, P2021, DOI 10.1101/gad.1103403; Jackson JG, 2006, CANCER RES, V66, P8356, DOI 10.1158/0008-5472.CAN-06-1752; Jiang H, 2009, GENE DEV, V23, P1895, DOI 10.1101/gad.1815309; Joenje H, 2011, GENE DEV, V475, P45; Koomen M, 2002, HUM MOL GENET, V11, P273, DOI 10.1093/hmg/11.3.273; Kruyt FAE, 1996, BLOOD, V87, P938, DOI 10.1182/blood.V87.3.938.bloodjournal873938; Kupfer GM, 1996, BLOOD, V88, P1019; Kutler DI, 2003, BLOOD, V101, P1249, DOI 10.1182/blood-2002-07-2170; Langevin F, 2011, NATURE, V475, P53, DOI 10.1038/nature10192; Li J, 2007, J CLIN INVEST, V117, P3283, DOI 10.1172/JCI31772; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; Milyavsky M, 2010, CELL STEM CELL, V7, P186, DOI 10.1016/j.stem.2010.05.016; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Naim V, 2009, NAT CELL BIOL, V11, P761, DOI 10.1038/ncb1883; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Neveling K, 2009, MUTAT RES-FUND MOL M, V668, P73, DOI 10.1016/j.mrfmmm.2009.05.006; Niedernhofer LJ, 2008, DNA REPAIR, V7, P523, DOI 10.1016/j.dnarep.2007.11.012; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Pang QS, 2009, MUTAT RES-FUND MOL M, V668, P42, DOI 10.1016/j.mrfmmm.2009.03.013; Parmar K, 2010, STEM CELLS, V28, P1186, DOI 10.1002/stem.437; Parmar K, 2009, MUTAT RES-FUND MOL M, V668, P133, DOI 10.1016/j.mrfmmm.2009.03.015; PLOEMACHER RE, 1991, BLOOD, V78, P2527; Quentin S, 2011, BLOOD, V117, pE161, DOI 10.1182/blood-2010-09-308726; Rani R, 2008, CANCER RES, V68, P9693, DOI 10.1158/0008-5472.CAN-08-1790; Rosenberg PS, 2005, BLOOD, V105, P67, DOI 10.1182/blood-2004-04-1652; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Seita J, 2010, CELL STEM CELL, V7, P145, DOI 10.1016/j.stem.2010.07.006; SEYSCHAB H, 1993, HUM GENET, V92, P61, DOI 10.1007/BF00216146; Shimamura A, 2010, BLOOD REV, V24, P101, DOI 10.1016/j.blre.2010.03.002; Soulier J, 2005, BLOOD, V105, P1329, DOI 10.1182/blood-2004-05-1852; Soulier J, 2011, HEMATOL-AM SOC HEMAT, P492, DOI 10.1182/asheducation-2011.1.492; Tolar J, 2011, MOL THER, V19, P1193, DOI 10.1038/mt.2011.78; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Vinciguerra P, 2010, J CLIN INVEST, V120, P3834, DOI 10.1172/JCI43391; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Waisfisz Q, 1999, NAT GENET, V22, P379, DOI 10.1038/11956; Zhang XL, 2007, J CELL SCI, V120, P1572, DOI 10.1242/jcs.003152; Zhang XL, 2005, BLOOD, V106, P75, DOI 10.1182/blood-2004-08-3033; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024	68	210	218	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 6	2012	11	1					36	49		10.1016/j.stem.2012.05.013	http://dx.doi.org/10.1016/j.stem.2012.05.013			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	975SS	22683204	Green Accepted, Bronze			2022-12-28	WOS:000306532400008
J	Keating, A				Keating, Armand			Mesenchymal Stromal Cells: New Directions	CELL STEM CELL			English	Review							HEMATOPOIETIC STEM-CELLS; TOLL-LIKE RECEPTORS; BONE-MARROW; HUMAN ADULT; CHROMOSOMAL-ABERRATIONS; INTERNATIONAL-SOCIETY; IN-VITRO; MULTIPOTENT; THERAPY; PROLIFERATION	Research into mesenchymal stromal/stem cells (MSCs) has been particularly exciting in the past five years. Our understanding of mechanisms of MSC-mediated tissue regeneration has undergone considerable evolution. Recent investigation of the primary in situ counterpart of cultured MSCs has led to fresh insights into MSC physiology and its role in the immune system. At the same time, the clinical application of MSCs continues to increase markedly. Taken together, a reappraisal of the definition of MSCs, a review of current research directions, and a reassessment of the approach to clinical investigation are timely and prudent.	Princess Margaret Hosp, Cell Therapy Program, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Keating, A (corresponding author), Princess Margaret Hosp, Cell Therapy Program, Toronto, ON M5G 2M9, Canada.	armand.keating@uhn.on.ca						Aslan H, 2006, STEM CELLS, V24, P1728, DOI 10.1634/stemcells.2005-0546; Auletta JJ, 2012, BLOOD, V119, P1801, DOI 10.1182/blood-2011-10-384354; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Ben-David U, 2011, CELL STEM CELL, V9, P97, DOI 10.1016/j.stem.2011.06.013; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; CASTROMALASPINA H, 1980, BLOOD, V56, P289; Chen PM, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-49; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Churchman SM, 2012, ARTHRITIS RHEUM-US, V64, P2632, DOI 10.1002/art.34434; Clark BR, 1995, ANN NY ACAD SCI, V770, P70, DOI 10.1111/j.1749-6632.1995.tb31044.x; Daquinag AC, 2011, CELL STEM CELL, V9, P74, DOI 10.1016/j.stem.2011.05.017; Dayan V, 2011, BASIC RES CARDIOL, V106, P1299, DOI 10.1007/s00395-011-0221-9; De Bari C, 2001, ARTHRITIS RHEUM-US, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P; DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Horwitz EM, 2008, CYTOTHERAPY, V10, P771, DOI 10.1080/14653240802618085; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; Johnson DJ, 2012, SCIENCE, V338, DOI 10.1126/science.1225996; Jones EA, 2002, ARTHRITIS RHEUM-US, V46, P3349, DOI 10.1002/art.10696; Jones S, 2007, J IMMUNOL, V179, P2824, DOI 10.4049/jimmunol.179.5.2824; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Lai RC, 2011, REGEN MED, V6, P481, DOI [10.2217/RME.11.35, 10.2217/rme.11.35]; Le Blanc K, 2007, J INTERN MED, V262, P509, DOI 10.1111/j.1365-2796.2007.01844.x; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lee CCI, 2010, EXP HEMATOL, V38, P46, DOI 10.1016/j.exphem.2009.11.001; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Lindner U, 2010, TRANSFUS MED HEMOTH, V37, P75, DOI 10.1159/000290897; Liotta F, 2008, STEM CELLS, V26, P279, DOI 10.1634/stemcells.2007-0454; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Muraglia A, 2000, J CELL SCI, V113, P1161; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Nadri S, 2007, CYTOTHERAPY, V9, P729, DOI 10.1080/14653240701656061; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Patki S, 2010, HUM CELL, V23, P35, DOI 10.1111/j.1749-0774.2010.00083.x; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 2012, STEM CELLS, V30, P1051, DOI 10.1002/stem.1103; Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ren GW, 2009, STEM CELLS, V27, P1954, DOI 10.1002/stem.118; Rose RA, 2008, STEM CELLS, V26, P2884, DOI 10.1634/stemcells.2008-0329; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sarugaser R, 2005, STEM CELLS, V23, P220, DOI 10.1634/stemcells.2004-0166; Sarugaser R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006498; Sensebe L, 2012, CELL STEM CELL, V10, P9, DOI 10.1016/j.stem.2011.12.005; Shih DTB, 2005, STEM CELLS, V23, P1012, DOI 10.1634/stemcells.2004-0125; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Tan JM, 2012, JAMA-J AM MED ASSOC, V307, P1169, DOI 10.1001/jama.2012.316; Tolar J, 2010, STEM CELLS, V28, P1446, DOI 10.1002/stem.459; Tomchuck SL, 2008, STEM CELLS, V26, P99, DOI 10.1634/stemcells.2007-0563; Tormin A, 2011, BLOOD, V117, P5067, DOI 10.1182/blood-2010-08-304287; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013; Waterman R.S., 2010, PLOS ONE, V5; WIGHT TN, 1986, BLOOD, V67, P1333; Yang SH, 2009, EXP MOL MED, V41, P315, DOI 10.3858/emm.2009.41.5.035; Yoshimura K, 2006, J CELL PHYSIOL, V208, P64, DOI 10.1002/jcp.20636; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	69	561	597	3	128	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 14	2012	10	6					709	716		10.1016/j.stem.2012.05.015	http://dx.doi.org/10.1016/j.stem.2012.05.015			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	965LD	22704511	Bronze			2022-12-28	WOS:000305768400017
J	Florian, MC; Dorr, K; Niebel, A; Daria, D; Schrezenmeier, H; Rojewski, M; Filippi, MD; Hasenberg, A; Gunzer, M; Scharffetter-Kochanek, K; Zheng, Y; Geiger, H				Florian, Maria Carolina; Doerr, Karin; Niebel, Anja; Daria, Deidre; Schrezenmeier, Hubert; Rojewski, Markus; Filippi, Marie-Dominique; Hasenberg, Anja; Gunzer, Matthias; Scharffetter-Kochanek, Karin; Zheng, Yi; Geiger, Hartmut			Cdc42 Activity Regulates Hematopoietic Stem Cell Aging and Rejuvenation	CELL STEM CELL			English	Article							EPIGENETIC INHERITANCE; POLARITY; DIVISION; BLOOD; DIFFERENTIATION; TRANSPLANTATION; ACTIVATION; EXPRESSION; PROTEINS; UNDERLIE	The decline in hematopoietic function seen during aging involves a progressive reduction in the immune response and an increased incidence of myeloid malignancy, and has been linked to aging of hematopoietic stem cells (HSCs). The molecular mechanisms underlying HSC aging remain unclear. Here we demonstrate that elevated activity of the small RhoGTPase Cdc42 in aged HSCs is causally linked to HSC aging and correlates with a loss of polarity in aged HSCs. Pharmacological inhibition of Cdc42 activity functionally rejuvenates aged HSCs, increases the percentage of polarized cells in an aged HSC population, and restores the level and spatial distribution of histone H4 lysine 16 acetylation to a status similar to that seen in young HSCs. Our data therefore suggest a mechanistic role for Cdc42 activity in HSC biology and epigenetic regulation, and identify Cdc42 activity as a pharmacological target for ameliorating stem cell aging.	[Florian, Maria Carolina; Doerr, Karin; Niebel, Anja; Daria, Deidre; Scharffetter-Kochanek, Karin; Geiger, Hartmut] Univ Ulm, Dept Dermatol & Allerg Dis, D-89091 Ulm, Germany; [Schrezenmeier, Hubert; Rojewski, Markus] Univ Ulm, Inst Clin Transfus Med & Immunogenet Ulm, D-89091 Ulm, Germany; [Filippi, Marie-Dominique; Zheng, Yi; Geiger, Hartmut] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Filippi, Marie-Dominique; Zheng, Yi; Geiger, Hartmut] Univ Cincinnati, Cincinnati, OH 45229 USA; [Hasenberg, Anja; Gunzer, Matthias] Univ Duisburg Essen, Univ Hosp, Inst Expt Immunol & Imaging, D-45141 Essen, Germany	Ulm University; Ulm University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Duisburg Essen	Geiger, H (corresponding author), Univ Ulm, Dept Dermatol & Allerg Dis, D-89091 Ulm, Germany.	hartmut.geiger@uni-ulm.de	Gunzer, Matthias/AAW-7026-2021; Zheng, Yi/J-7235-2015; Florian, M. Carolina/AAH-5309-2019	Gunzer, Matthias/0000-0002-5534-6055; Zheng, Yi/0000-0001-7089-6074; Florian, M. Carolina/0000-0002-5791-1310; Rojewski, Markus/0000-0003-4265-0442; Scharffetter-Kochanek, Karin/0000-0002-9655-685X	Deutsche Forschungsgemeinschaft [KFO 142, GE2063/1]; National Institute of Health [HL076604, DK077762, AG040118]; Department of Medicine Ulm; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK077762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040118] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Medicine Ulm; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Gary Van Zant, Jose A. Cancelas, Marnie A. Ryan, and Hartmut Weiler for advice and critical reading of the manuscript. We thank Frank Kirchhoff and Dre van der Merwe for cell sorting support, Angelika Ruck and the Institut fur Lasertechnologien in der Medizin und MeBtechnik of Ulm University for support with confocal microscopy, and the Tierforschungszentrum of the University of Ulm for supporting our animal work. This work was supported by grants from the Deutsche Forschungsgemeinschaft (KFO 142, GE2063/1) and from the National Institute of Health (HL076604, DK077762, and AG040118) to HG., and by a "Bausteinprogramm" of the Department of Medicine Ulm to M.C.F. M.C.F. and H.G. designed and interpreted experiments and wrote the manuscript. M.C.F. performed and analyzed experiments. H.G. helped in performing transplantation experiments. K.D. and D.D. assisted in transplantation procedures and K.D, D.D., MR., and H.S aided with cell sorting and flow analysis procedures. A.N. assisted in transplantation procedures and supported the Cdc42GAP mouse colony. A.H. and M.G. supported experiments with respect to intra-vital imaging. M.-D.F., K.S-K., and Y.Z. assisted in designing and interpreting experiments. The authors declare no competing financial interests.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Alberts AS, 1998, CELL, V92, P475, DOI 10.1016/S0092-8674(00)80941-1; BARFOD ET, 1993, J BIOL CHEM, V268, P26059; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Beghe C, 2004, AM J MED, V116, P3, DOI 10.1016/j.amjmed.2003.12.009; Cappello S, 2006, NAT NEUROSCI, V9, P1099, DOI 10.1038/nn1744; Cau JL, 2005, J CELL SCI, V118, P2579, DOI 10.1242/jcs.02385; Cavalli G, 1999, SCIENCE, V286, P955, DOI 10.1126/science.286.5441.955; Chambers SM, 2007, STEM CELL REV, V3, P201, DOI 10.1007/s12015-007-0027-1; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559; Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386; Chung YS, 2009, BLOOD, V114, P4968, DOI 10.1182/blood-2009-01-197780; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Dorshkind K, 2009, CURR OPIN IMMUNOL, V21, P404, DOI 10.1016/j.coi.2009.07.001; Dykstra B, 2011, J EXP MED, V208, P2691, DOI 10.1084/jem.20111490; Ergen AV, 2010, EXP GERONTOL, V45, P286, DOI 10.1016/j.exger.2009.12.010; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Florian MC, 2010, STEM CELLS, V28, P1623, DOI 10.1002/stem.481; Geiger H, 2005, P NATL ACAD SCI USA, V102, P5102, DOI 10.1073/pnas.0408654102; Geiger H, 2002, NAT IMMUNOL, V3, P329, DOI 10.1038/ni0402-329; Geiger H, 2007, CELL CYCLE, V6, P884, DOI 10.4161/cc.6.8.4131; Geiger H, 2009, TRENDS IMMUNOL, V30, P360, DOI 10.1016/j.it.2009.03.010; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Ju ZY, 2007, NAT MED, V13, P742, DOI 10.1038/nm1578; Kamminga LM, 2005, STEM CELLS, V23, P82, DOI 10.1634/stemcells.2004-0066; Karsunky H, 2008, BLOOD, V111, P5562, DOI 10.1182/blood-2007-11-126219; Kerber RA, 2009, AGING CELL, V8, P239, DOI 10.1111/j.1474-9726.2009.00467.x; Kiss TL, 2007, BONE MARROW TRANSPL, V40, P405, DOI 10.1038/sj.bmt.1705747; Kohler A, 2009, BLOOD, V114, P290, DOI 10.1182/blood-2008-12-195644; Krishnan V, 2011, P NATL ACAD SCI USA, V108, P12325, DOI 10.1073/pnas.1102789108; Liang Y, 2005, BLOOD, V106, P1479, DOI 10.1182/blood-2004-11-4282; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Ludford-Menting MJ, 2005, IMMUNITY, V22, P737, DOI 10.1016/j.immuni.2005.04.009; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Peterson JR, 2006, CHEM BIOL, V13, P443, DOI 10.1016/j.chembiol.2006.02.009; Pollina EA, 2011, ONCOGENE, V30, P3105, DOI 10.1038/onc.2011.45; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Rando TA, 2012, CELL, V148, P46, DOI 10.1016/j.cell.2012.01.003; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2007, CELL CYCLE, V6, P2371, DOI 10.4161/cc.6.19.4759; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Sakamori R, 2012, J CLIN INVEST, V122, P1052, DOI 10.1172/JCI60282; Sengupta A, 2011, P NATL ACAD SCI USA, V108, P9957, DOI 10.1073/pnas.1103132108; Signer RAJ, 2007, BLOOD, V110, P1831, DOI 10.1182/blood-2007-01-069401; Silva H., 2008, AGING STEM CELL RENE; Sinha S, 2008, CELL SIGNAL, V20, P1927, DOI 10.1016/j.cellsig.2008.05.002; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Vaquero A, 2007, ONCOGENE, V26, P5505, DOI 10.1038/sj.onc.1210617; Wang L, 2007, P NATL ACAD SCI USA, V104, P1248, DOI 10.1073/pnas.0609149104; Xing ZL, 2006, BLOOD, V108, P2190, DOI 10.1182/blood-2005-12-010272; Yang L, 2007, BLOOD, V110, P3853, DOI 10.1182/blood-2007-03-079582	56	322	332	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 4	2012	10	5					520	530		10.1016/j.stem.2012.04.007	http://dx.doi.org/10.1016/j.stem.2012.04.007			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	944WN	22560076	Green Accepted, Bronze			2022-12-28	WOS:000304234600011
J	Kubin, T; Poling, J; Kostin, S; Gajawada, P; Hein, S; Rees, W; Wietelmann, A; Tanaka, M; Lorchner, H; Schimanski, S; Szibor, M; Warnecke, H; Braun, T				Kubin, Thomas; Poeling, Jochen; Kostin, Sawa; Gajawada, Praveen; Hein, Stefan; Rees, Wolfgang; Wietelmann, Astrid; Tanaka, Minoru; Loerchner, Holger; Schimanski, Silvia; Szibor, Marten; Warnecke, Henning; Braun, Thomas			Oncostatin M Is a Major Mediator of Cardiomyocyte Dedifferentiation and Remodeling	CELL STEM CELL			English	Article							ADULT CARDIAC MYOCYTES; HEART-FAILURE; STEM-CELLS; GENE-EXPRESSION; TISSUE-REPAIR; GROWTH-FACTOR; REGENERATION; CYTOKINE; MUSCLE; GP130	Cardiomyocyte remodeling, which includes partial dedifferentiation of cardiomyocytes, is a process that occurs during both acute and chronic disease processes. Here, we demonstrate that oncostatin M (OSM) is a major mediator of cardiomyocyte dedifferentiation and remodeling during acute myocardial infarction (MI) and in chronic dilated cardiomyopathy (DCM). Patients suffering from DCM show a strong and lasting increase of OSM expression and signaling. OSM treatment induces dedifferentiation of cardiomyocytes and upregulation of stem cell markers and improves cardiac function after MI. Conversely, inhibition of OSM signaling suppresses cardiomyocyte remodeling after MI and in a mouse model of DCM, resulting in deterioration of heart function after MI but improvement of cardiac performance in DCM. We postulate that dedifferentiation of cardiomyocytes initially protects stressed hearts but fails to support cardiac structure and function upon continued activation. Manipulation of OSM signaling provides a means to control the differentiation state of cardiomyocytes and cellular plasticity.	[Kubin, Thomas; Poeling, Jochen; Kostin, Sawa; Gajawada, Praveen; Wietelmann, Astrid; Loerchner, Holger; Schimanski, Silvia; Szibor, Marten; Braun, Thomas] Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodelling, D-61321 Bad Nauheim, Germany; [Poeling, Jochen; Rees, Wolfgang; Warnecke, Henning] Schuchtermann Clin, Dept Cardiac Surg, D-49214 Bad Rothenfelde, Germany; [Hein, Stefan] Kerckhoff Hosp, Dept Cardiac Surg, D-61231 Bad Nauheim, Germany; [Tanaka, Minoru] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	Max Planck Society; Kerckhoff Clinic; University of Tokyo	Braun, T (corresponding author), Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodelling, Ludwigstr 43, D-61321 Bad Nauheim, Germany.	thomas.braun@mpi-bn.mpg.de	Braun, Thomas/B-2310-2008	Braun, Thomas/0000-0002-6165-4804	Max Planck Society; Excellence Initiative "Cardiopulmonary System" at the University of Giessen-Marburg Lung Center (UGMLC); HMWK	Max Planck Society(Max Planck Society); Excellence Initiative "Cardiopulmonary System" at the University of Giessen-Marburg Lung Center (UGMLC); HMWK	The authors thank Kerstin Richter, Brigitte Matzke, Ute Schuchmann, and Sylvia Jeratsch for excellent technical assistance and Gerhard Stammler for statistical analyses. This work was supported by the Max Planck Society and the Excellence Initiative "Cardiopulmonary System" at the University of Giessen-Marburg Lung Center (UGMLC), and the Cell and Gene Therapy Center (CGT) supported by the HMWK.	Apostolakis S, 2010, CARDIOVASC RES, V85, P649, DOI 10.1093/cvr/cvp327; Ausma J, 1998, MOL CELL BIOCHEM, V186, P159, DOI 10.1023/A:1006887803970; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Braun T, 2007, TRENDS BIOTECHNOL, V25, P441, DOI 10.1016/j.tibtech.2007.08.004; Dispersyn GD, 2002, EUR HEART J, V23, P849, DOI 10.1053/euhj.2001.2963; Driesen RB, 2009, J CELL MOL MED, V13, P896, DOI 10.1111/j.1582-4934.2008.00523.x; Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; Ebelt H, 2005, CIRC RES, V96, P509, DOI 10.1161/01.RES.0000159705.17322.57; Ebelt H, 2007, STEM CELLS, V25, P236, DOI 10.1634/stemcells.2006-0374; Gibson RM, 2000, J BIOL CHEM, V275, P22574, DOI 10.1074/jbc.M907658199; Gwechenberger M, 2004, CROAT MED J, V45, P149; Hein S, 2009, EXP CLIN CARDIOL, V14, pE68; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Heling A, 2000, CIRC RES, V86, P846, DOI 10.1161/01.RES.86.8.846; Hirota H, 1999, CELL, V97, P189, DOI 10.1016/S0092-8674(00)80729-1; Hohensinner PJ, 2009, FASEB J, V23, P774, DOI 10.1096/fj.08-108035; IZUMO S, 1988, P NATL ACAD SCI USA, V85, P339, DOI 10.1073/pnas.85.2.339; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kodama H, 1997, CIRC RES, V81, P656; Kolattukudy PE, 1998, AM J PATHOL, V152, P101; Kubin T, 1999, AM J PHYSIOL-HEART C, V276, pH2179, DOI 10.1152/ajpheart.1999.276.6.H2179; Laube F, 2006, J CELL SCI, V119, P4719, DOI 10.1242/jcs.03252; Neuhaus P, 2003, MOL CELL BIOL, V23, P6037, DOI 10.1128/MCB.23.17.6037-6048.2003; Osorio KM, 2011, J CELL BIOL, V193, P235, DOI 10.1083/jcb.201006068; Rucker-Martin C, 2002, CARDIOVASC RES, V55, P38, DOI 10.1016/S0008-6363(02)00338-3; Ruoslahti E, 1997, SCIENCE, V276, P1345, DOI 10.1126/science.276.5317.1345; SCHAPER J, 1991, CIRCULATION, V83, P504, DOI 10.1161/01.CIR.83.2.504; Sharov VG, 1997, INT J CARDIOL, V60, P273, DOI 10.1016/S0167-5273(97)00117-4; Shioi T, 1996, CIRCULATION, V94, P2930, DOI 10.1161/01.CIR.94.11.2930; Song HY, 2007, INT J BIOCHEM CELL B, V39, P439, DOI 10.1016/j.biocel.2006.07.014; Taegtmeyer H, 2010, ANN NY ACAD SCI, V1188, P191, DOI 10.1111/j.1749-6632.2009.05100.x; Tanaka M, 2003, BLOOD, V102, P3154, DOI 10.1182/blood-2003-02-0367; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Weiss TW, 2005, J MOL CELL CARDIOL, V39, P545, DOI 10.1016/j.yjmcc.2005.03.015; Weiss TW, 2003, CARDIOVASC RES, V59, P628, DOI 10.1016/S0008-6363(03)00463-2; Zhang YQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012559; Ziebart T, 2008, CIRC RES, V103, P1327, DOI 10.1161/CIRCRESAHA.108.180463	38	211	218	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV 4	2011	9	5					420	432		10.1016/j.stem.2011.08.013	http://dx.doi.org/10.1016/j.stem.2011.08.013			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	850FJ	22056139	Bronze			2022-12-28	WOS:000297180200010
J	Ben-David, U; Mayshar, Y; Benvenisty, N				Ben-David, Uri; Mayshar, Yoav; Benvenisty, Nissim			Large-Scale Analysis Reveals Acquisition of Lineage-Specific Chromosomal Aberrations in Human Adult Stem Cells	CELL STEM CELL			English	Editorial Material							CULTURE ADAPTATION; COPY NUMBER; IN-VITRO; PLURIPOTENCY; CLASSIFICATION; TRANSFORMATION; ABNORMALITIES; INSTABILITY; MALIGNANCY; MUTATIONS	In this study, we assessed the genetic integrity of over 400 samples of human multipotent stem cells using gene expression data sets. Our analysis reveals that neural and mesenchymal stem cells acquire characteristic large chromosomal aberrations at a similar, or somewhat lower, frequency to that seen in pluripotent stem cells, sometimes within a few passages in culture. Some of the identified chromosomal abnormalities can also be detected in human tumors of the respective tissues.	[Ben-David, Uri; Mayshar, Yoav; Benvenisty, Nissim] Hebrew Univ Jerusalem, Stem Cell Unit, Dept Genet, Silberman Inst Life Sci, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Mayshar, Y (corresponding author), Hebrew Univ Jerusalem, Stem Cell Unit, Dept Genet, Silberman Inst Life Sci, IL-91904 Jerusalem, Israel.	myoavi@cc.huji.ac.il; nissimb@cc.huji.ac.il	Ben-David, Uri/H-4119-2019	Ben-David, Uri/0000-0001-7098-2378; Mayshar, Yoav/0000-0002-5553-2472				Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Ben-David U, 2010, CELL CYCLE, V9, P4603, DOI 10.4161/cc.9.23.14094; Bernardo ME, 2007, CANCER RES, V67, P9142, DOI 10.1158/0008-5472.CAN-06-4690; Buyanovskaya OA, 2009, B EXP BIOL MED+, V148, P109, DOI 10.1007/s10517-009-0647-3; Casalbore P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004434; Dahlen A, 2003, INT J CANCER, V103, P616, DOI 10.1002/ijc.10864; De Filippis L, 2007, STEM CELLS, V25, P2312, DOI 10.1634/stemcells.2007-0040; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Harrison NJ, 2007, INT J ANDROL, V30, P275, DOI 10.1111/j.1365-2605.2007.00762.x; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lefort N, 2008, NAT BIOTECHNOL, V26, P1364, DOI 10.1038/nbt.1509; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Meza-Zepeda LA, 2008, J CELL MOL MED, V12, P553, DOI 10.1111/j.1582-4934.2007.00146.x; Mitelman F, 2019, MITELMAN DATABASE CH; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Pellagatti A, 2010, LEUKEMIA, V24, P756, DOI 10.1038/leu.2010.31; Rosland GV, 2009, CANCER RES, V69, P5331, DOI 10.1158/0008-5472.CAN-08-4630; Sareen D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007630; Schorle H, 2007, INT J ANDROL, V30, P281; Spits C, 2008, NAT BIOTECHNOL, V26, P1361, DOI 10.1038/nbt.1510; Taapken SM, 2011, NAT BIOTECHNOL, V29, P313, DOI 10.1038/nbt.1835; Takeuchi M, 2009, IN VITRO CELL DEV-AN, V45, P290, DOI 10.1007/s11626-008-9174-1; Ueyama H, 2012, J CELL MOL MED, V16, P72, DOI 10.1111/j.1582-4934.2011.01303.x; Villa A, 2004, EXP CELL RES, V294, P559, DOI 10.1016/j.yexcr.2003.11.025; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Yamaguchi T, 1996, ANTICANCER RES, V16, P2009; Zhang ZX, 2007, CELL BIOL INT, V31, P645, DOI 10.1016/j.cellbi.2006.11.025	30	179	188	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	AUG 5	2011	9	2					97	102		10.1016/j.stem.2011.06.013	http://dx.doi.org/10.1016/j.stem.2011.06.013			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	808PM	21816361	Bronze			2022-12-28	WOS:000293990900006
J	Hishida, T; Nozaki, Y; Nakachi, Y; Mizuno, Y; Okazaki, Y; Ema, M; Takahashi, S; Nishimoto, M; Okuda, A				Hishida, Tomoaki; Nozaki, Yuriko; Nakachi, Yutaka; Mizuno, Yosuke; Okazaki, Yasushi; Ema, Masatsugu; Takahashi, Satoru; Nishimoto, Masazumi; Okuda, Akihiko			Indefinite Self-Renewal of ESCs through Myc/Max Transcriptional Complex-Independent Mechanisms	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; C-MYC; RAT BLASTOCYSTS; PLURIPOTENCY; MAX; DIFFERENTIATION; EXPRESSION; PATHWAYS; PHOSPHORYLATION; SURVIVAL	Embryonic stem cells (ESCs) can self-renew indefinitely under the governance of ESC-specific transcriptional circuitries in which each transcriptional factor regulates distinct or overlapping sets of genes with other factors. c-Myc is a key player that is crucially involved in maintaining the undifferentiated state and the self-renewal of ESCs. However, the mechanism by which c-Myc helps preserve the ESC status is still poorly understood. Here we addressed this question by performing loss-of-function studies with the Max gene, which encodes the best-characterized partner protein for all Myc family proteins. Although Myc/Max complexes are widely regarded as crucial regulators of the ESC status, our data revealed that ESCs do not absolutely require these complexes in certain contexts and that this requirement is restricted to empirical ESC culture conditions without a MAPK inhibitor.	[Hishida, Tomoaki; Nozaki, Yuriko; Okuda, Akihiko] Saitama Med Univ, Res Ctr Genom Med, Div Dev Biol, Saitama 3501241, Japan; [Nakachi, Yutaka; Mizuno, Yosuke; Okazaki, Yasushi] Saitama Med Univ, Res Ctr Genom Med, Div Funct Genom & Syst Med, Saitama 3501241, Japan; [Nishimoto, Masazumi] Saitama Med Univ, Res Ctr Genom Med, Radioisotope Expt Lab, Saitama 3501241, Japan; [Hishida, Tomoaki; Nozaki, Yuriko; Okazaki, Yasushi; Takahashi, Satoru; Okuda, Akihiko] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol CREST, Saitama 3320012, Japan; [Ema, Masatsugu] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Saitama 3320012, Japan; [Ema, Masatsugu; Takahashi, Satoru] Univ Tsukuba, Grad Sch Comprehens Human Sci, Inst Basic Med Sci, Dept Anat & Embryol, Tsukuba, Ibaraki 3058575, Japan	Saitama Medical University; Saitama Medical University; Saitama Medical University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); University of Tsukuba	Okuda, A (corresponding author), Saitama Med Univ, Res Ctr Genom Med, Div Dev Biol, Saitama 3501241, Japan.	akiokuda@saitama-med.ac.jp	Nakachi, Yutaka/M-2446-2013	Nakachi, Yutaka/0000-0003-1964-2495; Okazaki, Yasushi/0000-0003-3241-5502; Ema, Masatsugu/0000-0003-0645-6183	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Strategic Research Center in Private Universities; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic Research Center in Private Universities; Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	We thank Dr. Hitoshi Niwa for helpful discussions and providing the EBRTcH3 ESCs and Tbx3 cDNA and Dr. Bruno Amati for c-Myc and Max cDNAs and their EG and RX derivatives. We also thank Keiko Amagai and Yukiko Yatsuka for technical assistance. This study was supported in part by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and primarily by a Grant-in-Aid for Support Project of Strategic Research Center in Private Universities to the Saitama Medical University Research Center for Genomic Medicine. This study was performed as a part of the Core Research for Evolutional Science and Technology (CREST) project supported by the Japan Science and Technology Agency.	AMATI B, 1993, CELL, V72, P233, DOI 10.1016/0092-8674(93)90663-B; Baudino TA, 2001, MOL CELL BIOL, V21, P691, DOI 10.1128/MCB.21.3.691-702.2001; Benassi B, 2006, MOL CELL, V21, P509, DOI 10.1016/j.molcel.2006.01.009; BLACKWOOD EM, 1992, GENE DEV, V6, P71, DOI 10.1101/gad.6.1.71; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chong ZZ, 2005, CURR NEUROVASC RES, V2, P271, DOI 10.2174/156720205774322584; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hong SL, 2000, GENE DEV, V14, P17; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Lee T, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000013; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Masui S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni043; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rossant J, 2008, CELL, V132, P527, DOI 10.1016/j.cell.2008.01.039; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; Smith KN, 2010, CELL STEM CELL, V7, P343, DOI 10.1016/j.stem.2010.06.023; Steiger D, 2008, NAT GENET, V40, P1084, DOI 10.1038/ng.178; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Varlakhanova NV, 2010, DIFFERENTIATION, V80, P9, DOI 10.1016/j.diff.2010.05.001; Wert M, 2001, ONCOGENE, V20, P3746, DOI 10.1038/sj.onc.1204466; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	37	51	52	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 8	2011	9	1					37	49		10.1016/j.stem.2011.04.020	http://dx.doi.org/10.1016/j.stem.2011.04.020			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	797VA	21726832	Bronze			2022-12-28	WOS:000293157000008
J	Lugert, S; Taylor, V				Lugert, Sebastian; Taylor, Verdon			Neural Stem Cells: Disposable, End-State Glia?	CELL STEM CELL			English	Editorial Material							ADULT; NEUROGENESIS; HIPPOCAMPUS; QUIESCENT	Neurogenesis in the brain diminishes with age. In this issue of Cell Stem C ell, Encinas et al. (2011) demonstrate that some hippocampal stem cells not only generate neurons, but also generate astrocytes in a mechanism that leads to extinction of the stem cell pool.	[Taylor, Verdon] Univ Sheffield, Dept Biomed Sci, Ctr Stem Cell Biol, Sheffield S10 2TN, S Yorkshire, England; [Lugert, Sebastian] Max Planck Inst Immunobiol, Dept Mol Embryol, D-79108 Freiburg, Germany	University of Sheffield; Max Planck Society	Taylor, V (corresponding author), Univ Sheffield, Dept Biomed Sci, Ctr Stem Cell Biol, Western Bank, Sheffield S10 2TN, S Yorkshire, England.	taylor@immunbio.mpg.de		Taylor, Verdon/0000-0003-3497-5976				Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Hattiangady B, 2008, NEUROBIOL AGING, V29, P129, DOI 10.1016/j.neurobiolaging.2006.09.015; Kempermann G, 2004, CURR OPIN NEUROBIOL, V14, P186, DOI 10.1016/j.conb.2004.03.001; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002	7	4	4	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAY 6	2011	8	5					464	465		10.1016/j.stem.2011.04.006	http://dx.doi.org/10.1016/j.stem.2011.04.006			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	768IN	21549320	Bronze			2022-12-28	WOS:000290927600004
J	Merlos-Suarez, A; Barriga, FM; Jung, P; Iglesias, M; Cespedes, MV; Rossell, D; Sevillano, M; Hernando-Momblona, X; da Silva-Diz, V; Munoz, P; Clevers, H; Sancho, E; Mangues, R; Batlle, E				Merlos-Suarez, Anna; Barriga, Francisco M.; Jung, Peter; Iglesias, Mar; Virtudes Cespedes, Maria; Rossell, David; Sevillano, Marta; Hernando-Momblona, Xavier; da Silva-Diz, Victoria; Munoz, Purificacion; Clevers, Hans; Sancho, Elena; Mangues, Ramon; Batlle, Eduard			The Intestinal Stem Cell Signature Identifies Colorectal Cancer Stem Cells and Predicts Disease Relapse	CELL STEM CELL			English	Article							COLON-CANCER; EMBRYONIC STEM; BETA-CATENIN; IN-VITRO; EXPRESSION; PROGRESSION; DIFFERENTIATION; TARGET; TUMORS; DEATH	A frequent complication in colorectal cancer (CRC) is regeneration of the tumor after therapy. Here, we report that a gene signature specific for adult intestinal stem cells (ISCs) predicts disease relapse in CRC patients. ISCs are marked by high expression of the EphB2 receptor, which becomes gradually silenced as cells differentiate. Using EphB2 and the ISC marker Lgr5, we have FACS-purified and profiled mouse ISCs, crypt proliferative progenitors, and late transient amplifying cells to define a gene program specific for normal ISCs. Furthermore, we discovered that ISC-specific genes identify a stem-like cell population positioned at the bottom of tumor structures reminiscent of crypts. EphB2 sorted ISC-like tumor cells display robust tumor-initiating capacity in immunodeficient mice as well as long-term self-renewal potential. Taken together, our data suggest that the ISC program defines a cancer stem cell niche within colorectal tumors and plays a central role in CRC relapse.	[Merlos-Suarez, Anna; Barriga, Francisco M.; Jung, Peter; Sevillano, Marta; Hernando-Momblona, Xavier; Sancho, Elena; Batlle, Eduard] IRB, Oncol Program, Barcelona 08028, Spain; [Rossell, David] IRB, Biostat Unit, Barcelona 08028, Spain; [Iglesias, Mar] Univ Autonoma Barcelona, Hosp Univ Mar, Dept Pathol, Barcelona 08003, Spain; [Virtudes Cespedes, Maria; Mangues, Ramon] MICINN, CIBER BBN, Inst Biomed Res IIB St Pau, Barcelona 08025, Spain; [Virtudes Cespedes, Maria; Mangues, Ramon] MICINN, CIBER BBN, Networking Res Ctr Bioengn Biomat & Nanomed, Barcelona 08025, Spain; [da Silva-Diz, Victoria; Munoz, Purificacion] Bellvitge Biomed Res Inst IDIBELL, Catalan Canc Epigenet & Biol Program PEBC, Barcelona 08907, Spain; [Clevers, Hans] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Batlle, Eduard] ICREA, Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; ICREA	Batlle, E (corresponding author), IRB, Oncol Program, Baldiri Reixac 10, Barcelona 08028, Spain.	eduard.batlle@irbbarcelona.org	Rossell, David/AAM-4292-2021; Sancho, Elena/ABH-4867-2020; Batlle, Eduard/K-8080-2014; Mangues, Ramon/J-6396-2014; Hernando-Momblona, Xavier/ABH-4881-2020	Rossell, David/0000-0002-7104-5789; Sancho, Elena/0000-0002-8182-513X; Batlle, Eduard/0000-0003-2422-0326; Mangues, Ramon/0000-0003-2661-9525; Hernando-Momblona, Xavier/0000-0003-0755-333X; Barriga, Francisco/0000-0002-0996-7707; SEVILLANO, MARTA/0000-0001-5761-0879	H.G. Palmer (Vali d'Hebron Hospital); ERC; MICINN [PS09/00965]; NanoCoMets (CIBER-BBN); ICREA Funding Source: Custom	H.G. Palmer (Vali d'Hebron Hospital); ERC(European Research Council (ERC)European Commission); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); NanoCoMets (CIBER-BBN); ICREA(ICREA)	We thank Genentech, Inc. for providing anti-EphB2 antibody Mab 2H9, Evarist Planet (IRB, Barcelona) for assistance with statistical methods, H.G. Palmer (Vali d'Hebron Hospital) for support, M. Trias (Hospital de la Santa Creu i Sant Pau) for tumor samples, A. Caton for assistance with bioinformatics, IRB Functional Genomics Facility (IRB) for technical assistance in microarray hybridization experiments, A. Rodolosse for help with ISHs, J. Comas and R. Alvarez (UB, Barcelona) for expert technical assistance with the FAGS, I. Joval for figure artwork, C. Nadal and X. Garcia (Clinic Hospital, Barcelona) for help with samples and discussions, and to all members of the Bathe Lab for support. A.M.-S. holds an AECC postdoctoral fellowship, and F.M.B. holds an IRB/La Caixa PhD fellowship. This work has been supported by grants to E.B. from ERC (FP7-EU) and MICINN (Plan Nacional I+D+i and Consolider programs) and by grants PS09/00965 (MICINN) and NanoCoMets (CIBER-BBN) to IR.M.	Anjomshoaa A, 2008, BRIT J CANCER, V99, P966, DOI 10.1038/sj.bjc.6604560; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Cortina C, 2007, NAT GENET, V39, P1376, DOI 10.1038/ng.2007.11; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Kemper K, 2010, CANCER RES, V70, P719, DOI 10.1158/0008-5472.CAN-09-1820; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Mao WG, 2004, CANCER RES, V64, P781, DOI 10.1158/0008-5472.CAN-03-1047; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Snippert HJ, 2009, GASTROENTEROLOGY, V136, P2187, DOI 10.1053/j.gastro.2009.03.002; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Zeilstra J, 2008, CANCER RES, V68, P3655, DOI 10.1158/0008-5472.CAN-07-2940	29	639	663	1	117	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 6	2011	8	5					511	524		10.1016/j.stem.2011.02.020	http://dx.doi.org/10.1016/j.stem.2011.02.020			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	768IN	21419747	Green Published, Bronze			2022-12-28	WOS:000290927600012
J	Panopoulos, AD; Ruiz, S; Belmonte, JCI				Panopoulos, Athanasia D.; Ruiz, Sergio; Izpisua Belmonte, Juan Carlos			iPSCs: Induced Back to Controversy	CELL STEM CELL			English	Editorial Material							PLURIPOTENT STEM-CELLS; COPY NUMBER	Several recent reports (Mayshar et al., 2010; Laurent et al., 2011; Lister et al., 2011; Gore et al., 2011; Hussein et al., 21)11) uncover genetic and epigenetic alterations in induced pluripotent stem cells, stimulating debate about their future. However, will these important findings really impact what we hope to gain?	[Panopoulos, Athanasia D.; Ruiz, Sergio; Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona, Barcelona 08003, Spain	Salk Institute; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines, La Jolla, CA 92037 USA.	belmonte@salk.edu	Ruiz, Sergio/G-1561-2016	Ruiz, Sergio/0000-0002-0177-6965; Panopoulos, Athanasia/0000-0002-9610-2604	NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Ng RK, 2005, P NATL ACAD SCI USA, V102, P1957, DOI 10.1073/pnas.0409813102; Strauss S, 2010, NAT BIOTECHNOL, V28, P989, DOI 10.1038/nbt1010-989; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024	10	44	44	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 8	2011	8	4					347	348		10.1016/j.stem.2011.03.003	http://dx.doi.org/10.1016/j.stem.2011.03.003			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	752QI	21474093	Bronze			2022-12-28	WOS:000289707100001
J	Yu, PZ; Pan, GJ; Yu, JY; Thomson, JA				Yu, Pengzhi; Pan, Guangjin; Yu, Junying; Thomson, James A.			FGF2 Sustains NANOG and Switches the Outcome of BMP4-Induced Human Embryonic Stem Cell Differentiation	CELL STEM CELL			English	Article							BONE MORPHOGENETIC PROTEIN-4; HUMAN ES CELLS; MOUSE EPIBLAST; MESODERM INDUCTION; BRACHYURY T; DUSP6 MKP3; PLURIPOTENCY; EXPRESSION; CLONING; FAMILY	Here, we show that as human embryonic stem cells (ESCs) exit the pluripotent state, NANOG can play a key role in determining lineage outcome. It has previously been reported that BMPs induce differentiation of human ESCs into extraembryonic lineages. Here, we find that FGF2, acting through the MEK-ERK pathway, switches BMP4-induced human ESC differentiation outcome to mesendoderm, characterized by the uniform expression of T (brachyury) and other primitive streak markers. We also find that MEK-ERK signaling prolongs NANOG expression during BMP-induced differentiation, that forced NANOG expression results in FGF-independent BMP4 induction of mesendoderm, and that knockdown of NANOG greatly reduces T induction. Together, our results demonstrate that FGF2 signaling switches the outcome of BMP4-induced differentiation of human ESCs by maintaining NANOG levels through the MEK-ERK pathway.	[Yu, Pengzhi; Pan, Guangjin; Thomson, James A.] Morgridge Inst Res, Madison, WI 53715 USA; [Yu, Pengzhi; Thomson, James A.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53707 USA; [Yu, Pengzhi] Univ Wisconsin, Grad Program Cellular & Mol Biol, Madison, WI 53706 USA; [Yu, Junying] Cellular Dynam Int Inc, Madison, WI 53707 USA; [Thomson, James A.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Santa Barbara	Thomson, JA (corresponding author), Morgridge Inst Res, Madison, WI 53715 USA.	jthomson@morgridgeinstitute.org	Yu, Pengzhi/I-3182-2016	Yu, Pengzhi/0000-0001-7637-404X	Charlotte Geyer Foundation; NIH [PO1 GM081629]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081629] Funding Source: NIH RePORTER	Charlotte Geyer Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Charlotte Geyer Foundation and NIH grant PO1 GM081629. We thank Zhonggang Hou for providing the doxycycline-inducible system vector; Shulan Tian and Ron Stewart for their bioinformatics support; Gudrun A. Jonsdottir for performing sample labeling and hybridization in microarray analysis; and Justin Brumbaugh, Deborah J. Faupel, and Krista Eastman for critical reading of the manuscript.	Arkell RS, 2008, CELL SIGNAL, V20, P836, DOI 10.1016/j.cellsig.2007.12.014; Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chesley P, 1935, J EXP ZOOL, V70, P429, DOI 10.1002/jez.1400700306; CUNLIFFE V, 1992, NATURE, V358, P427, DOI 10.1038/358427a0; Darr H, 2006, DEVELOPMENT, V133, P1193, DOI 10.1242/dev.02286; Dobrovolskaia-Zavadskaia N, 1927, CR SOC BIOL, V97, P114; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Greber B, 2008, STEM CELLS DEV, V17, P1065, DOI 10.1089/scd.2008.0035; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; Hyslop L, 2005, STEM CELLS, V23, P1035, DOI 10.1634/stemcells.2005-0080; Jones CM, 1996, DEVELOPMENT, V122, P1545; Kang HB, 2005, STEM CELLS DEV, V14, P395, DOI 10.1089/scd.2005.14.395; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Li CY, 2007, DEVELOPMENT, V134, P167, DOI 10.1242/dev.02701; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Maillet M, 2008, J BIOL CHEM, V283, P31246, DOI 10.1074/jbc.M806085200; Matsuura I, 2005, BIOCHEMISTRY-US, V44, P12546, DOI 10.1021/bi050560g; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Rodaway A, 1999, DEVELOPMENT, V126, P3067; Scholl FA, 2004, CANCER RES, V64, P6035, DOI 10.1158/0008-5472.CAN-04-0017; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Tanoue T, 1999, J BIOL CHEM, V274, P19949, DOI 10.1074/jbc.274.28.19949; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Theodosiou A, 1999, ONCOGENE, V18, P6981, DOI 10.1038/sj.onc.1203185; UMBHAUER M, 1995, NATURE, V376, P58, DOI 10.1038/376058a0; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; YANAGISAWA KO, 1981, DEV BIOL, V87, P242, DOI 10.1016/0012-1606(81)90147-0; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang PB, 2008, BLOOD, V111, P1933, DOI 10.1182/blood-2007-02-074120	44	175	184	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 4	2011	8	3					326	334		10.1016/j.stem.2011.01.001	http://dx.doi.org/10.1016/j.stem.2011.01.001			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	735HI	21362572	Bronze, Green Accepted			2022-12-28	WOS:000288404400014
J	Wakao, H; Yoshikiyo, K; Koshimizu, U; Furukawa, T; Enomoto, K; Matsunaga, T; Tanaka, T; Yasutomi, Y; Yamada, T; Minakami, H; Tanaka, J; Oda, A; Sasaki, T; Wakao, R; Lantz, O; Udagawa, T; Sekiya, Y; Higuchi, K; Harada, N; Nishimura, K; Ohtaka, M; Nakanishi, M; Fujita, H				Wakao, Hiroshi; Yoshikiyo, Kazunori; Koshimizu, Uichi; Furukawa, Tomoko; Enomoto, Kei; Matsunaga, Tomomi; Tanaka, Tomofumi; Yasutomi, Yusuke; Yamada, Takashi; Minakami, Hisanori; Tanaka, Jyunji; Oda, Atsushi; Sasaki, Tomoyuki; Wakao, Rika; Lantz, Olivier; Udagawa, Tadashi; Sekiya, Yukie; Higuchi, Kazue; Harada, Nobuyuki; Nishimura, Ken; Ohtaka, Manami; Nakanishi, Mahito; Fujita, Hiroyoshi			Expansion of Functional Human Mucosal-Associated Invariant T Cells via Reprogramming to Pluripotency and Redifferentiation	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; HUMAN PERIPHERAL-BLOOD; ANTIMICROBIAL ACTIVITY; IN-VITRO; INDUCTION; GENERATION; MR1; LYMPHOCYTES; GRANULYSIN; EXPRESSION	Mucosal-associated invariant T (MAIT) cells play an important physiological role in host pathogen defense and may also be involved in inflammatory disorders and multiple sclerosis. The rarity and inefficient expansion of these cells have hampered detailed analysis and application. Here, we report an induced pluripotent stem cell (iPSC)-based reprogramming approach for the expansion of functional MAIT cells. We found that human MAIT cells can be reprogrammed into iPSCs using a Sendai virus harboring standard reprogramming factors. Under T cell-permissive conditions, these iPSCs efficiently redifferentiate into MAIT-like lymphocytes expressing the T cell receptor V alpha 7.2, CD161, and interleukin-18 receptor chain alpha. Upon incubation with bacteria-fed monocytes, the derived MAIT cells show enhanced production of a broad range of cytokines. Following adoptive transfer into immunocompromised mice, these cells migrate to the bone marrow, liver, spleen, and intestine and protect against Mycobacterium abscessus. Our findings pave the way for further functional analysis of MAIT cells and determination of their therapeutic potential.	[Wakao, Hiroshi; Furukawa, Tomoko; Matsunaga, Tomomi; Oda, Atsushi; Sasaki, Tomoyuki; Fujita, Hiroyoshi] Hokkaido Univ, Sch Med, Dept Environm Biol, Sapporo, Hokkaido 0608638, Japan; [Yamada, Takashi; Minakami, Hisanori] Hokkaido Univ, Sch Med, Dept Obstet, Sapporo, Hokkaido 0608638, Japan; [Tanaka, Jyunji] Hokkaido Univ, Sch Med, Dept Hematol, Sapporo, Hokkaido 0608638, Japan; [Yoshikiyo, Kazunori; Koshimizu, Uichi; Enomoto, Kei; Tanaka, Tomofumi; Yasutomi, Yusuke] Asubio Pharma, Kobe, Hyogo 6500047, Japan; [Wakao, Rika] Pharmaceut & Med Devices Agcy, Secur Dept, Tokyo 1000013, Japan; [Lantz, Olivier] Inst Curie, Immunol Lab, F-75005 Paris, France; [Udagawa, Tadashi; Sekiya, Yukie; Higuchi, Kazue; Harada, Nobuyuki] Japan AntiTB Assoc, Res Inst TB, Dept Mycobacterium Reference & Res, Kiyose 2048533, Japan; [Nishimura, Ken] Univ Tsukuba, Sch Med, Lab Gene Regulat, Tsukuba, Ibaraki 3058575, Japan; [Ohtaka, Manami; Nakanishi, Mahito] Tsukuba Cent Res, Natl Inst Adv Ind Sci & Technol, Organ Dev Res Lab, Tsukuba, Ibaraki 3058562, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Asubio Pharma Co., Ltd.; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University of Tsukuba; National Institute of Advanced Industrial Science & Technology (AIST)	Wakao, H (corresponding author), Hokkaido Univ, Sch Med, Dept Environm Biol, Sapporo, Hokkaido 0608638, Japan.	hwakao@med.hokudai.ac.jp	Nishimura, KEN/HGC-6147-2022; Enomoto, Kei/GQP-7270-2022; Nakanishi, Mahito/I-9888-2018	Enomoto, Kei/0000-0001-6210-8699; Nakanishi, Mahito/0000-0002-7068-7587; Lantz, olivier/0000-0003-3161-7719	Adaptable and Seamless Technology Transfer Program through target-driven R&D (Japan Science and Technology Agency); Suzuken Memorial Foundation; Cooperative Research Program of the Institute for Frontier Medical Sciences, Kyoto University	Adaptable and Seamless Technology Transfer Program through target-driven R&D (Japan Science and Technology Agency); Suzuken Memorial Foundation; Cooperative Research Program of the Institute for Frontier Medical Sciences, Kyoto University	This work was supported in part by a Grant-in-Aid for Scientific Research (B) (KAKENHI; H.F. and H.W.), by a Grant-in-Aid for Scientific Research (C) (KAKENHI; H.W.), by a Grant-in-Aid for Challenging Exploratory Research (KAKENHI; H.F.), by the Adaptable and Seamless Technology Transfer Program through target-driven R&D (Japan Science and Technology Agency; H.W.), by a grant (A) (Hokkaido Translational Research; H.W.), and by the Suzuken Memorial Foundation (H.W.). The earliest phase of the work was supported in part by the Cooperative Research Program of the Institute for Frontier Medical Sciences, Kyoto University (H.W.). We thank the Hokkaido Cord Blood Bank for providing CB for RNA expression and Bio-Plex analysis. The experimental protocol on human subjects was approved by the Ethical Committee at the School of Medicine, Hokkaido University. All mouse experiments were approved by the Hokkaido University Animal Committee and by the Animal Committee of the Japan Anti-Tuberculosis Association (JATA). The entire work was performed in compliance with the Declaration of Helsinki.	Annibali V, 2011, BRAIN, V134, P542, DOI 10.1093/brain/awq354; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Billerbeck E, 2010, P NATL ACAD SCI USA, V107, P3006, DOI 10.1073/pnas.0914839107; Chua WJ, 2012, INFECT IMMUN, V80, P3256, DOI 10.1128/IAI.00279-12; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Freeman CM, 2007, AM J PATHOL, V171, P767, DOI 10.2353/ajpath.2007.061177; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Georgel P, 2011, MOL IMMUNOL, V48, P769, DOI 10.1016/j.molimm.2010.12.002; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; Huang SX, 2009, P NATL ACAD SCI USA, V106, P8290, DOI 10.1073/pnas.0903196106; Kiskinis E, 2010, J CLIN INVEST, V120, P51, DOI 10.1172/JCI40553; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Krensky AM, 2009, TISSUE ANTIGENS, V73, P193, DOI 10.1111/j.1399-0039.2008.01218.x; Kronenberg M, 2009, CURR OPIN IMMUNOL, V21, P391, DOI 10.1016/j.coi.2009.07.002; Le Bourhis L, 2011, TRENDS IMMUNOL, V32, P212, DOI 10.1016/j.it.2011.02.005; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Lengner CJ, 2010, ANN NY ACAD SCI, V1192, P38, DOI 10.1111/j.1749-6632.2009.05213.x; Liu ZW, 2009, J IMMUNOL, V183, P3616, DOI 10.4049/jimmunol.0804336; Loh YH, 2010, CELL STEM CELL, V7, P15, DOI 10.1016/j.stem.2010.06.004; Martin E, 2009, PLOS BIOL, V7, P525, DOI 10.1371/journal.pbio.1000054; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nishimura K, 2011, J BIOL CHEM, V286, P4760, DOI 10.1074/jbc.M110.183780; Nishimura T, 2013, CELL STEM CELL, V12, P114, DOI 10.1016/j.stem.2012.11.002; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Rottman M, 2007, INFECT IMMUN, V75, P5898, DOI 10.1128/IAI.00014-07; Sato T, 2005, J IMMUNOL, V174, P277, DOI 10.4049/jimmunol.174.1.277; Schmitt TM, 2004, NAT IMMUNOL, V5, P410, DOI 10.1038/ni1055; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Staerk J, 2010, CELL STEM CELL, V7, P20, DOI 10.1016/j.stem.2010.06.002; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Stenstad H, 2006, BLOOD, V107, P3447, DOI 10.1182/blood-2005-07-2860; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tilloy F, 1999, J EXP MED, V189, P1907, DOI 10.1084/jem.189.12.1907; Timmermans F, 2009, J IMMUNOL, V182, P6879, DOI 10.4049/jimmunol.0803670; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Vizcardo R, 2013, CELL STEM CELL, V12, P31, DOI 10.1016/j.stem.2012.12.006; Wakao H, 2008, FASEB J, V22, P2223, DOI 10.1096/fj.07-104687; Walker LJ, 2012, BLOOD, V119, P422, DOI 10.1182/blood-2011-05-353789; Zabel BA, 1999, J EXP MED, V190, P1241, DOI 10.1084/jem.190.9.1241	42	65	72	1	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 2	2013	12	5					546	558		10.1016/j.stem.2013.03.001	http://dx.doi.org/10.1016/j.stem.2013.03.001			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VE	23523177	Bronze			2022-12-28	WOS:000329569600011
J	Surani, MA				Surani, M. Azim			Cellular Reprogramming in Pursuit of Immortality	CELL STEM CELL			English	Editorial Material							MOUSE EMBRYOS; CELLS; LINE	The discovery that phenotypic diversity among differentiated cells results from epigenetic and not genetic differences, and can be reset to restore pluripotency, promises revolutionary advances in medicine. I discuss how this and related seminal discoveries have brought us to an exciting future.	[Surani, M. Azim] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Surani, M. Azim] Univ Cambridge, Wellcome Trust Med Res Council, Stem Cell Inst, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge	Surani, MA (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England.	a.surani@gurdon.cam.ac.uk		Surani, Azim/0000-0002-8640-4318	Wellcome Trust [079249] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622; HARRIS H, 1969, NATURE, V223, P363, DOI 10.1038/223363a0; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; STEPTOE PC, 1978, LANCET, V2, P366; STEVENS LC, 1954, P NATL ACAD SCI USA, V40, P1080, DOI 10.1073/pnas.40.11.1080; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145	10	8	9	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	DEC 7	2012	11	6					748	750		10.1016/j.stem.2012.11.014	http://dx.doi.org/10.1016/j.stem.2012.11.014			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	055MJ	23217420	Bronze			2022-12-28	WOS:000312420300007
J	Festuccia, N; Osorno, R; Halbritter, F; Karwacki-Neisius, V; Navarro, P; Colby, D; Wong, F; Yates, A; Tomlinson, SR; Chambers, I				Festuccia, Nicola; Osorno, Rodrigo; Halbritter, Florian; Karwacki-Neisius, Violetta; Navarro, Pablo; Colby, Douglas; Wong, Frederick; Yates, Adam; Tomlinson, Simon R.; Chambers, Ian			Esrrb Is a Direct Nanog Target Gene that Can Substitute for Nanog Function in Pluripotent Cells	CELL STEM CELL			English	Article							TRANSCRIPTIONAL REGULATORY CIRCUITRY; PROTEIN-INTERACTION NETWORK; STEM-CELLS; GROUND-STATE; SELF-RENEWAL; MOUSE EPIBLAST; SIGNALING PATHWAYS; OCT4; EXPRESSION; HETEROGENEITY	Embryonic stem cell (ESC) self-renewal efficiency is determined by the level of Nanog expression. However, the mechanisms by which Nanog functions remain unclear, and in particular, direct Nanog target genes are uncharacterized. Here we investigate ESCs expressing different Nanog levels and Nanog(-/-) cells with distinct functionally inducible Nanog proteins to identify Nanog-responsive genes. Surprisingly, these constitute a minor fraction of genes that Nanog binds. Prominent among Nanog-reponsive genes is Estrogen-related receptor b (Esrrb). Nanog binds directly to Esrrb, enhances binding of RNAPoIII, and stimulates Esrrb transcription. Overexpression of Esrrb in ESCs maintains cytokine-independent self-renewal and pluripotency. Remarkably, this activity is retained in Nanog(-/-) ESCs. Moreover, Esrrb can reprogram Nanog(-/-) EpiSCs and can rescue stalled reprogramming in Nanog(-/-) pre-iPSCs. Finally, Esrrb deletion abolishes the defining ability of Nanog to confer LIE-independent ESC selfrenewal. These findings are consistent with the functional placement of Esrrb downstream of Nanog.	[Festuccia, Nicola; Osorno, Rodrigo; Halbritter, Florian; Karwacki-Neisius, Violetta; Navarro, Pablo; Colby, Douglas; Wong, Frederick; Yates, Adam; Tomlinson, Simon R.; Chambers, Ian] Univ Edinburgh, MRC Ctr Regenerat Med, Inst Stem Cell Res, Sch Biol Sci, Edinburgh EH16 4UU, Midlothian, Scotland	University of Edinburgh	Chambers, I (corresponding author), Univ Edinburgh, MRC Ctr Regenerat Med, Inst Stem Cell Res, Sch Biol Sci, 5 Little France Dr, Edinburgh EH16 4UU, Midlothian, Scotland.	ichambers@ed.ac.uk	Halbritter, Florian/AAI-1000-2019; Halbritter, Florian/K-1746-2013	Halbritter, Florian/0000-0003-2452-4784; Halbritter, Florian/0000-0003-2452-4784; Chambers, Ian/0000-0003-2605-1597	Medical Research Council of the UK; Wellcome Trust; Human Frontier Sciences Program; EU FP7 program "EuroSyStem"; Conacyt studentship; MRC [G0901533] Funding Source: UKRI; Medical Research Council [G0901533, G0700711B] Funding Source: researchfish	Medical Research Council of the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Human Frontier Sciences Program(Human Frontier Science Program); EU FP7 program "EuroSyStem"(European Commission); Conacyt studentship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Jeremy Nathans for kindly sharing his Esrrb targeting vectors; Joe Mee, Lynsey Robertson, Sally Inverarity, Carolyn Manson, and animal house staff for embryo manipulation and animal husbandry; and Val Wilson and Sally Lowell for comments on the manuscript. This research was funded by the Medical Research Council of the UK, The Wellcome Trust, Human Frontier Sciences Program, the EU FP7 program "EuroSyStem," and a Conacyt studentship (R.O.). The authors declare no conflict of interests.	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chen J, 2007, DEV CELL, V13, P325, DOI 10.1016/j.devcel.2007.07.011; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Guo G, 2010, DEVELOPMENT, V137, P3185, DOI 10.1242/dev.052753; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Halbritter F, 2012, NAT METHODS, V9, P7, DOI 10.1038/nmeth.1809; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Han DW, 2010, CELL, V143, P617, DOI 10.1016/j.cell.2010.10.015; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Oliveri P, 2008, P NATL ACAD SCI USA, V105, P5955, DOI 10.1073/pnas.0711220105; Osorno R, 2012, DEVELOPMENT, V139, P2288, DOI 10.1242/dev.078071; Osorno R, 2011, PHILOS T R SOC B, V366, P2230, DOI 10.1098/rstb.2011.0043; Ptashne M, 2001, ESSAYS BIOCHEM, V37, P1; Robson P, 2001, DEV BIOL, V234, P317, DOI 10.1006/dbio.2001.0274; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Smith AG., 1991, J TISSUE CULT METHOD, V13, P89, DOI [10.1007/BF01666137, DOI 10.1007/BF01666137, 10.1007/bf01666137]; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Theunissen TW, 2011, CURR BIOL, V21, P65, DOI 10.1016/j.cub.2010.11.074; van den Berg DLC, 2008, MOL CELL BIOL, V28, P5986, DOI 10.1128/MCB.00301-08; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Vernallis AB, 1997, J BIOL CHEM, V272, P26947, DOI 10.1074/jbc.272.43.26947; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Yang JA, 2010, CELL STEM CELL, V7, P319, DOI 10.1016/j.stem.2010.06.022; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhang XF, 2008, J BIOL CHEM, V283, P35825, DOI 10.1074/jbc.M803481200	48	232	239	2	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 5	2012	11	4					477	490		10.1016/j.stem.2012.08.002	http://dx.doi.org/10.1016/j.stem.2012.08.002			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	021OZ	23040477	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000309896500009
J	Finkel, T				Finkel, Toren			Relief with Rapamycin: mTOR Inhibition Protects against Radiation-Induced Mucositis	CELL STEM CELL			English	Editorial Material							HEMATOPOIETIC STEM-CELLS	In this issue of Cell Stem Cell, Iglesias-Bartolome et al. (2012) show that mTOR inhibition with rapamycin protects against mucositis in mice, suggesting potential treatment strategies against this harmful side effect of anticancer therapies. In normal tissues, rapamycin prevents epithelial stem cell senescence by reducing oxidative stress through increased MnSOD.	NHLBI, Ctr Mol Med, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Finkel, T (corresponding author), NHLBI, Ctr Mol Med, NIH, Bldg 10, Bethesda, MD 20892 USA.	finkelt@nih.gov			Intramural NIH HHS [Z01 HL005012-12] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005012, Z01HL005012] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Hahn T, 2010, BIOL BLOOD MARROW TR, V16, P801, DOI 10.1016/j.bbmt.2010.01.001; Iglesias-Bartolome R, 2012, CELL STEM CELL, V11, P401, DOI 10.1016/j.stem.2012.06.007; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Sonis ST, 2011, ANTI-CANCER DRUG, V22, P607, DOI 10.1097/CAD.0b013e3283462086	8	6	8	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	SEP 7	2012	11	3					287	288		10.1016/j.stem.2012.08.003	http://dx.doi.org/10.1016/j.stem.2012.08.003			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	018DW	22958927	Green Accepted, Bronze			2022-12-28	WOS:000309641300004
J	Taylor, CJ; Peacock, S; Chaudhry, AN; Bradley, JA; Bolton, EM				Taylor, Craig J.; Peacock, Sarah; Chaudhry, Afzal N.; Bradley, J. Andrew; Bolton, Eleanor M.			Generating an iPSC Bank for HLA-Matched Tissue Transplantation Based on Known Donor and Recipient HLA Types	CELL STEM CELL			English	Editorial Material							NON-HODGKIN-LYMPHOMA; KIDNEY-TRANSPLANTATION; STEM-CELLS	The likelihood for immunological rejection of Human Leukocyte Antigens (HLA)-mismatched induced pluripotent stem cells (iPSCs) limits their therapeutic potential. Here we show how a tissue bank from 150 selected homozygous HLA-typed volunteers could match 93% of the UK population with a minimal requirement for immunosuppression. Our model provides a practical approach for using existing HLA-typed samples to generate an iPSC stem cell bank that circumvents prospective typing of a large number of individuals.	[Taylor, Craig J.; Peacock, Sarah] Univ Cambridge, Addenbrookes Hosp, Cambridge Univ Teaching Hosp NHS Fdn Trust, Histocompatibil & Immunogenet Lab, Cambridge CB2 0QQ, England; [Chaudhry, Afzal N.] Univ Cambridge, Addenbrookes Hosp, Cambridge Univ Teaching Hosp NHS Fdn Trust, Dept Renal Med, Cambridge CB2 0QQ, England; [Bradley, J. Andrew; Bolton, Eleanor M.] Univ Cambridge, Addenbrookes Hosp, Cambridge Univ Teaching Hosp NHS Fdn Trust, Dept Surg, Cambridge CB2 0QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Taylor, CJ (corresponding author), Univ Cambridge, Addenbrookes Hosp, Cambridge Univ Teaching Hosp NHS Fdn Trust, Histocompatibil & Immunogenet Lab, Hills Rd, Cambridge CB2 0QQ, England.	craig.taylor@addenbrookes.nhs.uk		Bolton, Eleanor/0000-0002-7253-6045				Bradley JA, 2002, NAT REV IMMUNOL, V2, P859, DOI 10.1038/nri934; Eisenstein M, 2010, NAT METHODS, V7, P81, DOI 10.1038/nmeth0110-81; Gourraud PA, 2012, STEM CELLS, V30, P180, DOI 10.1002/stem.772; Johnson RJ, 2010, TRANSPLANTATION, V89, P379, DOI 10.1097/TP.0b013e3181c90287; Kurtzberg J, 2008, BLOOD, V112, P4318, DOI 10.1182/blood-2007-06-098020; Lin G, 2009, CELL STEM CELL, V5, P461, DOI 10.1016/j.stem.2009.10.009; Marsh SGE, 2010, TISSUE ANTIGENS, V75, P291, DOI 10.1111/j.1399-0039.2010.01466.x; Nakatsuji N, 2008, NAT BIOTECHNOL, V26, P739, DOI 10.1038/nbt0708-739; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Opelz G, 2007, TRANSPLANTATION, V84, P137, DOI 10.1097/01.tp.0000269725.74189.b9; Opelz G, 2010, TRANSPLANTATION, V90, P292, DOI 10.1097/TP.0b013e3181e46a22; Opelz G, 2010, TRANSPLANTATION, V89, P567, DOI 10.1097/TP.0b013e3181c69855; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Suarez-Alvarez B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010192; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Taylor C J, 1993, Clin Transpl, P233; Taylor CJ, 2005, LANCET, V366, P2019, DOI 10.1016/S0140-6736(05)67813-0; Taylor CJ, 2011, PHILOS T R SOC B, V366, P2312, DOI 10.1098/rstb.2011.0030; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	19	259	265	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 3	2012	11	2					147	152		10.1016/j.stem.2012.07.014	http://dx.doi.org/10.1016/j.stem.2012.07.014			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	987QQ	22862941	Bronze			2022-12-28	WOS:000307432600006
J	Wutz, A				Wutz, Anton			Epigenetic Alterations in Human Pluripotent Stem Cells: A Tale of Two Cultures	CELL STEM CELL			English	Review							X-CHROMOSOME INACTIVATION; EPIBLAST; STATE; FIBROBLASTS; DERIVATION; FGF	Human somatic cells can be reprogrammed into induced pluripotent stem cells (hiPSCs) with wide lineage differentiation potential in culture. However, reprogramming and long-term culture can also induce abnormalities in these pluripotent cells.. This minireview discusses recent studies that have identified changes in imprinted gene expression and erosion of X chromosome inactivation in female hiPSCs and how understanding the sources and consequences of epigenetic variability in hiPSCs will impact disease modeling and clinical application in the future.	Univ Cambridge, Stem Cell Inst, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QR, England	University of Cambridge	Wutz, A (corresponding author), Univ Cambridge, Stem Cell Inst, Wellcome Trust Ctr Stem Cell Res, Tennis Court Rd, Cambridge CB2 1QR, England.	aw512@cam.ac.uk			Wellcome Trust [087530/Z/08/A]; Medical Research Council [G0800784B, G0800784] Funding Source: researchfish; MRC [G0800784] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Wellcome Trust Senior Research Fellowship (grant reference 087530/Z/08/A).	Augui S, 2011, NAT REV GENET, V12, P429, DOI 10.1038/nrg2987; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Cheng LZ, 2012, CELL STEM CELL, V10, P337, DOI 10.1016/j.stem.2012.01.005; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Ferguson-Smith AC, 2011, NAT REV GENET, V12, P565, DOI 10.1038/nrg3032; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Han DW, 2011, NAT CELL BIOL, V13, P66, DOI 10.1038/ncb2136; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hough SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007708; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Koch P, 2011, NATURE, V480, P543, DOI 10.1038/nature10671; Kuijk EW, 2012, DEVELOPMENT, V139, P871, DOI 10.1242/dev.071688; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Mekhoubad S, 2012, CELL STEM CELL, V10, P595, DOI 10.1016/j.stem.2012.02.014; Nazor KL, 2012, CELL STEM CELL, V10, P620, DOI 10.1016/j.stem.2012.02.013; Newman AM, 2010, CELL STEM CELL, V7, P258, DOI 10.1016/j.stem.2010.06.016; Niakan KK, 2012, DEVELOPMENT, V139, P829, DOI 10.1242/dev.060426; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Nishino K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002085; Okamoto I, 2011, NATURE, V472, P370, DOI 10.1038/nature09872; Panopoulos AD, 2011, CELL STEM CELL, V8, P347, DOI 10.1016/j.stem.2011.03.003; Pera MF, 2010, NATURE, V465, P713, DOI 10.1038/nature09228; Pick M, 2009, STEM CELLS, V27, P2686, DOI 10.1002/stem.205; Pomp O, 2011, CELL STEM CELL, V9, P156, DOI 10.1016/j.stem.2011.06.004; Roode M, 2012, DEV BIOL, V361, P358, DOI 10.1016/j.ydbio.2011.10.030; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Sommer CA, 2010, STEM CELLS, V28, P64, DOI 10.1002/stem.255; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tchieu J, 2010, CELL STEM CELL, V7, P329, DOI 10.1016/j.stem.2010.06.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; van den Berg IM, 2009, AM J HUM GENET, V84, P771, DOI 10.1016/j.ajhg.2009.05.003; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Wang WJ, 2011, APPL CATAL B-ENVIRON, V108, P108, DOI 10.1016/j.apcatb.2011.08.015; Ware CB, 2009, CELL STEM CELL, V4, P359, DOI 10.1016/j.stem.2009.03.001; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou HY, 2010, J BIOL CHEM, V285, P29676, DOI 10.1074/jbc.C110.150599	42	22	23	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 6	2012	11	1					9	15		10.1016/j.stem.2012.06.012	http://dx.doi.org/10.1016/j.stem.2012.06.012			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	975SS	22770238	Bronze			2022-12-28	WOS:000306532400005
J	Daley, GQ				Daley, George Q.			The Promise and Perils of Stem Cell Therapeutics	CELL STEM CELL			English	Review							UMBILICAL-CORD BLOOD; PANCREATIC BETA-CELLS; PARKINSONS-DISEASE; SPINAL-CORD; BONE-MARROW; DOPAMINE NEURONS; IN-VIVO; ISLET TRANSPLANTATION; CLINICAL-TRIALS; HUMAN ES	Stem cells are the seeds of tissue repair and regeneration and a promising source for novel therapies. However, apart from hematopoietic stem cell (HSC) transplantation, essentially all other stem cell treatments remain experimental. High hopes have inspired numerous clinical trials, but it has been difficult to obtain unequivocal evidence for robust clinical benefit. In recent years, unproven therapies have been widely practiced outside the standard clinical trial network, threatening the cause of legitimate clinical investigation. Numerous challenges and technical barriers must be overcome before novel stem cell therapies can achieve meaningful clinical impact.	[Daley, George Q.] Childrens Hosp Boston, Howard Hughes Med Inst, Stem Cell Transplantat Program, Div Pediat Hematol Oncol,Manton Ctr Orphan Dis Re, Boston, MA 02115 USA; [Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Daley, George Q.] Broad Inst, Cambridge, MA 02142 USA; [Daley, George Q.] Harvard Stem Cell Inst, Boston, MA 02138 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Daley, GQ (corresponding author), Childrens Hosp Boston, Howard Hughes Med Inst, Stem Cell Transplantat Program, Div Pediat Hematol Oncol,Manton Ctr Orphan Dis Re, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu			NIH [R24DK092760, UO1-HL100001, RC4-DK090913, P50HG005550]; ARRA [RC2-HL102815]; Roche Foundation for Anemia Research; Alex's Lemonade Stand; Ellison Medical Foundation; Doris Duke Medical Foundation; Harvard Stem Cell Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102815, U01HL100001] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG005550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC4DK090913, R24DK092760] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roche Foundation for Anemia Research; Alex's Lemonade Stand; Ellison Medical Foundation(Lawrence Ellison Foundation); Doris Duke Medical Foundation(Doris Duke Charitable Foundation (DDCF)); Harvard Stem Cell Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	G.Q.D. is supported by grants from the NIH (R24DK092760, UO1-HL100001, RC4-DK090913, P50HG005550, and special funds from the ARRA stimulus package- RC2-HL102815), the Roche Foundation for Anemia Research, Alex's Lemonade Stand, Ellison Medical Foundation, Doris Duke Medical Foundation, and the Harvard Stem Cell Institute. G.Q.D. is an affiliate member of the Broad Institute and an investigator of the Howard Hughes Medical Institute and the Manton Center for Orphan Disease Research. Disclosure: GOD is a member of the scientific advisory board and receives consulting fees and holds equity in the following companies that work with stem cells: Johnson & Johnson, Verastem, iPierian, and MPM Capital.	Aboushwareb T, 2008, NAT CLIN PRACT UROL, V5, P621, DOI 10.1038/ncpuro1228; Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; Atala A, 2011, BRIT MED BULL, V97, P81, DOI 10.1093/bmb/ldr003; Baker M, 2011, NATURE, V479, P459, DOI 10.1038/479459a; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Benraiss A, 2011, NEUROTHERAPEUTICS, V8, P577, DOI 10.1007/s13311-011-0075-8; Bonner-Weir S, 2005, NAT BIOTECHNOL, V23, P857, DOI 10.1038/nbt1115; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Cheng X, 2012, CELL STEM CELL, V10, P371, DOI 10.1016/j.stem.2012.02.024; Choi YH, 2011, HUM GENE THER, V22, P3, DOI 10.1089/hum.2010.211; Copeland N, 2009, CLIN MED, V9, P342, DOI 10.7861/clinmedicine.9-4-342; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Daley GQ, 2008, CELL, V132, P544, DOI 10.1016/j.cell.2008.02.009; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Dor Y, 2008, CELL, V132, P183, DOI 10.1016/j.cell.2008.01.004; Fasano CA, 2010, CELL STEM CELL, V6, P336, DOI 10.1016/j.stem.2010.03.001; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; FREED CR, 1992, NEW ENGL J MED, V327, P1549, DOI 10.1056/NEJM199211263272202; Gallina P, 2010, EXP NEUROL, V222, P30, DOI 10.1016/j.expneurol.2009.12.005; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Gourraud PA, 2012, STEM CELLS, V30, P180, DOI 10.1002/stem.772; Griffin M, 2011, J BONE JOINT SURG BR, V93B, P427, DOI 10.1302/0301-620X.93B4.25249; Grskovic M, 2011, NAT REV DRUG DISCOV, V10, P915, DOI 10.1038/nrd3577; Hargus G, 2010, P NATL ACAD SCI USA, V107, P15921, DOI 10.1073/pnas.1010209107; Harris DT, 2009, BRIT J HAEMATOL, V147, P177, DOI 10.1111/j.1365-2141.2009.07767.x; Hjelmgren J, 2006, PARKINSONISM RELAT D, V12, P443, DOI 10.1016/j.parkreldis.2006.04.006; Hyun I, 2008, CELL STEM CELL, V3, P607, DOI 10.1016/j.stem.2008.11.009; JACOBSON LO, 1951, SCIENCE, V113, P510, DOI 10.1126/science.113.2940.510; Kebriaei P, 2011, CYTOTHERAPY, V13, P262, DOI 10.3109/14653249.2010.549688; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kode JA, 2009, CYTOTHERAPY, V11, P377, DOI 10.1080/14653240903080367; Kogler G, 2004, J EXP MED, V200, P123, DOI 10.1084/jem.20040440; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lau D, 2008, CELL STEM CELL, V3, P591, DOI 10.1016/j.stem.2008.11.001; Ledford H, 2011, NATURE, V477, P526, DOI 10.1038/477526a; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; LINDVALL O, 1994, ANN NEUROL, V35, P172, DOI 10.1002/ana.410350208; Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543; Liu S, 2000, P NATL ACAD SCI USA, V97, P6126, DOI 10.1073/pnas.97.11.6126; LORENZ E, 1951, J NATL CANCER I, V12, P197; Ma YL, 2010, J NUCL MED, V51, P7, DOI 10.2967/jnumed.109.066811; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; McDonald JW, 2006, J NEUROTRAUM, V23, P345, DOI 10.1089/neu.2006.23.345; McDonald JW, 2002, PROG BRAIN RES, V137, P299; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; McKenna D, 2011, INDIAN J MED RES, V134, P261; Menasche P, 2011, J MOL CELL CARDIOL, V50, P258, DOI 10.1016/j.yjmcc.2010.06.010; Nakajima F, 2007, STEM CELLS, V25, P983, DOI 10.1634/stemcells.2006-0566; Nakamura T, 2001, ANN NEUROL, V50, P181, DOI 10.1002/ana.1075; Nicoleau C, 2011, NEUROTHERAPEUTICS, V8, P562, DOI 10.1007/s13311-011-0079-4; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Peck M, 2012, CELLS TISSUES ORGANS, V195, P144, DOI 10.1159/000331406; Pelosi E, 2012, BLOOD CELL MOL DIS, V49, P20, DOI 10.1016/j.bcmd.2012.02.007; Piccini P, 2005, BRAIN, V128, P2977, DOI 10.1093/brain/awh649; Piccini P, 1999, NAT NEUROSCI, V2, P1137, DOI 10.1038/16060; Piccini P, 2000, ANN NEUROL, V48, P689, DOI 10.1002/1531-8249(200011)48:5<689::AID-ANA1>3.0.CO;2-N; Prasad VK, 2009, BONE MARROW TRANSPL, V44, P643, DOI 10.1038/bmt.2009.290; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Rocha V, 2004, NEW ENGL J MED, V351, P2276, DOI 10.1056/NEJMoa041469; Sanchez-Pernaute R, 2008, BRAIN, V131, P2127, DOI 10.1093/brain/awn144; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Shi M, 2011, CLIN EXP IMMUNOL, V164, P1, DOI 10.1111/j.1365-2249.2011.04327.x; Sun Hengyun, 2011, Front Med, V5, P61, DOI 10.1007/s11684-011-0122-1; Tabar V, 2008, NAT MED, V14, P379, DOI 10.1038/nm1732; Taylor CJ, 2005, LANCET, V366, P2019, DOI 10.1016/S0140-6736(05)67813-0; Taylor CJ, 2011, PHILOS T R SOC B, V366, P2312, DOI 10.1098/rstb.2011.0030; Thomas ED, 2005, INT J HEMATOL, V81, P89, DOI 10.1532/IJH97.04197; THOMAS ED, 1957, NEW ENGL J MED, V257, P491, DOI 10.1056/NEJM195709122571102; Tian H, 2010, TISSUE ENG PT A, V16, P1769, DOI [10.1089/ten.tea.2009.0625, 10.1089/ten.TEA.2009.0625]; Tobita M, 2011, DISCOV MED, V11, P160; Tongers J, 2011, EUR HEART J, V32, P1197, DOI 10.1093/eurheartj/ehr018; Trounson A, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-52; Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202; Tsubota K, 1999, NEW ENGL J MED, V340, P1697, DOI 10.1056/NEJM199906033402201; Vierbuchen T, 2011, NAT BIOTECHNOL, V29, P892, DOI 10.1038/nbt.1946; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Williams AR, 2011, CIRC RES, V108, P792, DOI 10.1161/CIRCRESAHA.111.242610; Wilson JM, 2009, SCIENCE, V324, P727, DOI 10.1126/science.1174935; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	85	182	184	1	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 14	2012	10	6					740	749		10.1016/j.stem.2012.05.010	http://dx.doi.org/10.1016/j.stem.2012.05.010			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	965LD	22704514	Green Accepted, Bronze			2022-12-28	WOS:000305768400020
J	Visvader, JE; Lindeman, GJ				Visvader, Jane E.; Lindeman, Geoffrey J.			Cancer Stem Cells: Current Status and Evolving Complexities	CELL STEM CELL			English	Review							TUMOR-INITIATING CELLS; ACUTE MYELOID-LEUKEMIA; HUMAN COLORECTAL-CANCER; MAINTAINS SELF-RENEWAL; PANCREATIC-CANCER; MELANOMA-CELLS; HUMAN BREAST; PHENOTYPIC HETEROGENEITY; PROPAGATING CELLS; VASCULAR NICHE	The cancer stem cell (CSC) model has been established as a cellular mechanism that contributes to phenotypic and functional heterogeneity in diverse cancer types. Recent observations, however, have highlighted many complexities and challenges: the CSC phenotype can vary substantially between patients, tumors may harbor multiple phenotypically or genetically distinct CSCs, metastatic CSCs can evolve from primary CSCs, and tumor cells may undergo reversible phenotypic changes. Although the CSC concept will have clinical relevance in specific cases, accumulating evidence suggests that it will be imperative to target all CSC subsets within the tumor to prevent relapse.	[Visvader, Jane E.; Lindeman, Geoffrey J.] Walter & Eliza Hall Inst Med Res, VBCRC Lab, Melbourne, Vic 3052, Australia; [Visvader, Jane E.; Lindeman, Geoffrey J.] Univ Melbourne, Parkville, Vic 3050, Australia; [Lindeman, Geoffrey J.] Royal Melbourne Hosp, Dept Med Oncol, Parkville, Vic 3050, Australia	University of Melbourne; Royal Melbourne Hospital	Visvader, JE (corresponding author), Walter & Eliza Hall Inst Med Res, VBCRC Lab, Melbourne, Vic 3052, Australia.	visvader@wehi.edu.au		Lindeman, Geoffrey/0000-0001-9386-2416	Australian National Health and Medical Research Council (NHMRC); Victorian State Government through Victorian Cancer Agency of the Victorian Breast Cancer Research Consortium; OIS; NHMRC IRIISS	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government through Victorian Cancer Agency of the Victorian Breast Cancer Research Consortium; OIS; NHMRC IRIISS(National Health and Medical Research Council (NHMRC) of Australia)	We apologize to those authors whose papers could not be cited due to space constraints. We thank P. Maltezos for expert help with the figures. This work was supported by the Australian National Health and Medical Research Council (NHMRC), NHMRC IRIISS, and the Victorian State Government through Victorian Cancer Agency funding of the Victorian Breast Cancer Research Consortium and OIS.	Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Barroca V, 2009, NAT CELL BIOL, V11, P190, DOI 10.1038/ncb1826; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Chao MP, 2011, CANCER RES, V71, P1374, DOI 10.1158/0008-5472.CAN-10-2238; Charles N, 2010, CELL STEM CELL, V6, P141, DOI 10.1016/j.stem.2010.01.001; Chen RH, 2010, CANCER CELL, V17, P362, DOI 10.1016/j.ccr.2009.12.049; Cheng L, 2011, EMBO J, V30, P800, DOI 10.1038/emboj.2011.10; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Civenni G, 2011, CANCER RES, V71, P3098, DOI 10.1158/0008-5472.CAN-10-3997; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Curley MD, 2009, STEM CELLS, V27, P2875, DOI 10.1002/stem.236; Curtis SJ, 2010, CELL STEM CELL, V7, P127, DOI 10.1016/j.stem.2010.05.021; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dierks C, 2008, CANCER CELL, V14, P238, DOI 10.1016/j.ccr.2008.08.003; Dieter SM, 2011, CELL STEM CELL, V9, P357, DOI 10.1016/j.stem.2011.08.010; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Eyler CE, 2011, CELL, V146, P53, DOI 10.1016/j.cell.2011.06.006; Gentles AJ, 2010, JAMA-J AM MED ASSOC, V304, P2706, DOI 10.1001/jama.2010.1862; Gibbs KD, 2012, CELL STEM CELL, V10, P210, DOI 10.1016/j.stem.2012.01.004; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Guryanova OA, 2011, CANCER CELL, V19, P498, DOI 10.1016/j.ccr.2011.03.004; Hambardzumyan D, 2008, GENE DEV, V22, P436, DOI 10.1101/gad.1627008; Harrison H, 2010, CANCER RES, V70, P709, DOI 10.1158/0008-5472.CAN-09-1681; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Heuser M, 2009, BLOOD, V114, P3983, DOI 10.1182/blood-2009-06-227603; Hjelmeland AB, 2011, CELL DEATH DIFFER, V18, P829, DOI 10.1038/cdd.2010.150; Hoey T, 2009, CELL STEM CELL, V5, P168, DOI 10.1016/j.stem.2009.05.019; Ishizawa K, 2010, CELL STEM CELL, V7, P279, DOI 10.1016/j.stem.2010.08.009; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Jin LQ, 2009, CELL STEM CELL, V5, P31, DOI 10.1016/j.stem.2009.04.018; Kikushige Y, 2010, CELL STEM CELL, V7, P708, DOI 10.1016/j.stem.2010.11.014; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lathia JD, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.80; Lathia JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024807; Lathia JD, 2010, CELL STEM CELL, V6, P421, DOI 10.1016/j.stem.2010.02.018; Li C., 2011, GASTROENTEROLOGY, V141, pe5; Li CW, 2011, GASTROENTEROLOGY, V141, P2218, DOI 10.1053/j.gastro.2011.08.009; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Liu HP, 2010, P NATL ACAD SCI USA, V107, P18115, DOI 10.1073/pnas.1006732107; Lonardo E, 2011, CELL STEM CELL, V9, P433, DOI 10.1016/j.stem.2011.10.001; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McDermott SP, 2012, BLOOD, V119, P1200, DOI 10.1182/blood-2011-01-330019; Merchant AA, 2010, CLIN CANCER RES, V16, P3130, DOI 10.1158/1078-0432.CCR-09-2846; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Meyer M.J., 2010, CANCER RES, V70, P4624; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Read TA, 2009, CANCER CELL, V15, P135, DOI 10.1016/j.ccr.2008.12.016; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Saito Y, 2010, NAT BIOTECHNOL, V28, P275, DOI 10.1038/nbt.1607; Sarry JE, 2011, J CLIN INVEST, V121, P384, DOI 10.1172/JCI41495; Schober M, 2011, P NATL ACAD SCI USA, V108, P10544, DOI 10.1073/pnas.1107807108; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shats I, 2011, CANCER RES, V71, P1772, DOI 10.1158/0008-5472.CAN-10-1735; Silva IA, 2011, CANCER RES, V71, P3991, DOI 10.1158/0008-5472.CAN-10-3175; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Stewart JM, 2011, P NATL ACAD SCI USA, V108, P6468, DOI 10.1073/pnas.1005529108; Taussig DC, 2008, BLOOD, V112, P568, DOI 10.1182/blood-2007-10-118331; Tehranchi R, 2010, NEW ENGL J MED, V363, P1025, DOI 10.1056/NEJMoa0912228; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang CYY, 2012, CANCER RES, V72, P1013, DOI 10.1158/0008-5472.CAN-11-2531; Wang JL, 2010, STEM CELLS, V28, P17, DOI 10.1002/stem.261; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624; Ward RJ, 2009, CANCER RES, V69, P4682, DOI 10.1158/0008-5472.CAN-09-0342; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhang M, 2010, P NATL ACAD SCI USA, V107, P3522, DOI 10.1073/pnas.0910179107; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737	101	935	970	3	163	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 14	2012	10	6					717	728		10.1016/j.stem.2012.05.007	http://dx.doi.org/10.1016/j.stem.2012.05.007			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	965LD	22704512	Bronze			2022-12-28	WOS:000305768400018
J	Yamanaka, S				Yamanaka, Shinya			Induced Pluripotent Stem Cells: Past, Present, and Future	CELL STEM CELL			English	Review							FAMILIAL ALZHEIMERS-DISEASE; GENE-EXPRESSION; SOMATIC-CELLS; DIRECT CONVERSION; HUMAN FIBROBLASTS; IPS CELLS; HUMAN ES; MOUSE; GENERATION; DIFFERENTIATION	The development of iPSCs reflected the merging of three major scientific streams and has in turn led to additional new branches of investigation. However, there is still debate about whether iPSCs are functionally equivalent to ESCs. This question should be answered only by science, not by politics or business.	[Yamanaka, Shinya] Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto 6068507, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA	Kyoto University; University of California System; University of California San Francisco; The J David Gladstone Institutes	Yamanaka, S (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto 6068507, Japan.	yamanaka@cira.kyoto-u.ac.jp						Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Apostolou E, 2011, NATURE, V474, P165, DOI 10.1038/474165a; Ben-Nun IF, 2011, NAT METHODS, V8, P829, DOI [10.1038/NMETH.1706, 10.1038/nmeth.1706]; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Cheng LZ, 2012, CELL STEM CELL, V10, P337, DOI 10.1016/j.stem.2012.01.005; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Devine MJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1453; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Dolgin E, 2011, NATURE, V470, P13, DOI 10.1038/470013a; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hayden EC, 2011, NATURE, V473, P272, DOI 10.1038/473272a; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim J, 2011, STEM CELLS, V29, P992, DOI 10.1002/stem.641; Kim K, 2011, NAT BIOTECHNOL, V29, P1117, DOI 10.1038/nbt.2052; Kobayashi T, 2010, CELL, V142, P787, DOI 10.1016/j.cell.2010.07.039; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Newman AM, 2010, CELL STEM CELL, V7, P258, DOI 10.1016/j.stem.2010.06.016; Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Okamoto S, 2011, INVEST OPHTH VIS SCI, V52, P8785, DOI 10.1167/iovs.11-8129; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2011, CIRC RES, V109, P720, DOI 10.1161/RES.0b013e318232e187; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pera MF, 2011, NATURE, V471, P46, DOI 10.1038/471046a; Qian L, 2012, NATURE; Quinlan AR, 2011, CELL STEM CELL, V9, P366, DOI 10.1016/j.stem.2011.07.018; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; SCHNEUWLY S, 1987, NATURE, V325, P816, DOI 10.1038/325816a0; Shimada H, 2010, MOL REPROD DEV, V77, P2, DOI 10.1002/mrd.21117; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takayama N, 2010, J EXP MED, V207, P2817, DOI 10.1084/jem.20100844; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107; Varela E, 2011, P NATL ACAD SCI USA, V108, P15207, DOI 10.1073/pnas.1105414108; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Ward CM, 2004, EXP CELL RES, V293, P229, DOI 10.1016/j.yexcr.2003.10.017; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; West FD, 2010, STEM CELLS DEV, V19, P1211, DOI 10.1089/scd.2009.0458; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yagi T, 2011, HUM MOL GENET, V20, P4530, DOI 10.1093/hmg/ddr394; Yahata N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025788; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Young M.A., 2012, CELL STEM C IN PRESS; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zwaka TP, 2010, NATURE, V467, P280, DOI 10.1038/467280a	90	493	535	3	410	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 14	2012	10	6					678	684		10.1016/j.stem.2012.05.005	http://dx.doi.org/10.1016/j.stem.2012.05.005			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	965LD	22704507	Bronze			2022-12-28	WOS:000305768400013
J	Csaszar, E; Kirouac, DC; Yu, M; Wang, WJ; Qiao, WL; Cooke, MP; Boitano, AE; Ito, C; Zandstra, PW				Csaszar, Elizabeth; Kirouac, Daniel C.; Yu, Mei; Wang, WeiJia; Qiao, Wenlian; Cooke, Michael P.; Boitano, Anthony E.; Ito, Caryn; Zandstra, Peter W.			Rapid Expansion of Human Hematopoietic Stem Cells by Automated Control of Inhibitory Feedback Signaling	CELL STEM CELL			English	Article							EX-VIVO EXPANSION; CORD-BLOOD; IN-VITRO; INTERACTION NETWORKS; PROGENITOR CELLS; TNF-ALPHA; TGF-BETA; TRANSPLANTATION; PROLIFERATION; MIP-1-ALPHA	Clinical hematopoietic transplantation outcomes are strongly correlated with the numbers of cells infused. Anticipated novel therapeutic implementations of hematopoietic stem cells (HSCs) and their derivatives further increase interest in strategies to expand HSCs ex vivo. A fundamental limitation in all HSC-driven culture systems is the rapid generation of differentiating cells and their secreted inhibitory feedback signals. Herein we describe an integrated computational and experimental strategy that enables a tunable reduction in the global levels and impact of paracrine signaling factors in an automated closed-system process by employing a controlled fed-batch media dilution approach. Application of this system to human cord blood cells yielded a rapid (12-day) 11-fold increase of HSCs with self-renewing, multilineage repopulating ability. These results highlight the marked improvements that control of feedback signaling can offer primary stem cell culture and demonstrate a clinically relevant rapid and relatively low culture volume strategy for ex vivo HSC expansion.	[Csaszar, Elizabeth; Kirouac, Daniel C.; Yu, Mei; Wang, WeiJia; Qiao, Wenlian; Ito, Caryn; Zandstra, Peter W.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3E1, Canada; [Csaszar, Elizabeth; Zandstra, Peter W.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E1, Canada; [Zandstra, Peter W.] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Cooke, Michael P.; Boitano, Anthony E.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Zandstra, Peter W.] Univ Toronto, Heart & Stroke Richard Lewar Ctr Excellence, Toronto, ON M5G 1L7, Canada; [Zandstra, Peter W.] Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON M5G 1L7, Canada	University of Toronto; University of Toronto; University of Toronto; Novartis; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Zandstra, PW (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3E1, Canada.	peter.zandstra@utoronto.ca	Wang, Weijia/O-6061-2017	Wang, Weijia/0000-0002-0270-8366	Leukemia and Lymphoma Society of Canada; Canadian Stem Cell Network; Canadian Institutes for Health Research [MOP-57885]; Ontario Ministry of Research and Innovation; NSERC	Leukemia and Lymphoma Society of Canada; Canadian Stem Cell Network; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	The authors thank the donors and the Research Centre for Women's and Infants' Health BioBank of Mount Sinai Hospital for the human specimens used in this study. The authors thank Dr. Connie Eaves and members of the P.W.Z. laboratory for their helpful discussion. This work was funded by the Leukemia and Lymphoma Society of Canada, the Canadian Stem Cell Network, the Canadian Institutes for Health Research (MOP-57885), and the Ontario Ministry of Research and Innovation. E.C. and D.C.K. were supported by NSERC Graduate Scholarships. P.W.Z. is the Canada Research Chair in Stem Cell Bioengineering.	Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; BONNET D, 1995, EXP HEMATOL, V23, P551; BROXMEYER HE, 1995, ANN HEMATOL, V71, P235, DOI 10.1007/s002770050112; Broxmeyer HE, 1999, EXP HEMATOL, V27, P1113, DOI 10.1016/S0301-472X(99)00045-4; Cashman JD, 1998, BLOOD, V92, P2338, DOI 10.1182/blood.V92.7.2338.2338_2338_2344; Collins PC, 1997, BIOTECHNOL BIOENG, V55, P693, DOI 10.1002/(SICI)1097-0290(19970820)55:4<693::AID-BIT11>3.0.CO;2-D; Csaszar E, 2009, BIOTECHNOL BIOENG, V103, P402, DOI 10.1002/bit.22297; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Durand EM, 2010, CURR OPIN HEMATOL, V17, P308, DOI 10.1097/MOH.0b013e32833a888c; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Farid SS, 2006, ADV BIOCHEM ENG BIOT, V101, P1, DOI 10.1007/10_014; Fortunel NO, 2000, BLOOD, V96, P2022; Gluckman E, 2009, BONE MARROW TRANSPL, V44, P621, DOI 10.1038/bmt.2009.280; Hofmeister CC, 2007, BONE MARROW TRANSPL, V39, P11, DOI 10.1038/sj.bmt.1705538; Ito CY, 2010, BLOOD, V115, P257, DOI 10.1182/blood-2009-07-228106; Jackson M., 2011, STEM CELLS IN PRESS; Kirouac DC, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.71; Kirouac DC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.49; Klostranec JM, 2007, NANO LETT, V7, P2812, DOI 10.1021/nl071415m; Koller MR, 1998, BONE MARROW TRANSPL, V21, P653, DOI 10.1038/sj.bmt.1701157; Krosl J, 2003, NAT MED, V9, P1428, DOI 10.1038/nm951; Madlambayan GJ, 2005, EXP HEMATOL, V33, P1229, DOI 10.1016/j.exphem.2005.05.018; Majka M, 2001, BLOOD, V97, P3075, DOI 10.1182/blood.V97.10.3075; McDermott SP, 2010, BLOOD, V116, P193, DOI 10.1182/blood-2010-02-271841; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Patel SD, 2000, BIOTECHNOL PROGR, V16, P885, DOI 10.1021/bp000080a; Rizo A, 2006, HUM MOL GENET, V15, pR210, DOI 10.1093/hmg/ddl175; Sautois B, 1997, EXP HEMATOL, V25, P103; Wagner JE, 2010, SEMIN HEMATOL, V47, P3, DOI 10.1053/j.seminhematol.2009.10.011; Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119; ZHANG Y, 1995, BLOOD, V86, P2930; Zhong YM, 2010, BIOCHEM BIOPH RES CO, V398, P377, DOI 10.1016/j.bbrc.2010.06.075	34	184	193	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 3	2012	10	2					218	229		10.1016/j.stem.2012.01.003	http://dx.doi.org/10.1016/j.stem.2012.01.003			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	892FM	22305571	Bronze			2022-12-28	WOS:000300272100014
J	Camahort, R; Cowan, CA				Camahort, Raymond; Cowan, Chad A.			Cbx Proteins Help ESCs Walk the Line between Self-Renewal and Differentiation	CELL STEM CELL			English	Editorial Material							X-INACTIVATION; POLYCOMB; GENES	The Polycomb repressive complexes (PRC) regulate self-renewal and differentiation in embryonic stem cells (ESCs). In this issue of Cell Stem Cell, Morey et al. (2012) and O'Loghlen et al. (2012) report that dynamic interchange of PRC subunits modulates the balance between self-renewal and lineage commitment in ESCs.	[Camahort, Raymond; Cowan, Chad A.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Camahort, Raymond; Cowan, Chad A.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA	Harvard University; Harvard University; Massachusetts General Hospital	Cowan, CA (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	ccowan@fas.harvard.edu						Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Gil J, 2004, NAT CELL BIOL, V6, P67, DOI 10.1038/ncb1077; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Leeb M, 2007, J CELL BIOL, V178, P219, DOI 10.1083/jcb.200612127; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Melton C, 2010, ADV EXP MED BIOL, V695, P105, DOI 10.1007/978-1-4419-7037-4_8; Morey L, 2012, CELL STEM CELL, V10, P47, DOI 10.1016/j.stem.2011.12.006; O'Loghlen A, 2012, CELL STEM CELL, V10, P33, DOI 10.1016/j.stem.2011.12.004	11	5	5	2	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JAN 6	2012	10	1					4	6		10.1016/j.stem.2011.12.011	http://dx.doi.org/10.1016/j.stem.2011.12.011			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	880ZQ	22226347	Bronze			2022-12-28	WOS:000299449500003
J	Shi, YF; Wei, LX; Wang, Y; Ren, GW				Shi, Yufang; Wei, Lixin; Wang, Ying; Ren, Guangwen			Stem Cells Deployed for Bone Repair Hijacked by T Cells	CELL STEM CELL			English	Editorial Material							IMMUNOSUPPRESSION; LYMPHOCYTES	Mesenchymal stem cells (MSCs) are a promising source for bone regeneration. Recently, in Nature Medicine, Liu et al. (2011) reported that host lymphocytes secrete IFN-gamma and TNF-alpha to initiate apoptosis of transplanted MSCs and that aspirin can alleviate these effects to improve bone repair.	[Shi, Yufang; Wei, Lixin; Wang, Ying] Shanghai Jiao Tong Univ, Shanghai Inst Biol Sci, Chinese Acad Sci, Key Lab Stem Cell Biol,Inst Hlth Sci,Sch Med, Shanghai 200025, Peoples R China; [Shi, Yufang; Ren, Guangwen] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Child Hlth Inst New Jersey, New Brunswick, NJ 08901 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Shi, YF (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Biol Sci, Chinese Acad Sci, Key Lab Stem Cell Biol,Inst Hlth Sci,Sch Med, Shanghai 200025, Peoples R China.	yufangshi@sibs.ac.cn	Ren, Guangwen/D-8895-2012; Shi, Yufang/AAE-4431-2020	Shi, Yufang/0000-0001-8964-319X; Ren, Guangwen/0000-0003-2436-9593; wang, ying/0000-0002-2571-9367; Wei, Lixin/0000-0002-9526-5348				Askmyr M, 2009, TRENDS ENDOCRIN MET, V20, P303, DOI 10.1016/j.tem.2009.03.004; Boyle JJ, 2002, ARTERIOSCL THROM VAS, V22, P1624, DOI 10.1161/01.ATV.0000033517.48444.1A; Deschaseaux F, 2009, TRENDS MOL MED, V15, P417, DOI 10.1016/j.molmed.2009.07.002; Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Shi YF, 2010, CELL RES, V20, P510, DOI 10.1038/cr.2010.44; Tokoyoda K, 2009, IMMUNITY, V30, P721, DOI 10.1016/j.immuni.2009.03.015	8	4	6	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JAN 6	2012	10	1					6	8		10.1016/j.stem.2011.12.010	http://dx.doi.org/10.1016/j.stem.2011.12.010			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	880ZQ	22226348	Bronze			2022-12-28	WOS:000299449500004
J	Kim, HW; Svendsen, CN				Kim, Ho Won; Svendsen, Clive Niels			Gene Editing in Stem Cells Hits the Target	CELL STEM CELL			English	Editorial Material							PARKINSONS-DISEASE; IPSCS; MUTATIONS	Two recent reports describe promising, highly efficient methods to modify genes in pluripotent stem cells using zinc finger nuclease (ZFN)-mediated (Soldner et al., 2011) or helper-dependent adenovirus (HDAdV)-mediated (Liu et al., 2011b) gene modification. These technical developments will have far ranging effects on the rapidly growing field of regenerative medicine.	[Kim, Ho Won; Svendsen, Clive Niels] Cedars Sinai Med Ctr, Regenerat Med Inst, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center	Svendsen, CN (corresponding author), Cedars Sinai Med Ctr, Regenerat Med Inst, 8700 Beverly Blvd, Los Angeles, CA 90048 USA.	clive.svendsen@cshs.org						Burtner CR, 2010, NAT REV MOL CELL BIO, V11, P567, DOI 10.1038/nrm2944; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Liu GH, 2011, CELL STEM CELL, V8, P688, DOI 10.1016/j.stem.2011.04.019; Liu GH, 2011, NATURE, V472, P221, DOI 10.1038/nature09879; Schneider BL, 2007, HUM MOL GENET, V16, P651, DOI 10.1093/hmg/ddm008; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Zhang JQ, 2011, CELL STEM CELL, V8, P31, DOI 10.1016/j.stem.2010.12.002; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	10	6	6	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	AUG 5	2011	9	2					93	94		10.1016/j.stem.2011.07.011	http://dx.doi.org/10.1016/j.stem.2011.07.011			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	808PM	21816359	Bronze			2022-12-28	WOS:000293990900004
J	Anokye-Danso, F; Trivedi, CM; Juhr, D; Gupta, M; Cui, Z; Tian, Y; Zhang, YZ; Yang, WL; Gruber, PJ; Epstein, JA; Morrisey, EE				Anokye-Danso, Frederick; Trivedi, Chinmay M.; Juhr, Denise; Gupta, Mudit; Cui, Zheng; Tian, Ying; Zhang, Yuzhen; Yang, Wenli; Gruber, Peter J.; Epstein, Jonathan A.; Morrisey, Edward E.			Highly Efficient miRNA-Mediated Reprogramming of Mouse and Human Somatic Cells to Pluripotency	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; SELF-RENEWAL; HUMAN FIBROBLASTS; DEFINED FACTORS; GENERATION; INDUCTION; PROLIFERATION; EXPRESSION; MICRORNAS; SELECTION	Transcription factor-based cellular reprogramming has opened the way to converting somatic cells to a pluripotent state, but has faced limitations resulting from the requirement for transcription factors and the relative inefficiency of the process. We show here that expression of the miR302/367 cluster rapidly and efficiently reprograms mouse and human somatic cells to an iPSC state without a requirement for exogenous transcription factors. This miRNA-based reprogramming approach is two orders of magnitude more efficient than standard Oct4/Sox2/K1f4/Myc-mediated methods. Mouse and human miR302/367 iPSCs display similar characteristics to Oct4/Sox2/K1f4/Myc-iPSCs, including pluripotency marker expression, teratoma formation, and, for mouse cells, chimera contribution and germline contribution. We found that miR367 expression is required for miR3021367-mediated reprogramming and activates Oct4 gene expression, and that suppression of Hdac2 is also required. Thus, our data show that miRNA and Hdac-mediated pathways can cooperate in a powerful way to reprogram somatic cells to pluripotency.	[Anokye-Danso, Frederick; Cui, Zheng; Tian, Ying; Zhang, Yuzhen; Yang, Wenli; Epstein, Jonathan A.; Morrisey, Edward E.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Trivedi, Chinmay M.; Gupta, Mudit; Epstein, Jonathan A.; Morrisey, Edward E.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Gruber, Peter J.; Epstein, Jonathan A.; Morrisey, Edward E.] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Yang, Wenli; Gruber, Peter J.; Epstein, Jonathan A.; Morrisey, Edward E.] Univ Penn, Inst Regenerat Med, Philadelphia, PA 19104 USA; [Juhr, Denise; Gruber, Peter J.] Childrens Hosp Philadelphia, Cardiac Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Morrisey, EE (corresponding author), Univ Penn, Dept Med, Philadelphia, PA 19104 USA.	emorrise@mail.med.upenn.edu	Trivedi, Chinmay M/ABA-4097-2021	Trivedi, Chinmay/0000-0002-3544-0474; Epstein, Jonathan/0000-0001-8637-4465	NIH [HL064632, HL0871325, HL100405, HL071546, HL098366]; American Heart Association Jon Holden DeHaan Myogenesis Center; Penn Institute for Regenerative Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064632, U01HL100405, R01HL087825, K99HL098366, R00HL098366] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Jon Holden DeHaan Myogenesis Center(American Heart Association); Penn Institute for Regenerative Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported by funding from the NIH to E.E.M. (HL064632, HL0871325, and HL100405), J.A.E. (HL071546 and HL100405), C.M.T. (HL098366), and an American Heart Association Jon Holden DeHaan Myogenesis Center Award to E.E.M. and J.A.E. The authors thank K. Zaret for the Rosa126-laoZ MEFs and gratefully acknowledge the support of the Penn Institute for Regenerative Medicine during these studies.	Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Cohen ED, 2009, J CLIN INVEST, V119, P2538, DOI 10.1172/JCI38079; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kramer OH, 2003, EMBO J, V22, P3411, DOI 10.1093/emboj/cdg315; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lagarkova MA, 2010, CELL CYCLE, V9, P937, DOI 10.4161/cc.9.5.10869; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Moretti A, 2010, FASEB J, V24, P700, DOI 10.1096/fj.09-139477; Raya A, 2010, NAT PROTOC, V5, P647, DOI 10.1038/nprot.2010.9; Rosa A, 2009, DEV CELL, V16, P517, DOI 10.1016/j.devcel.2009.02.007; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Shu WG, 2002, DEVELOPMENT, V129, P4831; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Trivedi CM, 2008, J BIOL CHEM, V283, P26484, DOI 10.1074/jbc.M803686200; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wang YM, 2009, CANCER RES, V69, P4093, DOI 10.1158/0008-5472.CAN-09-0309; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001	34	852	927	1	158	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 8	2011	8	4					376	388		10.1016/j.stem.2011.03.001	http://dx.doi.org/10.1016/j.stem.2011.03.001			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	752QI	21474102	Green Accepted, Bronze			2022-12-28	WOS:000289707100010
J	Lin, JW; Shi, LY; Zhang, M; Yang, H; Qin, YR; Zhang, J; Gong, DQ; Zhang, X; Li, DS; Li, JS				Lin, Jiangwei; Shi, Linyu; Zhang, Man; Yang, Hui; Qin, Yiren; Zhang, Jun; Gong, Daoqing; Zhang, Xuan; Li, Dangsheng; Li, Jinsong			Defects in Trophoblast Cell Lineage Account for the Impaired In Vivo Development of Cloned Embryos Generated by Somatic Nuclear Transfer	CELL STEM CELL			English	Article							STEM-CELLS; ES CELLS; MOUSE BLASTOCYSTS; TETRAPLOID CELLS; MICE	The low success rate of somatic nuclear transfer (NT) is hypothesized to be mainly due to functional defects in the trophoblast cell lineage rather than the inner cell mass (ICM); this hypothesis, however, remains to be tested directly. Here we separated the ICMs from cloned blastocysts and aggregated the cloned ICM with two fertilization-derived (FD) tetraploid (4N) embryos. We found that the full-term development of cloned ICMs was dramatically improved after the trophoblast cells in the cloned blastocysts were replaced by cells from tetraploid embryos, thus providing direct evidence that defects in trophoblast cell lineage underlie the low success rate of somatic NT.	[Lin, Jiangwei; Shi, Linyu; Zhang, Man; Yang, Hui; Qin, Yiren; Zhang, Xuan; Li, Jinsong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai 200031, Peoples R China; [Lin, Jiangwei; Zhang, Jun; Gong, Daoqing] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou 225009, Peoples R China; [Li, Dangsheng] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Informat Ctr Life Sci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Yangzhou University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Information Center for Life Sciences	Li, JS (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	jsli@sibs.ac.cn	Qin, Yiren/AEJ-4970-2022	Qin, Yiren/0000-0001-5137-318X; yang, hui/0000-0003-3590-722X; li, jin song/0000-0003-3456-662X	Chinese Academy of Sciences [KSCX2-YIN-R-110, KSCX2-YW-R-229, XDA01010403]; Ministry of Science and Technology [2007CB947101, 2009CB941101]; National Natural Science Foundation of China [30871430]; Shanghai Municipal Commission for Science and Technology [07DZ22919, 08DJ1400502, 09PJ1410900]	Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission for Science and Technology	We thank W. Tang, D. Liang, Y. Tao and Y. Li for technical assistance. We thank Drs. N. Jing and X. Ding for critical and useful comments on the manuscript. The study was supported by grants from the Chinese Academy of Sciences (KSCX2-YIN-R-110, KSCX2-YW-R-229, XDA01010403), the Ministry of Science and Technology (2007CB947101, 2009CB941101), the National Natural Science Foundation of China (30871430), and the Shanghai Municipal Commission for Science and Technology (07DZ22919, 08DJ1400502, 09PJ1410900).	Amano T, 2002, CELL TISSUE RES, V307, P367, DOI 10.1007/s00441-002-0513-3; Brambrink T, 2006, P NATL ACAD SCI USA, V103, P933, DOI 10.1073/pnas.0510485103; Eakin GS, 2003, DEV DYNAM, V228, P751, DOI 10.1002/dvdy.10363; Eakin GS, 2005, DEV BIOL, V288, P150, DOI 10.1016/j.ydbio.2005.09.028; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Jouneau A, 2006, DEVELOPMENT, V133, P1597, DOI 10.1242/dev.02317; Kato Y, 1999, DEVELOPMENT, V126, P1823; Li JS, 2007, P NATL ACAD SCI USA, V104, P2738, DOI 10.1073/pnas.0611358104; Li JS, 2005, CURR BIOL, V15, pR756, DOI 10.1016/j.cub.2005.09.010; MacKay GE, 2005, MECH DEVELOP, V122, P1266, DOI 10.1016/j.mod.2005.09.001; Miki H, 2009, PLACENTA, V30, P543, DOI 10.1016/j.placenta.2009.03.006; NAGY A, 1990, DEVELOPMENT, V110, P815; Oda M, 2009, P NATL ACAD SCI USA, V106, P16293, DOI 10.1073/pnas.0908009106; Ohta H, 2008, BIOL REPROD, V79, P486, DOI 10.1095/biolreprod.107.067116; Okada Y, 2007, NAT BIOTECHNOL, V25, P233, DOI 10.1038/nbt1280; Rielland M, 2009, DEV BIOL, V334, P325, DOI 10.1016/j.ydbio.2009.07.022; Soares MJ, 2009, P NATL ACAD SCI USA, V106, P16014, DOI 10.1073/pnas.0908646106; Wakayama S, 2006, STEM CELLS, V24, P2023, DOI 10.1634/stemcells.2005-0537; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973	20	34	42	1	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 8	2011	8	4					371	375		10.1016/j.stem.2011.02.007	http://dx.doi.org/10.1016/j.stem.2011.02.007			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	752QI	21474101	Bronze			2022-12-28	WOS:000289707100009
J	Iscove, N				Iscove, Norman			Ernest McCulloch Obituary	CELL STEM CELL			English	Biographical-Item									[Iscove, Norman] Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Iscove, Norman] Univ Toronto, Dept Med Biophys, Campbell Family Inst Canc Res, Toronto, ON M5S 1A8, Canada; [Iscove, Norman] Univ Toronto, Dept Immunol, Campbell Family Inst Canc Res, Toronto, ON M5S 1A8, Canada; [Iscove, Norman] McEwen Ctr Regenerat Med, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Iscove, N (corresponding author), Ontario Canc Inst, Toronto, ON M5G 2M9, Canada.	iscove@uhnresearch.ca						MCCULLOCH EA, PUBLICATION LIST	1	2	2	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAR 4	2011	8	3					250	251		10.1016/j.stem.2011.02.011	http://dx.doi.org/10.1016/j.stem.2011.02.011			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	735HI	21480557	Bronze			2022-12-28	WOS:000288404400006
J	Smith, A				Smith, Austin			Nanog Heterogeneity: Tilting at Windmills?	CELL STEM CELL			English	Editorial Material							GROUND-STATE PLURIPOTENCY	Fluctuating expression of transcription factors in embryonic stem cells is an alluring observation, but, as outlined by two articles in this issue, appearances can be misleading.	Univ Cambridge, Cambridge Stem Cell Inst, Wellcome Trust Med Res Council, Cambridge CB2 1TN, England	University of Cambridge	Smith, A (corresponding author), Univ Cambridge, Cambridge Stem Cell Inst, Wellcome Trust Med Res Council, Cambridge CB2 1TN, England.	austin.smith@cscr.cam.ac.uk		Smith, Austin/0000-0002-3029-4682	Medical Research Council [G1001028, MC_PC_12009, G1100526] Funding Source: Medline; Wellcome Trust [079249] Funding Source: Medline; MRC [G1001028] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Faddah DA, 2013, CELL STEM CELL, V13, P23, DOI 10.1016/j.stem.2013.04.019; Filipczyk A, 2013, CELL STEM CELL, V13, P12, DOI 10.1016/j.stem.2013.04.025; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Miyanari Y, 2012, NATURE, V483, P470, DOI 10.1038/nature10807; Nichols J, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008128; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Yang JA, 2010, CELL STEM CELL, V7, P319, DOI 10.1016/j.stem.2010.06.022	10	33	33	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2013	13	1					6	7		10.1016/j.stem.2013.06.016	http://dx.doi.org/10.1016/j.stem.2013.06.016			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VJ	23827703	hybrid, Green Published			2022-12-28	WOS:000329570100004
J	Vizcardo, R; Masuda, K; Yamada, D; Ikawa, T; Shimizu, K; Fujii, S; Koseki, H; Kawamoto, H				Vizcardo, Raul; Masuda, Kyoko; Yamada, Daisuke; Ikawa, Tomokatsu; Shimizu, Kanako; Fujii, Shin-ichiro; Koseki, Haruhiko; Kawamoto, Hiroshi			Regeneration of Human Tumor Antigen-Specific T Cells from iPSCs Derived from Mature CD8(+) T Cells	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; DEFINED FACTORS; GENERATION; DIFFERENTIATION; PROGENITORS; INDUCTION; GENOME; VITRO	Antigen-specific T cells represent a potential therapeutic avenue for a variety of conditions, but current approaches for generating such cells for therapeutic purposes are limited. In this study, we established iPSCs from mature cytotoxic T cells specific for the melanoma epitope MART-1. When cocultured with OP9/DLL1 cells, these iPSCs efficiently generated TCR beta(+)CD4(+)CD8(+) double positive (DP) cells expressing a T cell receptor (TCR) specific for the MART-1 epitope. Stimulation of these DP cells with anti-CD3 antibody generated a large number of CD8(+) T cells, and more than 90% of the resulting cells were specific for the original MART-1 epitope. Stimulation of the CD8(+) T cells with MART-1 antigen-presenting cells led to the secretion of IFN gamma, demonstrating their specific reactivity. The present study therefore illustrates an approach for cloning and expanding functional antigen-specific CD8(+) T cells that might be applicable in cell-based therapy of cancer.	[Vizcardo, Raul; Yamada, Daisuke; Koseki, Haruhiko] RIKEN Res Ctr Allergy & Immunol, Lab Dev Genet, Yokohama, Kanagawa 2300045, Japan; [Masuda, Kyoko; Ikawa, Tomokatsu; Kawamoto, Hiroshi] RIKEN Res Ctr Allergy & Immunol, Lab Lymphocyte Dev, Yokohama, Kanagawa 2300045, Japan; [Shimizu, Kanako] RIKEN Res Ctr Allergy & Immunol, Res Unit Therapeut Model, Yokohama, Kanagawa 2300045, Japan; [Fujii, Shin-ichiro] RIKEN Res Ctr Allergy & Immunol, Res Unit Cellular Immunotherapy, Yokohama, Kanagawa 2300045, Japan; [Vizcardo, Raul; Koseki, Haruhiko] Chiba Univ, Dept Immune Regulat Res, Grad Sch Med & Pharmaceut Sci, Chiba 2608670, Japan	RIKEN; RIKEN; RIKEN; RIKEN; Chiba University	Kawamoto, H (corresponding author), Kyoto Univ, Dept Immunol, Inst Frontier Med Sci, Kyoto 6068507, Japan.	kawamoto@rcai.riken.jp	Fujii, Shin-ichiro/O-6218-2015; Koseki, Haruhiko/I-3825-2014	Koseki, Haruhiko/0000-0001-8424-5854; Vizcardo, Raul/0000-0002-5652-1513; Fujii, Shin-ichiro/0000-0003-3586-3976	Japan Science and Technology Agency (JST), CREST	Japan Science and Technology Agency (JST), CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported by the Japan Science and Technology Agency (JST), CREST. We thank Chieko Tezuka, Genta Kitahara, and Momoko Ookoshi for their technical support. We also thank Ken-ichi Hanada and Steven A. Rosenberg for kindly providing JKF6 cells, and we thank Yoshimoto Katsura for critical reading of the paper.	Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Grskovic M, 2011, NAT REV DRUG DISCOV, V10, P915, DOI 10.1038/nrd3577; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Ikawa T, 2010, SCIENCE, V329, P93, DOI 10.1126/science.1188995; Loh YH, 2010, CELL STEM CELL, V7, P15, DOI 10.1016/j.stem.2010.06.004; Meek B, 2010, BLOOD, V115, P261, DOI 10.1182/blood-2009-05-223990; Mescher MF, 2007, SEMIN CANCER BIOL, V17, P299, DOI 10.1016/j.semcancer.2007.06.008; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; PETRIE HT, 1993, J EXP MED, V178, P615, DOI 10.1084/jem.178.2.615; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Sensi M, 2006, CLIN CANCER RES, V12, P5023, DOI 10.1158/1078-0432.CCR-05-2682; TAKAHAMA Y, 1994, NATURE, V371, P67, DOI 10.1038/371067a0; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Timmermans F, 2009, J IMMUNOL, V182, P6879, DOI 10.4049/jimmunol.0803670; Vodyanik MA, 2006, BLOOD, V108, P2095, DOI 10.1182/blood-2006-02-003327; Vodyanik Maxim A, 2007, Curr Protoc Cell Biol, VChapter 23, DOI 10.1002/0471143030.cb2306s36; Wada H, 2011, INT IMMUNOL, V23, P65, DOI 10.1093/intimm/dxq458; Watarai H, 2010, J CLIN INVEST, V120, P2610, DOI 10.1172/JCI42027; Watarai H, 2010, BLOOD, V115, P230, DOI 10.1182/blood-2009-04-217729; Willimsky G, 2005, NATURE, V437, P141, DOI 10.1038/nature03954; Yang SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022560	23	200	216	3	49	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JAN 3	2013	12	1					31	36		10.1016/j.stem.2012.12.006	http://dx.doi.org/10.1016/j.stem.2012.12.006			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	074UM	23290135	Bronze			2022-12-28	WOS:000313839500008
J	Insco, ML; Bailey, AS; Kim, J; Olivares, GH; Wapinski, OL; Tam, CH; Fuller, MT				Insco, Megan L.; Bailey, Alexis S.; Kim, Jongmin; Olivares, Gonzalo H.; Wapinski, Orly L.; Tam, Cheuk Ho; Fuller, Margaret T.			A Self-Limiting Switch Based on Translational Control Regulates the Transition from Proliferation to Differentiation in an Adult Stem Cell Lineage	CELL STEM CELL			English	Article							BAG-OF-MARBLES; TUMOR-SUPPRESSOR; DROSOPHILA; GERMLINE; GENE; PROTEIN; RNA; MICRORNA; MUTATIONS; DIVISION	In adult stem cell lineages, progenitor cells commonly undergo mitotic transit amplifying (TA) divisions before terminal differentiation, allowing production of many differentiated progeny per stem cell division. Mechanisms that limit TA divisions and trigger the switch to differentiation may protect against cancer by preventing accumulation of oncogenic mutations in the proliferating population. Here we show that the switch from TA proliferation to differentiation in the Drosophila male germline stem cell lineage is mediated by translational control. The TRIM-NHL tumor suppressor homolog Mei-P26 facilitates accumulation of the differentiation regulator Bam in TA cells. In turn, Bam and its partner Bgcn bind the mei-P26 3' untranslated region and repress translation of mei-P26 in late TA cells. Thus, germ cells progress through distinct, sequential regulatory states, from Mei-P26 on/Bam off to Barn on/Mei-P26 off. TRIM-NHL homologs across species facilitate the switch from proliferation to differentiation, suggesting a conserved developmentally programmed tumor suppressor mechanism.	[Insco, Megan L.; Bailey, Alexis S.; Kim, Jongmin; Olivares, Gonzalo H.; Wapinski, Orly L.; Tam, Cheuk Ho; Fuller, Margaret T.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA	Stanford University	Fuller, MT (corresponding author), Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA.	mtfuller@stanford.edu	Bailey, Alexis/AAI-1489-2020	Bailey, Alexis/0000-0003-1541-1964; Fuller, Margaret T/0000-0002-3804-4987; Olivares, Gonzalo/0000-0002-2784-0160; Kim, Jongmin/0000-0002-1836-2064	California Institute of Regenerative Medicine; Stanford Medical Scientist Training Program [GM007365]; National Science Foundation predoctoral fellowship; Anne T. and Robert M. Bass Stanford Graduate Fellowship; PEW Latin American Fellow Program; Chilean post-doctoral fellowship Becas Chile [74100040]; National Institutes of Health (NIH) Training Grant [5T32 CA009302-33]; NIH [RO1 GM080501]; Reed-Hodgson Professorship in Human Biology; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080501, T32GM007365] Funding Source: NIH RePORTER	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Stanford Medical Scientist Training Program; National Science Foundation predoctoral fellowship(National Science Foundation (NSF)); Anne T. and Robert M. Bass Stanford Graduate Fellowship; PEW Latin American Fellow Program; Chilean post-doctoral fellowship Becas Chile; National Institutes of Health (NIH) Training Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Reed-Hodgson Professorship in Human Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Karla Kirkegaard for helpful advice with the RNA pull-down experiments, Michael Buszczak for thoughtful discussion and sharing of data prior to publication, and Catherine Baker for valuable comments on the manuscript. This work was supported by a predoctoral fellowship from the California Institute of Regenerative Medicine and the Stanford Medical Scientist Training Program (GM007365) to M.L.I., a National Science Foundation predoctoral fellowship to A.S.B., the Anne T. and Robert M. Bass Stanford Graduate Fellowship to J.K., a PEW Latin American Fellow Program and Chilean post-doctoral fellowship Becas Chile (74100040) to G.H.O., a National Institutes of Health (NIH) Training Grant (5T32 CA009302-33) to O.L.W., and NIH RO1 GM080501 and the Reed-Hodgson Professorship in Human Biology to M.T.F.	Arama E, 2000, ONCOGENE, V19, P3706, DOI 10.1038/sj.onc.1203706; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004; Chen DH, 2003, DEVELOPMENT, V130, P1159, DOI 10.1242/dev.00325; Chen X, 2005, SCIENCE, V310, P869, DOI 10.1126/science.1118101; Chi SW, 2012, NAT STRUCT MOL BIOL, V19, P321, DOI 10.1038/nsmb.2230; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Fuller Margaret T., 1993, P71; Gallegos M, 1998, EMBO J, V17, P6337, DOI 10.1093/emboj/17.21.6337; GATEFF E, 1994, INT J DEV BIOL, V38, P565; Gonczy P, 1997, DEVELOPMENT, V124, P4361; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; HEDGECOCK EM, 1995, GENETICS, V141, P989; Insco ML, 2009, P NATL ACAD SCI USA, V106, P22311, DOI 10.1073/pnas.0912454106; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Kimble J, 2007, ANNU REV CELL DEV BI, V23, P405, DOI 10.1146/annurev.cellbio.23.090506.123326; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Li Y, 2012, DEVELOPMENT, V139, P1547, DOI 10.1242/dev.077412; Li Y, 2009, P NATL ACAD SCI USA, V106, P9304, DOI 10.1073/pnas.0901452106; Lin YC, 2007, MOL BIOL EVOL, V24, P2525, DOI 10.1093/molbev/msm195; Liu NK, 2009, GENE DEV, V23, P2742, DOI 10.1101/gad.1820709; MCKEARIN D, 1995, DEVELOPMENT, V121, P2937; MCKEARIN DM, 1990, GENE DEV, V4, P2242, DOI 10.1101/gad.4.12b.2242; Monk AC, 2010, CELL STEM CELL, V6, P348, DOI 10.1016/j.stem.2010.02.016; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Neumuller RA, 2008, NATURE, V454, P241, DOI 10.1038/nature07014; O'Farrell F, 2008, DEV DYNAM, V237, P196, DOI 10.1002/dvdy.21396; Ohlstein B, 1997, DEVELOPMENT, V124, P3651; Page SL, 2000, GENETICS, V155, P1757; Puoti A, 1999, MOL CELL BIOL, V19, P2189; Puoti A, 2000, P NATL ACAD SCI USA, V97, P3276, DOI 10.1073/pnas.97.7.3276; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; RIGGLEMAN B, 1990, CELL, V63, P549, DOI 10.1016/0092-8674(90)90451-J; Rodriguez A, 1996, GENETICS, V143, P929; Rybak A, 2009, NAT CELL BIOL, V11, P1411, DOI 10.1038/ncb1987; Schneider MD, 2006, J CELL BIOL, V174, P349, DOI 10.1083/jcb.200512103; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Shen R, 2009, P NATL ACAD SCI USA, V106, P11623, DOI 10.1073/pnas.0903325106; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Sokol NS, 2008, GENE DEV, V22, P1591, DOI 10.1101/gad.1671708; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Wakimoto BT, 2004, GENETICS, V167, P207, DOI 10.1534/genetics.167.1.207; Woodhouse E, 1998, DEV GENES EVOL, V207, P542, DOI 10.1007/s004270050145	48	44	44	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 2	2012	11	5					689	700		10.1016/j.stem.2012.08.012	http://dx.doi.org/10.1016/j.stem.2012.08.012			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	042LE	23122292	Green Accepted, Bronze			2022-12-28	WOS:000311471900014
J	Kentsis, A; Look, AT				Kentsis, Alex; Look, A. Thomas			Distinct and Dynamic Requirements for mTOR Signaling in Hematopoiesis and Leukemogenesis	CELL STEM CELL			English	Editorial Material							STEM-CELLS; LEUKEMIA; PTEN; PI3K	Signaling involving PI3K and AKT regulates cell growth, partly through the mTOR kinase complexes 1 and 2. In this issue of Cell Stem Cell, Kalaitzidis et al. and Magee et al. reveal unique requirements for mTORC1 and mTORC2 signaling during blood development and leukemogenesis induced by loss of PTEN.	[Kentsis, Alex; Look, A. Thomas] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Kentsis, Alex; Look, A. Thomas] Harvard Univ, Sch Med, Childrens Hosp Boston, Div Hematol Oncol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Kentsis, A (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, 44 Binney St, Boston, MA 02115 USA.	alex.kentsis@childrens.harvard.edu; thomas_look@dfci.harvard.edu		Kentsis, Alex/0000-0002-8063-9191	NCI NIH HHS [K08 CA160660] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K08CA160660] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Gutierrez A, 2009, BLOOD, V114, P647, DOI 10.1182/blood-2009-02-206722; Kalaitzidis D, 2012, CELL STEM CELL, V11, P429, DOI 10.1016/j.stem.2012.06.009; Kharas MG, 2010, BLOOD, V115, P1406, DOI 10.1182/blood-2009-06-229443; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Magee JA, 2012, CELL STEM CELL, V11, P415, DOI 10.1016/j.stem.2012.05.026; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747	9	10	11	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	SEP 7	2012	11	3					281	282		10.1016/j.stem.2012.08.007	http://dx.doi.org/10.1016/j.stem.2012.08.007			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	018DW	22958924	Bronze			2022-12-28	WOS:000309641300001
J	Perrier, A; Peschanski, M				Perrier, Anselme; Peschanski, Marc			How Can Human Pluripotent Stem Cells Help Decipher and Cure Huntington's Disease?	CELL STEM CELL			English	Review							STRIATAL ALLOGRAFTS; NEURAL TRANSPLANTS; DIRECT CONVERSION; HUMAN FIBROBLASTS; PRIMATE MODEL; EXPRESSION; LINES; NEURONS; MOUSE; GENERATION	Pluripotent stem cell (PSC) technologies are becoming a key asset for deciphering pathological cascades and for developing new treatments against many neurodegenerative disorders, including Huntington's disease (HD). This perspective discusses the challenges and opportunities facing the use of PSCs for treating HD, focusing on four major applications: namely, the use of PSCs as a substitute source of human striatal cells for current HD cell therapy, as a cellular model of HD for the validation of human-specific gene therapies, for deciphering molecular mechanisms underlying HD, and in drug discovery.	[Perrier, Anselme; Peschanski, Marc] I Stem AFM, INSERM, U861, F-91030 Paris, France; [Perrier, Anselme; Peschanski, Marc] I Stem AFM, UEVE, U861, F-91030 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Peschanski, M (corresponding author), I Stem AFM, INSERM, U861, 5 Rue Henri Desbrueres Evry, F-91030 Paris, France.	mpeschanski@istem.fr	Peschanski, Marc/N-5769-2017; Perrier, Anselme/E-3764-2010; Perrier, Anselme L/B-2272-2019	Perrier, Anselme L/0000-0001-7915-1968				An W. Frank, 2009, V486, P1, DOI 10.1007/978-1-60327-545-3_1; Aubry L, 2008, P NATL ACAD SCI USA, V105, P16707, DOI 10.1073/pnas.0808488105; Bachoud-Levi A, 2000, LANCET, V356, P1975, DOI 10.1016/S0140-6736(00)03310-9; Bachoud-Levi AC, 2006, LANCET NEUROL, V5, P303, DOI 10.1016/S1474-4422(06)70381-7; Becanovic K, 2010, HUM MOL GENET, V19, P1438, DOI 10.1093/hmg/ddq018; Borovecki F, 2005, P NATL ACAD SCI USA, V102, P11023, DOI 10.1073/pnas.0504921102; Camnasio S, 2012, NEUROBIOL DIS, V46, P41, DOI 10.1016/j.nbd.2011.12.042; Capetian P, 2009, NEUROSCIENCE, V160, P661, DOI 10.1016/j.neuroscience.2009.02.035; Chambers SM, 2011, CELL, V145, P827, DOI 10.1016/j.cell.2011.05.036; Cicchetti F, 2009, P NATL ACAD SCI USA, V106, P12483, DOI 10.1073/pnas.0904239106; Colman A, 2009, CELL STEM CELL, V5, P244, DOI 10.1016/j.stem.2009.08.010; Dunnett SB, 2011, CURR OPIN ORGAN TRAN, V16, P632, DOI 10.1097/MOT.0b013e32834c2356; Eiges R, 2007, CELL STEM CELL, V1, P568, DOI 10.1016/j.stem.2007.09.001; FEYEUX M, 2012, HUM MOL GENET, DOI DOI 10.1097/MOT.0B013E32834C2356; Freeman TB, 2011, EXP NEUROL, V227, P1, DOI 10.1016/j.expneurol.2010.08.031; Gallina P, 2008, STEREOT FUNCT NEUROS, V86, P308, DOI 10.1159/000155233; Gourraud PA, 2012, STEM CELLS, V30, P180, DOI 10.1002/stem.772; Grskovic M, 2011, NAT REV DRUG DISCOV, V10, P915, DOI 10.1038/nrd3577; Gu A, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010067, 10.1371/currents.RRN1193]; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Juopperi TA, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-17; Kendall AL, 1998, NAT MED, V4, P727, DOI 10.1038/nm0698-727; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Krystkowiak P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000166; Kuhn A, 2007, HUM MOL GENET, V16, P1845, DOI 10.1093/hmg/ddm133; Kuhn A, 2011, NAT METHODS, V8, P945, DOI [10.1038/NMETH.1710, 10.1038/nmeth.1710]; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Leegwater-Kim Julie, 2004, NeuroRx, V1, P128, DOI 10.1602/neurorx.1.1.128; Liu HS, 2011, CELL MOL LIFE SCI, V68, P3995, DOI 10.1007/s00018-011-0770-y; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Ma LX, 2012, CELL STEM CELL, V10, P455, DOI 10.1016/j.stem.2012.01.021; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Marteyn A, 2011, CELL STEM CELL, V8, P434, DOI 10.1016/j.stem.2011.02.004; Matsui M, 2012, DRUG DISCOV TODAY, V17, P443, DOI 10.1016/j.drudis.2012.01.006; Moon J, 2012, STEM CELLS; *NAT RES COUNC, 2007, TOX TEST 21 CENT VIS, DOI DOI 10.1016/J.STEM.2011.02.004; Niclis JC, 2009, REPROD BIOMED ONLINE, V19, P106, DOI 10.1016/S1472-6483(10)60053-3; Nicoleau C, 2011, NEUROTHERAPEUTICS, V8, P562, DOI 10.1007/s13311-011-0079-4; Palfi S, 1998, NAT MED, V4, P963, DOI 10.1038/nm0898-963; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Parmar M, 2012, CELL STEM CELL, V10, P349, DOI 10.1016/j.stem.2012.03.004; PESCHANSKI M, 1995, NEUROSCIENCE, V68, P273, DOI 10.1016/0306-4522(95)00162-C; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Runne H, 2007, P NATL ACAD SCI USA, V104, P14424, DOI 10.1073/pnas.0703652104; Stiles DK, 2012, EXP NEUROL, V233, P463, DOI 10.1016/j.expneurol.2011.11.020; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Taylor CJ, 2005, LANCET, V366, P2019, DOI 10.1016/S0140-6736(05)67813-0; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Varma H, 2011, NEUROBIOLOGY HUNTING; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005; Yang N, 2011, CELL STEM CELL, V9, P517, DOI 10.1016/j.stem.2011.11.015; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135	55	13	14	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 3	2012	11	2					153	161		10.1016/j.stem.2012.07.015	http://dx.doi.org/10.1016/j.stem.2012.07.015			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	987QQ	22862942	Bronze			2022-12-28	WOS:000307432600007
J	Pedersen, RA; Mascetti, V; Mendjan, S				Pedersen, Roger A.; Mascetti, Victoria; Mendjan, Sasha			Synthetic Organs for Regenerative Medicine	CELL STEM CELL			English	Editorial Material							STEM-CELL	Differentiating tissue stem cells can self-assemble into structures that strikingly resemble functional organ subunits. Translating this insight to regenerative medicine presents several challenges.	[Pedersen, Roger A.; Mascetti, Victoria; Mendjan, Sasha] Univ Cambridge, Stem Cell Inst, Anne McLaren Lab Regenerat Med, Cambridge CB2 0SZ, England; [Pedersen, Roger A.; Mascetti, Victoria] Univ Cambridge, Dept Surg, Cambridge CB2 0QQ, England	University of Cambridge; University of Cambridge	Pedersen, RA (corresponding author), Univ Cambridge, Stem Cell Inst, Anne McLaren Lab Regenerat Med, Cambridge CB2 0SZ, England.	roger@stemcells.cam.ac.uk	Mendjan, Sasha/HHN-7384-2022	Mendjan, Sasha/0000-0001-7539-3951	MRC [G0800784, G0600275] Funding Source: UKRI; Medical Research Council [G0800784B] Funding Source: researchfish; Medical Research Council [G0800784, G0600275] Funding Source: Medline; Wellcome Trust [079249] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Badylak SF, 2012, LANCET, V379, P943, DOI 10.1016/S0140-6736(12)60073-7; Chanson L, 2011, P NATL ACAD SCI USA, V108, P3264, DOI 10.1073/pnas.1019556108; Eiraku M, 2012, CURR OPIN NEUROBIOL, V22, P768, DOI 10.1016/j.conb.2012.02.005; Grapin-Botton A, 2005, INT J DEV BIOL, V49, P335, DOI 10.1387/ijdb.041946ag; Kadzik RS, 2012, CELL STEM CELL, V10, P355, DOI 10.1016/j.stem.2012.03.013; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; van Vliet P, 2010, J CELL MOL MED, V14, P861, DOI 10.1111/j.1582-4934.2010.01053.x; Vierbuchen T, 2011, NAT BIOTECHNOL, V29, P892, DOI 10.1038/nbt.1946; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695; Zhou Q, 2012, CELL STEM CELL, V10, P347, DOI 10.1016/j.stem.2012.03.005	10	4	4	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 14	2012	10	6					646	647		10.1016/j.stem.2012.04.003	http://dx.doi.org/10.1016/j.stem.2012.04.003			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	965LD	22704499	Bronze			2022-12-28	WOS:000305768400005
J	Carrillo-Garcia, C; Janzen, V				Carrillo-Garcia, Carmen; Janzen, Viktor			Restoring Cell Polarity: An HSC Fountain of Youth	CELL STEM CELL			English	Editorial Material							AGE		[Carrillo-Garcia, Carmen; Janzen, Viktor] Univ Hosp Bonn, Dept Hematol Oncol, D-53127 Bonn, Germany	University of Bonn	Janzen, V (corresponding author), Univ Hosp Bonn, Dept Hematol Oncol, D-53127 Bonn, Germany.	viktor.janzen@ukb.uni-bonn.de		Carrillo Garcia, Carmen/0000-0003-1692-7460				Alberts AS, 1998, CELL, V92, P475, DOI 10.1016/S0092-8674(00)80941-1; Ergen AV, 2010, EXP GERONTOL, V45, P286, DOI 10.1016/j.exger.2009.12.010; Florian MC, 2012, CELL STEM CELL, V10, P520, DOI 10.1016/j.stem.2012.04.007; Kiss TL, 2007, BONE MARROW TRANSPL, V40, P405, DOI 10.1038/sj.bmt.1705747; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Wang L, 2007, P NATL ACAD SCI USA, V104, P1248, DOI 10.1073/pnas.0609149104	8	3	4	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAY 4	2012	10	5					481	482		10.1016/j.stem.2012.04.015	http://dx.doi.org/10.1016/j.stem.2012.04.015			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	944WN	22560067	Bronze			2022-12-28	WOS:000304234600001
J	Mekhoubad, S; Bock, C; de Boer, AS; Kiskinis, E; Meissner, A; Eggan, K				Mekhoubad, Shila; Bock, Christoph; de Boer, A. Sophie; Kiskinis, Evangelos; Meissner, Alexander; Eggan, Kevin			Erosion of Dosage Compensation Impacts Human iPSC Disease Modeling	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; X-CHROMOSOME INACTIVATION; LESCH-NYHAN SYNDROME; RETT-SYNDROME; GENE-EXPRESSION; CULTURE	Although distinct human induced pluripotent stem cell (hiPSC) lines can display considerable epigenetic variation, it has been unclear whether such variability impacts their utility for disease modeling. Here, we show that although low-passage female hiPSCs retain the inactive X chromosome of the somatic cell they are derived from, over time in culture they undergo an "erosion" of X chromosome inactivation (XCI). This erosion of XCI is characterized by loss of XIST expression and foci of H3-K27-trimethylation, as well as transcriptional derepression of genes on the inactive X that cannot be reversed by either differentiation or further reprogramming. We specifically demonstrate that erosion of XCI has a significant impact on the use of female hiPSCs for modeling Lesch-Nyhan syndrome. However, our finding that most genes subject to XCI are derepressed by this erosion of XCI suggests that it should be a significant consideration when selecting hiPSC lines for modeling any disease.	[Mekhoubad, Shila; Bock, Christoph; de Boer, A. Sophie; Kiskinis, Evangelos; Meissner, Alexander; Eggan, Kevin] Harvard Univ, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Mekhoubad, Shila; de Boer, A. Sophie; Kiskinis, Evangelos; Eggan, Kevin] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Mekhoubad, Shila; Eggan, Kevin] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Bock, Christoph; Meissner, Alexander] Broad Inst, Cambridge, MA 02142 USA; [Bock, Christoph] Max Planck Inst Informat, D-66123 Saarbrucken, Germany; [de Boer, A. Sophie] Leiden Univ, Med Ctr, Dept Anat & Embryol, NL-2333 ZA Leiden, Netherlands	Harvard University; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Max Planck Society; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Meissner, A (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Cambridge, MA 02138 USA.	alexander_meissner@harvard.edu; keggan@scrb.harvard.edu	Bock, Christoph/AAE-7618-2019; Eggan, Kevin/P-7119-2018	Bock, Christoph/0000-0001-6091-3088; 	HHMI; Stowers Medical Institute; NYSTEM-NYSCF; NICHD [HD045732-03]; NIGMS [GM099117]; NIH [U01E5017155, P01GM099117]; Alexander von Humboldt Foundation; Charles A. King Trust, NA., Bank of America, Co-Trustee; Boehringer Ingelheim Fonds; NYSCF; Pew Charitable Trusts; MacArthur Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099117] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); Stowers Medical Institute; NYSTEM-NYSCF; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Charles A. King Trust, NA., Bank of America, Co-Trustee; Boehringer Ingelheim Fonds(Boehringer Ingelheim); NYSCF; Pew Charitable Trusts; MacArthur Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors wish to thank all K.E. lab members for their technical support and helpful discussions, as well as J.F. Loring and M.H. Stewart for critical reading of this manuscript. This work was supported by HHMI, the Stowers Medical Institute, NYSTEM-NYSCF, NICHD grant #HD045732-03, and NIGMS P01 grant GM099117 to K.E. This work was also supported by NIH grants U01E5017155 and P01GM099117 to A.M. C.B. was supported by a Feodor Lynen Fellowship (Alexander von Humboldt Foundation) and a Charles A. King Trust Postdoctoral Fellowship (Charles A. King Trust, NA., Bank of America, Co-Trustee). A.S.B. is supported by the Boehringer Ingelheim Fonds, E.K. is a NYSCF Postdoctoral Fellow, A.M. is supported by the Pew Charitable Trusts, and K.E. is an HHMI early career scientist and fellow of the MacArthur Foundation.	Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; BAUMEISTER AA, 1985, NEUROSCI BIOBEHAV R, V9, P169, DOI 10.1016/0149-7634(85)90043-0; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; BROWN CJ, 1994, NATURE, V368, P154, DOI 10.1038/368154a0; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Cheung AYL, 2011, HUM MOL GENET, V20, P2103, DOI 10.1093/hmg/ddr093; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Chiurazzi P, 2008, EUR J HUM GENET, V16, P422, DOI 10.1038/sj.ejhg.5201994; Cristini S, 2010, HUM MOL GENET, V19, P1939, DOI 10.1093/hmg/ddq072; Csankovszki G, 2001, J CELL BIOL, V153, P773, DOI 10.1083/jcb.153.4.773; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Dvash T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011330; Engle SJ, 1996, HUM MOL GENET, V5, P1607, DOI 10.1093/hmg/5.10.1607; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Erwin JA, 2010, CURR PROTOC STEM CEL; FINGER S, 1988, J NEUROL SCI, V86, P203, DOI 10.1016/0022-510X(88)90099-8; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Guibinga GH, 2010, MOL THER, V18, P54, DOI 10.1038/mt.2009.178; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Jinnah HA, 2009, DIS MODEL MECH, V2, P116, DOI 10.1242/dmm.002543; Kim KY, 2011, P NATL ACAD SCI USA, V108, P14169, DOI 10.1073/pnas.1018979108; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; MCDONALD JA, 1971, SCIENCE, V171, P689, DOI 10.1126/science.171.3972.689; Nazor KL, 2012, CELL STEM CELL, V10, P620, DOI 10.1016/j.stem.2012.02.013; Pomp O, 2011, CELL STEM CELL, V9, P156, DOI 10.1016/j.stem.2011.06.004; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4709, DOI 10.1073/pnas.0712018105; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tchieu J, 2010, CELL STEM CELL, V7, P329, DOI 10.1016/j.stem.2010.06.024; Visser JE, 2000, BRAIN RES REV, V32, P449, DOI 10.1016/S0165-0173(99)00094-6	32	240	243	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAY 4	2012	10	5					595	609		10.1016/j.stem.2012.02.014	http://dx.doi.org/10.1016/j.stem.2012.02.014			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	944WN	22560080	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000304234600017
J	Pasut, A; Rudnicki, MA				Pasut, Alessandra; Rudnicki, Michael A.			The Long, the Short, and the Micro: A PolyA Tale of Pax3 in Satellite Cells	CELL STEM CELL			English	Editorial Material							MUSCLE; DISTINCT	The use of alternative polyadenylation sites is emerging as an important regulator of gene expression. In this issue of Cell Stem Cell, Boutet et al. (2012) report that alternative 3'UTRs of the Pax3 transcript restrict its expression to axial satellite cells through miR-mediated targeting of one of the isoforms.	[Pasut, Alessandra; Rudnicki, Michael A.] Ottawa Hosp, Res Inst, Regenerat Med Program, Ottawa, ON K1H 8L6, Canada; [Pasut, Alessandra; Rudnicki, Michael A.] Univ Ottawa, Fac Med, Ottawa, ON K1H 8M5, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Rudnicki, MA (corresponding author), Ottawa Hosp, Res Inst, Regenerat Med Program, Ottawa, ON K1H 8L6, Canada.	mrudnicki@ohri.ca		Rudnicki, Michael/0000-0002-3866-5249	NIAMS NIH HHS [R01 AR044031-16, R01 AR044031] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044031] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Boutet SC, 2007, CELL, V130, P349, DOI 10.1016/j.cell.2007.05.044; Boutet SC, 2012, CELL STEM CELL, V10, P327, DOI 10.1016/j.stem.2012.01.017; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Crist CG, 2009, P NATL ACAD SCI USA, V106, P13383, DOI 10.1073/pnas.0900210106; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Kuang S, 2006, J CELL BIOL, V172, P103, DOI 10.1083/jcb.200508001; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158	11	4	5	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 2	2012	10	3					237	238		10.1016/j.stem.2012.02.009	http://dx.doi.org/10.1016/j.stem.2012.02.009			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	908BX	22385651	Green Accepted, Bronze			2022-12-28	WOS:000301466500004
J	Yuan, WP; Sipp, D; Wang, ZZ; Deng, HK; Pei, DQ; Zhou, Q; Cheng, T				Yuan, Weiping; Sipp, Douglas; Wang, Zack Z.; Deng, Hongkui; Pei, Duanqing; Zhou, Qi; Cheng, Tao			Stem Cell Science On the Rise in China	CELL STEM CELL			English	Editorial Material							GENERATION	China's output in fundamental stem cell research has increased markedly in recent years. Vigorous public investment and infrastructure development have enabled major productivity gains, but challenges in regulation, governance, and the management of clinical expectations must be addressed to ensure scientific quality and sustainable growth.	[Yuan, Weiping; Cheng, Tao] Chinese Acad Med Sci, State Key Lab Expt Hematol, Inst Hematol, Tianjin 300020, Peoples R China; [Yuan, Weiping; Cheng, Tao] Chinese Acad Med Sci, Ctr Stem Cell Med, Blood Dis Hosp, Tianjin 300020, Peoples R China; [Yuan, Weiping; Cheng, Tao] Peking Union Med Coll, Tianjin 300020, Peoples R China; [Sipp, Douglas] RIKEN Ctr Dev Biol, Kobe, Hyogo 6500047, Japan; [Wang, Zack Z.] Maine Med Ctr, Res Inst, Ctr Mol Med, Scarborough, ME 04074 USA; [Deng, Hongkui] Peking Univ, Coll Life Sci, Minist Educ, Key Lab Cell Proliferat & Differentiat, Beijing 100871, Peoples R China; [Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, CAS Key Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med, Guangzhou 510663, Guangdong, Peoples R China; [Zhou, Qi] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; RIKEN; Maine Medical Center; Peking University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS	Cheng, T (corresponding author), Chinese Acad Med Sci, State Key Lab Expt Hematol, Inst Hematol, Tianjin 300020, Peoples R China.	chengtao@ihcams.ac.cn	Sipp, Doug/C-9218-2017	Sipp, Doug/0000-0002-5979-0938; Cheng, Tao/0000-0002-5925-2769				He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Lin GN, 2008, NATURE, V455, P1119, DOI 10.1038/nature07329; LU DP, 1981, EXP HEMATOL, V9, P257; Murray F, 2006, NEW ENGL J MED, V355, P1191, DOI 10.1056/NEJMp068151; Tong DZ, 1963, SCI B, V7, P60; WU CT, 1985, INT J CELL CLONING, V3, P388; Wu Z, 2009, J MOL CELL BIOL, V1, P46, DOI 10.1093/jmcb/mjp003; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002	12	15	22	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JAN 6	2012	10	1					12	15		10.1016/j.stem.2011.12.002	http://dx.doi.org/10.1016/j.stem.2011.12.002			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	880ZQ	22226351	Bronze			2022-12-28	WOS:000299449500007
J	Berg, DA; Kirkham, M; Wang, H; Frisen, J; Simon, A				Berg, Daniel A.; Kirkham, Matthew; Wang, Heng; Frisen, Jonas; Simon, Andras			Dopamine Controls Neurogenesis in the Adult Salamander Midbrain in Homeostasis and during Regeneration of Dopamine Neurons	CELL STEM CELL			English	Article							SUBSTANTIA-NIGRA; PARKINSONS-DISEASE; SUBVENTRICULAR ZONE; CELL-PROLIFERATION; TAIL REGENERATION; SPINAL-CORD; STEM-CELLS; IN-VIVO; PROGENITORS; ACTIVATION	Appropriate termination of regenerative processes is critical for producing the correct number of cells in tissues. Here we provide evidence for an end-product inhibition of dopamine neuron regeneration that is mediated by dopamine. Ablation of midbrain dopamine neurons leads to complete regeneration in salamanders. Regeneration involves extensive neurogenesis and requires activation of quiescent ependymoglia cells, which express dopamine receptors. Pharmacological compensation for dopamine loss by L-dopa inhibits ependymoglia proliferation and regeneration in a dopamine receptor-signaling-dependent manner, specifically after ablation of dopamine neurons. Systemic administration of the dopamine receptor antagonist haloperidol alone causes ependymoglia proliferation and the appearance of excessive number of neurons. Our data show that stem cell quiescence is under dopamine control and provide a model for termination once normal homeostasis is restored. The findings establish a role for dopamine in the reversible suppression of neurogenesis in the midbrain and have implications for regenerative strategies in Parkinson's disease.	[Berg, Daniel A.; Kirkham, Matthew; Wang, Heng; Frisen, Jonas; Simon, Andras] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Berg, Daniel A.; Kirkham, Matthew; Wang, Heng; Frisen, Jonas; Simon, Andras] Karolinska Inst, Ctr Dev Biol Regenerat Med DBRM, SE-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Simon, A (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden.	andras.simon@ki.se	Kirkham, Matthew/I-5458-2012	Berg, Daniel/0000-0001-9595-2052; Simon, Andras/0000-0002-1018-1891; Kirkham, Matthew/0000-0003-0920-5355	Karolinska Institute, Swedish Research Council, Parkinsonfonden, Cancerfonden; AFA Forsakringar; HFSPO; Wenner-Gren Foundation	Karolinska Institute, Swedish Research Council, Parkinsonfonden, Cancerfonden(Karolinska InstitutetSwedish Research CouncilSwedish Cancer Society); AFA Forsakringar; HFSPO(Human Frontier Science Program); Wenner-Gren Foundation	We thank E. Arenas, J. Ericson, U. Lendahl, and T. Perlmann for critical reading of the manuscript. This work was supported by the Karolinska Institute, Swedish Research Council, Parkinsonfonden, Cancerfonden to A.S. and AFA Forsakringar to A.S. and J.F. M.K. was supported by a HFSPO long-term postdoctoral fellowship and H.W. was supported by a postdoctoral fellowship from the Wenner-Gren Foundation.	Barnabe-Heider F, 2008, NAT METHODS, V5, P189, DOI 10.1038/NMETH.1174; Benraiss A, 1996, DEV DYNAM, V205, P135, DOI 10.1002/(SICI)1097-0177(199602)205:2<135::AID-AJA5>3.0.CO;2-J; Berg DA, 2010, DEVELOPMENT, V137, P4127, DOI 10.1242/dev.055541; Brockes J, 2005, CURR BIOL, V15, pR42, DOI 10.1016/j.cub.2004.12.049; BULLOUGH WS, 1965, CANCER RES, V25, P1683; Carlsson T, 2007, CURR GENE THER, V7, P109, DOI 10.2174/156652307780363125; CHERAMY A, 1981, NATURE, V289, P537, DOI 10.1038/289537a0; Echeverri K, 2002, SCIENCE, V298, P1993, DOI 10.1126/science.1077804; Friling S, 2009, P NATL ACAD SCI USA, V106, P7613, DOI 10.1073/pnas.0902396106; Ge SY, 2007, TRENDS NEUROSCI, V30, P1, DOI 10.1016/j.tins.2006.11.001; GEFFEN LB, 1976, NATURE, V260, P258, DOI 10.1038/260258a0; Goetz CG, 2005, MOVEMENT DISORD, V20, P523, DOI 10.1002/mds.20464; Gonzalez A., 1994, P77; Harms C, 2007, J NEUROSCI, V27, P4562, DOI 10.1523/JNEUROSCI.5110-06.2007; Hoglinger GU, 2004, NAT NEUROSCI, V7, P726, DOI 10.1038/nn1265; JACKSON DM, 1994, PHARMACOL THERAPEUT, V64, P291, DOI 10.1016/0163-7258(94)90041-8; Kim SY, 2006, J NEUROSCI, V26, P4567, DOI 10.1523/JNEUROSCI.5236-05.2006; Kippin TE, 2005, J NEUROSCI, V25, P5815, DOI 10.1523/JNEUROSCI.1120-05.2005; Lander AD, 2009, PLOS BIOL, V7, P84, DOI 10.1371/journal.pbio.1000015; Lazzari M, 1997, J BRAIN RES, V38, P187; Lie DC, 2002, J NEUROSCI, V22, P6639; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Liu XX, 2005, NAT NEUROSCI, V8, P1179, DOI 10.1038/nn1522; Mchedlishvili L, 2007, DEVELOPMENT, V134, P2083, DOI 10.1242/dev.02852; O'Keeffe GC, 2009, P NATL ACAD SCI USA, V106, P8754, DOI 10.1073/pnas.0803955106; OBOYLE KM, 1987, J NEUROCHEM, V48, P1039, DOI 10.1111/j.1471-4159.1987.tb05623.x; Parish CL, 2008, J CLIN INVEST, V118, P149, DOI 10.1172/JCI32273; Parish CL, 2007, DEVELOPMENT, V134, P2881, DOI 10.1242/dev.002329; Pellettieri J, 2007, ANNU REV GENET, V41, P83, DOI 10.1146/annurev.genet.41.110306.130244; Rinner WA, 1997, NEUROSCIENCE, V79, P535, DOI 10.1016/S0306-4522(96)00687-2; Shan XY, 2006, STEM CELLS, V24, P1280, DOI 10.1634/stemcells.2005-0487; Zhao M, 2003, P NATL ACAD SCI USA, V100, P7925, DOI 10.1073/pnas.1131955100	32	62	64	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 8	2011	8	4					426	433		10.1016/j.stem.2011.02.001	http://dx.doi.org/10.1016/j.stem.2011.02.001			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	752QI	21474106	Bronze			2022-12-28	WOS:000289707100014
J	Ha, NN; Byers, B; Cord, B; Shcheglovitov, A; Byrne, J; Gujar, P; Kee, K; Schule, B; Dolmetsch, RE; Langston, W; Palmer, TD; Pera, RR				Ha Nam Nguyen; Byers, Blake; Cord, Branden; Shcheglovitov, Aleksandr; Byrne, James; Gujar, Prachi; Kee, Kehkooi; Schuele, Birgitt; Dolmetsch, Ricardo E.; Langston, William; Palmer, Theo D.; Pera, Renee Reijo			LRRK2 Mutant iPSC-Derived DA Neurons Demonstrate Increased Susceptibility to Oxidative Stress	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; MIDBRAIN DOPAMINERGIC-NEURONS; LEWY-BODY-DISEASE; PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; SUBSTANTIA-NIGRA; ALZHEIMERS-DISEASE; HUMAN FIBROBLASTS; KINASE-ACTIVITY; ANIMAL-MODELS	Studies of Parkinson's disease (PD) have been hindered by lack of access to affected human dopaminergic (DA) neurons. Here, we report generation of induced pluripotent stem cells that carry the p.G2019S mutation (G2019S-iPSCs) in the Leucine-Rich Repeat Kinase-2 (LRRK2) gene, the most common PD-related mutation, and their differentiation into DA neurons. The high penetrance of the LRRK2 mutation and its clinical resemblance to sporadic PD suggest that these cells could provide a valuable platform for disease analysis and drug development. We found that DA neurons derived from G2019S-iPSCs showed increased expression of key oxidative stress-response genes and alpha-synuclein protein. The mutant neurons were also more sensitive to caspase-3 activation and cell death caused by exposure to stress agents, such as hydrogen peroxide, MG-132, and 6-hydroxydopamine, than control DA neurons. This enhanced stress sensitivity is consistent with existing understanding of early PD phenotypes and represents a potential therapeutic target.	[Ha Nam Nguyen; Byers, Blake; Cord, Branden; Byrne, James; Gujar, Prachi; Kee, Kehkooi; Palmer, Theo D.; Pera, Renee Reijo] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Ha Nam Nguyen; Byers, Blake; Byrne, James; Gujar, Prachi; Kee, Kehkooi; Pera, Renee Reijo] Stanford Univ, Dept Obstet & Gynecol, Stanford, CA 94305 USA; [Byers, Blake; Palmer, Theo D.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Cord, Branden] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Shcheglovitov, Aleksandr; Dolmetsch, Ricardo E.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Schuele, Birgitt; Langston, William] Parkinsons Inst & Clin Ctr, Sunnyvale, CA 94085 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Palmer, TD (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	tpalmer@stanford.edu; reneer@stanford.edu	Palmer, Theo/GSI-6635-2022	Schuele, Birgitt/0000-0002-9952-5776; KEE, KEHKOOI/0000-0001-6926-7203; Cord, Branden/0000-0002-9120-5989; Palmer, Theo/0000-0002-6266-1862	CIRM [RL1-00670-1, CL-00518-1, TG2-01159]; Blume Foundation; Kinetics Foundation; Parkinson's Alliance; Stanford Institute for Stem Cell Biology and Regenerative Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069375] Funding Source: NIH RePORTER	CIRM(California Institute for Regenerative Medicine); Blume Foundation; Kinetics Foundation; Parkinson's Alliance; Stanford Institute for Stem Cell Biology and Regenerative Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Reijo Pera Lab for their helpful suggestions and feedback and Matha Isla and Ian Irwin for HPLC analysis of dopamine release studies. This research was supported by funds from CIRM (RL1-00670-1 and CL-00518-1, RRP, TG2-01159, A.S.), the Blume Foundation (T.D.P. and B.S.), Kinetics Foundation (T.D.P.), Parkinson's Alliance (J.W.L. and B.S.), Stanford Institute for Stem Cell Biology and Regenerative Medicine (R.R.P.), and a generous donor (T.D.P. and R.R.P.).	Baba M, 1998, AM J PATHOL, V152, P879; Bayer TA, 1999, NEUROSCI LETT, V266, P213, DOI 10.1016/S0304-3940(99)00311-0; Berretta N, 2005, NEUROTOXICOLOGY, V26, P869, DOI 10.1016/j.neuro.2005.01.014; Betarbet R, 2002, BIOESSAYS, V24, P308, DOI 10.1002/bies.10067; Byrne JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007118; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Cookson MR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-9; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; de Rijk MC, 2000, NEUROLOGY, V54, pS21; Di Salvio M, 2010, INT J DEV BIOL, V54, P939, DOI 10.1387/ijdb.092974ms; Ding YM, 2004, J NEUROCHEM, V89, P776, DOI 10.1111/j.1471-4159.2004.02415.x; Duan WR, 2003, J PATHOL, V199, P221, DOI 10.1002/path.1289; Giasson BI, 2006, ANN NEUROL, V59, P315, DOI 10.1002/ana.20791; Han BS, 2008, NEUROSCI LETT, V442, P190, DOI 10.1016/j.neulet.2008.06.086; Hashimoto M, 1999, BRAIN PATHOL, V9, P707; Heo HY, 2010, EXP CELL RES, V316, P649, DOI 10.1016/j.yexcr.2009.09.014; Hernandez D, 2005, NEUROSCI LETT, V389, P137, DOI 10.1016/j.neulet.2005.07.044; Ichinose H, 1999, GENE, V230, P233, DOI 10.1016/S0378-1119(99)00065-7; Kachergus J, 2005, AM J HUM GENET, V76, P672, DOI 10.1086/429256; Kittappa R, 2007, PLOS BIOL, V5, P2875, DOI 10.1371/journal.pbio.0050325; Kossack N, 2009, STEM CELLS, V27, P138, DOI 10.1634/stemcells.2008-0439; Liang CL, 1996, NEURODEGENERATION, V5, P313, DOI 10.1006/neur.1996.0042; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Milosevic J, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-25; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Ng CH, 2009, J NEUROSCI, V29, P11257, DOI 10.1523/JNEUROSCI.2375-09.2009; Nichols RJ, 2009, BIOCHEM J, V424, P47, DOI 10.1042/BJ20091035; Nichols WC, 2005, LANCET, V365, P410, DOI 10.1016/S0140-6736(05)17828-3; Nunes I, 2003, P NATL ACAD SCI USA, V100, P4245, DOI 10.1073/pnas.0230529100; Paisan-Ruiz C, 2005, NEUROLOGY, V65, P696, DOI 10.1212/01.WNL.0000167552.79769.b3; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Ross OA, 2006, ANN NEUROL, V59, P388, DOI 10.1002/ana.20731; SAUER H, 1994, NEUROSCIENCE, V59, P401, DOI 10.1016/0306-4522(94)90605-X; Schule B, 2009, BBA-MOL BASIS DIS, V1792, P1043, DOI 10.1016/j.bbadis.2009.08.014; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Sun F, 2006, NEUROTOXICOLOGY, V27, P807, DOI 10.1016/j.neuro.2006.06.006; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vernay B, 2005, J NEUROSCI, V25, P4856, DOI 10.1523/JNEUROSCI.5158-04.2005; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102	44	542	565	0	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 4	2011	8	3					267	280		10.1016/j.stem.2011.01.013	http://dx.doi.org/10.1016/j.stem.2011.01.013			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	735HI	21362567	Green Accepted, Bronze			2022-12-28	WOS:000288404400009
J	Feng, WJ; Khan, MA; Bellvis, P; Zhu, Z; Bernhardt, O; Herold-Mende, C; Liu, HK				Feng, Weijun; Khan, Muhammad Amir; Bellvis, Pablo; Zhu, Zhe; Bernhardt, Olga; Herold-Mende, Christel; Liu, Hai-Kun			The Chromatin Remodeler CHD7 Regulates Adult Neurogenesis via Activation of SoxC Transcription Factors	CELL STEM CELL			English	Article							NEURAL STEM-CELLS; NUCLEAR RECEPTOR TAILLESS; DE-NOVO MUTATIONS; CHARGE-SYNDROME; SUBVENTRICULAR ZONE; MAMMALIAN BRAIN; ANALYSIS REVEALS; GENES; EXPANSION; PROTEIN	Chromatin factors that regulate neurogenesis in the central nervous system remain to be explored. Here, we demonstrate that the chromatin remodeler chromodomain-helicase-DNA-binding protein 7 (CHD7), a protein frequently mutated in human CHARGE syndrome, is a master regulator of neurogenesis in mammalian brain. CHD7 is selectively expressed in actively dividing neural stem cells (NSCs) and progenitors. Genetic inactivation of CHD7 in NSCs leads to a reduction of neuronal differentiation and aberrant dendritic development of newborn neurons. Strikingly, physical exercise can rescue the CHD7 mutant phenotype in the adult hippocampal dentate gyrus. We further show that in NSCs, CHD7 stimulates the expression of Sox4 and Sox11 genes via remodeling their promoters to an open chromatin state. Our study demonstrates an essential role of CHD7 in activation of the neuronal differentiation program in NSCs, thus providing insights into epigenetic regulation of stem cell differentiation and molecular mechanism of human CHARGE syndrome.	[Feng, Weijun; Khan, Muhammad Amir; Bellvis, Pablo; Zhu, Zhe; Bernhardt, Olga; Liu, Hai-Kun] DKFZ ZMBH Alliance, German Canc Res Ctr DKFZ, Helmholtz Young Investigator Grp Normal & Neoplas, D-69120 Heidelberg, Germany; [Herold-Mende, Christel] Heidelberg Univ, Dept Neurosurg, Div Neurosurg Res, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Liu, HK (corresponding author), DKFZ ZMBH Alliance, German Canc Res Ctr DKFZ, Helmholtz Young Investigator Grp Normal & Neoplas, Neuenheimer Feld 581, D-69120 Heidelberg, Germany.	l.haikun@dkfz-heidelberg.de	Zhu, Zhe/H-6009-2019	Zhu, Zhe/0000-0002-5385-948X; liu, hai-kun/0000-0003-3338-4066	Helmholtz Young Investigator Award [VH-NG-702]; Deutsche Forschungsgemeinschaft [LI 2140/1-1, LI2140/2-1]; Deutsche Krebshilfe [110226]; Helmholtz Alliance PCCC; DKFZ Intramural Grant Program	Helmholtz Young Investigator Award; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Helmholtz Alliance PCCC; DKFZ Intramural Grant Program	We thank Ingrid Grummt for her constructive comments. We thank Gunther Schutz, Patricia Rusu, and Monika Bock for their critical reading of the manu-script. We thank the Imaging Facility of the DKFZ and the Carl Zeiss Imaging Center in the DKFZ for their support with image acquisition. This work was supported by the Helmholtz Young Investigator Award (VH-NG-702), the Deutsche Forschungsgemeinschaft (LI 2140/1-1 and LI2140/2-1), the Deutsche Krebshilfe (110226), the Helmholtz Alliance PCCC, and the DKFZ Intramural Grant Program.	Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Marques-Torrejon MA, 2013, CELL STEM CELL, V12, P88, DOI 10.1016/j.stem.2012.12.001; Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Batsukh T, 2010, HUM MOL GENET, V19, P2858, DOI 10.1093/hmg/ddq189; Beckervordersandforth R, 2010, CELL STEM CELL, V7, P744, DOI 10.1016/j.stem.2010.11.017; Berdasco M, 2010, DEV CELL, V19, P698, DOI 10.1016/j.devcel.2010.10.005; Bergman JEH, 2011, J MED GENET, V48, P334, DOI 10.1136/jmg.2010.087106; Bergsland M, 2006, GENE DEV, V20, P3475, DOI 10.1101/gad.403406; Bergsland M, 2011, GENE DEV, V25, P2453, DOI 10.1101/gad.176008.111; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blustajn J, 2008, AM J NEURORADIOL, V29, P1266, DOI 10.3174/ajnr.A1099; Bouazoune K, 2012, P NATL ACAD SCI USA, V109, P19238, DOI 10.1073/pnas.1213825109; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Corsini NS, 2009, CELL STEM CELL, V5, P178, DOI 10.1016/j.stem.2009.05.004; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1997, J NEUROSCI, V17, P5046; Engelen E, 2011, NAT GENET, V43, P607, DOI 10.1038/ng.825; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Hall JA, 2007, BIOCHEM CELL BIOL, V85, P463, DOI 10.1139/O07-063; Hartshorne TS, 2005, AM J MED GENET A, V133A, P257, DOI 10.1002/ajmg.a.30545; Jakovcevski M, 2012, NAT MED, V18, P1194, DOI 10.1038/nm.2828; Julian LM, 2013, CELL STEM CELL, V12, P440, DOI 10.1016/j.stem.2013.02.001; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kuhlbrodt K, 1998, J BIOL CHEM, V273, P16050, DOI 10.1074/jbc.273.26.16050; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Liu HK, 2008, GENE DEV, V22, P2473, DOI 10.1101/gad.479308; Liu HK, 2010, GENE DEV, V24, P683, DOI 10.1101/gad.560310; Ma DKK, 2010, NAT NEUROSCI, V13, P1338, DOI 10.1038/nn.2672; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mu LF, 2012, J NEUROSCI, V32, P3067, DOI 10.1523/JNEUROSCI.4679-11.2012; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Niu WZ, 2011, J NEUROSCI, V31, P13816, DOI 10.1523/JNEUROSCI.1038-11.2011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Schnetz MP, 2009, GENOME RES, V19, P590, DOI 10.1101/gr.086983.108; Sock E, 2004, MOL CELL BIOL, V24, P6635, DOI 10.1128/mcb.24.15.6635-6644.2004; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Walter K, 2008, BLOOD, V112, P1673, DOI 10.1182/blood-2008-02-142786; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	49	103	105	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2013	13	1					62	72		10.1016/j.stem.2013.05.002	http://dx.doi.org/10.1016/j.stem.2013.05.002			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VJ	23827709	Bronze			2022-12-28	WOS:000329570100013
J	Engle, SJ; Puppala, D				Engle, Sandra J.; Puppala, Dinesh			Integrating Human Pluripotent Stem Cells into Drug Development	CELL STEM CELL			English	Review							RESEARCH-AND-DEVELOPMENT; PHARMACEUTICAL RESEARCH; IPS CELLS; HUMAN ES; DIFFERENTIATION; INDUCTION; LINES; DISCOVERY; MEDICINES; PARADIGM	Integration of physiologically relevant in vitro assays at the earliest stages of drug discovery may improve the likelihood of successfully translating preclinical discoveries to the clinic. Assays based on in vitro-differentiated, human pluripotent stem cell (IVD hPSC)-derived cells, which may better model human physiology, are starting to impact the drug discovery process, but their implementation has been slower than originally anticipated. In this Perspective, we discuss imperatives for incorporating IVD hPSCs into drug discovery and the associated challenges.	[Engle, Sandra J.] Pfizer Inc, Pharmacokinet Dynam & Metab, Groton, CT 06340 USA; [Puppala, Dinesh] Pfizer Inc, Compound Safety Predict, Groton, CT 06340 USA	Pfizer; Pfizer	Engle, SJ (corresponding author), Pfizer Inc, Pharmacokinet Dynam & Metab, Eastern Point Rd, Groton, CT 06340 USA.	sandra.j.engle@pfizer.com						Allen MJ, 2010, CLIN CHEM, V56, P1675, DOI 10.1373/clinchem.2010.150672; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; An WF, 2010, MOL BIOTECHNOL, V45, P180, DOI 10.1007/s12033-010-9251-z; Baker MH, 2012, RICHMOND THEATER FIRE: EARLY AMERICA'S FIRST GREAT DISASTER, P215; Campbell Angela, 2005, Med Law Int, V7, P113; Cezar GG, 2007, CURR OPIN CHEM BIOL, V11, P405, DOI 10.1016/j.cbpa.2007.05.033; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chan SY, 2012, CIRC RES, V111, P359, DOI 10.1161/CIRCRESAHA.111.258541; Cheng LT, 2012, GENES CELLS, V17, P431, DOI 10.1111/j.1365-2443.2012.01599.x; Czepiel M, 2011, GLIA, V59, P882, DOI 10.1002/glia.21159; De Trizio Ella, 2004, J Biolaw Bus, V7, P14; Dolsten M, 2012, CLIN TRANSL MED, V1, DOI 10.1186/2001-1326-1-7; Eggert US, 2013, NAT CHEM BIOL, V9, P206, DOI 10.1038/nchembio.1206; Eglen R, 2011, ASSAY DRUG DEV TECHN, V9, P108, DOI 10.1089/adt.2010.0305; Eglen RM, 2008, COMB CHEM HIGH T SCR, V11, P560, DOI 10.2174/138620708785204144; Fakunle ES, 2012, TRENDS MOL MED, V18, P709, DOI 10.1016/j.molmed.2012.10.007; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Garbes L, 2013, HUM MOL GENET, V22, P398, DOI 10.1093/hmg/dds437; Georgieva BP, 2010, REGEN MED, V5, P581, DOI 10.2217/RME.10.43; Gittes GK, 2009, DEV BIOL, V326, P4, DOI 10.1016/j.ydbio.2008.10.024; Goldbard S, 2006, CURR OPIN DRUG DISC, V9, P110; Goldin E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029861; Greek R, 2012, THEOR BIOL MED MODEL, V9, DOI 10.1186/1742-4682-9-40; Gulbrandsen C, 2007, NAT BIOTECHNOL, V25, P387, DOI 10.1038/nbt0407-387; Hart Y, 2012, P NATL ACAD SCI USA, V109, P8346, DOI 10.1073/pnas.1117475109; Knight A, 2007, ALTEX-ALTERN TIEREXP, V24, P320, DOI 10.14573/altex.2007.4.320; Lasser KE, 2002, JAMA-J AM MED ASSOC, V287, P2215, DOI 10.1001/jama.287.17.2215; LEONARDBARTON D, 1985, HARVARD BUS REV, V63, P102; Levine AD, 2011, NAT BIOTECHNOL, V29, P1079, DOI 10.1038/nbt.2029; Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150; Liang P, 2013, CIRCULATION, V127, P1677, DOI 10.1161/CIRCULATIONAHA.113.001883; Lodge AP, 2010, J BIOMOL SCREEN, V15, P159, DOI 10.1177/1087057109355468; Lowenthal J, 2012, STEM CELL TRANSL MED, V1, P409, DOI 10.5966/sctm.2012-0029; Macarron R, 2011, NAT REV DRUG DISCOV, V10, P188, DOI 10.1038/nrd3368; Makley LN, 2013, CHEM BIOL DRUG DES, V81, P22, DOI 10.1111/cbdd.12066; Merkle FT, 2013, CELL STEM CELL, V12, P656, DOI 10.1016/j.stem.2013.05.016; Munos BH, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000155; Nicholas CR, 2013, CELL STEM CELL, V12, P573, DOI 10.1016/j.stem.2013.04.005; Nolan GP, 2007, NAT CHEM BIOL, V3, P187, DOI 10.1038/nchembio0407-187; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576; President's Council of Advisors on Science and Technology (PCAST), 2008, PRIOR PERS MED REP P; Puppala D, 2013, TOXICOL SCI, V131, P292, DOI 10.1093/toxsci/kfs282; Rao M, 2013, CELL STEM CELL, V12, P149, DOI 10.1016/j.stem.2013.01.010; Rowntree RK, 2010, REGEN MED, V5, P557, DOI [10.2217/rme.10.36, 10.2217/RME.10.36]; Sahi Jasminder, 2010, Curr Drug Discov Technol, V7, P188; Sams-Dodd F, 2013, DRUG DISCOV TODAY, V18, P211, DOI 10.1016/j.drudis.2012.10.010; Sandusky G, 2009, VET PATHOL, V46, P2, DOI 10.1354/vp.46-1-2; Sartipy P, 2007, DRUG DISCOV TODAY, V12, P688, DOI 10.1016/j.drudis.2007.07.005; Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681; Schuster D, 2005, CURR PHARM DESIGN, V11, P3545, DOI 10.2174/138161205774414510; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Song ZH, 2009, CELL RES, V19, P1233, DOI 10.1038/cr.2009.107; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tohyama S, 2013, CELL STEM CELL, V12, P127, DOI 10.1016/j.stem.2012.09.013; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; Van Vliet P, 2012, CARDIOVASC RES, V96, P352, DOI 10.1093/cvr/cvs270; Vidal R, 2011, CURR PHARM DESIGN, V17, P521, DOI 10.2174/138161211795164086; Vieira C, 2010, INT J DEV BIOL, V54, P7, DOI 10.1387/ijdb.092853cv; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Yang YM, 2013, CELL STEM CELL, V12, P713, DOI 10.1016/j.stem.2013.04.003; Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855; Yi P, 2013, CELL, V153, P747, DOI 10.1016/j.cell.2013.04.008; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang DH, 2009, CELL RES, V19, P429, DOI 10.1038/cr.2009.28	69	99	103	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 6	2013	12	6					669	677		10.1016/j.stem.2013.05.011	http://dx.doi.org/10.1016/j.stem.2013.05.011			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VH	23746976	Bronze			2022-12-28	WOS:000329569900010
J	Trounson, A; DeWitt, ND				Trounson, Alan; DeWitt, Natalie D.			Pluripotent Stem Cells from Cloned Human Embryos: Success at Long Last	CELL STEM CELL			English	Editorial Material							NUCLEAR TRANSFER; FIBROBLASTS	Recently in Cell, Mitalipov and colleagues report an advance that has eluded scientists for over a decade-the successful derivation of embryonic stem cell lines using somatic cell nuclear transfer, or SCNT (Tachibana et al., 2013).	[Trounson, Alan; DeWitt, Natalie D.] Calif Inst Regenerat Med, San Francisco, CA 94107 USA; [Trounson, Alan] Monash Med Res Inst, Ritchie Ctr, Clayton, Vic 3168, Australia		Trounson, A (corresponding author), Calif Inst Regenerat Med, 210 King St, San Francisco, CA 94107 USA.	atrounson@cirm.ca.gov; ndewitt@cirm.ca.gov		Trounson, Alan/0000-0001-5469-0500				Byrne JA, 2007, NATURE, V450, P497, DOI 10.1038/nature06357; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; French AJ, 2008, STEM CELLS, V26, P485, DOI 10.1634/stemcells.2007-0252; Grieshammer U, 2011, NAT BIOTECHNOL, V29, P701, DOI 10.1038/nbt.1933; GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Kim K, 2007, CELL STEM CELL, V1, P346, DOI 10.1016/j.stem.2007.07.001; Noggle S, 2011, NATURE, V478, P70, DOI 10.1038/nature10397; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019	10	14	14	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 6	2013	12	6					636	638		10.1016/j.stem.2013.05.022	http://dx.doi.org/10.1016/j.stem.2013.05.022			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VH	23746970	Bronze			2022-12-28	WOS:000329569900004
J	Yang, YM; Gupta, SK; Kim, KJ; Powers, BE; Cerqueira, A; Wainger, BJ; Ngo, HD; Rosowski, KA; Schein, PA; Ackeifi, CA; Arvanites, AC; Davidow, LS; Woolf, CJ; Rubin, LL				Yang, Yin M.; Gupta, Shailesh K.; Kim, Kevin J.; Powers, Berit E.; Cerqueira, Antonio; Wainger, Brian J.; Ngo, Hien D.; Rosowski, Kathryn A.; Schein, Pamela A.; Ackeifi, Courtney A.; Arvanites, Anthony C.; Davidow, Lance S.; Woolf, Clifford J.; Rubin, Lee L.			A Small Molecule Screen in Stem-Cell-Derived Motor Neurons Identifies a Kinase Inhibitor as a Candidate Therapeutic for ALS	CELL STEM CELL			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; MOUSE MODEL; C-JUN; MATRIX METALLOPROTEINASES; DISEASE PROGRESSION; PROTEIN-KINASE; SURVIVAL; TDP-43; DEATH	Amyotrophic lateral sclerosis (ALS) is a rapidly progressing neurodegenerative disease, characterized by motor neuron (MN) death, for which there are no truly effective treatments. Here, we describe a new small molecule survival screen carried out using MNs from both wild-type and mutant SOD1 mouse embryonic stem cells. Among the hits we found, kenpaullone had a particularly impressive ability to prolong the healthy survival of both types of MNs that can be attributed to its dual inhibition of GSK-3 and HGK kinases. Furthermore, kenpaullone also strongly improved the survival of human MNs derived from ALS-patient-induced pluripotent stem cells and was more active than either of two compounds, olesoxime and dexpramipexole, that recently failed in ALS clinical trials. Our studies demonstrate the value of a stem cell approach to drug discovery and point to a new paradigm for identification and preclinical testing of future ALS therapeutics.	[Yang, Yin M.; Gupta, Shailesh K.; Kim, Kevin J.; Powers, Berit E.; Cerqueira, Antonio; Ngo, Hien D.; Rosowski, Kathryn A.; Schein, Pamela A.; Ackeifi, Courtney A.; Rubin, Lee L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Yang, Yin M.; Gupta, Shailesh K.; Kim, Kevin J.; Powers, Berit E.; Cerqueira, Antonio; Ngo, Hien D.; Rosowski, Kathryn A.; Schein, Pamela A.; Ackeifi, Courtney A.; Arvanites, Anthony C.; Davidow, Lance S.; Rubin, Lee L.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Rosowski, Kathryn A.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Wainger, Brian J.; Woolf, Clifford J.] Childrens Hosp, Program Neurobiol, Boston, MA 02115 USA; [Wainger, Brian J.; Woolf, Clifford J.] Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Wainger, Brian J.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA	Harvard University; Harvard University; Yale University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital	Rubin, LL (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	lee_rubin@harvard.edu	Wainger, Brian/L-7553-2017; Woolf, Clifford/A-9784-2010	Kim, Kevin/0000-0002-7015-5871; Ackeifi, Courtney/0000-0002-7110-5841; Rubin, Lee/0000-0002-8658-841X	ALS Association; New York Stem Cell Foundation; NINDS [P01NS066888]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS066888] Funding Source: NIH RePORTER	ALS Association; New York Stem Cell Foundation; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to K. Eggan for providing mouse ESCs and human ESCs and iPSCs, G. Daley for providing the TDP-43 human iPSCs, and B. Doble and J. Woodgett for providing mouse GSK-KO ESC lines. We would also like to thank B. Tilton and P. Rogers for assistance with FACS; K. Kotkow, A. D. Sinor-Anderson, N. Makhortova, M. Hayhurst, K. Krumholz, G. Boulting, J. Ichida, E. Kiskinis, and A. Blumenstein for providing reagents and helpful discussions; and J. LaLonde for editorial assistance. This work was supported by the ALS Association, the New York Stem Cell Foundation, NINDS (P01NS066888), and the Harvard Stem Cell Institute. L.L.R. is a founder of iPierian Inc. and a member of its Scientific Advisory Board.	Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Barthelemy C, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-48; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bordet T, 2007, J PHARMACOL EXP THER, V322, P709, DOI 10.1124/jpet.107.123000; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Brown RH, 1997, ARCH NEUROL-CHICAGO, V54, P1246, DOI 10.1001/archneur.1997.00550220050013; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Cudkowicz M, 2011, NAT MED, V17, P1652, DOI 10.1038/nm.2579; Dewil M, 2007, NEUROPATH APPL NEURO, V33, P499, DOI 10.1111/j.1365-2990.2007.00850.x; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Diaz-Amarilla P, 2011, P NATL ACAD SCI USA, V108, P18126, DOI 10.1073/pnas.1110689108; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Gribkoff VK, 2008, CNS NEUROSCI THER, V14, P215, DOI 10.1111/j.1755-5949.2008.00048.x; Grosskreutz J, 2010, CELL CALCIUM, V47, P165, DOI 10.1016/j.ceca.2009.12.002; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; HAM J, 1995, NEURON, V14, P927, DOI 10.1016/0896-6273(95)90331-3; Hetman M, 2000, ACTA NEUROBIOL EXP, V60, P531; Hoing S, 2012, CELL STEM CELL, V11, P620, DOI 10.1016/j.stem.2012.07.005; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Joyce PI, 2011, MAMM GENOME, V22, P420, DOI 10.1007/s00335-011-9339-1; Kieran D, 2008, J NEUROSCI, V28, P14056, DOI 10.1523/JNEUROSCI.3399-08.2008; Kim K, 2006, EUR J PHARMACOL, V542, P100, DOI 10.1016/j.ejphar.2006.05.025; Koh SH, 2007, EXP NEUROL, V205, P336, DOI 10.1016/j.expneurol.2007.03.004; Koh SH, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/205761; Koh SH, 2004, TOXICOLOGY, V202, P213, DOI 10.1016/j.tox.2004.05.008; Lange C, 2011, NEUROSCI LETT, V488, P36, DOI 10.1016/j.neulet.2010.10.076; Linseman DA, 2004, J NEUROSCI, V24, P9993, DOI 10.1523/JNEUROSCI.2057-04.2004; Lorenzl S, 2006, EXP NEUROL, V200, P166, DOI 10.1016/j.expneurol.2006.01.026; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; Makhortova NR, 2011, NAT CHEM BIOL, V7, P544, DOI [10.1038/NCHEMBIO.595, 10.1038/nchembio.595]; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; Martin LJ, 2001, INT J MOL MED, V7, P455; Mattson MP, 1997, APOPTOSIS, V2, P257, DOI 10.1023/A:1026433019210; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; Miller RG, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001447.pub2; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Niebroj-Dobosz I, 2010, EUR J NEUROL, V17, P226, DOI 10.1111/j.1468-1331.2009.02775.x; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rubin LL, 2008, CELL, V132, P549, DOI 10.1016/j.cell.2008.02.010; Saito Y, 2005, J BIOL CHEM, V280, P42826, DOI 10.1074/jbc.M507685200; Sandyk R, 2006, INT J NEUROSCI, V116, P775, DOI 10.1080/00207450600754087; Shoemaker JL, 2007, J NEUROCHEM, V101, P87, DOI 10.1111/j.1471-4159.2006.04346.x; Smith RA, 2006, J CLIN INVEST, V116, P2290, DOI 10.1172/JCI25424; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Sunyach C, 2012, NEUROPHARMACOLOGY, V62, P2346, DOI 10.1016/j.neuropharm.2012.02.013; Tradewell ML, 2010, NEUROREPORT, V21, P976, DOI 10.1097/WNR.0b013e32833ddd45; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Wang LJ, 2010, J NEUROCHEM, V113, P166, DOI 10.1111/j.1471-4159.2010.06594.x; Watson A, 1998, J NEUROSCI, V18, P751; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wootz H, 2006, EXP CELL RES, V312, P1890, DOI 10.1016/j.yexcr.2006.02.021; Yao ZB, 1999, J BIOL CHEM, V274, P2118, DOI 10.1074/jbc.274.4.2118	58	216	230	2	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 6	2013	12	6					713	726		10.1016/j.stem.2013.04.003	http://dx.doi.org/10.1016/j.stem.2013.04.003			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VH	23602540	Bronze, Green Accepted			2022-12-28	WOS:000329569900014
J	Beerman, I; Bock, C; Garrison, BS; Smith, ZD; Gu, HC; Meissner, A; Rossi, DJ				Beerman, Isabel; Bock, Christoph; Garrison, Brian S.; Smith, Zachary D.; Gu, Hongcang; Meissner, Alexander; Rossi, Derrick J.			Proliferation-Dependent Alterations of the DNA Methylation Landscape Underlie Hematopoietic Stem Cell Aging	CELL STEM CELL			English	Article							SELF-RENEWAL CAPACITY; AGE; DIFFERENTIATION; TRANSPLANTATION; FREQUENCY; SUBTYPES; LOCUS; BLOOD	The functional potential of hematopoietic stem cells (HSCs) declines during aging, and in doing so, significantly contributes to hematopoietic pathophysiology in the elderly. To explore the relationship between age-associated HSC decline and the epigenome, we examined global DNA methylation of HSCs during ontogeny in combination with functional analysis. Although the DNA methylome is generally stable during aging, site-specific alterations of DNA methylation occur at genomic regions associated with hematopoietic lineage potential and selectively target genes expressed in downstream progenitor and effector cells. We found that age-associated HSC decline, replicative limits, and DNA methylation are largely dependent on the proliferative history of HSCs, yet appear to be telomere-length independent. Physiological aging and experimentally enforced proliferation of HSCs both led to DNA hypermethylation of genes regulated by Polycomb Repressive Complex 2. Our results provide evidence that epigenomic alterations of the DNA methylation landscape contribute to the functional decline of HSCs during aging.	[Beerman, Isabel; Garrison, Brian S.; Rossi, Derrick J.] Boston Childrens Hosp, Div Hematol Oncol, Program Cellular & Mol Med, Boston, MA 02116 USA; [Beerman, Isabel; Garrison, Brian S.; Rossi, Derrick J.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Beerman, Isabel; Bock, Christoph; Garrison, Brian S.; Smith, Zachary D.; Meissner, Alexander; Rossi, Derrick J.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Bock, Christoph; Smith, Zachary D.; Gu, Hongcang; Meissner, Alexander] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Meissner, Alexander; Rossi, Derrick J.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Meissner, A (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	alexander_meissner@harvard.edu; derrick.rossi@childrens.harvard.edu	Beerman, Isabel/AAN-4216-2020; Beerman, Isabel/Y-2555-2019; Bock, Christoph/AAE-7618-2019	Bock, Christoph/0000-0001-6091-3088; Gu, Hongcang/0000-0002-1439-7606; Beerman, Isabel/0000-0002-7758-8231	Harvard Stem Cell Institute; Pew Charitable Trusts	Harvard Stem Cell Institute; Pew Charitable Trusts	We would like to thank A. Zguro, R. Gazit, L. Fang, and M. Ziller for technical assistance; P. Mandal for helpful discussions; and E. Beerman for editorial help. This work was supported by a grant from the Harvard Stem Cell Institute. A. M. is supported by the Pew Charitable Trusts. D.J.R. and A. M. are New York Stem Cell Foundation, Robertson Investigators.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Agherbi H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005622; Allsopp RC, 2003, NAT MED, V9, P369, DOI 10.1038/nm0403-369; Allsopp RC, 2001, J EXP MED, V193, P917, DOI 10.1084/jem.193.8.917; Beerman I, 2010, CURR OPIN IMMUNOL, V22, P500, DOI 10.1016/j.coi.2010.06.007; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Benz C, 2012, CELL STEM CELL, V10, P273, DOI 10.1016/j.stem.2012.02.007; Bock C, 2012, MOL CELL, V47, P633, DOI 10.1016/j.molcel.2012.06.019; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Brinkman AB, 2012, GENOME RES, V22, P1128, DOI 10.1101/gr.133728.111; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; deHaan G, 1997, BLOOD, V89, P1543, DOI 10.1182/blood.V89.5.1543.1543_1543_1550; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Dykstra B, 2011, J EXP MED, V208, P2691, DOI 10.1084/jem.20111490; EWING KL, 1964, J GERONTOL, V19, P165, DOI 10.1093/geronj/19.2.165; Florian MC, 2012, CELL STEM CELL, V10, P520, DOI 10.1016/j.stem.2012.04.007; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Fukumoto JS, 2005, CRIT REV ONCOL HEMAT, V56, P179, DOI 10.1016/j.critrevonc.2005.04.006; Gonzalo S, 2010, J APPL PHYSIOL, V109, P586, DOI 10.1152/japplphysiol.00238.2010; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; Gu H, 2010, NAT METHODS, V7, P133, DOI 10.1038/nmeth.1414; HARRISON DE, 1982, J EXP MED, V156, P1767, DOI 10.1084/jem.156.6.1767; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Kamminga LM, 2006, BLOOD, V107, P2170, DOI 10.1182/blood-2005-09-3585; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Mandal PK, 2011, NAT REV MOL CELL BIO, V12, P198, DOI 10.1038/nrm3060; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Muller-Sieburg CE, 2004, BLOOD, V103, P4111, DOI 10.1182/blood-2003-10-3448; Norddahl GL, 2012, AGING CELL, V11, P1128, DOI 10.1111/j.1474-9726.2012.00863.x; Oh IH, 2012, STEM CELLS, V30, P82, DOI 10.1002/stem.776; Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108; Pappu R, 1999, SCIENCE, V286, P1949, DOI 10.1126/science.286.5446.1949; Pawliuk R, 1996, BLOOD, V88, P2852, DOI 10.1182/blood.V88.8.2852.bloodjournal8882852; Rank G, 2009, BLOOD, V113, P3352, DOI 10.1182/blood-2008-08-172841; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Rossi L, 2012, CELL STEM CELL, V11, P302, DOI 10.1016/j.stem.2012.08.006; Rube CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017487; Seita J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040321; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Smith ZD, 2009, METHODS, V48, P226, DOI 10.1016/j.ymeth.2009.05.003; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Thomas DJ, 2007, NUCLEIC ACIDS RES, V35, pD663, DOI 10.1093/nar/gkl1017; Van Zant G, 2003, EXP HEMATOL, V31, P659, DOI 10.1016/S0301-472X(03)00088-2; Wang HS, 2008, BLOOD, V112, P4028, DOI 10.1182/blood-2008-01-129049; Wang JW, 2012, CELL, V148, P1001, DOI 10.1016/j.cell.2012.01.040; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Weinhofer I., 2010, PLOS GENET, V6, P6; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yahata T, 2011, BLOOD, V118, P2941, DOI 10.1182/blood-2011-01-330050	60	305	309	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 4	2013	12	4					413	425		10.1016/j.stem.2013.01.017	http://dx.doi.org/10.1016/j.stem.2013.01.017			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VD	23415915	Bronze			2022-12-28	WOS:000329569500009
J	Nusse, YM; Klein, OD				Nusse, Ysbrand M.; Klein, Ophir D.			If a Stem Cell Dies in the Crypt, and No One Is Around to See It ...	CELL STEM CELL			English	Editorial Material							SMALL-INTESTINE; LGR5	Two recent studies continue the debate regarding lineage and hierarchy in the intestinal epithelium. One reports that quiescent crypt cells are Paneth cell precursors (Buczacki et al., 2013). The second shows that tamoxifen induces apoptosis in crypt cells and that suppressing apoptosis alters lineage tracing patterns (Zhuet al., 2013).	[Nusse, Ysbrand M.; Klein, Ophir D.] Univ Calif San Francisco, Biomed Sci Grad Program, Program Craniofacial & Mesenchymal Biol, San Francisco, CA 94143 USA; [Nusse, Ysbrand M.; Klein, Ophir D.] Univ Calif San Francisco, Dept Orofacial Sci, San Francisco, CA 94143 USA; [Klein, Ophir D.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Klein, Ophir D.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Klein, OD (corresponding author), Univ Calif San Francisco, Biomed Sci Grad Program, Program Craniofacial & Mesenchymal Biol, San Francisco, CA 94143 USA.	ophir.klein@ucsf.edu		Nusse, Ysbrand/0000-0001-6437-1490; Klein, Ophir/0000-0002-6254-7082	NICHD NIH HHS [T32 HD007470] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007470] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Kretzschmar K, 2012, CELL, V148, P33, DOI 10.1016/j.cell.2012.01.002; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; WINTON DJ, 1990, P ROY SOC B-BIOL SCI, V241, P13, DOI 10.1098/rspb.1990.0059; Zhu YH, 2013, CELL STEM CELL, V12, P298, DOI 10.1016/j.stem.2013.01.003	10	3	3	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 4	2013	12	4					389	390		10.1016/j.stem.2013.03.009	http://dx.doi.org/10.1016/j.stem.2013.03.009			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VD	23561439	Bronze			2022-12-28	WOS:000329569500004
J	Tohyama, S; Hattori, F; Sano, M; Hishiki, T; Nagahata, Y; Matsuura, T; Hashimoto, H; Suzuki, T; Yamashita, H; Satoh, Y; Egashira, T; Seki, T; Muraoka, N; Yamakawa, H; Ohgino, Y; Tanaka, T; Yoichi, M; Yuasa, S; Murata, M; Suematsu, M; Fukuda, K				Tohyama, Shugo; Hattori, Fumiyuki; Sano, Motoaki; Hishiki, Takako; Nagahata, Yoshiko; Matsuura, Tomomi; Hashimoto, Hisayuki; Suzuki, Tomoyuki; Yamashita, Hiromi; Satoh, Yusuke; Egashira, Toru; Seki, Tomohisa; Muraoka, Naoto; Yamakawa, Hiroyuki; Ohgino, Yasuyuki; Tanaka, Tomofumi; Yoichi, Masatoshi; Yuasa, Shinsuke; Murata, Mitsushige; Suematsu, Makoto; Fukuda, Keiichi			Distinct Metabolic Flow Enables Large-Scale Purification of Mouse and Human Pluripotent Stem Cell-Derived Cardiomyocytes	CELL STEM CELL			English	Article							DIFFERENTIATION; LACTATE; MUSCLE; HEARTS; FETAL	Heart disease remains a major cause of death despite advances in medical technology. Heart-regenerative therapy that uses pluripotent stem cells (PSCs) is a potentially promising strategy for patients with heart disease, but the inability to generate highly purified cardiomyocytes in sufficient quantities has been a barrier to realizing this potential. Here, we report a nongenetic method for mass-producing cardiomyocytes from mouse and human PSC derivatives that is based on the marked biochemical differences in glucose and lactate metabolism between cardiomyocytes and noncardiomyocytes, including undifferentiated cells. We cultured PSC derivatives with glucose-depleted culture medium containing abundant lactate and found that only cardiomyocytes survived. Using this approach, we obtained cardiomyocytes of up to 99% purity that did not form tumors after transplantation. We believe that our technological method broadens the range of potential applications for purified PSC-derived cardiomyocytes and could facilitate progress toward PSC-based cardiac regenerative therapy.	[Tohyama, Shugo; Hattori, Fumiyuki; Sano, Motoaki; Hashimoto, Hisayuki; Yamashita, Hiromi; Satoh, Yusuke; Egashira, Toru; Seki, Tomohisa; Muraoka, Naoto; Yamakawa, Hiroyuki; Ohgino, Yasuyuki; Yuasa, Shinsuke; Murata, Mitsushige; Fukuda, Keiichi] Keio Univ, Dept Cardiol, Sch Med, Tokyo 1608582, Japan; [Hishiki, Takako; Nagahata, Yoshiko; Matsuura, Tomomi; Suematsu, Makoto] Keio Univ, Dept Biochem, Sch Med, Tokyo 1608582, Japan; [Tohyama, Shugo] Japan Soc Promot Sci, Tokyo 1028472, Japan; [Hattori, Fumiyuki; Yamashita, Hiromi; Tanaka, Tomofumi; Yoichi, Masatoshi] Asubio Pharma, Kobe, Hyogo 6500047, Japan; [Nagahata, Yoshiko; Matsuura, Tomomi; Suematsu, Makoto] Japan Sci & Technol Agcy JST, Exploratory Res Adv Technol ERATO Suematsu Gas Bi, Tokyo 1608582, Japan; [Suzuki, Tomoyuki] Nagoya Univ, Dept Cardiovasc Res, Environm Med Res Inst, Nagoya, Aichi 4648601, Japan	Keio University; Keio University; Japan Society for the Promotion of Science; Asubio Pharma Co., Ltd.; Japan Science & Technology Agency (JST); Nagoya University	Hattori, F (corresponding author), Keio Univ, Dept Cardiol, Sch Med, Tokyo 1608582, Japan.	hattori.fumiyuki.ef@asubio.co.jp; kfukuda@a2.keio.jp	Suematsu, Makoto/O-5762-2018; Hashimoto, Hisayuki/AAS-1938-2020; Fukuda, Keiichi/L-3777-2013; Suematsu, Makoto/I-8135-2013; Seki, Tomohisa/L-3524-2013; Yuasa, Shinsuke/L-8310-2013; YAMAKAWA, Hiroyuki/L-8582-2013; Sano, Motoaki/L-3405-2013	Suematsu, Makoto/0000-0002-7165-6336; Hashimoto, Hisayuki/0000-0001-7367-4805; Suematsu, Makoto/0000-0002-7165-6336; YAMAKAWA, Hiroyuki/0000-0003-3100-5077; Seki, Tomohisa/0000-0002-4281-135X; Yuasa, Shinsuke/0000-0001-5593-7552; Muraoka, Naoto/0000-0003-0057-0292	Strategic Funds for the Promotion of Science and Technology of the Japanese Ministry of Education Sports, Science, and Technology (MEXT); Highway Program for the Realization of Regenerative Medicine; Japan Heart Foundation; Japan Science and Technology Agency (JST); Exploratory Research for Advanced Technology (ERATO); Suematsu Gas Biology Project; Asubio Pharma; Grants-in-Aid for Scientific Research [11J30002, 25461117, 23390072] Funding Source: KAKEN	Strategic Funds for the Promotion of Science and Technology of the Japanese Ministry of Education Sports, Science, and Technology (MEXT); Highway Program for the Realization of Regenerative Medicine; Japan Heart Foundation; Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Exploratory Research for Advanced Technology (ERATO)(Japan Science & Technology Agency (JST)); Suematsu Gas Biology Project; Asubio Pharma; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K. Sekine in the Department of Anatomy, Keio University School of Medicine for technical assistance with primary culturing of neurons. This study was mainly supported by the Strategic Funds for the Promotion of Science and Technology of the Japanese Ministry of Education Sports, Science, and Technology (MEXT) and the Highway Program for the Realization of Regenerative Medicine and partially supported by a Japan Heart Foundation research grant, the Japan Science and Technology Agency (JST), Exploratory Research for Advanced Technology (ERATO), Suematsu Gas Biology Project, and a research grant from Asubio Pharma. F.H., T.T., and M.Y. are the employees and H.Y. is an indirect employee of Asubio Pharma Co., Ltd.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BURD LI, 1975, NATURE, V254, P710, DOI 10.1038/254710a0; Burridge PW, 2012, CELL STEM CELL, V10, P16, DOI 10.1016/j.stem.2011.12.013; Clement S, 2007, J CELL SCI, V120, P229, DOI 10.1242/jcs.03340; Dubois NC, 2011, NAT BIOTECHNOL, V29, P1011, DOI 10.1038/nbt.2005; Endo J, 2009, CIRC RES, V105, P1118, DOI 10.1161/CIRCRESAHA.109.206607; Fijnvandraat AC, 2003, J MOL CELL CARDIOL, V35, P1461, DOI 10.1016/j.yjmcc.2003.09.011; FISHER DJ, 1981, PEDIATR RES, V15, P843, DOI 10.1203/00006450-198115050-00003; Gassanov N, 2004, FASEB J, V18, P1710, DOI 10.1096/fj.04-1619fje; Hashimoto T, 2006, AM J PHYSIOL-ENDOC M, V290, pE1237, DOI 10.1152/ajpendo.00594.2005; Hattori F, 2012, TRANSPLANT REV-ORLAN, V26, P223, DOI 10.1016/j.trre.2011.09.003; Hattori F, 2010, NAT METHODS, V7, P61, DOI [10.1038/NMETH.1403, 10.1038/nmeth.1403]; Hidaka K, 2003, FASEB J, V17, P740, DOI 10.1096/fj.02-0104fje; Kinoshita A, 2007, J BIOL CHEM, V282, P10731, DOI 10.1074/jbc.M610717200; Klug MG, 1996, J CLIN INVEST, V98, P216, DOI 10.1172/JCI118769; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Ma JY, 2011, AM J PHYSIOL-HEART C, V301, pH2006, DOI 10.1152/ajpheart.00694.2011; Nagaoka M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000015; NEELY JR, 1974, ANNU REV PHYSIOL, V36, P413, DOI 10.1146/annurev.ph.36.030174.002213; Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040; Shintani T, 2009, HEPATOLOGY, V49, P141, DOI 10.1002/hep.22604; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tanaka T, 2009, BIOCHEM BIOPH RES CO, V385, P497, DOI 10.1016/j.bbrc.2009.05.073; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Uosaki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023657; WERNER JC, 1987, PEDIATR RES, V22, P552, DOI 10.1203/00006450-198711000-00016; Xu CH, 2006, STEM CELLS DEV, V15, P931, DOI 10.1089/scd.2006.15.931; Yuasa S, 2005, NAT BIOTECHNOL, V23, P607, DOI 10.1038/nbt1093; Zwi L, 2009, CIRCULATION, V120, P1513, DOI 10.1161/CIRCULATIONAHA.109.868885	30	587	608	5	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 3	2013	12	1					127	137		10.1016/j.stem.2012.09.013	http://dx.doi.org/10.1016/j.stem.2012.09.013			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	074UM	23168164	Bronze			2022-12-28	WOS:000313839500016
J	Sweet, DJ				Sweet, Deborah J.			A Win for Stem Cells	CELL STEM CELL			English	Editorial Material																		Graf T., 2011, CELL STEM CELL, V9, P504	1	0	0	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	DEC 7	2012	11	6					727	727		10.1016/j.stem.2012.11.017	http://dx.doi.org/10.1016/j.stem.2012.11.017			1	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	055MJ	23217414	Bronze			2022-12-28	WOS:000312420300001
J	Li, LB; Chang, KH; Wang, PR; Hirata, RK; Papayannopoulou, T; Russell, DW				Li, Li B.; Chang, Kai-Hsin; Wang, Pei-Rong; Hirata, Roli K.; Papayannopoulou, Thalia; Russell, David W.			Trisomy Correction in Down Syndrome Induced Pluripotent Stem Cells	CELL STEM CELL			English	Article							LEUKEMIA; IDENTIFICATION; PROLIFERATION; INDIVIDUALS; CULTURE; GROWTH; RATES	Human trisomies can alter cellular phenotypes and produce congenital abnormalities such as Down syndrome (DS). Here we have generated induced pluripotent stem cells (iPSCs) from DS fibroblasts and introduced a TKNEO transgene into one copy of chromosome 21 by gene targeting. When selecting against TKNEO, spontaneous chromosome loss was the most common cause for survival, with a frequency of similar to 10(-4), while point mutations, epigenetic silencing, and TKNEO deletions occurred at lower frequencies in this unbiased comparison of inactivating mutations. Mitotic recombination events resulting in extended loss of heterozygosity were not observed in DS iPSCs. The derived, disomic cells proliferated faster and produced more endothelia in vivo than their otherwise isogenic trisomic counterparts, but in vitro hematopoietic differentiation was not consistently altered. Our study describes a targeted removal of a human trisomy, which could prove useful in both clinical and research applications.	[Li, Li B.; Chang, Kai-Hsin; Wang, Pei-Rong; Hirata, Roli K.; Papayannopoulou, Thalia; Russell, David W.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Russell, David W.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Russell, DW (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	drussell@u.washington.edu	LI, LI/G-6197-2015		Horizon Discovery; NIH [DK55759, HL53750, GM086497, DK077864, HL46557]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046557, P01HL053750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055759, K01DK077864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086497] Funding Source: NIH RePORTER	Horizon Discovery; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant to D.R. from Horizon Discovery and NIH grants DK55759, HL53750, and GM086497 to DR.; DK077864 to K.C.; and HL46557 to T.P. The authors thank Yi Jiang, Gaoying Ren, Raise Stolitenko, Andrew Herman, and Sam Lam for technical assistance. The authors declare no competing financial interests.	Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Chamberlain JR, 2004, SCIENCE, V303, P1198, DOI 10.1126/science.1088757; Chan MF, 2001, MOL CELL BIOL, V21, P7587, DOI 10.1128/MCB.21.22.7587-7600.2001; Chou ST, 2008, BLOOD, V112, P4503, DOI 10.1182/blood-2008-05-157859; Costa V, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-40; CROSSEN PE, 1980, HUM GENET, V53, P311, DOI 10.1007/BF00287048; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; FONG C, 1987, CANCER GENET CYTOGEN, V28, P55, DOI 10.1016/0165-4608(87)90354-2; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; Gupta PK, 1997, CANCER RES, V57, P1188; Hasle H, 2000, LANCET, V355, P165, DOI 10.1016/S0140-6736(99)05264-2; Hassold T., 1980, AM J MED GENET, V44, P151; Khan IF, 2010, MOL THER, V18, P1192, DOI 10.1038/mt.2010.55; Lefebvre L, 2001, NAT GENET, V27, P257, DOI 10.1038/85808; Lewandoski M, 1997, NAT GENET, V17, P223, DOI 10.1038/ng1097-223; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Reynolds LE, 2010, NATURE, V465, P813, DOI 10.1038/nature09106; SEGAL DJ, 1974, J CELL PHYSIOL, V83, P85, DOI 10.1002/jcp.1040830112; Sikora Ewa, 1993, Acta Biochimica Polonica, V40, P269; Tang YC, 2011, CELL, V144, P499, DOI 10.1016/j.cell.2011.01.017; Torres EM, 2010, CELL, V143, P71, DOI 10.1016/j.cell.2010.08.038; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zwaan CM, 2002, BLOOD, V99, P245, DOI 10.1182/blood.V99.1.245	25	98	108	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 2	2012	11	5					615	619		10.1016/j.stem.2012.08.004	http://dx.doi.org/10.1016/j.stem.2012.08.004			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	042LE	23084023	Green Accepted, Bronze			2022-12-28	WOS:000311471900008
J	Fuentealba, LC; Obernier, K; Alvarez-Buylla, A				Fuentealba, Luis C.; Obernier, Kirsten; Alvarez-Buylla, Arturo			Adult Neural Stem Cells Bridge Their Niche	CELL STEM CELL			English	Review							EPIDERMAL-GROWTH-FACTOR; LONG-TERM POTENTIATION; SUBVENTRICULAR ZONE; VASCULAR NICHE; SONIC HEDGEHOG; HIPPOCAMPAL NEUROGENESIS; VENTRICULAR ZONE; ANALYSIS REVEALS; PRIMARY CILIA; SELF-RENEWAL	Major developments in the neural stem cell (NSC) field in recent years provide new insights into the nature of the NSC niche. In this perspective, we integrate recent anatomical data on the organization of the two main neurogenic niches in the adult brain, the ventricular-subventricular zone (V-SVZ) and the subgranular zone (SGZ), with signaling pathways that control the behavior of NSCs. NSCs in the adult brain stretch into physiologically distinct compartments of their niche. We propose how adult NSCs' morphology may allow these cells to integrate multiple signaling pathways arising from unique locations of their niche.	[Fuentealba, Luis C.; Obernier, Kirsten; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Fuentealba, Luis C.; Obernier, Kirsten; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Inst Regenerat Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Alvarez-Buylla, A (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	abuylla@stemcell.ucsf.edu	Obernier, Kirsten/O-4967-2015	Obernier, Kirsten/0000-0002-4025-1299; Alvarez-Buylla, Arturo/0000-0003-4426-8925	US National Institutes of Health [NS28478, HD32116]; John G. Bowes Research Fund; Helen Hay Whitney Foundation; German Research Foundation (Deutsche Forschungsgemeinschaft); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032116] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028478, R29NS028478, R01NS028478] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John G. Bowes Research Fund; Helen Hay Whitney Foundation; German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Robert A. Lindquist, Timothy R. Stowe, Shawn F. Sorrel Is, and Cheuk Ka Tong for critical discussion of the review. Special thanks also to Kenneth X. Probst for preparation of the illustrations. Due to limited space of this review, we could not cover all the exciting contributions to the field. The Alvarez-Buylla laboratory is funded by the US National Institutes of Health (NS28478 and HD32116) and the John G. Bowes Research Fund. A.A.-B. is the Heather and Melanie Muss Endowed Chair of Neurological Surgery at UCSF. L.C.F. is supported by the Helen Hay Whitney Foundation, and K.O. by the German Research Foundation (Deutsche Forschungsgemeinschaft).	Ables JL, 2010, J NEUROSCI, V30, P10484, DOI 10.1523/JNEUROSCI.4721-09.2010; Aguirre A, 2010, NATURE, V467, P323, DOI 10.1038/nature09347; Ahlenius H, 2009, J NEUROSCI, V29, P4408, DOI 10.1523/JNEUROSCI.6003-08.2009; Alfonso J, 2012, CELL STEM CELL, V10, P76, DOI 10.1016/j.stem.2011.11.011; Altman J, 2011, NEUROGENESIS IN THE ADULT BRAIN I: NEUROBIOLOGY, P3, DOI 10.1007/978-4-431-53933-9_1; Alvarez-Buylla A, 1998, J NEUROSCI, V18, P1020; Amador-Arjona A, 2011, J NEUROSCI, V31, P9933, DOI 10.1523/JNEUROSCI.1062-11.2011; Andreu-Agullo C, 2009, NAT NEUROSCI, V12, P1514, DOI 10.1038/nn.2437; Banasr M, 2004, NEUROPSYCHOPHARMACOL, V29, P450, DOI 10.1038/sj.npp.1300320; Banerjee SB, 2005, EUR J NEUROSCI, V22, P1570, DOI 10.1111/j.1460-9568.2005.04317.x; Beckervordersandforth R, 2010, CELL STEM CELL, V7, P744, DOI 10.1016/j.stem.2010.11.017; Bhattacharyya BJ, 2008, J NEUROSCI, V28, P6720, DOI 10.1523/JNEUROSCI.1677-08.2008; Bonaguidi MA, 2008, J NEUROSCI, V28, P9194, DOI 10.1523/JNEUROSCI.3314-07.2008; Bonaguidi MA, 2012, CURR OPIN NEUROBIOL, V22, P754, DOI 10.1016/j.conb.2012.03.013; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Bouab M, 2011, NEUROSCIENCE, V173, P135, DOI 10.1016/j.neuroscience.2010.11.032; Breunig JJ, 2008, P NATL ACAD SCI USA, V105, P13127, DOI 10.1073/pnas.0804558105; Breunig JJ, 2007, P NATL ACAD SCI USA, V104, P20558, DOI 10.1073/pnas.0710156104; Bruel-Jungerman E, 2006, J NEUROSCI, V26, P5888, DOI 10.1523/JNEUROSCI.0782-06.2006; Byrd CA, 2001, NEUROSCIENCE, V105, P793, DOI 10.1016/S0306-4522(01)00215-9; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Chapouton P, 2007, BIOESSAYS, V29, P745, DOI 10.1002/bies.20615; Chapouton P, 2010, J NEUROSCI, V30, P7961, DOI 10.1523/JNEUROSCI.6170-09.2010; Chen JL, 2005, J NEUROSCI, V25, P2366, DOI 10.1523/JNEUROSCI.5071-04.2005; Chiasson BJ, 1999, J NEUROSCI, V19, P4462; Colak D, 2008, J NEUROSCI, V28, P434, DOI 10.1523/JNEUROSCI.4374-07.2008; Conover JC, 2011, AGING DIS, V2, P49; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Ehm O, 2010, J NEUROSCI, V30, P13794, DOI 10.1523/JNEUROSCI.1567-10.2010; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Fasano CA, 2009, GENE DEV, V23, P561, DOI 10.1101/gad.1743709; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Fernando RN, 2011, P NATL ACAD SCI USA, V108, P5837, DOI 10.1073/pnas.1014993108; Filippov V, 2003, MOL CELL NEUROSCI, V23, P373, DOI 10.1016/S1044-7431(03)00060-5; Forster E, 2006, NAT REV NEUROSCI, V7, P259, DOI 10.1038/nrn1882; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gajera CR, 2010, J CELL SCI, V123, P1922, DOI 10.1242/jcs.065912; Garcia-Verdugo JM, 2002, BRAIN RES BULL, V57, P765, DOI 10.1016/S0361-9230(01)00769-9; Gobeske KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007506; GOLDMAN SA, 1983, P NATL ACAD SCI-BIOL, V80, P2390, DOI 10.1073/pnas.80.8.2390; Gomez-Gaviro MV, 2012, P NATL ACAD SCI USA, V109, P1317, DOI 10.1073/pnas.1016199109; Gonzalez-Perez O, 2009, STEM CELLS, V27, P2032, DOI 10.1002/stem.119; Guo WX, 2011, NEURON, V70, P924, DOI 10.1016/j.neuron.2011.03.027; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Hoglinger GU, 2004, NAT NEUROSCI, V7, P726, DOI 10.1038/nn1265; Huang X, 2010, P NATL ACAD SCI USA, V107, P8422, DOI 10.1073/pnas.0911838107; Ihrie RA, 2011, NEURON, V71, P250, DOI 10.1016/j.neuron.2011.05.018; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Inokuchi K, 2011, CURR OPIN NEUROBIOL, V21, P360, DOI 10.1016/j.conb.2011.02.006; Irvin DK, 2004, J NEUROSCI RES, V75, P330, DOI 10.1002/jnr.10843; Jablonska B, 2010, NAT NEUROSCI, V13, P541, DOI 10.1038/nn.2536; Jacques TS, 2010, EMBO J, V29, P222, DOI 10.1038/emboj.2009.327; Jessberger S, 2008, PSYCHOL AGING, V23, P684, DOI 10.1037/a0014188; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kim Y, 2010, J NEUROCHEM, V114, P750, DOI 10.1111/j.1471-4159.2010.06799.x; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Kokaia M, 2011, EUR J NEUROSCI, V33, P1133, DOI 10.1111/j.1460-9568.2011.07612.x; Kokovay E, 2010, CELL STEM CELL, V7, P163, DOI 10.1016/j.stem.2010.05.019; Kolodziej A, 2008, J NEUROSCI, V28, P4488, DOI 10.1523/JNEUROSCI.4721-07.2008; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kronenberg G, 2006, NEUROBIOL AGING, V27, P1505, DOI 10.1016/j.neurobiolaging.2005.09.016; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Lavado A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000460; Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023; Licht T, 2011, P NATL ACAD SCI USA, V108, P5081, DOI 10.1073/pnas.1007640108; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Liu XX, 2005, NAT NEUROSCI, V8, P1179, DOI 10.1038/nn1522; LLorens-Martin M, 2009, NEUROSCIENTIST, V15, P134, DOI 10.1177/1073858408331371; Lugert E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1670; Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017; Luo J, 2006, AGING CELL, V5, P139, DOI 10.1111/j.1474-9726.2006.00197.x; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Mira H, 2010, CELL STEM CELL, V7, P78, DOI 10.1016/j.stem.2010.04.016; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Nottebohm F, 2011, NEUROGENESIS IN THE ADULT BRAIN I: NEUROBIOLOGY, P47, DOI 10.1007/978-4-431-53933-9_2; O'Keeffe GC, 2009, P NATL ACAD SCI USA, V106, P8754, DOI 10.1073/pnas.0803955106; Okamoto M, 2011, FASEB J, V25, P3570, DOI 10.1096/fj.11-184697; Paez-Gonzalez P, 2011, NEURON, V71, P61, DOI 10.1016/j.neuron.2011.05.029; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Parent JM, 1997, J NEUROSCI, V17, P3727; Peretto P, 2004, NEUROSCIENCE, V128, P685, DOI 10.1016/j.neuroscience.2004.06.053; POLENOV AL, 1993, CELL TISSUE RES, V271, P351, DOI 10.1007/BF00318622; Ramirez-Castillejo C, 2006, NAT NEUROSCI, V9, P331, DOI 10.1038/nn1657; Rao MS, 2008, HIPPOCAMPUS, V18, P931, DOI 10.1002/hipo.20449; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Seri B, 2004, J COMP NEUROL, V478, P359, DOI 10.1002/cne.20288; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Wang LP, 2005, MOL CELL NEUROSCI, V29, P181, DOI 10.1016/j.mcn.2005.02.002; Weiss S, 1996, TRENDS NEUROSCI, V19, P387, DOI 10.1016/S0166-2236(96)10035-7; Wiedemeyer R, 2008, CANCER CELL, V13, P355, DOI 10.1016/j.ccr.2008.02.010; Wong SY, 2008, CURR TOP DEV BIOL, V85, P225, DOI 10.1016/S0070-2153(08)00809-0; Zappaterra MD, 2007, J PROTEOME RES, V6, P3537, DOI 10.1021/pr070247w; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	109	252	264	0	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 14	2012	10	6					698	708		10.1016/j.stem.2012.05.012	http://dx.doi.org/10.1016/j.stem.2012.05.012			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	965LD	22704510	Bronze, Green Accepted			2022-12-28	WOS:000305768400016
J	Thier, M; Worsdorfer, P; Lakes, YB; Gorris, R; Herms, S; Opitz, T; Seiferling, D; Quandel, T; Hoffmann, P; Nothen, MM; Brustle, O; Edenhofer, F				Thier, Marc; Woersdoerfer, Philipp; Lakes, Yenal B.; Gorris, Raphaela; Herms, Stefan; Opitz, Thoralf; Seiferling, Dominic; Quandel, Tamara; Hoffmann, Per; Noethen, Markus M.; Bruestle, Oliver; Edenhofer, Frank			Direct Conversion of Fibroblasts into Stably Expandable Neural Stem Cells	CELL STEM CELL			English	Article							MOUSE FIBROBLASTS; GENERATION; DIFFERENTIATION; CARDIOMYOCYTES; PLURIPOTENCY; NEURONS; OCT4	Recent advances have suggested that direct induction of neural stem cells (NSCs) could provide an alternative to derivation from somatic tissues or pluripotent cells. Here we show direct derivation of stably expandable NSCs from mouse fibroblasts through a curtailed version of reprogramming to pluripotency. By constitutively inducing Sox2, Klf4, and c-Myc while strictly limiting Oct4 activity to the initial phase of reprogramming, we generated neurosphere-like colonies that could be expanded for more than 50 passages and do not depend on sustained expression of the reprogramming factors. These induced neural stem cells (iNSCs) uniformly display morphological and molecular features of NSCs, such as the expression of Nestin, Pax6, and Olig2, and have a genome-wide transcriptional profile similar to that of brain-derived NSCs. Moreover, iNSCs can differentiate into neurons, astrocytes, and oligodendrocytes. Our results demonstrate that functional NSCs can be generated from somatic cells by factor-driven induction.	[Thier, Marc; Woersdoerfer, Philipp; Lakes, Yenal B.; Seiferling, Dominic; Edenhofer, Frank] Univ Bonn, Inst Reconstruct Neurobiol, Stem Cell Engn Grp, D-53105 Bonn, Germany; [Thier, Marc; Woersdoerfer, Philipp; Lakes, Yenal B.; Gorris, Raphaela; Seiferling, Dominic; Quandel, Tamara; Bruestle, Oliver; Edenhofer, Frank] Univ Bonn, Inst Reconstruct Neurobiol, Life & Brain Ctr, Hertie Fdn, D-53105 Bonn, Germany; [Herms, Stefan; Hoffmann, Per; Noethen, Markus M.] Univ Bonn, Inst Human Genet, D-53105 Bonn, Germany; [Opitz, Thoralf] Univ Bonn, Dept Epileptol, D-53105 Bonn, Germany; [Noethen, Markus M.] German Ctr Neurodegenerat Disorders DZNE, D-53105 Bonn, Germany	University of Bonn; University of Bonn; University of Bonn; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Edenhofer, F (corresponding author), Univ Bonn, Inst Reconstruct Neurobiol, Stem Cell Engn Grp, Sigmund Freud Str 25, D-53105 Bonn, Germany.	f.edenhofer@uni-bonn.de	Herms, Stefan/J-1949-2014; Hoffmann, Per/A-5149-2010; Edenhofer, Frank/ABG-9458-2020	Herms, Stefan/0000-0002-2786-8200; Hoffmann, Per/0000-0002-6573-983X; Edenhofer, Frank/0000-0002-6489-714X; Nothen, Markus/0000-0002-8770-2464; Worsdorfer, Philipp/0000-0003-3398-3229	Deutsche Forschungsgemeinschaft DFG [ED79/1-2]; German Ministry of Education and Research, BMBF [01GN1009B]; European Commission; Merck KGaA, Darmstadt, Germany	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); German Ministry of Education and Research, BMBF(Federal Ministry of Education & Research (BMBF)); European Commission(European CommissionEuropean Commission Joint Research Centre); Merck KGaA, Darmstadt, Germany	We thank Austin Smith (Cambridge University, UK) for providing us with the Oct4-GiP reporter and NS5 cell line and Rudolf Jaenisch (Whitehead Institute, USA) for the kind gift of FUW-vectors. We are indebted to Ian Duncan (University of Wisconsin, USA) for providing us with md rats, Didier Trono (EPFL Lausanne, Switzerland) for providing the helper plasmids psPAX2 and pMD2.G, and Shinya Yamanaka for providing the plasmids pMXs-Sox2, pMXs-Klf4, and pMXs-c-myc. We thank Sandra Meyer and Rajkumar Thummer for critical reading of the manuscript; and Benedikt Berninger (Ludwig-Maximilians University Munich, Germany), Magdalena Getz (Institute for Stem Cell Research Munich, Germany), Veit Hornung (University of Bonn, Germany), and all members of the Stem Cell Engineering Group for helpful discussions. We thank Nicole Russ, Kathrin Vogt, Stephanie Mielke, and Anke Leinhaas for excellent technical support. This work was supported by grants from the Deutsche Forschungsgemeinschaft DFG (ED79/1-2), the German Ministry of Education and Research, BMBF (NewNeurons; 01GN1009B), the European Commission, and Merck KGaA, Darmstadt, Germany.	Bosnali M, 2008, BIOL CHEM, V389, P851, DOI 10.1515/BC.2008.106; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; Glaser T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000298; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Pollard SM, 2006, CEREB CORTEX, V16, pI112, DOI 10.1093/cercor/bhj167; Sheng C, 2012, CELL RES, V22, P208, DOI 10.1038/cr.2011.175; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thier M, 2010, INT J DEV BIOL, V54, P1713, DOI 10.1387/ijdb.103193mt; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015	28	382	401	0	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 6	2012	10	4					473	479		10.1016/j.stem.2012.03.003	http://dx.doi.org/10.1016/j.stem.2012.03.003			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	929QA	22445518	Bronze			2022-12-28	WOS:000303079400015
J	Boutet, SC; Cheung, TH; Quach, NL; Liu, L; Prescott, SL; Edalati, A; Iori, K; Rando, TA				Boutet, Stephane C.; Cheung, Tom H.; Quach, Navaline L.; Liu, Ling; Prescott, Sara L.; Edalati, Abdolhossein; Iori, Kevin; Rando, Thomas A.			Alternative Polyadenylation Mediates MicroRNA Regulation of Muscle Stem Cell Function	CELL STEM CELL			English	Article							TRANSCRIPTION FACTOR PAX3; 3' UNTRANSLATED REGIONS; SATELLITE CELLS; PROGENITOR CELLS; MESSENGER-RNAS; MET RECEPTOR; EXPRESSION; DIFFERENTIATION; PROLIFERATION; MAINTENANCE	Pax3, a key myogenic regulator, is transiently expressed during activation of adult muscle stem cells, or satellite cells (SCs), and is also expressed in a subset of quiescent SCs (QSCs), but only in specific muscles. The mechanisms regulating these variations in expression are not well understood. Here we show that Pax3 levels are regulated by miR-206, a miRNA with a previously demonstrated role in myogenic differentiation. In most QSCs and activated SCs, miR-206 expression suppresses Pax3 expression. Paradoxically, QSCs that express high levels of Pax3 also express high levels of miR-206. In these QSCs, Pax3 transcripts are subject to alternative polyadenylation, resulting in transcripts with shorter 3' untranslated regions (3'UTRs) that render them resistant to regulation by miR-206. Similar alternate polyadenylation of the Pax3 transcript also occurs in myogenic progenitors during development. Our findings may reflect a general role of alternative polyadenylation in circumventing miRNA-mediated regulation of stem cell function.	[Boutet, Stephane C.; Cheung, Tom H.; Quach, Navaline L.; Liu, Ling; Rando, Thomas A.] Stanford Univ, Sch Med, Glenn Labs Biol Aging, Stanford, CA 94305 USA; [Boutet, Stephane C.; Cheung, Tom H.; Quach, Navaline L.; Liu, Ling; Prescott, Sara L.; Edalati, Abdolhossein; Iori, Kevin; Rando, Thomas A.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Rando, Thomas A.] VA Palo Alto Hlth Care Syst, Neurol Serv, Palo Alto, CA 94304 USA; [Rando, Thomas A.] VA Palo Alto Hlth Care Syst, RR&D Ctr Excellence, Palo Alto, CA 94304 USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Rando, TA (corresponding author), Stanford Univ, Sch Med, Glenn Labs Biol Aging, Stanford, CA 94305 USA.	rando@stanford.edu		Prescott, Sara/0000-0003-4348-9021; Rando, Thomas/0000-0001-5843-8564	Muscular Dystrophy Association; Glenn Foundation for Medical Research; NIH [P01 AG036695, R01 AG023806, R01 AR056849, R01 AR062185, DP1 OD000392]; Department of Veterans Affairs; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056849, R01AR062185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG036695, R01AG023806, R37AG023806] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000392] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); Glenn Foundation for Medical Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. B. Olwin for generously providing the chicken anti-Syndecan4 antibody. This work was supported by a Muscular Dystrophy Association Development Grant to S.C.B., and by grants from the Glenn Foundation for Medical Research, the NIH (P01 AG036695, R01 AG023806 [R37 MERIT Award], R01 AR056849, R01 AR062185, and DP1 OD000392 [an NIH Director's Pioneer Award]), and the Department of Veterans Affairs (Merit Review) to T.A.R.	Barber TD, 1999, GENE, V237, P311, DOI 10.1016/S0378-1119(99)00339-X; Biressi S, 2010, SEMIN CELL DEV BIOL, V21, P845, DOI 10.1016/j.semcdb.2010.09.003; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; BOBER E, 1994, DEVELOPMENT, V120, P603; Boutet SC, 2007, CELL, V130, P349, DOI 10.1016/j.cell.2007.05.044; Boutet SC, 2010, MOL CELL, V40, P749, DOI 10.1016/j.molcel.2010.09.029; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Cornelison DDW, 2001, DEV BIOL, V239, P79, DOI 10.1006/dbio.2001.0416; Costessi L, 2006, NUCLEIC ACIDS RES, V34, P243, DOI 10.1093/nar/gkj425; Crist CG, 2009, P NATL ACAD SCI USA, V106, P13383, DOI 10.1073/pnas.0900210106; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; EPSTEIN JA, 1995, J BIOL CHEM, V270, P11719, DOI 10.1074/jbc.270.20.11719; Goljanek-Whysall K, 2011, P NATL ACAD SCI USA, V108, P11936, DOI 10.1073/pnas.1105362108; GOULDING M, 1994, DEVELOPMENT, V120, P957; Hirai H, 2010, J CELL BIOL, V191, P347, DOI 10.1083/jcb.201006025; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Lutz CS, 2008, ACS CHEM BIOL, V3, P609, DOI 10.1021/cb800138w; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Parker CJ, 2004, INT J CANCER, V108, P314, DOI 10.1002/ijc.11527; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pritchard C, 2003, GENE, V305, P61, DOI 10.1016/S0378-1119(02)01186-1; Quach NL, 2006, DEV BIOL, V293, P38, DOI 10.1016/j.ydbio.2005.12.040; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Sweetman D, 2008, DEV BIOL, V321, P491, DOI 10.1016/j.ydbio.2008.06.019; Tanaka KK, 2009, CELL STEM CELL, V4, P217, DOI 10.1016/j.stem.2009.01.016; Tian HJ, 2005, MOL BRAIN RES, V137, P174, DOI 10.1016/j.molbrainres.2005.03.001; Tranter M, 2011, J BIOL CHEM, V286, P29828, DOI 10.1074/jbc.M111.221796; Wang QY, 2006, CANCER RES, V66, P8574, DOI 10.1158/0008-5472.CAN-06-0947; Winter J, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-105; Yang XM, 1996, DEVELOPMENT, V122, P2163; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	45	110	116	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 2	2012	10	3					327	336		10.1016/j.stem.2012.01.017	http://dx.doi.org/10.1016/j.stem.2012.01.017			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	908BX	22385659	Green Accepted, Bronze			2022-12-28	WOS:000301466500013
J	Kiem, HP; Jerome, KR; Deeks, SG; McCune, JM				Kiem, Hans-Peter; Jerome, Keith R.; Deeks, Steven G.; McCune, Joseph M.			Hematopoietic-Stem-Cell-Based Gene Therapy for HIV Disease	CELL STEM CELL			English	Review							BLOOD PROGENITOR CELLS; MARROW REPOPULATING CELLS; IN-VIVO; T-CELLS; MULTILINEAGE HEMATOPOIESIS; EFFICIENT TRANSDUCTION; LENTIVIRAL VECTOR; MURINE MARROW; SELF-RENEWAL; IMMUNODEFICIENCY		[McCune, Joseph M.] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94110 USA; [Kiem, Hans-Peter] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Jerome, Keith R.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA; [Kiem, Hans-Peter] Univ Washington, Dept Med, Seattle, WA 98109 USA; [Kiem, Hans-Peter] Univ Washington, Dept Pathol, Seattle, WA 98109 USA; [Jerome, Keith R.] Univ Washington, Dept Lab Med, Seattle, WA 98109 USA; [Deeks, Steven G.] Univ Calif San Francisco, HIV AIDS Program, San Francisco, CA 94110 USA	University of California System; University of California San Francisco; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco	McCune, JM (corresponding author), Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94110 USA.	mike.mccune@ucsf.edu			NIH [U19 AI 096111, U19 AI96109, DPI OD00329, 419 (AJ 096111)]; Bill and Melinda Gates Foundation [51763, OPP1018811, K24 AI069994, R01 AI40312]; Jose Carreras/E.Donnall Thomas Endowed Chair for Cancer Research;  [R01 AI80326];  [R01 HL84345]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI096111, P30AI027763, R37AI040312, U19AI096109, R01AI080326, K24AI069994, R01AI040312] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000329] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Jose Carreras/E.Donnall Thomas Endowed Chair for Cancer Research; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would like to acknowledge the impact of NIH-supported Martin Delaney Col laboratory grants (including U19 AI 096111, of which H.P.K. and K.R.J. are co-Pls, and U19 AI96109, of which S.G.D. and J.M.M. are co-Pls) in bridging efforts to complete this review. We also thank the amfAR Eradication Program for its contributions in moving the cure agenda forward. This effort was supported in part by R01 AI80326 and R01 HL84345 (to H.P.K.), Bill and Melinda Gates Foundation Grand Challenges Explorations Phase I award 51763 and Phase II award OPP1018811 (to K.R.J.), K24 AI069994 (to S.G.D.), and R01 AI40312 (to J.M.M.). H.P.K. is a Markey Molecular Medicine Investigator and also supported by the Jose Carreras/E.Donnall Thomas Endowed Chair for Cancer Research, and J.M.M. is a recipient of the NIH Director's Pioneer Award Program, part of the NIH Roadmap for Medical Research, through grant DPI OD00329. Sangamo Biosciences is the corporate partner on an NIH 419 (AJ 096111) grant awarded to H.P.K. and K.R.J. and has awarded a research grant to S.G.D.	Abad JL, 2003, MOL THER, V8, P475, DOI 10.1016/S01525-0016(03)00202-8; Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Amado RG, 2004, HUM GENE THER, V15, P251, DOI 10.1089/104303404322886101; Anderson J, 2008, HUM GENE THER, V19, P217, DOI 10.1089/hum.2007.108; Aubert M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016825; BALTIMORE D, 1988, NATURE, V335, P395, DOI 10.1038/335395a0; Banerjea Akhil, 2004, AIDS Res Ther, V1, P2, DOI 10.1186/1742-6405-1-2; Baum C, 2011, STEM CELLS, V29, P1479, DOI 10.1002/stem.716; Beard BC, 2010, J CLIN INVEST, V120, P2345, DOI 10.1172/JCI40767; BERENSON RJ, 1988, J CLIN INVEST, V81, P951, DOI 10.1172/JCI113409; Bhatia M, 1998, NAT MED, V4, P1038, DOI 10.1038/2023; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Bonyhadi ML, 1997, J VIROL, V71, P4707, DOI 10.1128/JVI.71.6.4707-4716.1997; Burnett JC, 2009, GENE THER, V16, P1178, DOI 10.1038/gt.2009.86; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; DiGiusto DL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000931; Feng Y, 2000, VIROLOGY, V276, P271, DOI 10.1006/viro.2000.0536; Fischer A, 2010, NAT IMMUNOL, V11, P457, DOI 10.1038/ni0610-457; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; GILBOA E, 1994, TRENDS GENET, V10, P139, DOI 10.1016/0168-9525(94)90216-X; Gilliam BL, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S9; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Guenechea G, 2001, NAT IMMUNOL, V2, P75, DOI 10.1038/83199; Gurevich RM, 2004, BLOOD, V104, P1127, DOI 10.1182/blood-2003-10-3550; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hanenberg H, 1996, NAT MED, V2, P876, DOI 10.1038/nm0896-876; Himburg HA, 2010, NAT MED, V16, P475, DOI 10.1038/nm.2119; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Horn PA, 2002, BLOOD, V100, P3960, DOI 10.1182/blood-2002-05-1359; Hutter G, 2011, AIDS, V25, P273, DOI 10.1097/QAD.0b013e328340fe28; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Husman AMD, 1997, ANN INTERN MED, V127, P882, DOI 10.7326/0003-4819-127-10-199711150-00004; Jenkins M, 1998, BLOOD, V91, P2672, DOI 10.1182/blood.V91.8.2672.2672_2672_2678; Jung CW, 2007, EXP HEMATOL, V35, P1132, DOI 10.1016/j.exphem.2007.04.004; KANESHIMA H, 1990, NATURE, V348, P561, DOI 10.1038/348561a0; Kang EM, 2002, BLOOD, V99, P698, DOI 10.1182/blood.V99.2.698; Kiem HP, 2007, BLOOD, V109, P65, DOI 10.1182/blood-2006-04-016741; Kiem HP, 1998, BLOOD, V92, P1878, DOI 10.1182/blood.V92.6.1878.418k39_1878_1886; Kim SS, 2010, MOL THER, V18, P370, DOI 10.1038/mt.2009.271; Krosl J, 2003, NAT MED, V9, P1428, DOI 10.1038/nm951; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; LAPIDOT T, 1992, SCIENCE, V255, P1137, DOI 10.1126/science.1372131; Larochelle A, 1996, NAT MED, V2, P1329, DOI 10.1038/nm1296-1329; Li XF, 2005, J RHEUMATOL, V32, P887; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Lombardo A, 2011, NAT METHODS, V8, P861, DOI [10.1038/NMETH.1674, 10.1038/nmeth.1674]; Mazurier F, 2003, NAT MED, V9, P959, DOI 10.1038/nm886; MCCUNE JM, 1991, IMMUNOL REV, V124, P45, DOI 10.1111/j.1600-065X.1991.tb00615.x; McCune JM, 2001, NATURE, V410, P974, DOI 10.1038/35073648; McKenzie JL, 2007, BLOOD, V109, P543, DOI 10.1182/blood-2006-06-030270; McNiece I, 2000, BLOOD, V96, P3001; Mitsuyasu RT, 2009, NAT MED, V15, P285, DOI 10.1038/nm.1932; Modlich U, 2009, MOL THER, V17, P1919, DOI 10.1038/mt.2009.179; Mussolino C, 2011, NAT METHODS, V8, P725, DOI 10.1038/nmeth.1680; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; NAMIKAWA R, 1990, J EXP MED, V172, P1055, DOI 10.1084/jem.172.4.1055; Neagu MR, 2009, J CLIN INVEST, V119, P3035, DOI 10.1172/JCI39354; Neff T, 2004, MOL THER, V9, P157, DOI 10.1016/j.ymthe.2003.11.011; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; Okazuka K, 2011, MOL THER, V19, P1287, DOI 10.1038/mt.2011.8; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Podsakoff GM, 2005, MOL THER, V12, P77, DOI 10.1016/j.ymthe.2005.02.024; QUESENBERRY PJ, 1994, BLOOD CELLS, V20, P348; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Rossi JJ, 2007, NAT BIOTECHNOL, V25, P1444, DOI 10.1038/nbt1367; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Sarkar I, 2007, SCIENCE, V316, P1912, DOI 10.1126/science.1141453; Sauce D, 2011, BLOOD, V117, P5142, DOI 10.1182/blood-2011-01-331306; Sauvageau G, 2004, ONCOGENE, V23, P7223, DOI 10.1038/sj.onc.1207942; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Shimizu S, 2010, BLOOD, V115, P1534, DOI 10.1182/blood-2009-04-215855; Steinberger P, 2000, P NATL ACAD SCI USA, V97, P805, DOI 10.1073/pnas.97.2.805; STEWART FM, 1993, BLOOD, V81, P2566; Stewart FM, 1998, BLOOD, V91, P3681; Stoddard BL, 2011, STRUCTURE, V19, P7, DOI 10.1016/j.str.2010.12.003; STORB R, 1970, CANCER RES, V30, P2195; Su LS, 1997, BLOOD, V89, P2283, DOI 10.1182/blood.V89.7.2283; Swan CH, 2006, GENE THER, V13, P1480, DOI 10.1038/sj.gt.3302801; Tiemann K, 2009, EMBO MOL MED, V1, P142, DOI 10.1002/emmm.200900023; Trobridge GD, 2008, BLOOD, V111, P5537, DOI 10.1182/blood-2007-09-115022; Trobridge GD, 2010, MOL THER, V18, P725, DOI 10.1038/mt.2009.282; Trobridge GD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007693; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; van Lunzen J, 2007, MOL THER, V15, P1024, DOI 10.1038/mt.sj.6300124; VONKALLE C, 1994, BLOOD, V84, P2890; Watts KL, 2010, BLOOD, V116, P5859, DOI 10.1182/blood-2010-05-286062; Wilen CB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002020; Yanez-Munoz RJ, 2006, NAT MED, V12, P348, DOI 10.1038/nm1365; YU M, 1994, GENE THER, V1, P13; Yukl SA, 2010, AIDS, V24, P2450, DOI 10.1097/QAD.0b013e32833ef7bb; Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119; Zhou S, 2010, BLOOD, V116, P900, DOI 10.1182/blood-2009-10-250209; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	99	91	100	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 3	2012	10	2					137	147		10.1016/j.stem.2011.12.015	http://dx.doi.org/10.1016/j.stem.2011.12.015			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	892FM	22305563	Green Accepted, Bronze			2022-12-28	WOS:000300272100008
J	Burridge, PW; Keller, G; Gold, JD; Wu, JC				Burridge, Paul W.; Keller, Gordon; Gold, Joseph D.; Wu, Joseph C.			Production of De Novo Cardiomyocytes: Human Pluripotent Stem Cell Differentiation and Direct Reprogramming	CELL STEM CELL			English	Review							PROMOTES CARDIAC DIFFERENTIATION; FUNCTIONAL-PROPERTIES; HEART REGENERATION; MOUSE FIBROBLASTS; MASTER REGULATOR; SMOOTH-MUSCLE; PROLIFERATION; MESODERM; MESP1; PROGENITORS	Cardiovascular disease is a leading cause of death worldwide. The limited capability of heart tissue to regenerate has prompted methodological developments for creating de novo cardiomyocytes, both in vitro and in vivo. Beyond uses in cell replacement therapy, patient-specific cardiomyocytes may find applications in drug testing, drug discovery, and disease modeling. Recently, approaches for generating cardiomyocytes have expanded to encompass three major sources of starting cells: human pluripotent stem cells (hPSCs), adult heart-derived cardiac progenitor cells (CPCs), and reprogrammed fibroblasts. We discuss state-of-the-art methods for generating de novo cardiomyocytes from hPSCs and reprogrammed fibroblasts, highlighting potential applications and future challenges.	[Burridge, Paul W.; Wu, Joseph C.] Stanford Univ, Sch Med, Dept Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Burridge, Paul W.; Wu, Joseph C.] Stanford Univ, Sch Med, Cardiovasc Inst, Stanford, CA 94305 USA; [Keller, Gordon] MaRS Ctr, Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON MG5 1L7, Canada; [Gold, Joseph D.] Geron Corp, Neurobiol & Cell Therapies Res, Menlo Pk, CA 94025 USA	Stanford University; Stanford University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Geron Corporation	Wu, JC (corresponding author), Stanford Univ, Sch Med, Dept Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	joewu@stanford.edu	Burridge, Paul Wesley/AAI-2717-2021; Wu, Joseph/H-1067-2013	Keller, Gordon/0000-0001-9309-9297; Wu, Joseph/0000-0002-6068-8041	NIH [DP2OD004437, RC1AG036142, R33HL089027]; California Institute of Regenerative Medicine [RB3-05219]; Burroughs Wellcome Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL089027] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC1AG036142] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004437] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to acknowledge funding support from the NIH New Innovator Award DP2OD004437, RC1AG036142, R33HL089027, the California Institute of Regenerative Medicine RB3-05219, and the Burroughs Wellcome Foundation Career Award for Medical Scientists (J.C.W.). Due to space limitations, we are unable to include all of the important papers relevant to induced pluripotent stem cell derivation and application; we apologize to those investigators whose work was omitted here. Joseph Gold is an employee of Geron Corporation.	Akopian V, 2010, IN VITRO CELL DEV-AN, V46, P247, DOI 10.1007/s11626-010-9297-z; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Amit M, 2011, NAT PROTOC, V6, P572, DOI 10.1038/nprot.2011.325; Anderson D, 2007, MOL THER, V15, P2027, DOI 10.1038/sj.mt.6300303; Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Beqqali A, 2006, STEM CELLS, V24, P1956, DOI 10.1634/stemcells.2006-0054; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bondue A, 2008, CELL STEM CELL, V3, P69, DOI 10.1016/j.stem.2008.06.009; Bondue A, 2010, CIRC RES, V107, P1414, DOI 10.1161/CIRCRESAHA.110.227058; Boudoulas KD, 2009, DIS MODEL MECH, V2, P344, DOI 10.1242/dmm.000240; Braam SR, 2010, STEM CELL RES, V4, P107, DOI 10.1016/j.scr.2009.11.004; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Burridge PW, 2007, STEM CELLS, V25, P929, DOI 10.1634/stemcells.2006-0598; Burridge PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018293; Cao F, 2009, CANCER RES, V69, P2709, DOI 10.1158/0008-5472.CAN-08-4122; Cao F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003474; Cao N, 2012, CELL RES, V22, P219, DOI 10.1038/cr.2011.195; Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005; Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; CHOI J, 1990, P NATL ACAD SCI USA, V87, P7988, DOI 10.1073/pnas.87.20.7988; Chung HCY, 2012, STEM CELLS DEV, V21, P206, DOI 10.1089/scd.2010.0440; Costello I, 2011, NAT CELL BIOL, V13, P1084, DOI 10.1038/ncb2304; David R, 2008, NAT CELL BIOL, V10, P338, DOI 10.1038/ncb1696; David R, 2011, CARDIOVASC RES, V92, P115, DOI 10.1093/cvr/cvr158; Davis RP, 2011, TRENDS MOL MED, V17, P475, DOI 10.1016/j.molmed.2011.05.001; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Denning C., 2008, DRUG DISCOV TODAY TH, V5, P223, DOI [10.1016/j.ddstr.2008.08.002, DOI 10.1016/J.DDSTR.2008.08.002]; Dubois NC, 2011, NAT BIOTECHNOL, V29, P1011, DOI 10.1038/nbt.2005; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; Elliott DA, 2011, NAT METHODS, V8, P1037, DOI [10.1038/NMETH.1740, 10.1038/nmeth.1740]; Freund C, 2008, STEM CELLS, V26, P724, DOI 10.1634/stemcells.2007-0617; Gaur M, 2010, CYTOTHERAPY, V12, P807, DOI 10.3109/14653249.2010.491821; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Grego-Bessa J, 2007, DEV CELL, V12, P415, DOI 10.1016/j.devcel.2006.12.011; Hansson EM, 2009, CELL STEM CELL, V5, P364, DOI 10.1016/j.stem.2009.09.004; Hattori F, 2010, NAT METHODS, V7, P61, DOI [10.1038/NMETH.1403, 10.1038/nmeth.1403]; Huber I, 2007, FASEB J, V21, P2551, DOI 10.1096/fj.05-5711com; Hudson J, 2012, STEM CELLS DEV, V21, P1513, DOI 10.1089/scd.2011.0254; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Itzhaki I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018037; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Jang J, 2008, STEM CELLS, V26, P2782, DOI 10.1634/stemcells.2007-1053; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Josowitz R, 2011, CURR OPIN CARDIOL, V26, P223, DOI 10.1097/HCO.0b013e32834598ad; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Kim C, 2010, STEM CELLS DEV, V19, P783, DOI 10.1089/scd.2009.0349; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Kwon C, 2007, P NATL ACAD SCI USA, V104, P10894, DOI 10.1073/pnas.0704044104; Kwon C, 2009, NAT CELL BIOL, V11, P951, DOI 10.1038/ncb1906; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lavine KJ, 2005, DEV CELL, V8, P85, DOI 10.1016/j.devcel.2004.12.002; Lee AS, 2009, CELL CYCLE, V8, P2608, DOI 10.4161/cc.8.16.9353; Lee YK, 2010, MOL ENDOCRINOL, V24, P1728, DOI 10.1210/me.2010-0032; Li W, 2012, HUM MOL GENET, V21, P32, DOI 10.1093/hmg/ddr435; Li Y, 2005, BIOTECHNOL BIOENG, V91, P688, DOI 10.1002/bit.20536; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Loffredo FS, 2011, CELL STEM CELL, V8, P389, DOI 10.1016/j.stem.2011.02.002; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Ma JY, 2011, AM J PHYSIOL-HEART C, V301, pH2006, DOI 10.1152/ajpheart.00694.2011; Martinez-Fernandez A, 2011, J CARDIOVASC TRANSL, V4, P131, DOI 10.1007/s12265-010-9250-2; Martinez-Fernandez A, 2010, J CARDIOVASC TRANSL, V3, P13, DOI 10.1007/s12265-009-9150-5; Matsa E, 2011, EUR HEART J, V32, P952, DOI 10.1093/eurheartj/ehr073; McDevitt TC, 2005, J MOL CELL CARDIOL, V39, P865, DOI 10.1016/j.yjmcc.2005.09.007; Menasche P, 2008, CIRCULATION, V117, P1189, DOI 10.1161/CIRCULATIONAHA.107.734103; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Narsinh KH, 2011, J CLIN INVEST, V121, P1217, DOI 10.1172/JCI44635; Nguyen PK, 2011, CIRC RES, V109, P962, DOI 10.1161/CIRCRESAHA.111.242909; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Paige SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011134; Passier R, 2005, STEM CELLS, V23, P772, DOI 10.1634/stemcells.2004-0184; Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67; Pearl JI, 2011, CELL STEM CELL, V8, P309, DOI 10.1016/j.stem.2011.01.012; Perino MG, 2008, J MOL CELL CARDIOL, V45, P475, DOI 10.1016/j.yjmcc.2008.05.002; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Ramirez JM, 2011, STEM CELLS, V29, P1469, DOI 10.1002/stem.681; Reinecke H, 1999, CIRCULATION, V100, P193, DOI 10.1161/01.CIR.100.2.193; Ren YM, 2011, J MOL CELL CARDIOL, V51, P280, DOI 10.1016/j.yjmcc.2011.04.012; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Shimoji K, 2010, CELL STEM CELL, V6, P227, DOI 10.1016/j.stem.2010.01.002; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Solloway MJ, 2003, CARDIOVASC RES, V58, P264, DOI 10.1016/S0008-6363(03)00286-4; Swijnenburg RJ, 2008, P NATL ACAD SCI USA, V105, P12991, DOI 10.1073/pnas.0805802105; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takei S, 2009, AM J PHYSIOL-HEART C, V296, pH1793, DOI 10.1152/ajpheart.01288.2008; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Tanasijevic B, 2009, EPIGENETICS-US, V4, P330, DOI 10.4161/epi.4.5.9275; Tang C, 2011, NAT BIOTECHNOL, V29, P829, DOI 10.1038/nbt.1947; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tran TH, 2009, STEM CELLS, V27, P1869, DOI 10.1002/stem.95; Tulloch NL, 2011, CIRC RES, V109, P47, DOI 10.1161/CIRCRESAHA.110.237206; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Uosaki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023657; Van Hoof D, 2010, J PROTEOME RES, V9, P1610, DOI 10.1021/pr901138a; van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Willems E, 2011, CIRC RES, V109, P360, DOI 10.1161/CIRCRESAHA.111.249540; Willems E, 2009, PEDIATR CARDIOL, V30, P635, DOI 10.1007/s00246-009-9409-2; Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu XQ, 2008, DIFFERENTIATION, V76, P958, DOI 10.1111/j.1432-0436.2008.00284.x; Yamanaka S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003896; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001; Zhang QZ, 2011, CELL RES, V21, P579, DOI 10.1038/cr.2010.163; Zhang Y, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010498, 10.1371/journal.pone.0015300, 10.1371/journal.pone.0015570, 10.1371/journal.pone.0012559]; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Zhu WZ, 2010, CIRC RES, V107, P776, DOI 10.1161/CIRCRESAHA.110.223917; Zwi L, 2009, CIRCULATION, V120, P1513, DOI 10.1161/CIRCULATIONAHA.109.868885	128	465	483	3	112	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 6	2012	10	1					16	28		10.1016/j.stem.2011.12.013	http://dx.doi.org/10.1016/j.stem.2011.12.013			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	880ZQ	22226352	Green Accepted, Bronze			2022-12-28	WOS:000299449500008
J	Carlone, DL; Breault, DT				Carlone, Diana L.; Breault, David T.			Tales From the Crypt: The Expanding Role of Slow Cycling Intestinal Stem Cells	CELL STEM CELL			English	Editorial Material							RENEWAL	Similar to other highly self-renewing tissues, the intestinal epithelium contains both slowly and rapidly cycling progenitor/stem cells, though their relationship has been largely unexplored. Two recent reports in Nature (Tian et al., 2011) and Science (Takeda et al., 2011) shed new light on their dynamic interplay.	[Carlone, Diana L.; Breault, David T.] Harvard Univ, Sch Med, Childrens Hosp Boston, Div Endocrinol, Boston, MA 02115 USA; [Breault, David T.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University	Breault, DT (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Div Endocrinol, Boston, MA 02115 USA.	david.breault@childrens.harvard.edu	Breault, David/HDN-6048-2022		NIDDK NIH HHS [R01 DK084056] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084056] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bjerknes M, 1999, GASTROENTEROLOGY, V116, P7, DOI 10.1016/S0016-5085(99)70222-2; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Montgomery RK, 2008, J ANAT, V213, P52, DOI 10.1111/j.1469-7580.2008.00925.x; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; POTTEN CS, 1974, CELL TISSUE KINET, V7, P271, DOI 10.1111/j.1365-2184.1974.tb00907.x; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048	11	22	25	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JAN 6	2012	10	1					2	4		10.1016/j.stem.2011.12.012	http://dx.doi.org/10.1016/j.stem.2011.12.012			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	880ZQ	22226346	Green Accepted, Bronze			2022-12-28	WOS:000299449500002
J	Wang, T; Chen, KS; Zeng, XM; Yang, JG; Wu, Y; Shi, X; Qin, BM; Zeng, LW; Esteban, MA; Pan, GJ; Pei, DQ				Wang, Tao; Chen, Keshi; Zeng, Xiaoming; Yang, Jianguo; Wu, Yun; Shi, Xi; Qin, Baoming; Zeng, Lingwen; Esteban, Miguel Angel; Pan, Guangjin; Pei, Duanqing			The Histone Demethylases Jhdm1a/1b Enhance Somatic Cell Reprogramming in a Vitamin-C-Dependent Manner	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; HUMAN FIBROBLASTS; MOUSE FIBROBLASTS; SELF-RENEWAL; INDUCTION; WIDESPREAD; GENERATION; OCT4; GENE; EXPRESSION	Reprogramming of somatic cells into induced pluripotent stem cells (iPSCs) resets the epigenome to an embryonic-like state. Vitamin C enhances the reprogramming process, but the underlying mechanisms are unclear. Here we show that the histone demethylases Jhdm1a/1b are key effectors of somatic cell reprogramming downstream of vitamin C. We first observed that vitamin C induces H3K36me2/3 demethylation in mouse embryonic fibroblasts in culture and during reprogramming. We then identified Jhdm1a/1b, two known vitamin-C-dependent H3K36 demethylases, as potent regulators of reprogramming through gain- and loss-of-function approaches. Furthermore, we found that Jhdm1b accelerates cell cycle progression and suppresses cell senescence during reprogramming by repressing the Ink4/Arf locus. Jhdm1b also cooperates with Oct4 to activate the microRNA cluster 302/367, an integral component of the pluripotency machinery. Our results therefore reveal a role for H3K36me2/3 in cell fate determination and establish a link between histone demethylases and vitamin-C-induced reprogramming.	[Wang, Tao; Chen, Keshi; Zeng, Xiaoming; Yang, Jianguo; Wu, Yun; Shi, Xi; Qin, Baoming; Zeng, Lingwen; Esteban, Miguel Angel; Pan, Guangjin; Pei, Duanqing] Chinese Acad Sci, Key Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed, Guangzhou 510530, Guangdong, Peoples R China; [Wang, Tao; Chen, Keshi; Zeng, Xiaoming; Yang, Jianguo; Wu, Yun; Shi, Xi; Qin, Baoming; Zeng, Lingwen; Esteban, Miguel Angel; Pan, Guangjin; Pei, Duanqing] Chinese Acad Sci, Key Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Hlth, Guangzhou 510530, Guangdong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences	Pei, DQ (corresponding author), Chinese Acad Sci, Key Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed, Guangzhou 510530, Guangdong, Peoples R China.	pei_duanqing@gibh.ac.cn	Chen, Keshi/AAE-4600-2020; Qin, Baoming/G-1553-2015; wang, tom/M-6808-2014	Qin, Baoming/0000-0001-7652-161X; Chen, Keshi/0000-0003-0402-4555	Ministry of Science and Technology [2009CB941102, 2011CB965200, 2011CBA01106]; Chinese Academy of Sciences [XDA01020401, XDA01020106, XDA01020202, XDA01020404]; National Natural Science Foundation of China [90813033]; National S&T Major Special Project on Major New Drug Innovation [2011ZX09102-010]; Bureau of Science and Technology of Guangzhou Municipality [2010U1-E00521]; Chinese Academy of Sciences/SAFEA	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National S&T Major Special Project on Major New Drug Innovation; Bureau of Science and Technology of Guangzhou Municipality; Chinese Academy of Sciences/SAFEA(Chinese Academy of Sciences)	We thank Eryun Zhong, Baojian Liao, Yanting Xue, and Chunlan Chen, along with other members of our laboratory for their support. This work was funded in part by grants from the Ministry of Science and Technology 973 program (2009CB941102, 2011CB965200, and 2011CBA01106), the "Strategic Priority Research Program" of the Chinese Academy of Sciences (Grant No. XDA01020401, XDA01020106, XDA01020202, and XDA01020404); the National Natural Science Foundation of China (90813033), the Ministry of Science and Technology International Technology Cooperation Program (2010DFB30430), the National S&T Major Special Project on Major New Drug Innovation (Grant No.2011ZX09102-010), the Bureau of Science and Technology of Guangzhou Municipality (2010U1-E00521), and the Chinese Academy of Sciences/SAFEA International Partnership Program for Creative Research Teams (to D.P.). We thank Dr. Degui Chen of Shanghai Institute of Biochemistry and Cell Biology for discussions and help in the early phase of this work.	Adamo A, 2011, NAT CELL BIOL, V13, P652, DOI 10.1038/ncb2246; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Barroso-delJesus A, 2008, MOL CELL BIOL, V28, P6609, DOI 10.1128/MCB.00398-08; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blackledge NP, 2010, MOL CELL, V38, P179, DOI 10.1016/j.molcel.2010.04.009; Chen JK, 2011, CELL RES, V21, P205, DOI 10.1038/cr.2010.172; Chen JK, 2010, J BIOL CHEM, V285, P31066, DOI 10.1074/jbc.M110.139436; Chung TL, 2010, STEM CELLS, V28, P1848, DOI 10.1002/stem.493; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; He J, 2008, NAT STRUCT MOL BIOL, V15, P1169, DOI 10.1038/nsmb.1499; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Knowles HJ, 2003, CANCER RES, V63, P1764; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li YQ, 2011, CELL RES, V21, P196, DOI 10.1038/cr.2010.142; Liang GY, 2010, J BIOL CHEM, V285, P25516, DOI 10.1074/jbc.M110.142059; Liao BJ, 2011, J BIOL CHEM, V286, P17359, DOI 10.1074/jbc.C111.235960; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/NMETH.1393, 10.1038/nmeth.1393]; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Ma DK, 2008, STEM CELLS, V26, P2131, DOI 10.1634/stemcells.2008-0388; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Nelson JD, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj004; Pawlak M, 2011, GENE DEV, V25, P1035, DOI 10.1101/gad.2039011; PETERKOFSKY B, 1991, AM J CLIN NUTR, V54, pS1135, DOI 10.1093/ajcn/54.6.1135s; Plath K, 2011, NAT REV GENET, V12, P253, DOI 10.1038/nrg2955; ROBERTSON WV, 1953, J BIOL CHEM, V201, P689; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Traber MG, 2011, FREE RADICAL BIO MED, V51, P1000, DOI 10.1016/j.freeradbiomed.2011.05.017; Tzatsos A, 2009, P NATL ACAD SCI USA, V106, P2641, DOI 10.1073/pnas.0813139106; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; WILSON CWM, 1973, LANCET, V1, P1058; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang SQ, 2011, HUM MOL GENET, V20, P3176, DOI 10.1093/hmg/ddr223; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zhou T, 2011, J AM SOC NEPHROL, V22, P1221, DOI 10.1681/ASN.2011010106; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	52	328	362	3	88	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 2	2011	9	6					575	587		10.1016/j.stem.2011.10.005	http://dx.doi.org/10.1016/j.stem.2011.10.005			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	859SB	22100412	Bronze			2022-12-28	WOS:000297895000017
J	Luis, NM; Morey, L; Mejetta, S; Pascual, G; Janich, P; Kuebler, B; Roma, G; Nascimento, E; Frye, M; Di Croce, L; Benitah, SA				Luis, Nuno Miguel; Morey, Lluis; Mejetta, Stefania; Pascual, Gloria; Janich, Peggy; Kuebler, Bernd; Roma, Guglielmo; Nascimento, Elisabete; Frye, Michaela; Di Croce, Luciano; Benitah, Salvador Aznar			Regulation of Human Epidermal Stem Cell Proliferation and Senescence Requires Polycomb-Dependent and -Independent Functions of Cbx4	CELL STEM CELL			English	Article							TRANSIT-AMPLIFYING CELLS; GROUP PROTEINS; METHYLTRANSFERASE ACTIVITY; REPRESSIVE COMPLEX; GENE-EXPRESSION; X-INACTIVATION; HISTONE H2A; DIFFERENTIATION; KERATINOCYTE; RING1B	Human epidermal stem cells transit from a slow cycling to an actively proliferating state to contribute to homeostasis. Both stem cell states differ in their cell cycle profiles but must remain guarded from differentiation and senescence. Here we show that Cbx4, a Polycomb Repressive Complex 1 (PRC1)-associated protein, maintains human epidermal stem cells as slow-cycling and undifferentiated, while protecting them from senescence. Interestingly, abrogating the polycomb activity of Cbx4 impairs its antisenescent function without affecting stem cell differentiation, indicating that differentiation and senescence are independent processes in human epidermis. Conversely, Cbx4 inhibits stem cell activation and differentiation through its SUMO ligase activity. Global transcriptome and chromatin occupancy analyses indicate that Cbx4 regulates modulators of epidermal homeostasis and represses factors such as Ezh2, Dnmt1, and Bmi1 to prevent the active stem cell state. Our results suggest that distinct Polycomb complexes balance epidermal stem cell dormancy and activation, while continually preventing senescence and differentiation.	[Luis, Nuno Miguel; Morey, Lluis; Mejetta, Stefania; Pascual, Gloria; Janich, Peggy; Kuebler, Bernd; Roma, Guglielmo; Di Croce, Luciano; Benitah, Salvador Aznar] CRG, Barcelona 08003, Spain; [Luis, Nuno Miguel; Morey, Lluis; Mejetta, Stefania; Pascual, Gloria; Janich, Peggy; Kuebler, Bernd; Roma, Guglielmo; Di Croce, Luciano; Benitah, Salvador Aznar] UPF, Barcelona 08003, Spain; [Nascimento, Elisabete; Frye, Michaela] Wellcome Trust Cambridge Stem Cell Inst, Cambridge CB2 1QR, England	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; University of Cambridge	Benitah, SA (corresponding author), CRG, Barcelona 08003, Spain.	salvador.aznar-benitah@crg.es	Di Croce, Luciano/E-7759-2015; Luis, Nuno Miguel/ABD-9784-2020; Luis, Nuno/F-2405-2012; Cozzuto, Luca/K-5385-2015; Angulo, Gloria Pascual/AAA-7668-2019; Kuebler, Bernd/K-2823-2017; Aznar-Benitah, Salvador/F-4761-2016	Di Croce, Luciano/0000-0003-3488-6228; Luis, Nuno Miguel/0000-0001-5438-9638; Luis, Nuno/0000-0001-5438-9638; Cozzuto, Luca/0000-0003-3194-8892; Angulo, Gloria Pascual/0000-0003-3810-6647; Kuebler, Bernd/0000-0002-4472-871X; Aznar-Benitah, Salvador/0000-0002-9059-5049; Morey, Lluis/0000-0001-9851-4066; Janich, Peggy/0000-0003-1045-7365; Frye, Michaela/0000-0002-5636-6840	Fondo de Investigacion Sanitario (FIS, Spanish Ministerio de Sanidad, MICINN); AGAUR (Government of Cataluna); Spanish "Ministerio de Educacion y Ciencia" [BFU2010-18692]; Fundacao pars a Ciencia e Tecnologia (Portugal); Spanish Ministerio de Sanidad; CRG-Novartis; La Caixa International Ph.D. Fellowship; MRC [G0801904] Funding Source: UKRI; Medical Research Council [G0801904] Funding Source: researchfish	Fondo de Investigacion Sanitario (FIS, Spanish Ministerio de Sanidad, MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentInstituto de Salud Carlos III); AGAUR (Government of Cataluna)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Spanish "Ministerio de Educacion y Ciencia"(Spanish Government); Fundacao pars a Ciencia e Tecnologia (Portugal); Spanish Ministerio de Sanidad(Spanish Government); CRG-Novartis; La Caixa International Ph.D. Fellowship(La Caixa Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Fondo de Investigacion Sanitario (FIS, Spanish Ministerio de Sanidad, MICINN) and AGAUR (Government of Cataluna) to S.A.B., and by the Spanish "Ministerio de Educacion y Ciencia" (BFU2010-18692) and Consolider to L.D.C. N.M.L. is funded by a fellowship from Fundacao pars a Ciencia e Tecnologia (Portugal). G.P. is the recipient of a FIS fellowship (Spanish Ministerio de Sanidad). L.M. is funded by CRG-Novartis Fellowship; S.M. is funded by La Caixa International Ph.D. Fellowship. We would like to thank David Wotton for providing us with the SUMO mutant versions of Cbx4, and Agusti Toll and Ramon Pujol from the Hospital del Mar (Barcelona) for kindly providing the human skin biopsies. Special thanks to all the CRG core facilities and Animal Unit for technical support, and to Veronica Raker for manuscript proofreading and helpful discussions.	BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dahiya A, 2001, MOL CELL, V8, P557, DOI 10.1016/S1097-2765(01)00346-X; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Dietrich N, 2007, EMBO J, V26, P1637, DOI 10.1038/sj.emboj.7601632; Drayton S, 2003, CANCER CELL, V4, P301, DOI 10.1016/S1535-6108(03)00242-3; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Frye M, 2003, DEVELOPMENT, V130, P2793, DOI 10.1242/dev.00462; Frye M, 2006, CURR BIOL, V16, P971, DOI 10.1016/j.cub.2006.04.027; Fuchs E, 2009, CELL STEM CELL, V4, P499, DOI 10.1016/j.stem.2009.05.001; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Gangatirkar P, 2007, NAT PROTOC, V2, P178, DOI 10.1038/nprot.2006.448; Gebhardt A, 2006, J CELL BIOL, V172, P139, DOI 10.1083/jcb.200506057; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Gosselet FP, 2007, CELL SIGNAL, V19, P731, DOI 10.1016/j.cellsig.2006.09.006; Gosselin K, 2009, AM J PATHOL, V174, P423, DOI 10.2353/ajpath.2009.080332; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jensen KB, 2006, P NATL ACAD SCI USA, V103, P11958, DOI 10.1073/pnas.0601886103; Jensen UB, 1999, DEVELOPMENT, V126, P2409; JONES PH, 1995, CELL, V80, P83, DOI 10.1016/0092-8674(95)90453-0; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kang XL, 2010, MOL CELL, V38, P191, DOI 10.1016/j.molcel.2010.03.005; Kerppola TK, 2009, TRENDS CELL BIOL, V19, P692, DOI 10.1016/j.tcb.2009.10.001; Kim RH, 2010, EXP CELL RES, V316, P2600, DOI 10.1016/j.yexcr.2010.04.013; Kim SH, 2008, INT J BIOCHEM CELL B, V40, P2462, DOI 10.1016/j.biocel.2008.04.018; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Klein AM, 2011, J R SOC INTERFACE, V8, P1815, DOI 10.1098/rsif.2011.0240; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Leeb M, 2007, J CELL BIOL, V178, P219, DOI 10.1083/jcb.200612127; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Legg J, 2003, DEVELOPMENT, V130, P6049, DOI 10.1242/dev.00837; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; Li A, 1998, P NATL ACAD SCI USA, V95, P3902, DOI 10.1073/pnas.95.7.3902; Li A, 2004, J CLIN INVEST, V113, P390, DOI 10.1172/JCI.200419140; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Satijn DPE, 1997, MOL CELL BIOL, V17, P6076, DOI 10.1128/MCB.17.10.6076; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; van der Stoop P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002235; Vandamme J, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002642; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Watt FM, 2008, CURR OPIN CELL BIOL, V20, P171, DOI 10.1016/j.ceb.2008.01.010; Watt FM, 2006, CURR OPIN GENET DEV, V16, P518, DOI 10.1016/j.gde.2006.08.006; Watt FM, 2009, EMBO MOL MED, V1, P260, DOI 10.1002/emmm.200900033; Webb A, 2004, DIFFERENTIATION, V72, P387, DOI 10.1111/j.1432-0436.2004.07208005.x; Whitcomb SJ, 2007, TRENDS GENET, V23, P494, DOI 10.1016/j.tig.2007.08.006; Wotton D, 2007, BIOCHEM SOC T, V35, P1401, DOI 10.1042/BST0351401; Yang SH, 2010, MOL CELL BIOL, V30, P2193, DOI 10.1128/MCB.01510-09; Zhou W, 2009, BMB REP, V42, P154, DOI 10.5483/BMBRep.2009.42.3.154	64	109	118	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 2	2011	9	3					233	246		10.1016/j.stem.2011.07.013	http://dx.doi.org/10.1016/j.stem.2011.07.013			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	822DN	21885019	Bronze			2022-12-28	WOS:000295024200010
J	Condomines, M; Sadelain, M				Condomines, Maud; Sadelain, Michel			Tolerance Induction by Allogeneic Hematopoietic Stem Cells	CELL STEM CELL			English	Editorial Material							IMMUNE PRIVILEGE	In this issue of Cell Stem Cell, Zheng et al. (2011) report that HSCs expressing PD-L1 display enhanced engraftment in irradiated allogeneic recipients. Independently in Nature, Fujisaki et al. (2011) observe allogeneic HSCs persisting in proximity to regulatory T cells in nonirradiated recipients, further connecting HSCs and immune tolerance.	[Condomines, Maud; Sadelain, Michel] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, Mol Pharmacol & Chem Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Sadelain, M (corresponding author), Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, Mol Pharmacol & Chem Program, New York, NY 10065 USA.	m-sadelain@ski.mskcc.org						Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Fujisaki J, 2011, NATURE, V474, P216, DOI 10.1038/nature10160; Kuang DM, 2009, J EXP MED, V206, P1327, DOI 10.1084/jem.20082173; Mueller SN, 2010, J CLIN INVEST, V120, P2508, DOI 10.1172/JCI40040; Nador RG, 2010, AM J TRANSPLANT, V10, P262, DOI 10.1111/j.1600-6143.2009.02942.x; Shizuru J A, 1996, Biol Blood Marrow Transplant, V2, P3; Welniak LA, 2007, ANNU REV IMMUNOL, V25, P139, DOI 10.1146/annurev.immunol.25.022106.141606; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Zheng JK, 2011, CELL STEM CELL, V9, P119, DOI 10.1016/j.stem.2011.06.003	11	3	3	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	AUG 5	2011	9	2					87	88		10.1016/j.stem.2011.07.005	http://dx.doi.org/10.1016/j.stem.2011.07.005			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	808PM	21816356	Bronze			2022-12-28	WOS:000293990900001
J	Kalista, T; Freeman, HA; Behr, B; Pera, RR; Scott, CT				Kalista, Tasha; Freeman, H. Austinn; Behr, Barry; Pera, Renee Reijo; Scott, Christopher Thomas			Donation of Embryos for Human Development and Stem Cell Research	CELL STEM CELL			English	Editorial Material								Using donated human embryos for scientific research raises ethical questions about the donation process. We describe a two-stage consent process designed to help couples make informed decisions about embryo disposition. This consent methodology minimizes conflict of interest, respects patient choice, and provides a much-needed resource to patients and the research community.	[Scott, Christopher Thomas] Stanford Univ, Ctr Biomed Eth, Program Stem Cells & Soc, Stanford, CA 94305 USA; [Kalista, Tasha; Freeman, H. Austinn; Pera, Renee Reijo] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Behr, Barry; Pera, Renee Reijo] Stanford Univ, Dept Obstet & Gynecol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Scott, CT (corresponding author), Stanford Univ, Ctr Biomed Eth, Program Stem Cells & Soc, Stanford, CA 94305 USA.	cscott@stanford.edu	Kalista, Tasha/AAY-8985-2021	Reijo Pera, Renee/0000-0002-6487-1329				Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Cohen CB, 2009, STEM CELL REV REP, V5, P116, DOI 10.1007/s12015-009-9060-6; Hoffman DI, 2003, FERTIL STERIL, V79, P1063, DOI 10.1016/S0015-0282(03)00172-9; Knopman JM, 2010, FERTIL STERIL, V94, P1689, DOI 10.1016/j.fertnstert.2009.11.010; Lerou PH, 2008, NAT PROTOC, V3, P923, DOI 10.1038/nprot.2008.60; Lyerly AD, 2007, SCIENCE, V317, P46, DOI 10.1126/science.1145067; Racowsky C, 2000, FERTIL STERIL, V73, P558, DOI 10.1016/S0015-0282(99)00565-8; Wong CC, 2010, NAT BIOTECHNOL, V28, P1115, DOI 10.1038/nbt.1686	8	24	24	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	APR 8	2011	8	4					360	362		10.1016/j.stem.2011.02.018	http://dx.doi.org/10.1016/j.stem.2011.02.018			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	752QI	21474099	Bronze			2022-12-28	WOS:000289707100007
J	Pera, MF				Pera, Martin F.			Safely Modulating the Immune System in Regenerative Medicine	CELL STEM CELL			English	Editorial Material							COSTIMULATION BLOCKADE; CELLS; TOLERANCE	The destruction of pluripotent stem cell-derived grafts by the host immune system presents a significant barrier to clinical translation of cell therapies. Pearl et al. (2011) report in this issue of Cell Stem Cell that a brief, nontoxic immunosuppressive regimen, achieved by blockade of leucocyte costimulatory pathways, may overcome this problem.	Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90089 USA	University of Southern California	Pera, MF (corresponding author), Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90089 USA.	pera@usc.edu	PERA, MARTIN/A-9812-2012	PERA, MARTIN/0000-0001-6239-0428				Chidgey AP, 2008, CELL STEM CELL, V3, P357, DOI 10.1016/j.stem.2008.09.011; Chidgey AP, 2008, NATURE, V453, P330, DOI 10.1038/nature07041; Ford ML, 2009, IMMUNOL REV, V229, P294, DOI 10.1111/j.1600-065X.2009.00776.x; Grinnemo KH, 2008, STEM CELLS, V26, P1850, DOI 10.1634/stemcells.2008.0111; Okamura RM, 2007, J NEUROIMMUNOL, V192, P134, DOI 10.1016/j.jneuroim.2007.09.030; Pearl JI, 2011, CELL STEM CELL, V8, P309, DOI 10.1016/j.stem.2011.01.012; Swijnenburg RJ, 2008, P NATL ACAD SCI USA, V105, P12991, DOI 10.1073/pnas.0805802105	7	0	0	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAR 4	2011	8	3					246	247		10.1016/j.stem.2011.02.013	http://dx.doi.org/10.1016/j.stem.2011.02.013			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	735HI	21362563	Bronze			2022-12-28	WOS:000288404400004
J	Mukherjee, S; Hsieh, J				Mukherjee, Shradha; Hsieh, Jenny			On Your (Methyl) Mark, Get TET1, Go!	CELL STEM CELL			English	Editorial Material							NEUROGENESIS; ADULT; DNA	Tet proteins and DNA demethylation are key regulators of embryonic stem cells, but their roles in development and tissue stem cells remain unclear. In this issue, Zhang et al. (2013) show that Tet1 regulates adult hippocampal neurogenesis by controlling progenitor proliferation, and Tet1 deficiency generates defects in learning and memory.	[Mukherjee, Shradha; Hsieh, Jenny] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Hsieh, J (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	jenny.hsieh@utsouthwestern.edu	mukherjee, shradha/M-5028-2015	mukherjee, shradha/0000-0002-3249-2551				Dawlaty MM, 2013, DEV CELL, V24, P310, DOI 10.1016/j.devcel.2012.12.015; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Goritz C, 2012, CELL STEM CELL, V10, P657, DOI 10.1016/j.stem.2012.04.005; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Zhang RR, 2013, CELL STEM CELL, V13, P237, DOI 10.1016/j.stem.2013.05.006	7	0	0	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 1	2013	13	2					133	134		10.1016/j.stem.2013.07.011	http://dx.doi.org/10.1016/j.stem.2013.07.011			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VO	23910076	Bronze			2022-12-28	WOS:000329570600002
J	Apostolou, E; Ferrari, F; Walsh, RM; Bar-Nur, O; Stadtfeld, M; Cheloufi, S; Stuart, HT; Polo, JM; Ohsumi, TK; Borowsky, ML; Kharchenko, PV; Park, PJ; Hochedlinger, K				Apostolou, Effie; Ferrari, Francesco; Walsh, Ryan M.; Bar-Nur, Ori; Stadtfeld, Matthias; Cheloufi, Sihem; Stuart, Hannah T.; Polo, Jose M.; Ohsumi, Toshiro K.; Borowsky, Mark L.; Kharchenko, Peter V.; Park, Peter J.; Hochedlinger, Konrad			Genome-wide Chromatin Interactions of the Nanog Locus in Pluripotency, Differentiation, and Reprogramming	CELL STEM CELL			English	Article							CHROMOSOMAL REARRANGEMENTS; TRANSCRIPTIONAL NETWORK; GENE; ORGANIZATION; EXPRESSION; MEDIATOR; COMPLEX; MED12; ESTABLISHMENT; MAINTENANCE	The chromatin state of pluripotency genes has been studied extensively in embryonic stem cells (ESCs) and differentiated cells, but their potential interactions with other parts of the genome remain largely unexplored. Here, we identified a genome-wide, pluripotency-specific interaction network around the Nanog promoter by adapting circular chromosome conformation capture sequencing. This network was rearranged during differentiation and restored in induced pluripotent stem cells. A large fraction of Nanog-interacting loci were bound by Mediator or cohesin in pluripotent cells. Depletion of these proteins from ESCs resulted in a disruption of contacts and the acquisition of a differentiation-specific interaction pattern prior to obvious transcriptional and phenotypic changes. Similarly, the establishment of Nanog interactions during reprogramming often preceded transcriptional upregulation of associated genes, suggesting a causative link. Our results document a complex, pluripotency-specific chromatin "interactome'' for Nanog and suggest a functional role for long-range genomic interactions in the maintenance and induction of pluripotency.	[Apostolou, Effie; Walsh, Ryan M.; Bar-Nur, Ori; Stadtfeld, Matthias; Cheloufi, Sihem; Stuart, Hannah T.; Polo, Jose M.; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Apostolou, Effie; Walsh, Ryan M.; Bar-Nur, Ori; Stadtfeld, Matthias; Cheloufi, Sihem; Stuart, Hannah T.; Polo, Jose M.; Hochedlinger, Konrad] Ctr Regenerat Med, Boston, MA 02114 USA; [Apostolou, Effie; Walsh, Ryan M.; Bar-Nur, Ori; Stadtfeld, Matthias; Cheloufi, Sihem; Stuart, Hannah T.; Polo, Jose M.; Hochedlinger, Konrad] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Apostolou, Effie; Walsh, Ryan M.; Bar-Nur, Ori; Stadtfeld, Matthias; Cheloufi, Sihem; Stuart, Hannah T.; Polo, Jose M.; Hochedlinger, Konrad] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Apostolou, Effie; Walsh, Ryan M.; Bar-Nur, Ori; Stadtfeld, Matthias; Cheloufi, Sihem; Stuart, Hannah T.; Polo, Jose M.; Hochedlinger, Konrad] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Apostolou, Effie; Walsh, Ryan M.; Bar-Nur, Ori; Stadtfeld, Matthias; Cheloufi, Sihem; Stuart, Hannah T.; Polo, Jose M.; Hochedlinger, Konrad] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Ferrari, Francesco; Kharchenko, Peter V.; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Ohsumi, Toshiro K.; Borowsky, Mark L.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Ohsumi, Toshiro K.; Borowsky, Mark L.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Kharchenko, Peter V.] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Park, Peter J.] Childrens Hosp, Informat Program, Boston, MA 02115 USA; [Park, Peter J.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital	Park, PJ (corresponding author), Harvard Univ, Sch Med, Ctr Biomed Informat, 10 Shattuck St, Boston, MA 02115 USA.	peter_park@harvard.edu; khochedlinger@helix.mgh.harvard.edu	Apostolou, Effie/AAG-1559-2020; Ferrari, Francesco/H-5007-2012; Bar-Nur, Ori/GWQ-5917-2022	Ferrari, Francesco/0000-0002-9811-3753; Polo, Jose M/0000-0002-2531-778X; Stuart, Hannah/0000-0001-9563-9760; Stadtfeld, Matthias/0000-0002-5852-9906; Park, Peter/0000-0001-9378-960X; Cheloufi, Sihem/0000-0002-1726-4796	JCCF; HHMI; NIH [RC2HL102815, K25AG037596, DP2OD003266, R01HD058013]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058013] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K25AG037596] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD003266] Funding Source: NIH RePORTER	JCCF; HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We acknowledge Peter Fraser, Frank Grosveld, Jane Skok, and Job Dekker for comments and suggestions. We thank Mariann Miscinai and Triantiafyllos Paparountas for discussing bioinformatics analysis, Eda Yildirim and Berni Peyer for advice about FISH experiments, and all members of the Hochedlinger and Park groups for suggestions. E.A. was supported by post-doctoral fellowships from JCCF and HHMI. P.J.P. was supported by a Sloan Research Fellowship and NIH (RC2HL102815), P.V.K was supported by NIH (K25AG037596), and K.H. was supported by NIH (DP2OD003266 and R01HD058013).	Apostolou E, 2008, CELL, V134, P85, DOI 10.1016/j.cell.2008.05.052; Bantignies F, 2011, CELL, V144, P214, DOI 10.1016/j.cell.2010.12.026; Borggrefe T, 2011, SEMIN CELL DEV BIOL, V22, P759, DOI 10.1016/j.semcdb.2011.07.022; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Clowney EJ, 2012, CELL, V151, P724, DOI 10.1016/j.cell.2012.09.043; Costa Y, 2013, NATURE, V495, P370, DOI 10.1038/nature11925; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Donohoe ME, 2009, NATURE, V460, P128, DOI 10.1038/nature08098; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Engel JD, 2000, CELL, V100, P499, DOI 10.1016/S0092-8674(00)80686-8; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Gao F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01588; Golipour A, 2012, CELL STEM CELL, V11, P769, DOI 10.1016/j.stem.2012.11.008; Hiratani I, 2010, GENOME RES, V20, P155, DOI 10.1101/gr.099796.109; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Huang SD, 2012, CELL, V151, P937, DOI 10.1016/j.cell.2012.10.035; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Levasseur DN, 2008, GENE DEV, V22, P575, DOI 10.1101/gad.1606308; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nitzsche A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019470; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Rocha PP, 2012, MOL CELL, V47, P873, DOI 10.1016/j.molcel.2012.06.036; Rocha PP, 2010, DEVELOPMENT, V137, P2723, DOI 10.1242/dev.053660; SCHARDIN M, 1985, HUM GENET, V71, P281, DOI 10.1007/BF00388452; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Shiue CN, 2009, ONCOGENE, V28, P1833, DOI 10.1038/onc.2009.21; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Simonis M, 2009, NAT METHODS, V6, P837, DOI [10.1038/NMETH.1391, 10.1038/nmeth.1391]; Smith K, 2010, REGEN MED, V5, P947, DOI 10.2217/RME.10.79; Smith KN, 2010, CELL STEM CELL, V7, P343, DOI 10.1016/j.stem.2010.06.023; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M., 2012, NAT GENET, V44, pS1, DOI DOI 10.1038/NG.1110; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Stadtfeld M, 2010, NAT METHODS, V7, P53, DOI [10.1038/NMETH.1409, 10.1038/nmeth.1409]; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tutter AV, 2009, J BIOL CHEM, V284, P3709, DOI 10.1074/jbc.M805677200; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wood AJ, 2010, NAT REV GENET, V11, P391, DOI 10.1038/nrg2794; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	62	153	157	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 6	2013	12	6					699	712		10.1016/j.stem.2013.04.013	http://dx.doi.org/10.1016/j.stem.2013.04.013			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VH	23665121	Bronze, Green Accepted			2022-12-28	WOS:000329569900013
J	Sirko, S; Behrendt, G; Johansson, PA; Tripathi, P; Costa, MR; Bek, S; Heinrich, C; Tiedt, S; Colak, D; Dichgans, M; Fischer, IR; Plesnila, N; Staufenbiel, M; Haass, C; Snapyan, M; Saghatelyan, A; Tsai, LH; Fischer, A; Grobe, K; Dimou, L; Gotz, M				Sirko, Swetlana; Behrendt, Gwendolyn; Johansson, Pia Annette; Tripathi, Pratibha; Costa, Marcos Romualdo; Bek, Sarah; Heinrich, Christophe; Tiedt, Steffen; Colak, Dilek; Dichgans, Martin; Fischer, Isabel Rebekka; Plesnila, Nikolaus; Staufenbiel, Matthias; Haass, Christian; Snapyan, Marina; Saghatelyan, Armen; Tsai, Li-Huei; Fischer, Andre; Grobe, Kay; Dimou, Leda; Goetz, Magdalena			Reactive Glia in the Injured Brain Acquire Stem Cell Properties in Response to Sonic Hedgehog	CELL STEM CELL			English	Article							NEURAL STEM/PROGENITOR CELLS; IN-VITRO; ASTROCYTE PROLIFERATION; SUBVENTRICULAR ZONE; SELF-RENEWAL; RADIAL GLIA; SPINAL-CORD; ADULT; DIFFERENTIATION; REGENERATION	As a result of brain injury, astrocytes become activated and start to proliferate in the vicinity of the injury site. Recently, we had demonstrated that these reactive astrocytes, or glia, can form self-renewing and multipotent neurospheres in vitro. In the present study, we demonstrate that it is only invasive injury, such as stab wounding or cerebral ischemia, and not noninvasive injury conditions, such as chronic amyloidosis or induced neuronal death, that can elicit this increase in plasticity. Furthermore, we find that Sonic hedgehog (SHH) is the signal that acts directly on the astrocytes and is necessary and sufficient to elicit the stem cell response both in vitro and in vivo. These findings provide a molecular basis for how cells with neural stem cell lineage emerge at sites of brain injury and imply that the high levels of SHH known to enter the brain from extraneural sources after invasive injury can trigger this response.	[Sirko, Swetlana; Behrendt, Gwendolyn; Bek, Sarah; Heinrich, Christophe; Tiedt, Steffen; Dimou, Leda; Goetz, Magdalena] Univ Munich, Inst Physiol, D-80336 Munich, Germany; [Haass, Christian] Univ Munich, German Ctr Neurodegenerat Dis DZNE, D-80336 Munich, Germany; [Haass, Christian] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Sirko, Swetlana; Johansson, Pia Annette; Tripathi, Pratibha; Costa, Marcos Romualdo; Bek, Sarah; Colak, Dilek; Dimou, Leda; Goetz, Magdalena] German Res Ctr Environm Hlth, Helmholtz Zentrum Munich, Inst Stem Cell Res, D-85764 Neuherberg, Germany; [Colak, Dilek] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA; [Dichgans, Martin; Fischer, Isabel Rebekka; Plesnila, Nikolaus] Univ Munich, Inst Stroke & Dementia Res, D-81377 Munich, Germany; [Dichgans, Martin; Plesnila, Nikolaus; Haass, Christian; Goetz, Magdalena] Munich Cluster Syst Neurol SyNergy, D-80336 Munich, Germany; [Staufenbiel, Matthias] Novartis Pharma AG, Dept Neurosci, Inst Biomed Res, CH-4057 Basel, Switzerland; [Snapyan, Marina; Saghatelyan, Armen] Univ Laval, Cellular Neurobiol Unit, Inst Univ Sante Mentale Quebec, Quebec City, PQ G1J 2G3, Canada; [Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Tsai, Li-Huei] Howard Hughes Med Inst, Chevy Chase, MD USA; [Fischer, Andre] Univ Med Ctr, Dept Psychiat & Psychotherapy, D-37077 Gottingen, Germany; [Fischer, Andre] German Ctr Neurodegenerat Dis DZNE, D-37077 Gottingen, Germany; [Grobe, Kay] Univ Munster, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany	University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Cornell University; University of Munich; University of Munich; Novartis; Universita della Svizzera Italiana; Laval University; Massachusetts Institute of Technology (MIT); Northwell Health; Howard Hughes Medical Institute; University of Gottingen; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munster	Gotz, M (corresponding author), Univ Munich, Inst Physiol, D-80336 Munich, Germany.	magdalena.goetz@helmholtz-muenchen.de	Dichgans, Martin/HCH-3247-2022; Grobe, Kay/F-2399-2011; Fischer, Andre/AAU-7487-2021; Plesnila, Nikolaus/T-7522-2019; Costa, Marcos R/F-8071-2012; Dimou, Leda/E-7968-2012; Fischer, Isabel/GRX-2167-2022; HEINRICH, Christophe/K-1300-2017; Sirko, Swetlana/O-5725-2019	Dichgans, Martin/0000-0002-0654-387X; Costa, Marcos R/0000-0002-4928-2163; HEINRICH, Christophe/0000-0003-1266-718X; Sirko, Swetlana/0000-0001-5950-616X; Fischer, Andre/0000-0001-8546-1161; Johansson, Pia/0000-0002-6938-4060; Saghatelyan, Armen/0000-0003-4962-0465	Graduate School of Systemic Neurosciences; DFG Collaborative Research Center on Molecular Mechanisms of Neurodegeneration [SFB 596, SFB 870]; Hans and Ilse Breuer Foundation; German Federal Ministry for Education and Research (BMBF); DFG [GO640/6-1, GO640/7-1, GO640/8-1]; Friedrich Baur Foundation; Alexander von Humboldt Foundation; EU; NIH [NS051874]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051874] Funding Source: NIH RePORTER	Graduate School of Systemic Neurosciences; DFG Collaborative Research Center on Molecular Mechanisms of Neurodegeneration; Hans and Ilse Breuer Foundation; German Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); Friedrich Baur Foundation; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); EU(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are particularly grateful to Andreas Faissner for providing the 473HD antibody and would like to thank Gabi Jager, Angelika Waiser, Ines Muhlhahn, Andrea Steiner, Tatjana Simon-Ebert, and Uta Mamrak for excellent technical assistance, and Timucin Ozturk and Detlef Franzen for help with the colony of Smoothened floxed mice. It is a pleasure to thank Benedikt Berninger, Marisa Karow, Jovica Ninkovic, Stefanie Robel, and Paul Hardy for excellent comments on the manuscript and the Graduate School of Systemic Neurosciences for support. Funding to M. G. was provided by SFB 596 (DFG Collaborative Research Center on Molecular Mechanisms of Neurodegeneration), SFB 870, the award of the Breuer Prize 2008 by the Hans and Ilse Breuer Foundation, the German Federal Ministry for Education and Research (BMBF), and DFG grants GO640/6-1, 7-1, and 8-1. S. S. was supported by a grant from the Friedrich Baur Foundation, M. C. by a Research Fellowship from the Alexander von Humboldt Foundation, and N.P. by an EU MicroFlow grant. L.-H. T. is an Investigator of the Howard Hughes Medical Institute and acknowledges support from NIH (RO1 Grant NS051874).	Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Amankulor NM, 2009, J NEUROSCI, V29, P10299, DOI 10.1523/JNEUROSCI.2500-09.2009; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Antos CL, 2010, ADV EXP MED BIOL, V695, P184, DOI 10.1007/978-1-4419-7037-4_13; Bambakidis NC, 2012, J NEUROSURG, V116, P1114, DOI 10.3171/2012.1.JNS111285; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Baumgart EV, 2012, GLIA, V60, P343, DOI 10.1002/glia.22269; Behrendt G, 2013, GLIA, V61, P273, DOI 10.1002/glia.22432; Boncristiano S, 2005, NEUROBIOL AGING, V26, P607, DOI 10.1016/j.neurobiolaging.2004.06.010; Bozoyan L, 2012, J NEUROSCI, V32, P1687, DOI 10.1523/JNEUROSCI.5531-11.2012; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Cruz JC, 2006, J NEUROSCI, V26, P10536, DOI 10.1523/JNEUROSCI.3133-06.2006; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Denes A, 2007, J CEREBR BLOOD F MET, V27, P1941, DOI 10.1038/sj.jcbfm.9600495; Duyckaerts C, 2009, ACTA NEUROPATHOL, V118, P5, DOI 10.1007/s00401-009-0532-1; El-Zaatari M, 2012, PANCREAS, V41, P1019, DOI 10.1097/MPA.0b013e31824a0eeb; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Gadea A, 2008, J NEUROSCI, V28, P2394, DOI 10.1523/JNEUROSCI.5652-07.2008; Garcia ADR, 2010, J NEUROSCI, V30, P13597, DOI 10.1523/JNEUROSCI.0830-10.2010; GATES MA, 1995, J COMP NEUROL, V361, P249, DOI 10.1002/cne.903610205; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Hashimoto M, 2008, J NEUROCHEM, V107, P918, DOI 10.1111/j.1471-4159.2008.05666.x; Huang X, 2009, DEVELOPMENT, V136, P2535, DOI 10.1242/dev.033795; Kamphuis W, 2012, GLIA, V60, P615, DOI 10.1002/glia.22295; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Lang B, 2004, NEUROSCIENCE, V128, P775, DOI 10.1016/j.neuroscience.2004.06.033; Long FX, 2001, DEVELOPMENT, V128, P5099; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Marz M, 2011, DEV DYNAM, V240, P2221, DOI 10.1002/dvdy.22710; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; Nakamura T, 2006, CIRC RES, V98, P1547, DOI 10.1161/01.RES.0000227505.19472.69; Ohlig S, 2011, DEV CELL, V20, P764, DOI 10.1016/j.devcel.2011.05.010; Plesnila N, 2004, J CEREBR BLOOD F MET, V24, P458, DOI 10.1097/00004647-200404000-00011; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Robel S, 2011, J NEUROSCI, V31, P12471, DOI 10.1523/JNEUROSCI.2696-11.2011; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Rodriguez JJ, 2009, CELL DEATH DIFFER, V16, P378, DOI 10.1038/cdd.2008.172; Rupp NJ, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.08.014; Sehgal R, 2009, DEV BIOL, V332, P429, DOI 10.1016/j.ydbio.2009.05.579; Shimada IS, 2012, J NEUROSCI, V32, P7926, DOI 10.1523/JNEUROSCI.4303-11.2012; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Sims JR, 2009, STROKE, V40, P3618, DOI 10.1161/STROKEAHA.109.561951; Sirko S, 2009, BRAIN, V132, P2252, DOI 10.1093/brain/awp043; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Stoick-Cooper CL, 2007, GENE DEV, V21, P1292, DOI 10.1101/gad.1540507; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Traiffort E, 1999, EUR J NEUROSCI, V11, P3199, DOI 10.1046/j.1460-9568.1999.00777.x; Tsuda M, 2011, BRAIN, V134, P1127, DOI 10.1093/brain/awr025; Veeraraghavalu K, 2010, J NEUROSCI, V30, P6903, DOI 10.1523/JNEUROSCI.0527-10.2010	54	258	271	2	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 4	2013	12	4					426	439		10.1016/j.stem.2013.01.019	http://dx.doi.org/10.1016/j.stem.2013.01.019			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VD	23561443	Bronze, Green Published			2022-12-28	WOS:000329569500010
J	Lagadinou, ED; Sach, A; Callahan, K; Rossi, RM; Neering, SJ; Minhajuddin, M; Ashton, JM; Pei, SS; Grose, V; O'Dwyer, KM; Liesveld, JL; Brookes, PS; Becker, MW; Jordan, CT				Lagadinou, Eleni D.; Sach, Alexander; Callahan, Kevin; Rossi, Randall M.; Neering, Sarah J.; Minhajuddin, Mohammad; Ashton, John M.; Pei, Shanshan; Grose, Valerie; O'Dwyer, Kristen M.; Liesveld, Jane L.; Brookes, Paul S.; Becker, Michael W.; Jordan, Craig T.			BCL-2 Inhibition Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells	CELL STEM CELL			English	Article							ACUTE MYELOID-LEUKEMIA; BH3 MIMETIC ABT-737; CANCER-CELLS; APOPTOSIS; STATE; AML; MECHANISMS; EXPRESSION; RESISTANCE; NICHE	Most forms of chemotherapy employ mechanisms involving induction of oxidative stress, a strategy that can be effective due to the elevated oxidative state commonly observed in cancer cells. However, recent studies have shown that relative redox levels in primary tumors can be heterogeneous, suggesting that regimens dependent on differential oxidative state may not be uniformly effective. To investigate this issue in hematological malignancies, we evaluated mechanisms controlling oxidative state in primary specimens derived from acute myelogenous leukemia (AML) patients. Our studies demonstrate three striking findings. First, the majority of functionally defined leukemia stem cells (LSCs) are characterized by relatively low levels of reactive oxygen species (termed "ROS-low"). Second, ROS-low LSCs aberrantly overexpress BCL-2. Third, BCL-2 inhibition reduced oxidative phosphorylation and selectively eradicated quiescent LSCs. Based on these findings, we propose a model wherein the unique physiology of ROS-low LSCs provides an opportunity for selective targeting via disruption of BCL-2-dependent oxidative phosphorylation.	[Lagadinou, Eleni D.; Sach, Alexander; Callahan, Kevin; Rossi, Randall M.; Neering, Sarah J.; Minhajuddin, Mohammad; Ashton, John M.; Pei, Shanshan; Grose, Valerie; O'Dwyer, Kristen M.; Liesveld, Jane L.; Becker, Michael W.; Jordan, Craig T.] Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Rochester, NY 14642 USA; [O'Dwyer, Kristen M.; Liesveld, Jane L.; Becker, Michael W.; Jordan, Craig T.] Univ Rochester, Med Ctr, Div Hematol Oncol, Rochester, NY 14642 USA; [Pei, Shanshan; Jordan, Craig T.] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA; [Brookes, Paul S.] Univ Rochester, Med Ctr, Anesthesiol Dept, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester	Jordan, CT (corresponding author), Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, 601 Elmwood Ave, Rochester, NY 14642 USA.	craig_jordan@urmc.rochester.edu	PEI, SHANSHAN/D-8200-2016; Minhajuddin, Mohammad/AAC-9227-2022; jordan, craig/D-7666-2014	PEI, SHANSHAN/0000-0001-9619-2614; jordan, craig/0000-0003-0869-3465; Becker, Michael/0000-0001-9890-8815; Ashton, John/0000-0001-9875-5994; Brookes, Paul/0000-0002-8639-8413	Leukemia and Lymphoma Society [6230-11, 6133-12]; NYSTEM [CO24964]; US National Institutes of Health [HL-071158]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071158] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NYSTEM; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors gratefully acknowledge critical review and comments by Drs. Fay Young, H. Leighton Grimes, Martin Carroll, and Helene McMurray, and technical assistance by the Functional Genomics Center of the University of Rochester. Craig Jordan is supported by an endowed chair generously provided by Philip and Marilyn Wehrheim. Research studies described in this manuscript were supported by grants from the Leukemia and Lymphoma Society (6230-11 and 6133-12, C.T.J.), NYSTEM (CO24964, C.T.J.), and the US National Institutes of Health (HL-071158, P.S.B.).	Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chen ZX, 2007, CELL DEATH DIFFER, V14, P1617, DOI 10.1038/sj.cdd.4402165; Del Poeta G, 2003, BLOOD, V101, P2125, DOI 10.1182/blood-2002-06-1714; DELIA D, 1992, BLOOD, V79, P1291, DOI 10.1182/blood.V79.5.1291.bloodjournal7951291; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Falini B, 2007, BLOOD, V109, P874, DOI 10.1182/blood-2006-07-012252; Hole PS, 2010, BLOOD, V115, P1238, DOI 10.1182/blood-2009-06-222869; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Nakajima EC, 2012, MOL CARCINOG; Saito Y, 2010, NAT BIOTECHNOL, V28, P275, DOI 10.1038/nbt.1607; Sarry JE, 2011, J CLIN INVEST, V121, P384, DOI 10.1172/JCI41495; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Smith J, 2000, P NATL ACAD SCI USA, V97, P10032, DOI 10.1073/pnas.170209797; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Trachootham D, 2008, BLOOD, V112, P1912, DOI 10.1182/blood-2008-04-149815; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Vlashi E, 2011, P NATL ACAD SCI USA, V108, P16062, DOI 10.1073/pnas.1106704108; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013	25	766	786	5	68	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 7	2013	12	3					329	341		10.1016/j.stem.2012.12.013	http://dx.doi.org/10.1016/j.stem.2012.12.013			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VC	23333149	Green Accepted, Bronze			2022-12-28	WOS:000329569400011
J	Marques-Torrejon, MA; Porlan, E; Banito, A; Gomez-Ibarlucea, E; Lopez-Contreras, AJ; Fernandez-Capetillo, O; Vidal, A; Gil, J; Torres, J; Farinas, I				Angeles Marques-Torrejon, M.; Porlan, Eva; Banito, Ana; Gomez-Ibarlucea, Esther; Lopez-Contreras, Andres J.; Fernandez-Capetillo, Oscar; Vidal, Anxo; Gil, Jesus; Torres, Josema; Farinas, Isabel			Cyclin-Dependent Kinase Inhibitor p21 Controls Adult Neural Stem Cell Expansion by Regulating Sox2 Gene Expression	CELL STEM CELL			English	Article							ONCOGENE-INDUCED SENESCENCE; DNA-DAMAGE; SELF-RENEWAL; REPLICATIVE STRESS; COPY NUMBER; PROLIFERATION; ATR; P53; DIFFERENTIATION; P21(WAF1/CIP1)	In the adult brain, continual neurogenesis of olfactory neurons is sustained by the existence of neural stem cells (NSCs) in the subependymal niche. Elimination of the cyclin-dependent kinase inhibitor 1A (p21) leads to premature exhaustion of the subependymal NSC pool, suggesting a relationship between cell cycle control and long-term self-renewal, but the molecular mechanisms underlying NSC maintenance by p21 remain unexplored. Here we identify a function of p21 in the direct regulation of the expression of pluripotency factor Sox2, a key regulator of the specification and maintenance of neural progenitors. We observe that p21 directly binds a Sox2 enhancer and negatively regulates Sox2 expression in NSCs. Augmented levels of Sox2 in p21 null cells induce replicative stress and a DNA damage response that leads to cell growth arrest mediated by increased levels of p19(Arf) and p53. Our results show a regulation of NSC expansion driven by a p21/Sox2/p53 axis.	[Angeles Marques-Torrejon, M.; Porlan, Eva; Torres, Josema; Farinas, Isabel] Univ Valencia, Dept Biol Celular, E-46100 Valencia, Spain; [Angeles Marques-Torrejon, M.; Porlan, Eva; Farinas, Isabel] Univ Valencia, Ctr Invest Biomed Red Enfermedades Neurodegenerat, E-46100 Valencia, Spain; [Banito, Ana; Gil, Jesus] Univ London Imperial Coll Sci Technol & Med, Cell Proliferat Grp, MRC Clin Sci Ctr, Fac Med, London W12 0NN, England; [Gomez-Ibarlucea, Esther; Vidal, Anxo] Univ Santiago de Compostela, Dept Fisiol, Inst Invest Sanitaria Santiago IDIS, Santiago De Compostela 15782, Spain; [Gomez-Ibarlucea, Esther; Vidal, Anxo] Univ Santiago de Compostela, Ctr Invest Med Mol CIMUS, Inst Invest Sanitaria Santiago IDIS, Santiago De Compostela 15782, Spain; [Lopez-Contreras, Andres J.; Fernandez-Capetillo, Oscar] Spanish Natl Canc Res Ctr CNIO, Genom Instabil Grp, Madrid 28029, Spain	University of Valencia; CIBERNED; University of Valencia; Imperial College London; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Centro Nacional de Investigaciones Oncologicas (CNIO)	Torres, J (corresponding author), Univ Valencia, Dept Biol Celular, E-46100 Valencia, Spain.	josema.torres@uv.es; isabel.farinas@uv.es	Fernandez-Capetillo, Oscar/H-3508-2015; Lopez-Contreras, Andres J/AAA-1110-2020; Gómez-Ibarlucea, Esther/AAA-8536-2020; Marques, Maria Angeles/AAH-2720-2019; Gil, Jesus/C-7739-2012; Vidal, Anxo/B-5010-2015; Banito, Ana/P-6168-2017; porlan, Eva/AAE-6561-2022; Torres, Josema/F-7070-2013; Farinas, Isabel/L-7118-2014	Fernandez-Capetillo, Oscar/0000-0002-2690-6885; Gil, Jesus/0000-0002-4303-6260; Vidal, Anxo/0000-0002-0866-4202; porlan, Eva/0000-0003-0934-9711; Torres, Josema/0000-0001-6906-7164; Farinas, Isabel/0000-0003-2903-4960; Lopez-Contreras, Andres Joaquin/0000-0002-5517-7327; Banito, Ana/0000-0003-2188-0003	Spanish Ministerio de Ciencia e Innovacion (MICINN) (Programa de Biomedicina); Spanish Ministerio de Ciencia e Innovacion (MICINN) (CIBERNED); Spanish Ministerio de Ciencia e Innovacion (MICINN) (RETIC Terapia Celular); Generalitat Valenciana (Programas Prometeo); Generalitat Valenciana (ISIC); MICINN; Xunta de Galicia; MICINN/Fondo de Investigacion Sanitaria; Association for International Cancer Research (AICR); Howard Hughes Medical Institute; European Research Council; Medical Research Council; Cancer Research UK; Association for International Cancer Research; Spanish MICINN/FPI predoctoral fellowship; Spanish Association Against Cancer; Portuguese Fundacao para Ciencia ea Tecnologia; Medical Research Council [MC_U120085810] Funding Source: researchfish; Worldwide Cancer Research [12-0229] Funding Source: researchfish; MRC [MC_U120085810] Funding Source: UKRI	Spanish Ministerio de Ciencia e Innovacion (MICINN) (Programa de Biomedicina)(Ministry of Science and Innovation, Spain (MICINN)); Spanish Ministerio de Ciencia e Innovacion (MICINN) (CIBERNED); Spanish Ministerio de Ciencia e Innovacion (MICINN) (RETIC Terapia Celular); Generalitat Valenciana (Programas Prometeo)(Center for Forestry Research & Experimentation (CIEF)); Generalitat Valenciana (ISIC)(Center for Forestry Research & Experimentation (CIEF)); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Xunta de Galicia(Xunta de GaliciaEuropean Commission); MICINN/Fondo de Investigacion Sanitaria; Association for International Cancer Research (AICR); Howard Hughes Medical Institute(Howard Hughes Medical Institute); European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Association for International Cancer Research; Spanish MICINN/FPI predoctoral fellowship; Spanish Association Against Cancer; Portuguese Fundacao para Ciencia ea Tecnologia(Portuguese Foundation for Science and Technology); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Worldwide Cancer Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank R. Lovell-Badge for the Sox2 mouse strain, and K. Nakashima and O. Okuda for mouse Sox2 and SRR2-TK-Venus reporter constructs, respectively. We are grateful to M.J. Palop for help with the mouse colonies and to A. Flores, A. Martinez, and D. Martinez for their assistance with flow cytometry and high content cellular analysis. We thank L. Sevilla and J.M. Morante-Redolat for critical reading of the manuscript and valuable discussions. We also thank members of the I.F. lab for helpful discussions. This work was supported by grants from Spanish Ministerio de Ciencia e Innovacion (MICINN) (Programa de Biomedicina, CIBERNED, and RETIC Terapia Celular) and Generalitat Valenciana (Programas Prometeo and ISIC) to I.F.; MICINN and Xunta de Galicia to A.V.; MICINN/Fondo de Investigacion Sanitaria to J.T.; MICINN, Association for International Cancer Research (AICR), Howard Hughes Medical Institute, and European Research Council to O.F.-C.; and Medical Research Council, Cancer Research UK, and the Association for International Cancer Research to J.G. J.T. is a Ramon y Cajal investigator and J.G is a EMBO Young Investigator. M.A.M.-T. was funded by a Spanish MICINN/FPI predoctoral fellowship. E.G.-I. is supported by a predoctoral fellowship from Xunta de Galicia. A.J.L. is the recipient of a postdoctoral fellowship from the Spanish Association Against Cancer. A.B. is funded by the Portuguese Fundacao para Ciencia ea Tecnologia. All of the authors designed and discussed the experiments and contributed to the text of the manuscript. M.A.M.-T. conducted most of the experimental work and wrote a draft of the manuscript. A.B. conducted the MEF experiments. E.P. and E.G.-I. carried out the ChIP assays. A.L.-C. generated the p21-Chk1<SUP>Tg</SUP> mice. J.T. and I.F. conceived the project, supervised the experiments, and wrote the manuscript. The authors declare no competing financial interests.	Andreu-Agullo C, 2009, NAT NEUROSCI, V12, P1514, DOI 10.1038/nn.2437; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bani-Yaghoub M, 2006, DEV BIOL, V295, P52, DOI 10.1016/j.ydbio.2006.03.007; Banito A, 2010, EMBO REP, V11, P353, DOI 10.1038/embor.2010.47; Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Blasco MA, 2011, EMBO J, V30, P991, DOI 10.1038/emboj.2011.50; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Devgan V, 2005, GENE DEV, V19, P1485, DOI 10.1101/gad.341405; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Dotto GP, 2000, BBA-REV CANCER, V1471, pM43, DOI 10.1016/S0304-419X(00)00019-6; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Fernando RN, 2011, P NATL ACAD SCI USA, V108, P5837, DOI 10.1073/pnas.1014993108; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Ferron SR, 2007, NAT PROTOC, V2, P849, DOI 10.1038/nprot.2007.104; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lee Y, 2012, EMBO J, V31, P1177, DOI 10.1038/emboj.2011.493; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Liu Y, 2007, EMBO J, V26, P4683, DOI 10.1038/sj.emboj.7601886; Lopez-Contreras AJ, 2012, J EXP MED, V209, P455, DOI 10.1084/jem.20112147; Maier S, 2011, HUM PATHOL, V42, P1078, DOI 10.1016/j.humpath.2010.11.010; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Miyagi S, 2006, J BIOL CHEM, V281, P13374, DOI 10.1074/jbc.M512669200; Miyagi S, 2004, MOL CELL BIOL, V24, P4207, DOI 10.1128/MCB.24.10.4207-4220.2004; Miyagi S, 2008, FEBS LETT, V582, P2811, DOI 10.1016/j.febslet.2008.07.011; Murga M, 2009, NAT GENET, V41, P891, DOI 10.1038/ng.420; Narva E, 2010, NAT BIOTECHNOL, V28, P371, DOI 10.1038/nbt.1615; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Phi JH, 2008, AM J SURG PATHOL, V32, P103, DOI 10.1097/PAS.0b013e31812f6ba6; Pippa R, 2012, ONCOGENE, V31, P4207, DOI 10.1038/onc.2011.582; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Ruzankina Y, 2009, NAT GENET, V41, P1144, DOI 10.1038/ng.441; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sisodiya SM, 2006, EPILEPSIA, V47, P534, DOI 10.1111/j.1528-1167.2006.00464.x; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Toledo LI, 2011, MOL ONCOL, V5, P368, DOI 10.1016/j.molonc.2011.07.002; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Wegner M, 2011, GENE DEV, V25, P2423, DOI 10.1101/gad.181487.111; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	55	132	137	2	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 3	2013	12	1					88	100		10.1016/j.stem.2012.12.001	http://dx.doi.org/10.1016/j.stem.2012.12.001			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	074UM	23260487	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000313839500013
J	Folmes, CDL; Dzeja, PP; Nelson, TJ; Terzic, A				Folmes, Clifford D. L.; Dzeja, Petras P.; Nelson, Timothy J.; Terzic, Andre			Metabolic Plasticity in Stem Cell Homeostasis and Differentiation	CELL STEM CELL			English	Review							ENERGY-METABOLISM; MITOCHONDRIAL BIOGENESIS; HEMATOPOIETIC PROGENITORS; ANTIOXIDANT ENZYMES; PLURIPOTENCY; ACETYLATION; PROLIFERATION; REJUVENATION; QUIESCENCE; GLYCOLYSIS	Plasticity in energy metabolism allows stem cells to match the divergent demands of self-renewal and lineage specification. Beyond a role in energetic support, new evidence implicates nutrient-responsive metabolites as mediators of crosstalk between metabolic flux, cellular signaling, and epigenetic regulation of cell fate. Stem cell metabolism also offers a potential target for controlling tissue homeostasis and regeneration in aging and disease. In this Perspective, we cover recent progress establishing an emerging relationship between stem cell metabolism and cell fate control.	[Folmes, Clifford D. L.; Dzeja, Petras P.; Nelson, Timothy J.; Terzic, Andre] Mayo Clin, Ctr Regenerat Med, Rochester, MN 55905 USA	Mayo Clinic	Terzic, A (corresponding author), Mayo Clin, Ctr Regenerat Med, Rochester, MN 55905 USA.	terzic.andre@mayo.edu	Lorkiewicz, Pawel/A-2126-2011	Lorkiewicz, Pawel/0000-0002-1755-9826; Folmes, Clifford/0000-0002-3683-9970; Nelson, Timothy/0000-0002-3862-7023	National Institutes of Health; Canadian Institutes of Health Research; Fondation Leducq; Marriott Foundation; Mayo Clinic Center for Regenerative Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fondation Leducq(Leducq Foundation); Marriott Foundation; Mayo Clinic Center for Regenerative Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health, Canadian Institutes of Health Research, Fondation Leducq, Marriott Foundation, and Mayo Clinic Center for Regenerative Medicine. A.T. holds the Marriott Family Professorship in Cardiovascular Diseases Research at Mayo Clinic.	Agathocleous M, 2012, NAT CELL BIOL, V14, P859, DOI 10.1038/ncb2531; Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bracha AL, 2010, NAT CHEM BIOL, V6, P202, DOI 10.1038/NCHEMBIO.301; Brookes E, 2012, CELL STEM CELL, V10, P157, DOI 10.1016/j.stem.2011.12.017; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Cerletti M, 2012, CELL STEM CELL, V10, P515, DOI 10.1016/j.stem.2012.04.002; Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; Chung S, 2010, J MOL CELL CARDIOL, V48, P725, DOI 10.1016/j.yjmcc.2009.12.014; Chung S, 2008, ANN NY ACAD SCI, V1147, P254, DOI 10.1196/annals.1427.004; Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Demaria M., 2010, AGING-US, V2, P823; Dzeja PP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019300; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Facucho-Oliveira JM, 2007, J CELL SCI, V120, P4025, DOI 10.1242/jcs.016972; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; Folmes CDL, 2012, CIRC RES, V110, P526, DOI 10.1161/RES.0b013e31824ae5c1; Folmes CDL, 2011, BIOMARK MED, V5, P715, DOI [10.2217/bmm.11.87, 10.2217/BMM.11.87]; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Forristal CE, 2010, REPRODUCTION, V139, P85, DOI 10.1530/REP-09-0300; Friis RMN, 2009, NUCLEIC ACIDS RES, V37, P3969, DOI 10.1093/nar/gkp270; Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595; GUPPY M, 1993, EUR J BIOCHEM, V212, P95, DOI 10.1111/j.1432-1033.1993.tb17637.x; Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hom JR, 2011, DEV CELL, V21, P469, DOI 10.1016/j.devcel.2011.08.008; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; Jang H, 2012, CELL STEM CELL, V11, P62, DOI 10.1016/j.stem.2012.03.001; Jasper H, 2010, CELL METAB, V12, P561, DOI 10.1016/j.cmet.2010.11.010; Johnson MT, 2003, J BIOL CHEM, V278, P31457, DOI 10.1074/jbc.R300002200; Kalaitzidis D, 2012, CELL STEM CELL, V11, P429, DOI 10.1016/j.stem.2012.06.009; Kang JS, 2009, TRENDS BIOCHEM SCI, V34, P491, DOI 10.1016/j.tibs.2009.06.003; Kentsis A, 2012, CELL STEM CELL, V11, P281, DOI 10.1016/j.stem.2012.08.007; Kondoh H, 2005, CANCER RES, V65, P177; Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467; Krizhanovsky V, 2009, NATURE, V460, P1085, DOI 10.1038/4601085a; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Latil M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1890; Liu L, 2011, J CELL BIOL, V193, P257, DOI 10.1083/jcb.201010131; Lonergan T, 2007, MITOCHONDRION, V7, P289, DOI 10.1016/j.mito.2007.05.002; Lonergan T, 2006, J CELL PHYSIOL, V208, P149, DOI 10.1002/jcp.20641; Magee JA, 2012, CELL STEM CELL, V11, P415, DOI 10.1016/j.stem.2012.05.026; Mandal S, 2011, STEM CELLS, V29, P486, DOI 10.1002/stem.590; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; McKnight S.L., 2010, CELL STEM CELL, V330, p[1338, 150]; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Panopoulos AD, 2012, CELL RES, V22, P168, DOI 10.1038/cr.2011.177; Piccoli C, 2005, J BIOL CHEM, V280, P26467, DOI 10.1074/jbc.M500047200; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Prigione A, 2011, STEM CELLS, V29, P1338, DOI 10.1002/stem.683; Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404; Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007; Renault VM, 2009, CELL STEM CELL, V5, P527, DOI 10.1016/j.stem.2009.09.014; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; San Martin N, 2011, STEM CELLS, V29, P1064, DOI 10.1002/stem.654; Schieke SM, 2008, J BIOL CHEM, V283, P28506, DOI 10.1074/jbc.M802763200; Shakya A, 2009, NAT CELL BIOL, V11, P320, DOI 10.1038/ncb1840; Shim J, 2012, NAT CELL BIOL, V14, P394, DOI 10.1038/ncb2453; Shoubridge EA, 2008, SCIENCE, V319, P914, DOI 10.1126/science.1154515; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Tormos KV, 2011, CELL METAB, V14, P537, DOI 10.1016/j.cmet.2011.08.007; Turner WS, 2008, STEM CELLS, V26, P1547, DOI 10.1634/stemcells.2007-0863; Valcourt JR, 2012, CELL CYCLE, V11, P1680, DOI 10.4161/cc.19879; Van Blerkom J, 2009, SEMIN CELL DEV BIOL, V20, P354, DOI 10.1016/j.semcdb.2008.12.005; Varum S, 2009, STEM CELL RES, V3, P142, DOI 10.1016/j.scr.2009.07.002; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Wang J, 2009, SCIENCE, V325, P435, DOI 10.1126/science.1173288; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Yanes O, 2010, NAT CHEM BIOL, V6, P411, DOI 10.1038/nchembio.364; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Zhang J, 2012, CELL STEM CELL, V11, P589, DOI 10.1016/j.stem.2012.10.005; Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401; Zhou WY, 2012, EMBO J, V31, P2103, DOI 10.1038/emboj.2012.71; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	98	431	442	3	89	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 2	2012	11	5					596	606		10.1016/j.stem.2012.10.002	http://dx.doi.org/10.1016/j.stem.2012.10.002			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	042LE	23122287	Green Accepted, Bronze			2022-12-28	WOS:000311471900006
J	McKinney-Freeman, S; Cahan, P; Li, H; Lacadie, SA; Huang, HT; Curran, M; Loewer, S; Naveiras, O; Kathrein, KL; Konantz, M; Langdon, EM; Lengerke, C; Zon, LI; Collins, JJ; Daley, GQ				McKinney-Freeman, Shannon; Cahan, Patrick; Li, Hu; Lacadie, Scott A.; Huang, Hsuan-Ting; Curran, Matthew; Loewer, Sabine; Naveiras, Olaia; Kathrein, Katie L.; Konantz, Martina; Langdon, Erin M.; Lengerke, Claudia; Zon, Leonard I.; Collins, James J.; Daley, George Q.			The Transcriptional Landscape of Hematopoietic Stem Cell Ontogeny	CELL STEM CELL			English	Article							DEFINITIVE HEMATOPOIESIS; NETWORK BIOLOGY; AGM REGION; YOLK-SAC; EXPRESSION; GENE; DIFFERENTIATION; FETAL; PROLIFERATION; MAINTENANCE	Transcriptome analysis of adult hematopoietic stem cells (HSCs) and their progeny has revealed mechanisms of blood differentiation and leukemogenesis, but a similar analysis of HSC development is lacking. Here, we acquired the transcriptomes of developing HSCs purified from >2,500 murine embryos and adult mice. We found that embryonic hematopoietic elements clustered into three distinct transcriptional states characteristic of the definitive yolk sac, HSCs undergoing specification, and definitive HSCs. We applied a network-biology-based analysis to reconstruct the gene regulatory networks of sequential stages of HSC development and functionally validated candidate transcriptional regulators of HSC ontogeny by morpholino-mediated knockdown in zebrafish embryos. Moreover, we found that HSCs from in vitro differentiated embryonic stem cells closely resemble definitive HSCs, yet lack a Notch-signaling signature, likely accounting for their defective lymphopoiesis. Our analysis and web resource will enhance efforts to identify regulators of HSC ontogeny and facilitate the engineering of hematopoietic specification.	[McKinney-Freeman, Shannon; Cahan, Patrick; Lacadie, Scott A.; Huang, Hsuan-Ting; Curran, Matthew; Loewer, Sabine; Naveiras, Olaia; Kathrein, Katie L.; Langdon, Erin M.; Zon, Leonard I.; Daley, George Q.] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [McKinney-Freeman, Shannon; Cahan, Patrick; Lacadie, Scott A.; Huang, Hsuan-Ting; Curran, Matthew; Loewer, Sabine; Naveiras, Olaia; Kathrein, Katie L.; Langdon, Erin M.; Zon, Leonard I.; Daley, George Q.] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA 02115 USA; [McKinney-Freeman, Shannon] St Jude Childrens Res Hosp, Dept Hematol, Memphis, TN 38105 USA; [Li, Hu; Collins, James J.] Boston Univ, Dept Biomed Engn, Ctr BioDynam, Boston, MA 02215 USA; [Li, Hu; Collins, James J.] Boston Univ, Ctr Adv Biotechnol, Boston, MA 02215 USA; [Li, Hu; Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Konantz, Martina; Lengerke, Claudia] Univ Tubingen, Div Hematol & Oncol, Med Ctr 2, D-72076 Tubingen, Germany; [Konantz, Martina] Max Planck Inst Dev Biol, Dept Genet 3, D-72076 Tubingen, Germany; [Zon, Leonard I.; Collins, James J.; Daley, George Q.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Zon, Leonard I.; Daley, George Q.] Stem Cell Transplantat Program, Boston, MA 02115 USA; [Zon, Leonard I.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Daley, George Q.] Harvard Univ, Sch Med, Broad Inst, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; St Jude Children's Research Hospital; Boston University; Boston University; Harvard University; Eberhard Karls University of Tubingen; Max Planck Society; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Broad Institute	Daley, GQ (corresponding author), Childrens Hosp, Div Pediat Hematol Oncol, 300 Longwood Ave, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu	McKinney-Freeman, Shannon/N-8161-2018; Lengerke, Claudia/AAV-8745-2021	McKinney-Freeman, Shannon/0000-0001-8061-2557; Lengerke, Claudia/0000-0001-5442-2805; Konantz, Martina/0000-0002-4319-3119; Cahan, Patrick/0000-0003-3652-2540; Naveiras, Olaia/0000-0003-3434-0022	NIH [K01 DK080846, RO1-DK70055, RO1-DK59279, UO1-HL100001, RL1DE019021, R24-DK092760]; ARRA stimulus package [RC2-HL102815]; Roche Foundation for Anemia Research; Alex's Lemonade Stand; Harvard Stem Cell Institute; Burroughs Wellcome Fund; Leukemia and Lymphoma Society; NHLBI [T32HL007623, 2T32HL66987-11]; HHMI; NIH NIDDK [1R24DK092760-01]; Howard Hughes Medical Institute; SysCODE (Systems-based Consortium for Organ Design Engineering); Boston University Clinical and Translational Science Institute (CTSI) [UL1-TR000157]; Deutsche Krebshilfe (Max Eder Program); Deutsche Forschungsgemeinschaft [SFB773];  [NIH-P50-NS40828];  [NIH-P30-HD18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000157] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102815, T32HL066987, R01HL048801, T32HL007623, U01HL100001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RL1DE019021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK092760, K01DK080846, R01DK059279, R01DK070055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS040828] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARRA stimulus package; Roche Foundation for Anemia Research; Alex's Lemonade Stand; Harvard Stem Cell Institute; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); HHMI(Howard Hughes Medical Institute); NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); SysCODE (Systems-based Consortium for Organ Design Engineering); Boston University Clinical and Translational Science Institute (CTSI); Deutsche Krebshilfe (Max Eder Program)(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M.W. Lensch for helpful discussions and critical review of the manuscript, N. Gerry for assistance with gene expression arrays, and J. Daley and S. Lazo-Kallanian of the Dana Farber Cancer Institute (Boston, MA) and Richard Ashman and Jim Houston of St. Jude Children's Research Hospital (Memphis, TN) for expertise in cell sorting and flow cytometry. Fluidigm experiments were performed by the Molecular Genetics Core Facility at Children's Hospital Boston supported by NIH-P50-NS40828 and NIH-P30-HD18655. S.M.F. was supported by NIH grant K01 DK080846. G.Q.D. is supported by grants from the NIH (RO1-DK70055, RO1-DK59279, UO1-HL100001, Progenitor cell biology consortium, R24-DK092760, and special funds from the ARRA stimulus package RC2-HL102815), the Roche Foundation for Anemia Research, Alex's Lemonade Stand, and the Harvard Stem Cell Institute. G.Q.D. is an affiliate member of the Broad Institute, a recipient of Clinical Scientist Awards in Translational Research from the Burroughs Wellcome Fund and the Leukemia and Lymphoma Society, and an investigator of the Manton Center for Orphan Disease Research. P.C. is supported by grants T32HL007623 and 2T32HL66987-11 from the NHLBI. G.Q.D., LIZ., and J.J.C. are investigators of the Howard Hughes Medical Institute. L.I.Z. is supported by HHMI and NIH NIDDK 1R24DK092760-01. J.J.C. and H.L. are supported by Howard Hughes Medical Institute, SysCODE (Systems-based Consortium for Organ Design & Engineering), and NIH grant # RL1DE019021, and H.L. is supported by Boston University Clinical and Translational Science Institute (CTSI) grant # UL1-TR000157. C.L. was supported by grants from the Deutsche Krebshilfe (Max Eder Program) and the Deutsche Forschungsgemeinschaft (SFB773). L.I.Z. is a founder and stock holder of Fate, Inc. and a scientific advisor for Stemgent.	Aguilo F, 2011, BLOOD, V117, P5057, DOI 10.1182/blood-2010-08-300145; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bonde S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003212; Chuikov S, 2010, NAT CELL BIOL, V12, P999, DOI 10.1038/ncb2101; Ciaccio MF, 2010, NAT METHODS, V7, P148, DOI [10.1038/nmeth.1418, 10.1038/NMETH.1418]; Collins EC, 2002, MOL CELL BIOL, V22, P7313, DOI 10.1128/MCB.22.20.7313-7324.2002; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Ergun A, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100125; Ernst P, 2002, CURR OPIN HEMATOL, V9, P282, DOI 10.1097/00062752-200207000-00004; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; Godin I, 2002, NAT REV IMMUNOL, V2, P593, DOI 10.1038/nri857; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Hirose K, 2010, BLOOD, V116, P962, DOI 10.1182/blood-2009-09-244673; Hock H, 2006, CURR OPIN HEMATOL, V13, P1, DOI 10.1097/01.moh.0000190111.85284.8f; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Iacovino M, 2011, NAT CELL BIOL, V13, P72, DOI 10.1038/ncb2137; IIDA S, 1993, ONCOGENE, V8, P3085; Izraeli S, 2004, BRIT J HAEMATOL, V126, P3, DOI 10.1111/j.1365-2141.2004.04986.x; Jeanson NT, 2010, BLOOD, V116, P4126, DOI 10.1182/blood-2010-04-280552; Jin H, 2009, DEVELOPMENT, V136, P647, DOI 10.1242/dev.029637; Kandasamy K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r3; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Krens SFG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-196; Kumaravelu P, 2002, DEVELOPMENT, V129, P4891; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Lawrence HJ, 1997, BLOOD, V89, P1922, DOI 10.1182/blood.V89.6.1922; Leddin M, 2011, BLOOD, V117, P2827, DOI 10.1182/blood-2010-08-302976; Ledran MH, 2008, CELL STEM CELL, V3, P85, DOI 10.1016/j.stem.2008.06.001; Magnusson M, 2007, EXP HEMATOL, V35, P1421, DOI 10.1016/j.exphem.2007.05.011; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; McKinney-Freeman SL, 2008, BLOOD, V111, P4944, DOI 10.1182/blood-2007-11-124644; McKinney-Freeman SL, 2007, CURR OPIN HEMATOL, V14, P343, DOI 10.1097/MOH.0b013e3281900edd; McKinney-Freeman SL, 2009, BLOOD, V114, P268, DOI 10.1182/blood-2008-12-193888; Medvinsky AL, 1996, BLOOD, V87, P557, DOI 10.1182/blood.V87.2.557.bloodjournal872557; Medvinsky A, 2011, DEVELOPMENT, V138, P1017, DOI 10.1242/dev.040998; Michoel T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-49; Mikkola HKA, 2005, EXP HEMATOL, V33, P1048, DOI 10.1016/j.exphem.2005.06.011; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Okada S, 1999, BLOOD, V93, P816, DOI 10.1182/blood.V93.3.816.403k21_816_825; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Pina C, 2008, CELL STEM CELL, V2, P264, DOI 10.1016/j.stem.2008.01.013; Randrianarison-Huetz V, 2010, BLOOD, V115, P2784, DOI 10.1182/blood-2009-09-241752; Rhodes KE, 2008, CELL STEM CELL, V2, P252, DOI 10.1016/j.stem.2008.01.001; Robin C, 2006, DEV CELL, V11, P171, DOI 10.1016/j.devcel.2006.07.002; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Seita J, 2010, WIRES SYST BIOL MED, V2, P640, DOI 10.1002/wsbm.86; Srinivasan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008283; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Tabayoyong WB, 2009, J IMMUNOL, V183, P5449, DOI 10.4049/jimmunol.0901807; Takakura N, 1998, IMMUNITY, V9, P677, DOI 10.1016/S1074-7613(00)80665-2; Taoudi S, 2005, DEVELOPMENT, V132, P4179, DOI 10.1242/dev.01974; Taoudi S, 2008, CELL STEM CELL, V3, P99, DOI 10.1016/j.stem.2008.06.004; Taoudi S, 2011, GENE DEV, V25, P251, DOI 10.1101/gad.2009211; Taylor RC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000166; Wang LS, 2005, J EXP MED, V201, P1603, DOI 10.1084/jem.20041888; Wang Y, 2005, P NATL ACAD SCI USA, V102, P19081, DOI 10.1073/pnas.0506127102; Wilson A, 2009, CURR OPIN GENET DEV, V19, P461, DOI 10.1016/j.gde.2009.08.005; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	66	129	134	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 2	2012	11	5					701	714		10.1016/j.stem.2012.07.018	http://dx.doi.org/10.1016/j.stem.2012.07.018			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	042LE	23122293	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000311471900015
J	Wicha, MS				Wicha, Max S.			PSA Lo and Behold: Prostate Cancer Stem Cells	CELL STEM CELL			English	Editorial Material									Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Wicha, MS (corresponding author), Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA.	mwicha@umich.edu	Wicha, Max/AAE-7268-2019		NATIONAL CANCER INSTITUTE [R01CA101860] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA101860] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABRAHAMSSON PA, 1988, PROSTATE, V12, P39, DOI 10.1002/pros.2990120106; Isaacs JT, 2008, PROSTATE, V68, P1025, DOI 10.1002/pros.20763; Maitland Norman J., 2011, Hormones & Cancer, V2, P47, DOI 10.1007/s12672-010-0058-y; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Qin JC, 2012, CELL STEM CELL, V10, P556, DOI 10.1016/j.stem.2012.03.009; Rajasekhar VK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1159; Tombal B, 2011, EUR J CANCER, V47, pS179, DOI 10.1016/S0959-8049(11)70163-0; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024	8	2	2	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAY 4	2012	10	5					482	483		10.1016/j.stem.2012.04.014	http://dx.doi.org/10.1016/j.stem.2012.04.014			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	944WN	22560068	Bronze			2022-12-28	WOS:000304234600002
J	Wang, Z; Oron, E; Nelson, B; Razis, S; Ivanova, N				Wang, Zheng; Oron, Efrat; Nelson, Brynna; Razis, Spiro; Ivanova, Natalia			Distinct Lineage Specification Roles for NANOG, OCT4, and SOX2 in Human Embryonic Stem Cells	CELL STEM CELL			English	Article							SELF-RENEWAL; RNA INTERFERENCE; MOUSE EPIBLAST; NEURAL CREST; PLURIPOTENCY; DIFFERENTIATION; EXPRESSION; ENDODERM; ES; ESTABLISHMENT	Nanog, Oct4, and Sox2 are the core regulators of mouse (m)ESC pluripotency. Although their basic importance in human (h)ESCs has been demonstrated, the mechanistic functions are not well defined. Here, we identify general and cell-line-specific requirements for NANOG, OCT4, and SOX2 in hESCs. We show that OCT4 regulates, and interacts with, the BMP4 pathway to specify four developmental fates. High levels of OCT4 enable self-renewal in the absence of BMP4 but specify mesendoderm in the presence of BMP4. Low levels of OCT4 induce embryonic ectoderm differentiation in the absence of BMP4 but specify extraembryonic lineages in the presence of BMP4. NANOG represses embryonic ectoderm differentiation but has little effect on other lineages, whereas SOX2 and SOX3 are redundant and repress mesendoderm differentiation. Thus, instead of being panrepressors of differentiation, each factor controls specific cell fates. Our study revises the view of how self-renewal is orchestrated in hESCs.	[Wang, Zheng; Oron, Efrat; Nelson, Brynna; Razis, Spiro; Ivanova, Natalia] Yale Univ, Yale Stem Cell Ctr, Dept Genet, New Haven, CT 06520 USA	Yale University	Ivanova, N (corresponding author), Yale Univ, Yale Stem Cell Ctr, Dept Genet, New Haven, CT 06520 USA.	natalia.ivanova@yale.edu	wang, zheng/H-6328-2013	Wang, Zheng/0000-0003-4471-5983	Connecticut Stem Cell Funds; Mallinckrodt Foundation; Brown-Coxe Fellowship; Connecticut Stem Cell grant	Connecticut Stem Cell Funds; Mallinckrodt Foundation; Brown-Coxe Fellowship; Connecticut Stem Cell grant	We thank I.-H. Park (Yale University) for help with teratoma assays; V. Horsley (Yale University) for help with keratinocyte differentiation; V. Schulz (Yale University) for assistance with microarray data analysis; and H. Lin, D. Krause (Yale University), F. Santori (New York University), and three anonymous referees for comments on the manuscript. This research has been supported by funding from Connecticut Stem Cell Funds and the Mallinckrodt Foundation to NI., a Brown-Coxe Fellowship to Z.W., and a Connecticut Stem Cell grant to E.O.	Acloque H, 2011, DEV CELL, V21, P546, DOI 10.1016/j.devcel.2011.07.005; Adachi K, 2010, GENES CELLS, V15, P455, DOI 10.1111/j.1365-2443.2010.01400.x; Adamo A, 2011, NAT CELL BIOL, V13, P652, DOI 10.1038/ncb2246; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; Barnes RM, 2010, DEV DYNAM, V239, P3086, DOI 10.1002/dvdy.22428; Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Coucouvanis E, 1999, DEVELOPMENT, V126, P535; Fong HL, 2008, STEM CELLS, V26, P1931, DOI 10.1634/stemcells.2007-1002; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Han DW, 2010, CELL, V143, P617, DOI 10.1016/j.cell.2010.10.015; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; Hay DC, 2004, STEM CELLS, V22, P225, DOI 10.1634/stemcells.22-2-225; Hemberger M, 2010, HUM MOL GENET, V19, P2456, DOI 10.1093/hmg/ddq128; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hyslop L, 2005, STEM CELLS, V23, P1035, DOI 10.1634/stemcells.2005-0080; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kurokawa D, 2004, DEVELOPMENT, V131, P3307, DOI 10.1242/dev.01219; Li B, 2009, DEVELOPMENT, V136, P3267, DOI 10.1242/dev.036954; Li WL, 2011, P NATL ACAD SCI USA, V108, P8299, DOI 10.1073/pnas.1014041108; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lu SJ, 2008, BLOOD, V112, P4475, DOI 10.1182/blood-2008-05-157198; Martinez-Barbera JP, 2001, DEVELOPMENT, V128, P4789; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Matin MM, 2004, STEM CELLS, V22, P659, DOI 10.1634/stemcells.22-5-659; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Morkel M, 2003, DEVELOPMENT, V130, P6283, DOI 10.1242/dev.00859; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Pearton DJ, 2011, DEV BIOL, V360, P343, DOI 10.1016/j.ydbio.2011.10.007; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zaehres H, 2005, STEM CELLS, V23, P299, DOI 10.1634/stemcells.2004-0252; Zhang X, 2011, NAT CELL BIOL, V13, P1092, DOI 10.1038/ncb2293	52	364	390	1	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 6	2012	10	4					440	454		10.1016/j.stem.2012.02.016	http://dx.doi.org/10.1016/j.stem.2012.02.016			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	929QA	22482508	Bronze			2022-12-28	WOS:000303079400012
J	Chen, YG; Li, ZW; Wang, XF				Chen, Ye-Guang; Li, Zhongwei; Wang, Xiao-Fan			Where PI3K/Akt Meets Smads: The Crosstalk Determines Human Embryonic Stem Cell Fate	CELL STEM CELL			English	Editorial Material							SELF-RENEWAL; MAINTENANCE; PLURIPOTENCY	Coordinated interactions between signaling networks govern the balance of cell fate decisions in human embryonic stem cells. In this issue, Singh et al. (2012) report that PI3K/Akt signaling switches Activin/Smad activity between pro-self-renewal and prodifferentiation by regulating ERK and GSK3 beta/beta-catenin signaling.	[Chen, Ye-Guang; Li, Zhongwei] Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Wang, Xiao-Fan] Duke Univ, Dept Pharmacol & Canc Biol, Med Ctr, Durham, NC 27710 USA	Tsinghua University; Duke University	Chen, YG (corresponding author), Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	ygchen@tsinghua.edu.cn; wang0011@mc.duke.edu	Chen, Ye-Guang/L-6998-2019		NCI NIH HHS [R01 CA151541, R01 CA151541-03] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA151541] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; Li ZW, 2012, CELL STEM CELL, V10, P171, DOI 10.1016/j.stem.2011.12.016; Na J, 2010, STEM CELL RES, V5, P157, DOI 10.1016/j.scr.2010.06.002; Pera MF, 2010, NATURE, V465, P713, DOI 10.1038/nature09228; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Singh AM, 2012, CELL STEM CELL, V10, P312, DOI 10.1016/j.stem.2012.01.014; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	10	28	32	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAR 2	2012	10	3					231	232		10.1016/j.stem.2012.02.008	http://dx.doi.org/10.1016/j.stem.2012.02.008			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	908BX	22385648	Bronze, Green Accepted			2022-12-28	WOS:000301466500001
J	Hobbs, RM; Fagoonee, S; Papa, A; Webster, K; Altruda, F; Nishinakamura, R; Chai, L; Pandolfi, PP				Hobbs, Robin M.; Fagoonee, Sharmila; Papa, Antonella; Webster, Kaitlyn; Altruda, Fiorella; Nishinakamura, Ryuichi; Chai, Li; Pandolfi, Pier Paolo			Functional Antagonism between Sall4 and Plzf Defines Germline Progenitors	CELL STEM CELL			English	Article							SPERMATOGONIAL STEM-CELLS; TOWNES-BROCKS-SYNDROME; LEUKEMIA ZINC-FINGER; SELF-RENEWAL; PROMYELOCYTIC LEUKEMIA; OKIHIRO-SYNDROME; RETINOIC ACID; MOUSE TESTIS; GENE-EXPRESSION; TRANSGENIC MICE	Transcription factors required for formation of embryonic tissues often maintain their expression in adult stem cell populations, but whether their function remains equivalent is not clear. Here we demonstrate critical and distinct roles for Sall4 in development of embryonic germ cells and differentiation of postnatal spermatogonial progenitor cells (SPCs). In differentiating SPCs, Sall4 levels transiently increase and Sall4 physically interacts with Plzf, a transcription factor exclusively required for adult stem cell maintenance. Mechanistically, Sall4 sequesters Plzf to noncognate chromatin domains to induce expression of Kit, a target of Plzf-mediated repression required for differentiation. Plzf in turn antagonizes Sall4 function by displacing Sall4 from cognate chromatin to induce Sall4 expression. Taken together, these data suggest that transcription factors required for embryonic tissue development postnatally take on distinct roles through interaction with opposing factors, which hence define properties of the adult stem cell compartment.	[Hobbs, Robin M.; Papa, Antonella; Webster, Kaitlyn; Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Canc Ctr, Beth Israel Deaconess Med Ctr, Canc Genet Program,Sch Med,Dept Med, Boston, MA 02115 USA; [Hobbs, Robin M.; Papa, Antonella; Webster, Kaitlyn; Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Canc Ctr, Beth Israel Deaconess Med Ctr, Canc Genet Program,Sch Med,Dept Pathol, Boston, MA 02115 USA; [Chai, Li] Harvard Univ, Brigham & Womans Hosp, Sch Med, Dept Pathol,Joint Program Transfus Med, Boston, MA 02115 USA; [Fagoonee, Sharmila; Altruda, Fiorella] Univ Turin, Dept Genet Biol & Biochem, Ctr Mol Biotechnol, I-10126 Turin, Italy; [Nishinakamura, Ryuichi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Kidney Dev, Global COE Cell Fate Regulat Res & Educ Unit, Kumamoto 8600811, Japan	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Turin; Kumamoto University	Pandolfi, PP (corresponding author), Harvard Univ, Beth Israel Deaconess Canc Ctr, Beth Israel Deaconess Med Ctr, Canc Genet Program,Sch Med,Dept Med, Boston, MA 02115 USA.	ppandolf@bidmc.harvard.edu	Fagoonee, Sharmila/L-1940-2019; Hobbs, Robin/I-2577-2014	Fagoonee, Sharmila/0000-0001-6070-6716; Hobbs, Robin/0000-0002-3853-2614; Papa, Antonella/0000-0001-8653-7121; Pandolfi, Pier Paolo/0000-0002-5352-5295; Webster, Kaitlyn/0000-0001-9902-0500; Chai, Li/0000-0003-1937-4750	NIH [RO1HL092437]; NATIONAL CANCER INSTITUTE [R01CA071692] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092437] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are particularly indebted to Marco Seandel for initial comments regarding this work. We would also like to thank Shahin Raft, Bing Lim, Dan Tenen, and members of the Pandolfi lab for helpful discussions. This work was supported by NIH grants to P.P.P. and by RO1HL092437 to L.C.	Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]; Barna M, 2002, DEV CELL, V3, P499, DOI 10.1016/S1534-5807(02)00289-7; Barna M, 2000, NAT GENET, V25, P166, DOI 10.1038/76014; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Cao DF, 2009, AM J SURG PATHOL, V33, P1065, DOI 10.1097/PAS.0b013e3181a13eef; Costoya JA, 2008, ONCOGENE, V27, P3789, DOI 10.1038/onc.2008.7; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Dann CT, 2008, STEM CELLS, V26, P2928, DOI 10.1634/stemcells.2008-0134; de Celis JF, 2009, INT J DEV BIOL, V53, P1385, DOI 10.1387/ijdb.072408jd; De Rooij DG, 2000, J ANDROL, V21, P776; Doulatov S, 2009, GENE DEV, V23, P2076, DOI 10.1101/gad.1788109; Durcova-Hills G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003531; Ebata KT, 2007, BIOL REPROD, V76, P841, DOI 10.1095/biolreprod.106.058305; Filipponi D, 2007, MOL CELL BIOL, V27, P6770, DOI 10.1128/MCB.00479-07; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Hayashi K, 2007, SCIENCE, V316, P394, DOI 10.1126/science.1137545; He LZ, 2000, MOL CELL, V6, P1131, DOI 10.1016/S1097-2765(00)00111-8; Hobbs RM, 2010, CELL, V142, P468, DOI 10.1016/j.cell.2010.06.041; Kawakami Y, 2009, DEVELOPMENT, V136, P585, DOI 10.1242/dev.027748; Kohlhase J, 2005, HUM MUTAT, V26, P176, DOI 10.1002/humu.20215; Kohlhase J, 2002, CYTOGENET GENOME RES, V98, P274, DOI 10.1159/000071048; Kohlhase J, 2000, HUM MUTAT, V16, P460, DOI 10.1002/1098-1004(200012)16:6<460::AID-HUMU2>3.0.CO;2-4; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Lu JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005577; Ma YP, 2006, BLOOD, V108, P2726, DOI 10.1182/blood-2006-02-001594; McLean DJ, 2003, BIOL REPROD, V69, P2085, DOI 10.1095/biolreprod.103.017020; Melnick A, 2000, MOL CELL BIOL, V20, P6550, DOI 10.1128/MCB.20.17.6550-6567.2000; Mithraprabhu S, 2009, REPRODUCTION, V138, P743, DOI 10.1530/REP-08-0537; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Ohta H, 2003, BIOL REPROD, V69, P1815, DOI 10.1095/biolreprod.103.019323; Osafune K, 2006, DEVELOPMENT, V133, P151, DOI 10.1242/dev.02174; Payne CJ, 2010, STEM CELLS, V28, P1424, DOI 10.1002/stem.464; Pellegrini M, 2008, CELL CYCLE, V7, P3878, DOI 10.4161/cc.7.24.7262; Rao S, 2010, MOL CELL BIOL, V30, P5364, DOI 10.1128/MCB.00419-10; Sadate-Ngatchou PI, 2008, GENESIS, V46, P738, DOI 10.1002/dvg.20437; Sakaki-Yumoto M, 2006, DEVELOPMENT, V133, P3005, DOI 10.1242/dev.02457; Schefe JH, 2006, CIRC RES, V99, P1355, DOI 10.1161/01.RES.0000251700.00994.0d; Schrans-Stassen BHGJ, 1999, ENDOCRINOLOGY, V140, P5894, DOI 10.1210/en.140.12.5894; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Shinohara T, 2001, P NATL ACAD SCI USA, V98, P6186, DOI 10.1073/pnas.111158198; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Slack JMW, 2008, SCIENCE, V322, P1498, DOI 10.1126/science.1162782; Toyoda S, 2009, DEV BIOL, V325, P238, DOI 10.1016/j.ydbio.2008.10.019; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Yamashita K, 2007, GENES CELLS, V12, P171, DOI 10.1111/j.1365-2443.2007.01042.x; Yoshida S, 2006, DEVELOPMENT, V133, P1495, DOI 10.1242/dev.02316; Yuri S, 2009, STEM CELLS, V27, P796, DOI 10.1002/stem.14; Zhou Q, 2008, BIOL REPROD, V79, P35, DOI 10.1095/biolreprod.107.066795	49	124	130	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAR 2	2012	10	3					284	298		10.1016/j.stem.2012.02.004	http://dx.doi.org/10.1016/j.stem.2012.02.004			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	908BX	22385656	Green Accepted, Bronze			2022-12-28	WOS:000301466500010
J	Ranganath, SH; Levy, O; Inamdar, MS; Karp, JM				Ranganath, Sudhir H.; Levy, Oren; Inamdar, Maneesha S.; Karp, Jeffrey M.			Harnessing the Mesenchymal Stem Cell Secretome for the Treatment of Cardiovascular Disease	CELL STEM CELL			English	Review							ENDOTHELIAL GROWTH-FACTOR; COLONY-STIMULATING FACTOR; ELEVATION MYOCARDIAL-INFARCTION; CARDIAC PROGENITOR CELLS; BONE-MARROW; STROMAL CELLS; HEART-FAILURE; RAT MODEL; FACTOR-I; PARACRINE MECHANISMS	The broad repertoire of secreted trophic and immunomodulatory cytokines produced by mesenchymal stem cells (MSCs), generally referred to as the MSC secretome, has considerable potential for the treatment of cardiovascular disease. However, harnessing this MSC secretome for meaningful therapeutic outcomes is challenging due to the limited control of cytokine production following their transplantation. This review outlines the current understanding of the MSC secretome as a therapeutic for treatment of ischemic heart disease. We discuss ongoing investigative directions aimed at improving cellular activity and characterizing the secretome and its regulation in greater detail. Finally, we provide insights on and perspectives for future development of the MSC secretome as a therapeutic tool.	[Ranganath, Sudhir H.; Inamdar, Maneesha S.] Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560064, Karnataka, India; [Ranganath, Sudhir H.; Levy, Oren; Karp, Jeffrey M.] Harvard Univ, Brigham & Womens Hosp, Ctr Regenerat Therapeut, Sch Med, Cambridge, MA 02139 USA; [Ranganath, Sudhir H.; Levy, Oren; Karp, Jeffrey M.] Harvard Univ, Brigham & Womens Hosp, Dept Med, Sch Med, Cambridge, MA 02139 USA; [Ranganath, Sudhir H.; Levy, Oren; Karp, Jeffrey M.] Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Ranganath, Sudhir H.; Levy, Oren; Karp, Jeffrey M.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Ranganath, Sudhir H.; Inamdar, Maneesha S.] GKVK, Inst Stem Cell Biol & Regenerat Med, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Inamdar, MS (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560064, Karnataka, India.	inamdar@jncasr.ac.in; jkarp@rics.bwh.harvard.edu	Levey, Allan/F-2104-2011	Levey, Allan/0000-0002-3153-502X; INAMDAR, MANEESHA/0000-0002-8243-2821	Indo US Science and Technology Forum (IUSSTF); JNCASR; Sanofi; National Institute of Health [HL097172, HL095722]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095722, R21HL097172] Funding Source: NIH RePORTER	Indo US Science and Technology Forum (IUSSTF); JNCASR; Sanofi; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Abhishek Sinha, Chandan Kadur, Weian Zhao and Mamta Jain for helpful and enlightening discussions. This work was supported by an Indo US Science and Technology Forum (IUSSTF) grant to J.M.K. and M.S.I., by a JNCASR grant to MSI, by Sanofi, and by the National Institute of Health grants HL097172 and HL095722 to J.M.K.. J.M.K. is a co-owner of Megacell Therapeutics, a company that has an option to license IP generated by J.M.K. J.M.K. may benefit financially if the IP is licensed and further validated. J.M.K.'s interests were reviewed and are subject to a management plan over-seen by the Brigham and Women's Hospital and Partners HealthCare in accordance with their conflict of interest policies.	Afzal MR, 2010, ANTIOXID REDOX SIGN, V12, P693, DOI 10.1089/ars.2009.2755; Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Ankrum J, 2010, TRENDS MOL MED, V16, P203, DOI 10.1016/j.molmed.2010.02.005; Assis ACM, 2010, CELL TRANSPLANT, V19, P219, DOI 10.3727/096368909X479677; Bartosh TJ, 2010, P NATL ACAD SCI USA, V107, P13724, DOI 10.1073/pnas.1008117107; Bassaneze V, 2010, STEM CELLS DEV, V19, P371, DOI 10.1089/scd.2009.0195; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Beohar N, 2010, J AM COLL CARDIOL, V56, P1287, DOI 10.1016/j.jacc.2010.05.039; Berry MF, 2006, AM J PHYSIOL-HEART C, V290, pH2196, DOI 10.1152/ajpheart.01017.2005; Berthonneche C, 2004, AM J PHYSIOL-HEART C, V287, pH340, DOI 10.1152/ajpheart.01210.2003; Biswas Santanu, 2010, Korean Journal of Internal Medicine, V25, P44, DOI 10.3904/kjim.2010.25.1.44; Block GJ, 2009, STEM CELLS, V27, P670, DOI [10.1634/stemcells.stemcells.2008-0742, 10.1002/stem.20080742]; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Chavakis E, 2010, CIRCULATION, V121, P325, DOI 10.1161/CIRCULATIONAHA.109.901405; Cheng ZK, 2008, MOL THER, V16, P571, DOI 10.1038/sj.mt.6300374; Crisostomo PR, 2008, AM J PHYSIOL-CELL PH, V294, pC675, DOI 10.1152/ajpcell.00437.2007; Croitoru-Lamoury J, 2007, J INTERF CYTOK RES, V27, P53, DOI 10.1089/jir.2006.0037; Danoviz ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012077; Debrunner M, 2008, CLIN RES CARDIOL, V97, P298, DOI 10.1007/s00392-007-0626-5; Engelmann MG, 2006, J AM COLL CARDIOL, V48, P1712, DOI 10.1016/j.jacc.2006.07.044; Epstein SE, 2001, CIRCULATION, V104, P115, DOI 10.1161/01.CIR.104.1.115; Fierro FA, 2011, STEM CELLS, V29, P1727, DOI 10.1002/stem.720; Francois M, 2012, MOL THER, V20, P187, DOI 10.1038/mt.2011.189; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; Godier-Furnemont AFG, 2011, P NATL ACAD SCI USA, V108, P7974, DOI 10.1073/pnas.1104619108; Hahn JY, 2008, J AM COLL CARDIOL, V51, P933, DOI 10.1016/j.jacc.2007.11.040; Haider HK, 2008, CIRC RES, V103, P1300, DOI 10.1161/CIRCRESAHA.108.186742; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Hatzistergos KE, 2010, CIRC RES, V107, P913, DOI 10.1161/CIRCRESAHA.110.222703; Henry TD, 2003, CIRCULATION, V107, P1359, DOI 10.1161/01.CIR.0000061911.47710.8A; Henry TD, 2001, AM HEART J, V142, P872, DOI 10.1067/mhj.2001.118471; Herrmann JL, 2011, SHOCK, V35, P512, DOI 10.1097/SHK.0b013e31820b2fb9; Herrmann JL, 2010, SHOCK, V33, P24, DOI 10.1097/SHK.0b013e3181b7d137; Huang J, 2010, CIRC RES, V106, P1753, DOI 10.1161/CIRCRESAHA.109.196030; Ip JE, 2007, MOL BIOL CELL, V18, P2873, DOI 10.1091/mbc.E07-02-0166; Iso Y, 2007, BIOCHEM BIOPH RES CO, V354, P700, DOI 10.1016/j.bbrc.2007.01.045; Kamota T, 2009, J AM COLL CARDIOL, V53, P1814, DOI 10.1016/j.jacc.2009.02.015; Kanki S, 2011, CIRC-HEART FAIL, V4, P509, DOI 10.1161/CIRCHEARTFAILURE.110.960302; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Lee MJ, 2010, J PROTEOME RES, V9, P1754, DOI 10.1021/pr900898n; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Leiker M, 2008, CELL TRANSPLANT, V17, P911, DOI 10.3727/096368908786576444; Li HX, 2010, AM J PHYSIOL-HEART C, V299, pH1772, DOI 10.1152/ajpheart.00557.2010; Liu CP, 2011, BRIT J PHARMACOL, V162, P126, DOI 10.1111/j.1476-5381.2010.01024.x; Loffredo FS, 2011, CELL STEM CELL, V8, P389, DOI 10.1016/j.stem.2011.02.002; Lozito TP, 2011, J CELL PHYSIOL, V226, P385, DOI 10.1002/jcp.22344; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Matsumoto R, 2005, ARTERIOSCL THROM VAS, V25, P1168, DOI 10.1161/01.ATV.0000165696.25680.ce; Matsumura S, 2005, J CLIN INVEST, V115, P599, DOI 10.1172/JCI200522304; Mazhari Ramesh, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS21, DOI 10.1038/ncpcardio0770; Mias C, 2008, STEM CELLS, V26, P1749, DOI 10.1634/stemcells.2007-1000; Mirotsou M, 2011, J MOL CELL CARDIOL, V50, P280, DOI 10.1016/j.yjmcc.2010.08.005; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; Moro C, 2007, AM J PHYSIOL-HEART C, V293, pH3014, DOI 10.1152/ajpheart.00797.2007; Nagaya N, 2005, CIRCULATION, V112, P1128, DOI 10.1161/CIRCULATIONAHA.104.500447; Nakanishi C, 2008, BIOCHEM BIOPH RES CO, V374, P11, DOI 10.1016/j.bbrc.2008.06.074; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Nguyen BK, 2010, J CARDIOVASC TRANSL, V3, P547, DOI 10.1007/s12265-010-9171-0; Noiseux N, 2006, MOL THER, V14, P840, DOI 10.1016/j.ymthe.2006.05.016; Ohnishi S, 2007, STEM CELLS, V25, P1166, DOI 10.1634/stemcells.2006-0347; Oskowitz A, 2011, STEM CELL RES, V6, P215, DOI 10.1016/j.scr.2011.01.004; Padin-Iruegas ME, 2009, CIRCULATION, V120, P876, DOI 10.1161/CIRCULATIONAHA.109.852285; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Parekkadan B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000941; Park Chae Woon, 2009, Int J Stem Cells, V2, P59; Pasha Z, 2008, CARDIOVASC RES, V77, P134, DOI 10.1093/cvr/cvm025; Potapova IA, 2008, J BIOL CHEM, V283, P13100, DOI 10.1074/jbc.M800184200; Potapova IA, 2007, STEM CELLS, V25, P1761, DOI 10.1634/stemcells.2007-0022; Prockop DJ, 2012, MOL THER, V20, P14, DOI 10.1038/mt.2011.211; Psaltis PJ, 2010, J CELL PHYSIOL, V223, P530, DOI 10.1002/jcp.22081; Rattigan Y, 2010, EXP CELL RES, V316, P3417, DOI 10.1016/j.yexcr.2010.07.002; Ripa RS, 2006, CIRCULATION, V113, P1983, DOI 10.1161/CIRCULATIONAHA.105.610469; Rodrigues M, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt32; Sarkar D, 2011, BLOOD, V118, pE184, DOI 10.1182/blood-2010-10-311464; Sarkar D, 2011, BIOMATERIALS, V32, P3053, DOI 10.1016/j.biomaterials.2010.12.036; Schoen F.J., 2007, ROBBINS COTRAN PATHO, P577; Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718; Seib FP, 2009, BIOCHEM BIOPH RES CO, V389, P663, DOI 10.1016/j.bbrc.2009.09.051; Shabbir A, 2009, AM J PHYSIOL-HEART C, V296, pH1888, DOI 10.1152/ajpheart.00186.2009; Shi MX, 2007, HAEMATOLOGICA, V92, P897, DOI 10.3324/haematol.10669; Shi RZ, 2009, EXP CELL RES, V315, P10, DOI 10.1016/j.yexcr.2008.09.024; Singelyn JM, 2010, J CARDIOVASC TRANSL, V3, P478, DOI 10.1007/s12265-010-9202-x; Skalnikova H, 2011, PROTEOMICS, V11, P691, DOI 10.1002/pmic.201000402; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Song H, 2010, STEM CELLS, V28, P555, DOI 10.1002/stem.302; Sze SK, 2007, MOL CELL PROTEOMICS, V6, P1680, DOI 10.1074/mcp.M600393-MCP200; Tang JM, 2010, MOL CELLS, V29, P9, DOI 10.1007/s10059-010-0001-7; Tang YL, 2005, ANN THORAC SURG, V80, P229, DOI 10.1016/j.athoracsur.2005.02.072; Terrovitis JV, 2010, CIRC RES, V106, P479, DOI 10.1161/CIRCRESAHA.109.208991; Timmers L, 2011, STEM CELL RES, V6, P206, DOI 10.1016/j.scr.2011.01.001; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Urbanek K, 2005, CIRC RES, V97, P663, DOI 10.1161/01.RES.0000183733.53101.11; Valgimigli M, 2005, EUR HEART J, V26, P1838, DOI 10.1093/eurheartj/ehi289; Van Linthout S, 2011, EUR HEART J, V32, P2168, DOI 10.1093/eurheartj/ehq467; van Poll D, 2008, CELL MOL BIOENG, V1, P42, DOI 10.1007/s12195-008-0001-2; Velagaleti RS, 2008, CIRCULATION, V118, P2057, DOI 10.1161/CIRCULATIONAHA.108.784215; Wang J, 2005, MOL CELL BIOL, V25, P9829, DOI 10.1128/MCB.25.22.9829-9844.2005; Wang MJ, 2007, J MOL CELL CARDIOL, V42, P1009, DOI 10.1016/j.yjmcc.2007.04.010; Wang MJ, 2006, AM J PHYSIOL-REG I, V291, pR880, DOI 10.1152/ajpregu.00280.2006; Wang Y, 2009, AM J PHYSIOL-CELL PH, V297, pC1284, DOI 10.1152/ajpcell.00183.2009; Wang YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013951; Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088; Webber MJ, 2010, J TISSUE ENG REGEN M, V4, P600, DOI 10.1002/term.273; Weil BR, 2010, SURGERY, V148, P444, DOI 10.1016/j.surg.2010.03.010; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Wisel S., 2009, J PHARMACOL EXP THER, V329, P543; Wollert KC, 2010, NAT REV CARDIOL, V7, P204, DOI 10.1038/nrcardio.2010.1; World Health Organization, 2021, TOP 10 CAUS DEATH; Xu HS, 2011, NAT CELL BIOL, V13, P191, DOI 10.1038/ncb0311-191; Yagi H, 2010, MOL THER, V18, P1857, DOI 10.1038/mt.2010.155; Yang F, 2010, P NATL ACAD SCI USA, V107, P3317, DOI 10.1073/pnas.0905432106; Yang YJ, 2008, EUR HEART J, V29, P1578, DOI 10.1093/eurheartj/ehn167; Yao YW, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-74; Yew TL, 2011, CELL TRANSPLANT, V20, P693, DOI 10.3727/096368910X550198; Yu KM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002470	122	598	639	1	110	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 2	2012	10	3					244	258		10.1016/j.stem.2012.02.005	http://dx.doi.org/10.1016/j.stem.2012.02.005			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	908BX	22385653	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000301466500007
J	Salero, E; Blenkinsop, TA; Corneo, B; Harris, A; Rabin, D; Stern, JH; Temple, S				Salero, Enrique; Blenkinsop, Timothy A.; Corneo, Barbara; Harris, Ashley; Rabin, David; Stern, Jeffrey H.; Temple, Sally			Adult Human RPE Can Be Activated into a Multipotent Stem Cell that Produces Mesenchymal Derivatives	CELL STEM CELL			English	Article							RETINAL-PIGMENT EPITHELIUM; SELF-RENEWAL; OSSEOUS METAPLASIA; MAMMALIAN EYE; IN-VITRO; DIFFERENTIATION; REGENERATION; TISSUE; EXPRESSION	The retinal pigment epithelium (RPE) is a monolayer of cells underlying and supporting the neural retina. It begins as a plastic tissue, capable, in some species, of generating lens and retina, but differentiates early in development and remains normally nonproliferative throughout life. Here we show that a subpopulation of adult human APE cells can be activated in vitro to a self-renewing cell, the retinal pigment epithelial stem cell (RPESC) that loses RPE markers, proliferates extensively, and can redifferentiate into stable cobblestone RPE monolayers. Clonal studies demonstrate that RPESCs are multipotent and in defined conditions can generate both neural and mesenchymal progeny. This plasticity may explain human pathologies in which mesenchymal fates are seen in the eye, for example in proliferative vitroretinopathy (PVR) and phthisis bulbi. This study establishes the RPESC as an accessible, human CNS-derived multipotent stem cell, useful for the study of fate choice, replacement therapy, and disease modeling.	[Salero, Enrique; Blenkinsop, Timothy A.; Corneo, Barbara; Rabin, David; Stern, Jeffrey H.; Temple, Sally] Neural Stem Cell Inst, Rensselaer, NY 12144 USA; [Harris, Ashley] Univ Michigan, Ann Arbor, MI 48109 USA; [Rabin, David; Temple, Sally] Albany Med Coll, Albany, NY 12208 USA	University of Michigan System; University of Michigan; Albany Medical College	Temple, S (corresponding author), Neural Stem Cell Inst, Rensselaer, NY 12144 USA.	sallytemple@nynsci.org		Corneo, Barbara/0000-0001-5189-6749	NYSTEM DOH [C024399, C024414]; American Health Assistance Foundation [M200037]; Steinbach Foundation; Regenerative Research Foundation	NYSTEM DOH; American Health Assistance Foundation(BrightFocus Foundation); Steinbach Foundation; Regenerative Research Foundation	This work was supported by NYSTEM DOH (grants C024399 to E.S. and C024414 to S.T.), American Health Assistance Foundation (M200037 to S.T.), the Steinbach Foundation, and the Regenerative Research Foundation. We acknowledge with deep gratitude the support and encouragement of Dr. Heinrich Medicus. We thank Soma De for early help in establishing the culture system, Meredithe Applebury and Michael Radosevich for helpful discussions, Sheldon Miller and Arvydas Maminishkis for fetal RPE cultures and invaluable insight, and Carol Charniga and Patricia Lederman for technical assistance. We are indebted to the eye donors and their families.	Ahmad I, 2000, BIOCHEM BIOPH RES CO, V270, P517, DOI 10.1006/bbrc.2000.2473; Amemiya K, 2004, BIOCHEM BIOPH RES CO, V316, P1, DOI 10.1016/j.bbrc.2004.01.172; APPLE DJ, 1982, AM J OPHTHALMOL, V94, P344, DOI 10.1016/0002-9394(82)90360-9; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blenkinsop T.A., 2011, METHOD MOL IN PRESS; Burke JM, 1996, EXP EYE RES, V62, P63, DOI 10.1006/exer.1996.0008; Cicero SA, 2009, P NATL ACAD SCI USA, V106, P6685, DOI 10.1073/pnas.0901596106; De S, 2007, ARCH OPHTHALMOL-CHIC, V125, P641, DOI 10.1001/archopht.125.5.641; Haruta M, 2001, NAT NEUROSCI, V4, P1163, DOI 10.1038/nn762; Idelson M, 2009, CELL STEM CELL, V5, P396, DOI 10.1016/j.stem.2009.07.002; Ikegami Y, 2002, J NEUROBIOL, V50, P209, DOI 10.1002/neu.10031; KAMPIK A, 1981, ARCH OPHTHALMOL-CHIC, V99, P1445, DOI 10.1001/archopht.1981.03930020319025; Lamba D, 2008, CELL STEM CELL, V2, P538, DOI 10.1016/j.stem.2008.05.002; Levine EM, 2000, CELL MOL LIFE SCI, V57, P224, DOI 10.1007/PL00000686; Loeffler KU, 1996, GRAEF ARCH CLIN EXP, V234, pS70, DOI 10.1007/BF02343051; Loewenstein JI, 1997, ARCH OPHTHALMOL-CHIC, V115, P117, DOI 10.1001/archopht.1997.01100150119023; Maminishkis A, 2006, INVEST OPHTH VIS SCI, V47, P3612, DOI 10.1167/iovs.05-1622; Mann I, 1964, ARCH OPHTHALMOL-CHIC, V99, P873; Osakada F, 2009, NAT PROTOC, V4, P811, DOI 10.1038/nprot.2009.51; PEER J, 1988, AM J OPHTHALMOL, V106, P742, DOI 10.1016/0002-9394(88)90714-3; Petzer AL, 1996, P NATL ACAD SCI USA, V93, P1470, DOI 10.1073/pnas.93.4.1470; Piacibello W, 1997, BLOOD, V89, P2644, DOI 10.1182/blood.V89.8.2644; Rapaport DH, 1995, J COMP NEUROL, V363, P359, DOI 10.1002/cne.903630303; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; Shields CL, 2006, RETINA-J RET VIT DIS, V26, P328, DOI 10.1097/00006982-200603000-00012; Smith R.S., 2002, SYSTEMATIC EVALUATIO; Spence JR, 2007, DEV DYNAM, V236, P1161, DOI 10.1002/dvdy.21115; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Toyran S, 2005, BRIT J OPHTHALMOL, V89, P885, DOI 10.1136/bjo.2004.056374; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; Tucker BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018992; Vemuganti Geeta K., 2002, Indian Journal of Ophthalmology, V50, P183	32	182	193	1	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JAN 6	2012	10	1					88	95		10.1016/j.stem.2011.11.018	http://dx.doi.org/10.1016/j.stem.2011.11.018			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	880ZQ	22226358	Bronze			2022-12-28	WOS:000299449500013
J	Tabar, V				Tabar, Viviane			Making a Pituitary Gland in a Dish	CELL STEM CELL			English	Editorial Material								The adenohypophysis secretes multiple hormones that control vital physiological functions. A recent article in Nature (Suga et al., 2011) describes a 3D protocol for the derivation of several endocrine pituitary cell types from mouse ESCs.	[Tabar, Viviane] Mem Sloan Kettering Ctr Canc Res, Dept Neurosurg, New York, NY 10065 USA; [Tabar, Viviane] Mem Sloan Kettering Ctr Canc Res, Ctr Stem Cell Biol, New York, NY 10065 USA		Tabar, V (corresponding author), Mem Sloan Kettering Ctr Canc Res, Dept Neurosurg, New York, NY 10065 USA.	tabarv@mskcc.org			NATIONAL CANCER INSTITUTE [R21CA176700, P30CA008748] Funding Source: NIH RePORTER; NCI NIH HHS [R21 CA176700, P30 CA008748] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Appelman-Dijkstra NM, 2011, J CLIN ENDOCR METAB, V96, P2330, DOI 10.1210/jc.2011-0306; Darzy KH, 2009, NAT CLIN PRACT ENDOC, V5, P88, DOI 10.1038/ncpendmet1051; Gleiberman AS, 2008, P NATL ACAD SCI USA, V105, P6332, DOI 10.1073/pnas.0801644105; Karavitaki N, 2005, CLIN ENDOCRINOL, V62, P397, DOI 10.1111/j.1365-2265.2005.02231.x; Melmed S, 2011, NAT REV ENDOCRINOL, V7, P257, DOI 10.1038/nrendo.2011.40; Scully KM, 2002, SCIENCE, V295, P2231, DOI 10.1126/science.1062736; Suga H, 2011, NATURE; Takuma N, 1998, DEVELOPMENT, V125, P4835; Wataya T, 2008, P NATL ACAD SCI USA, V105, P11796, DOI 10.1073/pnas.0803078105; Zhu XY, 2007, CURR OPIN CELL BIOL, V19, P605, DOI 10.1016/j.ceb.2007.09.011	10	4	6	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	DEC 2	2011	9	6					490	491		10.1016/j.stem.2011.11.013	http://dx.doi.org/10.1016/j.stem.2011.11.013			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	859SB	22136918	Green Accepted, Bronze			2022-12-28	WOS:000297895000003
J	Takashima, S; Kanatsu-Shinohara, M; Tanaka, T; Takehashi, M; Morimoto, H; Shinohara, T				Takashima, Seiji; Kanatsu-Shinohara, Mito; Tanaka, Takashi; Takehashi, Masanori; Morimoto, Hiroko; Shinohara, Takashi			Rac Mediates Mouse Spermatogonial Stem Cell Homing to Germline Niches by Regulating Transmigration through the Blood-Testis Barrier	CELL STEM CELL			English	Article							TIGHT JUNCTION STRANDS; SELF-RENEWAL; MICE; SPERMATOGENESIS; TRANSPLANTATION; PROLIFERATION; TRANSMISSION; ACTIVATION; GENERATION; MIGRATION	The homing ability of spermatogonial stem cells (SSCs) allows them to migrate into niches after being transplantated into infertile testes. Transplanted SSCs attach to Sertoli cells and transmigrate through the blood-testis barrier (BTB), formed by inter-Sertoli tight junctions, toward niches on the basement membrane. The most critical step is the passage through the BTB, which limits the homing efficiency to <10%. Here we demonstrated the involvement of Rac1 in SSC transmigration. Rac1-deficient SSCs did not colonize the adult testes, but they reinitiated spermatogenesis when transplanted into pup testes without a BTB. Moreover, a dominant-negative Rac1 construct not only reduced the expression of several claudin proteins, which comprise the BTB, but also increased SSC proliferation both in vitro and in vivo. Short hairpin RNA (shRNA) -mediated suppression of claudin3, which was downregulated by Rac inhibition, reduced the SSC homing efficiency. Thus, Rac1 is a critical regulator of SSC homing and proliferation.	[Takashima, Seiji; Kanatsu-Shinohara, Mito; Tanaka, Takashi; Takehashi, Masanori; Morimoto, Hiroko; Shinohara, Takashi] Kyoto Univ, Grad Sch Med, Dept Mol Genet, Kyoto 6068501, Japan; [Shinohara, Takashi] CREST, Japan Sci & Technol Agcy, Kyoto 6068501, Japan	Kyoto University; Japan Science & Technology Agency (JST)	Kanatsu-Shinohara, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Mol Genet, Kyoto 6068501, Japan.	mshinoha@virus.kyoto-u.ac.jp; tshinoha@virus.kyoto-u.ac.jp	Takashima, Seiji/I-4993-2019	Takashima, Seiji/0000-0002-9176-3139	Japan Science and Technology Agency (CREST); Program for Promotion of Basic and Applied Researches for Innovation in Bio-Oriented Industry; Senri Life Science Foundation; Ministry of Health, Labour, and Welfare; Government of Japan; Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan	Japan Science and Technology Agency (CREST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Program for Promotion of Basic and Applied Researches for Innovation in Bio-Oriented Industry; Senri Life Science Foundation; Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Government of Japan; Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors declare they have no financial conflicts of interest. We thank Ms. Y. Ogata for technical assistance and Dr. S. Tsukita for the generous gifts of KO mice and antibodies against claudins. This research was supported by Japan Science and Technology Agency (CREST); Program for Promotion of Basic and Applied Researches for Innovation in Bio-Oriented Industry; Senri Life Science Foundation; the Ministry of Health, Labour, and Welfare; Government of Japan through its "Funding Program for Next Generation World-Leading Researchers:" and the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan.	BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Cancelas JA, 2006, EXP HEMATOL, V34, P976, DOI 10.1016/j.exphem.2006.03.016; Chiarini-Garcia H, 2001, BIOL REPROD, V65, P1179, DOI 10.1095/biolreprod65.4.1179; De Rooij DG, 2000, J ANDROL, V21, P776; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Glogauer M, 2003, J IMMUNOL, V170, P5652, DOI 10.4049/jimmunol.170.11.5652; Gow A, 1999, CELL, V99, P649, DOI 10.1016/S0092-8674(00)81553-6; Hubsman MW, 2007, BIOCHEM J, V404, P487, DOI 10.1042/BJ20061696; Joyce D, 1999, J BIOL CHEM, V274, P25245, DOI 10.1074/jbc.274.36.25245; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2008, CELL STEM CELL, V3, P533, DOI 10.1016/j.stem.2008.08.002; Kanatsu-Shinohara M, 2006, P NATL ACAD SCI USA, V103, P8018, DOI 10.1073/pnas.0601139103; Kanatsu-Shinohara M, 2010, P NATL ACAD SCI USA, V107, P6210, DOI 10.1073/pnas.0914448107; Kitajiri SI, 2004, J CELL SCI, V117, P5087, DOI 10.1242/jcs.01393; Knaus UG, 1998, INT J BIOCHEM CELL B, V30, P857, DOI 10.1016/S1357-2725(98)00059-4; Lee J, 2009, CELL STEM CELL, V5, P76, DOI 10.1016/j.stem.2009.04.020; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Meistrich ML, 1993, CELL MOL BIOL TESTIS, P266; Meng J, 2005, P NATL ACAD SCI USA, V102, P16696, DOI 10.1073/pnas.0506084102; Morrow CMK, 2009, BIOL REPROD, V81, P871, DOI 10.1095/biolreprod.109.077040; Mruk DD, 2004, ENDOCR REV, V25, P747, DOI 10.1210/er.2003-0022; Nagano M, 2001, P NATL ACAD SCI USA, V98, P13090, DOI 10.1073/pnas.231473498; Nagano M, 1999, BIOL REPROD, V60, P1429, DOI 10.1095/biolreprod60.6.1429; Nagano MC, 2003, BIOL REPROD, V69, P701, DOI 10.1095/biolreprod.103.016352; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Ohta H, 2004, BIOL REPROD, V70, P1286, DOI 10.1095/biolreprod.103.024612; Paratcha G, 2006, MOL CELL NEUROSCI, V31, P505, DOI 10.1016/j.mcn.2005.11.007; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; RUSSELL L, 1977, AM J ANAT, V148, P313, DOI 10.1002/aja.1001480303; Russell LD, 1996, J ANDROL, V17, P603; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Shinohara T, 2001, P NATL ACAD SCI USA, V98, P6186, DOI 10.1073/pnas.111158198; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tang MJ, 1998, J CELL BIOL, V142, P1337, DOI 10.1083/jcb.142.5.1337; Worthylake RA, 2001, CURR OPIN CELL BIOL, V13, P569, DOI 10.1016/S0955-0674(00)00253-2; Yoshida S, 2010, DEV GROWTH DIFFER, V52, P311, DOI 10.1111/j.1440-169X.2010.01174.x	40	43	44	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV 4	2011	9	5					463	475		10.1016/j.stem.2011.08.011	http://dx.doi.org/10.1016/j.stem.2011.08.011			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	850FJ	22056142	Bronze			2022-12-28	WOS:000297180200013
J	Cimadamore, F; Fishwick, K; Giusto, E; Gnedeva, K; Cattarossi, G; Miller, A; Pluchino, S; Brill, LM; Bronner-Fraser, M; Terskikh, AV				Cimadamore, Flavio; Fishwick, Katherine; Giusto, Elena; Gnedeva, Ksenia; Cattarossi, Giulio; Miller, Amber; Pluchino, Stefano; Brill, Laurence M.; Bronner-Fraser, Marianne; Terskikh, Alexey V.			Human ESC-Derived Neural Crest Model Reveals a Key Role for SOX2 in Sensory Neurogenesis	CELL STEM CELL			English	Article							ACHAETE-SCUTE HOMOLOG-1; EXTRACELLULAR-MATRIX; TRANSCRIPTION FACTOR; LATERAL INHIBITION; NERVOUS-SYSTEM; CELL-ADHESION; STEM-CELLS; EXPRESSION; NEURONS; GENES	The transcription factor SOX2 is widely known to play a critical role in the central nervous system; however, its role in peripheral neurogenesis remains poorly understood. We recently developed an hESC-based model in which migratory cells undergo epithelial to mesenchymal transition (EMT) to acquire properties of neural crest (NC) cells. In this model, we found that migratory NC progenitors downregulate SOX2, but then start re-expressing SOX2 as they differentiate to form neurogenic dorsal root ganglion (DRG)like clusters. SOX2 downregulation was sufficient to induce EMT and resulted in massive apoptosis when neuronal differentiation was induced. In vivo, downregulation of SOX2 in chick and mouse NC cells significantly reduced the numbers of neurons within DRG. We found that SOX2 binds directly to NGN1 and MASH1 promoters and is required for their expression. Our data suggest that SOX2 plays a key role for NGN1-dependent acquisition of neuronal fates in sensory ganglia.	[Cimadamore, Flavio; Giusto, Elena; Gnedeva, Ksenia; Cattarossi, Giulio; Miller, Amber; Brill, Laurence M.; Terskikh, Alexey V.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Fishwick, Katherine; Bronner-Fraser, Marianne] CALTECH, Pasadena, CA 91125 USA; [Giusto, Elena; Pluchino, Stefano] IRCCS, Inst Expt Neurol, I-20132 Milan, Italy	Sanford Burnham Prebys Medical Discovery Institute; California Institute of Technology	Cimadamore, F (corresponding author), Sanford Burnham Med Res Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	flavioc@burnham.org; terskikh@burnham.org	Pluchino, Stefano/AAE-9037-2019; Giusto, Elena/AAY-9554-2021; Terskikh, Alexey/U-8407-2019	Pluchino, Stefano/0000-0002-6267-9472; Giusto, Elena/0000-0003-0562-1466; Cimadamore, Flavio/0000-0002-3649-0545; Bronner, Marianne/0000-0003-4274-1862	CIRM [RS1004661]; Sanford-Burnham Medical Research Institute; NIH Blueprint; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD037105] Funding Source: NIH RePORTER	CIRM(California Institute for Regenerative Medicine); Sanford-Burnham Medical Research Institute; NIH Blueprint(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank C.-T. Huang and K. Liu for their help with cloning, lentiviral production, and microarray analysis. We thank Dr. S. Albini, Dr. S. Forcales, and Professor L. Puri for sharing their expertise in chromatin immunoprecipitation techniques. Sox2LoxP mice were kindly provided by Dr. Nicolis, and Wnt1-CRE mice were kindly provided by Dr. Y. Yamaguchi. We thank Dr. J. Hou for helping with IP-MS data analysis. This work has been supported by CIRM postdoctoral fellowship to F.C., CIRM grant RS1004661 to A.T., and transient research support to A.V. Terskikh from the Sanford-Burnham Medical Research Institute and an NIH Blueprint core grant (PI, S.A. Lipton).	Adachi K, 2010, GENES CELLS, V15, P455, DOI 10.1111/j.1365-2443.2010.01400.x; AKITAYA T, 1992, DEV DYNAM, V194, P12, DOI 10.1002/aja.1001940103; Araki T, 2000, J NEUROSCI, V20, P187, DOI 10.1523/JNEUROSCI.20-01-00187.2000; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bajpai R, 2009, CELL DEATH DIFFER, V16, P807, DOI 10.1038/cdd.2009.18; Barasch J, 1999, CELL, V99, P377, DOI 10.1016/S0092-8674(00)81524-X; Cai L, 2000, DEVELOPMENT, V127, P3021; Carl TF, 1999, DEV BIOL, V213, P101, DOI 10.1006/dbio.1999.9320; Cau E, 2000, DEVELOPMENT, V127, P2323; Cavallaro M, 2008, DEVELOPMENT, V135, P541, DOI 10.1242/dev.010801; Chen B, 2009, DEV BIOL, V326, P75, DOI 10.1016/j.ydbio.2008.10.039; Chen H, 1997, P NATL ACAD SCI USA, V94, P5355, DOI 10.1073/pnas.94.10.5355; Cimadamore F, 2009, STEM CELLS, V27, P1772, DOI 10.1002/stem.107; Curchoe CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013890; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Farinas I, 2002, BRAIN RES BULL, V57, P809, DOI 10.1016/S0361-9230(01)00767-5; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; FEDTSOVA NG, 1995, MECH DEVELOP, V53, P291, DOI 10.1016/0925-4773(95)00435-1; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Grifone R, 2005, DEVELOPMENT, V132, P2235, DOI 10.1242/dev.01773; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Hagstrom SA, 2005, AM J MED GENET A, V138A, P95, DOI 10.1002/ajmg.a.30803; HAMBURGER V, 1988, J NEUROSCI, V8, P3535; Henderson DJ, 1997, J ANAT, V191, P507, DOI 10.1046/j.1469-7580.1997.19140507.x; HOLLYDAY M, 1995, MECH DEVELOP, V52, P9, DOI 10.1016/0925-4773(95)00385-E; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; Jordanova A, 2003, BRAIN, V126, P590, DOI 10.1093/brain/awg059; Kahane N, 1998, CELL TISSUE RES, V294, P297, DOI 10.1007/s004410051180; Kil SH, 1998, DEV BIOL, V202, P29, DOI 10.1006/dbio.1998.8985; Kim J, 2003, NEURON, V38, P17, DOI 10.1016/S0896-6273(03)00163-6; Kobayashi M, 2000, MECH DEVELOP, V98, P151, DOI 10.1016/S0925-4773(00)00451-2; Konishi Y, 2006, BRAIN RES, V1116, P93, DOI 10.1016/j.brainres.2006.07.103; Le N, 2005, P NATL ACAD SCI USA, V102, P2596, DOI 10.1073/pnas.0407836102; Linker C, 2000, DEV BIOL, V224, P215, DOI 10.1006/dbio.2000.9723; Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Marmigere F, 2007, NAT REV NEUROSCI, V8, P114, DOI 10.1038/nrn2057; Mersiyanova IV, 2000, AM J HUM GENET, V67, P37, DOI 10.1086/302962; Meulemans D, 2004, DEV CELL, V7, P291, DOI 10.1016/j.devcel.2004.08.007; Miyagi S, 2008, FEBS LETT, V582, P2811, DOI 10.1016/j.febslet.2008.07.011; Montelius A, 2007, DIFFERENTIATION, V75, P404, DOI 10.1111/j.1432-0436.2006.00154.x; MOULD AP, 1994, J BIOL CHEM, V269, P27224; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Olson JM, 2001, DEV BIOL, V234, P174, DOI 10.1006/dbio.2001.0245; Paratore C, 2001, DEVELOPMENT, V128, P3949; Perris R, 2000, MECH DEVELOP, V95, P3, DOI 10.1016/S0925-4773(00)00365-8; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Rex M, 1997, DEV DYNAM, V209, P323, DOI 10.1002/(SICI)1097-0177(199707)209:3<323::AID-AJA7>3.3.CO;2-B; Sanlaville D, 2007, EUR J HUM GENET, V15, P389, DOI 10.1038/sj.ejhg.5201778; Sela-Donenfeld D, 1999, DEVELOPMENT, V126, P4749; Shoval I, 2007, DEVELOPMENT, V134, P491, DOI 10.1242/dev.02742; Thomas S, 2008, HUM MOL GENET, V17, P3411, DOI 10.1093/hmg/ddn235; Varadkar P, 2008, DEV DYNAM, V237, P1144, DOI 10.1002/dvdy.21502; Voroteliak E A, 2002, Izv Akad Nauk Ser Biol, P30; Wakamatsu Y, 2000, DEVELOPMENT, V127, P2811; Wakamatsu Y, 2004, DEV DYNAM, V229, P74, DOI 10.1002/dvdy.10498; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008	61	70	76	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 6	2011	8	5					538	551		10.1016/j.stem.2011.03.011	http://dx.doi.org/10.1016/j.stem.2011.03.011			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	768IN	21549328	Green Accepted, Bronze			2022-12-28	WOS:000290927600014
J	Kessenbrock, K; Dijkgraaf, GJP; Lawson, DA; Littlepage, LE; Shahi, P; Pieper, U; Werb, Z				Kessenbrock, Kai; Dijkgraaf, Gerrit J. P.; Lawson, Devon A.; Littlepage, Laurie E.; Shahi, Payam; Pieper, Ursula; Werb, Zena			A Role for Matrix Metalloproteinases in Regulating Mammary Stem Cell Function via the Wnt Signaling Pathway	CELL STEM CELL			English	Article							BRANCHING MORPHOGENESIS; GLAND DEVELOPMENT; TGF-BETA; HEMOPEXIN DOMAIN; PROGENITOR CELLS; CANCER; PROTEINS; GROWTH; SUBPOPULATIONS; STROMELYSIN	The microenvironment provides cues that control the behavior of epithelial stem and progenitor cells. Here, we identify matrix metalloproteinase-3 (MMP3) as a regulator of Wnt signaling and mammary stem cell (MaSC) activity. We show that MMP3 overexpression promotes hyperplastic epithelial growth, surprisingly, in a nonproteolytic manner via its hemopexin (HPX) domain. We demonstrate that MMP3-HPX specifically binds and inactivates Wnt5b, a noncanonical Wnt ligand that inhibits canonical Wnt signaling and mammary epithelial outgrowth in vivo. Indeed, transplants overexpressing MMP3 display increased canonical Wnt signaling, demonstrating that MMP3 is an extracellular regulator of the Wnt signaling pathway. MMP3-deficient mice exhibit decreased MaSC populations and diminished mammary-reconstituting activity, whereas MMP3 overexpression elevates MaSC function, indicating that MMP3 is necessary for the maintenance of MaSCs. Our study reveals a mechanism by a microenvironmental protease that regulates Wnt signaling and impacts adult epithelial stem cell function.	[Kessenbrock, Kai; Dijkgraaf, Gerrit J. P.; Lawson, Devon A.; Littlepage, Laurie E.; Shahi, Payam; Werb, Zena] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Kessenbrock, Kai; Dijkgraaf, Gerrit J. P.; Lawson, Devon A.; Littlepage, Laurie E.; Shahi, Payam; Werb, Zena] Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94143 USA; [Pieper, Ursula] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Werb, Z (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	zena.werb@ucsf.edu	Kessenbrock, Kai/B-6936-2011	Pieper, Ursula/0000-0002-3168-8122	National Cancer Institute [R01 CA057621]; Komen Foundation; American Cancer Society; Congressionally Directed Breast Cancer Research Program, U.S. Department of Defense [DAMD-17-02-1-0333, W81XWH-11-1-0742]; NATIONAL CANCER INSTITUTE [K99CA181490, T32CA108462, R01CA057621] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Komen Foundation(Susan G. Komen Breast Cancer Foundation); American Cancer Society(American Cancer Society); Congressionally Directed Breast Cancer Research Program, U.S. Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. Howard Bussey (McGill University, Canada) for Y2H reagents and Dr. Sandra Werner (Institute of Molecular Health Sciences, Switzerland) for the murine MMP10 cDNA. We thank Markus Brown, Ying Yu, and Elena Atamuniac for technical assistance. This work was supported by a grant from the National Cancer Institute (R01 CA057621 to Z.W.), postdoctoral fellowships from the Komen Foundation (to K.K.), the American Cancer Society (to L.E.L.), and the Congressionally Directed Breast Cancer Research Program, U.S. Department of Defense (DAMD-17-02-1-0333 to G.J.P.D. and W81XWH-11-1-0742 to D.A.L.).	BARTEL PL, 1995, METHOD ENZYMOL, V254, P241; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Correia AL, 2013, GENE DEV, V27, P805, DOI 10.1101/gad.211383.112; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; CRABBE T, 1994, BIOCHEMISTRY-US, V33, P6684, DOI 10.1021/bi00187a039; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Ji H, 2011, PROTEOMICS, V11, P4029, DOI 10.1002/pmic.201100102; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kendrick H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-591; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kouros-Mehr H, 2006, DEV DYNAM, V235, P3404, DOI 10.1002/dvdy.20978; Li HJ, 2002, YEAST, V19, P1097, DOI 10.1002/yea.904; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Ling L, 2009, GENE, V433, P1, DOI 10.1016/j.gene.2008.12.008; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Lu PF, 2008, SCIENCE, V322, P1506, DOI 10.1126/science.1162783; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; Miyoshi H, 2012, SCIENCE, V338, P108, DOI 10.1126/science.1223821; Mudgett JS, 1998, ARTHRITIS RHEUM-US, V41, P110, DOI 10.1002/1529-0131(199801)41:1<110::AID-ART14>3.0.CO;2-G; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Piccard H, 2007, J LEUKOCYTE BIOL, V81, P870, DOI 10.1189/jlb.1006629; Plaks V, 2013, CELL REP, V3, P70, DOI 10.1016/j.celrep.2012.12.017; Prieve Mary G, 2003, BMC Dev Biol, V3, P2, DOI 10.1186/1471-213X-3-2; Remacle AG, 2012, CANCER RES, V72, P2339, DOI 10.1158/0008-5472.CAN-11-4149; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250; Roarty K, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2244; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shahi P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030814; SIRUM KL, 1989, BIOCHEMISTRY-US, V28, P8691, DOI 10.1021/bi00448a004; Sternlicht MD, 2000, ONCOGENE, V19, P1102, DOI 10.1038/sj.onc.1203347; Sternlicht MD, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1368; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Wagers AJ, 2012, CELL STEM CELL, V10, P362, DOI 10.1016/j.stem.2012.02.018; Welm Bryan E, 2008, Cell Stem Cell, V2, P90, DOI 10.1016/j.stem.2007.10.002; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Wiseman BS, 2003, J CELL BIOL, V162, P1123, DOI 10.1083/jcb.200302090; Witty Jean P., 1995, Molecular Biology of the Cell, V6, P1287; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020	47	101	103	2	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 5	2013	13	3					300	313		10.1016/j.stem.2013.06.005	http://dx.doi.org/10.1016/j.stem.2013.06.005			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VQ	23871604	Green Accepted, Bronze			2022-12-28	WOS:000329570800008
J	Crompton, JG; Rao, M; Restifo, NP				Crompton, Joseph G.; Rao, Mahendra; Restifo, Nicholas P.			Memoirs of a Reincarnated T Cell	CELL STEM CELL			English	Editorial Material							IMMUNOTHERAPY; MEMORY	In two studies published in this issue of Cell Stem Cell, Nishimura et al. (2013) and Vizcardo etal. (2013) reprogram mature, antigen-specific cytotoxic T cells into induced pluripotent stem cells (iPSCs). The antigen-specific iPSCs can be redifferentiated into "rejuvenated" proliferative T cells and have broad applications for adoptive immunotherapy.	[Crompton, Joseph G.; Restifo, Nicholas P.] NCI, NIH, Bethesda, MD 20892 USA; [Rao, Mahendra; Restifo, Nicholas P.] NIH, Ctr Regenerat Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA	Restifo, NP (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.	restifon@mail.nih.gov	Restifo, Nicholas P/A-5713-2008; Restifo, Nicholas Phillip/Z-1614-2019; Restifo, Nicholas Phillip/M-6549-2019	Restifo, Nicholas P./0000-0003-4229-4580	NATIONAL CANCER INSTITUTE [ZIABC010763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041193] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 BC010763-03] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Fearon DT, 2007, ADV IMMUNOL, V96, P103, DOI 10.1016/S0065-2776(07)96003-4; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Klebanoff CA, 2006, IMMUNOL REV, V211, P214, DOI 10.1111/j.0105-2896.2006.00391.x; Nishimura T, 2013, CELL STEM CELL, V12, P114, DOI 10.1016/j.stem.2012.11.002; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Rosenberg SA, 2011, NAT REV CLIN ONCOL, V8, P577, DOI 10.1038/nrclinonc.2011.116; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vizcardo R, 2013, CELL STEM CELL, V12, P31, DOI 10.1016/j.stem.2012.12.006; Wu SM, 2011, NAT CELL BIOL, V13, P497, DOI 10.1038/ncb0511-497	10	8	8	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JAN 3	2013	12	1					6	8		10.1016/j.stem.2012.12.009	http://dx.doi.org/10.1016/j.stem.2012.12.009			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	074UM	23290132	Green Accepted, Bronze			2022-12-28	WOS:000313839500003
J	Lan, F; Lee, AS; Liang, P; Sanchez-Freire, V; Nguyen, PK; Wang, L; Han, L; Yen, M; Wang, YM; Sun, N; Abilez, OJ; Hu, SJ; Ebert, AD; Navarrete, EG; Simmons, CS; Wheeler, M; Pruitt, B; Lewis, R; Yamaguchi, Y; Ashley, EA; Bers, DM; Robbins, RC; Longaker, MT; Wu, JC				Lan, Feng; Lee, Andrew S.; Liang, Ping; Sanchez-Freire, Veronica; Nguyen, Patricia K.; Wang, Li; Han, Leng; Yen, Michelle; Wang, Yongming; Sun, Ning; Abilez, Oscar J.; Hu, Shijun; Ebert, Antje D.; Navarrete, Enrique G.; Simmons, Chelsey S.; Wheeler, Matthew; Pruitt, Beth; Lewis, Richard; Yamaguchi, Yoshinori; Ashley, Euan A.; Bers, Donald M.; Robbins, Robert C.; Longaker, Michael T.; Wu, Joseph C.			Abnormal Calcium Handling Properties Underlie Familial Hypertrophic Cardiomyopathy Pathology in Patient-Specific Induced Pluripotent Stem Cells	CELL STEM CELL			English	Article							TROPONIN-T; MYOSIN; MECHANISMS; MUTATION; MODELS	Familial hypertrophic cardiomyopathy (HCM) is a prevalent hereditary cardiac disorder linked to arrhythmia and sudden cardiac death. While the causes of HCM have been identified as genetic mutations in the cardiac sarcomere, the pathways by which sarcomeric mutations engender myocyte hypertrophy and electrophysiological abnormalities are not understood. To elucidate the mechanisms underlying HCM development, we generated patient-specific induced pluripotent stem cell cardiornyocytes (iPSC-CMs) from a ten-member family cohort carrying a hereditary HCM missense mutation (Arg663His) in the MYH7 gene. Diseased iPSC-CMs recapitulated numerous aspects of the HCM phenotype including cellular enlargement and contractile arrhythmia at the single-cell level. Calcium (Ca2+) imaging indicated dysregulation of Ca2+ cycling and elevation in intracellular Ca2+ ([Ca2+](i)) are central mechanisms for disease pathogenesis. Pharmacological restoration of Ca2+ homeostasis prevented development of hypertrophy and electrophysiological irregularities. We anticipate that these findings will help elucidate the mechanisms underlying HCM development and identify novel therapies for the disease.	[Lan, Feng; Lee, Andrew S.; Liang, Ping; Sanchez-Freire, Veronica; Nguyen, Patricia K.; Wang, Li; Han, Leng; Wang, Yongming; Sun, Ning; Hu, Shijun; Ebert, Antje D.; Wheeler, Matthew; Ashley, Euan A.; Wu, Joseph C.] Stanford Univ, Dept Med, Div Cardiol, Sch Med, Stanford, CA 94305 USA; [Lan, Feng; Lee, Andrew S.; Liang, Ping; Sanchez-Freire, Veronica; Nguyen, Patricia K.; Wang, Li; Han, Leng; Wang, Yongming; Sun, Ning; Hu, Shijun; Ebert, Antje D.; Navarrete, Enrique G.; Robbins, Robert C.; Wu, Joseph C.] Stanford Univ, Stanford Cardiovasc Inst, Sch Med, Stanford, CA 94305 USA; [Lan, Feng; Lee, Andrew S.; Liang, Ping; Sanchez-Freire, Veronica; Wang, Yongming; Hu, Shijun; Ebert, Antje D.; Longaker, Michael T.; Wu, Joseph C.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA; [Yen, Michelle; Lewis, Richard] Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA; [Abilez, Oscar J.] Stanford Univ, Dept Surg, Div Vasc Surg, Sch Med, Stanford, CA 94305 USA; [Robbins, Robert C.] Stanford Univ, Dept Cardiothorac Surg, Sch Med, Stanford, CA 94305 USA; [Wu, Joseph C.] Stanford Univ, Dept Radiol, Mol Imaging Program, Sch Med, Stanford, CA 94305 USA; [Longaker, Michael T.] Stanford Univ, Dept Surg, Div Plast & Reconstruct Surg, Sch Med, Stanford, CA 94305 USA; [Simmons, Chelsey S.; Pruitt, Beth] Stanford Univ, Dept Mech Engn, Sch Engn, Stanford, CA 94305 USA; [Yamaguchi, Yoshinori] Osaka Univ, Dept Appl Phys, Suita, Osaka 5650871, Japan; [Bers, Donald M.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Osaka University; University of California System; University of California Davis	Wu, JC (corresponding author), Stanford Univ, Dept Med, Div Cardiol, Sch Med, Stanford, CA 94305 USA.	joewu@stanford.edu	Simmons, Chelsey/AAG-8859-2020; Lan, Feng/I-2023-2012; Han, Leng/HCH-3491-2022; Lee, Andrew/GVU-2817-2022; Hu, Shijun/I-5818-2012; Abilez, Oscar J./B-5014-2012; Wu, Joseph/H-1067-2013	Simmons, Chelsey/0000-0001-6973-9813; Lan, Feng/0000-0002-9038-4014; Han, Leng/0000-0002-7380-2640; Abilez, Oscar J./0000-0002-9991-400X; Bers, Donald/0000-0002-2237-9483; Sun, Ning/0000-0002-7861-3646; Pruitt, Beth L./0000-0002-4861-2124; Lewis, Richard/0000-0002-6010-7403; Hu, Shijun/0000-0002-0068-8429; Wu, Joseph/0000-0002-6068-8041; Wheeler, Matthew/0000-0001-8721-3022	Burroughs Wellcome Foundation; Foundation Ledvcq; NIH New Innovator Award [DP2OD004437, R01 HL113006, CIRM RB3-05129, RC1 HL100490]; HHMI; Bio-X;  [U01 HL099776]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100490, R01HL113006, U01HL099776, R37HL030077] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004437] Funding Source: NIH RePORTER	Burroughs Wellcome Foundation(Burroughs Wellcome Fund); Foundation Ledvcq; NIH New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); Bio-X; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We gratefully acknowledge funding support from Burroughs Wellcome Foundation, Foundation Ledvcq, NIH New Innovator Award DP2OD004437, R01 HL113006 CIRM RB3-05129 (J.C.W.), RC1 HL100490 (M.T.L.), HHMI (A.S.L.), Bio-X (A.S.L.), and U01 HL099776 (R.C.R.).	Adabag AS, 2008, J AM COLL CARDIOL, V51, P1369, DOI 10.1016/j.jacc.2007.11.071; Arad M, 2002, HUM MOL GENET, V11, P2499, DOI 10.1093/hmg/11.20.2499; BERLIN JR, 1989, CIRC RES, V65, P115, DOI 10.1161/01.RES.65.1.115; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Burridge PW, 2012, CELL STEM CELL, V10, P16, DOI 10.1016/j.stem.2011.12.013; Cao F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003474; Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005; DEFERRARI GM, 1995, CIRCULATION, V91, P2510, DOI 10.1161/01.CIR.91.10.2510; Fatkin D, 2002, PHYSIOL REV, V82, P945, DOI 10.1152/physrev.00012.2002; Fatkin D, 2000, J CLIN INVEST, V106, P1351, DOI 10.1172/JCI11093; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; Gruver EJ, 1999, AM J CARDIOL, V83, p13H; Hossain MM, 2010, ANALYST, V135, P1624, DOI 10.1039/c0an00208a; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Iyer V, 2007, CIRC RES, V100, pE22, DOI 10.1161/01.RES.0000258468.31815.42; Knollmann BC, 2003, CIRC RES, V92, P428, DOI 10.1161/01.RES.0000059562.91384.1A; LOMPRE AM, 1981, DEV BIOL, V84, P286, DOI 10.1016/0012-1606(81)90396-1; Lowey S, 2008, J BIOL CHEM, V283, P20579, DOI 10.1074/jbc.M800554200; Marian AJ, 1997, CIRC RES, V81, P76, DOI 10.1161/01.RES.81.1.76; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785; Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199; Maron MS, 2003, NEW ENGL J MED, V348, P295, DOI 10.1056/NEJMoa021332; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Narsinh K, 2011, CIRC RES, V108, P1146, DOI 10.1161/CIRCRESAHA.111.240374; Narsinh KH, 2011, J CLIN INVEST, V121, P1217, DOI 10.1172/JCI44635; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Semsarian C, 2002, J CLIN INVEST, V109, P1013, DOI 10.1172/JCI200214677; Sun N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003552; Sussman MA, 1998, SCIENCE, V281, P1690, DOI 10.1126/science.281.5383.1690; TEARE D, 1958, BRIT HEART J, V20, P1; Tyska MJ, 2000, CIRC RES, V86, P737, DOI 10.1161/01.RES.86.7.737; Wolf CM, 2005, P NATL ACAD SCI USA, V102, P18123, DOI 10.1073/pnas.0509145102; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855	36	423	440	2	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 3	2013	12	1					101	113		10.1016/j.stem.2012.10.010	http://dx.doi.org/10.1016/j.stem.2012.10.010			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	074UM	23290139	Green Accepted, Bronze			2022-12-28	WOS:000313839500014
J	Valdez, JM; Zhang, L; Su, QT; Dakhova, O; Zhang, YQ; Shahi, P; Spencer, DM; Creighton, CJ; Ittmann, MM; Xin, L				Valdez, Joseph M.; Zhang, Li; Su, Qingtai; Dakhova, Olga; Zhang, Yiqun; Shahi, Payam; Spencer, David M.; Creighton, Chad J.; Ittmann, Michael M.; Xin, Li			Notch and TGF beta Form a Reciprocal Positive Regulatory Loop that Suppresses Murine Prostate Basal Stem/Progenitor Cell Activity	CELL STEM CELL			English	Article							STEM-CELLS; VENTRAL PROSTATE; PROXIMAL REGION; CROSS-TALK; IN-VITRO; DIFFERENTIATION; MECHANISM; COMMITMENT; EPITHELIUM; PATHWAY	The role of Notch signaling in the maintenance of adult murine prostate epithelial homeostasis remains unclear. We found that Notch ligands are mainly expressed within the basal cell lineage, while active Notch signaling is detected in both the prostate basal and luminal cell lineages. Disrupting the canonical Notch effector Rbp-j impairs the differentiation of prostate basal stem cells and increases their proliferation in vitro and in vivo, but does not affect luminal cell biology. Conversely, ectopic Notch activation in adult prostates results in a decrease in basal cell number and luminal cell hyperproliferation. TGF beta dominates over Notch signaling and overrides Notch ablation-induced proliferation of prostate basal cells. However, Notch confers sensitivity and positive feedback by upregulating a plethora of TGF beta signaling components including Tgf beta R1. These findings reveal crucial roles of the self-enforced positive reciprocal regulatory loop between TGF beta and Notch in maintaining prostate basal stem cell dormancy.	[Valdez, Joseph M.; Zhang, Li; Su, Qingtai; Xin, Li] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Dakhova, Olga; Shahi, Payam; Spencer, David M.; Ittmann, Michael M.; Xin, Li] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Zhang, Yiqun; Shahi, Payam; Spencer, David M.; Creighton, Chad J.; Ittmann, Michael M.; Xin, Li] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Xin, L (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	xin@bcm.edu	Zhang, YiQun/HCI-2427-2022		Research Supplement to Promote Diversity in Health-Related Research [NIH CA125937S1]; NIH [R00CA125937, R01DK092202, U01CA141497]; NATIONAL CANCER INSTITUTE [R00CA125937, U01CA141497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092202] Funding Source: NIH RePORTER	Research Supplement to Promote Diversity in Health-Related Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Tasuku Honjo for the Rbp-j conditional mice; Dr. Jon Aster for the dnMAML construct; the Cytometry and Cell Sorting Facility at the Baylor College of Medicine for technical support; Drs. Francesco DeMayo, Vi Li, Brendan Lee, and Michael Lewis for sharing mouse colonies; and Drs. Andy Groves and Jeffrey Rosen for critical comments. J.M.V. is supported by a Research Supplement to Promote Diversity in Health-Related Research (NIH CA125937S1). This work is supported by NIH R00CA125937 (L.X.), R01DK092202 (L.X.), and U01CA141497 (M.M.I.).	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Blokzijl A, 2003, J CELL BIOL, V163, P723, DOI 10.1083/jcb.200305112; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Buono KD, 2006, DEV BIOL, V293, P565, DOI 10.1016/j.ydbio.2006.02.043; Burger PE, 2005, P NATL ACAD SCI USA, V102, P7180, DOI 10.1073/pnas.0502761102; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Chiba S, 2006, STEM CELLS, V24, P2437, DOI 10.1634/stemcells.2005-0661; Choi N, 2012, CANCER CELL, V21, P253, DOI 10.1016/j.ccr.2012.01.005; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; del Alamo D, 2011, CURR BIOL, V21, pR40, DOI 10.1016/j.cub.2010.10.034; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; El-Alfy M, 2000, MICROSC RES TECHNIQ, V51, P436, DOI 10.1002/1097-0029(20001201)51:5<436::AID-JEMT6>3.0.CO;2-T; Goldstein AS, 2008, P NATL ACAD SCI USA, V105, P20882, DOI 10.1073/pnas.0811411106; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Heitzler P, 2010, CURR TOP DEV BIOL, V92, P457, DOI 10.1016/S0070-2153(10)92014-0; Jin CL, 2003, PROSTATE, V57, P160, DOI 10.1002/pros.10283; Kluppel M, 2005, BIOESSAYS, V27, P115, DOI 10.1002/bies.20187; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kundu SD, 2000, PROSTATE, V43, P118; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Lee J, 2007, DEVELOPMENT, V134, P2795, DOI 10.1242/dev.02868; Litvinov IV, 2006, CANCER RES, V66, P8598, DOI 10.1158/0008-5472.CAN-06-1228; Maillard I, 2008, CELL STEM CELL, V2, P356, DOI 10.1016/j.stem.2008.02.011; Marker PC, 2003, DEV BIOL, V253, P165, DOI 10.1016/S0012-1606(02)00031-3; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Nantermet PV, 2004, J BIOL CHEM, V279, P1310, DOI 10.1074/jbc.M310206200; Nemeth JA, 1996, PROSTATE, V28, P124; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Niimi H, 2007, J CELL BIOL, V176, P695, DOI 10.1083/jcb.200612129; Niranjan T, 2008, NAT MED, V14, P290, DOI 10.1038/nm1731; Okuyama R, 2004, DEV CELL, V6, P551, DOI 10.1016/S1534-5807(04)00098-X; Orr B, 2009, ENDOCRINOLOGY, V150, P463, DOI 10.1210/en.2008-0383; Placencio VR, 2008, CANCER RES, V68, P4709, DOI 10.1158/0008-5472.CAN-07-6289; Salm SN, 2005, J CELL BIOL, V170, P81, DOI 10.1083/jcb.200412015; Shahi P, 2011, STEM CELLS, V29, P678, DOI 10.1002/stem.606; Staack A, 2003, DIFFERENTIATION, V71, P402, DOI 10.1046/j.1432-0436.2003.7107004.x; Stanger BZ, 2005, P NATL ACAD SCI USA, V102, P12443, DOI 10.1073/pnas.0505690102; Wang XD, 2006, DEV BIOL, V290, P66, DOI 10.1016/j.ydbio.2005.11.009; Wang XD, 2004, J BIOL CHEM, V279, P24733, DOI 10.1074/jbc.M401602200; Wang YZ, 2001, DIFFERENTIATION, V68, P270, DOI 10.1046/j.1432-0436.2001.680414.x; Wu XY, 2011, DEV BIOL, V356, P337, DOI 10.1016/j.ydbio.2011.05.659; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; Xin L, 2003, P NATL ACAD SCI USA, V100, P11896, DOI 10.1073/pnas.1734139100; Xin L, 2007, STEM CELLS, V25, P2760, DOI 10.1634/stemcells.2007-0355; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zhao B, 2006, P NATL ACAD SCI USA, V103, P1900, DOI 10.1073/pnas.0510612103	48	65	67	1	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV 2	2012	11	5					676	688		10.1016/j.stem.2012.07.003	http://dx.doi.org/10.1016/j.stem.2012.07.003			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	042LE	23122291	Green Accepted, Bronze			2022-12-28	WOS:000311471900013
J	Troy, A; Cadwallader, AB; Fedorov, Y; Tyner, K; Tanaka, KK; Olwin, BB				Troy, Andrew; Cadwallader, Adam B.; Fedorov, Yuri; Tyner, Kristina; Tanaka, Kathleen Kelly; Olwin, Bradley B.			Coordination of Satellite Cell Activation and Self-Renewal by Par-Complex-Dependent Asymmetric Activation of p38 alpha/beta MAPK	CELL STEM CELL			English	Article							TEMPLATE DNA STRANDS; STEM-CELLS; CYTOSINE-ARABINOSIDE; PROGENITOR CELLS; MECHANISM; EXPANSION; POLARITY; DIFFERENTIATION; INHIBITION; SYNDECAN-3	In response to muscle injury, satellite cells activate the p38 alpha/beta MAPK pathway to exit quiescence, then proliferate, repair skeletal muscle, and self-renew, replenishing the quiescent satellite cell pool. Although satellite cells are capable of asymmetric division, the mechanisms regulating satellite cell self-renewal are not understood. We found that satellite cells, once activated, enter the cell cycle and a subset undergoes asymmetric division, renewing the satellite cell pool. Asymmetric localization of the Par complex activates p38 alpha/beta MAPK in only one daughter cell, inducing MyoD, which permits cell cycle entry and generates a proliferating myoblast. The absence of p38 alpha/beta MAPK signaling in the other daughter cell prevents MyoD induction, renewing the quiescent satellite cell. Thus, satellite cells employ a mechanism to generate distinct daughter cells, coupling the Par complex and p38 alpha/beta MAPK signaling to link the response to muscle injury with satellite cell self-renewal.	[Troy, Andrew; Cadwallader, Adam B.; Fedorov, Yuri; Tyner, Kristina; Tanaka, Kathleen Kelly; Olwin, Bradley B.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Olwin, BB (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	bradley.olwin@colorado.edu	Olwin, Bradley B/A-1333-2014	Kelly, Kathleen/0000-0002-1102-6279	NIH [AR049446]; Muscular Dystrophy Association; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049446] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Tiffany Antwine and Nicole Dalla Betta for technical assistance. The work was supported by grants from the NIH (AR049446) and the Muscular Dystrophy Association to B.B.O.	Aguirre-Ghiso JA, 2003, CANCER RES, V63, P1684; Bandyopadhyay G, 1999, BIOCHEM J, V337, P461, DOI 10.1042/0264-6021:3370461; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Conboy MJ, 2007, PLOS BIOL, V5, P1120, DOI 10.1371/journal.pbio.0050102; Cornelison DDW, 2001, DEV BIOL, V239, P79, DOI 10.1006/dbio.2001.0416; Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977; Doe CQ, 2001, NAT CELL BIOL, V3, pE7, DOI 10.1038/35050684; FURTH JJ, 1968, CANCER RES, V28, P2061; Giebel B, 2008, CURR STEM CELL RES T, V3, P9, DOI 10.2174/157488808783489444; Hall JK, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001081; Jones NC, 2005, J CELL BIOL, V169, P105, DOI 10.1083/jcb.200408066; Kampfer S, 1998, EMBO J, V17, P4046, DOI 10.1093/emboj/17.14.4046; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Lin HF, 2008, J CELL BIOL, V180, P257, DOI 10.1083/jcb.200712159; Lyons AB, 1999, IMMUNOL CELL BIOL, V77, P509, DOI 10.1046/j.1440-1711.1999.00864.x; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Olguin HC, 2007, J CELL BIOL, V177, P769, DOI 10.1083/jcb.200608122; PARK JK, 1991, LIFE SCI, V48, P1255; Pisconti A, 2010, J CELL BIOL, V190, P427, DOI 10.1083/jcb.201003081; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; SCHULTZ E, 1984, ANAT REC, V208, P501, DOI 10.1002/ar.1092080405; SCHULTZ E, 1994, REV PHYSIOL BIOCH P, V123, P213, DOI 10.1007/BFb0030904; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Sekizawa K, 2007, MUTAT RES-FUND MOL M, V619, P1, DOI 10.1016/j.mrfmmm.2006.09.011; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Tabuse Y, 1998, DEVELOPMENT, V125, P3607; Tanaka KK, 2009, CELL STEM CELL, V4, P217, DOI 10.1016/j.stem.2009.01.016; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; vanLeeuwen FN, 1995, ONCOGENE, V11, P2215; YABLONKAREUVENI Z, 1994, DEV BIOL, V164, P588, DOI 10.1006/dbio.1994.1226; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007; ZDUNSKI D, 1980, CELL DIFFER DEV, V9, P181, DOI 10.1016/0045-6039(80)90042-1; Zhang KM, 2010, J CELL BIOL, V188, P39, DOI 10.1083/jcb.200904144; Zhang YV, 2009, CELL STEM CELL, V5, P267, DOI 10.1016/j.stem.2009.06.004	42	165	174	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 5	2012	11	4					541	553		10.1016/j.stem.2012.05.025	http://dx.doi.org/10.1016/j.stem.2012.05.025			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	021OZ	23040480	Green Accepted, Bronze			2022-12-28	WOS:000309896500014
J	Li, XZ; Li, L; Pandey, R; Byun, JS; Gardner, K; Qin, ZH; Dou, YL				Li, Xiangzhi; Li, Li; Pandey, Ruchi; Byun, Jung S.; Gardner, Kevin; Qin, Zhaohui; Dou, Yali			The Histone Acetyltransferase MOF Is a Key Regulator of the Embryonic Stem Cell Core Transcriptional Network	CELL STEM CELL			English	Article							SELF-RENEWAL; DOSAGE COMPENSATION; ES CELLS; CHROMATIN-STRUCTURE; H4-K16 ACETYLATION; PLURIPOTENCY; NANOG; DIFFERENTIATION; METHYLATION; DROSOPHILA	Pluripotent embryonic stem cells (ESCs) maintain self-renewal and the potential for rapid response to differentiation cues. Both ESC features are subject to epigenetic regulation. Here we show that the histone acetyltransferase Mof plays an essential role in the maintenance of ESC self-renewal and pluripotency. ESCs with Mof deletion lose characteristic morphology, alkaline phosphatase (AP) staining, and differentiation potential. They also have aberrant expression of the core transcription factors Nanog, Oct4, and Sox2. Importantly, the phenotypes of Mof null ESCs can be partially suppressed by Nanog overexpression, supporting the idea that Mof functions as an upstream regulator of Nanog in ESCs. Genome-wide ChIP-sequencing and transcriptome analyses further demonstrate that Mof is an integral component of the ESC core transcriptional network and that Mof primes genes for diverse developmental programs. Mof is also required for Wdr5 recruitment and H3K4 methylation at key regulatory loci, highlighting the complexity and interconnectivity of various chromatin regulators in ESCs.	[Li, Xiangzhi; Pandey, Ruchi; Dou, Yali] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Dou, Yali] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Li, Xiangzhi] Shandong Univ, Sch Med, Inst Cell Biol, Jinan 250100, Shandong, Peoples R China; [Li, Li; Qin, Zhaohui] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Byun, Jung S.; Gardner, Kevin] NIH, Gene Express Lab, Bethesda, MD 20892 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Shandong University; Emory University; Rollins School Public Health; National Institutes of Health (NIH) - USA	Dou, YL (corresponding author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.	yalid@umich.edu	Qin, Zhaohui/Q-3133-2019; Pandey, Ruchi/D-2882-2013	Qin, Zhaohui/0000-0002-1583-146X; Pandey, Ruchi/0000-0001-6417-0971; Byun, Jung Shin/0000-0001-9049-9594	NIGMS [R01GM082856]; American Cancer Society [RSG 117573]; NHGRI [R01HG005119]; NSFC [31171428]; NATIONAL CANCER INSTITUTE [ZIABC010846, ZIABC010847] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082856] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Cancer Society(American Cancer Society); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NSFC(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Yi Zhang for the anti-Nanog antibody and the Nanog expression vector. This work is supported by NIGMS (R01GM082856) and American Cancer Society (RSG 117573) grants to Y.D., NHGRI (R01HG005119) grant to Z.Q., and NSFC (31171428) grant to X.L.	Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Aoto T, 2006, DEV BIOL, V298, P354, DOI 10.1016/j.ydbio.2006.04.450; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Byun JS, 2009, P NATL ACAD SCI USA, V106, P19292, DOI 10.1073/pnas.0905469106; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Conrad T, 2012, NAT REV GENET, V13, P123, DOI 10.1038/nrg3124; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Feng B, 2009, CELL STEM CELL, V4, P301, DOI 10.1016/j.stem.2009.03.005; Fischer T, 2011, DEV BIOL, V350, P496, DOI 10.1016/j.ydbio.2010.12.017; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Gelbart ME, 2009, DEVELOPMENT, V136, P1399, DOI 10.1242/dev.029645; Gupta A, 2008, MOL CELL BIOL, V28, P397, DOI 10.1128/MCB.01045-07; Isakoff MS, 2005, P NATL ACAD SCI USA, V102, P17745, DOI 10.1073/pnas.0509014102; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jiang H, 2011, CELL, V144, P513, DOI 10.1016/j.cell.2011.01.020; Kind J, 2008, CELL, V133, P813, DOI 10.1016/j.cell.2008.04.036; Kobayakawa S, 2007, GENES CELLS, V12, P447, DOI 10.1111/j.1365-2443.2007.01063.x; Li X., 2010, EPIGENETICS, V5, P5; Li XZ, 2010, MOL CELL BIOL, V30, P5335, DOI 10.1128/MCB.00350-10; Li XZ, 2009, MOL CELL, V36, P290, DOI 10.1016/j.molcel.2009.07.031; Lin W, 2007, DEV DYNAM, V236, P1547, DOI 10.1002/dvdy.21160; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lucchesi JC, 2005, ANNU REV GENET, V39, P615, DOI 10.1146/annurev.genet.39.073003.094210; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; Meshorer E, 2007, HISTOL HISTOPATHOL, V22, P311, DOI 10.14670/HH-22.311; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2007, GENE DEV, V21, P2071, DOI 10.1101/gad.1615707; Orkin SH, 2008, COLD SH Q B, V73, P195, DOI 10.1101/sqb.2008.72.001; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Park SH, 2004, ULTRASTRUCT PATHOL, V28, P229, DOI 10.1080/01913120490515595; Prestel M, 2010, MOL CELL, V38, P815, DOI 10.1016/j.molcel.2010.05.022; Qin ZHS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-369; Robinson PJJ, 2008, J MOL BIOL, V381, P816, DOI 10.1016/j.jmb.2008.04.050; Ruthenburg AJ, 2011, CELL, V145, P692, DOI 10.1016/j.cell.2011.03.053; Schiemann AH, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-80; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Thomas T, 2008, MOL CELL BIOL, V28, P5093, DOI 10.1128/MCB.02202-07; Ura H, 2011, EMBO J, V30, P2190, DOI 10.1038/emboj.2011.126; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wu LP, 2011, MOL CELL, V43, P132, DOI 10.1016/j.molcel.2011.05.015; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhong XM, 2009, J BIOL CHEM, V284, P9168, DOI 10.1074/jbc.M805562200; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	53	135	140	2	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 3	2012	11	2					163	178		10.1016/j.stem.2012.04.023	http://dx.doi.org/10.1016/j.stem.2012.04.023			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	987QQ	22862943	Green Accepted, Bronze			2022-12-28	WOS:000307432600008
J	Guenther, MG; Young, RA				Guenther, Matthew G.; Young, Richard A.			Grounded: Transcriptional Pausing in Naive mESCs	CELL STEM CELL			English	Editorial Material							MOUSE EMBRYOS; CELLS		[Guenther, Matthew G.; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	young@wi.mit.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647				De Los Angeles A., 2012, CURR OPIN G IN PRESS, DOI [10.1016/j.gde.2012.03.00, DOI 10.1016/J.GDE.2012.03.00]; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	10	2	2	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAY 4	2012	10	5					484	485		10.1016/j.stem.2012.04.016	http://dx.doi.org/10.1016/j.stem.2012.04.016			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	944WN	22560069	Bronze, Green Published			2022-12-28	WOS:000304234600003
J	Graf, T				Graf, Thomas			Historical Origins of Transdifferentiation and Reprogramming	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; DEPENDENT DNA-POLYMERASE; CHICKEN ERYTHROID-CELLS; E26 LEUKEMIA-VIRUS; LINEAGE COMMITMENT; T-CELLS; B-CELLS; HEMATOPOIETIC-CELLS; DIRECT CONVERSION; MYELOID-LEUKEMIA	Transcription factor-induced reprogramming of specialized cells into other cell types and to pluripotency has revolutionized our thinking about cell plasticity, differentiation, and stem cells. The recent advances in this area were enabled by the confluence of a number of experimental breakthroughs that took place over the past 60 years. In this article, I give a historical and personal perspective of the events that set the stage for our current understanding of cellular reprogramming.	[Graf, Thomas] Ctr Genom Regulat, Barcelona 08003, Spain; [Graf, Thomas] Pompeu Fabra Univ, Barcelona 08003, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University	Graf, T (corresponding author), Ctr Genom Regulat, Barcelona 08003, Spain.	thomas.graf@crg.es	Graf, Thomas/B-4252-2015	Graf, Thomas/0000-0003-2774-4117	Ministerio de Ciencia e Inovacion [SAF2007-63058]	Ministerio de Ciencia e Inovacion(Spanish Government)	This review is dedicated to Hartmut Beug (1945-2011). I would also like to thank Konrad Hochedlinger, Mark Ptashne, Matthias Stadtfeld, Helen Blau, Stephen Tapscott, Timm Schroeder, Andrew Lassar, Meinrad Busslinger, Rudolf Jaenisch, Tariq Enver, Denis Thieffry, Pura Munoz, Pia Cosma, Salvador Aznar Benitah, and my coworkers for comments, anecdotes, and materials. This work was supported by the Ministerio de Ciencia e Inovacion, SAF2007-63058.	Arber N, 1997, CANCER RES, V57, P1569; BALTIMORE D, 1970, NATURE, V226, P1209, DOI 10.1038/2261209a0; BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; BEUG H, 1984, CELL, V39, P579, DOI 10.1016/0092-8674(84)90465-3; BEUG H, 1987, GENE DEV, V1, P277, DOI 10.1101/gad.1.3.277; BLAU HM, 1991, J CELL BIOL, V112, P781, DOI 10.1083/jcb.112.5.781; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; BRIGGS R, 1952, P NATL ACAD SCI USA, V38, P455, DOI 10.1073/pnas.38.5.455; Bussmann LH, 2009, CELL STEM CELL, V5, P554, DOI 10.1016/j.stem.2009.10.004; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CEPKO CL, 1984, CELL, V37, P1053, DOI 10.1016/0092-8674(84)90440-9; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Di Tullio A, 2011, P NATL ACAD SCI USA, V108, P17016, DOI 10.1073/pnas.1112169108; Egli D, 2007, NATURE, V447, P679, DOI 10.1038/nature05879; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Enver T, 1998, BLOOD, V92, P348, DOI 10.1182/blood.V92.2.348.Con3_348_351; Evans M, 2011, NAT REV MOL CELL BIO, V12, P680, DOI 10.1038/nrm3190; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Frykberg L, 1988, Oncogene Res, V3, P313; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; GRAF T, 1992, CELL, V70, P201, DOI 10.1016/0092-8674(92)90096-U; GRAF T, 1978, NATURE, V275, P496, DOI 10.1038/275496a0; Graf T, 2002, BLOOD, V99, P3089, DOI 10.1182/blood.V99.9.3089; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; GURDON JB, 1958, NATURE, V182, P64, DOI 10.1038/182064a0; Gurdon JB, 2003, P NATL ACAD SCI USA, V100, P8048, DOI 10.1073/pnas.1337135100; GURDON JB, 1966, NATURE, V210, P1240, DOI 10.1038/2101240a0; HADORN E, 1968, SCI AM, V219, P110, DOI 10.1038/scientificamerican1168-110; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Han JY, 2010, NATURE, V463, P1096, DOI 10.1038/nature08735; HARRIS H, 1965, NATURE, V205, P640, DOI 10.1038/205640a0; Heyworth C, 2002, EMBO J, V21, P3770, DOI 10.1093/emboj/cdf368; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; INTRONA M, 1990, CELL, V63, P1287, DOI 10.1016/0092-8674(90)90424-D; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; JAENISCH R, 1976, P NATL ACAD SCI USA, V73, P1260, DOI 10.1073/pnas.73.4.1260; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Jones P, 2011, NAT CELL BIOL, V13, P2, DOI 10.1038/ncb0111-2; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; KING TJ, 1955, P NATL ACAD SCI USA, V41, P321, DOI 10.1073/pnas.41.5.321; KLEINSMITH LJ, 1964, CANCER RES, V24, P1544; KOLLER BH, 1989, P NATL ACAD SCI USA, V86, P8932, DOI 10.1073/pnas.86.22.8932; Kondo M, 2000, NATURE, V407, P383, DOI 10.1038/35030112; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; LASSAR AB, 1986, CELL, V47, P649, DOI 10.1016/0092-8674(86)90507-6; LEVIMONTALCINI R, 1951, J EXP ZOOL, V116, P321, DOI 10.1002/jez.1401160206; Li L, 2010, SCIENCE, V329, P89, DOI 10.1126/science.1188989; Li P, 2010, SCIENCE, V329, P85, DOI 10.1126/science.1188063; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Marro S, 2011, CELL STEM CELL, V9, P374, DOI 10.1016/j.stem.2011.09.002; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Maves L, 2003, CURR OPIN GENET DEV, V13, P472, DOI 10.1016/j.gde.2003.08.006; MCGRATH J, 1984, SCIENCE, V226, P1317, DOI 10.1126/science.6542249; Metcalf D, 1998, BLOOD, V92, P345, DOI 10.1182/blood.V92.2.345b.Con2_345_347; METZ T, 1991, GENE DEV, V5, P369, DOI 10.1101/gad.5.3.369; MILLER RA, 1976, CELL, V9, P45, DOI 10.1016/0092-8674(76)90051-9; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; NAGY A, 1990, DEVELOPMENT, V110, P815; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; NESS SA, 1987, CELL, V51, P41, DOI 10.1016/0092-8674(87)90008-0; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Noggle S, 2011, NATURE, V478, P70, DOI 10.1038/nature10397; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; ORKIN SH, 1990, CELL, V63, P665, DOI 10.1016/0092-8674(90)90133-Y; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; PICARD D, 1988, CELL, V54, P1073, DOI 10.1016/0092-8674(88)90122-5; Piccolo FM, 2011, PHILOS T R SOC B, V366, P2260, DOI 10.1098/rstb.2011.0004; PTASHNE M, 1967, NATURE, V214, P232, DOI 10.1038/214232a0; Ptashne M, 2011, NAT CHEM BIOL, V7, P484, DOI 10.1038/nchembio.611; Rieger MA, 2009, SCIENCE, V325, P217, DOI 10.1126/science.1171461; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; ROUSSEL M, 1979, NATURE, V281, P452, DOI 10.1038/281452a0; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Slack JMW, 2007, NAT REV MOL CELL BIO, V8, P369, DOI 10.1038/nrm2146; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stadtfeld M, 2005, DEVELOPMENT, V132, P203, DOI 10.1242/dev.01558; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Stadtfeld M, 2010, NAT METHODS, V7, P53, DOI [10.1038/NMETH.1409, 10.1038/nmeth.1409]; STEHELIN D, 1976, NATURE, V260, P170, DOI 10.1038/260170a0; Sterneckert J, 2012, STEM CELLS, V30, P15, DOI 10.1002/stem.765; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; TEMIN HM, 1970, NATURE, V226, P1211, DOI 10.1038/2261211a0; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; URSPRUNG H, 1962, DEV BIOL, V4, P40, DOI 10.1016/0012-1606(62)90032-5; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; WEINTRAUB H, 1982, CELL, V28, P931, DOI 10.1016/0092-8674(82)90072-1; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wouters BJ, 2009, BLOOD, V113, P3088, DOI 10.1182/blood-2008-09-179895; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang N, 2011, CELL STEM CELL, V9, P517, DOI 10.1016/j.stem.2011.11.015; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zinyk DL, 1998, CURR BIOL, V8, P665, DOI 10.1016/S0960-9822(98)70255-6; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	132	135	145	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 2	2011	9	6					504	516		10.1016/j.stem.2011.11.012	http://dx.doi.org/10.1016/j.stem.2011.11.012			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	859SB	22136926	Bronze			2022-12-28	WOS:000297895000011
J	Loeffler, D; Kokkaliaris, KD; Schroeder, T				Loeffler, Dirk; Kokkaliaris, Konstantinos D.; Schroeder, Timm			Wnt to Notch Relay Signaling Induces Definitive Hematopoiesis	CELL STEM CELL			English	Editorial Material							STEM-CELLS; ENDOTHELIUM; ZEBRAFISH	The molecular mechanisms specifying hematopoietic stem cells (HSCs) in the vertebrate embryo remain poorly understood. Recently in Nature, Traver and colleagues demonstrate that timed wnt to Notch relay signaling across multiple cell types serves as an early upstream mechanism of HSC induction in zebrafish (Clements et al., 2011).	[Loeffler, Dirk; Kokkaliaris, Konstantinos D.; Schroeder, Timm] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Res Unit Stem Cell Dynam, D-85764 Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Schroeder, T (corresponding author), German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Res Unit Stem Cell Dynam, Landstr 1, D-85764 Neuherberg, Germany.	timm.schroeder@helmholtz-muenchen.de	Schroeder, Timm/F-8448-2010; Kokkaliaris, Konstantinos/GWQ-3400-2022	Schroeder, Timm/0000-0001-9320-0252; Loeffler, Dirk/0000-0001-9870-0088; KOKKALIARIS, KONSTANTINOS/0000-0002-9952-3463				Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Cerdan C, 2010, INT J DEV BIOL, V54, P955, DOI 10.1387/ijdb.103067cc; Chiang PM, 2011, DEVELOPMENT, V138, P2833, DOI 10.1242/dev.061440; Ciau-Uitz A, 2010, INT J DEV BIOL, V54, P1139, DOI 10.1387/ijdb.093055ac; Clements WK, 2011, NATURE, V474, P220, DOI 10.1038/nature10107; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Maillard I, 2008, CELL STEM CELL, V2, P356, DOI 10.1016/j.stem.2008.02.011; Malhotra S, 2009, CELL STEM CELL, V4, P27, DOI 10.1016/j.stem.2008.12.004; Paik EJ, 2010, INT J DEV BIOL, V54, P1127, DOI 10.1387/ijdb.093042ep; Wright GJ, 2011, DEVELOPMENT, V138, P2947, DOI 10.1242/dev.066654	10	6	7	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUL 8	2011	9	1					2	4		10.1016/j.stem.2011.06.011	http://dx.doi.org/10.1016/j.stem.2011.06.011			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	797VA	21726826	Bronze			2022-12-28	WOS:000293157000002
J	Panman, L; Andersson, E; Alekseenko, Z; Hedlund, E; Kee, N; Mong, J; Uhde, CW; Deng, QL; Sandberg, R; Stanton, LW; Ericson, J; Perlmann, T				Panman, Lia; Andersson, Elisabet; Alekseenko, Zhanna; Hedlund, Eva; Kee, Nigel; Mong, Jamie; Uhde, Christopher W.; Deng, Qiaolin; Sandberg, Rickard; Stanton, Lawrence W.; Ericson, Johan; Perlmann, Thomas			Transcription Factor-Induced Lineage Selection of Stem-Cell-Derived Neural Progenitor Cells	CELL STEM CELL			English	Article							DOPAMINERGIC-NEURONS; SONIC HEDGEHOG; MOTOR-NEURON; DIRECTED DIFFERENTIATION; VENTRAL MESENCEPHALON; PARKINSONS-DISEASE; DEFINED FACTORS; SPINAL-CORD; IN-VITRO; IDENTITY	The generation of specific types of neurons from stem cells offers important opportunities in regenerative medicine. However, future applications and proper verification of cell identities will require stringent ways to generate homogeneous neuronal cultures. Here we show that transcription factors like Lmx1a, Phox2b, Nkx2.2, and Olig2 can induce desired neuronal lineages from most expressing neural progenitor cells by a mechanism resembling developmental binary cell-fate switching. Such efficient selection of cell fate resulted in remarkable cellular enrichment that enabled global gene-expression validation of generated neurons and identification of previously unrecognized features in the studied cell lineages. Several sources of stem cells have a limited competence to differentiate into specific neuronal cell types; e.g., dopamine neurons. However, we show that the combination of factors that normally promote either regional or dedicated neuronal specification can overcome limitations in cellular competence and also promote efficient reprogramming in more remote neural contexts, including human neural progenitor cells.	[Andersson, Elisabet; Alekseenko, Zhanna; Kee, Nigel; Mong, Jamie; Uhde, Christopher W.; Deng, Qiaolin; Sandberg, Rickard; Ericson, Johan; Perlmann, Thomas] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Panman, Lia; Hedlund, Eva; Kee, Nigel; Mong, Jamie; Sandberg, Rickard; Perlmann, Thomas] Ludwig Inst Canc Res, S-17177 Stockholm, Sweden; [Mong, Jamie; Stanton, Lawrence W.] Genome Inst Singapore, Singapore 138672, Singapore	Karolinska Institutet; Ludwig Institute for Cancer Research; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Ericson, J (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden.	johan.ericson@ki.se; thomas.perlmann@licr.ki.se	Deng, Qiaolin/AAD-6905-2020; Mong, Jamie/AFU-5649-2022	Deng, Qiaolin/0000-0001-5934-7816; Sandberg, Rickard/0000-0001-6473-1740; Hedlund, Eva/0000-0001-6347-0075; Alekseenko, Zhanna/0000-0002-6560-9699; andersson, elisabet/0000-0003-3095-465X; Ericson, Johan/0000-0002-8019-7127; Mong, Jamie/0000-0003-0312-4482; Kee, Nigel/0000-0002-7095-0760	Wennergren stiftelsen; European Union [222943, 222999]; Knut och Alice Wallenberg Foundation; Michael J. Fox Foundation for Parkinson's Research; Vetenskapsradet; Goran Gustafssons Stiftelse; Swedish Foundation for Strategic Research	Wennergren stiftelsen; European Union(European Commission); Knut och Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Michael J. Fox Foundation for Parkinson's Research; Vetenskapsradet(Swedish Research Council); Goran Gustafssons Stiftelse; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	We are grateful to S. Friling and C.Y. Leung for valuable experimental help and discussions and members of the Ericson and Perlmann laboratories for discussions. This work was supported by funding from the Wennergren stiftelsen (L.P.); European Union, seventh framework programme under the grant agreements NEuroStemCell (grant 222943 to T.P. and J.E.) and mdDANeurodev (grant 222999 to T.P.); Knut och Alice Wallenberg Foundation (J.E. and T.P.); the Michael J. Fox Foundation for Parkinson's Research (J.E. and T.P.); Vetenskapsradet via support to the Linne Center for Developmental Biology and Regenerative Medicine, Vetenskapsradet (J.E. and T.P.); Goran Gustafssons Stiftelse; and Swedish Foundation for Strategic Research (J.E.).	Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Caldwell MA, 2001, NAT BIOTECHNOL, V19, P475, DOI 10.1038/88158; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chung S, 2006, STEM CELLS, V24, P1583, DOI 10.1634/stemcells.2005-0558; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dessaud E, 2008, DEVELOPMENT, V135, P2489, DOI 10.1242/dev.009324; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Du ZW, 2006, MOL CELL NEUROSCI, V33, P371, DOI 10.1016/j.mcn.2006.08.007; Dubreuil V, 2000, DEVELOPMENT, V127, P5191; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Friling S, 2009, P NATL ACAD SCI USA, V106, P7613, DOI 10.1073/pnas.0902396106; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hedlund E, 2009, J INTERN MED, V266, P358, DOI 10.1111/j.1365-2796.2009.02155.x; HYNES M, 1995, NEURON, V15, P35, DOI 10.1016/0896-6273(95)90062-4; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jacob J, 2007, NAT NEUROSCI, V10, P1433, DOI 10.1038/nn1985; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Lee H, 2007, STEM CELLS, V25, P1931, DOI 10.1634/stemcells.2007-0097; Liu AM, 2001, ANNU REV NEUROSCI, V24, P869, DOI 10.1146/annurev.neuro.24.1.869; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Niederreither K, 2000, DEVELOPMENT, V127, P75; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Okada Y, 2004, DEV BIOL, V275, P124, DOI 10.1016/j.ydbio.2004.07.038; Pattyn A, 2000, DEVELOPMENT, V127, P1349; Pattyn A, 2003, GENE DEV, V17, P729, DOI 10.1101/gad.255803; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Peljto M, 2010, CELL STEM CELL, V7, P355, DOI 10.1016/j.stem.2010.07.013; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; Prakash N, 2006, DEVELOPMENT, V133, P89, DOI 10.1242/dev.02181; Prakash N, 2006, CELL MOL LIFE SCI, V63, P187, DOI 10.1007/s00018-005-5387-6; Simeone A, 2002, CURR OPIN GENET DEV, V12, P409, DOI 10.1016/S0959-437X(02)00318-0; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Tabar V, 2005, NAT BIOTECHNOL, V23, P601, DOI 10.1038/nbt1088; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Volakakis N, 2010, P NATL ACAD SCI USA, V107, P12317, DOI 10.1073/pnas.1007088107; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; WURST W, 1994, DEVELOPMENT, V120, P2065; Wylie CJ, 2010, J NEUROSCI, V30, P670, DOI 10.1523/JNEUROSCI.4656-09.2010; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Yin M, 2009, J NEUROSCI, V29, P5170, DOI 10.1523/JNEUROSCI.5569-08.2009; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	45	48	48	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 3	2011	8	6					663	675		10.1016/j.stem.2011.04.001	http://dx.doi.org/10.1016/j.stem.2011.04.001			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	780HC	21624811	Bronze			2022-12-28	WOS:000291844100014
J	Buxbaum, JD; Sklar, P				Buxbaum, Joseph D.; Sklar, Pamela			Human Induced Pluripotent Stem Cells: A New Model for Schizophrenia?	CELL STEM CELL			English	Editorial Material								Lack of patient tissue and relevant disease models have constrained progress toward discovering the causes of schizophrenia. Recently in Nature, Brennand et al. (2011) reprogram schizophrenia patient fibroblasts to derive four iPSC lines, perform subsequent neural differentiation, and provide early insights into a novel approach that may address these issues.	[Buxbaum, Joseph D.; Sklar, Pamela] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Buxbaum, Joseph D.; Sklar, Pamela] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Buxbaum, Joseph D.; Sklar, Pamela] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Buxbaum, Joseph D.; Sklar, Pamela] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Buxbaum, JD (corresponding author), Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA.	joseph.buxbaum@mssm.edu	Buxbaum, Joseph D/G-6001-2010	Buxbaum, Joseph/0000-0001-8898-8313				Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Dean B, 2009, CURR OPIN PSYCHIATR, V22, P154, DOI 10.1097/YCO.0b013e328323d52e; Deep-Soboslay A, 2011, BIOL PSYCHIAT, V69, P104, DOI 10.1016/j.biopsych.2010.05.025; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; Koenen KC, 2009, AM J PSYCHIAT, V166, P50, DOI 10.1176/appi.ajp.2008.08030343; Owen MJ, 2010, ARCH GEN PSYCHIAT, V67, P667, DOI 10.1001/archgenpsychiatry.2010.69; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Sebat J, 2009, TRENDS GENET, V25, P528, DOI 10.1016/j.tig.2009.10.004; Takahashi N, 2011, PROG NEUROBIOL, V93, P13, DOI 10.1016/j.pneurobio.2010.09.004	9	4	6	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAY 6	2011	8	5					461	462		10.1016/j.stem.2011.04.016	http://dx.doi.org/10.1016/j.stem.2011.04.016			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	768IN	21549318	Bronze			2022-12-28	WOS:000290927600002
J	Kim, YJ; Lee, G				Kim, Yong Jun; Lee, Gabsang			Candidate ALS Therapeutics Motor toward "In Vitro Clinical Trials''	CELL STEM CELL			English	Editorial Material							STEM-CELLS	Conducting drug discovery efforts in patient- and disease-specific cells can maximize their likelihood of success. In this issue of Cell Stem Cell, Yang et al. (2013) demonstrate the power of lineage-specific cell-based drug screens by identifying a compound that promotes survival of stem-cell-derived ALS mutant motor neurons.	[Kim, Yong Jun; Lee, Gabsang] Johns Hopkins Univ, Sch Med, Dept Neurol & Neurosci, Inst Cell Engn, Baltimore, MD 21205 USA	Johns Hopkins University	Lee, G (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol & Neurosci, Inst Cell Engn, Baltimore, MD 21205 USA.	glee48@jhmi.edu		Kim, Yong Jun/0000-0002-5374-712X; Lee, Gabsang/0000-0002-5052-5927				Choi S.M., 2013, HEPATOLOGY IN PRESS, DOI DOI 10.1002/HEP.26237; Cudkowicz M, 2011, NAT MED, V17, P1652, DOI 10.1038/nm.2579; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Egawa N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004052; Kieran D, 2008, J NEUROSCI, V28, P14056, DOI 10.1523/JNEUROSCI.3399-08.2008; Lee G, 2012, NAT BIOTECHNOL, V30, P1244, DOI 10.1038/nbt.2435; Maragakis NJ, 2010, AMYOTROPH LATERAL SC, V11, P417, DOI 10.3109/17482968.2010.489116; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Yang YM, 2013, CELL STEM CELL, V12, P713, DOI 10.1016/j.stem.2013.04.003	10	8	8	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 6	2013	12	6					633	634		10.1016/j.stem.2013.05.009	http://dx.doi.org/10.1016/j.stem.2013.05.009			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VH	23746968	Bronze			2022-12-28	WOS:000329569900002
J	Pandey, R; Dou, YL				Pandey, Ruchi; Dou, Yali			H2A.Z Sets the Stage in ESCs	CELL STEM CELL			English	Editorial Material							HISTONE VARIANTS; NUCLEOSOME; STATE	ESCs undergo drastic changes in chromatin states during differentiation. Two recent papers in Cell (Li et al., 2012) and Cell Stem Cell (Hu et al., 2013) demonstrate that histone variant H2A.Z plays essential roles in this process by preconfiguring nucleosomes for depletion and recruiting transcription cofactors to cis-regulatory elements.	[Pandey, Ruchi; Dou, Yali] Univ Michigan, Dept Pathol & Biol Chem, Ann Arbor, MI 48019 USA	University of Michigan System; University of Michigan	Dou, YL (corresponding author), Univ Michigan, Dept Pathol & Biol Chem, Ann Arbor, MI 48019 USA.	yalid@umich.edu	Pandey, Ruchi/D-2882-2013	Pandey, Ruchi/0000-0001-6417-0971				Banaszynski LA, 2010, DEV CELL, V19, P662, DOI 10.1016/j.devcel.2010.10.014; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Hu GQ, 2013, CELL STEM CELL, V12, P180, DOI 10.1016/j.stem.2012.11.003; Li ZY, 2012, CELL, V151, P1608, DOI 10.1016/j.cell.2012.11.018; Luger K, 2012, NAT REV MOL CELL BIO, V13, P436, DOI 10.1038/nrm3382; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	9	9	9	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 7	2013	12	2					143	144		10.1016/j.stem.2013.01.012	http://dx.doi.org/10.1016/j.stem.2013.01.012			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VB	23395439	Bronze			2022-12-28	WOS:000329569300003
J	Perdigoto, CN; Bardot, ES; Ezhkova, E				Perdigoto, Carolina N.; Bardot, Evan S.; Ezhkova, Elena			SWItching On Epidermal Cell Fate	CELL STEM CELL			English	Editorial Material							NEURAL DEVELOPMENT; CHROMATIN; PLURIPOTENCY; COMPLEXES; SUBUNIT; SKIN	Chromatin regulatory complexes are well known regulators of stem cell fate; however, the mechanisms regulating their activity are not well understood. In this issue of Cell Stem Cell, Bao et al. (2013) show that ACTL6a inhibits targeting of the SWI/SNF complex to differentiation genes, thereby preserving the epidermal progenitor state.	[Perdigoto, Carolina N.; Bardot, Evan S.; Ezhkova, Elena] Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA; [Perdigoto, Carolina N.; Bardot, Evan S.; Ezhkova, Elena] Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Perdigoto, Carolina N.; Bardot, Evan S.; Ezhkova, Elena] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Ezhkova, E (corresponding author), Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA.	elena.ezhkova@mssm.edu		Bardot, Evan/0000-0002-0872-4957; Ezhkova, Elena/0000-0003-4154-1615	NIAMS NIH HHS [R00 AR057817, R01 AR063724] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R00AR057817, R01AR063724] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bao XM, 2013, CELL STEM CELL, V12, P193, DOI 10.1016/j.stem.2012.12.014; Hu G, 2012, CELL STEM CELL, V10, P497, DOI 10.1016/j.stem.2012.04.011; Indra AK, 2005, DEVELOPMENT, V132, P4533, DOI 10.1242/dev.02019; Krasteva V, 2012, BLOOD, V120, P4720, DOI 10.1182/blood-2012-04-427047; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Lessard JA, 2010, ANNU REV CELL DEV BI, V26, P503, DOI 10.1146/annurev-cellbio-051809-102012; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139	10	5	5	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 7	2013	12	2					141	142		10.1016/j.stem.2013.01.011	http://dx.doi.org/10.1016/j.stem.2013.01.011			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VB	23395438	Bronze, Green Accepted			2022-12-28	WOS:000329569300002
J	Mason, C; McCall, MJ; Culme-Seymour, EJ; Suthasan, S; Edwards-Parton, S; Bonfiglio, GA; Reeve, BC				Mason, Chris; McCall, Mark J.; Culme-Seymour, Emily J.; Suthasan, Shalini; Edwards-Parton, Simon; Bonfiglio, Gregory A.; Reeve, Brock C.			The Global Cell Therapy Industry Continues to Rise during the Second and Third Quarters of 2012	CELL STEM CELL			English	Editorial Material							SIGNALS	During Q2-Q3 2012, the cell therapy industry benefited from a number of positive external influences including advantageous changes to future FDA regulation, but stock market activity was highly mixed. The FDA approved two more products and an appreciable number of public-company-sponsored clinical trials are progressing through phases 1-3.	[Mason, Chris; Suthasan, Shalini; Edwards-Parton, Simon] UCL, Adv Ctr Biochem Engn, London WC1E 6BT, England; [McCall, Mark J.] Univ Loughborough, Ctr Biol Engn, Loughborough LE11 3TU, Leics, England; [Culme-Seymour, Emily J.] London Regenerat Med Network, London EC1R 0DP, England; [Bonfiglio, Gregory A.] Proteus Venture Partners, Portola Valley, CA 94028 USA; [Bonfiglio, Gregory A.] Ctr Commercializat Regenerat Med, Toronto, ON M5G 1L5, Canada; [Reeve, Brock C.] Holyoke Ctr, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	University of London; University College London; Loughborough University; Harvard University	Mason, C (corresponding author), UCL, Adv Ctr Biochem Engn, Torrington Pl, London WC1E 6BT, England.	chris.mason@ucl.ac.uk		McCall, Mark/0000-0002-8606-5280				Brindley DA, 2012, REGEN MED, V7, P7, DOI [10.2217/rme.11.112, 10.2217/RME.11.112]; Brindley DA, 2011, CELL STEM CELL, V9, P397, DOI 10.1016/j.stem.2011.10.010; Fox JL, 2012, NAT BIOTECHNOL, V30, P733, DOI 10.1038/nbt0812-733; Fox JL, 2012, NAT BIOTECHNOL, V30, P306, DOI 10.1038/nbt.2175; McKernan R, 2010, CELL STEM CELL, V6, P517, DOI 10.1016/j.stem.2010.05.012; Schmidt C, 2012, NAT BIOTECHNOL, V30, P479, DOI 10.1038/nbt0612-479; Trounson Alan, 2012, Nat Rev Drug Discov, V11, P512, DOI 10.1038/nrd3769; Yang W, 2012, NAT BIOTECHNOL, V30, P738, DOI 10.1038/nbt.2332	8	17	17	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	DEC 7	2012	11	6					735	739		10.1016/j.stem.2012.11.013	http://dx.doi.org/10.1016/j.stem.2012.11.013			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	055MJ	23217418	Bronze			2022-12-28	WOS:000312420300005
J	Oshimori, N; Fuchs, E				Oshimori, Naoki; Fuchs, Elaine			The Harmonies Played by TGF-beta in Stem Cell Biology	CELL STEM CELL			English	Review							HUMAN EMBRYONIC STEM; GROWTH-FACTOR-BETA; HEMATOPOIETIC STEM/PROGENITOR CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; BONE-MARROW NICHE; HAIR FOLLICLE; SELF-RENEWAL; INITIATING CELLS; IN-VIVO; MOUSE EMBRYO	To rejuvenate tissues and/or repair wounds, stem cells must receive extrinsic signals from their surrounding environment and integrate them with their intrinsic abilities to self-renew and differentiate to make tissues. Increasing evidence suggests that the superfamily of transforming growth factor-beta s (TGF-beta s) constitute integral components in the intercellular crosstalk between stem cells and their microenvironment. In this review, we summarize recent advances in our understanding of TGF-beta superfamily functions in embryonic and adult stem cells. We discuss how these pathways help to define the physiological environment where stem cells reside, and how perturbations in the signaling circuitry contribute to cancers.	[Oshimori, Naoki; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016		Japan Society for the Promotion of Science; National Institutes of Health [R01-AR050452, R01-AR31737]; Emerald Foundation; Human Frontier Science Program (HFSP); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050452, R01AR031737] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emerald Foundation; Human Frontier Science Program (HFSP)(Human Frontier Science Program); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank S. Beronja and Y.C. Hsu for valuable discussions. N.O. was supported by the Human Frontier Science Program (HFSP) and is currently supported by the Japan Society for the Promotion of Science. E.F. is an investigator of the Howard Hughes Medical Institute. The authors' research that led up to this review was supported by grants to E.F. from National Institutes of Health (R01-AR050452 and R01-AR31737) and the Emerald Foundation.	Agricola E, 2011, MOL CELL, V43, P85, DOI 10.1016/j.molcel.2011.05.020; Akhurst RJ, 2006, CURR OPIN INVEST DR, V7, P513; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Besser D, 2004, J BIOL CHEM, V279, P45076, DOI 10.1074/jbc.M404979200; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Botchkarev VA, 2001, FASEB J, V15, P2205, DOI 10.1096/fj.01-0207com; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Brownell I, 2011, CELL STEM CELL, V8, P552, DOI 10.1016/j.stem.2011.02.021; Camus A, 2006, DEV BIOL, V295, P743, DOI 10.1016/j.ydbio.2006.03.047; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chang CB, 2003, DEV BIOL, V255, P1, DOI 10.1016/S0012-1606(02)00075-1; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Chen T, 2012, NATURE, V485, P104, DOI 10.1038/nature10940; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Chng ZZ, 2010, CELL STEM CELL, V6, P59, DOI 10.1016/j.stem.2009.11.015; Christophersen NS, 2010, J EXP MED, V207, P2287, DOI 10.1084/jem.20101438; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; CONLON FL, 1994, DEVELOPMENT, V120, P1919; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Dahle O, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000841; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; DERYNCK R, 1994, TRENDS BIOCHEM SCI, V19, P548, DOI 10.1016/0968-0004(94)90059-0; Derynck R., 2008, TGF BETA FAMILY; Descargues P, 2008, P NATL ACAD SCI USA, V105, P2487, DOI 10.1073/pnas.0712044105; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Dunn NR, 2004, DEVELOPMENT, V131, P1717, DOI 10.1242/dev.01072; Dupont S, 2005, CELL, V121, P87, DOI 10.1016/j.cell.2005.01.033; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Enshell-Seijffers D, 2010, DEV CELL, V18, P633, DOI 10.1016/j.devcel.2010.01.016; Evans M, 2011, NAT REV MOL CELL BIO, V12, P680, DOI 10.1038/nrm3190; Falk S, 2008, CELL STEM CELL, V2, P472, DOI 10.1016/j.stem.2008.03.006; Festa E, 2011, CELL, V146, P761, DOI 10.1016/j.cell.2011.07.019; Fortunel N, 2000, STEM CELLS, V18, P102, DOI 10.1634/stemcells.18-2-102; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Fujiwara H, 2011, CELL, V144, P577, DOI 10.1016/j.cell.2011.01.014; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; GRAY AM, 1990, SCIENCE, V247, P1328, DOI 10.1126/science.2315700; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Guasch G, 2007, CANCER CELL, V12, P313, DOI 10.1016/j.ccr.2007.08.020; Hattiangady B, 2008, NEUROBIOL AGING, V29, P129, DOI 10.1016/j.neurobiolaging.2006.09.015; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Hsu YC, 2012, NAT REV MOL CELL BIO, V13, P103, DOI 10.1038/nrm3272; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Katagiri T, 2002, GENES CELLS, V7, P949, DOI 10.1046/j.1365-2443.2002.00573.x; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim M, 2003, ANN NY ACAD SCI, V996, P195, DOI 10.1111/j.1749-6632.2003.tb03247.x; Kim SW, 2011, DEV BIOL, V357, P492, DOI 10.1016/j.ydbio.2011.06.009; Kobielak K, 2003, J CELL BIOL, V163, P609, DOI 10.1083/jcb.200309042; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kulessa H, 2000, EMBO J, V19, P6664, DOI 10.1093/emboj/19.24.6664; Lapraz F, 2006, DEV BIOL, V300, P132, DOI 10.1016/j.ydbio.2006.08.048; Lee J, 2008, CANCER CELL, V13, P69, DOI 10.1016/j.ccr.2007.12.005; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li ZW, 2012, CELL STEM CELL, V10, P171, DOI 10.1016/j.stem.2011.12.016; Lien WH, 2011, CELL STEM CELL, V9, P219, DOI 10.1016/j.stem.2011.07.015; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2012, FEBS LETT, V586, P1953, DOI 10.1016/j.febslet.2012.03.023; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; McLean GW, 2004, GENE DEV, V18, P2998, DOI 10.1101/gad.316304; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Mira H, 2010, CELL STEM CELL, V7, P78, DOI 10.1016/j.stem.2010.04.016; Morikawa M, 2011, NUCLEIC ACIDS RES, V39, P8712, DOI 10.1093/nar/gkr572; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Munger JS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005017; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Nishimura EK, 2010, CELL STEM CELL, V6, P130, DOI 10.1016/j.stem.2009.12.010; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Oshimori N, 2012, CELL STEM CELL, V10, P63, DOI 10.1016/j.stem.2011.11.005; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Penuelas S, 2009, CANCER CELL, V15, P315, DOI 10.1016/j.ccr.2009.02.011; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Qi XX, 2004, P NATL ACAD SCI USA, V101, P6027, DOI 10.1073/pnas.0401367101; Rabbani P, 2011, CELL, V145, P941, DOI 10.1016/j.cell.2011.05.004; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; Ross S, 2006, EMBO J, V25, P4490, DOI 10.1038/sj.emboj.7601332; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Schober M, 2011, P NATL ACAD SCI USA, V108, P10544, DOI 10.1073/pnas.1107807108; Sengle G, 2011, J BIOL CHEM, V286, P5087, DOI 10.1074/jbc.M110.188615; Seoane J, 2008, CLIN TRANSL ONCOL, V10, P14, DOI 10.1007/s12094-008-0148-2; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Sieburg HB, 2006, BLOOD, V107, P2311, DOI 10.1182/blood-2005-07-2970; Singh AM, 2012, CELL STEM CELL, V10, P312, DOI 10.1016/j.stem.2012.01.014; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; SMITH LG, 1991, P NATL ACAD SCI USA, V88, P2788, DOI 10.1073/pnas.88.7.2788; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Sumi T, 2008, DEVELOPMENT, V135, P2969, DOI 10.1242/dev.021121; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Trompouki E, 2011, CELL, V147, P577, DOI 10.1016/j.cell.2011.09.044; Tsujimura T, 2006, J ORTHOP SCI, V11, P185, DOI 10.1007/s00776-005-0991-8; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Valdez JM, 2012, CELL STEM CELL, V11, P676, DOI 10.1016/j.stem.2012.07.003; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Wang H, 2010, DEV CELL, V18, P643, DOI 10.1016/j.devcel.2010.02.008; Wang LD, 2011, NAT REV MOL CELL BIO, V12, P643, DOI 10.1038/nrm3184; Wilkes MC, 2003, MOL CELL BIOL, V23, P8878, DOI 10.1128/MCB.23.23.8878-8889.2003; WILLIAMS PE, 1971, J CELL SCI, V9, P751; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Xi QR, 2011, CELL, V147, P1511, DOI 10.1016/j.cell.2011.11.032; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yamazaki S, 2006, EMBO J, V25, P3515, DOI 10.1038/sj.emboj.7601236; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Yamazaki S, 2009, BLOOD, V113, P1250, DOI 10.1182/blood-2008-04-146480; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zhang JW, 2006, STEM CELLS, V24, P2826, DOI 10.1634/stemcells.2005-0544; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhang PB, 2008, BLOOD, V111, P1933, DOI 10.1182/blood-2007-02-074120; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zorn AM, 2007, INT REV CYTOL, V259, P49, DOI 10.1016/S0074-7696(06)59002-3	155	140	144	0	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 7	2012	11	6					751	764		10.1016/j.stem.2012.11.001	http://dx.doi.org/10.1016/j.stem.2012.11.001			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	055MJ	23217421	Green Accepted, Bronze			2022-12-28	WOS:000312420300008
J	Dumitriu, B; Young, NS				Dumitriu, Bogdan; Young, Neal S.			Damage Control and Its Costs: BM Failure in Fanconi Anemia Stems from Overactive p53/p21	CELL STEM CELL			English	Editorial Material								Despite having well-characterized disease-associated mutations, the mechanisms underlying the progressive bone marrow failure and cancer susceptibility of Fanconi anemia have been unclear. In this issue of Cell Stem Cell, Ceccaldi et al. identify an overactive p53/p21 stress response and cell cycle arrest as an underlying cause that starts during fetal development.	[Dumitriu, Bogdan; Young, Neal S.] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Young, NS (corresponding author), NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA.	youngns@mail.nih.gov			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006088] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA HL006089-02, ZIA HL002315-28, ZIA HL002315-27, ZIA HL006089-01, ZIA HL002315-29] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Ceccaldi R, 2011, J CLIN INVEST, V121, P184, DOI 10.1172/JCI43836; Fanconi G., 1927, JAHRB KINDERHEILK, V117, P257; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; ROCHOWSKI A, 2012, PEDIAT BLOOD CANC, DOI DOI 10.1002/PBC.24168; Shimamura A, 2010, BLOOD REV, V24, P101, DOI 10.1016/j.blre.2010.03.002	7	3	3	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUL 6	2012	11	1					7	8		10.1016/j.stem.2012.06.013	http://dx.doi.org/10.1016/j.stem.2012.06.013			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	975SS	22770237	Bronze, Green Accepted			2022-12-28	WOS:000306532400004
J	Fuchs, E				Fuchs, Elaine			The Impact of Cell Culture on Stem Cell Research	CELL STEM CELL			English	Editorial Material							PLURIPOTENTIAL CELLS; MOUSE EMBRYOS; LINE	Induced pluripotent stem cell research has broadened possibilities for regenerative medicine and captured the world's attention in a way that science rarely does. However, clinical applications utilizing cultured stem cells have existed for >30 years and can assist benchers and bedsiders in identifying and expediting promising avenues for future therapies.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050452, R01AR031737, R01AR027883, R37AR027883] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAMS NIH HHS [R01 AR027883, R01 AR050452, R01 AR031737, R37 AR027883] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Chambers SM, 2011, CELL, V145, P827, DOI 10.1016/j.cell.2011.05.036; Chen T., 2012, NATURE IN PRESS; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Goessling W, 2011, CELL STEM CELL, V8, P445, DOI 10.1016/j.stem.2011.02.003; GREEN H, 1991, Scientific American, V265, P96; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; ROBERTSON E, 1986, NATURE, V323, P445, DOI 10.1038/323445a0; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892	12	10	10	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 14	2012	10	6					640	641		10.1016/j.stem.2012.03.010	http://dx.doi.org/10.1016/j.stem.2012.03.010			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	965LD	22704497	Green Accepted, Bronze			2022-12-28	WOS:000305768400003
J	Marchetto, MC; Gage, FH				Marchetto, Maria C.; Gage, Fred H.			Modeling Brain Disease in a Dish: Really?	CELL STEM CELL			English	Editorial Material							PLURIPOTENT STEM-CELLS	Cellular programming and reprogramming technology (CPART) presents a novel approach for understanding disease progression and mechanism. In addition, CPART provides an innovative opportunity for developing diagnostic tools and novel drug candidates for therapy. In this Forum, we will discuss obstacles and solutions for modeling brain disease using CPART.	[Marchetto, Maria C.; Gage, Fred H.] Salk Inst Biol Studies, La Jolla, CA 92037 USA	Salk Institute	Gage, FH (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu						Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Hayden EC, 2011, NATURE, V473, P272, DOI 10.1038/473272a; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Krencik R, 2011, NAT PROTOC, V6, P1710, DOI 10.1038/nprot.2011.405; Marchetto MC, 2011, HUM MOL GENET, V20, pR109, DOI 10.1093/hmg/ddr336; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Muller FJ, 2010, CELL STEM CELL, V6, P412, DOI 10.1016/j.stem.2010.04.009; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540; Zhou Q, 2012, CELL STEM CELL, V10, P347, DOI 10.1016/j.stem.2012.03.005	10	33	33	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 14	2012	10	6					642	645		10.1016/j.stem.2012.05.008	http://dx.doi.org/10.1016/j.stem.2012.05.008			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	965LD	22704498	Bronze			2022-12-28	WOS:000305768400004
J	Yamamizu, K; Fujihara, M; Tachibana, M; Katayama, S; Takahashi, A; Hara, E; Imai, H; Shinkai, Y; Yamashita, JK				Yamamizu, Kohei; Fujihara, Mayako; Tachibana, Makoto; Katayama, Shiori; Takahashi, Akiko; Hara, Eiji; Imai, Hiroshi; Shinkai, Yoichi; Yamashita, Jun K.			RETRACTED: Protein Kinase A Determines Timing of Early Differentiation through Epigenetic Regulation with G9a (Retracted article. See vol. 24, pg. 193, 2019)	CELL STEM CELL			English	Article; Retracted Publication							EMBRYONIC STEM-CELLS; HISTONE METHYLTRANSFERASES; METHYLATION; NETWORKS; CULTURE; GENES; NOTCH	Timing of cell differentiation is strictly controlled and is crucial for normal development and stem cell differentiation. However, underlying mechanisms regulating differentiation timing are fully unknown. Here, we show a molecular mechanism determining differentiation timing from mouse embryonic stem cells (ESCs). Activation of protein kinase A (PKA) modulates differentiation timing to accelerate the appearance of mesoderm and other germ layer cells, reciprocally correlated with the earlier disappearance of pluripotent markers after ESC differentiation. PKA activation increases protein expression of G9a, an H3K9 methyltransferase, along with earlier H3K9 dimethylation and DNA methylation in Oct3/4 and Nanog gene promoters. Deletion of G9a completely abolishes PKA-elicited acceleration of differentiation and epigenetic modification. Furthermore, G9a knockout mice show prolonged expressions of Oct3/4 and Nanog at embryonic day 7.5 and delayed development. In this study, we demonstrate molecular machinery that regulates timing of multilineage differentiation by linking signaling with epigenetics.	[Yamamizu, Kohei; Katayama, Shiori; Yamashita, Jun K.] Kyoto Univ, Inst Frontier Med Sci, Dept Stem Cell Differentiat, Kyoto 6068507, Japan; [Yamamizu, Kohei; Katayama, Shiori; Yamashita, Jun K.] Kyoto Univ, Dept Cell Growth & Differentiat, Ctr iPS Cell Res & Applicat CiRA, Kyoto 6068507, Japan; [Fujihara, Mayako; Imai, Hiroshi] Kyoto Univ, Grad Sch Agr, Reprod Biol Lab, Kyoto 6068502, Japan; [Tachibana, Makoto; Shinkai, Yoichi] Kyoto Univ, Inst Virus Res, Expt Res Ctr Infect Dis, Kyoto 6068507, Japan; [Takahashi, Akiko; Hara, Eiji] Japanese Fdn Canc Res, Inst Canc, Tokyo 1358550, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Japanese Foundation for Cancer Research	Yamashita, JK (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Stem Cell Differentiat, Kyoto 6068507, Japan.	juny@frontier.kyoto-u.ac.jp	Shinkai, Yoichi/N-3909-2014; Fujihara, Mayako/N-9965-2019	Shinkai, Yoichi/0000-0002-6051-2484; 	Ministry of Education, Science, Sports and Culture of Japan; Ministry of Health, Labour and Welfare of Japan; Project for Realization of Regenerative Medicine; Japan Society for the Promotion of Science; Japan Heart Foundation Young Investigator's Research Grant	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Project for Realization of Regenerative Medicine(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Heart Foundation Young Investigator's Research Grant	We are grateful to Dr. Shinji Kuninaka and Dr. Hideyuki Saya for the Cdh1 plasmid. We are also grateful to Dr. Shin Yonehara for the DN-CREB plasmid. We thank Dr. Meiko Takahashi (Kyoto University, Kyoto, Japan) for a critical reading of the manuscript. This study was supported by grants from the Ministry of Education, Science, Sports and Culture of Japan; the Ministry of Health, Labour and Welfare of Japan; the Project for Realization of Regenerative Medicine; the Japan Society for the Promotion of Science, and a Japan Heart Foundation Young Investigator's Research Grant.	Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Epsztejn-Litman S, 2008, NAT STRUCT MOL BIOL, V15, P1176, DOI 10.1038/nsmb.1476; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Huang YZ, 2002, J BIOL CHEM, V277, P19889, DOI 10.1074/jbc.M111412200; Imamura M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-34; Jenuwein T, 2006, FEBS J, V273, P3121, DOI 10.1111/j.1742-4658.2006.05343.x; LANE ME, 1995, MECH DEVELOP, V49, P191, DOI 10.1016/0925-4773(94)00317-G; LANE ME, 1993, GENE DEV, V7, P1229, DOI 10.1101/gad.7.7a.1229; Li MY, 2006, J CLIN INVEST, V116, P2653, DOI 10.1172/JC128462; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; Nishiyama A, 2009, CELL STEM CELL, V5, P420, DOI 10.1016/j.stem.2009.07.012; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Takahashi A, 2012, MOL CELL, V45, P123, DOI 10.1016/j.molcel.2011.10.018; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tsukamoto S, 2006, BIOCHEM BIOPH RES CO, V343, P1105, DOI 10.1016/j.bbrc.2006.03.063; Uosaki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023657; Waddington C.H., 1957, STRATEGY GENES; Walker MR, 2009, J PATHOL, V217, P169, DOI 10.1002/path.2474; Yamada H, 1997, J CELL SCI, V110, P1793; Yamamizu K, 2010, J CELL BIOL, V189, P325, DOI 10.1083/jcb.200904114; Yamamizu K, 2009, BLOOD, V114, P3707, DOI 10.1182/blood-2008-12-195750; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yamashita JK, 2005, FASEB J, V19, P1534, DOI 10.1096/fj.04-3540fje; Yamashita YM, 1996, NATURE, V384, P276, DOI 10.1038/384276a0; Yokochi T, 2009, P NATL ACAD SCI USA, V106, P19363, DOI 10.1073/pnas.0906142106; Yurugi-Kobayashi T, 2006, ARTERIOSCL THROM VAS, V26, P1977, DOI 10.1161/01.ATV.0000234978.10658.41	36	35	37	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 14	2012	10	6					759	770		10.1016/j.stem.2012.02.022	http://dx.doi.org/10.1016/j.stem.2012.02.022			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	965LD	22704517	Bronze			2022-12-28	WOS:000305768400022
J	Cerletti, M; Jang, YC; Finley, LWS; Haigis, MC; Wagers, AJ				Cerletti, Massimiliano; Jang, Young C.; Finley, Lydia W. S.; Haigis, Marcia C.; Wagers, Amy J.			Short-Term Calorie Restriction Enhances Skeletal Muscle Stem Cell Function	CELL STEM CELL			English	Article							SATELLITE CELLS; PROGENITOR CELLS; SELF-RENEWAL; REGENERATION; MYOGENESIS; CANCER; MOUSE; FAT	Calorie restriction (CR) extends life span and ameliorates age-related pathologies in most species studied, yet the mechanisms underlying these effects remain unclear. Using mouse skeletal muscle as a model, we show that CR acts in part by enhancing the function of tissue-specific stem cells. Even short-term CR significantly enhanced stem cell availability and activity in the muscle of young and old animals, in concert with an increase in mitochondrial abundance and induction of conserved metabolic and longevity regulators. Moreover, CR enhanced endogenous muscle repair and CR initiated in either donor or recipient animals improved the contribution of donor cells to regenerating muscle after transplant. These studies indicate that metabolic factors play a critical role in regulating stem cell function and that this regulation can influence the efficacy of recovery from injury and the engraftment of transplanted cells.	[Wagers, Amy J.] Harvard Univ, Harvard Stem Cell Inst, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Cerletti, Massimiliano; Jang, Young C.; Wagers, Amy J.] Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Cerletti, Massimiliano; Jang, Young C.; Wagers, Amy J.] Joslin Diabet Ctr, Boston, MA 02215 USA; [Finley, Lydia W. S.; Haigis, Marcia C.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Wagers, AJ (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Howard Hughes Med Inst, 7 Divin Ave, Cambridge, MA 02138 USA.	amy_wagers@harvard.edu			NIH [P30DK036836, 1R01 AG033053, 1P30 AG031679]; Harvard Stem Cell Institute; Glenn Foundation; NIA [AG032375]; Ellison Medical Foundation; NSF; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033053, R01AG032375, P30AG031679] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; Glenn Foundation; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical Foundation(Lawrence Ellison Foundation); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors gratefully acknowledge Joslin's HSCl/DERC Flow Cytometry Core (NIH award number P30DK036836) and the HSCRB Flow Cytometry Core at Harvard for excellent flow cytometry support. This work was funded in part by grants from the Harvard Stem Cell Institute, NIH (1R01 AG033053 and 1P30 AG031679), and Glenn Foundation to A.J.W.; grants from the NIA (AG032375), Glenn Foundation, Ellison Medical Foundation, and MDA to M.N.; and an NSF graduate research fellowship to L.F. All experiments involving animals were approved by appropriate Institutional Animal Care and Use Committees. Content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or other funding agencies.	Ahmet I, 2005, CIRCULATION, V112, P3115, DOI 10.1161/CIRCULATIONAHA.105.563817; Anderson RM, 2010, TRENDS ENDOCRIN MET, V21, P134, DOI 10.1016/j.tem.2009.11.005; BAHT HS, 1989, BIOCHEM J, V258, P369, DOI 10.1042/bj2580369; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Cerletti M, 2008, COLD SH Q B, V73, P317, DOI 10.1101/sqb.2008.73.054; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Ertl RP, 2008, BLOOD, V111, P1709, DOI 10.1182/blood-2007-01-069807; Fontana L, 2009, EXP GERONTOL, V44, P41, DOI 10.1016/j.exger.2008.04.005; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Hettmer S, 2011, P NATL ACAD SCI USA, V108, P20002, DOI 10.1073/pnas.1111733108; Hursting SD, 2003, ANNU REV MED, V54, P131, DOI 10.1146/annurev.med.54.101601.152156; Jacobs KM, 2008, INT J BIOL SCI, V4, P291; Jang YC, 2011, COLD SPRING HARB S Q; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Russell SJ, 2007, NAT REV MOL CELL BIO, V8, P681, DOI 10.1038/nrm2234; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Tan KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026406; Tanaka KK, 2009, CELL STEM CELL, V4, P217, DOI 10.1016/j.stem.2009.01.016; Tremblay JP, 1997, BASIC APPL MYOL, V7, P221; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	34	260	265	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAY 4	2012	10	5					515	519		10.1016/j.stem.2012.04.002	http://dx.doi.org/10.1016/j.stem.2012.04.002			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	944WN	22560075	Green Accepted, Bronze			2022-12-28	WOS:000304234600010
J	Pomp, O; Dreesen, O; Leong, DFM; Meller-Pomp, O; Tan, TT; Zhou, F; Colman, A				Pomp, Oz; Dreesen, Oliver; Leong, Denise Fong Mei; Meller-Pomp, Orit; Tan, Thong Teck; Zhou, Fan; Colman, Alan			Unexpected X Chromosome Skewing during Culture and Reprogramming of Human Somatic Cells Can Be Alleviated by Exogenous Telomerase	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; HUMAN FIBROBLASTS; BLOOD-CELLS; INACTIVATION; GENE; FEMALES; CANCER	Somatic tissues in female eutherian mammals are mosaic due to random X inactivation. In contrast to mice, X chromosome reactivation does not occur during the reprogramming of human female somatic cells to induced pluripotent stem cells (iPSCs), although this view is contested. Using balanced populations of female Rett patient and control fibroblasts, we confirm that all cells in iPSC colonies contain an inactive X, and additionally find that all colonies made from the same donor fibroblasts contain the same inactive X chromosome. Notably, this extreme "skewing" toward a particular dominant, active X is also a general feature of primary female fibroblasts during proliferation, and the skewing seen in reprogramming and fibroblast culture can be alleviated by overexpression of telomerase. These results have important implications for in vitro modeling of X-linked diseases and the interpretation of long-term culture studies in cancer and senescence using primary female fibroblast cell lines.	[Pomp, Oz; Dreesen, Oliver; Leong, Denise Fong Mei; Meller-Pomp, Orit; Tan, Thong Teck; Zhou, Fan; Colman, Alan] Inst Med Biol, Singapore 138648, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Colman, A (corresponding author), Inst Med Biol, 8A Biomed Grove,06-06 Immunos, Singapore 138648, Singapore.	alan.colman@imb.a-staredu.sg	Dreesen, Oliver/AAJ-2132-2020					Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bolduc V, 2008, J CLIN INVEST, V118, P333, DOI 10.1172/JCI33166; Bretherick K, 2005, CYTOGENET GENOME RES, V111, P260, DOI 10.1159/000086898; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Cheung AYL, 2011, HUM MOL GENET, V20, P2103, DOI 10.1093/hmg/ddr093; Colman A, 2009, CELL STEM CELL, V5, P244, DOI 10.1016/j.stem.2009.08.010; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; Dvash T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011330; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Knudsen PS, 2007, CYTOGENET GENOME RES, V116, P24, DOI 10.1159/000097414; Kubota T, 1999, AM J MED GENET, V87, P258, DOI 10.1002/(SICI)1096-8628(19991126)87:3<258::AID-AJMG12>3.0.CO;2-Q; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Li G, 2006, ONCOL REP, V16, P859; Lose F, 2008, JNCI-J NATL CANCER I, V100, DOI 10.1093/jnci/djn345; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; Meetei AR, 2004, NAT GENET, V36, P1219, DOI 10.1038/ng1458; Minks J, 2008, J CLIN INVEST, V118, P20, DOI 10.1172/JCI34470; NICHOLS WW, 1977, SCIENCE, V196, P60, DOI 10.1126/science.841339; Okamoto I, 2011, NATURE, V472, P370, DOI 10.1038/nature09872; Ozbalkan Z, 2005, ARTHRITIS RHEUM-US, V52, P1564, DOI 10.1002/art.21026; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4709, DOI 10.1073/pnas.0712018105; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tchieu J, 2010, CELL STEM CELL, V7, P329, DOI 10.1016/j.stem.2010.06.024; Zvetkova I, 2005, NAT GENET, V37, P1274, DOI 10.1038/ng1663	36	69	71	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 5	2011	9	2					156	165		10.1016/j.stem.2011.06.004	http://dx.doi.org/10.1016/j.stem.2011.06.004			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	808PM	21816366	Bronze			2022-12-28	WOS:000293990900012
J	Goldring, CEP; Duffy, PA; Benvenisty, N; Andrews, PW; Ben-David, U; Eakins, R; French, N; Hanley, NA; Kelly, L; Kitteringham, NR; Kurth, J; Ladenheim, D; Laverty, H; McBlane, J; Narayanan, G; Patel, S; Reinhardt, J; Rossi, A; Sharpe, M; Park, BK				Goldring, Chris E. P.; Duffy, Paul A.; Benvenisty, Nissim; Andrews, Peter W.; Ben-David, Uri; Eakins, Rowena; French, Neil; Hanley, Neil A.; Kelly, Lorna; Kitteringham, Neil R.; Kurth, Jens; Ladenheim, Deborah; Laverty, Hugh; McBlane, James; Narayanan, Gopalan; Patel, Sara; Reinhardt, Jens; Rossi, Annamaria; Sharpe, Michaela; Park, B. Kevin			Assessing the Safety of Stem Cell Therapeutics	CELL STEM CELL			English	Article							FUNCTIONAL-PROPERTIES; HEPATIC ENDODERM; FDA REGULATION; COPY NUMBER; SERUM-FREE; IN-VITRO; DIFFERENTIATION; GENERATION; TUMORIGENICITY; IMMUNOGENICITY	Unprecedented developments in stem cell research herald a new era of hope and expectation for novel therapies. However, they also present a major challenge for regulators since safety assessment criteria, designed for conventional agents, are largely inappropriate for cell-based therapies. This article aims to set out the safety issues pertaining to novel stem cell-derived treatments, to identify knowledge gaps that require further research, and to suggest a roadmap for developing safety assessment criteria. It is essential that regulators, pharmaceutical providers, and safety scientists work together to frame new safety guidelines, based on "acceptable risk," so that patients are adequately protected but the safety "bar" is not set so high that exciting new treatments are lost.	[Goldring, Chris E. P.; Eakins, Rowena; French, Neil; Kelly, Lorna; Kitteringham, Neil R.; Laverty, Hugh; Park, B. Kevin] Univ Liverpool, Inst Translat Med, Div Mol & Clin Pharmacol, MRC Ctr Drug Safety Sci, Liverpool L69 3GE, Merseyside, England; [Duffy, Paul A.] Safety Assessment UK, AstraZeneca R&D Alderley Pk, Macclesfield SK10 4TG, Cheshire, England; [Benvenisty, Nissim; Ben-David, Uri] Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, Stem Cell Unit, IL-91904 Jerusalem, Israel; [Benvenisty, Nissim] Cedars Sinai Med Ctr, Regenerat Med Inst, Los Angeles, CA 90048 USA; [Andrews, Peter W.] Univ Sheffield, Dept Biomed Sci, Ctr Stem Cell Biol, Sheffield S10 2TN, S Yorkshire, England; [Hanley, Neil A.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Endocrinol & Diabet Grp, Manchester M13 9PT, Lancs, England; [Kurth, Jens] Novartis Pharma AG, CH-4056 Basel, Switzerland; [Ladenheim, Deborah] Athersys, Cleveland, OH 44115 USA; [McBlane, James; Narayanan, Gopalan] Med & Healthcare Prod Regulatory Agcy MHRA, London SW1W 9SZ, England; [Patel, Sara] ReNeuron Ltd, Surrey GU2 7AF, England; [Reinhardt, Jens] Paul Ehrlich Inst, D-63225 Langen, Germany; [Rossi, Annamaria; Sharpe, Michaela] Pfizer Ltd, Sandwich Labs, Drug Safety Res & Dev, Sandwich CT13 9NJ, Kent, England	University of Liverpool; AstraZeneca; Hebrew University of Jerusalem; Cedars Sinai Medical Center; University of Sheffield; University of Manchester; Novartis; The Medicines & Healthcare Products Regulatory Agency; Paul Ehrlich Institute; Pfizer	Goldring, CEP (corresponding author), Univ Liverpool, Inst Translat Med, Div Mol & Clin Pharmacol, MRC Ctr Drug Safety Sci, Liverpool L69 3GE, Merseyside, England.	C.E.P.Goldring@liverpool.ac.uk; nissimb@cc.huji.ac.il; neilk@liv.ac.uk	Ben-David, Uri/H-4119-2019	Ben-David, Uri/0000-0001-7098-2378; Hanley, Neil/0000-0003-3234-4038; French, Neil/0000-0002-9376-3482; Kelly, Lorna/0000-0002-1886-5067; Andrews, Peter/0000-0001-7215-4410; Sharpe, Michaela/0000-0002-0850-4639	MRC [G0700654, G0700785] Funding Source: UKRI; Medical Research Council [G0700654, G0700785] Funding Source: Medline; Wellcome Trust [088566] Funding Source: Medline; Medical Research Council [1092875] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; Anisimov SV, 2010, STEM CELL REV REP, V6, P411, DOI 10.1007/s12015-010-9134-5; Anisimov VN, 2005, NAT REV CANCER, V5, P807, DOI 10.1038/nrc1715; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Baxter MA, 2010, STEM CELL RES, V5, P4, DOI 10.1016/j.scr.2010.02.002; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Blum B, 2008, ADV CANCER RES, V100, P133, DOI 10.1016/S0065-230X(08)00005-5; Blum B, 2007, STEM CELLS, V25, P1924, DOI 10.1634/stemcells.2007-0073; Blum B, 2009, CELL CYCLE, V8, P3822, DOI 10.4161/cc.8.23.10067; BONE HK, 2011, J CELL SCI IN PRESS; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; CRISTOFANILLI M, 2011, STEM CELLS IN PRESS, DOI DOI 10.1089/SCD.2010.0547; Drukker M, 2004, TRENDS BIOTECHNOL, V22, P136, DOI 10.1016/j.tibtech.2004.01.003; Duan YY, 2007, STEM CELLS, V25, P3058, DOI 10.1634/stemcells.2007-0291; Ellis J, 2010, CELL STEM CELL, V7, P429, DOI 10.1016/j.stem.2010.09.010; Fairchild PJ, 2010, NAT REV IMMUNOL, V10, P868, DOI 10.1038/nri2878; Fink DW, 2009, SCIENCE, V324, P1662, DOI 10.1126/science.1173712; Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856; *GER, 2009, GER COMM FDA HOLD SP; *GER, 2009, GER REC FDA CLEAR BE; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Halme DG, 2006, NEW ENGL J MED, V355, P1730, DOI 10.1056/NEJMhpr063086; HAMBURGER AW, 1987, INT J CELL CLONING, V5, P89, DOI 10.1002/stem.5530050202; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hay DC, 2008, P NATL ACAD SCI USA, V105, P12301, DOI 10.1073/pnas.0806522105; Hertlein T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018246; Hovatta O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010263; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Hyun I, 2008, CELL STEM CELL, V3, P607, DOI 10.1016/j.stem.2008.11.009; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Koay EJ, 2007, STEM CELLS, V25, P2183, DOI 10.1634/stemcells.2007-0105; Krishna KA, 2007, REGEN MED, V2, P171, DOI 10.2217/17460751.2.2.171; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lavon N, 2004, DIFFERENTIATION, V72, P230, DOI 10.1111/j.1432-0436.2004.07205002.x; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; Mayor Susan, 2010, BMJ, V341, pc5724, DOI 10.1136/bmj.c5724; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; National Institutes of Health, 2006, REG MED; Nelson TJ, 2010, STEM CELLS CLONING, V3, P29; Nishikawa S, 2008, NAT REV MOL CELL BIO, V9, P725, DOI 10.1038/nrm2466; Noaksson K, 2005, STEM CELLS, V23, P1460, DOI 10.1634/stemcells.2005-0093; Noort WA, 2002, EXP HEMATOL, V30, P870, DOI 10.1016/S0301-472X(02)00820-2; Okamura RM, 2007, J NEUROIMMUNOL, V192, P134, DOI 10.1016/j.jneuroim.2007.09.030; Papapetrou EP, 2011, NAT BIOTECHNOL, V29, P73, DOI 10.1038/nbt.1717; Passier R, 2005, STEM CELLS, V23, P772, DOI 10.1634/stemcells.2004-0184; Perin L, 2008, PEDIATR RES, V63, P467, DOI 10.1203/PDR.0b013e3181660653; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Redmond DE, 2007, P NATL ACAD SCI USA, V104, P12175, DOI 10.1073/pnas.0704091104; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Sallam K, 2010, METHODS MOL BIOL, V660, P185, DOI 10.1007/978-1-60761-705-1_12; Sareen D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007630; Schuldiner M, 2003, METHOD ENZYMOL, V365, P446; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Stephenson E, 2010, J R SOC INTERFACE, V7, pS677, DOI 10.1098/rsif.2010.0343.focus; Sullivan GJ, 2010, HEPATOLOGY, V51, P329, DOI 10.1002/hep.23335; Swijnenburg RJ, 2008, P NATL ACAD SCI USA, V105, P12991, DOI 10.1073/pnas.0805802105; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Touboul T, 2010, HEPATOLOGY, V51, P1754, DOI 10.1002/hep.23506; Ueyama H, 2012, J CELL MOL MED, V16, P72, DOI 10.1111/j.1582-4934.2011.01303.x; Vallier L, 2011, METHODS MOL BIOL, V690, P57, DOI 10.1007/978-1-60761-962-8_3; Vitale AM, 2011, INT J BIOCHEM CELL B, V43, P843, DOI 10.1016/j.biocel.2011.03.013; Wise J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6574; Wong SSY, 2010, REGEN MED, V5, P763, DOI 10.2217/RME.10.52; Xiong QA, 2011, STEM CELLS, V29, P367, DOI 10.1002/stem.580; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; ZHAO T, 2011, NATURE IN PRESS, DOI DOI 10.1038/NATURE10135	72	159	165	2	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 3	2011	8	6					618	628		10.1016/j.stem.2011.05.012	http://dx.doi.org/10.1016/j.stem.2011.05.012			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	780HC	21624806	Bronze			2022-12-28	WOS:000291844100010
J	Norddahl, GL; Pronk, CJ; Wahlestedt, M; Sten, G; Nygren, JM; Ugale, A; Sigvardsson, M; Bryder, D				Norddahl, Gudmundur L.; Pronk, Cornelis J.; Wahlestedt, Martin; Sten, Gerd; Nygren, Jens M.; Ugale, Amol; Sigvardsson, Mikael; Bryder, David			Accumulating Mitochondrial DNA Mutations Drive Premature Hematopoietic Aging Phenotypes Distinct from Physiological Stem Cell Aging	CELL STEM CELL			English	Article							SERIAL TRANSPLANTATION; P-GLYCOPROTEIN; EXPRESSION; APOPTOSIS; PROLIFERATION; REPOPULATION; PATHWAYS; EFFLUX; NUMBER; REPAIR	Somatic stem cells mediate tissue maintenance for the lifetime of an organism. Despite the well-established longevity that is a prerequisite for such function, accumulating data argue for compromised stem cell function with age. Identifying the mechanisms underlying age-dependent stem cell dysfunction is therefore key to understanding the aging process. Here, using a model carrying a proofreading-defective mitochondrial DNA polymerase, we demonstrate hematopoietic defects reminiscent of premature HSC aging, including anemia, lymphopenia, and myeloid lineage skewing. However, in contrast to physiological stem cell aging, rapidly accumulating mitochondria! DNA mutations had little functional effect on the hematopoietic stem cell pool, and instead caused distinct differentiation blocks and/or disappearance of downstream progenitors. These results show that intact mitochondrial function is required for appropriate multilineage stem cell differentiation, but argue against mitochondria! DNA mutations per se being a primary driver of somatic stern cell aging.	[Norddahl, Gudmundur L.; Pronk, Cornelis J.; Wahlestedt, Martin; Sten, Gerd; Nygren, Jens M.; Ugale, Amol; Bryder, David] Lund Univ, BMC D14, Inst Expt Med Sci, Immunol Sect, S-22184 Lund, Sweden; [Sten, Gerd; Bryder, David] Lund Univ, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, SE-22100 Lund, Sweden; [Nygren, Jens M.] Halmstad Univ, Ctr Res Welf Hlth & Sport, S-30118 Halmstad, Sweden; [Sigvardsson, Mikael] Linkoping Univ, Inst Clin & Expt Med, S-58183 Linkoping, Sweden	Lund University; Lund University; Halmstad University; Linkoping University	Bryder, D (corresponding author), Lund Univ, BMC D14, Inst Expt Med Sci, Immunol Sect, Tornavagen 10, S-22184 Lund, Sweden.	david.bryder@med.lu.se	Bryder, David/Q-6292-2019	Sigvardsson, Mikael/0000-0001-8527-7276; Bryder, David/0000-0002-8761-4237; Nygren, Jens M/0000-0002-3576-2393	Swedish Cancer Foundation; Swedish Medical Research Council; Swedish Pediatric Leukemia Foundation; Crafoord Foundation	Swedish Cancer Foundation; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Pediatric Leukemia Foundation; Crafoord Foundation	We gratefully acknowledge N.-G. Larsson for making mutator mice available, T. Suda for details on ATP measurements, and the Stanford PAN facility for help with microarray experiments. The work was supported by grants to D.B. from the Swedish Cancer Foundation, the Swedish Medical Research Council, the Swedish Pediatric Leukemia Foundation, and the Crafoord Foundation. G.L.N., C.J.P. and D.B. designed studies. All authors contributed to experiments. D.B. and G.L.N. wrote the manuscript.	Allsopp RC, 2001, J EXP MED, V193, P917, DOI 10.1084/jem.193.8.917; Attema JL, 2009, ONCOGENE, V28, P2238, DOI 10.1038/onc.2009.94; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; CHAUDHARY PM, 1991, CELL, V66, P85, DOI 10.1016/0092-8674(91)90141-K; Chen ML, 2009, BLOOD, V114, P4045, DOI 10.1182/blood-2008-08-169474; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Facucho-Oliveira JM, 2009, STEM CELL REV REP, V5, P140, DOI 10.1007/s12015-009-9058-0; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Fontenay M, 2006, ONCOGENE, V25, P4757, DOI 10.1038/sj.onc.1209606; Gogvadze V, 2006, BBA-BIOENERGETICS, V1757, P639, DOI 10.1016/j.bbabio.2006.03.016; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; HARRISON DE, 1980, BLOOD, V55, P77; HARRISON DE, 1978, J EXP MED, V147, P1526, DOI 10.1084/jem.147.5.1526; Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468; Huttemann M, 2008, J BIOENERG BIOMEMBR, V40, P445, DOI 10.1007/s10863-008-9169-3; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Khrapko K, 2006, AGING CELL, V5, P279, DOI 10.1111/j.1474-9726.2006.00209.x; Kollman C, 2001, BLOOD, V98, P2043, DOI 10.1182/blood.V98.7.2043; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701; Marques-Santos LF, 2003, BIOSCIENCE REP, V23, P199, DOI 10.1023/B:BIRE.0000007693.33521.18; Morales M, 2005, GENE DEV, V19, P3043, DOI 10.1101/gad.1373705; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Peachman KK, 2001, P NATL ACAD SCI USA, V98, P1717, DOI 10.1073/pnas.98.4.1717; Pronk CJ, 2008, CELL CYCLE, V7, P706, DOI 10.4161/cc.7.6.5565; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Pronk CJH, 2011, METHODS MOL BIOL, V699, P275, DOI 10.1007/978-1-61737-950-5_13; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Unwin RD, 2006, BLOOD, V107, P4687, DOI 10.1182/blood-2005-12-4995; Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988; Wong Alice, 2002, Methods Mol Biol, V197, P129, DOI 10.1385/1-59259-284-8:129	39	180	185	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 6	2011	8	5					499	510		10.1016/j.stem.2011.03.009	http://dx.doi.org/10.1016/j.stem.2011.03.009			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	768IN	21549326	Bronze			2022-12-28	WOS:000290927600011
J	Habibi, E; Brinkman, AB; Arand, J; Kroeze, LI; Kerstens, HHD; Matarese, F; Lepikhov, K; Gut, M; Brun-Heath, I; Hubner, NC; Benedetti, R; Altucci, L; Jansen, JH; Walter, J; Gut, IG; Marks, H; Stunnenberg, HG				Habibi, Ehsan; Brinkman, Arie B.; Arand, Julia; Kroeze, Leonie I.; Kerstens, Hindrik H. D.; Matarese, Filomena; Lepikhov, Konstantin; Gut, Marta; Brun-Heath, Isabelle; Hubner, Nina C.; Benedetti, Rosaria; Altucci, Lucia; Jansen, Joop H.; Walter, Joern; Gut, Ivo G.; Marks, Hendrik; Stunnenberg, Hendrik G.			Whole-Genome Bisulfite Sequencing of Two Distinct Interconvertible DNA Methylomes of Mouse Embryonic Stem Cells	CELL STEM CELL			English	Article							GROUND-STATE; METHYLATION; 5-HYDROXYMETHYLCYTOSINE; HYPOMETHYLATION; PLURIPOTENCY; HETEROGENEITY; ENHANCERS; UHRF1; TET1	The use of two kinase inhibitors (2i) enables derivation of mouse embryonic stem cells (ESCs) in the pluripotent ground state. Using whole-genome bisulfite sequencing (WGBS), we show that male 2i ESCs are globally hypomethylated compared to conventional ESCs maintained in serum. In serum, female ESCs are hypomethyated similarly to male ESCs in 2i, and DNA methylation is further reduced in 2i. Regions with elevated DNA methylation in 2i strongly correlate with the presence of H3K9me3 on endogenous retroviruses (ERVs) and imprinted loci. The methylome of male ESCs in serum parallels post-implantation blastocyst cells, while 2i stalls ESCs in a hypomethylated, ICM-like state. WGBS analysis during adaptation of 2i ESCs to serum suggests that deposition of DNA methylation is largely random, while loss of DNA methylation during reversion to 2i occurs passively, initiating at TET1 binding sites. Together, our analysis provides insight into DNA methylation dynamics in cultured ESCs paralleling early developmental processes.	[Habibi, Ehsan; Brinkman, Arie B.; Kerstens, Hindrik H. D.; Matarese, Filomena; Hubner, Nina C.; Marks, Hendrik; Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, NCMLS, Fac Sci, Dept Mol Biol, NL-6525 GA Nijmegen, Netherlands; [Arand, Julia; Lepikhov, Konstantin; Walter, Joern] Univ Saarland, Dept Genet Epigenet, D-66123 Saarbrucken, Germany; [Kroeze, Leonie I.; Jansen, Joop H.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Hematol Lab, NL-6525 GA Nijmegen, Netherlands; [Kroeze, Leonie I.; Jansen, Joop H.] Nijmegen Ctr Mol Life Sci, NL-6525 GA Nijmegen, Netherlands; [Gut, Marta; Brun-Heath, Isabelle; Gut, Ivo G.] Ctr Nacl Anal Genom, Barcelona 08028, Spain; [Benedetti, Rosaria; Altucci, Lucia] Univ Naples 2, Dipartimento Biochim Biofis & Patol Gen, I-80138 Naples, Italy; [Altucci, Lucia] IGB, I-80131 Naples, Italy	Radboud University Nijmegen; Saarland University; Radboud University Nijmegen; Radboud University Nijmegen; Universita della Campania Vanvitelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR)	Marks, H (corresponding author), Radboud Univ Nijmegen, NCMLS, Fac Sci, Dept Mol Biol, NL-6525 GA Nijmegen, Netherlands.	h.marks@ncmls.ru.nl; h.stunnenberg@ncmls.ru.nl	Gut, Ivo/ABF-3188-2020; Habibi, Ehsan/R-7756-2019; Habibi, Ehsan/E-3196-2016; Arand, Julia/AFQ-8652-2022; Kroeze, Leonie/D-9673-2016; Jansen, J.H./H-8054-2014; Marks, Hendrik/E-2801-2012; Habibi, Ehsan/AAE-6053-2021; Arand, Julia/AAD-8640-2020; Stunnenberg, Hendrik G./D-6875-2012; Walter, Jörn/AFN-6428-2022; Brun-Heath, Isabelle/G-9844-2013; Brinkman, Arie/V-1533-2018; Lepikhov, Konstantin/AAN-3634-2021; Altucci, Lucia/S-8031-2019; Arand, Julia/AAU-9679-2020; Hubner, Nina C/C-4298-2008; Benedetti, Rosaria/AAF-2398-2020; Benedetti, Rosaria/AHE-8039-2022	Gut, Ivo/0000-0001-7219-632X; Habibi, Ehsan/0000-0002-7208-7999; Jansen, J.H./0000-0001-9459-568X; Marks, Hendrik/0000-0002-4198-3731; Stunnenberg, Hendrik G./0000-0002-0066-1576; Walter, Jörn/0000-0003-0563-7417; Brun-Heath, Isabelle/0000-0002-5828-0020; Brinkman, Arie/0000-0002-9875-1835; Arand, Julia/0000-0002-2357-1119; Hubner, Nina C/0000-0002-7864-2877; Benedetti, Rosaria/0000-0001-5517-5519; Kroeze, Leonie/0000-0002-2666-1742; altucci, lucia/0000-0002-7312-5387	Dutch KWF [KUN2008-4130]; Netherlands National Computing Facilities foundation [MP-266-13]; Netherlands Institute for Regenerative Medicine (NIRM); Epigenomics Flagship Project "EPIGEN'' (MIUR-CNR); Deutsche Forschungsgemeinschaft (DFG) priority program SPP1356 "Pluripotency and Cellular Reprogramming'' [WA1029]; European Union [NWO/Zoom 90201134, FP7/2008: 235447, FP7/2011: 282510, FP7/2009: 223485];  [PON_0101227]	Dutch KWF; Netherlands National Computing Facilities foundation; Netherlands Institute for Regenerative Medicine (NIRM); Epigenomics Flagship Project "EPIGEN'' (MIUR-CNR)(Consiglio Nazionale delle Ricerche (CNR)); Deutsche Forschungsgemeinschaft (DFG) priority program SPP1356 "Pluripotency and Cellular Reprogramming''(German Research Foundation (DFG)); European Union(European Commission); 	We thank Eva Janssen-Megens, Anita Kaan, and Yan Tan for sequencing, Kees-Jan Francoijs and Simon van Heeringen for bioinformatic assistance, Roberta Menafra and Gianluigi Franci for general practical advice, and Pascal Giehr, Christina LoPorto, Jasmin Gries, and Karl Nordstrom for help with hairpin BS-seq. Felix Krueger helped with preprocessing of the sequencing data, and Andrew Smith, Qiang Song, Fang Fang, and Meng Zhou helped with the WGBS analysis. Yuanxin Xi provided advice for RRBSMAP data analysis. Joost Martens and Colin Logie gave useful comments on the manuscript. Tuzer Kalkan and Austin Smith provided the Rex/GFP-2i cells, and Alice Jouneau provided the EpiSCs. The research leading to these results has received funding from the Dutch KWF (KUN2008-4130), Netherlands National Computing Facilities foundation grant MP-266-13, the Netherlands Institute for Regenerative Medicine (NIRM), the Epigenomics Flagship Project "EPIGEN'' (MIUR-CNR), PON_0101227, Deutsche Forschungsgemeinschaft (DFG) priority program SPP1356 "Pluripotency and Cellular Reprogramming'' (grant number WA1029), and the European Union grants SYNERGY (NWO/Zoom 90201134; within ERASYSBIO+, FP7/2008: 235447), BLUEPRINT (FP7/2011: 282510), and PluriSys (FP7/2009: 223485). E.H. and H.M. carried out most of the wet-lab experiments and F. M. helped with western blots and DNA isolation. M.G., I.B.H., and I.G.G. performed bisulfite conversion and sequencing of the samples. E.H. and H.H.D.K. mapped sequencing data and determined methylation levels. E.H. and A.B.B. performed bioinformatic analysis. J.A., K.L., and J.W. performed hairpin-bisulfite amplicon sequencing and cell stainings. N.C.H. performed MS analysis of DNMT1 and L.I.K. and J.H.J. performed MS analysis of DNA (hydroxy) methylation. R.B. and L.A. measured DNMT1 activity. H.M., E.H., A.B.B., and H.G.S. wrote the manuscript. H.M. and H.G.S. designed and supervised the experiments.	Arand J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002750; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Kulis M, 2012, NAT GENET, V44, P1236, DOI 10.1038/ng.2443; Leitch HG, 2013, NAT STRUCT MOL BIOL, V20, P311, DOI 10.1038/nsmb.2510; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Marks H, 2009, GENOME RES, V19, P1361, DOI 10.1101/gr.092643.109; Maruotti J, 2010, STEM CELLS, V28, P743, DOI 10.1002/stem.400; Matarese F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.95; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI 10.1038/nbt.1684; MONK M, 1987, DEVELOPMENT, V99, P371; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Rothbart SB, 2012, NAT STRUCT MOL BIOL, V19, P1155, DOI 10.1038/nsmb.2391; Rottach A, 2010, NUCLEIC ACIDS RES, V38, P1796, DOI 10.1093/nar/gkp1152; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Smith AD, 2009, BIOINFORMATICS, V25, P2841, DOI 10.1093/bioinformatics/btp533; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Xi YX, 2012, BIOINFORMATICS, V28, P430, DOI 10.1093/bioinformatics/btr668; Yamaji M, 2013, CELL STEM CELL, V12, P368, DOI 10.1016/j.stem.2012.12.012; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zvetkova I, 2005, NAT GENET, V37, P1274, DOI 10.1038/ng1663	38	309	314	5	50	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 5	2013	13	3					360	369		10.1016/j.stem.2013.06.002	http://dx.doi.org/10.1016/j.stem.2013.06.002			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VQ	23850244	Bronze			2022-12-28	WOS:000329570800013
J	Gu, BN; Watanabe, K; Sun, P; Fallahi, M; Dai, X				Gu, Bingnan; Watanabe, Kazuhide; Sun, Peng; Fallahi, Magid; Dai, Xing			Chromatin Effector Pygo2 Mediates Wnt-Notch Crosstalk to Suppress Luminal/Alveolar Potential of Mammary Stem and Basal Cells	CELL STEM CELL			English	Article							GENOME-WIDE MAPS; SIGNALING PATHWAY; EPITHELIAL-CELLS; BETA-CATENIN; GLAND DEVELOPMENT; COMMITTED CELLS; SELF-RENEWAL; IN-VIVO; DIFFERENTIATION; EXPRESSION	Epigenetic mechanisms regulating lineage differentiation of mammary stem cells (MaSCs) remain poorly understood. Pygopus 2 (Pygo2) is a histone methylation reader and a context-dependent Wnt/beta-catenin coactivator. Here we provide evidence for Pygo2's function in suppressing luminal/alveolar differentiation of MaSC-enriched basal cells. We show that Pygo2-deficient MaSC/basal cells exhibit partial molecular resemblance to luminal cells, such as elevated Notch signaling and reduced mammary repopulating capability upon transplantation. Inhibition of Notch signaling suppresses basal-level and Pygo2-deficiency-induced luminal/alveolar differentiation of MaSC/basal cells, whereas activation of Wnt/beta-catenin signaling suppresses luminal/alveolar differentiation and Notch3 expression in a Pygo2-dependent manner. We show that Notch3 is a direct target of Pygo2 and that Pygo2 is required for beta-catenin binding and maintenance of a poised/ repressed chromatin state at the Notch3 locus in MaSC/basal cells. Together, our data support a model where Pygo2-mediated chromatin regulation connects Wnt signaling and Notch signaling to restrict the luminal/alveolar differentiation competence of MaSC/basal cells.	[Gu, Bingnan; Watanabe, Kazuhide; Sun, Peng; Fallahi, Magid; Dai, Xing] Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine	Dai, X (corresponding author), Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92697 USA.	xdai@uci.edu	Watanabe, Kazuhide/C-9667-2017; Sun, Peng/P-6099-2014	Watanabe, Kazuhide/0000-0002-5331-0593; Dai, Xing/0000-0001-8134-1365	Susan G. Komen grant [KG110897]; NSF [DMS-1161621]; NIH [R01-GM083089]; CBCRP Postdoctoral Fellowship [14FB-0129]; U.S. DOD BCRP Postdoctoral Fellowship [W81XWH-10-1-0383]; Division Of Mathematical Sciences [1161621] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083089] Funding Source: NIH RePORTER	Susan G. Komen grant(Susan G. Komen Breast Cancer Foundation); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CBCRP Postdoctoral Fellowship; U.S. DOD BCRP Postdoctoral Fellowship; Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Eva Lee, Wen-Hwa Lee, and Bogi Andersen for discussions and the UCI Genomics High Throughput Facility (GHTF) and Sue and Bill Gross Stem Cell Research Center Core Facility for expert service. This work was supported by Susan G. Komen grant KG110897, NSF grant DMS-1161621, and NIH grant R01-GM083089 (to X. D.). B. G. and K. W. were supported by CBCRP Postdoctoral Fellowship (14FB-0129) and U.S. DOD BCRP Postdoctoral Fellowship (W81XWH-10-1-0383), respectively.	Andrews PGP, 2009, BIOCHEM J, V422, P493, DOI 10.1042/BJ20090134; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; BARTEK J, 1985, INT J CANCER, V36, P299, DOI 10.1002/ijc.1985.36.3.299; Belenkaya TY, 2002, DEVELOPMENT, V129, P4089; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Buono KD, 2006, DEV BIOL, V293, P565, DOI 10.1016/j.ydbio.2006.02.043; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Chen JK, 2010, MOL CELL BIOL, V30, P5621, DOI 10.1128/MCB.00465-10; Chung CW, 2012, PROGR MED CHEM, V51, P1, DOI 10.1016/B978-0-12-396493-9.00001-7; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Dahl JA, 2008, NAT PROTOC, V3, P1032, DOI 10.1038/nprot.2008.68; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Fiedler M, 2008, MOL CELL, V30, P507, DOI 10.1016/j.molcel.2008.03.011; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Gjorevski N, 2011, NAT REV MOL CELL BIO, V12, P581, DOI 10.1038/nrm3168; Gu BN, 2012, CELL CYCLE, V11, P79, DOI 10.4161/cc.11.1.18402; Gu BN, 2009, J CELL BIOL, V185, P811, DOI 10.1083/jcb.200810133; GUGLIOTTA P, 1988, J HISTOCHEM CYTOCHEM, V36, P659, DOI 10.1177/36.6.3367051; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Hoverter NP, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.139pe43; Huper G, 2007, CANCER RES, V67, P2990, DOI 10.1158/0008-5472.CAN-06-4065; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jessen S, 2008, BIOESSAYS, V30, P448, DOI 10.1002/bies.20757; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kessler R, 2009, MECH DEVELOP, V126, P752, DOI 10.1016/j.mod.2009.04.003; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Lien WH, 2011, CELL STEM CELL, V9, P219, DOI 10.1016/j.stem.2011.07.015; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Maruyama R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001369; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nair M, 2008, DEV BIOL, V320, P446, DOI 10.1016/j.ydbio.2008.05.553; Pal B, 2013, CELL REP, V3, P411, DOI 10.1016/j.celrep.2012.12.020; Parker DS, 2002, DEVELOPMENT, V129, P2565; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Pietersen AM, 2008, CURR BIOL, V18, P1094, DOI 10.1016/j.cub.2008.06.070; Raafat A, 2011, J CELL PHYSIOL, V226, P1940, DOI 10.1002/jcp.22526; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Roarty K, 2010, CURR OPIN PHARMACOL, V10, P643, DOI 10.1016/j.coph.2010.07.004; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shahi P, 2011, STEM CELLS, V29, P678, DOI 10.1002/stem.606; Stadeli R, 2005, MECH DEVELOP, V122, P1171, DOI 10.1016/j.mod.2005.07.004; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun P, 2010, HISTOCHEM CELL BIOL, V133, P213, DOI 10.1007/s00418-009-0662-5; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; Teuliere J, 2005, DEVELOPMENT, V132, P267, DOI 10.1242/dev.01583; Thompson B, 2002, NAT CELL BIOL, V4, P367, DOI 10.1038/ncb786; Townsley FM, 2004, NAT CELL BIOL, V6, P626, DOI 10.1038/ncb1141; Ungerback J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017957; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Watanabe K., 2013, ONCOGENE IN PRESS; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020	63	60	63	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2013	13	1					48	61		10.1016/j.stem.2013.04.012	http://dx.doi.org/10.1016/j.stem.2013.04.012			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VJ	23684539	Green Accepted, Bronze			2022-12-28	WOS:000329570100012
J	Suratt, BT; Fessler, MB				Suratt, Benjamin T.; Fessler, Michael B.			Greasing the Way: The ABCs of HSPC Efflux from the Marrow	CELL STEM CELL			English	Editorial Material							STEM-CELL PROLIFERATION; ACCUMULATION; HOMEOSTASIS; MICE	In this issue of Cell Stem Cell, Westerterp et al. demonstrate that cholesterol flux through splenic phagocytes regulates hematopoietic stem and multipotential progenitor cell mobilization from the bone marrow. These exciting findings suggest new avenues for therapy of myeloproliferative disorders and atherosclerosis.	[Fessler, Michael B.] NIEHS, Lab Resp Biol, NIH, Res Triangle Pk, NC 27709 USA; [Suratt, Benjamin T.] Univ Vermont, Coll Med, Vermont Lung Ctr, Burlington, VT 05405 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Vermont	Fessler, MB (corresponding author), NIEHS, Lab Resp Biol, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	fesslerm@niehs.nih.gov	Fessler, Michael B/C-6323-2019; , Ben/L-5749-2019	Fessler, Michael B/0000-0002-8262-8613; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103532] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA ES102005-06] Funding Source: Medline; NHLBI NIH HHS [R01 HL084200] Funding Source: Medline; NIGMS NIH HHS [P30 GM103532] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Azzam KM, 2012, TRENDS ENDOCRIN MET, V23, P169, DOI 10.1016/j.tem.2012.02.001; Gomes AL, 2010, BLOOD, V115, P3886, DOI 10.1182/blood-2009-08-240580; Hong C, 2012, J CLIN INVEST, V122, P337, DOI 10.1172/JCI58393; Mauldin JP, 2008, CIRCULATION, V117, P2785, DOI 10.1161/CIRCULATIONAHA.107.741314; Murphy AJ, 2011, J CLIN INVEST, V121, P4138, DOI 10.1172/JCI57559; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Yvan-Charvet L, 2010, CIRC RES, V106, P1861, DOI 10.1161/CIRCRESAHA.110.217281; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731	9	2	2	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	AUG 3	2012	11	2					143	144		10.1016/j.stem.2012.07.009	http://dx.doi.org/10.1016/j.stem.2012.07.009			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	987QQ	22862939	Bronze, Green Accepted			2022-12-28	WOS:000307432600004
J	Jang, H; Kim, TW; Yoon, S; Choi, SY; Kang, TW; Kim, SY; Kwon, YW; Cho, EJ; Youn, HD				Jang, Hyonchol; Kim, Tae Wan; Yoon, Sungho; Choi, Soo-Youn; Kang, Tae-Wook; Kim, Seon-Young; Kwon, Yoo-Wook; Cho, Eun-Jung; Youn, Hong-Duk			O-GlcNAc Regulates Pluripotency and Reprogramming by Directly Acting on Core Components of the Pluripotency Network	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; SELF-RENEWAL; IN-VITRO; ES CELLS; MOUSE; PROTEINS; DIFFERENTIATION; OCT4; EXPRESSION; GLUCOSE	O-linked-N-acetylglucosamine (O-GlcNAc) has emerged as a critical regulator of diverse cellular processes, but its role in embryonic stem cells (ESCs) and pluripotency has not been investigated. Here we show that O-GlcNAcylation directly regulates core components of the pluripotency network. Blocking O-GlcNAcylation disrupts ESC self-renewal and reprogramming of somatic cells to induced pluripotent stem cells. The core reprogramming factors Oct4 and Sox2 are O-GlcNAcylated in ESCs, but the O-GlcNAc modification is rapidly removed upon differentiation. O-GlcNAc modification of threonine 228 in Oct4 regulates Oct4 transcriptional activity and is important for inducing many pluripotency-related genes, including Klf2, Klf5, Nr5a2, Tbx3, and Tcl1. A T228A point mutation that eliminates this O-GlcNAc modification reduces the capacity of Oct4 to maintain ESC self-renewal and reprogram somatic cells. Overall, our study makes a direct connection between O-GlcNAcylation of key regulatory transcription factors and the activity of the pluripotency network.	[Jang, Hyonchol; Kim, Tae Wan; Yoon, Sungho; Choi, Soo-Youn; Youn, Hong-Duk] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Natl Res Lab Metab Checkpoint, Seoul 110799, South Korea; [Jang, Hyonchol; Kim, Tae Wan; Yoon, Sungho; Choi, Soo-Youn; Youn, Hong-Duk] Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, Natl Res Lab Metab Checkpoint, Seoul 110799, South Korea; [Kang, Tae-Wook; Kim, Seon-Young] KRIBB, Med Genom Res Ctr, Taejon 305806, South Korea; [Kwon, Yoo-Wook] Seoul Natl Univ Hosp, Innovat Res Inst Cell Therapy, Natl Res Lab Cardiovasc Stem Cells, Seoul 110744, South Korea; [Cho, Eun-Jung] Sungkyunkwan Univ, Coll Pharm, Natl Res Lab Chromatin Dynam, Suwon 440746, South Korea; [Youn, Hong-Duk] Seoul Natl Univ, Grad Sch Convergence Sci, WCU Dept Mol Med & Biopharmaceut Sci, Seoul 110799, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Seoul National University (SNU); Seoul National University Hospital; Sungkyunkwan University (SKKU); Seoul National University (SNU)	Youn, HD (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, Natl Res Lab Metab Checkpoint, Seoul 110799, South Korea.	hdyoun@snu.ac.kr	Youn, Hong-Duk/J-2774-2012; Cho, Eun-Jung/AAR-1785-2020; Kan, Tae Wook/CAI-4750-2022; Kim, Tae Wan/GRK-0135-2022	Cho, Eun-Jung/0000-0002-6610-5329; Kim, Tae Wan/0000-0002-0831-6881; Jang, Hyonchol/0000-0003-1436-457X; Kang, Tae-Wook/0000-0002-1121-1562	Mid-Career Research Program; National Research Foundation [NRF-2010-0018896, 2010-0007646]; World Class University Program of the MEST; NRF [R31-2008-000-10103-0]; National Research Foundation of Korea; Korean Government Ministry of Education, Science and Technology [NRF-2010-355-000068]	Mid-Career Research Program; National Research Foundation; World Class University Program of the MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); NRF; National Research Foundation of Korea(National Research Foundation of Korea); Korean Government Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	We thank Dae-Sik Lim (KAIST, Korea) and Sungjoong Lee (Seoul National University, Korea) for advice on setting up the mouse ESC culture, Dong-Yeon Hwang (Cha University, Korea) for advice on iPSC generation and Stbl3 competent cells, Su Cheong Yeom (Center for Animal Resource Development of Seoul National University College of Medicine, Korea) for advice on mouse care and MEF isolation, T. Kitamura (University of Tokyo, Japan) for Plat-E cells, Jungho Kim (Sogang University. Korea) for the pOct4 (10x) TATA luc reporter vector, Lisa Dailey (New York University School of Medicine, USA) for 6xO/S Fgf4 promoter luc reporter vector, Hitoshi Niwa (RIKEN, Japan) for ZHBTc4 cells and pCAG-IP vector, Raymond A. Poot (Erasmus MC, The Netherlands) for ZHBTc4 F-Oct4 cells, Hee-Jin Kim (KRIBB, Korea) for technical assistance to mass spectrometry, and Gum-Yong Kang and Hyung Soon Park (Diatech Korea., Co. LTD) for ESI-MS/MS analysis. This work was supported by grants from the Mid-Career Research Program, the National Research Foundation (NRF-2010-0018896 and 2010-0007646 to H.-D.Y.), the World Class University Program of the MEST and the NRF (R31-2008-000-10103-0), and the National Research Foundation of Korea Grant, funded by the Korean Government Ministry of Education, Science and Technology (NRF-2010-355-000068 to H.J.).	Ambrosetti DC, 2000, J BIOL CHEM, V275, P23387, DOI 10.1074/jbc.M000932200; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Cho HJ, 2010, BLOOD, V116, P386, DOI 10.1182/blood-2010-02-269589; CONAGHAN J, 1993, J REPROD FERTIL, V99, P87; Faherty S, 2007, IN VITRO CELL DEV-AN, V43, P37, DOI 10.1007/s11626-006-9001-5; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Gandy JC, 2006, FEBS LETT, V580, P3051, DOI 10.1016/j.febslet.2006.04.051; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Han JY, 2010, NATURE, V463, P1096, DOI 10.1038/nature08735; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Hanover JA, 2010, BBA-GEN SUBJECTS, V1800, P80, DOI 10.1016/j.bbagen.2009.07.017; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 2010, CELL, V143, P672, DOI 10.1016/j.cell.2010.11.008; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Hu P, 2010, FEBS LETT, V584, P2526, DOI 10.1016/j.febslet.2010.04.044; Jang H, 2009, NAT STRUCT MOL BIOL, V16, P910, DOI 10.1038/nsmb.1657; Khidekel N, 2004, P NATL ACAD SCI USA, V101, P13132, DOI 10.1073/pnas.0403471101; Kim HS, 2009, FEBS LETT, V583, P2474, DOI 10.1016/j.febslet.2009.06.052; Lee J, 2010, BIOCHEM J, V426, P171, DOI 10.1042/BJ20091439; Lee JW, 2005, STEM CELLS, V23, P738, DOI 10.1634/stemcells.2004-0375; Love DC, 2010, SEMIN CELL DEV BIOL, V21, P646, DOI 10.1016/j.semcdb.2010.05.001; Mochizuki H, 2011, J BIOSCI BIOENG, V111, P92, DOI 10.1016/j.jbiosc.2010.09.001; Myers SA, 2011, P NATL ACAD SCI USA, V108, P9490, DOI 10.1073/pnas.1019289108; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; Okita K, 2010, EXP CELL RES, V316, P2565, DOI 10.1016/j.yexcr.2010.04.023; Pannell D, 2001, REV MED VIROL, V11, P205, DOI 10.1002/rmv.316; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Patel M, 2010, STEM CELL REV REP, V6, P367, DOI 10.1007/s12015-010-9123-8; QUINN P, 1995, J ASSIST REPROD GEN, V12, P97, DOI 10.1007/BF02211377; Rigbolt KTG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001570; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Saxe JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004467; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Sharov AA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-269; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Sutton-McDowall ML, 2006, BIOL REPROD, V74, P881, DOI 10.1095/biolreprod.105.048553; Swaney DL, 2009, P NATL ACAD SCI USA, V106, P995, DOI 10.1073/pnas.0811964106; Toleman C, 2006, BIOCHEM BIOPH RES CO, V340, P526, DOI 10.1016/j.bbrc.2005.12.041; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Webster DM, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-28; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678	45	215	219	0	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUL 6	2012	11	1					62	74		10.1016/j.stem.2012.03.001	http://dx.doi.org/10.1016/j.stem.2012.03.001			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	975SS	22608532	Bronze			2022-12-28	WOS:000306532400010
J	Luis, NM; Morey, L; Di Croce, L; Benitah, SA				Miguel Luis, Nuno; Morey, Lluis; Di Croce, Luciano; Aznar Benitah, Salvador			Polycomb in Stem Cells: PRC1 Branches Out	CELL STEM CELL			English	Review							SELF-RENEWAL; HEMATOPOIETIC STEM; CHROMATIN-STRUCTURE; SMALL-INTESTINE; PROTEINS; GENES; BMI-1; PROLIFERATION; MAINTENANCE; CBX7	Polycomb group proteins (PcGs) generate chromatin-modifying complexes that regulate gene expression. PcGs are categorized into two major groups, polycomb repressive complex 1 (PRC1) and 2 (PRC2), which have classically been thought to function together. Here we discuss recent data challenging this model indicating that the distinct subunit composition of PRC1 confers specific and nonoverlapping functions in embryonic and adult stem cells.	[Miguel Luis, Nuno; Morey, Lluis; Di Croce, Luciano; Aznar Benitah, Salvador] CRG, Barcelona 08003, Spain; [Miguel Luis, Nuno; Morey, Lluis; Di Croce, Luciano; Aznar Benitah, Salvador] UPF, Barcelona 08003, Spain; [Di Croce, Luciano] ICREA, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; ICREA	Di Croce, L (corresponding author), CRG, Dr Aiguader 88, Barcelona 08003, Spain.	luciano.dicroce@crg.eu; salvador.aznar-benitah@crg.eu	Di Croce, Luciano/E-7759-2015; Luis, Nuno/F-2405-2012; Aznar-Benitah, Salvador/F-4761-2016; Luis, Nuno Miguel/ABD-9784-2020	Di Croce, Luciano/0000-0003-3488-6228; Luis, Nuno/0000-0001-5438-9638; Aznar-Benitah, Salvador/0000-0002-9059-5049; Luis, Nuno Miguel/0000-0001-5438-9638; Morey, Lluis/0000-0001-9851-4066	Spanish "Ministerio de Educacion y Ciencia"; AICR (Association for International Cancer Research); AGAUR (Government of Catalunya); ICREA Funding Source: Custom; Worldwide Cancer Research [10-0177] Funding Source: researchfish	Spanish "Ministerio de Educacion y Ciencia"(Spanish Government); AICR (Association for International Cancer Research); AGAUR (Government of Catalunya); ICREA(ICREA); Worldwide Cancer Research	We are indebted to V.A. Raker, the reviewers, and the editorial board of Cell Stem Cell for help in preparing and editing the manuscript. This work was supported by grants from the Spanish "Ministerio de Educacion y Ciencia," from AICR (Association for International Cancer Research) and from AGAUR (Government of Catalunya) to L.D.C. and to S.A.B. We apologize to those whose primary work has not been cited because of space limitations.	Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Brookes E, 2012, CELL STEM CELL, V10, P157, DOI 10.1016/j.stem.2011.12.017; Bruggeman SWM, 2009, BBA-GEN SUBJECTS, V1790, P351, DOI 10.1016/j.bbagen.2009.03.009; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Chagraoui J, 2006, GENE DEV, V20, P2110, DOI 10.1101/gad.1453406; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Fasano CA, 2009, GENE DEV, V23, P561, DOI 10.1101/gad.1743709; Forzati F, 2012, J CLIN INVEST, V122, P612, DOI 10.1172/JCI58620; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Hisada K, 2012, MOL CELL BIOL, V32, P1139, DOI 10.1128/MCB.06441-11; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Luis NM, 2011, CELL STEM CELL, V9, P233, DOI 10.1016/j.stem.2011.07.013; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Morey L, 2012, CELL STEM CELL, V10, P47, DOI 10.1016/j.stem.2011.12.006; O'Loghlen A, 2012, CELL STEM CELL, V10, P33, DOI 10.1016/j.stem.2011.12.004; Oguro H, 2006, J EXP MED, V203, P2247, DOI 10.1084/jem.20052477; Oguro H, 2010, CELL STEM CELL, V6, P279, DOI 10.1016/j.stem.2010.01.005; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Pietersen AM, 2008, CURR BIOL, V18, P1094, DOI 10.1016/j.cub.2008.06.070; Qin J., 2012, CELL STEM CELL; Richly H, 2010, NATURE, V468, P1124, DOI 10.1038/nature09574; Rizo A, 2008, BLOOD, V111, P2621, DOI 10.1182/blood-2007-08-106666; Roman-Trufero M, 2009, STEM CELLS, V27, P1559, DOI 10.1002/stem.82; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Senthilkumar R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-549; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Trojer P, 2011, MOL CELL, V42, P438, DOI 10.1016/j.molcel.2011.04.004; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Yang LQ, 2011, CELL, V147, P773, DOI 10.1016/j.cell.2011.08.054; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yu M, 2012, MOL CELL, V45, P330, DOI 10.1016/j.molcel.2011.11.032	45	55	57	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 6	2012	11	1					16	21		10.1016/j.stem.2012.06.005	http://dx.doi.org/10.1016/j.stem.2012.06.005			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	975SS	22770239	Bronze			2022-12-28	WOS:000306532400006
J	Wang, J; Gallagher, D; DeVito, LM; Cancino, GI; Tsui, D; He, L; Keller, GM; Frankland, PW; Kaplan, DR; Miller, FD				Wang, Jing; Gallagher, Denis; DeVito, Loren M.; Cancino, Gonzalo I.; Tsui, David; He, Ling; Keller, Gordon M.; Frankland, Paul W.; Kaplan, David R.; Miller, Freda D.			Metformin Activates an Atypical PKC-CBP Pathway to Promote Neurogenesis and Enhance Spatial Memory Formation	CELL STEM CELL			English	Article							RUBINSTEIN-TAYBI-SYNDROME; STEM-CELLS; ADULT NEUROGENESIS; NEURAL CONVERSION; HUMAN ES; BRAIN; PROTEIN; PHOSPHORYLATION; DIFFERENTIATION; HEMATOPOIESIS	Although endogenous recruitment of adult neural stem cells has been proposed as a therapeutic strategy, clinical approaches for achieving this are lacking. Here, we show that metformin, a widely used drug, promotes neurogenesis and enhances spatial memory formation. Specifically, we show that an atypical PKC-CBP pathway is essential for the normal genesis of neurons from neural precursors and that metformin activates this pathway to promote rodent and human neurogenesis in culture. Metformin also enhances neurogenesis in the adult mouse brain in a CBP-dependent fashion, and in so doing enhances spatial reversal learning in the water maze. Thus, metformin, by activating an aPKC-CBP pathway, recruits neural stem cells and enhances neural function, thereby providing a candidate pharmacological approach for nervous system therapy.	[Wang, Jing; Gallagher, Denis; Cancino, Gonzalo I.; Tsui, David; Miller, Freda D.] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Wang, Jing; Gallagher, Denis; Cancino, Gonzalo I.; Kaplan, David R.] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [DeVito, Loren M.; Frankland, Paul W.] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Gallagher, Denis; Keller, Gordon M.; Miller, Freda D.] Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON M5G 1L7, Canada; [Tsui, David; Frankland, Paul W.; Kaplan, David R.; Miller, Freda D.] Univ Toronto, Inst Med Sci, Toronto, ON M5SG 1A8, Canada; [Frankland, Paul W.; Miller, Freda D.] Univ Toronto, Dept Physiol, Toronto, ON M5SG 1A8, Canada; [Kaplan, David R.; Miller, Freda D.] Univ Toronto, Dept Mol Genet, Toronto, ON M5SG 1A8, Canada; [He, Ling] Johns Hopkins Med Sch, Dept Pediat & Med, Baltimore, MD 21287 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; Johns Hopkins University; Johns Hopkins Medicine	Miller, FD (corresponding author), Hosp Sick Children, Program Dev & Stem Cell Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	fredam@sickkids.ca	Cancino, Gonzalo/ABF-6049-2021	Wang, Jing/0000-0003-2410-4771; Keller, Gordon/0000-0001-9309-9297; Cancino, Gonzalo/0000-0001-8697-7282; , Loren/0000-0003-3695-1513	Multiple Sclerosis Society of Canada; Three to Be Foundation; McEwen Center; Alzheimer Society; Heart and Stroke Foundation of Canada; CIHR [MOP86762, MOP13958]; McEwen Center for Regenerative Medicine; Canadian Stem Cell Network; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK085142] Funding Source: NIH RePORTER	Multiple Sclerosis Society of Canada; Three to Be Foundation; McEwen Center; Alzheimer Society; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); CIHR(Canadian Institutes of Health Research (CIHR)); McEwen Center for Regenerative Medicine; Canadian Stem Cell Network; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors would like to thank Dennis Aquino, Sibel Naska, and Mark Gagliardi for technical support, advice, and discussions and Fred Wondisford for valuable insights and support. J.W. was supported by fellowships from the Multiple Sclerosis Society of Canada and the Three to Be Foundation, D.G. by a McEwen Center McMurrich fellowship, L.M.D. by an Alzheimer Society of Canada fellowship, G.I.C. by a Heart and Stroke Foundation of Canada fellowship, and D.T. by a CIHR Michael Smith studentship. P.W.F., D.R.K., and F.D.M. are Canada Research Chairs. This work was supported by funding from the CIHR (MOP86762 and MOP13958), the McEwen Center for Regenerative Medicine, the Canadian Stem Cell Network, and the Three to Be Foundation.	Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Beeri MS, 2008, NEUROLOGY, V71, P750, DOI 10.1212/01.wnl.0000324925.95210.6d; Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Costa MR, 2008, DEVELOPMENT, V135, P11, DOI 10.1242/dev.009951; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Fujitani M, 2010, CURR BIOL, V20, P2058, DOI 10.1016/j.cub.2010.10.029; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Imai F, 2006, DEVELOPMENT, V133, P1735, DOI 10.1242/dev.02330; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kung AL, 2000, GENE DEV, V14, P272; Li WL, 2012, STEM CELLS, V30, P61, DOI 10.1002/stem.768; Lopez-Atalaya JP, 2011, EMBO J, V30, P4287, DOI 10.1038/emboj.2011.299; Ma TC, 2007, NEUROSCI LETT, V411, P98, DOI 10.1016/j.neulet.2006.10.039; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Messerschmidt A, 2005, J MOL BIOL, V352, P918, DOI 10.1016/j.jmb.2005.07.060; Miller FD, 2012, CELL STEM CELL, V10, P650, DOI 10.1016/j.stem.2012.05.004; Morshead CM, 1998, DEVELOPMENT, V125, P2251; Naik MU, 2000, J COMP NEUROL, V426, P243, DOI 10.1002/1096-9861(20001016)426:2<243::AID-CNE6>3.0.CO;2-8; Oster H, 2004, MOL BRAIN RES, V127, P79, DOI 10.1016/j.molbrainres.2004.05.009; Stone SSD, 2011, J NEUROSCI, V31, P13469, DOI 10.1523/JNEUROSCI.3100-11.2011; Wang J, 2010, DEV CELL, V18, P114, DOI 10.1016/j.devcel.2009.10.023; Wojtowicz JM, 2006, NAT PROTOC, V1, P1399, DOI 10.1038/nprot.2006.224; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhou JX, 2010, STEM CELLS, V28, P1741, DOI 10.1002/stem.504	28	312	320	2	55	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUL 6	2012	11	1					23	35		10.1016/j.stem.2012.03.016	http://dx.doi.org/10.1016/j.stem.2012.03.016			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	975SS	22770240	Bronze			2022-12-28	WOS:000306532400007
J	Benz, C; Copley, MR; Kent, DG; Wohrer, S; Cortes, A; Aghaeepour, N; Ma, E; Mader, H; Rowe, K; Day, C; Treloar, D; Brinkman, RR; Eaves, CJ				Benz, Claudia; Copley, Michael R.; Kent, David G.; Wohrer, Stefan; Cortes, Adrian; Aghaeepour, Nima; Ma, Elaine; Mader, Heidi; Rowe, Keegan; Day, Christopher; Treloar, David; Brinkman, Ryan R.; Eaves, Connie J.			Hematopoietic Stem Cell Subtypes Expand Differentially during Development and Display Distinct Lymphopoietic Programs	CELL STEM CELL			English	Article							LIMITING DILUTION ANALYSIS; IN-VIVO; B-LYMPHOPOIESIS; CLONAL ANALYSIS; AGED MICE; TERM; POPULATIONS; COMPARTMENT; HETEROGENEITY; REPOPULATION	Adult hematopoietic stem cells (HSCs) with serially transplantable activity comprise two subtypes. One shows a balanced output of mature lymphoid and myeloid cells; the other appears selectively lymphoid deficient. We now show that both of these HSC subtypes are present in the fetal liver (at a 1:10 ratio) with the rarer, lymphoid-deficient HSCs immediately gaining an increased representation in the fetal bone marrow, suggesting that the marrow niche plays a key role in regulating their ensuing preferential amplification. Clonal analysis of HSC expansion posttransplant showed that both subtypes display an extensive but variable self-renewal activity with occasional interconversion. Clonal analysis of their differentiation programs demonstrated functional and molecular as well as quantitative HSC subtype-specific differences in the lymphoid progenitors they generate but an indistinguishable production of multipotent and myeloid-restricted progenitors. These findings establish a level of heterogeneity in HSC differentiation and expansion control that may have relevance to stem cell populations in other hierarchically organized tissues.	[Benz, Claudia; Copley, Michael R.; Kent, David G.; Wohrer, Stefan; Cortes, Adrian; Aghaeepour, Nima; Ma, Elaine; Mader, Heidi; Rowe, Keegan; Day, Christopher; Treloar, David; Brinkman, Ryan R.; Eaves, Connie J.] BC Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Brinkman, Ryan R.; Eaves, Connie J.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada	British Columbia Cancer Agency; University of British Columbia	Eaves, CJ (corresponding author), BC Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada.	ceaves@bccrc.ca	Kent, David/F-1084-2013; Brinkman, Ryan/B-1108-2008; Kent, David/AAZ-4916-2021	Brinkman, Ryan/0000-0002-9765-2990; Kent, David/0000-0001-7871-8811; Day, Christopher/0000-0001-8737-2322; Eaves, Connie/0000-0002-3452-1926	National Cancer Institute of Canada (NCIC, Toronto, ON); Terry Fox Foundation; Canadian Institutes of Health Research (CIHR, Toronto, ON); Canadian Cancer Society [700374]; Terry Fox Research Institute; Deutsche Forschungsgemeinschaft (DFG, Bonn, Germany); Michael Smith Foundation for Health Research (MSFHR); CIHR; MSFHR; Austrian Science Fund (Vienna, Austria	National Cancer Institute of Canada (NCIC, Toronto, ON); Terry Fox Foundation; Canadian Institutes of Health Research (CIHR, Toronto, ON)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Terry Fox Research Institute; Deutsche Forschungsgemeinschaft (DFG, Bonn, Germany)(German Research Foundation (DFG)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); CIHR(Canadian Institutes of Health Research (CIHR)); MSFHR(Michael Smith Foundation for Health Research); Austrian Science Fund (Vienna, Austria(Austrian Science Fund (FWF))	We thank the Flow Cytometry Facility of the Terry Fox Laboratory, the Animal Resource Centre of the BC Cancer Agency, and A. Cheung, M. Kardel, I. Sloma, and B. Dykstra for helpful comments. This work was supported by grants from the National Cancer Institute of Canada (NCIC, Toronto, ON, with funds from the Terry Fox Foundation), the Canadian Institutes of Health Research (CIHR, Toronto, ON), the Canadian Cancer Society (grant 700374), the Terry Fox Research Institute, and the Terry Fox Foundation. C.B. received a fellowship from the Deutsche Forschungsgemeinschaft (DFG, Bonn, Germany); M.R.C. received a studentship from the Michael Smith Foundation for Health Research (MSFHR), Vanier Canada Graduate Scholarship from CIHR, and an MD/PhD Graduate Training Award from CIHR; D.G.K. received studentships from CIHR and MSFHR; S.W. received an Erwin Schroedinger Auslands Fellowship from the Austrian Science Fund (Vienna, Austria); and R.R.B. held a MSFHR Scholar Award.	Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; BOGGS DR, 1984, AM J HEMATOL, V16, P277, DOI 10.1002/ajh.2830160309; Bowie MB, 2007, P NATL ACAD SCI USA, V104, P5878, DOI 10.1073/pnas.0700460104; Bowie MB, 2006, J CLIN INVEST, V116, P2808, DOI 10.1172/JCI28310; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Cho RH, 2008, BLOOD, V111, P5553, DOI 10.1182/blood-2007-11-123547; Colvin GA, 2004, LEUKEMIA, V18, P575, DOI 10.1038/sj.leu.2403268; DICK JE, 1985, CELL, V42, P71, DOI 10.1016/S0092-8674(85)80102-1; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Dykstra B, 2011, J EXP MED, V208, P2691, DOI 10.1084/jem.20111490; Dzierzak E, 2005, CURR OPIN HEMATOL, V12, P197, DOI 10.1097/01.moh.0000160736.44726.0e; FLEMING WH, 1993, J CELL BIOL, V122, P897, DOI 10.1083/jcb.122.4.897; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; KELLER G, 1990, J EXP MED, V171, P1407, DOI 10.1084/jem.171.5.1407; Kent D, 2007, CURR PROTOC STEM CEL; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kiel MJ, 2005, DEV BIOL, V283, P29, DOI 10.1016/j.ydbio.2005.03.037; Labrie JE, 2004, J EXP MED, V200, P411, DOI 10.1084/jem.20040845; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; Lescale C, 2010, AGING CELL, V9, P410, DOI 10.1111/j.1474-9726.2010.00566.x; Lu R, 2011, NAT BIOTECHNOL, V29, P928, DOI 10.1038/nbt.1977; Miller JP, 2005, SEMIN IMMUNOL, V17, P321, DOI 10.1016/j.smim.2005.05.003; Miller JP, 2003, J IMMUNOL, V171, P2326, DOI 10.4049/jimmunol.171.5.2326; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Muller-Sieburg CE, 2004, BLOOD, V103, P4111, DOI 10.1182/blood-2003-10-3448; Muller-Sieburg CE, 2006, CURR OPIN HEMATOL, V13, P243, DOI 10.1097/01.moh.0000231421.00407.65; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Northrup DL, 2008, IMMUNOL RES, V42, P106, DOI 10.1007/s12026-008-8043-z; Papathanasiou P, 2009, STEM CELLS, V27, P2498, DOI 10.1002/stem.170; Pawliuk R, 1996, BLOOD, V88, P2852, DOI 10.1182/blood.V88.8.2852.bloodjournal8882852; Randall TD, 1997, BLOOD, V89, P3596, DOI 10.1182/blood.V89.10.3596.3596_3596_3606; Rebel VI, 1996, BLOOD, V87, P3500, DOI 10.1182/blood.V87.8.3500.bloodjournal8783500; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; SMITH LG, 1991, P NATL ACAD SCI USA, V88, P2788, DOI 10.1073/pnas.88.7.2788; SPANGRUDE GJ, 1995, BLOOD, V85, P1006, DOI 10.1182/blood.V85.4.1006.bloodjournal8541006; Szilvassy SJ, 2003, EXP HEMATOL, V31, P331, DOI 10.1016/S0301-472X(03)00005-5; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; WU AM, 1968, J EXP MED, V127, P455, DOI 10.1084/jem.127.3.455; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Zhong RK, 1996, J IMMUNOL, V157, P138	47	208	210	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAR 2	2012	10	3					273	283		10.1016/j.stem.2012.02.007	http://dx.doi.org/10.1016/j.stem.2012.02.007			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	908BX	22385655	Bronze			2022-12-28	WOS:000301466500009
J	Zaidi, M; Sun, L; Blair, HC				Zaidi, Mone; Sun, Li; Blair, Harry C.			Special Stem Cells for Bone	CELL STEM CELL			English	Editorial Material							MARROW; NICHE	Mesenchymal stem cells (MSCs) are multipotential in vitro, but their endogenous properties are poorly defined. In this issue of Cell Stem Cell, Park et al. (2012) report that an MSC-like, osteolineage-directed Mx1+ population generates new osteoblasts at sites of bone damage, suggesting its potential for skeletal repair and regeneration.	[Zaidi, Mone; Sun, Li] Mt Sinai Sch Med, Dept Med, Mt Sinai Bone Program, New York, NY 10029 USA; [Blair, Harry C.] Univ Pittsburgh, Sch Med, Pittsburgh VA Med Ctr, Pittsburgh, PA 15260 USA; [Blair, Harry C.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA; [Blair, Harry C.] Univ Pittsburgh, Sch Med, Dept Physiol & Cell Biol, Pittsburgh, PA 15260 USA	Icahn School of Medicine at Mount Sinai; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zaidi, M (corresponding author), Mt Sinai Sch Med, Dept Med, Mt Sinai Bone Program, New York, NY 10029 USA.	mone.zaidi@mssm.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080459] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK080459] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baliram R, 2011, P NATL ACAD SCI USA, V108, P16277, DOI 10.1073/pnas.1110286108; Egea V, 2011, CELL DEATH DIFFER, V18, P853, DOI 10.1038/cdd.2010.154; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Khosla S, 2010, STEM CELLS, V28, P2124, DOI 10.1002/stem.546; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Sun L, 2006, CELL, V125, P247, DOI 10.1016/j.cell.2006.01.051; Wynn RF, 2004, BLOOD, V104, P2643, DOI 10.1182/blood-2004-02-0526; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593	10	8	9	1	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAR 2	2012	10	3					233	234		10.1016/j.stem.2012.02.012	http://dx.doi.org/10.1016/j.stem.2012.02.012			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	908BX	22385649	Bronze			2022-12-28	WOS:000301466500002
J	Wang, Z; Ouyang, GL				Wang, Zhe; Ouyang, Gaoliang			Periostin: A Bridge between Cancer Stem Cells and Their Metastatic Niche	CELL STEM CELL			English	Editorial Material							TUMOR-GROWTH; COLON-CANCER		[Wang, Zhe; Ouyang, Gaoliang] Xiamen Univ, State Key Lab Cellular Stress Biol, Xiamen 361005, Peoples R China; [Wang, Zhe; Ouyang, Gaoliang] Xiamen Univ, Sch Life Sci, Lab Stem Cells & Tumor Metastasis, Xiamen 361005, Peoples R China	Xiamen University; Xiamen University	Ouyang, GL (corresponding author), Xiamen Univ, State Key Lab Cellular Stress Biol, Xiamen 361005, Peoples R China.	oygldz@yahoo.com.cn						Bao SD, 2004, CANCER CELL, V5, P329, DOI 10.1016/S1535-6108(04)00081-9; Coutu DL, 2008, J BIOL CHEM, V283, P17991, DOI 10.1074/jbc.M708029200; Dieter SM, 2011, CELL STEM CELL, V9, P357, DOI 10.1016/j.stem.2011.08.010; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Ouyang GL, 2010, CELL MOL LIFE SCI, V67, P2605, DOI 10.1007/s00018-010-0338-2; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001	10	80	82	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	FEB 3	2012	10	2					111	112		10.1016/j.stem.2012.01.002	http://dx.doi.org/10.1016/j.stem.2012.01.002			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	892FM	22305559	Bronze			2022-12-28	WOS:000300272100004
J	Oshimori, N; Fuchs, E				Oshimori, Naoki; Fuchs, Elaine			Paracrine TGF-beta Signaling Counterbalances BMP-Mediated Repression in Hair Follicle Stem Cell Activation	CELL STEM CELL			English	Article							GROWTH-FACTOR-BETA; BONE MORPHOGENETIC PROTEIN; SELF-RENEWAL; SKIN; REGENERATION; INDUCTION; NICHE; DIFFERENTIATION; PROLIFERATION; HOMEOSTASIS	Hair follicle (HF) regeneration begins when communication between quiescent epithelial stem cells (SCs) and underlying mesenchymal dermal papillae (DP) generates sufficient activating cues to overcome repressive BMP signals from surrounding niche cells. Here, we uncover a hitherto unrecognized DP transmitter, TGF-beta 2, which activates Smad2/3 transiently in HFSCs concomitant with entry into tissue regeneration. This signaling is critical: HFSCs that cannot sense TGF-beta exhibit significant delays in HF regeneration, whereas exogenous TGF-beta 2 stimulates HFSCs in vivo and in vitro. By engineering TGF-beta- and BMP-reporter mice, we show that TGF-beta 2 signaling antagonizes BMP signaling in HFSCs but not through competition for limiting Smad4-coactivator. Rather, our microarray, molecular, and genetic studies unveil Tmeff1 as a direct TGF-beta 2/Smad2/3 target gene, expressed by activated HFSCs and physiologically relevant in restricting and lowering BMP thresholds in the niche. Connecting BMP activity to an SC's response to TGF-beta s may explain why these signaling factors wield such diverse cellular effects.	[Oshimori, Naoki; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016		International Human Frontier Science Program Organization; Japan Society for the Promotion of Science; National Institutes of Health [R01-AR050452]; Emerald Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR031737, R01AR050452] Funding Source: NIH RePORTER	International Human Frontier Science Program Organization(Human Frontier Science Program); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emerald Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank S. Karlsson for floxed-T beta RII mice; D. Padua and S. Tavazoie for information about pSmad2 antibodies; N. Stokes and D. Oristian for in utero lentiviral injections and assistance in the mouse facility; S. Beronja and Y.C. Hsu for critical reading of the manuscript; and S. Williams, M. Schober, T. Chen, M. Kadaja, and other E.F. laboratory members for discussions. We appreciate the assistance of S. Mazel in the RU Flow Cytometry Resource Center, the Comparative Bioscience Center (an American Association of Accreditation of Laboratory Animal Care facility) for expert handling and care of the mice, and Memorial Sloan Kettering Genomics Core Facility for RNA and microarray processing. N.O. was supported by International Human Frontier Science Program Organization and is currently supported by the Japan Society for the Promotion of Science. E.F. is an investigator of the Howard Hughes Medical Institute. This work was supported by grants to E.F. from National Institutes of Health (R01-AR050452) and Emerald Foundation.	Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Botchkarev VA, 2001, FASEB J, V15, P2205, DOI 10.1096/fj.01-0207com; Chang CB, 2003, DEV BIOL, V255, P1, DOI 10.1016/S0012-1606(02)00075-1; CHEIFETZ S, 1987, CELL, V48, P409, DOI 10.1016/0092-8674(87)90192-9; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Enshell-Seijffers D, 2010, DEV CELL, V18, P633, DOI 10.1016/j.devcel.2010.01.016; Foitzik K, 1999, DEV BIOL, V212, P278, DOI 10.1006/dbio.1999.9325; Giacomini D, 2009, MOL ENDOCRINOL, V23, P1102, DOI 10.1210/me.2008-0425; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Guasch G, 2007, CANCER CELL, V12, P313, DOI 10.1016/j.ccr.2007.08.020; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Harms PW, 2003, GENE DEV, V17, P2624, DOI 10.1101/gad.1127703; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Izumi N, 2006, AM J PHYSIOL-LUNG C, V290, pL120, DOI 10.1152/ajplung.00171.2005; Jamora C, 2005, PLOS BIOL, V3, P131, DOI 10.1371/journal.pbio.0030011; Jian HY, 2006, GENE DEV, V20, P666, DOI 10.1101/gad.1388806; Keller B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016421; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Kulessa H, 2000, EMBO J, V19, P6664, DOI 10.1093/emboj/19.24.6664; Leveen P, 2002, BLOOD, V100, P560, DOI 10.1182/blood.V100.2.560; Liu ZY, 2006, J BIOL CHEM, V281, P17156, DOI 10.1074/jbc.M513812200; MASSAGUE J, 1992, MOL REPROD DEV, V32, P99, DOI 10.1002/mrd.1080320204; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; Nishimura EK, 2010, CELL STEM CELL, V6, P130, DOI 10.1016/j.stem.2009.12.010; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Rabbani P, 2011, CELL, V145, P941, DOI 10.1016/j.cell.2011.05.004; Rendl M, 2008, GENE DEV, V22, P543, DOI 10.1101/gad.1614408; RICE RH, 1979, CELL, V18, P681, DOI 10.1016/0092-8674(79)90123-5; Schmidt-Ullrich R, 2005, BIOESSAYS, V27, P247, DOI 10.1002/bies.20184; Sekiya T, 2004, BIOCHEM BIOPH RES CO, V320, P680, DOI 10.1016/j.bbrc.2004.06.017; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tanimura S, 2011, CELL STEM CELL, V8, P177, DOI 10.1016/j.stem.2010.11.029; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Wang SN, 2003, AM J PHYSIOL-RENAL, V284, pF1006, DOI 10.1152/ajprenal.00382.2002; Wrighton KH, 2009, J BIOL CHEM, V284, P9755, DOI 10.1074/jbc.M809223200; Yew KH, 2005, J BIOL CHEM, V280, P32209, DOI 10.1074/jbc.M505465200; Zhang JW, 2006, STEM CELLS, V24, P2826, DOI 10.1634/stemcells.2005-0544	49	244	260	1	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JAN 6	2012	10	1					63	75		10.1016/j.stem.2011.11.005	http://dx.doi.org/10.1016/j.stem.2011.11.005			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	880ZQ	22226356	Bronze, Green Accepted			2022-12-28	WOS:000299449500011
J	Driessens, G; Blanpain, C				Driessens, Gregory; Blanpain, Cedric			Long Live Sox2: Sox2 Lasts a Lifetime	CELL STEM CELL			English	Editorial Material							NEURAL STEM-CELLS; SELF-RENEWAL; ADULT; MULTIPOTENT; ROLES		[Driessens, Gregory; Blanpain, Cedric] Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium	Universite Libre de Bruxelles	Blanpain, C (corresponding author), Univ Libre Bruxelles, IRIBHM, 808 Route Lennik, B-1070 Brussels, Belgium.	cedric.blanpain@ulb.ac.be	Blanpain, Cedric/ABD-8392-2021					Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; Que JW, 2009, DEVELOPMENT, V136, P1899, DOI 10.1242/dev.034629; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002	10	18	20	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	OCT 7	2011	9	4					283	284		10.1016/j.stem.2011.09.007	http://dx.doi.org/10.1016/j.stem.2011.09.007			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	835MT	21982223	Bronze			2022-12-28	WOS:000296041200001
J	Ficz, G; Hore, TA; Santos, F; Lee, HJ; Dean, W; Arand, J; Krueger, F; Oxley, D; Paul, YL; Walter, J; Cook, SJ; Andrews, S; Branco, MR; Reik, W				Ficz, Gabriella; Hore, Timothy A.; Santos, Fatima; Lee, Heather J.; Dean, Wendy; Arand, Julia; Krueger, Felix; Oxley, David; Paul, Yu-Lee; Walter, Joern; Cook, Simon J.; Andrews, Simon; Branco, Miguel R.; Reik, Wolf			FGF Signaling Inhibition in ESCs Drives Rapid Genome-wide Demethylation to the Epigenetic Ground State of Pluripotency	CELL STEM CELL			English	Article							DNA METHYLATION; NAIVE PLURIPOTENCY; ERASURE; CELLS; 5-HYDROXYMETHYLCYTOSINE; IMPRINTS; PROTEINS; DYNAMICS	Genome-wide erasure of DNA methylation takes place in primordial germ cells (PGCs) and early embryos and is linked with pluripotency. Inhibition of Erk1/2 and Gsk3 beta signaling in mouse embryonic stem cells (ESCs) by small-molecule inhibitors (called 2i) has recently been shown to induce hypomethylation. We show by whole-genome bisulphite sequencing that 2i induces rapid and genome-wide demethylation on a scale and pattern similar to that in migratory PGCs and early embryos. Major satellites, intracisternal A particles (IAPs), and imprinted genes remain relatively resistant to erasure. Demethylation involves oxidation of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC), impaired maintenance of 5mC and 5hmC, and repression of the de novo methyltransferases (Dnmt3a and Dnmt3b) and Dnmt3L. We identify a Prdm14- and Nanog-binding cis-acting regulatory region in Dnmt3b that is highly responsive to signaling. These insights provide a framework for understanding how signaling pathways regulate reprogramming to an epigenetic ground state of pluripotency.	[Ficz, Gabriella; Hore, Timothy A.; Santos, Fatima; Lee, Heather J.; Dean, Wendy; Paul, Yu-Lee; Branco, Miguel R.; Reik, Wolf] Babraham Inst, Epigenet Programme, Cambridge CB22 3AT, England; [Krueger, Felix; Andrews, Simon] Babraham Inst, Bioinformat Grp, Cambridge CB22 3AT, England; [Oxley, David] Babraham Inst, Prote Res Grp, Cambridge CB22 3AT, England; [Cook, Simon J.] Babraham Inst, Signalling Programme, Cambridge CB22 3AT, England; [Arand, Julia; Walter, Joern] Univ Saarland, Inst Genet Epigenet, Dept Biol Sci, D-66123 Saarbrucken, Germany; [Branco, Miguel R.; Reik, Wolf] Univ Cambridge, Ctr Trophoblast Res, Cambridge CB2 3EG, England; [Reik, Wolf] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Saarland University; University of Cambridge; Wellcome Trust Sanger Institute	Ficz, G (corresponding author), Babraham Inst, Epigenet Programme, Cambridge CB22 3AT, England.	gabriella.ficz@babraham.ac.uk; wolf.reik@babraham.ac.uk	Arand, Julia/AAD-8640-2020; Branco, Miguel/H-9509-2019; Arand, Julia/AAU-9679-2020; Ficz, Gabriella/HCH-3771-2022; Lee, Heather/M-2670-2019; Reik, Wolf/I-6794-2012; Arand, Julia/AFQ-8652-2022; Walter, Jörn/AFN-6428-2022; Dean, Wendy/GSE-3948-2022; Krueger, Felix/J-3340-2019	Branco, Miguel/0000-0001-9447-1548; Arand, Julia/0000-0002-2357-1119; Lee, Heather/0000-0002-6482-0337; Walter, Jörn/0000-0003-0563-7417; Dean, Wendy/0000-0001-9441-5044; Ficz, Gabriella/0000-0001-9313-9578; Krueger, Felix/0000-0002-5513-3324; Reik, Wolf/0000-0003-0216-9881; Cook, Simon/0000-0001-9087-1616; Hore, Timothy/0000-0002-6735-225X; Santos, Fatima/0000-0002-3854-4084	Wellcome Trust; BBSRC; MRC; EU NoE Epigenesys; EU BLUEPRINT; Human Frontier Science Program; BBSRC [BBS/E/B/0000H334, BBS/E/B/0000S266, BBS/E/B/000C0419, BBS/E/B/000C0417] Funding Source: UKRI; MRC [G0801156, G0801727] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0419, BBS/E/B/0000S266, BBS/E/B/0000H334, BBS/E/B/000C0417, BBS/E/B/0000C199] Funding Source: researchfish; Cancer Research UK [14867] Funding Source: researchfish; Medical Research Council [G0801727, G0801156] Funding Source: researchfish; Worldwide Cancer Research [12-1259] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU NoE Epigenesys; EU BLUEPRINT; Human Frontier Science Program(Human Frontier Science Program); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Worldwide Cancer Research	We thank Kristina Tabbada for help with epigenomics and transcriptomics sequencing, Kristian Helin for providing the TET1 antibody, Shoji Tajima for providing the DNMT3L antibody, Guoliang Xu for providing Tet1<SUP>-/-</SUP> and Tet1wt ESCs, Tony Green for providing Tet2 <SUP>/</SUP> and Tet2wt ESCs, and Kiyoe Ura for providing the p3b -8615/+93 construct. We would like to thank Stefanie Seisenberger for discussions and Cambridge Epigenetix for a prototype oxBS kit to process our samples. This work was funded by the Wellcome Trust, BBSRC, MRC, EU NoE Epigenesys, EU BLUEPRINT, and the Human Frontier Science Program (T.H.).	Arand J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002750; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Grabole N., 2013, EMBO REP; Guibert S, 2012, GENOME RES, V22, P633, DOI 10.1101/gr.130997.111; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; Kagiwada S, 2013, EMBO J, V32, P340, DOI 10.1038/emboj.2012.331; Lanner F, 2010, DEVELOPMENT, V137, P3351, DOI 10.1242/dev.050146; Leitch HG, 2013, NAT STRUCT MOL BIOL, V20, P311, DOI 10.1038/nsmb.2510; Ma ZY, 2011, NAT STRUCT MOL BIOL, V18, P120, DOI 10.1038/nsmb.2000; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Nakamura T, 2012, NATURE, V486, P415, DOI 10.1038/nature11093; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Piccolo FM, 2013, MOL CELL, V49, P1023, DOI 10.1016/j.molcel.2013.01.032; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Seisenberger S, 2013, CURR OPIN CELL BIOL, V25, P281, DOI 10.1016/j.ceb.2013.02.013; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Tomizawa S, 2011, DEVELOPMENT, V138, P811, DOI 10.1242/dev.061416; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Yamaji M, 2013, CELL STEM CELL, V12, P368, DOI 10.1016/j.stem.2012.12.012; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	30	295	299	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 5	2013	13	3					351	359		10.1016/j.stem.2013.06.004	http://dx.doi.org/10.1016/j.stem.2013.06.004			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VQ	23850245	Green Published, hybrid			2022-12-28	WOS:000329570800012
J	Pfaff, N; Cantz, T				Pfaff, Nils; Cantz, Tobias			From Skin to Blood: A New Member Joins the iClub	CELL STEM CELL			English	Editorial Material							STEM-CELL	Transcription-factor-driven direct reprogramming allows lineage conversion of somatic cells that bypasses an intermediate pluripotent state. In this issue of Cell Stem Cell, Pereira et al. (2013) report the induction of cells with hemogenic potential from murine fibroblasts, an important step toward generating patient-specific hematopoietic (stem) cells for clinical application.	[Pfaff, Nils; Cantz, Tobias] Hannover Med Sch, REBIRTH Cluster Excellence, D-30625 Hannover, Germany; [Pfaff, Nils] Max Planck Inst Mol Biomed, Res Grp Reprogramming & Gene Therapy, D-48149 Munster, Germany; [Pfaff, Nils] Max Planck Inst Mol Biomed, Inst Expt Hematol, D-48149 Munster, Germany; [Cantz, Tobias] Max Planck Inst Mol Biomed, Res Grp Translat Hepatol & Stem Cell Biol, D-48149 Munster, Germany; [Cantz, Tobias] Max Planck Inst Mol Biomed, D-48149 Munster, Germany	Hannover Medical School; Max Planck Society; Max Planck Society; Max Planck Society; Max Planck Society	Cantz, T (corresponding author), Hannover Med Sch, REBIRTH Cluster Excellence, D-30625 Hannover, Germany.	cantz.tobias@mh-hannover.de	Cantz, Tobias/Q-7081-2019	Cantz, Tobias/0000-0002-1382-9577				Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Graf T, 2011, CELL STEM CELL, V9, P504, DOI 10.1016/j.stem.2011.11.012; Ladewig J, 2013, NAT REV MOL CELL BIO, V14, P225, DOI 10.1038/nrm3543; Liu XP, 2013, NAT CELL BIOL, V15, P829, DOI 10.1038/ncb2765; McKinney-Freeman S, 2012, CELL STEM CELL, V11, P701, DOI 10.1016/j.stem.2012.07.018; Pereira CF, 2013, CELL STEM CELL, V13, P205, DOI 10.1016/j.stem.2013.05.024; Pfaff N, 2012, J MOL MED, V90, P747, DOI 10.1007/s00109-012-0922-z; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wu GM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001099; Zhou Q, 2012, CELL STEM CELL, V10, P347, DOI 10.1016/j.stem.2012.03.005	10	3	4	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 1	2013	13	2					131	133		10.1016/j.stem.2013.07.007	http://dx.doi.org/10.1016/j.stem.2013.07.007			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VO	23910075	Bronze			2022-12-28	WOS:000329570600001
J	Merkle, FT; Eggan, K				Merkle, Florian T.; Eggan, Kevin			Modeling Human Disease with Pluripotent Stem Cells: from Genome Association to Function	CELL STEM CELL			English	Review							DEPENDENT ADENOVIRAL VECTORS; PATIENT-SPECIFIC IPSCS; GENE-EXPRESSION; DEFINED FACTORS; DIRECT CONVERSION; HUMAN FIBROBLASTS; MOTOR-NEURONS; BIOMEDICAL-RESEARCH; ALZHEIMERS-DISEASE; RETT-SYNDROME	Mechanistic insights into human disease may enable the development of treatments that are effective in broad patient populations. The confluence of gene-editing technologies, induced pluripotent stem cells, and genome-wide association as well as DNA sequencing studies is enabling new approaches for illuminating the molecular basis of human disease. We discuss the opportunities and challenges of combining these technologies and provide a workflow for interrogating the contribution of disease-associated candidate genetic variants to disease-relevant phenotypes. Finally, we discuss the potential utility of human pluripotent stem cells for placing disease-associated genetic variants into molecular pathways.	[Merkle, Florian T.; Eggan, Kevin] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Merkle, Florian T.; Eggan, Kevin] Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Merkle, Florian T.; Eggan, Kevin] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University	Eggan, K (corresponding author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.	keggan@scrb.harvard.edu	Eggan, Kevin/P-7119-2018	Merkle, Florian/0000-0002-8513-2998	Harvard Stem Cell Institute	Harvard Stem Cell Institute	We thank L. Williams, S. Han, B. Davis-Dusenbery, and A. Pauli for comments and discussions that improved this manuscript. F.T.M. is supported by a grant from the Harvard Stem Cell Institute. K.E. is an investigator with the Howard Hughes Medical Institute.	Aizawa E, 2012, MOL THER, V20, P424, DOI 10.1038/mt.2011.266; Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; Bellin M, 2012, NAT REV MOL CELL BIO, V13, P713, DOI 10.1038/nrm3448; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blum B, 2012, NAT BIOTECHNOL, V30, P261, DOI 10.1038/nbt.2141; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Carroll D, 2006, NAT PROTOC, V1, P1329, DOI 10.1038/nprot.2006.231; Chae JI, 2012, BIOCHEM J, V446, P359, DOI 10.1042/BJ20111495; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938; Colten HR, 2006, SLEEP DISORDERS SLEE; Committee on a Framework for Developing a New Taxonomy of Disease, 2011, PREC MED BUILD KNOWL; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cooper-Knock J, 2012, NAT REV NEUROL, V8, P518, DOI 10.1038/nrneurol.2012.156; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Dyken ME, 2005, PRIMARY CARE, V32, P389, DOI 10.1016/j.pop.2005.02.012; Engle SJ, 2013, CELL STEM CELL, V12, P669, DOI 10.1016/j.stem.2013.05.011; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Garbern JC, 2013, CELL STEM CELL, V12, P689, DOI 10.1016/j.stem.2013.05.008; Gotter AL, 2012, PROG BRAIN RES, V198, P163, DOI 10.1016/B978-0-444-59489-1.00010-0; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; HD iPSC Consortium, 2012, CELL STEM CELL, V11, P264, DOI 10.1016/j.stem.2012.04.027; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kim C, 2013, NATURE, V494, P105, DOI 10.1038/nature11799; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lafaille FG, 2012, NATURE, V491, P769, DOI 10.1038/nature11583; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Larsson HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049874; Lee G, 2012, NAT BIOTECHNOL, V30, P1244, DOI 10.1038/nbt.2435; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Li LB, 2012, CELL STEM CELL, V11, P615, DOI 10.1016/j.stem.2012.08.004; Liu GH, 2012, NATURE, V491, P603, DOI 10.1038/nature11557; Lloyd KCK, 2011, ANN NY ACAD SCI, V1245, P24, DOI 10.1111/j.1749-6632.2011.06311.x; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Mekhoubad S, 2012, CELL STEM CELL, V10, P595, DOI 10.1016/j.stem.2012.02.014; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Prigodich AE, 2009, ACS NANO, V3, P2147, DOI 10.1021/nn9003814; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Reinhardt P, 2013, CELL STEM CELL, V12, P354, DOI 10.1016/j.stem.2013.01.008; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Rosenberg NA, 2010, NAT REV GENET, V11, P356, DOI 10.1038/nrg2760; Rubin LL, 2008, CELL, V132, P549, DOI 10.1016/j.cell.2008.02.010; Saha K, 2009, CELL STEM CELL, V5, P584, DOI 10.1016/j.stem.2009.11.009; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Seok J., 2013, P NATL ACAD SCI; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Spear BB, 2001, TRENDS MOL MED, V7, P201, DOI 10.1016/S1471-4914(01)01986-4; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; Suzuki K, 2008, P NATL ACAD SCI USA, V105, P13781, DOI 10.1073/pnas.0806976105; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Taneja P, 2009, J NEUROSCI, V29, P12187, DOI 10.1523/JNEUROSCI.3156-09.2009; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tohyama S, 2013, CELL STEM CELL, V12, P127, DOI 10.1016/j.stem.2012.09.013; Vierbuchen T, 2011, NAT BIOTECHNOL, V29, P892, DOI 10.1038/nbt.1946; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Williams LA, 2012, CELL, V149, P1174, DOI 10.1016/j.cell.2012.05.015; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Young MA, 2012, CELL STEM CELL, V10, P570, DOI 10.1016/j.stem.2012.03.002; Yu DX, 2013, CELL STEM CELL, V12, P678, DOI 10.1016/j.stem.2013.05.018; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	89	134	139	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 6	2013	12	6					656	668		10.1016/j.stem.2013.05.016	http://dx.doi.org/10.1016/j.stem.2013.05.016			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VH	23746975	Bronze			2022-12-28	WOS:000329569900009
J	Maroof, AM; Keros, S; Tyson, JA; Ying, SW; Ganat, YM; Merkle, FT; Liu, B; Goulburn, A; Stanley, EG; Elefanty, AG; Widmer, HR; Eggan, K; Goldstein, PA; Anderson, SA; Studer, L				Maroof, Asif M.; Keros, Sotirios; Tyson, Jennifer A.; Ying, Shui-Wang; Ganat, Yosif M.; Merkle, Florian T.; Liu, Becky; Goulburn, Adam; Stanley, Edouard G.; Elefanty, Andrew G.; Widmer, Hans Ruedi; Eggan, Kevin; Goldstein, Peter A.; Anderson, Stewart A.; Studer, Lorenz			Directed Differentiation and Functional Maturation of Cortical Interneurons from Human Embryonic Stem Cells	CELL STEM CELL			English	Article							MEDIAL GANGLIONIC EMINENCE; HUMAN CEREBRAL-CORTEX; NEURAL DEVELOPMENT; BASAL FOREBRAIN; HUMAN NEOCORTEX; FLOOR PLATE; MOUSE-BRAIN; HUMAN ES; NEURONS; EXPRESSION	Human pluripotent stem cells are a powerful tool for modeling brain development and disease. The human cortex is composed of two major neuronal populations: projection neurons and local interneurons. Cortical interneurons comprise a diverse class of cell types expressing the neurotransmitter GABA. Dysfunction of cortical interneurons has been implicated in neuropsychiatric diseases, including schizophrenia, autism, and epilepsy. Here, we demonstrate the highly efficient derivation of human cortical interneurons in an NKX2.1::GFP human embryonic stem cell reporter line. Manipulating the timing of SHH activation yields three distinct GFP+ populations with specific transcriptional profiles, neurotransmitter phenotypes, and migratory behaviors. Further differentiation in a murine cortical environment yields parvalbumin- and somatostatin-expressing neurons that exhibit synaptic inputs and electrophysiological properties of cortical interneurons. Our study defines the signals sufficient for modeling human ventral forebrain development in vitro and lays the foundation for studying cortical interneuron involvement in human disease pathology.	[Maroof, Asif M.; Ganat, Yosif M.; Liu, Becky; Studer, Lorenz] Sloan Kettering Inst Canc Res, Ctr Stem Cell Biol, New York, NY 10065 USA; [Maroof, Asif M.; Ganat, Yosif M.; Liu, Becky; Studer, Lorenz] Sloan Kettering Inst Canc Res, Dev Biol Program, New York, NY 10065 USA; [Tyson, Jennifer A.; Goulburn, Adam; Anderson, Stewart A.] Weill Cornell Med Coll, Dept Psychiat, New York, NY 10021 USA; [Keros, Sotirios; Ying, Shui-Wang; Goldstein, Peter A.] Weill Cornell Med Coll, Dept Anesthesiol, New York, NY 10021 USA; [Keros, Sotirios] Weill Cornell Med Coll, Div Pediat Neurol, Dept Pediat, New York, NY 10021 USA; [Stanley, Edouard G.; Elefanty, Andrew G.] Monash Univ, Monash Immunol & Stem Cell Labs, Clayton, Vic 3800, Australia; [Widmer, Hans Ruedi] Univ Bern, Dept Neurosurg, Inselspital, CH-3010 Bern, Switzerland; [Maroof, Asif M.; Merkle, Florian T.; Eggan, Kevin] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Anderson, Stewart A.] Childrens Hosp Philadelphia, Dept Psychiat, Philadelphia, PA 19104 USA; [Anderson, Stewart A.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Stanley, Edouard G.; Elefanty, Andrew G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Cornell University; Monash University; University of Bern; Harvard University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Anderson, SA (corresponding author), Sloan Kettering Inst Canc Res, Ctr Stem Cell Biol, New York, NY 10065 USA.	andersons3@email.chop.edu; studerl@mskcc.org	Studer, Lorenz/ABH-1491-2021; Stanley, Ed G/A-2985-2013; Ritter, Stefanie L/D-9312-2012; Eggan, Kevin/P-7119-2018; Widmer, Hans R./AAC-8948-2022; Widmer, Hans Rudolf/O-5172-2017; Elefanty, Andrew G/A-6066-2008	Studer, Lorenz/0000-0003-0741-7987; Stanley, Ed G/0000-0002-6389-3665; Widmer, Hans Rudolf/0000-0003-3378-8765; Merkle, Florian/0000-0002-8513-2998; Keros, Sotirios/0000-0001-9264-9824; Goldstein, Peter/0000-0002-5973-9104; Elefanty, Andrew/0000-0001-6448-8314	NIMH [2RO1 MH066912, 1RC1MH089690]; Swiss National Science Foundation [31003A_135565]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060600] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC1MH089690, R01MH066912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066390, K12NS066274] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank J. Hendrikx (Sloan-Kettering Institute [SKI] Flow Cytometry Core), A. Viale (SKI Genomics Core laboratory), M. Leversha (Molecular Cytogenetics Core), and E. Tu and M. Tomishima (SKI Stem Cell Facility) for excellent technical support. We further thank the Department of Gynecology (directors: M. Mueller and D. Surbek), University of Bern, Switzerland for providing us with the human fetal tissue. Studies using the NKX2.1::GFP hESC line were supported by grants from NYSTEM (S.A.), the European Commission project NeuroStemcell (L.S.), and the C.V. Starr Foundation (S.A. and L.S.). Experiments using hESC line WA-09 or iPSC lines were supported by NIMH grants 2RO1 MH066912 (S.A.) and 1RC1MH089690 (S.A. and L.S.) and by the Swiss National Science Foundation grant no. 31003A_135565 (H.R.W.).	Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anderson SA, 2001, DEVELOPMENT, V128, P353; ANDERSON SA, 1995, NEUROSCIENCE, V67, P7, DOI 10.1016/0306-4522(95)00051-J; Baraban SC, 2009, P NATL ACAD SCI USA, V106, P15472, DOI 10.1073/pnas.0900141106; Batista-Brito R, 2009, CURR TOP DEV BIOL, V87, P81, DOI 10.1016/S0070-2153(09)01203-4; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Espuny-Camacho I, 2013, NEURON, V77, P440, DOI 10.1016/j.neuron.2012.12.011; Fasano CA, 2010, CELL STEM CELL, V6, P336, DOI 10.1016/j.stem.2010.03.001; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Fertuzinhos S, 2009, CEREB CORTEX, V19, P2196, DOI 10.1093/cercor/bhp009; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Fogarty M, 2007, J NEUROSCI, V27, P10935, DOI 10.1523/JNEUROSCI.1629-07.2007; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Goulburn AL, 2011, STEM CELLS, V29, P462, DOI 10.1002/stem.587; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kerwin J, 2010, J ANAT, V217, P289, DOI 10.1111/j.1469-7580.2010.01290.x; Kim H, 2011, CELL STEM CELL, V8, P695, DOI 10.1016/j.stem.2011.04.002; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Ma LX, 2012, CELL STEM CELL, V10, P455, DOI 10.1016/j.stem.2012.01.021; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Marin O, 2000, J NEUROSCI, V20, P6063; Maroof AM, 2010, J NEUROSCI, V30, P4667, DOI 10.1523/JNEUROSCI.4255-09.2010; Martinez-Cerdeno V, 2010, CELL STEM CELL, V6, P238, DOI 10.1016/j.stem.2010.01.004; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Placzek M, 2005, NAT REV NEUROSCI, V6, P230, DOI 10.1038/nrn1628; Rakic S, 2003, CEREB CORTEX, V13, P1072, DOI 10.1093/cercor/13.10.1072; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Southwell DG, 2010, SCIENCE, V327, P1145, DOI 10.1126/science.1183962; Sussel L, 1999, DEVELOPMENT, V126, P3359; Tekki-Kessaris N, 2001, DEVELOPMENT, V128, P2545; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Wonders CP, 2008, DEV BIOL, V314, P127, DOI 10.1016/j.ydbio.2007.11.018; Wu H, 2007, P NATL ACAD SCI USA, V104, P13821, DOI 10.1073/pnas.0706199104; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004; Xu Q, 2010, NEURON, V65, P328, DOI 10.1016/j.neuron.2010.01.004; Yee CL, 2009, J COMP NEUROL, V517, P37, DOI 10.1002/cne.22132; Ying SW, 2007, J NEUROSCI, V27, P8719, DOI 10.1523/JNEUROSCI.1630-07.2007; Yu XJ, 2011, J NEUROSCI, V31, P2413, DOI 10.1523/JNEUROSCI.5249-10.2011; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540; Zecevic N, 2011, DEV NEUROBIOL, V71, P18, DOI 10.1002/dneu.20812	54	384	396	0	64	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 2	2013	12	5					559	572		10.1016/j.stem.2013.04.008	http://dx.doi.org/10.1016/j.stem.2013.04.008			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VE	23642365	Green Accepted, Bronze			2022-12-28	WOS:000329569600012
J	Kaneko, S; Yamanaka, S				Kaneko, Shin; Yamanaka, Shinya			To Be Immunogenic, or Not to Be: That's the iPSC Question	CELL STEM CELL			English	Editorial Material							PLURIPOTENT STEM-CELLS; INTEGRATION	The unexpected finding that autologous induced pluripotent stem cell (iPSC)-derived teratomas are immunogenic in syngeneic hosts sparked pessimism over their therapeutic potential; however, two recent reports (Guha et al., 2013 and Araki et al., 2013; the latter in this issue of Cell Stem Cell) contradict previous findings, showing no immunogenicity of in vitro differentiated syngeneic iPS-derived cells and supporting their safety.	[Kaneko, Shin; Yamanaka, Shinya] Kyoto Univ, Ctr IPS Cell Res & Applicat, Kyoto 6068507, Japan; [Yamanaka, Shinya] Gladstone Inst, San Francisco, CA 94158 USA	Kyoto University; University of California System; University of California San Francisco; The J David Gladstone Institutes	Kaneko, S (corresponding author), Kyoto Univ, Ctr IPS Cell Res & Applicat, Kyoto 6068507, Japan.	kaneko.shin@cira.kyoto-u.ac.jp; yamanaka@cira.kyoto-u.ac.jp						Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807; Dhodapkar KM, 2010, P NATL ACAD SCI USA, V107, P8718, DOI 10.1073/pnas.0915086107; Guha P, 2013, CELL STEM CELL, V12, P407, DOI 10.1016/j.stem.2013.01.006; Montini E, 2006, NAT BIOTECHNOL, V24, P687, DOI 10.1038/nbt1216; Okano H, 2013, CIRC RES, V112, P523, DOI 10.1161/CIRCRESAHA.111.256149; Okita K, 2011, CIRC RES, V109, P720, DOI 10.1161/RES.0b013e318232e187; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Taylor CJ, 2012, CELL STEM CELL, V11, P147, DOI 10.1016/j.stem.2012.07.014; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135	10	57	58	0	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 4	2013	12	4					385	386		10.1016/j.stem.2013.03.008	http://dx.doi.org/10.1016/j.stem.2013.03.008			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VD	23561437	Bronze			2022-12-28	WOS:000329569500002
J	Pucci, F; Gardano, L; Harrington, L				Pucci, Fabio; Gardano, Laura; Harrington, Lea			Short Telomeres in ESCs Lead to Unstable Differentiation	CELL STEM CELL			English	Article							SELF-RENEWAL; STEM-CELLS; DNA METHYLATION; NANOG; PLURIPOTENCY; EXPRESSION; CHROMATIN; DNMT3A; LENGTH; GENE	Functional telomeres are critical for stem cell proliferation; however, whether they are equally important for the stability of stem cell differentiation is not known. We found that mouse embryonic stem cells (ESCs) with critically short telomeres (Tert(-/-) ESCs) initiated normal differentiation after leukemia inhibitory factor (LIF) withdrawal but, unlike control ESCs, failed to maintain stable differentiation when LIF was reintroduced to the growth medium. Tert(-/-) ESCs expressed higher levels of Nanog and, overall, had decreased genomic CpG methylation levels, which included the promoters of Oct4 and Nanog. This unstable differentiation phenotype could be rescued by telomere elongation via reintroduction of Tert, via suppression of Nanog by small hairpin RNA (shRNA) knockdown, or via enforced expression of the de novo DNA methyltransferase 3b. These results demonstrate an unexpected role of functional telomeres in the genome-wide epigenetic regulation of cell differentiation and suggest a potentially important role of telomere instability in cell fate during development or disease.	[Pucci, Fabio; Gardano, Laura; Harrington, Lea] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Pucci, Fabio; Gardano, Laura; Harrington, Lea] Univ Edinburgh, Inst Cell Biol, Sch Biol Sci, Edinburgh EH9 3JR, Midlothian, Scotland; [Harrington, Lea] Univ Montreal, Inst Rech Immunol & Cancerol, Montreal, PQ H3T 1J4, Canada	University of Edinburgh; University of Edinburgh; Universite de Montreal	Harrington, L (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Michael Swann Bldg, Edinburgh EH9 3JR, Midlothian, Scotland.	lea.harrington@umontreal.ca		Gardano, Laura/0000-0003-4333-9891	Wellcome Trust [086580, 084637]; MRC [G0800081] Funding Source: UKRI; Medical Research Council [G0800081] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank A. Bird, K. Kaji, I. Stancheva, and L. H. Wong for discussion and input; C. Furlan, S. Catania, D. Kelly, N. Martins, M. Robson, A. Termanis, M. Waterfall, and G. Vargiu for technical assistance; and K. Kaji for the pCAG-MKOSiE plasmid. This work was funded by Wellcome Trust grants 086580 and 084637 to L.H.	Agarwal S, 2010, NATURE, V464, P292, DOI 10.1038/nature08792; Batista LFZ, 2011, NATURE, V474, P399, DOI 10.1038/nature10084; Benetti R, 2007, NAT GENET, V39, P243, DOI 10.1038/ng1952; Bergmann JH, 2011, EMBO J, V30, P328, DOI 10.1038/emboj.2010.329; Brinkman AB, 2012, GENOME RES, V22, P1128, DOI 10.1101/gr.133728.111; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Clouaire T, 2010, NUCLEIC ACIDS RES, V38, P4620, DOI 10.1093/nar/gkq228; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Fidalgo M, 2011, STEM CELLS, V29, P1705, DOI 10.1002/stem.736; Heng JCD, 2010, COLD SH Q B, V75, P237, DOI 10.1101/sqb.2010.75.003; Huang JJ, 2011, CELL RES, V21, P779, DOI 10.1038/cr.2011.16; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li YQ, 2010, CELL REPROGRAM, V12, P3, DOI 10.1089/cell.2009.0033; Liu Y, 2000, CURR BIOL, V10, P1459, DOI 10.1016/S0960-9822(00)00805-8; Lu R, 2011, J BIOL CHEM, V286, P8425, DOI 10.1074/jbc.M110.202150; Lynch MD, 2012, EMBO J, V31, P317, DOI 10.1038/emboj.2011.399; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Petrie K, 2009, CURR OPIN HEMATOL, V16, P84, DOI 10.1097/MOH.0b013e3283257aee; Savarese F, 2009, GENE DEV, V23, P2625, DOI 10.1101/gad.1815709; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shi WJ, 2006, J BIOL CHEM, V281, P23319, DOI 10.1074/jbc.M601811200; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Tysnes BB, 2010, NEOPLASIA, V12, P506, DOI 10.1593/neo.10290; Villasante A, 2011, CELL CYCLE, V10, P1488, DOI 10.4161/cc.10.9.15658	33	66	68	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 4	2013	12	4					479	486		10.1016/j.stem.2013.01.018	http://dx.doi.org/10.1016/j.stem.2013.01.018			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VD	23561444	Green Published, hybrid			2022-12-28	WOS:000329569500014
J	Aguirre, A; Sancho-Martinez, I; Belmonte, JCI				Aguirre, Aitor; Sancho-Martinez, Ignacio; Izpisua Belmonte, Juan Carlos			Reprogramming toward Heart Regeneration: Stem Cells and Beyond	CELL STEM CELL			English	Review							DE-NOVO CARDIOMYOCYTES; CARDIAC FIBROBLASTS; THERAPY; DISEASE; LINEAGE; MOUSE; DEDIFFERENTIATION; MULTIPOTENT; PROGENITORS; ACTIVATION	Finding a cure for cardiovascular disease remains a major unmet medical need. Recent investigations have started to unveil the mechanisms of mammalian heart regeneration. The study of the regenerative mechanisms in lower vertebrate and mammalian animal models has provided clues for the experimental activation of proregenerative responses in the heart. In parallel, the use of endogenous adult stem cell populations alongside the recent application of reprogramming technologies has created major expectations for the development of therapies targeting heart disease. Together, these new approaches are bringing us closer to more successful strategies for the treatment of heart disease.	[Aguirre, Aitor; Sancho-Martinez, Ignacio; Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Sancho-Martinez, Ignacio; Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona, Barcelona 08003, Spain	Salk Institute; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	Aguirre, Aitor/L-6407-2019; Aguirre, Aitor/A-3294-2013	Aguirre, Aitor/0000-0002-1383-2792; Sancho-Martinez, Ignacio/0000-0003-4348-1038	Nomis Foundation Fellowship; TERCEL-ISCIII-MINECO; CIBER; Fundacion Cellex; G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust	Nomis Foundation Fellowship; TERCEL-ISCIII-MINECO; CIBER; Fundacion Cellex; G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust	We would first like to apologize to all those authors whose outstanding work could not be cited due to space constraints. We thank all members of the Izpisua Belmonte laboratory for critical discussion. I. S.-M. was partially supported by a Nomis Foundation Fellowship. Work in the laboratory of J.C.I.B. was supported by TERCEL-ISCIII-MINECO, CIBER, Fundacion Cellex, G. Harold and Leila Y. Mathers Charitable Foundation, and The Leona M. and Harry B. Helmsley Charitable Trust.	Alvarado AS, 2000, BIOESSAYS, V22, P578, DOI 10.1002/(SICI)1521-1878(200006)22:6<578::AID-BIES11>3.0.CO;2-#; Andersen DC, 2009, STEM CELLS, V27, P1571, DOI 10.1002/stem.72; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Braam SR, 2009, TRENDS PHARMACOL SCI, V30, P536, DOI 10.1016/j.tips.2009.07.001; Brockes JR, 2008, ANNU REV CELL DEV BI, V24, P525, DOI 10.1146/annurev.cellbio.24.110707.175336; Burridge PW, 2012, CELL STEM CELL, V10, P16, DOI 10.1016/j.stem.2011.12.013; Cherry ABC, 2013, ANNU REV MED, V64, P277, DOI 10.1146/annurev-med-050311-163324; Daley GQ, 2012, CELL STEM CELL, V10, P740, DOI 10.1016/j.stem.2012.05.010; Ellison Georgina M, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS52, DOI 10.1038/ncpcardio0773; Eulalio A, 2012, NATURE, V492, P376, DOI 10.1038/nature11739; Guan K, 2007, J MOL CELL CARDIOL, V43, P377, DOI 10.1016/j.yjmcc.2007.07.056; Huang GN, 2012, SCIENCE, V338, P1599, DOI 10.1126/science.1229765; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Itou J, 2012, DEVELOPMENT, V139, P4133, DOI 10.1242/dev.079756; Jayawardena TM, 2012, CIRC RES, V110, P1465, DOI 10.1161/CIRCRESAHA.112.269035; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kelly BB, 2012, MT SINAI J MED, V79, P632, DOI 10.1002/msj.21345; Kikuchi K, 2011, DEVELOPMENT, V138, P2895, DOI 10.1242/dev.067041; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Kubin T, 2011, CELL STEM CELL, V9, P420, DOI 10.1016/j.stem.2011.08.013; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Letellier E, 2010, IMMUNITY, V32, P240, DOI 10.1016/j.immuni.2010.01.011; Loffredo FS, 2011, CELL STEM CELL, V8, P389, DOI 10.1016/j.stem.2011.02.002; Marsano A, 2013, BIOMATERIALS, V34, P393, DOI 10.1016/j.biomaterials.2012.09.038; Miyagawa S, 2011, ANN THORAC SURG, V91, P320, DOI 10.1016/j.athoracsur.2010.09.080; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Okano H, 2013, CIRC RES, V112, P523, DOI 10.1161/CIRCRESAHA.111.256149; Panopoulos AD, 2011, CELL STEM CELL, V8, P347, DOI 10.1016/j.stem.2011.03.003; Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040; Passier R, 2010, CELL STEM CELL, V7, P139, DOI 10.1016/j.stem.2010.07.004; Porrello ER, 2013, P NATL ACAD SCI USA, V110, P187, DOI 10.1073/pnas.1208863110; Porrello ER, 2011, CIRC RES, V109, P670, DOI 10.1161/CIRCRESAHA.111.248880; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005; Raya A, 2003, P NATL ACAD SCI USA, V100, P11889, DOI 10.1073/pnas.1834204100; Sancho-Martinez I, 2012, NAT CELL BIOL, V14, P892, DOI 10.1038/ncb2567; Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503; Seifert AW, 2012, NATURE, V489, P561, DOI 10.1038/nature11499; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Soldner F, 2012, SCIENCE, V338, P1155, DOI 10.1126/science.1227682; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Tiscornia G, 2011, NAT MED, V17, P1570, DOI 10.1038/nm.2504; Tohyama S, 2013, CELL STEM CELL, V12, P127, DOI 10.1016/j.stem.2012.09.013; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Vierbuchen T, 2011, NAT BIOTECHNOL, V29, P892, DOI 10.1038/nbt.1946; Willems E, 2012, CELL STEM CELL, V11, P242, DOI 10.1016/j.stem.2012.04.025; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	55	47	51	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 7	2013	12	3					275	284		10.1016/j.stem.2013.02.008	http://dx.doi.org/10.1016/j.stem.2013.02.008			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VC	23472869	Bronze			2022-12-28	WOS:000329569400005
J	Ben-David, U; Gan, QF; Golan-Lev, T; Arora, P; Yanuka, O; Oren, YS; Leikin-Frenkel, A; Graf, M; Garippa, R; Boehringer, M; Gromo, G; Benvenisty, N				Ben-David, Uri; Gan, Qing-Fen; Golan-Lev, Tamar; Arora, Payal; Yanuka, Ofra; Oren, Yifat S.; Leikin-Frenkel, Alicia; Graf, Martin; Garippa, Ralph; Boehringer, Markus; Gromo, Gianni; Benvenisty, Nissim			Selective Elimination of Human Pluripotent Stem Cells by an Oleate Synthesis Inhibitor Discovered in a High-Throughput Screen	CELL STEM CELL			English	Article							STEAROYL-COA DESATURASE; TERATOMA FORMATION; STRESS; GENE; DIFFERENTIATION; TUMORIGENICITY; DISRUPTION; ANTIBODY	The use of human pluripotent stem cells (hPSCs) in cell therapy is hindered by the tumorigenic risk from residual undifferentiated cells. Here we performed a high-throughput screen of over 52,000 small molecules and identified 15 pluripotent cell-specific inhibitors (PluriSIns), nine of which share a common structural moiety. The PluriSIns selectively eliminated hPSCs while sparing a large array of progenitor and differentiated cells. Cellular and molecular analyses demonstrated that the most selective compound, PluriSIn #1, induces ER stress, protein synthesis attenuation, and apoptosis in hPSCs. Close examination identified this molecule as an inhibitor of stearoyl-coA desaturase (SCD1), the key enzyme in oleic acid biosynthesis, revealing a unique role for lipid metabolism in hPSCs. PluriSIn #1 was also cytotoxic to mouse blastocysts, indicating that the dependence on oleate is inherent to the pluripotent state. Finally, application of PluriSIn #1 prevented teratoma formation from tumorigenic undifferentiated cells. These findings should increase the safety of hPSC-based treatments.	[Ben-David, Uri; Golan-Lev, Tamar; Yanuka, Ofra; Benvenisty, Nissim] Hebrew Univ Jerusalem, Stem Cell Unit, IL-91904 Jerusalem, Israel; [Ben-David, Uri; Golan-Lev, Tamar; Yanuka, Ofra; Oren, Yifat S.; Benvenisty, Nissim] Hebrew Univ Jerusalem, Silberman Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel; [Gan, Qing-Fen; Arora, Payal; Garippa, Ralph] Hoffmann La Roche Inc, Nutley, NJ 07110 USA; [Leikin-Frenkel, Alicia] Chaim Sheba Med Ctr, Bert W Strassburger Lipid Ctr, IL-52621 Tel Hashomer, Israel; [Leikin-Frenkel, Alicia] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Graf, Martin; Boehringer, Markus; Gromo, Gianni] F Hoffmann La Roche & Cie AG, CH-4070 Basel, Switzerland	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Roche Holding; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Roche Holding	Benvenisty, N (corresponding author), Hebrew Univ Jerusalem, Stem Cell Unit, IL-91904 Jerusalem, Israel.	nissimb@cc.huji.ac.il	Ben-David, Uri/H-4119-2019	Ben-David, Uri/0000-0001-7098-2378	Hoffmann La Roche-Yissum collaboration	Hoffmann La Roche-Yissum collaboration	The authors would like to thank Hong Ma and Adva Maimon for their assistance with tissue culture; Dr. Eric Chiao, Dr. Josh Babiarz, Dr. Jenny Cohen, and Sei Kameoka for their assistance with assay development; Sean Walker for his assistance with the liquid handler; Dr. Ann Hoffman for her assistance with microscopy imaging; Dr. Rachel Eiges for her assistance with the in vitro embryonic development assay and for critically reading the manuscript; Dr. Sonia Steiner-Mordoch and Professor Oded Meyuhas for their assistance with the protein synthesis inhibition assay; Dr. Simona Ceccarelli for her assistance with the chemical analysis of compounds; Tamar Shiloach for her assistance with apoptosis assays; Dr. Eran Meshorer for the mouse ESCs and for critically reading the manuscript; Oded Kopper for the CSES2-SO2/3 cells; Professor Batsheva Kerem, Dr. Kyle Kolaja, Dr. Jacques Mizrahi, and Dr. David Mark for fruitful discussions and helpful suggestions. N.B. is the Herbert Cohn Chair in Cancer Research. U.B.-D. is a Clore Fellow. This work was supported by a grant from Hoffmann La Roche-Yissum collaboration. Q. F. G., M. G., M. B., and G. G. are employees of the company. R. G. and P. A. are former employees of the company.	Alexander PB, 2011, P NATL ACAD SCI USA, V108, P15828, DOI 10.1073/pnas.1111312108; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Blum B, 2009, NAT BIOTECHNOL, V27, P281, DOI 10.1038/nbt.1527; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Borradaile NM, 2006, MOL BIOL CELL, V17, P770, DOI 10.1091/mbc.E05-08-0742; Choo AB, 2008, STEM CELLS, V26, P1454, DOI 10.1634/stemcells.2007-0576; Garcia-Gonzalo FR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001384; Germain ND, 2012, CELL TRANSPLANT, V21, P1603, DOI 10.3727/096368912X647243; Hapala I, 2011, BIOL CELL, V103, P271, DOI 10.1042/BC20100144; Hentze H, 2009, STEM CELL RES, V2, P198, DOI 10.1016/j.scr.2009.02.002; Hess D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011394; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iorio F, 2010, P NATL ACAD SCI USA, V107, P14621, DOI 10.1073/pnas.1000138107; Kopper O, 2012, STEM CELL RES, V8, P335, DOI 10.1016/j.scr.2011.12.006; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee AS, 2009, CELL CYCLE, V8, P2608, DOI 10.4161/cc.8.16.9353; Liu LH, 2012, BIOCHEM BIOPH RES CO, V417, P738, DOI 10.1016/j.bbrc.2011.12.026; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Mason P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033823; Menendez S, 2012, AGING CELL, V11, P41, DOI 10.1111/j.1474-9726.2011.00754.x; Minville-Walz M., 2010, PLOS ONE, V5; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Miyazaki M, 2000, J BIOL CHEM, V275, P30132, DOI 10.1074/jbc.M005488200; Ntambi JM, 2004, LIPIDS, V39, P1061, DOI 10.1007/s11745-004-1331-2; Peng G, 2011, ENDOCRINOLOGY, V152, P2206, DOI 10.1210/en.2010-1369; Preston AM, 2009, DIABETOLOGIA, V52, P2369, DOI 10.1007/s00125-009-1506-5; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Roongta UV, 2011, MOL CANCER RES, V9, P1551, DOI 10.1158/1541-7786.MCR-11-0126; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Schuldiner M, 2003, STEM CELLS, V21, P257, DOI 10.1634/stemcells.21-3-257; Tang C, 2011, NAT BIOTECHNOL, V29, P829, DOI 10.1038/nbt.1947; Wernig M, 2004, J NEUROSCI, V24, P5258, DOI 10.1523/JNEUROSCI.0428-04.200; Xie XY, 2007, CLONING STEM CELLS, V9, P549, DOI 10.1089/clo.2007.0032	35	226	238	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 7	2013	12	2					167	179		10.1016/j.stem.2012.11.015	http://dx.doi.org/10.1016/j.stem.2012.11.015			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VB	23318055	Bronze			2022-12-28	WOS:000329569300008
J	Jang, MH; Bonaguidi, MA; Kitabatake, Y; Sun, JQ; Song, J; Kang, EC; Jun, H; Zhong, C; Su, YJ; Guo, JJU; Wang, MX; Sailor, KA; Kim, JY; Gao, Y; Christian, KM; Ming, GL; Song, HJ				Jang, Mi-Hyeon; Bonaguidi, Michael A.; Kitabatake, Yasuji; Sun, Jiaqi; Song, Juan; Kang, Eunchai; Jun, Heechul; Zhong, Chun; Su, Yijing; Guo, Junjie U.; Wang, Marie Xun; Sailor, Kurt A.; Kim, Ju-Young; Gao, Yuan; Christian, Kimberly M.; Ming, Guo-li; Song, Hongjun			Secreted Frizzled-Related Protein 3 Regulates Activity-Dependent Adult Hippocampal Neurogenesis	CELL STEM CELL			English	Article							DNA DEMETHYLATION; RAT HIPPOCAMPUS; BRAIN; SEIZURES; WNT; INTEGRATION; EXPRESSION; NEURONS; MEMORY; CELLS	Adult neurogenesis, the process of generating mature neurons from adult neural stem cells, proceeds concurrently with ongoing neuronal circuit activity and is modulated by various physiological and pathological stimuli. The niche mechanism underlying the activity-dependent regulation of the sequential steps of adult neurogenesis remains largely unknown. Here, we report that neuronal activity decreases the expression of secreted frizzled-related protein 3 (sFRP3), a naturally secreted Wnt inhibitor highly expressed by adult dentate gyrus granule neurons. Sfrp3 deletion activates quiescent radial neural stem cells and promotes newborn neuron maturation, dendritic growth, and dendritic spine formation in the adult mouse hippocampus. Furthermore, sfrp3 reduction is essential for activity-induced adult neural progenitor proliferation and the acceleration of new neuron development. Our study identifies sFRP3 as an inhibitory niche factor from local mature dentate granule neurons that regulates multiple phases of adult hippocampal neurogenesis and suggests an interesting activity-dependent mechanism governing adult neurogenesis via the acute release of tonic inhibition.	[Jang, Mi-Hyeon; Bonaguidi, Michael A.; Kitabatake, Yasuji; Sun, Jiaqi; Song, Juan; Kang, Eunchai; Jun, Heechul; Zhong, Chun; Su, Yijing; Guo, Junjie U.; Wang, Marie Xun; Sailor, Kurt A.; Kim, Ju-Young; Gao, Yuan; Christian, Kimberly M.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; [Jang, Mi-Hyeon; Bonaguidi, Michael A.; Kitabatake, Yasuji; Song, Juan; Kang, Eunchai; Zhong, Chun; Su, Yijing; Kim, Ju-Young; Christian, Kimberly M.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Guo, Junjie U.; Sailor, Kurt A.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Gao, Yuan] Johns Hopkins Univ, Sch Med, Lieber Inst Brain Dev, Baltimore, MD 21205 USA; [Jang, Mi-Hyeon; Jun, Heechul] Mayo Coll Med, Dept Neurol Surg, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Kitabatake, Yasuji] Osaka Univ, Sch Med, Dept Pediat, Suita, Osaka 5650871, Japan; [Sun, Jiaqi] Tsinghua Univ, Sch Life Sci, Beijing 100081, Peoples R China	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Mayo Clinic; Osaka University; Tsinghua University	Jang, MH (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.	jang.mihyeon@mayo.edu; shongju1@jhmi.edu	Sailor, Kurt Andrew/AFN-4046-2022; Jun, Heechul/K-7623-2013; Sailor, Kurt/GSO-2237-2022	Sailor, Kurt Andrew/0000-0002-9574-6838; Jun, Heechul/0000-0002-5905-2716; Sailor, Kurt/0000-0002-9574-6838; Kitabatake, Yasuji/0000-0002-2907-9512; Kang, Eunchai/0000-0001-6884-622X	NIH [NS047344, MH087874, ES021957, NS048271, HD069184, MH090115, NS080913]; NARSAD; MSCRF; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069184] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [T32EY017203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES021957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH090115, R33MH087874, R21MH087874, R00MH090115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS080913, R56NS047344, R01NS048271, R37NS047344, R01NS047344] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD(NARSAD); MSCRF; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Drs. D. Ginty, S. Jessberger, X. He, and members of the Song and Ming laboratories for their suggestions, A. Rattner and J. Nathans for generating sfrp3 KO mice, J. H. Shin and B. Xie for help with RNA-seq, and P. Worley for Arc antibodies and initial help with ECS. This work was supported by the NIH (NS047344, MH087874, and ES021957 to H. S; NS048271 and HD069184 to G. M.; MH090115 to M.-H. J.; and NS080913 to M. A. B) and NARSAD (Independent Investigator awards to H. S. and G.-I. M., and a Young Investigator award to M.-H.J.) and by postdoctoral fellowship awards from MSCRF to J.S., E. K., Y.S., and K.C.	Bonaguidi MA, 2012, CURR OPIN NEUROBIOL, V22, P754, DOI 10.1016/j.conb.2012.03.013; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Bracko O, 2012, J NEUROSCI, V32, P3376, DOI 10.1523/JNEUROSCI.4248-11.2012; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Guo JJU, 2011, NAT NEUROSCI, V14, P1345, DOI 10.1038/nn.2900; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Jessberger S, 2007, J NEUROSCI, V27, P9400, DOI 10.1523/JNEUROSCI.2002-07.2007; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Jones SE, 2002, BIOESSAYS, V24, P811, DOI 10.1002/bies.10136; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Madsen TM, 2000, BIOL PSYCHIAT, V47, P1043, DOI 10.1016/S0006-3223(00)00228-6; Madsen TM, 2003, BIOL PSYCHIAT, V54, P1006, DOI 10.1016/S0006-3223(03)00700-5; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Miranda CJ, 2012, AGING CELL, V11, P542, DOI 10.1111/j.1474-9726.2012.00816.x; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P4095, DOI 10.1523/JNEUROSCI.5508-05.2006; Parent JM, 1997, J NEUROSCI, V17, P3727; Seib DRM, 2013, CELL STEM CELL, V12, P204, DOI 10.1016/j.stem.2012.11.010; Shibley H, 2002, EPILEPSY RES, V49, P109, DOI 10.1016/S0920-1211(02)00012-8; Shimogori T, 2004, J COMP NEUROL, V473, P496, DOI 10.1002/cne.20135; Song J, 2012, NATURE, V489, P150, DOI 10.1038/nature11306; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Thompson CL, 2008, NEURON, V60, P1010, DOI 10.1016/j.neuron.2008.12.008; Zhao CM, 2012, DEV NEUROBIOL, V72, P937, DOI 10.1002/dneu.20986	28	144	152	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 7	2013	12	2					215	223		10.1016/j.stem.2012.11.021	http://dx.doi.org/10.1016/j.stem.2012.11.021			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VB	23395446	Green Accepted, Bronze			2022-12-28	WOS:000329569300012
J	Tomoda, K; Takahashi, K; Leung, K; Okada, A; Narita, M; Yamada, NA; Eilertson, KE; Tsang, P; Baba, S; White, MP; Sarni, S; Srivastava, D; Conklin, BR; Panning, B; Yamanaka, S				Tomoda, Kiichiro; Takahashi, Kazutoshi; Leung, Karen; Okada, Aki; Narita, Megumi; Yamada, N. Alice; Eilertson, Kirsten E.; Tsang, Peter; Baba, Shiro; White, Mark P.; Sarni, Salma; Srivastava, Deepak; Conklin, Bruce R.; Panning, Barbara; Yamanaka, Shinya			Derivation Conditions Impact X-Inactivation Status in Female Human Induced Pluripotent Stem Cells	CELL STEM CELL			English	Article							CHROMOSOME INACTIVATION; DOSAGE COMPENSATION; RETT-SYNDROME; HUMAN FIBROBLASTS; MOUSE; MAMMALS; EXPRESSION; INDUCTION; PROFILE	Female human induced pluripotent stem cell (hiPSC) lines exhibit variability in X-inactivation status. The majority of hiPSC lines maintain one transcriptionally active X (Xa) and one inactive X (Xi) chromosome from donor cells. However, at low frequency, hiPSC lines with two)(as are produced, suggesting that epigenetic alterations of the Xi occur sporadically during reprogramming. We show here that X-inactivation status in female hiPSC lines depends on derivation conditions. hiPSC Lines generated by the Kyoto method (retroviral or episomal reprogramming), which uses leukemia inhibitory factor (LIF)-expressing SNL feeders, frequently had two Xas. Early passage Xa/Xi hiPSC lines generated on non-SNL feeders were converted into Xa/Xa hiPSC lines after several passages on SNL feeders, and supplementation with recombinant LIF caused reactivation of some of X-linked genes. Thus, feeders are a significant factor affecting X-inactivation status. The efficient production of Xa/Xa hiPSC lines provides unprecedented opportunities to understand human X-reactivation and -inactivation.	[Leung, Karen; Panning, Barbara] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Tomoda, Kiichiro; Eilertson, Kirsten E.; Baba, Shiro; White, Mark P.; Sarni, Salma; Srivastava, Deepak; Conklin, Bruce R.; Yamanaka, Shinya] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Takahashi, Kazutoshi; Okada, Aki; Narita, Megumi; Yamanaka, Shinya] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto 6068507, Japan; [Yamada, N. Alice; Tsang, Peter] Agilent Technol, Agilent Labs, Santa Clara, CA 95051 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; Kyoto University; Agilent Technologies	Panning, B (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	barbara.panning@ucsf.edu; syamanaka@gladstone.ucsf.edu	Conklin, Bruce/E-4738-2019; Takahashi, Kazutoshi/ABE-5504-2020	Takahashi, Kazutoshi/0000-0002-5329-8395; Conklin, Bruce/0000-0003-1463-6061	NIH [F32 GM099389-01A1, R01 GM088506]; MEXT (Japan); Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) of the JSPS (Japan); JSPS; Program for Promotion of Fundamental Studies in Health Sciences of NIBIO (Japan); Gladstone Institutes; L.K. Whittier Foundation; NHLBI/NIH [U01-HL100406, U01-HL098179]; CIRM; National Center for Research Resources [RR18928-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL098179, U01HL100406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM099389, R01GM088506] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MEXT (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) of the JSPS (Japan); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Promotion of Fundamental Studies in Health Sciences of NIBIO (Japan); Gladstone Institutes(University of California System); L.K. Whittier Foundation; NHLBI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); CIRM(California Institute for Regenerative Medicine); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Yamanaka laboratory for useful discussions, Tim Rand for plotting the results of bisulfite sequencing and X/A ratios, Kenta Nakamura for hiPSC differentiation and useful discussions, Laura Mitic for maintaining the confocal microscope, Lei Lue for the endothelial cell differentiation, Michiyo Koyanagi for microarray analyses, Mari Ohnuki for discussion of neural differentiation, Gary Howard and Anna Lisa Lucido for editorial review, Karena Essex for administrative supports, Stem Cell Core for providing stem cell culture services, and Bioinformatics Core for conducting the statistic analyses. We also would like to thank Kathrin Plath and Sanjeet Patel for providing their hiPSC lines. K.T. is a scholar of the California Institute for Regenerative Medicine (CIRM). K.L. is supported by an NIH fellowship (F32 GM099389-01A1). B.P. is funded by NIH R01 GM088506. This work was supported in part by grants from the Leading Project of MEXT (Japan, to S.Y.), the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) of the JSPS (Japan, to S.Y.), Grants-in-Aid for Scientific Research of the JSPS and MEXT (Japan, to S.Y.), and the Program for Promotion of Fundamental Studies in Health Sciences of NIBIO (Japan, to S.Y.). These studies were also made possible by funding from the Gladstone Institutes, the L.K. Whittier Foundation, NHLBI/NIH (U01-HL100406, U01-HL098179), and the CIRM. The Gladstone Institutes received support from a National Center for Research Resources Grant RR18928-01. S.Y. is a member without salary of the Scientific Advisory Board of iPierian, iPS Academia Japan, and Megakaryon Corporation; D.S. is a member of the Scientific Advisory Board of iPierian, Inc. and RegeneRx Pharmaceuticals; B.R.C. is a member of the Scientific Advisory Board of iPierian, Inc.; and NAY. and P.T. are employees of Agilent Technologies, Inc.	Blanchard F, 1998, J BIOL CHEM, V273, P20886, DOI 10.1074/jbc.273.33.20886; BROWN CJ, 1994, NATURE, V368, P154, DOI 10.1038/368154a0; Bruck T, 2011, STEM CELL RES, V6, P187, DOI 10.1016/j.scr.2010.12.001; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Cheung AYL, 2011, HUM MOL GENET, V20, P2103, DOI 10.1093/hmg/ddr093; Fan GP, 2011, HUM GENET, V130, P217, DOI 10.1007/s00439-011-1038-1; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Heard E, 2006, GENE DEV, V20, P1848, DOI 10.1101/gad.1422906; Hoffman LM, 2005, STEM CELLS, V23, P1468, DOI 10.1634/stemcells.2004-0371; Kim KY, 2011, P NATL ACAD SCI USA, V108, P14169, DOI 10.1073/pnas.1018979108; Lagarkova MA, 2010, CELL CYCLE, V9, P937, DOI 10.4161/cc.9.5.10869; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Lin H, 2007, PLOS BIOL, V5, P2809, DOI 10.1371/journal.pbio.0050326; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Mekhoubad S, 2012, CELL STEM CELL, V10, P595, DOI 10.1016/j.stem.2012.02.014; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nguyen DK, 2006, NAT GENET, V38, P47, DOI 10.1038/ng1705; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Okamoto I, 2011, NATURE, V472, P370, DOI 10.1038/nature09872; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Payer B, 2011, HUM GENET, V130, P265, DOI 10.1007/s00439-011-1024-7; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Pomp O, 2011, CELL STEM CELL, V9, P156, DOI 10.1016/j.stem.2011.06.004; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4709, DOI 10.1073/pnas.0712018105; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008067; Tchieu J, 2010, CELL STEM CELL, V7, P329, DOI 10.1016/j.stem.2010.06.024; Teichroeb JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023436; van den Berg IM, 2009, AM J HUM GENET, V84, P771, DOI 10.1016/j.ajhg.2009.05.003; Ware CB, 2009, CELL STEM CELL, V4, P359, DOI 10.1016/j.stem.2009.03.001	33	87	92	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUL 6	2012	11	1					91	99		10.1016/j.stem.2012.05.019	http://dx.doi.org/10.1016/j.stem.2012.05.019			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	975SS	22770243	Green Accepted, Bronze			2022-12-28	WOS:000306532400012
J	Scadden, DT				Scadden, David T.			Rethinking Stroma: Lessons from the Blood	CELL STEM CELL			English	Editorial Material							HEMATOPOIETIC STEM-CELLS; MORPHOGENESIS; REGENERATION	Stroma is a largely understudied component of all organs that contributes to stem cell niches. Studies to define stromal components in the bone marrow have led to some unexpected findings that prompt further research.	[Scadden, David T.] Harvard Univ, Massachusetts Gen Hosp, Dept Stem Cell & Regenerat Biol, Ctr Regenerat Med,Harvard Stem Cell Inst, Boston, MA 02114 USA; [Scadden, David T.] Harvard Univ, Massachusetts Gen Hosp, Dept Stem Cell & Regenerat Biol, Canc Ctr,Harvard Stem Cell Inst, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Scadden, DT (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Dept Stem Cell & Regenerat Biol, Ctr Regenerat Med,Harvard Stem Cell Inst, 185 Cambridge St, Boston, MA 02114 USA.	david_scadden@harvard.edu			NHLBI NIH HHS [R01 HL044851, U01 HL100402] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100402, R01HL044851] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Affolter M, 2003, DEV CELL, V4, P11, DOI 10.1016/S1534-5807(02)00410-0; Benazet JD, 2009, SCIENCE, V323, P1050, DOI 10.1126/science.1168755; DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Enshell-Seijffers D, 2010, DEV CELL, V18, P633, DOI 10.1016/j.devcel.2010.01.016; Mercier FE, 2012, NAT REV IMMUNOL, V12, P49, DOI 10.1038/nri3132; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014	10	16	16	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 14	2012	10	6					648	649		10.1016/j.stem.2012.05.011	http://dx.doi.org/10.1016/j.stem.2012.05.011			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	965LD	22704500	Green Accepted, Bronze			2022-12-28	WOS:000305768400006
J	Suzuki, S; Iwamoto, M; Saito, Y; Fuchimoto, D; Sembon, S; Suzuki, M; Mikawa, S; Hashimoto, M; Aoki, Y; Najima, Y; Takagi, S; Suzuki, N; Suzuki, E; Kubo, M; Mimuro, J; Kashiwakura, Y; Madoiwa, S; Sakata, Y; Perry, ACF; Ishikawa, F; Onishi, A				Suzuki, Shunichi; Iwamoto, Masaki; Saito, Yoriko; Fuchimoto, Daiichiro; Sembon, Shoichiro; Suzuki, Misae; Mikawa, Satoshi; Hashimoto, Michiko; Aoki, Yuki; Najima, Yuho; Takagi, Shinsuke; Suzuki, Nahoko; Suzuki, Emi; Kubo, Masanori; Mimuro, Jun; Kashiwakura, Yuji; Madoiwa, Seiji; Sakata, Yoichi; Perry, Anthony C. F.; Ishikawa, Fumihiko; Onishi, Akira			Il2rg Gene-Targeted Severe Combined Immunodeficiency Pigs	CELL STEM CELL			English	Article							INTERLEUKIN-2-RECEPTOR GAMMA-CHAIN; T-CELL PROLIFERATION; IL-2 RECEPTOR; BETA-CHAIN; FUNCTIONAL COMPONENT; CYTOPLASMIC DOMAINS; IMMUNE-SYSTEM; CLONED MICE; STEM-CELLS; EXPRESSION	A porcine model of severe combined immunodeficiency (SCID) promises to facilitate human cancer studies, the humanization of tissue for xenotransplantation, and the evaluation of stem cells for clinical therapy, but SCID pigs have not been described. We report here the generation and preliminary evaluation of a porcine SCID model. Fibroblasts containing a targeted disruption of the X-linked interleukin-2 receptor gamma chain gene, Il2rg, were used as donors to generate cloned pigs by serial nuclear transfer. Germline transmission of the Il2rg deletion produced healthy Il2rg(+/-) females, while Il2rg(-/Y) males were athymic and exhibited markedly impaired immunoglobulin and T and NK cell production, robustly recapitulating human SCID. Following allogeneic bone marrow transplantation, donor cells stably integrated in Il2rg(-/Y) heterozygotes and reconstituted the Il2rg(-/Y) lymphoid lineage. The SCID pigs described here represent a step toward the comprehensive evaluation of preclinical cellular regenerative strategies.	[Saito, Yoriko; Aoki, Yuki; Najima, Yuho; Takagi, Shinsuke; Suzuki, Nahoko; Ishikawa, Fumihiko] RIKEN Res Ctr Allergy & Immunol, Res Unit Human Dis Model, Yokohama, Kanagawa 2300045, Japan; [Suzuki, Emi] RIKEN Res Ctr Dev Biol, Lab Mammalian Mol Embryol, Kobe, Hyogo 6500047, Japan; [Suzuki, Shunichi; Fuchimoto, Daiichiro; Sembon, Shoichiro; Suzuki, Misae; Onishi, Akira] Natl Inst Agrobiol Sci, Transgen Anim Res Ctr, Tsukuba, Ibaraki 3050901, Japan; [Mikawa, Satoshi] Natl Inst Agrobiol Sci, Anim Genome Res Unit, Tsukuba, Ibaraki 3050901, Japan; [Iwamoto, Masaki; Hashimoto, Michiko] Prime Tech Ltd, Tsuchiura, Ibaraki 3000841, Japan; [Kubo, Masanori] Natl Inst Anim Hlth, Ctr Anim Dis Control & Prevent, Tsukuba, Ibaraki 3050856, Japan; [Mimuro, Jun; Kashiwakura, Yuji; Madoiwa, Seiji; Sakata, Yoichi] Jichi Med Univ, Ctr Mol Med, Div Cell & Mol Med, Shimotsuke, Tochigi 3290498, Japan; [Perry, Anthony C. F.] Univ Bath, Dept Biol & Biochem, Lab Mammalian Mol Embryol, Bath BA2 7AY, Avon, England	RIKEN; RIKEN; National Institute of Agrobiological Sciences - Japan; National Institute of Agrobiological Sciences - Japan; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Jichi Medical University; University of Bath	Ishikawa, F (corresponding author), RIKEN Res Ctr Allergy & Immunol, Res Unit Human Dis Model, Yokohama, Kanagawa 2300045, Japan.	f_ishika@rcai.riken.jp; onishi@affrc.go.jp	Najima, Yuho/W-3858-2019; 石川, 文彦/L-4488-2014	Najima, Yuho/0000-0001-8910-0021; Perry, Tony/0000-0003-3136-5355	Ministry of Agriculture, Forestry, and Fisheries of Japan; MRC [G1000839] Funding Source: UKRI; Medical Research Council [G1000839] Funding Source: researchfish	Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by a Grant-in-Aid from the Ministry of Agriculture, Forestry, and Fisheries of Japan. We thank staff in the Pig Management Section of the National Institute of Livestock and Grassland Science for assistance with animal management and Dr. T. Yagi for providing PKJ2 and MC1-DTA-p(A).	Asao H, 2001, J IMMUNOL, V167, P1, DOI 10.4049/jimmunol.167.1.1; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Felsburg PJ, 1999, VET IMMUNOL IMMUNOP, V69, P127, DOI 10.1016/S0165-2427(99)00049-5; Fischer A, 1997, ANNU REV IMMUNOL, V15, P93, DOI 10.1146/annurev.immunol.15.1.93; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; ISHII N, 1994, INT IMMUNOL, V6, P1273, DOI 10.1093/intimm/6.8.1273; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Jiang L, 2008, MOL REPROD DEV, V75, P265, DOI 10.1002/mrd.20758; Kanai N, 1999, HUM GENET, V104, P36, DOI 10.1007/s004390050907; KIMURA Y, 1995, INT IMMUNOL, V7, P115, DOI 10.1093/intimm/7.1.115; KONDO M, 1993, SCIENCE, V262, P1874, DOI 10.1126/science.8266076; Leonard WJ, 1996, ANNU REV MED, V47, P229; NAKAMURA Y, 1994, NATURE, V369, P330, DOI 10.1038/369330a0; Nelson BH, 1997, P NATL ACAD SCI USA, V94, P1878, DOI 10.1073/pnas.94.5.1878; NELSON BH, 1994, NATURE, V369, P333, DOI 10.1038/369333a0; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; Nolen LD, 2005, DEV BIOL, V279, P525, DOI 10.1016/j.ydbio.2005.01.016; Ohbo K, 1996, BLOOD, V87, P956, DOI 10.1182/blood.V87.3.956.bloodjournal873956; Perryman LE, 2004, VET PATHOL, V41, P95, DOI 10.1354/vp.41-2-95; PUCK JM, 1987, J CLIN INVEST, V79, P1395, DOI 10.1172/JCI112967; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; Senda S, 2004, BIOCHEM BIOPH RES CO, V321, P38, DOI 10.1016/j.bbrc.2004.06.096; Shimozawa N, 2002, GENESIS, V34, P203, DOI 10.1002/gene.10143; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Watanabe S, 2005, BIOL REPROD, V72, P309, DOI 10.1095/biolreprod.104.031591	30	104	112	1	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 14	2012	10	6					753	758		10.1016/j.stem.2012.04.021	http://dx.doi.org/10.1016/j.stem.2012.04.021			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	965LD	22704516	Bronze			2022-12-28	WOS:000305768400021
J	Darabi, R; Arpke, RW; Irion, S; Dimos, JT; Grskovic, M; Kyba, M; Perlingeiro, RCR				Darabi, Radbod; Arpke, Robert W.; Irion, Stefan; Dimos, John T.; Grskovic, Marica; Kyba, Michael; Perlingeiro, Rita C. R.			Human ES- and iPS-Derived Myogenic Progenitors Restore DYSTROPHIN and Improve Contractility upon Transplantation in Dystrophic Mice	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; SKELETAL-MUSCLE; SATELLITE CELLS; FIBROBLASTS; EXPRESSION; GENERATION; REGENERATION; INDUCTION; MYOBLASTS; RENEWAL	A major obstacle in the application of cell-based therapies for the treatment of neuromuscular disorders is obtaining the appropriate number of stem/progenitor cells to produce effective engraftment. The use of embryonic stem (ES) or induced pluripotent stem (iPS) cells could overcome this hurdle. However, to date, derivation of engraftable skeletal muscle precursors that can restore muscle function from human pluripotent cells has not been achieved. Here we applied conditional expression of PAX7 in human ES/iPS cells to successfully derive large quantities of myogenic precursors, which, upon transplantation into dystrophic muscle, are able to engraft efficiently, producing abundant human-derived DYSTROPHIN-positive myofibers that exhibit superior strength. Importantly, transplanted cells also seed the muscle satellite cell compartment, and engraftment is present over 11 months post-transplant. This study provides the proof of principle for the derivation of functional skeletal myogenic progenitors from human ES/iPS cells and highlights their potential for future therapeutic application in muscular dystrophies.	[Darabi, Radbod; Perlingeiro, Rita C. R.] Univ Minnesota, Dept Med, Lillehei Heart Inst, Minneapolis, MN 55455 USA; [Arpke, Robert W.; Kyba, Michael] Univ Minnesota, Dept Pediat, Lillehei Heart Inst, Minneapolis, MN 55455 USA; [Irion, Stefan; Dimos, John T.; Grskovic, Marica] iPierian, San Francisco, CA 94080 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Perlingeiro, RCR (corresponding author), Univ Minnesota, Dept Med, Lillehei Heart Inst, Box 736 UMHC, Minneapolis, MN 55455 USA.	perli032@umn.edu	Grskovic, Marica/AAJ-4080-2021	Arpke, Robert W/0000-0002-0876-078X; Kyba, Michael/0000-0002-5579-7534	NIH [RC1 AR058118, RO1 AR055299, RC2 AR058919, RO1 AR055685, R21 AG034370, P01 GM081627]; Dr. Bob and Jean Smith Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055299, RC2AR058919, RC1AR058118, R01AR055685] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG034370] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Bob and Jean Smith Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was supported by NIH grants RC1 AR058118, RO1 AR055299, RC2 AR058919, RO1 AR055685, R21 AG034370, and P01 GM081627. We also thank the generous support from the Dr. Bob and Jean Smith Foundation. The monoclonal antibody to MHC was obtained from the Developmental Studies Hybridoma Bank, developed under the auspices of the NICHD and maintained by the University of Iowa. We thank Cynthia Dekay for assistance in graphic design and members of iPierian's R&D team for technical support. R.D. designed and conducted the in vitro and in vivo experiments with iPAX7 ES and iPS cells, performed final analysis of the data, and contributed, to writing the paper. S.I., J.T.D., and M.G. designed and conducted experiments regarding the generation and characterization of iPS cells. R.W.A. and M.K. developed the NSG-mdx<SUP>4Cv</SUP> mice and M.K. contributed to writing the paper. R.C.R.P. supervised the overall project, designed experiments, analyzed the data, and wrote the paper.	Alipio Z, 2010, P NATL ACAD SCI USA, V107, P13426, DOI 10.1073/pnas.1007884107; Barberi T, 2007, NAT MED, V13, P642, DOI 10.1038/nm1533; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; COULTON GR, 1992, J CELL SCI, V102, P653; DANKO I, 1992, PEDIATR RES, V32, P128, DOI 10.1203/00006450-199207000-00025; Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705; Darabi R, 2011, STEM CELL REV REP, V7, P948, DOI 10.1007/s12015-011-9258-2; Darabi R, 2011, STEM CELLS, V29, P777, DOI 10.1002/stem.625; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Espejel S, 2010, J CLIN INVEST, V120, P3120, DOI 10.1172/JCI43267; Guenechea G, 1999, BLOOD, V93, P1097, DOI 10.1182/blood.V93.3.1097.403k04_1097_1105; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hargus G, 2010, P NATL ACAD SCI USA, V107, P15921, DOI 10.1073/pnas.1010209107; Im WB, 1996, HUM MOL GENET, V5, P1149, DOI 10.1093/hmg/5.8.1149; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; MENDELL JR, 1995, NEW ENGL J MED, V333, P832, DOI 10.1056/NEJM199509283331303; Mizuno Y, 2010, FASEB J, V24, P2245, DOI 10.1096/fj.09-137174; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sacco A, 2010, CELL, V143, P1059, DOI 10.1016/j.cell.2010.11.039; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Sherwood RI, 2004, STEM CELLS, V22, P1292, DOI 10.1634/stemcells.2004-0090; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Skuk D, 2010, MOL THER, V18, P1689, DOI 10.1038/mt.2010.128; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Tabayoyong WB, 2009, J IMMUNOL, V183, P5449, DOI 10.4049/jimmunol.0901807; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Vilquin J T, 2005, Acta Myol, V24, P119; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Xu D, 2009, P NATL ACAD SCI USA, V106, P808, DOI 10.1073/pnas.0812090106; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	45	295	312	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 4	2012	10	5					610	619		10.1016/j.stem.2012.02.015	http://dx.doi.org/10.1016/j.stem.2012.02.015			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	944WN	22560081	Bronze, Green Accepted			2022-12-28	WOS:000304234600018
J	Wu, H; Zhang, Y				Wu, Hao; Zhang, Yi			Early Embryos Reprogram DNA Methylation in Two Steps	CELL STEM CELL			English	Editorial Material							PREIMPLANTATION EMBRYOS; 5-HYDROXYMETHYLCYTOSINE; OOCYTES; GENOME		[Wu, Hao; Zhang, Yi] Univ N Carolina, Lineberger Comprehens Canc Ctr, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA; [Wu, Hao; Zhang, Yi] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Wu, Hao] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Wu, Hao] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Massachusetts General Hospital; Harvard University	Zhang, Y (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu	Wu, Hao/G-4145-2013	Wu, Hao/0000-0002-1256-6891; Wu, Hao/0000-0003-4395-6929; Zhang, Yi/0000-0002-2789-0811				Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Inoue A, 2011, CELL RES, V21, P1670, DOI 10.1038/cr.2011.189; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smith Z. D., 2012, NATURE IN PRESS, DOI [10.1038/nature10960, DOI 10.1038/NATURE10960]; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111	10	10	10	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAY 4	2012	10	5					487	489		10.1016/j.stem.2012.04.012	http://dx.doi.org/10.1016/j.stem.2012.04.012			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	944WN	22560071	Bronze			2022-12-28	WOS:000304234600005
J	Kleppe, M; Levine, RL				Kleppe, Maria; Levine, Ross L.			Targeting beta-catenin in CML: Leukemia Stem Cells Beware!	CELL STEM CELL			English	Editorial Material							CHRONIC MYELOID-LEUKEMIA; BCR-ABL; TYROSINE KINASE; IMATINIB; COMBINATION; INHIBITION	In this issue of Cell Stem Cell, Heidel et al. (2012) use genetic and pharmacological approaches to reveal that Wnt/beta-catenin signaling is required for leukemic stem cell (LSC) maintenance in chronic myeloid leukemia. They demonstrate that beta-catenin inactivation targets imanitib-resistant LSCs in vivo.	[Kleppe, Maria; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Levine, RL (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave,Box 20, New York, NY 10065 USA.	leviner@mskcc.org	levine, ross/AAE-7658-2019; Kleppe, Maria/C-6341-2014	Kleppe, Maria/0000-0002-4372-6704				Bellodi C, 2009, J CLIN INVEST, V119, P1109, DOI 10.1172/JCI35660; DEKLEIN A, 1982, NATURE, V300, P765, DOI 10.1038/300765a0; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Heidel FH, 2012, CELL STEM CELL, V10, P412, DOI 10.1016/j.stem.2012.02.017; Hu Y, 2009, LEUKEMIA, V23, P109, DOI 10.1038/leu.2008.262; Li L, 2012, CANCER CELL, V21, P266, DOI 10.1016/j.ccr.2011.12.020; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624; Weisberg E, 2007, NAT REV CANCER, V7, P345, DOI 10.1038/nrc2126; Zhang B, 2010, CANCER CELL, V17, P427, DOI 10.1016/j.ccr.2010.03.011; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003	10	13	15	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	APR 6	2012	10	4					351	353		10.1016/j.stem.2012.03.006	http://dx.doi.org/10.1016/j.stem.2012.03.006			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	929QA	22482499	Bronze			2022-12-28	WOS:000303079400003
J	Mou, HM; Zhao, R; Sherwood, R; Ahfeldt, T; Lapey, A; Wain, J; Sicilian, L; Izvolsky, K; Musunuru, K; Cowan, C; Rajagopal, J				Mou, Hongmei; Zhao, Rui; Sherwood, Richard; Ahfeldt, Tim; Lapey, Allen; Wain, John; Sicilian, Leonard; Izvolsky, Konstantin; Musunuru, Kiran; Cowan, Chad; Rajagopal, Jayaraj			Generation of Multipotent Lung and Airway Progenitors from Mouse ESCs and Patient-Specific Cystic Fibrosis iPSCs	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; DIRECTED DIFFERENTIATION; GENETIC MODIFIERS; II CELLS; ENDODERM; MODEL; BMP; MORPHOGENESIS; EXPRESSION; EPITHELIUM	Deriving lung progenitors from patient-specific pluripotent cells is a key step in producing differentiated lung epithelium for disease modeling and transplantation. By mimicking the signaling events that occur during mouse lung development, we generated murine lung progenitors in a series of discrete steps. Definitive endoderm derived from mouse embryonic stem cells (ESCs) was converted into foregut endoderm, then into replicating Nkx2.1+ lung endoderm, and finally into multipotent embryonic lung progenitor and airway progenitor cells. We demonstrated that precisely-timed BMP, FGF, and WNT signaling are required for NKX2.1 induction. Mouse ESC-derived Nkx2.1+ progenitor cells formed respiratory epithelium (tracheospheres) when transplanted subcutaneously into mice. We then adapted this strategy to produce disease-specific lung progenitor cells from human Cystic Fibrosis induced pluripotent stem cells (iPSCs), creating a platform for dissecting human lung disease. These disease-specific human lung progenitors formed respiratory epithelium when subcutaneously engrafted into immunodeficient mice.	[Mou, Hongmei; Zhao, Rui; Ahfeldt, Tim; Wain, John; Izvolsky, Konstantin; Musunuru, Kiran; Cowan, Chad; Rajagopal, Jayaraj] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Mou, Hongmei; Zhao, Rui; Sicilian, Leonard; Rajagopal, Jayaraj] Massachusetts Gen Hosp, Pulm & Crit Care Unit, Dept Internal Med, Boston, MA 02114 USA; [Lapey, Allen; Rajagopal, Jayaraj] Massachusetts Gen Hosp, Pulm Unit, Dept Pediat, Boston, MA 02114 USA; [Wain, John] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Sherwood, Richard; Musunuru, Kiran] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Ahfeldt, Tim; Musunuru, Kiran; Cowan, Chad] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Musunuru, Kiran; Cowan, Chad; Rajagopal, Jayaraj] Holyoke Ctr, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University	Rajagopal, J (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.	jrajagopal@partners.org	Ahfeldt, Tim/E-2935-2017; Zhao, Rui/J-7110-2014	Ahfeldt, Tim/0000-0001-6377-7376	Harvard Stem Cell Institute; NIH-NHLBI [P30]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL108055, R21HL109786, P30HL101287] Funding Source: NIH RePORTER	Harvard Stem Cell Institute; NIH-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work in this manuscript was supported by a Harvard Stem Cell Institute Seed Grant and an NIH-NHLBI Early Career Research New Faculty (P30) award to J.R. We thank Drs. William Anderson and Darrell Kotton for reading this manuscript and for their critical comments. We also wish to extend our thanks to all of the members of the Rajagopal Laboratory for their reading of the text, their constructive criticisms and comments, and valuable discussion and support.	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Ameri J, 2010, STEM CELLS, V28, P45, DOI 10.1002/stem.249; Aubin J, 2004, GENE DEV, V18, P1482, DOI 10.1101/gad.1202604; Bellusci S, 1996, DEVELOPMENT, V122, P1693; Cao L, 2011, DIFFERENTIATION, V81, P1, DOI 10.1016/j.diff.2010.09.182; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; CLARKE LL, 1992, SCIENCE, V257, P1125, DOI 10.1126/science.257.5073.1125; Coraux C, 2005, AM J RESP CELL MOL, V32, P87, DOI 10.1165/rcmb.2004-0079RC; Cutting GR, 2005, ANNU REV GENOM HUM G, V6, P237, DOI 10.1146/annurev.genom.6.080604.162254; Domyan ET, 2011, DEVELOPMENT, V138, P971, DOI 10.1242/dev.053694; Drumm ML, 2005, NEW ENGL J MED, V353, P1443, DOI 10.1056/NEJMoa051469; Goss AM, 2009, DEV CELL, V17, P290, DOI 10.1016/j.devcel.2009.06.005; Green MD, 2011, NAT BIOTECHNOL, V29, P267, DOI 10.1038/nbt.1788; Guilbault C, 2007, AM J RESP CELL MOL, V36, P1, DOI 10.1165/rcmb.2006-0184TR; Haston CK, 2005, NEW ENGL J MED, V353, P1509, DOI 10.1056/NEJMe058185; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KEREM E, 1990, NEW ENGL J MED, V323, P1517, DOI 10.1056/NEJM199011293232203; KEREM E, 1992, NEW ENGL J MED, V326, P1187, DOI 10.1056/NEJM199204303261804; Knowles MR, 2006, CURR OPIN PULM MED, V12, P416, DOI 10.1097/01.mcp.0000245707.59138.40; Kozawa O, 2002, J CELL BIOCHEM, V84, P583, DOI 10.1002/jcb.10056; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; Lebeche D, 1999, MECH DEVELOP, V86, P125, DOI 10.1016/S0925-4773(99)00124-0; Malpel S, 2000, DEVELOPMENT, V127, P3057; Minoo P, 1999, DEV BIOL, V209, P60, DOI 10.1006/dbio.1999.9234; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Okubo Tadashi, 2004, J Biol, V3, P11, DOI 10.1186/jbiol3; Perl AKT, 2005, GENESIS, V41, P23, DOI 10.1002/gene.20093; Powell PP, 1998, AM J RESP CELL MOL, V19, P563, DOI 10.1165/ajrcmb.19.4.2994; Que JW, 2006, DIFFERENTIATION, V74, P422, DOI 10.1111/j.1432-0436.2006.00096.x; Que JW, 2009, DEVELOPMENT, V136, P1899, DOI 10.1242/dev.034629; Rawlins EL, 2009, DEVELOPMENT, V136, P3741, DOI 10.1242/dev.037317; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Roszell B, 2009, TISSUE ENG PT A, V15, P3351, DOI 10.1089/ten.TEA.2008.0664; Samadikuchaksaraei A, 2006, TISSUE ENG, V12, P867, DOI 10.1089/ten.2006.12.867; Serls AE, 2005, DEVELOPMENT, V132, P35, DOI 10.1242/dev.01570; Sherwood RI, 2011, MECH DEVELOP, V128, P387, DOI 10.1016/j.mod.2011.07.005; Shu WG, 2007, DEVELOPMENT, V134, P1991, DOI 10.1242/dev.02846; Shu WG, 2005, DEV BIOL, V283, P226, DOI 10.1016/j.ydbio.2005.04.014; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Stoltz DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000928; Sun XS, 2010, J CLIN INVEST, V120, P3149, DOI 10.1172/JCI43052; Van Haute L, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-105; van Vranken BE, 2005, TISSUE ENG, V11, P1177; von Bubnoff A, 2001, DEV BIOL, V239, P1, DOI 10.1006/dbio.2001.0388; Wang D, 2007, P NATL ACAD SCI USA, V104, P4449, DOI 10.1073/pnas.0700052104; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Weaver M, 1999, DEVELOPMENT, V126, P4005; Wells JM, 2000, DEVELOPMENT, V127, P1563; WERT SE, 1993, DEV BIOL, V156, P426, DOI 10.1006/dbio.1993.1090; Zaret KS, 2008, COLD SH Q B, V73, P119, DOI 10.1101/sqb.2008.73.040; Zhang KJ, 2010, DEVELOPMENT, V137, P2095, DOI 10.1242/dev.049494	57	218	236	0	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 6	2012	10	4					385	397		10.1016/j.stem.2012.01.018	http://dx.doi.org/10.1016/j.stem.2012.01.018			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	929QA	22482504	Green Accepted, Bronze			2022-12-28	WOS:000303079400008
J	Cheng, LZ; Hansen, NF; Zhao, L; Du, YT; Zou, CL; Donovan, FX; Chou, BK; Zhou, GY; Li, SJ; Dowey, SN; Ye, ZH; Chandrasekharappa, SC; Yang, HM; Mullikin, JC; Liu, PP				Cheng, Linzhao; Hansen, Nancy F.; Zhao, Ling; Du, Yutao; Zou, Chunlin; Donovan, Frank X.; Chou, Bin-Kuan; Zhou, Guangyu; Li, Shijie; Dowey, Sarah N.; Ye, Zhaohui; Chandrasekharappa, Settara C.; Yang, Huanming; Mullikin, James C.; Liu, P. Paul		NISC Comparative Sequencing Progra	Low Incidence of DNA Sequence Variation in Human Induced Pluripotent Stem Cells Generated by Nonintegrating Plasmid Expression	CELL STEM CELL			English	Article							COPY NUMBER VARIATION; MUTATIONS; ACCURATE; DERIVATION; SPECTRUM	The utility of induced pluripotent stem cells (iPSCs) as models to study diseases and as sources for cell therapy depends on the integrity of their genomes. Despite recent publications of DNA sequence variations in the iPSCs, the true scope of such changes for the entire genome is not clear. Here we report the whole-genome sequencing of three human iPSC lines derived from two cell types of an adult donor by episomal vectors. The vector sequence was undetectable in the deeply sequenced iPSC lines. We identified 1,058-1,808 heterozygous single-nucleotide variants (SNVs), but no copy-number variants, in each iPSC line. Six to twelve of these SNVs were within coding regions in each iPSC line, but 50% of them are synonymous changes and the remaining are not selectively enriched for known genes associated with cancers. Our data thus suggest that episome-mediated reprogramming is not inherently mutagenic during integration-free iPSC induction.	[Cheng, Linzhao; Zou, Chunlin; Chou, Bin-Kuan; Dowey, Sarah N.; Ye, Zhaohui] Johns Hopkins Univ, Inst Cell Engn, Stem Cell Program, Baltimore, MD 21205 USA; [Cheng, Linzhao; Zou, Chunlin; Chou, Bin-Kuan; Dowey, Sarah N.; Ye, Zhaohui] Johns Hopkins Univ, Div Hematol, Baltimore, MD 21205 USA; [Hansen, Nancy F.; Mullikin, James C.] NHGRI, Comparat Genom Unit, NIH, Bethesda, MD 20892 USA; [Zhao, Ling; Liu, P. Paul] NHGRI, Oncogenesis & Dev Sect, NIH, Bethesda, MD 20892 USA; [Mullikin, James C.; NISC Comparative Sequencing Progra] NHGRI, NIH Intramural Sequencing Ctr NISC, NIH, Bethesda, MD 20892 USA; [Du, Yutao; Zhou, Guangyu; Li, Shijie; Yang, Huanming] Beijing Genom Inst BGI Shenzhen, Shenzhen 518000, Peoples R China	Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Beijing Genomics Institute (BGI)	Cheng, LZ (corresponding author), Johns Hopkins Univ, Inst Cell Engn, Stem Cell Program, Baltimore, MD 21205 USA.	lcheng@welch.jhu.edu; pliu@mail.nih.gov	Liu, Paul/A-7976-2012	Liu, Paul/0000-0002-6779-025X; Donovan, Frank X./0000-0002-7712-2335; Ye, Zhaohui/0000-0001-5272-9168; ZOU, CHUNLIN/0000-0002-3308-5544	Johns Hopkins University; NIH [RC2 HL101582, U01 HL099775, R01 HL073781]; NIH Center for Regenerative Medicine (NCRM); National Human Genome Research Institute at NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099775, RC2HL101582, R01HL073781] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZICHG200346, ZIAHG200330, ZIAHG000030, ZIBHG000196, ZIAHG000029] Funding Source: NIH RePORTER	Johns Hopkins University(Johns Hopkins University); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Center for Regenerative Medicine (NCRM); National Human Genome Research Institute at NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Raman Sood and Blake Carrington for PCR and Sanger sequencing for confirming mutations and Xianmin Zeng in The Buck Institute in California for providing DNA from neural progenitor cells derived from BC1 iPSCs. This study was supported in part by Johns Hopkins University and NIH grants (RC2 HL101582, U01 HL099775, and R01 HL073781), an award from the NIH Center for Regenerative Medicine (NCRM), and The Intramural Research Program of The National Human Genome Research Institute at NIH.	Ajay SS, 2011, GENOME RES, V21, P1498, DOI 10.1101/gr.123638.111; Araten DJ, 2005, CANCER RES, V65, P8111, DOI 10.1158/0008-5472.CAN-04-1198; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Cheng LZ, 2003, STEM CELLS, V21, P131, DOI 10.1634/stemcells.21-2-131; Chou BK, 2011, CELL RES, V21, P518, DOI 10.1038/cr.2011.12; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; Martins-Taylor K, 2011, NAT BIOTECHNOL, V29, P488, DOI 10.1038/nbt.1890; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Pera MF, 2011, NATURE, V471, P46, DOI 10.1038/471046a; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Xie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-80; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	25	188	200	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 2	2012	10	3					337	344		10.1016/j.stem.2012.01.005	http://dx.doi.org/10.1016/j.stem.2012.01.005			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	908BX	22385660	Green Accepted, Bronze			2022-12-28	WOS:000301466500014
J	Brookes, E; de Santiago, I; Hebenstreit, D; Morris, KJ; Carroll, T; Xie, SQ; Stock, JK; Heidemann, M; Eick, D; Nozaki, N; Kimura, H; Ragoussis, J; Teichmann, SA; Pombo, A				Brookes, Emily; de Santiago, Ines; Hebenstreit, Daniel; Morris, Kelly J.; Carroll, Tom; Xie, Sheila Q.; Stock, Julie K.; Heidemann, Martin; Eick, Dirk; Nozaki, Naohito; Kimura, Hiroshi; Ragoussis, Jiannis; Teichmann, Sarah A.; Pombo, Ana			Polycomb Associates Genome-wide with a Specific RNA Polymerase II Variant, and Regulates Metabolic Genes in ESCs	CELL STEM CELL			English	Article							STEM-CELLS; BIVALENT GENES; SELF-RENEWAL; PLURIPOTENT; MARKS; HETEROGENEITY; CIRCUITRY; NETWORKS; NANOG	Polycomb repressor complexes (PRCs) are important chromatin modifiers fundamentally implicated in pluripotency and cancer. Polycomb silencing in embryonic stem cells (ESCs) can be accompanied by active chromatin and primed RNA polymerase II (RNAPII), but the relationship between PRCs and RNAPII remains unclear genome-wide. We mapped PRC repression markers and four RNAPII states in ESCs using ChIP-seq, and found that PRC targets exhibit a range of RNAPII variants. First, developmental PAC targets are bound by unproductive RNAPII (S5p(+)S7p(-)S2p(-)) genonne-wide. Sequential ChIP, Ring1B depletion, and genome-wide correlations show that PRCs and RNAPII-S5p physically bind to the same chromatin and functionally synergize. Second, we identify a cohort of genes marked by PRC and elongating RNAPII (S5p(+)S7p(+)S2p(+); they produce mRNA and protein, and their expression increases upon PRC1 knockdown. We show that this group of PRC targets switches between active and PRC-repressed states within the ESC population, and that many have roles in metabolism.	[Brookes, Emily; de Santiago, Ines; Morris, Kelly J.; Carroll, Tom; Xie, Sheila Q.; Stock, Julie K.; Pombo, Ana] Univ London Imperial Coll Sci Technol & Med, Sch Med, Ctr Clin Sci, MRC,Genome Funct Grp, London W12 0NN, England; [de Santiago, Ines] Gulbenkian Inst Sci, P-62780 Oeiras, Portugal; [Hebenstreit, Daniel; Teichmann, Sarah A.] MRC, Mol Biol Lab, Computat Genom Grp, Cambridge CB2 2QH, England; [Heidemann, Martin; Eick, Dirk] Ctr Integrated Prot Sci, Helmholtz Ctr Munich, Dept Mol Epigenet, D-81377 Munich, Germany; [Nozaki, Naohito] Tokyo Inst Technol, Biofrontier Res Ctr, Yokohama, Kanagawa 2268503, Japan; [Kimura, Hiroshi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Ragoussis, Jiannis] Wellcome Trust Ctr Human Genet, Genom Res Grp, Oxford OX3 7BN, England	Imperial College London; MRC Laboratory Molecular Biology; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Tokyo Institute of Technology; Osaka University; University of Oxford; Wellcome Centre for Human Genetics	Pombo, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Med, Ctr Clin Sci, MRC,Genome Funct Grp, Hammersmith Hosp Campus,Du Cane Rd, London W12 0NN, England.	ana.pombo@csc.mrc.ac.uk	Ragoussis, Ioannis/AAD-9790-2022; hebenstreit, daniel/GWZ-2082-2022; Pombo, Ana/A-1045-2010; de Santiago, Ines/AAP-5859-2020; Kimura, Hiroshi/B-9524-2015	hebenstreit, daniel/0000-0003-0144-6728; Pombo, Ana/0000-0002-7493-6288; de Santiago, Ines/0000-0002-8172-1322; Kimura, Hiroshi/0000-0003-0854-083X; Ragoussis, Ioannis/0000-0002-8515-0934; Teichmann, Sarah/0000-0002-6294-6366; Brookes, Emily/0000-0003-2175-4349	InteGeR FP7 Marie Curie Initial Training Network [PITN-GA-2007-214902]; Medical Research Council (UK); Fundacao para a Ciencia e a Tecnologia [SFRH/BD/33205/2007]; MEXT of Japan; Deutsche Forschungsgemeinschaft [SFBTR5]; Wellcome Trust [075491/Z/04]; Children's Hospital Boston; Medical Research Council [MC_U105161047, MC_U120061476] Funding Source: researchfish; MRC [MC_U105161047, MC_U120061476] Funding Source: UKRI	InteGeR FP7 Marie Curie Initial Training Network; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wellcome Trust(Wellcome TrustEuropean Commission); Children's Hospital Boston; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Lorne Lonie, Lorna Gregory, and Carme Camps (WTCHG, UK) for genome-wide libraries; Wendy Bickmore (MRC-HGU, UK) for ES-OS25 cells; Haruhiko Koseki (RIKEN, Japan) for Ring1B antibody; Haruhiko Koseki and Miguel Vidal (CSIC, Spain) for ES-ERT2 cells; Sanofi Aventis and the National Cancer Institute (NIH) for flavopiridol; Zoe Webster (CSC) for ESC culture assistance; Gopuraja Dharmalingam for next generation sequencing data processing; Niall Dillon and the Pombo laboratory (CSC) for critical reading of the manuscript; Madan Babu (MRC-LMB, UK) and Boris Lenhard (MRC-CSC) for helpful discussions; and the Medical Research Council (UK) and InteGeR FP7 Marie Curie Initial Training Network (project number PITN-GA-2007-214902) for support. I.d.S. was supported by Fundacao para a Ciencia e a Tecnologia (grant SFRH/BD/33205/2007; Portugal); H.K., by grants-in-aid from the MEXT of Japan; D.E., by Deutsche Forschungsgemeinschaft (SFBTR5); and J.R., by The Wellcome Trust (grant 075491/Z/04). E.B. thanks Yang Shi (Children's Hospital Boston) for support during the review process of this manuscript. E.B., K.J.M., J.K.S., S.X., M.H., D.E., N.N., H.K., J.R., and A.P. designed and/or performed laboratory experiments; I.d.S., D.H., T.C., SAT., and A.P. designed and/or performed bioinformatic analyses; E.B., I.d.S., D.H., S.A.T., and A.P. analyzed the data; and E.B., I.d.S., and A.P. designed the project and wrote the manuscript. N.N. is a founder of MAB Institute Inc.	Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016; Alder O, 2010, DEVELOPMENT, V137, P2483, DOI 10.1242/dev.048363; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Brookes E, 2009, EMBO REP, V10, P1213, DOI 10.1038/embor.2009.221; Canham MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000379; Carter MG, 2008, GENE EXPR PATTERNS, V8, P181, DOI 10.1016/j.gep.2007.10.009; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; De Gobbi M, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-9; Enderle D, 2011, GENOME RES, V21, P216, DOI 10.1101/gr.114348.110; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Ferrai C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000270; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Graumann J, 2008, MOL CELL PROTEOMICS, V7, P672, DOI 10.1074/mcp.M700460-MCP200; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hammond SM, 2008, CELL, V135, P1013, DOI 10.1016/j.cell.2008.11.026; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hebenstreit D, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1226; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lienert F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002090; Lu R, 2011, J BIOL CHEM, V286, P8425, DOI 10.1074/jbc.M110.202150; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nishiyama A, 2009, CELL STEM CELL, V5, P420, DOI 10.1016/j.stem.2009.07.012; Richly H, 2010, BIOESSAYS, V32, P669, DOI 10.1002/bies.201000016; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Sharov AA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-102; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tietjen JR, 2010, NAT STRUCT MOL BIOL, V17, P1154, DOI 10.1038/nsmb.1900; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van der Stoop P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002235; Walker E, 2010, CELL STEM CELL, V6, P153, DOI 10.1016/j.stem.2009.12.014; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; Young MD, 2011, NUCLEIC ACIDS RES, V39, P7415, DOI 10.1093/nar/gkr416	49	213	216	3	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 3	2012	10	2					157	170		10.1016/j.stem.2011.12.017	http://dx.doi.org/10.1016/j.stem.2011.12.017			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	892FM	22305566	hybrid, Green Published			2022-12-28	WOS:000300272100009
J	Morey, L; Pascual, G; Cozzuto, L; Roma, G; Wutz, A; Benitah, SA; Di Croce, L				Morey, Lluis; Pascual, Gloria; Cozzuto, Luca; Roma, Guglielmo; Wutz, Anton; Aznar Benitah, Salvador; Di Croce, Luciano			Nonoverlapping Functions of the Polycomb Group Cbx Family of Proteins in Embryonic Stem Cells	CELL STEM CELL			English	Article							METHYLATED HISTONE H3; DEVELOPMENTAL REGULATORS; GENE-EXPRESSION; X-INACTIVATION; RING1B; PRC1; UBIQUITYLATION; PROLIFERATION; GASTRULATION; MAINTENANCE	Polycomb group proteins are essential regulators of cell fate decisions during embryogenesis. In mammals, at least five different Cbx proteins (Cbx2, Cbx4, Cbx6, Cbx7, and Cbx8) are known to associate with the core Polycomb repressive complex 1 (PRC1). Here we show that pluripotency and differentiation of mouse embryonic stem cells (ESCs) is regulated by different Cbx-associated PRC1 complexes with unique functions. Maintenance of pluripotency primarily depends on Cbx7, while lineage commitment is orchestrated by Cbx2 and Cbx4. At the molecular level, we have uncovered a Polycomb autoregulatory loop in which Cbx7 represses the expression of prodifferentiation Cbx proteins, thereby maintaining the pluripotent state. We additionally show that the occupancy of Cbx7 on promoters is completely dependent on PRC2 activity but only partially dependent on a functional PRC1 complex. Thus, Cbx proteins confer distinct target selectivity to the PRC1 complex, achieving a balance between the self-renewal and the differentiation of ESCs.	[Morey, Lluis; Pascual, Gloria; Cozzuto, Luca; Roma, Guglielmo; Aznar Benitah, Salvador; Di Croce, Luciano] CRG, Barcelona 08003, Spain; [Morey, Lluis; Pascual, Gloria; Cozzuto, Luca; Roma, Guglielmo; Aznar Benitah, Salvador; Di Croce, Luciano] UPF, Barcelona 08003, Spain; [Wutz, Anton] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QR, England	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; University of Cambridge	Di Croce, L (corresponding author), CRG, Dr Aiguader 88, Barcelona 08003, Spain.	luciano.dicroce@crg.es	Cozzuto, Luca/K-5385-2015; Di Croce, Luciano/E-7759-2015; Angulo, Gloria Pascual/AAA-7668-2019; Aznar-Benitah, Salvador/F-4761-2016	Cozzuto, Luca/0000-0003-3194-8892; Di Croce, Luciano/0000-0003-3488-6228; Angulo, Gloria Pascual/0000-0003-3810-6647; Aznar-Benitah, Salvador/0000-0002-9059-5049; Morey, Lluis/0000-0001-9851-4066	Spanish "Ministerio de Educacion y Ciencia" [BFU2010-18692]; AGAUR; CRG-Novartis; MRC [G0800784] Funding Source: UKRI; Medical Research Council [G0800784, G0800784B] Funding Source: researchfish	Spanish "Ministerio de Educacion y Ciencia"(Spanish Government); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); CRG-Novartis; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are indebted to V.A. Raker for help in preparing the manuscript, J. Walfridsson and M. Morey for critical reading of the manuscript, members of the Di Croce laboratory for discussions, and the CRG Genomic Unit. This work was supported by grants from the Spanish "Ministerio de Educacion y Ciencia" (CONSOLIDER and BFU2010-18692), from AGAUR to L.D.C. L.M. was supported by a postdoctoral CRG-Novartis fellowship. L.M designed the study and conducted all the experiments, except for the teratoma experiments performed by G.P. L.C. and G.R. performed the ChIP-seq peak calling and gene identification, and L.D.C. supervisec the experiments and provided intellectual support toward design and interpretation of the results. L.M, S.A.B, A.W., and L.C.D wrote the manuscript.	Akasaka T, 2001, DEVELOPMENT, V128, P1587; Aloia L, 2010, J BIOL CHEM, V285, P7776, DOI 10.1074/jbc.M109.077156; Bejarano F, 2005, MECH DEVELOP, V122, P1118, DOI 10.1016/j.mod.2005.06.001; Bel S, 1998, DEVELOPMENT, V125, P3543; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Core N, 1997, DEVELOPMENT, V124, P721; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Dietrich N, 2007, EMBO J, V26, P1637, DOI 10.1038/sj.emboj.7601632; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Faust C, 1998, DEVELOPMENT, V125, P4495; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Garcia E, 1999, EMBO J, V18, P3404, DOI 10.1093/emboj/18.12.3404; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Leeb M, 2007, J CELL BIOL, V178, P219, DOI 10.1083/jcb.200612127; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Lorente MD, 2000, DEVELOPMENT, V127, P5093; Luis NM, 2011, CELL STEM CELL, V9, P233, DOI 10.1016/j.stem.2011.07.013; Maertens GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006380; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Piunti A, 2011, FUTURE ONCOL, V7, P57, DOI 10.2217/FON.10.157; Puschendorf M, 2008, NAT GENET, V40, P411, DOI 10.1038/ng.99; Richly H, 2010, NATURE, V468, P1124, DOI 10.1038/nature09574; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Vandamme J, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002642; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wang RJ, 2008, BIOCHEMISTRY-US, V47, P8007, DOI 10.1021/bi800857f; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021	42	238	250	0	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 6	2012	10	1					47	62		10.1016/j.stem.2011.12.006	http://dx.doi.org/10.1016/j.stem.2011.12.006			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	880ZQ	22226355	Bronze			2022-12-28	WOS:000299449500010
J	Keller, PJ; Arendt, LM; Kuperwasser, C				Keller, Patricia J.; Arendt, Lisa M.; Kuperwasser, Charlotte			Stem Cell Maintenance of the Mammary Gland: It Takes Two	CELL STEM CELL			English	Editorial Material							PROGENITORS; POPULATION	Transplantation assays suggest that multipotent stem cells maintain the two lineages of the mammary gland. Recently in Nature, Van Keymeulen et al. (2011) used lineage tracing to discover unipotent stem cells that maintain the bulk of the mouse mammary gland after birth and during pregnancy.	[Keller, Patricia J.; Arendt, Lisa M.; Kuperwasser, Charlotte] Tufts Univ, Sch Med, Dept Anat & Cellular Biol, Sackler Sch, Boston, MA 02111 USA; [Keller, Patricia J.; Arendt, Lisa M.; Kuperwasser, Charlotte] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA	Tufts University; Tufts Medical Center	Kuperwasser, C (corresponding author), Tufts Univ, Sch Med, Dept Anat & Cellular Biol, Sackler Sch, Boston, MA 02111 USA.	charlotte.kuperwasser@tufts.edu		Arendt, Lisa/0000-0002-7954-3635	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD073035] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD073035] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Barker N, 2010, CELL STEM CELL, V7, P656, DOI 10.1016/j.stem.2010.11.016; Keller PJ, 2012, P NATL ACAD SCI USA, V109, P2772, DOI 10.1073/pnas.1017626108; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Petersen OW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003160; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Wagner KU, 2002, DEVELOPMENT, V129, P1377	10	13	13	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 2	2011	9	6					496	497		10.1016/j.stem.2011.11.008	http://dx.doi.org/10.1016/j.stem.2011.11.008			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	859SB	22136921	Bronze			2022-12-28	WOS:000297895000006
J	Donahue, TR; Dawson, DW				Donahue, Timothy R.; Dawson, David W.			Nodal/Activin Signaling: A Novel Target for Pancreatic Cancer Stem Cell Therapy	CELL STEM CELL			English	Editorial Material									[Donahue, Timothy R.; Dawson, David W.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Donahue, Timothy R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA; [Donahue, Timothy R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Donahue, Timothy R.] Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Med, Los Angeles, CA 90095 USA; [Dawson, David W.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Dawson, DW (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA.	ddawson@mednet.ucla.edu	Dawson, David/I-5917-2014					Bianco C, 2010, AM J PATHOL, V177, P532, DOI 10.2353/ajpath.2010.100102; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Lee CJ, 2008, TRANSL ONCOL, V1, P14, DOI 10.1593/tlo.08013; Lee KL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002130; LI C, 2011, GASTROENTER IN PRESS, DOI DOI 10.1053/J.GASTRO.2011.08.009; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Lonardo E, 2011, CELL STEM CELL, V9, P433, DOI 10.1016/j.stem.2011.10.001; Mueller MT, 2009, GASTROENTEROLOGY, V137, P1102, DOI 10.1053/j.gastro.2009.05.053; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; Pera MF, 2010, NATURE, V465, P713, DOI 10.1038/nature09228	10	6	7	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV 4	2011	9	5					383	384		10.1016/j.stem.2011.10.006	http://dx.doi.org/10.1016/j.stem.2011.10.006			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	850FJ	22056131	Bronze			2022-12-28	WOS:000297180200001
J	Yang, ZG; Ming, GL; Song, HJ				Yang, Zhengang; Ming, Guo-li; Song, Hongjun			Postnatal Neurogenesis in the Human Forebrain: From Two Migratory Streams to Dribbles	CELL STEM CELL			English	Editorial Material							NEURAL STEM-CELLS; HUMAN HIPPOCAMPUS; HUMAN BRAIN; NEURONS		[Yang, Zhengang] Fudan Univ, Inst Brain Sci, Shanghai 200032, Peoples R China; [Yang, Zhengang] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China; [Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; [Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA	Fudan University; Fudan University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Yang, ZG (corresponding author), Fudan Univ, Inst Brain Sci, Shanghai 200032, Peoples R China.	yangz@fudan.edu.cn; shongju1@jhmi.edu	Ming, Guo-li/J-7880-2013		NICHD NIH HHS [R01 HD069184-02, R01 HD069184] Funding Source: Medline; NIMH NIH HHS [R33 MH087874-03, R33 MH087874] Funding Source: Medline; NINDS NIH HHS [R01 NS048271, R01 NS047344, R01 NS047344-08, R01 NS048271-07] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R33MH087874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047344, R01NS048271] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Guerrero-Cazares H, 2011, J COMP NEUROL, V519, P1165, DOI 10.1002/cne.22566; Inta D, 2008, P NATL ACAD SCI USA, V105, P20994, DOI 10.1073/pnas.0807059105; Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; WANG C, 2011, CELL RES, DOI DOI 10.1038/CR201183	10	11	11	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV 4	2011	9	5					385	386		10.1016/j.stem.2011.10.007	http://dx.doi.org/10.1016/j.stem.2011.10.007			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	850FJ	22056132	Green Accepted, Bronze			2022-12-28	WOS:000297180200002
J	Kim, KS				Kim, Kwang-Soo			Converting Human Skin Cells to Neurons: A New Tool to Study and Treat Brain Disorders?	CELL STEM CELL			English	Editorial Material							HUMAN FIBROBLASTS; DOPAMINERGIC-NEURONS; FUNCTIONAL-NEURONS; DIRECT CONVERSION; MOUSE		[Kim, Kwang-Soo] Harvard Univ, McLean Hosp, Sch Med, Mol Neurobiol Lab,Dept Psychiat,Program Neurosci, Belmont, MA 02478 USA; [Kim, Kwang-Soo] Harvard Univ, Harvard Stem Cell Inst, McLean Hosp, Sch Med, Belmont, MA 02478 USA	Harvard University; McLean Hospital; Harvard University; McLean Hospital	Kim, KS (corresponding author), Harvard Univ, McLean Hosp, Sch Med, Mol Neurobiol Lab,Dept Psychiat,Program Neurosci, Belmont, MA 02478 USA.	kskim@mclean.harvard.edu						Ambasudhan R, 2011, CELL STEM CELL, V9, P113, DOI 10.1016/j.stem.2011.07.002; Barrilleaux B, 2011, CELL STEM CELL, V9, P103, DOI 10.1016/j.stem.2011.07.006; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323	11	15	16	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	SEP 2	2011	9	3					179	181		10.1016/j.stem.2011.08.004	http://dx.doi.org/10.1016/j.stem.2011.08.004			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	822DN	21885012	Bronze			2022-12-28	WOS:000295024200002
J	Miyoshi, N; Ishii, H; Nagano, H; Haraguchi, N; Dewi, DL; Kano, Y; Nishikawa, S; Tanemura, M; Mimori, K; Tanaka, F; Saito, T; Nishimura, J; Takemasa, I; Mizushima, T; Ikeda, M; Yamamoto, H; Sekimoto, M; Doki, Y; Mori, M				Miyoshi, Norikatsu; Ishii, Hideshi; Nagano, Hiroaki; Haraguchi, Naotsugu; Dewi, Dyah Laksmi; Kano, Yoshihiro; Nishikawa, Shinpei; Tanemura, Masahiro; Mimori, Koshi; Tanaka, Fumiaki; Saito, Toshiyuki; Nishimura, Junichi; Takemasa, Ichiro; Mizushima, Tsunekazu; Ikeda, Masataka; Yamamoto, Hirofumi; Sekimoto, Mitsugu; Doki, Yuichiro; Mori, Masaki			Reprogramming of Mouse and Human Cells to Pluripotency Using Mature MicroRNAs	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; DEFINED FACTORS; GENERATION; INDUCTION; FIBROBLASTS; RNA	Induced pluripotent stem cells (iPSCs) can be generated from differentiated human and mouse somatic cells using transcription factors such as Oct4, Sox2, Klf4, and c-Myc. It is possible to augment the reprogramming process with chemical compounds, but issues related to low reprogramming efficiencies and, with a number of protocols, residual vector sequences, remain to be resolved. We show here that it is possible to reprogram mouse and human cells to pluripotency by direct transfection of mature double-stranded microRNAs (miRNAs). Our approaches use a combination of mir-200c plus mir-302 s and mir-369 s family miRNAs. Because this reprogramming method does not require vector-based gene transfer, it holds significant potential for biomedical research and regenerative medicine.	[Ishii, Hideshi; Mimori, Koshi; Tanaka, Fumiaki; Mori, Masaki] Kyushu Univ, Med Inst Bioregulat, Div Mol & Surg Oncol, Dept Mol & Cellular Biol, Beppu, Oita 8740838, Japan; [Miyoshi, Norikatsu; Ishii, Hideshi; Nagano, Hiroaki; Haraguchi, Naotsugu; Dewi, Dyah Laksmi; Kano, Yoshihiro; Nishikawa, Shinpei; Tanemura, Masahiro; Nishimura, Junichi; Takemasa, Ichiro; Mizushima, Tsunekazu; Ikeda, Masataka; Yamamoto, Hirofumi; Sekimoto, Mitsugu; Doki, Yuichiro; Mori, Masaki] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka 5650871, Japan; [Saito, Toshiyuki] Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Transcriptome Profiling Grp, Chiba 2638555, Japan	Kyushu University; Osaka University; National Institutes for Quantum Science & Technology	Ishii, H (corresponding author), Kyushu Univ, Med Inst Bioregulat, Div Mol & Surg Oncol, Dept Mol & Cellular Biol, Tsurumihara 4546, Beppu, Oita 8740838, Japan.	hishii@gesurg.med.osaka-u.ac.jp; mmori@gesurg.med.osaka-u.ac.jp	Ishii, Hideshi/AAV-5317-2020; Sekimoto, Mitsugu/T-2217-2019; Sekimoto, MItsugu/AAE-5878-2019; Nishimura, Junichi/K-8390-2015; Mizushima, Tsunekazu/AAS-7245-2020; Dewi, Dyah Laksmi/GOP-2412-2022	Nishimura, Junichi/0000-0001-8220-3423; Mizushima, Tsunekazu/0000-0002-0825-6823; Dewi, Dyah Laksmi/0000-0001-7937-4221; Mimori, Koshi/0000-0003-3897-9974	Core Research for Evolutional Science and Technology (CREST); Ministry of Education, Culture, Sports, Science, and Technology [S: 21229015]; Ministry of Health, Labour and Welfare; Funding Program for Next Generation World-Leading Researchers, Japan [LS094]; Tokyo Biochemical Research Foundation; Grants-in-Aid for Scientific Research [21591644] Funding Source: KAKEN	Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Funding Program for Next Generation World-Leading Researchers, Japan; Tokyo Biochemical Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We would like to thank Dr. S. Yamanaka (Kyoto University) for fruitful discussions. We thank Drs. J.H. Moon, S. Miyazaki, H. Hoshnino, and Y. Omura for fruitful discussions and K. Kitagawa and S. Yamane for special technical assistance. This work was partly supported by a grant from Core Research for Evolutional Science and Technology (CREST) (M.M. and K.M.), a Grant-in-Aid for Scientific Research on Innovative Areas (M.M.), Grants-in-Aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology (S: 21229015) (M.M.), Grants-in-Aid for the 3rd Comprehensive 10-year Strategy for Cancer Control from the Ministry of Health, Labour and Welfare (M.M., H.I.), the Funding Program for Next Generation World-Leading Researchers, Japan (LS094) (K.M.), and a Grant-in-Aid from the Tokyo Biochemical Research Foundation (M.M.). The authors declare no competing financial interests.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Ciccone DN, 2009, NATURE, V461, P415, DOI 10.1038/nature08315; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/NMETH.1426, 10.1038/nmeth.1426]; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Miyoshi N, 2010, P NATL ACAD SCI USA, V107, P40, DOI 10.1073/pnas.0912407107; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Rosa A, 2011, EMBO J, V30, P237, DOI 10.1038/emboj.2010.319; Ruvkun G, 2001, SCIENCE, V294, P797, DOI 10.1126/science.1066315; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	29	549	590	0	73	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 3	2011	8	6					633	638		10.1016/j.stem.2011.05.001	http://dx.doi.org/10.1016/j.stem.2011.05.001			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	780HC	21620789	Bronze			2022-12-28	WOS:000291844100011
J	Rock, JR; Gao, X; Xue, Y; Randell, SH; Kong, YY; Hogan, BLM				Rock, Jason R.; Gao, Xia; Xue, Yan; Randell, Scott H.; Kong, Young-Yun; Hogan, Brigid L. M.			Notch-Dependent Differentiation of Adult Airway Basal Stem Cells	CELL STEM CELL			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; SIGNALING CONTROLS; UBIQUITIN LIGASE; PROGENITOR CELLS; LUNG DEVELOPMENT; CLARA CELLS; MIND BOMB; EPITHELIUM; MAINTENANCE; FATES	The epithelium lining the airways of the adult human lung is composed of ciliated and secretory cells together with undifferentiated basal cells (BCs). The composition and organization of this epithelium is severely disrupted in many respiratory diseases. However, little is known about the mechanisms controlling airway homeostasis and repair after epithelial damage. Here, we exploit the mouse tracheobronchial epithelium, in which BCs function as resident stem cells, as a genetically tractable model of human small airways. Using a reporter allele we show that the low level of Notch signaling at steady state is greatly enhanced during repair and the generation of lumina! progenitors. Loss-of-function experiments show that Notch signaling is required for the differentiation, but not self-renewal, of BCs. Moreover, sustained Notch activation in BCs promotes their luminal differentiation, primarily toward secretory lineages. We also provide evidence that this function of Notch signaling is conserved in BCs from human airways.	[Rock, Jason R.; Gao, Xia; Xue, Yan; Hogan, Brigid L. M.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Randell, Scott H.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; [Kong, Young-Yun] Seoul Natl Univ, Coll Nat Sci, Dept Biol Chem, Seoul 151747, South Korea; [Randell, Scott H.] Univ N Carolina, CF Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; Seoul National University (SNU); University of North Carolina; University of North Carolina Chapel Hill	Hogan, BLM (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	b.hogan@cellbio.duke.edu			CFF [HL071303, F32-HL102920, R026-CR07]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071303, F32HL102920, T32HL007538, R37HL071303] Funding Source: NIH RePORTER	CFF; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This manuscript is dedicated to the memory of our friend and colleague Dr. Tim Oliver. The work was supported, in part, by NIH grants HL071303 (B.L.M.H.), F32-HL102920 (J.R.R.) and R026-CR07 from the CFF (S.H.R.). We thank Ryoichiro Kageyama, Nadean Brown, Jeffrey Whitsett, Chay Kuo, Terry Lechler, Emma Rawlins, Tannishtha Reya, Blanche Capel, and their lab members for advice and reagents.	Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Boers JE, 1998, AM J RESP CRIT CARE, V157, P2000, DOI 10.1164/ajrccm.157.6.9707011; Borthwick DW, 2001, AM J RESP CELL MOL, V24, P662, DOI 10.1165/ajrcmb.24.6.4217; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Chiba S, 2006, STEM CELLS, V24, P2437, DOI 10.1634/stemcells.2005-0661; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Evans MJ, 2001, EXP LUNG RES, V27, P401, DOI 10.1080/019021401300317125; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Guseh JS, 2009, DEVELOPMENT, V136, P1751, DOI 10.1242/dev.029249; Hackett TL, 2008, STEM CELLS, V26, P2576, DOI 10.1634/stemcells.2008-0171; Hong KU, 2004, AM J PHYSIOL-LUNG C, V286, pL643, DOI 10.1152/ajplung.00155.2003; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Ito T, 2000, DEVELOPMENT, V127, P3913; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Kauffman S L, 1980, Int Rev Exp Pathol, V22, P131; Koo BK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001221; Lai EC, 2005, DEVELOPMENT, V132, P2319, DOI 10.1242/dev.01825; Liu JN, 2010, CURR TOP DEV BIOL, V92, P367, DOI [10.1016/S0070-2153(10)92012-7, 10.1016/S0070-2153(10)91012-7]; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Morimoto M, 2010, J CELL SCI, V123, P213, DOI 10.1242/jcs.058669; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Nakajima M, 1998, PATHOL INT, V48, P944; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Park KS, 2007, J CLIN INVEST, V117, P978, DOI 10.1172/JCI29176; Randell Scott H, 2006, Proc Am Thorac Soc, V3, P718, DOI 10.1513/pats.200605-117SF; RANDELL SH, 1991, AM J RESP CELL MOL, V4, P544, DOI 10.1165/ajrcmb/4.6.544; Rawlins EL, 2007, P NATL ACAD SCI USA, V104, P410, DOI 10.1073/pnas.0610770104; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031; Shi Wei, 2009, Proc Am Thorac Soc, V6, P558, DOI 10.1513/pats.200905-031RM; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tilley AE, 2009, AM J RESP CRIT CARE, V179, P457, DOI 10.1164/rccm.200705-795OC; Tsao PN, 2008, J BIOL CHEM, V283, P29532, DOI 10.1074/jbc.M801565200; Tsao PN, 2009, DEVELOPMENT, V136, P2297, DOI 10.1242/dev.034884; Voynow JA, 2005, AM J RESP CRIT CARE, V172, P1013, DOI 10.1164/rccm.200410-1398OC; Westhoff B, 2009, P NATL ACAD SCI USA, V106, P22293, DOI 10.1073/pnas.0907781106; Xu KL, 2010, AM J PHYSIOL-LUNG C, V298, pL45, DOI 10.1152/ajplung.90550.2008; Yu XB, 2006, STEM CELLS, V24, P876, DOI 10.1634/stemcells.2005-0598	40	290	293	2	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 3	2011	8	6					639	648		10.1016/j.stem.2011.04.003	http://dx.doi.org/10.1016/j.stem.2011.04.003			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	780HC	21624809	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000291844100012
J	Kusy, S; Gault, N; Ferri, F; Lewandowski, D; Barroca, V; Jaracz-Ros, A; Losson, R; Romeo, PH				Kusy, Sophie; Gault, Nathalie; Ferri, Federica; Lewandowski, Daniel; Barroca, Vilma; Jaracz-Ros, Agnieszka; Losson, Regine; Romeo, Paul-Henri			Adult Hematopoiesis is Regulated by TIF1 gamma, a Repressor of TAL1 and PU.1 Transcriptional Activity	CELL STEM CELL			English	Article							STEM-CELLS; SELF-RENEWAL; MYELOID PROGENITORS; EXPRESSION; GENE; SCL; DIFFERENTIATION; PROLIFERATION; FAMILY; ERYTHROPOIESIS	Crosstalk between transcription factors and cytokines precisely regulates tissue homeostasis. Transcriptional intermediary factor 1 gamma (TIF1 gamma) regulates vertebrate hematopoietic development, can control transcription elongation, and is a component of the TGF-beta signaling pathway. Here we show that deletion of TIF1 gamma in adult hematopoiesis is compatible with life and long-term maintenance of essential blood cell lineages. However, loss of TIF1 gamma results in deficient long-term hematopoietic stem cell (LTHSC) transplantation activity, deficient short-term HSC (ST-HSC) bone marrow retention, and priming ST-HSCs to myelomonocytic lineage. These defects are hematopoietic cell-autonomous, and priming of TIF1 gamma-deficient ST-HSCs can be partially rescued by wild-type hematopoietic cells. TIF1 gamma can form complexes with TAL1 or PU.1 two essential DNA-binding proteins in hematopoiesis occupy specific subsets of their DNA binding sites in vivo, and repress their transcriptional activity. These results suggest a regulation of adult hematopoiesis through TIF1 gamma-mediated transcriptional repression of TAL1 and PU.1 target genes.	[Gault, Nathalie; Ferri, Federica; Lewandowski, Daniel; Barroca, Vilma; Jaracz-Ros, Agnieszka; Romeo, Paul-Henri] INSERM, U967, F-92265 Fontenay Aux Roses, France; [Gault, Nathalie; Ferri, Federica; Lewandowski, Daniel; Barroca, Vilma; Jaracz-Ros, Agnieszka; Romeo, Paul-Henri] Univ Paris 07, F-92265 Fontenay Aux Roses, France; [Gault, Nathalie; Ferri, Federica; Lewandowski, Daniel; Barroca, Vilma; Jaracz-Ros, Agnieszka; Romeo, Paul-Henri] Univ Paris 11, F-92265 Fontenay Aux Roses, France; [Losson, Regine] CNRS INSERM ULP, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, Cu Strasbourg, France; [Kusy, Sophie; Gault, Nathalie; Ferri, Federica; Lewandowski, Daniel; Jaracz-Ros, Agnieszka; Romeo, Paul-Henri] CEA DSV IRCM LRTS, F-92265 Fontenay Aux Roses, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CEA; UDICE-French Research Universities; Universite Paris Saclay	Romeo, PH (corresponding author), Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA.	paul-henri.romeo@cea.fr	Lewandowski, Daniel/E-3154-2018; Romeo, Paul-Henri/L-5989-2017	Lewandowski, Daniel/0000-0001-8416-2629; Romeo, Paul-Henri/0000-0002-8294-0367; Ferri, Federica/0000-0003-4083-1362; Gault, Nathalie/0000-0001-6233-1946	Fondation contre la Leucemie; ARC [3710]; Inserm; CEA/DSV	Fondation contre la Leucemie; ARC(Australian Research Council); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CEA/DSV(French Atomic Energy Commission)	This work is dedicated to R. Losson, who recently passed away. We acknowledge T. Hoang, N. Goardon, and F. Pflumio for helpful discussions and initial experiment, and P. Chambon, F. Moreau-Gachelin, P. Jalinot, and Y. Pekarsky for the gift of the plasmids. We are grateful to the staff of the iRCM animal facility for excellent support during the mouse studies and to H. Benjelloun, N. Dechamps, and J. Baijer of the iRCM cytometry platform for excellent support during the FAGS and cell sorting experiments. S.K., F.F., A.J.-R., and V.B. are supperted by fellowships from ARC, DimStem Pole, CEA, and lnserm. This project was supported by grants from La Fondation contre la Leucemie, ARC (3710), Inserm, and CEA/DSV.	Abrink M, 2001, P NATL ACAD SCI USA, V98, P1422, DOI 10.1073/pnas.041616998; Bai XY, 2010, CELL, V142, P133, DOI 10.1016/j.cell.2010.05.028; Burda P, 2010, LEUKEMIA, V24, P1249, DOI 10.1038/leu.2010.104; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674; Chickarmane V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000268; Dakic A, 2005, J EXP MED, V201, P1487, DOI 10.1084/jem.20050075; de la Grange PB, 2008, STEM CELLS, V26, P1658, DOI 10.1634/stemcells.2007-0952; de la Grange PB, 2006, BLOOD, V108, P2998, DOI 10.1182/blood-2006-05-022988; Dey S, 2010, MOL CELL BIOL, V30, P2181, DOI 10.1128/MCB.01441-09; Dupont S, 2005, CELL, V121, P87, DOI 10.1016/j.cell.2005.01.033; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Goardon N, 2006, EMBO J, V25, P357, DOI 10.1038/sj.emboj.7600934; Hall MA, 2003, P NATL ACAD SCI USA, V100, P992, DOI 10.1073/pnas.0237324100; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Jalili A, 2010, TRANSFUSION, V50, P2002, DOI 10.1111/j.1537-2995.2010.02664.x; Kim J, 2008, GENESIS, V46, P329, DOI 10.1002/dvg.20401; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kusy S, 2010, J EXP MED, V207, P2141, DOI 10.1084/jem.20100745; Lacombe J, 2010, BLOOD, V115, P792, DOI 10.1182/blood-2009-01-201384; Lahlil R, 2004, MOL CELL BIOL, V24, P1439, DOI 10.1128/MCB.24.4.1439-1452.2004; Larsson J, 2003, BLOOD, V102, P3129, DOI 10.1182/blood-2003-04-1300; Lymperi S, 2010, ANN NY ACAD SCI, V1192, P12, DOI 10.1111/j.1749-6632.2009.05223.x; Maillard I, 2008, CELL STEM CELL, V2, P356, DOI 10.1016/j.stem.2008.02.011; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Morsut L, 2010, DEVELOPMENT, V137, P2571, DOI 10.1242/dev.053801; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Peng HZ, 2002, J MOL BIOL, V320, P629, DOI 10.1016/S0022-2836(02)00477-1; Ransom DG, 2004, PLOS BIOL, V2, P1188, DOI 10.1371/journal.pbio.0020237; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Santaguida M, 2009, CANCER CELL, V15, P341, DOI 10.1016/j.ccr.2009.02.016; Spooner CJ, 2009, IMMUNITY, V31, P576, DOI 10.1016/j.immuni.2009.07.011; Tripic T, 2009, BLOOD, V113, P2191, DOI 10.1182/blood-2008-07-169417; Venturini L, 1999, ONCOGENE, V18, P1209, DOI 10.1038/sj.onc.1202655; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Wozniak RJ, 2007, J BIOL CHEM, V282, P14665, DOI 10.1074/jbc.M700792200; Yan KP, 2004, GENE, V334, P3, DOI 10.1016/j.gene.2004.02.056; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Zhong S, 1999, NAT GENET, V23, P287, DOI 10.1038/15463; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038	42	34	35	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 8	2011	8	4					412	425		10.1016/j.stem.2011.02.005	http://dx.doi.org/10.1016/j.stem.2011.02.005			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	752QI	21474105	Bronze			2022-12-28	WOS:000289707100013
J	Goodell, MA				Goodell, Margaret A.			Parental Permissions: H19 and Keeping the Stem Cell Progeny under Control	CELL STEM CELL			English	Editorial Material							IMPRINTED GENE NETWORK; GROWTH	H19 is shown by Venkatraman et al. (2013), using maternal-allele-specific deletion of the differentially methylated region, to maintain hematopoietic stem cell repopulating ability through a miR-675-Igf1r signaling circuit. This work establishes function in somatic stem cells for another member of a putative imprinted gene network that may influence organismal growth.	Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA	Baylor College of Medicine	Goodell, MA (corresponding author), Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA.	goodell@bcm.edu		Goodell, Margaret A./0000-0003-1111-2932	NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092883] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA125123] Funding Source: Medline; NIDDK NIH HHS [R01 DK092883] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bartolomei M.S., 2011, COLD SPRING HARB PER, V3, P3; Berg JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026410; Ferron SR, 2011, NATURE, V475, P381, DOI 10.1038/nature10229; Lui JC, 2008, AM J PHYSIOL-REG I, V295, pR189, DOI 10.1152/ajpregu.00182.2008; Rossi L, 2012, CELL STEM CELL, V11, P302, DOI 10.1016/j.stem.2012.08.006; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Venkatraman A., 2013, NATURE IN PRESS 0717, DOI DOI 10.1038/NATURE12303; Zacharek SJ, 2011, CELL STEM CELL, V9, P272, DOI 10.1016/j.stem.2011.07.007	8	8	8	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 1	2013	13	2					137	138		10.1016/j.stem.2013.07.008	http://dx.doi.org/10.1016/j.stem.2013.07.008			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VO	23910078	Bronze			2022-12-28	WOS:000329570600004
J	Boehm, T				Boehm, Thomas			Same Function, Different Origins: Multipotent Stromal Precursors in Lymphoid Tissues	CELL STEM CELL			English	Editorial Material							CELLS	The evolutionary and lineage relationships between various stromal cell types that support the immune system are not well understood. Recently, in Immunity, Castagnaro et al. (2013) identified multipotent mesenchymal precursors that specifically give rise to stromal cell types in the spleen, but not other lymphoid tissue, and support injury-induced regeneration.	Max Planck Inst Immunobiol & Epigenet, Dept Dev Immunol, D-79108 Freiburg, Germany	Max Planck Society	Boehm, T (corresponding author), Max Planck Inst Immunobiol & Epigenet, Dept Dev Immunol, Stuebeweg 51, D-79108 Freiburg, Germany.	boehm@immunbio.mpg.de						Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Benezech C, 2012, IMMUNITY, V37, P721, DOI 10.1016/j.immuni.2012.06.010; Brendolan A, 2007, BIOESSAYS, V29, P166, DOI 10.1002/bies.20528; Castagnaro L, 2013, IMMUNITY, V38, P782, DOI 10.1016/j.immuni.2012.12.005; Kobayashi Y, 2011, DISCOV MED, V12, P351; Koning JJ, 2012, TRENDS IMMUNOL, V33, P264, DOI 10.1016/j.it.2011.10.006; Koss M, 2012, DEV CELL, V22, P913, DOI 10.1016/j.devcel.2012.02.009; Landsman L, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001143; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Neyt K, 2012, TRENDS IMMUNOL, V33, P297, DOI 10.1016/j.it.2012.04.006	10	1	1	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 2	2013	12	5					501	503		10.1016/j.stem.2013.04.011	http://dx.doi.org/10.1016/j.stem.2013.04.011			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VE	23642357	Bronze			2022-12-28	WOS:000329569600003
J	Hyun, I				Hyun, Insoo			Therapeutic Hope, Spiritual Distress, and the Problem of Stem Cell Tourism	CELL STEM CELL			English	Editorial Material							PHYSICIANS	Managing patients' therapeutic hope and spiritual distress-in addition to tighter regulation of commercial therapies and improved patient understanding-may offer a more comprehensive approach to reducing the overall incidence of stem cell tourism. Such patient support must occur early in the clinical relationship after appropriate assessment and discussion.	Case Western Reserve Univ, Sch Med, Dept Bioeth, Cleveland, OH 44106 USA	Case Western Reserve University	Hyun, I (corresponding author), Case Western Reserve Univ, Sch Med, Dept Bioeth, Cleveland, OH 44106 USA.	insoo.hyun@case.edu						Anandarajah G, 2001, AM FAM PHYSICIAN, V63, P81; [Anonymous], 1998, SELF REGULATION BEHA, DOI DOI 10.1017/CBO9781139174794; Caulfield T, 2012, CAN FAM PHYSICIAN, V58, P365; Caulfield T, 2012, CAN FAM PHYSICIAN, V58, pE182; Feudtner C, 2009, NEW ENGL J MED, V361, P2306, DOI 10.1056/NEJMp0906516; Levine AD, 2012, J LAW MED ETHICS, V40, P122, DOI 10.1111/j.1748-720X.2012.00650.x; Maugans TA, 1996, ARCH FAM MED, V5, P11, DOI 10.1001/archfami.5.1.11; Murdoch CE, 2010, AM J BIOETHICS, V10, P16, DOI 10.1080/15265161003728860; Petersen A, 2011, NEW GENET SOC, V30, P329, DOI 10.1080/14636778.2011.592003; ROSS L, 1995, INT J NURS STUD, V32, P457, DOI 10.1016/0020-7489(95)00007-K; Snyder C. R., 2000, HDB HOPE THEORY MEAS, P3, DOI DOI 10.1016/B978-012654050-5/50003-8	11	28	28	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 2	2013	12	5					505	507		10.1016/j.stem.2013.04.010	http://dx.doi.org/10.1016/j.stem.2013.04.010			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VE	23642359	Bronze			2022-12-28	WOS:000329569600005
J	Longstaff, H; Khramova, V; Eijkholt, M; Mizgalewicz, A; Illes, J				Longstaff, Holly; Khramova, Vera; Eijkholt, Marleen; Mizgalewicz, Ania; Illes, Judy			Hopes and Fears for Professional Movement in the Stem Cell Community	CELL STEM CELL			English	Editorial Material							SCIENTISTS; POLICY	We examine here how the issue of professional migration in stem cell research has been explored in news media, government documents, and the peer-reviewed literature. The results shed light on how patterns of and forces that motivate these movements are depicted and highlight issues of significance to the stem cell community.	[Longstaff, Holly; Khramova, Vera; Eijkholt, Marleen; Mizgalewicz, Ania; Illes, Judy] Univ British Columbia, Dept Med, Natl Core Neuroeth, Div Neurol, Vancouver, BC V6T 2B5, Canada	University of British Columbia	Illes, J (corresponding author), Univ British Columbia, Dept Med, Natl Core Neuroeth, Div Neurol, Vancouver, BC V6T 2B5, Canada.	jilles@mail.ubc.ca		Longstaff, Holly/0000-0002-1662-0832	Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Dresser R, 2010, J LAW MED ETHICS, V38, P332, DOI 10.1111/j.1748-720X.2010.00492.x; Levine AD, 2012, SCI PUBL POLICY, V39, P530, DOI 10.1093/scipol/scs038; Longstaff H, 2009, STEM CELL REV REP, V5, P89, DOI 10.1007/s12015-009-9068-y; Mahroum S, 2005, TECHNOL ANAL STRATEG, V17, P219, DOI 10.1080/09537320500088906; Racine E., 2010, PRAGMATIC NEUROETHIC, P27; Russo E, 2005, PLOS BIOL, V3, P1167, DOI 10.1371/journal.pbio.0030234; Salter B, 2006, REGEN MED, V1, P671, DOI 10.2217/17460751.1.5.671; Trounson A, 2008, CELL STEM CELL, V2, P118, DOI 10.1016/j.stem.2008.01.019; Van Hecke A, 2008, J EVAL CLIN PRACT, V14, P812, DOI 10.1111/j.1365-2753.2007.00846.x	9	5	5	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 2	2013	12	5					517	519		10.1016/j.stem.2013.04.016	http://dx.doi.org/10.1016/j.stem.2013.04.016			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Cell Biology	287VE	23642362	Bronze			2022-12-28	WOS:000329569600008
J	Zhu, YH; Huang, YF; Kek, C; Bulavin, DV				Zhu, Yunhua; Huang, Yi-Fu; Kek, Calvina; Bulavin, Dmitry V.			Apoptosis Differently Affects Lineage Tracing of Lgr5 and Bmi1 Intestinal Stem Cell Populations	CELL STEM CELL			English	Article							IN-VIVO; TUMORIGENESIS	Emerging lineage-tracing data support the existence of several pools of intestinal stem cells (ISCs) in the adult mouse. The +4 location is known to harbor proliferative cells undergoing robust apoptosis in response to irradiation, but their relationship with recently reported ISC models is unclear. Here, we found that tamoxifen, at doses commonly used to induce lineage tracing, mimics the irradiation-induced apoptotic response of the +4 cells. We found that about 40% of apoptotic cells were Lgr5-positive whereas Bmi1-positive ISCs became sensitive to tamoxifen upon entering a proliferative state. In turn, when we suppressed apoptosis by either Bcl2 overexpression or Chk2 deletion, we found that lineage tracing of Lgr5-positive cells was efficiently reduced. In contrast, lineage tracing from Bmi1-positive ISCs was substantially increased in apoptosis-deficient backgrounds. We propose that apoptosis plays an important role in controlling lineage tracing from different ISC populations in the mouse intestine.	[Zhu, Yunhua; Huang, Yi-Fu; Kek, Calvina; Bulavin, Dmitry V.] Inst Mol & Cell Biol, Singapore 138673, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Bulavin, DV (corresponding author), Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore.	dvbulavin@imcb.a-star.edu.sg			Agency for Science, Technology and Research (Singapore)	Agency for Science, Technology and Research (Singapore)(Agency for Science Technology & Research (A*STAR))	The research for D. V. B. was supported by the Agency for Science, Technology and Research (Singapore). We are extremely grateful to Dr. Natalia Gunko for her help with transmission electron microscopy. All animal protocols used in this study were approved by the Institute of Molecular and Cell Biology Animal Safety and Use Committee.	Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Demidov ON, 2012, CELL DEATH DIFFER, V19, P1761, DOI 10.1038/cdd.2012.57; Demidov ON, 2007, CELL STEM CELL, V1, P180, DOI 10.1016/j.stem.2007.05.020; Hua GQ, 2012, GASTROENTEROLOGY, V143, P1266, DOI 10.1053/j.gastro.2012.07.106; Mandlekar S, 2001, APOPTOSIS, V6, P469, DOI 10.1023/A:1012437607881; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Potten CS, 2009, CELL PROLIFERAT, V42, P731, DOI 10.1111/j.1365-2184.2009.00642.x; POTTEN CS, 1994, INT J RADIAT BIOL, V65, P71, DOI 10.1080/09553009414550101; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Zhu JJ, 2012, GENESIS, V50, P102, DOI 10.1002/dvg.20799	18	69	69	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 7	2013	12	3					298	303		10.1016/j.stem.2013.01.003	http://dx.doi.org/10.1016/j.stem.2013.01.003			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VC	23415913	Bronze			2022-12-28	WOS:000329569400008
J	Bao, XM; Tang, J; Lopez-Pajares, V; Tao, SY; Qu, K; Crabtree, GR; Khavari, PA				Bao, Xiaomin; Tang, Jiong; Lopez-Pajares, Vanessa; Tao, Shiying; Qu, Kun; Crabtree, Gerald R.; Khavari, Paul A.			ACTL6a Enforces the Epidermal Progenitor State by Suppressing SWI/SNF-Dependent Induction of KLF4	CELL STEM CELL			English	Article							CHROMATIN REMODELING COMPLEX; TRANSCRIPTION FACTORS; C-MYC; TERMINAL DIFFERENTIATION; NEURAL DEVELOPMENT; STEM-CELLS; TISSUE; SKIN; ACTIN; BRG1	Somatic progenitors suppress differentiation to maintain tissue self-renewal. The mammalian SWI/SNF chromatin-remodeling complex regulates nucleosome packaging to control differentiation in embryonic and adult stem cells. Catalytic Brg1 and Brm subunits are required for these processes; however, the roles of SWI/SNF regulatory subunits are not fully understood. Here, we show that ACTL6a/BAF53A modulates the SWI/SNF complex to suppress differentiation in epidermis. Conditional loss of ACTL6a resulted in terminal differentiation, cell-cycle exit, and hypoplasia, whereas ectopic expression of ACTL6a promoted the progenitor state. A significant portion of genes regulated by ACTL6a were found to also be targets of KLF4, a known activator of epidermal differentiation. Mechanistically, we show that ACTL6a prevents SWI/SNF complex binding to promoters of KLF4 and other differentiation genes and that SWI/SNF catalytic subunits are required for full induction of KLF4 targets. Thus, ACTL6a controls the epidermal progenitor state by sequestering SWI/SNF to prevent activation of differentiation programs.	[Bao, Xiaomin; Lopez-Pajares, Vanessa; Tao, Shiying; Qu, Kun; Khavari, Paul A.] Stanford Univ, Program Epithelial Biol, Stanford, CA 94305 USA; [Tang, Jiong; Crabtree, Gerald R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Khavari, Paul A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Khavari, PA (corresponding author), Stanford Univ, Program Epithelial Biol, Stanford, CA 94305 USA.	khavari@stanford.edu	Qu, Kun/G-3359-2012	Bao, Xiaomin/0000-0002-8845-5012; Crabtree, Robert/0000-0002-6639-8707	U.S. Department of Veterans Affairs Office of Research and Development; NIAMS NIH [R01 AR45192]; F32 Award [AR061230]; NATIONAL CANCER INSTITUTE [R01CA163915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045192, F32AR061230] Funding Source: NIH RePORTER	U.S. Department of Veterans Affairs Office of Research and Development(US Department of Veterans Affairs); NIAMS NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); F32 Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank H. Chang and A. Oro for their presubmission review, B. Zarnegar for the FPLC fractions of undifferentiated human keratinocytes, D. Johnston for technical support, and L. Boxer for suggestions and reagents. We thank L. Morcom and P. Bernstein for their administrative assistance. This work is supported by the U.S. Department of Veterans Affairs Office of Research and Development, by NIAMS NIH R01 AR45192 (P. A. K), and by an F32 Award (AR061230) to X. B.	Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; De S, 2011, MOL CELL BIOL, V31, P1512, DOI 10.1128/MCB.00920-10; Debril MB, 2004, J BIOL CHEM, V279, P16677, DOI 10.1074/jbc.M312288200; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Driskell I, 2012, EMBO J, V31, P616, DOI 10.1038/emboj.2011.421; Euskirchen GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002008; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Grummt I, 2006, CURR OPIN GENET DEV, V16, P191, DOI 10.1016/j.gde.2006.02.001; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Indra AK, 2005, DEVELOPMENT, V132, P4533, DOI 10.1242/dev.02019; Jaubert J, 2003, DEVELOPMENT, V130, P2767, DOI 10.1242/dev.00477; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Kim JK, 2001, MOL CELL BIOL, V21, P7787, DOI 10.1128/MCB.21.22.7787-7795.2001; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; Krasteva V, 2012, BLOOD, V120, P4720, DOI 10.1182/blood-2012-04-427047; Kuroda Y, 2002, BIOCHEM BIOPH RES CO, V299, P328, DOI 10.1016/S0006-291X(02)02637-2; LeBoeuf M, 2010, DEV CELL, V19, P807, DOI 10.1016/j.devcel.2010.10.015; Lee JH, 2003, MOL CELLS, V16, P78; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Luis NM, 2011, CELL STEM CELL, V9, P233, DOI 10.1016/j.stem.2011.07.013; Magnusdottir E, 2007, P NATL ACAD SCI USA, V104, P14988, DOI 10.1073/pnas.0707323104; Mejetta S, 2011, EMBO J, V30, P3635, DOI 10.1038/emboj.2011.265; MELINO G, 1994, MOL CELL BIOL, V14, P6584, DOI 10.1128/MCB.14.10.6584; Nascimento EM, 2011, NAT CELL BIOL, V13, P1395, DOI 10.1038/ncb2385; Nishimoto N, 2012, J CELL SCI, V125, P3870, DOI 10.1242/jcs.104349; Olave I, 2002, GENE DEV, V16, P2509, DOI 10.1101/gad.992102; Park J, 2002, MOL CELL BIOL, V22, P1307, DOI 10.1128/MCB.22.5.1307-1316.2002; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Rezai-Zadeh N, 2003, GENE DEV, V17, P1019, DOI 10.1101/gad.1068003; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Salma N, 2004, MOL CELL BIOL, V24, P4651, DOI 10.1128/MCB.24.11.4651-4663.2004; Scholl FA, 2007, DEV CELL, V12, P615, DOI 10.1016/j.devcel.2007.03.009; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Sen GL, 2012, DEV CELL, V22, P669, DOI 10.1016/j.devcel.2011.12.001; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; Tea JS, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-5; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Vangapandu H, 2009, GENE THER MOL BIOL, V13A, P194; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Visa N., 2010, COLD SPRING HARB PER, V2; Vreugde S, 2006, MOL CELL, V23, P749, DOI 10.1016/j.molcel.2006.07.005; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Yang JM, 2010, EUR J CELL BIOL, V89, P537, DOI 10.1016/j.ejcb.2010.01.005; Ye J, 2008, GENE DEV, V22, P322, DOI 10.1101/gad.455908; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Yu ZQ, 2006, DEV BIOL, V299, P122, DOI 10.1016/j.ydbio.2006.07.015; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	49	77	78	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 7	2013	12	2					193	203		10.1016/j.stem.2012.12.014	http://dx.doi.org/10.1016/j.stem.2012.12.014			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VB	23395444	Green Accepted, Bronze			2022-12-28	WOS:000329569300010
J	Kawabe, YI; Wang, YX; McKinnell, IW; Bedford, MT; Rudnicki, MA				Kawabe, Yoh-ichi; Wang, Yu Xin; McKinnell, Iain W.; Bedford, Mark T.; Rudnicki, Michael A.			Carm1 Regulates Pax7 Transcriptional Activity through MLL1/2 Recruitment during Asymmetric Satellite Stem Cell Divisions	CELL STEM CELL			English	Article							ARGININE METHYLTRANSFERASE; HISTONE H3; SELF-RENEWAL; MUSCLE; METHYLATION; DISTINCT; DIFFERENTIATION; EXPRESSION; GENES; MYF5	In skeletal muscle, asymmetrically dividing satellite stem cells give rise to committed satellite cells that transcribe the myogenic determination factor Myf5, a Pax7-target gene. We identified the arginine methyltransferase Carm1 as a Pax7 interacting protein and found that Carm1 specifically methylates multiple arginines in the N terminus of Pax7. Methylated Pax7 directly binds the C-terminal cleavage forms of the trithorax proteins MLL1/2 resulting in the recruitment of the ASH2L:MLL1/2:WDR5:RBBP5 histone H3K4 methyltransferase complex to regulatory enhancers and the proximal promoter of Myf5. Finally, Carm1 is required for the induction of de novo Myf5 transcription following asymmetric satellite stem cell divisions. We defined the C-terminal MLL region as a reader domain for the recognition of arginine methylated proteins such as Pax7. Thus, arginine methylation of Pax7 by Carm1 functions as a molecular switch controlling the epigenetic induction of Myf5 during satellite stem cell asymmetric division and entry into the myogenic program.	[Kawabe, Yoh-ichi; Wang, Yu Xin; McKinnell, Iain W.; Rudnicki, Michael A.] Ottawa Hosp Res Inst, Regenerat Med Program, Sprott Ctr Stem Cell Res, Ottawa, ON K1H 8L6, Canada; [Kawabe, Yoh-ichi; Wang, Yu Xin; Rudnicki, Michael A.] Univ Ottawa, Dept Med, Ottawa, ON K1H 8M5, Canada; [Kawabe, Yoh-ichi; Wang, Yu Xin; Rudnicki, Michael A.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [Bedford, Mark T.] Univ Texas Dallas, MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX 78957 USA	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Texas System; University of Texas Dallas; UTMD Anderson Cancer Center	Rudnicki, MA (corresponding author), Ottawa Hosp Res Inst, Regenerat Med Program, Sprott Ctr Stem Cell Res, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.	mrudnicki@ohri.ca		Wang, Yu Xin/0000-0001-8440-9388; Rudnicki, Michael/0000-0002-3866-5249	Uehara Memorial Foundation Scholarship; Ontario Research Fund; QEII-GSST; CIHR's Training Program in Regenerative Medicine; National Institutes of Health [R01AR044031]; Howard Hughes Medical Institute; Canadian Institutes of Health Research; Muscular Dystrophy Association; Stem Cell Network; Canada Research Chair Program; NIH [DK6224]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062248] Funding Source: NIH RePORTER	Uehara Memorial Foundation Scholarship(Uehara Memorial Foundation); Ontario Research Fund; QEII-GSST; CIHR's Training Program in Regenerative Medicine(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Muscular Dystrophy Association(Muscular Dystrophy Association); Stem Cell Network; Canada Research Chair Program(Canada Research Chairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs. F. Jeffrey Dilworth and Marjorie Brand for critical reading of the manuscript, Jennifer Ritchie for expert technical assistance on animal experiments, Dr. Lawrence Puente for mass spectrometry analysis, Paul Oleynick for fluorescent-activated cell sorting, David Wilson for histological analysis, Feo Price for providing P21 primary myoblasts, and Dr. Chandra Prakash Chaturvedi, Dr. Carmen Palii, and Rudnicki lab members for helpful discussions. We thank Dr. Hess L. Jay for MLL1 cDNA, Dr. Jocelyn Cote for SMN-Tdr and TDRD3-Tdr plasmids, and Dr. F. Jeffrey Dilworth for FLAG-tagged Mef2c protein. We thank Dr. Mark Gillespie and Dr. Jeffrey A. Ranish for preliminary identification of Pax7 methylation site by mass spectrometry analysis. Y.K. is supported by fellowships from Uehara Memorial Foundation Scholarship and Ontario Research Fund. Y.X.W is supported by fellowships from QEII-GSST and CIHR's Training Program in Regenerative Medicine. M.A.R. holds the Canada Research Chair in Molecular Genetics and is an International Research Scholar of the Howard Hughes Medical Institute. M.A.R. is supported by grants from the National Institutes of Health (R01AR044031), the Howard Hughes Medical Institute, the Canadian Institutes of Health Research, the Ontario Research Fund, the Muscular Dystrophy Association, the Stem Cell Network, and the Canada Research Chair Program. M.B. is supported by NIH grant DK6224.	Abou-Khalil R, 2009, CELL STEM CELL, V5, P298, DOI 10.1016/j.stem.2009.06.001; Bajard L, 2006, GENE DEV, V20, P2450, DOI 10.1101/gad.382806; Bauer UM, 2002, EMBO REP, V3, P39, DOI 10.1093/embo-reports/kvf013; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bertani S, 2011, MOL CELL, V43, P1040, DOI 10.1016/j.molcel.2011.08.019; Bischoff R, 1994, MYOLOGY, P97; Borycki AG, 1999, DEVELOPMENT, V126, P4053; Capotosti F, 2007, MOL CELL BIOL, V27, P7063, DOI 10.1128/MCB.00769-07; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen C, 2011, NAT REV MOL CELL BIO, V12, P629, DOI 10.1038/nrm3185; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chen SL, 2002, J BIOL CHEM, V277, P4324, DOI 10.1074/jbc.M109835200; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Cote J, 2005, J BIOL CHEM, V280, P28476, DOI 10.1074/jbc.M414328200; Dacwag CS, 2009, MOL CELL BIOL, V29, P1909, DOI 10.1128/MCB.00742-08; Feng Q, 2006, MOL CELL BIOL, V26, P7846, DOI 10.1128/MCB.00568-06; Feng Q, 2009, J BIOL CHEM, V284, P36167, DOI 10.1074/jbc.M109.065524; Gao X, 2010, J CELL BIOCHEM, V110, P162, DOI 10.1002/jcb.22522; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Higashimoto K, 2007, P NATL ACAD SCI USA, V104, P12318, DOI 10.1073/pnas.0610792104; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Kassar-Duchossoy L, 2005, GENE DEV, V19, P1426, DOI 10.1101/gad.345505; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kowenz-Leutz E, 2010, EMBO J, V29, P1105, DOI 10.1038/emboj.2010.3; Kuang S, 2006, J CELL BIOL, V172, P103, DOI 10.1083/jcb.200508001; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Lee J, 2002, EMBO REP, V3, P268, DOI 10.1093/embo-reports/kvf052; Lee YH, 2002, MOL CELL BIOL, V22, P3621, DOI 10.1128/MCB.22.11.3621-3632.2002; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Ma H, 2001, CURR BIOL, V11, P1981, DOI 10.1016/S0960-9822(01)00600-5; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Nishijo K, 2009, FASEB J, V23, P2681, DOI 10.1096/fj.08-128116; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Parfitt DE, 2010, MOL BIOL CELL, V21, P2649, DOI 10.1091/mbc.E10-01-0053; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Schuettengruber B, 2011, NAT REV MOL CELL BIO, V12, P799, DOI 10.1038/nrm3230; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Sims RJ, 2008, NAT REV MOL CELL BIO, V9, P815, DOI 10.1038/nrm2502; Sims RJ, 2011, SCIENCE, V332, P99, DOI 10.1126/science.1202663; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Tajbakbsh S, 2009, ANNU REV CELL DEV BI, V25, P671, DOI 10.1146/annurev.cellbio.24.110707.175415; Tajbakhsh S, 1998, DEVELOPMENT, V125, P4155; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xu W, 2004, GENE DEV, V18, P144, DOI 10.1101/gad.1141704; Xu W, 2001, SCIENCE, V294, P2507, DOI 10.1126/science.1065961; Yadav N, 2003, P NATL ACAD SCI USA, V100, P6464, DOI 10.1073/pnas.1232272100; Yang YZ, 2010, MOL CELL, V40, P1016, DOI 10.1016/j.molcel.2010.11.024; Yun MY, 2011, CELL RES, V21, P564, DOI 10.1038/cr.2011.42; Zhao HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027026	58	140	142	2	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 7	2012	11	3					333	345		10.1016/j.stem.2012.07.001	http://dx.doi.org/10.1016/j.stem.2012.07.001			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	018DW	22863532	Green Accepted, Bronze			2022-12-28	WOS:000309641300008
J	Diao, YR; Guo, X; Li, YF; Sun, K; Lu, LN; Jiang, L; Fu, XR; Zhu, H; Sun, H; Wang, HT; Wu, ZG				Diao, Yarui; Guo, Xing; Li, Yanfeng; Sun, Kun; Lu, Leina; Jiang, Lei; Fu, Xinrong; Zhu, Han; Sun, Hao; Wang, Huating; Wu, Zhenguo			Pax3/7BP Is a Pax7-and Pax3-Binding Protein that Regulates the Proliferation of Muscle Precursor Cells by an Epigenetic Mechanism	CELL STEM CELL			English	Article							MIXED LINEAGE LEUKEMIA; SATELLITE CELLS; SKELETAL-MUSCLE; HISTONE H3; MOLECULAR REGULATION; STEM-CELL; PAX GENES; ROLES; METHYLATION; QUIESCENT	In mouse skeletal muscles, Pax7 uniquely marks muscle satellite cells and plays some important yet unknown functions at the perinatal stage. To elucidate its in vivo functions, we initiated a yeast two-hybrid screening to look for Pax7-interacting proteins and identified a previously uncharacterized Pax7- and Pax3-binding protein (Pax3/7BP). Pax3/7BP is a ubiquitously expressed nuclear protein, enriched in Pax7+ muscle precursor cells (MPCs), and serves as an indispensable adaptor for Pax7 to recruit the histone 3 lysine 4 (H3K4) methyltransferase (HMT) complex by bridging Pax7 and Wdr5. Knockdown of Pax3/7BP abolished the Pax3/7-associated H3K4 HMT activity and inhibited the proliferation of Pax7+ MPCs from young mice both in culture and in vivo. Id3 and Cdc20 were direct target genes of Pax7 and Pax3/7BP involved in the proliferation of Pax7+ MPCs. Collectively, our work establishes Pax3/7BP as an essential adaptor linking Pax3/7 with the H3K4 HMT to regulate the proliferation of MPCs.	[Diao, Yarui; Guo, Xing; Li, Yanfeng; Jiang, Lei; Fu, Xinrong; Zhu, Han; Wu, Zhenguo] Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Sun, Kun; Sun, Hao] Chinese Univ Hong Kong, Dept Chem Pathol, Hong Kong, Hong Kong, Peoples R China; [Lu, Leina; Wang, Huating] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Sun, Kun; Lu, Leina; Sun, Hao; Wang, Huating] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Sun, Kun; Lu, Leina; Sun, Hao; Wang, Huating] Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [Diao, Yarui; Wu, Zhenguo] Shenzhen PKU HKUST Med Ctr, Biomed Res Inst, Shenzhen 518036, Guangdong, Peoples R China	Hong Kong University of Science & Technology; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center	Wu, ZG (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China.	bczgwu@ust.hk	li, yan/GTI-4638-2022; Wang, Huating/C-6719-2014; Sun, Hao/T-5576-2019; Sun, Kun/Q-6479-2018; Sun, Hao/J-9964-2013; sun, hao/GRS-7732-2022	Wang, Huating/0000-0001-5474-2905; Sun, Hao/0000-0002-5547-9501; Sun, Kun/0000-0002-9883-1616; Sun, Hao/0000-0002-5547-9501; Diao, Yarui/0000-0001-5842-4082; Zhu, Han/0000-0003-1896-7140; Wu, Zhenguo/0000-0003-3049-8324	Hong Kong Research Grant Council [663609]; Shenzhen Science and Technology Project [JC200903180682A]; State Key Laboratory of Molecular Neuroscience at HKUST	Hong Kong Research Grant Council(Hong Kong Research Grants Council); Shenzhen Science and Technology Project; State Key Laboratory of Molecular Neuroscience at HKUST	We thank Drs. K. Ge (NIH) and W. Herr (U of Lausanne) for the anti-MLL3/MLL4 and anti-Wdr5 antibodies, respectively; Drs. M. Rudnicki (University of Ottawa) and A. Lassar (Harvard Medical School) for Flag-Pax3 and the Id3-Luc reporter constructs, respectively; Dr. G. Zhu (HKUST) for HA-SMYD2; and Dr. M. Zhang (HKUST) for the 6xHis-3C-pET32M vector and the Rosetta E. Coli strain. We also thank Ms. C. Wong and the Shenzhen Biomedical Research Support Platform for technical help. The work was supported by grants from the Hong Kong Research Grant Council (663609), Shenzhen Science and Technology Project (JC200903180682A), and the State Key Laboratory of Molecular Neuroscience at HKUST.	Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Ansari KI, 2010, FEBS J, V277, P1790, DOI 10.1111/j.1742-4658.2010.07606.x; Atherton GT, 1996, CELL GROWTH DIFFER, V7, P1059; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Ben-Yair R, 2005, DEVELOPMENT, V132, P689, DOI 10.1242/dev.01617; Biressi S, 2010, SEMIN CELL DEV BIOL, V21, P845, DOI 10.1016/j.semcdb.2010.09.003; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Cosgrove MS, 2010, FEBS J, V277, P1832, DOI 10.1111/j.1742-4658.2010.07609.x; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; Kassar-Duchossoy L, 2005, GENE DEV, V19, P1426, DOI 10.1101/gad.345505; Kim S, 2011, SEMIN CELL DEV BIOL, V22, P551, DOI 10.1016/j.semcdb.2011.03.008; Kuang S, 2006, J CELL BIOL, V172, P103, DOI 10.1083/jcb.200508001; Kumar D, 2009, MOL BIOL CELL, V20, P3170, DOI 10.1091/mbc.E08-12-1185; Lang D, 2007, BIOCHEM PHARMACOL, V73, P1, DOI 10.1016/j.bcp.2006.06.024; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Malik S, 2010, FEBS J, V277, P1805, DOI 10.1111/j.1742-4658.2010.07607.x; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Munoz IM, 2009, EMBO REP, V10, P239, DOI 10.1038/embor.2009.21; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Pallafacchina G, 2010, STEM CELL RES, V4, P77, DOI 10.1016/j.scr.2009.10.003; Patel SR, 2007, DEV CELL, V13, P580, DOI 10.1016/j.devcel.2007.09.004; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Puri PL, 2000, J CELL PHYSIOL, V185, P155, DOI 10.1002/1097-4652(200011)185:2<155::AID-JCP1>3.0.CO;2-Z; Rampalli S, 2007, NAT STRUCT MOL BIOL, V14, P1150, DOI 10.1038/nsmb1316; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Tan CC, 2008, P NATL ACAD SCI USA, V105, P7472, DOI 10.1073/pnas.0711896105; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021; Watchko JF, 2002, J APPL PHYSIOL, V93, P407, DOI 10.1152/japplphysiol.01242.2001; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Zammit PS, 2008, J CELL SCI, V121, P2975, DOI 10.1242/jcs.019661; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	45	67	75	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 3	2012	11	2					231	241		10.1016/j.stem.2012.05.022	http://dx.doi.org/10.1016/j.stem.2012.05.022			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	987QQ	22862948	Bronze			2022-12-28	WOS:000307432600013
J	Crist, CG; Montarras, D; Buckingham, M				Crist, Colin G.; Montarras, Didier; Buckingham, Margaret			Muscle Satellite Cells Are Primed for Myogenesis but Maintain Quiescence with Sequestration of Myf5 mRNA Targeted by microRNA-31 in mRNP Granules	CELL STEM CELL			English	Article							DETERMINATION GENE MYF5; IN-VIVO; STRESS GRANULES; STEM-CELL; EXPRESSION; DISTINCT; PAX7	Regeneration of adult tissues depends on stem cells that are primed to enter a differentiation program, while remaining quiescent. How these two characteristics can be reconciled is exemplified by skeletal muscle in which the majority of quiescent satellite cells transcribe the myogenic determination gene Myf5, without activating the myogenic program. We show that Myf5 mRNA, together with microRNA-31, which regulates its translation, is sequestered in mRNP granules present in the quiescent satellite cell. In activated satellite cells, mRNP granules are dissociated, relative levels of miR-31 are reduced, and Myf5 protein accumulates, which initially requires translation, but not transcription. Conditions that promote the continued presence of mRNP granules delay the onset of myogenesis. Manipulation of miR-31 levels affects satellite cell differentiation ex vivo and muscle regeneration in vivo. We therefore propose a model in which posttranscriptional mechanisms hold quiescent stem cells poised to enter a tissue-specific differentiation program.	[Crist, Colin G.; Montarras, Didier; Buckingham, Margaret] Inst Pasteur, Dept Dev Biol, CNRS, URA 2578, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Buckingham, M (corresponding author), Inst Pasteur, Dept Dev Biol, CNRS, URA 2578, 25 Rue Dr Roux, F-75724 Paris 15, France.	margaret.buckingham@pasteur.fr			Institut Pasteur; CNRS; AFM; EU networks EuroSyStem [Health F4-2007, 200720]; OptiStem [Health FP7-2007, 223098]	Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); AFM(Association Francaise contre les Myopathies); EU networks EuroSyStem; OptiStem	We are thankful to S. Coqueran, P.H. Commere, M. Livingstone, and F. Lescroart for technical assistance. T. Braun (MPI, Bad Nauheim) generously provided the Myf5<SUP>-/-</SUP> mouse line. This work was supported by the Institut Pasteur and the CNRS, as well as by grants from the AFM and EU networks EuroSyStem (Health F4-2007, 200720) and OptiStem (Health FP7-2007, 223098), which also supported C.G.C.	Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Buckingham M, 2008, CURR OPIN GENET DEV, V18, P330, DOI 10.1016/j.gde.2008.06.005; Cacchiarelli D, 2011, EMBO REP, V12, P136, DOI 10.1038/embor.2010.208; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Crist CG, 2009, P NATL ACAD SCI USA, V106, P13383, DOI 10.1073/pnas.0900210106; Daubas P, 2009, DEV BIOL, V327, P71, DOI 10.1016/j.ydbio.2008.11.031; Eulalio A, 2009, RNA, V15, P1067, DOI 10.1261/rna.1605509; Gayraud-Morel B, 2007, DEV BIOL, V312, P13, DOI 10.1016/j.ydbio.2007.08.059; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Montarras D, 2000, BIOL CELL, V92, P565, DOI 10.1016/S0248-4900(00)01110-2; Muddashetty RS, 2011, MOL CELL, V42, P673, DOI 10.1016/j.molcel.2011.05.006; Nguyen VT, 1996, NUCLEIC ACIDS RES, V24, P2924, DOI 10.1093/nar/24.15.2924; Pallafacchina G, 2010, STEM CELL RES, V4, P77, DOI 10.1016/j.scr.2009.10.003; Pena JTG, 2009, NAT METHODS, V6, P139, DOI [10.1038/NMETH.1294, 10.1038/nmeth.1294]; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Ustanina S, 2007, STEM CELLS, V25, P2006, DOI 10.1634/stemcells.2006-0736; Williams AH, 2009, CURR OPIN CELL BIOL, V21, P461, DOI 10.1016/j.ceb.2009.01.029	27	212	223	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 6	2012	11	1					118	126		10.1016/j.stem.2012.03.011	http://dx.doi.org/10.1016/j.stem.2012.03.011			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	975SS	22770245	Bronze			2022-12-28	WOS:000306532400015
J	Brindley, DA; Davie, NL; Sahlman, WA; Bonfiglio, GA; Culme-Seymour, EJ; Reeve, BC; Mason, C				Brindley, David A.; Davie, Natasha L.; Sahlman, William A.; Bonfiglio, Gregory A.; Culme-Seymour, Emily J.; Reeve, Brock C.; Mason, Chris			Promising Growth and Investment in the Cell Therapy Industry during the First Quarter of 2012	CELL STEM CELL			English	Editorial Material							SPLEEN COLONIES	In the first quarter of 2012, publicly traded companies in the cell-based therapy industry continued to show promising overall growth. Highlights included $85 million in new capital investment and steady clinical trial progress.	[Brindley, David A.; Davie, Natasha L.; Mason, Chris] UCL, Adv Ctr Biochem Engn, London WC1E 6BT, England; [Brindley, David A.; Davie, Natasha L.; Reeve, Brock C.] Holyoke Ctr, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Brindley, David A.; Sahlman, William A.] Harvard Univ, Sch Business, Boston, MA 02163 USA; [Davie, Natasha L.] Harvard Univ, Sch Med, Ctr Excellence Vasc Biol, Boston, MA 02115 USA; [Bonfiglio, Gregory A.] Proteus Venture Partners, Portola Valley, CA 94028 USA; [Bonfiglio, Gregory A.] Ctr Commercializat Regenerat Med, Toronto, ON M5G 1L5, Canada; [Culme-Seymour, Emily J.] London Regenerat Med Network, London EC1R 0DP, England	University of London; University College London; Harvard University; Harvard University; Harvard University; Harvard Medical School	Mason, C (corresponding author), UCL, Adv Ctr Biochem Engn, Torrington Pl, London WC1E 6BT, England.	chris.mason@ucl.ac.uk			Technology Strategy Board; ImmunoCellular	Technology Strategy Board; ImmunoCellular	Unless otherwise stated, all company-specific information was sourced from company press releases issued to the general public during the period of January 1 to March 31, 2012. The authors apologize if they have omitted or misrepresented the achievements of any companies featured. The authors wish to extend their thanks to James Zeitler (Harvard Business School) for invaluable assistance in the construction of analysis of the Cell Therapy Industry Index. C.M. is Principal Investigator and DAB., E.J.C-S., and N.L.D. are investigators on the British Regen Industry Tool Set (BRITS) project funded by the Technology Strategy Board under their Regenerative Medicine Program: Value Systems and Business Modeling. B.C.R. is a Director of Pathfinder Cell Therapy, and C.J. and B.L. receive research funding from ImmunoCellular. The authors and advisory board members have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. D.A.B. is subject to the CFA Institute's Codes, Standards, and Guidelines, and as such, the authors must stress that this piece is provided for academic interest only and must not be construed in any way as an investment recommendation.	BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0; Blendon RJ, 2011, NEW ENGL J MED, V365, P1853, DOI 10.1056/NEJMp1110340; Brindley DA, 2011, CELL STEM CELL, V9, P397, DOI 10.1016/j.stem.2011.10.010; Jaklenec A, 2012, TISSUE ENG PART B-RE, V18, P155, DOI [10.1089/ten.teb.2011.0553, 10.1089/ten.TEB.2011.0553]; Mason C, 2011, REGEN MED, V6, P265, DOI [10.2217/RME.11.28, 10.2217/rme.11.28]; McKernan R, 2010, CELL STEM CELL, V6, P517, DOI 10.1016/j.stem.2010.05.012; Rao MS, 2011, CELL STEM CELL, V9, P7, DOI 10.1016/j.stem.2011.06.009; SIMINOVITCH L, 1963, J CELL COMPAR PHYSL, V62, P327, DOI 10.1002/jcp.1030620313	8	10	10	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAY 4	2012	10	5					492	496		10.1016/j.stem.2012.04.018	http://dx.doi.org/10.1016/j.stem.2012.04.018			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	944WN	22560072	Bronze			2022-12-28	WOS:000304234600007
J	Doulatov, S; Notta, F; Laurenti, E; Dick, JE				Doulatov, Sergei; Notta, Faiyaz; Laurenti, Elisa; Dick, John E.			Hematopoiesis: A Human Perspective	CELL STEM CELL			English	Review							HUMAN CORD BLOOD; SEVERE COMBINED IMMUNODEFICIENCY; HUMAN-BONE-MARROW; ACUTE LYMPHOBLASTIC-LEUKEMIA; COMMON LYMPHOID PROGENITORS; MOBILIZED PERIPHERAL-BLOOD; ACUTE MYELOID-LEUKEMIA; IMMUNE-DEFICIENT MICE; STEM-CELL HOMEOSTASIS; COLONY-FORMING CELLS		[Doulatov, Sergei; Notta, Faiyaz; Laurenti, Elisa; Dick, John E.] Ontario Canc Inst, Campbell Family Inst Canc Res, Div Stem Cell & Dev Biol, Toronto, ON M5G 1L7, Canada; [Doulatov, Sergei; Notta, Faiyaz; Laurenti, Elisa; Dick, John E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Dick, JE (corresponding author), Ontario Canc Inst, Campbell Family Inst Canc Res, Div Stem Cell & Dev Biol, Toronto, ON M5G 1L7, Canada.	jdick@uhnres.utoronto.ca		Dick, John/0000-0002-9527-8317; Laurenti, Elisa/0000-0002-9917-9092	Canadian Institutes for Health Research (CIHR); Swiss National Science Foundation; Roche; CIHR; Canadian Cancer Society Research Institute; Terry Fox Foundation; Genome Canada through the Ontario Genomics Institute; Ontario Institute for Cancer Research; province of Ontario; Cancer Stem Cell Consortium; Government of Canada through Genome Canada; Ontario Genomics Institute [OGI-047]; Canada Research Chair; Ontario Ministry of Health and Long Term Care (OMOHLTC)	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Roche(Roche Holding); CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Terry Fox Foundation; Genome Canada through the Ontario Genomics Institute(Genome Canada); Ontario Institute for Cancer Research; province of Ontario; Cancer Stem Cell Consortium; Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Ontario Ministry of Health and Long Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario)	This work was supported by Canadian Institutes for Health Research (CIHR) studentships (to F.N. and S.D.), the Swiss National Science Foundation (E.L.), and Roche fellowships (E.L.). Grants were from the CIHR, Canadian Cancer Society Research Institute, Terry Fox Foundation, Genome Canada through the Ontario Genomics Institute, Ontario Institute for Cancer Research with funds from the province of Ontario, the Cancer Stem Cell Consortium with funding from the Government of Canada through Genome Canada, the Ontario Genomics Institute (OGI-047), and a Canada Research Chair. This research was funded in part by the Ontario Ministry of Health and Long Term Care (OMOHLTC). The views expressed do not necessarily reflect those of the OMOHLTC. Due to length restrictions, we apologize to all the colleagues whose contributions we could not properly acknowledge in this review.	Abkowitz JL, 1996, NAT MED, V2, P190, DOI 10.1038/nm0296-190; Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Amsellem S, 2003, NAT MED, V9, P1423, DOI 10.1038/nm953; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Barabe F, 2007, SCIENCE, V316, P600, DOI 10.1126/science.1139851; BAUM CM, 1992, P NATL ACAD SCI USA, V89, P2804, DOI 10.1073/pnas.89.7.2804; BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0; Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bhatia M, 1998, NAT MED, V4, P1038, DOI 10.1038/2023; Bhatia M, 1997, P NATL ACAD SCI USA, V94, P5320, DOI 10.1073/pnas.94.10.5320; Bigley V, 2011, J EXP MED, V208, P227, DOI 10.1084/jem.20101459; BILLIPS LG, 1992, BLOOD, V79, P1185; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; Boyer SW, 2011, CELL STEM CELL, V9, P64, DOI 10.1016/j.stem.2011.04.021; Broske AM, 2009, NAT GENET, V41, P1207, DOI 10.1038/ng.463; Brunstein CG, 2006, ANNU REV MED, V57, P403, DOI 10.1146/annurev.med.57.051804.123642; Buske C, 2002, BLOOD, V100, P862, DOI 10.1182/blood-2002-01-0220; Buza-Vidas N, 2011, BLOOD, V118, P1544, DOI 10.1182/blood-2010-10-316232; Carotta S, 2010, IMMUNOL REV, V238, P63, DOI 10.1111/j.1600-065X.2010.00955.x; Catlin SN, 2011, BLOOD, V117, P4460, DOI 10.1182/blood-2010-08-303537; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Chicha L, 2004, J EXP MED, V200, P1519, DOI 10.1084/jem.20040809; CIVIN CI, 1984, J IMMUNOL, V133, P157; COLLINS LS, 1987, J IMMUNOL, V138, P1082; Conneally E, 1997, P NATL ACAD SCI USA, V94, P9836, DOI 10.1073/pnas.94.18.9836; Cravens PD, 2005, STEM CELLS, V23, P264, DOI 10.1634/stemcells.2004-0116; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; DEXTER TM, 1974, BRIT J HAEMATOL, V28, P525, DOI 10.1111/j.1365-2141.1974.tb06671.x; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Dickinson RE, 2011, BLOOD, V118, P2656, DOI 10.1182/blood-2011-06-360313; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Doulatov S, 2009, GENE DEV, V23, P2076, DOI 10.1101/gad.1788109; Ehrlich LIR, 2011, BLOOD, V117, P2618, DOI 10.1182/blood-2010-05-287102; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Ernst P, 2004, DEV CELL, V6, P437, DOI 10.1016/S1534-5807(04)00061-9; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; FULOP GM, 1990, NATURE, V347, P479, DOI 10.1038/347479a0; GALY A, 1995, IMMUNITY, V3, P459, DOI 10.1016/1074-7613(95)90175-2; GARTNER S, 1980, P NATL ACAD SCI-BIOL, V77, P4756, DOI 10.1073/pnas.77.8.4756; Georgantas RW, 2004, CANCER RES, V64, P4434, DOI 10.1158/0008-5472.CAN-03-3247; Glimm H, 2001, J CLIN INVEST, V107, P199, DOI 10.1172/JCI11519; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Goessling W, 2011, CELL STEM CELL, V8, P445, DOI 10.1016/j.stem.2011.02.003; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Gupta R, 2007, SCIENCE, V316, P590, DOI 10.1126/science.1136031; Haddad R, 2006, IMMUNITY, V24, P217, DOI 10.1016/j.immuni.2006.01.008; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hao QL, 2001, BLOOD, V97, P3683, DOI 10.1182/blood.V97.12.3683; Hao QL, 1996, BLOOD, V88, P3306, DOI 10.1182/blood.V88.9.3306.bloodjournal8893306; Himburg HA, 2010, NAT MED, V16, P475, DOI 10.1038/nm.2119; Hoebeke I, 2007, LEUKEMIA, V21, P311, DOI 10.1038/sj.leu.2404488; Hsu AP, 2011, BLOOD, V118, P2653, DOI 10.1182/blood-2011-05-356352; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; Ishii M, 2011, EXP HEMATOL, V39, P203, DOI 10.1016/j.exphem.2010.11.008; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; ITOH K, 1989, EXP HEMATOL, V17, P145; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Jude CD, 2007, CELL STEM CELL, V1, P324, DOI 10.1016/j.stem.2007.05.019; KAMELREID S, 1988, SCIENCE, V242, P1706, DOI 10.1126/science.2904703; Kang YB, 2008, CURR OPIN HEMATOL, V15, P561, DOI 10.1097/MOH.0b013e32831366eb; Kawamoto H, 1999, J IMMUNOL, V162, P2725; Kawamoto H, 2010, IMMUNOL REV, V238, P23, DOI 10.1111/j.1600-065X.2010.00959.x; Kerkvliet NI, 2002, TOXICOL APPL PHARM, V185, P146, DOI 10.1006/taap.2002.9537; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Klein C, 2011, ANNU REV IMMUNOL, V29, P399, DOI 10.1146/annurev-immunol-030409-101259; Koch U, 2008, BLOOD, V111, P160, DOI 10.1182/blood-2007-07-099754; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; La Motte-Mohs RN, 2005, BLOOD, V105, P1431, DOI 10.1182/blood-2004-04-1293; Lagresle-Peyrou C, 2009, NAT GENET, V41, P106, DOI 10.1038/ng.278; LANSDORP PM, 1990, J EXP MED, V172, P363, DOI 10.1084/jem.172.1.363; LAPIDOT T, 1992, SCIENCE, V255, P1137, DOI 10.1126/science.1372131; Larochelle A, 2011, BLOOD, V117, P1550, DOI 10.1182/blood-2009-03-212803; Lathia JD, 2010, CELL STEM CELL, V6, P421, DOI 10.1016/j.stem.2010.02.018; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; LORENZ E, 1951, J NATL CANCER I, V12, P197; Maillard I, 2008, CELL STEM CELL, V2, P356, DOI 10.1016/j.stem.2008.02.011; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; Maximow A, 1909, FOLIA HAEMATOL LEIPZ, V8, P125; Mazurier F, 2003, NAT MED, V9, P959, DOI 10.1038/nm886; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miller Cindy L, 2002, Methods Mol Med, V63, P189, DOI 10.1385/1-59259-140-X:189; Milyavsky M, 2010, CELL STEM CELL, V7, P186, DOI 10.1016/j.stem.2010.05.016; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; MOORE MAS, 1973, J NATL CANCER I, V50, P603, DOI 10.1093/jnci/50.3.603; Morrison SJ, 1997, DEVELOPMENT, V124, P1929; MOSIER DE, 1988, NATURE, V335, P256, DOI 10.1038/335256a0; MOSIER DE, 1991, SCIENCE, V251, P791, DOI 10.1126/science.1990441; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; MURRAY L, 1995, BLOOD, V85, P368; NAMIKAWA R, 1988, SCIENCE, V242, P1684, DOI 10.1126/science.3201256; Negrin RS, 2000, BIOL BLOOD MARROW TR, V6, P262, DOI 10.1016/S1083-8791(00)70008-5; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; Niebuhr B, 2009, LEUKEMIA, V23, P978, DOI 10.1038/leu.2008.332; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Notta F, 2010, BLOOD, V115, P3704, DOI 10.1182/blood-2009-10-249326; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Ohishi K, 2002, J CLIN INVEST, V110, P1165, DOI 10.1172/JCI200216167; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Owen C, 2008, BRIT J HAEMATOL, V140, P123, DOI 10.1111/j.1365-2141.2007.06909.x; Pajcini KV, 2011, LEUKEMIA, V25, P1525, DOI 10.1038/leu.2011.127; PIKE BL, 1970, J CELL PHYSIOL, V76, P77, DOI 10.1002/jcp.1040760111; Pribyl JAR, 1996, P NATL ACAD SCI USA, V93, P10348, DOI 10.1073/pnas.93.19.10348; Puel A, 1998, NAT GENET, V20, P394, DOI 10.1038/3877; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Raya A, 2009, NATURE, V460, P53, DOI 10.1038/nature08129; Raymond K, 2009, CURR OPIN CELL BIOL, V21, P623, DOI 10.1016/j.ceb.2009.05.004; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rizo A, 2008, BLOOD, V111, P2621, DOI 10.1182/blood-2007-08-106666; Rizo A, 2009, BLOOD, V114, P1498, DOI 10.1182/blood-2009-03-209734; Rodrigues NP, 2005, BLOOD, V106, P477, DOI 10.1182/blood-2004-08-2989; Rongvaux A, 2011, P NATL ACAD SCI USA, V108, P2378, DOI 10.1073/pnas.1019524108; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi MID, 2003, BLOOD, V101, P576, DOI 10.1182/blood-2002-03-0896; Sakai R, 2003, TOXICOL SCI, V72, P84, DOI 10.1093/toxsci/kfg002; Sakamoto K, 2002, J BIOL CHEM, V277, P29399, DOI 10.1074/jbc.M203727200; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Saran N, 2010, BLOOD, V115, P1137, DOI 10.1182/blood-2009-07-230821; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Schuringa JJ, 2010, CURR OPIN HEMATOL, V17, P294, DOI 10.1097/MOH.0b013e328338c439; Schwieger M, 2004, BLOOD, V103, P2744, DOI 10.1182/blood-2003-07-2280; Shepherd BE, 2004, EXP HEMATOL, V32, P1040, DOI 10.1016/j.exphem.2004.07.023; Shojaei F, 2005, DEV CELL, V8, P651, DOI 10.1016/j.devcel.2005.03.004; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Sitnicka E, 2003, BLOOD, V102, P881, DOI 10.1182/blood-2002-06-1694; Six EM, 2007, J EXP MED, V204, P3085, DOI 10.1084/jem.20071003; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Stingl J, 1998, DIFFERENTIATION, V63, P201, DOI 10.1111/j.1432-0436.1998.00201.x; SUTHERLAND HJ, 1989, BLOOD, V74, P1563; SUTHERLAND HJ, 1991, BLOOD, V78, P666, DOI 10.1182/blood.V78.3.666.bloodjournal783666; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; Trowbridge JJ, 2006, NAT MED, V12, P89, DOI 10.1038/nm1339; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; van der Meer LT, 2010, LEUKEMIA, V24, P1834, DOI 10.1038/leu.2010.195; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Varnum-Finney B, 2000, NAT MED, V6, P1278, DOI 10.1038/81390; Vinh DC, 2010, BLOOD, V115, P1519, DOI 10.1182/blood-2009-03-208629; Vogel W, 2000, STEM CELLS, V18, P87, DOI 10.1634/stemcells.18-2-87; Wada H, 2008, NATURE, V452, P768, DOI 10.1038/nature06839; Wang JCY, 1997, BLOOD, V89, P3919, DOI 10.1182/blood.V89.11.3919; Wang LS, 2005, J EXP MED, V201, P1603, DOI 10.1084/jem.20041888; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020; Welner RS, 2008, NAT REV IMMUNOL, V8, P95, DOI 10.1038/nri2234; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Willinger T, 2011, TRENDS IMMUNOL, V32, P321, DOI 10.1016/j.it.2011.04.005; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119	171	515	529	1	119	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 3	2012	10	2					120	136		10.1016/j.stem.2012.01.006	http://dx.doi.org/10.1016/j.stem.2012.01.006			17	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	892FM	22305562	Bronze			2022-12-28	WOS:000300272100007
J	Schimenti, J				Schimenti, John			Haploid Embryonic Stem Cells and the Dominance of Recessive Traits	CELL STEM CELL			English	Editorial Material							ES CELLS; DERIVATION	Diploidy, though essential for normal development, is a foil to geneticists. Two recent studies (El ling et al., 2011, this issue of Cell Stem Cell; Leeb and Wutz 2011, Nature), report the isolation of haploid pluripotent mouse ESCs, thus enabling efficient functional screening for genes involved in diverse cellular and developmental processes.	Cornell Univ, Ctr Vertebrate Genom, Ithaca, NY 14850 USA	Cornell University	Schimenti, J (corresponding author), Cornell Univ, Ctr Vertebrate Genom, Ithaca, NY 14850 USA.	jcs92@cornell.edu						Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; Horie K, 2011, NAT METHODS, V8, P1071, DOI [10.1038/NMETH.1739, 10.1038/nmeth.1739]; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Koike H, 2002, EMBO REP, V3, P433, DOI 10.1093/embo-reports/kvf097; Leeb M, 2011, NATURE, V479, P131, DOI 10.1038/nature10448; Malcuit C, 2006, J CELL PHYSIOL, V206, P565, DOI 10.1002/jcp.20471; MORTENSEN RM, 1992, MOL CELL BIOL, V12, P2391, DOI 10.1128/MCB.12.5.2391; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033	10	4	10	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 2	2011	9	6					488	489		10.1016/j.stem.2011.11.006	http://dx.doi.org/10.1016/j.stem.2011.11.006			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	859SB	22136917	Bronze			2022-12-28	WOS:000297895000002
J	Boyer, SW; Schroeder, AV; Smith-Berdan, S; Forsberg, EC				Boyer, Scott W.; Schroeder, Aaron V.; Smith-Berdan, Stephanie; Forsberg, E. Camilla			All Hematopoietic Cells Develop from Hematopoietic Stem Cells through Flk2/Flt3-Positive Progenitor Cells	CELL STEM CELL			English	Article							COMMON LYMPHOID PROGENITORS; MULTIPOTENT PROGENITORS; DENDRITIC CELLS; FLT3 LIGAND; HETEROGENEITY; EXPRESSION; DIFFERENTIATION; IDENTIFICATION; PRECURSORS; STAGE	While it is clear that a single hematopoietic stem cell (HSC) is capable of giving rise to all other hematopoietic cell types, the differentiation paths beyond HSC remain controversial. Contradictory reports on the lineage potential of progenitor populations have questioned their physiological contribution of progenitor populations to multilineage differentiation. Here, we established a lineage tracing mouse model that enabled direct assessment of differentiation pathways in vivo. We provide definitive evidence that differentiation into all hematopoietic lineages, including megakaryocyte/erythroid cell types, involves Flk2-expressing non-self-renewing progenitors. A Flk2+ stage was used during steady-state hematopoiesis, after irradiation-induced stress and upon HSC transplantation. In contrast, HSC origin and maintenance do not include a Flk2+ stage. These data demonstrate that HSC specification and maintenance are Flk2 independent, and that hematopoietic lineage separation occurs downstream of Flk2 upregulation.	[Boyer, Scott W.; Forsberg, E. Camilla] Univ Calif Santa Cruz, Program Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Schroeder, Aaron V.; Smith-Berdan, Stephanie; Forsberg, E. Camilla] Univ Calif Santa Cruz, Inst Biol Stem Cells, Dept Biomol Engn, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Forsberg, EC (corresponding author), Univ Calif Santa Cruz, Program Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	cforsber@ucsc.edu			California Institute for Regenerative Medicine (CIRM); CIRM; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008646] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); CIRM(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Bleul and Boehm for providing the Flk2-Cre mice. We thank Daniel Carlin, Joshua Stuart, and Abel Rodriguez for expert advice on statistical analyses, Holger Karsunky and Hanno Hock for comments on the manuscript, and Matthew Zimmer for animal care. This work was supported by a California Institute for Regenerative Medicine (CIRM) New Faculty Award to E.C.F and a CIRM Shared Stem Cell Facility award to UCSC. The authors declare no conflicts of interest.	Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Akashi K, 2005, CELL, V121, P160, DOI 10.1016/j.cell.2005.04.005; Akashi K, 2009, ANN NY ACAD SCI, V1176, P18, DOI 10.1111/j.1749-6632.2009.04570.x; Benz C, 2008, J EXP MED, V205, P1187, DOI 10.1084/jem.20072168; Boiers C, 2010, BLOOD, V115, P5061, DOI 10.1182/blood-2009-12-258756; Ceredig R, 2009, NAT REV IMMUNOL, V9, P293, DOI 10.1038/nri2525; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; Ema H, 2005, DEV CELL, V8, P907, DOI 10.1016/j.devcel.2005.03.019; FLEMING WH, 1993, J CELL BIOL, V122, P897, DOI 10.1083/jcb.122.4.897; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; Hock H, 2005, NATURE, V435, P573, DOI 10.1038/435573a; Hock H, 2010, J EXP MED, V207, P1127, DOI 10.1084/jem.20100950; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Karsunky H, 2008, BLOOD, V111, P5562, DOI 10.1182/blood-2007-11-126219; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lai AY, 2006, J EXP MED, V203, P1867, DOI 10.1084/jem.20060697; Lai AY, 2005, J IMMUNOL, V175, P5016, DOI 10.4049/jimmunol.175.8.5016; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Luc S, 2008, SEMIN IMMUNOL, V20, P213, DOI 10.1016/j.smim.2008.07.005; Luc S, 2008, BLOOD, V111, P3424, DOI 10.1182/blood-2007-08-108324; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nakorn TN, 2003, P NATL ACAD SCI USA, V100, P205, DOI 10.1073/pnas.262655099; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Schroeder T, 2010, CELL STEM CELL, V6, P203, DOI 10.1016/j.stem.2010.02.006; Sitnicka E, 2007, BLOOD, V110, P2955, DOI 10.1182/blood-2006-10-054726; Smith-Berdan S, 2011, CELL STEM CELL, V8, P72, DOI 10.1016/j.stem.2010.11.030; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807	37	141	141	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 8	2011	9	1					64	73		10.1016/j.stem.2011.04.021	http://dx.doi.org/10.1016/j.stem.2011.04.021			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	797VA	21726834	Green Accepted, Bronze			2022-12-28	WOS:000293157000010
J	Gordon, W; Andersen, B				Gordon, William; Andersen, Bogi			A Nervous Hedgehog Rolls into the Hair Follicle Stem Cell Scene	CELL STEM CELL			English	Editorial Material							EXPRESSION; INDUCTION; EPIDERMIS	In this issue of Cell Stem Cell, Brownell et al. (2011) identify stem cells in the hair follicle bulge that receive Hedgehog signals from adjacent sensory nerves. These stem cells regenerate the cycling hair follicle and, upon wounding, transit into the epidermis to become long-term resident interfollicular epidermal stem cells.	[Gordon, William; Andersen, Bogi] Univ Calif Irvine, Dept Med, Irvine, CA 92697 USA; [Gordon, William; Andersen, Bogi] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Gordon, William; Andersen, Bogi] Univ Calif Irvine, Ctr Complex Biol Syst, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Andersen, B (corresponding author), Univ Calif Irvine, Dept Med, Irvine, CA 92697 USA.	bogi@uci.edu						Brownell I, 2011, CELL STEM CELL, V8, P552, DOI 10.1016/j.stem.2011.02.021; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Maurer M, 1998, ARCH DERMATOL RES, V290, P574, DOI 10.1007/s004030050354; Oro AE, 2003, DEV BIOL, V255, P238, DOI 10.1016/S0012-1606(02)00042-8; Sato N, 1999, J CLIN INVEST, V104, P855, DOI 10.1172/JCI7691; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733	10	6	6	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAY 6	2011	8	5					459	460		10.1016/j.stem.2011.04.005	http://dx.doi.org/10.1016/j.stem.2011.04.005			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	768IN	21549317	Bronze			2022-12-28	WOS:000290927600001
J	Heredia, F; Nieto, MA				Heredia, Fabiana; Angela Nieto, M.			An Epigenetic Mark that Protects the Epithelial Phenotype in Health and Disease	CELL STEM CELL			English	Editorial Material							MESENCHYMAL TRANSITION	Epithelial plasticity is crucial during embryonic development and progression of carcinomas. In this issue, Abell et al. (2011) show that acetylation on histones H2A/H2B prevents epithelial cells from undergoing epithelial-to-mesenchymal transition (EMT). Their findings also suggest that under conditions where EMT and stemness coexist, they can be independently regulated.	[Heredia, Fabiana; Angela Nieto, M.] UMH, Inst Neurociencias CSIC, Alacant 03550, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	Nieto, MA (corresponding author), UMH, Inst Neurociencias CSIC, Avda Ramon & Cajal S-N, Alacant 03550, Spain.	anieto@umh.es	Nieto, M. Angela/A-6531-2008; Herédia, Fabiana/J-3999-2013	Nieto, M. Angela/0000-0002-3538-840X; Herédia, Fabiana/0000-0002-6390-7545; Heredia, Fabiana/0000-0003-0057-7654				Abell AN, 2011, CELL STEM CELL, V8, P525, DOI 10.1016/j.stem.2011.03.008; Abell AN, 2009, MOL CELL BIOL, V29, P2748, DOI 10.1128/MCB.01391-08; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Ocana OH, 2010, CELL RES, V20, P1086, DOI 10.1038/cr.2010.127; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007	10	4	4	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAY 6	2011	8	5					462	463		10.1016/j.stem.2011.04.011	http://dx.doi.org/10.1016/j.stem.2011.04.011			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	768IN	21549319	Bronze			2022-12-28	WOS:000290927600003
J	Zhang, LA; Stokes, N; Polak, L; Fuchs, E				Zhang, Liang; Stokes, Nicole; Polak, Lisa; Fuchs, Elaine			Specific MicroRNAs Are Preferentially Expressed by Skin Stem Cells To Balance Self-Renewal and Early Lineage Commitment	CELL STEM CELL			English	Article							VITAMIN-D-RECEPTOR; HAIR FOLLICLE; C-ELEGANS; ANIMAL MICRORNAS; GENE-EXPRESSION; B-LYMPHOCYTES; MOUSE SKIN; DIFFERENTIATION; MORPHOGENESIS; PROLIFERATION	Increasing evidence suggests that microRNAs may play important roles in regulating self-renewal and differentiation in mammalian stem cells (SCs). Here, we explore this issue in skin. We first characterize microRNA expression profiles of skin SCs versus their committed proliferative progenies and identify a microRNA subset associating with "stemness." Of these, miR-125b is dramatically downregulated in early SC progeny. We engineer an inducible mice system and show that when miR-125b is sustained in SC progenies, tissue balance is reversibly skewed toward stemness at the expense of epidermal, oil-gland, and HF differentiation. Using gain- and loss-of-function in vitro, we further implicate miR-125b as a repressor of SC differentiation. In vivo, transcripts repressed upon miR-125b induction are enriched >700% for predicted miR-125b targets normally downregulated upon SC-lineage commitment. We verify some of these miR-125b targets, and show that Blimp1 and VDR in particular can account for many tissue imbalances we see when miR-125b is deregulated.	[Zhang, Liang; Stokes, Nicole; Polak, Lisa; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Zhang, Liang; Stokes, Nicole; Polak, Lisa; Fuchs, Elaine] Rockefeller Univ, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016; Xie, Huangming/B-2260-2012; zhang, liang/F-4145-2011	Zhang, Liang/0000-0003-4396-9199	HHMI; NIH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050452] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We especially thank (1) Fuchs laboratory members J. Nowak, J. Ross, L. Fish, and S. Williams for developing initial strategies for FACS-purifications and for generating initial P4 HF-SC vs ORS microarray data and T. Chen, Y.-C. Hsu, and H. Zhang for discussions; (2) A. North (RU Bioimaging Resource Center) for assistance with image acquisition; (3) RU Comparative Biology Center, an ALAAC-accredited animal facility, for health care of our mice; and (4) Exiqon for providing LNA-modified antagomirs and other LNA reagents. E.F. is a Howard Hughes Medical Institute Investigator, and L.Z. is an HHMI postdoctoral associate. The work was supported by HHMI and a grant from the NIH.	Alexiou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009171; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Crist CG, 2009, CELL CYCLE, V8, P3627, DOI 10.4161/cc.8.22.9960; Delaloy C, 2010, CELL STEM CELL, V6, P323, DOI 10.1016/j.stem.2010.02.015; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; *GENSTAT, 2008, N01NSO2331 ROCK U NI; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107; Gururajan M, 2010, INT IMMUNOL, V22, P583, DOI 10.1093/intimm/dxq042; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Horsley V, 2006, CELL, V126, P597, DOI 10.1016/j.cell.2006.06.048; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lena AM, 2008, CELL DEATH DIFFER, V15, P1187, DOI 10.1038/cdd.2008.69; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li QT, 2008, CELL STEM CELL, V2, P195, DOI 10.1016/j.stem.2008.02.008; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Malumbres R, 2009, BLOOD, V113, P3754, DOI 10.1182/blood-2008-10-184077; Mohri T, 2009, INT J CANCER, V125, P1328, DOI 10.1002/ijc.24459; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Palmer HG, 2008, J INVEST DERMATOL, V128, P2113, DOI 10.1038/jid.2008.43; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu LG, 2005, MOL CELL BIOL, V25, P9198, DOI 10.1128/MCB.25.21.9198-9208.2005; Xia HF, 2009, CELL PHYSIOL BIOCHEM, V23, P347, DOI 10.1159/000218181; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Yi R, 2010, CELL DEATH DIFFER, V17, P229, DOI 10.1038/cdd.2009.92; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Yi R, 2009, P NATL ACAD SCI USA, V106, P498, DOI 10.1073/pnas.0810766105; Yu J, 2010, FASEB J, V24, P3950, DOI 10.1096/fj.10-157404; Zhang YJ, 2009, FEBS LETT, V583, P3725, DOI 10.1016/j.febslet.2009.10.002; Zhao C, 2010, P NATL ACAD SCI USA, V107, P1876, DOI 10.1073/pnas.0908750107; Zhou M, 2010, J BIOL CHEM, V285, P21496, DOI 10.1074/jbc.M109.083337	64	132	138	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 4	2011	8	3					294	308		10.1016/j.stem.2011.01.014	http://dx.doi.org/10.1016/j.stem.2011.01.014			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	735HI	21362569	Green Accepted, Bronze			2022-12-28	WOS:000288404400011
J	Okita, Y; Nakayama, KI				Okita, Yasutaka; Nakayama, Keiichi I.			UPS Delivers Pluripotency	CELL STEM CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; DIFFERENTIATION	In this issue of Cell Stem Cell, Buckley et al. (2012) show that the ubiquitin-proteasome system (UPS) regulates pluripotency in embryonic stem cells and induced pluripotent stem cells, opening the door to a better understanding at the system level of protein dynamics responsible for the maintenance and induction of pluripotency.	[Okita, Yasutaka; Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan; [Okita, Yasutaka; Nakayama, Keiichi I.] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Kyushu University; Japan Science & Technology Agency (JST)	Nakayama, KI (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	nakayak1@bioreg.kyushu-u.ac.jp						Buckley SM, 2012, CELL STEM CELL, V11, P783, DOI 10.1016/j.stem.2012.09.011; Graf T, 2011, CELL STEM CELL, V9, P504, DOI 10.1016/j.stem.2011.11.012; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Lu R, 2009, NATURE, V462, P358, DOI 10.1038/nature08575; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okita Y, 2012, GENES CELLS, V17, P768, DOI 10.1111/j.1365-2443.2012.01626.x; Vilchez D, 2012, NATURE, V489, P304, DOI 10.1038/nature11468; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005; Yumimoto K, 2012, J PROTEOME RES, V11, P3175, DOI 10.1021/pr201216u	10	14	14	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	DEC 7	2012	11	6					728	730		10.1016/j.stem.2012.11.009	http://dx.doi.org/10.1016/j.stem.2012.11.009			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	055MJ	23217415	Bronze			2022-12-28	WOS:000312420300002
J	Li, ZA; Lan, Y; He, WY; Chen, DB; Wang, J; Zhou, F; Wang, Y; Sun, HY; Chen, XD; Xu, CH; Li, S; Pang, YK; Zhang, GZ; Yang, LP; Zhu, LL; Fan, M; Shang, AJ; Ju, ZY; Luo, LF; Ding, YQ; Guo, W; Yuan, WP; Yang, X; Liu, B				Li, Zhuan; Lan, Yu; He, Wenyan; Chen, Dongbo; Wang, Jun; Zhou, Fan; Wang, Yu; Sun, Huayan; Chen, Xianda; Xu, Chunhong; Li, Sha; Pang, Yakun; Zhang, Guangzhou; Yang, Liping; Zhu, Lingling; Fan, Ming; Shang, Aijia; Ju, Zhenyu; Luo, Lingfei; Ding, Yuqiang; Guo, Wei; Yuan, Weiping; Yang, Xiao; Liu, Bing			Mouse Embryonic Head as a Site for Hematopoietic Stem Cell Development	CELL STEM CELL			English	Article							YOLK-SAC; DEFINITIVE HEMATOPOIESIS; AGM REGION; ENDOTHELIAL SMAD4; PROGENITOR CELLS; EXPRESSION; ZEBRAFISH; RUNX1; VASCULATURE; CIRCULATION	In the mouse embryo, the aorta-gonad-mesonephros (AGM) region is considered to be the sole location for intraembryonic emergence of hematopoietic stem cells (HSCs). Here we report that, in parallel to the AGM region, the E10.5-E11.5 mouse head harbors bona fide HSCs, as defined by long-term, high-level, multilineage reconstitution and self-renewal capacity in adult recipients, before HSCs enter the circulation. The presence of hemogenesis in the midgestation head is indicated by the appearance of intravascular cluster cells and the blood-forming capacity of a sorted endothelial cell population. In addition, lineage tracing via an inducible VE-cadherin-Cre transgene demonstrates the hemogenic capacity of head endothelium. Most importantly, a spatially restricted lineage labeling system reveals the physiological contribution of cerebrovascular endothelium to postnatal HSCs and multilineage hematopoiesis. We conclude that the mouse embryonic head is a previously unappreciated site for HSC emergence within the developing embryo.	[Li, Zhuan; He, Wenyan; Chen, Dongbo; Zhou, Fan; Sun, Huayan; Chen, Xianda; Xu, Chunhong; Li, Sha; Liu, Bing] Acad Mil Med Sci, Affiliated Hosp, Ivy Translat Med Ctr 307, Lab Oncol, Beijing 100071, Peoples R China; [Li, Zhuan; Luo, Lingfei; Liu, Bing] Southwest Univ, Key Lab Freshwater Fish Reprod & Dev, Minist Educ, Lab Mol Dev Biol,Sch Life Sci, Chongqing 400715, Peoples R China; [Lan, Yu; Wang, Jun; Wang, Yu; Yang, Xiao] Inst Biotechnol, State Key Lab Prote, Genet Lab Dev & Dis, Beijing 100071, Peoples R China; [Pang, Yakun; Yuan, Weiping; Liu, Bing] Chinese Acad Med Sci, State Key Lab Expt Hematol, Inst Hematol, Tianjin 300020, Peoples R China; [Pang, Yakun; Yuan, Weiping; Liu, Bing] Chinese Acad Med Sci, Blood Dis Hosp, Tianjin 300020, Peoples R China; [Zhang, Guangzhou; Yang, Liping] Acad Mil Med Sci, Lab Anim Ctr, Beijing 100071, Peoples R China; [Zhu, Lingling; Fan, Ming] Inst Basic Med Sci, Dept Brain Protect & Plast, Beijing 100850, Peoples R China; [Shang, Aijia] Gen Hosp Chinese PLA, Dept Neurosurg, Beijing 100853, Peoples R China; [Ju, Zhenyu] Hangzhou Normal Univ, Max Planck Partner Grp Stem Cell Aging, Inst Aging Res, Coll Med, Hangzhou 310036, Zhejiang, Peoples R China; [Ding, Yuqiang] Tongji Univ, Sch Med, Key Lab Arrhythmias, Minist Educ,East Hosp, Shanghai 200092, Peoples R China; [Guo, Wei] Tsinghua Univ, Sch Med, Ctr Stem Cell Biol & Regenerat Med, Beijing 100084, Peoples R China	Academy of Military Medical Sciences - China; Southwest University - China; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Academy of Military Medical Sciences - China; Hangzhou Normal University; Max Planck Society; Tongji University; Tsinghua University	Yang, X (corresponding author), Acad Mil Med Sci, Affiliated Hosp, Ivy Translat Med Ctr 307, Lab Oncol, Beijing 100071, Peoples R China.	yangx@nic.bmi.ac.cn; bingliu17@yahoo.com	XIAO, YANG/GPW-5529-2022; Lan, Yu/AAV-2236-2021; Liu, Bing/ABH-2370-2021	Lan, Yu/0000-0002-4731-5945; Liu, Bing/0000-0002-7313-6924; Wang, Jun/0000-0001-6498-0675; Ding, Yu-Qiang/0000-0003-1202-4635; Yang, Xiao/0000-0002-0298-9831	Chinese National Key Program on Basic Research [2011CB964800, 2012CB945100, 2012CB966904, 2009CB941102]; National Natural Science Foundation of China [30911130360, 31030040, 81090410, 30871410, 30900570, 81071055, 31171416, 31171410]	Chinese National Key Program on Basic Research; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Tao Cheng, Feng Ma, Sheng Zhou, Daohong Zhou, Yongchun Yu, Xiaobing Yuan, Tingxi Liu, Ting Zhou, and Jiabo Wang for helpful discussion. We thank M. Luisa Iruela-Arispe for kindly providing the inducible VE-cadherin-Cre mouse line. This work was supported by Chinese National Key Program on Basic Research (2011CB964800, 2012CB945100, 2012CB966904, and 2009CB941102) and National Natural Science Foundation of China (30911130360, 31030040, 81090410, 30871410, 30900570, 81071055, 31171416, and 31171410). The authors declare that they have no competing financial interests.	Bee T, 2010, BLOOD, V115, P3042, DOI 10.1182/blood-2009-08-238626; Bennett CM, 2001, BLOOD, V98, P643, DOI 10.1182/blood.V98.3.643; Boisset JC, 2011, NAT PROTOC, V6, P1792, DOI 10.1038/nprot.2011.401; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; Cumano A, 2007, ANNU REV IMMUNOL, V25, P745, DOI 10.1146/annurev.immunol.25.022106.141538; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; Drake CJ, 2000, BLOOD, V95, P1671, DOI 10.1182/blood.V95.5.1671.005k39_1671_1679; Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; Gekas C, 2005, DEV CELL, V8, P365, DOI 10.1016/j.devcel.2004.12.016; Glasker S, 2006, CANCER RES, V66, P4167, DOI 10.1158/0008-5472.CAN-05-3505; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Kanatsu M, 1996, DEVELOPMENT, V122, P823; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kumaravelu P, 2002, DEVELOPMENT, V129, P4891; Lan Y, 2007, MOL CELL BIOL, V27, P7683, DOI 10.1128/MCB.00577-07; Le Guyader D, 2008, BLOOD, V111, P132, DOI 10.1182/blood-2007-06-095398; Li FF, 2011, DEV CELL, V20, P291, DOI 10.1016/j.devcel.2011.01.011; Lux CT, 2008, BLOOD, V111, P3435, DOI 10.1182/blood-2007-08-107086; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; McGrath KE, 2005, EXP HEMATOL, V33, P1021, DOI 10.1016/j.exphem.2005.06.012; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Meng FW, 2007, MATRIX BIOL, V26, P54, DOI 10.1016/j.matbio.2006.09.003; Mikkola HKA, 2006, DEVELOPMENT, V133, P3733, DOI 10.1242/dev.02568; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Ottersbach K, 2005, DEV CELL, V8, P377, DOI 10.1016/j.devcel.2005.02.001; Palis J, 1999, DEVELOPMENT, V126, P5073; Rhodes KE, 2008, CELL STEM CELL, V2, P252, DOI 10.1016/j.stem.2008.01.001; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; Sanchez MJ, 1996, IMMUNITY, V5, P513, DOI 10.1016/S1074-7613(00)80267-8; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sroczynska P, 2009, BLOOD, V114, P5279, DOI 10.1182/blood-2009-05-222307; Tan XW, 2005, STEM CELLS, V23, P1443, DOI 10.1634/stemcells.2004-0169; Taoudi S, 2008, CELL STEM CELL, V3, P99, DOI 10.1016/j.stem.2008.06.004; Vortmeyer AO, 2003, CANCER RES, V63, P7051; Yoder MC, 1997, IMMUNITY, V7, P335, DOI 10.1016/S1074-7613(00)80355-6; Yokomizo T, 2010, DEVELOPMENT, V137, P3651, DOI 10.1242/dev.051094; Yoshimoto M, 2011, P NATL ACAD SCI USA, V108, P1468, DOI 10.1073/pnas.1015841108; Yoshimoto M, 2008, CELL STEM CELL, V3, P583, DOI 10.1016/j.stem.2008.11.002; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	44	126	131	4	81	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV 2	2012	11	5					663	675		10.1016/j.stem.2012.07.004	http://dx.doi.org/10.1016/j.stem.2012.07.004			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	042LE	23122290	Bronze			2022-12-28	WOS:000311471900012
J	Fitch, SR; Kimber, GM; Wilson, NK; Parker, A; Mirshekar-Syahkal, B; Gottgens, B; Medvinsky, A; Dzierzak, E; Ottersbach, K				Fitch, Simon R.; Kimber, Gillian M.; Wilson, Nicola K.; Parker, Aimee; Mirshekar-Syahkal, Bahar; Goettgens, Berthold; Medvinsky, Alexander; Dzierzak, Elaine; Ottersbach, Katrin			Signaling from the Sympathetic Nervous System Regulates Hematopoietic Stem Cell Emergence during Embryogenesis	CELL STEM CELL			English	Article							GATA TRANSCRIPTION FACTORS; TARGETED DISRUPTION; SELF-RENEWAL; AGM REGION; YOLK-SAC; EXPRESSION; MAINTENANCE; SPECIFICATION; REVEALS; LINEAGE	The first adult-repopulating hematopoietic stem cells (HSCs) emerge in the aorta-gonads-mesonephros (AGM) region of the embryo. We have recently identified the transcription factor Gata3 as being upregulated in this tissue specifically at the time of HSC emergence. We now demonstrate that the production of functional and phenotypic HSCs in the AGM is impaired in the absence of Gata3. Furthermore, we show that this effect on HSC generation is secondary to the role of Gata3 in the production of catecholamines, the mediators of the sympathetic nervous system (SNS), thus making these molecules key components of the AGM HSC niche. These findings demonstrate that the recently described functional interplay between the hematopoietic system and the SNS extends to the earliest stages of their codevelopment and highlight the fact that HSC development needs to be viewed in the context of the development of other organs.	[Fitch, Simon R.; Kimber, Gillian M.; Wilson, Nicola K.; Parker, Aimee; Mirshekar-Syahkal, Bahar; Goettgens, Berthold; Ottersbach, Katrin] Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge CB2 0XY, England; [Dzierzak, Elaine] Erasmus MC, Erasmus Stem Cell Inst, Dept Cell Biol, NL-3000 CA Rotterdam, Netherlands; [Medvinsky, Alexander] Univ Edinburgh, MRC Ctr Regenerat Med, Inst Stem Cell Res, Edinburgh EH9 3JQ, Midlothian, Scotland	University of Cambridge; Erasmus University Rotterdam; Erasmus MC; University of Edinburgh	Ottersbach, K (corresponding author), Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge CB2 0XY, England.	ko268@cam.ac.uk		Parker, Aimee/0000-0003-1765-9656; Gottgens, Berthold/0000-0001-6302-5705; Ottersbach, Katrin/0000-0002-6880-4895	Kay Kendall Leukaemia Fund [KKL276]; British Society for Haematology Early Stage Researcher Fellowship; Leukaemia & Lymphoma Research [10015, 07060]; National Institutes of Health [R37DK054077]; Netherlands Economic Ministry [BSIK 03038]; Biotechnology and Biological Sciences Research Council [BB/I00050X/1] Funding Source: researchfish; Cancer Research UK [12765] Funding Source: researchfish; Medical Research Council [G0800784B, G0900951, G0900962, G0800784, G0500950, G0700711B] Funding Source: researchfish; National Centre for the Replacement [G0900729/1] Funding Source: researchfish; BBSRC [BB/I00050X/1] Funding Source: UKRI; MRC [G0500950, G0900962, G0800784, G0900951] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK054077] Funding Source: NIH RePORTER	Kay Kendall Leukaemia Fund; British Society for Haematology Early Stage Researcher Fellowship; Leukaemia & Lymphoma Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Economic Ministry; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are very grateful to Prof. Frank Grosveld for providing us with the Gata3 knockout and Gata3-LacZ knockin mouse lines. We are equally indebted to Dr. Richard Palmiter for giving us the Th knockout mice. We would also like to thank Fredrik Wallberg, Dr. Anna Petrunkina, and Susan Kennelly for cell sorting services; Dr. Dorota Kurek and Dr. Jacqueline van der Wees for technical advice on the pharmacological rescue experiments; and our lab members for fruitful discussions and technical assistance. This work was supported by the Kay Kendall Leukaemia Fund (KKL276 to K.O.), a British Society for Haematology Early Stage Researcher Fellowship (K.O.), Leukaemia & Lymphoma Research (10015 to K.O.; 07060 to B.G.), the National Institutes of Health (R37DK054077 to E.D.), and the Netherlands Economic Ministry (BSIK 03038 Stem Cells in Development and Disease to E.D.).	Adamo L, 2009, NATURE, V459, P1131, DOI 10.1038/nature08073; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; Buza-Vidas N, 2011, BLOOD, V118, P1291, DOI 10.1182/blood-2011-02-338046; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; CSERJESI P, 1995, DEV BIOL, V170, P664, DOI 10.1006/dbio.1995.1245; de Bruijn MFTR, 2002, IMMUNITY, V16, P673, DOI 10.1016/S1074-7613(02)00313-8; Durand C, 2007, P NATL ACAD SCI USA, V104, P20838, DOI 10.1073/pnas.0706923105; Grote D, 2006, DEVELOPMENT, V133, P53, DOI 10.1242/dev.02184; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Huber K, 2006, DEV BIOL, V298, P335, DOI 10.1016/j.ydbio.2006.07.010; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Jaffredo T, 2000, DEV BIOL, V224, P204, DOI 10.1006/dbio.2000.9799; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Khandanpour C, 2010, BLOOD, V116, P5149, DOI 10.1182/blood-2010-04-280305; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Ku CJ, 2012, BLOOD, V119, P2242, DOI 10.1182/blood-2011-07-366070; Kumaravelu P, 2002, DEVELOPMENT, V129, P4891; Kurek D, 2007, DEVELOPMENT, V134, P261, DOI 10.1242/dev.02721; Lim KC, 2000, NAT GENET, V25, P209, DOI 10.1038/76080; Ling KW, 2004, J EXP MED, V200, P871, DOI 10.1084/jem.20031556; Manaia A, 2000, DEVELOPMENT, V127, P643; Mascarenhas MI, 2009, BLOOD, V114, P4645, DOI 10.1182/blood-2009-06-230037; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; MEDVINSKY AL, 1993, NATURE, V364, P64, DOI 10.1038/364064a0; Mendes SC, 2005, DEVELOPMENT, V132, P1127, DOI 10.1242/dev.01615; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Moriguchi T, 2006, DEVELOPMENT, V133, P3871, DOI 10.1242/dev.02553; Morikawa Y, 2004, DEVELOPMENT, V131, P2195, DOI 10.1242/dev.01091; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; North T, 1999, DEVELOPMENT, V126, P2563; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; Ohneda O, 2000, IMMUNITY, V12, P141, DOI 10.1016/S1074-7613(00)80167-3; Oostendorp RAJ, 2005, STEM CELLS, V23, P842, DOI 10.1634/stemcells.2004-0120; Ottersbach K, 2010, BRIT J HAEMATOL, V148, P343, DOI 10.1111/j.1365-2141.2009.07953.x; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; Panepucci RA, 2010, STEM CELLS DEV, V19, P321, DOI 10.1089/scd.2008.0397; Pattyn A, 2000, MOL CELL NEUROSCI, V15, P235, DOI 10.1006/mcne.1999.0826; Peeters M, 2009, DEVELOPMENT, V136, P2613, DOI 10.1242/dev.034728; Renstrom J, 2009, CELL STEM CELL, V5, P157, DOI 10.1016/j.stem.2009.05.020; Robin C, 2006, DEV CELL, V11, P171, DOI 10.1016/j.devcel.2006.07.002; Robin C, 2011, BLOOD, V117, P5088, DOI 10.1182/blood-2011-01-329516; Rybtsov S, 2011, J EXP MED, V208, P1305, DOI 10.1084/jem.20102419; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; Sanchez MJ, 1996, IMMUNITY, V5, P513, DOI 10.1016/S1074-7613(00)80267-8; Spiegel A, 2007, NAT IMMUNOL, V8, P1123, DOI 10.1038/ni1509; Tanaka Y, 2012, P NATL ACAD SCI USA, V109, P4515, DOI 10.1073/pnas.1115828109; Taoudi S, 2008, CELL STEM CELL, V3, P99, DOI 10.1016/j.stem.2008.06.004; Taoudi S, 2007, P NATL ACAD SCI USA, V104, P9399, DOI 10.1073/pnas.0700984104; THOMAS SA, 1995, NATURE, V374, P643, DOI 10.1038/374643a0; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Toda H, 2007, BRIT J PHARMACOL, V150, P1011, DOI 10.1038/sj.bjp.0707191; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; Tsarovina K, 2004, DEVELOPMENT, V131, P4775, DOI 10.1242/dev.01370; Tsarovina K, 2010, J NEUROSCI, V30, P10833, DOI 10.1523/JNEUROSCI.0175-10.2010; van Doorninck J H, 1999, J Neurosci, V19, pRC12; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395; Wei EH, 2007, J BIOL CHEM, V282, P8027, DOI 10.1074/jbc.M605789200; Wilson NK, 2010, MOL CELL BIOL, V30, P3853, DOI 10.1128/MCB.00032-10; Wolkersdorfer M, 1996, BIOCHEM J, V316, P953, DOI 10.1042/bj3160953; ZHOU QY, 1995, NATURE, V374, P640, DOI 10.1038/374640a0; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	66	76	81	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 5	2012	11	4					554	566		10.1016/j.stem.2012.07.002	http://dx.doi.org/10.1016/j.stem.2012.07.002			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	021OZ	23040481	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000309896500015
J	Goritz, C; Frisen, J				Goritz, Christian; Frisen, Jonas			Neural Stem Cells and Neurogenesis in the Adult	CELL STEM CELL			English	Editorial Material							HUMAN HIPPOCAMPUS; ORIGIN; NEURONS; BRAIN; AGE	Research in the field of adult neurogenesis has seen substantial progress over recent years. Here we discuss some of the major focus areas for future investigation: neural stem cell heterogeneity, the role of latent stem cells, and the extent of neurogenesis in the adult human brain.	[Goritz, Christian; Frisen, Jonas] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden	Karolinska Institutet	Frisen, J (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden.	jonas.frisen@ki.se	Göritz, Christian/AAK-5348-2021	Göritz, Christian/0000-0003-0799-766X				Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Bergmann O, 2012, NEURON, V74, P634, DOI 10.1016/j.neuron.2012.03.030; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809; Lledo PM, 2008, TRENDS NEUROSCI, V31, P392, DOI 10.1016/j.tins.2008.05.006; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487	10	73	78	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 14	2012	10	6					657	659		10.1016/j.stem.2012.04.005	http://dx.doi.org/10.1016/j.stem.2012.04.005			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	965LD	22704503	Bronze			2022-12-28	WOS:000305768400009
J	Davison, A				Davison, Anna			US Stem Cell Advocacy Groups Gear Up for Election 2012	CELL STEM CELL			English	News Item																			0	1	1	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAY 4	2012	10	5					490	491		10.1016/j.stem.2012.04.019	http://dx.doi.org/10.1016/j.stem.2012.04.019			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	944WN	22712067	Bronze			2022-12-28	WOS:000304234600006
J	Bruckner, K				Brueckner, Katja			Blood Cells Need Glia, Too: A New Role for the Nervous System in the Bone Marrow Niche	CELL STEM CELL			English	Editorial Material							STEM-CELLS; HIBERNATION	Regulation of hematopoietic stem cell (HSC) dormancy by specific cell types in the hematopoietic niche remains poorly understood. Yamazaki et al. (2011) now report that nerve-associated nonmyelinating Schwann cells activate TGF-beta to maintain dormant HSCs, suggesting that glia are novel players in the bone marrow niche.	Univ Calif San Francisco, Dept Anat, Dept Cell & Tissue Biol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Bruckner, K (corresponding author), Univ Calif San Francisco, Dept Anat, Dept Cell & Tissue Biol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, 35 Med Ctr Way, San Francisco, CA 94143 USA.	katja.brueckner@ucsf.edu						Ehninger A, 2011, J EXP MED, V208, P421, DOI 10.1084/jem.20110132; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Makhijani K, 2011, DEVELOPMENT, V138, P5379, DOI 10.1242/dev.067322; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Spiegel A, 2007, NAT IMMUNOL, V8, P1123, DOI 10.1038/ni1509; Straub RH, 2004, TRENDS PHARMACOL SCI, V25, P640, DOI 10.1016/j.tips.2004.10.007; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Yamazaki S, 2009, BLOOD, V113, P1250, DOI 10.1182/blood-2008-04-146480	10	13	14	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	DEC 2	2011	9	6					493	495		10.1016/j.stem.2011.11.016	http://dx.doi.org/10.1016/j.stem.2011.11.016			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	859SB	22136920	Bronze			2022-12-28	WOS:000297895000005
J	Smith, LL; Yeung, J; Zeisig, BB; Popov, N; Huijbers, I; Barnes, J; Wilson, AJ; Taskesen, E; Delwel, R; Gil, J; Van Lohuizen, M; So, CWE				Smith, Lan-Lan; Yeung, Jenny; Zeisig, Bernd B.; Popov, Nikolay; Huijbers, Ivo; Barnes, Josephine; Wilson, Amanda J.; Taskesen, Erdogan; Delwel, Ruud; Gil, Jesus; Van Lohuizen, Maarten; So, Chi Wai Eric			Functional Crosstalk between Bmi1 and MLL/Hoxa9 Axis in Establishment of Normal Hematopoietic and Leukemic Stem Cells	CELL STEM CELL			English	Article							ACUTE MYELOID-LEUKEMIA; PROLIFERATIVE CAPACITY; CHILDHOOD LEUKEMIA; HSC ACTIVITY; BONE-MARROW; CBF-BETA; TRANSFORMATION; EXPRESSION; POLYCOMB; MLL	Bmi1 is required for efficient self-renewal of hematopoietic stem cells (HSCs) and leukemic stem cells (LSCs). In this study, we investigated whether leukemia-associated fusion proteins, which differ in their ability to activate Hox expression, could initiate leukemia in the absence of Bmi1. AML1-ETO and PLZF-RAR alpha, which do not activate Hox, triggered senescence in Bmi1(-/-) cells. In contrast, MLL-AF9, which drives expression of Hoxa7 and Hoxa9, readily transformed Bmi1(-/-) cells. MLL-AF9 could not initiate leukemia in Bmi1(-/-)Hoxa9(-/-) mice, which have further compromised HSC functions. But either gene could restore the ability of MLL-AF9 to establish LSCs in the double null background. As reported for Bmi1, Hoxa9 regulates expression of p16(ink4a)/p19(ARF) locus and could overcome senescence induced by AML1-ETO. Together, these results reveal an important functional interplay between MLL/Hox and Bmi1 in regulating cellular senescence for LSC development, suggesting that a synergistic targeting of both molecules is required to eradicate a broader spectrum of LSCs.	[Smith, Lan-Lan; Yeung, Jenny; Zeisig, Bernd B.; Barnes, Josephine; Wilson, Amanda J.; So, Chi Wai Eric] Kings Coll London, Dept Haematol Med, Leukaemia & Stem Cell Biol Lab, London SE5 9NU, England; [Popov, Nikolay; Gil, Jesus] Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Clin Sci Ctr, Cell Proliferat Grp, London W12 0NN, England; [Huijbers, Ivo; Van Lohuizen, Maarten] Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; [Huijbers, Ivo; Van Lohuizen, Maarten] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [Taskesen, Erdogan; Delwel, Ruud] Erasmus Univ, Med Ctr, Dept Hematol, Rotterdam, Netherlands; [So, Chi Wai Eric] Inst Canc Res, Haematooncol Sect, Greater London SM5 2NG, England	University of London; King's College London; Imperial College London; Netherlands Cancer Institute; Netherlands Cancer Institute; Erasmus University Rotterdam; Erasmus MC; University of London; Institute of Cancer Research - UK	So, CWE (corresponding author), Kings Coll London, Dept Haematol Med, Leukaemia & Stem Cell Biol Lab, London SE5 9NU, England.	eric.so@kcl.ac.uk	Taskesen, Erdogan/N-4983-2015; Gil, Jesus/C-7739-2012; Huijbers, Ivo/I-3229-2019	Taskesen, Erdogan/0000-0002-3430-9618; Gil, Jesus/0000-0002-4303-6260; Yeung, Jenny/0000-0002-1452-1056; Wilson, Amanda/0000-0001-5681-9611; Barnes, Josephine/0000-0001-9938-3176	MRC; CRUK; LLR; Medical Research Council [G0800892, MC_U120085810] Funding Source: researchfish; MRC [MC_U120085810, G0800892] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CRUK(Cancer Research UK); LLR; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Cleary for his help and constructive advice in the early phase of the project in particular; M. Greaves for critical discussion; J. Licht and K. Rice for providing clinical data and bioinformatic support on the t(11; 17) cases; N. Cheung, E. Amin, W. Vetharoy, C. Kwok, A. Thornhill, C. Foley, I. Titley, and G. Vijayaraghavan for technical assistance; D.E. Zhang, R. Slany, and C.V. Dang for provision of useful reagents; G. Dickson, A. Thompson, and T. Lappin for initial help in Hox qPCR analysis; and P. Tse for professional graphic assistance. J.G. and N.P. are funded by the MRC. C.-W.-E.S. is an AICR fellow and EMBO young investigator. This work is supported by CRUK and in part by LLR.	Ananthanarayanan M, 2004, J BIOL CHEM, V279, P54348, DOI 10.1074/jbc.M410021200; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Bach C, 2010, BLOOD, V115, P2910, DOI 10.1182/blood-2009-04-216606; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Bijl J, 2006, BLOOD, V108, P116, DOI 10.1182/blood-2005-06-2245; Bishop CL, 2010, MOL CELL, V40, P533, DOI 10.1016/j.molcel.2010.10.027; Bjornsson JM, 2003, MOL CELL BIOL, V23, P3872, DOI 10.1128/MCB.23.11.3872-3883.2003; Boukarabila H, 2009, GENE DEV, V23, P1195, DOI 10.1101/gad.512009; Brun ACM, 2004, BLOOD, V103, P4126, DOI 10.1182/blood-2003-10-3557; Cheung N, 2007, NAT CELL BIOL, V9, P1208, DOI 10.1038/ncb1642; Cheung N, 2011, FEBS LETT, V585, P2100, DOI 10.1016/j.febslet.2011.03.068; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Faubert A, 2008, COLD SH Q B, V73, P555, DOI 10.1101/sqb.2008.73.030; Gil J, 2004, NAT CELL BIOL, V6, P67, DOI 10.1038/ncb1077; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Greaves MF, 2003, BLOOD, V102, P2321, DOI 10.1182/blood-2002-12-3817; Hanson RD, 1999, P NATL ACAD SCI USA, V96, P14372, DOI 10.1073/pnas.96.25.14372; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; Irelan JT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005067; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Krivtsov AV, 2008, CANCER CELL, V14, P355, DOI 10.1016/j.ccr.2008.10.001; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Kumar AR, 2004, BLOOD, V103, P1823, DOI 10.1182/blood-2003-07-2582; Kwok C, 2006, CANCER CELL, V9, P95, DOI 10.1016/j.ccr.2006.01.005; Kwok C, 2010, BLOOD, V115, P3176, DOI 10.1182/blood-2009-12-260570; Kwok C, 2009, P NATL ACAD SCI USA, V106, P2853, DOI 10.1073/pnas.0810558106; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Lawrence HJ, 2005, BLOOD, V106, P3988, DOI 10.1182/blood-2005-05-2003; Lawrence HJ, 1997, BLOOD, V89, P1922, DOI 10.1182/blood.V89.6.1922; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Liedtke M, 2009, BLOOD, V113, P6061, DOI 10.1182/blood-2008-12-197061; Liu H, 2009, CANCER BIOL THER, V8, P1204, DOI 10.4161/cbt.8.13.8924; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rice KL, 2009, BLOOD, V114, P5499, DOI 10.1182/blood-2009-03-206524; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; So CW, 2004, BLOOD, V104, P919, DOI 10.1182/blood-2004-03-0992; So CW, 2004, BLOOD, V103, P3192, DOI 10.1182/blood-2003-10-3722; So CW, 2003, CANCER CELL, V3, P161, DOI 10.1016/S1535-6108(03)00019-9; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Verhaak RGW, 2009, HAEMATOL-HEMATOL J, V94, P131, DOI 10.3324/haematol.13299; Wong P, 2007, GENE DEV, V21, P2762, DOI 10.1101/gad.1602107; Yeung J, 2010, CANCER CELL, V18, P606, DOI 10.1016/j.ccr.2010.10.032; Yeung Jenny, 2009, V538, P301, DOI 10.1007/978-1-59745-418-6_15; Zeisig BB, 2008, CANCER CELL, V14, P345, DOI 10.1016/j.ccr.2008.10.008; Zeisig BB, 2007, CANCER CELL, V12, P36, DOI 10.1016/j.ccr.2007.06.006; Zeisig Bernd B., 2009, V538, P207, DOI 10.1007/978-1-59745-418-6_10	55	97	102	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 3	2011	8	6					649	662		10.1016/j.stem.2011.05.004	http://dx.doi.org/10.1016/j.stem.2011.05.004			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	780HC	21624810	Bronze			2022-12-28	WOS:000291844100013
J	Lathia, JD; Heddleston, JM; Venere, M; Rich, JN				Lathia, Justin D.; Heddleston, John M.; Venere, Monica; Rich, Jeremy N.			Deadly Teamwork: Neural Cancer Stem Cells and the Tumor Microenvironment	CELL STEM CELL			English	Review							NICHE; HIF-2-ALPHA; EXPANSION; MAINTAINS; GLIOMAS	Neural cancers display cellular hierarchies with self-renewing tumorigenic cancer stem cells (CSCs) at the apex. Instructive cues to maintain CSCs are generated by both intrinsic networks and the niche microenvironment. The CSC-microenvironment relationship is complex, as CSCs can modify their environment and extrinsic forces induce plasticity in the cellular hierarchy.	[Lathia, Justin D.; Heddleston, John M.; Venere, Monica; Rich, Jeremy N.] Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44118 USA	Cleveland Clinic Foundation	Lathia, JD (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, 9500 Euclid Ave, Cleveland, OH 44118 USA.	lathiaj@ccf.org; richj@ccf.org	Rich, Jeremy/AAM-1445-2021; Lathia, Justin/AHB-8296-2022		NCI NIH HHS [R01 CA129958, R01 CA116659, F32 CA142159, R01 CA154130] Funding Source: Medline; NINDS NIH HHS [R01 NS054276, F32 NS058042] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA129958, R01CA154130] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Acker T, 2005, CANCER CELL, V8, P131, DOI 10.1016/j.ccr.2005.07.003; Bautch VL, 2010, NATURE, V468, P770, DOI 10.1038/468770a; Burgess DJ, 2011, NAT REV CANCER, V11, P153, DOI 10.1038/nrc3019; Charles NA, 2010, CELL STEM CELL, V6, P6, DOI 10.1016/j.stem.2009.12.005; Fan X, 2010, STEM CELLS, V28, P5, DOI 10.1002/stem.254; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Hambardzumyan D, 2008, GENE DEV, V22, P436, DOI 10.1101/gad.1627008; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Hjelmeland AB, 2011, CELL DEATH DIFFER, V18, P829, DOI 10.1038/cdd.2010.150; Huse JT, 2011, GLIA; Lathia JD, 2010, CELL STEM CELL, V6, P421, DOI 10.1016/j.stem.2010.02.018; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Li ZZ, 2009, J BIOL CHEM, V284, P16705, DOI 10.1074/jbc.R900013200; Markovic DS, 2009, P NATL ACAD SCI USA, V106, P12530, DOI 10.1073/pnas.0804273106; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Pietras A, 2009, P NATL ACAD SCI USA, V106, P16805, DOI 10.1073/pnas.0904606106; Pistollato F, 2010, STEM CELLS, V28, P1918, DOI 10.1002/stem.518; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Seidel S, 2010, BRAIN, V133, P983, DOI 10.1093/brain/awq042; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Wakimoto H, 2009, CANCER RES, V69, P3472, DOI 10.1158/0008-5472.CAN-08-3886	21	182	187	1	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAY 6	2011	8	5					482	485		10.1016/j.stem.2011.04.013	http://dx.doi.org/10.1016/j.stem.2011.04.013			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	768IN	21549324	Bronze, Green Accepted			2022-12-28	WOS:000290927600009
J	Lowry, WE				Lowry, William E.			-OH No! hiPSCs Misplace Their 5hmCs	CELL STEM CELL			English	Editorial Material							PLURIPOTENT STEM-CELLS; DNA METHYLATION; HOTSPOTS	hiPSCs and hESCs are thought to display subtle genetic and epigenetic variability. Recently in Nature Cell Biology, Wang et al. (2013) demonstrated a role for TET1 during reprogramming of human cells and showed that hiPSCs lack appropriate 5hmC marks in subtelomeric regions, contributing to epigenetic variation common to hiPSCs.	[Lowry, William E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Lowry, William E.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med, Los Angeles, CA 90095 USA; [Lowry, William E.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Lowry, William E.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lowry, WE (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	blowry@ucla.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099134] Funding Source: NIH RePORTER; NIGMS NIH HHS [P01 GM099134] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Nazor KL, 2012, CELL STEM CELL, V10, P620, DOI 10.1016/j.stem.2012.02.013; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Ruiz S, 2012, P NATL ACAD SCI USA, V109, P16196, DOI 10.1073/pnas.1202352109; Schneider RP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2946; Wang T, 2013, NAT CELL BIOL, V15, P700, DOI 10.1038/ncb2748; Watanabe A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0292	10	0	0	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2013	13	1					10	11		10.1016/j.stem.2013.06.007	http://dx.doi.org/10.1016/j.stem.2013.06.007			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VJ	23827705	Green Accepted, Bronze			2022-12-28	WOS:000329570100006
J	Nicholas, CR; Chen, JD; Tang, YS; Southwell, DG; Chalmers, N; Vogt, D; Arnold, CM; Chen, YJJ; Stanley, EG; Elefanty, AG; Sasai, Y; Alvarez-Buylla, A; Rubenstein, JLR; Kriegstein, AR				Nicholas, Cory R.; Chen, Jiadong; Tang, Yunshuo; Southwell, Derek G.; Chalmers, Nadine; Vogt, Daniel; Arnold, Christine M.; Chen, Ying-Jiun J.; Stanley, Edouard G.; Elefanty, Andrew G.; Sasai, Yoshiki; Alvarez-Buylla, Arturo; Rubenstein, John L. R.; Kriegstein, Arnold R.			Functional Maturation of hPSC-Derived Forebrain Interneurons Requires an Extended Timeline and Mimics Human Neural Development	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; TEMPORAL-LOBE EPILEPSY; HUMAN CEREBRAL-CORTEX; CORTICAL INTERNEURONS; HUMAN NEOCORTEX; RADIAL GLIA; HUMAN ES; NEURONS; PRECURSORS; INTEGRATE	Directed differentiation from human pluripotent stem cells (hPSCs) has seen significant progress in recent years. However, most differentiated populations exhibit immature properties of an early embryonic stage, raising concerns about their ability to model and treat disease. Here, we report the directed differentiation of hPSCs into medial ganglionic eminence (MGE)-like progenitors and their maturation into forebrain type interneurons. We find that early-stage progenitors progress via a radial glial-like stem cell enriched in the human fetal brain. Both in vitro and posttransplantation into the rodent cortex, the MGE-like cells develop into GABAergic interneuron subtypes with mature physiological properties along a prolonged intrinsic timeline of up to 7 months, mimicking endogenous human neural development. MGE-derived cortical interneuron deficiencies are implicated in a broad range of neurodevelopmental and degenerative disorders, highlighting the importance of these results for modeling human neural development and disease.	[Nicholas, Cory R.; Chen, Jiadong; Chalmers, Nadine; Kriegstein, Arnold R.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Neurol, San Francisco, CA 94158 USA; [Tang, Yunshuo; Southwell, Derek G.; Arnold, Christine M.; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Neurol Surg, San Francisco, CA 94158 USA; [Vogt, Daniel; Chen, Ying-Jiun J.; Rubenstein, John L. R.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; [Vogt, Daniel; Chen, Ying-Jiun J.; Rubenstein, John L. R.] Univ Calif San Francisco, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94158 USA; [Sasai, Yoshiki] RIKEN Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan; [Stanley, Edouard G.; Elefanty, Andrew G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Stanley, Edouard G.; Elefanty, Andrew G.] Monash Univ, MISCL, Clayton, Vic 3800, Australia	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; RIKEN; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Monash University	Kriegstein, AR (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Neurol, San Francisco, CA 94158 USA.	kriegsteina@stemcell.ucsf.edu	Ritter, Stefanie L/D-9312-2012; Elefanty, Andrew G/A-6066-2008; Stanley, Ed G/A-2985-2013	Stanley, Ed G/0000-0002-6389-3665; Southwell, Derek/0000-0001-6465-3869; Vogt, Daniel/0000-0003-1876-5936; Elefanty, Andrew/0000-0001-6448-8314; Alvarez-Buylla, Arturo/0000-0003-4426-8925	California Institute of Regenerative Medicine [RC1-00346, RB2-01602, TR2-01749]; National Institute of Neurological Disorders and Stroke; Osher Foundation; Epilepsy Foundation of Greater Los Angeles; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072630, R01NS075998] Funding Source: NIH RePORTER	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Osher Foundation; Epilepsy Foundation of Greater Los Angeles; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Baraban, R. Hunt, D. Wang, S. Gee, P. Parker, and M. Yang for electrophysiology guidance and discussion. We thank D. Hansen, J. Lui, M. Oldham, M. Paredes, C. Harwell, X. Wang, S. Wang, Y. Wang, S. Hart, R. Romero, T. Nguyen, and W. Walantus for helpful discussion, gene expression, cell culture, tissue procurement, processing, and technical assistance. We thank K. Probst for graphical design. We thank M. Ramalho-Santos and Y. Ohi for hiPSC lines, K. Deisseroth for the ChR2-EYFP plasmid, and K. Yoshikawa for the DLX2 antibody. We thank the staff and faculty at the San Francisco General Hospital Women's Options Center and at Advanced Bioscience Resources who assisted in human fetal tissue collection. This work was supported by the California Institute of Regenerative Medicine (RC1-00346 to A.R.K., RB2-01602 to J.L.R.R., and TR2-01749 to A.A.-B.), the National Institute of Neurological Disorders and Stroke, and the Osher Foundation. J.C. is a recipient of the CARE & CURE Pediatric Epilepsy Fellowship from Epilepsy Foundation of Greater Los Angeles. A.G.E. and E.G.S. are Senior Research Fellows of the National Health and Medical Research Council of Australia. C.R.N., A.A.-B., J.L.R.R., and A.R.K. are cofounders, board members, and shareholders of Neurona Therapeutics.	Anderson SA, 2001, DEVELOPMENT, V128, P353; Braz JM, 2012, NEURON, V74, P663, DOI 10.1016/j.neuron.2012.02.033; Butt SJB, 2005, NEURON, V48, P591, DOI 10.1016/j.neuron.2005.09.034; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Cheah CS, 2012, P NATL ACAD SCI USA, V109, P14646, DOI 10.1073/pnas.1211591109; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; de Lanerolle NC, 2003, EPILEPSIA, V44, P677, DOI 10.1046/j.1528-1157.2003.32701.x; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Espuny-Camacho I, 2013, NEURON, V77, P440, DOI 10.1016/j.neuron.2012.12.011; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Fertuzinhos S, 2009, CEREB CORTEX, V19, P2196, DOI 10.1093/cercor/bhp009; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Goldberg EM, 2011, CEREB CORTEX, V21, P666, DOI 10.1093/cercor/bhq138; Goulburn AL, 2011, STEM CELLS, V29, P462, DOI 10.1002/stem.587; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; Kim C, 2013, NATURE, V494, P105, DOI 10.1038/nature11799; Kim JE, 2011, P NATL ACAD SCI USA, V108, P3005, DOI 10.1073/pnas.1007753108; Kriegstein AR, 2003, GLIA, V43, P37, DOI 10.1002/glia.10250; Le Magueresse C, 2013, NEURON, V77, P388, DOI 10.1016/j.neuron.2013.01.011; Li XJ, 2009, DEVELOPMENT, V136, P4055, DOI 10.1242/dev.036624; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Ma LX, 2012, CELL STEM CELL, V10, P455, DOI 10.1016/j.stem.2012.01.021; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Maroof AM, 2010, J NEUROSCI, V30, P4667, DOI 10.1523/JNEUROSCI.4255-09.2010; Martinez-Cerdeno V, 2010, CELL STEM CELL, V6, P238, DOI 10.1016/j.stem.2010.01.004; Miyoshi G, 2007, J NEUROSCI, V27, P7786, DOI 10.1523/JNEUROSCI.1807-07.2007; Moore AR, 2009, CEREB CORTEX, V19, P1795, DOI 10.1093/cercor/bhn206; Nobrega-Pereira S, 2010, J NEUROSCI, V30, P2824, DOI 10.1523/JNEUROSCI.4023-09.2010; Rallu M, 2002, NAT REV NEUROSCI, V3, P943, DOI 10.1038/nrn989; ROBBINS RJ, 1991, ANN NEUROL, V29, P325, DOI 10.1002/ana.410290316; Schmandt T, 2005, STEM CELLS DEV, V14, P55, DOI 10.1089/scd.2005.14.55; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Shimamura K, 1997, DEVELOPMENT, V124, P2709; Sousa VH, 2009, CEREB CORTEX, V19, pI1, DOI 10.1093/cercor/bhp038; Southwell DG, 2012, NATURE, V491, P109, DOI 10.1038/nature11523; Southwell DG, 2010, SCIENCE, V327, P1145, DOI 10.1126/science.1183962; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Wang YL, 2011, NEURON, V69, P61, DOI 10.1016/j.neuron.2010.12.005; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Zaitsev AV, 2009, CEREB CORTEX, V19, P1597, DOI 10.1093/cercor/bhn198; Zhao Y, 2008, J COMP NEUROL, V510, P79, DOI 10.1002/cne.21772	45	359	367	1	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 2	2013	12	5					573	586		10.1016/j.stem.2013.04.005	http://dx.doi.org/10.1016/j.stem.2013.04.005			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VE	23642366	Green Accepted, Bronze			2022-12-28	WOS:000329569600013
J	Yamaji, M; Ueda, J; Hayashi, K; Ohta, H; Yabuta, Y; Kurimoto, K; Nakato, R; Yamada, Y; Shirahige, K; Saitou, M				Yamaji, Masashi; Ueda, Jun; Hayashi, Katsuhiko; Ohta, Hiroshi; Yabuta, Yukihiro; Kurimoto, Kazuki; Nakato, Ryuichiro; Yamada, Yasuhiro; Shirahige, Katsuhiko; Saitou, Mitinori			PRDM14 Ensures Naive Pluripotency through Dual Regulation of Signaling and Epigenetic Pathways in Mouse Embryonic Stem Cells	CELL STEM CELL			English	Article							SELF-RENEWAL; DNA METHYLATION; GROUND-STATE; ES CELLS; DIFFERENTIATION; LINEAGE; CULTURE; TARGET; DNMT3B; GENES	In serum, mouse embryonic stem cells (mESCs) fluctuate between a naive inner cell mass (ICM)-like state and a primed epiblast-like state, but when cultured with inhibitors of the mitogen-activated protein kinase (MAPK) and glycogen synthase kinase 3 pathways (2i), they are harnessed exclusively in a distinct naive pluropotent state, the ground state, that more faithfully recapitulates the ICM. Understanding the mechanism underlying this naive pluripotent state will be critical for realizing the full potential of ESCs. We show here that PRDM14, a PR-domain-containing transcriptional regulator, ensures naive pluripotency through a dual mechanism: antagonizing activation of the fibroblast growth factor receptor (FGFR) signaling by the core pluripotency transcriptional circuitry, and repressing expression of de novo DNA methyltransferases that modify the epigenome to a primed epiblast-like state. PRDM14 exerts these effects by recruiting polycomb repressive complex 2 (PRC2) specifically to key targets and repressing their expression.	[Yamaji, Masashi; Hayashi, Katsuhiko; Ohta, Hiroshi; Yabuta, Yukihiro; Kurimoto, Kazuki; Saitou, Mitinori] Kyoto Univ, Grad Sch Med, Dept Anat & Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; [Yamaji, Masashi; Ohta, Hiroshi; Yabuta, Yukihiro; Kurimoto, Kazuki; Saitou, Mitinori] CREST ERATO, JST, Sakyo Ku, Kyoto 6068501, Japan; [Ueda, Jun; Saitou, Mitinori] RIKEN Ctr Dev Biol, Lab Mammalian Germ Cell Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Ueda, Jun] Osaka Univ, Microbial Dis Res Inst, Ctr Genet Anal Biol Responses, Suita, Osaka 5650871, Japan; [Hayashi, Katsuhiko] PRESTO, JST, Sakyo Ku, Kyoto 6068501, Japan; [Hayashi, Katsuhiko; Yamada, Yasuhiro; Saitou, Mitinori] Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Reprogramming Sci, Sakyo Ku, Kyoto 6068507, Japan; [Nakato, Ryuichiro; Shirahige, Katsuhiko] Univ Tokyo, Lab Genome Struct & Funct, Res Ctr Epigenet Dis, Inst Mol & Cellular Biosci,Bunkyo Ku, Tokyo 1130032, Japan; [Yamada, Yasuhiro; Saitou, Mitinori] Kyoto Univ, Inst Integrated Cell Mat Sci, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; Japan Science & Technology Agency (JST); RIKEN; Osaka University; Japan Science & Technology Agency (JST); Kyoto University; University of Tokyo; Kyoto University	Saitou, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Anat & Cell Biol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	saitou@anat2.med.kyoto-u.ac.jp	Yamaji, Masashi/ABA-5267-2020; Nakato, Ryuichiro/AAV-6405-2020; Ueda, Jun/AAX-9704-2020	Yamaji, Masashi/0000-0002-8215-2184; Nakato, Ryuichiro/0000-0003-3019-5817; Ueda, Jun/0000-0002-9766-203X; Shirahige, Katsuhiko/0000-0002-7862-1144	Ministry of Education, Culture, Sports, Science, and Technology of Japan; JST-CREST/ERATO; Takeda Science Foundation; Uehara Memorial Foundation; Mitsubishi Foundation; Grants-in-Aid for Scientific Research [24681039] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST-CREST/ERATO; Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Mitsubishi Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to S. Yamanaka and M. Koyanagi for the anti-DNMT3L antibody, H. Kimura for the anti-H3K27Ac antibody, H. Niwa for the pBRPyCAG and pPyCAG-IRESneo/pac plasmids, M. Okano for the Dnmt3a2 and Dnmt3b1 expression plasmids and Dnmt TKO ESCs, K. Hata for the Dnmt3l expression plasmid, M. S. H. Ko for the Tcl1 expression plasmid, Y. Katou and S. Fukuzawa for assistance, and I. Oinuma and H. Harada for their comments and suggestions. We also thank R. Kabata, S. Ohsako, N. Konishi, K. Nakagawa, and K. Osugi for assistance. The authors were supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, by JST-CREST/ERATO, by the Takeda Science Foundation, by the Uehara Memorial Foundation, and by the Mitsubishi Foundation.	[Anonymous], 2010, R LANG ENV STAT COMP; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Cull MG, 2000, METHOD ENZYMOL, V326, P430; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Katou Y, 2006, METHOD ENZYMOL, V409, P389, DOI 10.1016/S0076-6879(05)09023-3; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Kurimoto K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl050; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; Laine J, 2000, MOL CELL, V6, P395, DOI 10.1016/S1097-2765(00)00039-3; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Ma ZY, 2011, NAT STRUCT MOL BIOL, V18, P120, DOI 10.1038/nsmb.2000; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Oda M, 2006, GENE DEV, V20, P3382, DOI 10.1101/gad.1470906; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Pekarsky Y, 2000, P NATL ACAD SCI USA, V97, P3028, DOI 10.1073/pnas.040557697; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rossant J, 2011, DEV CELL, V21, P20, DOI 10.1016/j.devcel.2011.06.010; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Smithies O, 2005, NAT REV GENET, V6, P419, DOI 10.1038/nrg1605; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Tsuneyoshi N, 2008, BIOCHEM BIOPH RES CO, V367, P899, DOI 10.1016/j.bbrc.2007.12.189; Wadhwa PD, 2009, SEMIN REPROD MED, V27, P358, DOI 10.1055/s-0029-1237424; Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032	48	218	227	0	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 7	2013	12	3					368	382		10.1016/j.stem.2012.12.012	http://dx.doi.org/10.1016/j.stem.2012.12.012			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VC	23333148	Bronze			2022-12-28	WOS:000329569400014
J	Bazzoli, E; Pulvirenti, T; Oberstadt, MC; Perna, F; Wee, B; Schultz, N; Huse, JT; Fomchenko, EI; Voza, F; Tabar, V; Brennan, CW; DeAngelis, LM; Nimer, SD; Holland, EC; Squatrito, M				Bazzoli, Elena; Pulvirenti, Teodoro; Oberstadt, Moritz C.; Perna, Fabiana; Wee, Boyoung; Schultz, Nikolaus; Huse, Jason T.; Fomchenko, Elena I.; Voza, Francesca; Tabar, Viviane; Brennan, Cameron W.; DeAngelis, Lisa M.; Nimer, Stephen D.; Holland, Eric C.; Squatrito, Massimo			MEF Promotes Stemness in the Pathogenesis of Gliomas	CELL STEM CELL			English	Article							SELF-RENEWAL; CELLS; TUMORIGENICITY; EXPRESSION	High-grade gliomas are aggressive and uniformly fatal tumors, composed of a heterogeneous population of cells that include many with stem-cell-like properties. The acquisition of stem-like traits might contribute to glioma initiation, growth, and recurrence. Here we investigated the role of the transcription factor myeloid Elf-1 like factor (MEF, also known as ELF4) in gliomas. We found that MEF is highly expressed in both human and mouse glioblastomas and its absence impairs gliomagenesis in a PDGF-driven glioma mouse model. We show that modulation of MEF levels in both mouse neural stem cells and human glioblastoma cells has a significant impact on neurosphere formation. Moreover, we identify Sox2 as a direct downstream target of MEF. Taken together, our studies implicate MEF as a previously unrecognized gatekeeper gene in gliomagenesis that promotes stem cell characteristics through Sox2 activation.	[Bazzoli, Elena; Oberstadt, Moritz C.; Wee, Boyoung; Fomchenko, Elena I.; Holland, Eric C.; Squatrito, Massimo] Azienda Osped Univ lntegrata, Canc Biol & Genet Program, I-37134 Verona, Italy; [Bazzoli, Elena; Oberstadt, Moritz C.; Wee, Boyoung; Huse, Jason T.; Fomchenko, Elena I.; Brennan, Cameron W.; DeAngelis, Lisa M.; Nimer, Stephen D.; Holland, Eric C.; Squatrito, Massimo] Azienda Osped Univ lntegrata, Brain Tumor Ctr, I-37134 Verona, Italy; [Bazzoli, Elena; DeAngelis, Lisa M.] Azienda Osped Univ lntegrata, Dept Neurol, I-37134 Verona, Italy; [Bazzoli, Elena] Azienda Osped Univ lntegrata, Dept Neurol Neuropsychol Morphol & Motor Sci, I-37134 Verona, Italy; [Pulvirenti, Teodoro] Ernst Moritz Arndt Univ Greifswald, Cell Biol Program, D-17487 Greifswald, Germany; [Oberstadt, Moritz C.] Ernst Moritz Arndt Univ Greifswald, Dept Pharmacol, D-17487 Greifswald, Germany; [Bazzoli, Elena; Perna, Fabiana; Voza, Francesca; Nimer, Stephen D.] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10021 USA; [Schultz, Nikolaus] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10021 USA; [Huse, Jason T.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Tabar, Viviane; Brennan, Cameron W.; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10021 USA	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Holland, EC (corresponding author), Azienda Osped Univ lntegrata, Canc Biol & Genet Program, I-37134 Verona, Italy.	hollande@mskcc.org; msquatrito@cnio.es	Schultz, Nikolaus/ABE-6347-2020; Brennan, Cameron/R-7082-2019; Pulvirenti, Teodoro/AAJ-7661-2020; Squatrito, Massimo/F-4149-2016	Brennan, Cameron/0000-0003-4064-8891; Pulvirenti, Teodoro/0000-0001-9342-6614; Squatrito, Massimo/0000-0002-4593-3790; Schultz, Nikolaus/0000-0002-0131-4904; DeAngelis, Lisa/0000-0002-6290-7818; Perna, Fabiana/0000-0002-3744-8672	National Brain Tumor Foundation [RO1-DK52208, U54CAI43798, UO1CA141502, RO1CA100688]; Brain Tumor Center of Memorial Sloan-Kettering Cancer Center; Rottendorf Foundation, Ennigerloh, Germany; Gerhard Domagk Scholarship Program, Greifswald, Germany; NATIONAL CANCER INSTITUTE [U54CA163167, U01CA141502, R01CA100688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052208] Funding Source: NIH RePORTER	National Brain Tumor Foundation; Brain Tumor Center of Memorial Sloan-Kettering Cancer Center; Rottendorf Foundation, Ennigerloh, Germany; Gerhard Domagk Scholarship Program, Greifswald, Germany; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Finney and Q. Zhang for technical assistance. We extend thanks to Dr. L. Abrey as well as to all members of Dr. E. Holland's and Dr. S. Nimer's laboratories for their helpful comments and suggestions. We sincerely thank Prof. F.H. Gage for providing the Sox2-promoter-driven luciferase construct, Dr. E.P. Papapetrou for providing the human pLM-YS SOX2 vector, and G. Sashida for providing the pBabe-Puro-lentivirus MEF vector and the pLKO.1-Puro-lentivirus vector containing mouse Mef-specific shRNA. This work was supported by a grant from National Brain Tumor Foundation, RO1-DK52208 grant (S.D.N.), and U54CAI43798, UO1CA141502 and RO1CA100688 grants (E.C.H). E.B. has been supported by Brain Tumor Center of Memorial Sloan-Kettering Cancer Center. M.C.O. has been supported by the Rottendorf Foundation, Ennigerloh, Germany, and the Gerhard Domagk Scholarship Program, Greifswald, Germany. This work is dedicated to the memory of Dr. Mark A. Zatzkis, a dear friend of S.D.N., who died of a GBM in 2007.	Barrett LE, 2012, CANCER CELL, V21, P11, DOI 10.1016/j.ccr.2011.11.025; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Charles NA, 2011, GLIA, V59, P1169, DOI 10.1002/glia.21136; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Denysenko T, 2010, CELL BIOCHEM FUNCT, V28, P343, DOI 10.1002/cbf.1666; Fukushima T, 2003, LEUKEMIA RES, V27, P387, DOI 10.1016/S0145-2126(02)00214-X; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Holmberg J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018454; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Kuwabara T, 2004, CELL, V116, P779, DOI 10.1016/S0092-8674(04)00248-X; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Mikkers H, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459b; Nam HS, 2009, CELL STEM CELL, V5, P515, DOI 10.1016/j.stem.2009.08.017; Ozawa T, 2010, GENE DEV, V24, P2205, DOI 10.1101/gad.1972310; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Patel M, 2010, STEM CELL REV REP, V6, P367, DOI 10.1007/s12015-010-9123-8; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Pulvirenti T, 2011, CANCER RES, V71, P7280, DOI 10.1158/0008-5472.CAN-11-1531; Sashida G, 2010, CELL CYCLE, V9, P3457, DOI 10.4161/cc.9.17.13000; Sashida G, 2009, MOL CELL BIOL, V29, P3687, DOI 10.1128/MCB.01551-08; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Uht RM, 2007, ONCOGENE, V26, P2885, DOI 10.1038/sj.onc.1210090; Venere M, 2011, GLIA, V59, P1148, DOI 10.1002/glia.21185; Verhaak RG, 2010, CANCER CELL, V17, P98; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wiebe MS, 2000, GENE, V246, P383, DOI 10.1016/S0378-1119(00)00086-X	31	29	32	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 7	2012	11	6					836	844		10.1016/j.stem.2012.09.012	http://dx.doi.org/10.1016/j.stem.2012.09.012			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	055MJ	23217424	Green Accepted, Bronze			2022-12-28	WOS:000312420300014
J	Laskowski, AI; Knoepfler, PS				Laskowski, Agnieszka I.; Knoepfler, Paul S.			Utf1: Goldilocks for ESC Bivalency	CELL STEM CELL			English	Editorial Material							EMBRYONIC STEM-CELLS	Recently in Cell, Jia et al. (2012) reported novel Utf1-controlled mechanisms of maintaining pluripotency and self-renewal in embryonic stem cells (ESCs). Utf1 buffers bivalent gene expression by competitive binding with polycomb repressive complex 2 and initiation of mRNA degradation.	[Laskowski, Agnieszka I.; Knoepfler, Paul S.] Univ Calif Davis, Sch Med, Dept Cell Biol & Human Anat, Sacramento, CA 95817 USA; [Laskowski, Agnieszka I.; Knoepfler, Paul S.] Univ Calif Davis, Sch Med, Inst Regenerat Cures, Sacramento, CA 95817 USA; [Laskowski, Agnieszka I.; Knoepfler, Paul S.] Shriners Hosp Children No Calif, Inst Pediat Regenerat Med, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis	Knoepfler, PS (corresponding author), Univ Calif Davis, Sch Med, Dept Cell Biol & Human Anat, Sacramento, CA 95817 USA.	knoepfler@ucdavis.edu		Knoepfler, Paul/0000-0001-5444-334X	NIGMS NIH HHS [R01 GM100782] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100782] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Jia JL, 2012, CELL, V151, P576, DOI 10.1016/j.cell.2012.09.023; Ling SHM, 2011, WIRES RNA, V2, P193, DOI 10.1002/wrna.44; Nishimoto M, 1999, MOL CELL BIOL, V19, P5453; Okuda A, 1998, EMBO J, V17, P2019, DOI 10.1093/emboj/17.7.2019; van den Boom V, 2007, J CELL BIOL, V178, P913, DOI 10.1083/jcb.200702058; Varlakhanova NV, 2010, DIFFERENTIATION, V80, P9, DOI 10.1016/j.diff.2010.05.001; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	10	6	6	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	DEC 7	2012	11	6					732	734		10.1016/j.stem.2012.11.012	http://dx.doi.org/10.1016/j.stem.2012.11.012			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	055MJ	23217417	Green Accepted, Bronze			2022-12-28	WOS:000312420300004
J	Parmar, K; D'Andrea, AD				Parmar, Kalindi; D'Andrea, Alan D.			Stressed Out: Endogenous Aldehydes Damage Hematopoietic Stem Cells	CELL STEM CELL			English	Editorial Material							DEFECTS; REPAIR; FANCD2; MICE	Despite a well-defined role for the Fanconi anemia (FA) pathway in mediating DNA repair, the mechanisms underlying the bone marrow failure in FA patients are poorly defined. Recently in Nature, Garaycoechea et al. (2012), identify aldehyde-mediated genotoxicity of hematopoietic stem cells as a cause for bone marrow failure.	[Parmar, Kalindi; D'Andrea, Alan D.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	D'Andrea, AD (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Radiat Oncol, 450 Brookline Ave, Boston, MA 02215 USA.	alan_dandrea@dfci.harvard.edu			NHLBI NIH HHS [P01 HL048546, R37 HL052725] Funding Source: Medline; NIDDK NIH HHS [R01 DK043889] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048546, R37HL052725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043889] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ceccaldi R, 2012, CELL STEM CELL, V11, P36, DOI 10.1016/j.stem.2012.05.013; Crossan GP, 2011, NAT GENET, V43, P147, DOI 10.1038/ng.752; Garaycoechea JI, 2012, NATURE, V489, P571, DOI 10.1038/nature11368; Kim H, 2012, GENE DEV, V26, P1393, DOI 10.1101/gad.195248.112; Langevin F, 2011, NATURE, V475, P53, DOI 10.1038/nature10192; Niedernhofer LJ, 2008, DNA REPAIR, V7, P523, DOI 10.1016/j.dnarep.2007.11.012; Parmar K, 2010, STEM CELLS, V28, P1186, DOI 10.1002/stem.437; Parmar K, 2009, MUTAT RES-FUND MOL M, V668, P133, DOI 10.1016/j.mrfmmm.2009.03.015; Zhang QS, 2010, BLOOD, V116, P5140, DOI 10.1182/blood-2010-04-278226	9	8	8	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 2	2012	11	5					583	584		10.1016/j.stem.2012.10.007	http://dx.doi.org/10.1016/j.stem.2012.10.007			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	042LE	23122283	Bronze			2022-12-28	WOS:000311471900002
J	Buganim, Y; Itskovich, E; Hu, YC; Cheng, AW; Ganz, K; Sarkar, S; Fu, DD; Welstead, GG; Page, DC; Jaenisch, R				Buganim, Yosef; Itskovich, Elena; Hu, Yueh-Chiang; Cheng, Albert W.; Ganz, Kibibi; Sarkar, Sovan; Fu, Dongdong; Welstead, G. Grant; Page, David C.; Jaenisch, Rudolf			Direct Reprogramming of Fibroblasts into Embryonic Sertoli-like Cells by Defined Factors	CELL STEM CELL			English	Article							EXTRACELLULAR-MATRIX COMPONENTS; STEM-CELLS; SEX DETERMINATION; SEMINIFEROUS TUBULES; MICROARRAY DATA; IN-VITRO; DIFFERENTIAL EXPRESSION; DOPAMINERGIC-NEURONS; GENE-EXPRESSION; TRANSGENIC MICE	Sertoli cells are considered the "supporting cells" of the testis that play an essential role in sex determination during embryogenesis and in spermatogenesis during adulthood. Their essential roles in male fertility along with their immunosuppressive and neurotrophic properties make them an attractive cell type for therapeutic applications. Here we demonstrate the generation of induced embryonic Sertoli-like cells (ieSCs) by ectopic expression of five transcription factors. We characterize the role of specific transcription factor combinations in the transition from fibroblasts to ieSCs and identify key steps in the process. Initially, transduced fibroblasts underwent a mesenchymal to epithelial transition and then acquired the ability to aggregate, formed tubular-like structures, and expressed embryonic Sertoli-specific markers. These Sertoli-like cells facilitated neuronal differentiation and self-renewal of neural progenitor cells (NPCs), supported the survival of germ cells in culture, and cooperated with endogenous embryonic Sertoli and primordial germ cells in the generation of testicular cords in the fetal gonad.	[Buganim, Yosef; Itskovich, Elena; Hu, Yueh-Chiang; Cheng, Albert W.; Ganz, Kibibi; Sarkar, Sovan; Fu, Dongdong; Welstead, G. Grant; Page, David C.; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Cheng, Albert W.; Page, David C.; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02139 USA; [Hu, Yueh-Chiang; Page, David C.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Buganim, Y (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	yossib@wi.mit.edu; jaenisch@wi.mit.edu	Sarkar, Sovan/F-8486-2017; Hu, Yueh-Chiang/AAX-2370-2020	Sarkar, Sovan/0000-0002-9456-4362; Hu, Yueh-Chiang/0000-0002-7992-0525; Cheng, Albert/0000-0003-2653-5743	National Institutes of Health [R37-CA084198, RO1-HD045022]; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA084198, R01CA084198] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants R37-CA084198 and RO1-HD045022 (R.J.) and the Howard Hughes Medical Institute (D.C.P. and Y.-C.H). We thank Y. Katz for technical assistance and for commenting on the manuscript. We also thank W.C. Salmon for microscopy assistance.	Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Bouma GJ, 2010, BIOL REPROD, V82, P380, DOI 10.1095/biolreprod.109.079822; Boyer A, 2004, BIOL REPROD, V71, P820, DOI 10.1095/biolreprod.104.029371; Brennan J, 2002, DEV BIOL, V244, P418, DOI 10.1006/dbio.2002.0578; Bucay N, 2009, STEM CELLS, V27, P68, DOI 10.1634/stemcells.2007-1018; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cool J, 2011, P NATL ACAD SCI USA, V108, P167, DOI 10.1073/pnas.1010299108; daSilva SM, 1996, NAT GENET, V14, P62, DOI 10.1038/ng0996-62; DAVIS CM, 1990, BIOL REPROD, V43, P860, DOI 10.1095/biolreprod43.5.860; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Gassei K, 2008, REPRODUCTION, V136, P459, DOI 10.1530/REP-08-0241; Gassei K, 2006, J ANDROL, V27, P611, DOI 10.2164/jandrol.05207; Huang HY, 2010, CELL MED, V1, P15, DOI 10.3727/215517910X516673; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Karl J, 1998, DEV BIOL, V203, P323, DOI 10.1006/dbio.1998.9068; Kim Y, 2006, PLOS BIOL, V4, P1000, DOI 10.1371/journal.pbio.0040187; KOOPMAN P, 1990, NATURE, V348, P450, DOI 10.1038/348450a0; Mackay S, 1999, J ELECTRON MICROSC, V48, P159, DOI 10.1093/oxfordjournals.jmicro.a023662; Manuylov NL, 2007, DEV BIOL, V307, P356, DOI 10.1016/j.ydbio.2007.04.040; McLachlan RI, 1998, REPROD FERT DEVELOP, V10, P97, DOI 10.1071/R98029; Mital P, 2010, REPRODUCTION, V139, P495, DOI 10.1530/REP-09-0384; Moniot B, 2009, DEVELOPMENT, V136, P1813, DOI 10.1242/dev.032631; Nel-Themaat L, 2011, BIOL REPROD, V84, P342, DOI 10.1095/biolreprod.110.086900; Ogawa T, 1997, INT J DEV BIOL, V41, P111; R: Development Core Team, 2004, R LANG ENV FORST COM; Roussa E, 2006, STEM CELLS, V24, P2120, DOI 10.1634/stemcells.2005-0514; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sanberg PR, 1997, NAT MED, V3, P1129, DOI 10.1038/nm1097-1129; Sariola Hannu, 2008, V450, P127, DOI 10.1007/978-1-60327-214-8_9; Schmahl J, 2000, DEVELOPMENT, V127, P65; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Skinner M.K., 2005, SERTOLI CELL BIOL; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Vidal VPI, 2001, NAT GENET, V28, P216, DOI 10.1038/90046; WANG MZ, 1995, NAT MED, V1, P1184, DOI 10.1038/nm1195-1184; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Willing AE, 1998, MOL MED TODAY, V4, P471, DOI 10.1016/S1357-4310(98)01355-0; Yan W, 2000, J CELL SCI, V113, P161; Yue FM, 2006, STEM CELLS, V24, P1695, DOI 10.1634/stemcells.2005-0409	44	122	130	0	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 7	2012	11	3					373	386		10.1016/j.stem.2012.07.019	http://dx.doi.org/10.1016/j.stem.2012.07.019			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	018DW	22958931	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000309641300011
J	Rossi, L; Lin, KYK; Boles, NC; Yang, LB; King, KY; Jeong, M; Mayle, A; Goodell, MA				Rossi, Lara; Lin, Kuanyin K.; Boles, Nathan C.; Yang, Liubin; King, Katherine Y.; Jeong, Mira; Mayle, Allison; Goodell, Margaret A.			Less Is More: Unveiling the Functional Core of Hematopoietic Stem Cells through Knockout Mice	CELL STEM CELL			English	Review							SELF-RENEWAL; TGF-BETA; DEPENDENCE DISTINGUISHES; CRITICAL REGULATOR; TUMOR-SUPPRESSOR; PROGENITOR CELLS; FACTOR RECEPTOR; LINEAGE CHOICE; IN-VIVO; ADULT	Hematopoietic stem cells (HSCs) represent one of the first recognized somatic stem cell types. As such, nearly 200 genes have been examined for roles in HSC function in knockout mice. In this review, we compile the majority of these reports to provide a broad overview of the functional modules revealed by these genetic analyses and highlight some key regulatory pathways involved, including cell cycle control, Tgf-beta signaling, Pten/Akt signaling, Wnt signaling, and cytokine signaling. Finally, we propose recommendations for characterization of HSC function in knockout mice to facilitate cross-study comparisons that would generate a more cohesive picture of HSC biology.	[Rossi, Lara; Lin, Kuanyin K.; Boles, Nathan C.; Yang, Liubin; King, Katherine Y.; Jeong, Mira; Mayle, Allison; Goodell, Margaret A.] Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA	Baylor College of Medicine	Goodell, MA (corresponding author), Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA.	goodell@bcm.edu	King, Katherine/AAI-2436-2021	Mayle, Allison/0000-0001-5060-5487; King, Katherine/0000-0002-5093-6005; Goodell, Margaret A./0000-0003-1111-2932	Italian Leukemia and Lymphoma Association, section of Bologna (BolognaAIL);  [DK092883];  [DK060445];  [AG036562];  [CA126752];  [CA125123];  [AI007495];  [NSC100-2811-B-002-163]; NATIONAL CANCER INSTITUTE [P50CA126752, P30CA125123] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL098898, T32HL092332] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK060445, R56DK092883, R01DK092883, R01DK058192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC2AG036562, R21AG034451] Funding Source: NIH RePORTER	Italian Leukemia and Lymphoma Association, section of Bologna (BolognaAIL); ; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We apologize to those authors whose work could not be referenced or discussed owing to space limitations. Readers can add to the HSC phenotype database and obtain updated versions of Table Si at http://www.bonemarrowhsc.com/hsc-phen/. We thank all members of the Goodell lab for helping to collate Table Si, particularly Aysegul Ergen, Min Luo, Maria Imperato, Sean Cullen, Xiaotian Zhang, and Grant Challen. We acknowledge support from DK092883, DK060445, AG036562, CA126752, CA125123, AI007495, and NSC100-2811-B-002-163 (Taiwan) and the Italian Leukemia and Lymphoma Association, section of Bologna (BolognaAIL). We thank Chad Shaw and lab (BCM) for constructing the online HSC phenotype database and offering many insightful discussions.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Berthet C, 2007, MOL CELL BIOL, V27, P5079, DOI 10.1128/MCB.00029-07; Boles NC, 2011, BLOOD, V118, P80, DOI 10.1182/blood-2010-12-322339; Cancelas JA, 2005, NAT MED, V11, P886, DOI 10.1038/nm1274; Capron C, 2006, BLOOD, V107, P4678, DOI 10.1182/blood-2005-08-3145; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Chen CZ, 2002, P NATL ACAD SCI USA, V99, P15468, DOI 10.1073/pnas.202614899; Chen J, 2002, J HEMATOTH STEM CELL, V11, P905, DOI 10.1089/152581602321080565; Cheng T, 2000, NAT MED, V6, P1235, DOI 10.1038/81335; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Christopher MJ, 2009, BLOOD, V114, P1331, DOI 10.1182/blood-2008-10-184754; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; Cobrinik D, 1996, GENE DEV, V10, P1633, DOI 10.1101/gad.10.13.1633; Daria D, 2008, BLOOD, V111, P1894, DOI 10.1182/blood-2007-02-071746; de Graaf CA, 2010, P NATL ACAD SCI USA, V107, P21689, DOI 10.1073/pnas.1016166108; DiMartino JF, 2001, BLOOD, V98, P618, DOI 10.1182/blood.V98.3.618; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Feng CG, 2008, CELL STEM CELL, V2, P83, DOI 10.1016/j.stem.2007.10.007; Ficara F, 2008, CELL STEM CELL, V2, P484, DOI 10.1016/j.stem.2008.03.004; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595; Gekas C, 2005, DEV CELL, V8, P365, DOI 10.1016/j.devcel.2004.12.016; Ghiaur G, 2008, BLOOD, V111, P3313, DOI 10.1182/blood-2007-08-110114; Guo W, 2008, NATURE, V453, P529, DOI 10.1038/nature06933; Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572; Hall MA, 2003, P NATL ACAD SCI USA, V100, P992, DOI 10.1073/pnas.0237324100; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Jansen M, 2005, STEM CELLS, V23, P335, DOI 10.1634/stemcells.2004-0216; Juntilla MM, 2010, BLOOD, V115, P4030, DOI 10.1182/blood-2009-09-241000; Kang YJ, 2007, STEM CELLS, V25, P1814, DOI 10.1634/stemcells.2007-0002; Karlsson G, 2007, J EXP MED, V204, P467, DOI 10.1084/jem.20060465; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kimura S, 1998, P NATL ACAD SCI USA, V95, P1195, DOI 10.1073/pnas.95.3.1195; King KY, 2011, NAT REV IMMUNOL, V11, P685, DOI 10.1038/nri3062; King KY, 2011, BLOOD, V118, P1525, DOI 10.1182/blood-2011-01-328682; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Ko M, 2011, P NATL ACAD SCI USA, V108, P14566, DOI 10.1073/pnas.1112317108; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Kubota Y, 2009, BLOOD, V114, P4383, DOI 10.1182/blood-2009-07-230292; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Langer JC, 2004, J EXP MED, V199, P5, DOI 10.1084/jem.20030980; Larsson J, 2001, EMBO J, V20, P1663, DOI 10.1093/emboj/20.7.1663; Larsson J, 2003, BLOOD, V102, P3129, DOI 10.1182/blood-2003-04-1300; Lawrence HJ, 2005, BLOOD, V106, P3988, DOI 10.1182/blood-2005-05-2003; LeCouter JE, 1998, DEVELOPMENT, V125, P4669; Lin KYK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001148; Liu FL, 1996, IMMUNITY, V5, P491, DOI 10.1016/S1074-7613(00)80504-X; Liu Y, 2009, CELL CYCLE, V8, P3120, DOI 10.4161/cc.8.19.9627; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; Luis TC, 2011, CELL STEM CELL, V9, P345, DOI 10.1016/j.stem.2011.07.017; Luis TC, 2009, BLOOD, V113, P546, DOI 10.1182/blood-2008-06-163774; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Matsumoto A, 2011, CELL STEM CELL, V9, P262, DOI 10.1016/j.stem.2011.06.014; MCCARTHY KF, 1977, CELL TISSUE KINET, V10, P121, DOI 10.1111/j.1365-2184.1977.tb00137.x; Mercier FE, 2012, NAT REV IMMUNOL, V12, P49, DOI 10.1038/nri3132; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Min IM, 2008, CELL STEM CELL, V2, P380, DOI 10.1016/j.stem.2008.01.015; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Naramura M, 2010, P NATL ACAD SCI USA, V107, P16274, DOI 10.1073/pnas.1007575107; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; Nie YC, 2008, J EXP MED, V205, P777, DOI 10.1084/jem.20072513; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Puri MC, 2003, P NATL ACAD SCI USA, V100, P12753, DOI 10.1073/pnas.2133552100; Purton LE, 2007, CELL STEM CELL, V1, P263, DOI 10.1016/j.stem.2007.08.016; Qian H, 2007, CELL STEM CELL, V1, P671, DOI 10.1016/j.stem.2007.10.008; Qian ZJ, 2008, J EXP MED, V205, P2163, DOI 10.1084/jem.20080578; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Rathinam C, 2008, GENE DEV, V22, P992, DOI 10.1101/gad.1651408; Rathinam C, 2011, NAT IMMUNOL, V12, P399, DOI 10.1038/ni.2021; Rebel VI, 1999, J EXP MED, V190, P1493, DOI 10.1084/jem.190.10.1493; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Renstrom J, 2009, CELL STEM CELL, V5, P157, DOI 10.1016/j.stem.2009.05.020; Sandberg ML, 2005, DEV CELL, V8, P153, DOI 10.1016/j.devcel.2004.12.015; Santibanez JF, 2007, J CELL PHYSIOL, V210, P456, DOI 10.1002/jcp.20878; Sato T, 2009, NAT MED, V15, P696, DOI 10.1038/nm.1973; Schaniel C, 2011, BLOOD, V118, P2420, DOI 10.1182/blood-2010-09-305664; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Singbrant S, 2006, BLOOD, V108, P3707, DOI 10.1182/blood-2006-02-003384; Sirin O, 2010, NAT CELL BIOL, V12, P1213, DOI 10.1038/ncb2125; Sitnicka E, 1996, BLOOD, V87, P4998, DOI 10.1182/blood.V87.12.4998.bloodjournal87124998; Souroullas GP, 2009, CELL STEM CELL, V4, P180, DOI 10.1016/j.stem.2009.01.001; Stenvers KL, 2003, MOL CELL BIOL, V23, P4371, DOI 10.1128/MCB.23.12.4371-4385.2003; Stepanova L, 2005, BLOOD, V106, P827, DOI 10.1182/blood-2004-06-2242; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Sugimura R, 2012, CELL, V150, P351, DOI 10.1016/j.cell.2012.05.041; Takakura N, 1998, IMMUNITY, V9, P677, DOI 10.1016/S1074-7613(00)80665-2; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Van Os R, 2007, STEM CELLS, V25, P836, DOI 10.1634/stemcells.2006-0631; Viatour P, 2008, CELL STEM CELL, V3, P416, DOI 10.1016/j.stem.2008.07.009; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; YAMASHITA H, 1994, J BIOL CHEM, V269, P1995; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Yamazaki S, 2009, BLOOD, V113, P1250, DOI 10.1182/blood-2008-04-146480; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126; Zhang CC, 2006, P NATL ACAD SCI USA, V103, P2184, DOI 10.1073/pnas.0510577103; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhang Y, 2011, BLOOD, V118, P3853, DOI 10.1182/blood-2011-02-334680; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003; Zou P, 2011, CELL STEM CELL, V9, P247, DOI 10.1016/j.stem.2011.07.003	110	138	140	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 7	2012	11	3					302	317		10.1016/j.stem.2012.08.006	http://dx.doi.org/10.1016/j.stem.2012.08.006			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	018DW	22958929	Bronze, Green Accepted			2022-12-28	WOS:000309641300006
J	An, MC; Zhang, NZ; Scott, G; Montoro, D; Wittkop, T; Mooney, S; Melov, S; Ellerby, LM				An, Mahru C.; Zhang, Ningzhe; Scott, Gary; Montoro, Daniel; Wittkop, Tobias; Mooney, Sean; Melov, Simon; Ellerby, Lisa M.			Genetic Correction of Huntington's Disease Phenotypes in Induced Pluripotent Stem Cells	CELL STEM CELL			English	Article							HOMOLOGOUS RECOMBINATION; HUMAN ESCS; MODEL; NEURONS; DEFICITS; BDNF	Huntington's disease (HD) is caused by a CAG expansion in the huntingtin gene. Expansion of the polyglutamine tract in the huntingtin protein results in massive cell death in the striatum of HD patients. We report that human induced pluripotent stem cells (iPSCs) derived from HD patient fibroblasts can be corrected by the replacement of the expanded CAG repeat with a normal repeat using homologous recombination, and that the correction persists in iPSC differentiation into DARPP-32-positive neurons in vitro and in vivo. Further, correction of the HD-iPSCs normalized pathogenic HD signaling pathways (cadherin, TGF-beta, BDNF, and caspase activation) and reversed disease phenotypes such as susceptibility to cell death and altered mitochondrial bioenergetics in neural stem cells. The ability to make patient-specific, genetically corrected iPSCs from HD patients will provide relevant disease models in identical genetic backgrounds and is a critical step for the eventual use of these cells in cell replacement therapy.	[An, Mahru C.; Zhang, Ningzhe; Scott, Gary; Montoro, Daniel; Wittkop, Tobias; Mooney, Sean; Melov, Simon; Ellerby, Lisa M.] Buck Inst Res Aging, Novato, CA 94945 USA	Buck Institute for Research on Aging	Ellerby, LM (corresponding author), Buck Inst Res Aging, Novato, CA 94945 USA.	lellerby@buckinstitute.org	Melov, Simon/AAC-9469-2020	Montoro, Daniel/0000-0002-6222-2149; MOONEY, SEAN D/0000-0003-2654-0833; Melov, Simon/0000-0001-8554-2834	Buck Institute for Research on Aging; NIH T32 training grant [AG000266]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000266] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009722] Funding Source: NIH RePORTER	Buck Institute for Research on Aging; NIH T32 training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank Dr. Daley for providing us with the normal iPSCs (hFib2-iPS5) and HD-iPSCs (HD-iPS4). Thanks to Laragen for sequencing of iPSC clones. This work was funded by the Buck Institute for Research on Aging and NIH T32 training grant AG000266 (to M.C.A.).	Bachoud-Levi AC, 2006, LANCET NEUROL, V5, P303, DOI 10.1016/S1474-4422(06)70381-7; Battaglia G, 2011, J CELL MOL MED, V15, P555, DOI 10.1111/j.1582-4934.2010.01011.x; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Costa M, 2007, NAT PROTOC, V2, P792, DOI 10.1038/nprot.2007.105; Davis Richard P, 2009, Curr Protoc Stem Cell Biol, VChapter 5, DOI 10.1002/9780470151808.sc05b01s11; Dey ND, 2010, BEHAV BRAIN RES, V214, P193, DOI 10.1016/j.bbr.2010.05.023; Dunnett Stephen B, 2004, NeuroRx, V1, P394, DOI 10.1007/BF03206626; Frendewey D, 2010, METHOD ENZYMOL, V476, P295, DOI 10.1016/S0076-6879(10)76017-1; Gu A, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010067, 10.1371/currents.RRN1193]; Hermel E, 2004, CELL DEATH DIFFER, V11, P424, DOI 10.1038/sj.cdd.4401358; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Kandasamy M, 2010, J NEUROPATH EXP NEUR, V69, P717, DOI 10.1097/NEN.0b013e3181e4f733; Kelly CM, 2009, BIOCHEM SOC T, V37, P323, DOI 10.1042/BST0370323; Kiechle T, 2002, NEUROMOL MED, V1, P183; Ku S, 2010, CELL STEM CELL, V7, P631, DOI 10.1016/j.stem.2010.09.014; Ma LX, 2012, CELL STEM CELL, V10, P455, DOI 10.1016/j.stem.2012.01.021; Mochel F, 2011, J CLIN INVEST, V121, P493, DOI 10.1172/JCI45691; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Reis SA, 2011, HUM MOL GENET, V20, P2344, DOI 10.1093/hmg/ddr127; Ruby KM, 2009, STEM CELLS, V27, P1496, DOI 10.1002/stem.73; Sakurai K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1234; Schwarz SC, 2010, TRANSL RES, V156, P155, DOI 10.1016/j.trsl.2010.07.002; Snyder BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009347; Song H, 2010, CELL STEM CELL, V6, P80, DOI 10.1016/j.stem.2009.11.016; Squitieri F, 2011, J NEURAL TRANSM, V118, P1599, DOI 10.1007/s00702-011-0646-1; Tong YA, 2011, J NEUROSCI, V31, P14794, DOI 10.1523/JNEUROSCI.2774-11.2011; Urbach A, 2004, STEM CELLS, V22, P635, DOI 10.1634/stemcells.22-4-635; Vazey EM, 2010, CELL TRANSPLANT, V19, P1055, DOI 10.3727/096368910X494632; Wu SM, 2011, NAT CELL BIOL, V13, P497, DOI 10.1038/ncb0511-497; Ye L, 2009, P NATL ACAD SCI USA, V106, P9826, DOI 10.1073/pnas.0904689106; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581; Zuccato C, 2008, BRAIN PATHOL, V18, P225, DOI 10.1111/j.1750-3639.2007.00111.x; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	37	258	279	0	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 3	2012	11	2					253	263		10.1016/j.stem.2012.04.026	http://dx.doi.org/10.1016/j.stem.2012.04.026			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	987QQ	22748967	Green Accepted, Bronze			2022-12-28	WOS:000307432600015
J	Murphy, WJ; Nolta, JA				Murphy, William J.; Nolta, Jan A.			Autoimmune T Cells Lured to a FASL Web of Death by MSCs	CELL STEM CELL			English	Editorial Material							MESENCHYMAL STEM-CELLS; HOST		[Murphy, William J.; Nolta, Jan A.] Univ Calif Davis, Dept Internal Med, Davis, CA 95616 USA; [Murphy, William J.] Univ Calif Davis, Dept Dermatol, Davis, CA 95616 USA; [Nolta, Jan A.] Univ Calif Davis, Stem Cell Program, Davis, CA 95616 USA; [Nolta, Jan A.] Univ Calif Davis, Inst Regenerat Cures, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Nolta, JA (corresponding author), Univ Calif Davis, Dept Internal Med, Davis, CA 95616 USA.	wmjmurphy@ucdavis.edu		Nolta, Jan/0000-0003-4576-8542				Akiyama K, 2012, CELL STEM CELL, V10, P544, DOI 10.1016/j.stem.2012.03.007; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; English K, 2011, J CELL BIOCHEM, V112, P1963, DOI 10.1002/jcb.23119; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Meyerrose T, 2010, ADV DRUG DELIVER REV, V62, P1167, DOI 10.1016/j.addr.2010.09.013; Nauta AJ, 2006, BLOOD, V108, P2114, DOI 10.1182/blood-2005-11-011650; Reich-Zeliger S, 2007, J IMMUNOL, V179, P6389, DOI 10.4049/jimmunol.179.10.6389; Ren GW, 2009, STEM CELLS, V27, P1954, DOI 10.1002/stem.118; Tolar J, 2010, STEM CELLS, V28, P1446, DOI 10.1002/stem.459	9	4	4	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 4	2012	10	5					485	487		10.1016/j.stem.2012.04.013	http://dx.doi.org/10.1016/j.stem.2012.04.013			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	944WN	22560070	Bronze			2022-12-28	WOS:000304234600004
J	Arnold, K; Sarkar, A; Yram, MA; Polo, JM; Bronson, R; Sengupta, S; Seandel, M; Geijsen, N; Hochedlinger, K				Arnold, Katrin; Sarkar, Abby; Yram, Mary Anna; Polo, Jose M.; Bronson, Rod; Sengupta, Sumitra; Seandel, Marco; Geijsen, Niels; Hochedlinger, Konrad			Sox2(+) Adult Stem and Progenitor Cells Are Important for Tissue Regeneration and Survival of Mice	CELL STEM CELL			English	Article							SELF-RENEWAL; IN-VITRO; EXPRESSION; MARKER; DIFFERENTIATION; INDUCTION; SPERMATOGENESIS; IDENTIFICATION; PLURIPOTENCY; MULTIPOTENT	The transcription factor Sox2 maintains the pluripotency of early embryonic cells and regulates the formation of several epithelia during fetal development. Whether Sox2 continues to play a role in adult tissues remains largely unknown. We show here that Sox2 marks adult cells in several epithelial tissues where its expression has not previously been characterized, including the stomach, cervix, anus, testes, lens, and multiple glands. Genetic lineage tracing and transplantation experiments demonstrate that Sox2-expressing cells continuously give rise to mature cell types within these tissues, documenting their self-renewal and differentiation potentials. Consistent with these findings, ablation of Sox2(+) cells in mice results in a disruption of epithelial tissue homeostasis and lethality. Developmental fate mapping reveals that Sox2(+) adult stem cells originate from fetal Sox2(+) tissue progenitors. Thus, our results identify Sox2 expression in numerous adult endodermal and ectodermal stem cell compartments, which are critical for normal tissue regeneration and survival.	[Arnold, Katrin; Sarkar, Abby; Yram, Mary Anna; Polo, Jose M.; Hochedlinger, Konrad] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Arnold, Katrin; Sarkar, Abby; Yram, Mary Anna; Polo, Jose M.; Hochedlinger, Konrad] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Arnold, Katrin; Sarkar, Abby; Yram, Mary Anna; Polo, Jose M.; Hochedlinger, Konrad] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Arnold, Katrin; Sarkar, Abby; Yram, Mary Anna; Polo, Jose M.; Geijsen, Niels; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Arnold, Katrin; Sarkar, Abby; Yram, Mary Anna; Polo, Jose M.; Geijsen, Niels; Hochedlinger, Konrad] Ctr Regenerat Med, Boston, MA 02114 USA; [Arnold, Katrin; Sarkar, Abby; Yram, Mary Anna; Polo, Jose M.; Geijsen, Niels; Hochedlinger, Konrad] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Bronson, Rod] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02215 USA; [Sengupta, Sumitra; Seandel, Marco] Weill Cornell Med Coll, Dept Surg, New York, NY 10065 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School; Cornell University	Hochedlinger, K (corresponding author), Harvard Univ, Howard Hughes Med Inst, 7 Divin Ave, Cambridge, MA 02138 USA.	khochedlinger@helix.mgh.harvard.edu	Sengupta, Sumitra/G-1814-2017	Sengupta, Sumitra/0000-0003-2861-5608; Sarkar, Abby/0000-0001-6101-1721; Polo, Jose M/0000-0002-2531-778X	Harvard Stem Cell Institute; NIH [R01HD058013-01A1]; Kimmel Foundation for Cancer Research; V Foundation for Cancer Research; MGH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058013] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD003266] Funding Source: NIH RePORTER	Harvard Stem Cell Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kimmel Foundation for Cancer Research; V Foundation for Cancer Research; MGH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Laura Prickett-Rice and Kat Folz-Donahoe for assistance with FACS, and Markus Schober, Nimet Maherali, and Matthias Stadtfeld for helpful discussions and critical reading of the manuscript. K.A. and K.H. were supported by a Seed Grant from the Harvard Stem Cell Institute. Additional support to K.H. was from the NIH Director's Innovator Award R01HD058013-01A1, the Kimmel and V Foundations for Cancer Research, and MGH startup funds.	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V7, P656, DOI 10.1016/j.stem.2010.11.016; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bjerknes M, 2002, AM J PHYSIOL-GASTR L, V283, pG767, DOI 10.1152/ajpgi.00415.2001; Brazel CY, 2005, AGING CELL, V4, P197, DOI 10.1111/j.1474-9726.2005.00158.x; Breault DT, 2008, P NATL ACAD SCI USA, V105, P10420, DOI 10.1073/pnas.0804800105; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Chen YT, 2000, GENESIS, V28, P31, DOI 10.1002/1526-968X(200009)28:1<31::AID-GENE40>3.0.CO;2-K; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Fauquier T, 2008, P NATL ACAD SCI USA, V105, P2907, DOI 10.1073/pnas.0707886105; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Graw J, 2010, CURR TOP DEV BIOL, V90, P343, DOI 10.1016/S0070-2153(10)90010-0; Imamura M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-34; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Kamachi Y, 1998, DEVELOPMENT, V125, P2521; KARAM SM, 1993, ANAT REC, V236, P259, DOI 10.1002/ar.1092360202; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Ko K, 2009, CELL STEM CELL, V5, P87, DOI 10.1016/j.stem.2009.05.025; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Lombaert IMA, 2010, FRONT ORAL BIOL, V14, P90, DOI 10.1159/000313709; Mansukhani A, 2005, J CELL BIOL, V168, P1065, DOI 10.1083/jcb.200409182; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Okubo T, 2006, GENE DEV, V20, P2654, DOI 10.1101/gad.1457106; Okubo T, 2009, STEM CELLS, V27, P442, DOI 10.1634/stemcells.2008-0611; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; Que JW, 2009, DEVELOPMENT, V136, P1899, DOI 10.1242/dev.034629; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sangiorgi E, 2009, P NATL ACAD SCI USA, V106, P7101, DOI 10.1073/pnas.0902508106; Shinohara T, 2000, P NATL ACAD SCI USA, V97, P8346, DOI 10.1073/pnas.97.15.8346; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Tian H., 2011, NATURE IN PRESS, DOI [10.1038/nature10408, DOI 10.1038/NATURE10408]; Yamada S, 2006, ENDOCR J, V53, P789, DOI 10.1507/endocrj.K06-116; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yoshida S, 2010, DEV GROWTH DIFFER, V52, P311, DOI 10.1111/j.1440-169X.2010.01174.x	46	494	515	2	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	OCT 7	2011	9	4					317	329		10.1016/j.stem.2011.09.001	http://dx.doi.org/10.1016/j.stem.2011.09.001			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	835MT	21982232	Green Accepted, Bronze			2022-12-28	WOS:000296041200010
J	Itskovitz-Eldor, J				Itskovitz-Eldor, Joseph			A Panel of Glycan Cell Surface Markers Define Pluripotency State and Promote Safer Cell-Based Therapies	CELL STEM CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; ANTIBODY		Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Dept Obstet & Gynecol, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Itskovitz-Eldor, J (corresponding author), Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Dept Obstet & Gynecol, Rambam Hlth Care Campus, IL-31096 Haifa, Israel.	itskovitz@rambam.health.gov.il						Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Fong CY, 2009, STEM CELL REV REP, V5, P72, DOI 10.1007/s12015-009-9054-4; Goldring CEP, 2011, CELL STEM CELL, V8, P618, DOI 10.1016/j.stem.2011.05.012; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hentze H, 2009, STEM CELL RES, V2, P198, DOI 10.1016/j.scr.2009.02.002; Liang YJ, 2010, P NATL ACAD SCI USA, V107, P22564, DOI 10.1073/pnas.1007290108; Schuldiner M, 2003, STEM CELLS, V21, P257, DOI 10.1634/stemcells.21-3-257; Tan HL, 2009, STEM CELLS, V27, P1792, DOI 10.1002/stem.109; Tang C, 2011, NAT BIOTECHNOL, V29, P829, DOI 10.1038/nbt.1947	10	6	8	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	OCT 7	2011	9	4					291	292		10.1016/j.stem.2011.09.005	http://dx.doi.org/10.1016/j.stem.2011.09.005			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	835MT	21982227	Bronze			2022-12-28	WOS:000296041200005
J	Luis, TC; Naber, BAE; Roozen, PPC; Brugman, MH; de Haas, EFE; Ghazvini, M; Fibbe, WE; van Dongen, JJM; Fodde, R; Staal, FJT				Luis, Tiago C.; Naber, Brigitta A. E.; Roozen, Paul P. C.; Brugman, Martijn H.; de Haas, Edwin F. E.; Ghazvini, Mehrnaz; Fibbe, Willem E.; van Dongen, Jacques J. M.; Fodde, Riccardo; Staal, Frank J. T.			Canonical Wnt Signaling Regulates Hematopoiesis in a Dosage-Dependent Fashion	CELL STEM CELL			English	Article							STEM-CELL FUNCTION; BETA-CATENIN IMPAIRS; SELF-RENEWAL; MOUSE DEVELOPMENT; APC; DIFFERENTIATION; MODEL; TRANSCRIPTION; EXPRESSION; ACTIVATION	Canonical Wnt signaling has been implicated in the regulation of hematopoiesis. By employing a Wnt-reporter mouse, we observed that Wnt signaling is differentially activated during hematopoiesis, suggesting an important regulatory role for specific Wnt signaling levels. To investigate whether canonical Wnt signaling regulates hematopoiesis in a dosage-dependent fashion, we analyzed the effect of different mutations in the Adenomatous polyposis coli gene (Apc), a negative modulator of the canonical Wnt pathway. By combining different targeted hypomorphic alleles and a conditional deletion allele of Apc, a gradient of five different Wnt signaling levels was obtained in vivo. We here show that different, lineage-specific Wnt dosages regulate hematopoietic stem cells (HSCs), myeloid precursors, and T lymphoid precursors during hematopoiesis. Differential, lineage-specific optimal Wnt dosages provide a unifying concept that explains the differences reported among inducible gain-of-function approaches, leading to either HSC expansion or depletion of the HSC pool.	[Luis, Tiago C.; Naber, Brigitta A. E.; de Haas, Edwin F. E.; van Dongen, Jacques J. M.; Staal, Frank J. T.] Erasmus Univ, Erasmus MC, Dept Immunol, Med Ctr, NL-3015 CE Rotterdam, Netherlands; [Luis, Tiago C.; Naber, Brigitta A. E.; Roozen, Paul P. C.; Brugman, Martijn H.; Fibbe, Willem E.; Staal, Frank J. T.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2333 ZA Leiden, Netherlands; [Ghazvini, Mehrnaz; Fodde, Riccardo] Erasmus Univ, Med Ctr, Erasmus MC, Dept Pathol,Josephine Nefkens Inst, NL-3015 CE Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC	Staal, FJT (corresponding author), Erasmus Univ, Erasmus MC, Dept Immunol, Med Ctr, NL-3015 CE Rotterdam, Netherlands.	f.j.t.staal@lumc.nl	van Dongen, Jacques J.M./F-8537-2015; Fodde, Riccardo/AAW-9394-2021; Brugman, Martijn/F-3389-2011	van Dongen, Jacques J.M./0000-0001-7686-0021; Fodde, Riccardo/0000-0001-9839-4324; Brugman, Martijn/0000-0003-2675-2705; van Dongen, Jacques J.M./0000-0002-3650-7087; Ghazvini, Mehrnaz/0000-0001-7859-6930; Cunha Luis, Tiago/0000-0002-6305-1257; Naber, Brigitta/0000-0002-0031-6086	Fundacao para a Ciencia e a Tecnologia, Portugal; Association of International Cancer Research (AICR); The Netherlands Organization for Health Research and Development [ZonMW 40-00812-98-09050]; Dutch Cancer Society; Dutch Government [03038]; EU; TuMIC	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Association of International Cancer Research (AICR); The Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Dutch Cancer Society(KWF Kankerbestrijding); Dutch Government; EU(European Commission); TuMIC	We acknowledge Prof. Dr. L. Parreira (Lisbon, Portugal) for continuous support and discussions and Dr. Bjorn Claussen for help with the Ctnb1<SUP>Delta ex3</SUP> mouse experiments. T.C.L. is supported by "Fundacao para a Ciencia e a Tecnologia, Portugal." F.J.T.S. is supported in part by the Association of International Cancer Research (AICR) and a TOP-Grant from The Netherlands Organization for Health Research and Development (ZonMW 40-00812-98-09050). R.F. is supported by the Dutch Cancer Society, the BSIK program of the Dutch Government (Grant No. 03038; http://www.stemcells.nl), the EU FP6 and FP7 consortia Migrating Cancer Stem Cells program (MCSCs; http://www.mcscs.eu), and TuMIC (integrated concept of tumor metastasis; http://itgmv1.fzk.de/www/tumic/tumic_main.htm).	Albuquerque C, 2002, HUM MOL GENET, V11, P1549, DOI 10.1093/hmg/11.13.1549; Baba Y, 2005, IMMUNITY, V23, P599, DOI 10.1016/j.immuni.2005.10.009; Barolo S, 2006, ONCOGENE, V25, P7505, DOI 10.1038/sj.onc.1210057; Bilechele Travis L., 2008, V468, P99, DOI 10.1007/978-1-59745-249-6_8; Blank U, 2008, BLOOD, V111, P492, DOI 10.1182/blood-2007-07-075168; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; Currier N, 2010, GENESIS, V48, P183, DOI 10.1002/dvg.20604; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Dervovic D, 2010, SEMIN IMMUNOL, V22, P276, DOI 10.1016/j.smim.2010.04.014; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Fodde R, 2003, NAT CELL BIOL, V5, P190, DOI 10.1038/ncb0303-190; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; FODDE R, 1994, P NATL ACAD SCI USA, V91, P8969, DOI 10.1073/pnas.91.19.8969; Fodde R, 2001, TRENDS MOL MED, V7, P369, DOI 10.1016/S1471-4914(01)02050-0; Gaspar C, 2004, INT J DEV BIOL, V48, P377, DOI 10.1387/ijdb.041807cg; Gaspar C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000547; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Gounari F, 2005, NAT IMMUNOL, V6, P800, DOI 10.1038/ni1228; Gounari F, 2001, NAT IMMUNOL, V2, P863, DOI 10.1038/ni0901-863; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Huang J, 2009, J CLIN INVEST, V119, P3519, DOI 10.1172/JCI40572; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Jaleco AC, 2001, J EXP MED, V194, P991, DOI 10.1084/jem.194.7.991; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Koch U, 2008, BLOOD, V111, P160, DOI 10.1182/blood-2007-07-099754; Lane SW, 2010, BLOOD, V115, P3489, DOI 10.1182/blood-2009-11-251728; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Luis TC, 2010, BLOOD, V116, P496, DOI 10.1182/blood-2010-04-282624; Luis TC, 2009, BLOOD, V113, P546, DOI 10.1182/blood-2008-06-163774; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Malhotra S, 2008, J IMMUNOL, V181, P3955, DOI 10.4049/jimmunol.181.6.3955; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Moriyama A, 2007, GENESIS, V45, P90, DOI 10.1002/dvg.20268; Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; Petropoulos K, 2008, J EXP MED, V205, P515, DOI 10.1084/jem.20071875; Pongracz J, 2003, EUR J IMMUNOL, V33, P1949, DOI 10.1002/eji.200323564; Qian ZJ, 2008, J EXP MED, V205, P2163, DOI 10.1084/jem.20080578; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Robanus-Maandag EC, 2010, CARCINOGENESIS, V31, P946, DOI 10.1093/carcin/bgq046; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Schilham MW, 1998, J IMMUNOL, V161, P3984; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Silva-Vargas V, 2005, DEV CELL, V9, P121, DOI 10.1016/j.devcel.2005.04.013; Smits R, 2000, GENE CHROMOSOME CANC, V29, P229, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1033>3.0.CO;2-R; Smits R, 1999, GENE DEV, V13, P1309, DOI 10.1101/gad.13.10.1309; STAAL FJ, 2008, CELL, V132, P729; Staal FJT, 2004, J IMMUNOL, V172, P1099, DOI 10.4049/jimmunol.172.2.1099; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Staal FJT, 2001, EUR J IMMUNOL, V31, P285, DOI 10.1002/1521-4141(200101)31:1<285::AID-IMMU285>3.3.CO;2-4; Tadokoro Y, 2007, J EXP MED, V204, P715, DOI 10.1084/jem.20060750; Trowbridge JJ, 2006, NAT IMMUNOL, V7, P1021, DOI 10.1038/ni1006-1021; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Weerkamp F, 2006, P NATL ACAD SCI USA, V103, P3322, DOI 10.1073/pnas.0511299103; Wielenga VJM, 1999, AM J PATHOL, V154, P515, DOI 10.1016/S0002-9440(10)65297-2; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; WILLIAMS DA, 1991, NATURE, V352, P438, DOI 10.1038/352438a0; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Xu YY, 2003, NAT IMMUNOL, V4, P1177, DOI 10.1038/ni1008; Yu Q, 2007, J IMMUNOL, V178, P5028, DOI 10.4049/jimmunol.178.8.5028; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003	68	222	230	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 7	2011	9	4					345	356		10.1016/j.stem.2011.07.017	http://dx.doi.org/10.1016/j.stem.2011.07.017			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	835MT	21982234	Bronze			2022-12-28	WOS:000296041200012
J	Dawlaty, MM; Ganz, K; Powell, BE; Hu, YC; Markoulaki, S; Cheng, AW; Gao, Q; Kim, J; Choi, SW; Page, DC; Jaenisch, R				Dawlaty, Meelad M.; Ganz, Kibibi; Powell, Benjamin E.; Hu, Yueh-Chiang; Markoulaki, Styliani; Cheng, Albert W.; Gao, Qing; Kim, Jongpil; Choi, Sang-Woon; Page, David C.; Jaenisch, Rudolf			Tet1 Is Dispensable for Maintaining Pluripotency and Its Loss Is Compatible with Embryonic and Postnatal Development	CELL STEM CELL			English	Article							ACTIVE DNA DEMETHYLATION; 5-HYDROXYMETHYLCYTOSINE; 5-METHYLCYTOSINE; CELLS; MICE; COMPLEMENTATION; SPECIFICATION; CONVERSION; GENOME; BRAIN	The Tet family of enzymes (Tet1/2/3) converts 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC). Mouse embryonic stem cells (mESCs) highly express Tet1 and have an elevated level of 5hmC. Tet1 has been implicated in ESC maintenance and lineage specification in vitro but its precise function in development is not well defined. To establish the role of Tet1 in pluripotency and development, we have generated Tet1 mutant mESCs and mice. Tet1(-/-) ESCs have reduced levels of 5hmC and subtle changes in global gene expression, and are pluripotent and support development of live-born mice in tetraploid complementation assay, but display skewed differentiation toward trophectoderm in vitro. Tet1 mutant mice are viable, fertile, and grossly normal, though some mutant mice have a slightly smaller body size at birth. Our data suggest that Tet1 loss leading to a partial reduction in 5hmC levels does not affect pluripotency in ESCs and is compatible with embryonic and postnatal development.	[Dawlaty, Meelad M.; Ganz, Kibibi; Powell, Benjamin E.; Hu, Yueh-Chiang; Markoulaki, Styliani; Cheng, Albert W.; Gao, Qing; Kim, Jongpil; Page, David C.; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Cheng, Albert W.; Page, David C.; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02142 USA; [Cheng, Albert W.] MIT, Computat & Syst Biol Program, Cambridge, MA 02142 USA; [Choi, Sang-Woon] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Page, David C.] Howard Hughes Med Inst, Chevy Chase, MD USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Tufts University; United States Department of Agriculture (USDA); Howard Hughes Medical Institute	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu	Hu, Yueh-Chiang/AAX-2370-2020	Powell, Benjamin/0000-0003-2533-8262; Hu, Yueh-Chiang/0000-0002-7992-0525; Cheng, Albert/0000-0003-2653-5743	Boehringer Ingelheim; Croucher; NIH [5-RO1-HDO45022, 5-R37-CA084198, 5-RO1-CA087869]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA084198, R01CA087869, R37CA084198] Funding Source: NIH RePORTER	Boehringer Ingelheim(Boehringer Ingelheim); Croucher; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	M.M.D is a Damon Runyon Fellow. B.E.P is supported by a Ph.D. fellowship from the Boehringer Ingelheim Fonds. A.W.C. is supported by a Croucher scholarship. D.C.P is an HHMI investigator. R.J. is funded by NIH grants 5-RO1-HDO45022, 5-R37-CA084198, and 5-RO1-CA087869. R.J. is an adviser to Stemgent and cofounder of Fate Therapeutics.	Dawlaty MM, 2006, METHODS, V39, P370, DOI 10.1016/j.ymeth.2006.06.009; Dean W, 2003, SEMIN CELL DEV BIOL, V14, P93, DOI 10.1016/S1084-9521(02)00141-6; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Valinluck V, 2007, CANCER RES, V67, P946, DOI 10.1158/0008-5472.CAN-06-3123; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	21	369	382	2	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	AUG 5	2011	9	2					166	175		10.1016/j.stem.2011.07.010	http://dx.doi.org/10.1016/j.stem.2011.07.010			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	808PM	21816367	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000293990900013
J	Wiese, KE; Eilers, M				Wiese, Katrin E.; Eilers, Martin			Pluripotency without Max	CELL STEM CELL			English	Editorial Material							EMBRYONIC STEM	Myc/Max complexes are thought to be essential for maintaining pluripotency and self-renewal of embryonic stem cells (ESCs). In this issue of Cell Stem Cell, Hishida et al. (2011) provide genetic evidence that this requirement can be bypassed in well-defined culture conditions.	[Wiese, Katrin E.; Eilers, Martin] Univ Wurzburg, Theodor Boveri Inst, Bioctr, D-97074 Wurzburg, Germany	University of Wurzburg	Eilers, M (corresponding author), Univ Wurzburg, Theodor Boveri Inst, Bioctr, D-97074 Wurzburg, Germany.	martin.eilers@biozentrum.uni-wuerzburg.de		Eilers, Martin/0000-0002-0376-6533; Wiese, Katrin Evelyn/0000-0002-1603-2846				Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Gallant P, 2009, CELL CYCLE, V8, P3848, DOI 10.4161/cc.8.23.10088; Hishida T, 2011, CELL STEM CELL, V9, P37, DOI 10.1016/j.stem.2011.04.020; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Lin CH, 2009, EMBO J, V28, P3157, DOI 10.1038/emboj.2009.254; Pierce SB, 2008, DEV BIOL, V315, P303, DOI 10.1016/j.ydbio.2007.12.026; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Smith K, 2010, REGEN MED, V5, P947, DOI 10.2217/RME.10.79; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	10	1	1	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUL 8	2011	9	1					4	6		10.1016/j.stem.2011.06.010	http://dx.doi.org/10.1016/j.stem.2011.06.010			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	797VA	21726827	Bronze			2022-12-28	WOS:000293157000003
J	Walkley, CR; Izon, DJ; Purton, LE				Walkley, Carl R.; Izon, David J.; Purton, Louise E.			Taking HSCs Down a Notch in Leukemia	CELL STEM CELL			English	Editorial Material							GAMMA-SECRETASE COMPLEX; PROTEIN; PATHWAY	The Notch signaling pathway is activated in the majority of T cell acute lymphoblastic leukemias (T-ALL). Adding to the complexity of Notch signaling in hematopoiesis, recently in Nature, Klinakis et al. (2011) demonstrate a tumor-suppressor function for the Notch pathway in myeloid malignancy.	[Walkley, Carl R.; Izon, David J.; Purton, Louise E.] Univ Melbourne, St Vincents Hosp, St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Walkley, Carl R.; Izon, David J.; Purton, Louise E.] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia	St Vincent's Hospital Melbourne; St. Vincent's Institute of Medical Research; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne	Purton, LE (corresponding author), Univ Melbourne, St Vincents Hosp, St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia.	Ipurton@svi.edu.au	Walkley, Carl/AAO-6021-2020; Purton, Louise/AAI-8956-2021	Walkley, Carl/0000-0002-4784-9031; Purton, Louise/0000-0001-6593-3168				De Strooper B, 2005, CELL, V122, P318, DOI 10.1016/j.cell.2005.07.021; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Laudon H, 2007, PHYSIOL BEHAV, V92, P115, DOI 10.1016/j.physbeh.2007.05.037; Maillard I, 2008, CELL STEM CELL, V2, P356, DOI 10.1016/j.stem.2008.02.011; Sanalkumar R, 2010, CELL MOL LIFE SCI, V67, P2957, DOI 10.1007/s00018-010-0391-x; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160	10	1	1	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 3	2011	8	6					602	603		10.1016/j.stem.2011.04.010	http://dx.doi.org/10.1016/j.stem.2011.04.010			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	780HC	21624800	Bronze			2022-12-28	WOS:000291844100004
J	Encinas, JM; Michurina, TV; Peunova, N; Park, JH; Tordo, J; Peterson, DA; Fishell, G; Koulakov, A; Enikolopov, G				Encinas, Juan M.; Michurina, Tatyana V.; Peunova, Natalia; Park, June-Hee; Tordo, Julie; Peterson, Daniel A.; Fishell, Gord; Koulakov, Alex; Enikolopov, Grigori			Division-Coupled Astrocytic Differentiation and Age-Related Depletion of Neural Stem Cells in the Adult Hippocampus	CELL STEM CELL			English	Article							DENTATE GYRUS; IMMUNOCYTOCHEMICAL ANALYSIS; PROGENITOR CELLS; SELF-RENEWAL; OLD-AGE; NEUROGENESIS; PROLIFERATION; QUIESCENT; NEURONS; BRAIN	Production of new neurons in the adult hippocampus decreases with age; this decline may underlie age-related cognitive impairment. Here we show that continuous depletion of the neural stem cell pool, as a consequence of their division, may contribute to the age-related decrease in hippocampal neurogenesis. Our results indicate that adult hippocampal stem cells, upon exiting their quiescent state, rapidly undergo a series of asymmetric divisions to produce dividing progeny destined to become neurons and subsequently convert into mature astrocytes. Thus, the decrease in the number of neural stem cells is a division-coupled process and is directly related to their production of new neurons. We present a scheme of the neurogenesis cascade in the adult hippocampus that includes a proposed "disposable stem cell" model and accounts for the disappearance of hippocampal neural stem cells, the appearance of new astrocytes, and the age-related decline in the production of new neurons.	[Encinas, Juan M.; Michurina, Tatyana V.; Peunova, Natalia; Park, June-Hee; Tordo, Julie; Koulakov, Alex; Enikolopov, Grigori] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Peterson, Daniel A.] Rosalind Franklin Univ Med & Sci, Ctr Stem Cell & Regenerat Med, N Chicago, IL 60064 USA; [Peterson, Daniel A.] Rosalind Franklin Univ Med & Sci, Dept Neurosci, N Chicago, IL 60064 USA; [Fishell, Gord] NYU, Sch Med, Smilow Neurosci Program, New York, NY 10016 USA	Cold Spring Harbor Laboratory; Rosalind Franklin University Medical & Science; Rosalind Franklin University Medical & Science; New York University	Enikolopov, G (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	enik@cshl.edu	Encinas, Juan Manuel/N-5906-2014; Enikolopov, Grigori/P-5731-2019; Encinas, Juan Manuel/ABB-5304-2020	Encinas, Juan Manuel/0000-0002-0402-972X; Enikolopov, Grigori/0000-0001-8178-8917; Encinas, Juan Manuel/0000-0002-0402-972X; Fishell, Gordon/0000-0002-9640-9278	National Institutes of Health; NIA; NICHD; NINDS; NIMH; NARSAD, NYSTEM; Ira Hazan Fund; Ellison Medical Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH081258] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NARSAD, NYSTEM(NARSAD); Ira Hazan Fund; Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. Krimmer for help with experiments, A. Joyner (MSKCC) for the Gli1-CreER line, J. Samanta (NYU) for the animals, Y. Lazebnik and B. Earnshaw for advice, and A. Sierra (BCM) and J. Banerji (MGH) for insightful discussions and comments. J.M.E. is a recipient of a Young Investigator Award from NARSAD. This work was supported by grants from the National Institutes of Health: from NIA to D.A.P., from NICHD to G.F., from NINDS and NIMH to G.E., and from NARSAD, NYSTEM, the Ira Hazan Fund, and The Ellison Medical Foundation to G.E.	Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Balordi F, 2007, J NEUROSCI, V27, P14248, DOI 10.1523/JNEUROSCI.4531-07.2007; Cameron HA, 1999, NAT NEUROSCI, V2, P894, DOI 10.1038/13197; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; ECKENHOFF MF, 1984, J COMP NEUROL, V223, P1, DOI 10.1002/cne.902230102; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Encinas JM, 2011, J COMP NEUROL, V519, P6, DOI 10.1002/cne.22503; Enikolopov G, 2008, ADULT NEUROGENESIS; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; Hattiangady B, 2008, NEUROBIOL AGING, V29, P129, DOI 10.1016/j.neurobiolaging.2006.09.015; Hayes NL, 2002, DEV BRAIN RES, V134, P77, DOI 10.1016/S0165-3806(01)00324-8; Hodge RD, 2008, J NEUROSCI, V28, P3707, DOI 10.1523/JNEUROSCI.4280-07.2008; Huttmann K, 2003, EUR J NEUROSCI, V18, P2769, DOI 10.1111/j.1460-9568.2003.03002.x; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; KOSAKA T, 1986, J COMP NEUROL, V249, P242, DOI 10.1002/cne.902490209; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Leuner B, 2007, P NATL ACAD SCI USA, V104, P17169, DOI 10.1073/pnas.0708228104; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Mouton PR, 2002, BRAIN RES, V956, P30, DOI 10.1016/S0006-8993(02)03475-3; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Olariu A, 2007, J COMP NEUROL, V501, P659, DOI 10.1002/cne.21268; Park JH, 2010, EXP NEUROL, V222, P267, DOI 10.1016/j.expneurol.2010.01.004; Pilegaard K, 1996, ANAL QUANT CYTOL, V18, P279; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Segi-Nishida E, 2008, P NATL ACAD SCI USA, V105, P11352, DOI 10.1073/pnas.0710858105; Seki T, 1995, NEUROREPORT, V6, P2479, DOI 10.1097/00001756-199512150-00010; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Seri B, 2004, J COMP NEUROL, V478, P359, DOI 10.1002/cne.20288; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Vega CJ, 2005, NAT METHODS, V2, P167, DOI 10.1038/NMETH741; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	40	592	609	2	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 6	2011	8	5					566	579		10.1016/j.stem.2011.03.010	http://dx.doi.org/10.1016/j.stem.2011.03.010			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	768IN	21549330	Green Accepted, Bronze			2022-12-28	WOS:000290927600016
J	Wang, Y; Liu, Y; Malek, SN; Zheng, P; Liu, Y				Wang, Yin; Liu, Yan; Malek, Sami N.; Zheng, Pan; Liu, Yang			Targeting HIF1 alpha Eliminates Cancer Stem Cells in Hematological Malignancies	CELL STEM CELL			English	Article							ACUTE MYELOID-LEUKEMIA; HYPOXIA-INDUCIBLE FACTORS; PROGENITOR CELLS; INITIATING CELLS; SELF-RENEWAL; TUMOR-GROWTH; NOTCH; IDENTIFICATION; ECHINOMYCIN; INHIBITOR	Molecular targeting of cancer stem cells (CSCs) has therapeutic potential for efficient treatment of cancer, although relatively few specific targets have been identified so far. Hypoxia-inducible factor (HIF) was recently shown to regulate the tumorigenic capacity of glioma stem cells under hypoxic conditions. Surprisingly, we found that, under normoxia, HIF1 alpha signaling was selectively activated in the stem cells of mouse lymphoma and human acute myeloid leukemia (AML). HIF1 alpha shRNA and HIF inhibitors abrogated the colony-forming unit (cfu) activity of mouse lymphoma and human AML CSCs. Importantly, the HIF-inhibitor echinomycin efficiently eradicated mouse lymphoma and serially transplantable human AML in xenogeneic models by preferential elimination of CSCs. Hif1 alpha maintains mouse lymphoma CSCs by repressing a negative feedback loop in the Notch pathway. Taken together, our results demonstrate an essential function of Hif1 alpha-Notch interaction in maintaining CSCs and provide an effective approach to target CSCs for therapy of hematological malignancies.	[Wang, Yin; Liu, Yan; Zheng, Pan; Liu, Yang] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Wang, Yin; Liu, Yan; Liu, Yang] Univ Michigan, Div Immunotherapy, Sect Gen Surg, Ann Arbor, MI 48109 USA; [Zheng, Pan] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Malek, Sami N.; Liu, Yang] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Zheng, P (corresponding author), Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA.	panz@umich.edu; yangl@umich.edu	Zheng, Pan/E-8691-2011	Zheng, Pan/0000-0003-2598-3544; Liu, Yang/0000-0002-9442-700X	National Institutes of Health, USA; NATIONAL CANCER INSTITUTE [R01CA058033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC1GM091648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG036690] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dr. Z. Xu for advice on the structure of Notch signaling complex, Dr. X. Chang, Dr. W. Zou, and Ms. L. Vatan for helping with flow cytometry, Drs. E. Fearon and Y. Zhu for helpful discussions, and Dr. J. Connett and Ms. D. Kroft for editorial assistance. This study is supported by grants from the National Institutes of Health, USA. All authors are coinventors of a pending patent application that was licensed to Oncolmmune, Inc. Y.L. and P.Z. are among the cofounders with equity interest in Oncolmmune, Inc.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Camenisch G, 2001, PFLUG ARCH EUR J PHY, V443, P240, DOI 10.1007/s004240100679; Costello RT, 2000, CANCER RES, V60, P4403; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Diehn M, 2009, SEMIN RADIAT ONCOL, V19, P78, DOI 10.1016/j.semradonc.2008.11.002; Dierks C, 2008, CANCER CELL, V14, P238, DOI 10.1016/j.ccr.2008.08.003; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Guzman ML, 2007, BLOOD, V110, P4427, DOI 10.1182/blood-2007-05-090621; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Kong DH, 2005, CANCER RES, V65, P9047, DOI 10.1158/0008-5472.CAN-05-1235; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; Maranchie JK, 2002, CANCER CELL, V1, P247, DOI 10.1016/S1535-6108(02)00044-2; Minet E, 1999, FEBS LETT, V460, P251, DOI 10.1016/S0014-5793(99)01359-9; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; MUSS HB, 1990, AM J CLIN ONCOL-CANC, V13, P191, DOI 10.1097/00000421-199006000-00002; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; Park CY, 2009, MOL THER, V17, P219, DOI 10.1038/mt.2008.254; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Pereira T, 2003, J BIOL CHEM, V278, P6816, DOI 10.1074/jbc.M209297200; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Slovak ML, 2000, BLOOD, V96, P4075, DOI 10.1182/blood.V96.13.4075; TAKEBAYASHI K, 1994, J BIOL CHEM, V269, P5150; Tomita K, 1999, GENE DEV, V13, P1203, DOI 10.1101/gad.13.9.1203; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Vlaminck B, 2007, FEBS J, V274, P5533, DOI 10.1111/j.1742-4658.2007.06072.x; Wang Y, 2006, CANCER CELL, V10, P179, DOI 10.1016/j.ccr.2006.08.008; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Wilson A, 2006, FEBS LETT, V580, P2860, DOI 10.1016/j.febslet.2006.03.024; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu XB, 2006, STEM CELLS, V24, P876, DOI 10.1634/stemcells.2005-0598; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737	51	301	318	1	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 8	2011	8	4					399	411		10.1016/j.stem.2011.02.006	http://dx.doi.org/10.1016/j.stem.2011.02.006			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	752QI	21474104	Green Accepted, Bronze			2022-12-28	WOS:000289707100012
J	Montserrat, N; Nivet, E; Sancho-Martinez, I; Hishida, T; Kumar, S; Miquel, L; Cortina, C; Hishida, Y; Xia, Y; Esteban, CR; Belmonte, JCI				Montserrat, Nuria; Nivet, Emmanuel; Sancho-Martinez, Ignacio; Hishida, Tomoaki; Kumar, Sachin; Miquel, Laia; Cortina, Carme; Hishida, Yuriko; Xia, Yun; Rodriguez Esteban, Concepcion; Izpisua Belmonte, Juan Carlos			Reprogramming of Human Fibroblasts to Pluripotency with Lineage Specifiers	CELL STEM CELL			English	Article							NEURAL STEM-CELLS; TRANSCRIPTION FACTORS; SOMATIC-CELLS; DIFFERENTIATION; OCT4; MOUSE; STATE; INDUCTION; FAMILY; CDX2	Since the initial discovery that OCT4, SOX2, KLF4, and c-MYC overexpression sufficed for the induction of pluripotency in somatic cells, methodologies replacing the original factors have enhanced our understanding of the reprogramming process. However, unlike in mouse, OCT4 has not been replaced successfully during reprogramming of human cells. Here we report on a strategy to accomplish this replacement. Through a combination of transcriptome and bioinformatic analysis we have identified factors previously characterized as being lineage specifiers that are able to replace OCT4 and SOX2 in the reprogramming of human fibroblasts. Our results show that it is possible to replace OCT4 and SOX2 simultaneously with alternative lineage specifiers in the reprogramming of human cells. At a broader level, they also support a model in which counteracting lineage specification networks underlies the induction of pluripotency.	[Montserrat, Nuria; Sancho-Martinez, Ignacio; Miquel, Laia; Cortina, Carme; Rodriguez Esteban, Concepcion; Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona, Barcelona 08003, Spain; [Montserrat, Nuria] Biomed Res Networking Ctr Bioengn Biomat & Nanome, Barcelona 08003, Spain; [Nivet, Emmanuel; Sancho-Martinez, Ignacio; Hishida, Tomoaki; Kumar, Sachin; Hishida, Yuriko; Xia, Yun; Rodriguez Esteban, Concepcion; Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Salk Institute	Belmonte, JCI (corresponding author), Ctr Regenerat Med Barcelona, Dr Aiguader 88, Barcelona 08003, Spain.	belmonte@salk.edu	Cortina Duran, Carme/K-7203-2017; Xia, Yun/K-4128-2015; Montserrat, Nuria/F-3136-2016; Nivet, Emmanuel/C-2729-2014	Cortina Duran, Carme/0000-0003-3477-4322; Xia, Yun/0000-0003-2184-4870; Montserrat, Nuria/0000-0002-1603-1755; Nivet, Emmanuel/0000-0001-7903-4059; Miquel Serra, Laia/0000-0001-8382-3341; Sancho-Martinez, Ignacio/0000-0003-4348-1038	Nomis Foundation; F.M. Kirby Foundation; Fundacion Cellex; G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust; Ministerio de Economia y Competitividad (MINECO); CIBER-BBN; TERCEL-ISCIII- MINECO; Cardiocel	Nomis Foundation; F.M. Kirby Foundation; Fundacion Cellex(Foundation CELLEX); G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust; Ministerio de Economia y Competitividad (MINECO); CIBER-BBN; TERCEL-ISCIII- MINECO; Cardiocel	We thank M. Schwarz for administrative support. We also thank Montserrat Barragan, Lola Mulero, Cristina Morera, Rafaella Fazzina, Kelly Herbert, and Krystal Moon for expert technical assistance and Lara Nonell and Eulalia Puigdecanet at the Microarray Service (SAM) of IMIM-Hospital del Mar for microarray processing and analysis. I.S.M. was partially supported by a Nomis Foundation postdoctoral fellowship. E.N. was partially supported by a F.M. Kirby Foundation postdoctoral fellowship. Work in the laboratory of J.C.I.B. was supported by grants from Fundacion Cellex, the G. Harold and Leila Y. Mathers Charitable Foundation, The Leona M. and Harry B. Helmsley Charitable Trust and Ministerio de Economia y Competitividad (MINECO), CIBER-BBN, TERCEL-ISCIII- MINECO, and Cardiocel.	Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Frum T, 2013, DEV CELL, V25, P610, DOI 10.1016/j.devcel.2013.05.004; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Home P, 2009, J BIOL CHEM, V284, P28729, DOI 10.1074/jbc.M109.016840; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Kamiya D, 2011, NATURE, V470, P503, DOI 10.1038/nature09726; Karwacki-Neisius V, 2013, CELL STEM CELL, V12, P531, DOI 10.1016/j.stem.2013.04.023; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kurian L, 2013, NAT METHODS, V10, P77, DOI [10.1038/NMETH.2255, 10.1038/nmeth.2255]; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nishiyama A, 2009, CELL STEM CELL, V5, P420, DOI 10.1016/j.stem.2009.07.012; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Radzisheuskaya A, 2013, NAT CELL BIOL, V15, P579, DOI 10.1038/ncb2742; Ralston A, 2010, DEVELOPMENT, V137, P395, DOI 10.1242/dev.038828; Redmer T, 2011, EMBO REP, V12, P720, DOI 10.1038/embor.2011.88; Sakaki-Yumoto M, 2013, BBA-GEN SUBJECTS, V1830, P2280, DOI 10.1016/j.bbagen.2012.08.008; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Shu J, 2013, CELL, V153, P963, DOI 10.1016/j.cell.2013.05.001; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Suzuki Atsushi, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS114, DOI 10.1038/ncpcardio0442; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Wang Y, 2011, EMBO REP, V12, P373, DOI 10.1038/embor.2011.11; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Xu Y, 2008, NATURE, V453, P338, DOI 10.1038/nature07042; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zipori D, 2004, NAT REV GENET, V5, P873, DOI 10.1038/nrg1475	30	110	116	0	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 5	2013	13	3					341	350		10.1016/j.stem.2013.06.019	http://dx.doi.org/10.1016/j.stem.2013.06.019			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VQ	23871606	Bronze			2022-12-28	WOS:000329570800011
J	Chen, HY; Chen, X; Zheng, YX				Chen, Haiyang; Chen, Xin; Zheng, Yixian			The Nuclear Lamina Regulates Germline Stem Cell Niche Organization via Modulation of EGFR Signaling	CELL STEM CELL			English	Article							SOMATIC SUPPORT CELLS; B-TYPE LAMINS; DROSOPHILA TESTIS; SELF-RENEWAL; MAP KINASE; EYE DEVELOPMENT; DIFFERENTIATION; RECEPTOR; SPERMATOGENESIS; PROLIFERATION	Stem cell niche interactions have been studied extensively with regard to cell polarity and extracellular signaling. Less is known about the way in which signals and polarity cues integrate with intracellular structures to ensure appropriate niche organization and function. Here, we report that nuclear lamins function in the cyst stem cells (CySCs) of Drosophila testes to control the interaction of CySCs with the hub. This interaction is important for regulation of CySC differentiation and organization of the niche that supports the germline stem cells (GSCs). Lamin promotes nuclear retention of phosphorylated ERK in the CySC lineage by regulating the distribution of specific nucleoporins within the nuclear pores. Lamin-regulated nuclear epidermal growth factor (EGF) receptor signaling in the CySC lineage is essential for proliferation and differentiation of the GSCs and the transient amplifying germ cells. Thus, we have uncovered a role for the nuclear lamina in the integration of EGF signaling to regulate stem cell niche function.	[Chen, Haiyang; Zheng, Yixian] Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA; [Chen, Xin; Zheng, Yixian] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Carnegie Institution for Science; Johns Hopkins University	Zheng, YX (corresponding author), Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA.	zheng@ciwemb.edu			NIH [R01 GM056312, R01 HD065816]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056312] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Allan Spradling and members of his group for valuable support; Drs. Mark Van Doren, Mitchell Dushay, Lori Wallrath, Kristen Johansen, Erica Selva, Silvia Gigliotti, and Ruth Lehmann for fly strains and antibodies; and Matthew Sieber, Alexis Marianes, William Yarosh, and members of the Zheng lab for critical comments. This work was supported by NIH grants R01 GM056312 (to Y.Z.) and R01 HD065816 (to X.C.).	Adachi M, 1999, EMBO J, V18, P5347, DOI 10.1093/emboj/18.19.5347; Al-Haboubi T, 2011, NUCLEUS-PHILA, V2, P500, DOI 10.4161/nucl.2.5.17913; Bank EM, 2011, BIOCHEM SOC T, V39, P1705, DOI 10.1042/BST20110603; Cherry CM, 2010, CELL STEM CELL, V6, P557, DOI 10.1016/j.stem.2010.04.018; Coffinier C, 2011, MOL BIOL CELL, V22, P4683, DOI 10.1091/mbc.E11-06-0504; Coffinier C, 2010, P NATL ACAD SCI USA, V107, P5076, DOI 10.1073/pnas.0908790107; Davies EL, 2008, COLD SH Q B, V73, P137, DOI 10.1101/sqb.2008.73.063; de Cuevas M, 2011, DEVELOPMENT, V138, P2861, DOI 10.1242/dev.056242; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Gabay L, 1997, DEVELOPMENT, V124, P3535; Gonczy P, 1996, DEVELOPMENT, V122, P2437; Goodman B, 2010, J BIOL CHEM, V285, P35238, DOI 10.1074/jbc.M110.140749; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; HARDY RW, 1979, J ULTRA MOL STRUCT R, V69, P180, DOI 10.1016/S0022-5320(79)90108-4; Herranz H, 2012, GENE DEV, V26, P1602, DOI 10.1101/gad.192021.112; Hime GR, 1996, J CELL SCI, V109, P2779; Issigonis M, 2009, SCIENCE, V326, P153, DOI 10.1126/science.1176817; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Kim Y, 2012, NUCLEUS-PHILA, V3, P256, DOI 10.4161/nucl.20392; Kim Y, 2011, SCIENCE, V334, P1706, DOI 10.1126/science.1211222; Kumar JP, 1998, DEVELOPMENT, V125, P3875; Kumaran RI, 2008, J CELL BIOL, V180, P51, DOI 10.1083/jcb.200706060; Leatherman JL, 2008, CELL STEM CELL, V3, P44, DOI 10.1016/j.stem.2008.05.001; Leatherman JL, 2010, NAT CELL BIOL, V12, P806, DOI 10.1038/ncb2086; Lesokhin AM, 1999, DEV BIOL, V205, P129, DOI 10.1006/dbio.1998.9121; Li MA, 2003, NAT CELL BIOL, V5, P994, DOI 10.1038/ncb1058; Lim JGY, 2012, P NATL ACAD SCI USA, V109, P18477, DOI 10.1073/pnas.1215516109; Lorenzen JA, 2001, DEVELOPMENT, V128, P1403; Ma L, 2009, NAT CELL BIOL, V11, P246, DOI 10.1038/ncb1832; Matsubayashi Y, 2001, J BIOL CHEM, V276, P41755, DOI 10.1074/jbc.M106012200; Munoz-Alarcon A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000532; Nilson LA, 1999, CURR TOP DEV BIOL, V44, P203; Parrott BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036460; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Pignoni F, 1997, DEVELOPMENT, V124, P271; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Sarkar A, 2007, CURR BIOL, V17, P1253, DOI 10.1016/j.cub.2007.06.048; Schulz C, 2002, DEVELOPMENT, V129, P4523; Simon DN, 2011, NAT REV MOL CELL BIO, V12, P695, DOI 10.1038/nrm3207; Smith ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009295; Smythe C, 2000, EMBO J, V19, P3918, DOI 10.1093/emboj/19.15.3918; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Tarayrah L, 2013, DEVELOPMENT, V140, P1014, DOI 10.1242/dev.089433; Tran J, 2000, NATURE, V407, P754, DOI 10.1038/35037613; Tsai MY, 2006, SCIENCE, V311, P1887, DOI 10.1126/science.1122771; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Vergnes L, 2004, P NATL ACAD SCI USA, V101, P10428, DOI 10.1073/pnas.0401424101; Vomastek T, 2008, MOL CELL BIOL, V28, P6954, DOI 10.1128/MCB.00925-08; Voog J, 2008, NATURE, V454, P1132, DOI 10.1038/nature07173; Whitehurst AW, 2002, P NATL ACAD SCI USA, V99, P7496, DOI 10.1073/pnas.112495999; XU T, 1993, DEVELOPMENT, V117, P1223; Yang SH, 2011, HUM MOL GENET, V20, P3537, DOI 10.1093/hmg/ddr266; Zhao DB, 2000, J CELL SCI, V113, P3781; Zheng YX, 2010, NAT REV MOL CELL BIO, V11, P529, DOI 10.1038/nrm2919; Zoller Richard, 2012, Spermatogenesis, V2, P145	58	55	57	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2013	13	1					73	86		10.1016/j.stem.2013.05.003	http://dx.doi.org/10.1016/j.stem.2013.05.003			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VJ	23827710	Green Accepted, Bronze			2022-12-28	WOS:000329570100014
J	Turner, SA; Bracken, AP				Turner, Siobhan A.; Bracken, Adrian P.			A "Complex" Issue: Deciphering the Role of Variant PRC1 in ESCs	CELL STEM CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; PROTEINS; FAMILY; GENES	Several noncanonical type-1 Polycomb Repressive Complexes (PRC1) that act independently of PRC2 have been recently identified, but their functions in embryonic stem cells (ESCs) are unclear. Two recent reports by Morey et al. (2012a) and Wu et al. (2013) define functionally distinct roles for canonical and noncanonical PRC1 in ESCs.	[Turner, Siobhan A.; Bracken, Adrian P.] Univ Dublin Trinity Coll, Smurfit Inst Genet, Dublin 2, Ireland; [Bracken, Adrian P.] Natl Childrens Hosp, Adelaide & Meath Hosp, Dublin 16, Ireland	Trinity College Dublin; Trinity College Dublin	Bracken, AP (corresponding author), Univ Dublin Trinity Coll, Smurfit Inst Genet, Dublin 2, Ireland.	adrian.bracken@tcd.ie		Bracken, Adrian/0000-0002-1547-9443				Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Farcas AM, 2012, ELIFE, V1, DOI 10.7554/eLife.00205; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Hisada K, 2012, MOL CELL BIOL, V32, P1139, DOI 10.1128/MCB.06441-11; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Morey L., 2012, CELL REPORTS, DOI DOI 10.1016/J.CELREP.2012.11.02; Morey L, 2012, CELL STEM CELL, V10, P47, DOI 10.1016/j.stem.2011.12.006; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Wu XD, 2013, MOL CELL, V49, P1134, DOI 10.1016/j.molcel.2013.01.016	10	19	21	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 7	2013	12	2					145	146		10.1016/j.stem.2013.01.014	http://dx.doi.org/10.1016/j.stem.2013.01.014			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VB	23395440	Green Published, Bronze			2022-12-28	WOS:000329569300004
J	van Amerongen, R; Bowman, AN; Nusse, R				van Amerongen, Renee; Bowman, Angela N.; Nusse, Roel			Developmental Stage and Time Dictate the Fate of Wnt/beta-Catenin-Responsive Stem Cells in the Mammary Gland	CELL STEM CELL			English	Article							FUNCTIONAL-CHARACTERIZATION; BRANCHING MORPHOGENESIS; EPITHELIAL-CELLS; SMALL-INTESTINE; MOUSE; DIFFERENTIATION; IDENTIFICATION; CONTRIBUTE; CANDIDATE; LINEAGE	The mammary epithelium undergoes extensive growth and remodeling during pregnancy, suggesting a role for stem cells. Yet their origin, identity, and behavior in the intact tissue remain unknown. Using an Axin2(CreERT2) allele, we labeled and traced Wnt/beta-catenin-responsive cells throughout mammary gland development. This reveals a switch in Wnt/beta-catenin signaling around birth and shows that, depending on the developmental stage, Axin2(+) cells contribute differently to basal and luminal epithelial cell lineages of the mammary epithelium. Moreover, an important difference exists between the developmental potential tested in transplantation assays and that displayed by the same cell population in situ. Finally, Axin2(+) cells in the adult build alveolar structures during multiple pregnancies, demonstrating the existence of a Wnt/beta-catenin-responsive adult stem cell. Our study uncovers dynamic changes in Wnt/beta-catenin signaling in the mammary epithelium and offers insights into the developmental fate of mammary gland stem and progenitor cells.	[van Amerongen, Renee; Bowman, Angela N.; Nusse, Roel] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [van Amerongen, Renee; Bowman, Angela N.; Nusse, Roel] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	van Amerongen, R (corresponding author), Netherlands Canc Inst, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	r.v.amerongen@nki.nl; rnusse@stanford.edu	van Amerongen, Renee/G-2945-2017; van Amerongen, Renee/N-6645-2019	van Amerongen, Renee/0000-0002-8808-2092; van Amerongen, Renee/0000-0002-8808-2092; Bowman, Angela/0000-0003-0980-8586	EMBO Long-Term Fellowship [ALTF 122-2007]; KWF fellowship from the Dutch Cancer Society; NSF GRF; CIRM Predoctoral Fellowship; Mary Kay Foundation; California Institute for Regenerative Medicine (CIRM) [TR1-01249]; Nadia's Gift Foundation	EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); KWF fellowship from the Dutch Cancer Society; NSF GRF(National Science Foundation (NSF)); CIRM Predoctoral Fellowship; Mary Kay Foundation; California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Nadia's Gift Foundation	We thank Boris Jerchow and Walter Birchmeier for the Axin2<SUP>lacZ</SUP> targeting construct, Anal Zeng and Tim Blauwkamp for valuable input and discussions, and Matt Fish for help with breeding the mice. Alan Cheng, Daniel Peeper, Taha Jan, Kristel Kemper, and Alexandra Pietersen provided helpful comments on the manuscript. R.v.A. was funded by an EMBO Long-Term Fellowship (ALTF 122-2007) and a KWF fellowship from the Dutch Cancer Society. A.N.B. was supported by an NSF GRF and a CIRM Predoctoral Fellowship. R.N. is an Investigator of the Howard Hughes Medical Institute. Funding was also obtained from the Mary Kay Foundation, the California Institute for Regenerative Medicine (CIRM Grant #TR1-01249), and the Nadia's Gift Foundation.	Al Alam D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023139; Andres AC, 1999, J MAMMARY GLAND BIOL, V4, P221, DOI 10.1023/A:1018737510695; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Booth BW, 2008, P NATL ACAD SCI USA, V105, P14891, DOI 10.1073/pnas.0803214105; Boulanger CA, 2005, ONCOGENE, V24, P552, DOI 10.1038/sj.onc.1208185; Boulanger CA, 2012, STEM CELLS DEV, V21, P948, DOI 10.1089/scd.2011.0148; Brisken C, 2000, GENE DEV, V14, P650; Bruno RD, 2011, STEM CELL REV REP, V7, P238, DOI 10.1007/s12015-010-9191-9; Buckingham ME, 2011, DEV CELL, V21, P394, DOI 10.1016/j.devcel.2011.07.019; Chepko G, 1997, TISSUE CELL, V29, P239, DOI 10.1016/S0040-8166(97)80024-9; Chu EY, 2004, DEVELOPMENT, V131, P4819, DOI 10.1242/dev.01347; DANIEL CW, 1968, P NATL ACAD SCI USA, V61, P53, DOI 10.1073/pnas.61.1.53; DEOME KB, 1959, CANCER RES, V19, P515; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kamiya K, 1998, P SOC EXP BIOL MED, V219, P217; Kendrick H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-591; Kim YC, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-55; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kouros-Mehr H, 2006, DEV DYNAM, V235, P3404, DOI 10.1002/dvdy.20978; Lindvall C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005813; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Macias H, 2011, DEV CELL, V20, P827, DOI 10.1016/j.devcel.2011.05.012; Minear S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000231; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Richert MM, 2000, J MAMMARY GLAND BIOL, V5, P227, DOI 10.1023/A:1026499523505; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Smith GH, 1996, BREAST CANCER RES TR, V39, P21, DOI 10.1007/BF01806075; Smith GH, 2002, CELL TISSUE RES, V310, P313, DOI 10.1007/s00441-002-0641-9; SMITH GH, 1988, J CELL SCI, V90, P173; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stingl J, 1998, DIFFERENTIATION, V63, P201, DOI 10.1111/j.1432-0436.1998.00201.x; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; STRANGE R, 1992, DEVELOPMENT, V115, P49; Teuliere J, 2005, DEVELOPMENT, V132, P267, DOI 10.1242/dev.01583; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Veltmaat JM, 2004, DEV DYNAM, V229, P349, DOI 10.1002/dvdy.10441; Visvader JE, 2011, EMBO J, V30, P4858, DOI 10.1038/emboj.2011.415; Visvader JE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004879; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Wagner KU, 2002, DEVELOPMENT, V129, P1377; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020	45	321	324	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 7	2012	11	3					387	400		10.1016/j.stem.2012.05.023	http://dx.doi.org/10.1016/j.stem.2012.05.023			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	018DW	22863533	Bronze			2022-12-28	WOS:000309641300012
J	Nakano, T; Ando, S; Takata, N; Kawada, M; Muguruma, K; Sekiguchi, K; Saito, K; Yonemura, S; Eiraku, M; Sasai, Y				Nakano, Tokushige; Ando, Satoshi; Takata, Nozomu; Kawada, Masako; Muguruma, Keiko; Sekiguchi, Kiyotoshi; Saito, Koichi; Yonemura, Shigenobu; Eiraku, Mototsugu; Sasai, Yoshiki			Self-Formation of Optic Cups and Storable Stratified Neural Retina from Human ESCs	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; PIGMENT EPITHELIUM; HOMEOBOX GENE; PHOTORECEPTOR; GENERATION; TRANSPLANTATION; EXPRESSION; MOUSE; DIFFERENTIATION; MORPHOGENESIS	In this report, we demonstrate that an optic cup structure can form by self-organization in human ESC culture. The human ESC-derived optic cup is much larger than the mouse ESC-derived one, presumably reflecting the species differences. The neural retina in human ESC culture is thick and spontaneously curves in an apically convex manner, which is not seen in mouse ESC culture. In addition, human ESC-derived neural retina grows into multilayered tissue containing both rods and cones, whereas cone differentiation is rare in mouse ESC culture. The accumulation of photoreceptors in human ESC culture can be greatly accelerated by Notch inhibition. In addition, we show that an optimized vitrification method enables en bloc cryopreservation of stratified neural retina of human origin. This storage method at an intermediate step during the time-consuming differentiation process provides a versatile solution for quality control in large-scale preparation of clinical-grade retinal tissues.	[Nakano, Tokushige; Ando, Satoshi; Takata, Nozomu; Kawada, Masako; Muguruma, Keiko; Eiraku, Mototsugu; Sasai, Yoshiki] RIKEN Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan; [Nakano, Tokushige; Ando, Satoshi; Eiraku, Mototsugu; Sasai, Yoshiki] RIKEN Ctr Dev Biol, Div Human Stem Cell Technol, Kobe, Hyogo 6500047, Japan; [Yonemura, Shigenobu] RIKEN Ctr Dev Biol, Electron Microscopy Lab, Kobe, Hyogo 6500047, Japan; [Nakano, Tokushige; Ando, Satoshi; Saito, Koichi] Sumitomo Chem Co Ltd, Environm Hlth Sci Lab, Osaka 5548558, Japan; [Nakano, Tokushige; Sasai, Yoshiki] Kyoto Univ, Grad Sch Med, Dept Med Embryol, Kyoto 6068501, Japan; [Sekiguchi, Kiyotoshi] Osaka Univ, Inst Prot Res, Lab Extracellular Matrix Biochem, Suita, Osaka 5650871, Japan	RIKEN; RIKEN; RIKEN; Sumitomo Chem Co Ltd; Kyoto University; Osaka University	Sasai, Y (corresponding author), RIKEN Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan.	yoshikisasai@cdb.riken.jp	Takata, Nozomu/AAI-9801-2020	Eiraku, Mototsugu/0000-0002-9433-9085; Takata, Nozomu/0000-0003-0171-6994; Muguruma, Keiko/0000-0002-3149-4408; Saito, Koichi/0000-0001-6497-5286	MEXT; Ministry of Health, Labor, and Welfare; S-Innovation from JST; Leading Project for Realization of Regenerative Medicine; Grants-in-Aid for Scientific Research [24112527, 24680037] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); S-Innovation from JST; Leading Project for Realization of Regenerative Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to Masatoshi Ohgushi, Hidetaka Suga, and Taisuke Kadoshima for invaluable comments; Kazuyo Misaki for electron microscopy analysis; Masayo Takahashi and Michiko Mandai for discussion on photoreceptor maturation; and Tadayoshi Ueda for discussion on cryopreservation. This work was supported by grants-in-aid from MEXT (VS., M.E., S.Y., and Ki.S.) and the Ministry of Health, Labor, and Welfare (K.M.); the S-Innovation from JST (S.A., Ko.S., Ki.S., and Y.S.); and the Leading Project for Realization of Regenerative Medicine (Y.S.).	Ali RR, 2011, NATURE, V472, P42, DOI 10.1038/472042a; Besharse J.C., 2010, RETINA ITS DISORDER; Boucherie C, 2011, REGEN MED, V6, P469, DOI [10.2217/rme.11.37, 10.2217/RME.11.37]; Brzezinski JA, 2010, DEVELOPMENT, V137, P619, DOI 10.1242/dev.043968; Carr AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008152; Cayouette M, 2006, TRENDS NEUROSCI, V29, P563, DOI 10.1016/j.tins.2006.08.003; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Eiraku M, 2012, BIOESSAYS, V34, P17, DOI 10.1002/bies.201100070; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Fuhrmann Sabine, 2008, Organogenesis, V4, P60; Fujimura N, 2009, DEV BIOL, V334, P31, DOI 10.1016/j.ydbio.2009.07.002; Fujitani Y, 2006, DEVELOPMENT, V133, P4439, DOI 10.1242/dev.02598; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Graw J, 2010, CURR TOP DEV BIOL, V90, P343, DOI 10.1016/S0070-2153(10)90010-0; Hendrickson A, 2006, RETINAL DEVELOPMENT, P126, DOI 10.1017/CBO9780511541629.009; HILFER SR, 1980, ANAT REC, V197, P423; Idelson M, 2009, CELL STEM CELL, V5, P396, DOI 10.1016/j.stem.2009.07.002; Ikeda H, 2005, P NATL ACAD SCI USA, V102, P11331, DOI 10.1073/pnas.0500010102; ISHIKAWA T, 1969, INVEST OPHTH VISUAL, V8, P302; Jadhav AR, 2006, DEVELOPMENT, V133, P913, DOI 10.1242/dev.02245; Janssen JJM, 2000, NEUROREPORT, V11, P1571, DOI 10.1097/00001756-200005150-00040; Janssen JJM, 1999, CURR EYE RES, V19, P338, DOI 10.1076/ceyr.19.4.338.5307; Katoh K, 2010, J NEUROSCI, V30, P6515, DOI 10.1523/JNEUROSCI.0771-10.2010; Kawasaki H, 2002, P NATL ACAD SCI USA, V99, P1580, DOI 10.1073/pnas.032662199; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; Lamba DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008763; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; Liu W, 2010, J CLIN INVEST, V120, P3568, DOI 10.1172/JCI43219; Lu B, 2009, STEM CELLS, V27, P2126, DOI 10.1002/stem.149; Lu JM, 2009, BIOORG MED CHEM LETT, V19, P3825, DOI 10.1016/j.bmcl.2009.04.040; Lund RD, 2006, CLONING STEM CELLS, V8, P189, DOI 10.1089/clo.2006.8.189; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; MacLaren RE, 1999, EYE, V13, P277, DOI 10.1038/eye.1999.77; Martinez-Morales JR, 2004, BIOESSAYS, V26, P766, DOI 10.1002/bies.20064; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Meyer JS, 2011, STEM CELLS, V29, P1206, DOI 10.1002/stem.674; Mu XQ, 2004, SEMIN CELL DEV BIOL, V15, P115, DOI 10.1016/j.semcdb.2003.09.009; Norden C, 2009, CELL, V138, P1195, DOI 10.1016/j.cell.2009.06.032; O'Brien KMB, 2003, MOL VIS, V9, P401; O'Rahilly R., 1999, EMBRYONIC HUMAN BRAI, P129; Ohgushi M, 2010, CELL STEM CELL, V7, P225, DOI 10.1016/j.stem.2010.06.018; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; Osborne NN, 2008, PROG BRAIN RES, V173, P339, DOI 10.1016/S0079-6123(08)01124-2; Pearson RA, 2012, NATURE, V485, P99, DOI 10.1038/nature10997; Pennesi M. E., 2010, RETINA ITS DISORDER; Martinez-Morales JR, 2009, DEVELOPMENT, V136, P2165, DOI 10.1242/dev.033563; Rivolta C, 2002, HUM MOL GENET, V11, P1219, DOI 10.1093/hmg/11.10.1219; Seiler MJ, 2010, EUR J NEUROSCI, V31, P508, DOI 10.1111/j.1460-9568.2010.07085.x; Ueno M, 2006, P NATL ACAD SCI USA, V103, P9554, DOI 10.1073/pnas.0600104103; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wataya T, 2008, P NATL ACAD SCI USA, V105, P11796, DOI 10.1073/pnas.0803078105; Westenskow P, 2009, DEVELOPMENT, V136, P2505, DOI 10.1242/dev.032136	53	852	909	6	120	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 14	2012	10	6					771	785		10.1016/j.stem.2012.05.009	http://dx.doi.org/10.1016/j.stem.2012.05.009			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	965LD	22704518	Green Submitted, Bronze			2022-12-28	WOS:000305768400023
J	Slukvin, II				Slukvin, Igor I.			Epicardial Origin of Cardiac CFU-Fs	CELL STEM CELL			English	Editorial Material							BONE-MARROW; STEM-CELLS; LINEAGE; HEART	The epicardium has been recognized as a source of cardiovascular progenitors during embryogenesis and postnatal life. In this issue of Cell Stem Cell, Chong et al. (2011) identify cardiac CFU-Fs as cardiac-resident cells of epicardial origin with broad multilineage differentiation potential.	[Slukvin, Igor I.] Univ Wisconsin, Grad Sch, Natl Primate Res Ctr, Madison, WI 53715 USA; [Slukvin, Igor I.] Univ Wisconsin, Sch Med, Dept Pathol & Lab Med, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Slukvin, II (corresponding author), Univ Wisconsin, Grad Sch, Natl Primate Res Ctr, 1220 Capitol Court, Madison, WI 53715 USA.	islukvin@wisc.edu						CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Chong JJH, 2011, CELL STEM CELL, V9, P527, DOI 10.1016/j.stem.2011.10.002; de Lange FJ, 2004, CIRC RES, V95, P645, DOI 10.1161/01.RES.0000141429.13560.cb; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Gittenberger-de Groot AC, 1998, CIRC RES, V82, P1043, DOI 10.1161/01.RES.82.10.1043; Hutson MR, 2007, SEMIN CELL DEV BIOL, V18, P101, DOI 10.1016/j.semcdb.2006.12.004; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Limana F, 2007, CIRC RES, V101, P1255, DOI 10.1161/CIRCRESAHA.107.150755; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	10	2	2	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 2	2011	9	6					492	493		10.1016/j.stem.2011.11.010	http://dx.doi.org/10.1016/j.stem.2011.11.010			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	859SB	22136919	Bronze			2022-12-28	WOS:000297895000004
J	Ambasudhan, R; Talantova, M; Coleman, R; Yuan, X; Zhu, SY; Lipton, SA; Ding, S				Ambasudhan, Rajesh; Talantova, Maria; Coleman, Ronald; Yuan, Xu; Zhu, Saiyong; Lipton, Stuart A.; Ding, Sheng			Direct Reprogramming of Adult Human Fibroblasts to Functional Neurons under Defined Conditions	CELL STEM CELL			English	Article							DIRECT CONVERSION; SOMATIC-CELLS; STEM-CELLS; MIR-124; DIFFERENTIATION; HYBRIDIZATION; EXPRESSION; MICRORNAS	Human induced pluripotent stem cells (hiPSCs) have been generated by reprogramming a number of different somatic cell types using a variety of approaches. In addition, direct reprogramming of mature cells from one lineage to another has emerged recently as an alternative strategy for generating cell types of interest. Here we show that a combination of a microRNA (miR-124) and two transcription factors (MYT1L and BRN2) is sufficient to directly reprogram postnatal and adult human primary dermal fibroblasts (mesoderm) to functional neurons (ectoderm) under precisely defined conditions. These human induced neurons (hiNs) exhibit typical neuronal morphology and marker gene expression, fire action potentials, and produce functional synapses between each other. Our findings have major implications for cell-replacement strategies in neurodegenerative diseases, disease modeling, and neural developmental studies.	[Ambasudhan, Rajesh; Talantova, Maria; Lipton, Stuart A.] Sanford Burnham Med Res Inst, Del E Webb Ctr Neurosci Aging & Stem Cell Res, La Jolla, CA 92037 USA; [Ambasudhan, Rajesh; Coleman, Ronald; Yuan, Xu; Zhu, Saiyong; Ding, Sheng] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Zhu, Saiyong; Ding, Sheng] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	Sanford Burnham Prebys Medical Discovery Institute; Scripps Research Institute; University of California System; University of California San Francisco; The J David Gladstone Institutes	Lipton, SA (corresponding author), Sanford Burnham Med Res Inst, Del E Webb Ctr Neurosci Aging & Stem Cell Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	slipton@sanfordburnham.org; sheng.ding@gladstone.ucsf.edu		Lipton, Stuart/0000-0002-3490-1259	NIH [P01 HD29587, P01 ES016738, P30 NS057096, R01 EY05477]; California Institute for Regenerative Medicine; NICHD; NICHD, NHLBI; NEI; NIMH/NIH; Prostate Cancer Foundation; Fate Therapeutics; Gladstone Institutes; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD029587] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY005477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES016738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057096] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Prostate Cancer Foundation; Fate Therapeutics; Gladstone Institutes(University of California System); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank Marius Wernig (Stanford University) for the generous gift of pBrn2-TetO-FUW and pMyt1I-TetO-FUW plasmids. We thank all members of the Ding lab for helpful discussions, and Wenlin Li and Jem Efe for critical reading of the manuscript. M.T. and S.A.L. were supported in part by NIH grants P01 HD29587, P01 ES016738, P30 NS057096, and R01 EY05477, and by the California Institute for Regenerative Medicine. S.D. was supported by funding from NICHD, NHLBI, NEI, and NIMH/NIH, California Institute for Regenerative Medicine, Prostate Cancer Foundation, Fate Therapeutics, and the Gladstone Institutes. R.A. conceived the study. R.A., MT., SAL., and S.D. designed experiments. R.A. performed viral infections, generated hiN cells, conducted cellular and molecular characterization, and interpreted the results. R.C. assisted in constructing viral vectors. X.Y. assisted in qPCR analysis and the cell culture. X.Y. and R.C. contributed equally to this work. S.Z. assisted in the cell culture. M.T. and SAL. designed, performed, and/or analyzed the electrophysiological assays. R.A. and M.T. produced the figures. R.A., SAL., and S.D. wrote and/or edited the manuscript.	Caiazzo M, 2011, NATURE; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Cao XW, 2007, GENE DEV, V21, P531, DOI 10.1101/gad.1519207; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Deo M, 2006, DEV DYNAM, V235, P2538, DOI 10.1002/dvdy.20847; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; GURDON JB, 1958, NATURE, V182, P64, DOI 10.1038/182064a0; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Pang Z.P., 2011, NATURE; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Yu JY, 2008, EXP CELL RES, V314, P2618, DOI 10.1016/j.yexcr.2008.06.002; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	26	358	396	2	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 5	2011	9	2					113	118		10.1016/j.stem.2011.07.002	http://dx.doi.org/10.1016/j.stem.2011.07.002			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	808PM	21802386	Green Accepted, Bronze			2022-12-28	WOS:000293990900008
J	Bar-Nur, O; Russ, HA; Efrat, S; Benvenisty, N				Bar-Nur, Ori; Russ, Holger A.; Efrat, Shimon; Benvenisty, Nissim			Epigenetic Memory and Preferential Lineage-Specific Differentiation in Induced Pluripotent Stem Cells Derived from Human Pancreatic Islet Beta Cells	CELL STEM CELL			English	Article							GENE-EXPRESSION; SOMATIC-CELLS; IN-VITRO; GENERATION; METHYLATION	Human induced pluripotent stem cells (HiPSCs) appear to be highly similar to human embryonic stem cells (HESCs). Using two genetic lineage-tracing systems, we demonstrate the generation of iPSC lines from human pancreatic islet beta cells. These reprogrammed cells acquired markers of pluripotent cells and differentiated into the three embryonic germ layers. However, the beta cell-derived iPSCs (BiPSCs) maintained open chromatin structure at key beta-cell genes, together with a unique DNA methylation signature that distinguishes them from other PSCs. BiPSCs also demonstrated an increased ability to differentiate into insulin-producing cells both in vitro and in vivo, compared with ESCs and isogenic non-beta iPSCs. Our results suggest that the epigenetic memory may predispose BiPSCs to differentiate more readily into insulin producing cells. These findings demonstrate that HiPSC phenotype may be influenced by their cells of origin, and suggest that their skewed differentiation potential may be advantageous for cell replacement therapy.	[Russ, Holger A.; Efrat, Shimon] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Bar-Nur, Ori; Benvenisty, Nissim] Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, Stem Cell Unit, IL-91904 Jerusalem, Israel	Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem	Efrat, S (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel.	sefrat@post.tau.ac.il; nissimb@cc.huji.ac.il	Bar-Nur, Ori/GWQ-5917-2022	Efrat, Shimon/0000-0001-5987-232X	JDRF [31-2008-413]; Integrated Islet Distribution Program; Juvenile Diabetes Research Foundation; Israeli Science Foundation	JDRF(Juvenile Diabetes Research Foundation); Integrated Islet Distribution Program; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Israeli Science Foundation(Israel Science Foundation)	Human islets were provided through the JDRF award 31-2008-413 (ECIT Islets for Basic Research Program) and the Integrated Islet Distribution Program. We thank Leeat Anker-Kitai, Sarah Knoller, Galina Weingarten, Adva Maimon, and Inbal Caspi for technical assistance. We thank Ran Elkon for assistance with the statistical analysis. This research was partially supported by the Juvenile Diabetes Research Foundation and the Israeli Science Foundation. This work was performed in partial fulfillment of the requirements for a Ph.D. degree of O.B.-N. and H.A.R. O.B.-N. is a Clore fellow. O.B.N., H.A.R., S.E., and N.B. conceived and designed the study, analyzed the data, and wrote the paper. O.B.N. and H.A.R. preformed the experimental work.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Feng Q, 2010, STEM CELLS, V28, P704, DOI 10.1002/stem.321; Gao SR, 2003, BIOL REPROD, V69, P48, DOI 10.1095/biolreprod.102.014522; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; McKnight KD, 2010, CELL STEM CELL, V6, P300, DOI 10.1016/j.stem.2010.03.003; Ng RK, 2008, NAT CELL BIOL, V10, P102, DOI 10.1038/ncb1674; Ng RK, 2005, P NATL ACAD SCI USA, V102, P1957, DOI 10.1073/pnas.0409813102; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pick M, 2009, STEM CELLS, V27, P2686, DOI 10.1002/stem.205; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; RUSS HA, CELL TRANSP IN PRESS; Russ HA, 2008, DIABETES, V57, P1575, DOI 10.2337/db07-1283; Russ HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006417; Santos F, 2003, CURR BIOL, V13, P1116, DOI 10.1016/S0960-9822(03)00419-6; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005; Wee G, 2006, J BIOL CHEM, V281, P6048, DOI 10.1074/jbc.M511340200; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	38	439	468	1	66	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 8	2011	9	1					17	23		10.1016/j.stem.2011.06.007	http://dx.doi.org/10.1016/j.stem.2011.06.007			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	797VA	21726830	Bronze			2022-12-28	WOS:000293157000006
J	Huang, K; Fan, GP				Huang, Kevin; Fan, Guoping			Epigenetic Modifications in Distinction: Histone versus DNA Methylation in ESCs	CELL STEM CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; REQUIRES; COMPLEX	In this issue of Cell Stem Cell, Karimi et al. (2011) show that DNA methylation and histone H3 lysine 9 trimethylation (H3K9me3) have distinct genomic targets in mouse ESCs. In particular, loss of H3K9me3 leads to derepression of select endogenous retroviruses and subsequent ectopic transcription of adjacent genes.	[Huang, Kevin; Fan, Guoping] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Fan, GP (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.	gfan@mednet.ucla.edu		Fan, Guoping/0000-0001-5235-6410				Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Dong KB, 2008, EMBO J, V27, P2691, DOI 10.1038/emboj.2008.193; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Hutnick LK, 2010, J BIOL CHEM, V285, P21082, DOI 10.1074/jbc.M110.125674; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Myant K, 2011, GENOME RES, V21, P83, DOI 10.1101/gr.108498.110; Rowe HM, 2011, VIROLOGY, V411, P273, DOI 10.1016/j.virol.2010.12.007; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x	10	3	3	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 3	2011	8	6					604	605		10.1016/j.stem.2011.05.007	http://dx.doi.org/10.1016/j.stem.2011.05.007			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	780HC	21624801	Bronze			2022-12-28	WOS:000291844100005
J	Luong, MX; Auerbach, J; Crook, JM; Daheron, L; Hei, D; Lomax, G; Loring, JF; Ludwig, T; Schlaeger, TM; Smith, KP; Stacey, G; Xu, RH; Zeng, FY				Luong, Mai X.; Auerbach, Jonathan; Crook, Jeremy M.; Daheron, Laurence; Hei, Derek; Lomax, Geoffrey; Loring, Jeanne F.; Ludwig, Tenneille; Schlaeger, Thorsten M.; Smith, Kelly P.; Stacey, Glyn; Xu, Ren-He; Zeng, Fanyi			A Call for Standardized Naming and Reporting of Human ESC and iPSC Lines	CELL STEM CELL			English	Editorial Material							PLURIPOTENT STEM-CELLS; FIBROBLASTS	Human embryonic and induced pluripotent stem cell lines are being generated at a rapid pace and now number in the thousands. We propose a standard nomenclature and suggest the use of a centralized database for all cell line names and a minimum set of information for reporting new derivations.	[Luong, Mai X.; Smith, Kelly P.] Univ Massachusetts, Sch Med, Dept Cell Biol, Int Stem Cell Registry, Shrewsbury, MA 01545 USA; [Auerbach, Jonathan] GlobalStem, Rockville, MD 20850 USA; [Crook, Jeremy M.] Univ Melbourne, St Vincents Hosp, Obrien Inst, Fitzroy, Vic 3065, Australia; [Crook, Jeremy M.] Univ Melbourne, St Vincents Hosp, Dept Surg, Fitzroy, Vic 3065, Australia; [Daheron, Laurence] Harvard IPSC Core Facil, Cambridge, MA 02138 USA; [Hei, Derek] Waisman Clin Biomfg Facil, Madison, WI 53705 USA; [Lomax, Geoffrey] CIRM, San Francisco, CA 94107 USA; [Loring, Jeanne F.] Scripps Res Inst, Ctr Regenerat Med, La Jolla, CA 92037 USA; [Ludwig, Tenneille] WiCell Res Inst, WISC Bank, Madison, WI 53705 USA; [Schlaeger, Thorsten M.] Childrens Hosp Boston, Human Embryon Stem Cell Core Facil, Boston, MA 02115 USA; [Stacey, Glyn] Natl Inst Biol Stand & Controls HPA, UK Stem Cell Bank, Potters Bar EN6 3QG, Herts, England; [Xu, Ren-He] Univ Connecticut, Ctr Hlth, Farmington, CT 06030 USA; [Zeng, Fanyi] Shanghai Jiao Tong Univ, Shanghai 200030, Peoples R China	University of Massachusetts System; St Vincent's Hospital Melbourne; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne; Scripps Research Institute; WiCell Research Institute; Harvard University; Boston Children's Hospital; National Institute for Biological Standards & Control; University of Connecticut; Shanghai Jiao Tong University	Luong, MX (corresponding author), Univ Massachusetts, Sch Med, Dept Cell Biol, Int Stem Cell Registry, Shrewsbury, MA 01545 USA.	mai.luong@umassmed.edu	Xu, Ren-He/M-3125-2016; Xu, Ren-He/AAK-7392-2021; Crook, Jeremy Micah/AAH-8441-2020; Loring, Jeanne F/A-1620-2011	Crook, Jeremy Micah/0000-0002-6415-1639; Loring, Jeanne F/0000-0001-6226-9767; Schlaeger, Thorsten/0000-0002-1599-9908	MRC [MC_qA137914, G1001045] Funding Source: UKRI; Medical Research Council [G1001045] Funding Source: Medline; Medical Research Council [MC_qA137914] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Andrews PW, 2009, STEM CELL REV REP, V5, P301, DOI 10.1007/s12015-009-9085-x; Coecke S, 2005, ATLA-ALTERN LAB ANIM, V33, P261, DOI 10.1177/026119290503300313; Galende E, 2010, CELL REPROGRAM, V12, P117, DOI 10.1089/cell.2009.0077; Kazuki Y, 2010, MOL THER, V18, P386, DOI 10.1038/mt.2009.274; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Ye L, 2009, P NATL ACAD SCI USA, V106, P9826, DOI 10.1073/pnas.0904689106; Zhou WB, 2009, STEM CELLS, V27, P2667, DOI 10.1002/stem.201	9	41	41	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 8	2011	8	4					357	359		10.1016/j.stem.2011.03.002	http://dx.doi.org/10.1016/j.stem.2011.03.002			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	752QI	21474098	Bronze			2022-12-28	WOS:000289707100006
J	Zhang, RR; Cui, QY; Murai, K; Lim, YC; Smith, ZD; Jin, SN; Ye, P; Rosa, L; Lee, YK; Wu, HP; Liu, W; Xu, ZM; Yang, L; Ding, YQ; Tang, FC; Meissner, A; Ding, CM; Shi, YH; Xu, GL				Zhang, Run-Rui; Cui, Qing-Yan; Murai, Kiyohito; Lim, Yen Ching; Smith, Zachary D.; Jin, Shengnan; Ye, Peng; Rosa, Luis; Lee, Yew Kok; Wu, Hai-Ping; Liu, Wei; Xu, Zhi-Mei; Yang, Lu; Ding, Yu-Qiang; Tang, Fuchou; Meissner, Alexander; Ding, Chunming; Shi, Yanhong; Xu, Guo-Liang			Tet1 Regulates Adult Hippocampal Neurogenesis and Cognition	CELL STEM CELL			English	Article							ACTIVE DNA DEMETHYLATION; EMBRYONIC STEM-CELLS; POSTNATAL-DEVELOPMENT; GENE-EXPRESSION; MAMMALIAN DNA; NEURAL STEM; 5-HYDROXYMETHYLCYTOSINE; BRAIN; NEURONS; 5-METHYLCYTOSINE	DNA hydroxylation catalyzed by Tet dioxygenases occurs abundantly in embryonic stem cells and neurons in mammals. However, its biological function in vivo is largely unknown. Here, we demonstrate that Tet1 plays an important role in regulating neural progenitor cell proliferation in adult mouse brain. Mice lacking Tet1 exhibit impaired hippocampal neurogenesis accompanied by poor learning and memory. In adult neural progenitor cells deficient in Tet1, a cohort of genes involved in progenitor proliferation were hypermethylated and downregulated. Our results indicate that Tet1 is positively involved in the epigenetic regulation of neural progenitor cell proliferation in the adult brain.	[Zhang, Run-Rui; Cui, Qing-Yan; Wu, Hai-Ping; Liu, Wei; Xu, Zhi-Mei; Xu, Guo-Liang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Murai, Kiyohito; Ye, Peng; Rosa, Luis; Shi, Yanhong] City Hope Natl Med Ctr, Beckman Res Inst, Ctr Gene Express & Drug Discovery, Dept Neurosci, Duarte, CA 91010 USA; [Lim, Yen Ching; Jin, Shengnan; Lee, Yew Kok; Ding, Chunming] Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore 117609, Singapore; [Smith, Zachary D.; Meissner, Alexander] Broad Inst, Cambridge, MA 02142 USA; [Smith, Zachary D.; Meissner, Alexander] Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Yang, Lu; Tang, Fuchou] Peking Univ, Sch Life Sci, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China; [Ding, Yu-Qiang] East Hosp, Minist Educ China, Key Lab Arrhythmias, Shanghai 200120, Peoples R China; [Ding, Yu-Qiang] Tongji Univ, Sch Med, Dept Anat & Neurobiol, Shanghai 200092, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; City of Hope; Beckman Research Institute of City of Hope; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Peking University; Ministry of Education, China; Tongji University	Ding, CM (corresponding author), Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore 117609, Singapore.	ding_chunming@sics.a-star.edu.sg; yshi@coh.org; glxu@sibs.ac.cn	Jin, Shengnan/I-6264-2012; Ding, Chunming/B-2593-2008	Jin, Shengnan/0000-0003-0467-6502; Ding, Chunming/0000-0002-2063-5594; Ding, Yu-Qiang/0000-0003-1202-4635; Shi, Yanhong/0000-0002-3938-5839; Cui, Qingyan/0000-0002-5029-4436	Ministry of Sciences and Technology of China [2012CB966903, 2009CB941101]; National Science Foundation of China [90919061, 31221001]; Chinese Academy of Sciences [XDA01010301]; NIH NINDS [R01 NS059546, RC1 NS068370]; California Institute for Regenerative Medicine [TR2-01832, RB4-06277]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059546, RC1NS068370] Funding Source: NIH RePORTER	Ministry of Sciences and Technology of China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Chun-Li Zhang and Qin Shen for comments; Hongjun Song, Haikun Liu, and Guoping Fan for discussions; Jianwei Jiao for Nestin-GFP and Nestin-Cre ERT2 mouse strains; Yujiang Shi for Tet1shRNA; Desmond Ng for help with sequencing; and Chenyan Ma, Ying Huang, Zelan Hu, Ningning Song, and Yingyu Zhang for technical assistance. This work was supported by grants from the Ministry of Sciences and Technology of China (2012CB966903 and 2009CB941101), the National Science Foundation of China (90919061 and 31221001), the "Strategic Priority Research Program" of the Chinese Academy of Sciences (XDA01010301) (to G.-L. X.), NIH NINDS (R01 NS059546 and RC1 NS068370), and the California Institute for Regenerative Medicine (TR2-01832 and RB4-06277) (to Y.S.).	Abbosh C, 2011, J NEUROCHEM, V117, P425, DOI 10.1111/j.1471-4159.2011.07204.x; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Calingasan NY, 2008, NEUROSCIENCE, V153, P986, DOI 10.1016/j.neuroscience.2008.02.071; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Dawlaty MM, 2013, DEV CELL, V24, P310, DOI 10.1016/j.devcel.2012.12.015; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Fan GP, 2005, DEVELOPMENT, V132, P3345, DOI 10.1242/dev.01912; Guo JJU, 2011, NAT NEUROSCI, V14, P1345, DOI 10.1038/nn.2900; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hahn MA, 2013, CELL REP, V3, P291, DOI 10.1016/j.celrep.2013.01.011; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Hutnick LK, 2009, HUM MOL GENET, V18, P2875, DOI 10.1093/hmg/ddp222; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Kucharova K, 2010, NEUROSCIENCE, V166, P185, DOI 10.1016/j.neuroscience.2009.12.014; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Ma DKK, 2010, NAT NEUROSCI, V13, P1338, DOI 10.1038/nn.2672; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Moens L, 2000, NATURE, V407, P461, DOI 10.1038/35035181; Mu YL, 2010, CURR OPIN NEUROBIOL, V20, P416, DOI 10.1016/j.conb.2010.04.010; Munzel M, 2010, ANGEW CHEM INT EDIT, V49, P5375, DOI 10.1002/anie.201002033; Ruzov A, 2011, CELL RES, V21, P1332, DOI 10.1038/cr.2011.113; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tan L, 2012, DEVELOPMENT, V139, P1895, DOI 10.1242/dev.070771; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yamaguchi S, 2012, NATURE, V492, P443, DOI 10.1038/nature11709; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao XY, 2003, P NATL ACAD SCI USA, V100, P6777, DOI 10.1073/pnas.1131928100	49	234	251	3	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 1	2013	13	2					237	245		10.1016/j.stem.2013.05.006	http://dx.doi.org/10.1016/j.stem.2013.05.006			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VO	23770080	Bronze, Green Accepted			2022-12-28	WOS:000329570600016
J	Choudhury, S; Almendro, V; Merino, VF; Wu, ZH; Maruyama, R; Su, Y; Martins, FC; Fackler, MJ; Bessarabova, M; Kowalczyk, A; Conway, T; Beresford-Smith, B; Macintyre, G; Cheng, YK; Lopez-Bujanda, Z; Kaspi, A; Hu, R; Robens, J; Nikolskaya, T; Haakensen, VD; Schnitt, SJ; Argani, P; Ethington, G; Panos, L; Grant, M; Clark, J; Herlihy, W; Lin, SJ; Chew, G; Thompson, EW; Greene-Colozzi, A; Richardson, AL; Rosson, GD; Pike, M; Garber, JE; Nikolsky, Y; Blum, JL; Au, A; Hwang, ES; Tamimi, RM; Michor, F; Haviv, I; Liu, XS; Sukumar, S; Polyak, K				Choudhury, Sibgat; Almendro, Vanessa; Merino, Vanessa F.; Wu, Zhenhua; Maruyama, Reo; Su, Ying; Martins, Filipe C.; Fackler, Mary Jo; Bessarabova, Marina; Kowalczyk, Adam; Conway, Thomas; Beresford-Smith, Bryan; Macintyre, Geoff; Cheng, Yu-Kang; Lopez-Bujanda, Zoila; Kaspi, Antony; Hu, Rong; Robens, Judith; Nikolskaya, Tatiana; Haakensen, Vilde D.; Schnitt, Stuart J.; Argani, Pedram; Ethington, Gabrielle; Panos, Laura; Grant, Michael; Clark, Jason; Herlihy, William; Lin, S. Joyce; Chew, Grace; Thompson, Erik W.; Greene-Colozzi, April; Richardson, Andrea L.; Rosson, Gedge D.; Pike, Malcolm; Garber, Judy E.; Nikolsky, Yuri; Blum, Joanne L.; Au, Alfred; Hwang, E. Shelley; Tamimi, Rulla M.; Michor, Franziska; Haviv, Izhak; Liu, X. Shirley; Sukumar, Saraswati; Polyak, Kornelia			Molecular Profiling of Human Mammary Gland Links Breast Cancer Risk to a p27(+) Cell Population with Progenitor Characteristics	CELL STEM CELL			English	Article							HORMONE-INDUCED PROTECTION; GENE-EXPRESSION; STEM-CELLS; MUTATION CARRIERS; GENOMIC SIGNATURE; PREGNANCY; P27(KIP1); INHIBITOR; GROWTH; TUMORIGENESIS	Early full-term pregnancy is one of the most effective natural protections against breast cancer. To investigate this effect, we have characterized the global gene expression and epigenetic profiles of multiple cell types from normal breast tissue of nulliparous and parous women and carriers of BRCA1 or BRCA2 mutations. We found significant differences in CD44(+) progenitor cells, where the levels of many stem cell-related genes and pathways, including the cell-cycle regulator p27, are lower in parous women without BRCA1/BRCA2 mutations. We also noted a significant reduction in the frequency of CD44(+)p27(+) cells in parous women and showed, using explant cultures, that parity-related signaling pathways play a role in regulating the number of p27(+) cells and their proliferation. Our results suggest that pathways controlling p27(+) mammary epithelial cells and the numbers of these cells relate to breast cancer risk and can be explored for cancer risk assessment and prevention.	[Choudhury, Sibgat; Almendro, Vanessa; Maruyama, Reo; Su, Ying; Martins, Filipe C.; Garber, Judy E.; Polyak, Kornelia] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Wu, Zhenhua; Cheng, Yu-Kang; Michor, Franziska; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Greene-Colozzi, April; Richardson, Andrea L.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Garber, Judy E.] Dana Farber Canc Inst, Ctr Clin Canc Genet, Boston, MA 02215 USA; [Choudhury, Sibgat; Almendro, Vanessa; Maruyama, Reo; Su, Ying; Hu, Rong; Garber, Judy E.; Tamimi, Rulla M.; Polyak, Kornelia] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Richardson, Andrea L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Choudhury, Sibgat; Almendro, Vanessa; Maruyama, Reo; Su, Ying; Garber, Judy E.; Polyak, Kornelia] Harvard Univ, Dept Med, Boston, MA 02115 USA; [Robens, Judith; Schnitt, Stuart J.; Richardson, Andrea L.] Harvard Univ, Dept Pathol, Boston, MA 02115 USA; [Wu, Zhenhua; Cheng, Yu-Kang; Tamimi, Rulla M.; Michor, Franziska; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Almendro, Vanessa] Hosp Clin Barcelona, Dept Med, Inst Invest Biomed August Pi & Sunyer, E-08036 Barcelona, Spain; [Merino, Vanessa F.; Fackler, Mary Jo; Lopez-Bujanda, Zoila; Sukumar, Saraswati] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21231 USA; [Argani, Pedram] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21231 USA; [Rosson, Gedge D.] Johns Hopkins Univ, Sch Med, Dept Plast Surg, Baltimore, MD 21231 USA; [Martins, Filipe C.] Coimbra Univ Hosp, Dept Obstet & Gynaecol, P-3000354 Coimbra, Portugal; [Martins, Filipe C.] Programa Gulbenkian Formacao Med Avancada, P-1067001 Lisbon, Portugal; [Bessarabova, Marina; Nikolskaya, Tatiana; Nikolsky, Yuri] Thomson Reuters Healthcare & Sci, Encinitas, CA 92024 USA; [Kowalczyk, Adam; Conway, Thomas; Beresford-Smith, Bryan; Macintyre, Geoff; Haviv, Izhak] Univ Melbourne, NICTA Victoria Res Lab, Parkville, Vic 3010, Australia; [Kowalczyk, Adam] Univ Melbourne, Dept Elect & Elect Engn, Parkville, Vic 3010, Australia; [Kowalczyk, Adam; Conway, Thomas; Beresford-Smith, Bryan; Macintyre, Geoff] Univ Melbourne, Dept Comp Sci & Software Engn, Parkville, Vic 3010, Australia; [Lin, S. Joyce; Haviv, Izhak] Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia; [Chew, Grace; Thompson, Erik W.] Univ Melbourne, Dept Surg, Parkville, Vic 3010, Australia; [Thompson, Erik W.] Univ Melbourne, Dept Biochem, Parkville, Vic 3010, Australia; [Kaspi, Antony; Haviv, Izhak] Baker IDI Heart & Diabet Inst, Prahran, Vic 3004, Australia; [Robens, Judith; Schnitt, Stuart J.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA; [Haakensen, Vilde D.] Univ Oslo, Oslo Univ Hosp, Dept Genet, Inst Canc Res, N-0424 Oslo, Norway; [Haakensen, Vilde D.] Univ Oslo, Oslo Univ Hosp, Inst Clin Med, KG Jebsen Ctr Breast Canc Res, N-0424 Oslo, Norway; [Ethington, Gabrielle; Panos, Laura; Grant, Michael; Clark, Jason; Herlihy, William; Blum, Joanne L.] Baylor Charles A Sammons Canc Ctr, Dallas, TX 75246 USA; [Thompson, Erik W.] St Vincents Inst, Fitzroy, Vic 3065, Australia; [Pike, Malcolm] Univ So Calif, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Au, Alfred; Hwang, E. Shelley] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Haviv, Izhak] Peter MacCallum Canc Ctr, East Melbourne, Vic 3002, Australia; [Polyak, Kornelia] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Clarivate; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Baker Heart and Diabetes Institute; Harvard University; Beth Israel Deaconess Medical Center; University of Oslo; University of Oslo; Baylor University Medical Center; Texas Oncology-Baylor Charles A Sammons Cancer Center; St. Vincent's Institute of Medical Research; University of Southern California; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Peter Maccallum Cancer Center; Harvard University	Sukumar, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21231 USA.	saras@jhmi.edu; kornelia_polyak@dfci.harvard.edu	Nikolskaya, Tatiana/M-5008-2013; Thompson, Erik/GPK-2067-2022; Haviv, Izhak/E-3782-2015; Thompson, Erik W/A-1425-2009	Thompson, Erik/0000-0002-9723-4924; Haviv, Izhak/0000-0002-0837-5005; Thompson, Erik W/0000-0002-9723-4924; Lopez Bujanda, Zoila/0000-0001-5729-7309; Rosson, Gedge/0000-0003-1817-9443; Su, Ying/0000-0003-0462-3865; Kaspi, Antony/0000-0001-6576-5862; Macintyre, Geoff/0000-0003-3906-467X; Haakensen, Vilde Drageset/0000-0003-0864-3628; Correia Martins, Filipe/0000-0001-6459-8206	Avon Foundation; National Cancer Institute [P50 CA89383, P01 CA080111, CA116235-04S1, CA087969]; Susan G. Komen Foundation; Terri Brodeur Foundation; US Army Congressionally Directed Research [W81XWH-07-1-0294]; Victorian Breast Cancer Research Consortium; St. Vincent's Hospital Research Endowment Fund; Victorian Government's OIS Program; Programme for Advanced Medical Education; Fundacao Calouste Gulbenkian; Cellex Foundation; NATIONAL CANCER INSTITUTE [P01CA080111, P50CA089393, R01CA116235, P01CA087969] Funding Source: NIH RePORTER	Avon Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Terri Brodeur Foundation; US Army Congressionally Directed Research; Victorian Breast Cancer Research Consortium; St. Vincent's Hospital Research Endowment Fund; Victorian Government's OIS Program; Programme for Advanced Medical Education; Fundacao Calouste Gulbenkian(European Commission); Cellex Foundation(Foundation CELLEX); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Lisa Cameron in the DFCI Confocal and Light Microscopy Core Facility, members of Dr. Massimo Loda's lab for technical assistance, members of our laboratories and Drs. Elgene Lim and David Livingston for their critical reading of this manuscript, Jonathan Yingling (Eli Lilly) for providing the LY2109761 TGF-beta receptor kinase inhibitor, Drs. Sally Knox, Jeffrey Lamont, and Dao Tuoc (Baylor University Medical Center-Baylor Sammons Cancer Center), Erin Bowlby (University of California San Francisco, San Francisco), and Drs. Eli Golomg and Pikarski (Hadassah Medical Centre) for their help with collecting tissue samples from patients with BRCA1/BRCA2 germline mutation. Samples from the Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center were used in this study. We thank contributors, including Indiana University who collected samples used in this study, as well as donors and their families, whose help and participation made this work possible. This work was supported by the Avon Foundation (to K. P. and S. S.), the National Cancer Institute P50 CA89383 and P01 CA080111 (to S.J.S., K. P., and A. L. R.), CA116235-04S1 (to K. P.), and CA087969 (to R. M. T.), the Susan G. Komen Foundation (to R. M., Y.S., I. H., J.E.G., and K. P.), the Terri Brodeur Foundation (to S. C.), US Army Congressionally Directed Research W81XWH-07-1-0294 (to K. P.), the Victorian Breast Cancer Research Consortium (to S.J.L., G. C., and E. W. T.), the St. Vincent's Hospital Research Endowment Fund and the Victorian Government's OIS Program (to E. W. T.), the Programme for Advanced Medical Education funded by Fundacao Calouste Gulbenkian (to F. M.), and the Cellex Foundation (to V.A.).	Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Asztalos S, 2010, CANCER PREV RES, V3, P301, DOI 10.1158/1940-6207.CAPR-09-0069; Belitskaya-Levy I, 2011, CANCER PREV RES, V4, P1457, DOI 10.1158/1940-6207.CAPR-11-0021; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blakely CM, 2006, CANCER RES, V66, P6421, DOI 10.1158/0008-5472.CAN-05-4235; Bloushtain-Qimron N, 2008, P NATL ACAD SCI USA, V105, P14076, DOI 10.1073/pnas.0805206105; Bock C, 2012, MOL CELL, V47, P633, DOI 10.1016/j.molcel.2012.06.019; Boyd NF, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2423; Brisken C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003178; Britt KL, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2245; Cheng T, 2000, NAT MED, V6, P1235, DOI 10.1038/81335; Chung K, 2012, BREAST CANCER RES TR, V132, P653, DOI 10.1007/s10549-011-1870-y; Colditz GA, 2004, JNCI-J NATL CANCER I, V96, P218, DOI 10.1093/jnci/djh025; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Cullinane CA, 2005, INT J CANCER, V117, P988, DOI 10.1002/ijc.21273; D'Cruz CM, 2002, MOL ENDOCRINOL, V16, P2034, DOI 10.1210/me.2002-0073; Davison EA, 2003, MOL ENDOCRINOL, V17, P2436, DOI 10.1210/me.2003-0199; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Garbe JC, 2009, CANCER RES, V69, P7557, DOI 10.1158/0008-5472.CAN-09-0270; Ginger MR, 2003, BREAST CANCER RES, V5, P192, DOI 10.1186/bcr603; GOING JJ, 1988, AM J PATHOL, V130, P193; Haakensen VD, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-77; Haakensen VD, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-332; Hu M, 2005, NAT GENET, V37, P899, DOI 10.1038/ng1596; Humbert PO, 2008, ONCOGENE, V27, P6888, DOI 10.1038/onc.2008.341; Jones PA, 1999, TRENDS GENET, V15, P34, DOI 10.1016/S0168-9525(98)01636-9; Key TJ, 2010, LANCET ONCOL, V11, P530, DOI 10.1016/S1470-2045(10)70095-4; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kowalczyk A, 2011, J COMPUT BIOL, V18, P391, DOI 10.1089/cmb.2010.0272; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Maruyama R, 2012, P NATL ACAD SCI USA, V109, P2820, DOI 10.1073/pnas.1010559107; Maruyama R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001369; Maxwell KN, 2012, NAT REV CLIN ONCOL, V9, P520, DOI 10.1038/nrclinonc.2012.123; Mitsuhashi T, 2001, P NATL ACAD SCI USA, V98, P6435, DOI 10.1073/pnas.111051398; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Muraoka RS, 2001, J CELL BIOL, V153, P917, DOI 10.1083/jcb.153.5.917; Nikolsky Y, 2008, CANCER RES, V68, P9532, DOI 10.1158/0008-5472.CAN-08-3082; Nikolsky Y, 2009, METHODS MOL BIOL, V563, P177, DOI 10.1007/978-1-60761-175-2_10; Oesterle EC, 2011, CELL CYCLE, V10, P1237, DOI 10.4161/cc.10.8.15301; Ohtsubo M, 2008, P NATL ACAD SCI USA, V105, P10396, DOI 10.1073/pnas.0800672105; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Poynter JN, 2010, CANCER CAUSE CONTROL, V21, P839, DOI 10.1007/s10552-010-9510-0; Rebbeck TR, 1999, AM J HUM GENET, V64, P1371, DOI 10.1086/302366; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Russo J, 2001, Breast J, V7, P278, DOI 10.1046/j.1524-4741.2001.21033.x; Russo J, 2005, BREAST CANCER RES, V7, P131, DOI 10.1186/bcr1029; Russo J, 2008, CANCER EPIDEM BIOMAR, V17, P51, DOI 10.1158/1055-9965.EPI-07-0678; Russo J, 2012, INT J CANCER, V131, P1059, DOI 10.1002/ijc.27323; Scollen S, 2011, CANCER EPIDEM BIOMAR, V20, P1112, DOI 10.1158/1055-9965.EPI-11-0062; Shinde SS, 2010, CANCER-AM CANCER SOC, V116, P4933, DOI 10.1002/cncr.25443; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Sivaraman L, 2002, J MAMMARY GLAND BIOL, V7, P77, DOI 10.1023/A:1015774524076; Siwko SK, 2008, STEM CELLS, V26, P3205, DOI 10.1634/stemcells.2008-0103; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Taylor D, 2009, BREAST CANCER RES TR, V118, P161, DOI 10.1007/s10549-009-0322-4; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Wu ZJ, 2010, GENOME RES, V20, P1730, DOI 10.1101/gr.108217.110	58	65	65	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2013	13	1					117	130		10.1016/j.stem.2013.05.004	http://dx.doi.org/10.1016/j.stem.2013.05.004			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VJ	23770079	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000329570100017
J	Kim, KH; Roberts, CWM				Kim, Kimberly H.; Roberts, Charles W. M.			CHD7 in Charge of Neurogenesis	CELL STEM CELL			English	Editorial Material							MUTATIONS	In this issue of Cell Stem Cell, Feng et al. (2013) report that the gene mutated in human CHARGE syndrome, ATP-dependent chromatin remodeling factor CHD7, contributes to the control of neurogenesis. The authors also report that exercise ameliorates these defects and suggest it as an intervention worthy of study in CHARGE syndrome.	[Kim, Kimberly H.; Roberts, Charles W. M.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA; [Kim, Kimberly H.; Roberts, Charles W. M.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Kim, Kimberly H.; Roberts, Charles W. M.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Roberts, CWM (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA.	charles_roberts@dfci.harvard.edu	Roberts, Charles/N-2541-2018	Roberts, Charles/0000-0003-1135-1896				Batsukh T, 2010, HUM MOL GENET, V19, P2858, DOI 10.1093/hmg/ddq189; Bergman JEH, 2011, J MED GENET, V48, P334, DOI 10.1136/jmg.2010.087106; Bosman EA, 2005, HUM MOL GENET, V14, P3463, DOI 10.1093/hmg/ddi375; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Feng WJ, 2013, CELL STEM CELL, V13, P62, DOI 10.1016/j.stem.2013.05.002; Frazzitta G, 2013, AM J PHYS MED REHAB, V92, P523, DOI 10.1097/PHM.0b013e31828cd254; Hurd EA, 2007, MAMM GENOME, V18, P94, DOI 10.1007/s00335-006-0107-6; Tsurusaki Y, 2012, NAT GENET, V44, P376, DOI 10.1038/ng.2219; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068	9	4	5	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2013	13	1					1	2		10.1016/j.stem.2013.06.010	http://dx.doi.org/10.1016/j.stem.2013.06.010			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VJ	23827700	Bronze			2022-12-28	WOS:000329570100001
J	Tulpule, A; Kelley, JM; Lensch, MW; McPherson, J; Park, IH; Hartung, O; Nakamura, T; Schlaeger, TM; Shimamura, A; Daley, GQ				Tulpule, Asmin; Kelley, James M.; Lensch, M. William; McPherson, Jade; Park, In Hyun; Hartung, Odelya; Nakamura, Tomoka; Schlaeger, Thorsten M.; Shimamura, Akiko; Daley, George Q.			Pluripotent Stem Cell Models of Shwachman-Diamond Syndrome Reveal a Common Mechanism for Pancreatic and Hematopoietic Dysfunction	CELL STEM CELL			English	Article							MARROW FAILURE SYNDROMES; SBDS GENE; MUTATIONS; DIFFERENTIATION; GENERATION; FEATURES; PROTEIN; DEATH; RNA	Shwachman-Diamond syndrome (SDS), a rare autosomal- recessive disorder characterized by exocrine pancreatic insufficiency and hematopoietic dysfunction, is caused by mutations in the Shwachman-Bodian- Diamond syndrome (SBDS) gene. We created human pluripotent stem cell models of SDS through knockdown of SBDS in human embryonic stem cells (hESCs) and generation of induced pluripotent stem cell (iPSC) lines from two patients with SDS. SBDS-deficient hESCs and iPSCs manifest deficits in exocrine pancreatic and hematopoietic differentiation in vitro, enhanced apoptosis, and elevated protease levels in culture supernatants, which could be reversed by restoring SBDS protein expression through transgene rescue or by supplementing culture media with protease inhibitors. Protease-mediated autodigestion provides a mechanistic link between the pancreatic and hematopoietic phenotypes in SDS, highlighting the utility of hESCs and iPSCs in obtaining novel insights into human disease.	[Tulpule, Asmin; Lensch, M. William; McPherson, Jade; Hartung, Odelya; Schlaeger, Thorsten M.; Shimamura, Akiko; Daley, George Q.] Boston Childrens Hosp, Dana Farber Canc Inst, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Tulpule, Asmin; Daley, George Q.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Kelley, James M.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Tulpule, Asmin; Lensch, M. William; McPherson, Jade; Hartung, Odelya; Schlaeger, Thorsten M.; Daley, George Q.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Lensch, M. William; Daley, George Q.] Howard Hughes Med Inst, New Haven, CT 06520 USA; [Park, In Hyun] Yale Stem Cell Ctr, New Haven, CT 06520 USA; [Nakamura, Tomoka; Shimamura, Akiko] Fred Hutchinson Canc Res Ctr, Clin Res Div, Seattle, WA 98109 USA; [Shimamura, Akiko] Seattle Childrens Hosp, Seattle, WA 98105 USA; [Shimamura, Akiko] Univ Washington, Seattle, WA 98105 USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Howard Hughes Medical Institute; Yale University; Fred Hutchinson Cancer Center; Seattle Children's Hospital; University of Washington; University of Washington Seattle	Daley, GQ (corresponding author), Boston Childrens Hosp, Dana Farber Canc Inst, Div Pediat Hematol Oncol, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu		Schlaeger, Thorsten/0000-0002-1599-9908	Manton Center for Orphan Disease Research (BCH); NIH [P30 DK056465-10, R01 HL079582-11, R24 DK092760, RC4 DK09091, U01 HL100001, UL1 DE019582]; Roche Foundation for Anemia Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079582, U01HL100001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [UL1DE019582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC4DK090913, P30DK056465, R24DK092760] Funding Source: NIH RePORTER	Manton Center for Orphan Disease Research (BCH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roche Foundation for Anemia Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Shuibing Chen (Weill Cornell Medical College) and Doug Melton (Harvard University) for their help with pancreatic differentiation protocols and Roderick Bronson (Harvard University) for his histopathological expertise. Harry Kozakewich (Boston Children's Hospital [BCH]) provided SDS patient slides. This work was supported by the Manton Center for Orphan Disease Research (BCH); NIH grants P30 DK056465-10, R01 HL079582-11, R24 DK092760, RC4 DK09091, U01 HL100001, and UL1 DE019582; and the Roche Foundation for Anemia Research. G.Q.D. is an investigator of the Howard Hughes Medical Institute.	Austin KM, 2008, J CLIN INVEST, V118, P1511, DOI 10.1172/JCI33764; Austin KM, 2005, BLOOD, V106, P1253, DOI 10.1182/blood-2005-02-0807; Boocock GRB, 2003, NAT GENET, V33, P97, DOI 10.1038/ng1062; Burwick N, 2012, BLOOD, V120, P5143, DOI 10.1182/blood-2012-04-420166; Cai J, 2010, J MOL CELL BIOL, V2, P50, DOI 10.1093/jmcb/mjp037; Calado RT, 2007, BLOOD, V110, P1141, DOI 10.1182/blood-2007-03-080044; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Chau YP, 2003, HISTOL HISTOPATHOL, V18, P715, DOI 10.14670/HH-18.715; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; Donadieu J, 2005, HAEMATOLOGICA, V90, P45; Finch AJ, 2011, GENE DEV, V25, P917, DOI 10.1101/gad.623011; Ganapathi KA, 2007, BLOOD, V110, P1458, DOI 10.1182/blood-2007-02-075184; Gartmann M, 2010, J BIOL CHEM, V285, P14848, DOI 10.1074/jbc.C109.096057; Hashmi SK, 2011, CLIN GENET, V79, P448, DOI 10.1111/j.1399-0004.2010.01468.x; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Minelli A, 2009, LEUKEMIA, V23, P708, DOI 10.1038/leu.2008.369; Nakashima E, 2004, HUM GENET, V114, P345, DOI 10.1007/s00439-004-1081-2; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Rujkijyanont P, 2008, HAEMATOLOGICA, V93, P363, DOI 10.3324/haematol.11579; Shah N, 2010, J CLIN PATHOL, V63, P592, DOI 10.1136/jcp.2010.077677; Shimamura A, 2006, SEMIN HEMATOL, V43, P178, DOI 10.1053/j.seminhematol.2006.04.006; Stormon MO, 2010, J PEDIATR GASTR NUTR, V51, P8, DOI 10.1097/MPG.0b013e3181d67e78; Toiviainen-Salo S, 2007, BONE, V41, P965, DOI 10.1016/j.bone.2007.08.035; Tourlakis ME, 2012, GASTROENTEROLOGY, V143, P481, DOI 10.1053/j.gastro.2012.04.012; Tsangaris E, 2011, J MED GENET, V48, P618, DOI 10.1136/jmg.2011.089821; Woloszynek JR, 2004, BLOOD, V104, P3588, DOI 10.1182/blood-2004-04-1516; Wong CC, 2011, BLOOD, V118, P4305, DOI 10.1182/blood-2011-06-353938; Yamaguchi M, 2007, EXP HEMATOL, V35, P579, DOI 10.1016/j.exphem.2006.12.010; Zhang SY, 2006, MOL CELL BIOL, V26, P6656, DOI 10.1128/MCB.00091-06	32	60	62	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 6	2013	12	6					727	736		10.1016/j.stem.2013.04.002	http://dx.doi.org/10.1016/j.stem.2013.04.002			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VH	23602541	Green Accepted, Bronze			2022-12-28	WOS:000329569900015
J	Shyh-Chang, N; Daley, GQ				Shyh-Chang, Ng; Daley, George Q.			Lin28: Primal Regulator of Growth and Metabolism in Stem Cells	CELL STEM CELL			English	Review							BINDING PROTEIN LIN28; PLURIPOTENCY FACTOR LIN28; TUMOR-INITIATING CELLS; LET-7 MICRORNA; SELF-RENEWAL; NUCLEAR RECEPTOR; POSTTRANSCRIPTIONAL REGULATION; PROMOTES TRANSFORMATION; DEVELOPMENTAL AGE; LIN-28 HOMOLOG	In recent years, the highly conserved Lin28 RNA-binding proteins have emerged as factors that define stemness in several tissue lineages. Lin28 proteins repress let-7 microRNAs and influence mRNA translation, thereby regulating the self-renewal of mammalian embryonic stem cells. Subsequent discoveries revealed that Lin28a and Lin28b are also important in organismal growth and metabolism, tissue development, somatic reprogramming, and cancer. In this review, we discuss the Lin28 pathway and its regulation, outline its roles in stem cells, tissue development, and pathogenesis, and examine the ramifications for re-engineering mammalian physiology.	[Shyh-Chang, Ng; Daley, George Q.] Boston Childrens Hosp, Div Pediat Hematol Oncol, Stem Cell Transplantat Program, Boston, MA 02115 USA; [Shyh-Chang, Ng; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Shyh-Chang, Ng; Daley, George Q.] Harvard Stem Cell Inst, Boston, MA 02115 USA; [Shyh-Chang, Ng; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Daley, George Q.] Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Daley, George Q.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Daley, GQ (corresponding author), Boston Childrens Hosp, Div Pediat Hematol Oncol, Stem Cell Transplantat Program, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu		Shyh-Chang, Ng/0000-0003-3138-9525	National Science Scholarship from the Agency for Science, Technology and Research, Singapore; Ellison Medical Foundation; Progenitor Cell Biology Consortium of the National Heart Lung Blood Institute [UO1-HL100001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100001] Funding Source: NIH RePORTER	National Science Scholarship from the Agency for Science, Technology and Research, Singapore; Ellison Medical Foundation(Lawrence Ellison Foundation); Progenitor Cell Biology Consortium of the National Heart Lung Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We apologize to those authors whose papers could not be cited due to space constraints. We thank H. Zhu, K. Tsanov, J.T. Powers, and three anonymous reviewers for constructive feedback on the manuscript. N.S.C. is supported by the National Science Scholarship from the Agency for Science, Technology and Research, Singapore. G. Q. D. is an investigator of the Howard Hughes Medical Institute. Support was provided by the Ellison Medical Foundation and the Progenitor Cell Biology Consortium of the National Heart Lung Blood Institute (UO1-HL100001).	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Alexander PB, 2011, P NATL ACAD SCI USA, V108, P15828, DOI 10.1073/pnas.1111312108; AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Antebi A, 2000, GENE DEV, V14, P1512; Antebi A, 1998, DEVELOPMENT, V125, P1191; Balzer E, 2007, RNA BIOL, V4, P16, DOI 10.4161/rna.4.1.4364; Balzer E, 2010, DEVELOPMENT, V137, P891, DOI 10.1242/dev.042895; Barbaux S, 2012, EPIGENETICS-US, V7, P1079, DOI 10.4161/epi.21495; Barbieri M, 2003, EXP GERONTOL, V38, P137, DOI 10.1016/S0531-5565(02)00153-5; Bartke A, 2012, GERONTOLOGY, V58, P337, DOI 10.1159/000335166; Beachy SH, 2012, BLOOD, V120, P1048, DOI 10.1182/blood-2012-01-401760; Benhamed M, 2012, NAT CELL BIOL, V14, P266, DOI 10.1038/ncb2443; Bethke A, 2009, SCIENCE, V324, P95, DOI 10.1126/science.1164899; Bhat-Nakshatri P, 2009, NUCLEIC ACIDS RES, V37, P4850, DOI 10.1093/nar/gkp500; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Bousquet M, 2008, J EXP MED, V205, P2499, DOI 10.1084/jem.20080285; Bousquet M, 2010, P NATL ACAD SCI USA, V107, P21558, DOI 10.1073/pnas.1016611107; Boyerinas B, 2008, CANCER RES, V68, P2587, DOI 10.1158/0008-5472.CAN-08-0264; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Cao DF, 2011, HUM PATHOL, V42, P710, DOI 10.1016/j.humpath.2010.09.007; Cao DF, 2011, MODERN PATHOL, V24, P288, DOI 10.1038/modpathol.2010.195; CHALFIE M, 1981, CELL, V24, P59, DOI 10.1016/0092-8674(81)90501-8; Chang HM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1909; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Chaudhuri AA, 2012, P NATL ACAD SCI USA, V109, P4233, DOI 10.1073/pnas.1200677109; Chawla G, 2012, DEVELOPMENT, V139, P1788, DOI 10.1242/dev.077743; Chiefari E, 2011, JAMA-J AM MED ASSOC, V305, P903, DOI 10.1001/jama.2011.207; Cho J, 2012, CELL, V151, P765, DOI 10.1016/j.cell.2012.10.019; Cox JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015486; Dang CV, 2011, COLD SH Q B, V76, P369, DOI 10.1101/sqb.2011.76.011296; Diskin SJ, 2012, NAT GENET, V44, P1126, DOI 10.1038/ng.2387; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Frost RJA, 2011, P NATL ACAD SCI USA, V108, P21075, DOI 10.1073/pnas.1118922109; Ge YJ, 2011, J CELL BIOL, V192, P69, DOI 10.1083/jcb.201007165; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; Gerisch B, 2007, P NATL ACAD SCI USA, V104, P5014, DOI 10.1073/pnas.0700847104; Gillis AJM, 2011, INT J ANDROL, V34, pE160, DOI 10.1111/j.1365-2605.2011.01148.x; Golipour A, 2012, CELL STEM CELL, V11, P769, DOI 10.1016/j.stem.2012.11.008; Guo G, 2010, DEVELOPMENT, V137, P3185, DOI 10.1242/dev.052753; Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Hafner M, 2013, RNA; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Hammell CM, 2009, P NATL ACAD SCI USA, V106, P18668, DOI 10.1073/pnas.0908131106; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2012, CELL, V151, P521, DOI 10.1016/j.cell.2012.09.022; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; HORVITZ HR, 1980, GENETICS, V96, P435; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Ishizawa K, 2010, CELL STEM CELL, V7, P279, DOI 10.1016/j.stem.2010.08.009; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Janiszewska M, 2012, GENE DEV, V26, P1926, DOI 10.1101/gad.188292.112; Jiang X, 2012, CANCER CELL, V22, P524, DOI 10.1016/j.ccr.2012.08.028; Jin JY, 2011, NUCLEIC ACIDS RES, V39, P3724, DOI 10.1093/nar/gkq1350; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kawahara H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.199166; King CE, 2011, CANCER RES, V71, P4260, DOI 10.1158/0008-5472.CAN-10-4637; Klusmann JH, 2010, GENE DEV, V24, P478, DOI 10.1101/gad.1856210; Kolquist KA, 1998, NAT GENET, V19, P182, DOI 10.1038/554; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Le MTN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002242; Le MTN, 2009, MOL CELL BIOL, V29, P5290, DOI 10.1128/MCB.01694-08; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Legesse-Miller A, 2009, J BIOL CHEM, V284, P6605, DOI 10.1074/jbc.C900002200; Lehrbach NJ, 2009, NAT STRUCT MOL BIOL, V16, P1016, DOI 10.1038/nsmb.1675; Li N, 2012, J BIOL CHEM, V287, P17386, DOI 10.1074/jbc.M111.321158; Liau SS, 2006, CANCER RES, V66, P11613, DOI 10.1158/0008-5472.CAN-06-1460; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Molenaar JJ, 2012, NAT GENET, V44, P1199, DOI 10.1038/ng.2436; Morita K, 2006, EMBO J, V25, P5794, DOI 10.1038/sj.emboj.7601451; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Shyh-Chang N, 2013, SCIENCE, V339, P222, DOI 10.1126/science.1226603; Nichols J, 2001, DEVELOPMENT, V128, P2333; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; O'Connell RM, 2010, P NATL ACAD SCI USA, V107, P14235, DOI 10.1073/pnas.1009798107; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Ooi AGL, 2010, P NATL ACAD SCI USA, V107, P21505, DOI 10.1073/pnas.1016218107; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Peng SP, 2011, STEM CELLS, V29, P496, DOI 10.1002/stem.591; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Picard D, 2012, LANCET ONCOL, V13, P838, DOI 10.1016/S1470-2045(12)70257-7; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Ramachandran R, 2010, NAT CELL BIOL, V12, P1101, DOI 10.1038/ncb2115; Rao SY, 2012, BLOOD, V120, P3764, DOI 10.1182/blood-2012-03-415349; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rodini CO, 2012, J NEURO-ONCOL, V106, P71, DOI 10.1007/s11060-011-0647-9; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Sacco A, 2010, CELL, V143, P1059, DOI 10.1016/j.cell.2010.11.039; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Sangiao-Alvarellos S, 2013, ENDOCRINOLOGY, V154, P942, DOI 10.1210/en.2012-2006; Schaetzlein S, 2004, P NATL ACAD SCI USA, V101, P8034, DOI 10.1073/pnas.0402400101; Schulz C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020820; Shinoda G., 2013, STEM CELLS; Shyh-Chang N., 2013, DEVELOPMENT; Shyh-Chang N, 2011, EMBO J, V30, P4851, DOI 10.1038/emboj.2011.436; Sokol NS, 2008, GENE DEV, V22, P1591, DOI 10.1101/gad.1671708; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; SULSTON JE, 1981, DEV BIOL, V82, P41, DOI 10.1016/0012-1606(81)90427-9; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Thornton JE, 2012, RNA, V18, P1875, DOI 10.1261/rna.034538.112; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Vadla B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002588; Van Wynsberghe PM, 2011, NAT STRUCT MOL BIOL, V18, P302, DOI 10.1038/nsmb.1986; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Vogt EJ, 2012, DEVELOPMENT, V139, P4514, DOI 10.1242/dev.083279; Wang J, 2009, SCIENCE, V325, P435, DOI 10.1126/science.1173288; Wang W, 2011, P NATL ACAD SCI USA, V108, P18283, DOI 10.1073/pnas.1100893108; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Wilbert ML, 2012, MOL CELL, V48, P195, DOI 10.1016/j.molcel.2012.08.004; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Xue DB, 2011, HISTOPATHOLOGY, V59, P452, DOI 10.1111/j.1365-2559.2011.03949.x; Yang DH, 2003, GENE EXPR PATTERNS, V3, P719, DOI 10.1016/S1567-133X(03)00140-6; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yuan J, 2012, SCIENCE, V335, P1195, DOI 10.1126/science.1216557; Yuan XM, 1999, GENES CELLS, V4, P563, DOI 10.1046/j.1365-2443.1999.00284.x; Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401; Zhang LA, 2011, CELL STEM CELL, V8, P294, DOI 10.1016/j.stem.2011.01.014; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050; Zheng K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-38; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	150	338	349	3	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 4	2013	12	4					395	406		10.1016/j.stem.2013.03.005	http://dx.doi.org/10.1016/j.stem.2013.03.005			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VD	23561442	Bronze, Green Accepted			2022-12-28	WOS:000329569500007
J	Hu, GQ; Cui, KR; Northrup, D; Liu, CY; Wang, CC; Tang, QS; Ge, K; Levens, D; Crane-Robinson, C; Zhao, KJ				Hu, Gangqing; Cui, Kairong; Northrup, Daniel; Liu, Chengyu; Wang, Chaochen; Tang, Qingsong; Ge, Kai; Levens, David; Crane-Robinson, Colyn; Zhao, Keji			H2A.Z Facilitates Access of Active and Repressive Complexes to Chromatin in Embryonic Stem Cell Self-Renewal and Differentiation	CELL STEM CELL			English	Article							HISTONE VARIANT H2A.Z; HUMAN GENOME; DNA METHYLATION; METHYLTRANSFERASE ACTIVITY; REGULATORY SEQUENCES; ES CELLS; ENHANCERS; ACETYLATION; PROMOTERS; GENES	Chromatin modifications have been implicated in the self-renewal and differentiation of embryonic stem cells (ESCs). However, the function of histone variant H2A.Z in ESCs remains unclear. We show that H2A.Z is highly enriched at promoters and enhancers and is required for both efficient self-renewal and differentiation of murine ESCs. H2A.Z deposition leads to an abnormal nucleosome structure, decreased nucleosome occupancy, and increased chromatin accessibility. In self-renewing ESCs, knockdown of H2A.Z compromises OCT4 binding to its target genes and leads to decreased binding of MLL complexes to active genes and of PRC2 complex to repressed genes. During differentiation of ESCs, inhibition of H2A.Z also compromises RA-induced RAR alpha binding, activation of differentiation markers, and the repression of pluripotency genes. We propose that H2A.Z mediates such contrasting activities by acting as a general facilitator that generates access for a variety of complexes, both activating and repressive.	[Hu, Gangqing; Cui, Kairong; Northrup, Daniel; Tang, Qingsong; Zhao, Keji] NHLBI, Syst Biol Ctr, NIH, Bethesda, MD 20892 USA; [Liu, Chengyu] NHLBI, Transgen Mouse Facil, NIH, Bethesda, MD 20892 USA; [Wang, Chaochen; Ge, Kai] Natl Inst Diabet & Digest & Kidney Dis, Lab Endocrinol & Receptor Biol, NIH, Bethesda, MD 20892 USA; [Levens, David] NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA; [Crane-Robinson, Colyn] Univ Portsmouth, Biophys Labs, Portsmouth PO1 2DT, Hants, England	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Portsmouth	Zhao, KJ (corresponding author), NHLBI, Syst Biol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	zhaok@nhlbi.nih.gov	HU, GANGQING/K-5849-2012; Wang, Chaochen/AAE-6657-2022; Hu, Gangqing/ABA-3507-2020; Levens, David/C-9216-2009; Ge, Kai/H-2810-2019; Wang, Chaochen/AAO-2998-2021	HU, GANGQING/0000-0001-5453-6888; Wang, Chaochen/0000-0003-2346-2884; Levens, David/0000-0002-7616-922X; Ge, Kai/0000-0002-7442-5138; Northrup, Daniel/0000-0002-2665-2686	NHLBI, NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006058, ZIAHL005801, ZICHL005907, Z01HL005801, ZIAHL006031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075003] Funding Source: NIH RePORTER	NHLBI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Zhibin Wang, Dustin E. Schones, Iouri Chepelev, Brian J. Abraham, Gang Wei, Daniel Kraushaar, and Benjamin Kidder for helpful discussions. The DNA Sequencing Core and the Flow Cytometry Core of the National Institute of Heart, Lung, and Blood Institute (NHLBI) assisted with this work. Support was provided by the Division of Intramural Research Program of the NHLBI, NIH.	Amat R, 2011, J CELL PHYSIOL, V226, P293, DOI 10.1002/jcp.22420; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bruce K, 2005, NUCLEIC ACIDS RES, V33, P5633, DOI 10.1093/nar/gki874; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Cho YW, 2009, CELL METAB, V10, P27, DOI 10.1016/j.cmet.2009.05.010; Conerly ML, 2010, GENOME RES, V20, P1383, DOI 10.1101/gr.106542.110; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Diez del Corral R, 2004, BIOESSAYS, V26, P857, DOI 10.1002/bies.20080; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dryhurst D, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-86; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fan JY, 2004, MOL CELL, V16, P655, DOI 10.1016/j.molcel.2004.10.023; Fan JY, 2002, NAT STRUCT BIOL, V9, P172, DOI 10.1038/nsb767; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Goldman JA, 2010, J BIOL CHEM, V285, P4645, DOI 10.1074/jbc.M109.072348; Grontved L, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-10; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hardy S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000687; Hawkins RD, 2011, CELL RES, V21, P1393, DOI 10.1038/cr.2011.146; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hu GQ, 2011, GENOME RES, V21, P1650, DOI 10.1101/gr.121145.111; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Kim HS, 2009, NAT STRUCT MOL BIOL, V16, P1286, DOI 10.1038/nsmb.1688; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Ku MC, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R85, 10.1186/gb-2012-13-10-r85]; Leach TJ, 2000, J BIOL CHEM, V275, P23267, DOI 10.1074/jbc.M910206199; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Pekowska A, 2011, EMBO J, V30, P4198, DOI 10.1038/emboj.2011.295; Pekowska A, 2010, GENOME RES, V20, P1493, DOI 10.1101/gr.109389.110; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rangasamy D, 2003, EMBO J, V22, P1599, DOI 10.1093/emboj/cdg160; Ren QH, 2001, MOL CELL, V7, P1329, DOI 10.1016/S1097-2765(01)00269-6; Roh TY, 2007, GENOME RES, V17, P74, DOI 10.1101/gr.5767907; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Thambirajah AA, 2006, J BIOL CHEM, V281, P20036, DOI 10.1074/jbc.M601975200; Tillo D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009129; Tolstorukov MY, 2009, GENOME RES, V19, P967, DOI 10.1101/gr.084830.108; Valdes-Mora F, 2012, GENOME RES, V22, P307, DOI 10.1101/gr.118919.110; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Yang XJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002604; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324; Zlatanova J, 2008, STRUCTURE, V16, P166, DOI 10.1016/j.str.2007.12.008	52	213	216	0	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 7	2013	12	2					180	192		10.1016/j.stem.2012.11.003	http://dx.doi.org/10.1016/j.stem.2012.11.003			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VB	23260488	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000329569300009
J	Jaenisch, R				Jaenisch, Rudolf			Nuclear Cloning and Direct Reprogramming: The Long and the Short Path to Stockholm	CELL STEM CELL			English	Editorial Material							CELLS	The two winners of the 2012 Nobel Prize in Physiology or Medicine share more than just this honor; they are both also fearless adventurers, in science and beyond.	Whitehead Inst, Cambridge Ctr 9, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Jaenisch, R (corresponding author), Whitehead Inst, Cambridge Ctr 9, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu			NCI NIH HHS [R01 CA084198] Funding Source: Medline; NICHD NIH HHS [R01 HD045022] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA084198] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		DEROBERTIS EM, 1977, P NATL ACAD SCI USA, V74, P2470; Graf T, 2011, CELL STEM CELL, V9, P504, DOI 10.1016/j.stem.2011.11.012; GURDON JB, 1966, NATURE, V210, P1240, DOI 10.1038/2101240a0; GURDON JB, 1960, J EMBRYOL EXP MORPH, V8, P505; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Hyun I, 2011, CELL STEM CELL, V9, P295, DOI 10.1016/j.stem.2011.08.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005	10	16	17	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	DEC 7	2012	11	6					744	747		10.1016/j.stem.2012.11.005	http://dx.doi.org/10.1016/j.stem.2012.11.005			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	055MJ	23217419	Green Published, Bronze			2022-12-28	WOS:000312420300006
J	Kusek, G; Campbell, M; Doyle, F; Tenenbaum, SA; Kiebler, M; Temple, S				Kusek, Gretchen; Campbell, Melissa; Doyle, Frank; Tenenbaum, Scott A.; Kiebler, Michael; Temple, Sally			Asymmetric Segregation of the Double-Stranded RNA Binding Protein Staufen2 during Mammalian Neural Stem Cell Divisions Promotes Lineage Progression	CELL STEM CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; CORTICAL NEUROGENESIS; PROGENITOR CELLS; SOMATODENDRITIC DOMAIN; NEURONAL PROGENITORS; BASAL PROGENITORS; CEREBRAL-CORTEX; MESSENGER-RNAS; SELF-RENEWAL; PROSPERO	Asymmetric cell divisions are a fundamental feature of neural development, and misregulation can lead to brain abnormalities or tumor formation. During an asymmetric cell division, molecular determinants are segregated preferentially into one daughter cell to specify its fate. An important goal is to identify the asymmetric determinants in neural progenitor cells, which could be tumor suppressors or inducers of specific neural fates. Here, we show that the double-stranded RNA-binding protein Stau2 is distributed asymmetrically during progenitor divisions in the developing mouse cortex, preferentially segregating into the Tbr2(+) neuroblast daughter, taking with it a subset of RNAs. Knockdown of Stau2 stimulates differentiation and overexpression produces periventricular neuronal masses, demonstrating its functional importance for normal cortical development. We immunoprecipitated Stau2 to examine its cargo mRNAs, and found enrichment for known asymmetric and basal cell determinants, such as Trim32, and identified candidates, including a subset involved in primary cilium function.	[Kusek, Gretchen; Campbell, Melissa; Temple, Sally] Regenerat Res Fdn, Neural Stem Cell Inst, Rensselaer, NY 12144 USA; [Doyle, Frank; Tenenbaum, Scott A.] SUNY Albany, Coll Nanoscale Sci & Engn, Albany, NY 12222 USA; [Kiebler, Michael] Med Univ Vienna, Ctr Brain Res, A-1090 Vienna, Austria	State University of New York (SUNY) System; State University of New York (SUNY) Albany; SUNY Polytechnic Institute; Medical University of Vienna	Temple, S (corresponding author), Regenerat Res Fdn, Neural Stem Cell Inst, Rensselaer, NY 12144 USA.	sallytemple@nynsci.org	Tenenbaum, Scott A/H-4744-2019	Kiebler, Michael/0000-0002-8850-6297	NIH [R01NS074047, F32 NS061461]; York State Department of Health [C024352]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS061461, R01NS074047] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); York State Department of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grant R01NS074047 (to S.T.) and F32 NS061461 (to G.K.) and the Empire State Stem Cell Fund through New York State Department of Health contract # C024352. We greatly appreciate the assistance of Dr. Sridar Chittur and the services provided by the Center for Functional Genomics Microarray Core Facility. We are also very grateful to Rachel Wurster (Neural Stem Cell Institute) for her excellent technical assistance.	Baroni Timothy E., 2008, V419, P93, DOI 10.1007/978-1-59745-033-1_6; Broadus J, 1998, NATURE, V391, P792, DOI 10.1038/35861; Buchman JJ, 2010, NEURON, V66, P386, DOI 10.1016/j.neuron.2010.03.036; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; Duchaine TF, 2002, J CELL SCI, V115, P3285; Farkas LM, 2008, NEURON, V60, P40, DOI 10.1016/j.neuron.2008.09.020; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Ferron SR, 2010, CELL STEM CELL, V7, P367, DOI 10.1016/j.stem.2010.06.021; Furic L, 2008, RNA, V14, P324, DOI 10.1261/rna.720308; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Goetze B, 2006, J CELL BIOL, V172, P221, DOI 10.1083/jcb.200509035; Gratton MO, 2003, MOL CELL BIOL, V23, P6922, DOI 10.1128/MCB.23.19.6922-6935.2003; HIRATA J, 1995, NATURE, V377, P627, DOI 10.1038/377627a0; Hsiao YC, 2009, HUM MOL GENET, V18, P3926, DOI 10.1093/hmg/ddp335; Huttner WB, 2005, CURR OPIN CELL BIOL, V17, P648, DOI 10.1016/j.ceb.2005.10.005; Jan YN, 2001, NAT REV NEUROSCI, V2, P772, DOI 10.1038/35097516; Jessberger S, 2009, TRENDS NEUROSCI, V32, P575, DOI 10.1016/j.tins.2009.07.002; Kawaguchi A, 2008, DEVELOPMENT, V135, P3113, DOI 10.1242/dev.022616; Kiebler MA, 1999, J NEUROSCI, V19, P288, DOI 10.1523/JNEUROSCI.19-01-00288.1999; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Kowalczyk T, 2009, CEREB CORTEX, V19, P2439, DOI 10.1093/cercor/bhn260; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410; Macchi P, 2004, J BIOL CHEM, V279, P31440, DOI 10.1074/jbc.C400226200; Maher-Laporte M, 2010, BMB REP, V43, P344, DOI 10.5483/BMBRep.2010.43.5.344; Miki T, 2005, CELL STRUCT FUNCT, V30, P51, DOI 10.1247/csf.30.51; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; Quinlan RJ, 2008, CURR TOP DEV BIOL, V84, P249, DOI 10.1016/S0070-2153(08)00605-4; Raj A, 2010, METHOD ENZYMOL, V472, P365, DOI 10.1016/S0076-6879(10)72004-8; Roegiers F, 2004, CURR OPIN CELL BIOL, V16, P195, DOI 10.1016/j.ceb.2004.02.010; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Shen Q, 2002, DEVELOPMENT, V129, P4843; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Srinivasan K, 2008, DEVELOPMENT, V135, P1781, DOI 10.1242/dev.013847; STJOHNSTON D, 1992, P NATL ACAD SCI USA, V89, P10979, DOI 10.1073/pnas.89.22.10979; Sun Y, 2005, NEURON, V45, P873, DOI 10.1016/j.neuron.2005.01.045; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Vessey J. P, 2012, CELL STEM CELL; Zaghloul NA, 2009, J CLIN INVEST, V119, P428, DOI 10.1172/JCI37041; Zenklusen D, 2010, METHOD ENZYMOL, V470, P641, DOI 10.1016/S0076-6879(10)70026-4; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	44	75	75	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	OCT 5	2012	11	4					505	516		10.1016/j.stem.2012.06.006	http://dx.doi.org/10.1016/j.stem.2012.06.006			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	021OZ	22902295	Bronze, Green Accepted			2022-12-28	WOS:000309896500011
J	Barker, N				Barker, Nick			Epithelial Stem Cells in the Esophagus: Who Needs Them?	CELL STEM CELL			English	Editorial Material								In their recent Science publication, Doupe et al. (2012) demonstrate that a single population of proliferating progenitor cells is solely responsible for homeostatic self-renewal and repair of injured esophageal epithelium. These findings argue against an obligate requirement for long-lived (reserve) stem cells in adult epithelia.	Inst Med Biol, Singapore 138648, Singapore	Agency for Science Technology & Research (ASTAR); A*STAR - Institute of Medical Biology (IMB)	Barker, N (corresponding author), Inst Med Biol, 8A Biomed Grove,06-06 Immunos, Singapore 138648, Singapore.	nicholas.barker@imb.a-star.edu.sg	Barker, Nick/A-5535-2011; Barker, Nick/AAE-9833-2021; Barker, Nick/AAS-2774-2020	Barker, Nick/0000-0003-3566-4475; 				Barker N, 2010, CELL STEM CELL, V7, P656, DOI 10.1016/j.stem.2010.11.016; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Croagh D, 2008, STEM CELL REV, V4, P261, DOI 10.1007/s12015-008-9031-3; Doupe D.P., 2012, SCIENCE; Kalabis J, 2008, J CLIN INVEST, V118, P3860, DOI 10.1172/JCI35012; Kasper M, 2011, P NATL ACAD SCI USA, V108, P4099, DOI 10.1073/pnas.1014489108; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; MARQUESPEREIRA JP, 1965, AM J ANAT, V117, P73, DOI 10.1002/aja.1001170106; MESSIER B, 1960, AM J ANAT, V106, P247, DOI 10.1002/aja.1001060305	9	4	4	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	SEP 7	2012	11	3					284	286		10.1016/j.stem.2012.08.005	http://dx.doi.org/10.1016/j.stem.2012.08.005			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	018DW	22958926	Bronze			2022-12-28	WOS:000309641300003
J	Tapia, N; Han, DW; Scholer, HR				Tapia, Natalia; Han, Dong Wook; Schoeler, Hans R.			Restoring Stem Cell Function in Aged Tissues by Direct Reprogramming?	CELL STEM CELL			English	Editorial Material							REGENERATIVE MEDICINE; NICHE; FATE	Adult stem cells are responsible for the cellular turnover of many organs, and an impairment in their function leads to aging and disease. In efforts to reverse the process of tissue stem cell aging, we speculate on the promise and challenges of in vivo direct reprogramming strategies.	[Tapia, Natalia; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Schoeler, Hans R.] Univ Munster, Fac Med, D-48149 Munster, Germany; [Han, Dong Wook] Konkuk Univ, Sch Med, Dept Stem Cell Biol, SMART Inst Adv Biomed Sci, Seoul 143701, South Korea	Max Planck Society; University of Munster; Konkuk University; Konkuk University Medical Center	Scholer, HR (corresponding author), Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Rontgenstr 20, D-48149 Munster, Germany.	office@mpi-muenster.mpg.de	, HS/AAB-4434-2019; Tapia, Natalia/H-5500-2012	, HS/0000-0003-2643-5136; Tapia, Natalia/0000-0003-0226-1952				Anliker B, 2010, NAT METHODS, V7, P929, DOI 10.1038/nmeth.1514; Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Pollina EA, 2011, ONCOGENE, V30, P3105, DOI 10.1038/onc.2011.45; Ryu BY, 2006, STEM CELLS, V24, P1505, DOI 10.1634/stemcells.2005-0580; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Wagers AJ, 2012, CELL STEM CELL, V10, P362, DOI 10.1016/j.stem.2012.02.018; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zhou Q, 2012, CELL STEM CELL, V10, P347, DOI 10.1016/j.stem.2012.03.005	10	7	8	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 14	2012	10	6					653	656		10.1016/j.stem.2012.04.010	http://dx.doi.org/10.1016/j.stem.2012.04.010			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	965LD	22704502	Bronze			2022-12-28	WOS:000305768400008
J	Gillich, A; Bao, SQ; Grabole, N; Hayashi, K; Trotter, MWB; Pasque, V; Magnusdottir, E; Surani, MA				Gillich, Astrid; Bao, Siqin; Grabole, Nils; Hayashi, Katsuhiko; Trotter, Matthew W. B.; Pasque, Vincent; Magnusdottir, Erna; Surani, M. Azim			Epiblast Stem Cell-Based System Reveals Reprogramming Synergy of Germline Factors	CELL STEM CELL			English	Article							GROUND-STATE PLURIPOTENCY; X-CHROMOSOME ACTIVITY; SELF-RENEWAL; MOUSE; MICE; SPECIFICATION; DYNAMICS; EXPRESSION; LINEAGE; BLIMP1	Epigenetic reprogramming in early germ cells is critical toward the establishment of totipotency, but investigations of the germline events are intractable. An objective cell culture-based system could provide mechanistic insight on how the key determinants of primordial germ cells (PGCs), including Prdm14, induce reprogramming in germ cells to an epigenetic ground state. Here we show a Prdm14-Klf2 synergistic effect that can accelerate and enhance reversion of mouse epiblast stem cells (epiSCs) to a naive pluripotent state, including X reactivation and DNA demethylation. Notably, Prdm14 alone has little effect on epiSC reversion, but it enhances the competence for reprogramming and potentially PGC specification. Reprogramming of epiSCs by the combinatorial effect of Prdm14-Klf2 involves key epigenetic changes, which might have an analogous role in PGCs. Our study provides a paradigm toward a systematic analysis of how other key genes contribute to complex and dynamic events of reprogramming in the germline.	[Gillich, Astrid; Bao, Siqin; Grabole, Nils; Pasque, Vincent; Magnusdottir, Erna; Surani, M. Azim] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Hayashi, Katsuhiko] Kyoto Univ, Grad Sch Med, Dept Anat & Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; [Trotter, Matthew W. B.] Univ Cambridge, Anne McLaren Lab Regenerat Med, Cambridge CB2 0SZ, England	University of Cambridge; Kyoto University; University of Cambridge	Surani, MA (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	a.surani@gurdon.cam.ac.uk	Magnúsdóttir, Erna/T-8993-2019; Pasque, Vincent/X-6720-2019; Pasque, Vincent/M-8231-2017; Magnúsdóttir, Erna/H-5181-2013	Pasque, Vincent/0000-0002-5129-0146; Pasque, Vincent/0000-0002-5129-0146; Magnúsdóttir, Erna/0000-0002-3369-4390; Grabole, Nils/0000-0002-1318-7383; Trotter, Matthew/0000-0003-3702-915X; Surani, Azim/0000-0002-8640-4318	Wellcome Trust [RG44593, 081277]; Medical Research Council [G0800784B, G0800784] Funding Source: researchfish; MRC [G0800784] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Nigel Miller and Rachael Walker for flow cytometry, Julien Bauer and Charles Bradshaw for bioinformatics analysis, Jose Silva, Austin Smith, and Ge Guo for constructs, Toru Nakano and Huck-Hui Ng for antibodies, Joanna Wysocka for sharing unpublished data, and Harry Leitch and Katarzyna Wilczynska for comments on the manuscript. This work was supported by grants from the Wellcome Trust to A.G., N.G., V.P., and M.A.S. (RG44593, 081277).	Agrelo R, 2009, DEV CELL, V16, P507, DOI 10.1016/j.devcel.2009.03.006; Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Chu LF, 2011, CURR BIOL, V21, P1759, DOI 10.1016/j.cub.2011.09.010; Lopes SMCD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040030; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Guo G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018189; Guo G, 2010, DEVELOPMENT, V137, P3185, DOI 10.1242/dev.052753; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hadjantonakis AK, 2001, GENESIS, V29, P133, DOI 10.1002/gene.1016; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Han DW, 2010, CELL, V143, P617, DOI 10.1016/j.cell.2010.10.015; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Hayashi K, 2009, DEVELOPMENT, V136, P3549, DOI 10.1242/dev.037747; Hayashi K, 2009, CELL STEM CELL, V4, P493, DOI 10.1016/j.stem.2009.05.007; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Jonkers I, 2009, CELL, V139, P999, DOI 10.1016/j.cell.2009.10.034; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; Ma ZY, 2011, NAT STRUCT MOL BIOL, V18, P120, DOI 10.1038/nsmb.2000; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Navarro P, 2010, NATURE, V468, P457, DOI 10.1038/nature09496; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Pasque V, 2011, EMBO J, V30, P2373, DOI 10.1038/emboj.2011.144; Payer B, 2006, GENESIS, V44, P75, DOI 10.1002/gene.20187; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Surani MA, 2010, COLD SH Q B, V75, P211, DOI 10.1101/sqb.2010.75.010; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Yang JA, 2010, CELL STEM CELL, V7, P319, DOI 10.1016/j.stem.2010.06.022; Yeom YI, 1996, DEVELOPMENT, V122, P881; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	45	105	109	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	APR 6	2012	10	4					425	439		10.1016/j.stem.2012.01.020	http://dx.doi.org/10.1016/j.stem.2012.01.020			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	929QA	22482507	Green Published, hybrid			2022-12-28	WOS:000303079400011
J	Opendak, M; Gould, E				Opendak, Maya; Gould, Elizabeth			New Neurons Maintain Efficient Stress Recovery	CELL STEM CELL			English	Editorial Material							ADULT HIPPOCAMPAL NEUROGENESIS		[Opendak, Maya; Gould, Elizabeth] Princeton Univ, Dept Psychol, Princeton Neurosci Inst, Princeton, NJ 08544 USA	Princeton University	Gould, E (corresponding author), Princeton Univ, Dept Psychol, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	goulde@princeton.edu		Opendak, Maya/0000-0003-4334-3188				Bannerman DM, 2003, BEHAV BRAIN RES, V139, P197, DOI 10.1016/S0166-4328(02)00268-1; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; HERMAN JP, 1992, BRAIN RES, V592, P228, DOI 10.1016/0006-8993(92)91680-D; Montaron MF, 2006, NEUROBIOL AGING, V27, P645, DOI 10.1016/j.neurobiolaging.2005.02.014; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; Pollak DD, 2008, NEURON, V60, P149, DOI 10.1016/j.neuron.2008.07.041; Royer S, 2010, J NEUROSCI, V30, P1777, DOI 10.1523/JNEUROSCI.4681-09.2010; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Wojtowicz JM, 2012, BEHAV BRAIN RES, V227, P490, DOI 10.1016/j.bbr.2011.08.013	10	10	10	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 7	2011	9	4					287	288		10.1016/j.stem.2011.09.003	http://dx.doi.org/10.1016/j.stem.2011.09.003			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	835MT	21982225	Bronze			2022-12-28	WOS:000296041200003
J	Karimi, MM; Goyal, P; Maksakova, IA; Bilenky, M; Leung, D; Tang, JX; Shinkai, Y; Mager, DL; Jones, S; Hirst, M; Lorincz, MC				Karimi, Mohammad M.; Goyal, Preeti; Maksakova, Irina A.; Bilenky, Misha; Leung, Danny; Tang, Jie Xin; Shinkai, Yoichi; Mager, Dixie L.; Jones, Steven; Hirst, Martin; Lorincz, Matthew C.			DNA Methylation and SETDB1/H3K9me3 Regulate Predominantly Distinct Sets of Genes, Retroelements, and Chimeric Transcripts in mESCs	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; ENDOGENOUS RETROVIRUSES; TRANSPOSABLE ELEMENTS; HISTONE H3; RNA-SEQ; CHROMATIN; GENOME; PARALLEL; COMPLEX; RETROTRANSPOSON	DNA methylation and histone H3 lysine 9 trimethylation (H3K9me3) play important roles in silencing of genes and retroelements. However, a comprehensive comparison of genes and repetitive elements repressed by these pathways has not been reported. Here we show that in mouse embryonic stem cells (mESCs), the genes upregulated after deletion of the H3K9 methyltransferase Setdb1 are distinct from those derepressed in mESC deficient in the DNA methyltransferases Dnmt1, Dnmt3a, and Dnmt3b, with the exception of a small number of primarily germline-specific genes. Numerous endogenous retroviruses (ERVs) lose H3K9me3 and are concomitantly derepressed exclusively in SETDB1 knockout mESCs. Strikingly, similar to 15% of upregulated genes are induced in association with derepression of promoter-proximal ERVs, half in the context of "chimeric" transcripts that initiate within these retroelements and splice to genic exons. Thus, SETDB1 plays a previously unappreciated yet critical role in inhibiting aberrant gene transcription by suppressing the expression of proximal ERVs.	[Karimi, Mohammad M.; Goyal, Preeti; Maksakova, Irina A.; Leung, Danny; Tang, Jie Xin; Mager, Dixie L.; Lorincz, Matthew C.] Univ British Columbia, Dept Med Genet, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada; [Bilenky, Misha; Jones, Steven; Hirst, Martin] British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Shinkai, Yoichi] Kyoto Univ, Inst Virus Res, Sakyo Ku, Expt Res Ctr Infect Dis, Kawara, Kyoto 6068507, Japan; [Shinkai, Yoichi] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kawara, Kyoto 6068507, Japan; [Mager, Dixie L.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada	University of British Columbia; British Columbia Cancer Agency; Kyoto University; Kyoto University; British Columbia Cancer Agency	Lorincz, MC (corresponding author), Univ British Columbia, Dept Med Genet, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada.	mlorincz@interchange.ubc.ca	Jones, Steven J/C-3621-2009; Shinkai, Yoichi/N-3909-2014; Hirst, Martin/B-7684-2016	Jones, Steven J/0000-0003-3394-2208; Shinkai, Yoichi/0000-0002-6051-2484; Karimi, Mohammad Mahdi/0000-0001-5017-1252; Leung, Danny Chi Yeu/0000-0002-2472-894X; Lorincz, Matthew/0000-0003-0885-0467; Mager, Dixie/0000-0002-5955-2550	MEXT of Japan; CIHR [77805, 92093]	MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CIHR(Canadian Institutes of Health Research (CIHR))	We thank M. Okano for Dnmt TKO mESCs and T. Jenuwein for Suv39h DKO mESCs. We are also grateful to Jim Bone, Bryeanna Villani, Nina Thiessen, and to members of the GSC Functional Genomics and Sequence Production groups and M.C.L. lab for technical support. We thank Keji Zhao, Ting Wang, Irina Stancheva, and Dirk Schubeler for helpful discussions. This work was supported by grants from the Genome Network Project from MEXT of Japan to Y.S. and CIHR grants 77805 to M.C.L. and 92093 to M.C.L. and M.H. M.C.L. is an MSFHR Scholar and a CIHR New Investigator.	Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Bushman F, 2005, NAT REV MICROBIOL, V3, P848, DOI 10.1038/nrmicro1263; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Dong KB, 2008, EMBO J, V27, P2691, DOI 10.1038/emboj.2008.193; Druker R, 2004, NUCLEIC ACIDS RES, V32, P5800, DOI 10.1093/nar/gkh914; DUHL DMJ, 1994, NAT GENET, V8, P59, DOI 10.1038/ng0994-59; Dunn CA, 2005, GENE, V364, P2, DOI 10.1016/j.gene.2005.05.045; Edwards JR, 2010, GENOME RES, V20, P972, DOI 10.1101/gr.101535.109; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; Flicek P, 2010, NUCLEIC ACIDS RES, V38, pD557, DOI 10.1093/nar/gkp972; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Freitag M, 2005, CURR OPIN GENET DEV, V15, P191, DOI 10.1016/j.gde.2005.02.003; Howard G, 2008, ONCOGENE, V27, P404, DOI 10.1038/sj.onc.1210631; Hutnick LK, 2010, J BIOL CHEM, V285, P21082, DOI 10.1074/jbc.M110.125674; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lamprecht B, 2010, NAT MED, V16, P571, DOI 10.1038/nm.2129; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lee JS, 1999, J VIROL, V73, P5166, DOI 10.1128/JVI.73.6.5166-5171.1999; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Lewinski MK, 2006, PLOS PATHOG, V2, P611, DOI 10.1371/journal.ppat.0020060; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Maksakova IA, 2006, PLOS GENET, V2, P1, DOI 10.1371/journal.pgen.0020002; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Medstrand P, 2002, GENOME RES, V12, P1483, DOI 10.1101/gr.388902; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Myant K, 2011, GENOME RES, V21, P83, DOI 10.1101/gr.108498.110; O'Neill LP, 2003, METHODS, V31, P76, DOI 10.1016/S1046-2023(03)00090-2; Oda M, 2006, GENE DEV, V20, P3382, DOI 10.1101/gad.1470906; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Peaston AE, 2004, DEV CELL, V7, P597, DOI 10.1016/j.devcel.2004.09.004; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Sugino H, 2004, GENE, V337, P91, DOI 10.1016/j.gene.2004.04.011; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; van de Lagemaat LN, 2003, TRENDS GENET, V19, P530, DOI 10.1016/j.tig.2003.08.004; Vasicek TJ, 1997, GENETICS, V147, P777; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yokochi T, 2009, P NATL ACAD SCI USA, V106, P19363, DOI 10.1073/pnas.0906142106; Yuan P, 2009, GENE DEV, V23, P2507, DOI 10.1101/gad.1831909; Zhang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000007	54	310	313	2	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 3	2011	8	6					676	687		10.1016/j.stem.2011.04.004	http://dx.doi.org/10.1016/j.stem.2011.04.004			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	780HC	21624812	Bronze, Green Accepted			2022-12-28	WOS:000291844100015
J	Maziarz, RT; Driscoll, D				Maziarz, Richard T.; Driscoll, Dawn			Hematopoietic Stem Cell Transplantation and Implications for Cell Therapy Reimbursement	CELL STEM CELL			English	Editorial Material							OREGON HEALTH PLAN; FDA REGULATION; LESSONS; NATION	As costly stem cell treatments progress from experimental concepts toward licensed products and routine procedures, governmental and private payers grapple with shrinking budgets to cover more lives. We describe efforts underway in the US to create mechanisms for reimbursement of cell therapies and discuss other reimbursement-related issues for the stem cell community.	[Driscoll, Dawn] DCi Biotech, Cell Therapy Commercializat, Perth, WA 6000, Australia; [Maziarz, Richard T.] Oregon Hlth & Sci Univ, Knight Canc Inst, Adult Blood & Marrow Stem Cell Transplant Program, Portland, OR 97239 USA	Oregon Health & Science University	Driscoll, D (corresponding author), DCi Biotech, Cell Therapy Commercializat, Perth, WA 6000, Australia.	ddriscoll@dci-biotech.com		Maziarz, Richard/0000-0002-8184-7099				Bodenheimer T, 1997, NEW ENGL J MED, V337, P651, DOI 10.1056/NEJM199708283370923; Bodenheimer T, 1997, NEW ENGL J MED, V337, P720, DOI 10.1056/NEJM199709043371021; Chambers JD, 2011, NEW ENGL J MED, V364, P1687, DOI 10.1056/NEJMp1103057; Fink DW, 2009, SCIENCE, V324, P1662, DOI 10.1126/science.1173712; Gajewski JL, 2005, BIOL BLOOD MARROW TR, V11, P871, DOI 10.1016/j.bbmt.2005.07.014; Goozner M, 2011, J NATL CANCER I, V103, P288, DOI 10.1093/jnci/djr041; Halme DG, 2006, NEW ENGL J MED, V355, P1730, DOI 10.1056/NEJMhpr063086; NUGENT ME, 2011, HTLH FINANC MANAGE, V65, P46; Nugent Michael E, 2011, Healthc Financ Manage, V65, P42; Shaughnessy P, 2011, BIOL BLOOD MARROW TR, V17, P729, DOI 10.1016/j.bbmt.2010.08.018; WELCH HG, 1988, NEW ENGL J MED, V319, P171, DOI 10.1056/NEJM198807213190310	11	11	11	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 3	2011	8	6					609	612		10.1016/j.stem.2011.05.013	http://dx.doi.org/10.1016/j.stem.2011.05.013			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	780HC	21624804	Bronze			2022-12-28	WOS:000291844100008
J	Karnik, R; Meissner, A				Karnik, Rahul; Meissner, Alexander			Browsing (Epi)genomes: A Guide to Data Resources and Epigenome Browsers for Stem Cell Researchers	CELL STEM CELL			English	Review							NOVO DNA METHYLATION; CHROMATIN STATE; GENOME BROWSER; PLURIPOTENT; DYNAMICS; ENSEMBL; GALAXY; MAPS	Over the past years we have witnessed an explosion in the generation of freely available genome-wide data sets, including maps of various histone modifications, transcription factor binding, DNase hypersensitivity, and DNA methylation, which provide valuable resources for data validation, exploration, and hypothesis generation. The goal of this review is to provide the reader with information on where to find many of the data sets and how to utilize the various (epi)genome browsers for display and initial analysis. We provide selected examples to highlight key features and demonstrate the application of these browsers to stem cell biology.	[Karnik, Rahul; Meissner, Alexander] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Karnik, Rahul; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Karnik, Rahul; Meissner, Alexander] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University	Meissner, A (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	alexander_meissner@harvard.edu		Karnik, Rahul/0000-0002-0400-635X	Pew Charitable Trusts; US National Institutes of Health (NIH) [U01ES017155, P01GM099117]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099117] Funding Source: NIH RePORTER	Pew Charitable Trusts; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Xin Zhou, Ting Wang, and Ian Fingerman for helpful suggestions on the manuscript. A. M. is supported by the Pew Charitable Trusts and US National Institutes of Health (NIH) grants (U01ES017155 and P01GM099117) and is a Robertson Investigator of The New York Stem Cell Foundation.	Athanasiadou R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009937; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Brinkman AB, 2012, GENOME RES, V22, P1128, DOI 10.1101/gr.133728.111; Chadwick LH, 2012, EPIGENOMICS-UK, V4, P317, DOI [10.2217/epi.12.18, 10.2217/EPI.12.18]; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Epsztejn-Litman S, 2008, NAT STRUCT MOL BIOL, V15, P1176, DOI 10.1038/nsmb.1476; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Illingworth RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001134; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI 10.1038/nbt.1684; Mekhoubad S, 2012, CELL STEM CELL, V10, P595, DOI 10.1016/j.stem.2012.02.014; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nielsen CB, 2012, GENOME RES, V22, P2262, DOI 10.1101/gr.140665.112; Nishino K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013017; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Rakyan VK, 2004, PLOS BIOL, V2, P2170, DOI 10.1371/journal.pbio.0020405; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rosenbloom KR, 2012, NUCLEIC ACIDS RES, V40, pD912, DOI 10.1093/nar/gkr1012; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Spudich GM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-295; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Zhou X, 2011, NAT METHODS, V8, P989, DOI 10.1038/nmeth.1772	41	15	15	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2013	13	1					14	22		10.1016/j.stem.2013.06.006	http://dx.doi.org/10.1016/j.stem.2013.06.006			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VJ	23827707	Bronze, Green Accepted			2022-12-28	WOS:000329570100008
J	Buckley, SM; Aranda-Orgilles, B; Strikoudis, A; Apostolou, E; Loizou, E; Moran-Crusio, K; Farnsworth, CL; Koller, AA; Dasgupta, R; Silva, JC; Stadtfeld, M; Hochedlinger, K; Chen, EI; Aifantis, I				Buckley, Shannon M.; Aranda-Orgilles, Beatriz; Strikoudis, Alexandros; Apostolou, Effie; Loizou, Evangelia; Moran-Crusio, Kelly; Farnsworth, Charles L.; Koller, Antonius A.; Dasgupta, Ramanuj; Silva, Jeffrey C.; Stadtfeld, Matthias; Hochedlinger, Konrad; Chen, Emily I.; Aifantis, Iannis			Regulation of Pluripotency and Cellular Reprogramming by the Ubiquitin-Proteasome System	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; SELF-RENEWAL; C-MYC; DIFFERENTIATION; DEGRADATION; MECHANISMS; EXPRESSION; ES; DEUBIQUITINATION; TRANSCRIPTION	Although transcriptional regulation of stem cell pluripotency and differentiation has been extensively studied, only a small number of studies have addressed the roles for posttranslational modifications in these processes. A key mechanism of posttranslational modification is ubiquitination by the ubiquitin-proteasome system (UPS). Here, using shotgun proteomics, we map the ubiquitinated protein landscape during embryonic stem cell (ESC) differentiation and induced pluripotency. Moreover, using UPS-targeted RNAi screens, we identify additional regulators of pluripotency and differentiation. We focus on two of these proteins, the deubiquitinating enzyme Psmd14 and the E3 ligase Fbxw7, and characterize their importance in ESC pluripotency and cellular reprogramming. This global characterization of the UPS as a key regulator of stem cell pluripotency opens the way for future studies that focus on specific UPS enzymes or ubiquitinated substrates.	[Buckley, Shannon M.; Aranda-Orgilles, Beatriz; Strikoudis, Alexandros; Loizou, Evangelia; Moran-Crusio, Kelly; Aifantis, Iannis] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Buckley, Shannon M.; Aranda-Orgilles, Beatriz; Strikoudis, Alexandros; Loizou, Evangelia; Moran-Crusio, Kelly; Aifantis, Iannis] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Buckley, Shannon M.; Aranda-Orgilles, Beatriz; Strikoudis, Alexandros; Loizou, Evangelia; Moran-Crusio, Kelly; Dasgupta, Ramanuj; Aifantis, Iannis] NYU, Sch Med, Canc Inst, New York, NY 10016 USA; [Buckley, Shannon M.; Aranda-Orgilles, Beatriz; Strikoudis, Alexandros; Loizou, Evangelia; Moran-Crusio, Kelly; Dasgupta, Ramanuj; Aifantis, Iannis] NYU, Sch Med, Helen & Martin S Kimmel Stem Cell Ctr, New York, NY 10016 USA; [Stadtfeld, Matthias] NYU, Sch Med, Dev Genet Program, Helen & Martin S Kimmel Stem Cell Ctr, New York, NY 10016 USA; [Stadtfeld, Matthias] NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA; [Apostolou, Effie; Hochedlinger, Konrad] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Hochedlinger, Konrad] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Farnsworth, Charles L.; Silva, Jeffrey C.] Cell Signaling Technol, Danvers, MA 01923 USA; [Koller, Antonius A.; Chen, Emily I.] SUNY Stony Brook, Med Ctr, Prote Ctr, Stony Brook, NY 11794 USA; [Chen, Emily I.] SUNY Stony Brook, Med Ctr, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	Howard Hughes Medical Institute; New York University; New York University; New York University; New York University; New York University; New York University; Harvard University; Howard Hughes Medical Institute; Harvard University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Aifantis, I (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA.	iannis.aifantis@nyumc.org	Apostolou, Effie/AAG-1559-2020	Stadtfeld, Matthias/0000-0002-5852-9906; Dasgupta, Ramanuj/0000-0001-9015-3729	National Institutes of Health [NIH]/National Cancer Institute [NCI) [P30 CA016087-30]; NIH [RO1CA133379, RO1CA105129, RO1CA149655, RO1GM088847, 1U19A1091175-01, 1S10 RR023680-1]; NYSTEM program of the New York State Health Department; NYU Hematology/Oncology NIH training grant [5T32HL007151-33]; NIH institutional training grant [1T32CA160002-01]; Alexander von Humboldt Foundation; NYSTEM institutional NYU Stem Cell training grant [C026880]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA133379, R01CA105129, T32CA160002, R01CA149655, P30CA016087, R01CA155125] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023680] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088847] Funding Source: NIH RePORTER	National Institutes of Health [NIH]/National Cancer Institute [NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSTEM program of the New York State Health Department; NYU Hematology/Oncology NIH training grant; NIH institutional training grant; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NYSTEM institutional NYU Stem Cell training grant; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Dr. I. Lemischka for the Nanog-GFP reporter ESC line; Dr. S. Dalton for the c-myc<SUP>T58A</SUP>ER ESCs; Drs. D. Reinberg, R. Bonasio, and L.-A. Rojas for providing the pINTA-SF vectors; Drs. F. Gonsalves and Beatrix Ueberheide for helpful discussions; and Drs. H. Li and T. Liu at the Center for Advanced Proteomics Research New Jersey School of Medicine, for selected mass-spectrometry analysis. We would also like to thank the NYU Genome Technology Center (supported in part by National Institutes of Health [NIH]/National Cancer Institute [NCI) grant P30 CA016087-30) for expert assistance with microarray experiments. I.A. is supported by the NIH (RO1CA133379, RO1CA105129, RO1CA149655, and RO1GM088847) and the NYSTEM program of the New York State Health Department. E.I.C. is supported by the NIH (1U19A1091175-01 and 1S10 RR023680-1). S.M.B. is supported by the NYU Hematology/Oncology NIH training grant (5T32HL007151-33) and the NIH institutional training grant (1T32CA160002-01), B.A.-O. is supported by the Alexander von Humboldt Foundation, and A.S. is supported by NYSTEM institutional NYU Stem Cell training grant (C026880). I.A. and K.H. are Howard Hughes Medical Institute Early Career Scientists.	Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Aghajan M, 2010, NAT BIOTECHNOL, V28, P738, DOI 10.1038/nbt.1645; An J, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-32; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Busino L, 2012, NAT CELL BIOL, V14, P375, DOI 10.1038/ncb2463; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Crusio KM, 2010, ONCOGENE, V29, P4865, DOI 10.1038/onc.2010.222; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Gallery M, 2007, MOL CANCER THER, V6, P262, DOI 10.1158/1535-7163.MCT-06-0542; Gloeckner Christian Johannes, 2009, Methods Mol Biol, V564, P359, DOI 10.1007/978-1-60761-157-8_21; Gontan C, 2012, NATURE, V485, P386, DOI 10.1038/nature11070; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang X, 2012, J PROTEOME RES, V11, P2091, DOI 10.1021/pr300155r; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kimura Y, 2010, J BIOCHEM, V147, P793, DOI 10.1093/jb/mvq044; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Li QR, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001750; Liao B, 2010, CELL RES, V20, P332, DOI 10.1038/cr.2009.136; Lu R, 2009, NATURE, V462, P358, DOI 10.1038/nature08575; Martinez NJ, 2010, CELL STEM CELL, V7, P31, DOI 10.1016/j.stem.2010.06.011; Matsumoto A, 2011, J BIOL CHEM, V286, P13754, DOI 10.1074/jbc.M110.194936; Matsuoka S, 2008, GENE DEV, V22, P986, DOI 10.1101/gad.1621808; Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI 10.1038/nbt.1684; Niakan KK, 2010, GENE DEV, V24, P312, DOI 10.1101/gad.1833510; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Orlicky S, 2010, NAT BIOTECHNOL, V28, P733, DOI 10.1038/nbt.1646; Phanstiel DH, 2011, NAT METHODS, V8, P821, DOI [10.1038/NMETH.1699, 10.1038/nmeth.1699]; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Ramakrishna S, 2011, STEM CELLS DEV, V20, P1512, DOI 10.1089/scd.2010.0410; Reavie L, 2010, NAT IMMUNOL, V11, P207, DOI 10.1038/ni.1839; Schaniel C, 2010, METHOD ENZYMOL, V477, P351, DOI 10.1016/S0076-6879(10)77018-X; Smith KN, 2010, CELL STEM CELL, V7, P343, DOI 10.1016/j.stem.2010.06.023; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Stadtfeld M, 2010, NAT METHODS, V7, P53, DOI [10.1038/NMETH.1409, 10.1038/nmeth.1409]; Szutorisz H, 2006, CELL, V127, P1375, DOI 10.1016/j.cell.2006.10.045; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thompson BJ, 2008, J EXP MED, V205, P1395, DOI 10.1084/jem.20080277; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Vilchez D, 2012, NATURE, V489, P304, DOI 10.1038/nature11468; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Xu GQ, 2010, NAT BIOTECHNOL, V28, P868, DOI 10.1038/nbt.1654; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Ye X, 2004, J BIOL CHEM, V279, P50110, DOI 10.1074/jbc.M409226200; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	49	191	202	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 7	2012	11	6					783	798		10.1016/j.stem.2012.09.011	http://dx.doi.org/10.1016/j.stem.2012.09.011			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	055MJ	23103054	Green Accepted, Bronze			2022-12-28	WOS:000312420300010
J	Mantovani, A				Mantovani, Alberto			MSCs, Macrophages, and Cancer: A Dangerous Menage-a-Trois	CELL STEM CELL			English	Editorial Material								Two studies in this issue of Cell Stem Cell highlight context-dependent roles for MSCs in controlling tumor growth. Lee et al. (2012) show that preactivated MSCs have antitumor effects upon adoptive transfer in vivo, and Ren et al. (2012) show that tumor-resident MSCs can promote tumor growth by influencing macrophages.	[Mantovani, Alberto] Univ Milan, Humanitas Clin & Res Ctr, I-20089 Milan, Italy; [Mantovani, Alberto] Univ Milan, Dept Biotechnol & Translat Med, I-20089 Milan, Italy	University of Milan; University of Milan	Mantovani, A (corresponding author), Univ Milan, Humanitas Clin & Res Ctr, Via Manzoni 56, I-20089 Milan, Italy.	alberto.mantovani@humanitasresearch.it	Mantovani, Alberto/HCI-7449-2022	Mantovani, Alberto/0000-0001-5578-236X				Freytes DO, 2013, J CELL BIOCHEM, V114, P220, DOI 10.1002/jcb.24357; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004; Lee RH, 2012, CELL STEM CELL, V11, P825, DOI 10.1016/j.stem.2012.10.001; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Menon LG, 2009, STEM CELLS, V27, P2320, DOI 10.1002/stem.136; Ren GW, 2012, CELL STEM CELL, V11, P812, DOI 10.1016/j.stem.2012.08.013; Servais C, 2013, J PATHOL, V229, P198, DOI 10.1002/path.4103; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Zhang J, 2010, JNCI-J NATL CANCER I, V102, P522, DOI 10.1093/jnci/djq044	10	27	27	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 7	2012	11	6					730	732		10.1016/j.stem.2012.11.016	http://dx.doi.org/10.1016/j.stem.2012.11.016			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	055MJ	23217416	Bronze			2022-12-28	WOS:000312420300003
J	Willems, E; Cabral-Teixeira, J; Schade, D; Cai, WQ; Reeves, P; Bushway, PJ; Lanier, M; Walsh, C; Kirchhausen, T; Belmonte, JCI; Cashman, J; Mercola, M				Willems, Erik; Cabral-Teixeira, Joaquim; Schade, Dennis; Cai, Wenqing; Reeves, Patrick; Bushway, Paul J.; Lanier, Marion; Walsh, Christopher; Kirchhausen, Tomas; Izpisua Belmonte, Juan Carlos; Cashman, John; Mercola, Mark			Small Molecule-Mediated TGF-beta Type II Receptor Degradation Promotes Cardiomyogenesis in Embryonic Stem Cells	CELL STEM CELL			English	Article							DIFFERENTIATION; MOUSE; BIOLOGY	The cellular signals controlling the formation of cardiomyocytes, vascular smooth muscle, and endothelial cells from stem cell-derived mesoderm are poorly understood. To identify these signals, a mouse embryonic stem cell (ESC)-based differentiation assay was screened against a small molecule library resulting in a 1,4-dihydropyridine inducer of type II TGF-beta receptor (TGFBR2) degradation-1 (ITD-1). ITD analogs enhanced proteasomal degradation of TGFBR2, effectively clearing the receptor from the cell surface and selectively inhibiting intracellular signaling (IC50 similar to 0.4-0.8 mu M). ITD-1 was used to evaluate TGF-beta involvement in mesoderm formation and cardiopoietic differentiation, which occur sequentially during early development, revealing an essential role in both processes in ESC cultures. ITD-1 selectively enhanced the differentiation of uncommitted mesoderm to cardiomyocytes, but not to vascular smooth muscle and endothelial cells. ITD-1 is a highly selective TGF-beta inhibitor and reveals an unexpected role for TGF-beta signaling in controlling cardiomyocyte differentiation from multipotent cardiovascular precursors.	[Willems, Erik; Cabral-Teixeira, Joaquim; Schade, Dennis; Cai, Wenqing; Bushway, Paul J.; Mercola, Mark] Sanford Burnham Med Res Inst, Muscle Dev & Regenerat Program, La Jolla, CA 92037 USA; [Cai, Wenqing] Sanford Burnham Med Res Inst, Grad Sch Biomed Sci, La Jolla, CA 92037 USA; [Willems, Erik; Schade, Dennis; Lanier, Marion; Cashman, John; Mercola, Mark] ChemRegen Inc, San Diego, CA 92130 USA; [Schade, Dennis; Lanier, Marion; Cashman, John] Human Biomol Res Inst, San Diego, CA 92121 USA; [Reeves, Patrick; Kirchhausen, Tomas] Harvard Univ, Sch Med, Immune Dis Inst, Dept Cell Biol, Boston, MA 02115 USA; [Walsh, Christopher; Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona, Barcelona 08003, Spain	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Salk Institute; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona	Willems, E (corresponding author), Sanford Burnham Med Res Inst, Muscle Dev & Regenerat Program, La Jolla, CA 92037 USA.	ewillems@sanfordburnham.org; mmercola@sanfordburnham.org	Cai, Wenqing/AAS-2248-2021; Schade, Dennis/AAH-4758-2019; Reeves, Patrick/I-1066-2018	Schade, Dennis/0000-0002-5515-1821; Reeves, Patrick/0000-0001-8202-0723; Willems, Erik/0000-0002-2735-8382; /0000-0002-8949-1701	CIRM [T2-00004, RS-00169-1, RC1-000132]; AHA; German Research Foundation [SCHA 1663/1-1]; NIH [HL088293, HL059502]; MINECO; T Foundation; NIH STIR [R41-HL108714]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL088293, R41HL108714, R01HL059502, R37HL059502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075252] Funding Source: NIH RePORTER	CIRM(California Institute for Regenerative Medicine); AHA(American Heart Association); German Research Foundation(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MINECO(Spanish Government); T Foundation; NIH STIR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank Fabio Cerignoli and Karl Willert for running calcium transient assays and Wnt TOPflash assays, respectively. This work was supported by CIRM T2-00004 and AHA fellowship to E.W., German Research Foundation Grant SCHA 1663/1-1 to D.S., NIH HL088293 and MINECO to J.C.I.B., CIRM Seed RS-00169-1 and T Foundation to J.C., CIRM RC1-000132 and NIH HL059502 to M.M., and NIH STIR R41-HL108714 to ChemRegen Inc. E.W., M.M., and J.C. are cofounders of ChemRegen, Inc.	Ao A, 2011, CHEM BIOL, V18, P413, DOI 10.1016/j.chembiol.2011.03.011; Behfar A, 2002, FASEB J, V16, P1558, DOI 10.1096/fj.02-0072com; Burridge PW, 2012, CELL STEM CELL, V10, P16, DOI 10.1016/j.stem.2011.12.013; Chen YG, 2009, CELL RES, V19, P58, DOI 10.1038/cr.2008.315; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; DICKSON MC, 1993, DEVELOPMENT, V117, P625; Edraki N, 2009, DRUG DISCOV TODAY, V14, P1058, DOI 10.1016/j.drudis.2009.08.004; Fukasawa H, 2010, INT J CANCER, V127, P1517, DOI 10.1002/ijc.25164; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kitamura R, 2007, CIRC RES, V101, P78, DOI 10.1161/CIRCRESAHA.106.147264; Larsson J, 2001, EMBO J, V20, P1663, DOI 10.1093/emboj/20.7.1663; Meng WX, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-88; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Oshima M, 1996, DEV BIOL, V179, P297, DOI 10.1006/dbio.1996.0259; Perea-Gomez A, 2002, DEV CELL, V3, P745, DOI 10.1016/S1534-5807(02)00321-0; Sturzu AC, 2011, CIRC RES, V108, P353, DOI 10.1161/CIRCRESAHA.110.227066; Wells RG, 1997, J BIOL CHEM, V272, P11444; Wharton K, 2009, DEVELOPMENT, V136, P3691, DOI 10.1242/dev.040584; Willems E, 2011, J CARDIOVASC TRANSL, V4, P340, DOI 10.1007/s12265-011-9270-6; Yuasa S, 2005, NAT BIOTECHNOL, V23, P607, DOI 10.1038/nbt1093	20	96	102	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 3	2012	11	2					242	252		10.1016/j.stem.2012.04.025	http://dx.doi.org/10.1016/j.stem.2012.04.025			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	987QQ	22862949	Green Accepted, Bronze			2022-12-28	WOS:000307432600014
J	Ben-David, U; Kopper, O; Benvenisty, N				Ben-David, Uri; Kopper, Oded; Benvenisty, Nissim			Expanding the Boundaries of Embryonic Stem Cells	CELL STEM CELL			English	Review							TRANSCRIPTIONAL REGULATORY CIRCUITRY; DEFINED CULTURE-SYSTEMS; HOMOLOGOUS RECOMBINATION; HUMAN ESCS; CHROMOSOMAL-ABERRATIONS; LINEAGE SPECIFICATION; INTERACTION NETWORK; DRUG DISCOVERY; NONCODING RNAS; OPEN CHROMATIN	The boundaries of embryonic stem cell (ESC) research have extended considerably in recent years in several important ways. Alongside a deeper understanding of the pluripotent state, ESCs have been successfully integrated into various fields, such as genomics, epigenetics, and disease modeling. Significant progress in cell fate control has pushed directed differentiation and tissue engineering further than ever before and promoted clinical trials. The geographical distribution of research activity has also expanded, especially for human ESCs. This review outlines these developments and future challenges that remain.	[Ben-David, Uri; Kopper, Oded; Benvenisty, Nissim] Hebrew Univ Jerusalem, Dept Genet, Stem Cell Unit, Silberman Inst Life Sci, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Benvenisty, N (corresponding author), Hebrew Univ Jerusalem, Dept Genet, Stem Cell Unit, Silberman Inst Life Sci, IL-91904 Jerusalem, Israel.	nissimb@cc.huji.ac.il	Ben-David, Uri/H-4119-2019	Ben-David, Uri/0000-0001-7098-2378	Legacy Heritage Biomedical Science Partnership Program of the Israel Science Foundation [943/09]; Centers of Excellence Legacy Heritage Biomedical Science Partnership [1801/10]; Juvenile Diabetes Research Foundation [1-2011-555]	Legacy Heritage Biomedical Science Partnership Program of the Israel Science Foundation; Centers of Excellence Legacy Heritage Biomedical Science Partnership; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	The authors thank Dr. Daniel Ronen for critically reading this manuscript and Tamar Golan-Lev for her assistance with the graphical design of the figures. N.B. is the Herbert Cohn Chair in Cancer Research. This research was partially supported by the Legacy Heritage Biomedical Science Partnership Program of the Israel Science Foundation (grant 943/09), the Centers of Excellence Legacy Heritage Biomedical Science Partnership (grant 1801/10), and the Juvenile Diabetes Research Foundation (grant 1-2011-555).	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Agarwal S, 2008, STEM CELLS, V26, P1117, DOI 10.1634/stemcells.2007-1102; Akopian V, 2010, IN VITRO CELL DEV-AN, V46, P247, DOI 10.1007/s11626-010-9297-z; Amit M, 2010, STEM CELL REV REP, V6, P248, DOI 10.1007/s12015-010-9149-y; Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; Andrews PW, 2009, STEM CELL REV REP, V5, P301, DOI 10.1007/s12015-009-9085-x; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Ariasi AM, 2011, CURR OPIN CELL BIOL, V23, P650, DOI 10.1016/j.ceb.2011.09.007; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Basma H, 2009, GASTROENTEROLOGY, V136, P990, DOI 10.1053/j.gastro.2008.10.047; Ben-David U, 2011, CELL STEM CELL, V9, P97, DOI 10.1016/j.stem.2011.06.013; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Ben-Yosef D, 2008, MOL CELL ENDOCRINOL, V282, P153, DOI 10.1016/j.mce.2007.11.010; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Biancotti JC, 2010, STEM CELLS, V28, P1530, DOI 10.1002/stem.483; Blum B, 2009, NAT BIOTECHNOL, V27, P281, DOI 10.1038/nbt.1527; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brill LM, 2009, CELL STEM CELL, V5, P204, DOI 10.1016/j.stem.2009.06.002; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buecker C, 2010, CELL STEM CELL, V7, P559, DOI 10.1016/j.stem.2010.10.007; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Canham MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000379; Chen GK, 2010, CELL STEM CELL, V7, P240, DOI 10.1016/j.stem.2010.06.017; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheng X, 2012, CELL STEM CELL, V10, P371, DOI 10.1016/j.stem.2012.02.024; Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938; Collin J, 2011, STEM CELLS, V29, P1021, DOI 10.1002/stem.658; Colman A, 2009, CELL STEM CELL, V5, P244, DOI 10.1016/j.stem.2009.08.010; Damjanov I, 2007, NAT BIOTECHNOL, V25, P1212, DOI 10.1038/nbt1107-1212a; Eiges R, 2001, CURR BIOL, V11, P514, DOI 10.1016/S0960-9822(01)00144-0; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012; Ellis J, 2010, CELL STEM CELL, V7, P429, DOI 10.1016/j.stem.2010.09.010; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Giudice A, 2008, CELL STEM CELL, V2, P422, DOI 10.1016/j.stem.2008.04.003; Goldring CEP, 2011, CELL STEM CELL, V8, P618, DOI 10.1016/j.stem.2011.05.012; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Han DW, 2010, CELL, V143, P617, DOI 10.1016/j.cell.2010.10.015; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Idelson M, 2009, CELL STEM CELL, V5, P396, DOI 10.1016/j.stem.2009.07.002; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jeddeloh JA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-231; Kadereit S, 2011, SEMIN IMMUNOPATHOL, V33, P551, DOI 10.1007/s00281-011-0265-9; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Kim K, 2007, CELL STEM CELL, V1, P346, DOI 10.1016/j.stem.2007.07.001; Kim K, 2007, SCIENCE, V315, P482, DOI 10.1126/science.1133542; Kobayashi T, 2010, CELL, V142, P787, DOI 10.1016/j.cell.2010.07.039; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kolata G., 2007, NY TIMES; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Laustriat D, 2010, BIOCHEM SOC T, V38, P1051, DOI 10.1042/BST0381051; Lavon N, 2004, DIFFERENTIATION, V72, P230, DOI 10.1111/j.1432-0436.2004.07205002.x; Leavitt AD, 2011, CTS-CLIN TRANSL SCI, V4, P298, DOI 10.1111/j.1752-8062.2011.00281.x; Leeb M, 2011, NATURE, V479, P131, DOI 10.1038/nature10448; Lefort N, 2008, NAT BIOTECHNOL, V26, P1364, DOI 10.1038/nbt.1509; Lei T, 2007, CELL RES, V17, P682, DOI 10.1038/cr.2007.61; Lensch MW, 2007, NAT BIOTECHNOL, V25, P1211, DOI 10.1038/nbt1107-1211a; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Loh YH, 2011, ANNU REV GENOM HUM G, V12, P165, DOI 10.1146/annurev-genom-082410-101506; Lu R, 2009, NATURE, V462, P358, DOI 10.1038/nature08575; Mandenius CF, 2011, J APPL TOXICOL, V31, P191, DOI 10.1002/jat.1663; Margaritis T, 2008, CELL, V133, P581, DOI 10.1016/j.cell.2008.04.027; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Martinez NJ, 2010, CELL STEM CELL, V7, P31, DOI 10.1016/j.stem.2010.06.011; Martins-Taylor K, 2010, J CELL BIOCHEM, V109, P16, DOI 10.1002/jcb.22402; Mayshar Y, 2011, J CELL MOL MED, V15, P1393, DOI 10.1111/j.1582-4934.2010.01105.x; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI 10.1038/nbt.1684; Mohamed JS, 2010, RNA, V16, P324, DOI 10.1261/rna.1441510; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Noggle S, 2011, NATURE, V478, P70, DOI 10.1038/nature10397; Normile D, 2006, SCIENCE, V311, P156, DOI 10.1126/science.311.5758.156; Ohgushi M, 2010, CELL STEM CELL, V7, P225, DOI 10.1016/j.stem.2010.06.018; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Oshima K, 2010, CELL, V141, P704, DOI 10.1016/j.cell.2010.03.035; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Robertson NJ, 2007, P NATL ACAD SCI USA, V104, P20920, DOI 10.1073/pnas.0710265105; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Roy NS, 2005, EXP NEUROL, V196, P224, DOI 10.1016/j.expneurol.2005.06.021; Rubin LL, 2008, CELL, V132, P549, DOI 10.1016/j.cell.2008.02.010; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Scott CT, 2011, CELL, V145, P820, DOI 10.1016/j.cell.2011.05.032; Sharon N, 2011, STEM CELLS, V29, P600, DOI 10.1002/stem.621; Song H, 2010, CELL STEM CELL, V6, P80, DOI 10.1016/j.stem.2009.11.016; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Steiner D, 2010, NAT BIOTECHNOL, V28, P361, DOI 10.1038/nbt.1616; Stelzer Y, 2011, NAT STRUCT MOL BIOL, V18, P735, DOI 10.1038/nsmb.2050; Stewart MH, 2010, NAT METHODS, V7, P917, DOI 10.1038/nmeth.1519; Suga H, 2011, NATURE, V480, P57, DOI 10.1038/nature10637; Tachibana M, 2012, CELL, V148, P285, DOI 10.1016/j.cell.2011.12.007; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takahashi T, 2003, CIRCULATION, V107, P1912, DOI 10.1161/01.CIR.0000064899.53876.A3; Tang C, 2011, NAT BIOTECHNOL, V29, P829, DOI 10.1038/nbt.1947; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Trounson A, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-52; Tulpule A, 2010, BLOOD, V115, P3453, DOI 10.1182/blood-2009-10-246694; Unger C, 2008, HUM MOL GENET, V17, pR48, DOI 10.1093/hmg/ddn079; Urbach A, 2004, STEM CELLS, V22, P635, DOI 10.1634/stemcells.22-4-635; Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005; Valamehr B, 2011, REGEN MED, V6, P623, DOI [10.2217/rme.11.54, 10.2217/RME.11.54]; Van Hoof D, 2009, CELL STEM CELL, V5, P214, DOI 10.1016/j.stem.2009.05.021; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang W, 2011, P NATL ACAD SCI USA, V108, P18283, DOI 10.1073/pnas.1100893108; Wang YC, 2011, CELL RES, V21, P1551, DOI 10.1038/cr.2011.148; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; West PR, 2010, TOXICOL APPL PHARM, V247, P18, DOI 10.1016/j.taap.2010.05.007; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wobus AM, 2011, ARCH TOXICOL, V85, P79, DOI 10.1007/s00204-010-0641-6; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Ziller MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002389	142	41	44	0	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 14	2012	10	6					666	677		10.1016/j.stem.2012.05.003	http://dx.doi.org/10.1016/j.stem.2012.05.003			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	965LD	22704506	Bronze			2022-12-28	WOS:000305768400012
J	Miller, FD; Kaplan, DR				Miller, Freda D.; Kaplan, David R.			Mobilizing Endogenous Stem Cells for Repair and Regeneration: Are We There Yet?	CELL STEM CELL			English	Editorial Material							MAMMALIAN BRAIN; NEUROGENESIS; PRECURSORS	Harnessing endogenous repair mechanisms to promote tissue regeneration in situations in which it does not normally occur has long been a goal in biomedical science. Recent advances in tissue stem cells indicate that this goal may now be achievable. Here we consider both the promise and the hurdles we still have to overcome.	[Miller, Freda D.] Hosp Sick Children, Dev & Stem Cell Biol Program, Toronto, ON M5G 1L7, Canada; [Kaplan, David R.] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1L7, Canada; [Miller, Freda D.] Univ Toronto, McEwen Ctr Regenerat Med, Toronto, ON M5G 1X5, Canada; [Miller, Freda D.; Kaplan, David R.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1X5, Canada; [Miller, Freda D.] Univ Toronto, Dept Physiol, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto	Miller, FD (corresponding author), Hosp Sick Children, Dev & Stem Cell Biol Program, Toronto, ON M5G 1L7, Canada.	fredam@sickkids.ca						Biernaskie J, 2009, CELL STEM CELL, V5, P610, DOI 10.1016/j.stem.2009.10.019; Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Kubin T, 2011, CELL STEM CELL, V9, P420, DOI 10.1016/j.stem.2011.08.013; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mitchell BD, 2004, DEV NEUROSCI-BASEL, V26, P101, DOI 10.1159/000082131; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Su XH, 2009, CELL STEM CELL, V5, P64, DOI 10.1016/j.stem.2009.04.003; Wagers AJ, 2012, CELL STEM CELL, V10, P362, DOI 10.1016/j.stem.2012.02.018	10	64	66	2	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 14	2012	10	6					650	652		10.1016/j.stem.2012.05.004	http://dx.doi.org/10.1016/j.stem.2012.05.004			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	965LD	22704501	Bronze			2022-12-28	WOS:000305768400007
J	Han, DW; Tapia, N; Hermann, A; Hemmer, K; Hoing, S; Arauzo-Bravo, MJ; Zaehres, H; Wu, GM; Frank, S; Moritz, S; Greber, B; Yang, JH; Lee, HT; Schwamborn, JC; Storch, A; Scholer, HR				Han, Dong Wook; Tapia, Natalia; Hermann, Andreas; Hemmer, Kathrin; Hoeing, Susanne; Arauzo-Bravo, Marcos J.; Zaehres, Holm; Wu, Guangming; Frank, Stefan; Moritz, Soeren; Greber, Boris; Yang, Ji Hun; Lee, Hoon Taek; Schwamborn, Jens C.; Storch, Alexander; Schoeler, Hans R.			Direct Reprogramming of Fibroblasts into Neural Stem Cells by Defined Factors	CELL STEM CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; DIRECT CONVERSION; MOUSE FIBROBLASTS; DOPAMINERGIC-NEURONS; FUNCTIONAL-NEURONS; HOMEOBOX GENES; GENERATION; EXPRESSION; BRAIN; PLURIPOTENCY	Recent studies have shown that defined sets of transcription factors can directly reprogram differentiated somatic cells to a different differentiated cell type without passing through a pluripotent state, but the restricted proliferative and lineage potential of the resulting cells limits the scope of their potential applications. Here we show that a combination of transcription factors (Brn4/Pou3f4, Sox2, Klf4, c-Myc, plus E47/Tcf3) induces mouse fibroblasts to directly acquire a neural stem cell identity which we term as induced neural stem cells (iNSCs). Direct reprogramming of fibroblasts into iNSCs is a gradual process in which the donor transcriptional program is silenced over time. iNSCs exhibit cell morphology, gene expression, epigenetic features, differentiation potential, and self-renewing capacity, as well as in vitro and in vivo functionality similar to those of wild-type NSCs. We conclude that differentiated cells can be reprogrammed directly into specific somatic stem cell types by defined sets of specific transcription factors.	[Han, Dong Wook; Tapia, Natalia; Hoeing, Susanne; Arauzo-Bravo, Marcos J.; Zaehres, Holm; Wu, Guangming; Frank, Stefan; Moritz, Soeren; Greber, Boris; Yang, Ji Hun; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Han, Dong Wook; Lee, Hoon Taek] Konkuk Univ, SMART Inst Adv Biomed Sci, Sch Med, Dept Stem Cell Biol, Seoul 143701, South Korea; [Hermann, Andreas; Storch, Alexander] Tech Univ Dresden, Dept Neurol, Div Neurodegenerat Dis, D-01307 Dresden, Germany; [Hermann, Andreas; Storch, Alexander] Tech Univ Dresden, CRTD, D-01307 Dresden, Germany; [Hermann, Andreas; Storch, Alexander] German Ctr Neurodegenerat Dis DZNE, D-01307 Dresden, Germany; [Hemmer, Kathrin; Schwamborn, Jens C.] Univ Munster, ZMBE, Inst Cell Biol, Stem Cell Biol & Regenerat Grp, D-48149 Munster, Germany; [Schoeler, Hans R.] Univ Munster, Fac Med, D-48149 Munster, Germany	Max Planck Society; Konkuk University; Konkuk University Medical Center; Technische Universitat Dresden; Technische Universitat Dresden; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technische Universitat Dresden; University of Munster; University of Munster	Han, DW (corresponding author), Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Rontgenstr 20, D-48149 Munster, Germany.	dwhan@konkuk.ac.kr; office@mpi-muenster.mpg.de	, HS/AAB-4434-2019; Marcos, Arauzo-Bravo/A-1706-2011; Hermann, Andreas/D-4213-2017; Schwamborn, Jens C/F-9395-2011; Tapia, Natalia/H-5500-2012	, HS/0000-0003-2643-5136; Marcos, Arauzo-Bravo/0000-0002-3264-464X; Hermann, Andreas/0000-0002-7364-7791; Schwamborn, Jens C/0000-0003-4496-0559; Tapia, Natalia/0000-0003-0226-1952; Greber, Boris/0000-0002-9404-7293; Wu, Guangming/0000-0003-1923-7609	Max Planck Society; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0013885]; National Research Foundation (NRF); Korean government (MEST) [2011-0019490]	Max Planck Society(Max Planck SocietyFoundation CELLEX); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation (NRF); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This research was supported by the Max Planck Society; the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0013885); and the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MEST) (2011-0019490). We are grateful to Areti Malapetsas for editing the manuscript. D.W.H. and H.R.S. designed the experiments. D.W.H., A.H., NT., K.H., S.H., H.Z., S.F., B.G., S.M., and J.H.Y. performed the experiments. D.W.H., A.H., N.T., S.H., M.J.A.-B., S.F., S.M., H.T.L., J.C.S., and A.S. analyzed the data. D.W.H., NT., and H.R.S. wrote the manuscript.	Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; DAVIS CA, 1988, GENE DEV, V2, P1736, DOI 10.1101/gad.2.12b.1736; Dou CL, 1999, CEREB CORTEX, V9, P543, DOI 10.1093/cercor/9.6.543; GIAMPAOLO A, 1989, DIFFERENTIATION, V40, P191, DOI 10.1111/j.1432-0436.1989.tb00598.x; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; Han DW, 2011, NAT CELL BIOL, V13, P66, DOI 10.1038/ncb2136; Han DW, 2009, STEM CELLS, V27, P1088, DOI 10.1002/stem.43; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Kawakami A, 1997, MECH DEVELOP, V66, P119, DOI 10.1016/S0925-4773(97)00097-X; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marro S, 2011, CELL STEM CELL, V9, P374, DOI 10.1016/j.stem.2011.09.002; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Poh A, 2002, INT J DEV BIOL, V46, P597; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Schildmeyer LA, 2000, FASEB J, V14, P2213, DOI 10.1096/fj.99-0927com; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; SIMEONE A, 1992, EMBO J, V11, P2541, DOI 10.1002/j.1460-2075.1992.tb05319.x; SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	38	395	426	3	79	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	APR 6	2012	10	4					465	472		10.1016/j.stem.2012.02.021	http://dx.doi.org/10.1016/j.stem.2012.02.021			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	929QA	22445517	Bronze			2022-12-28	WOS:000303079400014
J	Gibbs, KD; Jager, A; Crespo, O; Goltsev, Y; Trejo, A; Richard, CE; Nolan, GP				Gibbs, Kenneth D., Jr.; Jager, Astraea; Crespo, Oliver; Goltsev, Yury; Trejo, Angelica; Richard, Chase E.; Nolan, Garry P.			Decoupling of Tumor-Initiating Activity from Stable Immunophenotype in HoxA9-Meis1-Driven AML	CELL STEM CELL			English	Article							ACUTE MYELOID-LEUKEMIA; CANCER STEM-CELLS; EVOLUTION; HIERARCHY; CYTOMETRY; GENE; RARE	Increasing evidence suggests tumors are maintained by cancer stem cells; however, their nature remains controversial. In a HoxA9-Meis1 (H9M) model of acute myeloid leukemia (AML), we found that tumor-initiating activity existed in three, immunophenotypically distinct compartments, corresponding to disparate lineages on the normal hematopoietic hierarchy-stem/progenitor cells (Lin(-)kit(+)) and committed progenitors of the myeloid (Gr1(+)kit(+)) and lymphoid lineages (Lym(+)kit(+)). These distinct tumor-initiating cells (TICs) clonally recapitulated the immunophenotypic spectrum of the original tumor in vivo (including cells with a less-differentiated immunophenotype) and shared signaling networks, such that in vivo pharmacologic targeting of conserved TIC survival pathways (DNA methyltransferase and MEK phosphorylation) significantly increased survival. Collectively, H9M AML is organized as an atypical hierarchy that defies the strict lineage marker boundaries and unidirectional differentiation of normal hematopoiesis. Moreover, this suggests that in certain malignancies tumor-initiation activity (or "cancer stemness") can represent a cellular state that exists independently of distinct immunophenotypic definition.	[Gibbs, Kenneth D., Jr.; Jager, Astraea; Crespo, Oliver; Goltsev, Yury; Trejo, Angelica; Richard, Chase E.; Nolan, Garry P.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA; [Gibbs, Kenneth D., Jr.; Crespo, Oliver] Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA	Stanford University; Stanford University	Nolan, GP (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA.	gnolan@stanford.edu	Nolan, Garry/AAE-7903-2019	Nolan, Garry/0000-0002-8862-9043; Gibbs, Kenneth/0000-0002-3532-5396	NSF GRFP; Stanford DARE Fellowship; NIH/NCI [1R01CA130826, U54CA149145, 5U54CA143907]; CIRM [DR1-01477]; NATIONAL CANCER INSTITUTE [R01CA130826, U54CA143907, U54CA149145] Funding Source: NIH RePORTER	NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); Stanford DARE Fellowship; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CIRM(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank E. Simonds, G. Behbehani, and W. Fantl for critical review of the manuscript and S. Bendall, E. Zunder, A. Deshpande, and R. Majeti for helpful conversations. K.G. was funded by NSF GRFP and Stanford DARE Fellowship. This work was supported by NIH/NCI grants 1R01CA130826, U54CA149145, and 5U54CA143907, as well as CIRM grant DR1-01477. G.P.N. is the Rachford and Carlotta A. Harris Endowed Professor, is a member of the scientific advisory board at DVS Sciences, and is a paid consultant for BD Biosciences and Nodality, Inc. K.G. designed the study, performed experiments, analyzed results, and wrote the manuscript. A.J., O.C., Y.G., A.T., and C.E.R. performed experiments. G.P.N. designed experiments and wrote the manuscript.	Abramovich C, 2005, CURR OPIN HEMATOL, V12, P210, DOI 10.1097/01.moh.0000160737.52349.aa; Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Deshpande AJ, 2006, CANCER CELL, V10, P363, DOI 10.1016/j.ccr.2006.08.023; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Gibbs KD, 2011, BLOOD, V117, P4226, DOI 10.1182/blood-2010-07-298232; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Jin LQ, 2009, CELL STEM CELL, V5, P31, DOI 10.1016/j.stem.2009.04.018; Jordan CT, 2009, CELL STEM CELL, V4, P203, DOI 10.1016/j.stem.2009.02.003; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sarry JE, 2011, J CLIN INVEST, V121, P384, DOI 10.1172/JCI41495; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Steidl U, 2007, J CLIN INVEST, V117, P2611, DOI 10.1172/JCI30525; Taussig DC, 2010, BLOOD, V115, P1976, DOI 10.1182/blood-2009-02-206565; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624	29	46	47	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	FEB 3	2012	10	2					210	217		10.1016/j.stem.2012.01.004	http://dx.doi.org/10.1016/j.stem.2012.01.004			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	892FM	22305570	Bronze, Green Accepted			2022-12-28	WOS:000300272100013
J	Luckey, CJ; Weaver, CT				Luckey, C. John; Weaver, Casey T.			Stem-Cell-like Qualities of Immune Memory; CD4(+) T Cells Join the Party	CELL STEM CELL			English	Editorial Material							BETA-CATENIN; DIFFERENTIATION; LYMPHOCYTE		[Luckey, C. John] Harvard Univ, Sch Med, Dept Pathol, Brigham & Womens Hosp, Boston, MA 02115 USA; [Weaver, Casey T.] Univ Alabama Birmingham, Sch Med, Dept Pathol, Birmingham, AL 35209 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Alabama System; University of Alabama Birmingham	Luckey, CJ (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Brigham & Womens Hosp, Boston, MA 02115 USA.	cluckey@partners.org; cweaver@uab.edu		Luckey, Chance John/0000-0002-0787-9121; Weaver, Casey/0000-0002-2180-1793	NIAID NIH HHS [R21 AI095635-01, R21 AI095635, R01 AI077574, R01 AI077574-03] Funding Source: Medline; NIDDK NIH HHS [P01 DK071176-06S1, R01 DK093015-01A1, P01 DK044240, P01 DK071176, R01 DK093015] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077574, R21AI095635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK071176, R01DK093015, P01DK044240] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Driessens G, 2010, NAT MED, V16, P513, DOI 10.1038/nm0510-513; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Lee YK, 2009, CURR OPIN IMMUNOL, V21, P274, DOI 10.1016/j.coi.2009.05.021; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Muranski P, 2011, IMMUNITY, V35, P972, DOI 10.1016/j.immuni.2011.09.019; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; Pepper M, 2011, NAT IMMUNOL, V12, P467, DOI 10.1038/ni.2038; Prlic M, 2011, J IMMUNOL, V187, P1542, DOI 10.4049/jimmunol.1100907	10	18	19	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 3	2012	10	2					107	108		10.1016/j.stem.2012.01.011	http://dx.doi.org/10.1016/j.stem.2012.01.011			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	892FM	22305557	Green Accepted, Bronze			2022-12-28	WOS:000300272100002
J	Morrisey, EE				Morrisey, Edward E.			Rewind to Recover: Dedifferentiation after Cardiac Injury	CELL STEM CELL			English	Editorial Material							HYPERTROPHY; GATA-6		[Morrisey, Edward E.] Univ Penn, Dept Med, Translat Res Ctr, Inst Regenerat Med,Cardiovasc Inst, Philadelphia, PA 19104 USA; [Morrisey, Edward E.] Univ Penn, Dept Cell & Dev Biol, Translat Res Ctr, Inst Regenerat Med,Cardiovasc Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Morrisey, EE (corresponding author), Univ Penn, Dept Med, Translat Res Ctr, Inst Regenerat Med,Cardiovasc Inst, Room 11-124,3400 Civ Ctr Blvd,Bldg 421, Philadelphia, PA 19104 USA.	emorrise@mail.med.upenn.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100405] Funding Source: NIH RePORTER; NHLBI NIH HHS [U01 HL100405, HL100405] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Engel FB, 2006, P NATL ACAD SCI USA, V103, P15546, DOI 10.1073/pnas.0607382103; Gattenlohner S, 2003, AM J PATHOL, V163, P1081, DOI 10.1016/S0002-9440(10)63467-0; Kubin T, 2011, CELL STEM CELL, V9, P420, DOI 10.1016/j.stem.2011.08.013; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Morrisey EE, 2000, J BIOL CHEM, V275, P19949, DOI 10.1074/jbc.M001331200; van Berlo JH, 2010, CIRC RES, V107, P1032, DOI 10.1161/CIRCRESAHA.110.220764	8	12	12	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV 4	2011	9	5					387	388		10.1016/j.stem.2011.10.011	http://dx.doi.org/10.1016/j.stem.2011.10.011			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	850FJ	22056133	Green Accepted, Bronze			2022-12-28	WOS:000297180200003
J	Dieter, SM; Ball, CR; Hoffmann, CM; Nowrouzi, A; Herbst, F; Zavidij, O; Abel, U; Arens, A; Weichert, W; Brand, K; Koch, M; Weitz, J; Schmidt, M; von Kalle, C; Glimm, H				Dieter, Sebastian M.; Ball, Claudia R.; Hoffmann, Christopher M.; Nowrouzi, Ali; Herbst, Friederike; Zavidij, Oksana; Abel, Ulrich; Arens, Anne; Weichert, Wilko; Brand, Karsten; Koch, Moritz; Weitz, Juergen; Schmidt, Manfred; von Kalle, Christof; Glimm, Hanno			Distinct Types of Tumor-Initiating Cells Form Human Colon Cancer Tumors and Metastases	CELL STEM CELL			English	Article							INTESTINAL STEM-CELL; GENE-THERAPY; COLORECTAL-CANCER; PANCREATIC-CANCER; PHENOTYPIC CHARACTERIZATION; PROGNOSTIC-SIGNIFICANCE; REPOPULATING ACTIVITY; MELANOMA-CELLS; BONE-MARROW; VECTOR	Human colon cancer harbors a small subfraction of tumor-initiating cells (TICs) that is assumed to be a functionally homogeneous stem-cell-like population driving tumor maintenance and metastasis formation. We found unexpected cellular heterogeneity within the TIC compartment, which contains three types of TICs. Extensively self-renewing long-term TICs (LT-TICs) maintained tumor formation in serial xenotransplants. Tumor transient amplifying cells (T-TACs) with limited or no self-renewal capacity contributed to tumor formation only in primary mice. Rare delayed contributing TICs (DC-TICs) were exclusively active in secondary or tertiary mice. Bone marrow was identified as an important reservoir of LT-TICs. Metastasis formation was almost exclusively driven by self-renewing LT-TICs. Our results demonstrate that tumor initiation, self-renewal, and metastasis formation are limited to particular subpopulations of TICs in primary human colon cancer. We identify LT-TICs as a quantifiable target for therapies aimed toward eradication of self-renewing tumorigenic and metastatic colon cancer cells.	[Dieter, Sebastian M.; Ball, Claudia R.; Hoffmann, Christopher M.; Nowrouzi, Ali; Herbst, Friederike; Zavidij, Oksana; Abel, Ulrich; Arens, Anne; Schmidt, Manfred; von Kalle, Christof; Glimm, Hanno] Natl Ctr Tumor Dis NCT, Dept Translat Oncol, D-69120 Heidelberg, Germany; [Dieter, Sebastian M.; Ball, Claudia R.; Hoffmann, Christopher M.; Nowrouzi, Ali; Herbst, Friederike; Zavidij, Oksana; Abel, Ulrich; Arens, Anne; Schmidt, Manfred; von Kalle, Christof; Glimm, Hanno] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Weichert, Wilko; Brand, Karsten] Heidelberg Univ, Inst Pathol, D-69120 Heidelberg, Germany; [Koch, Moritz; Weitz, Juergen] Heidelberg Univ, Dept Surg, D-69120 Heidelberg, Germany; [Abel, Ulrich] Heidelberg Univ, Dept Med Biometry, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	von Kalle, C (corresponding author), Natl Ctr Tumor Dis NCT, Dept Translat Oncol, D-69120 Heidelberg, Germany.	christof.kalle@nct-heidelberg.de; hanno.glimm@nct-heidelberg.de	Weitz, Juergen/L-7136-2018	Ball, Claudia/0000-0002-1749-3791; Dieter, Sebastian/0000-0003-1324-7638	DKFZ Light Microscopy Facility; Deutsche Forschungsgemeinschaft [KFO 227]; Baden-Wurttemberg Stiftung; Konrad Adenauer Foundation	DKFZ Light Microscopy Facility; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Baden-Wurttemberg Stiftung; Konrad Adenauer Foundation	We gratefully acknowledge Manfred Jugold (Division of Medical Physics in Radiology, DKFZ) for small animal MRT imaging, Steffen Schmitt (Core facility flow cytometry, DKFZ) for cell sorting, Brigitte Engelhardt (AG Foto, DKFZ) for assistance in image preparation, and the support by the DKFZ Light Microscopy Facility. We thank Norma Howells and Silke Hamzaoui-Nord for animal care and Sylvia Fessler, Nadine Krenzer, and Stefanie Dietz for technical assistance. This work was supported by grants from the Deutsche Forschungsgemeinschaft (KFO 227) and the Baden-Wurttemberg Stiftung. S.M.D. was supported by a scholarship of the Konrad Adenauer Foundation.	Alonso L, 2003, P NATL ACAD SCI USA, V100, P11830, DOI 10.1073/pnas.1734203100; Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Boztug K, 2010, NEW ENGL J MED, V363, P1918, DOI 10.1056/NEJMoa1003548; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Eisterer W, 2005, LEUKEMIA, V19, P435, DOI 10.1038/sj.leu.2403649; Gabriel R, 2009, NAT MED, V15, P1431, DOI 10.1038/nm.2057; Glimm H, 2005, BLOOD, V106, P893, DOI 10.1182/blood-2004-07-2859; Glimm H, 2001, J CLIN INVEST, V107, P199, DOI 10.1172/JCI11519; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; LINDEMANN F, 1992, LANCET, V340, P685, DOI 10.1016/0140-6736(92)92230-D; Manfred S, 2007, NAT METHODS, V4, P1051, DOI 10.1038/nmeth1103; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Montini E, 2009, J CLIN INVEST, V119, P964, DOI 10.1172/JCI37630; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Ricci-Vitiani L, 2009, J MOL MED, V87, P1097, DOI 10.1007/s00109-009-0518-4; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; SCHLIMOK G, 1990, J CLIN ONCOL, V8, P831, DOI 10.1200/JCO.1990.8.5.831; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	36	222	232	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 7	2011	9	4					357	365		10.1016/j.stem.2011.08.010	http://dx.doi.org/10.1016/j.stem.2011.08.010			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	835MT	21982235	Bronze			2022-12-28	WOS:000296041200013
J	Daquinag, AC; Zhang, Y; Amaya-Manzanares, F; Simmons, PJ; Kolonin, MG				Daquinag, Alexes C.; Zhang, Yan; Amaya-Manzanares, Felipe; Simmons, Paul J.; Kolonin, Mikhail G.			An Isoform of Decorin Is a Resistin Receptor on the Surface of Adipose Progenitor Cells	CELL STEM CELL			English	Article							MESENCHYMAL STEM-CELLS; GROWTH-FACTOR-BETA; STROMAL CELLS; IN-VIVO; ENDOTHELIAL-CELLS; COLLAGEN FIBRILLOGENESIS; PHAGE DISPLAY; BONE-MARROW; TISSUE; PROLIFERATION	Adipose stromal cells (ASCs) serve as mesenchymal progenitors in white adipose tissue (WAT). Intercellular interactions involving ASCs have remained obscure. By merging phage display technology with fluorescence-activated cell sorting (FACS), we screened a combinatorial library for peptides that target mouse ASCs in vivo. We isolated peptide CSWKYWFGEC that specifically homes to ASCs, used it as bait to purify the corresponding ASC surface receptor, and identified it as a previously unreported cleavage product of decorin (DCN) lacking the glycanation site (termed Delta DCN). We demonstrate that Delta DCN is differentially expressed on ASC surface. In a screen for Delta DCN-binding proteins, we identified resistin, an adipokine for which the receptor has been unknown. Expression of Delta DCN in 3T3-L1 cells promoted proliferation and migration but suppressed lipid accumulation upon adipogenesis induction, which was resistin dependent. We conclude that Delta DCN serves as a functional receptor of resistin in adipocyte progenitors and may regulate WAT expansion.	[Daquinag, Alexes C.; Zhang, Yan; Amaya-Manzanares, Felipe; Simmons, Paul J.; Kolonin, Mikhail G.] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med Prevent Human Dis, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Kolonin, MG (corresponding author), Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med Prevent Human Dis, Houston, TX 77030 USA.	mikhail.g.kolonin@uth.tmc.edu		Kolonin, Mikhail/0000-0002-3743-7869	Komen for the Cure Award [KG080782]; American Heart Association [0835434N]; Cancer Prevention and Research Institute of Texas [RP100400]	Komen for the Cure Award(Susan G. Komen Breast Cancer Foundation); American Heart Association(American Heart Association); Cancer Prevention and Research Institute of Texas	We are grateful to Erkki Koivunen, Renata Pasqualini, Wadih Arap, and Keith L. March for providing reagents. We thank Magnus Hook, Philipp Scherer, and Mitchell Lazar for insightful discussions. This work was supported by Komen for the Cure Award KG080782, the American Heart Association Grant 0835434N, and the Cancer Prevention and Research Institute of Texas Award RP100400 to M.G.K.	Arap W, 2002, NAT MED, V8, P121, DOI 10.1038/nm0202-121; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; BELLOWS CF, 2011, OBESITY IN PRESS, DOI DOI 10.1038/OBY.2010.347; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bolton K, 2008, INT J OBESITY, V32, P1113, DOI 10.1038/ijo.2008.41; Calabro P, 2004, CIRCULATION, V110, P3335, DOI 10.1161/01.CIR.0000147825.97879.E7; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Copland I, 2008, EXP HEMATOL, V36, P93, DOI 10.1016/j.exphem.2007.08.032; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Daquinag AC, 2011, TRENDS PHARMACOL SCI, V32, P300, DOI 10.1016/j.tips.2011.01.004; DASILVA ML, 2006, J CELL SCI, V119, P2204, DOI DOI 10.1242/JCS.02932; DAY AA, 1987, BIOCHEM J, V248, P801, DOI 10.1042/bj2480801; Ferdous Z, 2010, J BIOMED MATER RES A, V93A, P419, DOI 10.1002/jbm.a.32545; Fiedler LR, 2008, J BIOL CHEM, V283, P17406, DOI 10.1074/jbc.M710025200; FRIEDENSTEIN AJ, 1980, BLOOD, V25, P19; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Giordano A, 2007, J CELL PHYSIOL, V211, P27, DOI 10.1002/jcp.20959; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Imai K, 1997, BIOCHEM J, V322, P809, DOI 10.1042/bj3220809; Iozzo RV, 1999, J BIOL CHEM, V274, P4489, DOI 10.1074/jbc.274.8.4489; Jarvelainen H, 2006, WOUND REPAIR REGEN, V14, P443, DOI 10.1111/j.1743-6109.2006.00150.x; Jones BJ, 2008, EXP HEMATOL, V36, P733, DOI 10.1016/j.exphem.2008.03.006; Kim KH, 2001, J BIOL CHEM, V276, P11252, DOI 10.1074/jbc.C100028200; Kolonin MG, 2006, CANCER RES, V66, P34, DOI 10.1158/0008-5472.CAN-05-2748; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Kolonin MG, 2002, P NATL ACAD SCI USA, V99, P13055, DOI 10.1073/pnas.162468499; Kolonin MG, 2006, FASEB J, V20, P979, DOI 10.1096/fj.05-5186fje; Kolonin MG, 2009, NAT BIOTECHNOL, V27, P252, DOI 10.1038/nbt0309-252; KRUSIUS T, 1986, P NATL ACAD SCI USA, V83, P7683, DOI 10.1073/pnas.83.20.7683; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; Mu H, 2006, CARDIOVASC RES, V70, P146, DOI 10.1016/j.cardiores.2006.01.015; Nagaev I, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000031; Nelimarkka L, 2001, AM J PATHOL, V158, P345, DOI 10.1016/S0002-9440(10)63975-2; Nie J, 2008, STEM CELLS, V26, P2735, DOI 10.1634/stemcells.2008-0212; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Reed CC, 2002, GLYCOCONJUGATE J, V19, P249, DOI 10.1023/A:1025383913444; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rosenzweig A, 2006, NEW ENGL J MED, V355, P1274, DOI 10.1056/NEJMe068172; Roughley PJ, 1996, BIOCHEM J, V318, P779, DOI 10.1042/bj3180779; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Samad F, 1997, MOL MED, V3, P37, DOI 10.1007/BF03401666; SCHOLZEN T, 1994, J BIOL CHEM, V269, P28270; Schonherr E, 2005, J BIOL CHEM, V280, P15767, DOI 10.1074/jbc.M500451200; Scott PG, 2004, P NATL ACAD SCI USA, V101, P15633, DOI 10.1073/pnas.0402976101; SIMMONS PJ, 1991, BLOOD, V78, P55; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Traktuev DO, 2009, CIRC RES, V104, P1410, DOI 10.1161/CIRCRESAHA.108.190926; Villena JA, 2002, HORM METAB RES, V34, P664, DOI 10.1055/s-2002-38244; Wagner J, 2009, CURR OPIN BIOTECH, V20, P531, DOI 10.1016/j.copbio.2009.08.009; Weber IT, 1996, J BIOL CHEM, V271, P31767, DOI 10.1074/jbc.271.50.31767; YAMAGUCHI Y, 1988, NATURE, V336, P244, DOI 10.1038/336244a0; Zhang Y, 2009, CANCER RES, V69, P5259, DOI 10.1158/0008-5472.CAN-08-3444; Zimmerlin L, 2010, CYTOM PART A, V77A, P22, DOI 10.1002/cyto.a.20813; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	60	147	151	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUL 8	2011	9	1					74	86		10.1016/j.stem.2011.05.017	http://dx.doi.org/10.1016/j.stem.2011.05.017			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	797VA	21683670	Bronze			2022-12-28	WOS:000293157000011
J	Bretzner, F; Gilbert, F; Baylis, F; Brownstone, RM				Bretzner, Frederic; Gilbert, Frederic; Baylis, Francoise; Brownstone, Robert M.			Target Populations for First-In-Human Embryonic Stem Cell Research in Spinal Cord Injury	CELL STEM CELL			English	Article							COMMITTED PROGENITOR CELLS; MULTIPLE-SCLEROSIS; CLINICAL-TRIALS; INFLAMMATORY RESPONSE; DOUBLE-BLIND; THERAPEUTIC MISCONCEPTION; TRANSPLANTATION; MACROPHAGES; DIFFERENTIATION; RECOVERY	Geron recently announced that it had begun enrolling patients in the world's first-in-human clinical trial involving cells derived from human embryonic stem cells (hESCs). This trial raises important questions regarding the future of hESC-based therapies, especially in spinal cord injury (SCI) patients. We address some safety and efficacy concerns with this research, as well as the ethics of fair subject selection. We consider other populations that might be better for this research: chronic complete SCI patients for a safety trial, subacute incomplete SCI patients for an efficacy trial, and perhaps primary progressive multiple sclerosis (MS) patients for a combined safety and efficacy trial.	[Bretzner, Frederic; Brownstone, Robert M.] Dalhousie Univ, Dept Anat & Neurobiol, Halifax, NS B3H 3J5, Canada; [Baylis, Francoise] Dalhousie Univ, Dept Philosophy, Halifax, NS B3H 3J5, Canada; [Baylis, Francoise] Dalhousie Univ, Dept Obstet & Gynaecol, Halifax, NS B3H 3J5, Canada; [Brownstone, Robert M.] Dalhousie Univ, Dept Surg Neurosurg, Halifax, NS B3H 3J5, Canada; [Gilbert, Frederic] Univ Tasmania, ACES, Hobart, Tas 7005, Australia	Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University; University of Tasmania	Bretzner, F (corresponding author), Dalhousie Univ, Dept Anat & Neurobiol, Halifax, NS B3H 3J5, Canada.	frederic.bretzner@dal.ca	Baylis, Francoise/AAP-4565-2021; Gilbert, Frederic/D-5452-2012	Gilbert, Frederic/0000-0003-0524-8649; Baylis, Francoise/0000-0003-2961-5802; Bretzner, Frederic/0000-0002-7387-3414; Brownstone, Robert/0000-0001-5135-2725	Canadian Institutes of Health Research (CIHR) [NNF 80045]; Canada Research Chair in Bioethics and Philosophy	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Bioethics and Philosophy	We thank members of the NovelTechEthics research team at Dalhousie University, Renee Hartlieb, and anonymous reviewers for helpful comments on an earlier version of this paper. We also thank Philippe Magown for discussion and comments on the design of clinical trials and Virender Bhan for discussion about MS patients. This work was funded in part by the Canadian Institutes of Health Research (CIHR) NNF 80045, States of Mind: Emerging Issues in Neuroethics awarded to Francoise Baylis, Canada Research Chair in Bioethics and Philosophy. The spinal cord research of Robert Brownstone is supported by grants from the CIHR. At the time of writing, Frederic Gilbert was a research postdoctoral fellow on the States of Mind grant. Frederic Bretzner is a CIHR and Paralysis Project of America (PPA) postdoctoral fellow researcher.	Alexander JK, 2009, PROG BRAIN RES, V175, P125, DOI 10.1016/S0079-6123(09)17508-8; Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; Anderson JA, 2010, KENNEDY INST ETHIC J, V20, P75, DOI 10.1353/ken.0.0307; [Anonymous], 2008, WMA DECL HELS ETH PR; [Anonymous], 2000, J SPINAL CORD MED, V23, P289; APPELBAUM PS, 1987, HASTINGS CENT REP, V17, P20, DOI 10.2307/3562038; Bottai D, 2010, EXP NEUROL, V223, P452, DOI 10.1016/j.expneurol.2010.01.010; Brederlau A, 2006, STEM CELLS, V24, P1433, DOI 10.1634/stemcells.2005-0393; Burns AS, 2003, J NEUROTRAUM, V20, P477, DOI 10.1089/089771503765355540; Busch SA, 2011, J NEUROSCI, V31, P944, DOI 10.1523/JNEUROSCI.3566-10.2011; Chang HT, 2007, SPINAL CORD, V45, P174, DOI 10.1038/sj.sc.3101910; Chien KR, 2004, NATURE, V428, P607, DOI 10.1038/nature02500; Cloutier F, 2006, REGEN MED, V1, P469, DOI 10.2217/17460751.1.4.469; Corbetta M, 2002, P NATL ACAD SCI USA, V99, P17066, DOI 10.1073/pnas.262669099; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; Coutts M, 2008, EXP NEUROL, V209, P368, DOI 10.1016/j.expneurol.2007.09.002; D Cardenas D, 2007, SPINAL CORD, V45, P158, DOI 10.1038/sj.sc.3101947; DeForge D, 2004, SPINAL CORD, V42, P674, DOI 10.1038/sj.sc.3101653; Dobkin BH, 2006, NEUROREHAB NEURAL RE, V20, P5, DOI 10.1177/1545968305284675; Dryden DM, 2005, NEUROEPIDEMIOLOGY, V25, P55, DOI 10.1159/000086284; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; ERGO F, 2003, J CEREB BLOOD FLOW M, V23, P780; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Gensel JC, 2011, EXPERT OPIN THER TAR, V15, P505, DOI 10.1517/14728222.2011.553605; *GER, 2010, PRECL SAF STUD; *GER, 2010, PHAS 1 SAF STUD GRNO; *GER, 2009, GER COMM FDA HOLD SP; *GER, 2009, GER REC FDA CLEAR BE; Geron, 2010, GER PROC 1 HUM CLIN; GILBERT F, 2009, GERONS HESC TRIAL SP; Goodman AD, 2007, MULT SCLER, V13, P357, DOI 10.1177/1352458506069538; Goodman AD, 2009, LANCET, V373, P732, DOI 10.1016/S0140-6736(09)60442-6; Guest JD, 2005, EXP NEUROL, V192, P384, DOI 10.1016/j.expneurol.2004.11.033; Hall VJ, 2008, ANN ACAD MED SINGAP, V37, P163; Hardison JL, 2006, EXP NEUROL, V197, P420, DOI 10.1016/j.expneurol.2005.10.016; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Hill CE, 2004, EXP NEUROL, V190, P289, DOI 10.1016/j.expneurol.2004.05.043; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Illes J, 2011, STEM CELL REV REP, V7, P997, DOI 10.1007/s12015-011-9259-1; Kakulas BA, 1999, SPINAL CORD, V37, P79, DOI 10.1038/sj.sc.3100807; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kennedy P, 2000, ARCH PHYS MED REHAB, V81, P932, DOI 10.1053/apmr.2000.5580; Kimmelman J, 2006, HASTINGS CENT REP, V36, P23, DOI 10.1353/hcr.2006.0012; Kimmelman J, 2007, HASTINGS CENT REP, V37, P36, DOI 10.1353/hcr.2007.0092; Knoepfler PS, 2009, STEM CELLS, V27, P1050, DOI 10.1002/stem.37; Kovacsovics-Bankowski M, 2009, CELL IMMUNOL, V255, P55, DOI 10.1016/j.cellimm.2008.10.004; Kwon BK, 2010, J NEUROTRAUM, V27, P21, DOI 10.1089/neu.2009.1048; Lasiene J, 2008, J NEUROSCI, V28, P3887, DOI 10.1523/JNEUROSCI.4756-07.2008; Lau D, 2008, CELL STEM CELL, V3, P591, DOI 10.1016/j.stem.2008.11.001; Levine RJ, 1988, ETHICS REGULATIONS C; Lo B, 2005, STEM CELLS, V23, P1454, DOI 10.1634/stemcells.2005-ed.4; MAYNARD FM, 1979, J NEUROSURG, V50, P611, DOI 10.3171/jns.1979.50.5.0611; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Miller FG, 2003, NEW ENGL J MED, V348, P1383, DOI 10.1056/NEJMsb030228; Moon Lawrence, 2005, J Neurol Phys Ther, V29, P55; Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Popovich PG, 2002, J NEUROPATH EXP NEUR, V61, P623, DOI 10.1093/jnen/61.7.623; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Ruof MC, 2004, KENNEDY INST ETHIC J, V14, P411, DOI 10.1353/ken.2004.0044; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; Schwartz M, 2006, J NEUROTRAUM, V23, P360, DOI 10.1089/neu.2006.23.360; Scott CT, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E23; Sellers DL, 2009, J NEUROSCI, V29, P6722, DOI 10.1523/JNEUROSCI.4538-08.2009; Sroga JM, 2003, J COMP NEUROL, V462, P223, DOI 10.1002/cne.10736; *STEAM CELL INC, 2011, IN WORLDS 1 NEUR STE; Steeves JD, 2007, SPINAL CORD, V45, P206, DOI 10.1038/sj.sc.3102008; Taoka Y, 1997, NEUROSCIENCE, V79, P1177, DOI 10.1016/S0306-4522(97)00011-0; Tetzlaff W, 2011, J NEUROTRAUM, V28, P1611, DOI 10.1089/neu.2009.1177; Totoiu MO, 2004, EXP NEUROL, V187, P254, DOI 10.1016/j.expneurol.2004.01.028; van der Bruggen MAM, 2001, J NEUROL, V248, P665, DOI 10.1007/s004150170111; Wade N., 2005, NY TIMES; Yang H, 2006, J NEUROSCI, V26, P2157, DOI 10.1523/JNEUROSCI.4070-05.2005; Yang LQ, 2004, SPINE, V29, P966, DOI 10.1097/00007632-200405010-00004; 2004, NAT NEUROSCI, V7, P1013; 2004, NATURE, V428, P587	78	85	86	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 6	2011	8	5					468	475		10.1016/j.stem.2011.04.012	http://dx.doi.org/10.1016/j.stem.2011.04.012			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Cell Biology	768IN	21549321	Bronze			2022-12-28	WOS:000290927600006
J	Smukler, SR; Arntfield, ME; Razavi, R; Bikopoulos, G; Karpowicz, P; Seaberg, R; Dai, FH; Lee, S; Ahrens, R; Fraser, PE; Wheeler, MB; van der Kooy, D				Smukler, Simon R.; Arntfield, Margot E.; Razavi, Rozita; Bikopoulos, George; Karpowicz, Phillip; Seaberg, Raewyn; Dai, Feihan; Lee, Simon; Ahrens, Rosemary; Fraser, Paul E.; Wheeler, Michael B.; van der Kooy, Derek			The Adult Mouse and Human Pancreas Contain Rare Multipotent Stem Cells that Express Insulin	CELL STEM CELL			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GREEN FLUORESCENT PROTEIN; BETA-CELLS; PROGENITOR CELLS; PRECURSOR CELLS; POSITIVE CELLS; NEURAL CREST; ISLET CELLS; IN-VITRO; PROLIFERATION	The search for putative precursor cells within the pancreas has been the focus of extensive research. Previously, we identified rare pancreas-derived multipotent precursor (PMP) cells in the mouse with the intriguing capacity to generate progeny in the pancreatic and neural lineages. Here, we establish the embryonic pancreas as the developmental source of PMPs through lineage-labeling experiments. We also show that PMPs express insulin and can contribute to multiple pancreatic and neural cell types in vivo. In addition, we have isolated PMPs from adult human islet tissue that are also capable of extensive proliferation, self-renewal, and generation of multiple differentiated pancreatic and neural cell types. Finally, both mouse and human PMP-derived cells ameliorated diabetes in transplanted mice. These findings demonstrate that the adult Mammalian pancreas contains a population of insulin(+) multipotent stem cells and suggest that these cells may provide a promising line of investigation toward potential therapeutic benefit.	[Smukler, Simon R.; Arntfield, Margot E.; Razavi, Rozita; Karpowicz, Phillip; Seaberg, Raewyn; van der Kooy, Derek] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Bikopoulos, George; Dai, Feihan; Lee, Simon; Wheeler, Michael B.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Ahrens, Rosemary; Fraser, Paul E.; van der Kooy, Derek] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; University of Toronto	Smukler, SR (corresponding author), Univ Toronto, Dept Mol Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada.	simon.smukler@utoronto.ca	Karpowicz, Phillip/C-3334-2016	Wheeler, Michael B./0000-0002-7480-7267; Karpowicz, Phillip/0000-0002-3116-4804	Juvenile Diabetes Research Foundation; Canadian Stem Cell Network; Banting & Best Diabetes Centre; Canadian Institutes of Health Research; MRC [MC_G1000734] Funding Source: UKRI; Medical Research Council [MC_G1000734] Funding Source: researchfish	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Canadian Stem Cell Network; Banting & Best Diabetes Centre; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors wish to thank members of the D.v.d.K. lab for thoughtful discussion and critical reading of the manuscript, D. Dixon for excellent tissue isolation and purification, M. Brown for assistance with the transplantation techniques, C. Smith, D. White, and P.A. Pentilla for expert assistance with FACS analysis, S. Doyle for electron microscopy sample preparation and imaging, J. Aubin for providing MSC samples, J. Shapiro for providing human islet tissue, and C. Lobe, D. Melton, M. Hara, and A. McMahon for generously providing transgenic mice. This work was supported by the Juvenile Diabetes Research Foundation, the Canadian Stem Cell Network, the Banting & Best Diabetes Centre, and the Canadian Institutes of Health Research.	Atouf F, 2007, DIABETES, V56, P699, DOI 10.2337/db06-1446; Brennand K, 2007, PLOS BIOL, V5, P1520, DOI 10.1371/journal.pbio.0050163; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Chase LG, 2007, DIABETES, V56, P3, DOI 10.2337/db06-1165; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Dror V, 2007, DIABETOLOGIA, V50, P2504, DOI 10.1007/s00125-007-0835-5; Dupin E, 2006, ADV EXP MED BIOL, V589, P96; ECHELARD Y, 1994, DEVELOPMENT, V120, P2213; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; Itoh S, 2009, J CELL BIOCHEM, V108, P368, DOI 10.1002/jcb.22262; Kassem SA, 2000, DIABETES, V49, P1325, DOI 10.2337/diabetes.49.8.1325; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; MacDonald PE, 2002, DIABETES, V51, pS434, DOI 10.2337/diabetes.51.2007.S434; Manesso E, 2009, AM J PHYSIOL-ENDOC M, V297, pE323, DOI 10.1152/ajpendo.00284.2009; MESSIER B, 1960, AM J ANAT, V106, P247, DOI 10.1002/aja.1001060305; Morshead CM, 2003, EUR J NEUROSCI, V18, P76, DOI 10.1046/j.1460-9568.2003.02727.x; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Ouziel-Yahalom L, 2006, BIOCHEM BIOPH RES CO, V341, P291, DOI 10.1016/j.bbrc.2005.12.187; Pierret C, 2006, STEM CELLS DEV, V15, P286, DOI 10.1089/scd.2006.15.286; Roe MW, 1996, J BIOL CHEM, V271, P32241, DOI 10.1074/jbc.271.50.32241; Russ HA, 2008, DIABETES, V57, P1575, DOI 10.2337/db07-1283; Seaberg RM, 2004, NAT BIOTECHNOL, V22, P1115, DOI 10.1038/nbt1004; Stanger BZ, 2007, NATURE, V445, P886, DOI 10.1038/nature05537; Szot GL, 2007, JOVE-J VIS EXP, V9, P404, DOI DOI 10.3791/404; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; WOLSWIJK G, 1992, J CELL BIOL, V118, P889, DOI 10.1083/jcb.118.4.889; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Zhang YQ, 2003, DIABETES-METAB RES, V19, P363, DOI 10.1002/dmrr.406	35	161	170	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 4	2011	8	3					281	293		10.1016/j.stem.2011.01.015	http://dx.doi.org/10.1016/j.stem.2011.01.015			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	735HI	21362568	Bronze			2022-12-28	WOS:000288404400010
J	Zeng, XK; Hou, SX				Zeng, Xiankun; Hou, Steven X.			Kidney Stem Cells Found in Adult Zebrafish	CELL STEM CELL			English	Editorial Material							DROSOPHILA MALPIGHIAN TUBULES	Recently in Nature, Davidson and coworkers (Diep et al., 2011) identified nephron progenitors/stem cells located at the point of fusion with the pronephric tubules in adult zebrafish. Clumps of progenitors give rise to functional nephrons after serial transplantation, demonstrating the ability of tissue stem cells to regenerate damaged kidney structures.	[Zeng, Xiankun; Hou, Steven X.] NCI, Mouse Canc Genet Program, NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hou, SX (corresponding author), NCI, Mouse Canc Genet Program, NIH, Frederick, MD 21702 USA.	hous@mail.nih.gov		Zeng, Xiankun (Kevin)/0000-0003-3526-8755	NATIONAL CANCER INSTITUTE [ZIABC010738] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Diep CQ, 2011, NATURE, V470, P95, DOI 10.1038/nature09669; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Georgas K, 2009, DEV BIOL, V332, P273, DOI 10.1016/j.ydbio.2009.05.578; Kobayashi A, 2005, DEVELOPMENT, V132, P2809, DOI 10.1242/dev.01858; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Singh SR, 2007, CELL STEM CELL, V1, P191, DOI 10.1016/j.stem.2007.07.003; Weavers H, 2009, NATURE, V457, P322, DOI 10.1038/nature07526; Wingert RA, 2008, KIDNEY INT, V73, P1120, DOI 10.1038/ki.2008.37; Zeng XK, 2010, J CELL PHYSIOL, V224, P766, DOI 10.1002/jcp.22179	9	4	5	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 4	2011	8	3					247	249		10.1016/j.stem.2011.02.008	http://dx.doi.org/10.1016/j.stem.2011.02.008			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	735HI	21362564	Bronze			2022-12-28	WOS:000288404400005
J	Bu, PC; Chen, KY; Chen, JH; Wang, LH; Walters, J; Shin, YJ; Goerger, JP; Sun, J; Witherspoon, M; Rakhilin, N; Li, JH; Yang, H; Milsom, J; Lee, S; Zipfel, W; Jin, MM; Gumus, ZH; Lipkin, SM; Shen, XL				Bu, Pengcheng; Chen, Kai-Yuan; Chen, Joyce Huan; Wang, Lihua; Walters, Jewell; Shin, Yong Jun; Goerger, Julian P.; Sun, Jian; Witherspoon, Mavee; Rakhilin, Nikolai; Li, Jiahe; Yang, Herman; Milsom, Jeff; Lee, Sang; Zipfel, Warren; Jin, Moonsoo M.; Guemues, Zeynep H.; Lipkin, Steven M.; Shen, Xiling			A microRNA miR-34a-Regulated Bimodal Switch Targets Notch in Colon Cancer Stem Cells	CELL STEM CELL			English	Article							TUMOR-INITIATING CELLS; INTESTINAL CRYPTS; MAMMALIAN-CELLS; SELF-RENEWAL; DIVISION; METASTASIS; RNAS; DIFFERENTIATION; MODULATION; REGULATORS	microRNAs regulate developmental cell-fate decisions, tissue homeostasis, and oncogenesis in distinct ways relative to proteins. Here, we show that the tumor suppressor microRNA miR-34a is a cell-fate determinant in early-stage dividing colon cancer stem cells (CCSCs). In pair-cell assays, miR-34a distributes at high levels in differentiating progeny, whereas low levels of miR-34a demarcate self-renewing CCSCs. Moreover, miR-34a loss of function and gain of function alter the balance between self-renewal versus differentiation both in vitro and in vivo. Mechanistically, miR-34a sequesters Notch1 mRNA to generate a sharp threshold response where a bimodal Notch signal specifies the choice between self-renewal and differentiation. In contrast, the canonical cell-fate determinant Numb regulates Notch levels in a continuously graded manner. Altogether, our findings highlight a unique microRNA-regulated mechanism that converts noisy input into a toggle switch for robust cell-fate decisions in CCSCs.	[Bu, Pengcheng; Chen, Kai-Yuan; Wang, Lihua; Shin, Yong Jun; Rakhilin, Nikolai; Yang, Herman; Shen, Xiling] Cornell Univ, Sch Elect & Comp Engn, Ithaca, NY 14853 USA; [Bu, Pengcheng; Chen, Joyce Huan; Goerger, Julian P.; Li, Jiahe; Zipfel, Warren; Jin, Moonsoo M.; Shen, Xiling] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA; [Wang, Lihua; Rakhilin, Nikolai; Shen, Xiling] Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY 14853 USA; [Walters, Jewell; Witherspoon, Mavee; Milsom, Jeff; Lee, Sang; Lipkin, Steven M.] Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA; [Walters, Jewell; Witherspoon, Mavee; Milsom, Jeff; Lee, Sang; Lipkin, Steven M.] Weill Cornell Med Coll, Dept Med Genet, New York, NY 10021 USA; [Walters, Jewell; Witherspoon, Mavee; Milsom, Jeff; Lee, Sang; Lipkin, Steven M.] Weill Cornell Med Coll, Dept Surg, New York, NY 10021 USA; [Sun, Jian; Guemues, Zeynep H.] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Jin, Moonsoo M.] Weill Cornell Med Coll, Dept Radiol, New York, NY 10021 USA; [Guemues, Zeynep H.] Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10021 USA; [Guemues, Zeynep H.] Weill Cornell Med Coll, Computat Biomed & Canc Ctr, New York, NY 10021 USA	Cornell University; Cornell University; Cornell University; Cornell University; Cornell University; Cornell University; Cornell University; Cornell University; Cornell University; Cornell University	Lipkin, SM (corresponding author), Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA.	stl2012@med.cornell.edu; xs66@cornell.edu	Bu, Pengcheng/N-4134-2013; Zipfel, Warren/B-4059-2016	Bu, Pengcheng/0000-0002-3208-0354; Zipfel, Warren/0000-0003-2640-329X; Gumus, Zeynep/0000-0002-7364-2202	Cornell Nanobiotechnology Center, the Cornell Stem Cell Program;  [NIGMS R01GM95990];  [NSF 1137269];  [DARPA 19-1091726];  [NCI R21CA162483];  [NCI R21CA153049]; NATIONAL CANCER INSTITUTE [R21CA153049, R21CA162483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095990] Funding Source: NIH RePORTER; Div Of Chem, Bioeng, Env, & Transp Sys [1106153] Funding Source: National Science Foundation	Cornell Nanobiotechnology Center, the Cornell Stem Cell Program; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	We thank Michael Elowitz and members of the Shen, Lipkin, Elowitz, and Jin laboratories for discussions and advice. We also thank Harley McAdams, Kenneth Kemphues, Tudorita Tumbar, and Robert Weiss for their comments on the manuscript. This work was supported by grants NIGMS R01GM95990, NSF 1137269, DARPA 19-1091726, NCI R21CA162483, and NCI R21CA153049 as well as the Cornell Nanobiotechnology Center, the Cornell Stem Cell Program, and a generous gift from Matthew Bell.	Alison MR, 2012, CANCER TREAT REV, V38, P589, DOI 10.1016/j.ctrv.2012.03.003; Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3439; Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3375; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Choi YJ, 2011, NAT CELL BIOL, V13, P1353, DOI 10.1038/ncb2366; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; DEYGUHA I, 2011, P NATL ACAD SCI US; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; EMELO FD, 2011, CELL STEM CELL, V9, P476; Emmink BL, 2011, GASTROENTEROLOGY, V141, P269, DOI 10.1053/j.gastro.2011.03.052; Goulas S, 2012, CELL STEM CELL, V11, P529, DOI 10.1016/j.stem.2012.06.017; Guardavaccaro D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002921; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Itzkovitz S, 2012, CELL, V148, P608, DOI 10.1016/j.cell.2011.12.025; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; JAHID S, 2012, CANC DISCOVERY; LaPointe LC, 2008, PHYSIOL GENOMICS, V33, P50, DOI 10.1152/physiolgenomics.00185.2006; Lathia JD, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.80; Levine E, 2007, PLOS COMPUT BIOL, V3, P2356, DOI 10.1371/journal.pcbi.0030233; Li X, 2007, PHYSIOL GENOMICS, V29, P290, DOI 10.1152/physiolgenomics.00269.2006; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Loboda A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-9; Lu J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp482; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; O'Brien CA, 2012, CANCER CELL, V21, P777, DOI 10.1016/j.ccr.2012.04.036; Osella M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001101; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Pine SR, 2010, P NATL ACAD SCI USA, V107, P2195, DOI 10.1073/pnas.0909390107; Potten CS, 2002, J CELL SCI, V115, P2381; Quyn AJ, 2010, CELL STEM CELL, V6, P175, DOI 10.1016/j.stem.2009.12.007; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sampieri K, 2012, SEMIN CANCER BIOL, V22, P187, DOI 10.1016/j.semcancer.2012.03.002; Sanchez-Tillo E, 2011, P NATL ACAD SCI USA, V108, P19204, DOI 10.1073/pnas.1108977108; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Sikandar SS, 2010, CANCER RES, V70, P1469, DOI 10.1158/0008-5472.CAN-09-2557; Sugiarto S, 2011, CANCER CELL, V20, P328, DOI 10.1016/j.ccr.2011.08.011; Taketo MM, 2011, CANCER PREV RES, V4, P324, DOI 10.1158/1940-6207.CAPR-11-0046; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Vohradsky J, 2010, NUCLEIC ACIDS RES, V38, P4579, DOI 10.1093/nar/gkq220; Wurbel MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016442; Youn BS, 2001, BLOOD, V98, P925, DOI 10.1182/blood.V98.4.925	53	282	294	1	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 2	2013	12	5					602	615		10.1016/j.stem.2013.03.002	http://dx.doi.org/10.1016/j.stem.2013.03.002			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VE	23642368	Bronze, Green Accepted			2022-12-28	WOS:000329569600015
J	Hogdal, LJ; Letai, A				Hogdal, Leah J.; Letai, Anthony			BCL-2 Inhibition: Stemming the Tide of Myeloid Malignancies	CELL STEM CELL			English	Editorial Material							BH3 MIMETIC ABT-737; LEUKEMIA; SENSITIVITY; APOPTOSIS	Leukemia stem cells (LSCs) are likely to be the source for both therapeutic resistance and relapse in myeloid malignancies. As reported in this issue of Cell Stem Cell, Lagadinou et al. (2013) and Goff et al. (2013) support selective targeting of LSCs by small molecule antagonists of anti-apoptotic BCL-2 family proteins.	[Hogdal, Leah J.; Letai, Anthony] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute	Letai, A (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave, Boston, MA 02215 USA.	anthony_letai@dfci.harvard.edu			NCI NIH HHS [R01 CA129974] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA129974] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Goff DJ, 2013, CELL STEM CELL, V12, P316, DOI 10.1016/j.stem.2012.12.011; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Lagadinou ED, 2013, CELL STEM CELL, V12, P329, DOI 10.1016/j.stem.2012.12.013; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Moore VD, 2008, BLOOD, V111, P2300, DOI 10.1182/blood-2007-06-098012; Roberts AW, 2012, J CLIN ONCOL, V30, P488, DOI 10.1200/JCO.2011.34.7898; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Vo TT, 2012, CELL, V151, P344, DOI 10.1016/j.cell.2012.08.038; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004	10	5	6	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 7	2013	12	3					269	270		10.1016/j.stem.2013.02.006	http://dx.doi.org/10.1016/j.stem.2013.02.006			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VC	23472867	Green Accepted, Bronze			2022-12-28	WOS:000329569400003
J	Kaur, P				Kaur, Pritinder			Christopher Stanislaus Potten Obituary	CELL STEM CELL			English	Biographical-Item									Peter MacCallum Canc Ctr, Epithelial Stem Cell Biol Lab, Melbourne, Vic 3002, Australia	Peter Maccallum Cancer Center	Kaur, P (corresponding author), Peter MacCallum Canc Ctr, Epithelial Stem Cell Biol Lab, St Andrews Pl, Melbourne, Vic 3002, Australia.	pritinder.kaur@petermac.org	Kaur, Pritinder/I-2605-2013	Kaur, Pritinder/0000-0002-4994-2782				POTTEN CS, PUBLICATION LIST	1	0	0	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	OCT 5	2012	11	4					450	451		10.1016/j.stem.2012.09.006	http://dx.doi.org/10.1016/j.stem.2012.09.006			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	021OZ	23213647	Bronze			2022-12-28	WOS:000309896500005
J	Martello, G; Sugimoto, T; Diamanti, E; Joshi, A; Hannah, R; Ohtsuka, S; Gottgens, B; Niwa, H; Smith, A				Martello, Graziano; Sugimoto, Toshimi; Diamanti, Evangelia; Joshi, Anagha; Hannah, Rebecca; Ohtsuka, Satoshi; Goettgens, Berthold; Niwa, Hitoshi; Smith, Austin			Esrrb Is a Pivotal Target of the Gsk3/Tcf3 Axis Regulating Embryonic Stem Cell Self-Renewal	CELL STEM CELL			English	Article							GROUND-STATE PLURIPOTENCY; MOUSE ES CELLS; BETA-CATENIN; PREVENT DIFFERENTIATION; TRANSCRIPTIONAL CONTROL; SIGNALING PATHWAYS; GENE-EXPRESSION; TCF3; WNT; NANOG	Inhibition of glycogen synthase kinase-3 (Gsk3) supports mouse embryonic stem cells (ESCs) by modulating Tcf3, but the critical targets downstream of Tcf3 are unclear. We analyzed the intersection between genome localization and transcriptome data sets to identify genes repressed by Tcf3. Among these, manipulations of Esrrb gave distinctive phenotypes in functional assays. Knockdown and knockout eliminated response to Gsk3 inhibition, causing extinction of pluripotency markers and loss of colony forming capability. Conversely, forced expression phenocopied Gsk3 inhibition or Tcf3 deletion by suppressing differentiation and sustaining self-renewal. Thus the nuclear receptor Esrrb is necessary and sufficient to mediate self-renewal downstream of Gsk3 inhibition. Leukaemia inhibitory factor (LIF) regulates ESCs through Stat3, independently of Gsk3 inhibition. Consistent with parallel operation, ESCs in LIF accommodated Esrrb deletion and remained pluripotent. These findings highlight a key role for Esrrb in regulating the naive pluripotent state and illustrate compensation among the core pluripotency factors.	[Martello, Graziano; Diamanti, Evangelia; Joshi, Anagha; Hannah, Rebecca; Goettgens, Berthold; Smith, Austin] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge, England; [Martello, Graziano; Smith, Austin] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Diamanti, Evangelia; Joshi, Anagha; Hannah, Rebecca; Goettgens, Berthold] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Diamanti, Evangelia; Joshi, Anagha; Hannah, Rebecca; Goettgens, Berthold] Univ Cambridge, Dept Haematol, Cambridge, England; [Sugimoto, Toshimi; Ohtsuka, Satoshi; Niwa, Hitoshi] RIKEN Ctr Dev Biol, Kobe, Hyogo 6500047, Japan; [Sugimoto, Toshimi; Niwa, Hitoshi] Kobe Univ, Grad Sch Med, Lab Dev & Regenerat Med, Chuo Ku, Kobe, Hyogo 6500017, Japan	University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; RIKEN; Kobe University	Gottgens, B (corresponding author), Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge, England.	bg200@cam.ac.uk; niwa@cdb.riken.jp; austin.smith@cscr.cam.ac.uk	Martello, Graziano/AAM-3325-2021	Joshi, Anagha/0000-0003-1184-3305; Gottgens, Berthold/0000-0001-6302-5705; Martello, Graziano/0000-0001-5520-085X; Smith, Austin/0000-0002-3029-4682	Medical Research Council of the UK; Wellcome Trust; RIKEN; NIHR Cambridge Biomedical Research Campus; BBSRC [BB/I00050X/1, BB/H531527/1] Funding Source: UKRI; MRC [G0800784] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I00050X/1, BB/H531527/1] Funding Source: researchfish; Cancer Research UK [12765] Funding Source: researchfish; Medical Research Council [MC_PC_12009, G1100526, G0800784, G0800784B] Funding Source: researchfish; National Centre for the Replacement [G0900729/1] Funding Source: researchfish	Medical Research Council of the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); RIKEN; NIHR Cambridge Biomedical Research Campus; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement	We thank Jason Wray for advice and discussion. We are grateful to Brad Merrill for generously providing Tcf3 null ESCs. Tuzer Kalkan, Jorg Betschinger, and Ge Guo provided reagents. Bill Mansfield, Charles Dumeau, Peter Humphreys, Rachael Walker, and Margaret McLeish provided specialist technical support. G.M. and T.S. performed and interpreted ESC experiments; E.T., A.J., and R.H. generated the ChIP-seq compendium; S.O. produced chimaeras; and B.G., H.N., and A.S. supervised the study and wrote the paper with G.M. This study was funded by the Medical Research Council of the UK, the Wellcome Trust, and RIKEN, and was facilitated by a Biotechnology and Biological Sciences Research Council Japan Partnering Award to A.S. and H.N. G.M. is a Human Frontier Science Program fellow, A.J. is an EMBO long term fellow, R.H. is supported by the NIHR Cambridge Biomedical Research Campus, and A.S. is a Medical Research Council Professor.	Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Blair K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002019; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Guo G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018189; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hannah R, 2011, EXP HEMATOL, V39, P531, DOI 10.1016/j.exphem.2011.02.009; Hao J, 2006, DEV BIOL, V290, P81, DOI 10.1016/j.ydbio.2005.11.011; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kelly KF, 2011, CELL STEM CELL, V8, P214, DOI 10.1016/j.stem.2010.12.010; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Luo JM, 1997, NATURE, V388, P778, DOI 10.1038/42022; Lyashenko N, 2011, NAT CELL BIOL, V13, P753, DOI 10.1038/ncb2260; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Merrill BJ, 2004, DEVELOPMENT, V131, P263, DOI 10.1242/dev.00935; Nichols J, 2012, COLD SPRING HARBOR P; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Ogawa K, 2006, BIOCHEM BIOPH RES CO, V343, P159, DOI 10.1016/j.bbrc.2006.02.127; Ouyang ZQ, 2009, P NATL ACAD SCI USA, V106, P21521, DOI 10.1073/pnas.0904863106; Pereira L, 2006, MOL CELL BIOL, V26, P7479, DOI 10.1128/MCB.00368-06; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Smith A, 2009, EMBO MOL MED, V1, P251, DOI 10.1002/emmm.200900035; Sokol SY, 2011, DEVELOPMENT, V138, P4341, DOI 10.1242/dev.066209; Tam WL, 2008, STEM CELLS, V26, P2019, DOI 10.1634/stemcells.2007-1115; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; van den Berg DLC, 2008, MOL CELL BIOL, V28, P5986, DOI 10.1128/MCB.00301-08; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhang XF, 2008, J BIOL CHEM, V283, P35825, DOI 10.1074/jbc.M803481200	52	294	299	0	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	OCT 5	2012	11	4					491	504		10.1016/j.stem.2012.06.008	http://dx.doi.org/10.1016/j.stem.2012.06.008			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	021OZ	23040478	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000309896500010
J	Kloc, A; Ivanova, N				Kloc, Anna; Ivanova, Natalia			Chromatin and Pluripotency: the MYSTerious Connection	CELL STEM CELL			English	Editorial Material							SELF-RENEWAL; MOF	Although histone acetylation is critical for maintaining embryonic stem cell pluripotency, the molecular machinery involved remains poorly understood. Li et al. (2012) now show that Mof, a MYST family histone acetyltransferase, functions as a coactivator of Nanog-mediated transcription, maintains the expression of pluripotency-associated genes, and primes developmental genes for differentiation.	[Kloc, Anna; Ivanova, Natalia] Yale Univ, Yale Stem Cell Ctr, Dept Genet, New Haven, CT 06520 USA	Yale University	Ivanova, N (corresponding author), Yale Univ, Yale Stem Cell Ctr, Dept Genet, New Haven, CT 06520 USA.	natalia.ivanova@yale.edu	Kloc, Anna/AAB-8853-2019	Kloc, Anna/0000-0003-2074-7884				Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Fazzio TG, 2008, CELL CYCLE, V7, P3302, DOI 10.4161/cc.7.21.6928; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Jiang H, 2011, CELL, V144, P513, DOI 10.1016/j.cell.2011.01.020; Li X., 2010, EPIGENETICS, V5, P5; Prestel M, 2010, MOL CELL, V38, P815, DOI 10.1016/j.molcel.2010.05.022; Rea S, 2007, ONCOGENE, V26, P5385, DOI 10.1038/sj.onc.1210607	9	2	3	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	AUG 3	2012	11	2					139	140		10.1016/j.stem.2012.07.013	http://dx.doi.org/10.1016/j.stem.2012.07.013			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	987QQ	22862937	Bronze			2022-12-28	WOS:000307432600002
J	Ma, LX; Hu, BY; Liu, Y; Vermilyea, SC; Liu, HS; Gao, L; Sun, Y; Zhang, XQ; Zhang, SC				Ma, Lixiang; Hu, Baoyang; Liu, Yan; Vermilyea, Scott Christopher; Liu, Huisheng; Gao, Lu; Sun, Yan; Zhang, Xiaoqing; Zhang, Su-Chun			Human Embryonic Stem Cell-Derived GABA Neurons Correct Locomotion Deficits in Quinolinic Acid-Lesioned Mice	CELL STEM CELL			English	Article							FETAL STRIATAL TRANSPLANTATION; HUNTINGTONS-DISEASE; NEURAL DIFFERENTIATION; ANIMAL-MODELS; AXON GROWTH; IN-VITRO; TELENCEPHALON; PROGENITORS; EXPRESSION; GENES	Degeneration of medium spiny GABA neurons in the basal ganglia underlies motor' dysfunction in Huntington's disease (HD), which presently lacks effective therapy. In this study, we have successfully directed human embryonic stem cells (hESCs) to enriched populations of DARPP32-expressing forebrain GABA neurons. Transplantation of these human forebrain GABA neurons and their progenitors, but not spinal GABA cells, into the striatum of quinolinic acid-lesioned mice results in generation of large populations of DARPP32(+) GABA neurons, which project to the substantia nigra as well as receiving glutamatergic and dopaminergic inputs, corresponding to correction of motor deficits. This finding raises hopes for cell therapy for HD.	[Ma, Lixiang; Liu, Yan; Gao, Lu; Sun, Yan; Zhang, Su-Chun] Fudan Univ, Shanghai Med Coll, Dept Anat Histol & Embryol, Shanghai 200032, Peoples R China; [Zhang, Su-Chun] Fudan Univ, Inst Biomed Sci, Inst Stem Cell & Regenerat Med, Shanghai 200032, Peoples R China; [Hu, Baoyang] Chinese Acad Sci, Inst Zool, Beijing 100101, Peoples R China; [Liu, Yan; Vermilyea, Scott Christopher; Liu, Huisheng; Zhang, Su-Chun] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Zhang, Su-Chun] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurosci, Madison, WI 53705 USA; [Zhang, Su-Chun] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurol, Madison, WI 53705 USA; [Zhang, Xiaoqing] Tongji Univ, Sch Med, Shanghai 200092, Peoples R China	Fudan University; Fudan University; Chinese Academy of Sciences; Institute of Zoology, CAS; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Tongji University	Zhang, SC (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Anat Histol & Embryol, Shanghai 200032, Peoples R China.	zhang@waisman.wisc.edu	Zhang, Xiaoqing/O-3424-2017; Hu, Baoyang/R-8374-2016	Zhang, Xiaoqing/0000-0002-7405-1893; Hu, Baoyang/0000-0003-3993-4014; ma, lixiang/0000-0001-9399-155X	NIH-NINDS [NS045926]; NICHD [P30 HD03352]; Ministry of Science and Technology, China [2006CB94700, 2006AA02A101]; Shanghai Municipality [06dj14001]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045926, R21NS064578] Funding Source: NIH RePORTER	NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Ministry of Science and Technology, China(Ministry of Science and Technology, China); Shanghai Municipality; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported in part by the NIH-NINDS (NS045926), the NICHD (P30 HD03352), Ministry of Science and Technology, China (2006CB94700, 2006AA02A101), and Shanghai Municipality (06dj14001).	Arlotta P, 2008, J NEUROSCI, V28, P622, DOI 10.1523/JNEUROSCI.2986-07.2008; Aubry L, 2008, P NATL ACAD SCI USA, V105, P16707, DOI 10.1073/pnas.0808488105; Bachoud-Levi AC, 2006, LANCET NEUROL, V5, P303, DOI 10.1016/S1474-4422(06)70381-7; Bachoud-Levi AC, 2000, EXP NEUROL, V161, P194, DOI 10.1006/exnr.1999.7239; Bonner JF, 2010, J NEUROSCI RES, V88, P1182, DOI 10.1002/jnr.22288; Campbell K, 2003, CURR OPIN NEUROBIOL, V13, P50, DOI 10.1016/S0959-4388(03)00009-6; CAMPBELL K, 1993, NEUROSCIENCE, V53, P403, DOI 10.1016/0306-4522(93)90204-S; Clelland CD, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E8; Danjo T, 2011, J NEUROSCI, V31, P1919, DOI 10.1523/JNEUROSCI.5128-10.2011; Dobrossy M, 2006, EXP NEUROL, V199, P373, DOI 10.1016/j.expneurol.2005.12.033; Dunnett SB, 2007, BRAIN RES BULL, V72, P132, DOI 10.1016/j.brainresbull.2006.10.019; Durieux PF, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00040; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Fode C, 2000, GENE DEV, V14, P67; Gallina P, 2010, EXP NEUROL, V222, P30, DOI 10.1016/j.expneurol.2009.12.005; GERFEN CR, 1988, J ELECTRON MICR TECH, V10, P265, DOI 10.1002/jemt.1060100305; Goto S, 1997, EXP NEUROL, V147, P503, DOI 10.1006/exnr.1997.6628; Gu A, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010067, 10.1371/currents.RRN1193]; Hansson O, 1999, P NATL ACAD SCI USA, V96, P8727, DOI 10.1073/pnas.96.15.8727; Hauser RA, 2002, NEUROLOGY, V58, P687, DOI 10.1212/WNL.58.5.687; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Hu BY, 2009, DEVELOPMENT, V136, P1443, DOI 10.1242/dev.029447; Johnson CD, 2010, HUM MOL GENET, V19, pR98, DOI 10.1093/hmg/ddq148; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; KOLLER WC, 1985, NEUROLOGY, V35, P1450, DOI 10.1212/WNL.35.10.1450; Li XJ, 2008, STEM CELLS, V26, P886, DOI 10.1634/stemcells.2007-0620; Li XJ, 2009, DEVELOPMENT, V136, P4055, DOI 10.1242/dev.036624; Mazzocchi-Jones D, 2011, NEUROREHAB NEURAL RE, V25, P548, DOI 10.1177/1545968311402090; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Nakao N, 2000, PROG NEUROBIOL, V61, P313, DOI 10.1016/S0301-0082(99)00058-1; OLSSON M, 1995, NEUROSCIENCE, V69, P1169, DOI 10.1016/0306-4522(95)00325-D; OUIMET CC, 1984, J NEUROSCI, V4, P111; Palfi S, 1998, NAT MED, V4, P963, DOI 10.1038/nm0898-963; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; PEARLMAN S, 1993, BRAIN RES, V613, P203, DOI 10.1016/0006-8993(93)90900-8; Peterson DA, 1999, METHODS, V18, P493, DOI 10.1006/meth.1999.0818; Pfeifer K, 2004, EUR J NEUROSCI, V20, P1695, DOI 10.1111/j.1460-9568.2004.03657.x; Philpott LM, 1997, CELL TRANSPLANT, V6, P203, DOI 10.1016/S0963-6897(97)00028-6; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; Reuter I, 2008, J NEUROL NEUROSUR PS, V79, P948, DOI 10.1136/jnnp.2007.142380; Rosser AE, 2002, J NEUROL NEUROSUR PS, V73, P678, DOI 10.1136/jnnp.73.6.678; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Sanberg P R, 1989, J Neural Transplant, V1, P23; Sussel L, 1999, DEVELOPMENT, V126, P3359; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Toresson H, 2000, MECH DEVELOP, V94, P183, DOI 10.1016/S0925-4773(00)00324-5; Toresson H, 2001, DEVELOPMENT, V128, P4769; Vandeputte C, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-92; Wichterle H, 2001, DEVELOPMENT, V128, P3759; WICTORIN K, 1990, NATURE, V347, P556, DOI 10.1038/347556a0; WICTORIN K, 1992, PROG NEUROBIOL, V38, P611, DOI 10.1016/0301-0082(92)90044-F; Wilburn B, 2011, NEURON, V70, P427, DOI 10.1016/j.neuron.2011.03.021; Wilson SW, 2000, NEURON, V28, P641, DOI 10.1016/S0896-6273(00)00171-9; Yang DL, 2008, STEM CELLS, V26, P55, DOI 10.1634/stemcells.2007-0494; Yun K, 2001, DEVELOPMENT, V128, P193; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	58	211	221	2	75	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 6	2012	10	4					455	464		10.1016/j.stem.2012.01.021	http://dx.doi.org/10.1016/j.stem.2012.01.021			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	929QA	22424902	Green Accepted, Bronze			2022-12-28	WOS:000303079400013
J	Choi, SH; Tanzi, RE				Choi, Se Hoon; Tanzi, Rudolph E.			iPSCs to the Rescue in Alzheimer's Research	CELL STEM CELL			English	Editorial Material							PLURIPOTENT STEM-CELLS; DISEASE; GENE	A crucial limitation to our understanding of Alzheimer's disease has been the inability to test hypotheses on live, patient-specific neurons. A recent study in Nature by Israel et al. (2012) reports that iPSC-derived neurons from AD patients recapitulate multiple aspects of disease pathology.	[Choi, Se Hoon; Tanzi, Rudolph E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Genet & Aging Res Unit,Dept Neurol, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Tanzi, RE (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Genet & Aging Res Unit,Dept Neurol, Charlestown, MA 02129 USA.	tanzi@helix.mgh.harvard.edu	Tanzi, Rudolph/AAE-9622-2019	Tanzi, Rudolph/0000-0002-7032-1454				Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Qiang L, 2011, CELL, V146, P359, DOI 10.1016/j.cell.2011.07.007; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Yagi T, 2011, HUM MOL GENET, V20, P4530, DOI 10.1093/hmg/ddr394	9	18	22	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAR 2	2012	10	3					235	236		10.1016/j.stem.2012.02.011	http://dx.doi.org/10.1016/j.stem.2012.02.011			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	908BX	22385650	Bronze			2022-12-28	WOS:000301466500003
J	Bernstein, ID; Delaney, C				Bernstein, Irwin D.; Delaney, Colleen			Engineering Stem Cell Expansion	CELL STEM CELL			English	Editorial Material							HUMAN HEMATOPOIETIC STEM; EX-VIVO EXPANSION		[Bernstein, Irwin D.; Delaney, Colleen] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Bernstein, Irwin D.; Delaney, Colleen] Seattle Childrens Hosp, Seattle, WA 98105 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Seattle Children's Hospital	Bernstein, ID (corresponding author), Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA.	ibernste@fhcrc.org			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100395] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Brunstein CG, 2010, BLOOD, V116, P4693, DOI 10.1182/blood-2010-05-285304; Campbell TB, 2008, FRONT BIOSCI-LANDMRK, V13, P1795, DOI 10.2741/2800; Csaszar E, 2012, CELL STEM CELL, V10, P218, DOI 10.1016/j.stem.2012.01.003; Dahlberg A, 2011, BLOOD, V117, P6083, DOI 10.1182/blood-2011-01-283606; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Hoggatt J, 2009, BLOOD, V113, P5444, DOI 10.1182/blood-2009-01-201335; Kirouac DC, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.71; Piacibello W, 1997, BLOOD, V89, P2644, DOI 10.1182/blood.V89.8.2644; Yang H, 2010, BONE MARROW TRANSPL, V45, P1000, DOI 10.1038/bmt.2009.289	10	8	8	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 3	2012	10	2					113	114		10.1016/j.stem.2012.01.012	http://dx.doi.org/10.1016/j.stem.2012.01.012			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	892FM	22305560	Bronze			2022-12-28	WOS:000300272100005
J	Ruckh, JM; Zhao, JW; Shadrach, JL; van Wijngaarden, P; Rao, TN; Wagers, AJ; Franklin, RJM				Ruckh, Julia M.; Zhao, Jing-Wei; Shadrach, Jennifer L.; van Wijngaarden, Peter; Rao, Tata Nageswara; Wagers, Amy J.; Franklin, Robin J. M.			Rejuvenation of Regeneration in the Aging Central Nervous System	CELL STEM CELL			English	Article							OLIGODENDROCYTE PRECURSOR CELLS; REMYELINATION EFFICIENCY; CHEMOKINE RECEPTOR; MULTIPLE-SCLEROSIS; HEMATOPOIETIC STEM; CNS REMYELINATION; PROGENITOR CELLS; DIFFERENTIATION; REPAIR; MICE	Remyelination is a regenerative process in the central nervous system (CNS) that produces new myelin sheaths from adult stem cells. The decline in remyelination that occurs with advancing age poses a significant barrier to therapy in the CNS, particularly for long-term demyelinating diseases such as multiple sclerosis (MS). Here we show that remyelination of experimentally induced demyelination is enhanced in old mice exposed to a youthful systemic milieu through heterochronic parabiosis. Restored remyelination in old animals involves recruitment to the repairing lesions of blood-derived monocytes from the young parabiotic partner, and preventing this recruitment partially inhibits rejuvenation of remyelination. These data suggest that enhanced remyelinating activity requires both youthful monocytes and other factors, and that remyelination-enhancing therapies targeting endogenous cells can be effective throughout life.	[Shadrach, Jennifer L.; Rao, Tata Nageswara; Wagers, Amy J.] Harvard Univ, Harvard Stem Cell Inst, Howard Hughes Med Inst, Cambridge, MA 02215 USA; [Ruckh, Julia M.; Zhao, Jing-Wei; van Wijngaarden, Peter; Franklin, Robin J. M.] Univ Cambridge, MRC Ctr Stem Cell Biol & Regenerat Med, Cambridge CB3 0ES, England; [Ruckh, Julia M.; Zhao, Jing-Wei; van Wijngaarden, Peter; Franklin, Robin J. M.] Univ Cambridge, Cambridge Ctr Brain Repair, Cambridge CB3 0ES, England; [Ruckh, Julia M.; Zhao, Jing-Wei; van Wijngaarden, Peter; Franklin, Robin J. M.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England; [Shadrach, Jennifer L.; Rao, Tata Nageswara; Wagers, Amy J.] Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02215 USA; [Shadrach, Jennifer L.; Rao, Tata Nageswara; Wagers, Amy J.] Joslin Diabet Ctr, Cambridge, MA 02215 USA	Harvard University; Howard Hughes Medical Institute; University of Cambridge; University of Cambridge; University of Cambridge; Harvard University; Harvard University; Joslin Diabetes Center, Inc.	Wagers, AJ (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Howard Hughes Med Inst, 7 Divin Ave, Cambridge, MA 02215 USA.	amy.wagers@joslin.harvard.edu; rjf1000@cam.ac.uk	Zhao, Jing-Wei/A-6887-2012; Zhao, Jing-Wei/L-9964-2014	Zhao, Jing-Wei/0000-0002-1135-9743; Franklin, Robin/0000-0001-6522-2104; Tata, Nageswara Rao/0000-0002-9928-5944; van Wijngaarden, Peter/0000-0002-8800-7834	European Leukodystrophy Association (ELA); Research into Ageing; UK Multiple Sclerosis Society; National Multiple Sclerosis Society; Burroughs-Wellcome Fund; Harvard Stem Cell Institute; British Consulate General Science and Innovation Network; National Institutes of Health [1 DP2 OD004345-01]; National Health and Medical Research Council of Australia; Medical Research Council, UK; MRC [G0800784] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004345] Funding Source: NIH RePORTER; Medical Research Council [G0800784B, G0800784] Funding Source: researchfish; Rosetrees Trust [M144] Funding Source: researchfish	European Leukodystrophy Association (ELA); Research into Ageing; UK Multiple Sclerosis Society; National Multiple Sclerosis Society(National Multiple Sclerosis Society); Burroughs-Wellcome Fund(Burroughs Wellcome Fund); Harvard Stem Cell Institute; British Consulate General Science and Innovation Network; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Rosetrees Trust(Rosetrees Trust)	We thank G. Buruzula and J. LaVecchio at Joslin's HSCl/DERC Flow Cytometry Core (NIH P30 DK036836) for their excellent technical support. This work was supported in part by grants from the European Leukodystrophy Association (ELA) (to R.J.M.F. and A.J.W), Research into Ageing, the UK Multiple Sclerosis Society and National Multiple Sclerosis Society (to R.J.M.F.), the Burroughs-Wellcome Fund, the Harvard Stem Cell Institute, the British Consulate General Science and Innovation Network, and National Institutes of Health 1 DP2 OD004345-01 (to A.J.W.). P.v.W. was supported by the National Health and Medical Research Council of Australia. J.M.R. was supported by a Ph.D. studentship from the Medical Research Council, UK.	Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Arai K, 2009, J NEUROSCI, V29, P4351, DOI 10.1523/JNEUROSCI.0035-09.2009; Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; Baer AS, 2009, BRAIN, V132, P465, DOI 10.1093/brain/awn334; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Confavreux C, 2006, BRAIN, V129, P595, DOI 10.1093/brain/awh714; CONNOR JR, 1986, BRAIN RES, V368, P319, DOI 10.1016/0006-8993(86)90576-7; DANON D, 1989, P NATL ACAD SCI USA, V86, P2018, DOI 10.1073/pnas.86.6.2018; Duncan ID, 2009, P NATL ACAD SCI USA, V106, P6832, DOI 10.1073/pnas.0812500106; Edgar JM, 2009, CURR OPIN NEUROBIOL, V19, P498, DOI 10.1016/j.conb.2009.08.003; Goldschmidt T, 2009, NEUROLOGY, V72, P1914, DOI 10.1212/WNL.0b013e3181a8260a; Hinks GL, 2000, MOL CELL NEUROSCI, V16, P542, DOI 10.1006/mcne.2000.0897; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; Kotter MR, 2006, J NEUROSCI, V26, P328, DOI 10.1523/JNEUROSCI.2615-05.2006; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; Mason JL, 2003, J NEUROSCI, V23, P7710; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Shen SM, 2008, NAT NEUROSCI, V11, P1024, DOI 10.1038/nn.2172; Sim FJ, 2002, J NEUROSCI, V22, P2451, DOI 10.1523/JNEUROSCI.22-07-02451.2002; SMITH KJ, 1979, NATURE, V280, P395, DOI 10.1038/280395a0; Tang DG, 2000, J CELL BIOL, V148, P971, DOI 10.1083/jcb.148.5.971; Vana AC, 2007, J NEUROPATH EXP NEUR, V66, P975, DOI 10.1097/NEN.0b013e3181587d46; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Woodruff RH, 2004, MOL CELL NEUROSCI, V25, P252, DOI 10.1016/j.mcn.2003.10.014; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081	30	437	460	1	65	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JAN 6	2012	10	1					96	103		10.1016/j.stem.2011.11.019	http://dx.doi.org/10.1016/j.stem.2011.11.019			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	880ZQ	22226359	Green Accepted, Bronze			2022-12-28	WOS:000299449500014
J	Kelsey, G				Kelsey, Gavin			A Web of Imprinting in Stem Cells	CELL STEM CELL			English	Editorial Material							GENE NETWORK; LUNG; GROWTH; CANCER		[Kelsey, Gavin] Babraham Inst, Epigenet Programme, Cambridge CB22 3AT, England; [Kelsey, Gavin] Univ Cambridge, Ctr Trophoblast Res, Cambridge CB2 3EG, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge	Kelsey, G (corresponding author), Babraham Inst, Epigenet Programme, Cambridge CB22 3AT, England.	gavin.kelsey@babraham.ac.uk		Kelsey, Gavin/0000-0002-9762-5634	MRC [G0800013] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C169] Funding Source: Medline; Medical Research Council [G0800013] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; Ferguson-Smith AC, 2011, NAT REV GENET, V12, P565, DOI 10.1038/nrg3032; Ferron SR, 2011, NATURE, V475, P381, DOI 10.1038/nature10229; Fine A, 2009, CELL STEM CELL, V4, P468, DOI 10.1016/j.stem.2009.05.012; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Lui JC, 2008, AM J PHYSIOL-REG I, V295, pR189, DOI 10.1152/ajpregu.00182.2008; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Zacharek SJ, 2011, CELL STEM CELL, V9, P272, DOI 10.1016/j.stem.2011.07.007	10	3	3	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	SEP 2	2011	9	3					177	178		10.1016/j.stem.2011.08.008	http://dx.doi.org/10.1016/j.stem.2011.08.008			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	822DN	21885011	Bronze			2022-12-28	WOS:000295024200001
J	Zheng, JK; Umikawa, M; Zhang, SC; Huynh, H; Silvany, R; Chen, BPC; Chen, LP; Zhang, CC				Zheng, Junke; Umikawa, Masato; Zhang, Shichuan; Huynh, HoangDinh; Silvany, Robert; Chen, Benjamin P. C.; Chen, Lieping; Zhang, Cheng Cheng			Ex Vivo Expanded Hematopoietic Stem Cells Overcome the MHC Barrier in Allogeneic Transplantation	CELL STEM CELL			English	Article							STROMAL CELLS; GROWTH-FACTOR; EXPANSION; POPULATION; MICE; RECONSTITUTION; PROGENITORS; ENGRAFTMENT; FACILITATE; SUPPORTS	The lack of understanding of the interplay between hematopoietic stem cells (HSCs) and the immune system has severely hampered the stem cell research and practice of transplantation. Major problems for allogeneic transplantation include low levels of donor engraftment and high risks of graft-versus-host disease (GVHD). Transplantation of purified allogeneic HSCs diminishes the risk of GVHD but results in decreased engraftment. Here we show that ex vivo expanded mouse HSCs efficiently overcame the major histocompatibility complex barrier and repopulated allogeneic-recipient mice. An 8-day expansion culture led to a 40-fold increase of the allograft ability of HSCs. Both increased numbers of HSCs and culture-induced elevation of expression of the immune inhibitor CD274 (B7-H1 or PD-L1) on the surface of HSCs contributed to the enhancement. Our study indicates the great potential of utilizing ex vivo expanded HSCs for allogeneic transplantation and suggests that the immune privilege of HSCs can be modulated.	[Zheng, Junke; Umikawa, Masato; Huynh, HoangDinh; Silvany, Robert; Zhang, Cheng Cheng] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Zheng, Junke; Umikawa, Masato; Huynh, HoangDinh; Silvany, Robert; Zhang, Cheng Cheng] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Zhang, Shichuan; Chen, Benjamin P. C.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Chen, Lieping] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06519 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Yale University	Zhang, CC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	alec.zhang@utsouthwestern.edu	Zhang, Cheng/GRS-8698-2022	Chen, Lieping/0000-0002-6825-3069	NIH [K01 CA 120099, R01 CA50519]; American Society of Hematology; DOD [PR093256]; CPRIT [RP100402]; Gabrielle's Angel Foundation; AHA [09BGIA2230372]; NATIONAL CANCER INSTITUTE [R01CA050519, K01CA120099] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Hematology; DOD(United States Department of Defense); CPRIT; Gabrielle's Angel Foundation; AHA(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support to C.C.Z. was from NIH grant K01 CA 120099, American Society of Hematology Junior Faculty Award, AHA 09BGIA2230372, DOD PR093256, CPRIT RP100402, and the Gabrielle's Angel Foundation. Support to B.P.C.C. was from NIH grant R01 CA50519.	Akala OO, 2008, NATURE, V453, P228, DOI 10.1038/nature06869; Bridenbaugh S, 2008, BLOOD, V111, P1735, DOI 10.1182/blood-2007-02-076000; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Carter CC, 2010, NAT MED, V16, P446, DOI 10.1038/nm.2109; Chen QF, 2009, P NATL ACAD SCI USA, V106, P21783, DOI 10.1073/pnas.0912274106; Chou S, 2010, P NATL ACAD SCI USA, V107, P7799, DOI 10.1073/pnas.1003586107; Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863; Dong HD, 2004, IMMUNITY, V20, P327, DOI 10.1016/S1074-7613(04)00050-0; Drake AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018382; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Gandy KL, 1999, IMMUNITY, V11, P579, DOI 10.1016/S1074-7613(00)80133-8; Gyurkocza B, 2010, EXPERT REV HEMATOL, V3, P285, DOI 10.1586/EHM.10.21; Heckl D, 2011, BLOOD, V117, P3737, DOI 10.1182/blood-2010-09-308262; Huynh HD, 2008, STEM CELLS, V26, P1628, DOI 10.1634/stemcells.2008-0064; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; KAUFMAN CL, 1994, BLOOD, V84, P2436; Khoury M, 2011, STEM CELLS DEV, V20, P1371, DOI 10.1089/scd.2010.0456; Kiel MJ, 2007, CELL STEM CELL, V1, P204, DOI 10.1016/j.stem.2007.06.001; Noda S, 2008, STEM CELLS, V26, P646, DOI 10.1634/stemcells.2007-0623; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Shizuru J A, 1996, Biol Blood Marrow Transplant, V2, P3; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Stern P, 2008, P NATL ACAD SCI USA, V105, P13895, DOI 10.1073/pnas.0806907105; Swijnenburg RJ, 2008, P NATL ACAD SCI USA, V105, P12991, DOI 10.1073/pnas.0805802105; Taylor KN, 2008, CELL IMMUNOL, V251, P43, DOI 10.1016/j.cellimm.2008.03.003; Wang BY, 1997, P NATL ACAD SCI USA, V94, P14632, DOI 10.1073/pnas.94.26.14632; Yao S, 2009, BLOOD, V113, P5811, DOI 10.1182/blood-2009-02-203141; Zhang CC, 2006, NAT MED, V12, P240, DOI 10.1038/nm1342; Zhang CC, 2005, BLOOD, V105, P4314, DOI 10.1182/blood-2004-11-4418; Zhang CC, 2004, BLOOD, V103, P2513, DOI 10.1182/blood-2003-08-2955; Zhang CC, 2008, CURR OPIN HEMATOL, V15, P307, DOI 10.1097/MOH.0b013e3283007db5; Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119; Zhang SC, 2011, J CELL BIOL, V193, P295, DOI 10.1083/jcb.201009074; Zhao Z, 2010, GENE DEV, V24, P1389, DOI 10.1101/gad.1940710; Zheng JK, 2011, BLOOD, V117, P470, DOI 10.1182/blood-2010-06-291716; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326	36	52	61	1	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	AUG 5	2011	9	2					119	130		10.1016/j.stem.2011.06.003	http://dx.doi.org/10.1016/j.stem.2011.06.003			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	808PM	21816363	Bronze, Green Accepted			2022-12-28	WOS:000293990900009
J	Rao, MS				Rao, Mahendra S.			Funding Translational Work in Cell-Based Therapy	CELL STEM CELL			English	Editorial Material							STEM; PRODUCTS; MEDICINE	The cell therapy branch of the regenerative medicine field has been innovative in developing new models of delivery and development and identifying alternative sources of funding. We discuss the implications of these changes for pharmaceutical companies and the opportunities they offer to a new entrepreneur.	Life Technol, Frederick, MD 21704 USA	Thermo Fisher Scientific	Rao, MS (corresponding author), Life Technol, 7335 Execut Way, Frederick, MD 21704 USA.	mahendra.rao@lifetech.com			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041192] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bergman K, 2007, NAT BIOTECHNOL, V25, P419, DOI 10.1038/nbt0407-419; Brown N, 2006, TECHNOL ANAL STRATEG, V18, P313, DOI 10.1080/09537320600777044; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Enserink M, 2006, SCIENCE, V313, P160, DOI 10.1126/science.313.5784.160; Fink DW, 2009, SCIENCE, V324, P1662, DOI 10.1126/science.1173712; Freeman SN, 2010, CELL STEM CELL, V7, P283, DOI 10.1016/j.stem.2010.08.003; Harvey O, 2009, POLITICS POLICY, V37, P51, DOI 10.1111/j.1747-1346.2008.00161.x; Lau D, 2008, CELL STEM CELL, V3, P591, DOI 10.1016/j.stem.2008.11.001; Lysaght MJ, 2008, TISSUE ENG PT A, V14, P305, DOI 10.1089/tea.2007.0267; McKernan R, 2010, CELL STEM CELL, V6, P517, DOI 10.1016/j.stem.2010.05.012; Salter B, 2006, REGEN MED, V1, P671, DOI 10.2217/17460751.1.5.671; Salter B, 2007, REGEN MED, V2, P75, DOI 10.2217/17460751.2.1.75	12	22	22	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUL 8	2011	9	1					7	10		10.1016/j.stem.2011.06.009	http://dx.doi.org/10.1016/j.stem.2011.06.009			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	797VA	21726828	Bronze			2022-12-28	WOS:000293157000004
J	Loffredo, FS; Steinhauser, ML; Gannon, J; Lee, RT				Loffredo, Francesco S.; Steinhauser, Matthew L.; Gannon, Joseph; Lee, Richard T.			Bone Marrow-Derived Cell Therapy Stimulates Endogenous Cardiomyocyte Progenitors and Promotes Cardiac Repair	CELL STEM CELL			English	Article							ACUTE MYOCARDIAL-INFARCTION; HEMATOPOIETIC STEM-CELLS; HEART; REGENERATION; MULTIPOTENT; DISEASE; INJURY; ADOPT; GATA4	Cell therapy can improve cardiac function in animals and humans after injury, but the mechanism is unclear,. We performed cell therapy experiments in genetically engineered mice that permanently express green fluorescent protein (GFP) only in cardiomyocytas after a pulse of 4-OH-tamoxifen. Myocardial infarction diluted the GFP(+) cardiomyocyte pool, indicating refreshment by non-GFP(+) progenitors. Cell therapy with bone marrow-derived c-kit(+) cells, but not mesenchymal stem cells, further diluted the GFP(+) pool, consistent with c-kit(+) cell-mediated augmentation of cardiomyocyte progenitor activity. This effect could not be explained by transdifferentiation to cardiomyocytes by exogenously delivered c-kit(+) cells or by cell fusion. Therapy with c-kit(+) cells but riot mesenchymal stem cells improved cardiac function. These findings suggest that stimulation of endogenous cardiogenic progenitor activity is a critical mechanism of cardiac cell therapy.	[Loffredo, Francesco S.; Steinhauser, Matthew L.; Gannon, Joseph; Lee, Richard T.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Harvard Stem Cell Inst, Cambridge, MA 02139 USA; [Loffredo, Francesco S.; Steinhauser, Matthew L.; Gannon, Joseph; Lee, Richard T.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Cardiovasc Div, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Lee, RT (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Harvard Stem Cell Inst, Cambridge, MA 02139 USA.	rlee@partners.org	Loffredo, Francesco S/F-6638-2014; Kalina, Roman Maciej RM Kalina/D-7937-2017; Loffredo, Francesco/P-1389-2019; Steinhauser, Matthew L./GVT-6393-2022	Loffredo, Francesco S/0000-0001-5911-780X; Kalina, Roman Maciej RM Kalina/0000-0003-2064-2724; Loffredo, Francesco/0000-0001-5911-780X; Steinhauser, Matthew L./0000-0001-5287-9246; Lee, Richard/0000-0003-4687-1381	NIH [R01 AG032977]; NATIONAL INSTITUTE ON AGING [R01AG032977] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	R.T.L. is a founder of Provasculon, Inc. This work was supported by a grant from the NIH (R01 AG032977).	Abdel-Latif A, 2007, ARCH INTERN MED, V167, P989, DOI 10.1001/archinte.167.10.989; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Beltrami AR, 2007, BLOOD, V110, P3438, DOI 10.1182/blood-2006-11-055566; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Dimmeler S, 2005, J CLIN INVEST, V115, P572, DOI 10.1172/JCI200524283; Hansson EM, 2009, CELL STEM CELL, V5, P364, DOI 10.1016/j.stem.2009.09.004; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Koitabashi N, 2009, CIRC RES, V105, P12, DOI 10.1161/CIRCRESAHA.109.198416; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Pijnappels DA, 2008, CIRC RES, V103, P167, DOI 10.1161/CIRCRESAHA.108.176131; Rota M, 2007, P NATL ACAD SCI USA, V104, P17783, DOI 10.1073/pnas.0706406104; Saxena A, 2008, CIRCULATION, V117, P2224, DOI 10.1161/CIRCULATIONAHA.107.694992; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718; Takagawa J, 2007, J APPL PHYSIOL, V102, P2104, DOI 10.1152/japplphysiol.00033.2007; Tang XL, 2010, CIRCULATION, V121, P293, DOI 10.1161/CIRCULATIONAHA.109.871905; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Xin M, 2006, P NATL ACAD SCI USA, V103, P11189, DOI 10.1073/pnas.0604604103; Zaruba MM, 2009, CELL STEM CELL, V4, P313, DOI 10.1016/j.stem.2009.02.013	30	317	332	2	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 8	2011	8	4					389	398		10.1016/j.stem.2011.02.002	http://dx.doi.org/10.1016/j.stem.2011.02.002			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	752QI	21474103	Bronze, Green Accepted			2022-12-28	WOS:000289707100011
J	Najm, FJ; Chenoweth, JG; Anderson, PD; Nadeau, JH; Redline, RW; McKay, RDG; Tesar, PJ				Najm, Fadi J.; Chenoweth, Josh G.; Anderson, Philip D.; Nadeau, Joseph H.; Redline, Raymond W.; McKay, Ronald D. G.; Tesar, Paul J.			Isolation of Epiblast Stem Cells from Preimplantation Mouse Embryos	CELL STEM CELL			English	Article							SELF-RENEWAL; BLASTOCYST INJECTION; GROUND-STATE; ES CELLS; PLURIPOTENCY; DERIVATION; LINES; FATE	Pluripotent stem cells provide a platform to interrogate control elements that function to generate all cell types of the body. Despite their utility for modeling development and disease, the relationship of mouse and human pluripotent stem cell states to one another remains largely undefined. We have shown that mouse embryonic stem (ES) cells and epiblast stem cells (EpiSCs) are distinct, pluripotent states isolated from pre- and post-implantation embryos respectively. Human ES cells are different than mouse ES cells and share defining features with EpiSCs, yet are derived from pre-implantation human embryos. Here we show that EpiSCs can be routinely derived from pre-implantation mouse embryos. The preimplantation-derived EpiSCs exhibit molecular features and functional properties consistent with bona fide EpiSCs. These results provide a simple method for isolating EpiSCs and offer direct insight into the intrinsic and extrinsic mechanisms that regulate the acquisition of distinct pluripotent states.	[Najm, Fadi J.; Anderson, Philip D.; Nadeau, Joseph H.; Tesar, Paul J.] Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; [Najm, Fadi J.; Anderson, Philip D.; Nadeau, Joseph H.; Tesar, Paul J.] Case Western Reserve Univ, Sch Med, Ctr Stem Cell & Regenerat Med, Cleveland, OH 44106 USA; [Redline, Raymond W.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Chenoweth, Josh G.; McKay, Ronald D. G.] NINDS, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Tesar, PJ (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA.	paul.tesar@case.edu	Tesar, Paul J/C-9848-2014; Tesar, Paul/GPK-5942-2022	Tesar, Paul J/0000-0003-1532-3155; Tesar, Paul/0000-0003-1532-3155	Case Western Reserve University School of Medicine; Center for Stem Cell and Regenerative Medicine; Athymic Animal and Radiation Resources Core facilities of the Case Comprehensive Cancer Center [P30 CA43703]; NIH/NINDS; NATIONAL CANCER INSTITUTE [R01CA075056, P30CA043703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R33MH087877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002981] Funding Source: NIH RePORTER	Case Western Reserve University School of Medicine; Center for Stem Cell and Regenerative Medicine; Athymic Animal and Radiation Resources Core facilities of the Case Comprehensive Cancer Center; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by funding from the Case Western Reserve University School of Medicine, the Center for Stem Cell and Regenerative Medicine, the Athymic Animal and Radiation Resources Core facilities of the Case Comprehensive Cancer Center (P30 CA43703), and the NIH/NINDS intramural research program. P.J.T. is a Robertson Investigator of the New York Stem Cell Foundation and a Mt. Sinai Health Care Foundation Scholar. We are grateful to Leslie Cooperman as well as members of the P. Scacheri laboratory for technical assistance and provision of reagents and Irene Tsung for graphical abstract artwork.	Anderson PD, 2009, CANCER RES, V69, P9112, DOI 10.1158/0008-5472.CAN-09-3342; Aoki H, 2009, DEV DYNAM, V238, P2266, DOI 10.1002/dvdy.22008; Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Brook FA, 2003, DIABETES, V52, P205, DOI 10.2337/diabetes.52.1.205; Chenoweth JG, 2010, DEV GROWTH DIFFER, V52, P293, DOI 10.1111/j.1440-169X.2010.01171.x; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Furusawa T, 2004, BIOL REPROD, V70, P1452, DOI 10.1095/biolreprod.103.024190; Gardner RL, 1997, INT J DEV BIOL, V41, P235; GARDNER RL, 1979, J EMBRYOL EXP MORPH, V52, P141; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Han DW, 2011, NAT CELL BIOL, V13, P66, DOI 10.1038/ncb2136; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hayashi K, 2009, DEVELOPMENT, V136, P3549, DOI 10.1242/dev.037747; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; LAWSON KA, 1991, DEVELOPMENT, V113, P891; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Niakan KK, 2006, MOL GENET METAB, V88, P261, DOI 10.1016/j.ymgme.2005.12.010; Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; ROSSANT J, 1978, J EMBRYOL EXP MORPH, V48, P239; STEVENS LC, 1954, P NATL ACAD SCI USA, V40, P1080, DOI 10.1073/pnas.40.11.1080; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Tesar PJ, 2005, P NATL ACAD SCI USA, V102, P8239, DOI 10.1073/pnas.0503231102; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yu RN, 1998, NAT GENET, V20, P353, DOI 10.1038/3822; Zhang XF, 2008, J BIOL CHEM, V283, P35825, DOI 10.1074/jbc.M803481200; Zwaka TP, 2005, DEVELOPMENT, V132, P227, DOI 10.1242/dev.01586	34	115	118	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 4	2011	8	3					318	325		10.1016/j.stem.2011.01.016	http://dx.doi.org/10.1016/j.stem.2011.01.016			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	735HI	21362571	Green Accepted, Bronze			2022-12-28	WOS:000288404400013
J	Sexton, T; Cavalli, G				Sexton, Tom; Cavalli, Giacomo			The 3D Genome Shapes Up For Pluripotency	CELL STEM CELL			English	Editorial Material							GENE-EXPRESSION; LOCUS	Chromosome folding has been long associated with gene expression. Articles in Cell Stem Cell and Cell by Apostolou et al., (2013), Phillips-Cremins et al., (2013), Wei et al., (2013), and Zhang et al., (2013) uncover chromatin interaction networks linked to the establishment or maintenance of pluripotency and identify some responsible factors.	[Sexton, Tom; Cavalli, Giacomo] CNRS, UPR 1142, Inst Human Genet, F-34396 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Cavalli, G (corresponding author), CNRS, UPR 1142, Inst Human Genet, 141 Rue Cardonille, F-34396 Montpellier 5, France.	giacomo.cavalli@igh.cnrs.fr	Cavalli, Giacomo/A-7958-2008; cavalli, giacomo/Z-2754-2019	Cavalli, Giacomo/0000-0003-3709-3469; cavalli, giacomo/0000-0003-3709-3469; Sexton, Thomas/0000-0002-7824-1846				Apostolou E, 2013, CELL STEM CELL, V12, P699, DOI 10.1016/j.stem.2013.04.013; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Noordermeer D, 2011, NAT CELL BIOL, V13, P944, DOI 10.1038/ncb2278; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wei Z., 2013, CELL STEM C IN PRESS; Zhang H., 2013, CELL STEM C IN PRESS	10	8	9	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2013	13	1					3	4		10.1016/j.stem.2013.06.013	http://dx.doi.org/10.1016/j.stem.2013.06.013			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VJ	23827701	Bronze			2022-12-28	WOS:000329570100002
J	Wei, Z; Gao, F; Kim, S; Yang, HZ; Lyu, J; An, WJ; Wang, K; Lu, WG				Wei, Zong; Gao, Fan; Kim, Sewoon; Yang, Hongzhen; Lyu, Jungmook; An, Woojin; Wang, Kai; Lu, Wange			Klf4 Organizes Long-Range Chromosomal Interactions with the Oct4 Locus inReprogramming andPluripotency	CELL STEM CELL			English	Article							GENOME-WIDE; CHROMATIN INTERACTIONS; GENE-EXPRESSION; NANOG LOCUS; STEM-CELLS; PLURIPOTENCY; TRANSCRIPTION; REVEALS; DOMAINS; MOUSE	Epigenetic mechanisms underlying somatic reprogramming have been extensively studied, but little is known about the nuclear architecture of pluripotent stem cells (PSCs). Using circular chromosome conformation capture with high-throughput sequencing (4C-seq) and fluorescence in situ hybridization (FISH), we identified chromosomal regions that colocalize frequently with the Oct4 locus in PSCs. These PSC-specific long-range interactions are established prior to transcriptional activation of endogenous Oct4 during reprogramming to induced PSCs and are facilitated by Klf4-mediated recruitment of cohesin. Depletion of Klf4 leads to unloading of cohesin at the Oct4 enhancer and disrupts long-range interactions prior to loss of Oct4 transcription and subsequent PSC differentiation, suggesting a causative role for Klf4 in facilitating long-range interactions independent of its transcriptional activity. Taken together, our results delineate the basic nuclear organization at the Oct4 locus in PSCs and suggest a functional role for Klf4-mediated higherorder chromatin structure in maintaining and inducing pluripotency.	[Wei, Zong; Gao, Fan; Kim, Sewoon; Yang, Hongzhen; Lu, Wange] Univ So Calif, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA; [Wei, Zong; Gao, Fan; Kim, Sewoon; Yang, Hongzhen; An, Woojin; Lu, Wange] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Gao, Fan; Wang, Kai] Univ So Calif, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Gao, Fan; Wang, Kai] Univ So Calif, Dept Prevent Med & Psychiat, Los Angeles, CA 90033 USA; [Lyu, Jungmook] Catholic Univ Korea, Coll Med, Dept Ophthalmol & Visual Sci, Catholic Inst Visual Sci, Seoul 137040, South Korea	University of Southern California; University of Southern California; University of Southern California; University of Southern California; Catholic University of Korea	Lu, WG (corresponding author), Univ So Calif, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA.	wangelu@usc.edu		Wei, Zong/0000-0002-4691-0101	CIRM [RB1-01353]	CIRM(California Institute for Regenerative Medicine)	We thank all members of the Lu laboratory for discussion, C. Yang for providing the inducible shRNA construct, G. Coetzee and M. Pera for critical comments, and L. Barsky for FACS sorting. This work was partially supported by a grant from CIRM (RB1-01353).	Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Apostolou E, 2013, CELL STEM CELL, V12, P699, DOI 10.1016/j.stem.2013.04.013; Brookes E, 2012, CELL STEM CELL, V10, P157, DOI 10.1016/j.stem.2011.12.017; Chakalova L, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000729; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cuylen S, 2010, CELL STEM CELL, V7, P424, DOI 10.1016/j.stem.2010.09.006; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; Evans PM, 2007, J BIOL CHEM, V282, P33994, DOI 10.1074/jbc.M701847200; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gamper AM, 2012, MOL CELL, V45, P233, DOI 10.1016/j.molcel.2011.11.031; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Hiratani I, 2010, GENOME RES, V20, P155, DOI 10.1101/gr.099796.109; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kidder BL, 2012, NUCLEIC ACIDS RES, V40, P2925, DOI 10.1093/nar/gkr1151; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kind J, 2013, CELL, V153, P178, DOI 10.1016/j.cell.2013.02.028; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Levasseur DN, 2008, GENE DEV, V22, P575, DOI 10.1101/gad.1606308; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; MERIKA M, 1995, MOL CELL BIOL, V15, P2437; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nitzsche A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019470; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Noordermeer D, 2011, NAT CELL BIOL, V13, P944, DOI 10.1038/ncb2278; Noti JD, 2005, J BIOL CHEM, V280, P3449, DOI 10.1074/jbc.M412627200; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Palstra RJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001661; Pan GJ, 2002, CELL RES, V12, P321, DOI 10.1038/sj.cr.7290134; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Plath K, 2011, NAT REV GENET, V12, P253, DOI 10.1038/nrg2955; Probst AV, 2011, TRENDS GENET, V27, P177, DOI 10.1016/j.tig.2011.02.002; Remeseiro S, 2013, CURR OPIN CELL BIOL, V25, P63, DOI 10.1016/j.ceb.2012.10.013; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Song SH, 2007, MOL CELL, V28, P810, DOI 10.1016/j.molcel.2007.09.025; Splinter E, 2011, GENE DEV, V25, P1371, DOI 10.1101/gad.633311; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takebayashi S, 2012, P NATL ACAD SCI USA, V109, P12574, DOI 10.1073/pnas.1207185109; Theunissen TW, 2011, CURR BIOL, V21, P65, DOI 10.1016/j.cub.2010.11.074; Tiwari VK, 2008, PLOS BIOL, V6, P2911, DOI 10.1371/journal.pbio.0060306; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; van de Werken HJG, 2012, METHOD ENZYMOL, V513, P89, DOI 10.1016/B978-0-12-391938-0.00004-5; Wei Z, 2009, STEM CELLS, V27, P2969, DOI 10.1002/stem.231; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Williams A, 2010, TRENDS GENET, V26, P188, DOI 10.1016/j.tig.2010.01.007; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang PL, 2010, J BIOL CHEM, V285, P9180, DOI 10.1074/jbc.M109.077958; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	63	153	156	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2013	13	1					36	47		10.1016/j.stem.2013.05.010	http://dx.doi.org/10.1016/j.stem.2013.05.010			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VJ	23747203	Bronze			2022-12-28	WOS:000329570100011
J	Yu, DX; Marchetto, MC; Gage, FH				Yu, Diana X.; Marchetto, Maria C.; Gage, Fred H.			Therapeutic Translation of iPSCs for Treating Neurological Disease	CELL STEM CELL			English	Review							PLURIPOTENT STEM-CELLS; FAMILIAL ALZHEIMERS-DISEASE; DIRECTED DIFFERENTIATION; FUNCTIONAL MATURATION; PARKINSONS-DISEASE; LONG-TERM; NEURONS; BRAIN; GENERATION; TRANSPLANTATION	Somatic cellular reprogramming is a fast-paced and evolving field that is changing the way scientists approach neurological diseases. For the first time in the history of neuroscience, it is feasible to study the behavior of live neurons from patients with neurodegenerative diseases, such as Alzheimer's and Parkinson's disease, and neuropsychiatric diseases, such as autism and schizophrenia. In this Perspective, we will discuss reprogramming technology in the context of its potential use for modeling and treating neurological and psychiatric diseases and will highlight areas of caution and opportunities for improvement.	[Yu, Diana X.; Marchetto, Maria C.; Gage, Fred H.] Salk Inst Biol Studies, La Jolla, CA 92037 USA	Salk Institute	Gage, FH (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu						An MC, 2012, CELL STEM CELL, V11, P253, DOI 10.1016/j.stem.2012.04.026; Ananiev G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025255; Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807; Bachoud-Levi AC, 2006, LANCET NEUROL, V5, P303, DOI 10.1016/S1474-4422(06)70381-7; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; BRIGGS R, 1952, P NATL ACAD SCI USA, V38, P455, DOI 10.1073/pnas.38.5.455; Camnasio S, 2012, NEUROBIOL DIS, V46, P41, DOI 10.1016/j.nbd.2011.12.042; Chae JI, 2012, BIOCHEM J, V446, P359, DOI 10.1042/BJ20111495; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Church JA, 2009, BRAIN, V132, P225, DOI 10.1093/brain/awn223; Devine MJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1453; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Duan XJ, 2012, NAT NANOTECHNOL, V7, P174, DOI [10.1038/nnano.2011.223, 10.1038/NNANO.2011.223]; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Egawa N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004052; Engle SJ, 2013, CELL STEM CELL, V12, P669, DOI 10.1016/j.stem.2013.05.011; Espuny-Camacho I, 2013, NEURON, V77, P440, DOI 10.1016/j.neuron.2012.12.011; Freeman T B, 2000, Prog Brain Res, V127, P405; Fung WT, 2009, LAB CHIP, V9, P2591, DOI [10.1039/b903753e, 10.1039/b903753c]; Glass JD, 2012, STEM CELLS, V30, P1144, DOI 10.1002/stem.1079; Gu A, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010067, 10.1371/currents.RRN1193]; Guha P, 2013, CELL STEM CELL, V12, P407, DOI 10.1016/j.stem.2013.01.006; GURDON JB, 1958, NATURE, V182, P64, DOI 10.1038/182064a0; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Hai A, 2010, J NEUROPHYSIOL, V104, P559, DOI 10.1152/jn.00265.2010; Hai A, 2010, NAT METHODS, V7, P200, DOI [10.1038/nmeth.1420, 10.1038/NMETH.1420]; Hargus G, 2010, P NATL ACAD SCI USA, V107, P15921, DOI 10.1073/pnas.1010209107; HD iPSC Consortium, 2012, CELL STEM CELL, V11, P264, DOI 10.1016/j.stem.2012.04.027; Homma K, 2013, STEM CELLS, V31, P1149, DOI 10.1002/stem.1372; Isacson O, 2003, ANN NEUROL, V53, pS135, DOI 10.1002/ana.10482; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Jang J, 2011, ANN NEUROL, V70, P402, DOI 10.1002/ana.22486; Jessberger S, 2008, NAT NEUROSCI, V11, P888, DOI 10.1038/nn.2148; Jiang HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1669; Jiang M, 2011, MOL CELL BIOCHEM, V354, P67, DOI 10.1007/s11010-011-0806-5; Kanagasabapathi Thirukumaran T, 2011, Front Neuroeng, V4, P13, DOI 10.3389/fneng.2011.00013; Kaneko S, 2013, CELL STEM CELL, V12, P385, DOI 10.1016/j.stem.2013.03.008; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Koch P, 2011, NATURE, V480, P543, DOI 10.1038/nature10671; Kunze A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026187; Kunze A, 2011, BIOMATERIALS, V32, P2088, DOI 10.1016/j.biomaterials.2010.11.047; Lee G, 2012, NAT BIOTECHNOL, V30, P1244, DOI 10.1038/nbt.2435; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Lee P, 2012, CIRC RES, V110, P1556, DOI 10.1161/CIRCRESAHA.111.262535; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; Lindvall Olle, 2004, NeuroRx, V1, P382; Lopez-Bendito G, 2012, DEV NEUROBIOL, V72, P145, DOI 10.1002/dneu.20897; Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020; Ma LX, 2012, CELL STEM CELL, V10, P455, DOI 10.1016/j.stem.2012.01.021; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Maroof AM, 2013, CELL STEM CELL, V12, P559, DOI 10.1016/j.stem.2013.04.008; Mendez I, 2005, BRAIN, V128, P1498, DOI 10.1093/brain/awh510; Merkle FT, 2013, CELL STEM CELL, V12, P656, DOI 10.1016/j.stem.2013.05.016; Mitne-Neto M, 2011, HUM MOL GENET, V20, P3642, DOI 10.1093/hmg/ddr284; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Musick K, 2009, LAB CHIP, V9, P2036, DOI 10.1039/b820596e; Nicholas CR, 2013, CELL STEM CELL, V12, P573, DOI 10.1016/j.stem.2013.04.005; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576; Paulsen BD, 2012, CELL TRANSPLANT, V21, P1547, DOI 10.3727/096368911X600957; Pedrosa E, 2011, J NEUROGENET, V25, P88, DOI 10.3109/01677063.2011.597908; Peng J., 2013, J BIOMOL SCREEN; Philpott LM, 1997, CELL TRANSPLANT, V6, P203, DOI 10.1016/S0963-6897(97)00028-6; Porteus M., 2010, COLD SPRING HARB PRO, V2010; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Ricciardi S, 2012, NAT CELL BIOL, V14, P911, DOI 10.1038/ncb2566; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Scott CW, 2013, TOXICOL LETT, V219, P49, DOI 10.1016/j.toxlet.2013.02.020; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Seibler P, 2011, J NEUROSCI, V31, P5970, DOI 10.1523/JNEUROSCI.4441-10.2011; Shi YC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003771; da Fonseca SAS, 2009, CELL PROLIFERAT, V42, P132, DOI 10.1111/j.1365-2184.2008.00578.x; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tian BZ, 2010, SCIENCE, V329, P830, DOI 10.1126/science.1192033; Torper O, 2013, P NATL ACAD SCI USA, V110, P7038, DOI 10.1073/pnas.1303829110; Villa-Diaz LG, 2009, LAB CHIP, V9, P1749, DOI 10.1039/b820380f; Weinacht KG, 2012, CURR OPIN IMMUNOL, V24, P617, DOI 10.1016/j.coi.2012.07.001; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Yagi T, 2011, HUM MOL GENET, V20, P4530, DOI 10.1093/hmg/ddr394; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005; Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135	89	76	79	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 6	2013	12	6					678	688		10.1016/j.stem.2013.05.018	http://dx.doi.org/10.1016/j.stem.2013.05.018			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VH	23746977	Bronze			2022-12-28	WOS:000329569900011
J	Sasai, Y				Sasai, Yoshiki			Next-Generation Regenerative Medicine: Organogenesis from Stem Cells in 3D Culture	CELL STEM CELL			English	Review							IN-VITRO; 3-DIMENSIONAL CULTURE; ES CELLS; EFFICIENT DIFFERENTIATION; DIRECTED DIFFERENTIATION; DEFINITIVE ENDODERM; SELF-ORGANIZATION; SMALL-INTESTINE; MOUSE; PROGENITORS	The behavior of stem cells, when they work collectively, can be much more sophisticated than one might expect from their individual programming. This Perspective covers recent discoveries about the dynamic patterning and structural self-formation of complex organ buds in 3D stem cell culture, including the generation of various neuroectodermal and endodermal tissues. For some tissues, epithelial-mesenchymal interactions can also be manipulated in coculture to guide organogenesis. This new area of stem cell research-the spatiotemporal control of dynamic cellular interactions-will open a new avenue for next-generation regenerative medicine.	RIKEN Ctr Dev Biol, Neurogenesis & Organogenesis Grp, Kobe, Hyogo 6500047, Japan	RIKEN	Sasai, Y (corresponding author), RIKEN Ctr Dev Biol, Neurogenesis & Organogenesis Grp, Kobe, Hyogo 6500047, Japan.	yoshikisasai@cdb.riken.jp						Antonica F, 2012, NATURE, V491, P66, DOI 10.1038/nature11525; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Behbahan IS, 2011, STEM CELL REV REP, V7, P748, DOI 10.1007/s12015-010-9216-4; Blum B, 2012, NAT BIOTECHNOL, V30, P261, DOI 10.1038/nbt.2141; Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Bosco D, 2010, DIABETES, V59, P1202, DOI 10.2337/db09-1177; Camazine S., 2001, SELF ORG BIOL SYSTEM, P7; Cao L, 2011, DIFFERENTIATION, V81, P1, DOI 10.1016/j.diff.2010.09.182; Carlone DL, 2012, CELL STEM CELL, V10, P2, DOI 10.1016/j.stem.2011.12.012; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; Chen W, 2012, NATURE, V490, P278, DOI 10.1038/nature11415; Cheng X, 2012, CELL STEM CELL, V10, P371, DOI 10.1016/j.stem.2012.02.024; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; De Robertis EM, 2009, MECH DEVELOP, V126, P925, DOI 10.1016/j.mod.2009.08.004; Dobrescu R, 2011, J Med Life, V4, P82; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Eiraku M, 2012, BIOESSAYS, V34, P17, DOI 10.1002/bies.201100070; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; GOLOSOW N, 1962, DEV BIOL, V4, P242, DOI 10.1016/0012-1606(62)90042-8; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Green MD, 2011, NAT BIOTECHNOL, V29, P267, DOI 10.1038/nbt.1788; Hay DC, 2008, STEM CELLS, V26, P894, DOI 10.1634/stemcells.2007-0718; Hevner RF, 2003, DEV NEUROSCI-BASEL, V25, P139, DOI 10.1159/000072263; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Ikeda E, 2009, P NATL ACAD SCI USA, V106, P13475, DOI 10.1073/pnas.0902944106; Kamiya D, 2011, NATURE, V470, P503, DOI 10.1038/nature09726; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Longmire TA, 2012, CELL STEM CELL, V10, P398, DOI 10.1016/j.stem.2012.01.019; Mao JJ, 2012, CELL STEM CELL, V11, P291, DOI 10.1016/j.stem.2012.08.010; Meng Q, 2010, EXPERT OPIN DRUG MET, V6, P733, DOI 10.1517/17425251003674356; Mizuseki K, 2003, P NATL ACAD SCI USA, V100, P5828, DOI 10.1073/pnas.1037282100; Mou HM, 2012, CELL STEM CELL, V10, P385, DOI 10.1016/j.stem.2012.01.018; Muguruma K, 2010, NAT NEUROSCI, V13, P1171, DOI 10.1038/nn.2638; Nakamura H, 2005, BRAIN RES REV, V49, P120, DOI 10.1016/j.brainresrev.2004.10.005; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; Nakao K, 2007, NAT METHODS, V4, P227, DOI 10.1038/nmeth1012; Nasu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053024; Niehrs C, 2010, DEVELOPMENT, V137, P845, DOI 10.1242/dev.039651; Nordstrom U, 2002, NAT NEUROSCI, V5, P525, DOI 10.1038/nn854; Pearson RA, 2012, NATURE, V485, P99, DOI 10.1038/nature10997; Rizzoti K, 2005, REV ENDOCR METAB DIS, V6, P161, DOI 10.1007/s11154-005-3047-7; Saito H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028209; Salero E, 2007, P NATL ACAD SCI USA, V104, P2997, DOI 10.1073/pnas.0610879104; Sasai Y, 2013, NATURE, V493, P318, DOI 10.1038/nature11859; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Seiler MJ, 2010, EUR J NEUROSCI, V31, P508, DOI 10.1111/j.1460-9568.2010.07085.x; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Smukler SR, 2006, J CELL BIOL, V172, P79, DOI 10.1083/jcb.200508085; Sneddon JB, 2012, NATURE, V491, P765, DOI 10.1038/nature11463; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Su HL, 2006, DEV BIOL, V290, P287, DOI 10.1016/j.ydbio.2005.11.010; Suga H, 2011, NATURE, V480, P57, DOI 10.1038/nature10637; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tam PPL, 2003, DEVELOPMENT, V130, P6155, DOI 10.1242/dev.00893; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Ueda T, 2010, BIOCHEM BIOPH RES CO, V391, P38, DOI 10.1016/j.bbrc.2009.10.157; Wang XL, 2009, TISSUE ENG PT A, V15, P1941, DOI 10.1089/ten.tea.2008.0181; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Woodford C, 2012, CURR OPIN BIOTECH, V23, P810, DOI 10.1016/j.copbio.2012.03.003; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695; Zervas M, 2005, CURR TOP DEV BIOL, V69, P101, DOI 10.1016/S0070-2153(05)69005-9	73	255	270	4	86	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 2	2013	12	5					520	530		10.1016/j.stem.2013.04.009	http://dx.doi.org/10.1016/j.stem.2013.04.009			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VE	23642363	Bronze			2022-12-28	WOS:000329569600009
J	Karow, M; Sanchez, R; Schichor, C; Masserdotti, G; Ortega, F; Heinrich, C; Gascon, S; Khan, MA; Lie, DC; Dellavalle, A; Cossu, G; Goldbrunner, R; Gotz, M; Berninger, B				Karow, Marisa; Sanchez, Rodrigo; Schichor, Christian; Masserdotti, Giacomo; Ortega, Felipe; Heinrich, Christophe; Gascon, Sergio; Khan, Muhammad A.; Lie, D. Chichung; Dellavalle, Arianna; Cossu, Giulio; Goldbrunner, Roland; Goetz, Magdalena; Berninger, Benedikt			Reprogramming of Pericyte-Derived Cells of the Adult Human Brain into Induced Neuronal Cells	CELL STEM CELL			English	Article							HUMAN FIBROBLASTS; DOPAMINERGIC-NEURONS; FUNCTIONAL-NEURONS; POSTNATAL ASTROGLIA; DIRECT CONVERSION; MOUSE; GENERATION; ORIGIN	Reprogramming of somatic cells into neurons provides a new approach toward cell-based therapy of neurodegenerative diseases. A major challenge for the translation of neuronal reprogramming into therapy is whether the adult human brain contains cell populations amenable to direct somatic cell conversion. Here we show that cells from the adult human cerebral cortex expressing pericyte hallmarks can be reprogrammed into neuronal cells by retrovirus-mediated coexpression of the transcription factors Sox2 and Mash1. These induced neuronal cells acquire the ability of repetitive action potential firing and serve as synaptic targets for other neurons, indicating their capability of integrating into neural networks. Genetic fate-mapping in mice expressing an inducible Cre recombinase under the tissue-nonspecific alkaline phosphatase promoter corroborated the pericytic origin of the reprogrammed cells. Our results raise the possibility of functional conversion of endogenous cells in the adult human brain to induced neuronal fates.	[Karow, Marisa; Sanchez, Rodrigo; Masserdotti, Giacomo; Ortega, Felipe; Heinrich, Christophe; Gascon, Sergio; Goetz, Magdalena; Berninger, Benedikt] Univ Munich, Dept Physiol Genom, Inst Physiol, D-80336 Munich, Germany; [Schichor, Christian; Goldbrunner, Roland] Klinikum Univ Munchen, Tumor Biol Lab, Neurosurg Clin, D-81377 Munich, Germany; [Masserdotti, Giacomo; Gascon, Sergio; Goetz, Magdalena; Berninger, Benedikt] Natl Res Ctr Environm & Hlth, Inst Stem Cell Res, D-85764 Neuherberg, Germany; [Khan, Muhammad A.; Lie, D. Chichung] Natl Res Ctr Environm & Hlth, Res Grp Adult Neural Stem Cells & Neurogenesis, Inst Dev Genet, D-85764 Neuherberg, Germany; [Lie, D. Chichung] Univ Erlangen Nurnberg, Inst Biochem, Emil Fischer Ctr, D-91054 Erlangen, Germany; [Dellavalle, Arianna; Cossu, Giulio] Ist Sci San Raffaele, Div Regenerat Med, I-20132 Milan, Italy; [Cossu, Giulio] UCL, Dept Cell & Dev Biol, London WC1E 6DE, England; [Goldbrunner, Roland] Univ Hosp Cologne, Ctr Neurosurg, D-50937 Cologne, Germany; [Berninger, Benedikt] Johannes Gutenberg Univ Mainz, Inst Physiol Chem, D-55128 Mainz, Germany; [Berninger, Benedikt] Johannes Gutenberg Univ Mainz, Focus Program Translat Neurosci, D-55128 Mainz, Germany	University of Munich; University of Munich; University of Erlangen Nuremberg; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of London; University College London; University of Cologne; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Berninger, B (corresponding author), Univ Munich, Dept Physiol Genom, Inst Physiol, Schillerstr 46, D-80336 Munich, Germany.	benedikt.berninger@lrz.uni-muenchen.de	Lie, Dieter Chichung/AAS-8604-2020; HEINRICH, Christophe/K-1300-2017; Lie, Dieter Chichung/S-7914-2017; Ortega, Felipe/N-2749-2015; Schichor, Christian/D-8635-2014; Berninger, Benedikt/H-4098-2019	Lie, Dieter Chichung/0000-0002-6035-6442; HEINRICH, Christophe/0000-0003-1266-718X; Lie, Dieter Chichung/0000-0002-6035-6442; Ortega, Felipe/0000-0001-6398-9520; Berninger, Benedikt/0000-0003-2652-2782; Karow, Marisa/0000-0003-4935-1365; Gascon, Sergio/0000-0001-8756-7082; Cossu, Giulio/0000-0001-5863-9593	Deutsche Forschungsgemeinschaft (DFG) [SPP1356]; BMBF; Bavarian State Ministry of Sciences, Research and the Arts; binational SYSTHER-INREMOS Virtual Institute (German and Slovenian Federal Ministries of Education and Research); DFG [SFB 824]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); Bavarian State Ministry of Sciences, Research and the Arts; binational SYSTHER-INREMOS Virtual Institute (German and Slovenian Federal Ministries of Education and Research); DFG(German Research Foundation (DFG))	We thank Dr. Marius Wernig (Stanford University) for generously providing us with the sox2 coding sequence. We are also very grateful to Tatiana Simon-Ebert and Gabi Jager for excellent technical assistance. This work was supported by grants from the SPP1356 of the Deutsche Forschungsgemeinschaft (DFG), the BMBF, and the Bavarian State Ministry of Sciences, Research and the Arts to M.G. and B.B. C.S. and R.G. received funding from the binational SYSTHER-INREMOS Virtual Institute (German and Slovenian Federal Ministries of Education and Research) and the DFG (SFB 824). We are deeply indebted to the Graduate School of Systemic Neurosciences (GSN-LMU) for allowing the use of the live-imaging microscope.	Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Berninger B, 2007, J NEUROSCI, V27, P8654, DOI 10.1523/JNEUROSCI.1615-07.2007; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Castro DS, 2011, GENE DEV, V25, P930, DOI 10.1101/gad.627811; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Dellavalle A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1508; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Heinrich C, 2011, NAT PROTOC, V6, P214, DOI 10.1038/nprot.2010.188; Heinrich C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000373; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Karram K, 2005, J ANAT, V207, P735, DOI 10.1111/j.1469-7580.2005.00461.x; Kim J, 2011, CELL STEM CELL, V9, P413, DOI 10.1016/j.stem.2011.09.011; Kormann MSD, 2011, NAT BIOTECHNOL, V29, P154, DOI 10.1038/nbt.1733; Marro S, 2011, CELL STEM CELL, V9, P374, DOI 10.1016/j.stem.2011.09.002; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Qiang L, 2011, CELL, V146, P359, DOI 10.1016/j.cell.2011.07.007; Rieger MA, 2009, SCIENCE, V325, P217, DOI 10.1126/science.1171461; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Vierbuchen T, 2011, NAT BIOTECHNOL, V29, P892, DOI 10.1038/nbt.1946; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323	24	224	238	1	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	OCT 5	2012	11	4					471	476		10.1016/j.stem.2012.07.007	http://dx.doi.org/10.1016/j.stem.2012.07.007			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	021OZ	23040476	Bronze			2022-12-28	WOS:000309896500008
J	Ye, L; Fan, ZP; Yu, B; Chang, J; Al Hezaimi, K; Zhou, XD; Park, NH; Wang, CY				Ye, Ling; Fan, Zhipeng; Yu, Bo; Chang, Jia; Al Hezaimi, Khalid; Zhou, Xuedong; Park, No-Hee; Wang, Cun-Yu			Histone Demethylases KDM4B and KDM6B Promote Osteogenic Differentiation of Human MSCs	CELL STEM CELL			English	Article							MESENCHYMAL STEM-CELLS; BONE-MARROW; GENE-EXPRESSION; STROMAL CELLS; PPAR-GAMMA; TRANSCRIPTIONAL REGULATION; KAPPA-B; TISSUE; JMJD3; OSTEOBLASTOGENESIS	Human bone marrow mesenchymal stem/stromal cells (MSCs) are multipotent progenitor cells with multilineage differentiation potentials including osteogenesis and adipogenesis. While significant progress has been made in understanding transcriptional controls of MSC fate, little is known about how MSC differentiation is epigenetically regulated. Here we show that the histone dennethylases KDM4B and KDM6B play critical roles in osteogenic commitment of MSCs by removing H3K9me3 and H3K27me3. Depletion of KDM4B or KDM6B significantly reduced osteogenic differentiation and increased adipogenic differentiation. Mechanistically, while KDM6B controlled HOX expression by removing H3K27me3, KDM4B promoted DLX expression by removing H3K9me3. Importantly, H3K27me3- and H3K9me3-positive MSCs of bone marrow were significantly elevated in ovariectomized and aging mice in which adipogenesis was highly active. Since histone demethylases are chemically modifiable, KDM4B and KDM6B may present as therapeutic targets for controlling MSC fate choices and lead to clues for new treatment in metabolic bone diseases such as osteoporosis.	[Ye, Ling; Yu, Bo; Chang, Jia; Wang, Cun-Yu] Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Mol Signalling Lab, Los Angeles, CA 90095 USA; [Ye, Ling; Yu, Bo; Chang, Jia; Wang, Cun-Yu] Univ Calif Los Angeles, Broad Stem Cell Res Ctr, Los Angeles, CA 90095 USA; [Ye, Ling; Zhou, Xuedong] Sichuan Univ, W China Sch Stomatol, State Key Lab Oral Dis, Chengdu 610041, Sichuan, Peoples R China; [Ye, Ling; Zhou, Xuedong] Sichuan Univ, W China Sch Stomatol, Dept Endodont, Chengdu 610041, Sichuan, Peoples R China; [Fan, Zhipeng] Capital Med Univ, Sch Stomatol, Beijing 100050, Peoples R China; [Al Hezaimi, Khalid] King Saud Univ, Coll Dent, Div Periodontol, Eng AB Res Chair Growth Factors & Bone Regenerat, Riyadh 11545, Saudi Arabia; [Park, No-Hee] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Sch Dent, Los Angeles, CA 90095 USA; [Park, No-Hee] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Wang, Cun-Yu] Univ Calif Los Angeles, Henry Samueli Sch Engn & Appl Sci, Dept Bioengn, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Sichuan University; Sichuan University; Capital Medical University; King Saud University; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Wang, CY (corresponding author), Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Mol Signalling Lab, Los Angeles, CA 90095 USA.	cwang@dentistry.ucla.edu	ye, ling/AFP-0048-2022; ye, ling/B-2423-2013; ZHOU, XUE/F-6129-2013	ye, ling/0000-0002-8417-7676; Zhou, Xuedong/0000-0002-9319-7302	NIH-NCRR [CJX1-443835-WS-29646]; NSF [CHE-0722519]; National Institute of Dental and Craniofacial Research [DE019412, DE16513]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016513, R90DE023057, R01DE019412, T90DE022734, R01DE015964] Funding Source: NIH RePORTER	NIH-NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NSF(National Science Foundation (NSF)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Dr. Steve Smale for critical reading the manuscript and suggestions and Dr. Tori Xiao for technical supports. We thank Dr. Paul Khavari for providing the catalytically mutant KDM6B construct. Confocal laser scanning microscopy was performed at CNSI Advanced Light Microscopy/Spectroscopy Shared Resource Facility at UCLA, supported with funding from NIH-NCRR shared resources grant (CJX1-443835-WS-29646) and NSF Major Research Instrumentation grant (CHE-0722519). This study was support by National Institute of Dental and Craniofacial Research grants DE019412 and DE16513.	Acampora D, 1999, DEVELOPMENT, V126, P3795; Agger K, 2008, CURR OPIN GENET DEV, V18, P159, DOI 10.1016/j.gde.2007.12.003; Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Chang J, 2009, NAT MED, V15, P682, DOI 10.1038/nm.1954; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fan ZP, 2009, NAT CELL BIOL, V11, P1002, DOI 10.1038/ncb1913; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; GRONTHOS S, 1994, BLOOD, V84, P4164, DOI 10.1182/blood.V84.12.4164.bloodjournal84124164; Hassan MQ, 2007, MOL CELL BIOL, V27, P3337, DOI 10.1128/MCB.01544-06; Hassan MQ, 2004, MOL CELL BIOL, V24, P9248, DOI 10.1128/MCB.24.20.9248-9261.2004; Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Justesen J, 2001, BIOGERONTOLOGY, V2, P165, DOI 10.1023/A:1011513223894; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Kawai M, 2010, NAT REV ENDOCRINOL, V6, P629, DOI 10.1038/nrendo.2010.155; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116; Kronenberg HM, 2010, ANN NY ACAD SCI, V1192, P327, DOI 10.1111/j.1749-6632.2009.05251.x; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; Levi B, 2011, STEM CELLS, V29, P576, DOI 10.1002/stem.612; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; McCauley LK, 2010, J CLIN INVEST, V120, P3440, DOI 10.1172/JCI44786; McEwen KR, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-2; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; MEUNIER P, 1971, CLIN ORTHOP RELAT R, V80, P147, DOI DOI 10.1097/00003086-197110000-00021; Miller SA, 2008, GENE DEV, V22, P2980, DOI 10.1101/gad.1689708; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Miller SA, 2010, IMMUNOL REV, V238, P233, DOI 10.1111/j.1600-065X.2010.00952.x; Muruganandan S, 2009, CELL MOL LIFE SCI, V66, P236, DOI 10.1007/s00018-008-8429-z; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Phimphilai M, 2006, J BONE MINER RES, V21, P637, DOI 10.1359/JBMR.060109; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Qiao LP, 2008, J BIOL CHEM, V283, P8788, DOI 10.1074/jbc.M800055200; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Stein GS, 2010, CRIT REV EUKAR GENE, V20, P149, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.50; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Takada I, 2009, NAT REV RHEUMATOL, V5, P442, DOI 10.1038/nrrheum.2009.137; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Teitelbaum SL, 2010, CELL STEM CELL, V7, P553, DOI 10.1016/j.stem.2010.10.004; Undale AH, 2009, MAYO CLIN PROC, V84, P893, DOI 10.1016/S0025-6196(11)60506-5; Wacker SA, 2004, DEV BIOL, V266, P123, DOI 10.1016/j.ydbio.2003.10.011; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028	59	231	250	3	72	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUL 6	2012	11	1					50	61		10.1016/j.stem.2012.04.009	http://dx.doi.org/10.1016/j.stem.2012.04.009			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	975SS	22770241	Bronze, Green Accepted			2022-12-28	WOS:000306532400009
J	Cheng, X; Ying, L; Lu, L; Galvao, AM; Mills, JA; Lin, HC; Kotton, DN; Shen, SS; Nostro, MC; Choi, JK; Weiss, MJ; French, DL; Gadue, P				Cheng, Xin; Ying, Lei; Lu, Lin; Galvao, Aline M.; Mills, Jason A.; Lin, Henry C.; Kotton, Darrell N.; Shen, Steven S.; Nostro, M. Cristina; Choi, John Kim; Weiss, Mitchell J.; French, Deborah L.; Gadue, Paul			Self-Renewing Endodermal Progenitor Lines Generated from Human Pluripotent Stem Cells	CELL STEM CELL			English	Article							DEFINITIVE ENDODERM; EFFICIENT DIFFERENTIATION; VISCERAL ENDODERM; GENE-EXPRESSION; ENDOCRINE-CELLS; IPS CELLS; IN-VITRO; MOUSE; INSULIN; GASTRULATION	The use of human pluripotent stem cells for laboratory studies and cell-based therapies is hampered by their tumor-forming potential and limited ability to generate pure populations of differentiated cell types in vitro. To address these issues, we established endodermal progenitor (EP) cell lines from human embryonic and induced pluripotent stem cells. Optimized growth conditions were established that allow near unlimited (>10(16)) EP cell self-renewal in which they display a morphology and gene expression pattern characteristic of definitive endoderm. Upon manipulation of their culture conditions in vitro or transplantation into mice, clonally derived EP cells differentiate into numerous endodermal lineages, including monohormonal glucose-responsive pancreatic beta-cells, hepatocytes, and intestinal epithelia. Importantly, EP cells are nontumorigenic in vivo. Thus, EP cells represent a powerful tool to study endoderm specification and offer a potentially safe source of endodermal-derived tissues for transplantation therapies.	[Cheng, Xin; Ying, Lei; Lu, Lin; Galvao, Aline M.; Mills, Jason A.; Choi, John Kim; French, Deborah L.; Gadue, Paul] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Cheng, Xin; Ying, Lei; Lu, Lin; Galvao, Aline M.; Mills, Jason A.; French, Deborah L.; Gadue, Paul] Childrens Hosp Philadelphia, Ctr Cellular & Mol Therapeut, Philadelphia, PA 19104 USA; [Weiss, Mitchell J.] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA; [Lin, Henry C.] Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA; [Kotton, Darrell N.] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [Kotton, Darrell N.] Boston Univ, Sch Med, Ctr Regenerat Med, Boston, MA 02118 USA; [Shen, Steven S.] Boston Univ, Sch Med, Dept Med, Sect Computat Biomed, Boston, MA 02118 USA; [Shen, Steven S.] Boston Med Ctr, Boston, MA 02118 USA; [Nostro, M. Cristina] Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON M5G 1L7, Canada	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Boston University; Boston University; Boston University; Boston Medical Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Gadue, P (corresponding author), Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	gaduep@email.chop.edu	Weiss, Mitchell J/A-1245-2013; Weiss, Mitchell J/W-9814-2018; Choi, John Kim/N-7558-2018	Weiss, Mitchell J/0000-0003-2460-3036; Choi, John Kim/0000-0002-2861-0180; Shen, Steven/0000-0001-7725-1260; Kotton, Darrell/0000-0002-9604-8476; Nostro, Maria Cristina/0000-0003-1166-8252	Ruth L. Kirschstein Institutional Training Grant [T32]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092113] Funding Source: NIH RePORTER	Ruth L. Kirschstein Institutional Training Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Gordon Keller for sharing his pancreatic differentiation protocol ahead of publication. We also thank members of the Gadue and French groups for critical discussion of the manuscript. X.C. was supported by a Ruth L. Kirschstein Institutional Training Grant (T32).	Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; ANG SL, 1993, DEVELOPMENT, V119, P1301; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Basma H, 2009, GASTROENTEROLOGY, V136, P990, DOI 10.1053/j.gastro.2008.10.047; BOWEN MA, 1995, J EXP MED, V181, P2213, DOI 10.1084/jem.181.6.2213; Choi MY, 2006, DEVELOPMENT, V133, P4119, DOI 10.1242/dev.02537; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Duncan SA, 1997, DEVELOPMENT, V124, P279; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Greber B, 2011, EMBO J, V30, P4874, DOI 10.1038/emboj.2011.407; Hentze H, 2009, STEM CELL RES, V2, P198, DOI 10.1016/j.scr.2009.02.002; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Jiang JJ, 2007, STEM CELLS, V25, P1940, DOI 10.1634/stemcells.2006-0761; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Lu CC, 2001, CURR OPIN GENET DEV, V11, P384, DOI 10.1016/S0959-437X(00)00208-2; Ludtke THW, 2009, HEPATOLOGY, V49, P969, DOI 10.1002/hep.22700; Lukowiak B, 2001, J HISTOCHEM CYTOCHEM, V49, P519, DOI 10.1177/002215540104900412; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; Morrison GM, 2008, CELL STEM CELL, V3, P402, DOI 10.1016/j.stem.2008.07.021; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; Rezania A, 2011, DIABETES, V60, P239, DOI 10.2337/db10-0573; Schmelzer E, 2006, STEM CELLS, V24, P1852, DOI 10.1634/stemcells.2006-0036; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; Sherwood RI, 2007, DEV BIOL, V304, P541, DOI 10.1016/j.ydbio.2007.01.011; Shu WG, 2001, J BIOL CHEM, V276, P27488, DOI 10.1074/jbc.M100636200; Smith SB, 2010, NATURE, V463, P775, DOI 10.1038/nature08748; Spence JR, 2007, DEV DYNAM, V236, P3218, DOI 10.1002/dvdy.21366; Spence JR, 2011, DEV DYNAM, V240, P501, DOI 10.1002/dvdy.22540; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Spence JR, 2009, DEV CELL, V17, P62, DOI 10.1016/j.devcel.2009.05.012; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Stroncek DF, 2007, CURR OPIN HEMATOL, V14, P688, DOI 10.1097/MOH.0b013e3282efed9e; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Thatava T, 2011, GENE THER, V18, P283, DOI 10.1038/gt.2010.145; Varlakhanova NV, 2010, DIFFERENTIATION, V80, P9, DOI 10.1016/j.diff.2010.05.001; Zhang DH, 2009, CELL RES, V19, P429, DOI 10.1038/cr.2009.28; Zhao DX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006468; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	42	162	195	0	45	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	APR 6	2012	10	4					371	384		10.1016/j.stem.2012.02.024	http://dx.doi.org/10.1016/j.stem.2012.02.024			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	929QA	22482503	Bronze, Green Accepted			2022-12-28	WOS:000303079400007
J	Zhou, Q; Tripathi, P				Zhou, Qiao; Tripathi, Pratibha			How to Remake a Fibroblast into a Neural Stem Cell	CELL STEM CELL			English	Editorial Material							MOUSE FIBROBLASTS; PLURIPOTENCY	In this issue of Cell Stem Cell and in a recent issue of PNAS, Thier et al. (2012), Han et al. (2012), and Lujan et al. (2012) report the derivation of multipotent neural stem/progenitor cells from cultured mouse fibroblasts using distinct reprograming approaches.	[Zhou, Qiao; Tripathi, Pratibha] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University	Zhou, Q (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	qiao_zhou@harvard.edu		Zhou, Qiao/0000-0002-0099-3909				Chambers SM, 2011, CELL, V145, P827, DOI 10.1016/j.cell.2011.05.036; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Yang N, 2011, CELL STEM CELL, V9, P517, DOI 10.1016/j.stem.2011.11.015	10	17	20	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	APR 6	2012	10	4					347	348		10.1016/j.stem.2012.03.005	http://dx.doi.org/10.1016/j.stem.2012.03.005			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	929QA	22482497	Bronze			2022-12-28	WOS:000303079400001
J	Brindley, DA; Reeve, BC; Sahlman, WA; Bonfiglio, GA; Davie, NL; Culme-Seymour, EJ; Mason, C				Brindley, David A.; Reeve, Brock C.; Sahlman, William A.; Bonfiglio, Greg A.; Davie, Natasha L.; Culme-Seymour, Emily J.; Mason, Chris			The Impact of Market Volatility on the Cell Therapy Industry	CELL STEM CELL			English	Editorial Material									[Brindley, David A.; Davie, Natasha L.; Mason, Chris] UCL, Adv Ctr Biochem Engn, London WC1E 6BT, England; [Brindley, David A.; Reeve, Brock C.; Davie, Natasha L.] Harvard Stem Cell Inst, Holyoke Ctr, Cambridge, MA 02138 USA; [Brindley, David A.; Sahlman, William A.] Harvard Univ, Sch Business, Soldiers Field, Boston, MA 02163 USA; [Bonfiglio, Greg A.] Proteus Venture Partners, Portola Valley, CA 94028 USA; [Bonfiglio, Greg A.] Ctr Commercializat Regenerat Med, Toronto, ON M5G 1L5, Canada; [Davie, Natasha L.] Harvard Univ, Sch Med, Ctr Excellence Vasc Biol, Boston, MA 02115 USA; [Brindley, David A.; Davie, Natasha L.; Culme-Seymour, Emily J.; Mason, Chris] London Regenerat Med Network, London EC1R 0DP, England	University of London; University College London; Harvard University; Harvard University; Harvard University; Harvard Medical School	Brindley, DA (corresponding author), UCL, Adv Ctr Biochem Engn, Torrington Pl, London WC1E 6BT, England.	david_brindley@harvard.edu						[Anonymous], 1985, J BUS VENTUR; Christensen CM, 2000, HARV BUS REV     SEP; COOKSEY D, 2006, REV UK HEALTHCARE RE; Fenn J., 2008, MASTERING HYPE CYCLE; Mason C, 2011, REGEN MED, V6, P265, DOI [10.2217/RME.11.28, 10.2217/rme.11.28]; Mason C, 2007, REGEN MED, V2, P11, DOI 10.2217/17460751.2.1.11; Mason C, 2010, REGEN MED, V5, P153, DOI 10.2217/RME.10.14; McKernan R, 2010, CELL STEM CELL, V6, P517, DOI 10.1016/j.stem.2010.05.012; Rao MS, 2011, CELL STEM CELL, V9, P7, DOI 10.1016/j.stem.2011.06.009	9	22	22	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV 4	2011	9	5					397	401		10.1016/j.stem.2011.10.010	http://dx.doi.org/10.1016/j.stem.2011.10.010			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	850FJ	22056137	Bronze			2022-12-28	WOS:000297180200007
J	Lysaght, T; Campbell, AV				Lysaght, Tamra; Campbell, Alastair V.			Regulating Autologous Adult Stem Cells: The FDA Steps Up	CELL STEM CELL			English	Editorial Material							MEDICINE; CLINICS		[Lysaght, Tamra; Campbell, Alastair V.] Natl Univ Singapore, Yong Loo Lin Sch Med, Ctr Biomed Eth, Singapore 119228, Singapore	National University of Singapore	Lysaght, T (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Ctr Biomed Eth, 1E Kent Ridge Rd,NUHS Tower Block,Level 11, Singapore 119228, Singapore.	tamra.lysaght@nuhs.edu.sg	Lysaght, Tamra/AAU-9525-2020					Cohen CB, 2010, KENNEDY INST ETHIC J, V20, P207, DOI 10.1353/ken.2010.0001; Food and Drug Administration, 2008, VACC BLOOD BIOL; Hyun I, 2010, J LAW MED ETHICS, V38, P277, DOI 10.1111/j.1748-720X.2010.00488.x; Hyun I, 2008, CELL STEM CELL, V3, P607, DOI 10.1016/j.stem.2008.11.009; Kiatpongsan S, 2009, SCIENCE, V323, P1564, DOI 10.1126/science.1168451; Lau D, 2008, CELL STEM CELL, V3, P591, DOI 10.1016/j.stem.2008.11.001; MARCHIONE M, 2011, DOCTORS QUESTION PER; Regenberg AC, 2009, STEM CELLS, V27, P2312, DOI 10.1002/stem.132; Sipp D, 2010, AM J BIOETHICS, V10, P33, DOI 10.1080/15265161003754106; Taylor PL, 2010, J LAW MED ETHICS, V38, P286, DOI 10.1111/j.1748-720X.2010.00489.x	10	42	44	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV 4	2011	9	5					393	396		10.1016/j.stem.2011.09.013	http://dx.doi.org/10.1016/j.stem.2011.09.013			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Cell Biology	850FJ	22056136	Bronze			2022-12-28	WOS:000297180200006
J	Barrilleaux, B; Knoepfler, PS				Barrilleaux, Bonnie; Knoepfler, Paul S.			Inducing iPSCs to Escape the Dish	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; CHROMOSOMAL-ABERRATIONS; DOPAMINERGIC-NEURONS; CHROMATIN-STRUCTURE; HUMAN FIBROBLASTS; SOMATIC-CELLS; COPY NUMBER; DNA-DAMAGE; MOUSE; EXPRESSION	Induced pluripotent stem cells (iPSCs) hold great promise for autologous cell therapies, but significant roadblocks remain to translating iPSCs to the bedside. For example, concerns about the presumed autologous transplantation potential of iPSCs have been raised by a recent paper demonstrating that iPSC-derived teratomas were rejected by syngeneic hosts. Additionally, the reprogramming process can alter genomic and epigenomic states, so a key goal at this point is to determine the clinical relevance of these changes and minimize those that prove to be deleterious. Finally, thus far few studies have examined the efficacy and tumorigenicity of iPSCs in clinically relevant transplantation scenarios, an essential requirement for the FDA. We discuss potential solutions to these hurdles to provide a roadmap for iPSCs to "jump the dish" and become useful therapies.	[Barrilleaux, Bonnie; Knoepfler, Paul S.] Univ Calif Davis, Sch Med, Dept Cell Biol & Human Anat, Sacramento, CA 95817 USA; [Barrilleaux, Bonnie; Knoepfler, Paul S.] Univ Calif Davis, Sch Med, Genome Ctr, Sacramento, CA 95817 USA; [Barrilleaux, Bonnie; Knoepfler, Paul S.] Shriners Hosp Children No Calif, Inst Pediat Regenerat Med, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis	Knoepfler, PS (corresponding author), Univ Calif Davis, Sch Med, Dept Cell Biol & Human Anat, Sacramento, CA 95817 USA.	knoepfler@ucdavis.edu		Knoepfler, Paul/0000-0001-5444-334X	California Institute for Regenerative Medicine [RN2-00922-1]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100782] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this work was provided by the California Institute for Regenerative Medicine via Grant RN2-00922-1 to P.K.	Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Armstrong L, 2010, STEM CELLS, V28, P661, DOI 10.1002/stem.307; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Barroso-delJesus A, 2011, FASEB J, V25, P1497, DOI 10.1096/fj.10-172221; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Ben-David U, 2011, CELL STEM CELL, V9, P97, DOI 10.1016/j.stem.2011.06.013; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bruck T, 2011, STEM CELL RES, V6, P187, DOI 10.1016/j.scr.2010.12.001; Cai JL, 2010, STEM CELLS DEV, V19, P1017, DOI 10.1089/scd.2009.0319; Chen Yao-Tseng, 2005, Cancer Immun, V5, P9; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; Crespo FL, 2010, STEM CELLS, V28, P1132, DOI 10.1002/stem.441; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Dolle MET, 2000, P NATL ACAD SCI USA, V97, P8403, DOI 10.1073/pnas.97.15.8403; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Felsher DW, 1999, P NATL ACAD SCI USA, V96, P3940, DOI 10.1073/pnas.96.7.3940; Gibbs CP, 2005, NEOPLASIA, V7, P967, DOI 10.1593/neo.05394; Goldring CEP, 2011, CELL STEM CELL, V8, P618, DOI 10.1016/j.stem.2011.05.012; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hoei-Hansen CE, 2005, HISTOPATHOLOGY, V47, P48, DOI 10.1111/j.1365-2559.2005.02182.x; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Issa F, 2010, TRANSPLANTATION, V90, P1321, DOI 10.1097/TP.0b013e3181ff8772; Kiedrowski LA, 2011, STEM CELL REV REP, V7, P969, DOI 10.1007/s12015-011-9238-6; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Knoepfler PS, 2009, STEM CELLS, V27, P1050, DOI 10.1002/stem.37; Laurent LC, 2008, STEM CELLS, V26, P1506, DOI 10.1634/stemcells.2007-1081; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lee JH, 2010, P NATL ACAD SCI USA, V107, P14639, DOI 10.1073/pnas.1008522107; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Li TS, 2010, STEM CELLS, V28, P1178, DOI 10.1002/stem.438; Lian QZ, 2010, CIRCULATION, V121, P1113, DOI 10.1161/CIRCULATIONAHA.109.898312; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Liu H, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002376; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Muller FJ, 2010, CELL STEM CELL, V6, P412, DOI 10.1016/j.stem.2010.04.009; Murray MJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-290; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; NUR OB, 2011, CELL STEM CELL, V9, P17; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Pan YM, 2010, PATHOBIOLOGY, V77, P283, DOI 10.1159/000320866; Pearl JI, 2011, CELL STEM CELL, V8, P309, DOI 10.1016/j.stem.2011.01.012; Pick M, 2009, STEM CELLS, V27, P2686, DOI 10.1002/stem.205; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Saha K, 2009, CELL STEM CELL, V5, P584, DOI 10.1016/j.stem.2009.11.009; Shih CC, 2007, STEM CELLS DEV, V16, P893, DOI 10.1089/scd.2007.0070; Smith KN, 2010, CELL STEM CELL, V7, P343, DOI 10.1016/j.stem.2010.06.023; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Swistowski A, 2010, STEM CELLS, V28, P1893, DOI 10.1002/stem.499; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tchieu J, 2010, CELL STEM CELL, V7, P329, DOI 10.1016/j.stem.2010.06.024; Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107; Tucker JD, 1999, MUTAT RES-FUND MOL M, V425, P135, DOI 10.1016/S0027-5107(99)00036-6; Varlakhanova NV, 2010, DIFFERENTIATION, V80, P9, DOI 10.1016/j.diff.2010.05.001; Varum S, 2009, STEM CELL RES, V3, P142, DOI 10.1016/j.scr.2009.07.002; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Vlad G, 2008, DIABETES, V57, P1878, DOI 10.2337/db08-0054; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wei DY, 2010, GASTROENTEROLOGY, V139, P2135, DOI 10.1053/j.gastro.2010.08.022; Wen J, 2010, PANCREAS, V39, P622, DOI 10.1097/MPA.0b013e3181c75f5e; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Zhao WD, 2004, ONCOGENE, V23, P395, DOI 10.1038/sj.onc.1207067	72	49	50	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 5	2011	9	2					103	111		10.1016/j.stem.2011.07.006	http://dx.doi.org/10.1016/j.stem.2011.07.006			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	808PM	21816362	Bronze, Green Accepted			2022-12-28	WOS:000293990900007
J	Liu, GH; Suzuki, K; Qu, J; Sancho-Martinez, I; Yi, F; Li, M; Kumar, S; Nivet, E; Kim, J; Soligalla, RD; Dubova, I; Goebl, A; Plongthongkum, N; Fung, HL; Zhang, K; Loring, JF; Laurent, LC; Belmonte, JCI				Liu, Guang-Hui; Suzuki, Keiichiro; Qu, Jing; Sancho-Martinez, Ignacio; Yi, Fei; Li, Mo; Kumar, Sachin; Nivet, Emmanuel; Kim, Jessica; Soligalla, Rupa Devi; Dubova, Ilir; Goebl, April; Plongthongkum, Nongluk; Fung, Ho-Lim; Zhang, Kun; Loring, Jeanne F.; Laurent, Louise C.; Izpisua Belmonte, Juan Carlos			Targeted Gene Correction of Laminopathy-Associated LMNA Mutations in Patient-Specific iPSCs	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; DEPENDENT ADENOVIRAL VECTORS; GILFORD-PROGERIA-SYNDROME; ZINC-FINGER NUCLEASES; HOMOLOGOUS RECOMBINATION; HUMAN ESCS; COPY NUMBER; DISEASE; PLURIPOTENCY; THERAPY	Combination of stem cell-based approaches with gene-editing technologies represents an attractive strategy for studying human disease and developing therapies. However, gene-editing methodologies described to date for human cells suffer from technical limitations including limited target gene size, low targeting efficiency at transcriptionally inactive loci, and off-target genetic effects that could hamper broad clinical application. To address these limitations, and as a proof of principle, we focused on homologous recombination-based gene correction of multiple mutations on lamin A (LMNA), which are associated with various degenerative diseases. We show that helper-dependent adenoviral vectors (HDAdVs) provide a highly efficient and safe method for correcting mutations in large genomic regions in human induced pluripotent stem cells and can also be effective in adult human mesenchymal stem cells. This type of approach could be used to generate genotype-matched cell lines for disease modeling and drug discovery and potentially also in therapeutics.	[Liu, Guang-Hui; Suzuki, Keiichiro; Qu, Jing; Sancho-Martinez, Ignacio; Yi, Fei; Li, Mo; Kumar, Sachin; Nivet, Emmanuel; Kim, Jessica; Soligalla, Rupa Devi; Dubova, Ilir; Goebl, April; Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Plongthongkum, Nongluk; Fung, Ho-Lim; Zhang, Kun] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Loring, Jeanne F.; Laurent, Louise C.] Scripps Res Inst, Ctr Regenerat Med, La Jolla, CA 92037 USA; [Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona, Barcelona 08003, Spain	Salk Institute; University of California System; University of California San Diego; Scripps Research Institute; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	Zhang, Kun/ABE-6349-2020; Li, Mo/J-2090-2014; Loring, Jeanne F/A-1620-2011; Li, Mo/AAM-8266-2021; Qu, Jing/ABB-9088-2020; Nivet, Emmanuel/C-2729-2014	Zhang, Kun/0000-0002-7596-5224; Loring, Jeanne F/0000-0001-6226-9767; Li, Mo/0000-0003-0827-8907; Nivet, Emmanuel/0000-0001-7903-4059; Liu, Guang-Hui/0000-0001-9289-8177; qu, jing/0000-0002-3988-5067; Sancho-Martinez, Ignacio/0000-0003-4348-1038; Plongthongkum, Nongluk/0000-0002-1305-285X; Suzuki, Keiichiro/0000-0001-5603-9105; Laurent, Louise/0000-0002-2095-7534	CIRM [TG2-01158, TR1-01250]; AFAR/Ellison Medical Foundation; F.M. Kirby Foundation; NIH [K12HD001259-11]; G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi-Aventis; Ellison Medical Foundation; Helmsley Foundation; MICINN; Fundacion Cellex;  [DA025779]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025779] Funding Source: NIH RePORTER	CIRM(California Institute for Regenerative Medicine); AFAR/Ellison Medical Foundation(Lawrence Ellison Foundation); F.M. Kirby Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi-Aventis(Sanofi-Aventis); Ellison Medical Foundation(Lawrence Ellison Foundation); Helmsley Foundation; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Fundacion Cellex(Foundation CELLEX); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to thank K. Mitani, P. Ng, and A. Lieber for kindly providing experimental materials, J. Karlseder, L. Gerace, M. Hetzer, and C. Rodriguez Esteban for helpful discussions, C. Lynch for running SNP genotyping arrays, M.C. Llach for karyotyping, M. Marti for teratoma analysis, Y. Xia and S.-L. Yang for technical help, and M. Schwarz for administrative help. G.-H.L. was partially supported by a CIRM grant (TG2-01158), and J.Q. was partially supported by an AFAR/Ellison Medical Foundation postdoctoral fellowship. E.N. was partially supported by a F.M. Kirby Foundation postdoctoral fellowship. L.C.L. is supported by NIH K12HD001259-11. The work by L.C.L. and J.F.L. was supported by CIRM TR1-01250. This study was supported by grants from DA025779 (K.Z.), the G. Harold and Leila Y. Mathers Charitable Foundation, Sanofi-Aventis, Ellison Medical Foundation, Helmsley Foundation, MICINN, and Fundacion Cellex (J.C.I.B.).	Arnould S, 2011, PROTEIN ENG DES SEL, V24, P27, DOI 10.1093/protein/gzq083; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Burke B, 2001, TRAFFIC, V2, P675, DOI 10.1034/j.1600-0854.2001.21001.x; Burtner CR, 2010, NAT REV MOL CELL BIO, V11, P567, DOI 10.1038/nrm2944; Csoka AB, 2004, J MED GENET, V41, P304, DOI 10.1136/jmg.2003.015651; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Delorme B, 2010, STEM CELLS DEV, V19, P853, DOI 10.1089/scd.2009.0267; Goulburn AL, 2011, STEM CELLS, V29, P462, DOI 10.1002/stem.587; Handel EM, 2011, CURR GENE THER, V11, P28, DOI 10.2174/156652311794520120; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Howden SE, 2011, P NATL ACAD SCI USA, V108, P6537, DOI 10.1073/pnas.1103388108; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Khan IF, 2010, MOL THER, V18, P1192, DOI 10.1038/mt.2010.55; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Liu GH, 2011, NATURE, V472, P221, DOI 10.1038/nature09879; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mitsui K, 2009, BIOCHEM BIOPH RES CO, V388, P711, DOI 10.1016/j.bbrc.2009.08.075; Nieminen M, 2010, EXP CELL RES, V316, P2578, DOI 10.1016/j.yexcr.2010.06.004; Palmer DJ, 2004, MOL THER, V10, P792, DOI 10.1016/j.ymthe.2004.06.1013; Ruby KM, 2009, STEM CELLS, V27, P1496, DOI 10.1002/stem.73; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Sancho-Martinez I, 2011, CLIN PHARMACOL THER, V89, P746, DOI 10.1038/clpt.2010.341; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Shayakhmetov DM, 2004, J VIROL, V78, P10009, DOI 10.1128/JVI.78.18.10009-10022.2004; Song H, 2010, CELL STEM CELL, V6, P80, DOI 10.1016/j.stem.2009.11.016; Suzuki K, 2008, P NATL ACAD SCI USA, V105, P13781, DOI 10.1073/pnas.0806976105; Tenzen T, 2010, J CELL PHYSIOL, V222, P278, DOI 10.1002/jcp.21948; Wang P, 2011, CELL STEM CELL, V8, P335, DOI 10.1016/j.stem.2011.01.017; Worman HJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000760; Xue HP, 2009, STEM CELLS, V27, P1836, DOI 10.1002/stem.129; Zaremba-Czogalla M, 2011, CELL MOL BIOL LETT, V16, P114, DOI 10.2478/s11658-010-0038-9; Zhang JQ, 2011, CELL STEM CELL, V8, P31, DOI 10.1016/j.stem.2010.12.002; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	39	185	196	0	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 3	2011	8	6					688	694		10.1016/j.stem.2011.04.019	http://dx.doi.org/10.1016/j.stem.2011.04.019			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	780HC	21596650	Green Accepted, Bronze			2022-12-28	WOS:000291844100016
J	Caretti, G; Palacios, D; Sartorelli, V; Puri, PL				Caretti, Giuseppina; Palacios, Daniela; Sartorelli, Vittorio; Puri, Pier Lorenzo			Phosphoryl-EZH-ion	CELL STEM CELL			English	Review							SUPPRESSES METHYLATION; SKELETAL-MUSCLE; GENE-EXPRESSION; PROTEIN EZH2; POLYCOMB; CHROMATIN; DIFFERENTIATION; KINASES; ATLAS; CELLS	Polycomb group (PcG) proteins regulate gene expression in embryonic and adult stem cells, but the mechanisms responsible for PcG gene targeting and regulation remain largely unknown. Recent evidence shows that EZH2, the enzymatic subunit of Polycomb Repressive Complex 2 (PRC2), is a nuclear phosphoprotein linking cell-cycle-intrinsic or extracellular signals to specific epigenetic signatures.	[Sartorelli, Vittorio] NIAMS, Lab Muscle Stem Cells & Gene Regulat, NIH, Bethesda, MD 20892 USA; [Caretti, Giuseppina] Univ Milan, Dept Biomol Sci & Biotechnol, I-20133 Milan, Italy; [Palacios, Daniela; Puri, Pier Lorenzo] IRCCS Fdn Santa Lucia, DTI, I-00143 Rome, Italy; [Palacios, Daniela; Puri, Pier Lorenzo] European Brain Res Inst, I-00143 Rome, Italy; [Puri, Pier Lorenzo] Sanford Burnham Inst Med Res, La Jolla, CA 92037 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Milan; IRCCS Santa Lucia; Sanford Burnham Prebys Medical Discovery Institute	Sartorelli, V (corresponding author), NIAMS, Lab Muscle Stem Cells & Gene Regulat, NIH, Bethesda, MD 20892 USA.	sartorev@mail.nih.gov; plpuri@dti.telethon.it	Palacios, Daniela/AAA-7608-2019; Palacios, Daniela/K-4698-2016	Palacios, Daniela/0000-0002-2207-2369; Palacios, Daniela/0000-0002-2207-2369; Puri, Pier Lorenzo/0000-0003-4964-0095; Sartorelli, Vittorio/0000-0002-9284-3675	National Institute of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R01 AR053779]; AIRC [MFAG 5386]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041126, R01AR052779] Funding Source: NIH RePORTER; Fondazione Telethon Funding Source: Custom	National Institute of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); AIRC(Fondazione AIRC per la ricerca sul cancro); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Fondazione Telethon(Fondazione Telethon)	P.L.P. is an Associate Telethon Scientist of the Dulbecco Telethon Institute (DTI) and Associate Investigator of Sanford Children's Health Research Center. This work has been supported by R01 AR053779 from the National Institute of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (PLP) and by the Intramural Program of the National Institute of Arthritis, Musculoskeletal, and Skin Diseases of the National Institutes of Health (V.S.). G.C. is supported by AIRC MFAG 5386. We thank Dr. D. Pasini and Dr. J.G. Ryall for critical reading of the manuscript.	Brill LM, 2009, CELL STEM CELL, V5, P204, DOI 10.1016/j.stem.2009.06.002; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chen SA, 2010, NAT CELL BIOL, V12, P1108, DOI 10.1038/ncb2116; Chow CW, 2006, CELL, V127, P887, DOI 10.1016/j.cell.2006.11.015; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Gehani SS, 2010, MOL CELL, V39, P886, DOI 10.1016/j.molcel.2010.08.020; Guasconi V, 2009, TRENDS CELL BIOL, V19, P286, DOI 10.1016/j.tcb.2009.03.002; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Mozzetta C, 2011, CELL CYCLE, V10, P191, DOI 10.4161/cc.10.2.14441; Niessen HEC, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-10; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Sawarkar R, 2010, DEV CELL, V19, P651, DOI 10.1016/j.devcel.2010.10.012; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Su I, 2005, CELL, V121, P425, DOI 10.1016/j.cell.2005.02.029; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	24	24	24	3	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 4	2011	8	3					262	265		10.1016/j.stem.2011.02.012	http://dx.doi.org/10.1016/j.stem.2011.02.012			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	735HI	21362566	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000288404400008
